0001214816-24-000024.txt : 20240227 0001214816-24-000024.hdr.sgml : 20240227 20240227171235 ACCESSION NUMBER: 0001214816-24-000024 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 169 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AXIS CAPITAL HOLDINGS LTD CENTRAL INDEX KEY: 0001214816 STANDARD INDUSTRIAL CLASSIFICATION: FIRE, MARINE & CASUALTY INSURANCE [6331] ORGANIZATION NAME: 02 Finance IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31721 FILM NUMBER: 24688393 BUSINESS ADDRESS: STREET 1: 92 PITTS BAY ROAD CITY: PEMBROKE STATE: D0 ZIP: HM 08 BUSINESS PHONE: (441) 496-2600 MAIL ADDRESS: STREET 1: 92 PITTS BAY ROAD CITY: PEMBROKE STATE: D0 ZIP: HM 08 10-K 1 axs-20231231.htm 10-K axs-20231231
FALSE2023FY0001214816P4Yhttp://www.axiscapital.com/20231231#InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents http://www.axiscapital.com/20231231#NetInvestmentGainLosshttp://fasb.org/us-gaap/2023#OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParenthttp://www.axiscapital.com/20231231#InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents http://www.axiscapital.com/20231231#NetInvestmentGainLosshttp://www.axiscapital.com/20231231#InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents http://www.axiscapital.com/20231231#NetInvestmentGainLosshttp://fasb.org/us-gaap/2023#OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParenthttp://www.axiscapital.com/20231231#InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents http://www.axiscapital.com/20231231#NetInvestmentGainLosshttp://www.axiscapital.com/20231231#InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents http://www.axiscapital.com/20231231#NetInvestmentGainLosshttp://www.axiscapital.com/20231231#InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents http://www.axiscapital.com/20231231#NetInvestmentGainLosshttp://fasb.org/us-gaap/2023#OtherAssetshttp://fasb.org/us-gaap/2023#OtherLiabilitieshttp://fasb.org/us-gaap/2023#OtherAssetshttp://fasb.org/us-gaap/2023#OtherLiabilities00012148162023-01-012023-12-310001214816us-gaap:CommonStockMember2023-01-012023-12-310001214816axs:SeriesEPreferredDepositaryShareMemberMember2023-01-012023-12-3100012148162023-06-30iso4217:USD00012148162024-02-23xbrli:shares00012148162023-12-3100012148162022-12-3100012148162022-01-012022-12-3100012148162021-01-012021-12-31iso4217:USDxbrli:shares0001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:AociGainLossDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossParentMember2023-01-012023-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:AociGainLossDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossParentMember2022-01-012022-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:AociGainLossDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossParentMember2021-01-012021-12-310001214816us-gaap:AociGainLossDebtSecuritiesAvailableForSaleWithAllowanceForCreditLossParentMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-12-310001214816us-gaap:AociGainLossDebtSecuritiesAvailableForSaleWithAllowanceForCreditLossParentMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-12-310001214816us-gaap:AociGainLossDebtSecuritiesAvailableForSaleWithAllowanceForCreditLossParentMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-12-310001214816us-gaap:PreferredStockMember2023-12-310001214816us-gaap:PreferredStockMember2022-12-310001214816us-gaap:PreferredStockMember2021-12-310001214816us-gaap:PreferredStockMember2020-12-310001214816us-gaap:CommonStockMember2023-12-310001214816us-gaap:CommonStockMember2022-12-310001214816us-gaap:CommonStockMember2021-12-310001214816us-gaap:CommonStockMember2020-12-310001214816us-gaap:AdditionalPaidInCapitalMember2022-12-310001214816us-gaap:AdditionalPaidInCapitalMember2021-12-310001214816us-gaap:AdditionalPaidInCapitalMember2020-12-310001214816us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001214816us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001214816us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001214816us-gaap:AdditionalPaidInCapitalMember2023-12-310001214816us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001214816us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001214816us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001214816us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001214816us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001214816us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001214816us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001214816us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-12-310001214816us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-12-310001214816us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001214816us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001214816us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001214816us-gaap:RetainedEarningsMember2022-12-310001214816us-gaap:RetainedEarningsMember2021-12-310001214816us-gaap:RetainedEarningsMember2020-12-310001214816us-gaap:RetainedEarningsMember2023-01-012023-12-310001214816us-gaap:RetainedEarningsMember2022-01-012022-12-310001214816us-gaap:RetainedEarningsMember2021-01-012021-12-310001214816us-gaap:RetainedEarningsMember2023-12-310001214816us-gaap:TreasuryStockCommonMember2022-12-310001214816us-gaap:TreasuryStockCommonMember2021-12-310001214816us-gaap:TreasuryStockCommonMember2020-12-310001214816us-gaap:TreasuryStockCommonMember2023-01-012023-12-310001214816us-gaap:TreasuryStockCommonMember2022-01-012022-12-310001214816us-gaap:TreasuryStockCommonMember2021-01-012021-12-310001214816us-gaap:TreasuryStockCommonMember2023-12-3100012148162021-12-3100012148162020-12-310001214816us-gaap:RelatedPartyMemberaxs:MonarchPointReMember2023-01-012023-12-310001214816us-gaap:RelatedPartyMemberaxs:MonarchPointReMemberaxs:RetrocessionAgreementWithMonarchPointReMember2023-01-012023-12-310001214816axs:LoanAgreementWithMonarchPointReMemberus-gaap:RelatedPartyMemberaxs:MonarchPointReMember2023-01-012023-12-310001214816us-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2023-01-012023-12-310001214816us-gaap:RelatedPartyMember2023-01-012023-12-310001214816srt:FederalHomeLoanBankOfChicagoMember2022-12-310001214816srt:FederalHomeLoanBankOfChicagoMember2022-01-012022-12-310001214816us-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2022-01-012022-12-310001214816us-gaap:RelatedPartyMember2022-01-012022-12-310001214816us-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2021-01-012021-12-310001214816us-gaap:RelatedPartyMember2021-01-012021-12-310001214816axs:AxisCorporateCapitalUKLimitedMember2023-01-012023-12-31xbrli:pure0001214816axs:AxisCorporateCapitalUKLimitedIIMember2023-01-012023-12-310001214816axs:NovaeMember2017-10-02axs:reportableSegment0001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMember2023-01-012023-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001214816us-gaap:OperatingSegmentsMember2023-01-012023-12-310001214816us-gaap:MaterialReconcilingItemsMember2023-01-012023-12-310001214816us-gaap:CorporateNonSegmentMember2023-01-012023-12-310001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2023-12-310001214816us-gaap:OperatingSegmentsMember2023-12-310001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMember2022-01-012022-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001214816us-gaap:OperatingSegmentsMember2022-01-012022-12-310001214816us-gaap:MaterialReconcilingItemsMember2022-01-012022-12-310001214816us-gaap:CorporateNonSegmentMember2022-01-012022-12-310001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2022-12-310001214816us-gaap:OperatingSegmentsMember2022-12-310001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMember2021-01-012021-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001214816us-gaap:OperatingSegmentsMember2021-01-012021-12-310001214816us-gaap:MaterialReconcilingItemsMember2021-01-012021-12-310001214816us-gaap:CorporateNonSegmentMember2021-01-012021-12-310001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2021-12-310001214816us-gaap:OperatingSegmentsMember2021-12-310001214816country:US2023-01-012023-12-310001214816country:US2022-01-012022-12-310001214816country:US2021-01-012021-12-310001214816country:IE2023-01-012023-12-310001214816country:IE2022-01-012022-12-310001214816country:IE2021-01-012021-12-310001214816country:GB2023-01-012023-12-310001214816country:GB2022-01-012022-12-310001214816country:GB2021-01-012021-12-310001214816country:BM2023-01-012023-12-310001214816country:BM2022-01-012022-12-310001214816country:BM2021-01-012021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2023-01-012023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2022-01-012022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2021-01-012021-12-310001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMemberus-gaap:PropertyInsuranceProductLineMember2023-01-012023-12-310001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMemberus-gaap:PropertyInsuranceProductLineMember2022-01-012022-12-310001214816us-gaap:OperatingSegmentsMemberaxs:InsuranceMemberus-gaap:PropertyInsuranceProductLineMember2021-01-012021-12-310001214816us-gaap:OperatingSegmentsMemberaxs:LiabilityLineMemberaxs:InsuranceMember2023-01-012023-12-310001214816us-gaap:OperatingSegmentsMemberaxs:LiabilityLineMemberaxs:InsuranceMember2022-01-012022-12-310001214816us-gaap:OperatingSegmentsMemberaxs:LiabilityLineMemberaxs:InsuranceMember2021-01-012021-12-310001214816axs:CyberLineMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2023-01-012023-12-310001214816axs:CyberLineMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2022-01-012022-12-310001214816axs:CyberLineMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2021-01-012021-12-310001214816axs:MarineAndAviationMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2023-01-012023-12-310001214816axs:MarineAndAviationMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2022-01-012022-12-310001214816axs:MarineAndAviationMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2021-01-012021-12-310001214816us-gaap:AccidentAndHealthInsuranceSegmentMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2023-01-012023-12-310001214816us-gaap:AccidentAndHealthInsuranceSegmentMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2022-01-012022-12-310001214816us-gaap:AccidentAndHealthInsuranceSegmentMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2021-01-012021-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2023-01-012023-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2022-01-012022-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:OperatingSegmentsMemberaxs:InsuranceMember2021-01-012021-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:LiabilityLineMember2023-01-012023-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:LiabilityLineMember2022-01-012022-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:LiabilityLineMember2021-01-012021-12-310001214816axs:ReinsuranceMemberus-gaap:AccidentAndHealthInsuranceSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001214816axs:ReinsuranceMemberus-gaap:AccidentAndHealthInsuranceSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001214816axs:ReinsuranceMemberus-gaap:AccidentAndHealthInsuranceSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:MotorMember2023-01-012023-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:MotorMember2022-01-012022-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:MotorMember2021-01-012021-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:AgricultureLineMember2023-01-012023-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:AgricultureLineMember2022-01-012022-12-310001214816axs:ReinsuranceMemberus-gaap:OperatingSegmentsMemberaxs:AgricultureLineMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:CatastropheReinsuranceMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:CatastropheReinsuranceMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:CatastropheReinsuranceMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMemberus-gaap:PropertyInsuranceProductLineMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMemberus-gaap:PropertyInsuranceProductLineMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMemberus-gaap:PropertyInsuranceProductLineMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMemberaxs:EngineeringMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMemberaxs:EngineeringMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMemberaxs:EngineeringMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001214816axs:UnitesStatesStateLicensesMember2023-12-310001214816axs:NovaeMemberaxs:SyndicateCapacityMember2023-12-310001214816us-gaap:CustomerRelationshipsMemberaxs:TiernanMember2023-12-310001214816us-gaap:IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationMemberaxs:NovaeMember2023-12-310001214816axs:NovaeMemberaxs:DistributionNetworksCoverholdersMember2023-12-310001214816axs:DistributionNetworksLargeBrokersMemberaxs:NovaeMember2023-12-310001214816axs:NovaeMemberaxs:DistributionNetworksSmallAndMidsizedEnterpriseBrokersMember2023-12-310001214816axs:UnitesStatesStateLicensesMember2022-12-310001214816axs:NovaeMemberaxs:SyndicateCapacityMember2022-12-310001214816us-gaap:CustomerRelationshipsMemberaxs:TiernanMember2022-12-310001214816us-gaap:IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationMemberaxs:NovaeMember2022-12-310001214816axs:NovaeMemberaxs:DistributionNetworksCoverholdersMember2022-12-310001214816axs:DistributionNetworksLargeBrokersMemberaxs:NovaeMember2022-12-310001214816axs:NovaeMemberaxs:DistributionNetworksSmallAndMidsizedEnterpriseBrokersMember2022-12-310001214816us-gaap:USTreasuryAndGovernmentMember2023-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMember2023-12-310001214816us-gaap:CorporateDebtSecuritiesMember2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-12-310001214816us-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2023-12-310001214816us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember2023-12-310001214816us-gaap:USStatesAndPoliticalSubdivisionsMember2023-12-310001214816us-gaap:USTreasuryAndGovernmentMember2022-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMember2022-12-310001214816us-gaap:CorporateDebtSecuritiesMember2022-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-12-310001214816us-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2022-12-310001214816us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember2022-12-310001214816us-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310001214816us-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:FixedMaturitiesMember2022-12-31axs:security0001214816us-gaap:FixedMaturitiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2023-12-310001214816us-gaap:FixedMaturitiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2022-12-310001214816srt:MinimumMemberus-gaap:CorporateDebtSecuritiesMember2023-01-012023-12-310001214816us-gaap:CorporateDebtSecuritiesMembersrt:MaximumMember2023-01-012023-12-310001214816us-gaap:CommonStockMember2023-12-310001214816us-gaap:CommonStockMember2023-01-012023-12-310001214816us-gaap:PreferredStockMember2023-12-310001214816us-gaap:PreferredStockMember2023-01-012023-12-310001214816us-gaap:ExchangeTradedFundsMember2023-12-310001214816us-gaap:ExchangeTradedFundsMember2023-01-012023-12-310001214816axs:NonUnitedStatesBondMutualFundMember2023-12-310001214816axs:NonUnitedStatesBondMutualFundMember2023-01-012023-12-310001214816us-gaap:CommonStockMember2022-12-310001214816us-gaap:CommonStockMember2022-01-012022-12-310001214816us-gaap:PreferredStockMember2022-12-310001214816us-gaap:PreferredStockMember2022-01-012022-12-310001214816us-gaap:ExchangeTradedFundsMember2022-12-310001214816us-gaap:ExchangeTradedFundsMember2022-01-012022-12-310001214816axs:NonUnitedStatesBondMutualFundMember2022-12-310001214816axs:NonUnitedStatesBondMutualFundMember2022-01-012022-12-31axs:loan0001214816us-gaap:HedgeFundsMultistrategyMember2023-12-310001214816srt:MinimumMemberus-gaap:HedgeFundsMultistrategyMember2023-01-012023-12-310001214816us-gaap:HedgeFundsMultistrategyMembersrt:MaximumMember2023-01-012023-12-310001214816axs:DirectLendingFundsMember2023-12-310001214816axs:DirectLendingFundsMember2023-01-012023-12-310001214816us-gaap:PrivateEquityFundsMember2023-12-310001214816us-gaap:RealEstateFundsMember2023-12-310001214816srt:MinimumMemberus-gaap:RealEstateFundsMember2023-01-012023-12-310001214816us-gaap:RealEstateFundsMembersrt:MaximumMember2023-01-012023-12-310001214816us-gaap:CollateralizedLoanObligationsMember2023-12-310001214816axs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816us-gaap:HedgeFundsMultistrategyMember2022-12-310001214816srt:MinimumMemberus-gaap:HedgeFundsMultistrategyMember2022-01-012022-12-310001214816us-gaap:HedgeFundsMultistrategyMembersrt:MaximumMember2022-01-012022-12-310001214816axs:DirectLendingFundsMember2022-12-310001214816axs:DirectLendingFundsMember2022-01-012022-12-310001214816us-gaap:PrivateEquityFundsMember2022-12-310001214816us-gaap:RealEstateFundsMember2022-12-310001214816srt:MinimumMemberus-gaap:RealEstateFundsMember2022-01-012022-12-310001214816us-gaap:RealEstateFundsMembersrt:MaximumMember2022-01-012022-12-310001214816us-gaap:CollateralizedLoanObligationsMember2022-12-310001214816axs:OtherPrivatelyHeldInvestmentsMember2022-12-310001214816axs:DirectLendingFundsMemberaxs:QuarterlyRedemptionMember2023-12-31axs:fund0001214816axs:DirectLendingFundsMemberaxs:QuarterlyRedemptionMember2022-12-310001214816us-gaap:RealEstateFundsMemberaxs:QuarterlyRedemptionMember2023-12-310001214816us-gaap:RealEstateFundsMemberaxs:QuarterlyRedemptionMember2022-12-310001214816us-gaap:RealEstateFundsMemberaxs:AnnuallyRedemptionMember2023-12-310001214816us-gaap:RealEstateFundsMemberaxs:AnnuallyRedemptionMember2022-12-310001214816us-gaap:HedgeFundsMultistrategyMemberaxs:LockupRedemptionRestrictionMember2023-12-310001214816us-gaap:HedgeFundsMultistrategyMemberaxs:LockupRedemptionRestrictionMember2022-12-310001214816us-gaap:HedgeFundsMultistrategyMemberaxs:OtherRedemptionRestrictionMember2023-12-310001214816us-gaap:HedgeFundsMultistrategyMemberaxs:OtherRedemptionRestrictionMember2022-12-310001214816us-gaap:HedgeFundsMultistrategyMemberaxs:OtherRedemptionRestrictionMember2023-01-012023-12-310001214816axs:DirectLendingFundsMemberaxs:OtherRedemptionRestrictionMember2023-12-310001214816axs:DirectLendingFundsMemberaxs:OtherRedemptionRestrictionMember2022-12-310001214816srt:MinimumMemberaxs:DirectLendingFundsMemberaxs:OtherRedemptionRestrictionMember2023-01-012023-12-310001214816axs:DirectLendingFundsMemberaxs:OtherRedemptionRestrictionMembersrt:MaximumMember2023-01-012023-12-310001214816axs:DirectLendingFundsMemberaxs:OtherRedemptionRestrictionMember2023-01-012023-12-310001214816us-gaap:PrivateEquityFundsMemberaxs:OtherRedemptionRestrictionMember2023-12-310001214816us-gaap:PrivateEquityFundsMemberaxs:OtherRedemptionRestrictionMember2022-12-310001214816us-gaap:PrivateEquityFundsMemberaxs:OtherRedemptionRestrictionMember2023-01-012023-12-310001214816us-gaap:RealEstateFundsMemberaxs:OtherRedemptionRestrictionMember2023-12-310001214816us-gaap:RealEstateFundsMemberaxs:OtherRedemptionRestrictionMember2022-12-310001214816us-gaap:RealEstateFundsMemberaxs:OtherRedemptionRestrictionMember2023-01-012023-12-310001214816axs:OtherRedemptionRestrictionMemberaxs:PrivateCompanyInvestmentFundsMember2023-12-310001214816axs:OtherRedemptionRestrictionMemberaxs:PrivateCompanyInvestmentFundsMember2022-12-310001214816axs:InvestmentFundsTermPeriodOneMemberaxs:OtherRedemptionRestrictionMemberaxs:PrivateCompanyInvestmentFundsMember2023-12-310001214816axs:InvestmentFundsTermPeriodOneMemberaxs:OtherRedemptionRestrictionMemberaxs:PrivateCompanyInvestmentFundsMember2023-01-012023-12-310001214816axs:OtherRedemptionRestrictionMemberaxs:PrivateCompanyInvestmentFundsMemberaxs:InvestmentFundsTermPeriodTwoMember2023-12-310001214816axs:OtherRedemptionRestrictionMemberaxs:PrivateCompanyInvestmentFundsMemberaxs:InvestmentFundsTermPeriodTwoMember2023-01-012023-12-310001214816axs:MonarchPointReMember2023-01-012023-12-310001214816axs:MonarchPointReMember2023-12-310001214816axs:HarringtonReinsuranceHoldingsLimitedMember2016-01-012016-12-310001214816axs:HarringtonReinsuranceHoldingsLimitedMember2016-12-310001214816us-gaap:LimitedPartnerMember2023-12-310001214816us-gaap:FixedMaturitiesMember2023-01-012023-12-310001214816us-gaap:FixedMaturitiesMember2022-01-012022-12-310001214816us-gaap:FixedMaturitiesMember2021-01-012021-12-310001214816axs:AlternativeInvestmentsMember2023-01-012023-12-310001214816axs:AlternativeInvestmentsMember2022-01-012022-12-310001214816axs:AlternativeInvestmentsMember2021-01-012021-12-310001214816us-gaap:EquitySecuritiesMember2023-01-012023-12-310001214816us-gaap:EquitySecuritiesMember2022-01-012022-12-310001214816us-gaap:EquitySecuritiesMember2021-01-012021-12-310001214816us-gaap:MortgagesMember2023-01-012023-12-310001214816us-gaap:MortgagesMember2022-01-012022-12-310001214816us-gaap:MortgagesMember2021-01-012021-12-310001214816us-gaap:CashAndCashEquivalentsMember2023-01-012023-12-310001214816us-gaap:CashAndCashEquivalentsMember2022-01-012022-12-310001214816us-gaap:CashAndCashEquivalentsMember2021-01-012021-12-310001214816us-gaap:ShortTermInvestmentsMember2023-01-012023-12-310001214816us-gaap:ShortTermInvestmentsMember2022-01-012022-12-310001214816us-gaap:ShortTermInvestmentsMember2021-01-012021-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMember2023-01-012023-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMember2022-01-012022-12-310001214816srt:WeightedAverageMemberus-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310001214816srt:WeightedAverageMemberus-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310001214816us-gaap:PrimeMemberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2023-12-310001214816us-gaap:PrimeMemberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2022-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMemberaxs:AltaMember2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMemberaxs:AltaMember2022-12-310001214816axs:AXISSyndicate1686Memberus-gaap:FixedMaturitiesMember2023-12-310001214816axs:AXISSyndicate1686Memberus-gaap:FixedMaturitiesMember2022-12-310001214816us-gaap:CashMemberaxs:AXISSyndicate1686Member2023-12-310001214816us-gaap:CashMemberaxs:AXISSyndicate1686Member2022-12-310001214816us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2023-12-310001214816us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2023-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2023-12-310001214816us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2023-12-310001214816us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310001214816us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2023-12-310001214816us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember2023-12-310001214816us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2023-12-310001214816us-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Member2023-12-310001214816us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMember2023-12-310001214816us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMember2023-12-310001214816us-gaap:FairValueInputsLevel1Memberus-gaap:ExchangeTradedFundsMember2023-12-310001214816us-gaap:ExchangeTradedFundsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ExchangeTradedFundsMember2023-12-310001214816axs:NonUnitedStatesBondMutualFundMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816axs:NonUnitedStatesBondMutualFundMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberaxs:NonUnitedStatesBondMutualFundMember2023-12-310001214816us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:HedgeFundsMultistrategyMember2023-12-310001214816us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-12-310001214816us-gaap:HedgeFundsMultistrategyMember2023-12-310001214816axs:DirectLendingFundsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816axs:DirectLendingFundsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberaxs:DirectLendingFundsMember2023-12-310001214816axs:DirectLendingFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-12-310001214816axs:DirectLendingFundsMember2023-12-310001214816us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:PrivateEquityFundsMember2023-12-310001214816us-gaap:PrivateEquityFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-12-310001214816us-gaap:PrivateEquityFundsMember2023-12-310001214816us-gaap:FairValueInputsLevel1Memberus-gaap:RealEstateFundsMember2023-12-310001214816us-gaap:RealEstateFundsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:RealEstateFundsMember2023-12-310001214816us-gaap:RealEstateFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-12-310001214816us-gaap:RealEstateFundsMember2023-12-310001214816us-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816us-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedLoanObligationsMember2023-12-310001214816us-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-12-310001214816us-gaap:CollateralizedLoanObligationsMember2023-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberus-gaap:FairValueInputsLevel1Member2023-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001214816us-gaap:FairValueInputsLevel3Memberaxs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-12-310001214816axs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-12-310001214816us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2022-12-310001214816us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2022-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-12-310001214816us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-12-310001214816us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310001214816us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember2022-12-310001214816us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember2022-12-310001214816us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310001214816us-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Member2022-12-310001214816us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMember2022-12-310001214816us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMember2022-12-310001214816us-gaap:FairValueInputsLevel1Memberus-gaap:ExchangeTradedFundsMember2022-12-310001214816us-gaap:ExchangeTradedFundsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ExchangeTradedFundsMember2022-12-310001214816axs:NonUnitedStatesBondMutualFundMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816axs:NonUnitedStatesBondMutualFundMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberaxs:NonUnitedStatesBondMutualFundMember2022-12-310001214816us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:HedgeFundsMultistrategyMember2022-12-310001214816us-gaap:HedgeFundsMultistrategyMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001214816us-gaap:HedgeFundsMultistrategyMember2022-12-310001214816axs:DirectLendingFundsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816axs:DirectLendingFundsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberaxs:DirectLendingFundsMember2022-12-310001214816axs:DirectLendingFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001214816axs:DirectLendingFundsMember2022-12-310001214816us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:PrivateEquityFundsMember2022-12-310001214816us-gaap:PrivateEquityFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001214816us-gaap:PrivateEquityFundsMember2022-12-310001214816us-gaap:FairValueInputsLevel1Memberus-gaap:RealEstateFundsMember2022-12-310001214816us-gaap:RealEstateFundsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:RealEstateFundsMember2022-12-310001214816us-gaap:RealEstateFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001214816us-gaap:RealEstateFundsMember2022-12-310001214816us-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816us-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:CollateralizedLoanObligationsMember2022-12-310001214816us-gaap:CollateralizedLoanObligationsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001214816us-gaap:CollateralizedLoanObligationsMember2022-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001214816us-gaap:FairValueInputsLevel3Memberaxs:OtherPrivatelyHeldInvestmentsMember2022-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001214816axs:OtherPrivatelyHeldInvestmentsMember2022-12-310001214816us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:MeasurementInputDefaultRateMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberus-gaap:MeasurementInputDefaultRateMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputLossSeverityMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:MeasurementInputLossSeverityMembersrt:WeightedAverageMemberus-gaap:CollateralizedLoanObligationsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:CollateralizedLoanObligationsMemberaxs:MeasurementInputCollateralSpreadsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberus-gaap:CollateralizedLoanObligationsMemberaxs:MeasurementInputCollateralSpreadsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:CollateralizedLoanObligationsMember2023-01-012023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberus-gaap:CollateralizedLoanObligationsMember2023-01-012023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberaxs:OtherPrivatelyHeldInvestmentsMemberus-gaap:MeasurementInputDiscountRateMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberaxs:OtherPrivatelyHeldInvestmentsMemberus-gaap:MeasurementInputDiscountRateMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:MeasurementInputDefaultRateMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberus-gaap:MeasurementInputDefaultRateMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberaxs:MeasurementInputLossAbsorptionYieldMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Memberaxs:MeasurementInputLossAbsorptionYieldMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816us-gaap:FairValueInputsLevel3Membersrt:MinimumMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-01-012023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-01-012023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-01-012023-12-310001214816us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMemberaxs:OtherPrivatelyHeldInvestmentsMember2023-12-310001214816us-gaap:FixedMaturitiesMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001214816us-gaap:FixedMaturitiesMemberus-gaap:CorporateDebtSecuritiesMember2023-01-012023-12-310001214816us-gaap:FixedMaturitiesMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001214816us-gaap:FixedMaturitiesMember2022-12-310001214816us-gaap:FixedMaturitiesMember2023-01-012023-12-310001214816us-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:CollateralizedLoanObligationsMemberaxs:AlternativeInvestmentsMember2022-12-310001214816us-gaap:CollateralizedLoanObligationsMemberaxs:AlternativeInvestmentsMember2023-01-012023-12-310001214816us-gaap:CollateralizedLoanObligationsMemberaxs:AlternativeInvestmentsMember2023-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberaxs:AlternativeInvestmentsMember2022-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberaxs:AlternativeInvestmentsMember2023-01-012023-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberaxs:AlternativeInvestmentsMember2023-12-310001214816axs:AlternativeInvestmentsMember2022-12-310001214816axs:AlternativeInvestmentsMember2023-01-012023-12-310001214816axs:AlternativeInvestmentsMember2023-12-310001214816us-gaap:DerivativeMember2022-12-310001214816us-gaap:DerivativeMember2023-01-012023-12-310001214816us-gaap:DerivativeMember2023-12-310001214816us-gaap:FixedMaturitiesMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310001214816us-gaap:FixedMaturitiesMemberus-gaap:CorporateDebtSecuritiesMember2022-01-012022-12-310001214816us-gaap:FixedMaturitiesMember2021-12-310001214816us-gaap:FixedMaturitiesMember2022-01-012022-12-310001214816us-gaap:CollateralizedLoanObligationsMemberaxs:AlternativeInvestmentsMember2021-12-310001214816us-gaap:CollateralizedLoanObligationsMemberaxs:AlternativeInvestmentsMember2022-01-012022-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberaxs:AlternativeInvestmentsMember2021-12-310001214816axs:OtherPrivatelyHeldInvestmentsMemberaxs:AlternativeInvestmentsMember2022-01-012022-12-310001214816axs:AlternativeInvestmentsMember2021-12-310001214816axs:AlternativeInvestmentsMember2022-01-012022-12-310001214816us-gaap:DerivativeMember2021-12-310001214816us-gaap:DerivativeMember2022-01-012022-12-310001214816us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001214816us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310001214816us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001214816us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001214816us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberaxs:InvestmentPortfolioMember2023-12-310001214816us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberaxs:InvestmentPortfolioMember2022-12-310001214816axs:UnderwritingPortfolioMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2023-12-310001214816axs:UnderwritingPortfolioMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-12-310001214816us-gaap:NondesignatedMember2023-12-310001214816us-gaap:NondesignatedMember2022-12-310001214816us-gaap:GainLossOnInvestmentsMember1us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberaxs:InvestmentPortfolioMember2023-01-012023-12-310001214816us-gaap:GainLossOnInvestmentsMember1us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberaxs:InvestmentPortfolioMember2022-01-012022-12-310001214816us-gaap:GainLossOnInvestmentsMember1us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberaxs:InvestmentPortfolioMember2021-01-012021-12-310001214816axs:UnderwritingPortfolioMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ForeignCurrencyGainLossMember2023-01-012023-12-310001214816axs:UnderwritingPortfolioMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ForeignCurrencyGainLossMember2022-01-012022-12-310001214816axs:UnderwritingPortfolioMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ForeignCurrencyGainLossMember2021-01-012021-12-310001214816axs:UnderwritingPortfolioMemberus-gaap:OtherContractMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2023-01-012023-12-310001214816axs:UnderwritingPortfolioMemberus-gaap:OtherContractMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2022-01-012022-12-310001214816axs:UnderwritingPortfolioMemberus-gaap:OtherContractMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2021-01-012021-12-310001214816us-gaap:NondesignatedMember2023-01-012023-12-310001214816us-gaap:NondesignatedMember2022-01-012022-12-310001214816us-gaap:NondesignatedMember2021-01-012021-12-310001214816us-gaap:CatastropheMember2023-01-012023-12-310001214816us-gaap:CatastropheMember2022-01-012022-12-310001214816us-gaap:CatastropheMember2021-01-012021-12-310001214816axs:ThirdPartyLossPortfolioTransferMember2023-01-012023-12-310001214816axs:ThirdPartyLossPortfolioTransferMember2022-01-012022-12-310001214816axs:NovaeSyndicate2007Member2021-01-012021-12-310001214816axs:InsuranceMember2023-01-012023-12-310001214816axs:ReinsuranceMember2023-01-012023-12-310001214816axs:InsuranceMember2022-01-012022-12-310001214816axs:ReinsuranceMember2022-01-012022-12-310001214816axs:InsuranceMember2021-01-012021-12-310001214816axs:ReinsuranceMember2021-01-012021-12-310001214816axs:InsuranceMemberaxs:PropertyLineMember2023-01-012023-12-310001214816axs:InsuranceMemberaxs:PropertyLineMember2022-01-012022-12-310001214816axs:InsuranceMemberaxs:PropertyLineMember2021-01-012021-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMember2023-01-012023-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMember2022-01-012022-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMember2021-01-012021-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMember2023-01-012023-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMember2022-01-012022-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMember2021-01-012021-12-310001214816axs:CyberLineMemberaxs:InsuranceMember2023-01-012023-12-310001214816axs:CyberLineMemberaxs:InsuranceMember2022-01-012022-12-310001214816axs:CyberLineMemberaxs:InsuranceMember2021-01-012021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMember2023-01-012023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMember2022-01-012022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMember2021-01-012021-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2023-01-012023-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2022-01-012022-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2021-01-012021-12-310001214816axs:InsuranceMemberaxs:LiabilityLineMember2023-01-012023-12-310001214816axs:InsuranceMemberaxs:LiabilityLineMember2022-01-012022-12-310001214816axs:InsuranceMemberaxs:LiabilityLineMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMember2021-01-012021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMember2023-01-012023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMember2022-01-012022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:CreditandSuretyBusinessMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:CreditandSuretyBusinessMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:CreditandSuretyBusinessMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:MotorMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:MotorMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:MotorMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:CatastropheReinsuranceMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:CatastropheReinsuranceMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:CatastropheReinsuranceMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:PropertyLineMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:PropertyLineMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:PropertyLineMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:EngineeringMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:EngineeringMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberaxs:EngineeringMember2021-01-012021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMember2023-01-012023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMember2022-01-012022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMember2021-01-012021-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-31axs:claim0001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:PropertyLineMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:PropertyLineMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:PropertyLineMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:PropertyLineMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:PropertyLineMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:PropertyLineMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:PropertyLineMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:PropertyLineMember2017-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:PropertyLineMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:PropertyLineMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:PropertyLineMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:PropertyLineMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:PropertyLineMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:PropertyLineMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:PropertyLineMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:PropertyLineMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:PropertyLineMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:PropertyLineMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:PropertyLineMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:PropertyLineMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:PropertyLineMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:PropertyLineMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMemberaxs:PropertyLineMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMemberaxs:PropertyLineMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMemberaxs:PropertyLineMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMemberaxs:PropertyLineMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMemberaxs:PropertyLineMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:InsuranceMemberaxs:PropertyLineMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816axs:InsuranceMemberaxs:PropertyLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:InsuranceMemberaxs:PropertyLineMember2023-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2017-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:InsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2023-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2016-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2017-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2018-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2019-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2020-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2021-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2022-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2023-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2018-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2019-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2020-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2021-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2022-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2023-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2019-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2020-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2021-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2022-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2023-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2020-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2021-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2022-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2023-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2021-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2022-12-310001214816axs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:MarineAndAviationMemberaxs:InsuranceMember2023-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:MarineAndAviationMemberaxs:InsuranceMember2023-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CyberLineMemberaxs:InsuranceMember2023-12-310001214816axs:CyberLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2016-12-310001214816axs:CyberLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2017-12-310001214816axs:CyberLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2018-12-310001214816axs:CyberLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2019-12-310001214816axs:CyberLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2020-12-310001214816axs:CyberLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2021-12-310001214816axs:CyberLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2022-12-310001214816axs:CyberLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CyberLineMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CyberLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CyberLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CyberLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CyberLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CyberLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CyberLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:CyberLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:CyberLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:CyberLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:CyberLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:CyberLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:CyberLineMemberaxs:InsuranceMember2023-12-310001214816axs:CyberLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2019-12-310001214816axs:CyberLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2020-12-310001214816axs:CyberLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2021-12-310001214816axs:CyberLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2022-12-310001214816axs:CyberLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:CyberLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:CyberLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:CyberLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:CyberLineMemberaxs:InsuranceMember2023-12-310001214816axs:CyberLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2021-12-310001214816axs:CyberLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2022-12-310001214816axs:CyberLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:CyberLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:CyberLineMemberaxs:InsuranceMember2023-12-310001214816axs:CyberLineMemberaxs:InsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:CyberLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2015-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2016-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2017-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2016-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2017-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMember2017-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMember2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMember2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMember2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMember2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:InsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:InsuranceMember2023-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2023-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2016-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2017-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2018-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2019-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2020-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2021-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2022-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2023-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2018-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2019-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2020-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2021-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2022-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:InsuranceMember2023-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2019-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2020-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2021-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2022-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:InsuranceMember2023-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2020-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2021-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2022-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:InsuranceMember2023-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2021-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2022-12-310001214816axs:CreditAndPoliticalRiskLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2023-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:CreditAndPoliticalRiskLineMemberaxs:InsuranceMember2023-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:LiabilityLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMemberaxs:InsuranceMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMemberaxs:InsuranceMember2017-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMemberaxs:InsuranceMember2018-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMemberaxs:InsuranceMember2019-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:LiabilityLineMemberaxs:InsuranceMember2020-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:LiabilityLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:LiabilityLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:LiabilityLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:LiabilityLineMemberaxs:InsuranceMember2021-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:LiabilityLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:LiabilityLineMemberaxs:InsuranceMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:LiabilityLineMemberaxs:InsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:LiabilityLineMemberaxs:InsuranceMember2023-12-310001214816axs:LiabilityLineMemberaxs:InsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:InsuranceMemberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AccidentAndHealthMember2016-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AccidentAndHealthMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AccidentAndHealthMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AccidentAndHealthMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AccidentAndHealthMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AccidentAndHealthMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AccidentAndHealthMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AccidentAndHealthMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AccidentAndHealthMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AccidentAndHealthMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AccidentAndHealthMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AccidentAndHealthMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AccidentAndHealthMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AccidentAndHealthMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AccidentAndHealthMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AccidentAndHealthMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AccidentAndHealthMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AccidentAndHealthMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AccidentAndHealthMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AccidentAndHealthMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AccidentAndHealthMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AccidentAndHealthMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AccidentAndHealthMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AccidentAndHealthMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AccidentAndHealthMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AccidentAndHealthMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:AccidentAndHealthMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:AccidentAndHealthMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:AccidentAndHealthMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:AccidentAndHealthMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:AccidentAndHealthMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:AccidentAndHealthMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:AccidentAndHealthMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:ReinsuranceMemberaxs:AccidentAndHealthMember2023-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AgricultureLineMember2016-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AgricultureLineMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AgricultureLineMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AgricultureLineMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AgricultureLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AgricultureLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AgricultureLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:AgricultureLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AgricultureLineMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AgricultureLineMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AgricultureLineMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AgricultureLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AgricultureLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AgricultureLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:AgricultureLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AgricultureLineMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AgricultureLineMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AgricultureLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AgricultureLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AgricultureLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:AgricultureLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AgricultureLineMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AgricultureLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AgricultureLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AgricultureLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:AgricultureLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:AgricultureLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:AgricultureLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:AgricultureLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:AgricultureLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:AgricultureLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:AgricultureLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:AgricultureLineMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:AgricultureLineMember2023-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:ReinsuranceMemberaxs:AgricultureLineMember2023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2016-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2017-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2018-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2019-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2020-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2021-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2022-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MarineAndAviationMember2023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2018-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2019-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2020-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2021-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2022-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2019-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2020-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2021-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2022-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2020-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2021-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2022-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2021-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2022-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:MarineAndAviationMember2023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:ReinsuranceMemberaxs:MarineAndAviationMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2015-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2016-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2017-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2016-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2017-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2017-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2018-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2019-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2020-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2021-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMember2022-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMember2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816us-gaap:ProfessionalLiabilityInsuranceMemberaxs:ReinsuranceMember2023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2016-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2017-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2018-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2019-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2020-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2021-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2022-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2017-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2018-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2019-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2020-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2021-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2022-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Member2023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2018-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2019-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2020-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2021-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2022-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2019-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2020-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2021-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2022-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2020-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2021-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2022-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2021-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2022-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:CreditandSuretyBusinessMemberaxs:ReinsuranceMember2023-12-310001214816axs:CreditandSuretyBusinessMemberaxs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:ReinsuranceMemberaxs:CreditandSuretyBusinessMember2023-12-310001214816srt:MinimumMemberaxs:ReinsuranceMemberaxs:MotorReserveClassMember2017-03-200001214816axs:ReinsuranceMembersrt:MaximumMemberaxs:MotorReserveClassMember2017-03-200001214816srt:MinimumMemberaxs:ReinsuranceMemberaxs:MotorReserveClassMember2019-08-050001214816axs:ReinsuranceMembersrt:MaximumMemberaxs:MotorReserveClassMember2019-08-050001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:MotorMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:MotorMember2016-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:MotorMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:MotorMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:MotorMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:MotorMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:MotorMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:MotorMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:MotorMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MotorMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MotorMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MotorMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MotorMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MotorMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MotorMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:MotorMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:MotorMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:MotorMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:MotorMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:MotorMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:MotorMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:MotorMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:MotorMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:MotorMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:MotorMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:MotorMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:MotorMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:MotorMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:MotorMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:MotorMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:MotorMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:MotorMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:MotorMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:MotorMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:MotorMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:MotorMember2023-12-310001214816axs:ReinsuranceMemberaxs:MotorMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:ReinsuranceMemberaxs:MotorMember2023-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMember2016-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Memberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Memberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Memberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:LiabilityLineMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:LiabilityLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:LiabilityLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Memberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:LiabilityLineMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:LiabilityLineMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Memberaxs:LiabilityLineMember2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:ReinsuranceMemberaxs:LiabilityLineMember2023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2014-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2015-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2016-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2017-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2018-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2019-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2020-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2014Member2023-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2015-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2016-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2017-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2018-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2019-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2020-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2021-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2022-12-310001214816us-gaap:ShortdurationInsuranceContractsAccidentYear2015Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2016-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2017-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2018-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2019-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2020-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortdurationInsuranceContractsAccidentYear2016Member2023-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:RunOffLinesMember2017-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:RunOffLinesMember2018-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:RunOffLinesMember2019-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:RunOffLinesMember2020-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:RunOffLinesMember2021-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:RunOffLinesMember2022-12-310001214816axs:ReinsuranceMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2017Memberaxs:RunOffLinesMember2023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2018-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2019-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2020-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractsAccidentYear2018Member2023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2019-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2020-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2019Member2023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2020-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2020Member2023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2021-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2022-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2021Member2023-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2022-12-310001214816us-gaap:ShortDurationInsuranceContractAccidentYear2022Memberaxs:ReinsuranceMemberaxs:RunOffLinesMember2023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMemberus-gaap:ShortDurationInsuranceContractAccidentYear2023Member2023-12-310001214816axs:ReinsuranceMemberaxs:RunOffLinesMember2023-12-310001214816axs:InsuranceMember2023-12-310001214816axs:ReinsuranceMember2023-12-310001214816axs:A5.15SeniorNotesMemberus-gaap:SeniorNotesMember2014-03-130001214816axs:A5.15SeniorNotesMemberus-gaap:SeniorNotesMember2023-12-310001214816axs:A5.15SeniorNotesMemberus-gaap:SeniorNotesMember2022-12-310001214816axs:A4.000SeniorNotesMemberus-gaap:SeniorNotesMember2017-12-060001214816axs:A4.000SeniorNotesMemberus-gaap:SeniorNotesMember2023-12-310001214816axs:A4.000SeniorNotesMemberus-gaap:SeniorNotesMember2022-12-310001214816us-gaap:SeniorNotesMemberaxs:A3.900SeniorNotesMember2019-06-190001214816us-gaap:SeniorNotesMemberaxs:A3.900SeniorNotesMember2023-12-310001214816us-gaap:SeniorNotesMemberaxs:A3.900SeniorNotesMember2022-12-310001214816us-gaap:JuniorSubordinatedDebtMember2023-12-310001214816us-gaap:JuniorSubordinatedDebtMember2022-12-310001214816axs:A5.15SeniorNotesMemberus-gaap:SeniorNotesMember2014-03-132014-03-130001214816axs:A4.000SeniorNotesMemberus-gaap:SeniorNotesMember2017-12-062017-12-060001214816us-gaap:SeniorNotesMemberaxs:A3.900SeniorNotesMember2019-06-192019-06-190001214816us-gaap:JuniorSubordinatedDebtMember2019-12-100001214816us-gaap:JuniorSubordinatedDebtMember2019-12-102019-12-100001214816us-gaap:JuniorSubordinatedDebtMemberus-gaap:UsTreasuryUstInterestRateMember2019-12-102019-12-100001214816srt:SubsidiaryIssuerMemberaxs:AXISSpecialtyFinancePLCMember2014-03-130001214816srt:SubsidiaryIssuerMemberaxs:AXISSpecialtyFinancePLCMember2017-12-060001214816srt:SubsidiaryIssuerMemberaxs:AXISSpecialtyFinanceLLCMember2019-06-190001214816us-gaap:SeniorNotesMember2023-01-012023-12-310001214816us-gaap:SeniorNotesMember2022-01-012022-12-310001214816us-gaap:SeniorNotesMember2021-01-012021-12-310001214816us-gaap:JuniorSubordinatedDebtMemberaxs:AXISSpecialtyFinanceLLCMember2019-12-100001214816srt:SubsidiaryIssuerMemberaxs:AXISSpecialtyFinanceLLCMember2023-12-310001214816us-gaap:JuniorSubordinatedDebtMember2023-01-012023-12-310001214816us-gaap:JuniorSubordinatedDebtMember2022-01-012022-12-310001214816axs:LoanAgreementWithThirdPartyReinsurerMemberus-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2023-01-012023-12-310001214816axs:LoanAgreementWithThirdPartyReinsurerMemberus-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2022-01-012022-12-310001214816axs:LoanAgreementWithThirdPartyReinsurerMemberus-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2023-12-310001214816axs:LoanAgreementWithThirdPartyReinsurerMemberus-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2022-12-310001214816srt:MinimumMemberaxs:LoanAgreementWithThirdPartyReinsurerMemberus-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2023-01-012023-12-310001214816srt:MinimumMemberaxs:LoanAgreementWithThirdPartyReinsurerMemberus-gaap:RelatedPartyMemberaxs:ThirdPartyReinsurerMember2022-01-012022-12-310001214816axs:LoanAgreementWithThirdPartyReinsurerMemberus-gaap:RelatedPartyMembersrt:MaximumMemberaxs:ThirdPartyReinsurerMember2022-01-012022-12-310001214816axs:LoanAgreementWithThirdPartyReinsurerMemberus-gaap:RelatedPartyMembersrt:MaximumMemberaxs:ThirdPartyReinsurerMember2023-01-012023-12-310001214816axs:LOCFacilityTwoMemberus-gaap:LetterOfCreditMember2023-12-290001214816axs:LOCFacilityTwoMemberus-gaap:LetterOfCreditMember2023-12-310001214816axs:LOCFacilityTwoMemberus-gaap:LetterOfCreditMemberaxs:CitibankMember2017-03-270001214816us-gaap:LetterOfCreditMemberaxs:CitibankMemberaxs:LOCFacilityMember2017-03-270001214816us-gaap:LetterOfCreditMemberaxs:CitibankMemberaxs:LOCFacilityThreeMember2017-03-270001214816us-gaap:LetterOfCreditMemberaxs:CitibankMember2017-03-270001214816us-gaap:LetterOfCreditMemberaxs:CitibankMemberaxs:LOCFacilityThreeMember2021-03-310001214816us-gaap:LetterOfCreditMemberaxs:CitibankMemberaxs:LOCFacilityMember2021-03-300001214816us-gaap:LetterOfCreditMemberaxs:CitibankMemberaxs:LOCFacilityMember2021-03-310001214816us-gaap:LetterOfCreditMemberaxs:CitibankMemberaxs:LOCFacilityThreeMember2021-03-300001214816axs:LOCFacilityTwoMemberus-gaap:LetterOfCreditMember2023-03-310001214816us-gaap:LetterOfCreditMemberaxs:CitibankMember2023-12-310001214816us-gaap:LetterOfCreditMemberaxs:CitibankMember2022-12-310001214816srt:FederalHomeLoanBankOfChicagoMember2023-12-310001214816srt:MinimumMembersrt:FederalHomeLoanBankOfChicagoMember2023-12-310001214816srt:FederalHomeLoanBankOfChicagoMembersrt:MaximumMember2023-12-310001214816srt:MinimumMembersrt:FederalHomeLoanBankOfChicagoMember2022-12-310001214816srt:FederalHomeLoanBankOfChicagoMembersrt:MaximumMember2022-12-310001214816srt:FederalHomeLoanBankOfChicagoMember2023-01-012023-12-310001214816us-gaap:ReinsurerConcentrationRiskMemberaxs:ReinsurerOneMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310001214816us-gaap:ReinsurerConcentrationRiskMemberaxs:ReinsurerTwoMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310001214816us-gaap:ReinsurerConcentrationRiskMemberaxs:ReinsurerThreeMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310001214816us-gaap:ReinsurerConcentrationRiskMemberaxs:ReinsurerOneMemberus-gaap:ReinsuranceRecoverableMember2022-01-012022-12-310001214816us-gaap:ReinsurerConcentrationRiskMemberaxs:ReinsurerTwoMemberus-gaap:ReinsuranceRecoverableMember2022-01-012022-12-310001214816us-gaap:ReinsurerConcentrationRiskMemberaxs:ReinsurerThreeMemberus-gaap:ReinsuranceRecoverableMember2022-01-012022-12-310001214816us-gaap:ReinsurerConcentrationRiskMembersrt:AMBestAMinusRatingMemberus-gaap:ReinsuranceRecoverableMember2023-01-012023-12-310001214816us-gaap:ReinsurerConcentrationRiskMembersrt:AMBestAMinusRatingMemberus-gaap:ReinsuranceRecoverableMember2022-01-012022-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMember2023-01-012023-12-31axs:broker0001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMember2022-01-012022-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:ThreeBrokersMember2023-01-012023-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:ThreeBrokersMember2022-01-012022-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:AonplcMember2023-01-012023-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:AonplcMember2022-01-012022-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:MarshMcLennanCompaniesIncMember2023-01-012023-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:MarshMcLennanCompaniesIncMember2022-01-012022-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:ArthurJGallagherCoMember2023-01-012023-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:ArthurJGallagherCoMember2022-01-012022-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMember2021-01-012021-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:ThreeBrokersMember2021-01-012021-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:MarshMcLennanCompaniesIncMember2021-01-012021-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:AonplcMember2021-01-012021-12-310001214816us-gaap:CustomerConcentrationRiskMemberaxs:PremiumsWrittenGrossMemberaxs:WillisTowerWatsonPLCMember2021-01-012021-12-310001214816us-gaap:CommercialMortgageBackedSecuritiesMember2023-12-310001214816us-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310001214816axs:LloydsMember2023-12-310001214816axs:LloydsMember2022-12-310001214816us-gaap:CommonStockMember2022-12-310001214816us-gaap:CommonStockMember2021-12-310001214816us-gaap:CommonStockMember2020-12-310001214816us-gaap:CommonStockMember2022-01-012022-12-310001214816us-gaap:CommonStockMember2021-01-012021-12-310001214816us-gaap:CommonStockMember2023-12-3100012148162023-12-070001214816axs:OpenMarketMemberus-gaap:CommonStockMember2023-01-012023-12-310001214816axs:OpenMarketMemberus-gaap:CommonStockMember2022-01-012022-12-310001214816axs:OpenMarketMemberus-gaap:CommonStockMember2021-01-012021-12-310001214816axs:EmployeesMemberus-gaap:CommonStockMember2023-01-012023-12-310001214816axs:EmployeesMemberus-gaap:CommonStockMember2022-01-012022-12-310001214816axs:EmployeesMemberus-gaap:CommonStockMember2021-01-012021-12-310001214816us-gaap:SeriesEPreferredStockMember2016-11-072016-11-070001214816us-gaap:SeriesEPreferredStockMember2016-11-070001214816us-gaap:SeriesEPreferredStockMember2023-01-012023-12-310001214816us-gaap:SeriesEPreferredStockMember2023-12-310001214816us-gaap:SeriesEPreferredStockMember2022-01-012022-12-310001214816us-gaap:SeriesEPreferredStockMember2022-12-310001214816us-gaap:SeriesEPreferredStockMember2021-01-012021-12-310001214816us-gaap:SeriesEPreferredStockMember2021-12-310001214816axs:A2017LongTermEquityCompensationPlanMember2017-05-310001214816axs:A2017LongTermEquityCompensationPlanMember2021-05-072021-05-070001214816axs:A2017LongTermEquityCompensationPlanMember2023-05-042023-05-040001214816axs:A2017LongTermEquityCompensationPlanMember2023-12-310001214816srt:MinimumMemberaxs:ShareSettledMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-31axs:installment0001214816axs:ShareSettledMembersrt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001214816srt:MinimumMemberaxs:CashSettledMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001214816axs:CashSettledMembersrt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001214816us-gaap:PerformanceSharesMember2023-01-012023-12-310001214816axs:A2017LongTermEquityCompensationPlanMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001214816us-gaap:ShareBasedCompensationAwardTrancheTwoMembersrt:MinimumMemberus-gaap:PerformanceSharesMember2023-01-012023-03-310001214816srt:MinimumMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310001214816us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMembersrt:MaximumMember2023-01-012023-03-310001214816us-gaap:PerformanceSharesMembersrt:MaximumMember2023-01-012023-12-310001214816us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheOneMemberaxs:ShareBasedPaymentArrangementSeniorLeadershipMember2023-01-012023-03-310001214816us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMemberaxs:ShareBasedPaymentArrangementSeniorLeadershipMember2023-01-012023-03-310001214816us-gaap:PerformanceSharesMemberaxs:ShareBasedPaymentArrangementSeniorLeadershipMember2023-04-012023-06-300001214816srt:MinimumMemberus-gaap:PerformanceSharesMemberaxs:ShareBasedPaymentArrangementSeniorLeadershipMember2023-04-012023-06-300001214816us-gaap:PerformanceSharesMemberaxs:ShareBasedPaymentArrangementSeniorLeadershipMembersrt:MaximumMember2023-04-012023-06-300001214816us-gaap:PerformanceSharesMember2023-01-012023-03-310001214816us-gaap:PerformanceSharesMember2023-04-012023-06-300001214816us-gaap:PerformanceSharesMember2022-01-012022-12-310001214816us-gaap:PerformanceSharesMember2021-01-012021-12-31axs:Trading_day0001214816axs:ShareBasedPaymentArrangementSeniorLeadershipMember2023-06-300001214816axs:PerformanceRestrictedStockUnitsGrantedIn2020And2019Memberus-gaap:PerformanceSharesMember2023-01-012023-12-310001214816axs:PerformanceRestrictedStockUnitsGrantedIn2020And2019Membersrt:MinimumMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310001214816axs:PerformanceRestrictedStockUnitsGrantedIn2020And2019Memberus-gaap:PerformanceSharesMembersrt:MaximumMember2023-01-012023-12-310001214816us-gaap:PerformanceSharesMemberaxs:ShareSettledMember2021-12-310001214816axs:ShareSettledMemberus-gaap:RestrictedStockUnitsRSUMember2021-12-310001214816us-gaap:PerformanceSharesMemberaxs:ShareSettledMember2022-01-012022-12-310001214816axs:ShareSettledMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001214816us-gaap:PerformanceSharesMemberaxs:ShareSettledMember2022-12-310001214816axs:ShareSettledMemberus-gaap:RestrictedStockUnitsRSUMember2022-12-310001214816us-gaap:PerformanceSharesMemberaxs:ShareSettledMember2023-01-012023-12-310001214816axs:ShareSettledMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001214816us-gaap:PerformanceSharesMemberaxs:ShareSettledMember2023-12-310001214816axs:ShareSettledMemberus-gaap:RestrictedStockUnitsRSUMember2023-12-310001214816axs:CashSettledMemberus-gaap:RestrictedStockUnitsRSUMember2021-12-310001214816axs:CashSettledMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001214816axs:CashSettledMemberus-gaap:RestrictedStockUnitsRSUMember2022-12-310001214816axs:CashSettledMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001214816axs:CashSettledMemberus-gaap:RestrictedStockUnitsRSUMember2023-12-310001214816us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001214816us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001214816us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001214816us-gaap:RestrictedStockUnitsRSUMember2023-12-310001214816us-gaap:RestrictedStockUnitsRSUMember2022-12-310001214816us-gaap:RestrictedStockUnitsRSUMember2021-12-310001214816us-gaap:RelatedPartyMemberaxs:SKYHarborCapitalManagementLLCMember2023-01-012023-12-310001214816us-gaap:RelatedPartyMemberaxs:SKYHarborCapitalManagementLLCMember2022-01-012022-12-310001214816us-gaap:RelatedPartyMemberaxs:SKYHarborCapitalManagementLLCMember2021-01-012021-12-310001214816axs:FreedomFinancialAssetManagementLLCFreedomMemberus-gaap:RelatedPartyMember2023-12-310001214816us-gaap:RelatedPartyMemberaxs:StonePointGroupMemberaxs:PantheonMember2023-01-012023-12-310001214816axs:FreedomFinancialAssetManagementLLCFreedomMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816axs:FreedomFinancialAssetManagementLLCFreedomMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001214816axs:FreedomFinancialAssetManagementLLCFreedomMemberus-gaap:RelatedPartyMember2021-01-012021-12-310001214816axs:StonePointTridentFundVIIIMemberus-gaap:RelatedPartyMember2023-12-310001214816us-gaap:RelatedPartyMemberaxs:StonePointTridentVIIICoInvestMember2023-12-310001214816axs:StonePointTridentFundVIIIMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816axs:StonePointTridentFundVIIIMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001214816axs:StonePointTridentFundVIIIMemberus-gaap:RelatedPartyMember2021-01-012021-12-310001214816axs:TridentIXLPTridentIXMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:TridentIXLPTridentIXMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816axs:TridentIXLPTridentIXMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001214816axs:TridentIXLPTridentIXMemberus-gaap:RelatedPartyMember2021-01-012021-12-310001214816axs:RialtoRealEstateIVPropertyMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:RialtoRealEstateFundIVPropertyMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:RialtoRealEstateFundIVPropertyMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816axs:RialtoRealEstateFundIVPropertyMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001214816axs:RialtoRealEstateFundIVPropertyMemberus-gaap:RelatedPartyMember2021-01-012021-12-310001214816axs:StonePointCreditCorporationMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:StonePointCreditCorporationMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816axs:StonePointCreditCorporationMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001214816axs:StonePointCreditCorporationMemberus-gaap:RelatedPartyMember2021-01-012021-12-310001214816axs:StonePointeCreditCorporationBondsMemberaxs:StonePointCreditCorporationMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:StonePointeCreditCorporationBondsMemberaxs:StonePointCreditCorporationMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816axs:StonePointeCreditCorporationBondsMemberaxs:StonePointCreditCorporationMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001214816axs:SoundPointCapitalBondMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:GordonBrothersMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:GordonBrothersMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816axs:GordonBrothersMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001214816axs:EaglePointCreditManagementLLCMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:EaglePointCreditManagementLLCMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816us-gaap:RelatedPartyMemberaxs:AspidaHoldingsLtdMember2023-12-310001214816us-gaap:RelatedPartyMemberaxs:AspidaHoldingsLtdMember2023-01-012023-12-310001214816us-gaap:RelatedPartyMemberaxs:MonarchPointReMember2023-12-310001214816us-gaap:RelatedPartyMember2023-12-310001214816us-gaap:RelatedPartyMember2022-12-310001214816us-gaap:RelatedPartyMemberaxs:MonarchPointReMember2023-09-222023-09-220001214816axs:LoanAgreementWithMonarchPointReMemberus-gaap:RelatedPartyMemberaxs:MonarchPointReMember2023-12-310001214816srt:MinimumMemberaxs:LoanAgreementWithMonarchPointReMemberus-gaap:RelatedPartyMemberaxs:MonarchPointReMember2023-10-012023-12-310001214816axs:LoanAgreementWithMonarchPointReMemberus-gaap:RelatedPartyMemberaxs:MonarchPointReMembersrt:MaximumMember2023-10-012023-12-310001214816axs:HarringtonReMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001214816axs:HarringtonReMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001214816axs:HarringtonReMemberus-gaap:RelatedPartyMember2021-01-012021-12-310001214816axs:HarringtonReMemberus-gaap:RelatedPartyMember2023-12-310001214816axs:HarringtonReMemberus-gaap:RelatedPartyMember2022-12-310001214816axs:InvestmentInRelatedPartyMemberaxs:SeniorUnsecuredNotesDue2031Member2021-06-290001214816axs:InvestmentInRelatedPartyMemberaxs:SeniorUnsecuredNotesDue2031Member2021-06-292021-06-290001214816us-gaap:InternalRevenueServiceIRSMember2023-01-012023-12-310001214816us-gaap:InternalRevenueServiceIRSMember2022-01-012022-12-310001214816us-gaap:InternalRevenueServiceIRSMember2021-01-012021-12-310001214816axs:EuropeanTaxAuthoritiesMember2023-01-012023-12-310001214816axs:EuropeanTaxAuthoritiesMember2022-01-012022-12-310001214816axs:EuropeanTaxAuthoritiesMember2021-01-012021-12-310001214816axs:OtherTaxAuthoritiesMember2023-01-012023-12-310001214816axs:OtherTaxAuthoritiesMember2022-01-012022-12-310001214816axs:OtherTaxAuthoritiesMember2021-01-012021-12-310001214816us-gaap:InlandRevenueSingaporeIRASMember2023-12-310001214816us-gaap:InlandRevenueSingaporeIRASMember2022-12-310001214816us-gaap:HerMajestysRevenueAndCustomsHMRCMember2023-12-310001214816us-gaap:HerMajestysRevenueAndCustomsHMRCMember2022-12-310001214816us-gaap:RevenueCommissionersIrelandMember2023-12-310001214816us-gaap:RevenueCommissionersIrelandMember2022-12-310001214816us-gaap:RevenueCommissionersIrelandMemberus-gaap:CapitalLossCarryforwardMember2023-12-310001214816us-gaap:RevenueCommissionersIrelandMemberus-gaap:CapitalLossCarryforwardMember2022-12-310001214816us-gaap:SwissFederalTaxAdministrationFTAMember2023-12-310001214816us-gaap:SwissFederalTaxAdministrationFTAMember2022-12-310001214816us-gaap:InternalRevenueServiceIRSMember2023-12-310001214816us-gaap:InternalRevenueServiceIRSMember2022-12-310001214816axs:TaxCarryForwardExpiry2029Memberus-gaap:SwissFederalTaxAdministrationFTAMember2023-12-310001214816axs:TaxCreditCarryforwardExpiring2032Memberus-gaap:InternalRevenueServiceIRSMember2023-12-310001214816axs:ValuationAllowanceIncomeTaxExpenseMember2022-12-310001214816axs:ValuationAllowanceIncomeTaxExpenseMember2021-12-310001214816us-gaap:ValuationAllowanceOperatingLossCarryforwardsMember2023-01-012023-12-310001214816us-gaap:ValuationAllowanceOperatingLossCarryforwardsMember2022-01-012022-12-310001214816us-gaap:ValuationAllowanceTaxCreditCarryforwardMember2023-01-012023-12-310001214816us-gaap:ValuationAllowanceTaxCreditCarryforwardMember2022-01-012022-12-310001214816us-gaap:ValuationAllowanceOtherTaxCarryforwardMember2023-01-012023-12-310001214816us-gaap:ValuationAllowanceOtherTaxCarryforwardMember2022-01-012022-12-310001214816axs:ValuationAllowanceIncomeTaxExpenseMember2023-12-310001214816axs:ValuationAllowanceAccumulatedOtherComprehensiveIncomeMember2022-12-310001214816axs:ValuationAllowanceAccumulatedOtherComprehensiveIncomeMember2021-12-310001214816axs:ValuationAllowanceInvestmentRelatedItemsMember2023-01-012023-12-310001214816axs:ValuationAllowanceInvestmentRelatedItemsMember2022-01-012022-12-310001214816axs:ValuationAllowanceAccumulatedOtherComprehensiveIncomeMember2023-12-310001214816us-gaap:RevenueCommissionersIrelandMember2023-01-012023-12-310001214816axs:NetIncomeLossMemberus-gaap:RevenueCommissionersIrelandMember2023-01-012023-12-310001214816us-gaap:OtherComprehensiveIncomeMemberus-gaap:RevenueCommissionersIrelandMember2023-01-012023-12-310001214816axs:ForeignTaxCreditsMemberus-gaap:InternalRevenueServiceIRSMember2023-01-012023-12-310001214816axs:ForeignTaxCreditsMemberus-gaap:RevenueCommissionersIrelandMember2023-01-012023-12-310001214816us-gaap:HerMajestysRevenueAndCustomsHMRCMember2020-01-012020-12-310001214816us-gaap:HerMajestysRevenueAndCustomsHMRCMember2021-01-012021-12-310001214816us-gaap:AdministrationOfTheTreasuryBelgiumMember2020-01-012020-12-310001214816us-gaap:AdministrationOfTheTreasuryBelgiumMember2021-01-012021-12-310001214816us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-12-310001214816us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-12-310001214816us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-12-310001214816country:BM2023-12-310001214816country:BM2022-12-310001214816country:IE2023-12-310001214816country:IE2022-12-310001214816country:US2023-12-310001214816country:US2022-12-310001214816country:BM2023-01-012023-12-31axs:board_member0001214816us-gaap:AssetPledgedAsCollateralMemberaxs:AxisCorporateCapitalUKLimitedMemberaxs:FixedMaturitiesAndShortTermInvestmentsMember2023-12-310001214816us-gaap:AssetPledgedAsCollateralMemberaxs:AxisCorporateCapitalUKLimitedMemberaxs:FixedMaturitiesAndShortTermInvestmentsMember2022-12-310001214816us-gaap:CashMemberus-gaap:AssetPledgedAsCollateralMemberaxs:AxisCorporateCapitalUKLimitedMember2023-12-310001214816us-gaap:CashMemberus-gaap:AssetPledgedAsCollateralMemberaxs:AxisCorporateCapitalUKLimitedMember2022-12-310001214816axs:AxisCorporateCapitalUKIILimitedMemberus-gaap:AssetPledgedAsCollateralMemberaxs:FixedMaturitiesAndShortTermInvestmentsMember2023-12-310001214816axs:AxisCorporateCapitalUKIILimitedMemberus-gaap:AssetPledgedAsCollateralMemberaxs:FixedMaturitiesAndShortTermInvestmentsMember2022-12-310001214816us-gaap:EquitySecuritiesMemberaxs:AxisCorporateCapitalUKIILimitedMemberus-gaap:AssetPledgedAsCollateralMember2023-12-310001214816us-gaap:EquitySecuritiesMemberaxs:AxisCorporateCapitalUKIILimitedMemberus-gaap:AssetPledgedAsCollateralMember2022-12-310001214816us-gaap:CashMemberaxs:AxisCorporateCapitalUKIILimitedMemberus-gaap:AssetPledgedAsCollateralMember2023-12-310001214816us-gaap:CashMemberaxs:AxisCorporateCapitalUKIILimitedMemberus-gaap:AssetPledgedAsCollateralMember2022-12-3100012148162023-10-012023-12-310001214816us-gaap:FixedMaturitiesMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001214816us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMemberus-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMemberus-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMemberus-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:FixedMaturitiesMember2023-12-310001214816us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedIncomeSecuritiesMember2023-12-310001214816us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMemberus-gaap:FixedIncomeSecuritiesMember2023-12-310001214816us-gaap:FixedIncomeSecuritiesMember2023-12-310001214816us-gaap:MortgagesMember2023-12-310001214816us-gaap:ShortTermInvestmentsMember2023-12-310001214816us-gaap:EquitySecuritiesMember2023-12-310001214816us-gaap:OtherInvestmentsMember2023-12-310001214816us-gaap:EquityMethodInvestmentsMember2023-12-310001214816srt:ParentCompanyMember2023-12-310001214816srt:ParentCompanyMember2022-12-310001214816srt:ParentCompanyMembersrt:AffiliatedEntityMember2023-12-310001214816srt:ParentCompanyMembersrt:AffiliatedEntityMember2022-12-310001214816srt:SubsidiaryIssuerMemberaxs:AXISSpecialtyFinancePLCMember2023-12-310001214816axs:A5.15SeniorNotesMembersrt:SubsidiaryIssuerMemberaxs:AXISSpecialtyFinancePLCMemberus-gaap:SeniorNotesMemberus-gaap:FinancialGuaranteeMember2023-12-310001214816axs:A4.000SeniorNotesMembersrt:SubsidiaryIssuerMemberaxs:AXISSpecialtyFinancePLCMemberus-gaap:SeniorNotesMemberus-gaap:FinancialGuaranteeMember2023-12-310001214816srt:SubsidiaryIssuerMemberaxs:A3.900SeniorNotesMemberus-gaap:SeniorNotesMemberaxs:AXISSpecialtyFinanceLLCMemberus-gaap:FinancialGuaranteeMember2023-12-310001214816srt:SubsidiaryIssuerMemberus-gaap:JuniorSubordinatedDebtMemberaxs:AXISSpecialtyFinanceLLCMemberus-gaap:FinancialGuaranteeMemberaxs:SeniorNotesAxisSpecialtyFinanceLlc2010Member2023-12-310001214816srt:ParentCompanyMember2023-01-012023-12-310001214816srt:ParentCompanyMember2022-01-012022-12-310001214816srt:ParentCompanyMember2021-01-012021-12-310001214816srt:ParentCompanyMember2021-12-310001214816srt:ParentCompanyMember2020-12-310001214816us-gaap:CorporateNonSegmentMember2023-12-310001214816us-gaap:CorporateNonSegmentMember2022-12-310001214816us-gaap:CorporateNonSegmentMember2021-12-310001214816us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember2023-01-012023-12-310001214816us-gaap:AccidentAndHealthInsuranceSegmentMember2023-01-012023-12-310001214816us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember2022-01-012022-12-310001214816us-gaap:AccidentAndHealthInsuranceSegmentMember2022-01-012022-12-310001214816us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember2021-01-012021-12-310001214816us-gaap:AccidentAndHealthInsuranceSegmentMember2021-01-012021-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K
        ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2023
OR
        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-31721
AXIS CAPITAL HOLDINGS LIMITED
(Exact name of registrant as specified in its charter)
 
Bermuda
(State or other jurisdiction of incorporation or organization)
98-0395986
(I.R.S. Employer Identification No.)
92 Pitts Bay Road, Pembroke, Bermuda HM 08
(Address of principal executive offices and zip code)
(441496-2600
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares, par value $0.0125 per shareAXSNew York Stock Exchange
Depositary shares, each representing a 1/100th interest in a 5.50% Series E preferred share
AXS PRE
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes    No  
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes    No  
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes    No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes    No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer        Accelerated filer    
Non-accelerated filer        Smaller reporting company    
        Emerging growth company    
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes     No   
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes     No  
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, computed by reference to the closing price at the last business day of the registrant’s most recently completed second fiscal quarter, June 30, 2023, was approximately $4.6 billion.
At February 23, 2024, there were 84,447,014 common shares outstanding, $0.0125 par value per share, of the registrant.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive proxy statement to be filed with the Securities and Exchange Commission pursuant to Regulation 14A relating to the annual meeting of shareholders to be held on May 16, 2024 are incorporated by reference in response to items 10, 11, 12, 13 and 14 in Part III of this Form 10-K. The definitive proxy statement will be filed with the Securities and Exchange Commission not later than 120 days after the registrant's fiscal year ended December 31, 2023.



AXIS CAPITAL HOLDINGS LIMITED
TABLE OF CONTENTS
  Page  
 PART I 
Item 1.
Item 1A.
Item 1B.
Item 1C.
Item 2.
Item 3.
Item 4.
PART II
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.
PART III
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
PART IV
Item 15.
Item 16.




Cautionary Note Regarding Forward-Looking Statements
This Annual Report on Form 10-K contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical facts included in this report, including statements regarding our estimates, beliefs, expectations, intentions, strategies or projections are forward-looking statements. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the United States ("U.S.") federal securities laws. In some cases, these statements can be identified by the use of forward-looking words such as "may", "should", "could", "anticipate", "estimate", "expect", "plan", "believe", "predict", "potential", "intend" or similar expressions. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections, and various assumptions, many of which, by their nature, are inherently uncertain and beyond management's control.
Forward-looking statements contained in this report may include, but are not limited to, information regarding our estimates for losses and loss expenses, measurements of potential losses in the fair market value of our investment portfolio and derivative contracts, our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, the outcome of our strategic initiatives including our exit from catastrophe and property reinsurance lines of business, our expectations regarding pricing, and other market and economic conditions including the liquidity of financial markets, developments in the commercial real estate market, inflation, our growth prospects, and valuations of the potential impact of movements in interest rates, credit spreads, equity securities' prices, and foreign currency exchange rates.
Forward-looking statements only reflect our expectations and are not guarantees of performance. These statements involve risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual events or results to differ materially from those indicated in such statements.
We believe that these factors include, but are not limited to, those described below in 'Summary of Risk Factors' and in more detail under Item 1A, 'Risk Factors' of this report, as those factors may be updated from time to time in our periodic and other filings with the Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov.
We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
In this Form 10-K, references to "AXIS Capital" refer to AXIS Capital Holdings Limited and references to "we", "us", "our", "AXIS", the "Group" or the "Company" refer to AXIS Capital Holdings Limited and its direct and indirect subsidiaries and branches.
Summary of Risk Factors
Investing in our common stock involves substantial risks, and our ability to successfully operate our business is subject to numerous risks, including those that are generally associated with operating in the insurance/reinsurance industry. Some of the more significant material challenges and risks include the following:
Insurance Risk
Insurance risk is the inherent uncertainty as to the occurrence, amount and timing of insurance and reinsurance liabilities transferred to us through the underwriting process.
The insurance and reinsurance business is historically cyclical, and we expect to experience periods with excess underwriting capacity and unfavorable premium rates.
We may be adversely impacted by a wide variety of natural catastrophes or man-made catastrophes. The incidence and severity of catastrophes are inherently unpredictable, and losses from catastrophes could be substantial. Our exposure to natural catastrophe losses may be increased by climate change, where we may have exposure to physical, transition and liability risks, as well as increasing regulation in the area of climate change. Other man-made catastrophes, such as cyber-attacks, remain relatively new and therefore incorporate high degrees of uncertainty around their impact.
We may be adversely affected by losses related to Russia's invasion of Ukraine, the Israel-Hamas conflict and the associated conflict in the Red Sea, terrorism and political unrest, or other unanticipated losses.
1


We may be adversely impacted by social and economic inflation. Our operations, like those of other insurers and reinsurers, are susceptible to the effects of inflation because premiums are established before the ultimate amounts of losses and loss expenses are known.
We may be adversely affected by the effects of emerging claims, systemic risks and coverage issues and/or if actual claims exceed our reserves for losses and loss expenses ("loss reserves"). The actual final cost of settling outstanding claims, as well as claims expected to arise from the unexpired period of risk, is uncertain. There are many other factors that would cause loss reserves to increase or decrease, which include, but are not limited to, emerging claims, systemic risks and coverage issues such as changes in claim severity.
We may be adversely affected by the failure of our loss limitation strategy, including the use of reinsurance.
We may be adversely affected by the failure of models used to support key decisions.
Strategic Risk
Strategic risks affect or are created by an organization’s business strategy and strategic objectives. Our review of strategic risk evaluates not only internal and external challenges that might cause our chosen strategy to fail but also evaluates major risks that could affect our long-term performance and position.
We may be adversely affected by competition and consolidation in the insurance and reinsurance industry. Increased competition could result in fewer submissions, lower premium rates, less favorable policy terms and conditions, and greater costs of customer acquisition and retention.
We have been and may continue to be adversely affected by a deterioration in global economic conditions. Economic uncertainty and market turmoil has affected and may in the future affect, among other aspects of our business, the demand for and claims made under our products, the ability of customers, counterparties and others to establish or maintain their relationships with us, our ability to access and efficiently use capital resources and our investment performance.
We may be adversely affected by changes in the political environment of certain countries in which we operate or underwrite business.
We may be adversely affected by loss of business provided by a major broker.
We may be adversely affected by a downgrade in our financial strength or credit rating. If we experience a credit rating downgrade, withdrawal or negative watch/outlook in the future, we could incur higher borrowing costs and may have more limited means to access capital. It could also result in a substantial loss of business for us.
We may be adversely affected by the increasing scrutiny and evolving expectations from investors, customers, regulators, policymakers and other stakeholders regarding environmental, social and governance matters.
Market Risk
Market risk is the risk that our financial instruments, which include derivatives, may be negatively impacted by movements in financial market prices or rates such as interest rates, credit spreads, equity securities' prices and foreign currency exchange rates.
Our operating results, investment and derivative instrument portfolios may be adversely impacted by capital markets risk related to changes in interest rates, foreign currency exchange rates, credit spreads, equity securities' prices and other factors.
2


Liquidity Risk
Liquidity risk is the risk that we may not have sufficient cash to meet our obligations when they are due, or would have to incur excessive costs to do so.
Our underwriting activities may expose us to liquidity risk. This stems mainly from the need to pay claims on potential extreme loss events and regulatory constraints that limit the flow of funds within the Group.
Credit Risk
Credit risk represents the risk of incurring financial loss due to the diminished creditworthiness (reduced financial strength and, ultimately, possibly default) and concentration of our third-party counterparties.
We may be adversely impacted if we are unable to collect amounts due to us from our counterparties – most materially reinsurers, but also including brokers, agents and customers.
Operational Risk
Operational risk represents the risk of loss as a result of inadequate processes, system and data security failures, human error or external events, including but not limited to direct or indirect financial loss, reputational damage, customer dissatisfaction, and legal and regulatory penalties.
We may be adversely impacted by failure of the processes, people or systems that we rely on to maintain our operations and manage the operational risks inherent to our business, including those outsourced to third parties.
We may be adversely affected by changes in accounting policies or practices.
Regulatory Risk
Regulatory risk represents the risk arising from our failure to comply with legal, statutory or regulatory obligations.
Our insurance and reinsurance subsidiaries conduct business globally and are subject to varying degrees of regulation, including data protection and privacy laws, in multiple jurisdictions. We may be adversely affected if we inadvertently fail to comply fully with, or obtain exemption from, relevant regulations.
Risks Related to the Ownership of our Securities
In addition to the risks to our business listed above, there are certain other risks related to the ownership of our securities, for example relating to our holding company structure or provisions in our organizational documents and bye-laws.
Risks Related to Taxation
We may be adversely impacted by changes in tax rules or changes in the interpretation of existing tax rules in the multiple jurisdictions in which we operate.
Readers should carefully consider the risks noted above together with the risks detailed in Item 1A, 'Risk Factors' and all of the other information included in this report.
Website and Social Media Disclosure
We use our website (www.axiscapital.com) and our corporate LinkedIn (AXIS Capital) and X Corp. (@AXIS_Capital) accounts as channels of distribution of Company information. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings and public conference calls and webcasts. In addition, e-mail alerts and other information about AXIS Capital may be received by those enrolled in our "E-mail Alerts" program, which can be found in the Investor Information section of our website (www.axiscapital.com). The contents of our website and social media channels are not part of this Annual Report on Form 10-K.
3



PART I
ITEM 1.    BUSINESS
In this Form 10-K, references to "AXIS Capital" refer to AXIS Capital Holdings Limited and references to "we", "us", "our", "AXIS", the "Group" or the "Company" refer to AXIS Capital Holdings Limited and its direct and indirect subsidiaries and branches, including: AXIS Specialty Holdings Bermuda Limited, AXIS Specialty Limited ("AXIS Specialty Bermuda"), AXIS Specialty Limited (Singapore Branch), AXIS Specialty Investments Limited, AXIS Specialty Investments II Limited, AXIS Specialty UK Holdings Limited, AXIS Managing Agency Ltd., AXIS Corporate Capital UK Limited (corporate member which provides 70% capital support to AXIS Syndicate 1686 ("Syndicate 1686")), Novae Group Limited, AXIS UK Services Limited, AXIS UK Services Limited (Irish Branch), AXIS Underwriting Limited, AXIS Corporate Capital UK II Limited (corporate member which provides 30% capital support to Syndicate 1686), AXIS ILS, Ltd. (formerly AXIS Ventures Limited ("AXIS Ventures")), AXIS Reinsurance Managers Limited ("AXIS Reinsurance Managers"), AXIS Specialty Holdings Ireland Limited, AXIS Specialty Europe SE ("AXIS Specialty Europe"), AXIS Specialty Europe SE (U.K. Branch), AXIS Specialty Europe SE (Belgium Branch), AXIS Re SE, AXIS Re SE, Dublin (Zurich Branch) ("AXIS Re Europe"), AXIS Re SE Escritório de Representação No Brasil Ltda., AXIS Specialty Global Holdings Limited, AXIS Specialty U.S. Holdings, Inc., AXIS Reinsurance Company ("AXIS Re U.S."), AXIS Reinsurance Company (Canadian Branch), AXIS Specialty U.S. Services, Inc., AXIS Specialty U.S. Services, Inc. (U.K. Branch), AXIS Specialty Canada Services, ULC, AXIS Group Services, Inc., AXIS ILS, Inc. (formerly AXIS Specialty Underwriters, Inc.), AXIS Insurance Company ("AXIS Insurance Co."), AXIS Surplus Insurance Company ("AXIS Surplus"), AXIS Group Benefits LLC (formerly Ternian Insurance Group LLC), AXIS Specialty Insurance Company ("AXIS Specialty U.S."), AXIS Specialty Finance LLC and AXIS Specialty Finance PLC, unless the context suggests otherwise.
Unless otherwise noted, tabular dollars are in thousands. Amounts may not reconcile due to rounding differences.

General
AXIS is a global specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore and Canada. Our underwriting operations are organized around our global underwriting platforms, AXIS Insurance and AXIS Re.
The markets in which we operate have historically been cyclical. During periods of reduced underwriting capacity, pricing and policy terms and conditions are generally more favorable for insurers and reinsurers. Conversely, during periods of excess underwriting capacity, defined by the availability of capital, competition can result in lower pricing and less favorable policy terms and conditions for insurers and reinsurers. Historically, underwriting capacity has been impacted by a range of factors, including systemic risks such as industry losses and catastrophes, as well as changes in legal, regulatory and rating agency guidelines, investment results, and the financial strength and ratings of competitors.
In 2023, we leveraged firming market conditions to grow in a number of attractive specialty lines insurance and treaty reinsurance markets and we continued to re-balance our portfolio towards less volatile lines of business. At December 31, 2023, we had common shareholders’ equity of $4.7 billion, total capital of $6.6 billion and total assets of $30.3 billion.
Our Business Strategy
We are a global specialty underwriter and provider of insurance and reinsurance solutions and are a leader in many of the markets where we choose to compete. We provide our clients and distribution partners with a broad range of risk transfer products and services, and strong capacity, backed by excellent financial strength. We manage our portfolio holistically, aiming to construct the optimum balance of risks, consistent with our risk appetite and the development of our franchise. We nurture an ethical, entrepreneurial, disciplined and diverse culture that promotes outstanding client service, intelligent risk taking, operating efficiency, corporate citizenship and the achievement of superior risk-adjusted returns for our shareholders. We believe that the achievement of our objectives will position us as a global leader in specialty risks, enabling us to deliver sustained profitable growth and increased shareholder value.

4


We aim to execute on our business strategy through the following multi-pronged approach:

We offer a diversified range of products and services across market segments and geographies: Our position as a global specialty underwriter and provider of insurance and reinsurance solutions gives us insight into the opportunities and challenges in a variety of markets. We are headquartered in Bermuda and have locations in the U.S., Canada and Europe including Dublin, London, Zurich and Brussels. We service the Latin America specialty insurance and facultative reinsurance market through London and our other locations. In addition, we provide specialty insurance and reinsurance solutions to the Asia Pacific region through our London, Zurich and Bermuda offices.
We underwrite a balanced portfolio of risks, including complex and volatile lines, moderating overall volatility with risk limits, diversification and risk management: Risk management is a strategic priority embedded in our organizational structure and we are continuously monitoring, reviewing and refining our enterprise risk management practices. We combine judgment and experience with data-driven analysis, enhancing our overall risk selection process.
We modulate our risk appetite and deployment of capital across the underwriting cycle, commensurate with available market opportunities and returns: In response to market dynamics, we recognize opportunities as they develop and react quickly as new trends emerge. Our risk analytics provide important and continuous feedback, further assisting with the ongoing assessment of our risk appetite and strategic capital deployment. We have been successful in adding new underwriting teams, extending our product lines, finding new distribution channels and entering new geographies. When we do not find sufficiently attractive uses for our capital, we may return excess capital to our shareholders through share repurchases and dividends.
We develop and maintain deep, trusting and mutually beneficial relationships with clients and distribution partners, offering high levels of service and effective solutions for risk management needs: Our management team has extensive industry experience, deep product knowledge, long-standing market relationships and a top caliber claims capability. We primarily transact in specialty markets, where risks are complex, and are also growing our transactional specialty business targeting the lower middle market. We invest in data and technology capabilities and tools to empower our underwriters and enhance the service that we provide to our customers. Our intellectual capital and proven client-service capability attract clients and distribution partners looking for solutions.
We maintain excellent financial strength, characterized by financial discipline and transparency: Our total capital of $6.6 billion at December 31, 2023, as well as our high-quality and liquid investment portfolio and our operating subsidiary ratings of "A+" ("Strong") by Standard & Poor's and "A" ("Excellent") by the A.M. Best Company, Inc. ("A.M. Best") are key indicators of our financial strength.
We attract, develop, retain and motivate teams of experts: We aim to attract and retain top talent in the industry and to motivate our employees to make decisions that are in the best interest of our clients and shareholders. We cultivate a culture that prioritizes ethics, risk awareness and achievement, while also promoting diversity, professionalism, responsibility, integrity, discipline and entrepreneurship. As a result, we believe that our staff is well-positioned to make the best underwriting and strategic decisions for AXIS.
In 2023, our key financial metrics for performance measurement of the Company included operating return on average common equity ("operating ROACE"), which is reconciled to the most comparable GAAP financial measure, return on average common equity ("ROACE"), in Item 7 'Management's Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Measures Reconciliation', on an annual basis and relative total shareholder return ("TSR") over the long-term. We believe that the successful execution against long-term strategic plans should drive an increase in TSR over the long-term, and that TSR directly correlates to other relevant key performance metrics, including growth in book value per diluted common share adjusted for dividends. Our goal is to deliver sustained profitable growth and increased shareholder value.
5


Segment Information
Our underwriting operations are organized around our global underwriting platforms, AXIS Insurance and AXIS Re. We have determined that we have two reportable segments, insurance and reinsurance. We do not allocate assets by segment, with the exception of goodwill and intangible assets.
Refer to Item 7 'Management’s Discussion and Analysis of Financial Condition and Results of Operations' for further details on our reportable segments and Item 8, Note 3 to the Consolidated Financial Statements 'Segment Information' for further details on our reportable segments and a description of the geographic distribution of gross premiums written based on the location of our subsidiaries.
The table below presents gross premiums written in each of our reportable segments for each of the most recent three years:
Year ended December 31,202320222021
Insurance$6,140,764 $5,585,581 $4,863,232 
Reinsurance2,215,761 2,629,014 2,822,752 
Total$8,356,525 $8,214,595 $7,685,984 
Insurance Segment
Lines of Business and Distribution
Our insurance segment offers specialty insurance products to a variety of niche markets on a worldwide basis. The following are the lines of business in our insurance segment:

Professional Lines: provides directors’ and officers’ liability, errors and omissions liability, employment practices liability, fiduciary liability, crime, professional indemnity, medical malpractice and other financial insurance related covers for public and private commercial enterprises, financial institutions, not-for-profit organizations and other professional service providers. This business is predominantly written on a claims-made basis.
Property: provides physical loss or damage, business interruption and machinery breakdown cover for virtually all types of property, including commercial buildings, residential premises, construction projects, property in transit, onshore renewable energy installations, and physical damage and business interruption following an act of terrorism. This line of business includes primary and excess risks, some of which are catastrophe-exposed.
Liability: provides cover for primary and low to mid-level excess and umbrella commercial liability risks in the U.S. wholesale markets in addition to primary and excess of loss employers, public, and products liability business predominately in the U.K. Target industry sectors include construction, manufacturing, transportation and trucking, and other services.
Cyber: provides cover for cyber, technology errors and omissions, media and miscellaneous professional liability. Cover is provided for a range of risks including data recovery and bricking, cyber-crime, liability and regulatory actions, business interruption, extortion, reputational harm, Payment Card Industry Data Security Standard and media liability.
Marine and Aviation: Marine provides cover for a range of exposures including offshore energy, renewable offshore energy, cargo, liability including kidnap and ransom, fine art, specie, and hull war. Offshore energy coverages include physical damage, business interruption, operator's extra expense and liability coverage for all aspects of offshore upstream energy from exploration and construction through the operation and distribution phases. Aviation provides hull and liability, and specific war cover primarily for passenger airlines but also for cargo operations, general aviation operations, airports, aviation authorities, security firms and product manufacturers.
Accident and Health: includes personal accident, travel insurance and specialty health products for employer and affinity groups, and pet insurance.
Credit and Political Risk: provides credit and political risk insurance products for banks, commodity traders, corporations and multilateral and export credit agencies. Cover is provided for a range of risks including sovereign and corporate credit default, political violence, currency inconvertibility and non-transfer, expropriation, aircraft non-repossession and contract frustration due to political events.
6


We produce business primarily through wholesale and retail brokers worldwide. Some of our insurance products are also distributed through managing general agents ("MGAs") and managing general underwriters ("MGUs"). In the U.S., we have the ability to write business on an admitted basis using forms and rates filed with state insurance regulators and on a non-admitted or surplus lines basis, which provides flexibility in forms and rates, as these are not filed with state regulators. Our ability to write business on a non-admitted basis in the U.S. provides us with the pricing flexibility needed to write non-standard coverages. Substantially all of our insurance business is subject to aggregate limits, in addition to event limits.
Gross premiums written by broker, shown individually where premiums by broker were 10% or more of the total in any of the last three years, were as follows:
Years ended December 31,202320222021
AmWINS Group Inc.$719,651 12 %$605,727 11 %$491,690 10 %
Aon plc677,930 11 %697,103 12 %621,879 13 %
Marsh & McLennan Companies Inc.610,186 10 %630,085 11 %548,964 11 %
Other brokers3,042,085 49 %2,746,828 50 %2,423,379 50 %
Managing general agencies and underwriters1,090,912 18 %905,838 16 %777,320 16 %
Total$6,140,764 100 %$5,585,581 100 %$4,863,232 100 %
No insured accounted for more than 10% of the gross premiums written in the insurance segment.
Competitive Environment
In our insurance segment, where competition is focused on price, service, availability of capacity, appetite and distribution, among other considerations, we compete globally and locally with North American and other carriers. We believe we can achieve positive differentiation through underwriting expertise in our chosen lines of business and market segments, providing customized solutions for our strategic partners and top caliber claims service levels to our customers. In addition, our investment in building an agile business model is expected to enable us to more quickly bring innovative products and services to market while delivering value to our customers and driving profitable growth.

Reinsurance Segment
Lines of Business and Distribution
Our reinsurance segment provides treaty reinsurance to insurance companies on a worldwide basis, written on an excess of loss or a proportional basis. For excess of loss business, we typically indemnify the reinsured for a portion of losses, individually and in the aggregate, in excess of a specified individual or aggregate loss deductible. For proportional business, we assume an agreed percentage of the underlying premiums and accept liability for the same percentage of losses and loss expenses. Our business is primarily produced through reinsurance brokers worldwide. The following are the lines of business in our reinsurance segment:
Liability: provides protection to insurers of admitted casualty business, excess and surplus lines casualty business and specialty casualty programs. The primary focus of the underlying business is general liability, workers' compensation, auto liability, and excess casualty.
Accident and Health: includes personal accident, specialty health, accidental death, travel, life and disability reinsurance products which are offered on a proportional and catastrophic or per life excess of loss basis.
Professional Lines: provides protection for directors’ and officers’ liability, employment practices liability, medical malpractice, professional indemnity, environmental liability, cyber, and miscellaneous errors and omissions insurance risks. The underlying business is predominantly written on a claims-made basis. This business is written on a proportional and excess of loss basis.
Credit and Surety: Credit reinsurance provides reinsurance of trade credit insurance products and includes proportional and excess of loss structures. The underlying insurance indemnifies sellers of goods and services in the event of a payment default by the buyer of those goods and services. Surety reinsurance provides protection for losses arising from a broad array of surety bonds issued by insurers to satisfy regulatory demands or contract obligations in a variety of jurisdictions around the world. Mortgage reinsurance is provided to mortgage guaranty insurers and U.S. government-sponsored entities for losses related to credit risk transfer into the private sector.
7


Motor: provides protection to insurers for motor liability and property damage losses arising out of any one occurrence. A loss occurrence can involve one or many claimants where the ceding insurer aggregates the claims from the occurrence. Traditional proportional and non-proportional reinsurance as well as structured solutions are offered.
Agriculture: provides protection for risks associated with the production of food and fiber on a global basis for primary insurance companies writing multi-peril crop insurance, crop hail, and named peril covers, as well as custom risk transfer mechanisms for agricultural dependent industries with exposures to crop yield and/or price deviations. This business is written on a proportional and aggregate stop loss reinsurance basis.
Marine and Aviation: Marine includes specialty marine exposures such as cargo, hull, pleasure craft, marine liability, inland marine and offshore energy. The principal perils covered by policies in this portfolio include physical loss, damage and/or liability arising from natural perils of the seas or land, man-made events including fire and explosion, stranding/sinking/salvage, pollution, shipowners and maritime employers liability. This business is written on a non-proportional and proportional basis. Aviation provides cover for airline, aerospace and general aviation exposures. This business is written on a proportional and non-proportional basis. The Company exited Aviation business effective January 1, 2023.
Run-off lines
Catastrophe: provides protection for most catastrophic losses that are covered in the underlying insurance policies written by our cedants. The underlying policies principally cover property-related exposures but other exposures including personal accident are also covered. The principal perils covered by policies in this portfolio include hurricane and windstorm, earthquake, flood, tornado, hail and fire. In some instances, terrorism may be a covered peril or the only peril. This business is written on a proportional and an excess of loss basis. The Company exited this line of business in June 2022.
Property: provides protection for property damage and related losses resulting from natural and man-made perils that are covered in the underlying personal and commercial lines insurance policies written by our cedants. The predominant exposure is to property damage, but other risks, including business interruption and other non-property losses, may also be covered when arising from a covered peril. The most significant perils covered by policies in this portfolio include windstorm, tornado and earthquake, but other perils such as freezes, riots, flood, industrial explosions, fire, hail and a number of other loss events are also included. This business is written on a proportional and excess of loss basis. The Company exited this line of business in June 2022.
Engineering: provides protection for all types of construction risks and risks associated with erection, testing and commissioning of machinery and plants during the construction stage. This line of business also includes cover for losses arising from operational failures of machinery, plant and equipment, and electronic equipment as well as business interruption. The Company exited this line of business in 2020.
Gross premiums written by broker, shown individually where premiums by broker were 10% or more of the total in any of the last three years, were as follows:
Years ended December 31,202320222021
Aon plc$595,587 27 %$659,811 25 %$716,585 25 %
Marsh & McLennan Companies Inc.594,287 27 %739,380 28 %858,049 30 %
Arthur J. Gallagher & Co398,093 18 %379,822 14 %164,678 %
Willis Tower Watson PLC  %— — %367,973 13 %
Other brokers343,130 16 %231,200 %350,058 13 %
Direct163,073 7 %444,930 17 %187,583 %
Managing general agencies and underwriters121,591 5 %173,871 %177,826 %
Total$2,215,761 100 %$2,629,014 100 %$2,822,752 100 %
(1)Effective December 1, 2021, Arthur J. Gallagher & Co. completed the acquisition of substantially all of the treaty reinsurance brokerage operations from Willis Towers Watson plc. and the combined businesses commenced trading as Gallagher Re. The above table includes gross premiums written by Willis Towers Watson plc. for the eleven-month period ended November 30, 2021.

No cedant accounted for more than 10% of the gross premiums written in the reinsurance segment.

8


Competitive Environment
In our reinsurance segment, competition tends to be focused on availability, service, financial strength and price. We compete with major North American and other reinsurers and reinsurance departments of numerous multi-line insurance organizations. In addition to traditional market participants, we also compete with new market entrants supported by alternative capital sources offering risk transfer solutions on a collateralized or other non-traditional basis. Our clients may also acquire reinsurance protection through capital market products such as catastrophe bonds and insurance loss warranties. We believe that we achieve a competitive advantage through our diversified global product offerings, responsiveness to customer needs and ability to provide sophisticated and innovative products. We offer excellent claims management, strong financial strength ratings and an ability to leverage our balance sheet and relationships with strategic capital partners to provide strong capacity.

Cash and Investments
We seek to balance the investment portfolio's objectives of increasing book value with the generation of relatively stable investment income, while providing sufficient liquidity to meet our claims and other obligations. Liquidity needs arising from potential claims are of primary importance and are considered in asset class participation and the asset allocation process. A significant portion of our investment portfolio is dedicated to investment grade fixed maturities that will generate cash flows that match expected claim payouts.
To diversify risk and optimize the growth in book value, we may invest in other asset classes such as equity securities, high yield securities and alternative investments (e.g., private equity funds), which provide higher potential total rates of return. These individual investment classes involve varying degrees of risk, including the potential for more volatile returns and reduced liquidity. However, as part of a balanced portfolio, they also provide diversification from interest rate and credit risk.
With regard to our investment portfolio, we primarily utilize third-party investment managers for security selection and trade execution functions, subject to guidelines and objectives for each asset class. This enables us to actively manage our investment portfolio with access to top performers specializing in various products and markets. We select managers based on various criteria including investment style, performance history and corporate governance. In addition, we monitor approved investment asset classes for each subsidiary through analysis of our operating environment, including expected volatility of cash flows, overall capital position, regulatory and rating agency considerations. The Finance Committee of our Board of Directors approves overall group asset allocation targets and investment policy to ensure that they are consistent with our overall goals, strategies and objectives. We also have an Investment and Finance Committee, comprised of members of our senior management team, which oversees the implementation of our investment strategy.
Refer to Item 7 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Cash and Investments' and Item 8, Note 5 to the Consolidated Financial Statements 'Investments' for further details on our investment portfolio.
Refer to 'Risk and Capital Management' for further details on management of investment risk.
9


REGULATION
General
Our insurance and reinsurance entities are regulated in most countries, although the degree and type of regulation varies significantly from one jurisdiction to another. We may become subject to regulation in new jurisdictions or to additional regulations in existing jurisdictions. To the extent we are aware of impending changes in regulation, our project teams prepare us to comply with such anticipated changes on a timely basis. The following describes the current material regulations under which the Company operates.
Bermuda
Our Bermuda insurance operating subsidiary, AXIS Specialty Bermuda, is a Class 4 general business insurer subject to the Insurance Act 1978 of Bermuda and related regulations, as amended ("Insurance Act"). The Insurance Act provides that no person may carry on any insurance or reinsurance business in or from within Bermuda unless registered as an insurer by the Bermuda Monetary Authority ("BMA") under the Insurance Act. The Insurance Act imposes upon Bermuda insurance companies' solvency and liquidity standards, and auditing and reporting requirements, and grants the BMA powers to supervise, investigate, require information and demand the production of documents and intervene in the affairs of insurance companies.
Significant requirements pertaining to Class 4 insurers include the appointment of an independent auditor, the appointment of a loss reserve specialist, the appointment of a principal representative in Bermuda, the filing of annual Statutory Financial Returns together with annual GAAP financial statements and an annual Capital and Solvency Return, compliance with minimum and enhanced capital requirements, together with certain restrictions on reductions of capital and the payment of dividends and distributions as well as group solvency and supervision rules, if applicable, and compliance with the Insurance Code of Conduct.
Effective January 1, 2016, the BMA was granted full "equivalence" under Solvency II (refer to 'Ireland' below) for Bermuda’s commercial insurance sector, including Class 4 insurers.
The BMA acts as group supervisor of AXIS Capital and has designated AXIS Specialty Bermuda as the ‘designated insurer’ of the Group. In accordance with the group supervision and insurance group solvency rules, AXIS Capital is required to prepare and submit an annual group Statutory Financial Return, annual audited group GAAP financial statements, an annual group Capital and Solvency Return and quarterly group unaudited GAAP financial statements, and to appoint a group actuary and a group auditor. AXIS Capital also files an annual capital and solvency return and must ensure compliance with minimum and enhanced capital requirements.
On July 30, 2018, the Insurance Amendment (No. 2) Act 2018 amended the Insurance Act to provide for the prior payment of policyholders' liabilities ahead of general unsecured creditors in the event of the liquidation or winding up of an insurer. Effective January 1, 2019, this amendment applies to general business insurers and provides that, subject to certain statutorily preferred debts, the insurance debts of an insurer must be paid in priority to all other unsecured debts of the insurer. Insurance debt is defined as a debt to which an insurer is or may become liable pursuant to an insurance contract, excluding debts owed to an insurer under an insurance contract where the insurer is the person insured.
In December 2018, Bermuda enacted the Economic Substance Act 2018 (as amended) of Bermuda and its related regulations (together, the "ES Act"). The ES Act came into force on December 31, 2018, and requires resident registered entities that carry on as a business any one or more of the "relevant activities" referred to in the ES Act to comply with economic substance requirements. The list of "relevant activities" includes carrying on as a business any one or more of the following activities: banking, insurance, fund management, financing and leasing, headquarters, shipping, distribution and service center, intellectual property, and holding entity. Under the ES Act, if a company is engaged in one or more "relevant activities" as a business, it is required to maintain a substantial economic presence in Bermuda and to comply with the economic substance requirements set forth in the ES Act.
In October 2020, the BMA established the Insurance Sector Operational Cyber Risk Management Code of Conduct. All Bermuda insurers, insurance managers and insurance intermediaries registered under the Insurance Act are required to comply with the BMA’s Insurance Sector Operational Cyber Risk Management Code of Conduct, which established duties, requirements and standards in relation to operational cyber risk management.
10


In August 2022, the BMA published a revised version of the Insurance Code of Conduct ("Insurance Code"). Overall, the amendments aim to improve and enhance the Insurance Code and its application, while at the same time incorporating various administrative changes. The most substantive changes to the Insurance Code relate to:
(i)    Corporate Governance, including a new requirement that the board of directors of an insurer that is a subsidiary of a Bermuda registered insurance group, such as AXIS Specialty Bermuda, must have an appropriate number of non-executive directors;
(ii)    Risk Management Framework, including the addition of a definition of "Environment, Social and Governance Risk"; and
(iii)    Outsourcing, including enhanced requirements for material outsourcing arrangements.
The Insurance Code, as amended, came into force on September 1, 2022. Bermuda insurers and insurance groups were required to be compliant with sections 1 through 7 of the Insurance Code by September 1, 2023 and applicable parts of section 8 of the Insurance Code by March 1, 2023.
AXIS Reinsurance Managers is regulated by the BMA as an insurance manager. As an insurance manager, AXIS Reinsurance Managers is required to register with the BMA pursuant to the Insurance Act. AXIS Reinsurance Managers is also required to comply with the Insurance Manager Code of Conduct.
AXIS Capital, AXIS Specialty Bermuda, AXIS Specialty Holdings Bermuda Limited, AXIS Specialty Investments Limited, AXIS ILS Ltd., AXIS Specialty Investments II Limited and AXIS Reinsurance Managers must comply with provisions of the Bermuda Companies Act 1981 of Bermuda, as amended ("Companies Act"), regulating the payment of dividends and distributions. A Bermuda company may not declare or pay a dividend or make a distribution out of contributed surplus if there are reasonable grounds for believing that:
(a)    the company is, or would after the payment be, unable to pay its liabilities as they become due; or
(b)    the realizable value of the company’s assets would thereby be less than its liabilities.
The Singapore branch of AXIS Specialty Bermuda, AXIS Specialty Limited (Singapore Branch), established in 2008, is regulated by the Monetary Authority of Singapore ("MAS") pursuant to The Insurance Act of Singapore, which imposes significant regulations relating to capital adequacy, risk management, governance, audit and actuarial requirements. AXIS Specialty Limited (Singapore Branch) is registered by the Accounting and Corporate Regulatory Authority ("ACRA") as a foreign company in Singapore and is also regulated by ACRA pursuant to the Singapore Companies Act. Prior to establishing its Singapore branch, AXIS Specialty Bermuda had maintained a representative office in Singapore since 2004. AXIS Specialty Bermuda ceased writing new business through its branch in Singapore, effective January 1, 2024, and plans to close this branch, subject to meeting all regulatory and legal requirements.
AXIS Specialty Bermuda has reinsurance permissions in China and the Netherlands. AXIS Specialty Limited (Singapore Branch) has separate reinsurance permissions in China.
AXIS Re SE may write reinsurance in Bermuda under Solvency II equivalence between Bermuda and the European Union ("E.U.").
AXIS Managing Agency Ltd. may write general insurance and reinsurance in Bermuda using Lloyd's of London ("Lloyd's") licenses (refer to 'U.K. and Lloyd's of London' below).
United States
U.S. Insurance Holding Company Regulation of AXIS Capital’s Insurance Subsidiaries
As members of an insurance holding company system, each of AXIS Insurance Co., AXIS Re U.S., AXIS Specialty U.S. and AXIS Surplus (collectively the "U.S. Insurance Subsidiaries") are subject to the insurance holding company laws and regulations of the states in which they do business. These laws generally require each of the U.S. Insurance Subsidiaries to register with its domestic state insurance department and to furnish financial and other information which may materially affect the operations, management or financial condition within the holding company system. All transactions within a holding company system that involve an insurance company must be fair and equitable. Notice to the applicable insurance department is required prior to the consummation of transactions affecting the ownership or control of an insurer and of certain material transactions between an insurer and an entity in its holding company system, and certain transactions may not be consummated without the department’s prior approval.
11


State Insurance Regulation
AXIS Re U.S. is licensed to transact insurance and reinsurance throughout the U.S. and in Puerto Rico. AXIS Re U.S. is also authorized to transact insurance and reinsurance throughout Canada through its Canadian branch and has reinsurance permissions in Argentina, Brazil, Colombia, Ecuador, Guam, Guatemala, Panama and Mexico. AXIS Insurance Co. is licensed to transact insurance and reinsurance throughout the U.S. AXIS Specialty U.S. is licensed to transact insurance and reinsurance throughout the U.S., except California, Iowa, Maine, New Mexico, New York and Wyoming. AXIS Surplus is eligible to write insurance on a surplus lines basis throughout the U.S., Puerto Rico and the U.S. Virgin Islands.
Our U.S. Insurance Subsidiaries are subject to regulation and supervision by their respective states of domicile and by other jurisdictions in which they do business. The regulations generally are derived from statutes that delegate regulatory and supervisory powers to an insurance official. The regulatory framework varies from state to state, but generally relates to approval of policy forms and rates, the standards of solvency that must be met and maintained, including risk-based capital standards, material transactions between an insurer and its affiliates, the licensing of insurers, agents and brokers, restrictions on insurance policy terminations, and limitations on the amount and nature of certain investments, limitations on the net amount of insurance of a single risk compared to the insurer’s surplus, deposits of securities for the benefit of policyholders, methods of accounting, periodic examinations of the financial condition and market conduct of insurance companies, the form and content of reports of financial condition required to be filed, and reserves for unearned premiums, losses, expenses and other obligations.
Our U.S. Insurance Subsidiaries are required to file detailed quarterly statutory financial statements with state insurance regulators in each of the states in which they conduct business. In addition, the U.S. Insurance Subsidiaries’ operations and accounts are subject to financial condition and market conduct examination at regular intervals by state regulators.
Regulators and rating agencies use statutory surplus as a measure to assess our U.S. Insurance Subsidiaries’ ability to support business operations and pay dividends. Our U.S. Insurance Subsidiaries are subject to various state statutory and regulatory restrictions that limit the amount of dividends that may be paid from earned surplus without prior approval from regulatory authorities. These restrictions differ by state, but generally are based on calculations using statutory surplus, statutory net income and investment income. In addition, many state regulators use the National Association of Insurance Commissioners promulgated risk-based capital requirements as a means of identifying insurance companies that may be under-capitalized.
Although generally the insurance industry is not directly regulated by the federal government, federal legislation and initiatives can affect the industry and our business. Certain sections of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 ("Dodd-Frank") pertain to the regulation and business of insurance. Specifically, the Federal Insurance Office ("FIO") has limited authority to collect information and report on the business of insurance to Congress. In addition, Dodd-Frank contains the Non-Admitted and Reinsurance Reform Act of 2010 ("NRRA"). NRRA attempts to coordinate the payment of surplus lines taxes, simplify the granting of alien insurers to become surplus lines authorized and coordinate the credit for certain reinsurance. The Company continues to monitor the implementation of Dodd-Frank.
AXIS Group Benefits LLC, a leading provider of voluntary, limited benefit, affordable health plans and other employee benefits coverage for hourly and part-time workers and their families, is an authorized insurance producer in all U.S. states except Hawaii. As a resident insurance producer in Arizona, AXIS Group Benefits LLC is subject to regulation and supervision by the Arizona Department of Insurance and is also subject to the regulation and supervision of the other states in which AXIS Group Benefits LLC transacts business.

AXIS ILS, Inc. is a marketing services company for insurance linked securities sponsored by the Company. AXIS Specialty Underwriters, Inc. was a Florida licensed reinsurance intermediary. Following the closure of our Florida office in 2021, AXIS Specialty Underwriters' coverholder agreement with Syndicate 1686 was terminated, effective December 31, 2021. All regulatory licenses in Florida for AXIS Specialty Underwriters, Inc. were terminated in 2022, however, the entity remained registered in Delaware and was renamed AXIS ILS, Inc.
U.S. Authorizations of our Non-U.S. Insurance Subsidiaries
The insurance laws of each U.S. state regulate or prohibit the sale of insurance and reinsurance by insurers and reinsurers that are not admitted to do business within their jurisdictions or otherwise conduct business pursuant to exemptions. AXIS Specialty Europe is eligible to write surplus lines business throughout the U.S. and in Puerto Rico. AXIS Managing Agency Ltd. is eligible to use Lloyd's licenses to (i) write surplus lines business throughout the U.S. and in all U.S. territories, and (ii) write non-life reinsurance business throughout the U.S. and in all U.S. territories, except for accident and health reinsurance in New York.
12


In addition to the regulatory requirements imposed by the jurisdictions in which they are licensed, reinsurers’ business operations are affected by regulatory requirements in various states of the U.S. governing "credit for reinsurance" that are imposed on their ceding companies. In general, a ceding company obtaining reinsurance from a reinsurer that is licensed or approved by the jurisdiction or state in which the ceding company files statutory financial statements is permitted to reflect in its statutory financial statements a credit in an aggregate amount equal to the ceding company’s liability for unearned premiums (which is that portion of premiums written which applies to the unexpired portion of the policy period), loss reserves and loss expense reserves ceded to the reinsurer. The great majority of states, however, permit a credit to statutory surplus to be recognized resulting from reinsurance obtained from a non-licensed or non-accredited reinsurer to the extent that the reinsurer provides a letter of credit, trust fund or other acceptable security arrangement. A few states do not allow credit for reinsurance ceded to non-licensed reinsurers except in certain limited circumstances, and others impose additional requirements that make it difficult to become accredited. In connection with the establishment of a Multi-Beneficiary Reinsurance Trust, AXIS Specialty Bermuda obtained accredited or trusted reinsurer status in all U.S. jurisdictions except for New York.
During 2022, AXIS Specialty Bermuda obtained reciprocal jurisdiction reinsurer status with Missouri as its lead state. Reinsurers licensed in reciprocal jurisdictions (which include E.U. member states, Bermuda, Japan and Switzerland) are not required to post reinsurance collateral if approved as reciprocal jurisdiction reinsurers. With its approval from Missouri, AXIS Specialty Bermuda applied for and received passporting approvals from California, Connecticut, Delaware, Florida, Illinois, New York, Ohio, Rhode Island, and Texas. "Passporting" refers to the process by which a state has the discretion to defer to the determination by another state that a reinsurer is a reciprocal jurisdiction reinsurer, thereby excusing the approved reinsurer from collateral requirements in such state.
Ireland
Our Ireland domiciled insurer and reinsurer are subject to the Solvency II Directive (Directive 2009/138/EC), as amended (“Solvency II”). Solvency II represents a consolidation and modernization of existing European Commission Solvency I insurance and reinsurance regulation and supervision and includes a harmonized risk-based solvency and reporting regime for the insurance/reinsurance sector. Solvency II covers three main areas: (i) the valuation of assets and liabilities and related solvency capital requirements; (ii) governance requirements including key functions of compliance, internal audit, actuarial and risk management; and (iii) legal entity and E.U. group reporting and disclosure requirements including public disclosures. The capital requirement must be computed using the Solvency II standard formula unless the Central Bank of Ireland ("CBI") has previously authorized a company to use its own internal model. Certain of our European legal entities are subject to Solvency II.
AXIS Specialty Europe
AXIS Specialty Europe is a European public limited liability company incorporated as a non-life insurer under the laws of Ireland. It is a Societas Europaea (SE), or European society company, and has been registered in accordance with E.U. law. As an SE company, AXIS Specialty Europe can more easily merge with companies in European member states and also transfer its domicile to other Member States of the E.U. AXIS Specialty Europe is authorized and regulated by the CBI pursuant to the Insurance Acts 1909 to 2000, as amended, repealed or replaced, the Central Bank Acts 1942 to 2014, as amended, repealed or replaced, and E.U. regulation relating to general insurance and statutory instruments made thereunder. AXIS Specialty Europe is authorized to conduct business in 16 non-life insurance classes throughout the E.U. and the European Economic Area ("EEA"), which includes each of the Member States of the E.U. with the addition of Iceland, Liechtenstein and Norway. AXIS Specialty Europe may also write reinsurance business within the classes of insurance business for which it is authorized.
AXIS Specialty Europe is subject to Solvency II. In accordance with Solvency II, AXIS Specialty Europe is permitted to provide insurance services to clients located in any EEA Member State ("Freedom of Services"), subject to compliance with any "general good requirements" as may be established by the applicable EEA Member State regulator. AXIS Specialty Europe has notified the CBI of its intention to provide insurance services on a Freedom of Services basis in all EEA countries.
13


Solvency II also permits AXIS Specialty Europe to carry on insurance business in any EEA Member State under the principle of "Freedom of Establishment" subject to the prior approval of the CBI. AXIS Specialty Europe operates under Freedom of Establishment in Belgium through its branch established in this jurisdiction.
AXIS Specialty Europe also has a U.K. branch that transacts general insurance business in the U.K. and trades as AXIS Specialty London. The U.K. withdrew from the E.U. on January 31, 2020 and is now considered a third-country. In order to maintain business continuity, AXIS Specialty Europe submitted an application to the Prudential Regulatory Authority ("PRA") in 2018 for authorization of a third-country branch. This application was approved on October 28, 2022, and the UK Branch of AXIS Specialty Europe is now fully regulated by both the PRA and the Financial Conduct Authority ("FCA").

AXIS Specialty Europe has local regulatory permission to carry on insurance business in Jersey, and has permission to write surplus lines business in all 50 U.S. states, Puerto Rico, and Washington D.C. It also has reinsurance permissions in India, China, Argentina, Mexico, Panama, Paraguay, Honduras, Ecuador, Colombia and Guatemala.
AXIS Re SE
AXIS Re SE is a European public limited liability company incorporated as a reinsurer under the laws of Ireland. AXIS Re SE is also a Societas Europaea (SE), or European society company, registered in accordance with E.U. law. AXIS Re SE is authorized by the CBI as a composite reinsurer (non-life and life) in accordance with the Insurance Acts 1909 to 2000, as amended, repealed or replaced, the Central Bank Acts 1942 to 2014, as amended, repealed or replaced, and E.U. regulation applicable to reinsurance and statutory instruments made thereunder. AXIS Re SE is authorized to transact reinsurance throughout the E.U. and the EEA and is subject to Solvency II.
AXIS Re SE conducts business through its branch in Zurich, Switzerland, trading as AXIS Re Europe (see 'Switzerland' below).
AXIS Re SE Escritório de Representação No Brasil Ltda. was established in Brazil as a subsidiary of AXIS Re SE to facilitate the Brazilian Superintendence of Private Insurance ("SUSEP") regulatory requirements for approval of a representative office of AXIS Re SE and for the registration of AXIS Re SE with SUSEP as an admitted reinsurer.
AXIS Re SE has reinsurance permissions in Argentina, Bolivia, Brazil, China, Chile, Colombia, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, India, Mexico, Nicaragua, Panama, Paraguay, Peru and Venezuela.

AXIS Specialty Holdings Ireland Limited

AXIS Specialty Holdings Ireland Limited is incorporated in Ireland, and is the limited liability holding company for AXIS Specialty Europe, AXIS Re SE, and Contessa Limited.

AXIS Specialty Global Holdings Limited

AXIS Specialty Global Holdings Limited is incorporated in Ireland, and is the limited liability holding company for AXIS Capital's U.S. Insurance subsidiaries.

Other AXIS Entities

AXIS Specialty Bermuda may write reinsurance under Solvency II equivalence granted to Bermuda by the E.U. AXIS Managing Agency Ltd. is eligible to write insurance (except permanent health) and reinsurance business in Ireland through Lloyd's Europe.

U.K. and Lloyd's of London
In the U.K., under the Financial Services and Markets Act 2000 ("FSMA"), no person may carry on a regulated activity unless authorized or exempt. Effecting or intermediating contracts of insurance or reinsurance are regulated activities requiring authorization. Effecting contracts of insurance requires authorization by the PRA and is regulated by the FCA. Intermediating contracts of insurance requires authorization by the FCA.
14


Under the Financial Services Act 2012, the FCA is a conduct regulator for all U.K. firms carrying on regulated activity in the U.K. while the PRA is the prudential regulator for U.K. banks, building societies, credit unions, insurers and major investment firms. As a prudential regulator, the PRA's general objective is to promote the safety and soundness of the firms it regulates. The PRA rules require financial firms to hold sufficient capital and have adequate risk controls in place.
The FCA's statutory strategic objective is to ensure that relevant markets function well and have operational objectives to protect consumers and protect financial markets and to promote competition. It makes rules covering how the firm must be managed and requirements relating to the firm’s systems and controls, how business must be conducted and the firm’s arrangements to manage financial crime risk. The PRA and the FCA require regular and ad hoc reporting and monitor compliance with their respective rule books through a variety of means including the collection of data, industry reviews and site visits.
AXIS Managing Agency Ltd.
AXIS Managing Agency Ltd. is authorized and regulated by the PRA and regulated by the FCA to conduct insurance and reinsurance business and is a Lloyd's managing agent authorized by Lloyd's to manage our syndicate, Syndicate 1686.

To consolidate our Lloyd’s business under Syndicate 1686, Novae Syndicate 2007 ("Syndicate 2007") ceased accepting new business and was placed into run-off on January 1, 2019. The final underwriting year of Syndicate 2007 and of SPA 6129, a third-party Lloyd's special purpose arrangement, closed by way of reinsurance to close arrangements that took effect on January 1, 2021.
Lloyd’s is a society of corporate and individual members that underwrite insurance and reinsurance as members of syndicates. A syndicate is made up of one or more members that form a group to accept insurance and reinsurance risks. Each syndicate is managed by a managing agent that writes insurance business on behalf of the members of the syndicate. Syndicate members receive profits or bear losses in proportion to their respective shares in the syndicate for each underwriting year of account.
Lloyd’s is subject to U.K. law and is authorized under the FSMA. The Lloyd’s Act 1982 defines the governance structure and rules under which the society operates. Under the Lloyd's Act 1982, the Council of Lloyd’s is responsible for managing, supervising and supporting the Lloyd's market. Lloyd's agrees to syndicates' business plans and evaluates performance against those plans. Syndicates are required to underwrite only in accordance with their agreed business plans. If they fail to do so, Lloyd’s can take a range of actions including, as a last resort, prohibiting a syndicate from underwriting.
Lloyd’s has a global network of licenses and authorizations, and underwriters at Lloyd's may write business in countries where Lloyd’s has authorized status or exemptions available to non-admitted insurers or reinsurers. Lloyd’s licenses can only be used if the Syndicate Business Forecast, agreed annually with Lloyd’s, names those countries. Lloyd’s also manages and protects the Lloyd’s network of international licenses, monitors syndicates’ compliance with Lloyd’s minimum standards and is responsible for setting both member and central capital levels.
AXIS Managing Agency Ltd. operated an underwriting division at Lloyd’s Insurance Company (China) Limited, a wholly-owned subsidiary of the Corporation of Lloyd’s which allowed it to underwrite reinsurance in China. Syndicate 1686 ceased underwriting business on the Lloyd's China platform effective December 31, 2021. This business was placed in run-off effective January 1, 2022.
AXIS Corporate Capital UK Limited

AXIS Corporate Capital UK Limited is a corporate member of Syndicate 1686, providing 70% capital support.

AXIS Corporate Capital UK II Limited
AXIS Corporate Capital UK II Limited, formerly known as Novae Corporate Underwriting Limited, is a corporate member of Syndicate 1686, providing 30% capital support.
AXIS Underwriting Limited
AXIS Underwriting Limited, formerly known as Novae Underwriting Limited, is authorized and regulated by the FCA as an insurance intermediary. AXIS Underwriting Limited underwrites insurance on behalf of AXIS Specialty Europe and at Lloyd's on behalf of Syndicate 1686.
15


Contessa Limited
Effective December 2019, Contessa Limited ceased writing insurance on behalf of AXIS Specialty Europe. AXIS Specialty Europe now manages this book of business on a run-off basis.
AXIS Specialty UK Holdings Limited
AXIS Specialty UK Holdings Limited is incorporated under the laws of England and Wales, and is the limited liability holding company for AXIS Managing Agency Ltd., AXIS Corporate Capital UK Limited and Novae Group Limited.
Reinsurance
AXIS Managing Agency Ltd. remains able to conduct non-life facultative, proportional and excess of loss reinsurance throughout the EEA via Lloyd’s Europe. The E.U. has yet to make equivalence decisions for the U.K. under Solvency II. As a result, UK regulated firms' access to E.U. markets generally depends on the rules each Member State applies to third country regulated firms.
AXIS Re SE currently transacts reinsurance business in the EEA pursuant to European law. In November 2020, the U.K. granted equivalence under Solvency II to EEA supervised reinsurers, including AXIS Re SE, allowing such reinsurers to continue operations without interruption.
Switzerland
AXIS Re SE's branch in Zurich, Switzerland trades as AXIS Re Europe and is registered in Zurich as AXIS Re SE, Dublin (Zurich Branch). The CBI remains responsible for the prudential supervision of the branch. The Swiss Financial Market Supervisory Authority does not impose additional regulation upon a Swiss branch of a company exclusively engaged in providing reinsurance.
AXIS Managing Agency Ltd. is eligible to use Lloyd's licenses to write all classes of insurance business, except life, sickness and legal expenses in Switzerland, and is authorized to write the same classes of reinsurance business in Switzerland.
Singapore
AXIS Specialty Bermuda conducts insurance and reinsurance business from its branch in Singapore, AXIS Specialty Limited (Singapore Branch), subject to the supervision of the BMA and the MAS. The BMA and the MAS impose significant regulations relating to capital adequacy, risk management, governance and audit and actuarial requirements. AXIS Specialty Limited (Singapore Branch) is registered by ACRA as a foreign company in Singapore and is also regulated by ACRA pursuant to the Singapore Companies Act. AXIS Specialty Bermuda ceased writing new business through its branch in Singapore, effective January 1, 2024, and plans to close this branch, subject to meeting all regulatory and legal requirements.
AXIS Managing Agency Ltd. is eligible to use Lloyd's licenses to write insurance from Singapore with the exception of certain compulsory classes and life business. Singapore business may also be written from outside Singapore in certain circumstances where it is placed with a Singapore intermediary licensed by the MAS to place business at Lloyd's or by dealing directly with the insured.
Canada
AXIS Re U.S. conducts insurance and reinsurance business from its branch in Canada, AXIS Reinsurance Company (Canadian Branch), subject to the supervision of the New York State Department of Financial Services and the Office of the Superintendent of Financial Institutions Canada ("OSFI"), the federal regulatory authority that supervises federal Canadian and non-Canadian insurance companies operating in Canada pursuant to the Insurance Companies Act (Canada). The branch is authorized by OSFI to transact insurance and reinsurance. In addition, the branch is subject to the laws and regulations of each of the provinces and territories in which it is licensed.

AXIS Managing Agency Ltd. is eligible to use Lloyd's licenses to write insurance in and from Canada, subject to the laws and regulations of each of the provinces and territories in which it is licensed, with the following exceptions: hail insurance in respect of crop in the province of Quebec; home warranty insurance in the province of British Columbia; life insurance; credit protection insurance; title insurance; surety; and mortgage default insurance. AXIS Managing Agency Ltd., through Lloyd's, is authorized to write reinsurance in and from Canada subject to certain restrictions relating to life reinsurance.
16


Belgium
AXIS Specialty Europe conducts insurance from its Belgium branch, AXIS Specialty Europe SE (Belgium Branch), which is subject to CBI prudential supervision and limited regulation by the NBB.
Non-Admitted Insurance and Reinsurance
The Company also insures and reinsures risks in many countries, including the above countries, pursuant to regulatory permissions and exemptions available to non-admitted insurers and reinsurers.
AXIS Managing Agency Ltd. is eligible to use Lloyd's licenses to write insurance and reinsurance business where Lloyd's has authorized status or pursuant to regulatory exemptions available to non-admitted insurers and reinsurers.

HUMAN CAPITAL MANAGEMENT

AXIS Capital’s mission is not only to deliver strong financial results, but also to help our clients, brokers and partners navigate the challenges of a volatile world. We believe our employees distinguish us from our competitors and are critical to our success as an insurance and reinsurance company that leads with purpose. Our workforce’s strength is grounded in our One AXIS culture, which celebrates collaboration, diversity and integrity, as well as relentless execution and continuous learning, adapting and improving. We recognize that our strength lies in our people, and therefore, one of our core strategies is to invest in and support our employees, including in the following areas of focus:

Talent Development

Investing in its people is a top priority for AXIS. We provide our employees with a variety of professional development resources to help them achieve their career goals. Some of our 2023 initiatives in furtherance of this goal are described below:
Career Mobility Within the Organization: In 2023, 19% of our employees progressed in their AXIS careers either through a promotion, transfer or role expansion.
Learning at AXIS: We provide our employees access to our online learning and development hub that reflects our commitment to continuing education. We offer over 9,800 online training courses.
Professional Development: We offer financial assistance for external professional development opportunities and tuition reimbursement for certain part-time business-related degree programs. We distributed a toolkit of career and leadership development options to managers to provide during recent talent reviews.
Career Planning: AXIS ensures its people feel empowered to "own their careers" and upskill to prepare for future roles. AXIS Careers offers employees a comprehensive suite of professional development tools, resources and training modules to help navigate career experiences and upskilling across our global organization. This includes leadership development, mentoring programs, and job secondments, shadows and swaps. In 2023, AXIS employees completed over 11,000 on-demand or instructor-led virtual learning and development courses.

Health, Safety and Wellness

We are committed to the health, safety and wellness of our workforce and offer our employees a variety of tools to support their physical, emotional and financial well-being. Examples include access to mental health resources, back-up child and elder care and on-demand fertility, maternity, postpartum and return-to-work assistance. We offer a hybrid working model that provides flexibility to our employees and encourages using our offices as a tool by being intentional about the time we spend in person. We strive to be an employer of choice and we expect this approach will help us recruit and retain talent.


17


Diversity, Equity and Inclusion
Fostering a culture that embraces diversity, equity and inclusion is foundational to our workplace environment at AXIS, which is why diversity, equity and inclusion ("DEI") is a key pillar of our Corporate Citizenship program. By actively embracing a variety of perspectives, experiences and backgrounds and ensuring equal treatment for all, we strive to make AXIS a more rewarding place to work.
Our Approach – AXIS continues to progress its DEI efforts through a formalized approach.
Internal Education and Awareness: AXIS continues to host a variety of DEI educational initiatives, including promotional videos, social media posts, philanthropy campaigns and learning experiences to promote awareness. We ask our employees to participate in our unconscious bias education during new hire onboarding, and we sponsor a global forum every year on a topic selected by our DEI Council and Employee Resource Groups (ERGs). 2023 highlights are as follows:
Collectively, our five ERGs (AXIS Pride, Ethically Diverse Group of Employees ("EDGE"), Parents and Caregivers, Veterans, and Women) hosted over 15 events in 2023 ranging from domestic abuse awareness and training, actions to address xenophobia, celebrating Black History Month with a renowned U.K. scholar and more.
DEI learning experiences are created by a committee of AXIS colleagues and published monthly.
Recruitment and Mobility: Our Talent Acquisition team continues to enhance and update its inclusive hiring best practices across AXIS. We prioritize having diverse interview slates, as well as identifying career mobility opportunities for existing staff. To reach talent in underrepresented communities we work with universities and professional organizations and partner with diverse internship programs. We also offer resources focused on eliminating bias during the selection process for hiring managers. 2023 highlights are as follows:
Became a signatory to the U.K. Armed Forces Covenant, a commitment to support and improve employment opportunities for veterans.
Launched Career Spotlights, a monthly event featuring three hiring managers who will spotlight their open roles to increase internal mobility within AXIS.
Career Development: AXIS is committed to the development and retention of its people. We provide a variety of resources to help colleagues, such as access to our learning and development hub and financing professional development opportunities. We provide a menu of development programs for managers to identify opportunities to build an internal pipeline of talent. These include targeted programs to develop women and ethnically diverse employees. 2023 highlights are as follows:
Our annual DEI Forum focused on developing careers to build our internal talent pipeline at AXIS and was attended by more than 1,200 employees.
Over 100 employees participated in the third annual mentorship event, which was held with leaders throughout the business who shared tips on networking, advancing careers, gaining broader exposure and provided realistic advice about the challenges and opportunities employees face in their careers.
Tools and Measurement: Understanding our progress is an important aspect of our program, which is why we have invested in tools to establish, report and benchmark progress against our DEI goals. We continue to measure diverse hiring, turnover, promotions, succession planning and candidate slates monthly and the gender pay gap annually. To continue holding ourselves accountable and in an effort to increase transparency, AXIS has published its Bloomberg Gender Equality data and response for the first time.
Our Voice: AXIS continues to raise awareness and promote DEI issues, policies and initiatives to drive change across the insurance industry. 2023 highlights are as follows:
AXIS received the Armed Forces Covenant Employer Recognition Scheme Bronze Award.
AXIS continued its partnership with the Center for Disability & Inclusion pledge, an organization focused on advancing inclusion in the workplace.
AXIS continued to be a signatory of the CEO Action for Diversity & Inclusion pledge, reflecting our commitment to fostering a culture of inclusion.
18


AXIS sponsored the 2023 Bermuda Pride Walk that was organized by OUTBermuda, an organization that promotes and supports the well-being of the LGBTQ community in Bermuda.
AXIS continued to support Dive In, the insurance industry's festival for DEI. Further, AXIS was a Global Festival Partner for the third year in a row and the country lead for Ireland.
AXIS supported its colleagues as they continued leadership positions in a variety of industry organizations dedicated to advancing DEI, such as Insider Progress, the National African American Insurance Association, the Association of Professional Insurance Women and the Wholesale & Specialty Insurance Association (WSIA) Diversity Foundation.
AXIS partnered with St. John's University in the National African American Insurance Association Talent Competition for the third year.
AXIS was awarded Insurance Business America's 5-Star DEI Award for the second year in a row.
AXIS was included in the Bloomberg Gender Equality Index (GEI) for the third year in a row.
Employee Engagement
We understand that employee engagement leads to a more satisfying and fulfilling workplace and motivates employees to do their best work. Our employee engagement initiatives include:
AXIS Applause is our global recognition program we use to recognize the contributions of AXIS colleagues and drive strong employee performance;
Community building events for AXIS employees and their families; and
Employee-led charitable giving program which helps our employees give back to their communities.
In addition, to provide an open and frequent line of communication between senior management and our employees, we host all-employee calls led by our CEO on a monthly basis and we encourage our people managers to periodically check in with their employees.
Each year, we conduct two enterprise-wide engagement surveys to better understand and improve the employee experience and identify opportunities to strengthen our culture. Managers and teams reflect on the survey results and develop enterprise-wide and local action plans to address areas identified for improvement. In 2023, on average 86% of employees participated in our biannual employee surveys. We are proud to have maintained strong survey engagement and scores in a year of organizational change.
Compensation and Benefits
To attract and retain our industry's top talent, we offer employees a total rewards program that is designed to incentivize exceptional performance. Our compensation packages align with our pay-for-performance philosophy and are assessed on an annual basis through year-end performance reviews. Our packages are also regularly benchmarked against similarly sized insurance, reinsurance and financial services companies in each of our talent markets. Compensation components include market competitive salaries and short-term annual incentive programs (i.e., bonus payments) and, for senior level employees, long-term incentives such as equity grants. Our comprehensive benefits packages include health and welfare plans for employees and their families, retirement savings plans with employer contributions and work-life benefits, including parental leave policies, flexible work arrangements for eligible employees and charitable matching programs.
At AXIS, we are committed to fair pay and delivering equal pay for equal work regardless of gender, race or other personal characteristics. In support of our commitment to equal pay practices, all compensation offers are reviewed against internal peers to ensure equal pay at the job level, while year-end incentive awards are reviewed for bias based on gender and ethnic diversity. Furthermore, regular pay equity audits are conducted with action taken to address any areas of concern. In particular, we have published the results of our global gender pay equity audits in connection with our participation in the Bloomberg Gender Equality Index.

19


Succession Planning
We have a robust talent and succession planning process. On an annual basis, management conducts a talent and succession plan for each member of our Executive Committee and their direct reports, focusing on high performing and high potential talent, diverse talent and the succession plan for each position. On an annual basis, our Board receives a comprehensive succession plan for each member of our Executive Committee, including the CEO.
Employees
At December 31, 2023, we had 2,048 employees. During 2023, the number of employees decreased by approximately 1% and our voluntary turnover rate was 10.9% compared to 12.7% in 2022.

Below is a summary of our employees by region at December 31, 2023:
Employees
North America (including Bermuda)1,289
Europe, Middle East and Africa741
Asia Pacific18
Total employees2,048

At December 31, 2023, our global employees had approximately the following gender demographics:
WomenMen
Total employees(1)
46%53%
(1)<1% of employees did not identify.

At December 31, 2023, our U.S. employees had approximately the following racial and ethnic demographics:
All U.S. Employees(1)
African American / Black16%
Asian11%
Hispanic / Latinx5%
White61%
Multiracial, Native American and Pacific Islander2%
No Response / Not Disclosed5%
Total employees100%
(1)This information is presented for U.S. employees only. We continue to gather global demographic information in compliance with laws and regulations to demonstrate our racial and ethnic diversity.

TRADEMARKS
We use our trademarks, including among others, our "AXIS" trademarks for the global marketing of our products and services, and we believe that we sufficiently safeguard our trademark portfolio to protect our rights.

AVAILABLE INFORMATION
Our Internet website address is www.axiscapital.com. Information contained in our website is not part of this report.
We make available free of charge, through our internet website, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC.
20


RISK AND CAPITAL MANAGEMENT 
Risk Management Framework – Overview
Mission and Objectives
The mission of Enterprise Risk Management ("ERM") is to promptly identify, assess, manage, monitor, and report risks that affect the achievement of our strategic, operational, and financial objectives. The key objectives of our ERM framework are to:
Protect our capital base and earnings by monitoring risks against our stated risk appetite and limits;
Promote a sound risk management culture through disciplined and informed risk taking;
Enhance value creation and contribute to an optimal risk-return profile by providing the basis for efficient capital deployment;
Support our group-wide decision-making process by providing reliable and timely risk information; and
Safeguard our reputation.
The ERM framework applies to all lines of business and corporate functions.
Risk Governance
At the heart of our ERM framework is a governance process with responsibilities for identifying, assessing, managing, monitoring, and reporting risks. We articulate roles and responsibilities for risk management throughout the organization, from the Board of Directors and the Chief Executive Officer to our business and corporate functions, thus embedding risk management throughout the Company (refer to 'Risk Governance and Risk Management Organization' below).
Our risk policies are a formal set of documents that outline key drivers of risk and responsibilities for managing individual and aggregate risks. Our qualitative and quantitative risk reporting framework provides transparency and early warning indicators to senior management with regard to our overall risk profile, adherence to risk appetite and limits and management actions at the Group and legal entity level.
Various governance and control bodies coordinate to help ensure that objectives are being achieved, risks are identified, and appropriately managed, and internal controls are in place and operating effectively.
Internal Capital Model
An important aspect of our ERM framework is our internal capital model. Utilizing this modeling framework provides us with a holistic view of the capital we put at risk in any year by allowing us to understand the relative interaction among the known risks impacting us. This integrated approach recognizes that a single risk factor can affect different sub-portfolios and that different risk factors can have different mutual dependencies. We continuously review and update our model and its parameters as our risk landscape and external environment continue to evolve.
As well as being used to measure internal risk capital (refer to 'Capital Management' below), our internal capital model is used as a tool in managing our business, specifically to help allocate capital to the businesses that will provide the best returns. We also use the internal model to support portfolio monitoring, reinsurance and retrocession (collectively referred to as "reinsurance") purchasing, and investment asset allocations.
Our internal capital model is an integral part of the business planning process which provides an assessment as to whether our prospective business and investment strategies are in line with our defined risk appetite and objectives at the Group and legal entity level. The model also provides a basis for optimizing our risk-return profile by providing consistent risk measurement across the Group. The model outputs are reviewed and supplemented with management’s judgment and business experience and expertise. The internal capital model is subject to regular updates and validations.
21


Risk Diversification
As a global insurer and reinsurer with a wide product offering across different businesses, diversification is a key component of our business model and risk framework. Diversification enhances our ability to manage our risks by limiting the impact of a single event and contributing to relatively stable long-term results and our general risk profile. The degree to which the diversification effect can be realized depends not only on the correlation between risks but also the level of relative concentration of those risks. Therefore, our aim is to maintain a balanced risk profile without any disproportionately large risks. Our internal capital model considers the level of correlation and diversification between individual risks, and we measure concentration risk consistently across our business in terms of pre/post diversified internal risk capital requirements.
Risk Appetite and Limit Framework
Our integrated ERM framework considers material risks that arise both internally and externally, that could impact our business. Material risks that might accumulate and have the potential to produce substantial losses are subject to our group-wide risk appetite and limit framework. Our risk appetite, as authorized by the Board of Directors, represents the amount of risk that we are willing to accept in pursuit of our strategic objectives, within the constraints imposed by our capital resources as well as the expectations of our stakeholders as to the type of risks we hold within our business. At an annual aggregated level, we also monitor and manage the potential financial loss from the accumulation of risk exposure in any one year.
Specific risk limits are defined and translated into a consistent framework across our identified risk categories and across our legal entities and are intended to limit the impact of individual risk types or accumulations of risk. Individual limits are established through an iterative process to ensure that the overall framework complies with our group-wide requirements on capital adequacy and risk accumulation.
We monitor risks against our documented risk appetite and defined limits and report any deviations through our risk reporting framework.
External Perspectives
Various external stakeholders, among them regulators, rating agencies, investors and accounting bodies, place emphasis on the importance of sound risk management in the insurance and reinsurance industry. We monitor developments in the external environment and evolve our ERM framework and risk management practices accordingly.
Risk Governance and Risk Management Organization
The key elements of our governance framework, as it relates specifically to risk management, are described below:
Board of Directors’ Level
The Risk Committee of the Board of Directors ("Risk Committee") assists the directors in overseeing the integrity and effectiveness of our ERM framework and ensuring that our risk mitigation activities are consistent with that framework. The Risk Committee reviews, approves and monitors our overall risk strategy, risk appetite, and key risk limits, and receives regular reports from the Group Risk Management function ("Group Risk") to ensure any significant risk issues are being addressed by management. The Risk Committee further reviews, with management and Internal Audit, the Group’s risk policies and satisfies itself that effective systems of risk management and controls are established and maintained.
Among its other responsibilities, the Risk Committee reviews and approves our annual Own Risk and Solvency Assessment ("ORSA") report. The Risk Committee also assesses the independence and objectivity of our Group Risk function, approves its terms of reference, and reviews its ongoing activities. In addition, the Risk Committee conducts a review and provides a recommendation to the Board of Directors regarding the appointment and/or removal of the Chief Risk Officer. The Risk Committee meets with the Chief Risk Officer in separate executive sessions on a regular basis.
The Finance Committee of the Board of Directors oversees the Group’s investment of funds and adequacy of financing facilities. This includes approval of the Group’s strategic asset allocation plan.
The Audit Committee of the Board of Directors, which is supported by Internal Audit, is responsible for overseeing internal controls and compliance procedures, and also reviews with management and the Chair of the Risk Committee the Group’s policies regarding risk assessment and risk management.
22


Group Executive Level
The Executive Committee formulates our business objectives and risk strategy within the overall risk appetite set by the Board of Directors. It allocates capital resources and sets limits across the Group, with the objective of balancing return and risk. While the Executive Committee is responsible overall for risk management, it has delegated some authority to the executive level Risk Management Committee ("RMC") consisting of the Chief Executive Officer, Chief Financial Officer, Chief Underwriting Officer, Chief Risk Officer, Chief Actuary - Reserving and Capital, and Chief Administrative and Legal Officer.
The RMC is responsible for overseeing the integrity and effectiveness of the Group's ERM framework and ensuring that the Group's risk mitigation activities are consistent with that framework, including a review of the annual business plan relative to our risk limits. In addition to the RMC, there is an established framework of separate yet complementary management committees and subcommittees, focusing on particular aspects of ERM including the following:
Management Committees
The Operating Committee oversees the day-to-day operations of the organization, ensuring decisions are aligned and prioritized with our strategic goals and values.
The Global Underwriting Committee oversees the integrity and effectiveness of our Underwriting Governance Framework ensuring our underwriting activities are consistent with that framework.
The Investment & Finance Committee oversees the Group’s investment activities, which includes monitoring market risks, the performance of our investment managers and the Group’s asset-liability management, liquidity positions and investment policies and guidelines. The Investment & Finance Committee also prepares the Group’s strategic asset allocation and presents it to the Finance Committee of the Board of Directors for approval.
The Capital Management Committee oversees the integrity and effectiveness our capital management policy, including the capital management policies of our legal entities and branches, and oversees the availability of capital within the Group.
The Group Reserving Committee ensures appropriate oversight and validation of the Group loss reserves.
RMC Sub-Committees
The Exposure Management Committee oversees the Group's exposure management framework for catastrophe and non-catastrophe lines, including the validation of modeling, threats framework, accumulation practices and monitoring of management appetites.
The Reinsurance Security Committee ("RSC") sets out the financial security requirements of our reinsurance counterparties and approves counterparties, as needed.
The Internal Model Committee oversees the Group's internal model framework, including the key model assumptions, methodology and validation framework.
The Operational Risk Committee oversees the Group's operational risk framework for identifying, assessing, managing, monitoring, and reporting of operational risk and facilitates the embedding of effective operational risk management practices throughout the Group.
The Emerging Risks Working Group oversees the processes for identifying, assessing, managing, monitoring, and reporting current and potential emerging risks.
The Climate Change Working Group focuses specifically on climate-related risks and opportunities and oversees climate risk initiatives.
Group Risk Management Organization
As a general principle, management in each of the lines of business and corporate functions is responsible in the first instance for the risks and returns of its decisions. Management is the 'owner' of risk management processes and is responsible for managing our business within defined risk limits.
23


The Chief Risk Officer, who reports to the Chief Financial Officer and the Chair of the Risk Committee leads our independent Group Risk function, and is responsible for oversight and implementation of the Group's ERM framework, as well as providing guidance and support for risk management practices. Group Risk is responsible for developing methods and processes for identifying, assessing, managing, monitoring, and reporting risk. This forms the basis for informing the Risk Committee and RMC of the Group’s risk profile. Group Risk develops our ERM framework and oversees the adherence to this framework at the Group and legal entity level. Our Chief Risk Officer regularly reports risk matters to the Chief Financial Officer, Executive Committee, RMC, and the Risk Committee.
Internal Audit, an independent, objective function, reports to the Audit Committee of the Board of Directors on the effectiveness of our ERM framework. This includes assurance that key business risks have been adequately identified and managed appropriately and that our system of internal control is operating effectively. Internal Audit also coordinates risk-based audits, compliance reviews and other specific initiatives to evaluate and address risk within targeted areas of our business.
Our risk governance structure is further complemented by our legal team which seeks to mitigate legal and regulatory compliance risks with support from other teams. This includes ensuring that significant developments in law and regulation are observed and that we react appropriately to impending legislative and regulatory changes and applicable court rulings.
Risk Landscape
Our risk landscape comprises insurance, strategic, market, liquidity, credit, and operational risks that arise as a result of undertaking our business activities. We provide definitions of these risk categories as well as descriptions of management of these risks below. Across these risk categories, we identify and evaluate emerging threats and opportunities through a framework that includes the assessment of potential surprise factors that could affect exposures.
Our risk landscape is reviewed and reported on a regular basis to ensure that it remains up-to-date based on the evolving risk profile of the Company. In addition, we undertake ongoing risk assessments across all enterprise risks, the output of which is captured in our risk register, which is reviewed and reported through our governance structure.
Insurance Risk
Insurance risk is the inherent uncertainty as to the occurrence, amount and timing of insurance and reinsurance liabilities transferred to us through the underwriting process.
Since our inception in 2001, we have expanded our international presence, with underwriting offices in Bermuda, the U.S., Europe, Singapore, and Canada. Our disciplined underwriting approach coupled with a peer review process has enabled us to manage this growth in a controlled and consistent manner.
A key component of the Group's underwriting risk governance is our peer review processes, which allow for a collaborative review of risk and pricing, and ensure that underwriting is within established guidelines and procedures. Underwriting guidelines are in place to provide a framework for consistent pricing and risk analysis and to ensure alignment to the Group's risk appetite. Limits are set on underwriting capacity and cascade authority to individuals based on their specific roles and expertise.
We also have significant audit coverage across our lines of business, including Management Initiated Audits ("MIAs"). MIAs are audits of underwriting and claims files performed by teams independent of those who originated the transactions, the purpose of which is to test the robustness of our underwriting and claims processes and to recognize any early indicators of future trends in our operational risk environment.
Pricing
Premiums for insurance and reinsurance contracts are intended to cover expected claim costs, acquisition costs, operating costs, and an adequate level of profit margin commensurate to the risk being assumed. Premium amounts are typically agreed upfront, whereas the claim costs materializes over an extended period, especially for liability lines. The social, economic, and legal environments may evolve differently over that period compared to the original expectation. Additionally, inherent variability in claim counts and amounts could result in higher overall claim costs than expected in a given year. These factors could lead to a shortfall in premiums charged at the time of underwriting the policy. Premium risk can increase in times of heightened uncertainty in claim cost trends and at times when demand-supply imbalance results in competitive pricing.

24


We mitigate premium risk in our portfolio through four main levers. First, we take a vigilant and cautious approach on claims cost trends, and we review these assumptions regularly and frequently. Second, in some of our contracts we include loss and/or exposure adjustment features that flex premium and/or acquisition costs in response to higher-than-expected exposures and/or claim costs. Third, we employ underwriting action and reinsurance protection to minimize volatility in our claims experience by managing aggregation of limits and by maintaining balance between portfolio margin and limits deployed. Last, we continually enhance our processes including refining our models to ensure we grow the portfolio at times when pricing is in surplus and we shrink the portfolio at times when pricing is in deficit.
Reinsurance Purchasing
Another key component of our mitigation of insurance risk is the purchase of reinsurance to protect our business on a treaty (covering a portfolio of risks) and facultative (single risk) basis.
For treaty reinsurance, we purchase proportional and non-proportional cover.
Under proportional reinsurance, we cede an agreed percentage of the premiums and the losses and loss expenses on the policies we underwrite. We primarily use proportional reinsurance on our liability, professional lines and cyber insurance portfolios, as well as on select property insurance portfolios, where we protect against higher loss frequency rather than specific events. We also purchase proportional reinsurance for our accident & health, credit and surety, liability, motor, and professional lines reinsurance portfolios, which includes cessions to our Strategic Capital Partners.
We use non-proportional reinsurance, whereby losses up to a certain amount (i.e., our retention) are borne by us. By using non-proportional reinsurance, we can limit our liability with a retention, which reflects our willingness and ability to bear risk, and is therefore in line with our risk appetite. We primarily purchase the following forms of non-proportional reinsurance:
Excess of loss per risk – our reinsurer(s) indemnify us for loss amounts in excess of our retention, for all individual policies effected, as defined in the treaty terms and conditions. Per-risk treaties are an effective means of risk mitigation against large single losses (e.g., a large fire claim).
Catastrophe excess of loss – provides aggregate loss cover for our insurance portfolio against the accumulation of losses incurred from a single event (e.g., windstorm).
We have a centralized risk funding department, which coordinates external treaty reinsurance purchasing (including retrocession) across the Group and a separate AXIS ILS (Insurance Linked Securities) team, which coordinates the sourcing and structuring of third-party capital to support AXIS underwriting. Risk funding and AXIS ILS is overseen by our Reinsurance Purchasing Group ("RPG"). The RPG, which includes, among others, our Chief Executive Officer, Chief Financial Officer, Chief Risk Officer, Chief Underwriting Officer and representatives from the business leadership team, approves each treaty placement and aims to ensure that appropriate diversification exists within our RSC approved counterparty panels.
Facultative reinsurance provides risk transfer on a case by case basis. In certain circumstances, we use facultative reinsurance to complement treaty reinsurance by covering additional risks over and above what is already covered by treaties. Facultative reinsurance is monitored by the risk funding team.
Natural Peril Catastrophe Risk
Natural catastrophes such as hurricanes, windstorms, earthquakes, floods, tornados, hail and fire represent a challenge for risk management due to their accumulation potential and occurrence volatility. In managing natural catastrophe risk, our internal risk limit framework aims to limit the loss of capital due to a single event and the loss of capital that would occur from multiple (but perhaps smaller) events in any year. Within this framework, we have an established risk limit for single event, single zone probable maximum loss ("PML") within defined zones and at various return periods. For example, at the 1-in-250-year return period, we are not willing to expose more than 10% of common equity to a single event within a single zone.
25


The table below shows our net PML to a single natural peril catastrophe event within certain defined single zones which correspond to peak industry catastrophe exposures at January 1, 2024 and 2023:
Estimated Net Exposures
(millions of U.S. dollars)
January 1, 2024January 1, 2023
TerritoryPeril50 Year
Return
Period
100 Year
Return
Period
250 Year
Return
Period
50 Year
Return
Period
100 Year
Return
Period
250 Year
Return
Period
Single zone, single event
SoutheastU.S. Hurricane$114 $131 $149 $74 $96 $125 
NortheastU.S. Hurricane9 26 59 11 35 72 
Mid-AtlanticU.S. Hurricane41 85 111 26 59 99 
Gulf of MexicoU.S. Hurricane104 124 143 67 86 121 
EuropeWindstorm59 87 107 39 57 77 
JapanWindstorm10 12 21 39 106 146 
JapanEarthquake41 67 114 50 115 195 
CaliforniaEarthquake115 137 163 65 98 144 
The return period refers to the frequency with which losses of a given amount or greater are expected to occur. A zone is a geographic area in which the insurance risks are considered to be correlated to a single catastrophic event. Estimated losses from a modeled event are grouped into a single zone, as shown above, based on where the majority of the total estimated industry loss is expected to occur. In managing zonal concentrations, we aim to ensure that the geography of single events is suitably captured, but distinct enough that they track specific types of events. For example, our definition of Southeast wind encompasses five states, including Florida, while our definition of Gulf Wind encompasses four states, including Texas.
Our PMLs take into account the fact that an event may trigger claims in a number of lines of business. For instance, our U.S. hurricane modeling includes the estimated pre-tax impact to our financial results arising from our catastrophe, property, engineering, energy, marine and aviation lines of business. Our PMLs include assumptions regarding the location, size and magnitude of an event, the frequency of events, the construction type and a property’s susceptibility to damage and the cost of rebuilding the property. Loss estimates for non-U.S. zones will be subject to foreign exchange rates, although we may mitigate this currency variability from a book value perspective.
As indicated in the table above, our modeled single occurrence 1-in-100-year return period PML for a Southeast U.S. hurricane, net of reinsurance, is approximately $131 million. According to our modeling, there is a one percent chance that on an annual basis losses incurred from a Southeast U.S. hurricane event could be in excess of $131 million. Conversely, there is a 99% chance that on an annual basis the loss from a Southeast U.S. hurricane will fall below $131 million.
PMLs are based on results of stochastic models that consider a wide range of possible events, their losses and probabilities. It is important to consider that an actual event does not necessarily resemble one of the stochastic events and the specific characteristics of an actual event can lead to substantial differences between actual and modeled loss.
We have developed our PML estimates by combining judgment and experience with the outputs from the catastrophe model, commercially available from Verisk Analytics, Inc., which we also use for pricing catastrophe risk. This model covers the major peril regions where we face potential exposure. Additionally, we have included our estimate of non-modeled perils and other factors, which we believe provides us with a more complete view of catastrophe risk.
Our PML estimates are based on assumptions that are inherently subject to significant uncertainties and contingencies. These uncertainties and contingencies can affect actual losses and could cause actual losses to differ materially from those expressed above. We aim to reduce the potential for model error in a number of ways, the most important of which is by ensuring that management’s judgment supplements the model outputs. Models are continuously validated at the line of business and at a group level by our catastrophe model validation team. These validation procedures include sensitivity testing of models to understand their key variables and, where possible, back testing the model outputs to actual results.
Estimated net losses from peak zone catastrophes may change from period to period as a result of several factors, which include but are not limited to, updates to vendor catastrophe models, changes to internal modeling, underwriting portfolios, reinsurance purchasing strategy and foreign exchange rates.
26


Man-Made Catastrophe Risk
Consistent with our management of natural peril catastrophe exposures, we take a similarly focused and analytical approach to the management of man-made catastrophes. Man-made catastrophes, which include such risks as train collisions, airplane crashes or terrorism, and other intentionally destructive acts, including cyber-attacks, are harder to model in terms of assumptions regarding intensity and frequency. For these risks we couple the vendor models, where available with our bespoke modeling and underwriting judgment and expertise. This allows us to take advantage of business opportunities related to man-made catastrophe exposures particularly where we can measure and limit the risk sufficiently as well as obtain risk-adequate pricing.
As an example of our approach, our assessment of terrorism risk is based on a mixture of qualitative and quantitative data (e.g., for estimating property damage, business interruption, mortality and morbidity subsequent to an attack of a predefined magnitude), which we use to limit and manage our aggregate terrorism exposure. We use commercially available vendor modeling and bespoke modeling tools to measure accumulations around potential terrorism accumulation zones on a deterministic and probabilistic basis. We supplement the results of our modeling with underwriting judgment.
Reserving Risk
The estimation of reserves for losses and loss expenses ("loss reserves") is subject to uncertainty as the settlement of claims is dependent on future events and developments. There are many factors that would cause loss reserves to increase or decrease, which include, but are not limited to emerging claims and coverage issues, changes in the legislative, regulatory, social and economic environment and unexpected changes in loss inflation. The estimation of loss reserves could also be adversely affected by the failure of our loss limitation strategy and/or the failure of models used to support key decisions.
We calculate loss reserves in accordance with actuarial best practice based on substantiated methodologies and assumptions. In addition, we have well established processes in place for determining loss reserves, which we ensure are consistently applied. Our loss reserving process demands data quality and reliability and requires a quantitative and qualitative review of overall reserves and individual large claims. Within a structured control framework, claims information is communicated on a regular basis throughout our organization, including to senior management, to provide an increased awareness of losses that have occurred throughout the insurance markets. The detailed and analytical reserving approach that follows is designed to absorb and understand the latest information on reported and unreported claims, to recognize the resultant exposure as quickly as possible, and to record appropriate loss reserves in our consolidated financial statements.
Reserving for longer tail lines of business represents a significant component of reserving risk. When loss trends prove to be higher than those underlying our reserving assumptions, the risk is greater because loss reserves recorded in our consolidated financial statements cover claims arising from several years of underwriting activity and these reserves are likely to be adversely affected by unfavorable loss trends. We manage and mitigate reserving risk on longer tail business in a variety of ways. First, the longer tail business we write is part of a well-balanced and diversified global portfolio of business. Second, we follow a disciplined underwriting process that utilizes available information, including industry trends.
Another significant component of reserving risk relates to the estimation of losses in the aftermath of a major catastrophe event. Refer to Item 7 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates – Reserves for Losses and Loss Expenses' for further details. Refer also to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserving Methodology – Reserving for Catastrophic Events' for further details.
Claims Handling Risk
In accepting risk, we are committing to the payment of claims and therefore these risks must be understood and controlled. We have claims teams dedicated to our main lines of business. Our claim teams include a diverse group of experienced professionals, including claims adjusters and attorneys. We also use approved external service providers, such as independent adjusters and appraisers, surveyors, accountants, investigators, and specialist attorneys, as appropriate.
We maintain claims handling guidelines, which include details on claims reporting controls and claims reporting escalation procedures, for all our claims teams. Large claims matters are reported on a weekly basis in claims summaries that are circulated to our underwriters, senior management and others involved in the reserving process. To maintain communication between underwriting and claims teams, claims personnel regularly report at underwriting meetings and frequently attend client meetings.
27


We foster a strong culture of review among our claims teams. This includes MIAs whereby senior claims handlers and/or external audit resources audit a sample of claim files. The process is designed to ensure consistency between the claims teams and to develop group-wide best practices.
When we receive notice of a claim, regardless of size, it is recorded in our claims and financial systems. In addition, we produce alerts regarding significant events and potential losses, regardless of whether we have exposure. These alerts allow a direct notification to be communicated to underwriters and senior management worldwide. Similarly, for natural peril catastrophes, we have developed a catastrophe database, along with catastrophe coding in certain systems, that allows for the gathering, analyzing, and reporting of loss information as it develops from early modeled results to fully adjusted and paid losses.
Strategic Risk
Strategic risks affect or are created by an organization’s business strategy and strategic objectives. Our review of strategic risk evaluates not only internal and external challenges that might cause our chosen strategy to fail but also evaluates major risks that could affect our long-term performance and position. 
We believe it is imperative that we consider the business risks associated with, and mitigated by, each strategy. We also view strategic risk not only as the negative impact of risk but also the sub-optimization of gain. Fundamentally, we believe that we are set up for success if we analyze both value protection and value creation.
Environmental, Social and Governance (ESG) and sustainability have become major topics that encompass a wide range of issues, including climate change and other environmental risks. In line with our strategy, we have put in place a number of measures in order to identify, assess, manage, and monitor potential exposure to climate risks, for example physical, transition and liability risks.
At least on a quarterly basis, the Executive Committee meets and receives holistic information about execution against strategy and makes decisions to adjust and/or advance strategy. In addition, strategies employed throughout our business in support of the broader enterprise strategy are reviewed in the context of a broader governance structure by business leadership and are ultimately approved by the Board of Directors.
Market Risk
Market risk is the risk that our financial instruments, which include derivatives, may be negatively impacted by movements in financial market prices or rates, such as interest rates, credit spreads, equity securities' prices and foreign currency exchange rates. Fluctuations in market prices or rates primarily affect our investment portfolio.
Through asset-liability management, we aim to ensure that market risks influence the economic value of our investments and our loss reserves and other liabilities in the same way, thus mitigating the effect of market fluctuations. For example, we reflect important features of our liabilities, such as maturity patterns and currency structures, on the asset side of the balance sheet by acquiring investments with similar characteristics.
We supplement our asset-liability management with various internal policies and limits. As part of our strategic asset allocation process, different strategic asset classes are simulated and stressed to evaluate the ‘optimal’ portfolio, given return objectives and risk constraints. Our investments team manages asset classes to control aggregation of risk and provide a consistent approach to constructing portfolios and the selection process of external asset managers. We have limits on the concentration of investments by single issuers and certain asset classes, and we limit the level of illiquid investments (refer to 'Liquidity Risk' below).
We stress test our investment portfolios using historical and hypothetical scenarios to analyze the impact of unusual market conditions and to ensure potential investment losses remain within our risk appetite. At an annual aggregated level, we manage the total risk exposure of our investment portfolio so that the 'total return' investment loss in any one year is unlikely to exceed a defined percentage of our common equity at a defined return period.
We mitigate foreign currency risk by seeking to match our estimated insurance and reinsurance liabilities payable in foreign currencies with assets, including cash and investments that are denominated in the same currencies. Where necessary, we use derivative financial instruments for economic hedging purposes. For example, in certain circumstances, we use forward contracts to economically hedge portions of our un-matched foreign currency exposures.

28


Liquidity Risk
Liquidity risk is the risk that we may not have sufficient cash to meet our obligations when they are due or would have to incur excessive costs to do so.
As an insurer and reinsurer, our core business generates liquidity primarily through premiums, investment income and the maturity/sale of investments. Our exposure to liquidity risk stems mainly from the need to pay claims on potential extreme loss events and regulatory constraints that limit the flow of funds within the Group. To manage these risks, we have a range of liquidity policies and procedures in place which are described below: 
We maintain cash and cash equivalents and a high quality, liquid investment portfolio to meet expected outflows, as well as those that could result from a range of potential stress events. We place limits on the maximum percentage of cash and investments that may be in an illiquid form as well as on the minimum percentage of unrestricted cash and liquid investment grade fixed maturity securities.
We maintain committed borrowing facilities, as well as access to diverse funding sources, to cover contingencies. Funding sources include liquid cash and invested assets, external debt issuances and lines of credit.
Credit Risk
Credit risk represents the risk of incurring financial loss due to the diminished creditworthiness (reduced financial strength and, ultimately, possibly default) of our third-party counterparties.
We distinguish between various forms of credit exposure including the risk of issuer default from instruments in which we invest, such as corporate bonds, counterparty exposure in a direct contractual relationship, such as reinsurance, the credit risk related to our premium receivables, including those from brokers and other intermediaries, and the risk we assume through our insurance contracts, such as our credit and political risk, and credit and surety lines of business.
Credit Risk Aggregation
Refer to Item 8, Note 12 to the Consolidated Financial Statements 'Commitment and Contingencies' – Concentration of Credit Risk – Credit Risk Aggregation
Credit Risk Relating to Cash and Investments
Refer to Item 8, Note 12 to the Consolidated Financial Statements 'Commitment and Contingencies' – Concentration of Credit Risk – Cash and Investments
Credit Risk Relating to Reinsurance Recoverable Assets
Refer to Item 8, Note 12 to the Consolidated Financial Statements 'Commitment and Contingencies' – Concentration of Credit Risk – Reinsurance Recoverable on Unpaid and Paid Losses and Loss Expenses
Credit Risk Relating to Premium Receivables
Refer to Item 8, Note 12 to the Consolidated Financial Statements 'Commitment and Contingencies' – Concentration of Credit Risk – Insurance and Reinsurance Premium Balances Receivable
Credit Risk Relating to our Underwriting Portfolio
We provide credit insurance primarily for lenders (financial institutions) and commodity traders seeking to mitigate the risk of non-payment from their borrowers and trading counterparties. This product complements our traditional political risk insurance business. For the credit insurance contracts, it is necessary for the buyer of the insurance, most often a bank or commodity trader, to hold an insured asset, most often an underlying loan, or sale and purchase contract in order to claim compensation under the insurance contract. The majority of the credit insurance provided is for single-name illiquid risks that can be individually analyzed and underwritten, primarily in the form of senior secured bank loans but also unsecured payment obligations in the case of shorter term trade credit. As part of the underwriting process, an evaluation of creditworthiness and reputation of the obligor is critical. We generally require our clients to retain a share of each transaction that we insure. A key element to our underwriting analysis is the assessment of recovery in the event of default, and, accordingly, the strength of the collateral and the enforceability of rights to the collateral are paramount.

29


Generally, we do not underwrite insurance for structured finance products that would expose us to mark-to-market losses. In addition, our credit insurance contracts typically do not include terms which would introduce liquidity risk, most notably in the form of a collateralization requirement upon a ratings downgrade.

We also provide protection against sovereign default or sovereign actions that result in impairment of cross-border investments for banks and corporations. Our contracts generally include conditions precedent to our liability relating to the enforceability of the insured transaction and restricting amendments to the transaction documentation, obligations on the insured to prevent and minimize losses, subrogation rights, including rights to have the insured asset transferred to us, and waiting periods. Under most of our policies, a loss payment is made in the event that the debtor failed to pay our client when payment is due subject to a waiting period of up to 180 days.

We provide reinsurance of credit and surety bond insurers exposed to the risks of financial loss arising from non-payment of trade receivables or other credit obligations covered by a policy (credit insurance) or non-performance of obligations (surety). Our credit insurance exposures are concentrated within developed economies, while our surety bond exposures are concentrated in Latin America and developed economies. We provide coverage to the mortgage industry through insurance and reinsurance of mortgage insurance companies and U.S. government-sponsored entity credit risk sharing transactions. We focus on credit risk transfer from Federal Home Loan Mortgage Corporation and Federal National Mortgage Association, in the single-family, fixed rate, conforming mortgage space. We also provide this cover globally in a select number of developed countries. Our exposure to credit risk (credit, surety and mortgage) is monitored and managed through robust underwriting within defined parameters for credit quality and concentration, continuous monitoring of the housing and credit markets, as well as limits on our PML resulting from a severe economic downturn.
Operational Risk
Operational risk represents the risk of loss as a result of inadequate processes, system failures, human error or external events, including but not limited to direct or indirect financial loss, reputational damage, customer dissatisfaction, and legal and regulatory penalties.
Group Risk is responsible for coordinating and overseeing a group-wide framework for operational risk management. As part of this oversight, we facilitate the identification, assessment and management of key operational risks through risk assessments, and these are recorded on our risk register. We also maintain an operational loss-event database which helps us monitor and analyze potential operational risk issues, identify any trends, and, where necessary, put in place improvement actions to avoid occurrence or recurrence of operational loss events. We further supplement this with deep dive reviews to identify the key drivers of risk and review and challenge the appropriateness of current mitigation strategies and make recommendations for improvement.
We manage transaction type operational risks through the application of process controls throughout our business.
We have specific processes and systems in place to focus on high priority operational matters, such as managing business resilience, information security, and third-party vendor risk, which are described below: 
Major failures and disasters that could cause a severe disruption to working environments, facilities, and personnel, represent a significant operational risk to our business. Our Business Continuity Management framework strives to protect critical business services and the functions that support these business services from these effects to enable us to carry out our core tasks in time and at the quality required.
We have developed a number of Information Technology ("IT") platforms, applications and security controls to support our business activities worldwide. Dedicated security standards are in place for our IT systems to ensure the proper use, availability and protection of our information assets.
We have enhanced our governance processes for the prioritization of projects, to ensure greater transparency of the decision-making process, the alignment of teams working on the same projects, consistency of approach and alignment to strategy.
Our use of third-party vendors exposes us to a number of increased operational risks, including the risk of security breaches, fraud, non-compliance with laws and regulations or internal guidelines and inadequate service. We manage material third-party vendor risk, by, among other things, performing a thorough risk assessment on potential large vendors, reviewing a vendor’s financial stability, ability to provide ongoing service and business resilience planning.

30


Capital Management
Our capital management strategy is to maximize long-term shareholder value by, among other things, optimizing capital allocation and minimizing our cost of capital. We manage our capital in accordance with our Target Capital Range ("TCR") concept. The TCR defines the preferred level of capital needed to absorb shock losses and still satisfy our minimum solvency targets in relation to key capital benchmarks including our "own view" of risk from our internal capital model and regulatory and rating agency capital requirements, which are described below:
Internal risk capital - We use our internal capital model to assess the capital consumption of our business, measuring and monitoring the potential aggregation of risk at extreme return periods.
Regulatory capital requirements - In each country in which we operate, the local regulator specifies the minimum amount and type of capital that each of the regulated entities must hold in support of their liabilities and business plans. We target to hold, in addition to the minimum capital required to comply with the solvency requirements, an adequate buffer to ensure that each of our regulated entities meets its local capital requirements. Refer to Item 8, Note 22 to the Consolidated Financial Statements 'Statutory Financial Information' for further details.
Rating agency capital requirements - Rating agencies apply their own models to evaluate the relationship between the required risk capital of a company and its available capital resources. The assessment of capital adequacy is usually an integral part of the rating agency process. Meeting rating agency capital requirements and maintaining strong credit ratings are strategic business objectives of the Company. Refer to Item 7 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources' for further details.
The TCR identifies the point at which management needs to consider raising capital, amending our business plan or executing capital management activities well before capital approaches the minimum requirements ("early warning indicator"). This allows us to take appropriate measures to ensure the continued strength and appropriateness of our capital and solvency positions, and enables us to take advantage of opportunities as they arise. Such measures are performed as and when required and include traditional capital management tools (e.g., dividends, share buy-backs, issuance of shares or debt) or through changes to our risk exposure (e.g., recalibration of our investment portfolio or changes to our reinsurance purchasing strategy).
The TCR also considers an amount of capital beyond which capital could be considered "excess". Where we do not find sufficiently attractive opportunities and returns for our excess capital, we may return capital to our shareholders through share repurchases and/or dividends. In doing so, we seek to maintain an appropriate balance between higher returns for our shareholders and the security provided by a sound capital position.

ITEM 1A.    RISK FACTORS
Insurance Risk
Insurance risk is the inherent uncertainty as to the occurrence, amount and timing of insurance and reinsurance liabilities transferred to us through the underwriting process.
The insurance and reinsurance business is historically cyclical, and we expect to experience periods with excess underwriting capacity and unfavorable premium rates.
The insurance and reinsurance business historically has been a cyclical industry characterized by periods of intense price competition due to excess underwriting capacity, as well as periods when shortages of capacity permit favorable premium levels. An increase in premium rates is often offset by an increased supply of insurance and reinsurance capacity, via capital driven by new entrants, new capital market instruments and structures and/or the commitment of additional capital by existing insurers and reinsurers. Any of these factors could lead to a significant reduction in premium rates, less favorable policy terms, increased expenses for customer acquisition and retention, and fewer submissions for our underwriting services. In addition to these considerations, changes in the frequency and severity of losses suffered by insureds and insurers may affect the cycles of the insurance and reinsurance business significantly, which in turn could affect our business, results of operations or financial condition.
31


Our results of operations, financial condition or liquidity could be adversely affected by the occurrence of natural and man-made disasters, as well as outbreaks of pandemic or contagious diseases.
While we exited the catastrophe and property reinsurance lines of business in 2022, we continue to have exposure to unexpected losses resulting from natural disasters, man-made catastrophes and other catastrophe events. Catastrophes can be caused by various events, including hurricanes, typhoons, earthquakes, tsunamis, hailstorms, floods, severe winter weather, fires, drought and other natural disasters and outbreaks of pandemic or contagious diseases. Catastrophes can also be man-made, such as terrorist attacks and other intentionally destructive acts, including those involving nuclear, biological, chemical or radiological events, cyber-attacks, explosions and infrastructure failures. The incidence and severity of catastrophes are inherently unpredictable and losses from catastrophes could be substantial.
Increases in the values and concentrations of insured property, particularly in coastal regions, and increases in the cost of construction materials required to rebuild affected properties, may continue to increase the impact of natural catastrophe events. Changes in global climate conditions may further increase the frequency and severity of natural catastrophe activity and losses. Similarly, changes in global political and economic conditions may increase both the frequency and severity of man-made catastrophe events. Our business also has exposure to global or nationally occurring pandemics caused by highly infectious and potentially fatal diseases. The impact of catastrophe events in years 2023, 2022 and 2021 included the recognition of the net losses and loss expenses of:
$138 million, in the aggregate, primarily related to Cyclone Gabrielle and other weather-related events in 2023;
$403 million, in the aggregate, primarily related to Hurricane Ian, the Russia-Ukraine war, Winter Storm Elliot, June European Convective Storms, and the COVID-19 pandemic in 2022; and
$443 million, in the aggregate, primarily related to Hurricane Ida, U.S. Winter Storms Uri and Viola, and July European Floods in 2021.
These events materially reduced net income in the years noted. Although we manage our exposure to such events through the use of underwriting controls and the purchase of third-party reinsurance protection, catastrophe events are inherently unpredictable and the actual nature of such events when they occur could be more frequent or severe than contemplated in our pricing and risk management expectations. As a result, the occurrence of one or more catastrophe events could have a material adverse effect on our results of operations, financial condition or liquidity.
Risks from cybersecurity threats are dynamic and fast evolving, and could be exacerbated by geopolitical tensions, including hostile actions taken by nation-states and terrorist organizations. There is a risk that increases in the frequency and severity of cybersecurity incidents affecting us, our clients, or our third-party service providers could materially adversely affect our results of operations, financial condition or liquidity. The losses incurred from these risks are also dependent on our clients’ and our third-party service providers' cybersecurity practices and defenses, as well as how policy terms and conditions interact with the evolving threat landscape. In addition, our exposure to cybersecurity incidents potentially includes exposure through “non-affirmative” coverages, meaning risks and potential losses associated with policies where cybersecurity risk is not explicitly included or excluded in the policy terms and conditions. As this is a relatively new risk, even in cases where losses from cybersecurity incidents are explicitly excluded, there can be no assurance that a court or arbitration panel will interpret policy language in line with the intention of the exclusion.
We could face unanticipated losses from war, terrorism, political unrest, and geopolitical uncertainty, and these or other unanticipated losses could have an adverse effect on our results of operations, financial condition or liquidity.
We have exposure to unexpected losses resulting from acts of terrorism, political unrest and geopolitical instability, including, but not limited to, events related to Russia’s invasion of Ukraine, the Israel-Hamas conflict and the associated conflict in the Red Sea and in many regions of the world. Russia’s invasion of Ukraine is having a profound impact on energy markets, particularly in Europe, which is impacting and may continue to impact economic conditions and investment returns. In certain instances, we specifically insure and reinsure risks resulting from acts of terrorism. Even in cases where we attempt to exclude losses from terrorism and certain other similar risks from some coverages written by us, there can be no assurance that a court or arbitration panel will interpret policy language or otherwise issue a ruling favorable to us. Accordingly, we can offer no assurance that our loss reserves will be adequate to cover losses should they materialize beyond expectation.

32


We have limited terrorism coverage in our own reinsurance program for our exposure to catastrophe losses related to acts of terrorism. On December 20, 2019, the President of the United States signed the Terrorism Risk Insurance Program Reauthorization Act of 2019 ("TRIP"), extending the program through December 31, 2027. Although TRIP provides benefits in the event of certain acts of terrorism, those benefits are subject to a deductible and to other limitations. Under TRIP, once losses attributable to certain acts of terrorism exceed 20% of direct commercial property and liability insurance premiums for the preceding calendar year, the federal government will reimburse insurers for 80% of losses in excess of this deductible.
Notably, TRIP does not provide coverage for reinsurance losses. Given the unpredictable frequency and severity of terrorism losses, as well as the limited terrorism coverage in our own reinsurance program, future losses from acts of terrorism could materially and adversely affect our results of operations, financial condition or liquidity in future periods.
Our credit and political risk insurance line of business protects insureds with interests in foreign jurisdictions in the event that governmental action prevents them from exercising their contractual rights, and may also protect their assets against physical damage perils. The insurance provided may include cover for losses arising from expropriation, forced abandonment, license cancellation, trade embargo, contract frustration, non-payment, war on land or political violence (including terrorism, revolution, insurrection and civil unrest).
Our credit and political risk line of business also provides non-payment coverage on specific loan obligations. We insure sovereign non-payment and corporate non-payment as a result of commercial as well as political risk events. The vast majority of the corporate non-payment credit insurance provided is for single-named illiquid risks, primarily in the form of senior bank loans that can be individually analyzed and underwritten. Generally, we do not underwrite insurance for structured finance products that would expose us to mark-to-market losses. In addition, our credit insurance contracts typically do not include terms which would introduce liquidity risk, most notably in the form of a collateralization requirement upon a ratings downgrade. We also manage our exposure by, among other things, setting credit limits by country, region, industry and individual counterparty, and regularly reviewing our aggregate exposures. However, due to globalization, political instability in one region can spread to other regions. Geopolitical uncertainty regarding a variety of domestic and international matters, such as the U.S. political and regulatory environment and the potential for default by U.S., Canadian and by one or more European sovereign debt issuers, could have a material adverse effect on our results of operations, financial condition or liquidity.
We may be adversely impacted by economic and social inflation
Our operations, like those of other insurers and reinsurers, are susceptible to the effects of economic and social inflation because premiums are established before actual losses and loss expenses are known. Although we consider the potential effects of economic and social inflation when setting premium rates, premiums may not fully offset the effects of inflation and thus may not adequately underwrite the risks we insure and reinsure. Loss reserves include assumptions about future payments for settlement of claims and claims-handling expenses. To the extent economic and social inflation causes costs to increase above loss reserves established for claims, we will be required to increase loss reserves with a corresponding reduction in net income in the period in which the deficiency is identified, which may have a material adverse effect on our results of operations or financial condition. Unanticipated higher economic inflation could also lead to higher interest rates, which would negatively impact the value of our fixed income securities and potentially other investments. In addition, to the extent that unanticipated higher economic inflation in different geographies leads to currency fluctuations, we may also experience increased volatility on foreign exchange gains and losses.

Global climate change, and increasing regulation relating to climate change, may have an adverse effect on our results of operations, financial condition or liquidity.
We are potentially exposed to different aspects of climate risk, specifically, physical, investment, liability and transition risks, as a result of climate change.
Physical risks include weather-related events and longer-term shifts in climate patterns and emanate primarily from the underwriting of property insurance and reinsurance. Climate change has added to the unpredictability and frequency of natural disasters in certain parts of the world and has created additional uncertainty as to future trends and exposures. Although the loss experience of catastrophe insurers and reinsurers has historically been characterized as low frequency, in recent years, the frequency of severe weather-related events has increased, and this trend may continue in the future. Climate change is likely to expose us to an increased frequency and/or severity of weather-related losses, and there is a risk that our pricing of these perils or our management of the associated aggregations does not appropriately allow for changes in climate.
33


Over the longer term, climate change may have an impact on the economic viability of certain lines of business if suitable adjustments in price and coverage cannot be achieved.
Additionally, catastrophic events and the effects of climate change could result in increased credit exposure to reinsurers and other counterparties with whom we transact business, declines in the value of investments we hold and disruptions to our physical infrastructure, systems and operations.
Changes in security asset prices such as real estate, stocks and long-term bonds may impact the value of our investments, resulting in realized or unrealized losses on our invested assets. Climate-related risks to security asset prices can include, but are not limited to: (i) changes in supply/demand characteristics for fossil fuels (e.g., coal, oil, natural gas); (ii) advances in low-carbon technology and renewable energy development; (iii) effects of extreme weather events on the physical and operational exposure of issuers; and the (iv) transition that these companies make towards addressing climate risk in their own businesses.
We may also be exposed to liability risks. Liability risks relate to losses or damages suffered by our insureds from physical or transition risks, such as losses stemming from climate-related litigation in liability lines. These risks could arise from management and boards of directors not fully considering or responding to the impacts of climate change, or not appropriately disclosing current and future risks. In addition, new regulatory developments, increased litigation activity and subsequent liability issues associated with climate change or greenhouse gas emissions may lead to losses under environmental liability, product liability and directors and officers or professional liability, particularly where the emitter is deemed to have misled investors. In addition, there is a link between liability risk and transition risk as the failure of companies to shift towards a low-carbon future and mitigate the impacts of climate change may lead to losses incurred by insureds.
There is additionally a risk that certain elements of our business cease to be viable as a result of climate change 'transition' risks, which relate to losses driven by policy, legal, technological, and market changes to address climate risks and include changes in consumer behavior, shareholder preferences, and any additional regulatory and legislative requirements, such as carbon taxes. Through its fossil fuel policy, AXIS Capital has committed to fully phasing out thermal coal from its insurance and facultative reinsurance portfolios no later than 2030 in OECD countries and 2040 globally. Additionally, by the end of 2025, AXIS has committed to phasing out any existing investments in companies in the thermal coal or oil sands industries that exceed its policy thresholds in its fossil fuel policy. There remains a risk that our financial condition or operating performance may be impacted by changes in our business model arising from climate change transition and by the performance of strategies we put in place to manage this transition.
We are also subject to complex and changing laws, regulations and public policy debates relating to climate change and other environmental risks, including overlapping, yet distinct, climate change-related disclosure requirements in multiple jurisdictions. These are difficult to predict and quantify, may conflict with one another, and may impose additional costs on us, which in turn could have an adverse impact on our business.
Changes in regulations relating to climate change or our own leadership decisions implemented as a result of assessing the impact of climate change on our business may result in an increase in the cost of doing business or a decrease in premiums.
The effects of emerging claim and coverage issues on our business are uncertain.
As industry practices and legal, judicial, social, political, technological and other environmental conditions change, unexpected issues related to systemic risks, claims and coverage may emerge. These issues may adversely affect our business by either extending coverage beyond our underwriting intent or by increasing the frequency and/or severity of claims. For example, the 2008 global financial crisis resulted in a higher level of claim activity on professional lines insurance and reinsurance business. Moreover, legislative, regulatory, judicial or social influences may impose new obligations on insurers or reinsurers that extend coverage beyond the intended contractual obligations, or result in an increase in the frequency or severity of claims beyond expected levels, for example as described in the climate change risk factor. In some instances, the effects of these changes may not become apparent until after we have issued the impacted insurance or reinsurance contracts. In addition, actual losses may vary materially from the current estimate of losses based on a number of factors (refer to 'If actual claims exceed our loss reserves, our financial results could be adversely affected' below). As a result, the full extent of liability under an insurance or reinsurance contract may not be known for many years after the contract is issued and a loss occurs.

34


If actual claims exceed loss reserves, our financial results could be adversely affected.
While we believe that loss reserves at December 31, 2023 are adequate, new information, events or circumstances, unknown at the original valuation date, may lead to future developments in ultimate losses being significantly greater or less than the loss reserves currently provided. The actual final cost of settling claims outstanding at December 31, 2023, as well as claims expected to arise from the unexpired period of risk, is uncertain. There are many factors that would cause loss reserves to increase or decrease, which include, but are not limited to, changes in claim severity, changes in the expected level of reported claims, judicial action changing the scope and/or liability of coverage, changes in the legislative, regulatory, social and economic environment and unexpected changes in loss inflation.
When establishing our single point best estimate of loss reserves at December 31, 2023, management considered actuarial estimates and applied informed judgment regarding qualitative factors that may not be fully captured in actuarial estimates. Such factors included, but were not limited to, an examination of trend assumptions, the timing of the emergence of claims, volume and complexity of claims, current social and judicial trends, potential severity of individual claims and the extent of internal historical loss data versus new industry information.
Changes to previous estimates of prior year loss reserves can adversely impact the reported calendar year underwriting results if loss reserves prove to be insufficient or can favorably impact reported results if loss reserves prove to be higher than actual claim payments. If net income is insufficient to absorb a required increase in loss reserves, we would incur a net loss and could incur a reduction in capital.
The failure of our loss limitation strategy could have a material adverse effect on our results of operations, financial condition or liquidity.
We seek to mitigate loss exposure through multiple methods. For example, we write a number of reinsurance contracts on an excess of loss basis. Excess of loss reinsurance indemnifies the reinsured for losses in excess of a specified amount. We generally limit the line size for each client and line of business on our insurance business and purchase reinsurance for many of our lines of business. In the case of proportional reinsurance treaties, we seek per occurrence limitations or losses and loss expenses ratio caps to limit the impact of losses from any one event. In proportional reinsurance, the reinsurer shares a proportional part of the premiums and losses of the reinsured. We also seek to limit our loss exposure through geographic diversification. Geographic zone limitations involve significant underwriting judgments, including the determination of the area of the zones and the inclusion of a particular policy within a particular zone’s limits. In addition, various provisions of our insurance policies and reinsurance contracts, such as limitations or exclusions from coverage or choice of forum negotiated to limit our risks, may not be enforceable in the manner we intend. We cannot be sure that these loss limitation methods will effectively prevent a material loss exposure, which could have a material adverse effect on our results of operations, financial condition or liquidity.
If we choose to purchase reinsurance, we may be unable to do so on favorable terms or at all.
We purchase reinsurance for our insurance and reinsurance operations in order to mitigate the volatility of losses on our financial results. From time to time, market conditions have limited, and in some cases have prevented, insurers and reinsurers from obtaining the types and amounts of reinsurance that they consider adequate for their business needs. There is no guarantee that our desired amounts of reinsurance or retrocessional reinsurance will be available in the marketplace in the future. In the current environment, our ability to renew our current reinsurance or retrocessional reinsurance arrangements or obtain desired amounts of new or replacement coverage on favorable terms may be substantially reduced as a result of the impact of inflation, industry catastrophic losses to reinsurer capital and the appetite for certain lines of business. In addition to capacity risk, the remaining capacity may not be on terms we deem appropriate or acceptable or with companies with whom we want to do business. If we are unable to renew our current reinsurance or retrocessional reinsurance or purchase new or replacement coverage, on favorable terms or at all the amount of business we are willing to write may be limited or our protection from losses due to large loss events may be materially reduced.

35


We utilize models to assist our decision making in key areas such as underwriting, reserving, investment management, capital assessment, risk management, reinsurance purchasing and the evaluation of our catastrophe risk, and we could be adversely impacted if these models are inadequate or unfit for the purpose for which they are being used.
We employ various modeling techniques (for example, scenarios, predictive, stochastic and/or forecasting) to analyze and estimate exposures and risks associated with our assets and liabilities. We utilize modeled outputs and related analyses to assist us in decision-making, for example, related to underwriting and pricing, reserving, investment, capital assessment, risk management, reinsurance purchasing and the evaluation of our catastrophe risk through estimates of probable maximum losses, or "PMLs". The modeled outputs and related analyses, both from proprietary and third-party models, are subject to various assumptions, professional judgment, uncertainties and the inherent limitations of any statistical analysis, including the use and quality of historical internal and industry data. These models may turn out to be inadequate representations of the underlying subject matter, including as a result of inaccurate inputs or application thereof (whether due to data error, human error or otherwise). Consequently, actual losses from loss events, whether from individual components (for example, wind, flood, earthquake, etc.) or in the aggregate, may differ materially from modeled results. If, based upon these models or other factors, we misprice our products or underestimate the frequency and/or severity of loss events, our results of operations, financial condition or liquidity may be adversely affected. In addition, PMLs are based on results of stochastic models that consider a wide range of possible events, their losses and probabilities. It is important to consider that stochastic events are not an exact representation of actual events. Thus, an actual event does not necessarily resemble one of the stochastic events, and the specific characteristics of the actual event can lead to substantial differences between actual and modelled losses.
With respect to the evaluation of our catastrophe risk, our modeling utilizes a mix of historical data, scientific theory and mathematical methods. Output from multiple commercially available vendor models serves as a key input in our PML estimation process. We believe that there is considerable inherent uncertainty in the data and parameter inputs for these vendor models. In that regard, there is no universal standard in the preparation of insured data for use in the models and the running of modeling software. In our view, the accuracy of the models depends heavily on the availability of detailed insured loss data from actual recent large catastrophes. Due to the limited number of events, there is significant potential for substantial differences between the modeled loss estimate and actual company experience for a single large catastrophe event. This potential difference could be even greater for perils with limited or no modeled annual frequency. We perform our own vendor model validation (including sensitivity analysis and backtesting, where possible) and supplement model output with historical loss information and analysis and management judgment. In addition, we derive our own estimates for non-modeled perils. Despite this, our PML estimates are subject to a high degree of uncertainty, and actual losses from catastrophe events may differ materially.
We could be materially adversely affected if managing general agents, general agents, coverholders, other producers and third-party administrators in our program business exceed their underwriting and/or claims settlement authorities or otherwise breach obligations owed to us.
In program business conducted by the insurance segment, following our underwriting, financial, claims and information technology due diligence reviews, we authorize managing general agents, general agents, coverholders and other producers to write business and settle claims on our behalf within prescribed authorities. Once a program/coverholder commences, we must rely on the underwriting, operational and claims controls of these entities to write business within the authorities provided by us. Although we monitor our programs/coverholders on an ongoing basis, our monitoring efforts may not be adequate or these entities may exceed their underwriting or claims settlement authorities or otherwise breach obligations owed to us. To the extent that these entities exceed their authorities or otherwise breach obligations owed to us in the future, our results of operations or financial condition could be materially adversely affected.
Strategic Risk
Strategic risks affect or are created by an organization’s business strategy and strategic objectives. Our review of strategic risk evaluates not only internal and external challenges that might cause our chosen strategy to fail but also evaluates major risks that could affect our long-term performance and position.
Competition and consolidation in the insurance/reinsurance industry could reduce our growth and profitability.
The insurance/reinsurance industry is highly competitive. We compete on an international and regional basis with major U.S., Bermuda, European and other international insurers and reinsurers, including Lloyd's syndicates, some of which have greater financial, marketing and management resources. We also compete with new companies that enter the insurance/reinsurance markets. In addition, capital market participants have created alternative products that are intended to compete with insurance and reinsurance products. New and alternative capital inflows in the insurance/reinsurance industry and the retention by
36


insured and cedants of more business may cause an excess supply of insurance and reinsurance capital. There has been a large amount of merger and acquisition activity in the insurance/reinsurance sector in recent years, which may continue; we may experience increased competition as a result of that consolidation with consolidated entities having enhanced market power. Increased competition could result in fewer submissions, lower premium rates, less favorable policy terms and conditions and greater costs of customer acquisition and retention. If industry pricing does not meet our hurdle rate, we may reduce our future underwriting activities. These factors could have a material adverse effect on our growth and profitability.
The insurance industry is undergoing extensive technological change. There is increasing focus by traditional insurance industry participants, technology companies, including new insurance technology companies ("InsurTech") and others on using technology and innovation (including artificial intelligence, digital platforms, data analytics, and robotics), to disrupt and/or enhance current business models and operations. This includes market-wide enabling technology initiatives (e.g. Blueprint 2 in the London Market). We expect this trend to enable enhanced customer focus, greater efficiencies, delivery of more relevant products and other sources of competitive advantage. If we do not adapt to these technological changes, it could harm our ability to compete, which could have a material adverse impact on our growth or profitability.
Furthermore, enhanced competition could drive innovation, technological change and changing customer preferences in the markets in which we operate, and these changes could pose other risks to our businesses. For example, they could result in increasing expenses as we make investments to innovate our products and services.
In addition, certain of our strategic choices, including our exit from catastrophe and property reinsurance lines of business in 2023, could impact our competitive position, which could have an impact on existing relationships and market share.
Global economic conditions could adversely affect our business, results of operations or financial condition.
The global economic environment continues to be impacted by inflationary pressures, high interest rates, and uncertainty regarding the geopolitical environment, the possibility of a recession, government shutdowns, debt ceilings and the tightening of capital availability. During 2022 and the first half of 2023, inflation reached and stayed unusually high in many parts of the world, and central banks in the U.S. and other countries raised interest rates to counter inflation by slowing economic activity. Monetary policy tightening actions are ongoing at December 31 2023, and their long-term impact on financial markets and the real economy is still uncertain. Uncertainty and market turmoil has affected and may in the future affect, among other aspects of our business, the demand for and claims made under our products, the ability of customers, counterparties and others to establish or maintain their relationships with us, our ability to access and efficiently use internal and external capital resources and our investment performance and portfolio. We also provide coverage to the mortgage industry through insurance and reinsurance of mortgage insurance companies and U.S. government sponsored entity credit risk sharing transactions, and deteriorating economic conditions could cause mortgage insurance losses to increase and adversely affect our results of operations or financial condition.
In addition, steps taken by central banks to control inflation and/or governments to stabilize financial markets and improve economic conditions may be ineffective, and actual or anticipated efforts to continue to unwind some of such steps could disrupt financial markets and/or could adversely impact the value of our investment portfolio. Further increases in interest rates would decrease unrealized gains and/or increase unrealized losses on our debt securities portfolio, partially offset by our ability to earn higher rates of return on reinvested funds. Higher inflation could lead to even higher interest rates, which would continue to negatively impact the value of our existing fixed income or other investments.
Given the ongoing global economic uncertainties, evolving market conditions may continue to affect our results of operations, financial condition, and capital resources. In the event that there is additional deterioration or volatility in financial markets or general economic conditions, our results of operations, financial condition, capital resources, and competitive landscape could be materially and adversely affected.
In connection with the implementation of our corporate strategies, we face risks associated with the acquisition or disposition of businesses, the entry into new lines of business, the integration of acquired businesses and the growth and development of these businesses.
As part of our strategy, we have pursued and may continue to pursue growth through acquisitions, or we may dispose of or exit businesses we currently own. The success of this strategy is dependent upon our ability to identify appropriate acquisition and disposition targets, negotiate transactions on favorable terms, complete transactions and, in the case of acquisitions, successfully integrate them into our existing businesses. If a proposed transaction is not consummated, the time and resources spent in researching it could adversely result in missed opportunities to locate and acquire other businesses. In addition, the negotiation of potential acquisitions as well as the integration of an acquired business or new personnel could result in a substantial diversion of management resources. Successful integration may depend on, among other things, our
37


ability to effectively integrate acquired businesses or new personnel into our existing risk management and financial and operational reporting systems, our ability to effectively manage any regulatory issues created by our entry into new markets and geographic locations, our ability to retain key personnel and other operational and economic factors. There can be no assurance that the integration of acquired businesses or new personnel will be successful, or that we will realize anticipated synergies, cost savings and operational efficiencies, or that the business acquired will prove to be profitable or sustainable. Acquisitions could involve numerous additional risks such as potential losses from unanticipated litigation, levels of claims and an inability to generate sufficient revenue to offset acquisition costs. Failure to manage these risks could materially and adversely affect our business, financial condition and results of operations. If we dispose of or otherwise exit certain businesses, there can be no assurance that we will not incur certain disposition related charges, or that we will be able to reduce overhead related to the divested assets.
From time to time, either through acquisitions or internal development, we may enter new lines of business or offer new products and services within existing lines of business. These new lines of business or new products and services may present additional risks, particularly in instances where the markets are not fully developed. Such risks include the investment of significant time and resources; the possibility that these efforts will not be successful, or that we are unable to retain clients; and the risk of additional liabilities associated with these efforts. Failure to manage these risks in the development of new lines of businesses could materially and adversely affect our business, financial condition and results of operations.
New regulations relating to the U.K.'s withdrawal from the E.U. could adversely affect us.
In January 2020, the U.K. ceased to be a member of the EU ("Brexit"). AXIS Specialty Europe SE accesses the U.K. market through a third country branch in the U.K. In February 2023 the European Insurance and Occupational Pensions Authority ("EIOPA") published a Supervisory Statement on governance of third country branches. Although this Supervisory Statement is directed towards national supervisory authorities, it does set out how EIOPA expects third country branches to be supervised across the European Union. In Ireland, the Central Bank of Ireland has published its response to this Supervisory Statement, and made its expectations of the insurers clear. AXIS Specialty Europe SE has conducted a gap analysis against these Central Bank of Ireland expectations, and has not found any gaps.
Lloyd’s accesses the European Union market through its Belgium based insurance company, Lloyd’s Insurance Company S.A., which has a third country branch in the U.K. In Belgium, the National Bank of Belgium has not yet made any public announcement regarding the EIOPA Supervisory Statement. As change the status quo by the National Bank of Belgium could impact Lloyd’s Insurance Company S.A., and consequently AXIS Managing Agency Limited. We continue to monitor this situation closely.
Since we depend on a few brokers for a large portion of our revenues, loss of business provided by any one of them could have a material adverse effect on our business.
We market our insurance and reinsurance products worldwide primarily through insurance and reinsurance brokers and derive a significant portion of our business from a limited number of brokers. Aon plc, Marsh & McLennan Companies, Inc., including its subsidiary Guy Carpenter & Company, Inc. and Arthur J. Gallagher & Co., provided 38% of gross premiums written in 2023. Our relationships with these brokers are based on the quality of our underwriting and claims services, as well as our financial strength ratings. Any deterioration in these factors could result in the brokers advising our clients to place their business with other insurers and reinsurers. In addition, these brokers also have, or may in the future acquire, ownership interests in insurance and reinsurance companies that may compete with us; these brokers may then favor their own insurers and reinsurers over other companies. Loss of all or a substantial portion of the business provided by one or more of these brokers could have a material adverse effect on our business.
A downgrade in our financial strength or credit ratings by one or more rating agencies could adversely affect our business, results of operations, financial condition or liquidity.
Financial strength, claims paying and credit ratings are important factors in establishing the competitive position of insurance companies and maintaining customer confidence in us and in our ability to market insurance products. Independent rating agencies analyze the financial performance and condition of insurers on an ongoing basis.
We have experienced, and there can be no assurance that we will not experience in the future, a ratings downgrade or other negative action from one of the independent rating agencies. This could arise from a change in our financial performance, our financial condition or a change in ratings methodology. Ratings agencies may also heighten the level of scrutiny they apply when analyzing companies in our industry, adjust upward the capital and other requirements employed in their models and/or discontinue credit and debt instruments or other structures deployed for maintenance of certain rating levels. A downgrade,
38


withdrawal or negative watch/outlook by any independent rating agency could cause our competitive position in the insurance/reinsurance industry to suffer and make it more difficult for us to market our products. In addition, if we experience a credit rating downgrade, withdrawal or negative watch/outlook in the future, we could incur higher borrowing costs and may have more limited means to access capital. A downgrade, withdrawal or negative watch/outlook could also result in a substantial loss of business for us, as ceding companies and brokers that place such business may move to other insurers and reinsurers with higher ratings. We would also be required to post collateral under the terms of certain of our policies of reinsurance.
We may require additional capital in the future, which may not be available or may only be available on unfavorable terms.
Our future capital requirements depend on many factors, including rating agency and regulatory requirements, the performance of our investment portfolio, our ability to write new business successfully, the frequency and severity of catastrophe events and our ability to establish premium rates and loss reserves at levels sufficient to cover losses. We may need to raise additional funds through financings. If we are unable to do so, it may curtail our ability to conduct our business.
Any equity or debt financing, if available at all, may be on terms that are not favorable to us. As economic and market uncertainty continues, it is possible that access to the capital markets may become more constrained and cost of capital may increase. Equity financings could be dilutive to our existing shareholders and could result in the issuance of securities that have rights, preferences and privileges that are senior to those of our other securities. If we cannot obtain adequate capital on favorable terms or at all, our business, operating results and financial condition could be adversely affected.
Our inability to obtain the necessary credit could adversely affect our ability to offer reinsurance in certain markets.
Neither AXIS Specialty Bermuda nor AXIS Re SE is licensed or admitted as an insurer or reinsurer in any jurisdiction other than Bermuda, Ireland, Singapore and Brazil. Because the U.S. and certain other jurisdictions do not permit insurance companies to take credit on their statutory financial statements for reinsurance obtained from unlicensed or non-admitted insurers unless appropriate security mechanisms are in place, our reinsurance clients in these jurisdictions typically require AXIS Specialty Bermuda and AXIS Re SE to provide letters of credit or other collateral, unless such reinsures have obtained reciprocal jurisdiction reinsurer status in the reinsured's domiciliary state. Our credit facilities are used to post letters of credit. However, if our credit facilities are not sufficient or if we are unable to renew our credit facilities or arrange for other types of security on commercially affordable terms, AXIS Specialty Bermuda and AXIS Re SE could be limited in their ability to write business for some of our clients.
We could be adversely affected by turnover of senior management, the loss of one or more key executives, an inability to attract and retain qualified personnel or by the inability of an executive to obtain a Bermuda work permit.
Our success depends on our ability to retain our existing key executives and to attract, hire and retain additional qualified personnel. There is significant competition from within the insurance industry and from businesses outside the industry for exceptional employees, especially in key positions. Our competitors may be able to offer a work environment with higher compensation or more opportunities. Any new personnel we hire may not be or become as productive as we expect, as we may face challenges in adequately or appropriately integrating them into our workforce and culture. Our effort to retain and develop personnel may also result in significant additional expenses, which could adversely affect our profitability. The loss of any of our key executives or the inability to attract, hire and retain other highly qualified personnel (whether as a result of an insufficient number of qualified applicants, difficulty in recruiting new employees, or inadequate resources to train, integrate, and retain qualified employees) could adversely affect our ability to conduct our business. Changes to or turnover among senior management or key executives could disrupt the Company’s strategic focus and operational capabilities. These changes, and the potential failure to retain and recruit senior management and other key employees, could have a material adverse effect on the Company’s operations and ability to manage the day-to-day aspects of its business. Unexpected or abrupt departures may result in the failure to effectively transfer roles, responsibilities, and institutional knowledge and may impede our ability to act quickly and efficiently in executing our business strategy as we devote resources to recruiting new personnel or transitioning existing personnel to fill those roles. Moreover, changes in local employment legislation, taxation and the approach of regulatory bodies to compensation practices within our operating jurisdictions may impact our ability to recruit and retain qualified personnel or the cost to us of doing so. In addition, health emergencies or pandemics could impact our ability to attract and retain key personnel. There can be no assurance that we will be successful in identifying, hiring or retaining successors on terms acceptable to us.

39


With few exceptions, generally only Bermudians, spouses of Bermudians or Permanent Resident Certificate holders (collectively, "Residents") may engage in any gainful occupation in Bermuda without an appropriate governmental work permit. Work permits may be granted or extended by the Bermuda government only upon showing that, after proper public advertisement (in most cases), no Residents who meet the minimum standard requirements for the advertised position have applied for the position. Work permits are generally granted for one-, three- or five-year durations. Expatriate workers can, subject to the above, continue to be employed in Bermuda indefinitely by reapplying for work permits. All executives who periodically work in our Bermuda office and who require work permits have obtained them.
Increasing scrutiny and evolving expectations from investors, customers, regulators, policymakers and other stakeholders regarding environmental, social and governance matters may adversely affect our reputation or otherwise adversely impact our share price, demand for our securities and business and results of operations.
Investors, customers, regulators, policymakers and other stakeholders have placed increased importance on environmental, social and governance ("ESG") practices and disclosures. Certain institutional investors, investor advocacy groups, investment funds, creditors and other influential financial markets participants have become increasingly focused on companies’ ESG practices and disclosures in evaluating their investments and business relationships. The heightened and sometimes conflicting stakeholder focus on ESG issues related to our business requires the continuous monitoring of various and evolving laws, regulations, standards and expectations and the associated reporting requirements.
In addition, regulators have adopted and likely will continue to adopt pro- or anti-ESG-related rules and guidance, which may conflict with one another and impose additional costs on us. Pressure from key stakeholders to comply with additional voluntary ESG-related initiatives or frameworks could also require us to make substantial investments in ESG matters, which could impact the results of our operations. ESG encompasses a wide range of issues, including climate change and other environmental risks, diversity and inclusion and governance standards. We cannot predict whether our business decisions, business strategy and disclosures relating to ESG issues will meet the expectations or requirements of relevant stakeholders, including certain key institutional shareholders. In the event that we publicly disclose, voluntarily or otherwise, certain goals or initiatives regarding ESG matters, we could fail, or we could be perceived to fail, in our achievement of such initiatives or goals, or we could be criticized for the scope of such initiatives or goals. This could result in adverse publicity, reputational harm, or loss of customer and/or investor confidence, which could adversely affect our business and results of operations. In addition, our share price and demand for our securities could be adversely affected.
Pandemics or other outbreaks of contagious diseases and efforts to mitigate their spread have had, and could in the future have, widespread impacts on the way we operate.
The spread of COVID-19 and mitigating measures caused unprecedented disruptions to the global economy and normal business operations across sectors and countries, including the sectors and countries in which we operate. A resurgence of the COVID-19 outbreak, including as a result of new variants, or future pandemics or other outbreaks of contagious diseases may result in similar or worse economic implications and disruptions.
Market Risk
Market risk is the risk that our financial instruments, which include derivatives, may be negatively impacted by movements in financial market prices or rates such as interest rates, credit spreads, equity securities' prices and foreign currency exchange rates.
Our investment portfolios are exposed to significant capital markets risk related to changes in interest rates, credit spreads and equity prices, as well as other risks, which may adversely affect our results of operations or financial condition.
The performance of our cash and investments portfolio has a significant impact on our financial results. A failure to successfully execute our investment strategy could have a significant impact on our results of operations or financial condition.
Our investment portfolio is subject to a variety of market risks, including risks relating to general economic conditions, interest rate fluctuations, equity price risk, foreign currency movements, pre-payment or reinvestment risk, liquidity risk and credit risk. We manage market risks through, among other things, stressing diversification and conservation of principal and liquidity in our investment guidelines. An extended period of poor global financial market returns would adversely impact the value of our investment portfolio.

40


Fixed maturities, which represent 85% of our total investments and 77% of total cash and investments at December 31, 2023, may be adversely impacted by changes in interest rates or credit spreads. Increases in yields could cause the fair value of our investment portfolio to decrease, resulting in a lower book value (refer to Item 7A 'Quantitative and Qualitative Disclosure About Market Risk' for further details) and capital resources. A decline in yields may result in reductions in our investment income as new funds and proceeds from sales and maturities of fixed income securities are reinvested at lower rates. This reduces our overall future profitability. Interest rates and credit spreads are highly sensitive to many factors, including governmental and central bank monetary policies, inflation, domestic and international economic and political conditions, corporate profitability and other factors beyond our control. In 2023, the U.S. Federal Reserve and other central banks increased interest rates at various times to stem inflation and may further increase rates in the future.
Our portfolios of "other investments" and equity securities expose us to market price variability, driven by a number of factors outside of our control including, but not limited to global equity market performance. Given our reliance on external investment managers, we are also exposed to operational risks, which may include, but are not limited to a failure to follow our investment guidelines, technological and staffing deficiencies and inadequate disaster recovery plans.
Our derivative instrument counterparties may default on amounts owed to us due to bankruptcy, insolvency, lack of liquidity, adverse economic conditions, operational failure, fraud or other reasons. Even if we are entitled to collateral in circumstances of default, such collateral may be illiquid or proceeds from such collateral when liquidated may not be sufficient to recover the full amount of the obligation.
Our operating results may be adversely affected by currency fluctuations.
Our reporting currency is the U.S. dollar. However, a portion of gross premiums are written and ceded in currencies other than the U.S. dollar and a portion of gross and ceded loss reserves in currencies other than the U.S. dollar. In addition, a portion of our investment portfolio is denominated in currencies other than the U.S dollar. We may experience losses or gains resulting from fluctuations in the values of these non-U.S. currencies. Although we manage our foreign currency exposure through matching of our major foreign-denominated assets and liabilities, as well as through use of currency derivatives, there is no guarantee that we will successfully mitigate our exposure to foreign exchange losses due to unfavorable currency fluctuations. If we fail to manage our foreign currency exposures or experience unfavorable currency fluctuations due to factors such as political unrest, sovereign debt concerns, inflation or other macro-economic factors in jurisdictions in which we operate our results of operations could be materially adversely impacted.
Liquidity Risk
Liquidity risk is the risk that we may not have sufficient cash to meet our obligations when they are due, or would have to incur excessive costs to do so.
Our underwriting activities may expose us to liquidity risks.
Our exposure to liquidity risk stems mainly from the need to pay claims on potential extreme loss events and regulatory constraints that limit the flow of funds within the Group. We maintain cash and cash equivalents and high quality, liquid securities to meet expected outflows, including outflows that could result from a range of potential stress events. We place internal limits on the maximum percentage of cash and investments that may be in an illiquid form as well as on the minimum percentage of our asset portfolio that must be invested in unrestricted cash and liquid investment grade fixed income securities.
Additionally, we have access to diverse funding sources to cover contingencies. Funding sources include asset sales and external debt issuances, and we may seek to establish additional borrowing facilities to cover such contingencies. We conduct stress tests to ensure the sufficiency of these funding sources in extreme scenarios; however, there remains a risk that in certain circumstances, our results of operations or financial condition may be adversely impacted by our inability to access appropriate liquidity or the cost of doing so.

41


Credit Risk
Credit risk represents the risk of incurring financial loss due to the diminished creditworthiness (reduced financial strength and, ultimately, possibly default) and concentration of our third-party counterparties (refer to 'Market Risk' above for a discussion of credit risk as it relates to the investment portfolio).
If we successfully purchase reinsurance, we may be unable to collect amounts due to us.
A reinsurer’s insolvency, inability or refusal to make payments under the terms of its reinsurance agreement with us, could have a material adverse effect on our business because we remain liable to the insured. We face counterparty risk whenever we purchase reinsurance or retrocessional reinsurance, and inflation and industry catastrophic losses have heightened this risk as counterparties experience economic strains and uncertainty. Consequently, the insolvency, inability or unwillingness of any of our present or future reinsurers to make timely payments to us under the terms of our reinsurance or retrocessional agreements could have a material adverse effect on our results of operations, financial condition, or liquidity.
Our reliance on brokers subjects us to credit risk.
In accordance with industry practice, we pay amounts owed on claims under our insurance and reinsurance contracts to brokers, and these brokers pay these amounts to clients that have purchased insurance and reinsurance from us. Although the law is unsettled and depends upon the facts and circumstances of the particular case, in some jurisdictions, if a broker fails to make such a payment, we might remain liable to the insured or ceding insurer for the deficiency.
Conversely, in certain jurisdictions, when the insured or ceding insurer pays premiums for these policies to brokers for payment to us, these premiums might be considered to have been paid to us and the insured or ceding insurer will no longer be liable to us for those amounts, whether or not we have actually received the premiums from the broker. Consequently, we assume a degree of credit risk associated with brokers with whom we transact business. These risks are heightened during periods characterized by financial market instability and/or an economic downturn or recession.
Certain of our policyholders and intermediaries may not pay premiums owed to us due to insolvency or other reasons.
Insolvency, liquidity problems, distressed financial conditions or the general macro-economic conditions may increase the risk that policyholders or intermediaries, such as insurance brokers, may not pay a part of or the full amount of premiums owed to us, despite an obligation to do so. The terms of our contracts may not permit us to cancel our insurance even though we have not received payment. If non-payment becomes widespread, due to insolvency, lack of liquidity, adverse economic conditions, operational failure or otherwise, it could have a material adverse impact on our revenues and results of operations.
Operational Risk
Operational risk represents the risk of loss as a result of inadequate processes, system failures, human error or external events, including but not limited to direct or indirect financial loss, reputational damage, customer dissatisfaction, and legal and regulatory penalties.
We rely on our processes, people, and systems to maintain our operations and manage the operational risks inherent to our business. Any errors, omissions or misconduct by our employees or third-party agents in the execution of these processes may result in financial losses.
We rely on the execution of our processes, people, and systems to maintain and execute our operations. We seek to monitor and control our exposure to risks arising from these processes through an enterprise risk management framework, internal controls, management review and other processes. We cannot provide total assurance that these processes will effectively identify or control all risks, or that our employees and third-party agents will effectively execute them. Loss may result from, among other things, actual or alleged fraud; errors; or failure to document transactions properly, obtain proper internal authorization, comply with underwriting or other internal guidelines, or comply with regulatory requirements. Further, we have launched a strategic initiative aimed at improving our operating model. As a result, we are experiencing a significant volume and pace of change activity, which could result in a higher frequency and higher impact of operational errors. In addition, employee turnover (including of employees in senior positions) could increase the risk of operational errors if we fail to effectively transfer roles and responsibilities. These risks could result in losses that adversely affect our business, results of operations, or financial condition. An extended period of remote work arrangements could increase or introduce new operational risk and adversely affect our ability to manage our exposure to risks arising from our internal processes. Furthermore, insurance policies provided by third parties may not cover us if we experience a significant loss from these risks.
42


If we experience difficulties with technology and/or data security, our ability to conduct our business might be adversely affected.
While technology can streamline many business processes and ultimately reduce the cost of operations, technology initiatives present certain risks. Our business is dependent upon our employees’ and outsourcers’ ability to perform, in an efficient and uninterrupted fashion, necessary business functions such as processing policies and paying claims. A shutdown or inability to access one or more of our outsourcers' facilities, a power outage, or a failure of one or more of our outsourcers' information technology, telecommunications or other systems could significantly impair our ability to perform such functions on a timely basis. If sustained or repeated, such a business interruption, system failure or service denial could result in a deterioration of our ability to write and process business, provide customer service, pay claims in a timely manner or perform other necessary business functions. Despite our robust business continuity plan, which addresses the risk of such business interruption, system failure or service denial with input from both internal and external stakeholders, our systems may still be impacted. Unauthorized access, computer viruses, deceptive communications (phishing), malware, hackers and other external hazards including catastrophe events could expose our data systems to security breaches. These risks could expose us to data loss and damages.
Any of these eventualities could result in a material and adverse effect on our business, results of operations and financial condition.
Like other global companies, we are regularly the target of attempted cyber and other security threats and must continuously monitor and develop our information technology networks and infrastructure to prevent, detect, address and mitigate the risk of threats to our data and systems. These attacks and incidents have included, or may in the future include: unauthorized access, viruses, malware or other malicious code, ransomware, deceptive social engineering campaigns (also known as "phishing" or "spoofing"), loss or theft of assets, employee errors or malfeasance, third-party errors or malfeasance, as well as system failures and other security events. Over time, and particularly recently, the sophistication of these threats continues to increase. While administrative and technical controls, along with other preventive actions, reduce the risk of cyber incidents and protect our information technology, they may be insufficient to thwart cyber-attacks and/or prevent other security breaches to our systems.
While we have not experienced a recent disruption or security breach, to the extent any such disruption or breach results in a loss or damage to our data, or inappropriate disclosure of our confidential information or that of others, it could impact our operations, cause significant damage to our reputation, affect our relationships with our customers and clients, lead to claims against us under various data privacy laws, result in regulatory action and ultimately have a material adverse effect on our business or operations. In addition, although we purchase limited cyber insurance, we may incur significant costs not covered by our cyber insurance, including costs to mitigate the damage caused by any security breach, address any interruptions in our business or protect against future damage.
We also operate in a number of jurisdictions with strict data privacy and other related laws, which could be violated in the event of a significant cybersecurity incident, or by personnel. Failure to comply with these obligations can give rise to monetary fines and other penalties that could be material.
Our business may be adversely affected if third-party service providers fail to satisfactorily perform certain technology and business process functions.
We outsource certain technology and business process functions to third parties. If we do not effectively develop and implement our outsourcing strategy, or if third-party service providers do not perform as anticipated or we experience technological or other problems with a transition to a third-party service provider, we may not realize productivity improvements or cost efficiencies and may experience operational difficulties, increased costs and a loss of business. In addition, our outsourcing of certain technology and business process functions to third parties may expose us to enhanced risk related to data security, which could result in monetary and reputational damages. In addition, our ability to receive services from third-party providers could be impacted by political instability or unanticipated regulatory requirements which in turn could materially adversely affect our ability to conduct our business.
43


Regulatory Risk
Regulatory risk represents the risk arising from our failure to comply with legal, statutory or regulatory obligations.
Compliance with data protection and privacy laws and regulations governing the processing of personal data and information is a legal requirement, and non-compliance may impede our services or result in increased costs. Failure to comply could result in material fines and/or penalties imposed by data protection and/or financial services regulators. In addition, any data breach may have an adverse effect on our reputation, results of operations or financial condition, or have other adverse consequences.
Our business relies on the processing of data in many jurisdictions and the movement of data across national borders. The collection, storage, handling, disclosure, use, transfer and security of personal information that occurs in connection with our business is subject to federal, state and foreign data privacy laws. These legal requirements are not uniform and continue to evolve, and regulatory scrutiny in this area is increasing around the world. In many cases, these laws apply not only to third-party transactions, but also to transfers of information within the Group. Privacy and data protection laws may be interpreted and applied differently from country to country and may create inconsistent or conflicting requirements.
The General Data Privacy Regulation ("GDPR") has extra-territorial effect. It requires all companies processing data of E.U. citizens to comply with the GDPR, regardless of the company’s location, and also imposes obligations on E.U. companies processing data of non-E.U. citizens. In particular, the GDPR imposes requirements regarding the processing of personal data and confers new rights on data subjects, including rights of access to their personal data, deletion of their personal data, the "right to be forgotten" and the right to "portability" of personal data. In the U.K., the Data Protection Act 2018 and the U.K. General Data Protection Regulation, which is the retained E.U. law version of the GDPR by virtue of the European Union (Withdrawal) Act 2018 and as amended by the Data Protection, Privacy and Electronic Communications (Amendments etc.) (E.U. Exit) Regulations 2019 (collectively, "U.K. GDPR"), regulates data protection for all individuals within the U.K. and applies to all our subsidiaries operating in the U.K. On September 1, 2023, Switzerland’s revised Federal Act on Data Protection ("FADP"”) came into effect, which like other privacy laws grants Swiss citizens privacy rights.
The California Consumer Privacy Act ("CCPA") effective on January 1, 2020 confers rights on California residents including rights to know what personal information is collected about them and whether their personal information is sold (and if so, to whom), to access any personal information that has been collected and to require a business to delete their personal information. The California Privacy Rights Act ("CPRA") took effect on January 1, 2023 with a "look back" to January 1, 2022, meaning that data collected in the 2022 calendar year became subject to the terms of the CPRA beginning on January 1, 2023. The California Privacy Protection Agency ("CPPA") also promulgated CPRA regulations that will become enforceable on March 29, 2024. The CCPA is expected to promulgate further CPRA regulations in the near future. The CPRA will work as an addendum to the CCPA, strengthening the rights of California residents, tightening business regulations on the use of personal information and establishing the CPPA as the state-wide data privacy enforcer. Washington state also passed the My Health My Data act ("MHMD"), which comes into effect March 29, 2024. MHDA is limited to certain health data, but individuals in Washington will have similar privacy rights for some health data that is covered under this law. Overall, in the US, there continues to be a lot of changes in the data protection and privacy landscape, which we continue to expect next year. As states continue to focus on data protection, our compliance burden may increase.
Compliance with the enhanced obligations imposed by data protection and other legislation, including Singapore's amended Personal Data Protection Act, Bermuda’s Personal Information Protection Act, and Quebec’s Law 25, requires investment in appropriate technical or organizational measures to safeguard the rights and freedoms of data subjects. Such investment may result in significant costs to our business and may require us to modify certain of our business practices. In addition, enforcement actions, investigations and the imposition of substantial fines and penalties by regulatory authorities as a result of data security incidents and privacy violations have increased dramatically over the past several years. The enactment of more restrictive laws, rules, regulations or future enforcement actions or investigations could impact us through increased costs or restrictions on our business, and noncompliance could result in regulatory penalties and significant legal liability.
Unauthorized disclosure or transfer of sensitive or confidential client or Company data, whether through systems failure, employee negligence, fraud or misappropriation, by the Company or other parties with whom we do business, could also subject us to significant litigation, monetary damages, regulatory enforcement actions, fines and criminal prosecution in one or more jurisdictions. Such events could also result in negative publicity and damage to our reputation and cause us to lose business, which could therefore have a material adverse effect on our results of operations or financial condition.
44


Our insurance and reinsurance subsidiaries are subject to supervision and regulation. Changes to existing regulation and supervisory standards, or failure to comply with them, could have an adverse effect on our business, results of operations and financial condition, or result in negative publicity, reputational damage or harm to our relationships.
Our insurance and reinsurance subsidiaries conduct business globally and are subject to varying degrees of regulation and supervision in multiple jurisdictions. In particular, in the U.K., Lloyd's has supervisory powers that pose unique regulatory risks. The laws and regulations of the jurisdictions and markets, including Lloyd's, in which our insurance and reinsurance subsidiaries are domiciled or operate require, among other things, that our subsidiaries maintain minimum levels of statutory capital and liquidity, meet solvency standards, participate in guaranty funds and submit to periodic examinations of their financial condition and compliance with underwriting and other regulations. These laws and regulations also limit or restrict payments of dividends and reductions in capital. Statutes, regulations and policies may also restrict the ability of these subsidiaries to write insurance and reinsurance contracts, make certain investments and distribute funds. The purpose of insurance laws and regulations generally is to protect insureds and ceding insurance companies, not our shareholders. We may not be able to comply fully with, or obtain appropriate exemptions from, these laws and regulations, which could result in restrictions on our ability to do business or undertake activities that are regulated in one or more of the jurisdictions in which we conduct business and could subject us to fines and other sanctions. In addition, changes in the laws or regulations to which our insurance and reinsurance subsidiaries are subject or in the interpretation thereof by enforcement or regulatory agencies could impact the competitive market, as well as the way we conduct our business and manage our capital, resulting in lower revenues and higher costs. This in turn could have a material adverse effect on our business, results of operations and financial condition. The rate of legal and regulatory change, particularly in the UK and Ireland, has been increasing in recent years, with initiatives such as Consumer Duty in the UK and the Individual Accountability Framework in Ireland adding to the regulatory burden on our operating entities. Further to this, increased regulatory scrutiny in the form of reviews and inspections can put a strain on our resources.
Insurance regulatory authorities have broad authority to initiate investigations or other proceedings, and, in connection with a failure to comply with applicable laws and regulations, could impose adverse consequences, including fines, penalties, injunctions, denial or revocation of an operating license or approval, increased scrutiny or oversight, limitations on engaging in a particular business, or redress to clients. Further to this, regimes such as the Senior Managers and Certification Regime in the UK, and the Individual Accountability Regime in Ireland, place personal responsibility on key members of senior staff and Board members, meaning the regulators can take action directly against these individuals as well. These actions also could result in negative publicity, reputational damage or harm to client, employee or other relationships.
Potential government intervention in our industry as a result of recent events and instability in the marketplace for insurance products could hinder our flexibility and negatively affect the business opportunities that may be available to us in the market.
Government intervention and the possibility of future government intervention have created uncertainty in insurance and reinsurance markets. Government and regulators generally require insurers and reinsurers to have high solvency ratios and localized capital to ensure the protection of policyholders to the possible detriment of other constituents, including shareholders of insurers and reinsurers. Government, regulatory and judicial actions across multiple jurisdictions in relation to business interruption insurance have exacerbated the uncertainty by altering the interpretation of our contracts or extending or changing coverage (beyond the obligations set forth within those contracts or beyond what was intended by the parties).
Certain U.S. and non-U.S. judicial and regulatory authorities, including U.S. Attorneys offices and certain state attorneys general, occasionally commence investigations into business practices in the insurance industry. In addition, although the U.S. federal government has not historically regulated insurance, there have been proposals from time to time to impose federal regulation on the U.S. insurance industry. Further, Dodd-Frank gives the Federal Reserve supervisory authority over certain U.S. financial services companies, including insurance companies, if they are designated as 'systemically important' by a two-thirds vote of a Financial Stability Oversight Council. While we do not believe that we are systemically important, as defined in Dodd-Frank, Dodd-Frank or additional federal or state regulation that is adopted in the future could impose significant burdens on us, impact the ways in which we conduct our business and govern our subsidiaries, increase compliance costs, increase the levels of capital required to operate our subsidiaries, duplicate state regulation and/or result in a competitive disadvantage.

45


Our European insurance and reinsurance entities are subject to local laws that implement the Solvency II Directive. Solvency II covers three main areas: (i) the valuation of assets and liabilities on a Solvency II economic basis and risk-based solvency and capital requirements; (ii) governance requirements including requirements relating to the key functions of compliance, internal audit, actuarial and risk management; and (iii) new supervisory legal entity and group reporting and disclosure requirements including public disclosures. In the lead-up to Brexit, the U.K. government onshored all Solvency II legislation into U.K. law. However, the U.K. is now seeking to make wholesale changes to its Solvency II regime, and is consulting with the industry on these proposed changes, which are due to come into effect for financial year ending December 31, 2024. The European Commission has not granted the U.K. Solvency II equivalence and is unlikely to do so in light of upcoming changes. The European Commission is also reviewing its Solvency II regime, with trialogue negotiations commencing in September 2023. Changes to the European Solvency II regime are not expected imminently.
While we cannot predict the exact nature, timing or scope of possible governmental initiatives, such proposals could materially adversely affect our business by, among other things:
Providing reinsurance capacity in markets and to consumers that we target;
Requiring our further participation in industry pools and guaranty associations;
Expanding the scope of coverage under existing policies; e.g., following large disasters;
Further regulating the terms of insurance and reinsurance contracts; or
Disproportionately benefiting the companies of one country over those of another.
Our business is subject to certain laws and regulations relating to sanctions and foreign corrupt practices, the violation of which could have a material adverse effect on our financial condition and operating results.
We must comply with all applicable economic and financial sanctions, other trade controls and anti-bribery laws and regulations of the U.S. and other foreign jurisdictions where we operate, including Bermuda, the U.K. and the European Union. U.S. laws and regulations applicable to us include the economic trade sanctions laws and regulations administered by the U.S. Department of Treasury’s Office of Foreign Assets Control as well as certain laws administered by the U.S. Department of State. These laws and regulations are complex, frequently changing, and increasing in number, and they may impose additional prohibitions or compliance obligations on our dealings in certain countries and territories, including sanctions imposed on Russia and certain Ukraine territories. In addition, we are subject to the Foreign Corrupt Practices Act and other anti-bribery laws, such as the Irish Criminal Justice (Corruption Offences) Act, the Bermuda Bribery Act and the U.K. Bribery Act, which generally bar corrupt payments or unreasonable gifts. Although we have policies and controls in place that are designed to ensure compliance with these laws and regulations, it is possible that an employee or an agent acting on our behalf could fail to comply with applicable laws and regulations and, due to the complex nature of the risks, it may not always be possible for us to ascertain compliance with such laws and regulations. In such event, we could be exposed to civil penalties, criminal penalties and other sanctions, including fines or other unintended punitive actions. In addition, such violations could damage our business and/or our reputation. All of the foregoing could have a material adverse effect on our financial condition and operating results.
Risks Related to the Ownership of our Securities
In addition to the risks to our business listed above, there are certain other risks related to the ownership of our securities.
The price of our common shares may be volatile.
There has been significant volatility in the market for equity securities in recent years. During 2023, 2022, and 2021 the closing price of our common shares fluctuated from a low of $51.68 to a high of $63.47, a low of $48.77 to a high of $60.66, and a low of $44.93 to a high of $57.93, respectively. The price of our common shares may not remain at or exceed current levels. The following factors, in addition to those described in other risk factors above, may have a material adverse effect on the market price of our common stock:
actual or anticipated variations in our quarterly results, including as a result of catastrophes or our investment performance;
any share repurchase program;
changes in market valuation of companies in the insurance/reinsurance industry;
changes in expectations of future financial performance or changes in estimates of securities analysts;
46


fluctuations in stock market processes and volumes;
issuances or sales of common shares or other securities in the future;
the addition or departure of key personnel;
changes in tax law; and
announcements by us or our competitors of acquisitions, investments or strategic alliances.
Stock markets in the U.S. continue to experience volatile price and volume fluctuations. Such fluctuations, as well as the general political situation, current economic conditions or interest rate or currency rate fluctuations, could materially adversely affect the market price of our stock.
Our ability to pay dividends and to make payments on indebtedness may be constrained by our holding company structure.
AXIS Capital is a holding company and has no direct operations of its own. AXIS Capital has no significant operations or assets other than its ownership of the shares of its operating insurance and reinsurance subsidiaries, AXIS Specialty Bermuda, AXIS Re SE, AXIS Specialty Europe SE, the Members of Lloyd's (AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited), AXIS Re U.S., AXIS Specialty U.S., AXIS Surplus and AXIS Insurance Co. (collectively, our "Insurance Subsidiaries"). Dividends and other permitted distributions from our Insurance Subsidiaries (in some cases through our subsidiary holding companies) are our primary source of funds to meet ongoing cash requirements, including debt service payments and other expenses, and to pay dividends to our shareholders. Our Insurance Subsidiaries are subject to significant regulatory restrictions limiting their ability to declare and pay dividends and make distributions. In addition, the ability of our Insurance Subsidiaries to pay dividends to AXIS Capital could be constrained by our dependence on financial strength ratings from independent rating agencies. Our ratings from these agencies depend to a large extent on the capitalization levels of our Insurance Subsidiaries. The inability of our Insurance Subsidiaries to pay dividends in an amount sufficient to enable us to meet our cash requirements at the holding company level could have a material adverse effect on our business and our ability to pay dividends and make payments on our indebtedness.
AXIS Capital is a Bermuda company and it may be difficult to enforce judgments against it or its directors and executive officers.
AXIS Capital is incorporated pursuant to the laws of Bermuda, and our business is based in Bermuda. In addition, some of our directors and officers reside outside the U.S., and all or a substantial portion of our assets and the assets of such persons are located in jurisdictions outside the U.S. As a result, it may be difficult or impossible to effect service of process within the U.S. upon us or those persons or to recover against us or them on judgments of U.S. courts, including judgments predicated upon civil liability provisions of the U.S. federal securities laws. Further, it may not be possible to bring a claim in Bermuda against us or our directors and officers for violation of U.S. federal securities laws because these laws may not have extraterritorial effect and/or may not be enforceable in Bermuda. A Bermuda court may, however, impose civil liability, including the possibility of monetary damages, on us or our directors and officers in a suit brought in the Supreme Court of Bermuda if the Bermuda court considers that it has jurisdiction to hear and decide any such claim.
There are provisions in our organizational documents that may reduce or increase the voting rights of our shares.
Our bye-laws generally provide that shareholders have one vote for each common share held by them and are entitled to vote, on a non-cumulative basis, at all meetings of shareholders. However, the voting rights exercisable by a shareholder may be limited so that certain persons or groups are not deemed to hold 9.5% or more of the voting power conferred by our shares. Under these provisions, some shareholders may have the right to exercise their voting rights limited to less than one vote per share. Moreover, these provisions could have the effect of reducing the voting power of some shareholders who would not otherwise be subject to the limitation by virtue of their direct share ownership. In addition, our Board of Directors may limit a shareholder’s exercise of voting rights where it deems it necessary to do so to avoid adverse tax, legal or regulatory consequences.
We also have the authority under our bye-laws to request information from any shareholder for the purpose of determining whether a shareholder’s voting rights are to be limited pursuant to the bye-laws. If a shareholder fails to respond to our request for information or submits incomplete or inaccurate information in response to a request by us, we may, in our sole discretion, eliminate the shareholder’s voting rights.

47


There are provisions in our bye-laws that may restrict the ability to transfer common shares and which may require shareholders to sell their common shares.
Our bye-laws provide that our Board of Directors may decline to register a transfer of any common shares under certain circumstances, including if the Board has reason to believe that any non-de minimis adverse tax, regulatory or legal consequences to us, any of our subsidiaries or any of our shareholders may occur as a result of such transfer. Our bye-laws also provide that if our Board of Directors determines that share ownership by a person may result in non-de minimis adverse tax, legal or regulatory consequences to us, any of our subsidiaries or any of our shareholders, then we have the option, but not the obligation, to require such person to sell to us or to third parties to whom we assign the repurchase right for fair value the minimum number of common shares held by such person that is necessary to eliminate the non-de minimis adverse tax, legal or regulatory consequences.
Applicable insurance laws may make it difficult to effect a change of control of our company.
Before a person can acquire control of a U.S. insurance company, prior written approval must be obtained from the insurance commissioner of the state where the domestic insurer is domiciled. Prior to granting approval of an application to acquire control of a domestic insurer, the state insurance commissioner will consider such factors as the financial strength of the acquirer, the integrity and management of the acquirer’s board of directors and executive officers, the acquirer’s plans for the future operations of the domestic insurer and any anti-competitive results that may arise from the consummation of the acquisition of control. Generally, state statutes provide that control over a domestic insurer is presumed to exist if any person, directly or indirectly, owns, controls, holds with the power to vote, or holds proxies representing, 10% or more of the voting securities of the domestic insurer. Because a person acquiring 10% or more of our common shares would indirectly control the same percentage of the stock of the AXIS U.S. Subsidiaries, the insurance change of control laws of Connecticut, Illinois and New York would likely apply to such a transaction.
The Insurance Act in Bermuda requires that where the shares of a registered insurer or reinsurer, or the shares of its parent, are traded on a recognized stock exchange, and a person becomes a 10%, 20%, 33% or 50% shareholder controller of that insurer or reinsurer, that person shall, within 45 days, notify the BMA in writing that they have become such a controller. In addition, a person who is a shareholder controller of a Class 4 insurer or reinsurer (such as AXIS Specialty Bermuda) whose shares or shares of its parent company are traded on a recognized stock exchange must serve the BMA with a notice in writing that they have reduced or disposed of their holding in the insurer or reinsurer where the proportion of voting rights in the insurer or reinsurer held by them will have reached or has fallen below 10%, 20%, 33% or 50%, as the case may be, not later than 45 days after such reduction or disposal. The definition of shareholder controller is set out in the Insurance Act but generally refers to a person who (i) holds 10% or more of the shares carrying rights to vote at a shareholders’ meeting of the registered insurer or reinsurer or its parent; (ii) is entitled to exercise, or control the exercise of, 10% or more of the voting power at any shareholders meeting of the registered insurer or reinsurer or its parent; or (iii) is able to exercise significant influence over the management of the registered insurer or reinsurer or its parent by virtue of its shareholding or its entitlement to exercise, or control the exercise of, the voting power at any shareholders’ meeting of the registered insurer or reinsurer or its parent company. The BMA may object to any person holding 10% or more of our common shares if it appears to the BMA that such person is not, or is no longer, a fit and proper person to be such a holder. In such a case, the BMA may require the shareholder to reduce its holding of common shares or direct, among other things, that voting rights attaching to the common shares shall not be exercisable. A person who does not comply with such a notice or direction from the BMA may be guilty of an offense and subject to a variety of enforcement actions.
In addition, the Insurance Acts and Regulations in Ireland require that anyone acquiring or disposing of a direct or indirect holding in an Irish authorized insurance or reinsurance company (such as AXIS Specialty Europe or AXIS Re SE) that represents 10% or more of the capital or of the voting rights of such company or that makes it possible to exercise a significant influence over the management of such company, or anyone who proposes to decrease or increase that holding to specified levels, must first notify the Central Bank of Ireland ("CBI") of their intention to do so. They also require any Irish authorized insurance or reinsurance company that becomes aware of any acquisitions or disposals of its capital involving the specified levels to notify the CBI. The specified levels are 20%, 33% and 50% or such other level of ownership that results in the company becoming the acquirer’s subsidiary within the meaning of article 20 of the European Communities (Non-Life Insurance) Framework Regulations 1994.

48


The CBI has three months from the date of submission of a notification within which to oppose the proposed transaction if the CBI is not satisfied as to the suitability of the acquirer in view of the necessity "to ensure prudent and sound management of the insurance or reinsurance undertaking concerned". Any person owning 10% or more of the capital or voting rights or an amount that makes it possible to exercise a significant influence over the management of AXIS Capital would be considered to have a "qualifying holding" in AXIS Specialty Europe SE and AXIS Re SE.
In the U.K., the Prudential Regulation Authority ("PRA") and the Financial Conduct Authority ("FCA") regulate the acquisition of "control" of any U.K. insurance companies and Lloyd's managing agents that are authorized under the Financial Services and Markets Act 2000 ("FSMA"). Any legal entity or individual that (together with any person with whom it or they are "acting in concert") directly or indirectly acquires 10% or more of the shares in a U.K. authorized insurance company or Lloyd's managing agent, or their parent company, or is entitled to exercise or control the exercise of 10% or more of the voting power in such authorized insurance company or Lloyd's managing agent or their parent company, would be considered to have acquired "control" for the purposes of the relevant legislation, as would a person who had significant influence over the management of such authorized insurance company or their parent company by virtue of their shareholding or voting power in either. A purchase of 10% or more of the ordinary shares of the Company would therefore be considered to have acquired "control" of AXIS Managing Agency Ltd. Under FSMA, any person proposing to acquire "control" over a U.K. authorized insurance company must give prior notification to the PRA of their intention to do so. The PRA, which will consult with the FCA, would then have 60 working days to consider that person's application to acquire "control" (although this 60 working day period can be extended by up to 30 additional working days in certain circumstances where the regulators have questions relating to the application). Failure to make the relevant prior application could result in action being taken against AXIS Managing Agency Ltd. by the PRA.
A person who is already deemed to have "control" will require prior approval of the PRA if such person increases their level of "control" beyond certain percentages. These percentages are 20%, 30% and 50%. Similar requirements apply in relation to the acquisition of control of a U.K. authorized person which is an insurance intermediary (such as AXIS Underwriting Limited) except that the approval must be obtained from the FCA rather than the PRA and the threshold triggering the requirement for prior approval is 20% of the shares or voting power in the insurance intermediary or its parent company. The approval of the Council of Lloyd's is also required in relation to the change of control of a Lloyd's managing agent or member. Broadly, Lloyd's applies the same tests in relation to control as are set out in the FSMA (see above) and in practice coordinates its approval process with that of the PRA.
While our bye-laws limit the voting power of any shareholder to less than 9.5%, there can be no assurance that the applicable regulatory body would agree that a shareholder who owned 10% or more of our shares did not, because of the limitation on the voting power of such shares, control the applicable Insurance Subsidiary. These laws may discourage potential acquisition proposals and may delay, deter or prevent a change of control of the Company, including transactions that some or all of our shareholders might consider to be desirable.
Anti-takeover provisions in our bye-laws could impede an attempt to replace our directors or to effect a change in control, which could diminish the value of our common shares.
Our bye-laws contain provisions that may make it more difficult for shareholders to replace our directors and could delay or prevent a change of control that a shareholder might consider favorable. These provisions include a staggered board of directors (in which the directors of the class elected at each annual general meeting holds office for a term of three years, with the term of each class expiring at successive annual general meetings of shareholders), limitations on the ability of shareholders to remove directors other than for cause, limitations on voting rights and restrictions on transfer of our common shares. These provisions may prevent a shareholder from receiving the benefit from any premium over the market price of our shares offered by a bidder in a potential takeover. Even in the absence of an attempt to effect a change in management or a takeover attempt, these provisions may adversely affect the prevailing market price of our shares if they are viewed as discouraging takeover attempts in the future.

49


Risks Related to Taxation

Changes in tax laws resulting from the recommendations of the Organization for Economic Corporation and Development ("OECD") could materially adversely affect us.
The OECD launched a global initiative among member and non-member countries on measures to limit harmful tax competition, known as the "Base Erosion and Profit Shifting" ("BEPS") project and, in 2015, published reports containing a suite of recommended actions. These measures are largely directed at counteracting the effects of low-tax and preferential tax regimes in countries around the world, including expanding the definition of permanent establishment and updating the rules for attributing profits to permanent establishments, tightening transfer pricing rules to ensure that outcomes are in line with value creation, neutralizing the effect of hybrid financial instruments and limiting the deductibility of interest costs for tax purposes and preventing double tax treaty abuse. Many countries have changed or announced future changes to their tax laws in response to the BEPS project. On May 31, 2019, the OECD published a "Programme of Work", designed to address the tax challenges created by an increasingly digitalized economy. This was divided into two pillars. The first pillar addresses the broader challenge of a digitalized economy and focuses on the allocation of group profits among taxing jurisdictions, based on a market-based concept rather than the historical "permanent establishment" concept ("Pillar One"). The second pillar addresses the remaining BEPS risk of profit shifting to entities in low tax jurisdictions by introducing a global minimum tax ("Pillar Two").
Pillar One
On October 11, 2023, the members of the OECD/G20 Inclusive Framework on BEPS (the "Inclusive Framework") published a multilateral convention to implement rules which coordinate a reallocation of taxing rights to market jurisdictions in accordance with Pillar One. Pillar One is expected to apply to groups with adjusted revenues in excess of €20 billion and specific exemptions have been incorporated in the multilateral convention for regulated financial institutions. The application of the multilateral convention on Pillar One is therefore not expected to have a material impact on our effective tax rate, however these rules remain subject to ongoing negotiation and implementation.
Pillar Two
On December 20, 2021, the OECD released proposed model legislation for Pillar Two which was approved by 135 countries (the "Model Rules"). The Model Rules included a set of rules, principally the income inclusion rule and undertaxed payments rules, which together have the intended effect of imposing a minimum tax rate of 15% on multinational groups with revenues in excess of €750 million. Additionally, the Model Rules anticipated the implementation of qualifying domestic top-up taxes ("QDMTT") in local jurisdictions. Broadly, these QDMTTs are intended to provide jurisdictions with the right to charge top-up taxes on entities located in that jurisdiction if those entities have an effective tax rate of less than 15%. The Model Rules are currently in the process of being implemented into domestic legislation by members of the Inclusive Framework, including the member states of the EU and the UK, with effect for accounting periods starting on or after December 31, 2023. Further, a number of jurisdictions have implemented QDMTTs into domestic legislation but these taxes remain subject to a multilateral review process which is subject to ongoing development.
Although domestic legislation implemented to effect the Model Rules is not applicable for the current accounting period, we operate in jurisdictions which intend to enact (or have enacted) such legislation. Responses to Pillar Two by various jurisdictions in which we operate will have a material effect on our future global effective tax rate and will result in a material compliance burden with ongoing monitoring and filing requirements.
We may be liable to tax under the Corporate Income Tax Act 2023 of Bermuda, which may have an adverse effect on our results of operations.
The Bermuda Minister of Finance, under the Exempted Undertakings Tax Protection Act 1966 of Bermuda, as amended, has given each of our Bermuda resident companies an assurance that if any legislation is enacted in Bermuda that would impose tax computed on profits or income, or computed on any capital asset, gain or appreciation, or any tax in the nature of estate duty or inheritance tax, then the imposition of any such tax will not be applicable to our Bermuda resident companies or any of their respective operations, shares, debentures or other obligations until March 31, 2035.
Notwithstanding the above, on December 27, 2023, the Bermuda government enacted a corporate income tax which will apply for accounting periods starting on or after January 1, 2025. Importantly, under the Corporate Income Tax Act 2023 of Bermuda, any liability to the tax will apply regardless of any assurances previously provided under the Exempted Undertakings Tax Protection Act 1966 of Bermuda. This tax will likely have a material impact on our effective tax rate.
50


Broadly, the Bermuda corporate income tax is intended to be treated as a covered tax for the purposes of Pillar Two and therefore no double taxation is expected to arise from these rules and the top-up taxes under Pillar Two in other jurisdictions. However, the treatment of the Bermuda corporate income tax as a covered tax is subject to interpretation in other jurisdictions and therefore remains uncertain at this time. If the Bermuda corporate income tax is not regarded as a covered tax for the purposes of Pillar Two in other jurisdictions, this may have a material impact on our future effective tax rate.
Our non-U.S. companies may be subject to U.S. tax that may have an adverse effect on our results of operations.
We intend to manage our business so that each of our non-U.S. companies, apart from our Lloyd's operations with U.S. effectively connected income, will operate in such a manner that none of these companies should be subject to U.S. tax (other than U.S. excise tax on insurance or reinsurance premiums attributable to insuring or reinsuring U.S. risks and U.S. withholding tax on some types of U.S. source investment income), because none of these companies should be treated as engaged in a trade or business within the U.S. However, because there is considerable uncertainty as to the activities that constitute being engaged in a trade or business within the U.S., we cannot be certain that the U.S. Internal Revenue Service will not contend successfully that any of our non-U.S. companies is/are engaged in a trade or business in the U.S. If any of our non-U.S. companies were considered to be engaged in a trade or business in the U.S., it could be subject to U.S. corporate income and additional branch profits taxes on the portion of its earnings effectively connected to such U.S. business. If this were to be the case, our results of operations could be materially adversely affected.
Changes in U.S. tax law could adversely affect us.
The tax treatment of non-U.S. companies and their U.S. and non-U.S. subsidiaries may be the subject of future legislation. We cannot predict the particulars of any proposed legislation, or whether such legislation would have any effect on us. Future legislation in the U.S. may arise in an effort to harmonize US tax law with OECD Pillar Two initiatives. No assurance may be given that future legislative, administrative, or judicial developments will not produce an adverse U.S. tax consequence to us. If any such adverse developments do occur, our results of operations may be materially adversely affected.

Our non-U.K. companies may be subject to U.K. tax that may have an adverse effect on our results of operations.
We intend to operate in such a manner so that none of our non-U.K. companies are resident in the U.K. for tax purposes and that none of our non-U.K. resident companies, other than AXIS Specialty Europe and AXIS Specialty U.S. Services, Inc., have a permanent establishment in the U.K. Accordingly, we expect that none of our non-U.K. resident companies, other than AXIS Specialty Europe and AXIS Specialty U.S. Services, Inc., will be subject to U.K. tax. Nevertheless, because neither case law nor U.K. statutes conclusively define the activities that constitute trading in the U.K. through a permanent establishment, the U.K. tax authority might contend successfully that one or more of our non-U.K. companies, in addition to AXIS Specialty Europe and AXIS Specialty U.S. Services, Inc., is trading in the U.K. through a permanent establishment in the U.K. and therefore subject to U.K. tax.
In addition, there are circumstances in which companies that are neither resident in the U.K., nor entitled to the protection afforded by a double tax treaty between the U.K. and the jurisdiction in which they are resident, may be exposed to income tax in the U.K. (other than by deduction or withholding) on the profits of a trade carried on there even if that trade is not carried on through a permanent establishment. We intend to operate in such a manner that none of our companies will be subject to U.K. income tax in this respect.
If any of our non-U.K. resident companies were treated as being resident in the U.K. for U.K. corporation tax purposes, or if any of our non-U.K. companies, other than AXIS Specialty Europe or AXIS Specialty U.S. Services, Inc., were to be treated as carrying on a trade in the U.K., whether or not through a permanent establishment, our results of operations could be materially adversely affected.
The U.K. diverted profits tax ("DPT") is separate from U.K. corporation tax and is charged at a higher rate. It is an anti-avoidance measure aimed at protecting the U.K. tax base against the artificial diversion of profits that are being earned by activities carried out in the U.K. but which are not otherwise being taxed in the U.K., in particular as a result of arrangements between companies in the same multinational group. The U.K. network of double tax treaties does not offer protection from a DPT charge. In the event that the rules apply to certain arrangements, upfront payment of the U.K. tax authority’s estimate of the deemed tax liability may be required. If any of our non-U.K. companies is liable to DPT, our results could be materially adversely affected.

51


In accordance with the Model Rules on Pillar Two, the U.K. government has enacted legislation to implement a QDMTT which seeks to ensure that U.K. tax resident companies have an effective tax rate in excess of 15% (broadly, this is determined in line with effective tax rates under the Model Rules on Pillar Two). Therefore, if our U.K. tax resident companies have an effective tax rate of less than 15%, the QDMTT may adversely affect our results.
Changes in U.K. tax law could adversely affect us.
AXIS Specialty Europe, AXIS Specialty U.S. Services, Inc. and our U.K. resident companies are treated as taxable in the U.K. On October 14, 2022, the U.K. government increased its corporate tax rate from 19% to 25% with effect from April 1, 2023. Future changes in the basis or rate of U.K. corporation tax could materially adversely affect the operations of these companies.
Our non-Irish companies may be subject to Irish tax that may have an adverse effect on our results of operations.
We intend to operate our non-Irish resident companies in such a manner so that none of our non-Irish resident companies are resident in Ireland for tax purposes and are not treated as carrying on a trade through a branch or agency in Ireland.
Accordingly, we expect that none of our non-Irish resident companies will be subject to Irish corporation tax. Nevertheless, since the determination as to whether a company is resident in Ireland is a question of fact to be determined based on a number of different factors and since neither case law nor Irish legislation conclusively defines the activities that constitute trading in Ireland through a branch or agency, the Irish Revenue Commissioners might contend successfully that one or more of our non-Irish companies is resident in or otherwise trading through a branch or agency in Ireland and therefore subject to Irish corporation tax. If this were the case, our results of operations could be materially adversely affected.
In accordance with the Model Rules on Pillar Two, the Irish government has enacted legislation to implement a QDMTT which seeks to ensure that Irish tax resident companies have an effective tax rate in excess of 15%. Therefore, if our Irish tax resident companies have an effective tax rate of less than 15%, the QDMTT may adversely affect our results.
Changes in Irish tax law could adversely affect us.
Trading income derived from the insurance and reinsurance business carried on in Ireland by AXIS Specialty Europe and AXIS Re SE is generally taxed in Ireland at a rate of 12.5%. Over the past number of years, various E.U. member states have, from time to time, called for harmonization of the corporate tax base within the E.U. Ireland, along with other member states, has consistently resisted any movement towards standardized corporate tax rates or tax base in the E.U. The Government of Ireland has also made clear its commitment to retain the 12.5% rate of corporation tax. If, however, tax laws in Ireland change so as to increase the general corporation tax rate, our results of operations could be materially adversely affected. Irish profits would become subject to the 15% global minimum tax rate pursuant to the European Commission Directive discussed above.
If investments held by AXIS Specialty Europe SE or AXIS Re SE are determined not to be integral to the insurance and reinsurance business carried on by those companies, additional Irish tax could be imposed and our business and financial results could be adversely affected.
Based on administrative practice, taxable income derived from investments made by AXIS Specialty Europe and AXIS Re SE is generally taxed in Ireland at the rate of 12.5% on the grounds that such investments either form part of the permanent capital required by regulatory authorities, or are otherwise integral to the insurance and reinsurance business carried on by those companies. AXIS Specialty Europe and AXIS Re SE intend to operate in such a manner so that the level of investments held by such companies does not exceed the amount that is integral to the insurance and reinsurance business carried on by AXIS Specialty Europe and AXIS Re SE. If, however, investment income earned by AXIS Specialty Europe or AXIS Re SE is deemed to be non-trading income, Irish corporation tax could apply to such investment income at a rate higher than the general 12.5% rate, and our results of operations could be materially adversely affected.

52


Changes in tax laws resulting from the proposals included in the European Commission’s draft third Anti-Tax Avoidance Directive ("ATAD III") could materially adversely affect us.
The E.U. has sought to harmonize the response of member states to the BEPS reports via the Anti-Tax Avoidance Directives ("the ATAD and the ATAD II"). The ATAD and the ATAD II require all E.U. member states to apply certain specified anti-avoidance measures, including a controlled foreign companies regime, limitations on interest deduction and anti-hybrid rules. On December 22, 2021, the European Commission proposed and issued a draft third directive (ATAD III) which aims to combat the abuse of investment structures that do not carry out actual economic activities, specifically "shell companies". ATAD III proposes to introduce a minimum substance test and reporting requirements for multinational groups to identify "shell companies". However, ATAD III must be unanimously agreed between EU Member States and remains subject to negotiation and opposition by certain EU Member States. Changes to tax laws and additional reporting requirements could increase the tax burden and the complexity and cost of tax compliance.
Our operations may be adversely affected by a transfer pricing adjustment in computing taxable profits.
Any affiliated arrangements between contracting parties established in different jurisdictions are subject to transfer pricing regimes. Consequently, if any arrangement (including any reinsurance or financing arrangements) is found not to be on arm’s length terms, an adjustment will be required to compute taxable profits as if the arrangement were on arm’s length terms. Any transfer pricing adjustment could materially adversely impact the tax charge suffered by the relevant tax-paying company.
Effective January 1, 2016, Bermuda implemented country by country reporting ("CBCR") whereby multinational groups are required to report details of their operations and intra-group transactions in each jurisdiction. It is possible that our approach to transfer pricing may become subject to greater scrutiny from the tax authorities in the jurisdictions in which we operate, which may lead to transfer pricing audits in the future.
General Risk Factors
Future changes in accounting standards may adversely impact our reported financial results.
Future changes in accounting standards and regulatory changes may result in significant additional expenses in order to implement and comply with any new requirements. In addition, such changes may require modifications to our accounting principles, which in turn could adversely affect our reported financial results. For example, this could occur if we are required to prepare information relating to prior periods or if we are required to apply new requirements retroactively.

53


ITEM 1B.    UNRESOLVED STAFF COMMENTS
At December 31, 2023, we had no outstanding, unresolved comments from the SEC staff.

ITEM 1C.    CYBERSECURITY
Risk Management and Strategy
The Company’s information risk management program is designed to protect the confidentiality of nonpublic, sensitive information and the integrity and availability of our information systems. The program includes policies and procedures that identify how security measures and controls are developed, implemented, and maintained. We have designed our enterprise-wide information security program consistent with industry standards using the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF) as a guide to help us identify, assess, and manage cybersecurity risks relevant to our business. Information about cybersecurity risks and our risk management processes is collected, analyzed and considered as part of our overall enterprise risk management program.
Key components of our cybersecurity risk management program include:
risk assessments designed to help identify cybersecurity risks to our critical systems, information, and services.
a security team principally responsible for managing (1) our cybersecurity policies & risk assessment processes, (2) our security controls & testing, (3) identifying vulnerabilities and managing remediation, and (4) our cybersecurity monitoring & incident response.
the use of external service providers, where appropriate, to assess, test or otherwise assist with aspects of our security processes.
managing a cybersecurity awareness and training program that covers employees and contractors who access internal systems.
a cybersecurity incident response plan that includes procedures for responding to various types of cybersecurity incidents and tested through periodic tabletop exercises.
a third-party security risk assessment team, which is involved with identifying, assessing, and controlling risks that occur due to interactions with third parties including vendors and procurement.
a cyber risk assessment process to assist in assessing the security posture of third parties.
restricted physical access to critical areas, servers, and network equipment.
business continuity and disaster response plans.
Impact of Material Risk
We have not experienced a material cybersecurity incident; however, financial institutions face risks from threat actors that focus on attacks of critical information systems infrastructure assets, disruption to operations, and ransomware groups that steal data, encrypt systems, and demand a payment. The Company relies on third-party software, third-party hardware, and third-party vendors to manage critical aspects of our operations which may be at risk of cybersecurity threats. Although the Company has implemented cybersecurity policies, procedures and controls intended to mitigate these risks and the likelihood of these risks occurring may not be high, if these risks are realized the impact could be material, such as in the event of a material cybersecurity incident.
Additionally, in Item 1A, 'Risk Factors' we discuss forward-looking cybersecurity risks that could have a material impact on us. Our disclosures in Item 1A should be read in conjunction with this Item 1C.

54


Management & Board Governance
With over 30 years of industry cybersecurity experience, the Company’s Chief Information Security Officer ("CISO") is the member of the Company’s management team with primary responsibility for the development, operation, and maintenance of the Company’s information security program. The CISO supervises the Company’s cybersecurity team, facilitates the incident response plan and acts as the liaison to the Company’s executive management team, including relaying strategies, resource requests and incident updates. The Company’s security event monitoring and detection capabilities are performed by our Cybersecurity team and third parties through the use of processes and tooling. Cybersecurity incidents are responded to by a multi-disciplinary Incident Response team and if appropriate, escalated to our Cybersecurity Disclosure Committee, Executive Management, and the Board. The level of escalation will vary depending on the severity and scope of the cyber incident. In the event of a severe cyber incident, the CISO will escalate to the relevant subcommittee to determine the course of action. All relevant roles are trained on their responsibilities regularly. The Board, along with the Risk and Audit Committees of the Board, oversees our information security program. In 2023, our Board and Risk and Audit Committees received periodic updates throughout the year on cybersecurity matters, and these updates are part of their standing agendas. These updates include reports regarding items such as cybersecurity strategies, program effectiveness, key risks and performance metrics related to the Company’s information security program and the Company’s mitigating controls.
The Company has an enterprise risk management function that oversees the identification, prioritization, and mitigation of the Company’s enterprise risks, and cybersecurity is a risk category addressed by that function. The Company uses governance, risk and compliance tools to assess, identify and manage its cybersecurity risks.

ITEM 2.    PROPERTIES
We maintain leased office facilities in Bermuda, the U.S., Europe, Singapore, and Canada. In January 2023, we sold the building in which our office in Dublin, Ireland was located. We renew and enter into leases in the ordinary course of business as required. Our global headquarters is located at AXIS House, 92 Pitts Bay Road, Pembroke HM 08, Bermuda. We believe that our office space is sufficient for us to conduct our operations for the foreseeable future.

ITEM 3.    LEGAL PROCEEDINGS
From time to time, we are subject to routine legal proceedings, including arbitrations, arising in the ordinary course of business. These legal proceedings generally relate to claims asserted by or against us in the ordinary course of its insurance or reinsurance operations. Estimated amounts payable related to these proceedings are included in reserve for losses and loss expenses in our consolidated balance sheets.
We are not party to any material legal proceedings arising outside the ordinary course of business.

ITEM 4.    MINE SAFETY DISCLOSURES
Not Applicable.

55


PART II
ITEM 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES                                
Our common shares are listed on the New York Stock Exchange under the symbol "AXS".
On February 23, 2024, the number of holders of record of our common shares was 16. This figure does not represent the actual number of beneficial owners of our common shares because shares are frequently held in "street name" by securities dealers and others for the benefit of beneficial owners who may vote the shares.
We have a history of paying quarterly cash dividends. While we expect to continue paying comparable cash dividends in the foreseeable future, the declaration and payment of future dividends is at the discretion of our Board of Directors and will depend on many factors including, but not limited to, our net income, financial condition, business needs, capital and surplus requirements of our operating subsidiaries and regulatory and contractual restrictions, including those detailed in our credit facilities. Refer to Item 7 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources' for further details.
Issuer Purchases of Equity Securities
Common Shares
The following table shows information regarding the number of common shares repurchased in the quarter ended December 31, 2023:
Period
Total number
of shares
purchased(a) (b)
Average
price paid
per share
Total number of shares
purchased as part of
publicly announced
programs
Maximum number (or approximate
dollar value) of shares that
may yet be purchased under the programs(c)
October 1-31, 202314 $57.62 — $100 million
November 1-30, 202329 $57.92 — $100 million
December 1-31, 202366 $55.45 — $100 million
Total109  $100 million
(a)In thousands.
(b)Includes shares repurchased from employees to satisfy personal withholding tax liabilities that arise on the vesting of share-settled restricted stock units.
(c)On December 8, 2022, our Board of Directors authorized a new share repurchase program for up to $100 million of our common shares, effective January 1, 2023 through December 31, 2023. On December 7, 2023, our Board of Directors renewed its authorization for the repurchase of up to $100 million of our common shares, effective January 1, 2024, through December 31, 2024. Share repurchases may be effected from time to time in the open market or privately negotiated transactions, depending on market conditions.
56


Performance Graph
Set forth below is a line graph comparing the dollar change in the cumulative total shareholder return on the Company's Common Shares from December 31, 2018, through December 31, 2023, as compared to the cumulative total return of the Standard & Poor's 500 Stock Index and the cumulative total return of the Standard & Poor's Property-Casualty Insurance Index. The cumulative total shareholder return is a concept used to compare the performance of a company's stock over time and is the ratio of the stock price change plus the cumulative amount of dividends over the specified time period (assuming dividend reinvestment), to the stock price at the beginning of the time period. The chart depicts the value on December 31, 2019, 2020, 2021, 2022, and 2023, of a $100 investment made on December 31, 2018, with all dividends reinvested.
22539988374919
12/31/201812/31/201912/31/202012/31/202112/30/202212/29/2023
AXIS Capital Holdings Limited
$100.00$118.26$104.19$116.49$119.56$126.18
S&P 500 P&C Index$100.00$125.87$134.63$160.58$190.89$211.53
S&P 500 Index$100.00$131.49$155.68$200.37$164.08$207.21

ITEM 6.    [RESERVED]
57


ITEM 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following is a discussion and analysis of our results of operations for the years ended December 31, 2023 and 2022, and our financial condition at December 31, 2023 and 2022. This should be read in conjunction with Item 8 'Financial Statements and Supplementary Data' of this report. Unless otherwise noted, tabular dollars are in thousands, except per share amounts. Amounts may not reconcile due to rounding differences.
   Page  
2023 Financial Highlights
Overview
Consolidated Results of Operations
Results by Segment:
i) Insurance Segment
ii) Reinsurance Segment
Net Investment Income and Net Investment Gains (Losses)
Other Expenses (Revenues), Net
Financial Measures
Non-GAAP Financial Measures Reconciliation
Cash and Investments
Liquidity and Capital Resources
Critical Accounting Estimates
i) Reserve for Losses and Loss Expenses
ii) Reinsurance Recoverable on Unpaid Losses and Loss Expenses
iii) Gross Premiums Written
iv) Net Premiums Earned
v) Fair Value Measurements of Financial Assets and Liabilities
vi) Impairment Losses and the Allowance for Expected Credit Losses - Fixed Maturities, Available for Sale
Recent Accounting Pronouncements

58



2023 FINANCIAL HIGHLIGHTS

2023 Consolidated Results of Operations
Net income available to common shareholders of $346 million, or $4.06 per common share, and $4.02 per diluted common share
Operating income(1) of $486 million, or $5.65 per diluted common share(1)
Gross premiums written of $8.4 billion
Net premiums written of $5.1 billion
Net premiums earned of $5.1 billion
Pre-tax catastrophe and weather-related losses, net of reinsurance, of $138 million ($116 million, after-tax), (Insurance: $111 million; Reinsurance: $27 million), or 2.7 points primarily attributable to Cyclone Gabrielle and other weather-related events.
Net adverse prior year reserve development of $412 million
Underwriting income(2) of $161 million and combined ratio of 99.9%
Net investment income of $612 million
Net investment losses of $75 million
Foreign exchange losses of $58 million
2023 Consolidated Financial Condition
Total cash and investments of $16.7 billion; fixed maturities, short-term investments, and cash and cash equivalents comprise 86% of total cash and investments and have an average credit rating of AA-
Total assets of $30.3 billion
Reserve for losses and loss expenses of $16.4 billion and reinsurance recoverable on unpaid and paid losses and loss expenses of $6.9 billion.
Debt of $1.3 billion and a debt to total capital ratio(3) of 20.0%
Common shares repurchased from employees to satisfy personal withholding tax liabilities that arise on the vesting of share-settled restricted stock units were 398,000 common shares for a total of $24 million
Common shareholders’ equity of $4.7 billion; book value per diluted common share of $54.06






(1) Operating income (loss) and operating income (loss) per diluted common share are non-GAAP financial measures as defined in Item 10(e) of SEC Regulation S-K. The reconciliations to the most comparable GAAP financial measures, net income (loss) available (attributable) to common shareholders and earnings (loss) per diluted common share, respectively, and a discussion of the rationale for the presentation of these items are provided in 'Management's Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Measures Reconciliation'.
(2)Consolidated underwriting income (loss) is a non-GAAP financial measure as defined in Item 10(e) of SEC Regulation S-K. The reconciliation to the most comparable GAAP financial measure, net income (loss), is presented in 'Management's Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Results of Operations', and a discussion of the rationale for its presentation is provided in 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Measures Reconciliation'.
(3)The debt to total capital ratio is calculated by dividing debt by total capital. Total capital represents the sum of total shareholders’ equity and debt.

59



OVERVIEW

Business Overview
AXIS Capital, through its operating subsidiaries, is a global specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the U.S., Europe, Singapore and Canada. Our underwriting operations are organized around our global underwriting platforms, AXIS Insurance and AXIS Re.
We provide our clients and distribution partners with a broad range of risk transfer products and services, and strong capacity, backed by excellent financial strength. We manage our portfolio holistically, aiming to construct the optimum portfolio of risks, consistent with our risk appetite and the development of our franchise. We nurture an ethical, entrepreneurial, disciplined and diverse culture that promotes outstanding client service, intelligent risk taking, operating efficiency, corporate citizenship and the achievement of superior risk-adjusted returns for our shareholders. We believe that the achievement of our objectives will position us as a global leader in specialty risks. The execution of our business strategy in 2023 included the following:
growing in a number of attractive specialty lines insurance and treaty reinsurance markets including U.S. excess and surplus lines, North America professional lines and Lloyd's specialty insurance business;

re-balancing our portfolio towards less volatile lines of business, that carry attractive returns while deploying capital within risk limits, diversification and risk management;

investing in attractive growth markets and advancing capabilities to address more transactional specialist business targeting the lower middle market with our key distribution partners;

leveraging our global platform to introduce our products and services to new regions including the expansion of our London specialty lines to North America markets;

continuing the implementation of a more focused distribution strategy while building mutually beneficial relationships with clients and partners;

improving the effectiveness and efficiency of our operating platforms and processes;

investing in data and technology capabilities, and tools to empower our underwriters and enhance the service that we provide to our customers;

utilizing reinsurance markets and third-party capital relationships;

fostering a positive workplace environment that enables us to attract, retain and develop top talent; and

growing our corporate citizenship program to give back to our communities and help contribute to a more sustainable future.

For discussion of our results of operations and changes in financial condition for year ended December 31, 2022, compared to year ended December 31, 2021, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2022 Form 10-K, which was filed with the SEC on February 27, 2023, and such discussions are incorporated herein by reference.





60


Outlook
We are committed to leadership in specialty insurance and reinsurance. We believe our market positioning, specialty underwriting acumen, global platform, claims management capabilities and deep relationships with our distributors and clients, supported by a conservative and well performing investment portfolio, will provide opportunities for increased profitability, with differences among our lines of business driven by our tactical response to market conditions.
We anticipate overall rate movement to remain positive, in excess of loss cost trends, in the traditional property and casualty insurance classes but to continue to be challenged across the professional lines sector. Following multiple years of rate increases outpacing loss cost trends, pricing across most lines remains above loss cost trends as we continue to pursue selective profitable growth areas.
Market dislocations in the admitted market continue to drive additional risk types into the Wholesale channel. We anticipate this continuing throughout 2024 with strong market opportunities arising predominantly in the Specialty and E&S lines. We continue to pursue targeted growth opportunities by employing a disciplined underwriting appetite and strategy.
Pricing momentum in non-proportional reinsurance continues to be strong while our proportional reinsurance business is benefiting from rate increases in the underlying business. We expect these market conditions to persist in the near term. We continue to focus on underwriting discipline to drive targeted profitable growth among the specialty and casualty reinsurance lines that we offer.
We are encouraged by the pricing improvements we are seeing across most markets, which we expect will carry through 2024, and that rate will continue to keep pace with loss cost trends in the majority of our lines. Where prices continue to deliver adequate profitability, we will look to grow within our risk and volatility guidelines. With a strengthened book of business, and a growing footprint in specialty markets that are seeing the most favorable conditions, we believe AXIS is well positioned to drive profitable growth within the current environment.
Recent Developments
Retrocession Agreement with Monarch Point Re
On September 22, 2023 (the "closing date"), we entered into an agreement, with an effective date of January 1, 2023, to retrocede a diversified portfolio of casualty reinsurance business to Monarch Point Re. The agreement covers losses both on a prospective basis and on a retroactive basis. Therefore, we have bifurcated the prospective and retroactive elements of the agreement and are accounting for each element separately. Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses' and Note 18 to the Consolidated Financial Statements 'Related Party Transactions' for further details.
Loan to Monarch Point Re
During 2023, we advanced an amount of $297 million to Monarch Point Re. This loan will be repaid in a manner consistent with the timing of amounts due to Monarch Point Re under the retrocession agreement. At December 31, 2023, the Company had committed to advance a further $16 million to Monarch Point Re.
How We Work Program
Reorganization expenses of $29 million include impairments of computer software assets and severance costs mainly attributable to our "How We Work" program which is focused on simplifying our operating structure.
Bermuda Corporate Income Tax Act of 2023
The Bermuda Minister of Finance, under the Exempted Undertakings Tax Protection Act 1966 of Bermuda, as amended, has given each of our Bermuda resident companies an assurance that if any legislation is enacted in Bermuda that would impose tax computed on profits or income, or computed on any capital asset, gain or appreciation, or any tax in the nature of estate duty or inheritance tax, then the imposition of any such tax will not be applicable to our Bermuda resident companies or any of their respective operations, shares, debentures or other obligations until March 31, 2035.
Notwithstanding the above, on December 27, 2023, the Bermuda government enacted a corporate income tax which will apply for accounting periods starting on or after January 1, 2025. Importantly, under the Corporate Income Tax Act 2023 of Bermuda, any liability to the tax will apply regardless of any assurances previously provided under the Exempted Undertakings Tax Protection Act 1966 of Bermuda. This tax will likely have a material impact on our effective tax rate.
61



CONSOLIDATED RESULTS OF OPERATIONS

Year ended December 31,2023% Change2022% Change2021
Underwriting revenues:
Gross premiums written$8,356,525 2%$8,214,595 7%$7,685,984 
Net premiums written5,102,325 (3%)5,263,056 7%4,926,624 
Net premiums earned5,083,781 (1%)5,160,326 10%4,709,850 
Other insurance related income22,495 72%13,073 (44%)23,295 
Underwriting expenses:
Net losses and loss expenses(3,393,102)5%(3,242,410)8%(3,008,783)
Acquisition costs(1,000,945)(2%)(1,022,017)11%(921,834)
Underwriting-related general and administrative expenses(1)
(551,467)—%(550,289)3%(536,834)
Underwriting income(2)
160,762 358,683 265,694 
Net investment income611,742 46%418,829 (8%)454,301 
Net investment gains (losses)(74,630)(84%)(456,789)nm134,279 
Corporate expenses(1)
(132,979)2%(130,054)3%(126,470)
Foreign exchange (losses) gains(58,115)nm157,945 nm(315)
Interest expense and financing costs(68,421)8%(63,146)1%(62,302)
Reorganization expenses(28,997)(8%)(31,426)nm— 
Amortization of value of business acquired —%— nm(3,854)
Amortization of intangible assets(10,917)—%(10,917)(12%)(12,424)
Income before income taxes and interest in income of equity method investments398,445 243,125 648,909 
Income tax expense
(26,316)19%(22,037)(65%)(62,384)
Interest in income of equity method investments
4,163 nm1,995 (94%)32,084 
Net income376,292 223,083 618,609 
Preferred share dividends(30,250)—%(30,250)—%(30,250)
Net income available to common shareholders$346,042 $192,833 $588,359 
nm – not meaningful is defined as a variance greater than +/-100%
(1)Underwriting-related general and administrative expenses is a non-GAAP financial measure as defined in Item 10(e) of SEC Regulation S-K. The reconciliation to general and administrative expenses, the most comparable GAAP financial measure, also included corporate expenses of $133 million, $130 million, and $126 million for 2023, 2022, and 2021, respectively. Refer to 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Other Expenses (Revenues), Net'' for further details on corporate expenses. Refer also to 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Measures Reconciliation' for further details.
(2)Consolidated underwriting income (loss) is a non-GAAP financial measure as defined in Item 10(e) of SEC Regulation S-K. The reconciliation to net income (loss), the most comparable GAAP financial measure, is presented in the table above. Refer also to 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Measures Reconciliation' for further details.

62


Underwriting Revenues

Underwriting revenues by segment were as follows:
Year ended December 31,2023% Change2022% Change2021
Gross premiums written:
Insurance$6,140,76410%$5,585,58115%$4,863,232
Reinsurance2,215,761(16%)2,629,014(7%)2,822,752
Total gross premiums written$8,356,5252%$8,214,5957%$7,685,984
Percent of gross premiums written ceded:
Insurance39 %(1 pt )40 %— pt 40 %
Reinsurance39 %11 pts28 %— pt28 %
Total percent of gross premiums written ceded39 %3 pts36 %— pt 36 %
Net premiums written:
Insurance$3,758,72011%$3,377,90617%$2,894,885
Reinsurance1,343,605(29%)1,885,150(7%)2,031,739
Total net premiums written$5,102,325(3%)$5,263,0567%$4,926,624
Net premiums earned:
Insurance$3,461,70010%$3,134,15518%$2,651,339
Reinsurance1,622,081(20%)2,026,171(2%)2,058,511
Total net premiums earned$5,083,781(1%)$5,160,32610%$4,709,850

Refer to 'Management's Discussion and Analysis of Financial Condition and Results of Operations Results by Segment' for further details on underwriting revenues.

Combined Ratio

The components of the combined ratio were as follows:
Year ended December 31,2023% Point
Change
2022% Point
Change
2021
Current accident year loss ratio, excluding catastrophe and weather-related losses55.9 %0.4 55.5 %0.4 55.1 %
Catastrophe and weather-related losses ratio2.7 %(5.1)7.8 %(1.7)9.5 %
Current accident year loss ratio58.6 %(4.7)63.3 %(1.3)64.6 %
Prior year reserve development ratio8.1 %8.6 (0.5 %)0.2 (0.7 %)
Net losses and loss expenses ratio66.7 %3.9 62.8 %(1.1)63.9 %
Acquisition cost ratio19.7 %(0.1)19.8 %0.2 19.6 %
General and administrative expense ratio(1)
13.5 %0.3 13.2 %(0.8)14.0 %
Combined ratio99.9 %4.1 95.8 %(1.7)97.5 %
(1)The general and administration expense ratio included corporate expenses not allocated to underwriting segments of 2.6%, 2.5% and 2.7% for 2023, 2022 and 2021, respectively. Refer to 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Other Expenses (Revenues), Net' for further details.

Refer to 'Management's Discussion and Analysis of Financial Condition and Results of Operations Results by Segment' for further details on underwriting expenses.




63



RESULTS BY SEGMENT

Insurance Segment
Results for the insurance segment were as follows:
Year ended December 31,2023% Change2022% Change2021
Revenues:
Gross premiums written$6,140,764 10%$5,585,581 15%$4,863,232 
Net premiums written3,758,720 11%3,377,906 17%2,894,885 
Net premiums earned3,461,700 10%3,134,155 18%2,651,339 
Other insurance related income (loss)
(198)nm559 (66%)1,662 
Expenses:
Current accident year net losses and loss expenses(1,903,648)(1,802,204)(1,533,358)
Prior year reserve development(176,353)16,350 18,360 
Acquisition costs(648,463)(577,838)(484,344)
Underwriting-related general and administrative expenses(472,094)(443,704)(429,282)
Underwriting income$260,944 $327,318 $224,377 
Ratios:% Point
Change
 % Point
Change
Current accident year loss ratio, excluding catastrophe and weather-related losses51.8 %0.851.0 %(0.4)51.4 %
Catastrophe and weather-related losses ratio3.2 %(3.3)6.5 %0.16.4 %
Current accident year loss ratio55.0 %(2.5)57.5 %(0.3)57.8 %
Prior year reserve development ratio5.1 %5.6(0.5 %)0.2(0.7 %)
Net losses and loss expenses ratio60.1 %3.157.0 %(0.1)57.1 %
Acquisition cost ratio18.7 %0.318.4 %0.118.3 %
Underwriting-related general and administrative expense ratio13.7 %(0.5)14.2 %(2.0)16.2 %
Combined ratio92.5 %2.989.6 %(2.0)91.6 %
nm – not meaningful


64


Gross Premiums Written
Gross premiums written by line of business were as follows:
        % Change
Year ended December 31,2023202220212022 to 20232021 to 2022
Professional lines$1,140,695 19 %$1,322,966 24 %$1,290,767 26 %(14 %)%
Property1,736,586 28 %1,357,489 24 %1,192,981 25 %28 %14 %
Liability1,256,951 20 %1,138,645 20 %930,999 19 %10 %22 %
Cyber649,160 11 %644,746 12 %525,349 11 %%23 %
Marine and aviation771,162 13 %652,687 12 %580,635 12 %18 %12 %
Accident and health333,559 5 %258,399 %178,899 %29 %44 %
Credit and political risk252,651 4 %210,649 %163,602 %20 %29 %
Total$6,140,764 100 %$5,585,581 100 %$4,863,232 100 %10 %15 %

Gross premiums written in 2023 increased by $555 million, or 10%, compared to 2022. The increase was primarily attributable to property, marine and aviation, liability, accident and health, and credit and political risk lines, partially offset by a decrease in professional lines.

The increases in property, marine and aviation, liability, and credit and political risk lines were due to favorable rate changes and new business. The increase in accident and health lines was due to new business.

The decrease in professional lines reflected the unattractive pricing environment for U.S. public D&O business, together with a lower level of activity in transactional liability business.

Ceded Premiums Written

Ceded premiums written in 2023 were $2,382 million, or 39% of gross premiums written, compared to $2,208 million, or 40% in 2022. The increase in ceded premiums written of $174 million, or 8% was primarily driven by increases in property, liability, and marine and aviation lines, partially offset by a decrease in professional lines.

The increases in property, liability, and marine and aviation lines reflected the increase in gross premiums written in 2023, compared to 2022. The increase in property lines was also attributable to the restructuring of a significant existing quota share treaty.

The decrease in professional lines reflected the decrease in gross premiums written for 2023, compared to 2022. The decrease in professional lines was also due to the restructuring of a significant existing quota share treaty.













65


Net Premiums Earned
Net premiums earned by line of business were as follows:
        % Change
Year ended December 31,2023202220212022 to 20232021 to 2022
Professional lines$764,558 22 %$817,924 26 %$646,390 23 %(7 %)27 %
Property878,849 26 %755,986 24 %711,297 27 %16 %%
Liability496,381 14 %459,775 15 %354,787 13 %%30 %
Cyber323,025 9 %309,004 10 %252,077 10 %%23 %
Marine and aviation567,292 16 %479,499 15 %439,050 17 %18 %%
Accident and health306,061 9 %209,548 %151,133 %46 %39 %
Credit and political risk125,534 4 %102,419 %96,605 %23 %%
Total$3,461,700 100 %$3,134,155 100 %$2,651,339 100 %10 %18 %

Net premiums earned in 2023 increased by $328 million, or 10% ($365 million, or 12%, on a constant currency basis(1)), compared to 2022. The increase was primarily driven by increases in gross premiums earned in property, liability, marine and aviation, accident and health, credit and political risk, and cyber lines, together with a decrease in ceded premiums earned in professional lines. These amounts were partially offset by increases in ceded premiums earned in property, liability, and marine and aviation lines together with a decrease in gross premiums earned in professional lines.
Loss Ratio
The components of the loss ratio were as follows:
Year ended December 31,2023% Point
Change
2022% Point
Change
2021
Current accident year loss ratio55.0 %(2.5)57.5 %(0.3)57.8 %
Prior year reserve development ratio5.1 %5.6 (0.5 %)0.2 (0.7 %)
Loss ratio60.1 %3.1 57.0 %(0.1)57.1 %

Current Accident Year Loss Ratio

The current accident year loss ratio decreased to 55.0% in 2023 from 57.5% in 2022. The decrease in the current accident year loss ratio was impacted by a lower level of catastrophe and weather-related losses.

During 2023, catastrophe and weather-related losses, net of reinsurance, were $111 million, or 3.2 points, primarily attributable to the Israel-Hamas conflict, the Earthquake in Turkey, Maui wildfires, Cyclone Gabrielle, Typhoon Mawar and other weather-related events.

Comparatively, in 2022, catastrophe and weather-related losses, net of reinstatement premiums, were $207 million, or 6.5 points, including natural catastrophe and weather-related losses of $177 million, or 5.6 points, primarily attributable to Hurricane Ian, Winter Storm Elliot, Eastern Australia floods, South Africa floods, and other weather-related events. The remaining losses of $29 million, or 0.9 points, were attributable to the Russia-Ukraine war.

Adjusting for the impact of the catastrophe and weather-related losses, the current accident year loss ratio increased to 51.8% in 2023 from 51.0% in 2022. The increase in the current accident year loss ratio, after adjusting for the impact of the catastrophe and weather-related losses was principally due to elevated loss experience in property, and marine and aviation lines, and heightened loss trends in liability lines consistent with changes in loss assumptions reflected in recent periods, partially offset by the changes in business mix associated with the increase in property business and the decrease in professional lines business written in recent periods.

(1) Amounts presented on a constant currency basis are non-GAAP financial measures as defined in Item10 (e) of SEC Regulation S-K. The constant currency basis is calculated by applying the average foreign exchange rate from the current year to the prior year balance.
66


Prior Year Reserve Development

Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses' for details on the lines of business and prior year development.

Acquisition Cost Ratio

The acquisition cost ratio increased to 18.7% in 2023 from 18.4% in 2022, principally related to a decrease in ceding commissions largely associated with changes in business mix driven by an increase in property business which is associated with relatively lower ceding commissions and a decrease in professional lines business written in recent periods which is associated with relatively higher ceding commissions.

Underwriting-Related General and Administrative Expense Ratio

The underwriting-related general and administrative expense ratio decreased to 13.7% in 2023 from 14.2% in 2022, mainly driven by an increase in net premiums earned, partially offset by increases in personnel costs and performance-related compensation costs.


Reinsurance Segment
Results for the reinsurance segment were as follows:
Year ended December 31,2023% Change2022% Change2021
Revenues:
Gross premiums written$2,215,761 (16%)$2,629,014 (7%)$2,822,752 
Net premiums written1,343,605 (29%)1,885,150 (7%)2,031,739 
Net premiums earned1,622,081 (20%)2,026,171 (2%)2,058,511 
Other insurance related income22,693 81%12,514 (42%)21,633 
Expenses:
Current accident year net losses and loss expenses(1,077,572)(1,465,739)(1,507,835)
Prior year reserve development(235,529)9,183 14,049 
Acquisition costs(352,482)(444,179)(437,490)
Underwriting-related general and administrative expenses(79,373)(106,585)(107,552)
Underwriting income (loss)
$(100,182)$31,365 $41,317 
Ratios:% Point
Change
 % Point
Change
Current accident year loss ratio, excluding catastrophe and weather-related losses64.8 %2.262.6 %2.759.9 %
Catastrophe and weather-related losses ratio1.6 %(8.1)9.7 %(3.6)13.3 %
Current accident year loss ratio66.4 %(5.9)72.3 %(0.9)73.2 %
Prior year reserve development ratio14.6 %15.0(0.4 %)0.2(0.6 %)
Net losses and loss expenses ratio81.0 %9.171.9 %(0.7)72.6 %
Acquisition cost ratio21.7 %(0.2)21.9 %0.621.3 %
Underwriting-related general and administrative expense ratio4.9 %(0.4)5.3 %0.25.1 %
Combined ratio107.6 %8.599.1 %0.199.0 %


67


Gross Premiums Written:
Gross premiums written by line of business were as follows:
              % Change
Year ended December 31,2023202220212022 to 20232021 to 2022
Liability$642,801 29 %$719,831 27 %$722,931 26 %(11 %)— %
Accident and health396,668 18 %411,891 16 %398,641 14 %(4 %)%
Professional lines379,222 17 %400,807 15 %353,671 13 %(5 %)13 %
Credit and surety351,083 16 %298,565 11 %208,108 %18 %43 %
Motor201,466 9 %239,794 %279,966 10 %(16 %)(14 %)
Agriculture126,300 6 %128,012 %86,128 %(1 %)49 %
Marine and aviation62,260 3 %93,371 %73,968 %(33 %)26 %
Run-off lines
Catastrophe30,175 1 %222,810 %492,397 16 %(86 %)(55 %)
Property21,513 1 %103,492 %213,406 %(79 %)(52 %)
Engineering4,273  %10,441 — %(6,464)— %(59 %)nm
Total run-off lines55,961 2 %336,743 13 %699,339 24 %(83 %)(52 %)
Total$2,215,761 100 %$2,629,014 100 %$2,822,752 100 %(16 %)(7 %)
nm – not meaningful

Gross premiums written in 2023 decreased by $413 million, or 16% ($365 million, or 14%, on a constant currency basis), compared to 2022. The decrease was primarily attributable to catastrophe, property, liability, motor, marine and aviation, professional lines, accident and health, and engineering lines, partially offset by an increase in credit and surety lines.

The decreases in catastrophe and property lines were associated with the exit from these lines of business in June 2022.

The decrease in liability lines was related to non-renewals of U.S. regional multi-line business that included a high proportion of property exposures and a decreased line size on a significant contract following the exit from catastrophe and property lines of business, together with non-renewals and decreased line sizes associated with repositioning the portfolio, partially offset by new business.

The decrease in motor lines was due to non-renewals and decreased line sizes associated with repositioning the portfolio and the timing of the renewal of a significant contract, partially offset by premium adjustments attributable to significant contracts associated with favorable market conditions, and new business.

The decrease in marine and aviation lines was driven by non-renewals of marine business and the exit from aviation business effective January 1, 2023.

The decrease in professional lines was attributable to lower premium adjustments associated with favorable market conditions in 2023, compared to 2022, together with the non-renewals of several under-performing contracts, partially offset by new business and increased line sizes.

The decrease in accident and health lines was related to lower premium adjustments in 2023, compared to 2022, together with the timing of renewals of two significant contracts, partially offset by the increased line size of a significant contract.

The decrease in engineering lines was attributable to premium adjustments related to a significant contract in 2022.

The increase in credit and surety lines was driven by new business, including mortgage business, partially offset by the timing of the renewal of a significant contract and premium adjustments related to several surety contracts.
68


Ceded Premiums Written

Ceded premiums written in 2023 were $872 million, or 39%, of gross premiums written, compared to $744 million, or 28%, in 2022. The increase in ceded premiums written of $128 million, or 17%, was primarily driven by increases in liability, professional lines, accident and health, credit and surety, motor, and agriculture lines, partially offset by a decrease in catastrophe lines.

The increases in liability, professional lines, accident and health, credit and surety, and motor lines were primarily attributable to premiums ceded to a quota share retrocession agreement entered into with Monarch Point Re on September 22, 2023 with an effective date of January 1, 2023. Refer to Item 7 'Management's Discussion and Analysis of Financial Condition and Results of Operations – Overview – Recent Developments – Retrocession Agreement with Monarch Point Re' for further information.

The increase in liability lines was partially offset by the decrease in gross premiums written in 2023, compared to 2022, the non-renewal of a significant retrocessional treaty with a strategic capital partner and the restructuring of a significant quota share retrocessional treaty.

The increase in professional lines was partially offset by the non-renewal of a significant retrocessional treaty with a strategic capital partner.

The increase in accident and health lines was also attributable to the restructuring of a significant quota share retrocessional treaty with a strategic capital partner.

The increase in credit and surety lines was partially offset by the restructuring of a significant quota share retrocessional treaty and the non-renewal of a fronting arrangement.

The increase in motor lines was partially offset by the decrease in gross premiums written in 2023, compared to 2022.

The increase in agriculture lines was attributable to premiums ceded to a new quota share retrocessional treaty.

The decrease in catastrophe lines was due to lower costs associated with catastrophe bond protection, together with the decrease in gross premiums written in 2023, compared to 2022 following the exit from this line of business in June 2022.

69


Net Premiums Earned

Net premiums earned by line of business were as follows:
              % Change
Year ended December 31,2023202220212022 to 20232021 to 2022
Liability$403,239 25 %$484,681 24 %$431,596 21 %(17 %)12 %
Accident and health341,806 21 %368,747 18 %361,196 18 %(7 %)%
Professional lines205,404 13 %250,911 12 %220,448 11 %(18 %)14 %
Credit and surety236,408 15 %192,926 10 %158,549 %23 %22 %
Motor155,942 10 %205,774 10 %247,099 12 %(24 %)(17 %)
Agriculture121,628 7 %122,289 %82,743 %(1 %)48 %
Marine and aviation65,658 4 %78,504 %58,775 %(16 %)34 %
Run-off lines
Catastrophe33,963 1 %156,232 %238,775 11 %(78 %)(35 %)
Property44,508 3 %135,480 %231,092 11 %(67 %)(41 %)
Engineering13,525 1 %30,627 %28,238 %(56 %)%
Total run-off lines91,996 5 %322,339 16 %498,105 23 %(71 %)(35 %)
Total$1,622,081 100 %$2,026,171 100 %$2,058,511 100 %(20 %)(2 %)

Net premiums earned in 2023 decreased by $404 million, or 20%, ($337 million, or 17%, on a constant currency basis), compared to 2022. The decrease was primarily driven by decreases in gross premiums earned in catastrophe, property, liability, motor, professional lines, engineering, marine and aviation, and accident and health lines, together with increases in ceded premiums earned in motor, accident and health, credit and surety, professional lines and liability lines. These amounts were partially offset by decreases in ceded premiums earned in catastrophe lines and increases in gross premiums earned in credit and surety lines.

Other Insurance Related Income (Loss)

Other insurance related income of $23 million in 2023, compared to other insurance related income of $13 million in 2022, an increase of $10 million, primarily associated with an increase in fees related to arrangements with strategic capital partners.
Loss Ratio

The components of the loss ratio were as follows:
Year ended December 31,2023% Point
Change
2022% Point
Change
2021
Current accident year loss ratio66.4 %(5.9)72.3 %(0.9)73.2 %
Prior year reserve development ratio14.6 %15.0 (0.4 %)0.2 (0.6 %)
Loss ratio81.0 %9.1 71.9 %(0.7)72.6 %

Current Accident Year Loss Ratio

The current accident year loss ratio decreased to 66.4% in 2023 from 72.3% in 2022. The decrease in the current accident year loss ratio was impacted by a lower level of catastrophe and weather-related losses.

During 2023, catastrophe and weather-related losses, net of reinsurance, were $27 million, or 1.6 points, primarily attributable to Cyclone Gabrielle and other weather-related events.

70


Comparatively, in 2022, catastrophe and weather-related losses, net of reinstatement premiums, were $196 million, or 9.7 points, including natural catastrophe and weather-related losses of $160 million, or 8.0 points, primarily attributable to Hurricane Ian, June European Convective Storms, Eastern Australia floods, South Africa floods, Winter Storm Elliot, and other weather-related events. The remaining losses included $23 million, or 1.1 points, attributable to the COVID-19 pandemic, and $13 million, or 0.6 points, attributable to the Russia-Ukraine war.

Adjusting for the impact of the catastrophe and weather-related losses, the current accident year loss ratio increased to 64.8% in 2023 from 62.6% in 2022, principally due to changes in business mix associated with the exit from catastrophe lines, partially offset by changes in business mix due to the increase in credit and surety business written in the recent periods which are associated with a relatively lower loss ratio.

Prior Year Reserve Development

Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses' for details on the lines of business and prior year development.

Acquisition Cost Ratio

The acquisition cost ratio decreased to 21.7% in 2023 from 21.9% in 2022, principally related to an increase in ceding commissions from retrocessional agreements due to changes in business mix driven by increases in credit and surety, professional lines, liability, accident and health, and motor business written in recent periods, together with decreases in catastrophe and property business written in recent periods.

Underwriting-Related General and Administrative Expense Ratio

The underwriting-related general and administrative expense ratio decreased to 4.9% in 2023 from 5.3% in 2022, mainly driven by a decrease in personnel costs associated with the exit from catastrophe and property lines, partially offset by decreases in net premiums earned and fees related to arrangements with strategic capital partners.


























71



NET INVESTMENT INCOME AND NET INVESTMENT GAINS (LOSSES)
Net Investment Income

Net investment income from our cash and investment portfolio by major asset class was as follows:
Year ended December 31,2023% Change2022% Change2021
Fixed maturities$514,842 56%$329,858 26%$262,049 
Other investments20,411 (64%)57,043 (69%)181,906 
Equity securities12,088 16%10,390 (19%)12,752 
Mortgage loans35,312 51%23,407 34%17,427 
Cash and cash equivalents50,261 nm20,273 nm4,454 
Short-term investments8,924 nm3,535 nm664 
Gross investment income641,838 44%444,506 (7%)479,252 
Investment expense(30,096)17%(25,677)3%(24,951)
Net investment income$611,742 46%$418,829 (8%)$454,301 
Pre-tax yield:(1)
Fixed maturities3.9 %2.6 %2.2 %
nm – not meaningful
(1)Pre-tax yield is calculated by dividing net investment income by the average month-end amortized cost balances.
Fixed Maturities
2023 versus 2022: Net investment income in 2023 increased by $185 million or 56%, compared to 2022 due to an increase in yields.

Other Investments
Other investments include multi-strategy funds, direct lending funds, private equity funds, real estate funds, other privately held investments and an indirect investment in CLO-Equities. These investments are recorded at fair value, with changes in fair value and income distributions reported in net investment income. Consequently, the pre-tax return on other investments may vary materially year over year, particularly during volatile equity and credit markets.

Net investment income from other investments was as follows:
Year ended December 31,202320222021
Multi-strategy, direct lending, private equity and real estate funds
$20,867 $39,151 $133,923 
Other privately held investments(2,875)14,931 44,482 
CLO-Equities2,419 2,961 3,501 
Total net investment income from other investments$20,411 $57,043 $181,906 
Pre-tax return on other investments(1)
2.1 %5.9 %21.4 %
(1)The pre-tax return on other investments is calculated by dividing total net investment income from other investments by the average month-end fair value balances held for the periods indicated.

2023 versus 2022: Pre-tax return on other investments in 2023 decreased to 2.1%, compared to 5.9% in 2022. The decrease was primarily attributable to lower returns from real estate funds and other privately held investments.
72


Net Investment Gains (Losses)
Fixed maturities classified as available for sale are reported at fair value. Realized gains (losses) on fixed maturities are reported in net investment gains (losses) when these securities are sold or impaired.
Equity securities are reported at fair value. Realized gains (losses) on equity securities are also reported in net investment gains (losses) when securities are sold or impaired. In addition, changes in the fair values of equity securities are reported in net investment gains (losses).
Changes in the fair value of investment derivatives, mainly foreign exchange forward contracts are recorded in net investment gains (losses).

Net investment gains (losses) were as follows:
Year ended December 31,202320222021
On sale of investments:
Fixed maturities and short-term investments$(125,160)$(311,822)$95,116 
Equity securities16,208 7,281 4,717 
(108,952)(304,541)99,833 
(Increase) decrease in allowance for expected credit losses, fixed maturities, available for sale
974 (11,421)11 
(Increase) decrease in allowance for expected credit losses, mortgage loans
(6,220)— — 
Impairment losses (1)
(12,757)(12,568)(22)
Change in fair value of investment derivatives(1,456)7,656 4,346 
Net unrealized gains (losses) on equity securities53,781 (135,915)30,111 
Net investment gains (losses)$(74,630)$(456,789)$134,279 
(1) Related to instances where we intend to sell securities, or it is more likely than not that we will be required to sell securities before their anticipated recovery.
2023 versus 2022: Net investment losses in 2023 were $75 million compared to net investment losses of $457 million in 2022. Net investment losses reported in 2023 mainly reflected net realized losses on the sale of corporate debt, U.S. government and Non-Agency CMBS, partially offset by net unrealized gains on equity securities. Net investment losses reported in 2022 mainly reflected net realized losses on the sale of corporate debt, U.S. government and Agency RMBS and net unrealized losses on equity securities.
On Sale of Investments
Generally, sales of individual securities occur when there are changes in the relative value, credit quality, or duration of a particular issue. We may also sell securities to re-balance our investment portfolio in order to change exposure to particular asset classes or sectors.
(Increase) Decrease in Allowance for Expected Credit Losses, Mortgage Loans

2023 versus 2022: The allowance for expected credit losses increased by $6 million in 2023 compared to $nil in 2022. The increase was primarily related to two collateral dependent mortgage loans.

Impairment Losses

The impairment losses (refer to 'Critical Accounting Estimates – Impairment losses' for further details) recognized in net income were as follows:

2023 versus 2022: Impairment losses in 2023 and 2022 were $13 million. The impairment losses in 2023 and 2022 were principally due to impairments of non-investment grade corporate debt securities that we intended to sell or where we determined that it was more likely than not that we were required to sell securities before their anticipated recovery.

73


Change in Fair Value of Investment Derivatives
We economically hedge foreign exchange exposure with derivative contracts.
During 2023, foreign exchange hedges resulted in $1 million of net losses which primarily related to securities denominated in pound sterling and euro which experienced volatility during 2023.
During 2022, foreign exchange hedges resulted in $8 million of net gains which primarily related to securities denominated in pound sterling and euro which experienced volatility during 2022.
Our derivative instruments are not designated as hedges. Therefore, net unrealized gains (losses) on the hedged securities were recorded in accumulated other comprehensive income (loss) in total shareholders’ equity.
Total Return
Our investment strategy is to take a long-term view by actively managing our investment portfolio to maximize total return within certain guidelines and constraints. In assessing returns under this approach, we include net investment income, net investment gains (losses), the change in unrealized gains (losses) on fixed maturities, and interest in income (loss) of equity method investments generated by our investment portfolio. 
Total return on cash and investments was as follows:
Year ended December 31,202320222021
Net investment income$611,742 $418,829 $454,301 
Net investments gains (losses)(74,630)(456,789)134,279 
Change in net unrealized gains (losses) on fixed maturities(1)
448,477 (909,150)(405,378)
Interest in income of equity method investments
4,163 1,995 32,084 
Total$989,752 $(945,115)$215,286 
Average cash and investments(2)
$16,155,418 $15,963,535 $16,107,523 
Total return on average cash and investments, pre-tax:
Including investment related foreign exchange movements6.1 %(5.9 %)1.3 %
Excluding investment related foreign exchange movements(3)
5.8 %(5.2 %)1.6 %
(1)Change in net unrealized gains (losses) on fixed maturities is calculated by taking net unrealized gains (losses) at year end less net unrealized gains (losses) at the prior year end.
(2)The average cash and investments balance is calculated by taking the average of the monthly fair value balances.
(3)Pre-tax total return on cash and investments excluding foreign exchange movements is a non-GAAP financial measure as defined in Item 10(e) of SEC Regulation S-K. The reconciliation to pre-tax total return on cash and investments, the most comparable GAAP financial measure, included foreign exchange (losses) gains of $51 million, $(110) million and $(40) million for the years ended December 31, 2023, 2022 and 2021, respectively.

74



OTHER EXPENSES (REVENUES), NET

The following table provides a summary of other expenses (revenues), net:
Year ended December 31,2023% Change2022% Change2021
Corporate expenses$132,979 2%$130,054 3%$126,470 
Foreign exchange losses (gains)58,115 nm(157,945)nm315 
Interest expense and financing costs68,421 8%63,146 1%62,302 
Income tax expense26,316 19%22,037 (65%)62,384 
Total$285,831 $57,292 $251,471 
nm – not meaningful

Corporate Expenses

Corporate expenses include holding company costs necessary to support our worldwide insurance and reinsurance operations and costs associated with operating as a publicly-traded company. As a percentage of net premiums earned, corporate expenses increased to 2.6% in 2023 from 2.5% in 2022.

The increase in corporate expenses in 2023 was mainly driven by increases in personnel costs and performance-related compensation costs, largely offset by a decrease in executive-related compensation costs associated with the transition in our senior leadership.

Foreign Exchange Losses (Gains)

Some of our business is written in currencies other than the U.S. dollar.

Foreign exchange losses in 2023 were primarily related to the impact of the weakening of the U.S. dollar on the remeasurement of net insurance-related liabilities denominated in pound sterling, euro and Canadian dollar.

Foreign exchange gains in 2022 were primarily related to the impact of the strengthening of the U.S. dollar on the remeasurement of net insurance-related liabilities denominated in pound sterling and euro.

Interest Expense and Financing Costs

Interest expense and financing costs are related to interest due on the 5.150% senior unsecured notes ("5.150% Senior Notes") issued in 2014, the 4.000% senior unsecured notes ("4.000% Senior Notes") issued in 2017, the 3.900% senior unsecured notes ("3.900% Senior Notes"), the 4.900% fixed-rate reset junior subordinated notes ("Junior Subordinated Notes") issued in 2019, and the Federal Home Loan advances ("FHLB advances") received in 2023 and 2022.

Interest expense and financing costs increased by $5 million in 2023, compared to 2022, due to the FHLB advances in 2023.

Income Tax Expense (Benefit)

Income tax expense (benefit) primarily results from income (loss) generated by our foreign operations in the U.S. and Europe. Our effective tax rate, which is calculated as income tax expense (benefit) divided by income (loss) before tax including interest in income (loss) of equity method investments, was 6.5%, 9.0%, and 9.2% in 2023, 2022, and 2021, respectively. This effective rate can vary between years depending on the distribution of net income (loss) among tax jurisdictions, as well as other factors.


75


The tax expense of $26 million in 2023 was principally due to the generation of pre-tax income in our U.K. and European insurance operations, partially offset by the recognition of a tax benefit in Bermuda on unrealized investment losses included in other comprehensive income (loss) due to the enactment of corporate income tax that will take effect in 2025, and the generation of pre-tax losses in our U.S. operations.

In 2023, the valuation allowance decreased by $21 million. The net gain incurred by the AXIS Re SE, the Irish reinsurance company, resulted in the release of a valuation allowance of $25 million against the net deferred tax assets of AXIS Re SE and AXIS Re Europe, the Swiss branch of the Irish reinsurance company, of which $12 million was released in net income (loss) and $13 million was released in other comprehensive income (loss). A valuation allowance of $2 million was also released against U.S. foreign tax credits that were utilized. A valuation allowance of $6 million was recorded against foreign tax credits held by AXIS Specialty Europe SE.

At December 31, 2023, the U.S. operations had a deferred tax asset of $54 million for the unrealized losses on its fixed maturities that were recorded in other comprehensive income (loss). We examined the need for a valuation allowance and after considering all positive and negative evidence concluded a valuation allowance against its net unrealized investment losses in the U.S was not required.

The tax expense of $22 million in 2022 was principally due to the generation of pre-tax income in our U.K., U.S. and European insurance operations, together with a valuation allowance on certain deferred tax assets, partially offset by the re-estimation of the amount of net deferred tax assets that would be realized at the 25% tax rate in the U.K. that took effect in 2023.

In 2022, the valuation allowance increased by $43 million. The net loss incurred by AXIS Re SE, the Irish reinsurance company, resulted in the recognition of a valuation allowance of $41 million against the net deferred tax assets of AXIS Re SE and AXIS Re Europe, the Swiss branch of the Irish reinsurance company, of which $22 million was recorded in net income (loss) and $19 million was recorded in other comprehensive income (loss). A partial valuation allowance of $2 million was also recorded against U.S. foreign tax credits.

At December 31, 2022, the U.S. operations had a deferred tax asset of $71 million for the unrealized losses on its fixed maturities that were recorded in other comprehensive income (loss). We examined the need for a valuation allowance and after considering all positive and negative evidence concluded a valuation allowance against its net unrealized investment losses in the U.S. was not required.

76



FINANCIAL MEASURES

We believe that the following financial indicators are important in evaluating performance and measuring the overall growth in value generated for common shareholders:
Year ended and at December 31,202320222021
Return on average common equity(1)
7.9 %4.3 %12.2 %
Operating return on average common equity(2)
11.0 %11.1 %9.1 %
Book value per diluted common share(3)
$54.06 $46.95 $55.78 
Cash dividends declared per common share$1.76 $1.73 $1.69 
Increase (decrease) in book value per diluted common share adjusted for dividends$8.87 $(7.10)$2.38 
(1)    Return on average common equity ("ROACE") is calculated by dividing net income (loss) available (attributable) to common shareholders for the year by the average common shareholders' equity determined using the common shareholders' equity balances at the beginning and end of the year.
(2)    Operating return on average common equity ("operating ROACE"), is a non-GAAP financial measure as defined in Item 10(e) of SEC Regulation S-K. The reconciliation to the most comparable GAAP financial measure, ROACE, and a discussion of the rationale for its presentation is provided in 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Measures Reconciliation'.
(3)    Book value per diluted common share represents common shareholders’ equity divided by the number of diluted common share outstanding, determined using the treasury stock method. Cash-settled restricted stock units are excluded.

Return on Average Common Equity

Our objective is to generate superior returns on capital that appropriately reward common shareholders for the risks we assume and to grow revenue only when we expect the returns will meet or exceed our requirements. We recognize that the nature of underwriting cycles and the frequency or severity of large loss events in any one year may challenge the ability to achieve a profitability target in any specific period.

ROACE reflects the impact of net income (loss) available (attributable) to common shareholders, including net investment gains (losses), foreign exchange losses (gains), reorganization expenses, and interest in income (loss) of equity method investments.

The increase in ROACE in 2023, compared to 2022, was primarily driven by a decrease in net investment losses, and an increase in net investment income, partially offset by foreign exchange losses, and a decrease in underwriting income.

Operating ROACE excludes the impact of net investment gains (losses), foreign exchange losses (gains), reorganization expenses, and interest in income (loss) of equity method investments.

Operating ROACE in 2023 was comparable to 2022 as a decrease in underwriting income was largely offset by an increase in net investment income.

Book Value per Diluted Common Share

We consider book value per diluted common share to be an appropriate measure of returns to common shareholders, as we believe growth in book value on a diluted basis will ultimately translate into appreciation of our stock price.

In 2023, book value per diluted common share increased by 15%, driven by net income for the year, and net unrealized investment gains reported in accumulated other comprehensive income (loss), partially offset by common dividends declared.

In 2022, book value per diluted common share decreased by 16%, due to the net unrealized investment losses reported in accumulated other comprehensive income (loss) and common dividends declared, partially offset by net income for the year.

77


Cash Dividends Declared per Common Share

We believe in returning excess capital to shareholders by way of dividends. Accordingly, dividend policy is an integral part of the value we create for shareholders. Our Board of Directors has approved quarterly common share dividends for twenty consecutive years.

Book Value per Diluted Common Share Adjusted for Dividends

Taken together, we believe that growth in book value per diluted common share and common share dividends declared represent the total value created for common shareholders. As companies in the insurance industry have differing dividend payout policies, we believe that investors use the book value per diluted common share adjusted for dividends metric to measure comparable performance across the industry.

In 2023, the increase in total value of $8.87, or 19%, was driven by net income for the year, and net unrealized investment gains reported in accumulated other comprehensive income (loss).

In 2022, the decrease in total value of $7.10, or 13%, was driven by net unrealized investment losses recognized in accumulated other comprehensive income (loss), partially offset by the net income for the year.




78



NON-GAAP FINANCIAL MEASURES RECONCILIATION

Years ended December 31,202320222021
Net income available to common shareholders$346,042$192,833 $588,359 
Net investment (gains) losses(1)
74,630456,789 (134,279)
Foreign exchange losses (gains)(2)
58,115(157,945)315 
Reorganization expenses(3)
28,99731,426 — 
Interest in income of equity method investments(4)
(4,163)(1,995)(32,084)
Income tax expense (benefit)(17,488)(23,177)14,166 
Operating income
$486,133$497,931 $436,477 
Earnings per diluted common share
$4.02$2.25$6.90
Net investment (gains) losses0.875.33(1.57)
Foreign exchange losses (gains)0.68(1.84)
Reorganization expenses0.340.37
Interest in income of equity method investments
(0.05)(0.02)(0.38)
Income tax expense (benefit)(0.21)(0.28)0.17
Operating income per diluted common share
$5.65$5.81$5.12
Weighted average diluted common shares outstanding(5)
86,01285,669 85,291 
Average common shareholders' equity$4,401,553$4,475,283$4,803,175
Return on average common equity7.9%4.3%12.2%
Operating return on average common equity11.0%11.1%9.1%
(1)Tax expense (benefit) of $(10) million, $(36) million and $11 million for the years ended December 31, 2023, 2022 and 2021, respectively. Tax impact is estimated by applying the statutory rates of applicable jurisdictions, after consideration of other relevant factors including the ability to utilize capital losses.
(2)Tax expense (benefit) of $(3) million, $16 million and $3 million for the years ended December 31, 2023, 2022 and 2021, respectively. Tax impact is estimated by applying the statutory rates of applicable jurisdictions, after consideration of other relevant factors including the tax status of specific foreign exchange transactions.
(3)Tax expense (benefit) of $(5) million, $(4) million and $nil for the years ended December 31, 2023, 2022 and 2021, respectively. Tax impact is estimated by applying the statutory rates of applicable jurisdictions.
(4)Tax expense (benefit) of $nil for the years ended December 31, 2023, 2022 and 2021, respectively, Tax impact is estimated by applying the statutory rates of applicable jurisdictions.
(5)Refer to Item 8, Note 14 to the Consolidated Financial Statements 'Earnings Per Common Share' for further details.





79


Rationale for the Use of Non-GAAP Financial Measures
We present our results of operations in a way we believe will be meaningful and useful to investors, analysts, rating agencies and others who use our financial information to evaluate our performance. Some of the measurements we use are considered non-GAAP financial measures under SEC rules and regulations. In this Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A"), we present underwriting-related general and administrative expenses, consolidated underwriting income (loss), operating income (loss) (in total and on a per share basis), operating return on average common equity ("operating ROACE"), amounts presented on a constant currency basis and pre-tax total return on cash and investments excluding foreign exchange movements, which are non-GAAP financial measures as defined in Item 10(e) of SEC Regulation S-K. We believe that these non-GAAP financial measures, which may be defined and calculated differently by other companies, help explain and enhance the understanding of our results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").
Underwriting-Related General and Administrative Expenses
Underwriting-related general and administrative expenses include those general and administrative expenses that are incremental and/or directly attributable to our underwriting operations. While this measure is presented in Item 8, Note 3 to the Consolidated Financial Statements 'Segment Information', it is considered a non-GAAP financial measure when presented elsewhere on a consolidated basis.
Corporate expenses include holding company costs necessary to support our worldwide insurance and reinsurance operations and costs associated with operating as a publicly-traded company. As these costs are not incremental and/or directly attributable to our underwriting operations, these costs are excluded from underwriting-related general and administrative expenses, and therefore, consolidated underwriting income (loss). General and administrative expenses, the most comparable GAAP financial measure to underwriting-related general and administrative expenses, also includes corporate expenses.
The reconciliation of underwriting-related general and administrative expenses to general and administrative expenses, the most comparable GAAP financial measure, is presented in 'Management's Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Results of Operations'.
Consolidated Underwriting Income (Loss)
Consolidated underwriting income (loss) is a pre-tax measure of underwriting profitability that takes into account net premiums earned and other insurance related income (loss) as revenues and net losses and loss expenses, acquisition costs and underwriting-related general and administrative expenses as expenses. While this measure is presented in Item 8, Note 3 to the Consolidated Financial Statements 'Segment Information', it is considered a non-GAAP financial measure when presented elsewhere on a consolidated basis.
We evaluate our underwriting results separately from the performance of our investment portfolio. As a result, we believe it is appropriate to exclude net investment income and net investment gains (losses) from our underwriting profitability measure.
Foreign exchange losses (gains) in our consolidated statements of operations primarily relate to the impact of foreign exchange rate movements on our net insurance-related liabilities. However, we manage our investment portfolio in such a way that unrealized and realized foreign exchange losses (gains) on our investment portfolio, including unrealized foreign exchange losses (gains) on our equity securities, and foreign exchange losses (gains) realized on the sale of our available for sale investments and equity securities recognized in net investment gains (losses), and unrealized foreign exchange losses (gains) on our available for sale investments in other comprehensive income (loss), generally offset a large portion of the foreign exchange losses (gains) arising from our underwriting portfolio, thereby minimizing the impact of foreign exchange rate movements on total shareholders' equity. As a result, we believe that foreign exchange losses (gains) in our consolidated statements of operations in isolation are not a meaningful contributor to our underwriting performance. Therefore, foreign exchange losses (gains) are excluded from consolidated underwriting income (loss).
Interest expense and financing costs primarily relate to interest payable on our debt and Federal Home Loan Bank advances. As these expenses are not incremental and/or directly attributable to our underwriting operations, these expenses are excluded from underwriting-related general and administrative expenses and, therefore, consolidated underwriting income (loss).
Reorganization expenses in 2023 include impairments of computer software assets and severance costs mainly attributable to our "How We Work" program which is focused on simplifying our operating structure. Reorganization expenses in 2022 included severance costs and impairments of computer software assets mainly attributable to our exit from catastrophe and
80


property reinsurance lines of business which was part of an overall approach to reduce our exposure to volatile catastrophe risk. Reorganization expenses are primarily driven by business decisions, the nature and timing of which are not related to the underwriting process. Therefore, these expenses are excluded from consolidated underwriting income (loss).
Amortization of intangible assets including the value of business acquired ("VOBA") arose from business decisions, the nature and timing of which are not related to the underwriting process. Therefore, these expenses are excluded from consolidated underwriting income (loss).
We believe that the presentation of underwriting-related general and administrative expenses and consolidated underwriting income (loss) provides investors with an enhanced understanding of our results of operations, by highlighting the underlying pre-tax profitability of our underwriting activities. The reconciliation of consolidated underwriting income (loss) to net income (loss), the most comparable GAAP financial measure, is presented in 'Management's Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Results of Operations'.
Operating Income (Loss)
Operating income (loss) represents after-tax operational results exclusive of net investment gains (losses), foreign exchange losses (gains), reorganization expenses and interest in income (loss) of equity method investments.
Although the investment of premiums to generate income and investment gains (losses) is an integral part of our operations, the determination to realize investment gains (losses) is independent of the underwriting process and is heavily influenced by the availability of market opportunities. Furthermore, many users believe that the timing of the realization of investment gains (losses) is somewhat opportunistic for many companies.
Foreign exchange losses (gains) in our consolidated statements of operations primarily relate to the impact of foreign exchange rate movements on net insurance-related liabilities. However, we manage our investment portfolio in such a way that unrealized and realized foreign exchange losses (gains) on our investment portfolio, including unrealized foreign exchange losses (gains) on our equity securities and foreign exchange losses (gains) realized on the sale of our available for sale investments and equity securities recognized in net investment gains (losses) and unrealized foreign exchange losses (gains) on our available for sale investments in other comprehensive income (loss), generally offset a large portion of the foreign exchange losses (gains) arising from our underwriting portfolio, thereby minimizing the impact of foreign exchange rate movements on total shareholders' equity. As a result, we believe that foreign exchange losses (gains) in our consolidated statements of operations in isolation are not a meaningful contributor to the performance of our business. Therefore, foreign exchange losses (gains) are excluded from operating income (loss).
Reorganization expenses in 2023 include impairments of computer software assets and severance costs mainly attributable to our "How We Work" program which is focused on simplifying our operating structure. Reorganization expenses in 2022 included severance costs and impairments of computer software assets mainly attributable to our exit from catastrophe and property reinsurance lines of business which was part of an overall approach to reduce our exposure to volatile catastrophe risk. Reorganization expenses are primarily driven by business decisions, the nature and timing of which are not related to the underwriting process. Therefore, these expenses are excluded from operating income (loss).
Interest in income (loss) of equity method investments is primarily driven by business decisions, the nature and timing of which are not related to the underwriting process. Therefore, this income (loss) is excluded from operating income (loss).
Certain users of our financial statements evaluate performance exclusive of after-tax net investment gains (losses), foreign exchange losses (gains), reorganization expenses, and interest in income (loss) of equity method investments in order to understand the profitability of recurring sources of income.
We believe that showing net income (loss) available (attributable) to common shareholders exclusive of after-tax net investment gains (losses), foreign exchange losses (gains), reorganization expenses and interest in income (loss) of equity method investments reflects the underlying fundamentals of our business. In addition, we believe that this presentation enables investors and other users of our financial information to analyze performance in a manner similar to how our management analyzes the underlying business performance. We also believe this measure follows industry practice and, therefore, facilitates comparison of our performance with our peer group. We believe that equity analysts and certain rating agencies that follow us, and the insurance industry as a whole, generally exclude these items from their analyses for the same reasons. The reconciliation of operating income (loss) to net income (loss) available (attributable) to common shareholders, the most comparable GAAP financial measure, is presented above.
81


We also present operating income (loss) per diluted common share and operating ROACE, which are derived from the operating income (loss) measure and are reconciled above to the most comparable GAAP financial measures, earnings (loss) per diluted common share and return on average common equity ("ROACE"), respectively.
Constant Currency Basis
We present gross premiums written and net premiums earned on a constant currency basis in this MD&A. The amounts presented on a constant currency basis are calculated by applying the average foreign exchange rate from the current year to the prior year amounts. We believe this presentation enables investors and other users of our financial information to analyze growth in gross premiums written and net premiums earned on a constant basis. The reconciliation to gross premiums written and net premiums earned on a GAAP basis is presented in 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results by Segment'.
Pre-Tax Total Return on Cash and Investments excluding Foreign Exchange Movements
Pre-tax total return on cash and investments excluding foreign exchange movements measures net investment income (loss), net investments gains (losses), interest in income (loss) of equity method investments, and change in unrealized gains (losses) generated by average cash and investment balances. We believe this presentation enables investors and other users of our financial information to analyze the performance of our investment portfolio. The reconciliation of pre-tax total return on cash and investments excluding foreign exchange movements to pre-tax total return on cash and investments, the most comparable GAAP financial measure, is presented in 'Management’s Discussion and Analysis of Financial Condition and Results of Operations – Net Investment Income and Net Investment Gains (Losses)'.


CASH AND INVESTMENTS

Details of cash and investments are as follows:
  December 31, 2023December 31, 2022
  Fair valueFair value
Fixed maturities, available for sale$12,234,742 $11,326,894 
Fixed maturities, held to maturity(1)
675,851 674,743 
Equity securities588,511 485,253 
Mortgage loans610,148 627,437 
Other investments949,413 996,751 
Equity method investments174,634 148,288 
Short-term investments17,216 70,310 
Total investments$15,250,515 $14,329,676 
Cash and cash equivalents(2)
$1,383,985 $1,174,653 
(1)Presented at net carrying value of $686 million (2022: $698 million) in the consolidated balance sheets.
(2)Includes restricted cash and cash equivalents of $431 million and $423 million for 2023 and 2022, respectively.


82


Overview

The fair value of total investments increased by $921 million in 2023, driven by the increase in market value of fixed maturities due to the decline in yields and the tightening of credit spreads, reinvestment of interest income and cashflows from operations.

An analysis of our investment portfolio by asset class is detailed below:

Fixed Maturities

Details of our fixed maturities portfolio are as follows:
  December 31, 2023December 31, 2022
  Fair value% of totalFair value% of total
Fixed maturities:
U.S. government and agency$3,007,528 23 %$2,639,330 22 %
Non-U.S. government723,959 6 %562,029 %
Corporate debt4,560,843 35 %4,329,328 36 %
Agency RMBS1,634,661 13 %1,202,785 10 %
CMBS839,696 7 %947,778 %
Non-agency RMBS153,396 1 %133,534 %
ABS1,832,151 14 %2,030,498 17 %
Municipals(1)
158,359 1 %156,355 %
Total$12,910,593 100 %$12,001,637 100 %
Credit ratings:
U.S. government and agency$3,007,528 23 %$2,639,330 22 %
AAA(2)
2,745,192 21 %4,189,661 36 %
AA2,646,798 21 %871,966 %
A2,044,683 16 %1,835,746 15 %
BBB1,416,552 11 %1,377,638 11 %
Below BBB(3)
1,049,840 8 %1,087,296 %
Total$12,910,593 100 %$12,001,637 100 %
(1)Includes bonds issued by states, municipalities, and political subdivisions.
(2)Includes U.S. government-sponsored agencies, residential mortgage-backed securities ("RMBS") and commercial mortgage-backed securities ("CMBS").
(3)Non-investment grade and non-rated securities.
At December 31, 2023, fixed maturities had a weighted average credit rating of AA- (2022: AA-), a book yield of 4.2% (2022: 3.5%), and an average duration of 3.0 years (2022: 3.0 years).
At December 31, 2023, fixed maturities together with short-term investments and cash and cash equivalents (i.e., total investments of $14.3 billion) had a weighted average credit rating of AA- (2022: AA-) and an average duration of 2.7 years (2022: 2.8 years).
Our methodology for assigning credit ratings to fixed maturities is in line with the methodology used for the Barclays U.S. Aggregate Bond index. This methodology uses the midpoint of Standard & Poor's (S&P), Moody's and Fitch ratings. When ratings from only two of these agencies are available, the lower rating is used. When only one agency rates a security, that rating is used. When ratings provided by S&P, Moody's and Fitch are not available, ratings from other nationally recognized agencies are used.
To calculate the weighted average credit rating for fixed maturities, we assign points to each rating with the highest points assigned to the highest rating (AAA) and the lowest points assigned to the lowest rating (D) and then calculate the weighted average based on the fair values of the individual securities. Securities that are not rated are excluded from weighted average calculations. At December 31, 2023, the fair value of fixed maturities not rated was $17 million (2022: $31 million).
83


In addition to managing credit risk exposure within our fixed maturities portfolio we also monitor the aggregation of country risk exposure on a group-wide basis. Country risk exposure is the risk that events in a country, such as currency crises, regulatory changes and other political events, will adversely affect the ability of obligors in the country to honor their obligations. For corporate debt and structured securities, we measure the country of risk exposure based on a number of factors including, but not limited to, location of management, principal operations and country of revenues.
An analysis of our fixed maturities portfolio by major asset classes is detailed below:
Non-U.S. Government
Non-U.S. government securities include bonds issued by non-U.S. governments and their agencies along with supranational organizations (collectively also known as sovereign debt securities).
Details of exposures to governments in the eurozone and other non-U.S. government concentrations by fair value are as follows:
  December 31, 2023December 31, 2022
CountryFair value% of totalWeighted
average
credit rating
Fair value% of totalWeighted
average
credit rating
Eurozone countries: 
Supranationals(1)
$41,888 6 %AAA$16,867 %AAA
Germany26,788 4 %AAA5,037 %AAA
Netherlands14,604 2 %AA+9,512 %AA+
France2,637  %A-1,061 — %AA
Austria  %2,346 — %AA+
Total eurozone85,917 12 %AAA34,823 %AA+
Other concentrations: 
Canada338,384 47 %AA+300,674 53 %AA+
United Kingdom224,809 31 %AA-168,068 30 %AA-
Mexico7,478 1 %BBB10,151 %BBB
Other67,371 9 %AA+48,313 %AA
Total other concentrations638,042 88 %AA527,206 94 %AA
Total non-U.S. government$723,959 100 %AA$562,029 100 %AA
(1)Includes supranationals only in the eurozone.
At December 31, 2023, net unrealized losses on non-U.S. government securities were $6 million (2022: $51 million) which included gross unrealized foreign exchange losses of $6 million (2022: $24 million), mainly related to U.K. government bonds.
84


Corporate Debt
Corporate debt securities consist primarily of investment grade debt of a wide variety of corporate issuers and industries.
Details of our corporate debt securities portfolio by sector are as follows:
  December 31, 2023December 31, 2022
  Fair value% of totalWeighted
average
credit rating
Fair value% of totalWeighted
average
credit rating
Financial institutions: 
U.S. banks$760,807 17 %A$786,541 18 %A
Corporate/commercial finance465,953 10 %BBB445,524 10 %BBB
Non-U.S. banks397,097 9 %A346,176 %A-
Insurance150,553 3 %A162,107 %A
Investment brokerage104,881 2 %BBB+117,706 %A
Total financial institutions1,879,291 41 %A-1,858,054 43 %A-
Consumer non-cyclicals518,596 11 %BBB533,543 12 %BBB-
Consumer cyclical472,162 10 %BB+411,559 10 %BB
Communications359,590 8 %BBB-369,295 %BB+
Industrials451,066 10 %BB407,318 %BB
Technology230,864 5 %BBB-211,740 %BBB-
Utilities215,787 5 %BBB+166,481 %BBB+
Energy204,682 4 %BBB-164,770 %BBB-
Other228,805 6 %A+206,568 %A
Total$4,560,843 100 %BBB$4,329,328 100 %BBB
Credit quality summary:
Investment grade$3,537,795 78 %A-$3,308,131 76 %A-
Non-investment grade1,023,048 22 %B+1,021,197 24 %B+
Total$4,560,843 100 %BBB$4,329,328 100 %BBB
At December 31, 2023, our non-investment grade portfolio had a fair value of $1,023 million (2022: $1,021 million), a weighted average credit rating of B+ (2022: B+) and duration of 2.4 years (2022: 2.9 years). At December 31, 2023, our corporate debt portfolio, including non-investment grade securities, had a duration of 3.4 years (2022: 3.6 years).

Mortgage-Backed Securities
Details of the fair values of our RMBS and CMBS portfolios by credit rating are as follows:
  December 31, 2023December 31, 2022
  RMBSCMBSRMBSCMBS
Government agency$1,634,661 $69,973 $1,202,785 $48,805 
AAA144,437 711,636 121,188 833,850 
AA5,389 45,094 4,192 60,207 
A1,371 6,937 3,682 4,916 
BBB100 650 122 — 
Below BBB(1)
2,099 5,406 4,350 — 
Total$1,788,057 $839,696 $1,336,319 $947,778 
(1)Non-investment grade securities.

85


Residential MBS
Agency RMBS consist of bonds issued by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association, which are primarily AA+ rated and are supported by loans which are diversified across geographical areas. At December 31, 2023, agency RMBS had an average duration of 5.2 years (2022: 5.7 years).
Non-agency RMBS mainly include investment grade bonds originated by non-agencies. At December 31, 2023, 98% (2022: 94%) of our non-agency RMBS were rated AA or better. At December 31, 2023, non-agency RMBS had an average duration of 4.0 years (2022: 4.6 years) and weighted average life of 5.6 years (2022: 6.7 years).
Commercial MBS
CMBS mainly include investment grade bonds originated by non-agencies. At December 31, 2023, 98% (2022: 99%) of our CMBS were rated AA or better. At December 31, 2023, the weighted average estimated subordination percentage of the portfolio was 37% (2022: 38%), which represents the current weighted average estimated percentage of the capital structure subordinated to the investment holding that is available to absorb losses before the security incurs the first dollar loss of principal. At December 31, 2023, CMBS had an average duration of 2.2 years (2022: 2.4 years) and weighted average life of 2.8 years (2022: 3.3 years).

Asset-Backed Securities

ABS mainly include investment grade bonds backed by pools of loans with a variety of underlying collateral, including auto loans, student loans, credit card receivables and collateralized loan obligations ("CLOs") originated by a variety of financial institutions.

Details of the fair value of our ABS portfolio by underlying collateral and credit rating are as follows:
  Asset-backed securities
  AAAAAABBBBelow BBBTotal
At December 31, 2023
CLO - debt tranches$793,769 $334,573 $71,621 $28,419 $ $1,228,382 
Auto loans267,430     267,430 
Student loans62,914 14,596    77,510 
Credit card receivables68,568 558    69,126 
Other155,826 7,888 18,879 6,763 347 189,703 
Total$1,348,507 $357,615 $90,500 $35,182 $347 $1,832,151 
% of total73%20%5%2%—%100%
At December 31, 2022
CLO - debt tranches$994,961 $306,934 $72,319 $26,257 $25,650 $1,426,121 
Auto loans237,884 4,728 — — — 242,612 
Student loans104,023 4,401 — — — 108,424 
Credit card receivables38,848 534 — — — 39,382 
Other178,447 12,351 16,803 6,017 341 213,959 
Total$1,554,163 $328,948 $89,122 $32,274 $25,991 $2,030,498 
% of total77%16%4%2%1%100%
At December 31, 2023, the average duration our ABS portfolio was 0.6 years (2022: 0.5 years) and the weighted average life was 3.0 years (2022: 3.7 years).


86


Municipals
Municipals comprise revenue bonds and general obligation bonds issued by U.S. domiciled state and municipal entities and are primarily held in the taxable portfolios of our U.S. subsidiaries.
At December 31, 2023, our municipals had a fair value of $158 million (2022: $156 million), a weighted average credit rating of AA- (2022: AA-) and duration of 3.9 years (2022: 4.4 years).

Gross Unrealized Losses

At December 31, 2023, the gross unrealized losses on our fixed maturities, available for sale portfolio were $481 million (2022: $857 million).
Investment grade fixed maturities, available for sale
The severity of the unrealized loss position as a percentage of amortized cost for all investment grade fixed maturities in an unrealized loss position including any impact of foreign exchange losses (gains) was as follows:
  December 31, 2023December 31, 2022
Severity of
Unrealized Loss
Fair valueGross
unrealized
losses
% of
total gross
unrealized
losses
Fair valueGross
unrealized
losses
% of
total gross
unrealized
losses
0-10%$5,843,552 $(194,115)42 %$6,176,828 $(265,175)33 %
10-20%1,590,548 (245,428)52 %2,315,291 (372,213)47 %
20-30%102,208 (26,886)6 %520,482 (147,575)19 %
30-40%193 (79) %15,622 (6,948)%
40-50%   %1,002 (735)— %
> 50%946 (1,070) %(27)— %
Total$7,537,447 $(467,578)100 %$9,029,229 $(792,673)100 %
The decrease in gross unrealized losses on investment grade fixed maturities reflected the impact of the decline in yields and the tightening of credit spreads on investment grade corporate debt securities.
Non-investment grade fixed maturities, available for sale
The severity of the unrealized loss position as a percentage of amortized cost for all non-investment grade fixed maturities in an unrealized loss position including any impact of foreign exchange losses (gains) was as follows:
  December 31, 2023December 31, 2022
Severity of
Unrealized Loss
Fair valueGross
unrealized
losses
% of
total gross
unrealized
losses
Fair valueGross
unrealized
losses
% of
total gross
unrealized
losses
0-10%$348,188 $(9,597)74 %$644,995 $(28,536)44 %
10-20%23,295 (3,073)24 %179,291 (26,642)42 %
20-30%1,475 (112)1 %28,414 (6,649)10 %
30-40%   %1,393 (495)%
40-50%   %738 (410)%
> 50%45 (155)1 %652 (1,183)%
Total$373,003 $(12,937)100 %$855,483 $(63,915)100 %
The decrease in gross unrealized losses on non-investment grade fixed maturities reflected the impact of the tightening of credit spreads on non-investment grade high yield corporate debt securities.

87


Equity Securities
At December 31, 2023, net unrealized gains on equity securities were $45 million (2022: net unrealized losses of $9 million). The increase was driven by the rally in global equity markets.
Mortgage Loans
During 2023, investment in commercial mortgage loans decreased to $610 million from $627 million, a decrease of $17 million. The commercial mortgage loans are high quality, and collateralized by a variety of commercial properties and diversified geographically throughout the U.S. and by property type to reduce the risk of concentration. At December 31, 2023, there are two collateral dependent loans with estimated loan-to-value ratios in excess of 100%, resulting in an allowance for expected credit loss of $6 million (2022: $nil).
Other Investments
Details of our other investments portfolio are as follows:
  December 31, 2023December 31, 2022
Multi-strategy funds$24,619 3 %$32,616 %
Direct lending funds192,270 20 %258,626 26 %
Private equity funds301,712 32 %265,836 27 %
Real estate funds317,325 33 %298,499 30 %
Total multi-strategy, direct lending, private equity and real estate funds
835,926 88 %855,577 86 %
CLO-Equities5,300 1 %5,016 — %
Other privately held investments108,187 11 %136,158 14 %
Total other investments$949,413 100 %$996,751 100 %
Refer to Item 8, Note 5(e) to the Consolidated Financial Statements 'Investments'.
Equity Method Investments
Our ownership interests in Harrington Reinsurance Holdings Limited ("Harrington") and Monarch Point Re (ISAC) Ltd. and Monarch Point Re (ISA 2023) Ltd. (collectively "Monarch Point Re") are reported in interest in income (loss) of equity method investments.
Interest in income (loss) of equity method investments of $4 million in 2023 was comparable to $2 million in 2022, as higher investment gains realized by Harrington were largely offset by higher underwriting losses at Harrington.
Restricted Assets
Refer to Item 8, Note 5(j) to the Consolidated Financial Statements 'Investments'.

88




LIQUIDITY AND CAPITAL RESOURCES

Liquidity
Liquidity is a measure of a company’s ability to generate cash flows sufficient to meet the short-term and long-term cash requirements of its business operations. We manage liquidity at the holding company and operating subsidiary level.
Holding Company
As a holding company, AXIS Capital has no operations of its own and its assets consist primarily of investments in its subsidiaries. Accordingly, AXIS Capital’s future cash flows depend on the availability of dividends or other statutorily permissible distributions, such as returns of capital, from its subsidiaries.
The ability to pay such dividends and/or distributions is limited by the applicable laws and regulations of the various countries and states in which AXIS Capital’s subsidiaries operate (refer to Item 8, Note 22 to the Consolidated Financial Statements 'Statutory Financial Information' for further details), as well as the need to maintain capital levels to adequately support insurance and reinsurance operations, and to preserve financial strength ratings issued by independent rating agencies.
During 2023, AXIS Capital received $375 million (2022: $225 million) of distributions from its subsidiaries. AXIS Capital’s primary uses of funds are dividend payments to common and preferred shareholders, interest and principal payments on debt, capital investments in subsidiaries, and payment of corporate operating expenses. We believe the dividend/distribution capacity of AXIS Capital’s subsidiaries, which was $0.9 billion at December 31, 2023, will provide AXIS Capital with sufficient liquidity for the foreseeable future.
Operating Subsidiaries
AXIS Capital’s operating subsidiaries primarily derive cash from the net inflow of premiums less claim payments related to underwriting activities and from net investment income. Historically, these cash receipts have been sufficient to fund the operating expenses of these subsidiaries, as well as to fund dividend payments to AXIS Capital. The subsidiaries’ remaining cash flows are generally invested in our investment portfolio and have also been used to fund common share repurchases in recent years.
The insurance and reinsurance business of our operating subsidiaries inherently provide liquidity, as premiums are received in advance (sometimes substantially in advance) of the time losses are paid. However, the amount of cash required to fund loss payments can fluctuate significantly from period to period, due to the low frequency/high severity nature of certain types of business we write.
Consolidated cash flows from operating, investing and financing activities in the last three years were as follows:
Total cash provided by (used in)(1)
202320222021
Operating activities$1,255,559 $798,038 $1,197,692 
Investing activities(855,610)(761,620)(1,197,065)
Financing activities(202,371)(149,622)(186,095)
Effect of exchange rate changes on cash11,754 (29,833)(74)
Increase (decrease) in cash and cash equivalents
$209,332 $(143,037)$(185,542)
(1)    Refer to Item 8, 'Consolidated Statements of Cash Flows' for further details.



89


Operating activities
Net cash provided by operating activities was $1,256 million in 2023 compared to $798 million in 2022. Cash inflows from insurance and reinsurance operations typically include premiums, net of acquisition costs, and reinsurance recoverables. Cash outflows principally include payments of losses and loss expenses, payments of premiums to reinsurers and operating expenses. Cash provided by operating activities can fluctuate due to timing differences between the collection of premiums and reinsurance recoverables and the payment of losses and loss expenses, and the payment of premiums to reinsurers.
Operating cash inflows increased in 2023 compared to 2022, primarily attributable to an increase in interest and dividends received from our investment portfolio and an increase in premiums received, partially offset by a decrease in reinsurance recoverables received and an increase in payments of premiums to reinsurers.
Investing activities
Investing cash outflows in 2023 were principally related to the net purchases of fixed maturities of $554 million, equity securities of $34 million, equity method investments of $22 million, loan advances made to third party reinsurers of $350 million and purchases of other assets of $31 million, partially offset by the net proceeds from the sale of other investments of $67 million and net proceeds from the sales and redemptions/repayments of short-term investments of $56 million and mortgage loans of $12 million.
Investing cash outflows in 2022 were principally related to the net purchases of fixed maturities of $599 million, loan advances made to third party reinsurers of $106 million, short term investment of $40 million, and mortgage loans of $33 million and purchases of other assets of $37 million, partially offset by the net proceeds from the sale of equity securities of $44 million, and other investments of $9 million.
Financing activities
Financing cash outflows in 2023 were principally due to dividends paid to common and preferred shareholders of $184 million, and the repurchase of common shares of $24 million, partially offset by the receipt of the Federal Home Loan Bank advances of $5 million.
Financing cash outflows in 2022 were principally due to dividends paid to common and preferred shareholders of $180 million, and the repurchase of common shares of $49 million, partially offset by the receipt of the Federal Home Loan Bank advances of $79 million.
The declaration and payment of future dividends and share repurchases is at the discretion of our Board of Directors and will depend on many factors including, but not limited to, our net income, financial condition, business needs, capital and surplus requirements of our operating subsidiaries and regulatory and contractual restrictions, including those detailed in our credit facilities (refer to 'Capital Resources – Share Repurchases' below for further details).
We have generated positive operating cash flows in all years since 2003, with the exception of 2009 which was impacted by the global financial crisis. These positive cash flows were generated even with the recognition of significant catastrophe and weather-related losses including the impact of the COVID-19 pandemic in 2020 and 2021.
Net losses and loss expenses, gross of reinstatement premiums, included estimates of ultimate losses for catastrophe and weather-related losses of $138 million in 2023, $404 million in 2022 and $450 million in 2021. There remains significant uncertainty associated with estimates of ultimate losses for certain of these events (refer to 'Underwriting Results – Insurance segment – Current Accident Year Loss' and 'Underwriting Results – Reinsurance segment – Current Accident Year Loss Ratio' for further details), as well as the timing of the associated cash outflows.
Should claim payment obligations accelerate beyond our ability to fund payments from operating cash flows, we would utilize cash and cash equivalent balances and/or liquidate a portion of our investment portfolio.
For context, at January 1, 2024, our largest 1-in-250 year return period, single occurrence, single-zone modeled probable maximum loss (California Earthquake) was approximately $163 million, net of reinsurance. Claim payments pertaining to such an event would be paid out over a period spanning many months. Our internal risk tolerance framework aims to limit the loss of capital due to a single event and the loss of capital that would occur from multiple but perhaps smaller events, in any year (refer to Item 1 'Risk and Capital Management' for further details).
Our investment portfolio is heavily weighted towards conservative, high quality and highly liquid securities. We expect that, if necessary, approximately $13.6 billion of cash and invested assets at December 31, 2023 could be available in one to three
90


business days under normal market conditions. Of this amount, $5.3 billion related to restricted assets, which primarily support our obligations in regulatory jurisdictions where we operate as a non-admitted carrier (refer to Item 8, Note 5(j) to the Consolidated Financial Statements 'Investments' for further details).
We expect that cash flows generated from operations, combined with the liquidity provided by our investment portfolio, to be sufficient to cover required cash outflows and other contractual commitments through the foreseeable future (refer to 'Contractual Obligations and Commitments' below for further details).
Capital Resources
In addition to common equity, we have utilized other external sources of financing, including debt, preferred shares, and letter of credit facilities to support our business operations. We believe that we hold sufficient capital to allow us to take advantage of market opportunities and to maintain our financial strength ratings, as well as to comply with various local statutory regulations. We monitor capital adequacy on a regular basis and will seek to adjust our capital base according to the needs of our business (refer to Item 1 'Risk and Capital Management' for further details).
The following table summarizes consolidated capital:
At December 31,20232022
Debt$1,313,714 $1,312,314 
Preferred shares550,000 550,000 
Common equity4,713,196 4,089,910 
Shareholders’ equity 5,263,196 4,639,910 
Total capital$6,576,910 $5,952,224 
Ratio of debt to total capital20.0 %22.0 %
We finance our operations with a combination of debt and equity capital. The debt to total capital ratio provides an indication of our capital structure, along with some insight into our financial strength.
While the impact of net unrealized investment losses recognized in accumulated other comprehensive income (loss), following a decrease in market value of our fixed maturities, has reduced common shareholders' equity, we believe that our financial flexibility remains strong, and adjustments are made if there are developments that are different from previous expectations.
Debt
Debt represents the 5.150% Senior Notes issued in 2014, which will mature in 2045, the 4.000% Senior Notes issued in 2017, which will mature in 2027, the 3.900% Senior Notes issued in 2019, which will mature in 2029, and the 4.900% Junior Subordinated Notes issued in 2019, which will mature in 2040 (refer to Item 8, Note 10(a) to the Consolidated Financial Statements 'Debt and Financing Arrangements' for further details).
The 3.900% Senior Notes and the 4.900% Junior Subordinated Notes were issued to finance the repayment of $500 million aggregate principal amount of 5.875% Senior Notes that matured in June 2020 and to finance the redemption of Series D preferred shares on January 17, 2020 (refer to 'Preferred Shares' below for further details).
Federal Home Loan Bank Advances
The Company's subsidiaries, AXIS Insurance Company and AXIS Surplus Insurance Company, are members of the Federal Home Loan Bank of Chicago ("FHLB").
Members may borrow from the FHLB at competitive rates subject to certain conditions. At December 31, 2023, the companies had admitted assets of approximately $3 billion which provides borrowing capacity of up to approximately $759 million. Conditions of membership include maintaining sufficient collateral deposits for funding, a requirement to maintain member stock at 0.4% of mortgage-related assets at December 31st of the prior year, and a requirement to purchase additional member stock of 2.0% or 4.5% of any amount borrowed (refer to Item 8, Note 11 to the Consolidated Financial Statements 'Federal Home Loan Bank Advances' for further details).
91


At December 31, 2023, the Company had $86 million (2022: $81 million) of borrowings under the FHLB program, with maturities in 2024 and interest payable at interest rates between 5.6% and 5.9% (2022: 2.3% and 4.7%).
For the year ended December 31, 2023, the Company incurred interest expense of $5 million (2022: $1 million). The borrowings under the FHLB program are secured by cash and investments with a fair value of $95 million (2022: $91 million).
Preferred Shares
Series E Preferred Shares
On November 7, 2016, we issued $550 million of 5.50% Series E preferred shares with a liquidation preference of $2,500 per share (equivalent to $25 per depositary share). Dividends on the Series E preferred shares are non-cumulative. To the extent declared, dividends accumulate, with respect to each dividend period, in an amount per share equal to 5.50% of the liquidation preference per annum (equivalent to $137.50 per Series E preferred share and $1.375 per depositary share). We may redeem these shares on or after November 7, 2021 at a redemption price of $2,500 per Series E preferred share (equivalent to $25 per depositary share) (refer to Item 8, Note 15 to the Consolidated Financial Statements 'Shareholders' Equity' for further details).
Secured Letter of Credit Facilities
We routinely enter into agreements with financial institutions to obtain secured letter of credit facilities.
These facilities are primarily used for the issuance of letters of credit, in the normal course of operations, to certain insurance and reinsurance entities that purchase reinsurance protection from us. These letters of credit allow those operations to take credit, under local insurance regulations, for reinsurance obtained in jurisdictions where AXIS Capital’s subsidiaries are not licensed or otherwise admitted as an insurer. The value of our letters of credit outstanding is driven by, among other factors, the amount of unearned premiums, development of loss reserves, the payment patterns of loss reserves, the expansion of our business and the loss experience of that business.
A portion of these facilities may also be used for liquidity purposes.
At December 31, 2023, certain of AXIS Capital’s operating subsidiaries (the "Participating Subsidiaries") had a $500 million letter of credit facility available from Citibank Europe plc ("Citibank") (the "$500 million Facility").
At December 31, 2023, letters of credit outstanding were $325 million (refer to Item 8, Note 10 to the Consolidated Financial Statements 'Debt and Financing Arrangements' for further details).

92


Common Equity
During the year ended December 31, 2023, common equity increased by $623 million. The following table reconciles opening and closing common equity positions:
Year ended December 31,20232022
Common equity - opening$4,089,910 $4,860,656 
Share-based compensation expense57,207 51,249 
Change in unrealized gains (losses) on available for sale investments, net of tax396,036 (805,850)
Foreign currency translation adjustment(1,572)(10,986)
Net income
376,292 223,083 
Preferred share dividends(30,250)(30,250)
Common share dividends(152,536)(150,556)
Treasury shares repurchased(23,596)(48,981)
Treasury shares reissued1,705 1,545 
Common equity - closing$4,713,196 $4,089,910 

Share Repurchases

During 2023, we repurchased 398,000 common shares for a total of $24 million from employees to facilitate the satisfaction of their personal withholding tax liabilities that arise on vesting of share-settled restricted stock units granted under our 2017 Long-Term Equity Compensation Plans.

As part of our capital management strategy, our Board of Directors authorizes common share repurchase programs. On December 8, 2022, our Board of Directors authorized a new share repurchase program for up to $100 million of our common shares, effective January 1, 2023, through December 31, 2023. (refer to Item 5 'Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities'). Share repurchases may be effected from time to time in the open market or privately negotiated transactions, depending on market conditions.

On December 7, 2023, our Board of Directors renewed its authorization for the repurchase of up to $100 million of our common shares, effective January 1, 2024, through December 31, 2024.

In 2024, we repurchased common shares for a total of $52 million pursuant to our Board-authorized share repurchase program.

Shelf Registrations
On November 9, 2022, we filed an unallocated universal shelf registration statement with the SEC, which became effective on filing. Pursuant to the shelf registration, we may issue an unlimited amount of equity, debt, warrants, purchase contracts or a combination of these securities. Our intent and ability to issue securities pursuant to this registration statement will depend on market conditions at the time of any proposed offering.
93


Financial Strength Ratings
Operating subsidiaries
Our principal insurance and reinsurance operating subsidiaries are assigned financial strength ratings from internationally recognized rating agencies, including Standard & Poor’s, A.M. Best, and Moody’s Investors Service. These ratings are publicly announced and are available directly from the agencies, and on our website.
Financial strength ratings represent the opinions of the rating agencies on the overall financial strength of a company and its capacity to meet the obligations of its insurance and reinsurance contracts. Independent ratings are one of the important factors that establish a competitive position in insurance and reinsurance markets. The rating agencies consider many factors in determining the financial strength rating of an insurance company, including the relative level of statutory surplus necessary to support the business operations of the company. These ratings are based on factors considered by the rating agencies to be relevant to policyholders, agents and intermediaries and are not directed toward the protection of investors. Ratings are not recommendations to buy, sell or hold securities.
The following are the most recent financial strength ratings from internationally recognized agencies in relation to our principal insurance and insurance operating subsidiaries:
Rating agency Agency’s description of rating Rating and outlook Agency’s rating
definition
 Ranking of rating
Standard & Poor’s An "opinion about the financial security characteristics of an insurance organization, with respect to its ability to pay under its insurance policies and contracts, in accordance with their terms". 
A+
(Stable) (1)
 "Strong capacity to meet its financial commitments" The 'A' category is the third highest out of ten major rating categories. The second through eighth major rating categories may be modified by the addition of a plus or minus sign to show relative standing within the major rating categories.
A.M. Best An "opinion of an insurer’s financial strength and ability to meet its ongoing insurance policy and contract obligations". 
A
(Stable) (2)
 "Excellent ability to meet ongoing insurance obligations"The 'A' category is the third highest rating out of fourteen. Ratings outlooks ('Positive', 'Negative' and 'Stable') are assigned to indicate a rating’s potential direction over an intermediate term, generally defined as 36 months.
Moody’s Investors Service "Opinions of the ability of insurance companies to pay punctually senior policyholder claims and obligations." 
A2
(Stable) (3)

 "Offers good financial security" The 'A' category is the third highest out of nine rating categories. Each of the second through seventh categories are subdivided into three subcategories, as indicated by an appended numerical modifier of '1', '2' and '3'. The '1' modifier indicates that the obligation ranks in the higher end of the rating category, the '2' modifier indicates a mid-category ranking and the '3' modifier indicates a ranking in the lower end of the rating category.
(1)    On July 20, 2022, Standard and Poor's revised its outlook from negative to stable due to improved underwriting performance and reduced prospective earnings volatility as a result of our exit from property and catastrophe reinsurance lines of business.
(2)    On May 5, 2020, A.M. Best revised its rating and outlook from A+ and negative to A and stable, respectively. The revised rating was based on unfavorable trends in operating performance over the past five years, particularly emanating from the insurance segment. The revised outlook continues to reflect our strong balance sheet, favorable business profile and appropriate risk management practices.
(3)    On May 31, 2022, Moody's Investors Service revised its outlook from negative to stable due to improved core underwriting profitability and reduced catastrophe risk exposure.
Non-operating holding companies
On November 17, 2023, Standard and Poor's placed AXIS Capital Holding Limited and the securities guaranteed by this non-operating holding company on CreditWatch Negative due to the potential regulatory restrictions to payments from Bermuda-based insurance and reinsurance operating companies to non-operating holding companies. On January 29, 2024, Standard and Poor's removed AXIS Capital Holdings Limited and related securities from Negative CreditWatch affirming the credit rating of AXIS Capital Holding Company at A- (Stable). In addition, Standard & Poor's also reaffirmed the A+ Financial Strength and issuer credit ratings on all core operating subsidiaries, with a Stable outlook. The stable outlook reflects Standard and Poor's expectation that AXIS will sustain its strong competitive position supported by solid, less-volatile underwriting performance, and will maintain capital adequacy at the 99.99% (or extreme stress) level in 2023-2025.

94


Contractual Obligations and Commitments
At December 31, 2023, contractual obligations and commitments by period due were:
  Payment due by period
Contractual obligations and commitmentsTotalLess than 1
year
1-3 years3-5 yearsMore than
5 years
Operating activities
Estimated gross losses and loss expenses payments(1)
$16,434,018 $4,541,740 $5,224,707 $2,876,765 $3,790,806 
Operating lease obligations(2)
123,101 12,416 25,411 19,684 65,590 
Investing activities
Unfunded investment commitments(3)
527,125 282,008 71,793 93,347 79,977 
Financing activities
Debt (principal payments)(4)
1,325,000 — — 350,000 975,000 
Debt (interest payments)(4)(5)
530,511 60,865 121,934 106,811 240,901 
Total$18,939,755 $4,897,029 $5,443,845 $3,446,607 $5,152,274 
(1)We are obligated to pay claims for specified loss events covered by the insurance and reinsurance contracts that we write. Loss payments represent our most significant future payment obligation. In contrast to our other contractual obligations, cash payments are not determinable from the terms specified within the underlying contracts. Our best estimate of reserve for losses and loss expenses is reflected in the table above. Actual amounts and timing may differ materially from our best estimate (refer to ‘Critical Accounting Estimates – Reserve for Losses and Loss Expenses’ for further details). We have not taken into account corresponding reinsurance recoverable on unpaid amounts that would be due to us.
(2)In the ordinary course of business, we renew and enter into new leases for office space which expire at various dates (refer to Item 8, Note 13 to the Consolidated Financial Statements 'Leases' for further details).
(3)We have $502 million of unfunded investment commitments related to our other investments portfolio, which are callable by our investment managers (refer to Item 8, Note 5(e) to the Consolidated Financial Statements 'Investments' for further details). In addition, we have $10 million of unfunded commitments related to our commercial mortgage loans portfolio and $16 million of unfunded commitments related to our corporate debt portfolio.
(4)Refer to Item 8, Note 10(a) to the Consolidated Financial Statements 'Debt and Financing Arrangements' for further details.
(5)Debt (interest payments) includes $11 million of unamortized discount and debt issuance expenses.


CRITICAL ACCOUNTING ESTIMATES

The consolidated financial statements include certain amounts that are inherently uncertain and judgmental in nature. As a result, we are required to make assumptions and best estimates to determine the reported values. We consider an accounting estimate to be critical if: (1) it requires that significant assumptions be made to deal with uncertainties and (2) changes in the estimate could have a material impact on our results of operations, financial condition, or liquidity.
We believe that the material items requiring such subjective and complex estimates are:
reserves for losses and loss expenses;
reinsurance recoverable on unpaid losses and loss expenses, including the allowance for expected credit losses;
gross premiums written and net premiums earned;
fair value measurements of financial assets and liabilities; and
the allowance for credit losses associated with fixed maturities, available for sale.
Significant accounting policies are also important to understanding the consolidated financial statements (refer to Item 8, Note 2 to the Consolidated Financial Statements 'Basis of Presentation and Significant Accounting Policies' for further details).
We believe that the amounts included in the consolidated financial statements reflect management's best judgment. However, factors such as those described in Item 1A 'Risk Factors' could cause actual events or results to differ materially from the underlying assumptions and estimates which could lead to a material adverse impact on our results of operations, financial condition, or liquidity.
95


Reserve for Losses and Loss Expenses
Overview
We believe the most significant accounting judgment we make is the estimate of reserve for losses and loss expenses ("loss reserves"). Loss reserves represent management’s estimate of the unpaid portion of our ultimate liability for losses and loss expenses ("ultimate losses") for insured and reinsured events that have occurred at or before the balance sheet date. Loss reserves reflect claims that have been reported ("case reserves") to us and claims that have been incurred but not reported ("IBNR") to us. Loss reserves represent our best estimate of what the ultimate settlement and administration of claims will cost, based on our assessment of facts and circumstances known at that particular point in time.
Loss reserves are not an exact calculation of the liability but instead are complex estimates. The process of estimating loss reserves involves a number of variables (refer to 'Selection of Reported Reserves Management's Best Estimate' below for further details). We review estimates of loss reserves each reporting period and consider all significant facts and circumstances known at that particular point in time. As additional experience and other data become available and/or laws and legal interpretations change, we may adjust previous estimates of loss reserves. Adjustments are recognized in the period in which they are determined. Therefore, they can impact that period's underwriting results either favorably, indicating that current estimates are lower than previous estimates, or adversely, indicating that current estimates are higher than previous estimates.
Case Reserves
With respect to insurance business, we are generally notified of losses by our insureds and/or their brokers. Based on this information, our claims personnel estimate ultimate losses arising from the claim, including the cost of administering the claims settlement process. These estimates reflect the judgment of our claims personnel based on general reserving practices, the experience and knowledge of such personnel regarding the nature of the specific claim and, where appropriate, the advice of legal counsel, loss adjusters and other relevant consultants.
With respect to reinsurance business, we are generally notified of losses by ceding companies and/or their brokers. For excess of loss contracts, we are typically notified of insured losses on specific contracts and record a case reserve for the estimated ultimate liability arising from the claim. For contracts written on a proportional basis, we typically receive aggregated claims information and record a case reserve for the estimated ultimate liability arising from the claim based on that information. Proportional reinsurance contracts typically require that losses in excess of pre-defined amounts be separately notified so we can adequately evaluate them. Our claims department evaluates each specific loss notification we receive and records additional case reserves when a ceding company’s reserve for a claim is not considered adequate. We also undertake an extensive program of cedant audits, using outsourced legal and industry experience where necessary. This allows us to review cedants’ claims administration practices to ensure that reserves are consistent with exposures, adequately established, and properly reported in a timely manner.
IBNR
The estimation of IBNR is necessary due to potential development on reported claims and the time lag between when a loss event occurs and when it is actually reported, which is referred to as a reporting lag. Reporting lags may arise from a number of factors, including but not limited to, the nature of the loss, the use of intermediaries and complexities in the claims adjusting process. As we do not have specific information on IBNR, it must be estimated. IBNR is calculated by deducting incurred losses (i.e., paid losses and case reserves) from management’s best estimate of ultimate losses. In contrast to case reserves, which are established at the contract level, IBNR reserves are generally estimated at an aggregate level and cannot be identified as reserves for a particular loss event or contract (refer to 'Reserving for Catastrophic Events' below for further details).
Reserving Methodology
Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserving Methodology – Sources of Information' for a description of the collection and analysis of data used in our quarterly loss reserving process.
Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserving Methodology – Actuarial Analysis' for a description of the reserve estimation methods, Expected Loss Ratio Method ("ELR Method"), Loss Development Method (also referred to as the "Chain Ladder Method" or "Link Ratio Method") and Bornhuetter-Ferguson Method ("BF Method") which are commonly employed by our actuaries together with a discussion of their strengths and weaknesses.
96


Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserving Methodology – Key Actuarial Assumptions', which notes that the most significant assumptions used in our quarterly loss reserving process are expected loss ratios ("ELRs) and loss development patterns.
Gross Loss Reserves by Line of Business
Gross loss reserves for each of the reportable segments, segregated between case reserves and IBNR, by line of business are shown below:
  20232022
At December 31,Case reservesIBNRTotalCase reservesIBNRTotal
Insurance segment:
Property$556,306 $523,713 $1,080,019 $565,954 $487,681 $1,053,635 
Accident and health28,767 89,371 118,137 22,770 60,795 83,565 
Marine and aviation449,455 532,284 981,739 490,895 419,712 910,606 
Cyber192,784 589,018 781,802 158,449 559,561 718,010 
Professional lines685,083 2,523,194 3,208,277 681,053 2,325,695 3,006,748 
Credit and political risk(1)
(45,138)208,975 163,838 (38,293)181,538 143,246 
Liability576,529 2,597,068 3,173,597 466,527 1,999,256 2,465,783 
Total Insurance2,443,786 7,063,623 9,507,409 2,347,355 6,034,238 8,381,593 
Reinsurance segment:
Accident and health55,185 177,602 232,787 64,949 207,953 272,902 
Agriculture43,011 109,372 152,383 40,598 95,645 136,243 
Marine and aviation79,792 91,369 171,161 99,019 115,582 214,601 
Professional lines558,556 860,748 1,419,304 550,786 761,575 1,312,361 
Credit and surety171,298 196,735 368,033 133,710 169,759 303,469 
Motor809,811 372,331 1,182,142 753,053 367,504 1,120,556 
Liability733,697 1,694,122 2,427,818 696,220 1,353,846 2,050,067 
Run-off lines
Catastrophe373,031 196,573 569,604 498,604 328,723 827,327 
Property204,217 77,440 281,657 273,607 124,253 397,860 
Engineering86,877 34,842 121,720 97,964 53,920 151,884 
Total run-off lines664,125 308,855 972,981 870,175 506,896 1,377,071 
Total Reinsurance3,115,475 3,811,134 6,926,609 3,208,510 3,578,760 6,787,270 
Total$5,559,261 $10,874,757 $16,434,018 $5,555,865 $9,612,998 $15,168,863 
(1)    During 2023 and 2022, significant gross claims associated with certain credit and political risk contracts were paid in advance of recoveries being received from the corresponding security which resulted in negative case reserves of $(60) million (2022: $(55) million) and related negative reinsurance recoverable on unpaid losses and loss expenses of $(29) million (2022: $(15) million). Refer to 'Reserving for Credit and Political Risk Business' below for further details.

In order to capture the key dynamics of loss reserve development and potential volatility, lines of business should be considered according to their potential expected length of loss emergence and settlement, generally referred to as the "tail". Favorable development on prior accident year reserves indicates that current estimates are lower than previous estimates, while adverse development on prior accident year reserves indicates that current estimates are higher than previous estimates.
Although estimates of ultimate losses for shorter tail business are inherently more certain than for longer tail business, significant judgment is still required. For example, much of our excess insurance and excess of loss reinsurance business has high attachment points. Therefore, it is often difficult to estimate whether claims will exceed those attachment points. In addition, the inherent uncertainties relating to catastrophe events further add to the complexity of estimating potential exposure. Further, we use managing general agents ("MGAs") and other producers for certain business in the insurance segment, which can delay the reporting of loss information. We expect the majority of development for an accident year or underwriting year to be recognized in the subsequent one to three years.
97


Factors that contribute additional uncertainty to estimates for longer tail business include, but are not limited to:
potential volatility of actuarial estimates, given the number of years of development it takes to produce a significant incurred loss as a percentage of ultimate losses;
inherent uncertainties about loss trends, claims inflation (e.g., medical, judicial, social) and general economic conditions; and
the possibility of future litigation, legislative or judicial change that may impact future loss experience relative to prior industry loss experience relied on in reserve estimation.
Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserve for Losses and Loss Expenses – Prior Year Reserve Development' for a detailed discussion of prior year reserve development by line of business and see further details below.
Refer to 'Reserving for Credit and Political Risk Business' below for a detailed discussion of specific loss reserve issues related to the credit and political risk line of business.
Reserving for Credit and Political Risk Business
Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – 'Net incurred and Paid Claims Development Tables by Accident Year – Insurance segment – Insurance Credit and Political Risk' for details of this line of business and the associated key actuarial assumptions.
An important and distinguishing feature of many of these contracts is the contractual right, subsequent to payment of a claim to an insured, to be subrogated to, or otherwise have an interest in, the insured’s rights of recovery under an insured loan or facility agreement. These estimated recoveries are recorded as an offset to credit and political risk gross loss reserves. The lag between the date of a claim payment and the ultimate recovery from the corresponding security can result in negative case reserves at a point in time. During 2023 and 2022, significant gross claims associated with certain credit and political risk contracts were paid in advance of recoveries being received from the corresponding security which resulted in negative case reserves of $(60) million (2022: $(55) million) and related negative reinsurance recoverable on unpaid losses and loss expenses of $(29) million (2022: $(15) million). Refer to 'Critical Accounting Estimates – Reinsurance Recoverable on Unpaid Losses and Loss Expenses' for further details.
The nature of the underlying collateral is specific to each transaction. Therefore, we estimate the value of this collateral on a contract-by-contract basis. This valuation process is inherently subjective and involves the application of management’s judgment because active markets for the collateral often do not exist. Estimates of values are based on numerous inputs, including information provided by our insureds, as well as third-party sources including rating agencies, asset valuation specialists and other publicly available information. We also assess any post-event circumstances, including restructurings, liquidations and possession of asset proposals/agreements.
In some instances, on becoming aware of a loss event related to credit and political risk business, we negotiate a final settlement of all of our policy liabilities for a fixed amount. In most circumstances, this occurs when the insured moves to realize the benefit of the collateral that underlies the insured loan or facility and presents us with a net settlement proposal that represents a full and final payment by us under the terms of the policy. In consideration for this payment, we secure a cancellation of the policy, or a release of all claims, and waive our right to pursue a recovery of these settlement payments against the collateral that may have been available to us under the insured loan or facility agreement. In certain circumstances, cancellation by way of net settlement or full payment can result in an adjustment to the premium associated with the policy.
Additionally, when we consider prior year reserve development for the credit and political risk line of business, it is important to note that the multi-year nature of this business distorts loss ratios when a single accident year is considered in isolation. Premiums for these contracts generally earn evenly over the contract term, therefore, are reflected in multiple accident years. In contrast, losses incurred on these contracts, which can be characterized as low in frequency and high in severity, are reflected in a single accident year.
Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserve for Losses and Loss Expenses – Prior Year Reserve Development' for further details.

98


Reserving for Catastrophic Events
Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserving Methodology – Reserving for Catastrophic Events' for further details.
In addition to those noted in Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserving Methodology – Reserving for Catastrophic Events' there are additional risks that affect our ability to accurately estimate ultimate losses for catastrophic events. For example, the estimates of loss reserves related to hurricanes and earthquakes can be affected by factors including, but not limited to, the inability to access portions of impacted areas, infrastructure disruptions, the complexity of factors contributing to losses, legal and regulatory uncertainties, complexities involved in estimating business interruption losses and additional living expenses, the impact of demand surge, fraud and the limited nature of information available. For hurricanes, additional complex coverage factors may include determining whether damage was caused by flooding or wind, evaluating general liability and pollution exposures, and mold damage. The timing of a catastrophe, for example, near the end of a reporting period, can also affect the level of information available to us to estimate loss reserves for that reporting period.
Results of operations for 2023 were impacted by natural and man-made catastrophe activity (refer to 'Underwriting Results – Insurance segment – Current Accident Year Loss Ratio' and 'Underwriting Results – Reinsurance segment – Current Accident Year Loss Ratio' for further details).
Selection of Reported Reserves Management’s Best Estimate
Refer to Item 8, Note 8 to the Consolidated Financial Statements 'Reserve for Losses and Loss Expenses – Reserving Methodology – Selection of Reported Reserves – Management’s Best Estimate' for further details.
Independent Actuarial Review
On an annual basis, we use an independent actuarial firm to provide an actuarial opinion on the reasonableness of loss reserves for each of our operating subsidiaries and statutory reporting entities as these actuarial opinions are required to meet various insurance regulatory requirements. The actuarial firm also discusses its conclusions from the annual review with management and presents its findings to the Audit Committee of the Board of Directors.
Sensitivity Analysis
While we believe that loss reserves at December 31, 2023 are adequate, new information, events or circumstances may result in ultimate losses that are materially greater or less than provided for in our loss reserves. As previously noted, there are many factors that may cause reserves to increase or decrease, particularly those related to catastrophe losses and longer tail lines of business.
Expected loss ratios are a key assumption in estimates of ultimate losses for business at an early stage of development. A higher expected loss ratio results in a higher ultimate loss estimate, and vice versa.
Assumed loss development patterns are another significant assumption in estimating loss reserves. Accelerating a loss reporting pattern (i.e., shortening the claim tail) results in lower ultimate losses, as the estimated proportion of losses already incurred would be higher.



99


The effect on estimates of gross loss reserves of reasonably likely changes in the two key assumptions used to estimate gross loss reserves at December 31, 2023 was as follows:
INSURANCE
Development patternExpected loss ratio
Higher Loss Reserves (Lower Loss Reserves)
Professional lines10% lowerUnchanged10% higher
6 months shorter$(288,175)$(94,560)$99,141 
Unchanged(198,491)— 199,401 
6 months longer(75,325)127,841 333,337 
Property5% lowerUnchanged5% higher
3 months shorter$(86,008)$(41,533)$(10,077)
Unchanged(29,329)— 29,692 
3 months longer32,034 61,455 94,245 
Liability10% lowerUnchanged10% higher
6 months shorter$(375,495)$(191,181)$(6,322)
Unchanged(196,669)— 198,534 
6 months longer20,722 225,448 435,439 
Cyber10% lowerUnchanged10% higher
6 months shorter$(95,647)$(29,914)$35,819 
Unchanged(67,568)— 67,665 
6 months longer(12,050)53,700 119,705 
Marine and aviation5% lowerUnchanged5% higher
3 months shorter$(54,069)$(29,019)$(3,969)
Unchanged(25,430)— 24,856 
3 months longer20,121 45,186 70,252 
Accident and health5% lowerUnchanged5% higher
3 months shorter$(21,958)$(13,671)$(5,181)
Unchanged(5,130)— 7,437 
3 months longer10,281 17,898 25,515 
Credit and political risk10% lowerUnchanged10% higher
6 months shorter$(8,811)$(93)$8,648 
Unchanged(8,617)— 8,750 
6 months longer(8,348)140 8,903 











100


REINSURANCE
Development patternExpected loss ratio
Higher Loss Reserves (Lower Loss Reserves)
Liability10% lowerUnchanged10% higher
6 months shorter$(268,341)$(138,120)$(7,408)
Unchanged(135,371)— 135,662 
6 months longer33,811 173,961 315,570 
Accident and health5% lowerUnchanged5% higher
3 months shorter$(60,492)$(40,184)$(16,764)
Unchanged(21,626)— 25,234 
3 months longer39,564 58,898 82,852 
Professional lines10% lowerUnchanged10% higher
6 months shorter$(133,996)$(59,239)$15,518 
Unchanged(76,043)— 76,058 
6 months longer1,485 78,892 156,467 
Credit and surety10% lowerUnchanged10% higher
6 months shorter$(32,681)$(12,602)$7,030 
Unchanged(21,028)— 21,207 
6 months longer(4,215)17,103 39,633 
Motor10% lowerUnchanged10% higher
6 months shorter$(49,664)$(15,750)$19,193 
Unchanged(31,229)— 35,349 
6 months longer15,071 47,538 81,399 
Agriculture5% lowerUnchanged5% higher
3 months shorter$(11,020)$— $11,020 
Unchanged(11,019)— 11,019 
3 months longer(11,019)— 11,019 
Marine and aviation5% lowerUnchanged5% higher
3 months shorter$(12,094)$(8,326)$(4,557)
Unchanged(3,527)— 4,160 
3 months longer6,336 10,212 14,088 
Catastrophe5% lowerUnchanged5% higher
3 months shorter$(27,503)$(339)$26,826 
Unchanged(27,165)— 27,164 
3 months longer(26,665)500 27,665 
Property5% lowerUnchanged5% higher
3 months shorter$(12,171)$(6,952)$(2,073)
Unchanged(5,376)— 5,325 
3 months longer4,905 10,434 16,546 
Engineering5% lowerUnchanged5% higher
3 months shorter$(4,137)$(2,944)$(1,751)
Unchanged(1,313)— 1,313 
3 months longer1,857 3,305 4,752 

The results show the cumulative increase (decrease) in loss reserves across all accident years.

For example, if assumed loss development pattern for insurance property business was three months shorter with no accompanying change in ELR assumption, loss reserves may decrease by approximately $42 million. Each of the impacts detailed in the tables is estimated individually, without consideration for any correlation among key assumptions or among lines of business. Therefore, it would be inappropriate to take each of the amounts and add them together in an attempt to
101


estimate total volatility. Additionally, it is noted that in some instances, for example the projection of catastrophe estimates or credit and political risks estimates, development patterns are not appropriate as more bespoke techniques are used. While we believe the variations in the expected loss ratios and loss development patterns presented could be reasonably expected, our historical loss data regarding variability is generally limited and actual variations may be greater or less than these amounts.

It is also important to note that the variations are not meant to be a "best-case" or "worst-case" series of scenarios and, therefore, it is possible that future variations in loss reserves may be more or less than the amounts presented. While we believe that these are reasonably likely scenarios, we do not believe this sensitivity analysis should be considered an actual reserve range.

Reinsurance Recoverable on Unpaid Losses and Loss Expenses
In the normal course of business, we purchase facultative and treaty reinsurance protection to limit ultimate losses and to reduce loss aggregation risk. To the extent that reinsurers do not meet their obligations under the reinsurance agreements, we remain liable. Consequently, we are exposed to credit risk associated with reinsurance recoverable on unpaid losses and loss expenses ("reinsurance recoverables") to the extent that any of our reinsurers are unable or unwilling to pay claims.
Reinsurance recoverables for each of the reportable segments, segregated between case reserves and IBNR, by line of business are shown below:
  20232022
At December 31,Case
reserves
IBNRTotalCase
reserves
IBNRTotal
Insurance segment:
Property$194,760 $207,462 $402,222 $221,616 $177,210 $398,826 
Accident and health1,411 1,595 3,006 820 5,698 6,518 
Marine and aviation153,065 125,149 278,215 195,845 83,131 278,976 
Cyber115,969 314,658 430,627 92,219 301,217 393,436 
Professional lines392,104 1,050,442 1,442,546 403,078 1,071,461 1,474,539 
Credit and political risk (1)
(21,575)56,767 35,191 (18,990)53,382 34,391 
Liability315,641 1,569,591 1,885,232 258,072 1,288,447 1,546,520 
Total Insurance1,151,375 3,325,664 4,477,039 1,152,660 2,980,546 4,133,206 
Reinsurance segment:
Accident and health8,556 40,758 49,314 7,303 31,344 38,647 
Agriculture5,917 2,425 8,343 8,600 1,418 10,018 
Marine and aviation19,432 13,754 33,185 27,209 30,484 57,692 
Professional lines89,621 280,724 370,345 81,413 222,436 303,849 
Credit and surety44,027 59,147 103,174 27,097 52,212 79,309 
Motor164,488 150,855 315,344 131,630 126,853 258,483 
Liability162,216 527,925 690,141 136,016 391,496 527,513 
Run-off lines
Catastrophe172,703 90,557 263,260 245,250 163,925 409,175 
Property12,788 (31)12,757 12,942 72 13,014 
Engineering111 71 181 131 135 266 
Total run-off lines185,602 90,597 276,198 258,323 164,132 422,455 
Total Reinsurance679,859 1,166,185 1,846,044 677,591 1,020,375 1,697,966 
Total$1,831,234 $4,491,849 $6,323,083 $1,830,251 $4,000,921 $5,831,172 
(1)    During 2023 and 2022, significant gross claims associated with certain credit and political risk contracts were paid in advance of recoveries being received from the corresponding security which resulted in negative case reserves of $(60) million (2022: $(55) million) and related negative reinsurance recoverables related to case reserves of $(29) million (2022: $(15) million). Refer to 'Critical Accounting Estimates – Reserve for Losses and Loss Expenses – Reserving for Credit and Political Risk Business' for further details.
102


At December 31, 2023, reinsurance recoverables as a percentage of loss reserves was 38% (2022: 38%). At December 31, 2023, reinsurance recoverables that were collectible from reinsurers rated A- or better by A.M Best were 83.1% (2022: 81.8%). Refer to Item 8, Note 12 to the Consolidated Financial Statements 'Commitments and Contingencies' for an analysis of the credit risk associated with reinsurance recoverables at December 31, 2023.
The recognition of reinsurance recoverables requires two key estimates as follows:
The first estimate is the amount of loss reserves to be ceded to our reinsurers. This amount consists of amounts related to case reserves and amounts related to IBNR. Refer to Item 8, Note 2 to the Consolidated Financial Statements 'Basis of Presentation and Significant Accounting Policies' for further details.
The second estimate is the amount of the reinsurance recoverable balance that we believe ultimately will not be collected from reinsurers. We are selective in choosing reinsurers, buying reinsurance principally from reinsurers with a strong financial condition and industry ratings. The amount we ultimately collect may differ from our estimate due to the ability and willingness of reinsurers to pay claims, which may be negatively impacted by factors such as insolvency, contractual disputes over contract language or coverage and/or other reasons. In addition, economic conditions and/or operational performance of a particular reinsurer may deteriorate, and this could also affect the ability and willingness of a reinsurer to meet their contractual obligations.
Consequently, we review reinsurance recoverables at least quarterly to estimate an allowance for expected credit losses. Refer to Item 8, Note 2 to the Consolidated Financial Statements 'Basis of Presentation and Significant Accounting Policies' for further details.
At December 31, 2023, the allowance for expected credit losses was $37 million (2022: $31 million). We have not written off any significant reinsurance recoverable balances in the last three years.
At December 31, 2023, the use of different assumptions could have a material effect on the allowance for expected credit losses. To the extent the creditworthiness of our reinsurers deteriorates due to an adverse event affecting the reinsurance industry, such as a large number of catastrophes, uncollectible amounts could be significantly greater than the allowance for expected credit losses. Given the various considerations used to estimate the allowance for expected credit losses, we cannot precisely quantify the effect a specific industry event may have on the allowance for expected credit losses.

Gross Premiums Written
Revenues primarily relate to premiums generated by our underwriting operations. The basis for recognizing gross premiums written varies by policy or contract type. Refer to Item 8, Note 2 to the Consolidated Financial Statements 'Basis of Presentation and Significant Accounting Policies' for further details.
Insurance Segment
For the majority of our insurance business, a fixed premium that is identified in the policy is recorded at the inception of the policy. This premium is adjusted if underlying insured values change. We actively monitor underlying insured values, and any adjustments to premiums are recognized in the period in which they are determined. Gross premiums written on a fixed premium basis accounted for 84% and 85% of the segment’s gross premiums written for the years ended December 31, 2023 and 2022, respectively. Some of this business is written through MGAs, third parties granted authority to bind risks on our behalf in accordance with our underwriting guidelines. For this business, premiums are recorded based on monthly statements received from MGAs or best estimates based on historical experience.
The remainder of our insurance business is written on a line slip or proportional basis, where we assume an agreed proportion of the premiums and losses of a particular risk or group of risks along with other unrelated insurers. As premiums for this business are not identified in the policy, premiums are recognized at the inception of the policy based on estimates provided by clients through brokers (refer to 'Reinsurance Segment' below for further details). We review these premium estimates on a quarterly basis and any adjustments to premium estimates are recognized in the period in which they are determined. Gross premiums written on a line slip or proportional basis accounted for 16% and 15% of the segment’s gross premiums written for the years ended December 31, 2023 and 2022, respectively.
For the credit and political risk line of business, we write certain policies on a multi-year basis. Premiums in respect of these policies are recorded at the inception of the policy based on management’s best estimate of premiums to be received, including assumptions relating to prepayments/refinancing. At December 31, 2023, the average duration of unearned premiums for credit and political risk line of business was 5.7 years (2022: 5.4 years).
103


Reinsurance Segment
The reinsurance segment provides cover to cedants (i.e., insurance companies) on an excess of loss or on a proportional basis. In most cases, cedants seek protection from us for business that they have not yet written at the time they enter into agreements with us. Therefore, cedants must estimate their underlying premiums when purchasing reinsurance cover from us.
Excess of loss reinsurance contracts with cedants typically include minimum or deposit premium provisions. For excess of loss reinsurance contracts, minimum or deposit premiums are generally considered to be the best estimate of premiums at the inception of the contract. The minimum or deposit premium is normally adjusted at the end of the contract period to reflect changes in the underlying risks in force during the contract period. Any adjustments to minimum or deposit premiums are recognized in the period in which they are determined. Gross premiums written for excess of loss reinsurance contracts accounted for 39% and 43% of the reinsurance segment’s gross premiums written for the years ended December 31, 2023 and 2022, respectively.
Many of our excess of loss reinsurance contracts also include provisions for automatic reinstatement of coverage in the event of a loss. In a year of significant loss events, reinstatement premiums will be higher than in a year in which there are no large loss events. Refer to Item 8, Note 2 to the Consolidated Financial Statements 'Basis of Presentation and Significant Accounting Policies' and 'Critical Accounting Estimates – Reserve for Losses and Loss Expenses' above for further details.
For proportional reinsurance contracts, premiums are recognized at the inception of the contract based on estimates to be received from ceding companies. We review these premium estimates on a quarterly basis and evaluate their reasonability in light of premiums reported by cedants. Factors contributing to changes in initial premium estimates may include:
changes in renewal rates or rates of new business accepted by cedants (changes could result from changes in the relevant insurance market that could affect more than one of our cedants or could be a consequence of changes in the marketing strategy or risk appetite of an individual cedant);
changes in underlying exposure values; and/or
changes in rates being charged by cedants.
As a result of this review process, any adjustments to premium estimates are recognized in the period in which they are determined. Changes in premium estimates could be material to gross premiums written in the period. Changes in premium estimates could be also material to net premiums earned in the period in which they are determined, as any adjustment may be substantially or fully earned. Gross premiums written for proportional reinsurance contracts, including adjustments to premium estimates established in prior years, accounted for 61% and 57% of the reinsurance segment’s gross premiums written for the years ended December 31, 2023 and 2022, respectively.
104


Gross premiums written for proportional reinsurance contracts incepting during the year were as follows:
Year ended December 31,202320222021
Liability$356,022 $376,462 $383,232 
Accident and health298,577 307,082 302,520 
Professional lines280,381 236,454 205,305 
Credit and surety169,297 133,853 93,638 
Motor68,136 135,954 187,569 
Agriculture99,806 112,452 72,897 
Marine and aviation19,839 22,081 23,912 
Run-off lines
Catastrophe1,343 3,463 12,733 
Property3,000 60,204 117,397 
Engineering — — 
Total run-off lines4,343 63,667 130,130 
Total estimated premiums$1,296,401 $1,388,005 $1,399,203 
Gross premiums written (reinsurance segment)$2,215,761 $2,629,014 $2,822,752 
As a % of total gross premiums written59 %53 %50 %
Historical experience has shown that cumulative adjustments to initial premium estimates for proportional reinsurance contracts have ranged from 0% to 8% over the last 5 years.
We believe that a reasonably likely change to 2023 initial premium estimates for proportional reinsurance contracts would be 4% in either direction. A change in initial premium estimates of this magnitude would result in a change in gross premiums written of approximately $52 million. A change in initial premium estimates of this magnitude would not have a material impact on pre-tax net income, after considering current losses and loss expenses ratios together with acquisition cost ratios.
However, larger variations, positive or negative, are possible.

Net Premiums Earned
Premiums are earned evenly over the period during which we are exposed to the underlying risk. Changes in circumstances subsequent to the inception of contracts can impact the earning periods. For example, when exposure limits for a contract are reached, any associated unearned premiums are fully earned. This can have a significant impact on net premiums earned, particularly for multi-year contracts such as those in the credit and political risk line of business.
Fixed premium insurance policies and excess of loss reinsurance contracts are generally written on a "losses occurring" or "claims made" basis over the term of the contract. Consequently, premiums are earned evenly over the contract term, which is generally 12 months.
Line slip or proportional insurance policies and proportional reinsurance contracts are generally written on a "risks attaching" basis, covering claims that relate to the underlying policies written during the terms of these contracts. As the underlying business incepts throughout the contract term which is typically one year, and the underlying business typically has a one year coverage period, these premiums are generally earned evenly over a 24-month period.


105


Fair Value Measurements of Financial Assets and Liabilities
Fair value is defined as the price to sell an asset or transfer a liability (i.e., the "exit price") in an orderly transaction between market participants. Refer to Item 8, Note 6 to the Consolidated Financial Statements 'Fair Value Measurements' for information on the valuation techniques, including significant inputs and assumptions generally used in estimating the fair values of our financial instruments.
Fixed Maturities and Equity Securities
At December 31, 2023, the fair values of 94% (2022: 93%) of total fixed maturities and equity securities were based on prices provided by globally recognized independent pricing services where we have a current and detailed understanding of how their prices were derived. The remaining securities were priced by either non-binding broker quotes or internal valuation models.
Generally, we obtain quotes directly from broker-dealers who are active in the corresponding markets when prices are unavailable from independent pricing services. This may also be the case if the pricing from pricing services is not reflective of current market levels, as detected by our pricing control tolerance procedures. Generally, broker-dealers value securities through their trading desks based on observable market inputs. Their pricing methodologies include mapping securities based on trade data, bids or offers, observed spreads and performance on newly issued securities. They may also establish pricing through observing secondary trading of similar securities.
At December 31, 2023 and 2022, we did not adjust any pricing provided by independent pricing services.
Management Pricing Validation
While we obtain pricing from independent pricing services and/or broker-dealers, management is ultimately responsible for determining the fair value measurements of all securities. To ensure fair value measurement is applied consistently and in accordance with U.S. GAAP, annually, we update our understanding of the pricing methodologies used by the pricing services and broker-dealers.
We also challenge any prices we believe may not be representative of fair value under current market conditions. Our review process includes, but is not limited to:
initial and ongoing evaluation of the pricing methodologies and valuation models used by outside parties to calculate fair value;
quantitative analysis;
a review of multiple quotes obtained in the pricing process and the range of resulting fair values for each security, if available; and
randomly selecting purchased or sold securities and comparing the executed prices to the fair value estimates provided by the independent pricing sources and broker-dealers.
Other Investments
Multi-strategy Funds, Direct Lending Funds, Private Equity Funds and Real Estate Funds
The fair values of multi-strategy funds, direct lending funds, private equity funds and real estate funds are estimated using net asset values (NAVs) as advised by external fund managers or third-party administrators. At December 31, 2023, the estimated fair value of our investments in these funds was $836 million (2022: $856 million). Refer to Item 8, Note 6 to the Consolidated Financial Statements 'Fair Value Measurements' for further details.
CLO-Equity Securities
The fair values of CLO-Equities are estimated using a discounted cash flow model prepared by an external investment manager. At December 31, 2023, the estimated fair value of our indirect investment in CLO-Equities was $5 million (2022: $5 million). Refer to Item 8, Note 6 to the Consolidated Financial Statements 'Fair Value Measurements' for further details.

106


Other Privately Held Investments
Other privately held investments include common shares, preferred shares, investments in limited partnerships, convertible notes, convertible preferred share and a variable yield security.
These investments are initially valued at cost, which approximates fair value. In subsequent measurement periods, the fair values of these investments are derived from one or a combination of valuation methodologies which consider factors including recent capital raises by the investee companies, comparable precedent transaction multiples, comparable publicly traded multiples, third-party valuations, discounted cash-flow models, and other techniques that consider the industry and development stage of each investee company. The fair value of the variable yield security was determined using an externally developed discounted cash flow model.
At December 31, 2023, the estimated fair value of these investments was $87 million (2022: $136 million). Refer to Item 8, Note 6 to the Consolidated Financial Statements 'Fair Value Measurements' for further details.
Other privately held investments also includes investments in private company investment funds focusing on financial services technology companies with an emphasis on insurance technology companies ("private company investment funds").
The fair values of private company investment funds are estimated using NAVs as advised by external fund managers or third-party administrators. At December 31, 2023, the estimated fair value of our investments in these funds was $21 million (2022: $nil). Refer to Item 8, Note 6 to the Consolidated Financial Statements 'Fair Value Measurements' for further details.
Impairment Losses and the Allowance for Expected Credit Losses - Fixed Maturities, Available for Sale
Fixed maturities classified as available for sale are reported at fair value at the balance sheet date and are presented net of an allowance for expected credit losses. Our available for sale ("AFS") investment portfolio is the largest component of consolidated total assets, and it is a multiple of shareholders’ equity. As a result, impairment losses could be material to our results of operations and financial condition particularly during periods of dislocation in financial markets.
A fixed maturity, available for sale security is impaired if the fair value of the investment is below amortized cost. On a quarterly basis, the Company evaluates all fixed maturities, available for sale for impairment losses.
Details regarding our processes for the identification of impairments of fixed maturities, available for sale and the recognition of the related impairment losses are disclosed in Item 8, Note 2 to the Consolidated Financial Statements 'Basis of Presentation and Significant Accounting Policies'.
In addition, the methodologies and significant inputs used to estimate the allowance for expected credit losses are disclosed in Item 8, Note 5 (i) to the Consolidated Financial Statements 'Investments'.
At December 31, 2023, we recorded an allowance for expected credit losses of $11 million (2022: $12 million) and for the year ended December 31, 2023, we recorded impairment losses of $13 million (2022: $13 million) (refer to 'Net Investment Income and Net Investment Gains (Losses)' for further details). The allowance for expected credit loss is charged to net income (loss) and is included in net investment gains (losses) in the consolidated statements of operations.
Intent or Requirement to Sell
From time to time, we may sell fixed maturities, available for sale subsequent to the balance sheet date that we did not intend to sell at the balance sheet date. Conversely, we may not sell fixed maturities, available for sale that we intended to sell at the balance sheet date. These changes in intent may arise due to events occurring subsequent to the balance sheet date. The types of events that may result in a change in intent include, but are not limited to, significant changes in the economic facts and circumstances related to the specific issuer, changes in liquidity needs, or changes in tax laws or the regulatory environment.
U.S. Treasury Securities and Other Highly Rated Debt Instruments
Our credit impairment review process excludes fixed maturities, available for sale guaranteed, either explicitly or implicitly, by the U.S. government and its agencies (U.S. Government, U.S. Agency and U.S. Agency RMBS) because we anticipate these securities will not be settled below amortized cost. These securities are evaluated for intent or requirement to sell at a loss.
107



RECENT ACCOUNTING PRONOUNCEMENTS
At December 31, 2023, there were no recently issued accounting pronouncements that we have not yet adopted that we expect could have a material impact on our results of operations, financial condition or liquidity.

ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
Market risk is the risk that our financial instruments, which include derivatives, may be negatively impacted by movements in financial market prices or rates such as interest rates, credit spreads, equity securities' prices, and foreign currency exchange rates (refer to Item 1 'Risk and Capital Management' for further details).
We own a substantial amount of assets whose fair values are subject to market risks.
At December 31, 2023, 95% (2022: 94%) of fixed maturities are classified as available for sale, therefore changes in fair values caused by changes in interest rates and foreign currency exchange rates have an immediate impact on other comprehensive income (loss), total shareholders’ equity and book value per common share but do not have an immediate impact on net income (loss). Changes in these market risks impact net income (loss) when, and if, securities are sold, or an impairment charge or an allowance for expected credit losses is recorded.
Equity securities are reported at fair value, with changes in fair values recognized in net income (loss).
At December 31, 2023 and 2022, we also invested in alternative investments including multi-strategy funds, direct lending funds, private equity funds, real estate funds, CLO-Equities and other privately held investments. These investments are also exposed to market risks, with the changes in fair values immediately reported in net income (loss).
Sensitivity Analysis
The following is a sensitivity analysis of our primary market risk exposures at December 31, 2023 and 2022.
Our policies to address these risks in 2023 were not materially different from 2022. We do not currently anticipate significant changes in our primary market risk exposures or in how those exposures are managed in future reporting periods based on what is known or expected to be in effect in future reporting periods.
Interest Rate and Credit Spread Risk
Interest rate risk includes fluctuations in interest rates and credit spreads that have a direct impact on the fair values of fixed maturities. As interest rates rise and credit spreads widen, the fair value of fixed maturities falls.
We monitor sensitivity to interest rate and credit spread changes by revaluing fixed maturities using a variety of different interest rates (inclusive of credit spreads). We use duration and convexity at the security level to estimate the change in fair value that would result from a change in each security’s yield. Duration measures the price sensitivity of an asset to changes in yield rates. Convexity measures how the duration of the security changes with interest rates. The duration and convexity analysis take into account changes in prepayment expectations for MBS and ABS. The analysis is performed at the security level and aggregated to the asset category levels.

108


The following table presents the estimated pre-tax impact on the fair value of fixed maturities classified as available for sale due to an instantaneous increase in the U.S. yield curve of 100 basis points and an additional 100 basis point credit spread widening for corporate debt, non-agency commercial MBS and residential MBS, ABS and municipal bond securities:
  Fair valuePotential adverse change in fair value
Increase in
interest rate
by 100
basis points
Widening of
credit spreads
by 100
basis points
Total
At December 31, 2023
U.S. government and agency$3,007,528 $(81,945)$ $(81,945)
Non-U.S. government723,959 (22,534) (22,534)
Agency RMBS1,634,661 (84,719) (84,719)
Securities exposed to credit spreads:
Corporate debt4,474,172 (151,894)(158,759)(310,653)
CMBS839,696 (18,120)(21,917)(40,037)
Non-agency RMBS153,396 (6,158)(5,849)(12,007)
ABS1,242,971 (10,436)(36,132)(46,568)
Municipals158,359 (6,234)(6,336)(12,570)
 $12,234,742 $(382,040)$(228,993)$(611,033)
At December 31, 2022
U.S. government and agency$2,639,330 $(78,870)$— $(78,870)
Non-U.S. government562,029 (15,428)— (15,428)
Agency RMBS1,202,785 (68,760)— (68,760)
Securities exposed to credit spreads:
Corporate debt4,255,556 (149,860)(160,439)(310,299)
CMBS947,778 (23,016)(29,792)(52,808)
Non-agency RMBS133,534 (6,086)(5,779)(11,865)
ABS1,429,527 (9,673)(47,191)(56,864)
Municipals156,355 (6,814)(7,197)(14,011)
 $11,326,894 $(358,507)$(250,398)$(608,905)
U.S. government agencies have a limited range of spread widening. Therefore, 100 basis points of spread widening for these securities is highly improbable in normal market conditions. Our non-U.S. government debt obligations are highly-rated, and we believe the potential for future widening of credit spreads would also be limited for these securities. Certain of our holdings in non-agency RMBS and ABS have floating interest rates, which mitigate interest rate risk exposure.
The above sensitivity analysis should not be construed as our prediction of future market events, but rather an illustration of the impact of such events.
In addition, our investment in bond mutual funds is exposed to interest rate risk. However, this exposure is largely mitigated by the short duration of the underlying securities.
Our investment in CLO-Equities is also exposed to interest rate risk, but an increase in the risk-free yield curve of 100 basis points would have an insignificant impact on its fair value.
Equity Price Risk
Our portfolio of equity securities, excluding the bond mutual funds, has exposure to equity price risk. This risk is defined as the potential loss in fair value resulting from adverse changes in stock prices. The global equity portfolio is managed to a benchmark composite index, which consists of a blend of the S&P 500 and MSCI World indices. Changes in the underlying indices have a corresponding impact on the overall portfolio. At December 31, 2023, the fair value of equity securities was
109


$295 million (2022: $277 million). At December 31, 2023, the impact of a 20% decline in the overall market prices of our equity exposures would be $59 million (2022: $55 million), on a pre-tax basis.
Our investment in multi-strategy funds has significant exposure to equity strategies with net long positions. At December 31, 2023, the fair value of multi-strategy funds was $25 million (2022: $33 million). At December 31, 2023, the impact of an instantaneous 15% decline in the fair value of our investment in multi-strategy funds would be $4 million (2022: $5 million), on a pre-tax basis.
Foreign Currency Risk
The following table presents a sensitivity analysis of total net foreign currency exposures:
AUDCADEURGBPJPYOtherTotal
At December 31, 2023
Net managed assets (liabilities), excluding derivatives
$38,348 $430,256 $(452,726)$(145,992)$(43,047)$56,012 $(117,149)
Foreign currency derivatives, net
(23,240)(403,952)401,195 127,122 24,317 (114,294)11,148 
Net managed foreign currency exposure
15,108 26,304 (51,531)(18,870)(18,730)(58,282)(106,001)
Other net foreign currency exposure 175 (555)(59)  (439)
Total net foreign currency exposure$15,108 $26,479 $(52,086)$(18,929)$(18,730)$(58,282)$(106,440)
Net foreign currency exposure as a percentage of total shareholders’ equity
0.3 %0.5 %(1.0 %)(0.4 %)(0.4 %)(1.1 %)(2.0 %)
Pre-tax impact of net foreign currency exposure on shareholders’ equity given a hypothetical 10% rate movement(1)
$1,511 $2,648 $(5,209)$(1,893)$(1,873)$(5,828)$(10,644)
At December 31, 2022
Net managed assets (liabilities), excluding derivatives
$11,331 $302,679 $(538,845)$(411,773)$(36,346)$48,959 $(623,995)
Foreign currency derivatives, net
7,160 (312,269)505,623 271,022 32,097 (74,438)429,195 
Net managed foreign currency exposure
18,491 (9,590)(33,222)(140,751)(4,249)(25,479)(194,800)
Other net foreign currency exposure— 102 (1,199)(924)— 995 (1,026)
Total net foreign currency exposure$18,491 $(9,488)$(34,421)$(141,675)$(4,249)$(24,484)$(195,826)
Net foreign currency exposure as a percentage of total shareholders’ equity
0.4 %(0.2 %)(0.7 %)(3.1 %)(0.1 %)(0.5 %)(4.2 %)
Pre-tax impact of net foreign currency exposure on shareholders’ equity given a hypothetical 10% rate movement(1)
$1,849 $(949)$(3,442)$(14,168)$(425)$(2,448)$(19,583)
(1)Assumes 10% appreciation in underlying currencies relative to the U.S. dollar.
Net Managed Foreign Currency Exposure
Our net managed foreign currency exposure is subject to internal risk tolerance standards. For significant foreign currency exposures, defined as those where net asset/liability position exceeds the greater of 1% of total shareholders' equity or $50 million, the value of assets denominated in those currencies should fall within a range of 90 - 110% of liabilities denominated in the same currency. In addition, aggregate foreign currency exposure is subject to the same tolerance range. We may use derivative instruments to maintain net managed foreign currency exposures within our risk tolerance levels.
Other Net Foreign Currency Exposure
In 2023, other net foreign currency exposure primarily consisted of residual foreign currency exposure from externally managed portfolios where the external manager hedges the foreign currency exposure.
During 2022, our emerging market debt securities portfolio which was included in other net foreign currency exposure, was liquidated.


110


ITEM 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Index to Consolidated Financial Statements and Accompanying NotesPage  
Report of Independent Registered Public Accounting Firm - PCAOB ID No.5230.
Consolidated Balance Sheets at December 31, 2023 and 2022
Consolidated Statements of Operations for the years ended December 31, 2023, 2022 and 2021
Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2023, 2022 and 2021
Consolidated Statements of Changes in Shareholders' Equity for the years ended December 31, 2023, 2022 and 2021
Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021
Notes to Consolidated Financial Statements
Note 1 – Organization
Note 2 – Basis of Presentation and Significant Accounting Policies
Note 3 – Segment Information
Note 4 – Goodwill and Intangible Assets
Note 5 – Investments
Note 6 – Fair Value Measurements
Note 7 – Derivative Instruments
Note 8 – Reserve for Losses and Loss Expenses
Note 9 – Reinsurance
Note 10 – Debt and Financing Arrangements
Note 11 – Federal Home Loan Bank Advances
Note 12 – Commitments and Contingencies
Note 13 – Leases
Note 14 – Earnings Per Common Share
Note 15 – Shareholders’ Equity
Note 16 – Retirement Plans
Note 17 – Share-Based Compensation
Note 18 – Related Party Transactions
Note 19 – Reorganization Expenses
Note 20 – Income Taxes
Note 21 – Other Comprehensive Income (Loss)
Note 22 – Statutory Financial Information

111


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of AXIS Capital Holdings Limited

Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of AXIS Capital Holdings Limited and subsidiaries (the "Company") as of December 31, 2023 and 2022, the related consolidated statements of operations, comprehensive income, changes in shareholders' equity, and cash flows, for each of the three years in the period ended December 31, 2023, and the related notes and the schedules listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 27, 2024, expressed an unqualified opinion on the Company's internal control over financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Reserve for losses and loss expenses - Refer to Notes 2 and 8 to the consolidated financial statements
Critical Audit Matter Description
The Company’s estimate of loss and loss expense reserves is derived using expected trends in claim severity and frequency and other factors that may vary significantly as claims are settled. The estimate is sensitive to significant assumptions, including the initial expected loss ratio and loss development factors. The estimate is also sensitive to the selection of actuarial methods and weighting of these methods applied to project the ultimate losses, the estimation of ultimate reserves associated with catastrophic events, and other factors. Further, not all catastrophic events can be modeled using traditional actuarial methodologies, which increases the degree of judgment needed in estimating loss reserves for such events.
Auditing the Company’s methods, assumptions and best estimate of the cost of the ultimate settlement and administration of claims represented by the incurred but not reported ("IBNR") claims included in recorded loss and loss adjustment reserves involved especially subjective auditor judgment and an increased extent of effort, including the involvement of our actuarial specialists.

112


How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to reserves for losses and loss expenses included the following, among others:
We tested the effectiveness of controls over the valuation of the recorded loss and loss expense reserves, including the review and approval process that management has in place for significant actuarial methods and assumptions used and the approval of management’s best estimate of loss and loss expense reserves.
We tested the completeness and accuracy of the underlying data that served as the basis for the Company’s actuarial analysis, including historical claims data, to test the reasonableness of key inputs to the actuarial estimate.
With the assistance of our actuarial specialists:
We independently developed an estimate of the reserves for selected classes of business, compared our estimates to those booked by the Company, and evaluated the differences.
We evaluated the Company’s methodologies against recognized actuarial practices for the remaining classes. We also evaluated the assumptions used by the Company using our industry knowledge and experience and other analytical procedures.
We compared the results of the reserve study prepared by third party actuaries to management’s best estimate and evaluated the differences.
 
/s/ Deloitte Ltd.
Hamilton, Bermuda
February 27, 2024

We have served as the Company's auditor since 2001.

113


AXIS CAPITAL HOLDINGS LIMITED
CONSOLIDATED BALANCE SHEETS
DECEMBER 31, 2023 AND 2022
20232022
 (in thousands)
Assets
Investments:
Fixed maturities, available for sale, at fair value
     (Amortized cost 2023: $12,634,254; 2022: $12,176,473
     Allowance for expected credit losses 2023: $10,759; 2022: $11,733)
$12,234,742 $11,326,894 
Fixed maturities, held to maturity, at amortized cost
    (Fair value 2023: $675,851; 2022: $674,743
    Allowance for expected credit losses 2023: $nil; 2022: $nil)
686,296 698,351 
Equity securities, at fair value
     (Cost 2023: $543,833; 2022: $494,356)
588,511 485,253 
Mortgage loans, held for investment, at fair value
     (Allowance for expected credit losses 2023: $6,220; 2022: $nil)
610,148 627,437 
Other investments, at fair value949,413 996,751 
Equity method investments174,634 148,288 
Short-term investments, at fair value17,216 70,310 
Total investments15,260,960 14,353,284 
Cash and cash equivalents953,476 751,415 
Restricted cash and cash equivalents430,509 423,238 
Accrued interest receivable106,055 94,418 
Insurance and reinsurance premium balances receivable
     (Allowance for expected credit losses 2023: $11,997; 2022: $9,521)
3,067,554 2,733,464 
Reinsurance recoverable on unpaid losses and loss expenses
     (Allowance for expected credit losses 2023: $36,611; 2022: $30,715)
6,323,083 5,831,172 
Reinsurance recoverable on paid losses and loss expenses575,847 539,676 
Deferred acquisition costs450,950 473,569 
Prepaid reinsurance premiums1,916,087 1,550,370 
Receivable for investments sold8,767 16,052 
Goodwill 100,801 100,801 
Intangible assets186,883 197,800 
Operating lease right-of-use assets108,093 92,214 
Loan advances made
305,222 87,160 
Other assets456,385 438,338 
Total assets$30,250,672 $27,682,971 
Liabilities
Reserve for losses and loss expenses$16,434,018 $15,168,863 
Unearned premiums4,747,602 4,361,447 
Insurance and reinsurance balances payable1,792,719 1,609,924 
Debt1,313,714 1,312,314 
Federal Home Loan Bank advances85,790 81,388 
Payable for investments purchased26,093 19,693 
Operating lease liabilities123,101 102,577 
Other liabilities 464,439 386,855 
Total liabilities24,987,476 23,043,061 
Commitments and Contingencies
Shareholders' equity
Preferred shares550,000 550,000 
Common shares (shares issued 2023: 176,580; 2022: 176,580
shares outstanding 2023: 85,286; 2022: 84,668)
2,206 2,206 
Additional paid-in capital2,383,030 2,366,253 
Accumulated other comprehensive income (loss)(365,836)(760,300)
Retained earnings6,440,528 6,247,022 
Treasury shares, at cost (2023: 91,294; 2022: 91,912)
(3,746,732)(3,765,271)
Total shareholders’ equity5,263,196 4,639,910 
Total liabilities and shareholders’ equity$30,250,672 $27,682,971 
 See accompanying notes to Consolidated Financial Statements.

114


AXIS CAPITAL HOLDINGS LIMITED
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED DECEMBER 31, 2023, 2022, AND 2021
202320222021
 (in thousands, except for per share amounts)
Revenues
Net premiums earned$5,083,781 $5,160,326 $4,709,850 
Net investment income611,742 418,829 454,301 
Other insurance related income22,495 13,073 23,295 
Net investment gains (losses):
(Increase) decrease in allowance for expected credit losses(5,246)(11,421)11 
Impairment losses(12,757)(12,568)(22)
Other realized and unrealized investment gains (losses)(56,627)(432,800)134,290 
Total net investment gains (losses)(74,630)(456,789)134,279 
Total revenues5,643,388 5,135,439 5,321,725 
Expenses
Net losses and loss expenses3,393,102 3,242,410 3,008,783 
Acquisition costs1,000,945 1,022,017 921,834 
General and administrative expenses684,446 680,343 663,304 
Foreign exchange losses (gains)58,115 (157,945)315 
Interest expense and financing costs68,421 63,146 62,302 
Reorganization expenses28,997 31,426  
Amortization of value of business acquired  3,854 
Amortization of intangible assets10,917 10,917 12,424 
Total expenses5,244,943 4,892,314 4,672,816 
Income before income taxes and interest in income of equity method investments398,445 243,125 648,909 
Income tax expense(26,316)(22,037)(62,384)
Interest in income of equity method investments4,163 1,995 32,084 
Net income 376,292 223,083 618,609 
Preferred share dividends30,250 30,250 30,250 
Net income available to common shareholders$346,042 $192,833 $588,359 
Per share data
Earnings per common share:
Earnings per common share$4.06 $2.27 $6.95 
Earnings per diluted common share$4.02 $2.25 $6.90 
Weighted average common shares outstanding85,142 84,864 84,707 
Weighted average diluted common shares outstanding86,012 85,669 85,291 

 See accompanying notes to Consolidated Financial Statements.

115


AXIS CAPITAL HOLDINGS LIMITED
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
FOR THE YEARS ENDED DECEMBER 31, 2023, 2022, AND 2021
 
202320222021
 (in thousands)
Net income$376,292 $223,083 $618,609 
Other comprehensive income (loss), net of tax:
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized257,940 (1,043,625)(271,447)
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized9,583 (67,150)81 
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)128,513 304,925 (87,114)
Unrealized gains (losses) arising during the year, net of reclassification adjustment396,036 (805,850)(358,480)
Foreign currency translation adjustment(1,572)(10,986)621 
Total other comprehensive income (loss), net of tax394,464 (816,836)(357,859)
Comprehensive income (loss)$770,756 $(593,753)$260,750 

 See accompanying notes to Consolidated Financial Statements.

116


AXIS CAPITAL HOLDINGS LIMITED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2023, 2022, AND 2021
202320222021
(in thousands)
Preferred shares
Balance at beginning and end of year
$550,000 $550,000 $550,000 
Common shares (par value)
Balance at beginning and end of year2,206 2,206 2,206 
Additional paid-in capital
Balance at beginning of year2,366,253 2,346,179 2,330,054 
Treasury shares reissued(40,430)(31,175)(24,655)
Share-based compensation expense57,207 51,249 40,780 
Balance at end of year2,383,030 2,366,253 2,346,179 
Accumulated other comprehensive income (loss)
Balance at beginning of year(760,300)56,536 414,395 
Unrealized gains (losses) on available for sale investments, net of tax:
Balance at beginning of year(743,695)62,155 420,635 
Unrealized gains (losses) arising during the year, net of reclassification adjustment396,036 (805,850)(358,480)
Balance at end of year(347,659)(743,695)62,155 
Cumulative foreign currency translation adjustments, net of tax:
Balance at beginning of year(16,605)(5,619)(6,240)
Foreign currency translation adjustment(1,572)(10,986)621 
Balance at end of year(18,177)(16,605)(5,619)
Balance at end of year(365,836)(760,300)56,536 
Retained earnings
Balance at beginning of year6,247,022 6,204,745 5,763,607 
Net income376,292 223,083 618,609 
Preferred share dividends (1)
(30,250)(30,250)(30,250)
Common share dividends (1)
(152,536)(150,556)(147,221)
Balance at end of year6,440,528 6,247,022 6,204,745 
Treasury shares, at cost
Balance at beginning of year(3,765,271)(3,749,010)(3,764,568)
Shares repurchased(23,596)(48,981)(10,242)
Shares reissued42,135 32,720 25,800 
Balance at end of year(3,746,732)(3,765,271)(3,749,010)
Total shareholders' equity$5,263,196 $4,639,910 $5,410,656 
(1) Refer to Note 15 'Shareholders' Equity' for details on dividends declared and paid related to the Company's common and preferred shares.
 See accompanying notes to Consolidated Financial Statements.

117


AXIS CAPITAL HOLDINGS LIMITED
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2023, 2022, AND 2021

202320222021
 (in thousands)
Cash flows from operating activities:
Net income$376,292 $223,083 $618,609 
Adjustments to reconcile net income to net cash provided by operating activities:
Net investment (gains) losses74,630 456,789 (134,279)
Net realized and unrealized gains on other investments(19,682)(55,757)(180,329)
Amortization of fixed maturities(20,167)26,138 35,839 
Interest in income of equity method investments(4,163)(1,995)(32,084)
Amortization of value of business acquired  3,854 
Other amortization and depreciation75,552 68,288 66,977 
Share-based compensation expense, net of cash payments54,120 48,494 37,744 
Changes in:
Accrued interest receivable(11,777)(30,432)633 
Reinsurance recoverable on unpaid losses and loss expenses(493,831)(825,608)(527,362)
Reinsurance recoverable on paid losses and loss expenses(60,860)92,781 (210,660)
Deferred acquisition costs21,499 (10,548)(34,386)
Prepaid reinsurance premiums(365,732)(176,498)(185,646)
Reserve for losses and loss expenses1,272,999 544,459 737,342 
Unearned premiums388,747 287,082 409,858 
Insurance and reinsurance balances, net13,813 197,610 435,603 
Other items(45,881)(45,848)155,979 
Net cash provided by operating activities1,255,559 798,038 1,197,692 
Cash flows from investing activities:
Purchases of:
Fixed maturities, available for sale(6,348,753)(7,476,440)(12,133,755)
Fixed maturities, held to maturity(37,499)(255,610)(196,775)
Equity securities(89,502)(94,324)(137,247)
Mortgage loans(24,867)(117,023)(145,832)
Other investments(91,010)(147,717)(263,712)
Equity method investments(22,183)  
Short-term investments(247,499)(176,968)(159,056)
Proceeds from the sale of:
Fixed maturities, available for sale4,848,826 6,110,148 9,203,241 
Equity securities55,651 138,542 24,862 
Other investments158,348 156,719 324,810 
Short-term investments227,318 116,752 177,672 
Proceeds from redemption of fixed maturities, available for sale934,017 1,018,922 1,817,482 
Proceeds from redemption of fixed maturities, held to maturity49,609 3,541 155,809 
Proceeds from redemption of short-term investments76,545 20,124 111,417 
Proceeds from the repayment of mortgage loans36,375 84,365 145,621 
Proceeds from the (purchase) sale of other assets, net(31,144)(36,829)(38,732)
Loan advances made(349,842)(105,822)(82,870)
Net cash used in investing activities(855,610)(761,620)(1,197,065)
Cash flows from financing activities:
Repurchase of common shares - open market (34,987) 
Taxes paid on withholding shares(23,596)(13,994)(10,242)
Dividends paid - common shares(153,775)(149,341)(145,603)
Dividends paid - preferred shares(30,250)(30,250)(30,250)
Federal Home Loan Bank advances, net5,250 78,950  
Net cash used in financing activities(202,371)(149,622)(186,095)
Effect of exchange rate changes on foreign currency cash, cash equivalents and restricted cash11,754 (29,833)(74)
Increase (decrease) in cash, cash equivalents and restricted cash209,332 (143,037)(185,542)
Cash, cash equivalents and restricted cash - beginning of year1,174,653 1,317,690 1,503,232 
Cash, cash equivalents and restricted cash - end of year$1,383,985 $1,174,653 $1,317,690 
 See accompanying notes to Consolidated Financial Statements.

118


AXIS CAPITAL HOLDINGS LIMITED
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
FOR THE YEARS ENDED DECEMBER 31, 2023, 2022, AND 2021

Supplemental disclosures of cash flow information:202320222021
Income taxes paid$77,479 $33,418 $45,083 
Interest paid$63,596 $59,886 $59,400 

Supplemental disclosures of cash flow information:
In 2023, $72 million related to a loan advanced to Monarch Point Re (ISA 2023) Ltd. ("Monarch Point Re") was repaid and was treated as a non-cash activity in the consolidated statement of cash flows. In addition, $66 million related to reinsurance balances payables due to Monarch Point Re under the retrocession agreement and $4 million related to ceded losses and loss expenses due from Monarch Point Re under the retrocession agreement were settled and both were treated as a non-cash activity in the consolidated statement of cash flows. Further, $12 million related to interest on the loan advanced to Monarch Point Re was received in advance and was treated as a non-cash activity in the consolidated statement of cash flows (refer to Note 18 'Related Party Transactions').
In 2023, $110 million related to a loan advanced to a third party reinsurer was repaid and was treated as a non-cash activity in the consolidated statement of cash flows. In addition, $107 million related to reinsurance balances payables due to the third party reinsurer under the retrocession agreement and $21 million related to ceded losses and loss expenses due from party reinsurer under the retrocession agreement were settled and both were treated as a non-cash activity in the consolidated statement of cash flows. Further, $4 million related to interest on the loan advanced to a third party reinsurer was received in advance and was treated as a non-cash activity in the consolidated statement of cash flows (refer to Note 10 'Debt').
In 2022, the Company borrowed $81 million under the FHLB program, of which $2 million was settled by way of a transfer of member stock (refer to Note 11 'Federal Home Loan Advances').
In 2022, $90 million related to a loan advanced to a third party reinsurer was repaid and was treated as a non-cash activity in the consolidated statement of cash flows. In addition, $88 million related to reinsurance balances payables due to the third party reinsurer under the retrocession agreement and $9 million related to ceded losses and loss expenses due from party reinsurer under the retrocession agreement were settled and both were treated as a non-cash activity in the consolidated statement of cash flows. Further, $1 million related to interest on the loan advanced to a third party reinsurer was received in advance and was treated as a non-cash activity in the consolidated statement of cash flows (refer to Note 10 'Debt').
In 2021, the transfer of securities with a fair value of $405 million from fixed maturities, available for sale to fixed maturities, held to maturity was treated as a non-cash activity in the consolidated statement of cash flows (refer to Note 5 'Investments').
In 2021, $71 million related to a loan advanced to a third party reinsurer was repaid and was treated as a non-cash activity in the consolidated statement of cash flows. In addition, $74 million related to reinsurance balances payables due to the third party reinsurer under the retrocession agreement and $3 million related to ceded losses and loss expenses due from party reinsurer under the retrocession agreement were settled and both were treated as a non-cash activity in the consolidated statement of cash flows.












 See accompanying notes to Consolidated Financial Statements.

119





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

1.    ORGANIZATION

AXIS Capital Holdings Limited ("AXIS Capital" and together with its wholly-owned subsidiaries the "Company"), was incorporated on December 9, 2002, under the laws of Bermuda. The Company is a global specialty underwriter and provider of insurance and reinsurance solutions. The Company's principal operating subsidiaries, located in Bermuda, the United States ("U.S."), Europe, Singapore and Canada, are described below:

AXIS Specialty Limited ("AXIS Specialty Bermuda"), a Bermuda domiciled company, is licensed to provide specialty lines insurance and treaty reinsurance products on a worldwide basis. In addition, AXIS Specialty Bermuda conducts insurance and reinsurance business through its branch in Singapore, AXIS Specialty Limited (Singapore Branch). AXIS Specialty Bermuda ceased writing new business through its branch in Singapore branch, effective 1 January 2024, and will close this branch, subject to meeting all regulatory and legal requirements.

AXIS Insurance Company, domiciled in Illinois, and AXIS Reinsurance Company, domiciled in New York, together with AXIS Reinsurance Company (Canadian Branch) are licensed to offer a range of specialty lines insurance and treaty reinsurance products to a variety of niche markets on a worldwide basis. AXIS Surplus Insurance Company, domiciled in Illinois, is eligible to write insurance on a surplus lines basis.

AXIS Specialty Europe SE ("AXIS Specialty Europe") is a European public limited liability company, incorporated as a non-life insurer under the laws of Ireland. It is a Societas Europaea (SE), or European society company registered in accordance with company law of the E.U. AXIS Specialty Europe also conducts insurance business through its branch in the United Kingdom ("U.K."), AXIS Specialty Europe SE ("UK Branch").

The U.K.'s withdrew from the European Union on January 31, 2020 and is now considered a third-country. In 2018, AXIS Specialty Europe submitted an application to have its UK Branch fully regulated by the Prudential Regulation Authority ("PRA") and the U.K. Financial Conduct Authority ("FCA") as a third-country branch. This application was approved by the PRA and FCA on October 28, 2022. Therefore, the UK Branch of AXIS Specialty Europe SE is now fully regulated by the PRA and FCA.

AXIS Re SE is a European public limited liability company, incorporated as a reinsurer under the laws of Ireland. AXIS Re SE is also a Societas Europaea (SE), or European society company registered in accordance with company law of the E.U. AXIS Re SE also conducts reinsurance business through its branch in Switzerland, AXIS Re SE, Dublin (Zurich Branch).

The Company operates in the Lloyd's of London ("Lloyd's") market through its corporate members AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited, which provide 70% and 30%, respectively, of AXIS Syndicate 1686's ("Syndicate 1686") capital support. AXIS Syndicate 1686 is managed by AXIS Managing Agency Ltd. ("AXIS Managing Agency").

On October 2, 2017, AXIS Specialty UK Holdings Limited, a limited liability holding company, incorporated under the laws of England and Wales, acquired a 100% ownership interest in Novae Group plc ("Novae"). AXIS Corporate Capital UK II Limited was the sole corporate member of Novae Syndicate 2007 ("Syndicate 2007"). Effective January 1, 2018, AXIS Managing Agency commenced management and oversight of Syndicate 2007. Effective January 1, 2019, Syndicate 2007 ceased accepting new business and was placed into run-off. Effective January 1, 2021, the Reinsurance to Close of the 2018 year of account of Syndicate 2007 was completed.

AXIS ILS, Ltd. (formerly AXIS Ventures Limited ("AXIS Ventures")) and AXIS Reinsurance Managers Limited ("AXIS Reinsurance Managers"), regulated by the BMA as insurance managers, generate fee income from services provided to strategic capital partners. Effective September 23, 2020, AXIS Ventures deregistered as an insurance manager with the BMA.
120





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") and include AXIS Capital Holdings Limited and its wholly-owned subsidiaries.
All inter-company accounts and transactions have been eliminated.
To facilitate comparison of information across periods, certain reclassifications have been made to prior year amounts to conform to the current year's presentation. At December 31, 2023, the Company presented loan advances made in 2022 separately in the consolidated balance sheets. These loan advances made were previously included in insurance and reinsurance balances payable in the consolidated balance sheets. This presentation was adopted to facilitate comparison to loan advances made in 2023 (refer to Note 10 'Debt' and Note 18 'Related Party Transactions'). This reclassification did not impact results of operations, financial condition or liquidity.

Tabular dollar and share amounts are in thousands, with the exception of per share amounts. All amounts are reported in U.S. dollars.
Use of Estimates
The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. While management believes that the amounts included in the consolidated financial statements reflect its best estimates and assumptions, actual results could differ from those estimates. The Company’s principal estimates include: 
reserve for losses and loss expenses;
reinsurance recoverable on unpaid losses and loss expenses, including the allowance for expected credit losses;
gross premiums written and net premiums earned;
fair value measurements of financial assets and liabilities; and
the allowance for credit losses associated with fixed maturities, available for sale.
The Company's significant accounting policies are as follows:
a)    Investments
Fixed Maturities, Available for Sale, at Fair Value and Fixed Maturities, Held to Maturity, at Amortized Cost
Fixed maturities classified as available for sale are reported at fair value (refer to Note 6 'Fair Value Measurements') and are presented net of an allowance for expected credit losses. The change in fair values of fixed maturities, net of tax is recognized in accumulated other comprehensive income (loss) ("AOCI") in total shareholders’ equity.
Fixed maturities are classified as held to maturity when the Company has the positive intent and ability to hold the securities to maturity or redemption. Fixed maturities classified as held to maturity are reported at amortized cost and are presented net of an allowance for expected credit losses.
Net investment income includes interest income and the amortization of market premiums and discounts and is presented net of investment expenses. Investment income is recognized when earned. Purchases and sales of fixed maturities are recorded on a trade-date basis and realized gains (losses) on sales of fixed maturities are determined based on the specific identification method. Realized gains (losses) on fixed maturities are included in net investment gains (losses) in the consolidated statements of operations.
121





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

The Company recognizes investment income from fixed maturities based on the constant effective yield method, which includes an adjustment for estimated principal repayments, if applicable. The effective yield used to determine the amortization of fixed maturities subject to prepayment risk (e.g., asset-backed, mortgage-backed and other structured securities) is recalculated and adjusted periodically based on historical and/or projected future cash flows. Adjustments to the yield for highly rated prepayable fixed maturities are accounted for using the retrospective method. Adjustments to the yield for other prepayable fixed maturities are accounted for using the prospective method.
Credit Losses - Fixed Maturities, Available for Sale
A fixed maturity, available for sale security is impaired if the fair value of the investment is below amortized cost. On a quarterly basis, the Company evaluates all fixed maturities, available for sale securities for impairment losses.
If a fixed maturity, available for sale security is impaired and the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before its anticipated recovery, the full amount of the impairment loss is charged to net income (loss) and is included in net investment gains (losses).

In instances where the Company intends to hold the impaired fixed maturity, available for sale security the Company determines whether the decline in fair value below the amortized cost basis has resulted from a credit loss or other factors. If the Company does not anticipate to fully recover the amortized cost, an allowance for expected credit losses is established. The allowance for expected credit losses is limited to the difference between a security's amortized cost basis and its fair value. The allowance for expected credit losses is charged to net income (loss) and is included in net investment gains (losses).
On a quarterly basis, the Company assesses whether unrealized losses on fixed maturities, available for sale represent credit impairments by considering the following factors:
a.the extent to which the fair value is less than amortized cost;
b.adverse conditions related to the security, industry, or geographical area;
c.downgrades in the security's credit rating by a credit rating agency; and
d.failure of the issuer to make scheduled principal or interest payments.
The length of time a security has been in an unrealized loss position no longer impacts the determination of whether a credit loss exists.
If a security is assessed to be credit impaired, it is subject to a discounted cash flow analysis by comparing the present value of expected future cash flows with the amortized cost basis. If the present value of expected cash flows is less than the amortized cost, a credit loss exists and an allowance for expected credit losses is recognized. If the present value of expected future cash flows is equal to or greater than the amortized cost basis, an expected credit loss does not exist.

The non-credit impairment amount of the loss (i.e., related to interest rates, market conditions, etc.) is recognized in other comprehensive income.

The Company reports accrued interest receivable related to available for sale debt securities separately and has elected not to measure an allowance for expected credit losses for accrued interest receivable. Write-offs of accrued interest receivable balances are recognized in net investment gains (losses) in the period in which they are deemed uncollectible.
122





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Credit Losses - Fixed Maturities, Held to Maturity
A fixed maturity, held to maturity security is impaired if the fair value of the investment is below amortized cost. On a quarterly basis, the Company evaluates all fixed maturities, held to maturity securities for impairment losses.
The Company's fixed maturity, held to maturity securities portfolio consists of asset-backed securities ("ABS") and corporate debt securities.
The Company's ABS, held to maturity consist of CLO debt tranched securities. The Company uses a scenario-based approach to review its CLO debt portfolio and reviews subordination levels of these securities to determine their ability to absorb credit losses of the underlying collateral. If losses are forecast to be below the subordination level for a tranche held by the Company, the security is determined not to have a credit loss.
To estimate expected credit losses for corporate debt securities, held to maturity, the Company's projected cash flows are primarily driven by assumptions regarding the severity of loss, which is a function of the probability of default and projected recovery rates. The Company's default and recovery rates are based on credit ratings, credit analysis and macroeconomic forecasts.
The allowance for expected credit losses is estimated based on the Company’s analysis of projected lifetime losses. The allowance for expected credit losses is charged to net income (loss) and is recognized in net investment gains (losses). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Equity Securities, at Fair Value
Equity securities are reported at fair value. The change in the fair values of equity securities, net of tax is recognized in net investment gains (losses) in the consolidated statements of operations.
Net investment income includes dividend income and is presented net of investment expenses. Investment income is recognized when earned. Purchases and sales of equity securities are recorded on a trade-date basis and realized gains (losses) on sales of equity securities are determined based on the specific identification method. Realized gains (losses) on equity securities are included in net investment gains (losses) in the consolidated statements of operations.
Mortgage Loans, Held for Investment, at Fair Value
Mortgage loans, held for investment are reported at amortized cost which is calculated as the unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses.
Interest income and prepayment fees are recognized when earned. Interest income is recognized based on an effective yield method which gives effect to the amortization of premiums and accretion of discounts.
Mortgage loans, held for investment are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company’s analysis of projected lifetime losses. These projections take into account the Company’s experience with credit quality indicators, loan losses, defaults, loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.
The allowance for expected credit losses is recognized in net investment gains (losses) in the consolidated statements of operations. Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Other Investments
Other investments are recorded at fair value (refer to Note 6 'Fair Value Measurements'). Changes in fair value and realized gains (losses) are reported in net investment income in the consolidated statements of operations.

123





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Equity Method Investments
Investments in which the Company has significant influence over the operating and financial policies of the investee are classified as equity method investments and are accounted for using the equity method of accounting. In applying the equity method of accounting, investments are initially recorded at cost and are subsequently adjusted based on the Company’s proportionate share of net income or loss of the investee. Adjustments are based on the most recently available financial information from the investee. Changes in the carrying value of these investments are recorded in net income (loss) as interest in income (loss) of equity method investments.
Short-term Investments
Short-term investments primarily comprise highly liquid debt securities with maturities greater than three months but less than one year from the date of purchase. These investments are carried at amortized cost, which approximates fair value.
b)    Cash and Cash Equivalents
Cash equivalents include money-market funds, fixed interest deposits and reverse repurchase agreements with a maturity of under 90 days when purchased. Cash and cash equivalents are recorded at amortized cost, which approximates fair value due to the short-term, liquid nature of these securities. Restricted cash primarily relates to funds held in trust to support obligations in regulatory jurisdictions where the Company operates as a non-admitted carrier and to support underwriting activities at Lloyd's. 
c)    Premiums and Acquisition Costs
Premiums
Insurance premiums written are recorded in accordance with the terms of the underlying policies.
Reinsurance premiums are recorded at the inception of the contract based on estimates received from ceding companies.
For multi-year contracts insurance and reinsurance premiums are recorded at the inception of the contract based on management’s best estimate of total premiums to be received. Premiums are recognized on an annual basis for multi-year contracts where the cedant has the ability to unilaterally commute or cancel coverage within the term of the contract.
Any adjustments to insurance and reinsurance premium estimates are recognized in the period in which they are determined.
Insurance and reinsurance premiums are earned evenly over the period during which the Company is exposed to the underlying risk, which is generally one to two years with the exception of multi-year contracts. Unearned premiums represent the portion of premiums which relate to the unexpired term under contracts in force.
Reinstatement premiums are recognized and earned at the time a loss event occurs and losses are recorded, where the coverage limits for the remaining life of the contract are reinstated under pre-defined contract terms. The recognition of reinstatement premiums is based on estimates of losses and loss expenses, which reflects management’s judgment (refer to Note 2(d) 'Losses and Loss Expenses' below).
Insurance and reinsurance premium balances receivable ("premium balances receivable") are reviewed for impairment at least quarterly and are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company's analysis of amounts due, historical delinquencies and write-offs, and current economic conditions, together with reasonable and supportable forecasts of short-term economic conditions.
The allowance for expected credit losses is recognized in net income (loss). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Write-offs of premium balances receivable, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs.
124





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Acquisition Costs
Acquisition costs vary with and are directly related to the successful acquisition efforts of acquiring new or renewing existing insurance and reinsurance contracts and consist primarily of fees and commissions paid to brokers and premium taxes. In addition, certain of our contracts include profit commission provisions or other adjustable features that are estimated based on expected losses and loss expenses for those contracts. Acquisition costs are shown net of commissions on reinsurance purchased. Net acquisition costs are deferred and charged to net income (loss) as the related premium is earned. Insurance and reinsurance premium balances receivable is presented net of acquisition costs when contract terms provide for the right of offset.
Anticipated losses and loss expenses, other costs and investment income related to these premiums are considered in assessing the recoverability of deferred acquisition costs. Deferred acquisition cost amounts that are assessed to be irrecoverable are recognized in net income (loss) in the period in which the determination is made. Compensation expenses for personnel involved in contract acquisition, and advertising costs, are charged to net income (loss) when incurred.
d)    Losses and Loss Expenses
Reserve for losses and loss expenses represents an estimate of the unpaid portion of the ultimate liability for losses and loss expenses for insured and reinsured events that have occurred at or before the balance sheet date. These amounts reflect claims that have been reported ("case reserves") and claims that have been incurred but have not yet been reported ("IBNR") and are reduced for estimated amounts of salvage and subrogation recoveries.
The Company reviews its reserve for losses and loss expenses on a quarterly basis. Case reserves are primarily established based on amounts reported by clients and/or their brokers. Management estimates IBNR after reviewing detailed actuarial analyses and applying informed judgment regarding qualitative factors that may not be fully captured in the actuarial estimates. A variety of actuarial methods are utilized in this process, including the Expected Loss Ratio, Chain Ladder and Bornhuetter-Ferguson methods. The estimate is highly dependent on management’s judgment as to which method(s) are most appropriate for a particular accident/underwriting year and line of business. Historical claims data may be supplemented with industry benchmarks when applying these methodologies.
Any adjustments to estimates of reserve for losses and loss expenses are recognized in the period in which they are determined. While the Company believes that its reserves for losses and loss expenses are adequate, this estimate requires significant judgment and new information, events or circumstances may result in ultimate losses that are materially greater or less than provided for in the consolidated balance sheets.
e)    Reinsurance
In the normal course of business, the Company purchases facultative and treaty reinsurance protection to limit its ultimate losses and to reduce its loss aggregation risk. The premiums paid to reinsurers (i.e., ceded premiums written) are recognized over the coverage period. Prepaid reinsurance premiums represent the portion of premiums ceded which relate to the unexpired term of the contracts in force. Reinstatement premiums are recognized and earned at the time a loss event occurs and losses are recorded, where the coverage limits for the remaining life of the contract are reinstated under pre-defined contract terms.
Reinsurance recoverable on unpaid losses and loss expenses ("reinsurance recoverables") related to case reserves is estimated on a case-by-case basis by applying the terms of applicable reinsurance cover to individual case reserve estimates. Reinsurance recoverables related to IBNR is generally developed as part of the Company's loss reserving process, therefore, its estimation is subject to similar risks and uncertainties as the estimation of IBNR. Estimates of amounts to be ceded under excess of loss reinsurance contracts also take into account pricing information for those contracts and require greater judgment than estimates for proportional contracts.
Reinsurance recoverable balances are reviewed for impairment at least quarterly and are presented net of an allowance for expected credit losses.
125





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

A case-specific allowance for expected credit losses against reinsurance recoverables that we deem are unlikely to be collected in full, is estimated based on the Company's analysis of amounts due, historical delinquencies and write-offs. In addition, a default analysis is used to estimate an allowance for expected credit losses on the remainder of the reinsurance recoverable balance. The principal components of the default analysis are reinsurance recoverable balances by reinsurer and default factors applied to estimate uncollectible amounts based on reinsurers’ credit ratings and the length of collection periods. The default factors are based on a model developed by a major rating agency. The default analysis considers current and forecasted economic conditions.
The allowance for expected credit losses is recognized in net income (loss). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined. Write-offs of reinsurance recoverable balances, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs.
Retroactive Reinsurance
Retroactive reinsurance reimburses a ceding company for liabilities incurred as a result of past insurable events covered under contracts subject to the reinsurance. In certain instances, reinsurance contracts cover losses both on a prospective basis and on a retroactive basis and where practical the Company bifurcates the prospective and retroactive elements of these reinsurance contracts and accounts for each element separately. Initial gains in connection with retroactive reinsurance contracts are deferred and amortized into net income over the claims settlement period while losses are recognized immediately. When changes in the estimated amount recoverable from the reinsurer or in the timing of receipts related to that amount occur, a cumulative amortization adjustment is recognized in net income in the period in which the change is determined so that the deferred gain reflects the balance that would have existed had the revised estimate been available at the inception of the reinsurance transaction.
f)    Foreign Exchange
The functional currency of the Company and the majority of its subsidiaries is the U.S. dollar. All foreign currency transactions are initially measured and recorded in functional currency using the rates of exchange prevailing at the transaction date.
Monetary assets and liabilities denominated in foreign currency are remeasured to functional currency at the rates of exchange in effect at the balance sheet date with the resulting foreign exchange losses (gains) generally being recognized in the consolidated statements of operations. Foreign exchange losses (gains) related to available for sale securities denominated in foreign currency represent an unrealized appreciation (depreciation) in the market value of the securities and are included in AOCI. Non-monetary assets and liabilities denominated in foreign currency are not subsequently remeasured.
The Company’s reporting currency is the U.S. dollar. Assets and liabilities of the Company's subsidiaries and branches where the functional currency is not the U.S. dollar, are translated into U.S. dollars using the rates of exchange in effect at the balance sheet date, and revenue and expenses are translated using the weighted average foreign exchange rates for the period. The effect of translation adjustments is reported as a separate component of AOCI in total shareholders’ equity.
g)    Share-based Compensation
The Company is authorized to issue restricted shares, restricted stock units, performance restricted stock units, stock options, stock appreciation rights and other equity-based awards to its employees and directors. The Company's plan includes share-settled and cash-settled service and performance awards.
Restricted Stock Units - Share-Settled and Cash-Settled
The fair value of share-settled and cash-settled service awards is based on market value of the Company's common shares measured at the grant date and is expensed over the requisite service period. The fair value of the cash-settled service awards is recognized as a liability in the consolidated balance sheets and is remeasured at the end of each reporting period. The Company recognizes forfeitures when they occur.
126





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Performance Restricted Stock Units - Share-Settled
The fair value of share-settled performance awards which include a market condition is measured on the grant date using a Monte Carlo simulation model which requires inputs including share price, expected volatility, expected term, expected dividend yield and risk-free interest rates. The fair value of share-settled performance awards which include a performance condition is based on the market value of the Company's common shares measured at the grant date.
The fair value of share-settled performance awards is recognized on a straight-line basis over the requisite service period. The Company recognizes forfeitures when they occur.
h)    Derivative Instruments
The Company may enter into derivative instruments such as futures, options, interest rate swaps and foreign currency forward contracts as part of its overall foreign currency risk management strategy, to obtain exposure to a particular financial market or for yield enhancement.
From time to time the Company may also enter into insurance and reinsurance contracts that meet the Financial Accounting Standards Board's ("FASB") definition of a derivative contract.
The Company measures all derivative instruments at fair value (refer to Note 6 'Fair Value Measurements') and recognizes these instruments in either other assets or other liabilities in the consolidated balance sheets. Subsequent changes in fair value and realized gains (losses) are recognized in net income (loss) in the consolidated statements of operations.
i)    Goodwill and Intangible Assets
The Company recognizes goodwill and other intangible assets in connection with certain acquisitions. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired in these acquisitions and is not amortized. Other intangible assets with a finite life are amortized over the estimated useful live of the intangible asset. Other intangible assets with an indefinite life are not amortized.
The Company tests goodwill and indefinite-lived intangible assets for potential impairment during the fourth quarter each year and between annual tests if an event occurs or changes in circumstances indicate that the asset is impaired. Such events or circumstances may include an economic downturn in a geographic market or a change in the assessment of future operations.
For the purpose of evaluating goodwill for impairment, the Company may first perform a qualitative assessment to determine whether it is necessary to perform a quantitative goodwill impairment test. If determined to be necessary, the quantitative test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired. If the carrying amount of the reporting unit exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.
For the purpose of evaluating indefinite-lived intangibles for impairment, the Company may first perform a qualitative assessment to determine whether it is necessary to perform the quantitative impairment test. If the Company elects to perform a qualitative assessment, it first assesses qualitative factors to determine whether it is more likely than not that an indefinite lived intangible asset is impaired. If the Company determines that it is more likely than not that the indefinite lived intangible asset is impaired, the Company performs the quantitative impairment test.
For the purposes of evaluating goodwill and indefinite-lived intangible assets for impairment, the Company has an unconditional option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test. The Company may resume performing the qualitative assessment in any subsequent period.
For other finite-lived intangible assets the Company tests for recoverability whenever events or changes in circumstances indicate its carrying amount may not be recoverable. The Company recognizes an impairment loss if the carrying amount of
127





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

the asset is not recoverable and exceeds its fair value. The carrying amount of a finite-lived intangible asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.
If goodwill or an intangible asset is impaired, the carrying value of the asset is reduced to fair value and a corresponding expense is recorded in the consolidated statements of operations.
 j)    Income Taxes
Certain subsidiaries and branches of the Company operate in jurisdictions where they are subject to taxation.
Current and deferred income taxes are charged or credited to net income (loss), or in certain cases to AOCI, based on enacted tax laws and rates applicable in the relevant jurisdiction in the period in which the tax becomes accruable or realizable.
Deferred income taxes are provided for all temporary differences between the bases of assets and liabilities reported in the consolidated balance sheets and those reported in the various jurisdictional tax returns. When the assessment indicates that it is more likely than not that a portion of a deferred tax asset will not be realized in the foreseeable future, a valuation allowance against deferred tax assets is recorded. 
The Company recognizes the tax benefits of uncertain tax positions only when the position is more-likely-than-not to be sustained on audit by the relevant taxing authorities.
k)    Treasury Shares
Common shares repurchased by the Company and not subsequently canceled are classified as treasury shares and are recorded at cost. This results in a reduction of shareholders’ equity in the consolidated balance sheets. The Company uses the average cost method to determine the cost of shares reissued from treasury.
l)    Leases
The Company recognizes a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term related to office property and equipment leases.
The Company accounts for non-lease components separately from lease components. As a result, the non-lease components associated with the Company's leases are not included in the lease liabilities and right-of-use assets in the Company's consolidated balance sheets.
The Company does not record office property and equipment leases with an initial term of 12 months or less (short-term) in the Company's consolidated balance sheets.
m)    Recently Issued Accounting Standards Not Yet Adopted
Segment Reporting
In November 2023, the FASB issued Accounting Standards Update ("ASU" or "Update") ASU 2023-07 "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures". The amendments in this Update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this update:
1.    Require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss (collectively referred to as the “significant expense principle”).
2.     Require that a public entity disclose, on an annual and interim basis, an amount for other segment items by reportable segment and a description of its composition. The other segment items category is the difference between segment
128





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss.
3.    Require that a public entity provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by Topic 280 in interim periods.
4.     Clarify that if the CODM uses more than one measure of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources, a public entity may report one or more of those additional measures of segment profit. However, at least one of the reported segment profit or loss measures (or the single reported measure, if only one is disclosed) should be the measure that is most consistent with the measurement principles used in measuring the corresponding amounts in the public entity’s consolidated financial statements. In other words, in addition to the measure that is most consistent with the measurement principles under generally accepted accounting principles (GAAP), a public entity is not precluded from reporting additional measures of a segment’s profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources.
5.    Require that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources.
6.    Require that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this Update and all existing segment disclosures in Topic 280.
This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. As this guidance relates solely to financial statement disclosures, the adoption of ASU 2023-07, will not impact the Company's results of operations, financial condition, or liquidity.
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures". The amendments in this Update provide more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information as follows:
Rate Reconciliation
The amendments in this Update require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate).
Income Taxes Paid
The amendments in this Update require that all entities disclose on an annual basis (1) the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes and (2) the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) if equal to or greater than 5 percent of total income taxes paid (net of refunds received).


129





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

2.    BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Other Disclosures
The amendments in this Update require that all entities disclose (1) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and (2) income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign.

The amendments in this Update eliminate the requirement for all entities to (1) disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or (2) make a statement that an estimate of the range cannot be made.

The amendments in this Update remove the requirement to disclose the cumulative amount of each type of temporary difference when a deferred tax liability is not recognized because of the exceptions to comprehensive recognition of deferred taxes related to subsidiaries.

The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis. Retrospective application permitted.
130




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

3.    SEGMENT INFORMATION

AXIS Capital's underwriting operations are organized around its global underwriting platforms, AXIS Insurance and AXIS Re. The Company has determined that it has two reportable segments, insurance and reinsurance. The Company does not allocate its assets by segment, with the exception of goodwill and intangible assets.
Insurance
The Company's insurance segment offers specialty insurance products to a variety of niche markets on a worldwide basis. The product lines in this segment are professional lines, property, liability, cyber, marine and aviation, accident and health, and credit and political risk.
Reinsurance
The Company's reinsurance segment provides treaty reinsurance to insurance companies on a worldwide basis. The product lines in this segment are liability, accident and health, professional lines, credit and surety, motor, agriculture, marine and aviation, and run-off lines which include catastrophe and property lines of business that the Company placed into run-off in 2022 and engineering lines of business that the Company placed into run-off in 2020.
The following tables present the underwriting results of the Company's reportable segments, as well as the carrying amounts of allocated goodwill and intangible assets:
131




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

3.    SEGMENT INFORMATION (CONTINUED)
At and year ended December 31, 2023InsuranceReinsuranceTotal
Gross premiums written$6,140,764 $2,215,761 $8,356,525 
Net premiums written3,758,720 1,343,605 5,102,325 
Net premiums earned3,461,700 1,622,081 5,083,781 
Other insurance related income (loss)(198)22,693 22,495 
Net losses and loss expenses(2,080,001)(1,313,101)(3,393,102)
Acquisition costs(648,463)(352,482)(1,000,945)
Underwriting-related general and administrative expenses(472,094)(79,373)(551,467)
Underwriting income (loss)$260,944 $(100,182)160,762 
Net investment income611,742 
Net investment gains (losses)(74,630)
Corporate expenses(132,979)
Foreign exchange (losses) gains(58,115)
Interest expense and financing costs(68,421)
Reorganization expenses(28,997)
Amortization of value of business acquired 
Amortization of intangible assets(10,917)
Income before income taxes and interest in income of equity method investments398,445 
Income tax expense(26,316)
Interest in income of equity method investments4,163 
Net income376,292 
Preferred share dividends30,250 
Net income available to common shareholders$346,042 
Net losses and loss expenses ratio60.1 %81.0 %66.7 %
Acquisition cost ratio18.7 %21.7 %19.7 %
General and administrative expense ratio 13.7 %4.9 %13.5 %
Combined ratio92.5 %107.6 %99.9 %
Goodwill and intangible assets$287,684 $ $287,684 
132




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

3.    SEGMENT INFORMATION (CONTINUED)
At and year ended December 31, 2022InsuranceReinsuranceTotal
Gross premiums written$5,585,581 $2,629,014 $8,214,595 
Net premiums written3,377,906 1,885,150 5,263,056 
Net premiums earned3,134,155 2,026,171 5,160,326 
Other insurance related income559 12,514 13,073 
Net losses and loss expenses(1,785,854)(1,456,556)(3,242,410)
Acquisition costs(577,838)(444,179)(1,022,017)
Underwriting-related general and administrative expenses(443,704)(106,585)(550,289)
Underwriting income$327,318 $31,365 358,683 
Net investment income418,829 
Net investment gains (losses)(456,789)
Corporate expenses(130,054)
Foreign exchange gains157,945 
Interest expense and financing costs(63,146)
Reorganization expenses(31,426)
Amortization of value of business acquired 
Amortization of intangible assets(10,917)
Income before income taxes and interest in income of equity method investments243,125 
Income tax expense(22,037)
Interest in income of equity method investments1,995 
Net income223,083 
Preferred share dividends30,250 
Net income available to common shareholders$192,833 
Net losses and loss expenses ratio57.0 %71.9 %62.8 %
Acquisition cost ratio18.4 %21.9 %19.8 %
General and administrative expense ratio14.2 %5.3 %13.2 %
Combined ratio89.6 %99.1 %95.8 %
Goodwill and intangible assets$298,601 $ $298,601 
133




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

3.    SEGMENT INFORMATION (CONTINUED)
At and year ended December 31, 2021InsuranceReinsuranceTotal
Gross premiums written$4,863,232 $2,822,752 $7,685,984 
Net premiums written2,894,885 2,031,739 4,926,624 
Net premiums earned2,651,339 2,058,511 4,709,850 
Other insurance related income1,662 21,633 23,295 
Net losses and loss expenses(1,514,998)(1,493,785)(3,008,783)
Acquisition costs(484,344)(437,490)(921,834)
Underwriting-related general and administrative expenses(429,282)(107,552)(536,834)
Underwriting income$224,377 $41,317 265,694 
Net investment income454,301 
Net investment gains134,279 
Corporate expenses(126,470)
Foreign exchange (losses) gains(315)
Interest expense and financing costs(62,302)
Reorganization expenses 
Amortization of value of business acquired(3,854)
Amortization of intangible assets(12,424)
Income before income taxes and interest in income of equity method investments648,909 
Income tax expense(62,384)
Interest in income of equity method investments32,084 
Net income618,609 
Preferred share dividends30,250 
Net income available to common shareholders$588,359 
Net losses and loss expenses ratio57.1 %72.6 %63.9 %
Acquisition cost ratio18.3 %21.3 %19.6 %
General and administrative expense ratio 16.2 %5.1 %14.0 %
Combined ratio91.6 %99.0 %97.5 %
Goodwill and intangible assets$309,518 $ $309,518 
 
The following table presents gross premiums written by the geographical location of the Company's subsidiaries:
Years ended December 31,202320222021
U.S.$4,484,789 $4,342,707 $4,002,748 
Ireland1,837,177 1,931,815 1,667,496 
Lloyd's of London1,759,990 1,567,458 1,473,047 
Bermuda274,569 372,615 542,693 
Gross premiums written$8,356,525 $8,214,595 $7,685,984 
134




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022, AND 2021

3.    SEGMENT INFORMATION (CONTINUED)
The following table presents net premiums earned by segment and line of business:    
Years ended December 31,202320222021
Insurance
Professional lines$764,558 $817,924 $646,390 
Property878,849 755,986 711,297 
Liability496,381 459,775 354,787 
Cyber323,025 309,004 252,077 
Marine and aviation567,292 479,499 439,050 
Accident and health306,061 209,548 151,133 
Credit and political risk125,534 102,419 96,605 
Total Insurance3,461,700 3,134,155 2,651,339 
Reinsurance
Liability403,239 484,681 431,596 
Accident and health341,806 368,747 361,196 
Professional lines205,404 250,911 220,448 
Credit and surety236,408 192,926 158,549 
Motor155,942 205,774 247,099 
Agriculture121,628 122,289 82,743 
Marine and aviation65,658 78,504 58,775 
Run-off lines
Catastrophe33,963 156,232 238,775 
Property44,508 135,480 231,092 
Engineering13,525 30,627 28,238 
Total run-off lines91,996 322,339 498,105 
Total Reinsurance1,622,081 2,026,171 2,058,511 
Total$5,083,781 $5,160,326 $4,709,850 

135




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

4.    GOODWILL AND INTANGIBLE ASSETS
The table below provides details of goodwill and intangible assets related to the Company's insurance segment:
GoodwillIntangible
assets with an
indefinite life
Intangible
assets with a
finite life
Total
December 31, 2021
Gross amount$95,890 $120,784 $394,604 $611,278 
Accumulated amortizationn/an/a(291,901)(291,901)
Accumulated translation adjustment4,911 — — 4,911 
100,801 120,784 102,703 324,288 
Amortizationn/an/a(14,770)(14,770)
Impairment charges    
At December 31, 2022
Gross amount95,890 120,784 394,604 611,278 
Accumulated amortizationn/an/a(306,671)(306,671)
Accumulated translation adjustment4,911 — — 4,911 
100,801 120,784 87,933 309,518 
Amortizationn/an/a(10,917)(10,917)
Impairment charges    
At December 31, 2023
Gross amount95,890 120,784 394,604 611,278 
Accumulated amortizationn/an/a(317,588)(317,588)
Accumulated translation adjustment4,911   4,911 
100,801 120,784 77,016 298,601 
Amortizationn/an/a(10,917)(10,917)
Impairment charges    
$100,801 $120,784 $66,099 $287,684 
n/a – not applicable
Intangible Assets with an Indefinite Life
Intangible assets with an indefinite life include U.S. state licenses that provide a legal right to transact business indefinitely and the value of Lloyd's syndicate capacity, which represents the right to underwrite a certain allocated limit of premium in the Lloyd's market.
Impairment Review
The Company's impairment review of goodwill and indefinite lived intangibles did not result in the recognition of an impairment loss for the years ended December 31, 2023 and 2022 and 2021.



136




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

4.    GOODWILL AND INTANGIBLE ASSETS (CONTINUED)

The tables below provide details of the gross amount and accumulated amortization by category of value of business acquired ("VOBA") and intangible assets:
VOBA and intangible assets
At December 31, 2023
Gross amountAccumulated amortizationTotal
U.S. state licenses$26,036 n/a$26,036 
Syndicate capacity (2)
94,748 n/a94,748 
Customer relationships and customers lists - Ternian (1)
13,330 (11,661)1,669 
VOBA - Novae (2)
256,942 (256,942) 
Coverholders (2)
63,565 (33,110)30,455 
Large brokers (2)
46,641 (19,435)27,206 
SME brokers (2)
14,126 (7,357)6,769 
$515,388 $(328,505)$186,883 
n/a – not applicable
(1)    On April 1, 2015, the Company completed its acquisition of Ternian Insurance Group LLC (renamed AXIS Group Benefits LLC in 2022) and recognized the definite life intangible assets detailed above.
(2)    On October 2, 2017, the Company acquired Novae and recognized finite lived intangible assets, including VOBA, distribution networks, and indefinite lived intangible assets related to Lloyd's syndicate capacity, all detailed above.

VOBA and intangible assets
At December 31, 2022
Gross amountAccumulated amortizationTotal
U.S. state licenses$26,036 n/a$26,036 
Syndicate capacity (2)
94,748 n/a94,748 
Customer relationships and customers lists - Ternian (1)
13,330 (10,329)3,001 
VOBA - Novae (2)
256,942 (256,942) 
Coverholders (2)
63,565 (27,812)35,753 
Large brokers (2)
46,641 (16,325)30,316 
SME brokers (2)
14,126 (6,180)7,946 
$515,388 $(317,588)$197,800 
n/a – not applicable
(1)     On April 1, 2015, the Company completed its acquisition of Ternian Insurance Group LLC (renamed AXIS Group Benefits LLC in 2022) and recognized the definite life intangible assets detailed above.
(2)    On October 2, 2017, the Company acquired Novae and recognized finite lived intangible assets, including VOBA, distribution networks, and indefinite lived intangible assets related to Lloyd's syndicate capacity, all detailed above.
137




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

4.    GOODWILL AND INTANGIBLE ASSETS (CONTINUED)

The table below provides details of estimated amortization expense of intangible assets with a finite life:
Total
2024$10,916 
20259,919 
20269,583 
20279,583 
20289,583 
After 202816,515 
Total remaining amortization expense66,099 
Indefinite lived intangible assets120,784 
Total intangible assets$186,883 
The estimated remaining average useful life of finite lived intangible assets is 7 years.





138





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS
a)    Fixed Maturities, Available for Sale

The following table provides the amortized cost and fair values of the Company's fixed maturities classified as available for sale:
Amortized
cost
Allowance for expected credit lossesGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Available for sale
U.S. government and agency$3,049,445 $ $13,211 $(55,128)$3,007,528 
Non-U.S. government729,761 (30)13,089 (18,861)723,959 
Corporate debt4,651,654 (10,438)49,434 (216,478)4,474,172 
Agency RMBS(1)
1,706,204  11,495 (83,038)1,634,661 
CMBS(2)
897,553  551 (58,408)839,696 
Non-agency RMBS165,910 (194)713 (13,033)153,396 
ABS(3)
1,265,187 (50)2,855 (25,021)1,242,971 
Municipals(4)
168,540 (47)414 (10,548)158,359 
Total fixed maturities, available for sale$12,634,254 $(10,759)$91,762 $(480,515)$12,234,742 
At December 31, 2022
Available for sale
U.S. government and agency$2,731,733 $ $5,386 $(97,789)$2,639,330 
Non-U.S. government612,546  2,395 (52,912)562,029 
Corporate debt4,680,798 (11,521)5,269 (418,990)4,255,556 
Agency RMBS(1)
1,297,423  4,663 (99,301)1,202,785 
CMBS(2)
1,029,863  60 (82,145)947,778 
Non-agency RMBS151,907 (123)275 (18,525)133,534 
ABS(3)
1,499,728 (35)555 (70,721)1,429,527 
Municipals(4)
172,475 (54)139 (16,205)156,355 
Total fixed maturities, available for sale$12,176,473 $(11,733)$18,742 $(856,588)$11,326,894 
(1)Residential mortgage-backed securities ("RMBS") originated by U.S. government-sponsored agencies.
(2)Commercial mortgage-backed securities ("CMBS").
(3)Asset-backed securities ("ABS") include debt tranched securities collateralized primarily by auto loans, student loans, credit card receivables and collateralized loan obligations ("CLOs").
(4)Municipals include bonds issued by states, municipalities and political subdivisions.
 
139





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
Contractual Maturities
Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
The table below provides the contractual maturities of fixed maturities classified as available for sale:
Amortized
cost
Fair
value
% of Total
fair value
At December 31, 2023
Maturity
Due in one year or less$474,557 $463,789 3.6 %
Due after one year through five years5,902,571 5,790,493 47.3 %
Due after five years through ten years2,064,619 1,954,449 16.0 %
Due after ten years157,653 155,287 1.3 %
8,599,400 8,364,018 68.2 %
Agency RMBS1,706,204 1,634,661 13.4 %
CMBS897,553 839,696 6.9 %
Non-agency RMBS165,910 153,396 1.3 %
ABS1,265,187 1,242,971 10.2 %
Total$12,634,254 $12,234,742 100.0 %
At December 31, 2022
Maturity
Due in one year or less$422,039 $409,972 3.7 %
Due after one year through five years5,349,123 5,078,273 44.8 %
Due after five years through ten years2,192,344 1,919,450 16.9 %
Due after ten years234,046 205,575 1.8 %
8,197,552 7,613,270 67.2 %
Agency RMBS1,297,423 1,202,785 10.6 %
CMBS1,029,863 947,778 8.4 %
Non-agency RMBS151,907 133,534 1.2 %
ABS1,499,728 1,429,527 12.6 %
Total$12,176,473 $11,326,894 100.0 %


140





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
Gross Unrealized Losses
The following table summarizes fixed maturities, available for sale in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position:
  12 months or greaterLess than 12 monthsTotal
  Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
At December 31, 2023
Fixed maturities, available for sale
U.S. government and agency$846,503 $(42,465)$867,733 $(12,663)$1,714,236 $(55,128)
Non-U.S. government233,038 (18,178)115,112 (683)348,150 (18,861)
Corporate debt2,623,304 (210,512)240,813 (5,966)2,864,117 (216,478)
Agency RMBS778,656 (80,070)218,606 (2,968)997,262 (83,038)
CMBS703,411 (54,856)75,242 (3,552)778,653 (58,408)
Non-agency RMBS98,483 (13,013)10,017 (20)108,500 (13,033)
ABS879,743 (24,747)83,582 (274)963,325 (25,021)
Municipals129,969 (10,156)6,238 (392)136,207 (10,548)
Total fixed maturities, available for sale$6,293,107 $(453,997)$1,617,343 $(26,518)$7,910,450 $(480,515)
At December 31, 2022
Fixed maturities, available for sale
U.S. government and agency$467,032 $(41,365)$1,414,181 $(56,424)$1,881,213 $(97,789)
Non-U.S. government207,637 (33,027)298,048 (19,885)505,685 (52,912)
Corporate debt1,562,355 (268,289)2,350,504 (150,701)3,912,859 (418,990)
Agency RMBS220,595 (40,469)771,191 (58,832)991,786 (99,301)
CMBS343,494 (40,888)599,877 (41,257)943,371 (82,145)
Non-agency RMBS75,137 (14,691)53,484 (3,834)128,621 (18,525)
ABS685,990 (48,913)686,190 (21,808)1,372,180 (70,721)
Municipals52,994 (10,120)96,003 (6,085)148,997 (16,205)
Total fixed maturities, available for sale$3,615,234 $(497,762)$6,269,478 $(358,826)$9,884,712 $(856,588)

At December 31, 2023, 3,535 fixed maturities (2022: 4,525) were in an unrealized loss position of $481 million (2022: $857 million) of which $13 million (2022: $64 million) was related to securities below investment grade or not rated.

At December 31, 2023, 3,212 fixed maturities (2022: 1,842) had been in a continuous unrealized loss position for twelve months or greater and had a fair value of $6,293 million (2022: $3,615 million).

The unrealized losses of $481 million (2022: $857 million) were due to non-credit factors and were expected to be recovered as the related securities approach maturity.

At December 31, 2023, the Company did not intend to sell the securities in an unrealized loss position and it is more likely than not that the Company will not be required to sell these securities before the anticipated recovery of their amortized costs.
141





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
b)    Fixed Maturities, Held to Maturity
The following table provides the amortized cost and fair values of the Company's fixed maturities classified as held to maturity:
Amortized
cost
Allowance for expected credit lossesNet carrying valueGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Held to maturity
Corporate debt$95,200 $ $95,200 $298 $(8,827)$86,671 
ABS(1)
591,096  591,096 5 (1,921)589,180 
Total fixed maturities, held to maturity$686,296 $ $686,296 $303 $(10,748)$675,851 
At December 31, 2022    
Held to maturity
Corporate debt$85,200 $ $85,200 $ $(11,428)$73,772 
ABS(1)
613,151  613,151  (12,180)600,971 
Total fixed maturities, held to maturity$698,351 $ $698,351 $ $(23,608)$674,743 
(1)Asset-backed securities ("ABS") include debt tranched securities collateralized primarily by collateralized loan obligations ("CLOs").

At December 31, 2023, fixed maturities, held to maturity of $686 million (2022: $698 million) were presented net of an allowance for expected credit losses of $nil (2022: $nil).

The Company's ABS, held to maturity consist of CLO debt tranched securities. The Company uses a scenario-based approach to review its CLO debt portfolio and reviews subordination levels of these securities to determine their ability to absorb credit losses of the underlying collateral. If losses are forecast to be below the subordination level for a tranche held by the Company, the security is determined not to have a credit loss. At December 31, 2023 and 2022, the allowance for credit losses expected to be recognized over the life of the Company's ABS, held to maturity was $nil.

To estimate expected credit losses for corporate debt securities, held to maturity, the Company's projected cash flows are primarily driven by assumptions regarding the severity of loss, which is a function of the probability of default and projected recovery rates. The Company's default and recovery rates are based on credit ratings, credit analysis and macroeconomic forecasts. At December 31, 2023 and 2022, the allowance for credit losses expected to be recognized over the life of the Company's corporate debt, held to maturity was $nil.
Contractual Maturities
Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. ABS classified as held to maturity with a net carrying value of $591 million (2022: $613 million) do not have a single maturity date and cannot be allocated over several maturity groupings.

Corporate debt classified as held to maturity with a net carrying value of $95 million (2022: $81 million) is due between 3 years and 10 years and corporate debt classified as held to maturity with a net carrying value of $nil (2022: $4 million) is due after ten years.
142





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
c)    Equity Securities

The following table provides the cost and fair values of the Company's equity securities:
CostGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Equity securities
Common stocks$2,843 $101 $(398)$2,546 
Preferred stocks5,496 218 (113)5,601 
Exchange-traded funds182,989 105,858 (1,572)287,275 
Bond mutual funds352,505 4,119 (63,535)293,089 
Total equity securities$543,833 $110,296 $(65,618)$588,511 
At December 31, 2022
Equity securities
Common stocks$7,279 $636 $(442)$7,473 
Preferred stocks115  (43)72 
Exchange-traded funds207,505 68,058 (5,757)269,806 
Bond mutual funds279,457  (71,555)207,902 
Total equity securities$494,356 $68,694 $(77,797)$485,253 

143





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
d)    Mortgage Loans

The following table provides details of the Company's mortgage loans, held for investment:
  
December 31, 2023December 31, 2022
  
Carrying value% of TotalCarrying value% of Total
Mortgage loans held for investment:
Commercial$616,368 101 %$627,437 100 %
Allowance for expected credit losses
(6,220)(1 %)  %
Total mortgage loans held for investment$610,148 100 %$627,437 100 %

The primary credit quality indicators for commercial mortgage loans are the debt service coverage ratio which compares a property’s net operating income to amounts needed to service the principal and interest due under the loan, (generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss) and the loan-to-value ratio which compares the unpaid principal balance of the loan to the estimated fair value of the underlying collateral (generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss). The debt service coverage ratio and loan-to-value ratio, as well as the values utilized in calculating these ratios, are updated quarterly.

The Company has a high quality mortgage loan portfolio with a weighted average debt service coverage ratio of 1.9x (2022: 2.3x) and a weighted average loan-to-value ratio of 71% (2022: 60%). At December 31, 2023 and 2022, there were no past due amounts associated with the commercial mortgage loans held by the Company.

On a quarterly basis, collateral dependent mortgage loans (e.g., when the borrower is experiencing financial difficulty, including when foreclosure is reasonably possible or probable) are evaluated individually for credit losses. The allowance for expected credit losses for a collateral dependent loan is established as the excess of amortized cost over the estimated fair value of the loan's underlying collateral, less selling cost when foreclosure is probable. Accordingly, the change in the estimated fair value of collateral dependent loans, which are evaluated individually for credit losses, is recognized as a change in the allowance for expected credit losses which is recorded in net investment gains (losses).

At December 31, 2023, there are two collateral dependent loans with estimated loan-to-value ratios in excess of 100%, resulting in an allowance for expected credit loss of $6 million (2022: $nil).

144





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
e)    Other Investments
The following table provides a summary of the Company's other investments, together with additional information relating to the liquidity of each category:
  Fair valueRedemption frequency
(if currently eligible)
Redemption
notice period
At December 31, 2023
Multi-strategy funds$24,619 3 %Quarterly
60-90 days
Direct lending funds192,270 20 %
Quarterly(1)
90 days
Private equity funds301,712 32 %n/an/a
Real estate funds317,325 33 %
Quarterly(2), Annually(3)
45-90 days
CLO-Equities5,300 1 %n/an/a
Other privately held investments108,187 11 %n/an/a
Total other investments$949,413 100 %
At December 31, 2022
Multi-strategy funds$32,616 3 %Quarterly
60-90 days
Direct lending funds258,626 26 %
Quarterly(1)
90 days
Private equity funds265,836 27 %n/an/a
Real estate funds298,499 30 %
Quarterly(2), Annually(3)
45-90 days
CLO-Equities5,016  %n/an/a
Other privately held investments136,158 14 %n/an/a
Total other investments$996,751 100 %
n/a – not applicable
(1)Applies to one fund with a fair value of $17 million (2022: $39 million).
(2)Applies to one fund with a fair value of $66 million (2022: $73 million).
(3)Applies to one fund with a fair value of $25 million (2022: $27 million).
 
The investment strategies for the above funds are as follows:
 
Multi-strategy funds: Seek to achieve above-market returns by pursuing multiple investment strategies to diversify risks and reduce volatility. This category includes funds of hedge funds which invest in a large pool of hedge funds across a diversified range of hedge fund strategies.
Direct lending funds: Seek to achieve attractive risk-adjusted returns, including current income generation, by investing in funds which provide financing directly to borrowers.
Private equity funds: Seek to achieve attractive risk-adjusted returns by investing in private transactions over the course of several years.
Real estate funds: Seek to achieve attractive risk-adjusted returns by making and managing investments in real estate and real estate securities and businesses.
145





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
Two common redemption restrictions which may impact the Company's ability to redeem multi-strategy funds are gates and lockups. A gate is a suspension of redemptions which may be implemented by the general partner or investment manager of the fund in order to defer, in whole or in part, the redemption request in the event the aggregate amount of redemption requests exceeds a predetermined percentage of the fund’s net assets which may otherwise hinder the general partner or investment manager’s ability to liquidate holdings in an orderly fashion in order to generate the cash necessary to fund extraordinarily large redemption payouts. A lockup period is the initial amount of time an investor is contractually required to hold the security before having the ability to redeem. During 2023 and 2022, neither of these restrictions impacted the Company's redemption requests. At December 31, 2023, there were no multi-strategy fund holdings (2022: nil) where the Company is still within the lockup period.
At December 31, 2023, the Company had $28 million (2022: $26 million) of unfunded commitments as a limited partner in multi-strategy funds. Once the full amount of committed capital has been called by the General Partner of each of these funds, the assets will not be fully returned until after the completion of the funds' investment term. These funds have investment terms ranging from two years to the dissolution of the underlying fund.
At December 31, 2023, the Company had $192 million (2022: $183 million) of unfunded commitments as a limited partner in direct lending funds. Once the full amount of committed capital has been called by the General Partner of each of these funds, the assets will not be fully returned until the completion of the fund's investment term. These funds have investment terms ranging from four to ten years and the General Partners of certain funds have the option to extend the term by up to three years.
At December 31, 2023, the Company had $145 million (2022: $158 million) of unfunded commitments as a limited partner in private equity funds. The life of the funds is subject to the dissolution of the underlying funds. The Company expects the overall holding period to be over six years.

At December 31, 2023, the Company had $107 million (2022: $141 million) of unfunded commitments as a limited partner in real estate funds. These funds include an open-ended fund and funds with investment terms ranging from two years to the dissolution of the underlying fund.

At December 31, 2023, the Company had $30 million (2022: $16 million) of unfunded commitments as a limited partner in three private company investment funds focusing on financial services technology companies with an emphasis on insurance technology companies ("private company investment funds"). Two of these funds have investment terms of 5 years and one fund has an investment term of 10 years.

f)    Equity Method Investments

During 2023, the Company paid $22 million to acquire 18% of the common equity of Monarch Point Re (ISAC) Ltd. ("Monarch Point Re") and Monarch Point Re (ISA 2023) Ltd. (and collectively "Monarch Point Re"), a collateralized reinsurance company formed under the laws of Bermuda as an incorporated segregated accounts company under the Incorporated Segregated Accounts Companies Act 2019, as amended (the “ISAC Act”). Monarch Point Re is an independent reinsurer jointly sponsored by the Company and Stone Point Credit, LLC ("Stone Point").

The Company retrocedes a diversified portfolio of casualty reinsurance business to Monarch Point Re and Stone Point serves as its investment manager. The Company expects to benefit from underwriting fees generated by Monarch Point Re and the income and capital appreciation Stone Point seeks to deliver through its investment management services.

Monarch Point Re is not a Variable Interest Entity ("VIE") that is required to be included in the Company's consolidated financial statements. The Company accounts for its ownership interest in Monarch Point Re under the equity method of accounting.


146





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
During 2016, the Company paid $108 million including direct transaction costs to acquire 19% of the common equity of Harrington Reinsurance Holdings Limited ("Harrington"), the parent company of Harrington Re Ltd. ("Harrington Re"), an independent reinsurance company jointly sponsored by the Company and The Blackstone Group L.P. ("Blackstone").

Through long-term service agreements, the Company serves as Harrington Re's reinsurance underwriting manager and Blackstone serves as exclusive investment management service provider. As an investor, the Company expects to benefit from underwriting profit generated by Harrington Re and the income and capital appreciation Blackstone seeks to deliver through its investment management services. In addition, the Company has entered into an arrangement with Blackstone under which underwriting and investment related fees will be shared equally.

Harrington is not a VIE that is required to be included in the Company's consolidated financial statements. The Company accounts for its ownership interest in Harrington under the equity method of accounting. The Company's proportionate share of the underlying equity in net assets resulted in a basis difference of $5 million which represents initial transactions costs.

g)    Variable Interest Entities

In the normal course of investing activities, the Company actively manages allocations to non-controlling tranches of structured securities which are variable interests issued by VIEs. These structured securities include RMBS, CMBS and ABS.

The Company also invests in limited partnerships which represent 75% of the Company's other investments. The investments in limited partnerships include multi-strategy funds, direct lending funds, private equity funds, real estate funds and CLO equity tranched securities, which are variable interests issued by VIEs (refer to Note 5(e) 'Other Investments').

The Company does not have the power to direct the activities that are most significant to the economic performance of these VIEs. Therefore, the Company is not the primary beneficiary of these VIEs. The maximum exposure to loss on these interests is limited to the amount of commitment made by the Company. The Company has not provided financial or other support to these structured securities other than the original investment.

h)    Net Investment Income
Net investment income was derived from the following sources:
Year ended December 31,202320222021
Fixed maturities$514,842 $329,858 $262,049 
Other investments20,411 57,043 181,906 
Equity securities12,088 10,390 12,752 
Mortgage loans35,312 23,407 17,427 
Cash and cash equivalents50,261 20,273 4,454 
Short-term investments8,924 3,535 664 
Gross investment income641,838 444,506 479,252 
Investment expenses(30,096)(25,677)(24,951)
Net investment income$611,742 $418,829 $454,301 
 
147





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
i)    Net Investment Gains (Losses)
The following table provides an analysis of net investment gains (losses):
Year ended December 31,202320222021
Gross realized investment gains
Fixed maturities and short-term investments$32,920 $16,671 $137,729 
Equity securities16,847 7,687 5,413 
Gross realized investment gains49,767 24,358 143,142 
Gross realized investment losses
Fixed maturities and short-term investments(158,080)(328,493)(42,613)
Equity securities(639)(406)(696)
Gross realized investment losses(158,719)(328,899)(43,309)
(Increase) decrease in allowance for expected credit losses, fixed maturities, available for sale
974 (11,421)11 
(Increase) decrease in allowance for expected credit losses, mortgage loans
(6,220)  
Impairment losses(1)
(12,757)(12,568)(22)
Change in fair value of investment derivatives(2)
(1,456)7,656 4,346 
Net unrealized gains (losses) on equity securities53,781 (135,915)30,111 
Net investment gains (losses)$(74,630)$(456,789)$134,279 
(1)Related to instances where the Company intends to sell securities or it is more likely than not that the Company will be required to sell securities before their anticipated recovery.
(2)Refer to Note 7 'Derivative Instruments'.

The following table provides a reconciliation of the beginning and ending balances of the allowance for expected credit losses on fixed maturities classified as available for sale:
Year ended December 31,202320222021
Balance at beginning of period$11,733 $313 $323 
Expected credit losses on securities where credit losses were not previously recognized
5,200 17,830 95 
Additions (reductions) for expected credit losses on securities where credit losses were previously recognized
4,934 (3,831)50 
Impairments of securities which the Company intends to sell or more likely than not will be required to sell   
Securities sold/redeemed/matured(11,108)(2,579)(155)
Balance at end of period$10,759 $11,733 $313 

148





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
Fixed Maturities
The Company evaluates available for sale securities for expected credit losses when fair value is below amortized cost. If the Company intends to sell or will be required to sell the security before its anticipated recovery, the full amount of the impairment loss is charged to net income (loss). If the Company does not intend to sell or will not be required to sell the security before its anticipated recovery, an allowance for expected credit losses is established and the portion of the loss that relates to credit losses is recorded in net income (loss).
A summary of credit loss activity by asset class, the significant inputs and the methodology used to estimate credit losses are described below.
U.S. Government, U.S. Agency and U.S. Agency RMBS
Unrealized losses on securities issued or backed, either explicitly or implicitly by the U.S. government are not analyzed for credit losses. The Company has concluded that the possibility of a credit loss on these securities is highly unlikely due to the explicit U.S. government guarantee related to certain securities (e.g., Government National Mortgage Association issuances) and the implicit guarantee related to other securities that has been validated by past actions (e.g., U.S. government bailout of Federal National Mortgage Association and Federal Home Loan Mortgage Corporation during the 2008 credit crisis).
Although these securities are not analyzed for credit losses, they are evaluated for intention to sell and likely requirement to sell.
Non-U.S. Government
Non-U.S. government securities are evaluated for expected credit losses primarily through qualitative assessments of the likelihood of credit losses using information such as severity of unrealized losses, credit ratings and price volatility. At December 31, 2023, the gross unrealized losses of $19 million included foreign exchange losses of $6 million. At December 31, 2023, the allowance for expected credit losses on non-U.S. government fixed maturities related to loss severity where the forecasted recovery to amortized cost is uncertain.
At December 31, 2022, the gross unrealized losses of $53 million included foreign exchange losses of $24 million. At December 31, 2022, the Company did not anticipate any credit losses on its non-U.S. government fixed maturities.
Corporate Debt
To estimate expected credit losses for corporate debt securities, the Company's projected cash flows are primarily driven by assumptions regarding the severity of loss, probability of default and projected recovery rates. The Company's default and loss severity rates are based on credit rating, credit analysis and macroeconomic forecasts. At December 31, 2023 and 2022, the allowance for expected credit losses on corporate debt securities mainly related to loss severity where the forecasted recovery to amortized cost was uncertain.
 
CMBS
The Company's investments in CMBS are diversified and primarily rated AA or better. At December 31, 2023, CMBS had a weighted average estimated subordination percentage of 37% (2022: 38%). Based on discounted cash flows at December 31, 2023 and 2022, the current level of subordination is sufficient to cover the estimated loan losses on the underlying collateral of the CMBS.
Non-agency RMBS
To estimate expected credit losses for non-agency RMBS, the Company's projected cash flows incorporated underlying data from widely accepted third-party data sources along with certain internal assumptions and judgments regarding the future performance of the security. These assumptions included default, delinquency, loss severity and prepayment rates.
149





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
At December 31, 2023, the fair value of the Company's non-agency RMBS was $153 million (2022: $134 million), consisting primarily of $34 million (2022: $39 million) of Prime and $100 million (2022: $76 million) of Alt-A, Non-qualified, and Home Equity MBS. At December 31, 2023 and 2022, the allowance for expected credit losses on non-agency RMBS related to loss severity where the forecasted recovery to amortized cost is uncertain.
ABS

The Company's investments in ABS consist mainly of CLO debt tranched securities ("CLO Debt") purchased primarily as new issues between 2018 and 2023. Substantially all of these new issues had credit ratings of AA or better. The Company utilizes a scenario-based approach to review its CLO Debt portfolio based on the current asset market price. The Company also reviews subordination levels of these securities to determine their ability to absorb credit losses of underlying collateral. If losses are forecast to be below the subordination level for a tranche held by the Company, the security is determined not to have a credit loss. At December 31, 2023 and 2022, the allowance for expected credit losses on ABS related to loss severity where the forecasted recovery to amortized cost is uncertain.

Municipals

Municipal securities are evaluated for expected credit losses primarily through qualitative assessments of the likelihood of credit losses using information such as severity of unrealized losses, credit ratings and price volatility. At December 31, 2023 and 2022, the allowance for expected credit losses on municipals related to loss severity where the forecasted recovery to amortized cost is uncertain.


150





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

5.    INVESTMENTS (CONTINUED)
j)    Restricted Assets
In order to support the Company's obligations in regulatory jurisdictions where it operates as a non-admitted carrier, the Company provides collateral in the form of assets held in trust and, to a lesser extent, letters of credit (refer to Note 10(c) 'Debt and Financing Arrangements').
In addition, the Company operates in the Lloyd’s market through its corporate members, AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited, which provide 70% and 30%, respectively of Syndicate 1686's capital support. Lloyd’s sets capital requirements for corporate members annually through the application of a capital model that is based on regulatory rules pursuant to Directive 2009/138/EC of the European Parliament and of the Council of 25 November 2009 on the taking up and pursuit of business of Insurance and Reinsurance (Solvency II) ("Solvency II").
The capital provided to support underwriting, or Funds at Lloyd’s ("FAL"), may be satisfied by cash, certain investments and letters of credit provided by approved banks (refer to Note 12 'Commitments and Contingencies' and Note 22 'Statutory Financial Information').
At December 31, 2023, collateral held in trust for third-party agreements of $2,598 million (2022: $2,491 million) included $550 million (2022: $539 million) of fixed maturities, and cash of $296 million (2022: $217 million) held on deposit to support the underwriting activities of Syndicate 1686.
The Company's restricted investments and cash primarily consist of high-quality fixed maturity and short-term investment securities.
The table below provides the fair values of the Company's restricted investments and cash:
At December 31,20232022
Collateral in trust for inter-company agreements
$614,089 $790,449 
Collateral for secured letter of credit facility423,522 424,624 
Funds at Lloyd's893,177 748,573 
Collateral in trust for third-party agreements
2,597,633 2,491,317 
Securities on deposit or in trust with regulatory authorities772,472 731,660 
Total restricted investments and cash$5,300,893 $5,186,623 

 k)    Reverse Repurchase Agreements

At December 31, 2023, the Company held $12 million (2022: $nil) of reverse repurchase agreements. These loans are fully collateralized, are generally outstanding for a short period of time and are presented on a gross basis as part of cash and cash equivalents in the Company's consolidated balance sheets. The required collateral for these loans is either cash or U.S. Treasuries at a minimum rate of 102% of the loan principal. Upon maturity, the Company receives principal and interest income. The Company monitors the estimated fair value of the securities loaned and borrowed on a daily basis with additional collateral obtained as necessary throughout the duration of the transaction.
151





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS
Fair Value Hierarchy

Fair value is defined as the price to sell an asset or transfer a liability (i.e., the "exit price") in an orderly transaction between market participants. U.S. GAAP prescribes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to quoted prices in active markets and the lowest priority to unobservable data. The level in the hierarchy within which a given fair value measurement falls is determined based on the lowest level input that is significant to the measurement. The hierarchy is broken down into three levels as follows:

Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Level 2 - Valuations based on quoted prices in active markets for similar assets or liabilities, quoted prices for identical assets or liabilities in inactive markets, or for which significant inputs are observable (e.g., interest rates, yield curves, prepayment speeds, default rates, loss severities, etc.) or can be corroborated by observable market data.

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The unobservable inputs reflect the Company's judgments about assumptions that market participants might use.

The availability of observable inputs can vary from financial instrument to financial instrument and is affected by a wide variety of factors including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment.

Accordingly, the degree of judgment exercised by management in determining fair value is greatest for financial instruments categorized as Level 3. In periods of market dislocation, the observability of prices and inputs may be reduced for many financial instruments. This may lead the Company to change the selection of valuation technique (from market to cash flow approach) or may cause the Company to use multiple valuation techniques to estimate the fair value of a financial instrument. This circumstance could cause an instrument to be reclassified between levels within the fair value hierarchy.

Valuation Techniques

The valuation techniques, including significant inputs and assumptions generally used to determine the fair values of the Company's financial instruments as well as the classification of the fair values of its financial instruments in the fair value hierarchy are described in detail below.

Fixed Maturities

At each valuation date, the Company uses the market approach valuation technique to estimate the fair value of its fixed maturities portfolio, where possible. The market approach includes, but is not limited to, prices obtained from third-party pricing services for identical or comparable securities and the use of "pricing matrix models" using observable market inputs such as yield curves, credit risks and spreads, measures of volatility, and prepayment speeds. Pricing from third-party pricing services is sourced from multiple vendors, where available, and the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Where prices are unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers who are active in the corresponding markets. The valuation techniques including significant inputs and assumptions generally used to determine the fair values of the Company's fixed maturities by asset class as well as the classifications of the fair values of these securities in the fair value hierarchy are described in detail below.

152





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
U.S. Government and Agency

U.S. government and agency securities consist primarily of bonds issued by the U.S. Treasury and mortgage pass-through agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. As the fair values of U.S. Treasury securities are based on unadjusted quoted market prices in active markets, the fair values of these securities are classified as Level 1. The fair values of U.S. government agency securities are determined using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads are observable market inputs, the fair values of U.S. government agency securities are classified as Level 2.

Non-U.S. Government

Non-U.S. government securities include bonds issued by non-U.S. governments and their agencies along with supranational organizations (collectively also known as sovereign debt securities). The fair values of these securities are based on prices obtained from international indices or valuation models that include inputs such as interest rate yield curves, cross-currency basis index spreads and country credit spreads for structures similar to the sovereign bond in terms of issuer, maturity and seniority. As the significant inputs used to price these securities are observable market inputs, the fair values of non-U.S. government securities are classified as Level 2.

Corporate Debt

Corporate debt securities consist primarily of investment grade debt of a wide variety of corporate issuers and industries. The fair values of these securities are generally determined using the spread above the risk-free yield curve. These spreads are generally obtained from the new issue market, secondary trading and broker-dealer quotes. As the yields for the risk-free yield curve and the spreads are observable market inputs, the fair values of corporate debt securities are generally classified as Level 2. Where pricing is unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers to estimate fair value. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. In this event, the fair values of these securities are classified as Level 3.

Agency RMBS

Agency RMBS consist of bonds issued by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. The fair values of these securities are priced using a mortgage pool specific model which uses daily inputs from the active to be announced market and the spread associated with each mortgage pool based on vintage. As the significant inputs used to price these securities are observable market inputs, the fair values of Agency RMBS are classified as Level 2.

CMBS

CMBS mainly include investment grade bonds originated by non-agencies. The fair values of these securities are determined using a pricing model which uses dealer quotes and other available trade information along with security level characteristics to determine deal specific spreads. As the significant inputs used to price these securities are observable market inputs, the fair values of CMBS are generally classified as Level 2. Where pricing is unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers to estimate fair value. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. In this event, the fair values of these securities are classified as Level 3.

153





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
Non-agency RMBS

Non-agency RMBS mainly include investment grade bonds originated by non-agencies. The fair values of these securities are determined using an option adjusted spread model or other relevant models, which use inputs including available trade information or broker quotes, prepayment and default projections based on historical statistics of the underlying collateral and current market data. As the significant inputs used to price these securities are observable market inputs, the fair values of non-agency RMBS are generally classified as Level 2. Where pricing is unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers to estimate fair value. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. In this event, the fair values of these securities are classified as Level 3.

ABS

ABS mainly include investment grade bonds backed by pools of loans with a variety of underlying collateral, including auto loans, student loans, credit card receivables and collateralized loan obligations ("CLOs"), originated by a variety of financial institutions. The fair values of these securities are determined using a model which uses prepayment speeds and spreads sourced primarily from the new issue market. As the significant inputs used to price these securities are observable market inputs, the fair values of ABS are generally classified as Level 2. Where pricing is unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers to estimate fair value. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. In this event, the fair values of these securities are classified as Level 3.

Municipals

Municipals comprise revenue bonds and general obligation bonds issued by U.S. domiciled state and municipal entities. The fair values of these securities are determined using spreads obtained from the new issue market, trade prices and broker-dealers quotes. As the significant inputs used to price these securities are observable market inputs, the fair values of municipals are classified as Level 2.

Equity Securities

Equity securities include common stocks, preferred stocks, exchange-traded funds and bond mutual funds. As the fair values of common stocks and exchange-traded funds are based on unadjusted quoted market prices in active markets, the fair values of these securities are classified as Level 1. As the significant inputs used to price preferred stocks are observable market inputs, the fair value of these securities are classified as Level 2. As bond mutual funds have daily liquidity, the fair values of these securities are classified as Level 2.

Other Investments

The fair value of an indirect investment in CLO-Equities is estimated using an income approach valuation technique, specifically an externally developed discounted cash flow model due to the lack of observable and relevant trades in secondary markets. As the significant inputs used to price this security are unobservable, the fair value of the indirect investment in CLO-Equities is classified as Level 3.
154





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
Other privately held investments include common shares, preferred shares, private company investment funds, investments in limited partnerships, convertible notes, convertible preferred shares, and a variable yield security. These investments are initially valued at cost, which approximates fair value. In subsequent measurement periods, the fair values of these investments are generally derived from one or a combination of valuation methodologies which consider factors including recent capital raises by the investee companies, comparable precedent transaction multiples, comparable publicly traded multiples, third-party valuations, discounted cash-flow models, and other techniques that consider the industry and development stage of each investee company. The fair value of the variable yield security is determined using an externally developed discounted cash flow model. In order to assess the reasonableness of the information received from investee companies, the Company maintains an understanding of current market conditions, historical results, and emerging trends that may impact the results of operations, financial condition or liquidity of these companies. In addition, the Company engages in regular communication with management at investee companies. As the significant inputs used to price these investments are unobservable, the fair values of other privately held investments are classified as Level 3. The fair values of private company investment funds are estimated using NAVs as advised by external fund managers or third-party administrators.
Short-term Investments

Short-term investments primarily comprise highly liquid securities with maturities greater than three months but less than one year from the date of purchase. These securities are typically not actively traded due to their approaching maturity, therefore their amortized cost approximates fair value. The fair values of short-term investments are classified as Level 2.

Derivative Instruments

Derivative instruments include foreign exchange forward contracts that are customized to the Company's economic hedging strategies and trade in the over-the-counter derivative market. The fair values of these derivatives are determined using a market approach valuation technique based on significant observable market inputs from third-party pricing vendors, non-binding broker-dealer quotes and/or recent trading activity. As the significant inputs used to price these derivatives are observable market inputs, the fair values of these derivatives are classified as Level 2.

Other underwriting-related derivatives include insurance and reinsurance contracts that are accounted for as derivatives. These derivative contracts are initially valued at cost which approximates fair value. In subsequent measurement periods, the fair values of these derivatives are determined using internally developed discounted cash flow models. As the significant inputs used to price these derivatives are unobservable, the fair values of these contracts are classified as Level 3.

Cash-Settled Awards

Cash-settled awards comprise restricted stock units that form part of the Company's compensation program. Although the fair values of these awards are determined using observable quoted market prices in active markets, the restricted stock units are not actively traded. As the significant inputs used to price these securities are observable market inputs, the fair values of these liabilities are classified as Level 2.

155





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
The tables below present the financial instruments measured at fair value on a recurring basis for the periods indicated:
Quoted prices in active markets
for identical assets (Level 1)
Significant other observable
inputs (Level 2)
Significant unobservable inputs (Level 3)Fair value based on NAV practical expedientTotal fair value
At December 31, 2023
Assets
Fixed maturities, available for sale
U.S. government and agency$2,989,612 $17,916 $ $ $3,007,528 
Non-U.S. government 723,959   723,959 
Corporate debt 4,338,419 135,753  4,474,172 
Agency RMBS 1,634,661   1,634,661 
CMBS 839,696   839,696 
Non-agency RMBS 153,396   153,396 
ABS 1,242,971   1,242,971 
Municipals 158,359   158,359 
 2,989,612 9,109,377 135,753 — 12,234,742 
Equity securities
Common stocks2,546    2,546 
Preferred stocks1 5,600   5,601 
Exchange-traded funds287,275    287,275 
Bond mutual funds 293,089   293,089 
 289,822 298,689   588,511 
Other investments
Multi-strategy funds
   24,619 24,619 
Direct lending funds   192,270 192,270 
Private equity funds   301,712 301,712 
Real estate funds   317,325 317,325 
CLO-Equities  5,300  5,300 
Other privately held investments  87,289 20,898 108,187 
  92,589 856,824 949,413 
Short-term investments 17,216   17,216 
Other assets
Derivative instruments (refer to Note 7) 4,424   4,424 
Total Assets$3,279,434 $9,429,706 $228,342 $856,824 $13,794,306 
Liabilities
Derivative instruments (refer to Note 7)$ $10,165 $ $ $10,165 
Cash-settled awards (refer to Note 17)     
Total Liabilities$ $10,165 $ $ $10,165 
156





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
Quoted prices in active markets
for identical assets (Level 1)
Significant other observable
inputs (Level 2)
Significant unobservable inputs (Level 3)Fair value based on NAV practical expedientTotal fair value
At December 31, 2022
Assets
Fixed maturities, available for sale
U.S. government and agency$2,600,636 $38,694 $ $— $2,639,330 
Non-U.S. government 562,029  — 562,029 
Corporate debt 4,136,452 119,104 — 4,255,556 
Agency RMBS 1,202,785  — 1,202,785 
CMBS 947,778  — 947,778 
Non-agency RMBS 133,534  — 133,534 
ABS 1,429,527  — 1,429,527 
Municipals 156,355  — 156,355 
 2,600,636 8,607,154 119,104 — 11,326,894 
Equity securities
Common stocks7,473   — 7,473 
Preferred stocks72   — 72 
Exchange-traded funds269,806   — 269,806 
Bond mutual funds 207,902  — 207,902 
 277,351 207,902  — 485,253 
Other investments
Multi-strategy funds
   32,616 32,616 
Direct lending funds   258,626 258,626 
Private equity funds   265,836 265,836 
Real estate funds   298,499 298,499 
CLO-Equities  5,016  5,016 
Other privately held investments  136,158  136,158 
  141,174 855,577 996,751 
Short-term investments 70,310  — 70,310 
Other assets
Derivative instruments (refer to Note 7) 37,682  — 37,682 
Total Assets$2,877,987 $8,923,048 $260,278 $855,577 $12,916,890 
Liabilities
Derivative instruments (refer to Note 7)$ $703 $ $— $703 
Cash-settled awards (refer to Note 17) 4,792  — 4,792 
Total Liabilities$ $5,495 $ $— $5,495 

 




157





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
The following table quantifies the significant unobservable inputs used in estimating fair values at December 31, 2023 of investments classified as Level 3 in the fair value hierarchy:
Asset fair valueValuation techniqueUnobservable inputAmount /RangeWeighted
average
Other investments - CLO-Equities$5,300 Discounted cash flowDefault rate4.5%4.5%
  Loss severity rate50.0%50.0%
  Collateral spread3.0%3.0%
Estimated maturity date4 years4 years
Other investments - Other privately
    held investments
$18,940 Discounted cash flowDiscount rate6.0%6.0%
Default rate0.5%0.5%
Loss absorption yield1.0%1.0%
Estimated maturity date
0 - 2 years
1 year
Note: Fixed maturities of $136 million that are classified as Level 3 are excluded from the above table as these securities are priced using broker-dealer quotes. In addition, other privately held investments of $68 million that are classified as Level 3 are excluded from the above table as these investments are priced using capital statements received from investee companies.

Other Investments - CLO-Equities

The CLO-Equities market continues to be relatively inactive with only a small number of transactions being observed, particularly related to transactions involving CLO-Equities held by the Company. Accordingly, the fair value of the Company's indirect investment in CLO-Equities is determined using a discounted cash flow model prepared by an external investment manager.

The default and loss severity rates are the most judgmental unobservable market inputs to the discounted cash flow model to which the valuation of the Company's indirect investment in CLO-Equities is most sensitive. A significant increase (decrease) in either of these significant inputs in isolation would result in a lower (higher) fair value estimate for the investment in CLO-Equities and, in general, a change in default rate assumptions would be accompanied by a directionally similar change in loss severity rate assumptions. Collateral spreads and estimated maturity dates are less judgmental inputs as they are based on the historical average of actual spreads and the weighted average life of the current underlying portfolios, respectively. A significant increase (decrease) in either of these significant inputs in isolation would result in a higher (lower) fair value estimate for the investment in CLO-Equities. In general, these inputs have no significant interrelationship with each other or with default and loss severity rates.

On a quarterly basis, the Company's valuation process for its indirect investment in CLO-Equities includes a review of the underlying cash flows and key assumptions used in the discounted cash flow model. The above significant unobservable inputs are reviewed and updated based on information obtained from secondary markets, including information received from the managers of the Company's CLO-Equities investment. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow model, the Company maintains an understanding of current market conditions, historical results, and emerging trends that may impact future cash flows. In addition, the assumptions the Company uses in its models are updated through regular communication with industry participants and ongoing monitoring of the deals in which the Company participates.


158





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
Other Investments - Other Privately Held Securities

Other privately held securities are initially valued at cost which approximates fair value. In subsequent measurement periods, the fair value of the variable yield security was determined using an externally developed discounted cash flow model. This model includes inputs that are specific to that investment. The inputs used in the fair value measurement include an appropriate discount rate, default rate, loss absorption rate and estimated maturity date. The selection of an appropriate discount rate is judgmental and is the most significant unobservable input used in the valuation of this investment. A significant increase (decrease) in this input in isolation could result in significantly lower (higher) fair value measurement for this investment. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow model, the Company maintains an understanding of current market conditions, historical results, as well as investee specific information that may impact future cash flows.















159





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
The following table presents changes in Level 3 for financial instruments measured at fair value on a recurring basis:
Opening
balance
Transfers
into
Level 3
Transfers
out of
Level 3
Included in net income(1)
Included
in OCI (2)
PurchasesSalesSettlements/
distributions
Closing
balance
Change in
unrealized
gains/(losses) (3)
Year ended December 31, 2023
Fixed maturities, available for sale         
Corporate debt$119,104 $ $ $(8,527)$2,438 $38,173 $(770)$(14,665)$135,753 $ 
 119,104   (8,527)2,438 38,173 (770)(14,665)135,753  
Other investments
CLO-Equities5,016   2,395    (2,111)5,300 2,395 
Other privately held investments136,158  (25,510)(9,904) 21,077 (34,532) 87,289 (17,986)
 141,174  (25,510)(7,509) 21,077 (34,532)(2,111)92,589 (15,591)
Total assets$260,278 $ $(25,510)$(16,036)$2,438 $59,250 $(35,302)$(16,776)$228,342 $(15,591)
Other liabilities
Derivative instruments$ $ $ $ $ $ $ $ $ $ 
Total liabilities$ $ $ $ $ $ $ $ $ $ 
Year ended December 31, 2022
Fixed maturities, available for sale         
Corporate debt$42,894 $ $ $(104)$(9,014)$90,130 $ $(4,802)$119,104 $ 
 42,894   (104)(9,014)90,130  (4,802)119,104  
Other investments
CLO-Equities5,910   2,611    (3,505)5,016 2,611 
Other privately held investments104,521   13,646  19,991  (2,000)136,158 13,646 
 110,431   16,257  19,991  (5,505)141,174 16,257 
Total assets$153,325 $ $ $16,153 $(9,014)$110,121 $ $(10,307)$260,278 $16,257 
Other liabilities
Derivative instruments$5,630 $ $ $(3,542)$ $ $ $(2,088)$ $ 
Total liabilities$5,630 $ $ $(3,542)$ $ $ $(2,088)$ $ 
(1)    Realized gains (losses) on fixed maturities and realized and unrealized gains (losses) on other assets and other liabilities included in net income are included in net investment gains (losses). Realized and unrealized gains (losses) on other investments included in net income are included in net investment income.
(2)    Unrealized gains (losses) on fixed maturities are included in other comprehensive income ("OCI").
(3)    Change in unrealized gains (losses) relating to assets and liabilities held at the reporting date.

160





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
Transfers into Level 3 from Level 2
There were no transfers into Level 3 from Level 2 during 2023 and 2022.
Transfers out of Level 3 into Level 2
There were no transfers out of Level 3 into Level 2 during 2023 and 2022.
Other Transfers out of Level 3
During 2023, two private company investment funds included in other privately held investments in the consolidated balance sheets were transferred from Level 3 to the NAV practical expedient. In addition, the Company's investment in Monarch Point Re was transferred from Level 3 to Equity method investments (refer to Note 5(f) 'Equity Method Investments', Note 8 'Reserve for Losses and Loss Expenses' and Note 18 'Related Party Transactions').
Measuring the Fair Value of Other Investments Using Net Asset Valuations
The fair values of multi-strategy funds, direct lending funds, private equity funds, real estate funds and private company investment funds are estimated using net asset valuations ("NAVs") as advised by external fund managers or third-party administrators. For these funds, NAVs are based on the manager's or administrator's valuation of the underlying holdings in accordance with the fund's governing documents and in accordance with U.S. GAAP.
For multi-strategy funds, direct lending funds, private equity funds, real estate funds and private company investment funds, valuation statements are typically released on a reporting lag. Therefore, the Company estimates the fair value of these funds by starting with the most recent fund valuations and adjusting for capital calls, redemptions, drawdowns and distributions. Return estimates are not available from the relevant fund managers for these funds, therefore the Company typically has a reporting lag in its fair value measurements of these funds. At December 31, 2023 and 2022, all funds measured at fair value using NAVs are reported generally on a one quarter lag.
The Company often does not have access to financial information relating to the underlying securities held within the funds, therefore, management is unable to corroborate the fair values placed on the securities underlying the asset valuations provided by fund managers or fund administrators. In order to assess the reasonableness of the NAVs, the Company performs a number of monitoring procedures on a quarterly basis, to assess the quality of the information provided by fund managers and fund administrators. These procedures include, but are not limited to, regular review and discussion of each fund's performance with its manager, regular evaluation of fund performance against applicable benchmarks and the backtesting of the Company's fair value estimates against subsequently received NAVs. Backtesting involves comparing the Company's previously reported fair values for each fund against NAVs per audited financial statements (for year-end values) and final NAVs from fund managers and fund administrators (for interim values).
The fair values of multi-strategy funds, direct lending funds, private equity funds, real estate funds and private company investment funds, are measured using the NAV practical expedient, therefore the fair values of these funds have not been categorized within the fair value hierarchy.
161





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

6.    FAIR VALUE MEASUREMENTS (CONTINUED)
Financial Instruments Disclosed, But Not Carried, at Fair Value
The fair value of financial instruments accounting guidance also applies to financial instruments disclosed, but not carried, at fair value, except for certain financial instruments, including insurance contracts.
At December 31, 2023, the carrying values of cash and cash equivalents including restricted amounts, accrued investment income, receivable for investments sold, certain other assets, payable for investments purchased and certain other liabilities approximated fair values due to their short maturities. As these financial instruments are not actively traded, their fair values are classified as Level 2.
At December 31, 2023, the Company's fixed maturities, held to maturity, were recorded at amortized cost with a carrying value of $686 million (2022: $698 million) and a fair value of $676 million (2022: $675 million). The fair values of these securities are determined using a model which uses prepayment speeds and spreads sourced primarily from the new issue market. As the significant inputs used to price these securities are observable market inputs, their fair values are classified as Level 2.
At December 31, 2023, the carrying value of mortgage loans, held for investment, approximated fair value. The fair values of mortgage loans are primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk or are determined from pricing for similar loans. As mortgage loans are not actively traded, their fair values are classified as Level 3.
At December 31, 2023, the Company's debt was recorded at amortized cost with a carrying value of $1,314 million (2022: $1,312 million) and a fair value of $1,198 million (2022: $1,160 million). The fair value of the Company's debt is based on prices obtained from a third-party pricing service and is determined using the spread above the risk-free yield curve. These spreads are generally obtained from the new issue market, secondary trading and broker-dealer quotes. As the yields for the risk-free yield curve and the spreads are observable market inputs, the fair value of this debt is classified as Level 2.
At December 31, 2023, Federal Home Loan Bank advances were recorded at amortized cost with a carrying value of $86 million (2022: $81 million) and a fair value of $86 million (2022: $81 million). As these advances are not actively traded, their fair values are classified as Level 2.










162





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

7.    DERIVATIVE INSTRUMENTS
The following table provides the balance sheet classifications of derivatives recorded at fair value:
  December 31, 2023December 31, 2022
  Derivative
notional
amount
Derivative asset
fair
value(1)
Derivative liability
fair
value(1)
Derivative
notional
amount
Derivative asset
fair
value(1)
Derivative liability
fair
value(1)
Relating to investment portfolio:
Foreign exchange forward contracts$49,307 $66 $274 $54,076 $81 $559 
Relating to underwriting portfolio:
Foreign exchange forward contracts1,347,559 4,358 9,891 1,441,273 37,601 144 
Total derivatives$4,424 $10,165 $37,682 $703 
(1)Derivative assets and derivative liabilities are classified within other assets and other liabilities in the consolidated balance sheets.
The notional amounts of derivative contracts represent the basis on which amounts paid or received are calculated and are presented in the above table to quantify the volume of the Company's derivative activities. Notional amounts are not reflective of credit risk.
None of the Company's derivative instruments are designated as hedges.
Offsetting Assets and Liabilities

The Company's derivative instruments are generally traded under International Swaps and Derivatives Association master netting agreements which establish terms that apply to all transactions. In the event of a bankruptcy or other stipulated event, master netting agreements provide that individual positions be replaced with a new amount, usually referred to as the termination amount, determined by taking into account market prices and converting into a single currency. Effectively, this contractual close-out netting reduces credit exposure from gross to net exposure.

The following table provides a reconciliation of gross derivative assets and liabilities to the net amounts presented in the consolidated balance sheets, with the difference being attributable to the impact of master netting agreements:
December 31, 2023December 31, 2022
Gross amountsGross amounts offset
Net
amounts(1)
Gross amountsGross amounts offset
Net
amounts(1)
Derivative assets$8,708 $(4,284)$4,424 $41,762 $(4,080)$37,682 
Derivative liabilities$14,449 $(4,284)$10,165 $4,783 $(4,080)$703 
(1)Net asset and liability derivatives are classified within other assets and other liabilities in the consolidated balance sheets.

Refer to Note 5 'Investments' for information on reverse repurchase agreements.

a)     Relating to Investment Portfolio
Foreign Currency Risk
The Company's investment portfolio is exposed to foreign currency risk. Therefore, the fair values of its investments are partially influenced by changes in foreign exchange rates. The Company may enter into foreign exchange forward contracts to manage the effect of this foreign currency risk. These foreign currency hedging activities are not designated as specific hedges for financial reporting purposes.
163





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

7.    DERIVATIVE INSTRUMENTS (CONTINUED)
b)     Relating to Underwriting Portfolio
Foreign Currency Risk
The Company's insurance and reinsurance subsidiaries and branches operate in various countries. Some of its business is written in currencies other than the U.S. dollar, therefore the underwriting portfolio is exposed to significant foreign currency risk. The Company manages foreign currency risk by seeking to match its foreign-denominated net liabilities under insurance and reinsurance contracts with cash and investments that are denominated in the same currencies. The Company uses derivative instruments, specifically, forward contracts to economically hedge foreign currency exposures.
Other Underwriting-related Risks

The Company enters into insurance and reinsurance contracts that are accounted for as derivatives. These insurance or reinsurance contracts provide indemnification to an insured or cedant as a result of a change in a variable as opposed to an identifiable insurable event. The Company considers these contracts to be part of its underwriting operations.

The following table provides the total unrealized and realized gains (losses) recognized in net income (loss) for derivatives not designated as hedges:
  Consolidated statement of operations line item that includes gain (loss) recognized
in net income (loss)
Amount of gain (loss) recognized in
net income (loss)
  202320222021
Relating to investment portfolio:
Foreign exchange forward contractsNet investment gains (losses)$(1,456)$7,656 $4,346 
Relating to underwriting portfolio:
Foreign exchange forward contractsForeign exchange (losses) gains8,121 (31,609)(50,738)
Other underwriting-related contractsOther insurance related income (loss) 3,542 2,742 
Total$6,665 $(20,411)$(43,650)
 






















164





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES

Reserving Methodology
Sources of Information
The Company's loss reserving process begins with the collection and analysis of paid and incurred claim data for each of the Company's segments. The segment data is disaggregated by line of business and further disaggregated by underwriting year and accident year. Underwriting year or accident year information is used to analyze the Company's business and to estimate reserves for losses and loss expenses. Lines of business are reviewed to ensure that the underlying contracts have homogeneous loss development characteristics, while remaining large enough to make the estimation of trends credible. The Company's lines of business are reviewed on a regular basis and adjusted over time as the Company's business evolves. The paid and incurred claim data serves as a key input to many of the methods employed by the Company's actuaries.
Actuarial Analysis
Multiple actuarial methods are available to estimate ultimate losses. Each method has its own assumptions and its own advantages and disadvantages, with no single estimation method being better than the others in all situations and no one set of assumption variables being meaningful for all lines of business. The relative strengths and weaknesses of the particular estimation methods when applied to a particular group of claims can also change over time.
The following is a brief description of the reserve estimation methods commonly employed by the Company's actuaries including a discussion of their particular strengths and weaknesses: 
Expected Loss Ratio Method ("ELR Method"): This method estimates ultimate losses for an accident year or underwriting year by applying an expected loss ratio ("ELR") to the earned or written premium for that year. Generally, expected loss ratios are based on one or more of (a) an analysis of historical loss experience to date, (b) pricing information and (c) industry data, adjusted as appropriate, to reflect changes in rates, loss and exposure trends, and terms and conditions. This method is insensitive to actual incurred losses for the accident year or underwriting year in question and is, therefore, often useful in the early stages of development when very few losses have been incurred. Conversely, the lack of sensitivity to incurred/paid losses for the accident year or underwriting year in question means that this method is usually inappropriate in later stages of an accident year or underwriting year’s development.
Loss Development Method (also referred to as the "Chain Ladder Method" or "Link Ratio Method"): This method assumes that the losses incurred/paid for each accident year or underwriting year at a particular development stage follow a relatively similar pattern. It assumes that on average, every accident year or underwriting year will display the same percentage of ultimate losses incurred/paid at the same point in time after the inception of that year. The percentages incurred/paid are established for each development stage (e.g., 12 months, 24 months, etc.) after examining averages from historical loss development data and/or, in limited instances, external industry benchmark information. Ultimate losses are then estimated by multiplying the actual incurred/paid losses by the reciprocal of the established incurred/paid percentage. The strengths of this method are that it reacts to loss emergence/payments and that it makes full use of historical claim emergence/payment experience. However, this method has weaknesses when the underlying assumption of stable loss development/payment patterns is not valid. This could be the consequence of changes in business mix, claim inflation trends or claim reporting practices and/or the presence of large claims, among other things. Furthermore, this method tends to produce volatile estimates of ultimate losses where there is volatility in the underlying incurred/paid patterns. In particular, where the expected percentage of incurred/paid losses is low, small deviations between actual and expected claims can lead to very volatile estimates of ultimate losses. As a result, this method is often unsuitable at early development stages for an accident year or underwriting year.
Bornhuetter-Ferguson Method ("BF Method"): This method can be seen as a combination of the ELR and Loss Development Methods, under which the Loss Development Method is given progressively more weight as an accident year or underwriting year matures. The main advantage of the BF Method is that it provides a more stable estimate of ultimate losses than the Loss Development Method at earlier stages of development, while remaining more responsive to emerging loss development than the ELR Method. In addition, the BF Method allows for the incorporation of external
165





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

market information through the use of expected loss ratios, whereas the Loss Development Method does not incorporate such information.
As part of the loss reserving process, the Company's actuaries employ the estimation method(s) that they believe will produce the most reliable estimate of ultimate losses, at that particular evaluation date, for each line of business and accident year or underwriting year combination. Often, this is a blend (i.e., weighted average) of the results of two or more appropriate actuarial methods.
These ultimate loss estimates are generally utilized to evaluate the adequacy of ultimate loss estimates for previous accident or underwriting years, established in the prior reporting period. For the initial estimate of the current accident or underwriting year, the available claim data is typically insufficient to produce a reliable estimate of ultimate losses. As a result, initial estimates for an accident or underwriting year are generally based on the ELR Method for longer tailed lines and a BF Method for shorter tailed lines.
The initial ELR for each line of business is established by the Company's actuaries at the start of the year as part of the planning process, taking into consideration prior accident years’ or underwriting years' experience and industry benchmarks, adjusted after considering factors such as loss and exposure trends, rate differences, changes in contract terms and conditions, business mix changes and other known differences between the current and prior accident or underwriting years. The initial expected loss ratios for a given accident or underwriting year may be modified over time if the underlying assumptions, such as loss development or premium rate changes, differ from the original assumptions.
Key Actuarial Assumptions
The use of the above actuarial methods requires the Company to make certain explicit assumptions, the most significant of which are expected loss ratios and loss development patterns and the Company relies on historical loss experience in establishing these assumptions. In establishing expected loss ratios for the insurance segment, consideration is given to a number of other factors, including exposure trends, rate adequacy on new and renewal business, ceded reinsurance costs, changes in claims emergence and the Company's underwriters’ view of terms and conditions in the market environment. For the reinsurance segment, expected loss ratios are based on a contract-by-contract review, which considers information provided by clients together with estimates provided by the Company's underwriters and actuaries about the impact of changes in pricing, terms and conditions and coverage. Market experience for some lines of business as compiled and analyzed by an independent actuarial firm is also considered, as appropriate.
Reserving for Catastrophic Events

The Company cannot estimate losses from widespread catastrophic events, such as hurricanes and earthquakes, using the traditional actuarial methods described above. The magnitude and complexity of losses associated with certain of these events inherently increase the level of uncertainty and, therefore, the level of management judgment involved in arriving at estimated net reserves for losses and loss expenses. As a result, actual losses for these events may ultimately differ materially from current estimates.
Net reserves for losses and loss expenses related to catastrophes represent the Company's best estimate of losses and loss expenses that have been incurred at December 31, 2023. The determination of these net reserves for losses and loss expenses is estimated by management after a catastrophe occurs by completing an in-depth analysis of individual contracts which may potentially have been impacted by the catastrophic event. This in-depth analysis may rely on several sources of information including:
estimates of the size of insured industry losses from the catastrophic event and the Company's corresponding market share;
a review of the Company's portfolio of contracts to identify those contracts which may be exposed to the catastrophic event;
166





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

a review of modeled loss estimates based on information previously reported by customers and brokers, including exposure data obtained during the underwriting process;
a review of the coverage provided by the Company's ceded reinsurance;
discussions of the impact of the event with customers and brokers; and
catastrophe bulletins published by various independent statistical reporting agencies.
A blend of these information sources is generally used to arrive at aggregate estimates of the ultimate losses arising from these catastrophic events.
While the Company believes its estimate of net reserves for losses and loss expenses is adequate for losses and loss expenses that have been incurred at December 31, 2023 based on current facts and circumstances, the Company monitors changes in paid and incurred losses in relation to each catastrophe in subsequent reporting periods and adjustments are made to estimates of ultimate losses for each event if there are developments that are different from previous expectations. Adjustments are recorded in the period in which they are identified. Actual losses for these events may ultimately differ materially from the Company's current estimates.
Selection of Reported Reserves – Management’s Best Estimate
The Company's loss reserving process involves the collaboration of its underwriting, claims, actuarial, ceded reinsurance and finance departments, including multiple committee meetings and culminates with the approval of a single point best estimate by the Company's Group Reserving Committee, which comprises senior management. In selecting this best estimate, management considers actuarial estimates and applies informed judgment regarding qualitative factors that may not be fully captured in these actuarial estimates. Such factors include, but are not limited to, the timing of the emergence of claims, volume and complexity of claims, social and judicial trends, potential severity of individual claims and the extent of Company historical loss data versus industry information. While these qualitative factors are considered in arriving at the point estimate, no specific provisions for qualitative factors are established.

Reserve for Losses and Loss Expenses

Reserve for losses and loss expenses comprise the following:
At December 31,20232022
Reserve for reported losses and loss expenses$5,559,261 $5,555,865 
Reserve for losses incurred but not reported10,874,757 9,612,998 
Reserve for losses and loss expenses$16,434,018 $15,168,863 
167





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reserve Roll-forward
The following table presents a reconciliation of the Company's beginning and ending gross reserves for losses and loss expenses and net reserves for unpaid losses and loss expenses:
Year ended December 31,202320222021
Gross reserve for losses and loss expenses, beginning of year$15,168,863 $14,653,094 $13,926,766 
Less reinsurance recoverable on unpaid losses and loss expenses, beginning of year(5,831,172)(5,017,611)(4,496,641)
Net reserve for unpaid losses and loss expenses, beginning of year9,337,691 9,635,483 9,430,125 
Net incurred losses and loss expenses related to:
Current year2,981,220 3,267,943 3,041,193 
Prior years411,882 (25,533)(32,410)
 3,393,102 3,242,410 3,008,783 
Net paid losses and loss expenses related to:
Current year(488,016)(457,857)(490,011)
Prior years(2,185,588)(2,397,213)(2,274,240)
 (2,673,604)(2,855,070)(2,764,251)
Foreign exchange and other53,746 (685,132)(39,174)
Net reserve for unpaid losses and loss expenses, end of year10,110,935 9,337,691 9,635,483 
Reinsurance recoverable on unpaid losses and loss expenses, end of year6,323,083 5,831,172 5,017,611 
Gross reserve for losses and loss expenses, end of year$16,434,018 $15,168,863 $14,653,094 
The Company writes business with loss experience generally characterized as low frequency and high severity in nature, which can result in volatility in its financial results. During 2023, 2022 and 2021, the Company recognized catastrophe and weather-related losses, net of reinstatement premiums, of $138 million, $403 million and $443 million.
On September 22, 2023, the Company entered into a retrocession reinsurance agreement with a third-party reinsurer which was deemed to have met the established criteria for retroactive reinsurance accounting. At December 31, 2023, foreign exchange and other included an increase in reinsurance recoverable on unpaid losses of $74 million related to this transaction (refer to Note 5(f) 'Equity Method Investments', Note 6 'Fair Value Measurements' and Note 18 'Related Party Transactions').
On December 9, 2022, the Company entered into loss portfolio transfer reinsurance agreements with a third-party reinsurer which were deemed to have met the established criteria for retroactive reinsurance accounting. At December 31, 2022, foreign exchange and other included an increase in reinsurance recoverable on unpaid losses of $422 million related to this transaction.
At December 31, 2021, foreign exchange and other included a decrease in reinsurance recoverable on unpaid losses of $49 million related to the Reinsurance to Close of the 2018 year of account of Syndicate 2007.

168





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Estimates for Catastrophe Events
At December 31, 2023, net reserves for losses and loss expenses included estimated amounts for numerous catastrophe events. The magnitude and complexity of losses arising from certain of these events inherently increase the level of uncertainty and, therefore, the level of management judgment involved in arriving at estimated net reserves for losses and loss expenses. These events include Cyclone Gabrielle in 2023, Hurricane Ian, Winter Storm Elliot, June European Convective Storms, the Russia-Ukraine war and COVID-19 in 2022, Hurricane Ida, U.S. Winter Storms Uri and Viola and July European Floods in 2021. As a result, actual losses for these events may ultimately differ materially from current estimates.
Prior Year Reserve Development
The Company's net favorable (adverse) prior year reserve development arises from changes to estimates for losses and loss expenses related to loss events that occurred in previous calendar years. The following table presents net prior year reserve development by segment:
Favorable (Adverse)
Insurance ReinsuranceTotal
Year ended December 31, 2023$(176,353)$(235,529)$(411,882)
Year ended December 31, 2022$16,350 $9,183 $25,533 
Year ended December 31, 2021$18,360 $14,049 $32,410 
The following sections provide further details on net prior year reserve development by segment, line of business and accident year.
Insurance Segment:
Favorable (Adverse)
Years ended December 31,202320222021
Property $16,195 $52,512 $71,032 
Accident and health(10,236)(12,856)15,844 
Marine and aviation26,977 27,927 42,535 
Cyber35,579 8,416 (7,329)
Professional lines(41,243)(29,093)(71,258)
Credit and political risk31,691 24,361 10,363 
Liability(235,316)(54,917)(42,827)
Total$(176,353)$16,350 $18,360 

In 2023, we recognized $176 million of net adverse prior year reserve development, the principal components of which were:

$235 million of net adverse prior year reserve development on liability business primarily due to reserve strengthening within the U.S. primary casualty book of business mainly related to the 2022 and older accident years and U.S. programs books of business mainly related to the 2017 through 2022 accident years. The reserve strengthening was attributable to updated trend assumptions, emerging development patterns and new industry data reflecting the impact of current economic and social inflation trends in the U.S. casualty market.

169





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

$41 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within the U.S. financial institutions, U.S. commercial management solutions, U.S. design professional and environmental, and international books of business related to 2019 and older accident years, and increases in loss estimates attributable to specific large claims within the international book of business related to 2012 and older accident years.

$10 million of net adverse prior year development on accident and health business primarily due to reserve strengthening within the international book of business mainly related to the 2021 and 2022 accident years.

$36 million of net favorable prior year reserve development on cyber business primarily due to better than expected loss emergence related to most accident years, partially offset by increases in loss estimates attributable to specific large claims related to the 2020 accident year.

$32 million of net favorable prior year reserve development on credit and political risk business primarily due to a decrease in the loss estimate attributable to a specific large claim related to the 2020 accident year and better than expected loss emergence related to several accident years.

$27 million of net favorable prior year reserve development on marine and aviation business primarily due to better than expected loss emergence attributable to the marine cargo and aviation books of business related to several accident years and better than expected loss emergence attributable to several catastrophe events.

$16 million of net favorable prior year reserve development on property business primarily due to better than expected loss emergence mainly related to the 2017 through 2019 accident years and better than expected loss emergence attributable to 2022 catastrophe events, partially offset by increases in loss estimates attributable to two specific large claims within the E&S book of business related to the 2016 and 2022 accident years.

In 2022, we recognized $16 million of net favorable prior year reserve development, the principal components of which were:

$53 million of net favorable prior year reserve development on property business primarily due to better than expected loss emergence attributable to 2018 and 2020 catastrophe events and decreases in loss estimates attributable to specific large claims related to 2012 and older accident years.

$28 million of net favorable prior year reserve development on marine and aviation business primarily due to better than expected loss emergence attributable to the marine cargo and specie, and marine offshore energy books of business mainly related to the 2018, 2019 and 2021 accident years, and better than expected loss emergence attributable to aviation business mainly related to the 2021 accident year.

$24 million of net favorable prior year reserve development on credit and political risk business primarily due to better than expected loss emergence mainly related to the 2017 through 2021 accident years.

$8 million of net favorable prior year reserve development on cyber business primarily due to better than expected loss emergence mainly related to 2020 and older accident years, partially offset by reserve strengthening related to the 2021 accident year.

$55 million of net adverse prior year reserve development on liability business primarily due to reserve strengthening within the U.S. programs book of business mainly related to the 2016 through 2021 accident years, and the U.S. primary casualty book of business mainly related to the 2015 through 2018 and the 2021 accident years.

$29 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within the U.S. commercial management solutions book of business mainly related to the 2015, 2018 and 2019 accident years.
170





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

$13 million of net adverse prior year development on accident and health business primarily due to reserve strengthening mainly related to the 2019 through 2021 accident years.

In 2021, we recognized $18 million of net favorable prior year reserve development, the principal components of which were:

$71 million of net favorable prior year reserve development on property business primarily due to decreases in loss estimates attributable to specific large claims related to the 2011 and 2012 accident years, and better than expected loss emergence attributable to 2018 to 2020 catastrophe events, and the global property book of business related to the 2017 through 2019 accident years.
 
$43 million of net favorable prior year reserve development on marine and aviation business primarily due to better than expected loss emergence attributable to marine cargo, marine offshore energy and marine specie books of business mainly related to the 2017, 2018 and 2020 accident years, decreases in loss estimates attributable to specific large marine claims related to the 2012 accident year, and better than expected loss emergence attributable to aviation business mainly related to the 2020 accident year.

$16 million of net favorable prior year reserve development on accident and health business primarily due to better than expected loss emergence related to the 2019 and 2020 accident years.

$10 million of net favorable prior year reserve development on credit and political risk business primarily due to better than expected loss emergence mainly related to the 2018 and 2019 accident years.

$71 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within run-off lines of business mainly related to the 2016 through 2019 accident years and the U.S. commercial management solutions book of business mainly related to the 2017 and 2019 accident years.

$43 million of net adverse prior year reserve development on liability business primarily due to reserve strengthening within the program book of business mainly related to the 2018 and 2019 accident years.

$7 million of net adverse prior year reserve development on cyber business primarily due to reserve strengthening within the global cyber and technology book of business mainly related to the 2019 accident year.


171





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance Segment:
Favorable (Adverse)
Years ended December 31,202320222021
Accident and health$29,947 $14,199 $5,861 
Agriculture10,781 11,703 423 
Marine and aviation12,595 2,597 (10,767)
Professional lines(92,181)(54,820)(23,718)
Credit and surety8,306 43,567 3,436 
Motor(9,653)18,161 43,968 
Liability(262,114)(58,148)(17,919)
Run-off lines
Catastrophe46,297 (504)(36)
Property15,225 42,523 17,651 
Engineering5,268 (10,095)(4,850)
Total run-off lines66,790 31,924 12,765 
Total$(235,529)$9,183 $14,049 
In 2023, we recognized $236 million of net adverse prior year reserve development, the principal components of which were:
$262 million of net adverse prior year reserve development on liability business primarily due to reserve strengthening within the U.S. casualty and U.S. multiline/regional books of business related to all accident years. The reserve strengthening was attributable to updated trend assumptions, emerging development patterns and new industry data reflecting the impact of current economic and social inflation trends in the U.S. casualty market.
$92 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within the U.S. proportional book of business mainly related to the accident years 2019 and older accident years, partially offset by better than expected loss emergence mainly related to the 2021 and 2022 accident years.

$10 million of net adverse prior year reserve development on motor business primarily due to reserve strengthening to reflect increased estimates of future loss trend due to inflation and reserve strengthening attributable to the proportional book of business mainly related to the 2018 through 2022 accident years.
$30 million of net favorable prior year reserve development on accident and health business primarily due to better than expected loss emergence mainly related to the 2018 through 2021 accident years.

$13 million of net favorable prior year reserve development on marine and aviation business primarily due to better than expected loss emergence mainly related to the 2021 and 2022 accident years.

$11 million of net favorable prior year reserve development on agriculture business primarily due to better than expected loss emergence mainly related to the 2022 accident year.

$8 million of net favorable prior year reserve development on credit and surety business primarily due to better than expected loss emergence attributable to the international credit and mortgage books of business mainly related to the 2018 and 2019 accident years and the 2021 and 2022 accident years, partially offset by increases in loss estimates attributable to specific large claims related to the 2020 accident year.



172





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Run-off lines

$46 million of net favorable prior year reserve development on catastrophe business primarily due to better than expected loss emergence mainly attributable to 2022 events.

$15 million of net favorable prior year reserve development on property business primarily due to better than expected loss emergence mainly attributable to 2022 catastrophe events.

$5 million of net favorable prior year reserve development on engineering business primarily due to better than expected loss emergence mainly related to older accident years.

In 2022, we recognized $9 million of net favorable prior year reserve development, the principal components of which were:

$44 million of net favorable prior year reserve development on credit and surety business primarily due to better than expected loss emergence mainly related to the 2015 through 2021 accident years, most notably within the mortgage book of business related to the 2020 and 2021 accident years.

$18 million of net favorable prior year reserve development on motor business primarily due to better than expected loss emergence mainly related to the 2017 through 2020 accident years.

$14 million of net favorable prior year reserve development on accident and health business primarily due to better than expected loss emergence mainly related to the 2019 through 2021 accident years.

$12 million of net favorable prior year reserve development on agriculture business primarily due to better than expected loss emergence mainly related to the 2019 and 2021 accident years.

$58 million of net adverse prior year reserve development on liability business primarily due to increases in loss estimates attributable to specific large claims related to the 2018 and 2021 accident years and reserve strengthening within the U.S. non-proportional books of business related to the 2016 through 2019 accident years.

$55 million of net adverse prior year reserve development on professional lines business primarily due to increases in loss estimates attributable to one cedant related to several accident years, and reserve strengthening within the U.S. public D&O proportional books of business related to 2017 and older accident years.

Run-off lines

$43 million of net favorable prior year reserve development on property business primarily due to better than expected loss emergence attributable to 2017 through 2021 catastrophe events and better than expected attritional loss emergence attributable to the 2021 accident year.

$10 million of net adverse prior year reserve development on engineering business primarily due to increases in loss estimates attributable to specific large claims mainly related to the 2011, 2018 and 2019 accident years.

In 2021, we recognized $14 million of net favorable prior year reserve development, the principal components of which were:
$44 million of net favorable prior year reserve development on motor business primarily due to proportional and non-proportional treaty business mainly related to 2016 and older accident years.

$6 million of net favorable prior year development on accident and health business primarily due to better than expected loss emergence mainly related to the 2019 and 2020 accident years.

173





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

$24 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within the U.S. and European books of business related to the 2015 through 2018 accident years and increases in the loss estimates attributable to specific large claims related to the 2015 to 2017 accident years.

$18 million of net adverse prior year reserve development on liability business primarily due to increases in loss estimates attributable to specific large claims related to the 2017 and 2018 accident years and reserve strengthening within the commercial auto liability and U.S. multiline/regional books of business related to the 2018 accident year.

$11 million of net adverse prior year development on marine and aviation business primarily due to an increase in the loss estimate attributable to specific large claim mainly related to 2018 accident year.

Run-off lines

$18 million of net favorable prior year reserve development on property business primarily due to decreases in loss estimates attributable to specific large claims related to the 2009, and 2017 through 2019 accident years, and better than expected loss emergence attributable to 2017 through 2019 catastrophe events, partially offset by reserve strengthening attributable to 2020 catastrophe events.

$5 million of net adverse prior year development on engineering business primarily due to reserve strengthening mainly related to the 2016, 2017 and 2019 accident years, partially offset by decreases in loss estimates attributable to specific large claims related to the 2018 accident year.

Net Incurred and Paid Claims Development Tables by Accident Year
The following tables present net incurred and paid claims development by accident year, total incurred-but-not-reported liabilities plus expected development on reported claims, cumulative reported claims frequency and average annual percentage payout of incurred claims by age for each line of business. The loss development tables are presented on an accident year basis for each line of business in the insurance and reinsurance segments. The Company does not discount reserves for losses and loss expenses.
Non-U.S. dollar denominated loss data is converted to U.S. dollar at the rates of exchange in effect at the balance sheet date for material underlying currencies. Fluctuations in foreign currency exchange rates may cause material shifts in loss development. Reserves for losses and loss expenses disclosed in the consolidated balance sheets are also remeasured using the rates of exchange in effect at the balance sheet date.
There are many considerations in establishing net reserves for losses and loss expenses. An attempt to evaluate net reserves for losses and loss expenses using solely the paid losses and claim counts presented in these tables could be misleading. When projecting net reserves for losses and loss expenses, the Company relies on several inputs in addition to the information presented in this disclosure including case incurred loss projections, changes in mix of business, external trends, and additional qualitative information. The Company cautions against mechanical application of standard actuarial methodologies to project ultimate losses using data presented in this disclosure.
Insurance Segment
The reporting of cumulative claims frequency for the lines of business within the insurance segment has been measured by counting the number of unique claim references including claim references assigned to nil and nominal case reserves. Claim references are grouped by claimant by loss event for each line of business. For certain insurance facilities and business produced by managing general agents where underlying data is reported to the Company in an aggregated format, the information necessary to provide cumulative claims frequency is not available therefore reporting of claims frequency is deemed to be impracticable.
174





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance Property
The property line of business provides physical loss or damage, business interruption and machinery breakdown cover for virtually all types of property, including commercial buildings, residential premises, construction projects, property in transit, onshore renewable energy installations, and physical damage and business interruption following an act of terrorism. This line of business includes primary and excess risks, some of which are catastrophe-exposed.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of catastrophe events.
Insurance property
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$289,270 $287,431 $277,183 $262,701 $262,173 $259,792 $255,887 $253,279 $253,203 $253,414 $775 4,174
2015207,711 200,398 192,736 190,310 186,952 189,066 179,075 181,323 181,928 85 4,194
2016263,762 287,858 279,532 265,152 259,319 260,370 259,786 264,976 1,951 6,668
2017794,042 700,638 688,755 679,243 675,085 675,409 669,951 6,375 10,096
2018608,422 639,465 618,888 611,057 609,977 600,596 12,492 9,659
2019374,678 364,350 359,092 369,962 353,671 4,503 9,561
2020654,495 635,344 584,921 593,780 24,336 12,417
2021378,554 375,607 372,223 9,213 7,730
2022414,743 419,139 49,138 7,410
2023399,165 188,657 5,732
Total$4,108,843 
175





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance property
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$100,736 $201,931 $244,372 $250,321 $254,051 $254,858 $251,701 $252,772 $252,787 $252,526 
201567,621 145,027 166,211 179,727 179,409 186,010 177,227 182,038 181,716 
201682,583 206,979 243,050 250,662 250,822 256,476 253,891 260,115 
2017190,861 513,044 622,040 650,218 645,841 635,493 647,610 
2018221,345 468,431 563,191 573,034 590,739 577,000 
2019148,181 257,515 306,415 343,463 332,848 
2020182,611 425,893 481,646 531,448 
2021134,273 286,801 323,656 
202297,622 262,381 
202390,855 
Total3,460,155 
All outstanding liabilities before 2014, net of reinsurance14,248 
Liabilities for claims and claim adjustment expenses, net of reinsurance$662,936 
Insurance property
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
32.9%41.2%13.4%5.3%0.1%0.4%(1.3%)1.8%(0.1%)(0.1%)
Insurance Accident and Health
The accident and health line of business includes personal accident, travel insurance and specialty health products for employer and affinity groups, and pet insurance.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of catastrophe events. An increase in limited benefits medical business written in 2017 resulted in a significant increase in reported claims observed in that year and subsequent years.
176





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance accident and health
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$71,520 $67,380 $66,874 $65,347 $64,973 $65,710 $64,938 $64,070 $62,703 $64,392 $1,621 58,081
201570,622 69,494 66,013 64,219 64,771 64,441 63,772 64,433 61,759 1,049 44,138
201685,244 85,892 86,338 87,470 87,154 88,180 87,972 87,399 2,179 87,001
2017113,921 121,146 118,949 117,050 117,131 117,012 118,125 36 688,000
2018111,119 115,977 115,077 113,118 114,134 114,844 291 745,012
201973,926 75,093 65,623 69,203 68,344 121 675,634
202069,679 63,963 67,525 64,297 1,275 718,512
202169,543 72,044 78,478 3,605 433,643
202298,796 100,629 9,807 380,675
2023172,795 67,393 222,537
Total$931,062 
Insurance accident and health
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$31,662 $56,693 $60,682 $61,855 $62,513 $62,844 $62,716 $61,588 $61,996 $62,660 
201531,518 56,988 60,168 61,051 62,065 61,926 62,584 62,677 60,575 
201641,583 79,237 83,077 83,929 85,010 85,413 86,123 85,272 
201763,285 109,312 114,555 115,981 117,100 116,280 118,138 
201861,849 106,748 109,194 112,884 113,787 114,595 
201945,133 61,526 63,046 68,088 68,030 
202036,317 52,290 60,804 59,240 
202139,185 61,593 69,661 
202246,568 82,209 
202395,951 
Total816,331 
All outstanding liabilities before 2014, net of reinsurance(238)
Liabilities for claims and claim adjustment expenses, net of reinsurance$114,493 
177





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance accident and health
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
53.0%34.9%6.0%1.9%0.9%0.2%0.8%(0.9%)(1.4%)1.0%
Insurance Marine and Aviation
The marine line of business provides cover for a range of exposures including offshore energy, renewable offshore energy, cargo, liability including kidnap and ransom, fine art, specie, and hull war. Offshore energy coverage includes physical damage, business interruption, operator's extra expense and liability coverage for all aspects of offshore upstream energy from exploration and construction through the operation and distribution phases.

The complex nature of claims arising under marine policies tends to result in reporting and payment patterns that are longer than those of the property line of business with marine liability exhibiting the longest reporting and payment patterns as claims involve passengers and third parties. Exposure to natural perils such as windstorm and earthquake can result in volatility.
The aviation line of business provides cover for hull and liability, and specific war cover primarily for passenger airlines but also for cargo operations, general aviation operations, airports, aviation authorities, security firms and product manufacturers.
The claims reporting pattern varies by insurance coverage provided. Losses arising from war or terrorism and damage to hulls of aircraft are generally reported quickly compared with liability claims which involve passengers and third parties and generally exhibit longer reporting and payment patterns.
Insurance marine and aviation
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$80,064 $66,878 $71,051 $64,768 $65,913 $63,693 $55,526 $53,013 $52,286 $52,308 $830 3,566
2015187,067 165,908 161,465 153,737 140,673 146,174 145,447 145,394 143,900 111 4,312
2016115,520 111,878 109,478 101,928 101,351 100,488 101,388 102,345 2,038 4,836
2017262,628 229,801 227,355 225,397 217,443 217,232 215,683 6,867 8,577
2018238,117 255,652 241,715 234,901 228,369 229,903 14,910 8,742
2019215,911 210,536 213,480 226,586 224,914 14,884 7,697
2020208,542 180,156 163,700 164,808 14,618 6,439
2021240,182 221,864 204,483 34,829 6,754
2022265,181 257,637 92,387 7,159
2023298,845 210,136 5,172
Total$1,894,826 
178





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance marine and aviation
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$10,336 $22,874 $36,805 $39,439 $48,583 $52,793 $53,941 $48,435 $50,255 $50,383 
201529,498 69,563 125,369 130,290 133,087 135,881 142,268 142,437 142,432 
201622,886 50,976 83,039 90,273 92,239 94,184 97,274 97,951 
201735,415 106,527 140,126 172,205 180,904 184,824 196,724 
201847,525 123,434 159,948 173,667 185,455 197,961 
201954,028 103,253 145,927 171,372 178,967 
202044,655 84,391 106,403 119,063 
202126,924 69,687 108,772 
202230,101 101,228 
202336,613 
Total1,230,094 
All outstanding liabilities before 2014, net of reinsurance13,750 
Liabilities for claims and claim adjustment expenses, net of reinsurance$678,482 
Insurance marine and aviation
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
18.8%26.6%22.5%7.9%5.6%3.8%3.8%(3.2%)1.8%0.2%
Insurance Cyber
The cyber line of business provides cover for cyber, technology errors and omissions, media and miscellaneous professional liability. Cover is provided for a range of risks including data recovery and bricking, cyber-crime, liability and regulatory actions, business interruption, extortion, reputational harm, Payment Card Industry Data Security Standard and media liability.

Typically, this line of business takes longer to develop but specific first party coverages tend to develop more quickly than third party coverages.
179





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance cyber
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$70,557 $69,690 $69,955 $57,876 $47,342 $42,887 $39,516 $43,576 $39,832 $40,743 $604 1,159
201565,231 63,595 63,066 51,250 50,357 50,758 52,526 49,795 48,042 2,046 1,427
201658,741 56,565 58,261 40,266 37,322 29,929 27,873 25,258 1,072 1,667
201753,187 50,794 56,783 51,931 50,905 48,685 48,333 3,234 1,817
201833,429 31,966 33,962 31,111 26,732 24,495 4,574 2,152
201954,444 58,717 81,982 82,006 73,152 14,109 2,900
2020114,209 106,333 103,175 126,457 25,132 2,856
2021125,460 134,382 105,642 20,662 2,432
2022129,361 120,494 71,510 1,730
2023128,252 102,582 1,503
Total$740,868 
Insurance cyber
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$3,136 $12,162 $23,330 $29,962 $31,260 $33,819 $33,732 $35,440 $36,070 $38,043 
20155,572 15,333 25,544 28,501 30,865 39,470 42,515 43,635 45,432 
20161,348 4,637 14,141 18,502 21,333 23,136 23,207 24,054 
20179,354 19,165 28,331 35,897 38,031 40,557 39,995 
20182,171 7,327 9,874 14,810 19,267 18,334 
20192,787 20,950 32,608 60,961 57,318 
202017,732 50,344 63,813 82,625 
202124,108 65,577 75,369 
20227,830 37,861 
20239,237 
Total428,268 
All outstanding liabilities before 2014, net of reinsurance9,471 
Liabilities for claims and claim adjustment expenses, net of reinsurance$322,071 
180





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance cyber
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
10.7%23.5%19.0%18.5%6.2%6.5%1.3%3.3%2.6%4.8%
Insurance Professional Lines
The professional lines line of business provides directors’ and officers’ liability, errors and omissions liability, employment practices liability, fiduciary liability, crime, professional indemnity, medical malpractice and other financial insurance related covers for public and private commercial enterprises, financial institutions, not-for-profit organizations and other professional service providers. This business is predominantly written on a claims-made basis.
Typically, this line of business is anticipated to exhibit longer reporting and payment patterns than most other insurance lines of business. For some professional lines in the insurance segment, the Company also relies on the evaluation of the open claim inventory in addition to the commonly employed actuarial methods when establishing reserves.
Insurance professional lines
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$338,378 $338,670 $348,064 $331,044 $321,027 $308,193 $305,201 $304,657 $301,289 $305,060 $35,601 8,881
2015309,864 310,926 317,455 304,062 291,176 274,091 272,909 283,894 282,238 20,475 9,341
2016288,595 293,399 297,852 316,592 329,270 339,513 340,465 356,814 32,954 10,590
2017339,231 343,055 376,569 376,993 394,154 392,002 396,732 53,138 12,605
2018325,926 342,931 392,819 423,162 449,212 468,504 76,008 15,333
2019347,810 363,998 378,899 412,150 460,120 83,773 14,606
2020322,386 321,530 302,097 293,935 130,739 9,318
2021378,660 369,587 326,128 198,067 8,127
2022461,196 447,359 371,912 8,041
2023441,477 414,023 7,251
Total$3,778,367 
181





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance professional lines
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$20,263 $57,536 $105,155 $160,677 $190,560 $206,982 $216,811 $238,969 $244,776 $253,033 
201514,353 51,709 111,149 139,574 171,000 200,892 213,465 225,062 249,916 
201614,428 66,048 131,831 172,360 210,701 235,136 276,175 290,732 
201711,515 51,823 109,107 167,645 198,859 269,668 291,943 
201818,446 74,859 143,248 204,941 265,501 336,329 
201925,061 76,711 133,453 206,462 289,475 
20208,729 44,076 97,847 125,713 
20219,781 38,605 83,605 
202210,983 46,224 
202312,183 
Total1,979,153 
All outstanding liabilities before 2014, net of reinsurance131,134 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,930,348 


Insurance professional lines
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
3.9%11.3%16.1%13.3%11.7%11.1%6.2%5.2%5.4%2.7%
Insurance Credit and Political Risk
The credit and political risk line of business provides credit and political risk insurance products for banks, commodity traders, corporations and multilateral and export credit agencies. Cover is provided for a range of risks including sovereign and corporate credit default, political violence, currency inconvertibility and non-transfer, expropriation, aircraft non-repossession and contract frustration due to political events.
The credit insurance coverage is primarily for lenders seeking to mitigate the risk of non-payment from their borrowers. In order to claim compensation under a credit insurance contract, the insured (most often a bank) cannot assign, without the Company's prior agreement, the insured contract (most often a loan) to any third party and is normally obliged to hold a material portion of insured asset on their books, unhedged and uninsured. Claims for this business tend to be characterized by their severity risk, as opposed to their frequency risk.
Given the nature of the business, under the notification provisions of credit insurance policies issued by the Company, it anticipates being advised of an insured event within a relatively short time period. Consequently, the Company generally estimates ultimate losses based on a contract-by-contract analysis which considers the contracts’ terms, the facts and circumstances of underlying loss events and qualitative input from claims managers. Despite notification, credit and political
182





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

risk claim reporting and payment patterns are anticipated to be volatile and can take longer to develop due to the complex nature of claims and the potential additional time that may be required to realize subrogation assets.

Insurance credit and political risk
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$38,825 $70,712 $67,109 $68,323 $69,589 $71,274 $70,748 $69,113 $69,677 $69,677 $ 6
201530,329 30,368 27,524 26,012 25,930 24,851 24,189 23,309 23,309  2
201645,006 45,079 42,589 43,160 26,946 25,965 24,885 24,885  2
201748,181 32,808 26,044 18,269 16,022 11,068 8,566 2,086 4
201842,976 33,747 32,738 24,845 21,182 24,356 5,584 2
201953,332 81,470 75,610 74,066 71,270 11,546 31
202061,928 70,428 62,235 50,987 19,594 43
202142,417 37,104 26,322 13,363 23
202245,444 44,450 37,463 24
202359,258 54,333 19
Total$403,080 
Insurance credit and political risk
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,924 $39,952 $61,108 $57,857 $57,857 $64,050 $70,224 $70,224 $69,677 $69,677 
2015 23,309 23,309 23,309 23,309 23,309 23,309 23,309 23,309 
2016 24,885 24,885 24,885 24,885 24,885 24,885 24,885 
2017403 4,035 9,251 11,710 10,925 10,394 8,666 
20185,370 13,488 15,517 11,851 19,963 23,841 
201916,026 46,456 53,750 56,956 55,067 
20209,825 90,299 58,492 53,786 
20212,769 (370)8,228 
20222,796 8,115 
20232,743 
Total278,317 
All outstanding liabilities before 2014, net of reinsurance592 
Liabilities for claims and claim adjustment expenses, net of reinsurance$125,355 
183





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance credit and political risk
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
9.3%59.0%10.0%0.6%3.6%3.7%(2.8%)%(0.4%)%
Insurance Liability
The liability line of business primarily targets primary and low to mid-level excess and umbrella commercial liability risks in the U.S. wholesale markets in addition to primary and excess of loss employers, public, and products liability business predominately in the U.K. Target industry sectors include construction, manufacturing, transportation and trucking and other services.
Typically, this line of business is anticipated to exhibit longer claim reporting and payment patterns than most other insurance lines of business and claims are often reported and ultimately paid or settled years, or even decades, after the related loss events occur.

Insurance liability
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$107,126 $124,289 $129,750 $130,666 $132,013 $131,469 $132,565 $132,043 $132,474 $131,210 $9,697 5,820
2015128,436 127,299 137,477 164,982 182,690 188,004 186,931 188,261 189,795 18,423 6,769
2016124,313 130,160 128,854 127,451 120,199 120,187 125,614 124,969 17,081 7,648
2017167,334 166,052 184,781 200,391 204,533 214,707 250,887 37,518 8,812
2018167,552 167,672 190,639 204,519 216,038 251,875 38,901 8,644
2019192,468 193,435 222,885 238,035 300,584 66,863 8,183
2020224,616 225,038 230,921 249,189 88,543 6,180
2021232,051 245,585 302,023 141,022 6,748
2022323,261 357,574 246,679 7,365
2023364,604 331,464 5,168
Total$2,522,710 
184





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Insurance liability
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,411 $18,633 $49,829 $71,589 $84,369 $93,569 $103,041 $106,205 $113,150 $116,384 
20155,438 22,353 39,581 92,598 120,136 140,809 150,640 159,004 162,656 
20166,315 23,260 36,356 56,403 66,290 79,519 95,787 102,773 
20175,463 29,432 58,988 115,568 143,440 168,615 190,475 
20189,374 34,860 72,219 119,152 158,622 188,910 
20197,833 39,846 83,692 139,077 192,435 
20208,148 25,174 75,907 118,306 
202113,397 51,859 103,892 
202213,212 53,507 
20239,855 
Total1,239,193 
All outstanding liabilities before 2014, net of reinsurance49,217 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,332,734 
Insurance liability
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
3.2%10.8%15.3%19.6%12.8%10.1%8.5%4.1%3.6%2.5%
Reinsurance Segment
The presentation of net incurred and paid claims development tables by accident year for the reinsurance segment is challenging due to the need to allocate loss information related to proportional treaties to the appropriate accident years. Information related to proportional treaty reinsurance contracts is generally submitted to the Company via quarterly bordereaux reporting by underwriting year, with a supplemental listing of large losses. Large losses can be allocated to the corresponding accident years accurately. The remaining losses can generally only be allocated to accident years based on estimated premiums earned and loss reporting patterns. To the extent management’s assumptions and allocation procedures differ from the actual loss development patterns, the actual loss development may differ materially from the net incurred and paid claims development presented in the tables below.
The reporting of cumulative claims frequency for the lines of business within the reinsurance segment is deemed to be impracticable as the information necessary to provide cumulative claims frequency for these lines of business is not available to the Company.
Reinsurance Accident and Health
The accident and health line of business includes personal accident, specialty health, accidental death, travel, life and disability reinsurance products which are offered on a proportional and catastrophic or per life excess of loss basis.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of catastrophe events.
185





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance accident and health
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$101,409 $102,403 $89,303 $86,833 $86,843 $86,846 $87,806 $88,095 $87,978 $87,664 $125 
201593,831 100,522 94,047 93,807 93,081 93,422 92,431 92,388 93,133 105 
2016170,687 191,299 188,454 190,067 189,538 190,574 190,534 190,662 16 
2017183,937 189,610 183,574 182,477 183,513 183,484 182,479 (16)
2018193,749 200,576 198,365 201,133 200,467 197,493 766 
2019217,477 212,307 207,794 205,403 199,419 1,328 
2020226,883 220,969 213,960 199,958 1,757 
2021232,091 227,326 222,718 9,765 
2022267,525 264,615 40,396 
2023243,174 91,280 
Total$1,881,315 
Reinsurance accident and health
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$36,571 $79,974 $85,931 $86,332 $86,534 $86,622 $87,302 $86,384 $86,771 $87,202 
201523,409 77,316 88,728 91,935 92,036 92,497 93,921 93,735 92,468 
201650,046 149,959 181,072 187,251 189,234 188,836 189,815 189,409 
201779,252 157,157 172,111 178,943 179,462 180,121 179,889 
201872,899 165,323 191,832 191,400 194,524 195,018 
201967,810 169,608 195,954 196,694 194,800 
202081,875 172,178 210,665 192,491 
202168,652 179,626 210,115 
2022101,596 214,611 
2023130,949 
Total1,686,952 
All outstanding liabilities before 2014, net of reinsurance(213)
Liabilities for claims and claim adjustment expenses, net of reinsurance$194,150 
186





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance accident and health
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
37.1%48.7%12.9%0.3%0.4%0.2%0.7%(0.5%)(0.5%)0.5%
Reinsurance Agriculture
The agriculture line of business provides protection for risks associated with the production of food and fiber on a global basis for primary insurance companies writing multi-peril crop insurance, crop hail, and named peril covers, as well as custom risk transfer mechanisms for agricultural dependent industries with exposures to crop yield and/or price deviations. This business is written on a proportional and aggregate stop loss reinsurance basis.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of extreme weather events and in some territories take longer to settle due to government involvement in the loss adjustment process.
Reinsurance agriculture
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$183,260 $164,351 $162,820 $162,388 $162,314 $162,327 $162,245 $162,068 $162,762 $162,927 $482 
2015103,199 95,608 95,346 95,332 95,339 95,516 95,503 95,634 96,251 (27)
2016124,229 117,960 111,045 109,633 109,863 109,068 109,012 109,763 (72)
2017151,768 144,401 138,439 139,510 138,984 137,516 136,658 (60)
2018141,040 147,359 140,883 140,618 139,989 142,760 646 
2019185,560 185,345 187,770 183,384 183,092 93 
202062,678 62,837 63,874 61,986 1,130 
202169,823 61,437 57,857 6,144 
2022101,082 91,534 16,972 
2023103,489 81,193 
Total$1,146,317 
187





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance agriculture
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$15,615 $133,137 $162,349 $161,575 $161,498 $162,011 $160,516 $161,167 $162,068 $162,194 
20151,716 65,870 92,979 94,535 94,873 95,468 95,457 95,612 96,224 
20169,489 62,530 108,378 109,922 109,410 109,172 109,211 109,762 
20177,444 124,528 137,502 138,640 137,482 137,429 136,605 
20185,115 127,577 135,674 141,768 138,398 144,070 
201928,854 154,533 174,250 178,264 177,760 
202017,454 47,377 54,269 55,359 
20212,953 32,846 46,117 
202215,347 55,508 
202314,633 
Total998,232 
All outstanding liabilities before 2014, net of reinsurance(463)
Liabilities for claims and claim adjustment expenses, net of reinsurance$147,622 
Reinsurance agriculture
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
10.9%63.5%18.5%1.7%(0.6%)0.9%(0.4%)0.4%0.6%0.1%
188





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance Marine and Aviation
The marine line of business includes specialty marine exposures such as cargo, hull, pleasure craft, marine liability, inland marine and offshore energy. The principal perils covered by policies in this portfolio include physical loss, damage and/or liability arising from natural perils of the seas or land, man-made events including fire and explosion, stranding/sinking/salvage, pollution, shipowners and maritime employers liability. This business is written on a non-proportional and proportional basis.
The aviation line of business provides cover for airline, aerospace and general aviation exposures. This business is written on a proportional and non-proportional basis. The Company exited Aviation business effective January 1, 2023.
Losses arising from marine and aviation lines of business are generally reported quickly with the exception of marine and aviation liability claims which tend to exhibit longer reporting and payment patterns as claims involve passengers and third parties.
Reinsurance marine and aviation
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$10,192 $9,162 $8,019 $7,209 $9,192 $8,535 $8,786 $9,025 $9,530 $9,841 $368 
201510,366 9,242 10,836 15,019 12,652 12,281 12,046 11,998 12,054 527 
201632,453 35,965 36,130 37,519 36,052 36,371 36,773 36,263 52 
201755,299 42,961 41,363 46,612 43,243 40,900 40,827 43 
201818,906 27,454 27,006 43,540 47,066 48,477 35 
201969,806 82,194 79,801 81,628 84,756 5,560 
202040,298 41,766 37,892 37,098 308 
202143,763 40,830 35,672 2,976 
202268,907 59,227 32,375 
202340,951 34,539 
Total$405,166 
189





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance marine and aviation
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,121 $2,307 $4,388 $5,256 $6,320 $6,499 $7,003 $7,370 $7,563 $8,477 
2015416 2,665 6,443 8,662 10,220 11,017 10,843 10,925 11,058 
20162,765 19,544 26,673 30,619 33,399 34,450 35,044 35,256 
20172,803 23,620 28,954 33,912 36,978 37,091 37,996 
20181,783 10,880 24,325 30,763 34,435 37,829 
201910,763 27,167 34,317 52,763 67,800 
20204,024 16,730 24,006 29,862 
20215,478 12,341 20,486 
20227,817 18,588 
20231,473 
Total268,825 
All outstanding liabilities before 2014, net of reinsurance1,923 
Liabilities for claims and claim adjustment expenses, net of reinsurance$138,264 
Reinsurance marine and aviation
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
8.9%26.4%20.5%14.4%10.7%3.7%1.9%1.7%1.6%9.3%
Reinsurance Professional Lines
The professional lines line of business provides protection for directors' and officers' liability, employment practices liability, medical malpractice, professional indemnity, environmental liability, cyber, and miscellaneous errors and omissions insurance risks. The underlying business is predominantly written on a claims-made basis. This business is written on a proportional and excess of loss basis.
Typically, this line of business is anticipated to exhibit longer claim reporting and payment patterns than most other reinsurance lines of business.

190





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance professional lines
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$219,162 $219,123 $219,052 $218,847 $233,169 $229,556 $228,193 $226,234 $234,311 $246,043 $13,578 
2015211,820 211,774 213,993 224,649 231,352 228,410 235,131 241,113 252,022 16,515 
2016195,019 196,073 199,715 227,468 255,088 255,012 266,979 278,699 26,195 
2017154,889 155,470 161,694 177,819 187,761 210,303 239,324 38,070 
2018145,994 148,458 155,390 165,981 173,954 195,575 24,160 
2019138,048 137,723 141,610 146,088 157,572 36,200 
2020140,886 141,559 136,107 134,478 69,314 
2021148,950 140,737 136,381 93,845 
2022169,576 153,853 125,013 
2023136,051 124,516 
Total$1,929,998 
Reinsurance professional lines
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$2,019 $13,062 $48,791 $74,479 $109,048 $146,917 $158,388 $178,058 $189,874 $196,444 
20153,134 13,504 41,512 79,208 111,743 131,543 152,328 170,555 184,073 
20161,765 20,487 52,540 95,084 124,881 153,575 181,141 202,925 
20172,813 14,871 39,857 62,723 88,791 116,293 137,492 
2018271 2,572 31,198 56,882 81,729 113,771 
2019368 13,614 33,628 53,221 76,094 
20203,823 13,969 26,926 40,718 
20214,337 11,366 22,619 
20223,234 11,713 
20233,435 
Total989,284 
All outstanding liabilities before 2014, net of reinsurance113,403 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,054,117 
191





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance professional lines
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
1.5%5.3%11.6%12.3%12.6%12.3%7.9%7.7%5.1%2.7%
Reinsurance Credit and Surety
The credit and surety line of business which provides reinsurance of trade credit insurance products and includes proportional and excess of loss structures. The underlying insurance indemnifies sellers of goods and services in the event of a payment default by the buyer of those goods and services. Surety reinsurance provides protection for losses arising from a broad array of surety bonds issued by insurers to satisfy regulatory demands or contract obligations in a variety of jurisdictions around the world. The Company also provides mortgage reinsurance to mortgage guaranty insurers and U.S. government sponsored entities for losses related to credit risk transfer into the private sector.
Initial and most recent underwriting year loss projections are generally based on the ELR Method, with consideration given to qualitative factors. Given that there is a quicker and more stable reporting pattern for trade credit and mortgage business, the Company generally commences the transition to experience-based methods sooner for these lines of business than for surety business.
Reinsurance credit and surety
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$134,434 $134,527 $141,621 $137,973 $126,744 $125,477 $121,780 $120,482 $120,790 $111,511 $1,914 
2015159,274 164,350 159,148 155,217 136,568 137,528 138,726 132,989 129,333 1,447 
2016140,892 140,188 147,955 122,495 114,957 112,631 110,316 112,465 35 
2017137,832 131,630 125,763 117,044 114,412 114,131 114,612 2,647 
2018111,022 119,227 113,535 110,531 105,503 94,229 4,053 
201974,101 67,825 67,759 65,573 57,322 6,315 
202076,917 83,559 68,987 94,943 8,385 
202152,005 43,967 41,463 13,732 
202263,653 51,231 33,129 
202386,367 64,350 
Total$893,476 
192





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance credit and surety
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$35,450 $60,597 $85,266 $94,274 $101,859 $106,267 $106,708 $106,519 $107,713 $98,533 
201532,863 81,001 98,709 115,549 117,462 121,115 121,975 120,617 118,116 
201641,937 72,691 91,490 101,065 102,149 100,682 100,426 102,558 
201737,246 73,362 89,715 101,337 99,463 102,390 103,252 
201838,868 67,839 72,096 83,736 85,505 87,073 
201919,301 30,985 44,702 46,835 49,050 
202025,339 34,050 39,495 43,888 
20214,471 9,170 17,175 
20226,883 11,302 
202310,335 
Total641,282 
All outstanding liabilities before 2014, net of reinsurance26,307 
Liabilities for claims and claim adjustment expenses, net of reinsurance$278,501 
Reinsurance credit and surety
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
26.5%22.1%15.0%8.6%2.3%2.0%0.4%0.2%(0.4%)(8.2%)
Reinsurance Motor
The motor line of business provides protection to insurers for motor liability and motor property damage losses arising out of any one occurrence. A loss occurrence can involve one or many claimants where the ceding insurer aggregates the claims from the occurrence. The Company offers traditional proportional and non-proportional reinsurance as well as structured solutions predominantly relating to European exposures.
The motor proportional business generally has a shorter reported and payment pattern, relative to the motor non-proportional business.
The motor non-proportional business consists of standard excess of loss contracts written for cedants in several European countries with most of the premium related to two major markets, U.K. and France. Since 2009/2010, an increasing number of large bodily injury settlements in the U.K. market were settled using indexed annuities (Periodical Payment Orders "PPOs"). This led to a materially longer development tail on the older accident years for the U.K. non-proportional motor book. This also resulted in the inclusion of capitalization clauses on a number of U.K. motor treaties which allow reinsurers to settle claims arising under PPOs with a lump sum payment, to help mitigate the lengthening of the development tail on more recent accident years.
In 2017, the U.K. Ministry of Justice announced a decrease in the discount rate to be used to calculate lump sum awards in U.K. bodily injury cases, known as the Ogden Rate. Effective March 20, 2017, the Ogden rate changed from plus 2.5% to minus 0.75%. This resulted in a trend toward a lower number of claims settlements using PPOs and an increase in projected ultimate losses, particularly related to recent accident years.
193





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Effective August 5, 2019, the Ogden rate changed from minus 0.75% to minus 0.25%. This resulted in a decrease in projected ultimate losses, particularly related to recent accident years.
Reinsurance motor
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$181,056 $180,792 $175,983 $173,139 $168,796 $165,481 $162,212 $161,835 $162,730 $161,844 $2,346 
2015221,182 215,201 219,055 220,820 209,908 208,620 205,780 206,090 204,673 8,979 
2016244,395 259,912 261,592 251,675 243,353 240,717 244,553 245,098 4,366 
2017361,782 368,517 357,741 358,286 359,026 354,392 361,134 22,422 
2018355,561 353,384 364,664 360,907 348,323 361,117 17,400 
2019338,031 336,957 337,404 328,522 332,952 12,894 
2020215,257 218,224 215,572 197,439 10,872 
2021180,372 182,010 184,244 25,813 
2022160,697 173,870 35,986 
2023125,498 60,323 
Total$2,347,869 
Reinsurance motor
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$43,148 $73,129 $92,183 $100,071 $109,989 $119,355 $114,654 $135,455 $138,281 $141,456 
201557,638 92,382 112,128 129,175 144,878 145,593 168,295 173,373 175,479 
201660,689 103,868 127,404 145,160 158,004 182,077 189,563 198,144 
201772,143 133,447 163,724 198,778 221,060 244,440 262,741 
201883,831 141,391 205,874 215,988 240,535 260,818 
201990,328 183,841 201,210 223,167 242,207 
202043,752 96,208 115,689 127,881 
202141,869 76,338 94,500 
202235,213 52,971 
202326,040 
Total1,582,237 
All outstanding liabilities before 2014, net of reinsurance255,320 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,020,952 
194





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance motor
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
23.6%18.8%10.3%6.5%6.3%5.6%4.1%6.3%1.4%2.0%
Reinsurance Liability
The liability line of business provides protection to insurers of admitted casualty business, excess and surplus lines casualty business and specialty casualty programs. The primary focus of the underlying business is general liability, workers' compensation, auto liability and excess casualty.
Typically, this line of business is anticipated to exhibit longer claim reporting and payment patterns than most other reinsurance lines of business and claims are often reported and ultimately paid or settled years, or even decades, after the related loss events occur.
Reinsurance liability
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$199,575 $202,526 $204,240 $200,138 $198,893 $196,747 $187,245 $183,101 $189,047 $193,578 $14,361 
2015214,346 214,689 215,633 215,461 213,256 213,485 203,268 206,204 217,019 22,070 
2016239,971 245,286 250,247 253,525 263,195 267,241 274,615 315,793 46,678 
2017275,306 270,080 279,262 287,818 297,380 306,648 343,290 62,419 
2018264,003 268,812 274,110 286,876 307,032 352,697 72,183 
2019263,522 272,513 274,393 272,905 331,729 103,836 
2020283,606 284,216 278,743 306,011 148,977 
2021304,160 311,735 346,161 185,421 
2022347,387 343,773 232,850 
2023275,232 241,263 
Total$3,025,283 
195





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance liability
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$7,075 $28,652 $48,397 $70,069 $89,328 $109,859 $129,802 $137,103 $148,342 $156,421 
20157,269 27,451 54,486 80,822 108,857 130,767 141,519 151,919 166,842 
201611,868 37,666 69,445 111,698 142,837 166,645 189,536 216,534 
201712,449 42,144 78,574 120,747 158,653 193,274 224,655 
201819,357 49,938 85,207 127,946 166,378 207,016 
201919,311 45,269 79,728 120,266 159,068 
202016,940 49,059 82,389 119,678 
202110,931 58,540 99,228 
202218,066 52,197 
202315,003 
Total1,416,642 
All outstanding liabilities before 2014, net of reinsurance130,039 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,738,680 
Reinsurance liability
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
4.5%9.8%10.8%12.2%11.1%10.0%7.9%5.7%6.4%4.2%
Reinsurance Run-off lines
Run-off lines include catastrophe, property, and engineering lines of business.
The catastrophe line of business provides protection for most catastrophic losses that are covered in the underlying insurance policies written by the Company's cedants. The underlying policies principally cover property-related exposures but other exposures including worker's compensation and personal accident are also covered. The principal perils covered by policies in this portfolio include hurricane and windstorm, earthquake, flood, tornado, hail and fire. In some instances, terrorism may be a covered peril or the only peril. This business is written on a proportional and an excess of loss basis. The Company exited this line of business in June 2022.
The property line of business provides protection for property damage and related losses resulting from natural and man-made perils that are covered in underlying personal and commercial lines insurance policies written by the Company's cedants. The predominant exposure is to property damage, but other risks, including business interruption and other non-property losses, may also be covered when arising from a covered peril. The most significant perils covered by policies in this portfolio include windstorm, tornado and earthquake, but other perils such as freezes, riots, floods, industrial explosions, fires, hail and a number of other loss events are also included. This business is written on a proportional and excess of loss basis. The Company exited this line of business in June 2022.
196





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

The engineering line of business provides protection for all types of construction risks and risks associated with erection, testing and commissioning of machinery and plants during the construction stage. This line of business also includes cover for losses arising from operational failures of machinery, plant and equipment, and electronic equipment as well as business interruption. The Company exited this line of business in 2020.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of catastrophe events. Losses from engineering exposures tend to develop slower than the other reinsurance run-off lines of business.
Reinsurance run-off
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$242,347 $246,616 $236,768 $227,865 $224,135 $223,970 $219,953 $219,748 $218,896 $219,012 $201 
2015267,709 256,648 256,665 247,377 246,266 251,245 249,050 247,183 244,790 475 
2016286,264 285,973 282,705 277,349 280,836 281,204 281,137 274,291 2,838 
2017705,205 702,378 740,074 741,278 739,258 729,812 722,172 19,886 
2018523,351 614,222 628,722 614,573 600,516 600,640 15,506 
2019448,745 432,299 411,886 395,134 387,944 17,304 
2020520,537 553,538 548,846 553,124 41,243 
2021430,820 441,530 438,082 39,301 
2022265,797 225,697 47,820 
202364,191 28,272 
Total$3,729,943 
197





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reinsurance run-off
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$49,217 $136,404 $180,580 $197,284 $202,114 $206,234 $203,726 $210,435 $211,708 $213,063 
201546,199 119,103 178,596 203,661 213,978 218,469 232,671 234,318 235,258 
201665,343 141,975 201,290 232,366 246,602 253,543 258,939 257,802 
2017163,254 417,693 528,640 586,833 611,106 646,826 657,803 
2018116,816 331,848 427,126 479,911 526,746 548,005 
201954,985 214,066 274,503 310,612 335,546 
2020105,245 240,193 324,105 392,613 
202187,860 235,617 302,383 
202250,250 103,881 
202322,862 
Total3,069,216 
All outstanding liabilities before 2014, net of reinsurance37,075 
Liabilities for claims and claim adjustment expenses, net of reinsurance$697,802 
Reinsurance run-off
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
21.8%32.4%17.9%9.7%4.9%2.9%2.1%1.1%0.5%0.6%





198





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

8.    RESERVE FOR LOSSES AND LOSS EXPENSES (CONTINUED)

Reconciliation of Loss Development Tables to Consolidated Balance Sheet
The following table reconciles the reserve for losses and loss expenses at December 31, 2023, included in the loss development tables to the reserve for losses and loss expenses reported in the consolidated balance sheet:
Reconciliation of the disclosure of incurred and paid claims development to the liability
for unpaid claims and claim adjustment expenses
At December 31, 2023
Net outstanding liabilitiesReinsurance recoverable on unpaid claimsGross outstanding liabilities
Insurance segment
Property$662,936 $402,222 $1,065,158 
Accident and health114,493 3,006 117,499 
Marine and aviation678,482 278,215 956,697 
Cyber322,071 430,627 752,698 
Professional lines1,930,348 1,442,546 3,372,894 
Credit and political risk125,355 35,191 160,546 
Liability1,332,734 1,885,232 3,217,966 
Total insurance segment5,166,419 4,477,039 9,643,458 
Reinsurance segment
Accident and health194,150 49,314 243,464 
Agriculture147,622 8,343 155,965 
Marine and aviation138,264 33,185 171,449 
Professional lines1,054,117 370,345 1,424,462 
Credit and surety278,501 103,174 381,675 
Motor1,020,952 315,344 1,336,296 
Liability1,738,680 690,141 2,428,821 
Run-off lines697,802 276,198 974,000 
Total reinsurance segment5,270,088 1,846,044 7,116,132 
Total$10,436,507 $6,323,083 16,759,590 
Unallocated claims adjustment expenses183,260 
Foreign exchange and other(1)
12,442 
Ceded reserves related to retroactive transactions (521,274)
Total liability for unpaid claims and claims adjustment expense$16,434,018 
(1)    Non-U.S. dollar denominated loss data is converted to U.S dollar at the rates of exchange in effect at the balance sheet date for material underlying currencies. Fluctuations in currency exchange rates may cause material shifts in loss development. Reserves for losses and loss expenses disclosed in the consolidated balance sheets are also remeasured using rates of exchange in effect at the balance sheet date.


199





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

9.    REINSURANCE
In the normal course of business, the Company purchases treaty and facultative reinsurance protection to limit ultimate losses and reduce loss aggregation risk.

Facultative reinsurance provides cover for all or a portion of the losses incurred for a single policy and the Company separately negotiates each facultative contract.

Treaty reinsurance provides cover for a specified type or category of risks. The Company's treaty reinsurance agreements provide this cover on either an excess of loss or a proportional basis. Excess of loss covers provide a contractually set amount of coverage after a specified loss amount has been reached. These treaties can provide cover for a number of lines of business within one contract. Under proportional reinsurance, the Company cedes an agreed percentage of the premiums and the losses and loss expenses on the policies it underwrites. These treaties provide the Company with a specified percentage of coverage from the first dollar of loss.
All of these reinsurance contracts provide the Company with the right to recover a specified amount of losses and loss expenses from reinsurers. To the extent that reinsurers do not meet their obligations under these agreements due to solvency issues, contractual disputes over contract language or coverage and/or other reasons, the Company remains liable. The Company predominantly cedes its business to reinsurers rated A- or better by A.M. Best.

The following table presents gross and net premiums written and earned:
Year ended December 31,202320222021
  Premiums
written
Premiums
earned
Premiums
written
Premiums
earned
Premiums
written
Premiums
earned
Gross$8,356,525 $7,973,577 $8,214,595 $7,936,382 $7,685,984 $7,281,709 
Ceded(3,254,200)(2,889,796)(2,951,539)(2,776,056)(2,759,360)(2,571,859)
Net$5,102,325 $5,083,781 $5,263,056 $5,160,326 $4,926,624 $4,709,850 
For the year ended December 31, 2023, the Company recognized ceded losses and loss expenses of $1,754 million (2022: $1,754 million; 2021: $1,782 million).
At December 31, 2023, the Company's allowance for expected credit losses was $37 million (2022: $31 million; 2021: $30 million).










200





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

10.    DEBT AND FINANCING ARRANGEMENTS
a)    Debt

The following table summarizes the Company's debt:
Year ended December 31,20232022
5.150% Senior Notes
$246,789 $246,708 
4.000% Senior Notes
348,389 348,020 
3.900% Senior Notes
297,076 296,615 
Junior Subordinated Notes421,460 420,971 
Total Debt$1,313,714 $1,312,314 

The tables below provide the key terms of the Company's debt:
DescriptionIssuance DateAggregate PrincipalIssue PriceNet ProceedsMaturity Date
5.150% Senior Notes
March 13, 2014$250,000 99.474 %$246,000 April 1, 2045
4.000% Senior Notes
December 6, 2017$350,000 99.780 %$347,000 December 6, 2027
3.900% Senior Notes
June 19, 2019$300,000 99.360 %$296,000 July 15, 2029
Junior Subordinated NotesDecember 10, 2019$425,000 99.000 %$420,750 January 15, 2040

DescriptionInterest RateInterest Payments Due
5.150% Senior Notes
5.150 %Semi-annually in arrears on April 1 and October 1 of each year
4.000% Senior Notes
4.000 % Semi-annually in arrears on June 6 and December 6 of each year
3.900% Senior Notes
3.900 %Semi-annually in arrears on January 15 and July 15 of each year
Junior Subordinated Notes(1)
4.900 %Semi-annually on January 15 and July 15 of each year
(1)    The Junior Subordinated Notes accrue interest from the date of issuance to, but excluding, January 15, 2030 (the "Par Call Date") at the fixed rate of 4.900% and from, and including, the Par Call Date, at a rate equal to the Five-Year Treasury Rate as of the Reset Interest Determination Date, plus 3.186%. Interest on the Junior Notes is payable semi-annually on January 15 and July 15 of each year, beginning on July 15, 2020.
5.150% Senior Notes
The 5.150% Senior Notes are ranked as unsecured senior obligations of AXIS Specialty Finance PLC, a 100% owned finance subsidiary. AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance PLC under the 5.150% Senior Notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.
4.000% Senior Notes
The 4.000% Senior Notes are ranked as unsecured senior obligations of AXIS Specialty Finance PLC, a 100% owned finance subsidiary. AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance PLC under the 4.000% Senior Notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.
3.900% Senior Notes
The 3.900% Senior Notes are ranked as unsecured senior obligations of AXIS Specialty Finance LLC, a 100% owned finance subsidiary. AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance LLC under the
201





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

10.    DEBT AND FINANCING ARRANGEMENTS (CONTINUED)
3.900% Senior Notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.
The Company has the option to redeem the Senior Notes at any time and from time to time, in whole or in part, at a ''make-whole'' redemption price, which is equal to the greater of the aggregate principal amount or the sum of the present values of the remaining scheduled payments of principal and interest. The related indentures contain various covenants, including limitations on liens on the stock of restricted subsidiaries, restrictions as to the disposition of the stock of restricted subsidiaries and limitations on mergers and consolidations. The Company was in compliance with all the covenants contained in the indentures at December 31, 2023.
Interest expense recognized in relation to the Senior Notes includes interest payable, amortization of the offering discounts and amortization of debt offering expenses. The offering discounts and debt offering expenses are amortized over the period of time during which the Senior Notes are outstanding. For the year ended December 31, 2023, the Company incurred interest expense of $40 million (2022: $40 million, 2021: $40 million).
Junior Subordinated Notes
The 4.900% Fixed-Rate Reset Junior Notes are ranked as unsecured junior subordinated obligations of AXIS Specialty Finance LLC, a 100% owned finance subsidiary. AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance LLC under the Junior Notes. AXIS Capital's obligation under this guarantee is an unsecured junior subordinated obligation and ranks equally with all future unsecured junior subordinated obligations of AXIS Capital, and junior in right of payment to all outstanding and future senior obligations of AXIS Capital.
Interest expense recognized in relation to the Junior Notes includes interest payable and amortization of debt offering expenses. The debt offering expenses are amortized over the period of time during which the Junior Notes are outstanding. For the year ended December 31, 2023, the Company incurred interest expense of $21 million (2022: $21 million).

Scheduled Debt Maturity
The following table provides the scheduled maturity of the Company's debt obligations at December 31, 2023:
Year ended December 31,
2024$ 
2025 
2026 
2027350,000 
2028 
After 2028975,000 
Unamortized discount and debt issuance expenses(11,286)
Total senior notes and notes payable$1,313,714 
b)    Loan Advances made to a Third Party Reinsurer
During 2023, the Company advanced $102 million (2022: $116 million) to a third party reinsurer. This loan is being repaid in a manner consistent with the timing of amounts due to the third party reinsurer under retrocession agreements. At December 31, 2023, $82 million (2022: $80 million) was repaid and was treated as a non-cash activity in the consolidated statement of cash flows. The loan is expected to be repaid in full by February 15, 2026 (2022: February 15, 2025). The loan balance receivable at December 31, 2023, of $80 million (2022: $87 million) is included in loan advances made in the consolidated balance sheets. At December 31, 2023, the Company had committed to advance a further $26 million to the third party reinsurer.

202





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

10.    DEBT AND FINANCING ARRANGEMENTS (CONTINUED)
Interest on this loan is payable at interest rates between 0.8% and 4.0% (2022: 0.8% and 4.0%). Interest of $1 million (2022: $1 million) related to this loan was received in advance and is included in other liabilities in the consolidated balance sheets and was treated as a non-cash activity in the consolidated statement of cash flows.

c)    Letter of Credit Facility
At December 31, 2023, certain of AXIS Capital’s operating subsidiaries (the "Participating Subsidiaries") had a $500 million letter of credit facility available from Citibank Europe plc ("Citibank") (the "$500 million Facility"). pursuant to a Master Reimbursement Agreement May 14, 2010, as amended, and Committed Letter of Credit Facility Letter dated December 18, 2015, as amended. (together, the "LOC Facility Documents").
Under the terms of the $500 million Facility, letters of credit to a maximum aggregate amount of $500 million are available for issuance on behalf of the Participating Subsidiaries. These letters of credit are principally used to support the reinsurance obligations of the Participating Subsidiaries. The $500 million Facility is subject to certain covenants, including the requirement to maintain sufficient collateral, as defined in the LOC Facility Documents to cover all of the obligations under the $500 million Facility. Such obligations include contingent reimbursement obligations for outstanding letters of credit and fees payable to Citibank. In the event of default, Citibank may exercise certain remedies, including the exercise of control over pledged collateral and the termination of the availability of the $500 million Facility to any or all of the Participating Subsidiaries.
On March 27, 2017, the Participating Subsidiaries amended their existing $500 million Facility to include an additional $250 million of secured letter of credit capacity (the "$250 million Facility"). Under the terms of the amended $750 million Facility, letters of credit to a maximum aggregate amount of $250 million are available for issuance on behalf of the Participating Subsidiaries once the $500 million Facility has been fully utilized.
On March 31, 2021, the Participating Subsidiaries amended their existing secured $750 million Facility to reduce the utilization capacity available under the $250 million Facility to $150 million, reducing the maximum aggregate utilization capacity of the credit facility from $750 million to $650 million.

On March 31, 2023, the $150 million secured letter of credit facility expired.

On December 29, 2023, the $500 million Facility was amended to extend the tenors of issuable letters of credit (i) denominated in a currency other than Australian or New Zealand dollars to March 31, 2025 and (ii) denominated in either Australian dollars or New Zealand dollars to March 31, 2026.

At December 31, 2023, letters of credit outstanding under the LOC Facility were $325 million (2022: $362 million). At December 31, 2023, the Participating Subsidiaries were in compliance with all LOC Facility covenants.
203




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

11.     FEDERAL HOME LOAN BANK ADVANCES
The Company's subsidiaries, AXIS Insurance Company and AXIS Surplus Insurance Company, are members of the Federal Home Loan Bank of Chicago ("FHLB").

Members may borrow from the FHLB at competitive rates subject to certain conditions. At December 31, 2023, the companies had admitted assets of approximately $3 billion (2022: $3 billion) which provides borrowing capacity of up to approximately $759 million (2022: $750 million). Conditions of membership include maintaining sufficient collateral deposits for funding, a requirement to maintain member stock at 0.4% of mortgage-related assets at December 31st of the prior year, and a requirement to purchase additional member stock of 2.0% or 4.5% of any amount borrowed.

At December 31, 2023, the Company had $86 million (2022: $81 million) of borrowings under the FHLB program, with maturities in 2024 and interest payable at interest rates between 5.6% and 5.9% (2022: 2.3% and 4.7%).

For the year ended December 31, 2023, the Company incurred interest expense of $5 million (2022: $1 million). The borrowings under the FHLB program are secured by cash and investments with a fair value of $95 million (2022: $91 million).


































204





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

12.    COMMITMENTS AND CONTINGENCIES

a)    Concentrations of Credit Risk
Credit Risk Aggregation
The Company monitors and manages the aggregation of credit risk on a group-wide basis allowing it to consider exposure management strategies for individual companies, countries, regions, sectors and any other relevant inter-dependencies. The Company's credit exposures are aggregated based on the origin of risk. Credit risk aggregation is also managed through minimizing overlaps in underwriting, financing and investing activities. As part of its credit aggregation framework, the Company also assigns aggregate credit limits by country and by single counterparty (or parent of affiliated counterparties). These limits are based on and adjusted for a variety of factors including the prevailing economic environment and the nature of the underlying credit exposures.
The Company's credit aggregation measurement and reporting process is facilitated by its credit risk exposure database, which contains relevant information on counterparty details and credit risk exposures. The database is accessible by management throughout the Company, therefore providing transparency to allow for the implementation of active exposure management strategies. The Company also licenses third-party tools to provide credit risk assessments. The Company monitors all its credit aggregations and, where appropriate, adjusts its internal risk limits and/or takes specific actions to reduce our risk exposures.
The assets that potentially subject the Company to concentrations of credit risk consist principally of cash and investments, reinsurance recoverable on unpaid and paid claims, and insurance and reinsurance premiums balances receivable, as described below:
(i)     Cash and Investments
In order to mitigate concentration and operational risks related to cash and cash equivalents, the Company limits the maximum amount of cash that can be deposited with a single counterparty and limits acceptable counterparties based on current rating, outlook and other relevant factors.
The Company's fixed maturities portfolio, which represents approximately $12.9 billion or 43% of its total assets, is exposed to potential losses arising from the diminished creditworthiness of issuers of bonds. The Company's investment portfolio is managed by external investment managers in accordance with its investment guidelines. The Company limits credit risk through diversification and issuer exposure limits graded by ratings and, with respect to custodians, through contractual and other legal remedies. Excluding Government and agency securities, the Company limits its concentration of credit risk to any single corporate issuer to 1% of its investment grade fixed maturities portfolio for securities rated A- or above and less than 1% of its investment grade fixed maturities portfolio for securities rated below A-.
At December 31, 2023, the Company was in compliance with these limits.
(ii)     Reinsurance Recoverable on Unpaid and Paid Losses and Loss Expenses

The Company is exposed to the credit risk associated with reinsurance recoverable on unpaid and paid losses and loss expenses to the extent that any of its reinsurers fail to meet their obligations under reinsurance contracts. To help mitigate this risk, the Company's purchase of reinsurance is subject to financial security requirements specified by its Reinsurance Security Committee. This Committee maintains a list of approved reinsurers, performs credit risk assessments for potential new reinsurers, regularly monitors approved reinsurers with consideration for events which may have a material impact on their creditworthiness, recommends counterparty tolerance levels for different types of ceded business and monitors concentrations of credit risk. This assessment considers a wide range of individual attributes, including a review of the counterparty’s financial strength, industry position and other qualitative factors. Generally, the Committee requires that reinsurers who do not meet specified requirements provide collateral.
 At December 31, 2023, the three largest balances by reinsurer accounted for 14%, 9% and 4% (2022: 13%, 9% and 6%) of reinsurance recoverable on unpaid and paid losses and loss expenses.
205





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

12.    COMMITMENTS AND CONTINGENCIES (CONTINUED)
At December 31, 2023, 83.1% (2022: 81.8%) of the Company's reinsurance recoverable on unpaid and paid losses and loss expenses were collectible from reinsurers rated the equivalent of A- or better by A.M. Best.
(iii)    Insurance and Reinsurance Premium Balances Receivable
The diversity of the Company's client base limits credit risk associated with its insurance and reinsurance premium balances receivable. In addition, for insurance contracts the Company has contractual rights to cancel coverage for non-payment of premiums and for reinsurance contracts the Company has contractual rights to offset premium balances receivable against corresponding payments for losses and loss expenses.
Brokers and other intermediaries collect premiums from customers on behalf of the Company. The Company has procedures in place to manage and monitor credit risk from intermediaries with a focus on day-to-day monitoring of the largest positions.
These contractual rights contribute to the mitigation of credit risk, together with the monitoring of aged premium balances receivable. In light of these mitigating factors and considering that a significant portion of premium balances receivable are not currently due based on the terms of the underlying contracts, the Company does not utilize specific credit quality indicators to monitor its premium balances receivable.
At December 31, 2023, the Company recorded an allowance for credit losses expected to be recognized over the life of the premium balances receivable of $12 million (2022: $10 million).
For the year ended December 31, 2023, bad debt expense was $2 million (2022: $nil; 2021: $nil).
b)    Brokers
The Company produces its business through brokers and direct relationships with insurance companies.
For the year ended December 31, 2023 and 2022, three brokers accounted for 38% and 43% of gross premiums written, respectively. Aon plc accounted for 15% (2022: 17%), Marsh & McLennan Companies Inc. accounted for 14% (2022: 17%), and Arthur J. Gallagher & Co. accounted for 9% (2022: 9%).
For the years ended December 31, 2021, three brokers accounted for 45% of gross premiums written. Marsh & McLennan Companies Inc. accounted for 18%, Aon plc accounted for 17%, and Willis Tower Watson plc accounted for 10%.
No other broker and no single insured or reinsured accounted for more than 10% of gross premiums written in any of the last three years.
c)    Reinsurance Purchase Commitment
In the normal course of business, the Company purchases reinsurance and retrocessional (collectively referred to as "reinsurance") protection for its insurance and reinsurance business. Minimum reinsurance premiums are contractually due in advance on a quarterly basis. At December 31, 2023, the Company had outstanding reinsurance purchase commitments of $6 million (2022: $11 million), all of which is due before June 30, 2025. Actual payments under the reinsurance contracts will depend on the underlying subject premium and may exceed the minimum reinsurance premiums.
d)    Legal Proceedings
From time to time, the Company is subject to routine legal proceedings, including arbitrations, arising in the ordinary course of business. These legal proceedings generally relate to claims asserted by or against the Company in the ordinary course of its insurance or reinsurance operations. Estimated amounts payable related to these proceedings are included in reserve for losses and loss expenses in the Company's consolidated balance sheets. The Company is not party to any material legal proceedings arising outside the ordinary course of business.
206





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

12.    COMMITMENTS AND CONTINGENCIES (CONTINUED)
e)    Investments
At December 31, 2023, the Company has $502 million (2022: $524 million) of unfunded investment commitments related to its other investment portfolio, which are callable by investment managers (refer to Note 5(e) 'Investments'). At December 31, 2023 the Company has $10 million (2022: $25 million) of unfunded investment commitments to purchase commercial mortgage loans and $16 million (2022: $20 million) of unfunded investment commitments to purchase corporate debt.
f)    Funds at Lloyd's
The Company operates in the Lloyd’s market through its corporate members, AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited, which provide 70% and 30%, respectively of Syndicate 1686's capital support. Lloyd’s sets capital requirements for corporate members annually through the application of a capital model that is based on regulatory rules pursuant to Solvency II.
The capital provided to support underwriting or FAL may be satisfied by cash, certain investments and letters of credit provided by approved banks.
At December 31, 2023, investments and cash of $893 million (2022: $749 million) were restricted to satisfy the Company's FAL requirements (refer to Note 5 'Investments' and Note 22 'Statutory Financial Information').















207





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

13.    LEASES
In the ordinary course of business, the Company renews and enters into new leases for office property and equipment, which expire at various dates.

At the lease inception date, the Company assesses whether a contract is or contains a lease. At the commencement date, the Company determines the classification of each separate lease component as either a finance lease or an operating lease. The Company's leases are all currently classified as operating leases. For operating leases that have a lease term of more than 12 months, the Company recognizes a lease liability and a right-of-use asset in the Company's consolidated balance sheets at the present value of the lease payments at the lease commencement date.

At the commencement date, the Company determines lease terms by assuming the exercise of those renewal options that are deemed to be reasonably certain. The exercise of lease renewal options is at the sole discretion of the Company.

As the lease contracts generally do not provide an implicit discount rate, the Company uses its incremental borrowing rate based on information available at the commencement date to determine the present value of lease payments. The incremental borrowing rate is based on a borrowing with a term that is similar to the term of the associated lease. The Company has made an accounting policy election not to include renewal, termination, or purchase options that are not reasonably certain of exercise when determining the term of the borrowing.

The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Operating lease rentals are expensed on a straight-line basis over the life of the lease beginning on the commencement date.

The following table presents the Company’s total lease expense and the cash flows arising from lease transactions:
Year ended December 31,202320222021
Lease cost:
Operating lease expense$21,499$20,611$21,864 
Short-term lease expense(1)
2,2918131,127 
Sublease income(2)
(4,531)(3,423)(3,116)
Total lease expense$19,259$18,001$19,875 
Other information:
Operating cash outflows from operating leases$20,190$22,932 $22,726 
Right-of-use assets obtained in exchange for new operating lease liabilities(3)
$34,988$6,514 $(1,739)
Weighted-average remaining lease term - operating leases(4)
9.8 years9.9 years10.0 years
Weighted-average discount rate - operating lease(5)
4.4%4.1 %4.1 %
(1)    Short-term lease expense is recognized on a straight-line basis over the lease term.
(2)    Sublease income largely relates to office properties in New York and Chicago.
(3)    In 2021, the Company modified a lease agreement to reflect a reduction in the floor space it occupies in its office property in Zurich.
(4)    Weighted-average remaining lease term was calculated on the basis of the remaining lease term and the lease liability balance for each lease at the reporting date.
(5)    Weighted-average discount was calculated on the basis of the discount rate that was used to calculate the lease liability balance for each lease at the reporting date and the remaining balance of the lease payments for each lease at the reporting date.


208





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

13.    LEASES (CONTINUED)

The following table presents the scheduled maturity of the Company's operating lease liabilities at December 31, 2023:
Year ended December 31,Expected cash flows
2024$17,543 
202518,122 
202615,767 
202713,519 
202812,691 
Later years74,852 
Discount(29,393)
Total discounted operating lease liabilities$123,101 

The following table presents the scheduled maturity of the Company's operating lease liabilities at December 31, 2022:
Year ended December 31,Expected cash flows
2023$19,774 
202413,725 
202513,148 
202611,052 
20279,052 
Later years58,516 
Discount(22,690)
Total discounted operating lease liabilities $102,577 

209





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

14.    EARNINGS PER COMMON SHARE
The following table presents a comparison of earnings (loss) per common share and earnings (loss) per diluted common share:
At and year ended December 31,202320222021
Earnings per common share
Net income$376,292 $223,083 $618,609 
Less: Preferred share dividends30,250 30,250 30,250 
Net income available to common shareholders$346,042 $192,833 $588,359 
Weighted average common shares outstanding85,142 84,864 84,707 
Earnings per common share$4.06 $2.27 $6.95 
Earnings per diluted common share
Net income available to common shareholders$346,042 $192,833 $588,359 
Weighted average common shares outstanding85,142 84,864 84,707 
Share-based compensation plans870 805 584 
Weighted average diluted common shares outstanding86,012 85,669 85,291 
Earnings per diluted common share$4.02 $2.25 $6.90 
Weighted average anti-dilutive shares excluded from the dilutive computation405 324 656 



15.    SHAREHOLDERS' EQUITY

a)    Common Shares
The Company's authorized share capital is 800,000,000 common shares, par value of $0.0125 per share.
The following table presents changes in common shares issued and outstanding:
Year ended December 31,202320222021
Shares issued, balance at beginning of year176,580 176,580 176,580 
Shares issued   
Total shares issued at end of year176,580 176,580 176,580 
Treasury shares, balance at beginning of year(91,912)(91,806)(92,227)
Shares repurchased(398)(897)(205)
Shares reissued 1,016 791 626 
Total treasury shares at end of year(91,294)(91,912)(91,806)
Total shares outstanding85,286 84,668 84,774 
210




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

15.    SHAREHOLDERS' EQUITY (CONTINUED)
Treasury Shares
On December 7, 2023, the Company's Board of Directors renewed its authorization for the repurchase of up to $100 million of the Company's common shares, effective January 1, 2024, through December 31, 2024.
The following table presents common shares repurchased from shares held in Treasury:
Year ended December 31,202320222021
In the open market: (1)
Total shares 634  
Total cost$ $34,987 $ 
Average price per share(2)
$ $55.22 $ 
From employees:(3)
Total shares398 263 205 
Total cost$23,596 $13,994 $10,242 
Average price per share(2)
$59.15 $53.13 $49.93 
Total shares repurchased:
Total shares398 897 205 
Total cost$23,596 $48,981 $10,242 
Average price per share(2)
$59.15 $54.61 $49.93 
(1)    Shares were repurchased pursuant to the Company's Board-authorized share repurchase program announced in December 2021, effective January 1, 2022 through to December 31, 2022.
(2)    Calculated using whole numbers.
(3)    Shares are repurchased from employees to satisfy personal withholding tax liabilities that arise on the vesting of share-settled restricted stock units.

b)    Preferred Shares
Series E Preferred Shares

On November 7, 2016, the Company issued $550 million of 5.50% Series E preferred shares, par value $0.0125 per share, with a liquidation preference of $2,500 per share. The Company could redeem the Series E preferred shares on or after November 7, 2021 at a redemption price of $2,500 per share. Dividends on the Series E preferred shares are non-cumulative. Holders of the Series E preferred shares are entitled to receive, only when, as and if declared by the Board of Directors, non-cumulative cash dividends from the original issue date, quarterly in arrears on the fifteenth day of January, April, July and October of each year, commencing on January 15, 2017. To the extent declared, dividends accumulate, with respect to each dividend period, in an amount per share equal to 5.50% of the liquidation preference per annum.












211




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

15.    SHAREHOLDERS' EQUITY (CONTINUED)
Dividends
The following table presents dividends declared and paid related to the Company's common and preferred shares:
Per share data
Dividends declared Dividends paid in year of declarationDividends paid in year following declaration
Year ended December 31, 2023
Common shares$1.76 $1.32 $0.44 
Series E preferred shares$137.50 $103.13 $34.38 
Year ended December 31, 2022
Common shares$1.73 $1.29 $0.44 
Series E preferred shares$137.50 $103.13 $34.38 
Year ended December 31, 2021
  Common shares$1.69 $1.26 $0.43 
  Series E preferred shares$137.50 $103.13 $34.38 


16.    RETIREMENT PLANS

The Company maintains defined contribution plans to provide retirement benefits to eligible employees. Contributions to the plans, which are managed externally, are based on eligible compensation.
For eligible U.S. employees, the Company provides a non-qualified deferred compensation plan that enables employees to make contributions to the plan that are in excess of those permitted under the Company's 401(k) Plan. In addition, employees are permitted to make additional contributions from any bonus received and to benefit from discretionary employer contribution to the Plan.
For the year ended December 31, 2023, total pension expenses were $35 million (2022: $34 million and 2021: $34 million) for the above retirement benefit.









212




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

17.    SHARE-BASED COMPENSATION
In May 2017, shareholders approved the establishment of the AXIS Capital Holdings Limited 2017 Long-Term Equity Compensation Plan (the "2017 Plan"). The 2017 Plan provides for, among other things, the issuance of restricted shares, restricted stock units (share-settled awards and cash-settled awards), performance units (share-settled awards and cash-settled
awards), stock options, stock appreciation rights and other equity-based awards to the Company's employees and directors.

The 2017 Plan authorizes the issuance of a total of 3,400,000 common shares. On May 7, 2021, at the Annual General Meeting of Shareholders of the Company, the Company’s shareholders approved an amendment to the Company’s 2017 Plan to increase by 1,600,000 the number of common shares authorized for issuance under the Plan. On May 4, 2023, at the Annual General Meeting of Shareholders of the Company, the Company’s shareholders approved an amendment to the Company’s 2017 Plan to increase by 1,125,000 the number of common shares authorized for issuance under the Plan.

At December 31, 2023, 2,864,183 equity-based awards remained available for grant pursuant to the 2017 Plan.

Restricted Stock Units - Share-Settled

The grant date fair value of share-settled restricted stock units granted pursuant to the 2017 Plan is established at the fair market value of the Company's common shares at the date of grant. These awards either cliff vest at the end of a three year period, vest in accordance with a three year graded vesting schedule in three annual installments beginning on the grant date, or vest in accordance with a four year graded vesting schedule in four annual installments beginning on the grant date.

Restricted Stock Units - Cash-Settled

The grant date fair value of cash-settled restricted stock units granted pursuant to the 2017 Plan is established at the fair market value of the Company's common shares at the date of grant. These awards are liability awards and generally cliff vest at the end of a three year period, or vest in accordance with a four year graded vesting schedule in four annual installments beginning on the grant date.

Performance Restricted Stock Units - Share-Settled

Performance restricted stock units granted pursuant to the 2017 Plan represent the right to receive a specified number of common shares in the future, based on the achievement of established performance criteria and continued service during the applicable performance period.

The grant date fair value of performance restricted stock units granted in 2023, 2022 and 2021 were measured on the grant date using a Monte Carlo simulation model.

The grant date fair values of performance restricted stock units granted prior to 2021 was established at the fair market value of the Company's common shares at the date of grant.

Awards granted pursuant to the 2017 Plan generally cliff vest at the end of a three year period. Compensation expense is recognized on a straight-line basis over the applicable requisite service period. Awards granted prior to 2021 are subject to periodic adjustment based on the achievement of established performance criteria during the applicable performance period.

Acceleration Provisions

Grants provided under the 2017 Plan generally allow for accelerated vesting provisions on the employee’s death, permanent disability, or certain terminations following a change in control of the Company occurring within two years of the change in control event. Notwithstanding these vesting provisions, the Compensation Committee of the Company's Board of Directors has broad authority to accelerate vesting at its discretion.
213





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

17.    SHARE-BASED COMPENSATION (CONTINUED)
Retirement Plan

In 2016, the Company established the AXIS Executive Restricted Stock Unit Retirement Plan (the "Plan") to reward certain eligible long-term employees of the Company for their dedicated service. The Plan was implemented in 2017. Subject to certain conditions being met, eligible employees do not forfeit all of their outstanding share-settled restricted stock units, share-settled performance restricted stock units or cash-settled restricted stock units on or following their retirement. Absent the Plan, outstanding restricted stock units are generally forfeited on termination of employment.

a)    Performance Restricted Stock Units

Performance Restricted Stock Units granted in 2023, 2022 and 2021
Performance restricted stock units granted in 2023, 2022 and 2021 include a market condition which is the Company’s total shareholder return relative to its peer group ("Relative TSR") over the performance period. Relative TSR is calculated in accordance with the terms of the applicable award agreement. If performance goals are achieved, these awards will cliff vest at the end of a three-year performance period within a range of 0% to 200% of target. Performance restricted stock units granted in 2023, 2022 and 2021 were share-settled awards.

Performance Restricted Stock Units granted in the three months ended March 31, 2023 in relation to senior leadership transition

Share-settled performance restricted stock units granted in the three months ended March 31, 2023 to one senior leader include a market condition which is the Company’s total shareholder return relative to its peer group ("Relative TSR") over the performance period. Relative TSR is calculated in accordance with the terms of the applicable award agreement. If performance goals are achieved, fifty percent of these awards will vest at the end of a one-year performance period, and the remaining fifty percent of these awards will vest at the end of a three-year vest period within a range of 0% to 200% of target.

Performance Restricted Stock Units granted in the three months ended June 30, 3023 in relation to senior leadership transition

Share-settled performance restricted stock units granted in the three months ended June 30, 2023 to one senior leader include a market condition which is the Company’s total shareholder return's compound annual growth rate ("TSR CAGR") over the performance period. TSR CAGR is calculated in accordance with the terms of the applicable award agreement. If performance goals are achieved, these awards will cliff vest at the end of a three-year performance period within a range of 0% to 200% of target.


214





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

17.    SHARE-BASED COMPENSATION (CONTINUED)
Valuation assumptions

The fair value of performance restricted stock units granted in 2023, 2022 and 2021 were measured on the grant date using a Monte Carlo simulation model.

The following table provides details of the significant inputs used in the Monte Carlo simulation model:
Year ended December 31,
2023 (1)
2023 (2)
2023 (3)
20222021
Expected volatility 36.24%29.30%30.05%33.44%32.99%
Expected term (in years)3.01.03.03.03.0
Expected dividend yieldn/an/an/an/an/a
Risk-free interest rate3.79%4.61%3.39%1.26%0.17%
n/a - not applicable
(1) Performance restricted stock units granted in the ordinary course of business
(2) Performance restricted stock units granted in the three months ended March 31, 2023 in relation to senior leadership transition
(3) Performance restricted stock units granted in the three months ended June 30, 2023 in relation to senior leadership transition

Beginning share price: The beginning share price was based on the average closing share price over the 10 trading days preceding and including the start of the performance period. The beginning share price of the awards granted in the three months ended June 30, 2023 to one senior leader was based on the average closing share price over the 30 trading days preceding and including the start of the performance period.

Ending share price: The ending share price was based on the average closing share price over the 10 trading days preceding and including the end of the performance period. The ending share price of the awards granted in the three months ended June 30, 2023 to one senior leader was based on the average closing share price over the 30 trading days preceding and including the end of the performance period.

Expected volatility: The expected volatility was estimated based on the Company's historical share price volatility.

Expected term: Performance for awards granted in 2023 is generally measured from January 1, 2023 to December 31, 2025, with performance for awards granted to one senior leader in the three months ended March 31, 2023 being measured from January 1, 2023 to December 31, 2023, and performance for awards granted to one senior leader in the three months ended June 30, 2023 being measured from May 4, 2023 to May 4, 2026. Performance for awards granted in 2022 is measured from January 1, 2022 to December 31, 2024, and performance for awards for awards granted in 2021 is measured from January 1, 2021 to December 31, 2023.

Expected dividend yield: The expected dividend yield is not applicable to the performance restricted stock units as dividends are paid at the end of the vesting period and do not affect the value of the performance restricted stock units.

Risk-free interest rate: The risk-free rate was estimated based on the yield on a U.S. treasury zero-coupon bond issued with a remaining term equal to the vesting period of the performance restricted stock units.

Compensation expense associated with performance restricted stock units granted in 2023, 2022 and 2021 is determined on the grant date based on the fair value calculated by the Monte Carlo simulation model and is recognized on a straight-line basis over the requisite service period. During the three months ended March 31, 2023, the transition in our senior leadership resulted in a modification of the previously existing vesting terms of the outstanding restricted stock units and performance restricted stock units granted in 2022 and earlier of one senior leader, and a modification of the performance period of that leader's performance restricted stock units granted in 2022. The modifications did not result in incremental compensation expense.

215





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

17.    SHARE-BASED COMPENSATION (CONTINUED)
Performance Restricted Stock Units granted in 2020 and 2019
Performance restricted stock units granted in 2020 and 2019 and include a market condition which is the Company’s total shareholder return relative to its peer group ("Relative TSR") over the performance period. Relative TSR is calculated in accordance with the terms of the applicable award agreement. If performance goals are achieved, these awards will cliff vest at the end of a three-year performance period within a range of 75% to 125% of target. Performance restricted stock units granted in 2020 and 2019 were share-settled awards.

Compensation expense associated with performance restricted stock units granted in 2020 and 2019 is determined based on market value of the Company's common shares measured at the grant date, is recognized on a straight-line basis over the requisite service period and is subject to periodic adjustment based on the achievement of established performance criteria during the performance period.

b)     Share-Settled Awards

The following table provides an activity summary of the Company's share-settled restricted stock units:
Share-Settled Performance
Restricted Stock Units
Share-Settled Service
Restricted Stock Units
Number of
restricted
stock units
Weighted average grant date
fair value
Number of
restricted
stock units
Weighted average
grant date
fair value
Nonvested restricted stock units - December 31, 2021311 $54.75 2,062 $51.59 
Granted140 68.63 993 56.09 
Vested(100)54.70 (690)52.67 
Forfeited(21)62.26 (248)53.22 
Nonvested restricted stock units - December 31, 2022330 60.01 2,117 53.16 
Granted122 66.13 918 57.53 
Vested(88)63.88 (929)53.02 
Forfeited(220)58.15 (251)54.49 
Nonvested restricted stock units - December 31, 2023144 $65.69 1,855 $55.21 
216





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

17.    SHARE-BASED COMPENSATION (CONTINUED)
c)    Cash-Settled Awards
The following table provides an activity summary of the Company's cash-settled restricted stock units:
Cash-Settled Service Restricted Stock Units
Number of
restricted stock units
Nonvested restricted stock units - December 31, 2021215 
Granted 
Vested(145)
Forfeited(10)
Nonvested restricted stock units - December 31, 202260 
Granted 
Vested(59)
Forfeited(1)
Nonvested restricted stock units - December 31, 2023 

The following table provides additional information related to share-based compensation:
Year ended December 31,202320222021
Share-based compensation expense (1)
$57,729 $56,136 $49,415 
Tax benefits associated with share-based compensation expense$8,819 $8,839 $7,613 
Liability for cash-settled restricted stock units (2)
$ $4,792 $9,091 
Fair value of restricted stock units vested (3)
$64,156 $49,792 $42,967 
Unrecognized share-based compensation expense$62,416 $74,601 $80,805 
Expected weighted average period associated with the recognition of unrecognized share-based compensation expense2.4 years2.3 years2.4 years
(1)    Related to share-settled restricted stock units and cash-settled restricted stock units.
(2)    Included in other liabilities in the consolidated balance sheets.
(3)    Fair value is based on the closing price of the Company's common shares on the vest date.
217




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

18.    RELATED PARTY TRANSACTIONS

A member of the Company’s Board of Directors, Mr. Charles Davis, is the Chief Executive Officer of Stone Point Capital, LLC ("Stone Point"). In the ordinary course of business, the Company engages SKY Harbor Capital Management, LLC, which is majority-owned by Stone Point's private equity fund Trident V L.P. ("Trident V"), to provide asset management services for certain high yield debt portfolios. For the year ended December 31, 2023, total fees paid to SKY Harbor Capital Management, LLC, were $3 million (2022: $2 million; 2021: $2 million).
In addition, the Company has an investment of $17 million in the Freedom Consumer Credit Fund, LLC - Series B. The manager of this fund is Freedom Financial Asset Management, LLC ("Freedom") which is an indirect subsidiary of Pantheon Partners, LLC ("Pantheon"). A Stone Point private equity fund, Trident VI L.P. ("Trident VI") owns approximately 14.5% of Pantheon. For the year ended December 31, 2023, fees paid to Freedom were $1 million (2022: $2 million; 2021: $3 million).
The Company has an investment of $87 million in Stone Point's private equity fund, Trident VIII L.P. ("Trident VIII") and co-investments of $26 million with Trident VIII. For the year ended December 31, 2023, fees paid to Stone Point in relation to Trident VIII were $2 million (2022: $2 million; 2021: $4 million).
The Company has an investment of $24 million in Stone Point's private equity fund, Trident IX L.P. ("Trident IX"). For the year ended December 31, 2023, fees paid to Stone Point in relation to Trident IX were $1 million (2022: $1 million; 2021: $nil).
The Company has an investment of $43 million with Rialto Real Estate IV-Property ("Rialto") and co-investments of $19 million with Rialto, a fund managed by a portfolio company of Stone Point's private equity fund, Trident VII L.P. ("Trident VII "). For the year ended December 31, 2023, fees paid to Rialto were $2 million (2022: $2 million; 2021: $1 million).
The Company has an investment of $18 million in Stone Point Credit Corporation. For the year ended December 31, 2023, fees paid to Stone Point in relation to Stone Point Credit Corporation were $0.5 million (2022: $0.3 million; 2021: $nil).
The Company has an investment of $18 million in Stone Point Credit Corporation bonds. For the year ended December 31, 2023, the Company earned income of $1 million (2022: $0.6 million) in relation to this bond.
The Company has an investment of $5 million in a syndicated accounts receivable loan for which Sound Point Capital Management LP ("Sound Point"), an affiliate of Stone Point, is the lead originator. For the year ended December 31, 2023, the Company has not paid any fees to Sound Point.
The Company has co-investments of $9 million with Gordon Brothers, which is majority-owned by Trident VII. For the year ended December 31, 2023, fees paid to Gordon Brothers were $0.1 million (2022: $0.1 million).
The Company has an investment of $7 million in a loan to Eagle Point Credit Management LLC ("Eagle Point"), which is majority-owned by Trident IX. For the year ended December 31, 2023, the Company has not paid any fees to Eagle Point.
The Company has an investment of $6 million in cumulative preferred shares of Aspida Holdings Ltd. ("Aspida"). The investment was syndicated to the Company by Stone Point. For the year ended December 31, 2023, the Company has not paid any fees to Aspida.
The Company has an investment of $22 million in Monarch Point Re (refer to Note 5 'Investments'), a newly created collateralized reinsurer which is jointly sponsored by the Company and Stone Point. For the year ended December 31, 2023, fees paid to Monarch Point Re were $0.1 million.
The Company's investment portfolio includes certain investments where it is considered to have the ability to exercise significant influence over the operating and financial policies of the investee. Significant influence is generally deemed to exist where the Company has an investment of 20% or more in the common stock of a corporation or an investment greater than 3% to 5% in closed end funds, limited partnerships, LLCs or similar investment vehicles. 
At December 31, 2023, the Company has $424 million (2022: $462 million) of investments where it is deemed to have the ability to exercise such significant influence. The Company generally pays management and performance fees to the
218





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

18.    RELATED PARTY TRANSACTIONS (CONTINUED)
investment managers of these investments. The Company considers all fees paid to the investment managers to be at market rates consistent with negotiated arms-length contracts.
Retrocession Agreement with Monarch Point Re
On September 22, 2023 (the "closing date"), the Company entered into an agreement, with an effective date of January 1, 2023, to retrocede a diversified portfolio of casualty reinsurance business to Monarch Point Re.
The agreement covers losses both on a prospective basis and on a retroactive basis. Therefore, the Company has bifurcated the prospective and retroactive elements of the agreement and is accounting for each element separately.

Retroactive element
Reinsurance premiums of $119 million were allocated to the retroactive element of the agreement which was deemed to have met the established criteria for retroactive reinsurance accounting. At the closing date, the Company recognized acquisition costs of $33 million and a loss expense of $7 million in the consolidated statement of operations associated with the retroactive element of the agreement. In addition, the Company recognized reinsurance recoverable on unpaid losses of $76 million and reinsurance recoverable on paid losses of $4 million in the consolidated balance sheets associated with the retroactive element of the agreement (refer to Note 8 'Reserve for Losses and Loss Expenses').

Prospective element
For the year ended December 31, 2023, the Company ceded reinsurance premiums of $287 million and ceded losses of $37 million to Monarch Point Re. In addition, Monarch Point Re paid certain acquisition costs and administrative fees to the Company.
At December 31, 2023, the amount of reinsurance recoverable on unpaid and paid losses was $37 million and the amount of ceded reinsurance payable included in insurance and reinsurance balances payable was $166 million in the consolidated balance sheets.
This transaction was conducted at market rates consistent with negotiated arms-length contracts.
Loan to Monarch Point Re
During 2023, the Company advanced an amount of $297 million to Monarch Point Re. This loan will be repaid in a manner consistent with the timing of amounts due to Monarch Point Re under the retrocession agreement. At December 31, 2023, an amount of $72 million was repaid and was treated as a non-cash activity in the consolidated statement of cash flows. The loan is expected to be repaid in full by May 15, 2025. The loan balance receivable at December 31, 2023 of $225 million is included in loan advances made in the consolidated balance sheets. At December 31, 2023, the Company had committed to advance a further $16 million to Monarch Point Re.
Interest on this loan was payable for the three months ended December 31, 2023 at interest rates between 5.7% and 5.85%. Interest related to this loan was received in advance and is included in other liabilities in the consolidated balance sheets and interest income for this period is included in other insurance related income in the consolidated statement of operations.
Retrocession Agreement with Harrington Re
Harrington and Harrington Re commenced operations in 2016 (refer to Note 5 'Investments'). The Company has the ability to exercise significant influence over the operating and financial policies of Harrington and Harrington Re. In the normal course of business, the Company enters into certain reinsurance transactions with Harrington Re.
For the year ended December 31, 2023, the Company ceded reinsurance premiums of $298 million (2022: $324 million; 2021: $283 million) and ceded losses of $229 million (2022: $234 million; 2021: $188 million) to Harrington Re. In addition, Harrington Re paid certain acquisition costs and administrative fees to the Company.
219





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

18.    RELATED PARTY TRANSACTIONS (CONTINUED)
At December 31, 2023, the amount of reinsurance recoverable on unpaid and paid losses was $933 million (2022: $819 million) and the amount of ceded reinsurance payable included in insurance and reinsurance balances payable was $219 million (2022: $220 million) in the consolidated balance sheets. This transaction was conducted at market rates consistent with negotiated arms-length contracts.
On June 29, 2021, the Company invested $10 million in 7.25% fixed to floating rate, senior unsecured notes due 2031, issued by Harrington.

19.    REORGANIZATION EXPENSES
For the year ended December 31, 2023, reorganization expenses were $29 million (2022: $31 million and 2021: $nil).
In 2023, reorganization expenses included impairments of computer software assets and severance costs mainly related to the Company's "How We Work" program which is focused on simplifying and improving the Company’s operating structure.
In 2022, reorganization expenses included severance costs and software asset impairments attributable to the Company's exit from catastrophe and property reinsurance lines of business in June.

20.    INCOME TAXES
Under current Bermuda law, AXIS Capital's Bermuda subsidiaries are not required to pay any taxes in Bermuda on income or capital gains. The Company has received assurance from the Minister of Finance in Bermuda that, in the event of any taxes being imposed, it will be exempt from taxation in Bermuda until March 2035. Notwithstanding the above, on December 27, 2023 the Bermuda government enacted a corporate income tax which will apply for accounting periods starting on or after January 1, 2025. Importantly, under the Corporate Income Tax Act 2023 of Bermuda, any liability to the tax will apply regardless of any assurances previously provided under the Exempted Undertakings Tax Protection Act 1966 of Bermuda.
AXIS Capital's primary Bermuda subsidiary has an operating branch in Singapore, which is subject to the relevant taxes in that jurisdiction. The Singapore branch is not under examination in that tax jurisdiction but remains subject to examination for tax years 2020 through 2023.
AXIS Capital's U.S. subsidiaries are subject to federal, state and local corporate income taxes, and other taxes applicable to U.S. corporations. The provision for federal income taxes has been determined under the principles of the consolidated tax provisions of the U.S. Internal Revenue Code and regulations. Should the U.S. subsidiaries pay a dividend outside the U.S. group, withholding taxes will apply. AXIS Capital's U.S. subsidiaries are not under examination but remain subject to examination for tax years 2020 through 2023. An Internal Revenue Service ("IRS") examination of the U.S. group was completed in 2023 with respect to tax years 2019 and 2020 and was closed without material adjustments.
In Canada, AXIS Capital's U.S. reinsurance company operates through a branch and its U.S. service company has an unlimited liability company subsidiary based in Canada. The Canadian operations are subject to the relevant taxes in that jurisdiction and remain subject to examination for tax years 2019 through 2023.
AXIS Capital had subsidiaries in Ireland, the U.K., and Brazil in 2023 and AXIS Capital's subsidiaries had branches in the U.K., Switzerland, and Belgium. The Company ceased operations in Dubai in March 2021 and in the Netherlands in December 2021. These subsidiaries and their branches are not under examination but remain subject to examination in all applicable jurisdictions for tax years 2019 through 2023.
In the U.K., the Company operates through a Lloyd’s syndicate whose income is subject to tax in the U.K., payable by its corporate members. The income from operations at Lloyd’s is also subject to taxes in other jurisdictions in which Lloyd's operates, including the U.S. Under a Closing Agreement between Lloyd’s and the IRS, Lloyd's corporate members pay U.S. income tax on U.S. connected income written by Lloyd’s syndicates. To the extent that the Lloyd’s syndicates incur taxes outside the U.K., they may claim a credit for foreign taxes incurred, limited to the U.K. equivalent tax on the same income.
220




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021


20.    INCOME TAXES (CONTINUED)
The following table provides an analysis of income tax expense (benefit) and net tax assets:
Year ended December 31,202320222021
Current income tax expense (benefit)
U.S.$12,021 $11,491 $35,229 
Europe32,386 2,366 (6,082)
Bermuda
291 (147) 
Deferred income tax expense (benefit)
U.S.(24,042)(8,147)(3,369)
Europe18,932 16,474 36,606 
Bermuda(1)
(13,272)  
Total income tax expense (benefit)$26,316 $22,037 $62,384 
Net current tax receivables$78,570 $46,704 $27,883 
Net deferred tax assets (liabilities)72,850 108,220 12,860 
Net tax assets$151,420 $154,924 $40,743 
(1)    Reflects the recognition of a tax benefit in Bermuda on unrealized investment losses included in other comprehensive income (loss) due to the enactment of corporate income tax that will take effect in 2025.


221




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021


20.    INCOME TAXES (CONTINUED)
Deferred income taxes reflect the tax impact of temporary differences between the carrying amounts of assets and liabilities for financial reporting and income tax purposes. The following table provides details of the significant components of deferred tax assets and liabilities:
At December 31,20232022
Deferred tax assets:
Discounting of net reserves for losses and loss expenses$62,316 $52,992 
Unearned premiums54,104 56,146 
Net unrealized investments losses54,395 71,251 
Operating and capital loss carryforwards
100,907 152,896 
Accruals not currently deductible36,407 42,045 
Tax credits 11,602 7,619 
Other deferred tax assets4,149 8,590 
Deferred tax assets before valuation allowance323,880 391,539 
Valuation allowance(38,711)(60,069)
Deferred tax assets net of valuation allowance285,169 331,470 
Deferred tax liabilities:
Deferred acquisition costs(27,109)(35,211)
Other investment adjustments and impairments(7,173)(20,068)
Intangible assets(49,486)(51,993)
Equalization reserves(2,726)(2,530)
Acquisition adjustments(79,466)(72,351)
Lloyd’s deferred year of account results(38,194)(34,068)
Other deferred tax liabilities(8,165)(7,029)
Deferred tax liabilities(212,319)(223,250)
Net deferred tax assets (liabilities)$72,850 $108,220 
The following table summarizes total operating and capital loss carryforwards and tax credits:
At December 31,20232022
Operating and Capital Loss Carryforwards(1)
Singapore operating loss carryforward
$70,815 $73,769 
U.K. operating loss carryforward
293,533 415,274 
Ireland operating loss carryforward78,154 200,822 
Ireland capital loss carryforward716 716 
Switzerland operating loss carryforward(2)
123,453 187,057 
Tax Credits(1)
Ireland foreign tax credit$6,922 $655 
U.K. foreign tax credit2,605 2,372 
U.S. foreign tax credit(3)
2,074 4,592 
(1)    At December 31, 2023, the Singapore, U.K., and Ireland operating and capital loss carryforwards and tax credits can be carried forward
(2)    At December 31, 2023, the Swiss net operating losses can be carried forward 7 years of which $123,453 expires 2029.
(3)    At December 31, 2023, the U.S. foreign tax credit can be carried back 1 year and carried forward 10 years of which, $2,074 expires 2032.
222




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021


20.    INCOME TAXES (CONTINUED)

The following table shows an analysis of the movement in the Company's valuation allowance:
At December 31,20232022
Income tax expense (benefit):
Valuation allowance - beginning of year$39,782 $16,918 
Operating loss carryforwards(8,713)21,724 
Foreign tax credit4,184 2,401 
U.K. branch assets and other foreign rate differentials(3,565)(1,261)
Valuation allowance - end of year$31,688 $39,782 
Accumulated other comprehensive income (loss):
Valuation allowance - beginning of year$20,287 $ 
Change in investment - related items(13,264)20,287 
Valuation allowance - end of year7,023 20,287 
Total valuation allowance - end of year$38,711 $60,069 
At December 31, 2023 and 2022, the Company had a full valuation allowance on operating loss carryforwards relating to operations in Singapore, Ireland and Switzerland, foreign tax credits available in Ireland and certain other deferred tax assets related to branch operations.
In 2023, the valuation allowance decreased by $21 million. The net gain incurred by the AXIS Re SE, the Irish reinsurance company, resulted in the release of a valuation allowance of $25 million against the net deferred tax assets of AXIS Re SE and AXIS Re Europe, the Swiss branch of the Irish reinsurance company, of which $12 million was released in net income (loss) and $13 million was released in other comprehensive income (loss). A valuation allowance of $2 million was also released against U.S. foreign tax credits that were utilized. A valuation allowance of $6 million was recorded against foreign tax credits held by AXIS Specialty Europe SE.
At December 31, 2023 and 2022, the Company's U.S. operations had a deferred tax asset of $54 million and $71 million, respectively, for the unrealized losses on its fixed maturities that were recorded in other comprehensive income (loss). The Company examined the need for a valuation allowance and after considering all positive and negative evidence concluded a valuation allowance against its net unrealized investment losses in the U.S was not required.
Although realization is not assured, management believes it is more likely than not that the tax benefit of the recorded net deferred tax assets will be realized. In evaluating the Company's ability to recover these tax assets within the jurisdiction from which they arise, it considered all available positive and negative evidence, including historical results, operating loss carry-back potential and scheduled reversals of deferred tax liabilities. The Company believes its U.S. and U.K. operations will produce significant taxable income in future periods and have deferred tax liabilities that will reverse in future periods, such that the Company believes sufficient ordinary taxable income is available to utilize all remaining ordinary deferred tax assets.
A deferred tax liability has not been recorded on undistributed earnings as the U.S. group satisfies the indefinite reversal criteria.
At December 31, 2023 and 2022, there were no unrecognized tax benefits.

223




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021


20.    INCOME TAXES (CONTINUED)
The following table presents the distribution of income before income taxes between domestic and foreign jurisdictions and a reconciliation of the actual income tax rate to the amount computed by applying the effective tax rate of 0% under Bermuda law to income before income taxes:
Year ended December 31,202320222021
Income (loss) before income taxes
Bermuda (domestic)$213,539 $236,781 $431,310 
Foreign189,067 8,340 249,686 
 Total income before income taxes$402,606 $245,121 $680,996 
Reconciliation of effective tax rate (% of income before income taxes)
Expected tax rate0.0 %0.0 %0.0 %
Foreign taxes at local expected rates:
U.S.(2.5 %)0.2 %4.8 %
Europe11.9 %1.9 %2.0 %
Valuation allowance(2.0 %)9.5 %(0.5 %)
Prior year adjustments
1.3 %(0.3)%0.2 %
Incremental branch taxes
0.9 %(0.4)%1.5 %
Change in enacted tax rate(1)
(3.3 %)(2.2 %)1.5 %
Other0.2 %0.3 %(0.3 %)
Actual tax rate6.5 %9.0 %9.2 %
(1)    At December 31, 2023, the change in enacted tax rate represents the enactment of the Bermuda Corporate Income Tax Act of 2023 related to unrealized investment losses included in other comprehensive income (loss). At December 31, 2022, the change in enacted tax rate included a change in the UK tax rate from 19% to 25% and in Belgium from 30% to 25%.



224




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

21.    OTHER COMPREHENSIVE INCOME (LOSS)
The following table presents the tax effects allocated to each component of other comprehensive income (loss):
Before tax amountIncome tax (expense) benefitNet of tax amount
Year ended December 31, 2023
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$294,933 $(36,993)$257,940 
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized11,220 (1,637)9,583 
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)
142,324 (13,811)128,513 
Unrealized gains (losses) arising during the year, net of reclassification adjustment448,477 (52,441)396,036 
Foreign currency translation adjustment(1,572) (1,572)
Total other comprehensive income (loss), net of tax$446,905 $(52,441)$394,464 
Year ended December 31, 2022
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$(1,171,381)$127,756 $(1,043,625)
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized(73,063)5,913 (67,150)
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)335,294 (30,369)304,925 
Unrealized gains (losses) arising during the year, net of reclassification adjustment(909,150)103,300 (805,850)
Foreign currency translation adjustment(10,986) (10,986)
Total other comprehensive income (loss), net of tax$(920,136)$103,300 $(816,836)
Year ended December 31, 2021
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$(310,710)$39,263 $(271,447)
Unrealized gains (losses) arising during the year for which an allowance
for expected credit losses has been recognized
81  81 
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)(94,749)7,635 (87,114)
Unrealized gains (losses) arising during the year, net of reclassification adjustment(405,378)46,898 (358,480)
Foreign currency translation adjustment621  621 
Total other comprehensive income (loss), net of tax$(404,757)$46,898 $(357,859)

225





AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

21.    OTHER COMPREHENSIVE INCOME (LOSS) (CONTINUED)
The following table presents details of amounts reclassified from accumulated other comprehensive income (loss) ("AOCI") to net income (loss):
Amounts reclassified from AOCI(1)
AOCI componentsConsolidated statement of operations line item that includes reclassification adjustmentYear ended December 31,
202320222021
Unrealized gains (losses) on available for sale investments
Other realized gains (losses)
$(129,567)$(322,726)$94,771 
Impairment losses(12,757)(12,568)(22)
Total before tax(142,324)(335,294)94,749 
Income tax (expense) benefit13,811 30,369 (7,635)
Net of tax$(128,513)$(304,925)$87,114 
(1)    Amounts in parentheses are charges to net income (loss).

22.    STATUTORY FINANCIAL INFORMATION
The Company's insurance and reinsurance operations are subject to laws and regulations in the jurisdictions in which they operate, the most significant of which include Bermuda, Ireland, and the U.S. In addition, the Company is regulated by Lloyd's. These regulations include certain restrictions on the amount of dividends or other distributions, such as loans or cash advances, available to shareholders without prior approval from insurance regulatory authorities.
The statutory capital and surplus in each of the Company's most significant regulatory jurisdictions is shown in the following table:
BermudaIrelandU.S.
At December 31,202320222023202220232022
Required statutory capital and surplus$1,269,943 $1,261,160 $755,076 $699,203 $739,829 $651,460 
Available statutory capital and surplus$3,170,556 $3,156,955 $1,160,932 $1,099,474 $2,187,371 $1,982,618 

Bermuda
Under the Insurance Act 1978, amendments thereto and related regulations of Bermuda (the "Act"), the Company's Bermuda subsidiary, AXIS Specialty Bermuda is required to maintain minimum statutory capital and surplus equal to the greater of a minimum solvency margin ("MSM") and the Enhanced Capital Requirement ("ECR"). The MSM is the greater of $100 million, 50% of net premiums written, 15% of net reserve for losses and loss expenses, and 25% of the ECR. The Company's ECR is calculated based on a standard risk-based capital model developed by the Bermuda Monetary Authority ("BMA"). In 2016, the BMA implemented an Economic Balance Sheet ("EBS") framework which is used as the basis to determine the ECR. At December 31, 2023 and 2022, the required and available statutory capital and surplus were based on this EBS framework.
Under the Act, AXIS Specialty Bermuda is restricted as to the payment of dividends for amounts greater than 25% of the prior year’s statutory capital and surplus, whereby an affidavit signed by at least two members of the Board of Directors is required, attesting that any dividend in excess of this amount would not cause the Company to fail to meet its relevant margins. At December 31, 2023, the maximum dividend AXIS Specialty Bermuda could pay, without a signed affidavit, having met minimum levels of statutory capital and surplus requirements, was approximately $730 million (2022: $709 million).
226




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

22.    STATUTORY FINANCIAL INFORMATION (CONTINUED)

Ireland
Effective January 1, 2016, the Company's Irish subsidiaries, AXIS Specialty Europe and AXIS Re SE, are required to maintain the Minimum Capital Requirement ("MCR") and the Solvency Capital Requirement ("SCR") at all times. The capital requirements are calculated by reference to Solvency II definitions. If an entity falls below the MCR or SCR, the Central Bank of Ireland is authorized to take action to restore the financial position of the Company's Irish subsidiaries. During 2023 and 2022, the Company's Irish subsidiaries were in compliance with these requirements.
The Company's Irish subsidiaries may declare dividends subject to meeting their solvency and capital requirements. The maximum dividend is limited to "excess eligible own funds" which is defined as excess Solvency II capital over the SCR and may also be limited to "profits available for distribution'', which is defined as accumulated realized profits less accumulated realized losses and statutory reserves. The Central Bank of Ireland requires the Company's Irish subsidiaries to notify the regulator prior to any distribution being made. The Central Bank of Ireland then has 30 days to request further information from the Company's Irish subsidiaries and where no further communication is received from the regulator the Company's Irish subsidiaries are free to proceed with the dividend distribution. At December 31, 2023, the maximum dividend the Company's Irish subsidiaries could pay, having met their solvency and capital requirements was approximately $28 million (2022: $51 million).
United States
The Company's U.S. operations required statutory capital and surplus is determined using the risk-based capital formula ("RBC"), which is the National Association of Insurance Commissioners' (the "Commissioner") method of measuring the minimum capital appropriate for U.S. reporting entities to support its overall business operations in consideration of its size and risk profile. If a company falls below the authorized control level as determined under the RBC, the Commissioner is authorized to take whatever regulatory actions may be considered necessary to protect policyholders and creditors. The maximum dividend that may be paid by the Company's U.S. insurance subsidiaries is restricted by the regulatory requirements of the domiciliary states. Generally, the maximum dividend that may be paid by each of the Company's U.S. insurance subsidiaries is limited to unassigned surplus (statutory equivalent of retained earnings) and may also be limited to statutory net income, net investment income or 10% of total statutory capital and surplus. At December 31, 2023, the maximum dividend that the Company's U.S. insurance operations could pay without regulatory approval was approximately $181 million (2022: $119 million).
Lloyd's of London
The Company operates in the Lloyd’s market through its corporate members, AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited, which provide 70% and 30%, respectively, of Syndicate 1686's capital support. Syndicate 1686 is managed by AXIS Managing Agency.
Corporate members of Lloyd’s and Lloyd’s syndicates are bound by the rules of Lloyd’s, which are prescribed by Bye-laws and Requirements made by the Council of Lloyd’s under powers conferred by the Lloyd’s Act 1982. These rules prescribe members’ membership subscription, the level of their contribution to the Lloyd’s Central Fund and the assets they must deposit with Lloyd’s in support of their underwriting. The Council of Lloyd’s has broad powers to sanction breaches of its rules, including the power to restrict or prohibit a member’s participation on Lloyd’s syndicates.
The capital provided to support underwriting, or FAL, is not available for distribution for the payment of dividends or for working capital requirements. Corporate members may also be required to maintain funds under the control of Lloyd’s in excess of their capital requirements and such funds also may not be available for distribution for the payment of dividends. Lloyd’s sets the corporate members’ required capital annually and reviews funds held compared to latest capital requirements on a quarterly basis. This process is supported by the application of a capital model that is based on regulatory rules pursuant to Solvency II.

227




AXIS CAPITAL HOLDINGS LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023, 2022 AND 2021

22.    STATUTORY FINANCIAL INFORMATION (CONTINUED)

FAL may be satisfied by cash, certain investments and letters of credit provided by approved banks. At December 31, 2023, fixed maturities and short-term investments with a fair value of $587 million (2022: $530 million) and cash of $13 million (2022: $13 million), respectively, were restricted to satisfy AXIS Corporate Capital UK Limited FAL requirements. At December 31, 2023, fixed maturities and short-term investments with a fair value of $261 million (2022: $176 million), equity securities with a fair value of $27 million (2022: $23 million), and cash of $6 million (2022: $6 million) were restricted to satisfy AXIS Corporate Capital UK II Limited FAL requirements (refer to Note 5 'Investments' and Note 12 'Commitments and Contingencies').
Corporate members can apply to Lloyd's to release accumulated funds, whether syndicate profits or interest on FAL, which are in excess of the agreed FAL requirements on a quarterly basis. At December 31, 2023 and 2022, actual capital and assets exceeded the FAL requirements for Syndicate 1686. Both AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited continue to support the FAL requirements of Syndicates 1686.

Branch Offices
The Company's operating subsidiaries in Bermuda and the U.S. maintain branch offices in Singapore and Canada, respectively. The Company's Irish operating subsidiaries maintain branch offices in the U.K., Switzerland and Belgium. The Company's Irish operating subsidiaries also maintained a branch office in the Netherlands until December 31, 2021. As branch offices are not considered separate entities for regulatory purposes, the required and actual statutory capital and surplus amounts for each jurisdiction in the table above, include amounts related to the applicable branch offices. The Company's branch offices in Singapore and Canada are subject to additional minimum capital or asset requirements in their countries of domicile. At December 31, 2023 and 2022, the actual capital/assets for each of these branches exceeded the relevant local regulatory requirements.
Total statutory net income (loss) of the Company's operating subsidiaries was $471 million, $134 million, and $569 million for 2023, 2022 and 2021, respectively. The differences between statutory financial statements and statements prepared in accordance with U.S. GAAP vary by jurisdiction, however, the primary differences are that statutory financial statements may not reflect deferred acquisition costs, certain net deferred tax assets, goodwill and intangible assets, unrealized gains (losses) on fixed maturities or certain unauthorized reinsurance recoverable balances.

228


ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.

ITEM 9A.    CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
The Company’s management has performed an evaluation, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the "Exchange Act")) at December 31, 2023. Based on that evaluation, the Company's Chief Executive Officer and Chief Financial Officer concluded that, at December 31, 2023, the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and is accumulated and communicated to management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures.
Management’s Annual Report on Internal Control Over Financial Reporting
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). The Company’s management has performed an assessment, with the participation of the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, of the Company's internal control over financial reporting at December 31, 2023. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013).
Based on that assessment, the Company’s management believes that, at December 31, 2023, the Company's internal control over financial reporting is effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
The Company's independent registered public accounting firm has issued an audit report on management's assessment of the Company's internal control over financial reporting at December 31, 2023. This report appears below.
All internal control systems, no matter how well designed, have inherent limitations. As a result, even those internal control systems determined to be effective can provide only reasonable assurance with respect to financial reporting and the preparation of financial statements.
Changes in Internal Control Over Financial Reporting
The Company’s management has performed an evaluation, with the participation of the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, of changes in the Company’s internal control over financial reporting that occurred during the three months ended ended December 31, 2023. Based on that evaluation, there were no changes in the Company's internal control over financial reporting that occurred during the three months ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
229


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of AXIS Capital Holdings Limited

Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of AXIS Capital Holdings Limited and subsidiaries (the “Company”) as of December 31, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2023, of the Company and our report dated February 27, 2024 expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Controls Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Deloitte Ltd.
Hamilton, Bermuda
February 27, 2024

230


ITEM 9B.    OTHER INFORMATION
Disclosure of Certain Activities Under Section 13(r) of the Securities Exchange Act of 1934
Section 13(r) of the Securities Exchange Act of 1934, as amended, requires issuers to disclose in their annual and quarterly reports whether they or any of their affiliates knowingly engaged in certain activities with Iran or with individuals or entities that are subject to certain sanctions under U.S. law. Issuers are required to provide this disclosure even where the activities, transactions or dealings are conducted outside of the U.S. in compliance with applicable law.
As and when allowed by the applicable law and regulations, certain of our non-U.S. subsidiaries provide treaty reinsurance coverage to non-U.S. insurers on a worldwide basis, including insurers of liability, marine, aviation and energy risks, and as a result, these underlying insurance and reinsurance portfolios may have some exposure to Iran. In addition, we provide insurance and facultative reinsurance on a global basis to non-U.S. insureds and insurers, including for liability, marine, aviation and energy risks. Coverage provided to non-Iranian business may indirectly cover an exposure in Iran. For example, certain of our operations underwrite global marine hull war and cargo policies that provide coverage for vessels navigating into and out of ports worldwide, including Iran. For the year ended December 31, 2023, there has been no material amount of premium allocated or apportioned to activities relating to Iran. We intend for our non-U.S. subsidiaries to continue to provide such coverage only to the extent permitted by applicable law.
Insider Trading Arrangements and Policies
During the three months ended December 31, 2023, no director or officer of the Company adopted, terminated or is currently party to a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

ITEM 9C.    DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not Applicable.
PART III
ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required by this item is incorporated by reference from the sections captioned "Proposal No. 1 – Election of Directors", "Corporate Governance", and "Executive Officers" in the definitive proxy statement that will be filed with the Securities and Exchange Commission not later than 120 days after the close of the fiscal year ended December 31, 2023 pursuant to Regulation 14A.
ITEM 11.    EXECUTIVE COMPENSATION
The information required by this item is incorporated by reference from the sections captioned "Executive Compensation", "Compensation Discussion and Analysis", "Director Compensation", "Human Capital and Compensation Committee Report" and "Human Capital and Compensation Committee Interlocks and Insider Participation" in the definitive proxy statement that will be filed with the Securities and Exchange Commission not later than 120 days after the close of the fiscal year ended December 31, 2023 pursuant to Regulation 14A.

231


ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
 The information required by this item is incorporated by reference from the sections captioned "Principal Shareholders" and "Equity Compensation Plan Information" in the definitive proxy statement that will be filed with the Securities and Exchange Commission not later than 120 days after the close of the fiscal year ended December 31, 2023 pursuant to Regulation 14A.

ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this item is incorporated by reference from the sections captioned "Certain Relationships and Related Transactions", and "Corporate Governance" in the definitive proxy statement that will be filed with the Securities and Exchange Commission not later than 120 days after the close of the fiscal year ended December 31, 2023 pursuant to Regulation 14A.
ITEM 14.    PRINCIPAL ACCOUNTING FEES AND SERVICES
The information required by this item is incorporated by reference from the section captioned "Principal Accounting Fees and Services" in the definitive proxy statement that will be filed with the Securities and Exchange Commission not later than 120 days after the close of the fiscal year ended December 31, 2023 pursuant to Regulation 14A.
PART IV
ITEM 15.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)Financial Statements, Financial Statement Schedules and Exhibits

1.    Financial Statements
Included in Part II –Refer to Item 8 of this report.

2.    Financial Statement Schedules

Report of Independent Registered Public Accounting Firm
Schedule I    –    Summary of Investments - Other than Investments in Related Parties
Schedule II    –    Condensed Financial Information of Registrant
Schedule III    –    Supplementary Insurance Information
Schedule IV    –    Supplementary Reinsurance Information
Schedules V and VI have been omitted as the information is provided in Item 8, Consolidated Financial Statements, or in the above schedules.

3.    Exhibits
Exhibit
Number
Description of Document
Rule 2.7 Announcement dated July 5, 2017 in connection with acquisition of Novae Group plc (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on July 6, 2017).
Rule 2.7 Announcement dated August 24, 2017 in connection with acquisition of Novae Group plc (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on August 25, 2017).
232


Certificate of Incorporation and Memorandum of Association of AXIS Capital Holdings Limited (incorporated by reference to Exhibit 3.1 to the Company's Registration Statement on Form S-1 (Amendment No. 1) (No. 333-103620) filed on April 16, 2003).
Amended and Restated Bye-laws of AXIS Capital Holdings Limited (incorporated by reference to Exhibit 4.2 to the Company's Registration Statement on Form S-8 filed on May 15, 2009).
Specimen Common Share Certificate (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form S-1 (Amendment No. 3) (No. 333-103620) filed on June 10, 2003).
Senior Indenture among AXIS Specialty Finance LLC, AXIS Capital Holdings Limited and The Bank of New York Mellon Trust Company, N.A., as trustee, dated as of March 23, 2010 (incorporated by reference to Exhibit 4.4 to the Company's Quarterly Report on Form 10-Q filed on April 27, 2010).
Senior Indenture among AXIS Specialty Finance PLC, as issuer, the Company, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee, dated as of March 13, 2014 (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on March 13, 2014).
First Supplemental Indenture, dated as of April 3, 2019, among AXIS Specialty Finance PLC, AXIS Capital Holdings Limited and The Bank of New York Mellon Trust Company, N.A., relating to the 5.150% Senior Notes due 2045 (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on April 4, 2019).
Junior Subordinated Indenture dated as of December 10, 2019, among AXIS Specialty Finance LLC, AXIS Capital Holdings Limited and The Bank of New York Mellon Trust Company, N.A. (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on December 11, 2019).
First Supplemental Indenture dated as of December 10, 2019, among AXIS Specialty Finance LLC, AXIS Capital Holdings Limited and The Bank of New York Mellon Trust Company, N.A., relating to the 4.900% Junior Subordinated Notes due 2040 (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on December 11, 2019).
Form of 5.150% Senior Notes due 2045 (incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed on March 13, 2014).
Form of 4.000% Senior Notes due 2027 (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on December 6, 2017).
Form of 3.900% Senior Notes due 2029 (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on June 19, 2019).
Form of 4.900% Junior Subordinated Notes due 2040 (incorporated by reference to Exhibit 4.2 (included as Exhibit A to Exhibit 4.2) to the Company's Current Report on Form 8-K filed on December 11, 2019).
Certificate of Designations setting forth the specific rights, preferences, limitations and other terms of the 5.50% Series E Preferred Shares (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on November 7, 2016).
4.12
Description of AXIS Capital Holdings Limited's Securities Registered under Section 12 of the Exchange Act.
Amended and Restated Shareholders Agreement dated December 31, 2002, among AXIS Capital Holdings Limited and each of the persons listed on Schedule A thereto (incorporated by reference to Exhibit 10.1 to the Company's Registration Statement on Form S-1 (Amendment No. 3) (No. 333-103620) filed on June 10, 2003).
Employment Agreement by and among Albert Benchimol, AXIS Capital Holdings Limited and AXIS Specialty U.S. Services, Inc. dated May 3, 2012 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K/A filed on May 9, 2012).
Amendment No. 1 to Employment Agreement by and among Albert Benchimol, AXIS Capital Holdings Limited and AXIS Specialty U.S. Services, Inc. dated March 9, 2015 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on March 11, 2015).
Amendment No. 2 to Employment Agreement by and among Albert Benchimol, AXIS Capital Holdings Limited and AXIS Specialty U.S. Services, Inc. dated January 19, 2016 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on January 25, 2016).
233


Amendment No. 3 to Employment Agreement by and among Albert Benchimol, AXIS Capital Holdings Limited, AXIS Specialty U.S. Services, Inc. and AXIS Specialty Limited dated January 1, 2017 (incorporated by reference to Exhibit 10.10 to the Company's Annual Report on Form 10-K filed on February 27, 2017).
Amendment No. 4 to Employment Agreement by and among Albert Benchimol, AXIS Capital Holdings Limited and AXIS Specialty Limited dated December 6, 2018 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on December 11, 2018).
Employment Agreement by and between Peter Vogt and AXIS Specialty U.S. Services, Inc. dated December 11, 2017 (incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form 10-K filed on February 28, 2018).
Amendment No. 1 to Employment Agreement by and between Peter Vogt and AXIS Specialty U.S. Services, Inc. dated October 2, 2020 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on October 7, 2020).
Amendment No. 2 to Employment Agreement by and between Peter Vogt and AXIS Specialty U.S. Services, Inc. dated June 17, 2021 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 21, 2021).
Amendment No. 3 to Employment Agreement by and between Peter Vogt and AXIS Specialty U.S. Services, Inc. dated October 6, 2023 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on October 10, 2023).
Employment Agreement by and between David Phillips and AXIS Specialty U.S. Services, Inc. dated March 21, 2014 (incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on February 26, 2019).
Amendment No. 1 to Employment Agreement by and between David Phillips and AXIS Specialty U.S. Services, Inc. dated June 17, 2021 (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on June 21, 2021).
*†10.13
Employment Agreement by and between Conrad D. Brooks and AXIS Specialty U.S. Services, Inc. dated December 14, 2016.
Employment Agreement by and between Vincent Tizzio and AXIS Specialty U.S. Services, Inc. dated May 27, 2021 (incorporated by reference to Exhibit 10.19 to the Company's Annual Report on Form 10-K filed on February 27, 2023).
Amendment No. 1 to Employment Agreement by and between Vincent Tizzio and AXIS Specialty U.S. Services, Inc. dated September 9, 2021 (incorporated by reference to Exhibit 10.20 to the Company's Annual Report on Form 10-K filed on February 27, 2023).
Employment Agreement by and between Vincent Tizzio, AXIS Capital Holdings Limited and AXIS Specialty U.S. Services, Inc. dated April 11, 2023 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K/A filed on April 14, 2023).
*†10.17
Employment Agreement by and between Daniel Draper and AXIS UK Services Limited dated January 19, 2023.
2007 Long-Term Equity Compensation Plan, as amended (incorporated by reference to Exhibit 4.4 to the Company's Registration Statement on Form S-8 filed on May 15, 2012).
Amended and Restated 2017 Long-Term Equity Compensation Plan (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 11, 2021).
Second Amended and Restated 2017 Long-Term Equity Compensation Plan (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 8, 2023).
Executive Long-Term Equity Compensation Program effective February 2021 (incorporated by reference to Exhibit 10.27 to the Company's Annual Report on Form 10-K filed on February 26, 2021).
*†10.22
Amended and Restated Long-Term Equity Compensation Program effective February 2024.
*†10.23
Amended and Restated Executive Annual Incentive Plan effective February 2024.
234


*†10.24
Amended and Restated AXIS Executive RSU Retirement Plan.
Form of Employee Restricted Stock Unit Award Agreement (Performance Vesting) (incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on February 27, 2017).
Form of Employee Restricted Stock Unit Award Agreement (Retirement Eligible/Performance Vesting) (incorporated by reference to Exhibit 10.27 to the Company's Annual Report on Form 10-K filed on February 27, 2017).
Form of Employee Restricted Stock Unit Award Agreement (Retirement Eligible) (incorporated by reference to Exhibit 10.28 to the Company's Annual Report on Form 10-K filed on February 27, 2017).
Form of Employee Restricted Stock Unit Award Agreement (Performance Vesting) (incorporated by reference to Exhibit 10.37 to the Company's Annual Report on Form 10-K filed on February 28, 2018).
Form of Employee Restricted Stock Unit Award Agreement (incorporated by reference to Exhibit 10.38 to the Company's Annual Report on Form 10-K filed on February 28, 2018).
Form of Employee Restricted Stock Unit Award Agreement (Performance Vesting) (incorporated by reference to Exhibit 10.36 to the Company's Annual Report on Form 10-K filed on February 26, 2019).
Form of Employee Restricted Stock Unit Award Agreement (incorporated by reference to Exhibit 10.37 to the Company's Annual Report on Form 10-K filed on February 26, 2019).
Form of Employee Restricted Stock Unit Award Agreement (Performance Vesting) (incorporated by reference to Exhibit 10.39 to the Company's Annual Report on Form 10-K filed on February 27, 2020).
Form of Employee Restricted Stock Unit Award Agreement (Performance Vesting) (incorporated by reference to Exhibit 10.40 to the Company's Annual Report on Form 10-K filed on February 26, 2021).
Form of Employee Restricted Stock Unit Award Agreement (incorporated by reference to Exhibit 10.41 to the Company's Annual Report on Form 10-K filed on February 26, 2021).
*†10.35
Form of Employee Restricted Stock Unit Award Agreement.
Form of Employee Restricted Stock Unit Award Agreement (Three Year - Performance Vesting) (incorporated by reference to Exhibit 10.37 of the Company’s Form 10-K filed on February 27, 2023).
Form of Employee Restricted Stock Unit Award Agreement (One Year - Performance Vesting) (incorporated by reference to Exhibit 10.38 of the Company’s Form 10-K filed on February 27, 2023).
Form of Employee Restricted Stock Unit Award Agreement (Three Year - Performance Vesting based on absolute total shareholder return) (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on August 1, 2023).
*†10.39
Form of Employee Restricted Stock Unit Award Agreement (Three Year - Performance Vesting based on relative total shareholder return and absolute diluted book value per share).
AXIS Specialty U.S. Services, Inc. Supplemental Retirement Plan (incorporated by reference to Exhibit 10.23 to the Company's Annual Report on Form 10-K filed on February 26, 2008).
Directors Annual Compensation Program, effective January 1, 2023 (incorporated by reference to Exhibit 10.41 to the Company’s Annual Report on Form 10-K filed on February 27, 2023).
*†10.42
Directors Annual Compensation Program, effective January 1, 2024.
Master Reimbursement Agreement, dated as of May 14, 2010, by and among AXIS Specialty Limited, AXIS Re Limited, AXIS Specialty Europe Limited, AXIS Insurance Company, AXIS Surplus Insurance Company, AXIS Specialty Insurance Company, AXIS Reinsurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 19, 2010).
Amendment to Master Reimbursement Agreement dated January 27, 2012 by and among AXIS Specialty Limited, AXIS Re Limited, AXIS Specialty Europe Limited, AXIS Insurance Company, AXIS Surplus Insurance Company, AXIS Specialty Insurance Company and AXIS Reinsurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on January 30, 2012).
235


Amendment to Committed Facility Letter dated November 20, 2013 by and among AXIS Specialty Limited, AXIS Re SE, AXIS Specialty Europe SE, AXIS Insurance Company, AXIS Surplus Insurance Company and AXIS Reinsurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on November 21, 2013).
Amendment to Committed Facility Letter dated March 31, 2015 by and among AXIS Specialty Limited, AXIS Re SE, AXIS Specialty Europe SE, AXIS Insurance Company, AXIS Reinsurance Company, AXIS Surplus Insurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on April 1, 2015).
Amendment to Facility Fee Letter dated March 31, 2015 by and among AXIS Specialty Limited, AXIS Re SE, AXIS Specialty Europe SE, AXIS Insurance Company, AXIS Reinsurance Company, AXIS Surplus Insurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on April 1, 2015).
Committed Facility Letter dated December 18, 2015 by and among AXIS Specialty Limited, AXIS Re SE, AXIS Specialty Europe SE, AXIS Insurance Company, AXIS Surplus Insurance Company and AXIS Reinsurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on December 22, 2015).
Amendment to Master Reimbursement Agreement dated March 27, 2017 by and among AXIS Specialty Limited, AXIS Re Limited, AXIS Specialty Europe Limited, AXIS Insurance Company, AXIS Surplus Insurance Company, AXIS Reinsurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on March 31, 2017).
Deed of Amendment to $500 million secured letter of credit facility dated December 24, 2019 by and among AXIS Specialty Limited, AXIS Re SE, AXIS Specialty Europe SE, AXIS Insurance Company, AXIS Surplus Insurance Company, AXIS Reinsurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on December 30, 2019).
Deed of Amendment to $500 million secured letter of credit facility dated April 1, 2021 by and among AXIS Specialty Limited, AXIS Re SE, AXIS Specialty Europe SE, AXIS Insurance Company, AXIS Surplus Insurance Company, AXIS Reinsurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on April 6, 2021).
Deed of Amendment to $500 million secured letter of credit facility dated December 29, 2023 by and among AXIS Specialty Limited, AXIS Re SE, AXIS Specialty Europe SE, AXIS Insurance Company, AXIS Surplus Insurance Company, AXIS Reinsurance Company and Citibank Europe plc (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on January 3, 2024).
21.1
Subsidiaries of the Registrant.
22.1
Subsidiary Guarantors and Issuers of Guaranteed Securities.
23.1
Consent of Deloitte Ltd.
†24.1Power of Attorney (included as part of signature pages hereto).
31.1
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
*†97.1
Amended and Restated Executive Compensation Recoupment Policy
†101The following financial information from AXIS Capital Holdings Limited’s Annual Report on Form 10-K for the year ended December 31, 2023 formatted in Inline XBRL: (i) Consolidated Balance Sheets at December 31, 2023 and 2022; (ii) Consolidated Statements of Operations for the years ended December 31, 2023, 2022 and 2021; (iii) Consolidated Statements of Comprehensive Income for the years ended December 31, 2023, 2022 and 2021; (iv) Consolidated Statements of Changes in Shareholders' Equity for the years ended December 31, 2023, 2022 and 2021; (v) Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021; and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and in detail.
†104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
236


*    Management contract, compensatory plan or arrangement.
    Filed herewith.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.

ITEM 16.    FORM 10-K SUMMARY
None.
237


SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on February 27, 2024.
 AXIS CAPITAL HOLDINGS LIMITED
 By: 
/s/ VINCENT TIZZIO
 
  
Vincent Tizzio
 
  President and Chief Executive Officer 
POWER OF ATTORNEY
We, the undersigned directors and executive officers of AXIS Capital Holdings Limited, hereby appoint Peter Vogt and Conrad D. Brooks, and each of them singly, as our true and lawful attorneys with full power to them and each of them to sign for us, and in our names in the capacities indicated below, any and all amendments to the Annual Report on Form 10-K filed with the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorneys to any and all amendments to said Annual Report on Form 10-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on February 27, 2024.
Signature  Title
/s/ VINCENT TIZZIO
Chief Executive Officer, President and Director
(Principal Executive Officer)
Vincent Tizzio
  
/s/ PETER VOGTChief Financial Officer
(Principal Financial Officer)
Peter Vogt  
/s/ KENT ZIEGLERGlobal Corporate Controller
(Principal Accounting Officer)
Kent Ziegler  
/s/ W. MARSTON BECKERDirector
W. Marston Becker
/s/ CHARLES DAVIS
Director
Charles Davis
/s/ ANNE MELISSA DOWLINGDirector
Anne Melissa Dowling
238


Signature  Title
/s/ STANLEY GALANSKI
Director
Stanley Galanski
  
/s/ ELANOR HARDWICK
Director
Elanor Hardwick
/s/ MICHAEL MILLEGANDirector
Michael Millegan
/s/ THOMAS RAMEY
Director
Thomas Ramey
  
/s/ HENRY SMITH
Director
Henry Smith
/s/ AXEL THEISDirector
Axel Theis
/s/ BARBARA YASTINE
Director
Barbara Yastine
  
/s/ LIZABETH ZLATKUS
Director
Lizabeth Zlatkus

239


SCHEDULE I
AXIS CAPITAL HOLDINGS LIMITED
SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES
 
At December 31, 2023
Amortized costFair valueAmount shown on the balance sheet
(in thousands)
Type of investment:
Fixed maturities, available for sale, at fair value
U.S. government and agency$3,049,445 $3,007,528 $3,007,528 
Non-U.S. government729,761 723,959 723,959 
Corporate debt4,651,654 4,474,172 4,474,172 
Agency RMBS1,706,204 1,634,661 1,634,661 
CMBS897,553 839,696 839,696 
Non-agency RMBS165,910 153,396 153,396 
ABS1,265,187 1,242,971 1,242,971 
Municipals168,540 158,359 158,359 
Total fixed maturities, available for sale$12,634,254 12,234,742 12,234,742 
Fixed maturities, held to maturity, at amortized cost
Corporate debt$95,200 86,671 95,200 
ABS591,096 589,180 591,096 
Total fixed maturities, held to maturity$686,296 675,851 686,296 
Mortgage loans, held for investment, at fair value610,148 610,148 
Short-term investments, at fair value17,216 17,216 
Equity securities, at fair value588,511 588,511 
Other investments, at fair value (1)
699,607 949,413 
Equity method investments (2)
 174,634 
Total investments$14,826,075 $15,260,960 
(1)Other investments exclude investments where the Company is considered to have the ability to exercise significant influence over the operating and financial policies of the investees.
(2)Equity method investments are excluded as the Company has the ability to exercise significant influence over the operating and financial policies of the investees.
240


SCHEDULE II
AXIS CAPITAL HOLDINGS LIMITED
CONDENSED BALANCE SHEETS – PARENT COMPANY
DECEMBER 31, 2023 AND 2022
 
20232022
(in thousands)
Assets
Investments in subsidiaries$5,415,302 $4,943,126 
Cash and cash equivalents412 1,932 
Other assets4,751 4,432 
Total assets$5,420,465 $4,949,490 
Liabilities
Intercompany payable$89,430 $225,490 
Dividends payable51,749 52,992 
Other liabilities16,090 31,098 
Total liabilities157,269 309,580 
Shareholders’ equity
Preferred shares550,000 550,000 
Common shares (shares issued 2023: 176,580; 2022: 176,580
     shares outstanding 2023: 85,286; 2022: 84,668)
2,206 2,206 
Additional paid-in capital2,383,030 2,366,253 
Accumulated other comprehensive income (loss)(365,836)(760,300)
Retained earnings6,440,528 6,247,022 
Treasury shares, at cost (2023: 91,294; 2022: 91,912)
(3,746,732)(3,765,271)
Total shareholders’ equity5,263,196 4,639,910 
Total liabilities and shareholders’ equity$5,420,465 $4,949,490 

(1)AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance PLC, a 100% owned finance subsidiary, related to the issuance of $250 million aggregate principal amount of 5.15% senior unsecured notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.

(2)AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance PLC, a 100% owned finance subsidiary, related to the issuance of $350 million aggregate principal amount of 4.0% senior unsecured notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.

(3)AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance LLC, a 100% owned finance subsidiary, related to the issuance of $300 million aggregate principal amount of 3.9% senior unsecured notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.

(4)AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance LLC, a 100% owned finance subsidiary, related to the issuance of $425 million aggregate principal amount of 4.9% fixed-rate reset junior unsecured notes. AXIS Capital's obligation under this guarantee is an unsecured junior subordinated obligation and ranks equally with all future unsecured and junior subordinated obligations of AXIS Capital, and junior in right of payment to all outstanding and future senior obligations of AXIS Capital.


241


SCHEDULE II
AXIS CAPITAL HOLDINGS LIMITED
CONDENSED STATEMENTS OF OPERATIONS – PARENT COMPANY
YEARS ENDED DECEMBER 31, 2023, 2022 AND 2021
 
202320222021
(in thousands)
Revenues
Net investment income
$ $ $ 
Total revenues   
Expenses
General and administrative expenses52,334 60,252 62,843 
Total expenses52,334 60,252 62,843 
Income (loss) before equity in net income of subsidiaries
(52,334)(60,252)(62,843)
Equity in net income of subsidiaries
428,626 283,335 681,452 
Net income376,292 223,083 618,609 
Preferred share dividends30,250 30,250 30,250 
Net income available to common shareholders$346,042 $192,833 $588,359 
Comprehensive income (loss)$770,756 $(593,753)$260,750 


242


SCHEDULE II
AXIS CAPITAL HOLDINGS LIMITED
CONDENSED STATEMENTS OF CASH FLOWS – PARENT COMPANY
YEARS ENDED DECEMBER 31, 2023, 2022 AND 2021
 
202320222021
 (in thousands)
Cash flows from operating activities:
Net income$376,292 $223,083 $618,609 
Adjustments to reconcile net income to net cash provided by operating activities:
Equity in income loss of subsidiaries
(428,626)(283,335)(681,452)
Change in intercompany payable(136,059)32,871 (96,868)
Dividends received from subsidiaries375,000 225,000 300,000 
Other items(34,626)(17,140)7,882 
Share-based compensation expense, net of cash payments54,119 48,494 37,744 
Net cash provided by operating activities206,100 228,973 185,915 
Cash flows from financing activities:
Taxes paid on withholding shares(23,595)(13,994)(10,242)
Dividends paid - common shares(153,775)(149,341)(145,603)
Repurchase of common shares - open market (34,987) 
Dividends paid - preferred shares(30,250)(30,250)(30,250)
Net cash used in financing activities(207,620)(228,572)(186,095)
Increase (decrease) in cash, cash equivalents and restricted cash(1,520)401 (180)
Cash, cash equivalents and restricted cash - beginning of year1,932 1,531 1,711 
Cash, cash equivalents and restricted cash - end of year$412 $1,932 $1,531 


243


SCHEDULE III
AXIS CAPITAL HOLDINGS LIMITED
SUPPLEMENTARY INSURANCE INFORMATION
 
 At and year ended December 31, 2023
(in thousands)Deferred
acquisition
costs
Reserve
for losses
and loss
expenses
Unearned
premiums
Net
premiums
earned
Net
investment income(1)
Net losses
and loss
expenses
Acquisition
costs
Other
operating expenses(2)
Net
premiums
written
Insurance$298,249 $9,507,409 $3,507,519 $3,461,700 $ $2,080,001 $648,463 $472,094 $3,758,720 
Reinsurance152,701 6,926,609 1,240,083 1,622,081  1,313,101 352,482 79,373 1,343,605 
Corporate    611,742   132,979  
Total$450,950 $16,434,018 $4,747,602 $5,083,781 $611,742 $3,393,102 $1,000,945 $684,446 $5,102,325 
 At and year ended December 31, 2022
(in thousands)Deferred
acquisition
costs
Reserve
for losses
and loss
expenses
Unearned
premiums
Net
premiums
earned
Net
investment income(1)
Net losses
and loss
expenses
Acquisition
costs
Other
operating expenses(2)
Net
premiums
written
Insurance$249,407 $8,381,593 $3,077,628 $3,134,155 $ $1,785,854 $577,838 $443,704 $3,377,906 
Reinsurance224,162 6,787,270 1,283,819 2,026,171  1,456,556 444,179 106,585 1,885,150 
Corporate    418,829   130,054  
Total$473,569 $15,168,863 $4,361,447 $5,160,326 $418,829 $3,242,410 $1,022,017 $680,343 $5,263,056 
 At and year ended December 31, 2021
(in thousands)Deferred
acquisition
costs
Reserve
for losses
and loss
expenses
Unearned
premiums
Net
premiums
earned
Net
investment income(1)
Net losses
and loss
expenses
Acquisition
costs
Other
operating expenses(2)
Net
premiums
written
Insurance$212,681 $7,803,529 $2,716,240 $2,651,339 $ $1,514,998 $484,344 $429,282 $2,894,885 
Reinsurance252,912 6,849,565 1,374,436 2,058,511  1,493,785 437,490 107,552 2,031,739 
Corporate    454,301   126,470  
Total$465,593 $14,653,094 $4,090,676 $4,709,850 $454,301 $3,008,783 $921,834 $663,304 $4,926,624 
(1)The Company evaluates underwriting results of its reportable segments separately from the performance of its investment portfolio. Therefore, the Company believes it is appropriate to exclude net investment income from its underwriting profitability measure.
(2)Amounts related to the Company's reportable segments reflect underwriting-related general and administrative expenses, which includes those general and administrative expenses that are incremental and/or directly attributable to the Company's underwriting operations. Underwriting-related general and administrative expenses is a non-GAAP financial measure as defined in Item 10(e) of SEC Regulation S-K. The reconciliation to general and administrative expenses, the most comparable GAAP financial measure, presented in the table above, also includes corporate expenses of $133 million, $130 million, and $126 million for the years ended December 31, 2023, 2022 and 2021, respectively. Corporate expenses include holding company costs necessary to support our worldwide insurance and reinsurance operations and costs associated with operating as a publicly-traded company. As these costs are not incremental and/or directly attributable to the Company's underwriting operations, these expenses are excluded from underwriting-related general and administrative expenses.


244


SCHEDULE IV
AXIS CAPITAL HOLDINGS LIMITED
SUPPLEMENTARY REINSURANCE INFORMATION
YEARS ENDED DECEMBER 31, 2023, 2022 AND 2021
 
(in thousands)
GROSS
AMOUNT
CEDED TO
OTHER
COMPANIES
ASSUMED
FROM
OTHER
COMPANIES
NET
AMOUNT
PERCENTAGE
OF AMOUNT
ASSUMED TO
NET
2023
Property and Casualty$5,223,919 $3,161,438 $2,402,378 $4,464,859 53.8 %
Accident and Health311,970 92,762 418,258 637,466 65.6 %
Total$5,535,889 $3,254,200 $2,820,636 $5,102,325 55.3 %
2022
Property and Casualty$4,858,629 $2,900,300 $2,685,677 $4,644,006 57.8 %
Accident and Health244,329 51,239 425,960 619,050 68.8 %
Total$5,102,958 $2,951,539 $3,111,637 $5,263,056 59.1 %
2021
Property and Casualty$4,233,758 $2,700,693 $2,874,687 $4,407,752 65.2 %
Accident and Health171,694 58,667 405,845 518,872 78.2 %
Total$4,405,452 $2,759,360 $3,280,532 $4,926,624 66.6 %


245
EX-101.SCH 2 axs-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - COVER link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - AUDIT INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - ORGANIZATION link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - DERIVATIVE INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - REINSURANCE link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - DEBT AND FINANCING ARRANGEMENTS link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - FEDERAL HOME LOAN BANK ADVANCES link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - EARNINGS PER COMMON SHARE link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - RETIREMENT PLANS link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - REORGANIZATION EXPENSES link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - STATUTORY FINANCIAL INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - REINSURANCE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - DEBT AND FINANCING ARRANGEMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - EARNINGS PER COMMON SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - SHAREHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) (Tables) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - STATUTORY FINANCIAL INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - ORGANIZATION (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - SEGMENT INFORMATION - Summary of Underwriting Results of Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - SEGMENT INFORMATION - Summary of Gross Premiums Written by Geographical Location of Subsidiaries (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - SEGMENT INFORMATION - Summary of Net Premiums Earned by Segment and Line of Business (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Gross Amount and Accumulated Amortization by Category (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Estimated Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - INVESTMENTS - Fixed Maturities Available For Sale (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - INVESTMENTS - Contractual Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - INVESTMENTS - Gross Unrealized Losses (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - INVESTMENTS - Fixed Maturities, Held to Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - INVESTMENTS - Fixed Maturities, Held to Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - INVESTMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - INVESTMENTS - Equity Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - INVESTMENTS - Mortgage Loans (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - INVESTMENTS - Other Investments (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - INVESTMENTS - Equity method investments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - INVESTMENTS - Variable Interest Entities (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - INVESTMENTS - Net Investment Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - INVESTMENTS - Net Investment Gains (Losses) (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - INVESTMENTS - Summary of Allowance for Credit Loss (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - INVESTMENTS - Fixed Maturity Securities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - INVESTMENTS - Restricted Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - INVESTMENTS - Reverse Repurchase Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Level 3 Fair Value Measurement Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Level 3 for Financial Instruments Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - DERIVATIVE INSTRUMENTS - Offsetting Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - DERIVATIVE INSTRUMENTS - Gains (Losses) on Derivatives Recognized in Net Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve for Losses and Loss Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve Roll-forward (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Losses Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Prior Year Reserve Development (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Summary of Prior Year Reserve Development by Segment and Reserving Class (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Details) link:presentationLink link:calculationLink link:definitionLink 9954527 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reconciliation of Development Tables to Consolidated Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 9954528 - Disclosure - REINSURANCE (Details) link:presentationLink link:calculationLink link:definitionLink 9954529 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Summary of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954530 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Debt terms (Details) link:presentationLink link:calculationLink link:definitionLink 9954531 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Senior and Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 9954532 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Summary of Debt Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954533 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Loan Advances Made to a Third Party Reinsurer (Details) link:presentationLink link:calculationLink link:definitionLink 9954534 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Letter of Credit facility (Details) link:presentationLink link:calculationLink link:definitionLink 9954535 - Disclosure - FEDERAL HOME LOAN BANK ADVANCES (Details) link:presentationLink link:calculationLink link:definitionLink 9954536 - Disclosure - COMMITMENTS AND CONTINGENCIES - Cash and Investments (Details) link:presentationLink link:calculationLink link:definitionLink 9954537 - Disclosure - COMMITMENTS AND CONTINGENCIES - Reinsurance and Premiums (Details) link:presentationLink link:calculationLink link:definitionLink 9954538 - Disclosure - COMMITMENTS AND CONTINGENCIES - Reinsurance Purchase Commitment, Investments and Funds at Lloyd's (Details) link:presentationLink link:calculationLink link:definitionLink 9954539 - Disclosure - LEASES - Summary of Lease Expense and Related Cash Flows (Details) link:presentationLink link:calculationLink link:definitionLink 9954540 - Disclosure - LEASES - Summary of Maturity and Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954541 - Disclosure - EARNINGS PER COMMON SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 9954542 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Common Shares Issued and Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 9954543 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Share Repurchases (Details) link:presentationLink link:calculationLink link:definitionLink 9954544 - Disclosure - SHAREHOLDERS' EQUITY - Preferred Shares Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954545 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Dividends Declared and Paid (Details) link:presentationLink link:calculationLink link:definitionLink 9954546 - Disclosure - RETIREMENT PLANS (Details) link:presentationLink link:calculationLink link:definitionLink 9954547 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954548 - Disclosure - SHARE-BASED COMPENSATION - Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954549 - Disclosure - SHARE-BASED COMPENSATION - Summary of Shares and Cash Settled Awards (Details) link:presentationLink link:calculationLink link:definitionLink 9954550 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Additional Information Related to Share-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 9954551 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 9954552 - Disclosure - REORGANIZATION EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 9954553 - Disclosure - INCOME TAXES - Summary of Income Tax Expense and Net Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954554 - Disclosure - INCOME TAXES - Summary of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954555 - Disclosure - INCOME TAXES - Summary of Operating and Capital Loss Carryforwards and Tax Credits (Details) link:presentationLink link:calculationLink link:definitionLink 9954556 - Disclosure - INCOME TAXES - Summary of Valuation Allowance (Details) link:presentationLink link:calculationLink link:definitionLink 9954557 - Disclosure - INCOME TAXES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954558 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 9954559 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 9954559 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 9954560 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders (Details) link:presentationLink link:calculationLink link:definitionLink 9954561 - Disclosure - STATUTORY FINANCIAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 9954562 - Disclosure - SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954563 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS (Details) link:presentationLink link:calculationLink link:definitionLink 9954564 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954565 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS - Footnotes (Details) link:presentationLink link:calculationLink link:definitionLink 9954566 - Disclosure - SCHEDULE II - CONDENSED STATEMENTS OF OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 9954567 - Disclosure - SCHEDULE II - CONDENSED STATEMENTS OF CASH FLOWS (Details) link:presentationLink link:calculationLink link:definitionLink 9954568 - Disclosure - SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 9954569 - Disclosure - SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 axs-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 axs-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 axs-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT FHLB advances, interest rate (as a percent) Federal Home Loan Bank, Advances, General Debt Obligations, Disclosures, Interest Rate at Period End Short-term investments, at fair value Short-term investments Other Short-Term Investments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Fixed maturities, available for sale Proceeds from Sale of Debt Securities, Available-for-Sale Maximum capacity Line of Credit Facility, Maximum Borrowing Capacity Changes in: Increase (Decrease) in Operating Capital [Abstract] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Accident Year 2017 Short-Duration Insurance Contracts, Accident Year 2017 [Member] Gross outstanding liabilities Short-Duration Insurance Contracts, Liability For Unpaid Claims And Allocated Claim Adjustment Expense, Gross Undiscounted amount, before reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense. Redemption Restriction Type [Axis] Redemption Restriction Type [Axis] Information by type of redemption restriction. Unrealized gains (losses) arising during the year, net of reclassification adjustment Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, before Tax, Portion Attributable to Parent Summary of Net Premiums Earned by Segment and Line of Business Revenue from External Customers by Products and Services [Table Text Block] Award Type [Domain] Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Award Type [Domain] Sales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales Combined ratio Combined Ratio Fair Value as of Grant Date Award Grant Date Fair Value Investment, Name [Domain] Investment, Name [Domain] Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Summary of Amortized Cost and Fair Values of Fixed Maturities Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Federal Home Loan Bank of Chicago Federal Home Loan Bank of Chicago [Member] Federal Home Loan Bank advances Advances from FHLB Advance from Federal Home Loan Bank Novae Novae [Member] Novae [Member] Opening balance Closing balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Insurance and reinsurance balances, net (Increase) Decrease In Premiums Receivable And Reinsurance Payable Net The net change in the premium receivable and the amount due to other insurance companies on the balance sheet. Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Expected cash flows, year five Lessee, Operating Lease, Liability, to be Paid, Year Five Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] SHAREHOLDERS' EQUITY Equity [Text Block] Freedom Freedom Financial Asset Management, LLC ("Freedom") [Member] Freedom Consumer Credit Fund, LLC Series B [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Agriculture Agriculture Line [Member] Agriculture line of business Equalization reserves Deferred Tax Liabilities Equalization Reserves Amount of deferred tax liability attributable to tax deductible temporary differences from credit insurance reserve increases. Statutory Accounting Practices [Table] Statutory Accounting Practices [Table] Customer [Axis] Customer [Axis] Discounted cash flow Alternative Investment, Measurement Input Related Portfolio [Axis] Related Portfolio [Axis] Information that identifies a derivative or a group of derivatives by related portfolio. Motor Reserve Class Motor Reserve Class [Member] Motor Reserve Class Preferred shares Preferred Stock, Value, Issued Dividends paid - common shares Payments of Ordinary Dividends, Common Stock Unrealized and Realized Gains (Losses) Recognized in Earnings for Derivatives Not Designated As Hedges [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Earnings per diluted common share (in dollars per share) Earnings per diluted common share (in dollars per share) Earnings Per Share, Diluted Fixed maturities, held to maturity, allowance for credit loss Allowance for expected credit losses Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest Funds at Lloyd's Pledged Financial Instruments, Underwriting Support Pledged Financial Instruments, Underwriting Support Allowance for credit losses on reinsurance recoverable for unpaid losses and loss expenses Reinsurance Recoverable, Allowance for Credit Loss Gross Premiums Earned Gross Amount, before premiums ceded to other entities, of premiums earned. Derivative asset, statement of financial position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Trading Symbol Trading Symbol Letters of credit outstanding Letters of Credit Outstanding, Amount Equity method investments Payments to acquire equity method investments Payments to Acquire Equity Method Investments Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature [Domain] Year 8 Short-Duration Insurance Contracts, Historical Claims Duration, Year Eight Valuation, Market Approach Valuation, Market Approach [Member] Other Investments [Line Items] Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] Reconciliation of effective tax rate (% of income before income taxes) Effective Income Tax Rate Reconciliation, Percent [Abstract] After 2028 Finite-Lived Intangible Asset, Expected Amortization, after Year Five Axis Corporate Capital UK Limited Axis Corporate Capital UK Limited [Member] Axis Corporate Capital UK Limited Other investments, at fair value Asset fair value Other investments Alternative Investment Syndicate 2007 Novae Syndicate 2007 [Member] Novae Syndicate 2007 [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Gross amount Intangible Assets, Gross (Excluding Goodwill) Gross investment income Investment Income For Investments And Cash And Cash Equivalents The net gain or loss (both realized and unrealized) related to investments in certain entities that calculate net asset value per share and the amount after accretion (amortization) of discount (premium), of interest income and dividend income on nonoperating securities. $250 Million Secured LOC LOC Facility [Member] LOC Facility [Member] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Other investments Proceeds from Sale and Maturity of Other Investments Percentage of investment composition (as a percent) Percentage Of Investment Composition Percentage Of Investment Composition INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Shareholders' equity Shareholders’ equity Equity, Attributable to Parent [Abstract] Change in enacted tax rate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Short-duration Insurance Contracts, Historical Claims Duration [Table] Short-Duration Insurance Contracts, Historical Claims Duration [Table] Unfunded commitments related to other investments Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments Reclassification out of accumulated comprehensive income into net income available to common shareholders [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Summary of Basic and Diluted Earnings (Loss) Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Income earned Related Party Transaction, Amounts of Transaction Total of incurred-but-not-reported liabilities plus expected development on reported claims Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net Derivative liability, statement of financial position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Total restricted investments and cash Debt Securities, Available-for-Sale, Restricted Executive Category: Executive Category [Axis] Summary of Changes in Level 3 Financial Instruments Measured at Fair Value on a Recurring Basis, Assets Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Ceded premiums Ceded CEDED TO OTHER COMPANIES Ceded Premiums Written Number of restricted stock units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Quoted prices in active markets for identical assets (Level 1) Fair Value, Inputs, Level 1 [Member] Catastrophe Catastrophe Reinsurance [Member] Catastrophe line of business Deferred tax assets net of valuation allowance Deferred Tax Assets, Net of Valuation Allowance Reported Value Measurement Reported Value Measurement [Member] Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized AOCI, Gain (Loss), Debt Securities, Available-for-Sale, with Allowance for Credit Loss, Parent [Member] Multi-strategy funds Hedge Funds, Multi-strategy [Member] Incremental branch taxes Effective Income Tax Rate Reconciliation, Incremental Branch Taxes, Percent Effective Income Tax Rate Reconciliation, Incremental Branch Taxes, Percent Equity Components [Axis] Statement, Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Number of awards available for grant under plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 3.900% Senior Notes 3.900% Senior Notes [Member] 3.900% Senior Notes [Member] Investment Type [Axis] Schedule Of Investment Income Reported Amounts By Category [Axis] Investment Type [Axis] Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year 2025 Long-Term Debt, Maturity, Year Two Entity Small Business Entity Small Business Credit and surety Credit and Surety Business [Member] Credit and Surety Business [Member] Investment Type Categorization [Domain] Investments [Domain] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Foreign exchange losses Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Letter of Credit Facility Letter of Credit [Member] Other realized and unrealized investment gains (losses) Marketable Security, Gain (Loss) Other investments Alternative Investments [Member] Fair value of investments in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest. Investments include, but are not limited to, investments in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] Derivative notional amount Derivative, Notional Amount Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized AOCI, Gain (Loss), Debt Securities, Available-for-Sale, without Allowance for Credit Loss, Parent [Member] Restricted Stock Units Restricted Stock Units (RSUs) [Member] Summary of Reconciliation of Beginning and Ending Balance of Non Vested Restricted Stock (Including RSUs) to be Settled in Shares Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Reserve for reported losses and loss expenses Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount Share Settled Share Settled [Member] Share-based compensation to be settled in stock. Summary of Cost and Fair Value of Equity Securities Marketable Securities [Table Text Block] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Minimum solvency margin amount Statutory Accounting Practices Minimum Solvency Margin Amount The minimum solvency margin amount, which is a factor of the minimum statutory capital and surplus calculation, required to be maintained, in terms of the Insurance Act 1978, amendments thereto and Related Regulations of Bermuda. Gross realized investment gains Debt And Equity Securities, Realized Gain [Abstract] Debt and Equity Securities, Realized Gain [Abstract] Professional lines Professional Liability Insurance [Member] Monarch Point Re Monarch Point Re [Member] Monarch Point Re (ISAC) Ltd. and Monarch Point Re (ISA 2023) Ltd. Impairments of securities which the Company intends to sell or more likely than not will be required to sell Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Sell before Recovery Reorganization expenses Reorganization expenses Restructuring, Settlement and Impairment Provisions Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Line of Credit Facility [Table] Line of Credit Facility [Table] Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Ceded Credit Risk [Axis] Reinsurer, Name [Axis] Number of investment funds Number Of Investment Funds Number Of Investment Funds Goodwill and intangible assets Goodwill and intangible assets net balance Intangible Assets, Net (Including Goodwill) Net tax assets Tax Assets Liabilities Net Amount of deferred tax assets, net of any valuation allowance and deferred tax liabilities, which result from applying the applicable tax rate to taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. This amount also includes the carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations. Aspida Holdings, Ltd Aspida Holdings, Ltd [Member] Aspida Holdings, Ltd Mortgage loans Mortgages [Member] Net income (loss) Net Income (Loss) [Member] Net Income (Loss) Ceded reserves related to retroactive transactions Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item Due after ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 U.S. state licenses Unites States, State licenses [Member] U.S. state licenses that provide a legal right to transact business indefinitely. Total revenues Revenues Investment term Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Redemption Restriction Period Interest expense Interest Expense, Debt Grantee Status [Axis] Grantee Status [Axis] SKY Harbor Capital Management, LLC SKY Harbor Capital Management, LLC [Member] SKY Harbor Capital Management, LLC Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Net investment income Net investment income Investment Income Net For Investments And Cash And Cash Equivalents The net gain or loss (both realized and unrealized) related to investments in certain entities that calculate net asset value per share and the amount after accretion (amortization) of discount (premium) of interest income and dividend income on nonoperating securities, net of investment expense. Impairment losses Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Senior notes Notes Payable, Fair Value Disclosure 2017 Long Term Equity Compensation Plan 2017 Long Term Equity Compensation Plan [Member] 2017 Long Term Equity Compensation Plan Award Type [Axis] Award Type [Axis] Weighted average anti-dilutive shares excluded from the dilutive computation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Jurisdiction [Axis] Jurisdiction [Axis] Condensed Financial Information of Parent Company [Line Items] Condensed Financial Statements, Captions [Line Items] U.K. United Kingdom Her Majesty's Revenue and Customs (HMRC) [Member] Net paid losses and loss expenses Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Subsidiary Issuer Subsidiary Issuer [Member] Hedging Designation [Axis] Hedging Designation [Axis] Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Premiums earned Premiums Earned, Net [Abstract] Summary of Dividends Declared and Paid Dividends Declared [Table Text Block] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Valuation allowance movement [Line Items] Valuation Allowance [Line Items] Amortization Amortization of Deferred Charges Derivative Fair Values on Consolidated Balance Sheet [Line Items] Derivatives, Fair Value [Line Items] Summary of Income Tax Expense and Net Tax Assets Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Interest received Proceeds from Interest Received Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent Net investment gains (losses): Realized Investment Gains (Losses) [Abstract] Accident Year 2021 Short-Duration Insurance Contract, Accident Year 2021 [Member] Intercompany payable Accounts Payable Expected cash flows, year three Lessee, Operating Lease, Liability, to be Paid, Year Three Unearned premiums Unearned Premiums Total finite-lived intangible assets Finite-Lived Intangible Assets, Net Recently Issued Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Redemption Frequency [Axis] Redemption Frequency [Axis] Redemption frequency for funds currently eligible Summary of Reconciliation of Gross Derivative Liabilities to Net Amounts Presented in Balance Sheets Offsetting Liabilities [Table Text Block] Average price per share (in usd per share) Shares Acquired, Average Cost Per Share Internal Credit Assessment [Axis] Internal Credit Assessment [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Accumulated amortization Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Expected cash flows, year two Lessee, Operating Lease, Liability, to be Paid, Year Two Collateral for secured letter of credit facility Pledged Financial Instruments, Not Separately Reported, Securities For Letter Of Credit Facility Pledged Financial Instruments, Not Separately Reported, Securities For Letter Of Credit Facility Intangible assets with a finite life Finite-Lived Intangible Assets [Roll Forward] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Exchange-traded funds Exchange Traded Funds [Member] Total fixed maturities with a single maturity date (amortized cost) Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost Bermuda BERMUDA Security Exchange Name Security Exchange Name Ceded Credit Risk, Reinsurer [Domain] Reinsurer, Name [Domain] Share-based Compensation Share-Based Payment Arrangement [Policy Text Block] Schedule Of Investment Income Reported Amounts By Category [Table] Investment Income [Table] SME brokers Distribution Networks, Small And Mid-sized Enterprise Brokers [Member] Distribution Networks, Small And Mid-sized Enterprise Brokers [Member] Continuous unrealized loss position Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions General and administrative expenses Underwriting-related general and administrative expenses Selling, General and Administrative Expense Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Including Modified Lease Adjustment, Net Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Including Modified Lease Adjustment, Net Vesting percentage (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Employee Stock Option Employee Stock Option [Member] Accident Year 2019 Short-Duration Insurance Contract, Accident Year 2019 [Member] DERIVATIVE INSTRUMENTS Derivative Instruments and Hedging Activities Disclosure [Text Block] Investments Investment, Policy [Policy Text Block] Total expenses Costs and Expenses Maximum Maximum [Member] Unrecognized share-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Other Comprehensive Income Location [Domain] Other Comprehensive Income Location [Domain] Loss absorption yield Measurement Input, Loss Absorption Yield [Member] Measurement Input, Loss Absorption Yield Reclassifications Out of Accumulated Other Comprehensive Income (Loss) [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Total expenses Benefits, Losses and Expenses Tabular List, Table Tabular List [Table Text Block] Net unrealized investments losses Deferred Tax Assets Net Unrealized Losses On Securities Amount before allocation of valuation allowances of deferred tax asset attributable to taxable temporary differences from net unrealized losses on investments (excluding impairments). Shares repurchased Total cost Treasury Stock, Value, Acquired, Cost Method After 2028 Long-Term Debt, Maturity, after Year Five Commercial (as a percent) Loans Held For Investment, Commercial, Percent Loans Held For Investment, Commercial, Percent Willis Towers Watson PLC Willis Tower Watson PLC [Member] Willis Tower Watson PLC Due in one year or less Available For Sale Securities Debt Maturities Within One Year Percentage Of Fair Value Amount of available-for-sale debt securities at fair value maturing in the next fiscal year following the latest fiscal year, expressed as a percentage of the total fair value of debt securities classified as available-for-sale. Gross unrealized gains Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain SHARE-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward] Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Performance Restricted Stock Units granted in 2020 and 2019 Performance Restricted Stock Units Granted In 2020 and 2019 [Member] Performance Restricted Stock Units Granted In 2020 and 2019 Fixed maturities, available for sale Payments to Acquire Debt Securities, Available-for-Sale Due after one year through five years Available For Sale Securities Debt Maturities After One Through Five Years Percentage Of Fair Value Amount of available-for-sale debt securities at fair value maturing in second through fifth fiscal year following latest fiscal year, expressed as a percentage of the total fair value of debt securities classified as available-for-sale. Dividends paid - preferred shares Payments of Ordinary Dividends, Preferred Stock and Preference Stock Business Acquisition [Axis] Business Acquisition [Axis] Gross unrealized losses Equity Securities, FV-NI, Unrealized Loss Expenses Benefits, Losses and Expenses [Abstract] VOBA - Novae Intangible Assets Arising from Insurance Contracts Acquired in Business Combination [Member] Customer Concentration Customer Concentration Risk [Member] Variable Rate [Axis] Variable Rate [Axis] Cash Cash [Member] Annually Redemption Annually Redemption [Member] Annually Redemption Expenses Costs and Expenses [Abstract] Alt A Alta [Member] Residential mortgages with higher risk profile than prime mortgages due to lower credit scores or lower loan to value (LTV) ratios but have a better risk profile than subprime mortgages. Title of 12(b) Security Title of 12(b) Security $750 Million Secured LOC LOC Facility Three [Member] LOC Facility Three Discount Lessee, Operating Lease, Liability, Discounted Amount Lessee, Operating Lease, Liability, Discounted Amount Unallocated claims adjustment expenses Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expense, Accumulated Unallocated Claim Adjustment Expense PERCENTAGE OF AMOUNT ASSUMED TO NET PremiumsPercentageAssumedToNetWritten Percentage of assumed premiums written by the entity to net premiums written. Sublease income Sublease Income Related Party [Domain] Related Party, Type [Domain] Treasury Shares Stockholders' Equity, Policy [Policy Text Block] Intangible assets with an indefinite life Indefinite lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) General and administrative expense ratio General and Administrative Expense Ratio Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] Minimum solvency margin percentage of net reserves Statutory Accounting Practices Minimum Solvency Margin Percentage Of Net Reserves The minimum solvency margin amount, which is a factor of the minimum statutory capital and surplus calculation, (expressed as a percentage of net reserve for losses and loss adjustment expenses) required to be maintained, in terms of the Insurance Act 1978, amendments thereto and Related Regulations of Bermuda. Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] CLO-Equities Collateralized Loan Obligations [Member] Operating Segments Operating Segments [Member] Nonvested restricted stock units - beginning of year (in usd per share) Nonvested restricted stock units - end of year (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Net premiums written SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Written Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] FHLB program, investments pledged as security Federal Home Loan Bank, Advances, General Debt Obligations, Disclosures, Collateral Pledged Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Unrealized gains (losses) arising during the period OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Summary of Mortgage Loans Net of Valuation Allowance Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Net premiums earned SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Revenue Accident Year 2022 Short-Duration Insurance Contract, Accident Year 2022 [Member] Underwriting Portfolio Underwriting Portfolio Underwriting Portfolio [Member] Derivative instruments related to the entity's underwriting portfolio. 4.000% Senior Notes 4.000% Senior Notes [Member] 4.000% Senior Notes [Member] Total lease expense Lease, Cost Other Comprehensive Income Other Comprehensive Income (Loss) [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Held to maturity securities with no single maturity date Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date Below Investment Grade or Not Rated External Credit Rating, Non Investment Grade [Member] Consolidation/VIEs Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block] Entity Interactive Data Current Entity Interactive Data Current Stone Point Trident Fund VIII Stone Point Trident Fund VIII [Member] Stone Point Trident Fund VIII [Member] Loan-to-value ratio, percent (less than) Weighted Average Loan-To-Value Ratios Weighted average loan-to-value ratios Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Proceeds from the repayment of mortgage loans Proceeds from Sale and Collection of Mortgage Notes Receivable Goodwill and Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Transfers into Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 Year 5 Short-Duration Insurance Contracts, Historical Claims Duration, Year Five Purchases of: Payments to Acquire Investments [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Reconciliation of Beginning and Ending Balance of Nonvested Restricted Stock (including RSUs) [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Premiums - Net Premiums Earned Revenue Recognition, Premiums Earned, Policy [Policy Text Block] Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Premiums written Premiums Written, Net [Abstract] Intangible assets Deferred Tax Liabilities, Goodwill and Intangible Assets Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Short-duration Insurance Contracts, Historical Claims Duration [Line Items] Short-Duration Insurance Contracts, Historical Claims Duration [Line Items] Summary of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Operating and capital loss carryforwards Deferred Tax Assets Operating And Capital Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating and capital loss carryforwards. Derivative Instruments Derivatives, Policy [Policy Text Block] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Operating cash outflows from operating leases Operating Lease, Payments Prepaid reinsurance premiums Increase (Decrease) in Prepaid Reinsurance Premiums Credit Rating, AM Best [Domain] Credit Rating, AM Best [Domain] Internal Credit Assessment [Domain] Internal Credit Assessment [Domain] Common shares, shares outstanding (in shares) Total shares outstanding (in shares) Common Stock, Shares, Outstanding Senior Unsecured Notes Due 2031 Senior Unsecured Notes Due 2031 [Member] Senior Unsecured Notes Due 2031 Foreign tax credit SEC Schedule, 12-09, Valuation Allowance, Tax Credit Carryforward [Member] Transfers out of Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 PEO PEO [Member] Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] Auditor Location Auditor Location RETIREMENT PLANS Retirement Benefits [Text Block] Summary of Common Shares Issued and Outstanding Schedule of Common Stock Outstanding Roll Forward [Table Text Block] Preferred shares, dividends paid per share (in usd per share) Preferred Stock, Dividends, Per Share, Cash Paid Sound Point Capital Bond Sound Point Capital Bond [Member] Sound Point Capital Bond Three Brokers Three Brokers [Member] Three Brokers Year 2 Short-Duration Insurance Contracts, Historical Claims Duration, Year Two Reinsurer 3 Reinsurer Three [Member] Amount relating to the reinsuer with the third largest balance. Par value per share, common (in usd per share) Common Stock, Par or Stated Value Per Share Number of installments Share-based Compensation Arrangement by Share-based Payment Award, Number of Installments Share-based Compensation Arrangement by Share-based Payment Award, Number of Installments Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Equity securities, at fair value (Cost 2023: $543,833; 2022: $494,356) Fair value Equity securities Equity Securities, FV-NI, Current Other operating expenses SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense (Increase) decrease in allowance for expected credit losses Allowance for Credit Loss, Period Increase (Decrease) Amount of Increase (Decrease) in the Total Allowance for Credit Loss of Investments Debt Instrument [Axis] Debt Instrument [Axis] Number of positions in an unrealized loss Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions (Increase) decrease in allowance for expected credit losses, fixed maturities, available for sale Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Period Increase (Decrease) Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Ireland Revenue Commissioners, Ireland [Member] Measurement Input Type [Domain] Measurement Input Type [Domain] Accumulated translation adjustment Accumulated translation adjustment Goodwill Accumulated Translation Adjustments Cumulative amount of increase (decrease) from foreign currency translation adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Liability For Catastrophe Claims By Catastrophic Event [Axis] Catastrophic Event [Axis] Credit Facility [Axis] Credit Facility [Axis] Value of reverse repurchase agreements Securities for Reverse Repurchase Agreements Summary of Debt Maturity Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Current income tax expense (benefit) Current Income Tax Expense (Benefit) Expected volatility (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Subordination percentage input for determining credit losses Other Than Temporary Impairment Losses Investments Available for sale Securities Portion Recognized In Earnings Net Qualitative Disclosures Level Of Subordination Percentage This item represents the current level of subordination of the entity's receipt of consideration should the assets underlying the security be liquidated when the level of subordination was considered as one of the potential factors in reaching a conclusion that the available-for-sale investments are other than temporarily impaired and the amount of such impairment determined to be related to credit loss recognized in earnings. Total Debt Securities, Available-for-Sale, Unrealized Loss Position Accrued interest receivable Increase (Decrease) in Accrued Investment Income Receivable Preferred shares, dividend declared per share (in usd per share) Preferred Stock, Dividends Per Share, Declared Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Text Block] Accident Year 2014 Short-Duration Insurance Contracts, Accident Year 2014 [Member] Credit Rating, AM Best [Axis] Credit Rating, AM Best [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Affiliate Affiliated Entity [Member] General and administrative expenses General and Administrative Expense Less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Transfers out of level 3 Fair Value Measurement With Unobservable Inputs, Reconciliation, Asset, Transfers Out Of Level 3 into Level 2 Fair Value Measurement With Unobservable Inputs, Reconciliation, Asset, Transfers Out Of Level 3 into Level 2 Gordon Brothers Gordon Brothers [Member] Gordon Brothers Equity method investments Equity Method Investments [Member] Short-duration Insurance Contracts, Accident Year [Domain] Short-Duration Insurance Contracts, Accident Year [Domain] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Net investment income Investment Income, Net Preferred stocks Preferred stocks Preferred Stock [Member] Before tax amount Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract] Settlement Type [Domain] Settlement Type [Domain] [Domain] for Information by settlement type pertaining to equity-based compensation. Equity securities Equity Securities [Member] Agency RMBS Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Foreign exchange and other Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expense, Accumulated Foreign Exchange Total Available For Sale Securities Debt Securities Percentage Of Fair Value Amount of available-for-sale debt securities at fair value, expressed as a percentage of the total fair value of debt securities classified as available-for-sale. FHLB program, admitted assets, actual Federal Home Loan Bank, Admitted Assets, Actual The amount of qualifying assets calculated using statutory rules that are used as a basis for borrowing capacity. Number of funds Number of Funds Redemption The number of funds that are currently eligible for redemption at the stated frequency. Other liabilities Other Liabilities Direct lending funds Direct Lending Funds [Member] Investments in funds that provide financing directly to borrowers. GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] AM Best, A- Rating AM Best, A- Rating [Member] Concentration risk, percentage of total Concentration Risk, Percentage Opening balance Closing balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Mortgage loans Payments to Acquire Mortgage Notes Receivable Summary of Tax Credits Summary of Tax Credit Carryforwards [Table Text Block] Total investments Investments Granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Transfers into Level 3 Fair Value Measurement With Unobservable Inputs, Reconciliation, Assets, Transfers From Level 2 Into Level 3 Fair Value Measurement With Unobservable Inputs, Reconciliation, Assets, Transfers From Level 2 Into Level 3 Changes in Level 3 Financial Instruments Measured at Fair Value on a Recurring Basis [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] U.S. government and agency US Treasury and Government [Member] 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Five SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract] SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract] Ireland IRELAND Debt securities, held-to-maturity, maturity period Debt Securities, Held-to-Maturity, Maturity Period Debt Securities, Held-to-Maturity, Maturity Period Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Summary of Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Percentage ownership by related parties Ordinary Shares Outstanding Held By Related Parties, Percentage Percentage of NXT Capital's ordinary shares outstanding held by Stone Point Capital. Optional extension of investment term Fair Value Investments Entities That Calculate Net Asset Value Redemption Restriction Period Optional Extension Period by which the General Partner of an investment for which net asset value per share is calculated has the option to extend a redemption restriction related to investments for which net asset value per share is calculated, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Other insurance related income Other insurance related income (loss) Other Operating Income (Expense), Net Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Discounting of net reserves for losses and loss expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves Harrington Re Harrington Re [Member] Harrington Re [Member] Accident Year 2023 Short-Duration Insurance Contract, Accident Year 2023 [Member] Available statutory capital and surplus Statutory Accounting Practices, Statutory Capital and Surplus, Balance Fixed maturities and short-term investments Debt Securities, Available-for-Sale, Realized Gain Consolidation Items [Axis] Consolidation Items [Axis] Settlements/ distributions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements Impairment charges Impairment charges Goodwill, Impairment Loss Deferred acquisition costs SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Deferred Policy Acquisition Cost Valuation allowance Valuation allowance - beginning of year Valuation allowance - end of year Deferred Tax Assets, Valuation Allowance Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Accident Year 2018 Short-Duration Insurance Contracts, Accident Year 2018 [Member] Subsegments [Axis] Subsegments [Axis] Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Retrocession Agreement With Monarch Point Re Retrocession Agreement With Monarch Point Re [Member] Retrocession Agreement With Monarch Point Re Percentage of total fair value Alternative Investments Fair Value Disclosure Percentage Of Total The percentage of the total fair value of investments in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest. Investments include, but are not limited to, investments in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Collateral in trust for inter-company agreements Pledged Financial Instruments Not Separately Reported Securities For Intercompany Insurance And Reinsurance Agreements The carrying amount as of the date of the latest financial statement presented of securities which are owned but transferred to serve as collateral for inter-company insurance and reinsurance agreements, and for which the transferee does not have the right by contract or custom to sell or re-pledge them to an unrelated party. Axis Corporate Capital UK Limited II Axis Corporate Capital UK Limited II [Member] Axis Corporate Capital UK Limited II [Member] Entity Emerging Growth Company Entity Emerging Growth Company Lloyd's of London UNITED KINGDOM Allowance for expected credit losses Allowance for expected credit losses Allowance for Loan and Lease Losses, Real Estate Fair value Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract] Securities on deposit or in trust with regulatory authorities Assets Held by Insurance Regulators Intangible assets Total Intangible Assets, Net (Excluding Goodwill) Deferred tax assets before valuation allowance Deferred Tax Assets, Gross Real estate funds Real Estate Funds [Member] AXIS Capital Holdings Limited Parent Company [Member] Stone Pointe Credit Corporation Bonds Stone Pointe Credit Corporation Bonds [Member] Stone Pointe Credit Corporation Bonds Expected cash flows, year one Lessee, Operating Lease, Liability, to be Paid, Year One Deferred acquisition costs Increase (Decrease) in Deferred Policy Acquisition Costs Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Title Trading Arrangement, Individual Title Gross realized investment losses Debt And Equity Securities, Realized Loss Amount of realized loss on investment in debt and equity securities. Maximum dividend/distribution payable without regulatory approval Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval Common shares Common shares (par value) Common stocks Common Stock [Member] Individual: Individual [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Income Statement Location [Domain] Income Statement Location [Domain] RESERVE FOR LOSSES AND LOSS EXPENSES Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] Discounted cash flow Valuation Technique, Discounted Cash Flow [Member] Summary of Changes in Level 3 Financial Instruments Measured at Fair Value on a Recurring Basis, Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Investments: Investments [Abstract] Minimum Minimum [Member] Additions (reductions) for expected credit losses on securities where credit losses were previously recognized Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal) Common shares, dividends paid per share (in usd per share) Common Stock, Dividends, Per Share, Cash Paid Property Property Insurance [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Net losses and loss expenses Net losses and loss expenses Net incurred losses and loss expenses Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Due after ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Summary of Location and Amounts of Derivative Fair Values on the Consolidated Balance Sheet Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Foreign exchange losses (gains) Foreign exchange (losses) gains Gain (Loss), Foreign Currency Transaction, before Tax Taxes paid on withholding shares Payment, Tax Withholding, Share-Based Payment Arrangement Other deferred tax assets Deferred Tax Assets, Other Liabilities Liabilities Liabilities [Abstract] Change in unrealized gains/(losses) Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Interests acquired Business Acquisition, Percentage of Voting Interests Acquired Retained earnings Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Credit Rating [Domain] External Credit Rating by Grouping [Domain] Due after ten years Available For Sale Securities Debt Maturities After Year Ten Percentage Of Fair Value Amount of available-for-sale debt securities at fair value maturing in the tenth fiscal year following latest fiscal year, expressed as a percentage of the total fair value of debt securities classified as available-for-sale. Amortized cost Debt Securities, Held-to-Maturity, Excluding Accrued Interest, before Allowance for Credit Loss Earnings per common share (in dollars per share) Earnings per common share (in dollars per share) Earnings Per Share, Basic Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent Impairment losses Impairment losses Debt Securities, Available-for-Sale, Allowance for Credit Loss, Writeoff Accounting Policies [Abstract] Accounting Policies [Abstract] Class Of Treasury Stock [Table] Class of Treasury Stock [Table] Fixed maturity portfolio - corporate issuer concentration limit below A- ConcentrationRiskCreditRiskFixedMaturitiesMaximumExposureCorporateIssuerBelowAMinusPercentageOfFixedMaturityPortfolio Reflects the maximum amount, expressed as a percentage of fixed maturity value, of concentration of credit risk to any single corporate debt issuer rated below A- (excluding U.S. government and agency securities). Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Year 7 Short-Duration Insurance Contracts, Historical Claims Duration, Year Seven Net deferred tax assets (liabilities) Net deferred tax assets (liabilities) Deferred Tax Assets, Net Allowance for credit losses on premium balances receivable Allowance for estimated uncollectible premium balances receivable Premium Receivable, Allowance for Credit Loss Summary of Fixed Maturities and Equities in an Unrealized Loss Position Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Private equity funds Private Equity Funds [Member] Citibank Citibank [Member] Citibank Europe plc ASSUMED FROM OTHER COMPANIES Assumed Premiums Written Acquisition costs SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Cost Cash Settled Cash Settled [Member] Share-based compensation to be settled in cash. Non-cash repayment of advance Increase (Decrease) Due from Affiliates Eagle Point Credit Management, LLC Eagle Point Credit Management, LLC [Member] Eagle Point Credit Management, LLC Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Tax Carry Forward Expiry 2028 Tax Carry Forward Expiry 2029 [Member] Tax Carry Forward Expiry 2029 Fixed maturities, held to maturity, at amortized cost (Fair value 2023: $675,851; 2022: $674,743 Allowance for expected credit losses 2023: $nil; 2022: $nil) Net carrying value Fixed maturities, held to maturity, at amortized cost Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Maximum dividend/distribution payable with regulatory approval Statutory Accounting Practices, Statutory Amount Available for Dividend Payments with Regulatory Approval Other amortization and depreciation Other Depreciation and Amortization Percentage ownership in subsidiary (percent) Ownership Percentage By Parent The parent entity's ownership interest in the subsidiary, expressed as a percentage. Net paid losses and loss expenses related to: Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract] Gross unrealized gains Equity Securities, FV-NI, Unrealized Gain Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] Entity Public Float Entity Public Float Summary of Net Investment Income Investment Income [Table Text Block] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Equity securities Equity Securities, FV-NI, Realized Gain Federal Home Loan Bank advances, net Proceeds from FHLBank Borrowings, Financing Activities Entity Address, Country Entity Address, Country Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Reinsurance recoverable on unpaid losses and loss expenses (Allowance for expected credit losses 2023: $36,611; 2022: $30,715) Less reinsurance recoverable on unpaid losses and loss expenses, beginning of year Reinsurance recoverable on unpaid losses and loss expenses, end of year Reinsurance recoverable on unpaid claims Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Change in valuation allowance Increase in (release of) valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount ABS Asset-Backed Securities, Securitized Loans and Receivables [Member] All Trading Arrangements All Trading Arrangements [Member] Due in one year or less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One All Adjustments to Compensation All Adjustments to Compensation [Member] Junior Subordinated Notes Junior Subordinated Debt [Member] Compensation Amount Outstanding Recovery Compensation Amount Cumulative number of reported claims Short-Duration Insurance Contract, Cumulative Number of Reported Claims Due after five years through ten years Available For Sale Securities Debt Maturities After Five Through Ten Years Percentage Of Fair Value Amount of available-for-sale debt securities at fair value maturing in sixth through tenth fiscal year following latest fiscal year, expressed as a percentage of the total fair value of debt securities classified as available-for-sale. Reinsurance Recoverable On Unpaid And Paid Losses Reinsurance Recoverable Including Reinsurance Premium Paid [Member] Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Rialto Real Estate Fund IV-Property Rialto Real Estate Fund IV-Property [Member] Rialto Real Estate Fund IV-Property Premiums receivable, bad debt expense charges Premium Receivable, Allowance for Credit Loss, Writeoff Net of tax amount Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Derivative instruments Derivative asset fair value Net amounts Derivative Asset Forfeited (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Deferred income tax expense (benefit) Deferred Income Tax Expense (Benefit) Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Summary of Statutory Capital and Surplus by Jurisdiction Statutory Accounting Practices Disclosure [Table Text Block] Gross premiums written Gross Premiums Written, Gross Gross amount Intangible Assets Including Goodwill Gross Amount before accumulated impairment loss of goodwill and intangible assets, both finite and indefinite-lived. Document Financial Statement Error Correction Document Financial Statement Error Correction [Flag] Fixed maturities and short-term investments Fixed Maturities And Short-Term Investments [Member] This element provides types of investments that may be contained within the fixed maturity category which are securities having a stated final repayment date. Examples of items within this category may include bonds, including convertibles and bonds with warrants, and redeemable preferred stocks. This element also includes investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet. Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Summary of Goodwill and Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Stone Point Trident VIII Co-Invest Stone Point Trident VIII Co-Invest [Member] Stone Point Trident VIII Co-Invest 2024 Long-Term Debt, Maturity, Year One Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other assets Other Assets Share-based compensation plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Syndicate 1686 AXIS Syndicate 1686 [Member] AXIS Syndicate 1686 [Member] Net unrealized gains (losses) on equity securities Equity Securities, FV-NI, Unrealized Gain (Loss) Reinsurance recoverable on paid losses and loss expenses Increase Decrease Reinsurance Recoverable On Paid Losses And Loss Expenses Increase Decrease Reinsurance Recoverable On Paid Losses And Loss Expenses Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Document Period End Date Document Period End Date Adoption Date Trading Arrangement Adoption Date Cash-settled awards Liability for cash-settled restricted stock units Deferred Compensation Share-Based Arrangements, Liability, Current and Noncurrent GROSS AMOUNT Direct Premiums Written Treasury shares, at cost Treasury Stock, Common [Member] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Prime Prime [Member] Segment Information [Line Items] Segment Reporting Information [Line Items] Change in investment - related items Valuation Allowance Investment Related Items [Member] The portion of the valuation allowance pertaining to the deferred tax asset representing investment related items for which it is more likely than not that a tax benefit will not be realized. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] Held to maturity securities debt maturities after three through ten years net carrying amount Held To Maturity Securities Debt Maturities After Three Through Ten Years Net Carrying Amount Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in third through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Income tax expense Income tax expense Total income tax expense (benefit) Income tax (expense) benefit Income Tax Expense (Benefit) Tax credits Deferred Tax Assets, Tax Credit Carryforwards, Foreign Rialto Real Estate IV-Property Rialto Real Estate IV-Property [Member] Rialto Real Estate IV-Property Switzerland Swiss Federal Tax Administration (FTA) [Member] Vesting [Axis] Vesting [Axis] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] 2010 AXIS Specialty Finance LLC Senior Notes Senior Notes Axis Specialty Finance Llc 2010 [Member] Senior notes issued by AXIS Specialty Finance LLC on March 23, 2010. Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss) Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Lender Name [Axis] Lender Name [Axis] 12 months or greater Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Operating loss carryforwards SEC Schedule, 12-09, Valuation Allowance, Operating Loss Carryforward [Member] Equity [Abstract] Equity [Abstract] Schedule Of Available For Sale Securities [Line Items] Debt Securities, Available-for-Sale [Line Items] Weighted-average remaining lease term - operating leases Operating Lease, Weighted Average Remaining Lease Term Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Preferred share dividends Less: Preferred share dividends Preferred Stock Dividends, Income Statement Impact Preferred shares, redemption price per share (in usd per share) Preferred Stock, Redemption Price Per Share Amortization of value of business acquired Amortization of value of business acquired Amortization of value of business acquired Amortization of Value of Business Acquired (VOBA) Year 6 Short-Duration Insurance Contracts, Historical Claims Duration, Year Six Capital loss carryforwards Tax Credit Carryforward, Amount Less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Credit Facility [Domain] Credit Facility [Domain] Summary of Fixed Maturities, Held-to-Maturity Debt Securities, Held-to-Maturity [Table Text Block] Shares repurchased (in shares) Total shares (in shares) Treasury Stock, Shares, Acquired Basis spread on variable rate (percent) Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Proceeds from the sale of: Proceeds from Sale, Maturity and Collection of Investments [Abstract] Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Redemption Restriction Type [Domain] Redemption Restriction Type [Domain] Circumstances in which an otherwise redeemable investment, comprising or included in the major category, of those certain investments for which net asset value per share is calculated (including by unit, membership interest, or other equity (ownership interest) unit measure) (alternative investments) is not redeemable (for example, investments subject to a lockup or gate). Summary of Valuation Allowance Roll Forward Summary of Valuation Allowance [Table Text Block] Change in intercompany payable Increase (Decrease) in Due to Affiliates Other Commitment Other Commitment Minimum required collateral for reverse repurchase agreements, expressed as a percentage of loan principal Securities Purchased Under Agreements To Resell, Required Collateral, Percentage Of Principal Minimum value of securities received as collateral against securities purchased under agreement to resell, expressed as a percentage of loan principal. Year 9 Short-Duration Insurance Contracts, Historical Claims Duration, Year Nine Mortgage loans held for investment: Loans and Leases Receivable Disclosure [Abstract] Additional paid-in capital Additional Paid in Capital, Common Stock Additional paid-in capital Additional Paid-in Capital [Member] Document Annual Report Document Annual Report Equity securities Proceeds from Sale of Equity Securities, FV-NI Premiums - Receivables Premiums Receivable, Allowance for Doubtful Accounts, Estimation Methodology, Policy [Policy Text Block] % of Total fair value Available For Sale Securities Percentage Of Fair Value [Abstract] Available For Sale Securities Percentage Of Fair Value [Abstract] Interest in income of equity method investments Income (Loss) from Equity Method Investments Other investment adjustments and impairments Deferred Tax Liabilities, Investments Cover page. Cover [Abstract] Discount rate (percent) Short-Duration Contract, Discounted Liability, Discount Rate Insurance and reinsurance premium balances receivable (Allowance for expected credit losses 2023: $11,997; 2022: $9,521) Premiums Receivable, Net Tax Period [Axis] Tax Period [Axis] U.S. UNITED STATES Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Other privately held investments Other Privately Held Investments [Member] Other Privately Held Investments [Member] Fixed maturities, available for sale, amortized cost Amortized cost Amortized cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss Fair Value Inputs Assets Quantitative Information [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] AXIS Specialty Finance PLC AXIS Specialty Finance PLC [Member] AXIS Specialty Finance PLC Lloyd’s deferred year of account results Deferred Tax Liabilities, Deferred Expense Credit Loss Status [Axis] Credit Loss Status [Axis] Purchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Line of credit facility, aggregate utilization capacity Line Of Credit Facility, Aggregate Utilization Capacity Line Of Credit Facility, Aggregate Utilization Capacity Bond mutual funds Non United States Bond Mutual Fund [Member] An investment in a fund that invests in non-U.S. fixed maturities and provides daily liquidity. Non-U.S. government Debt Security, Government, Non-US [Member] Increase (decrease) in cash, cash equivalents and restricted cash Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Equity Component [Domain] Equity Component [Domain] Summary of Reconciliation of Gross Derivative Assets to Net Amounts Presented in Balance Sheets Offsetting Assets [Table Text Block] Liability Liability Line [Member] Liability line of business Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Property and Casualty Property, Liability and Casualty Insurance Product Line [Member] Other deferred tax liabilities Deferred Tax Liabilities, Other Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total net investment gains (losses) Net investment (gains) losses Net investment gains (losses) Net Investment Gain (Loss) This item represents the net realized gains and losses on available for sale debt securities, the net realized and unrealized gains and losses on equity securities with FV recorded in net income, together with the change in fair value of investment derivatives, and expected and realized credit losses. Reinsurance Disclosures [Abstract] Reinsurance Disclosures [Abstract] Redemption Frequency [Domain] Redemption Frequency [Domain] Redemption Frequency Cash and cash equivalents Cash and Cash Equivalents [Member] Deferred tax liabilities Deferred Tax Liabilities, Gross Consolidated Entities [Domain] Consolidated Entities [Domain] Catastrophic Event [Domain] Catastrophic Event [Domain] Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Axis] Borrowings from FHLB Federal Home Loan Bank Borrowings, Fair Value Disclosure Unrealized gains (losses) arising during the year, net of reclassification adjustment Other Comprehensive Income (Loss), Available-for-Sale Securities, Tax, Portion Attributable to Parent Segments [Axis] Segments [Axis] Estimate of Fair Value Estimate of Fair Value Measurement [Member] Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Required statutory capital and surplus Statutory Accounting Practices, Statutory Capital and Surplus Required Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Fixed maturities without a single maturity date (% of total fair value) Available For Sale Securities Debt Maturities Without Single Maturity Date Percentage Of Fair Value Amount of available-for-sale debt securities at fair value that do not have a single maturity date and which the entity has decided to disclose separately rather than allocating the fair value over several maturity groupings, expressed as a percentage of the total fair value of debt securities classified as available-for-sale. Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Customer relationships and customers lists - Ternian Customer Relationships [Member] Reinsurer 2 Reinsurer Two [Member] Amount relating to the reinsuer with the second largest balance. Other information: Leases Other Information [Abstract] Leases Other Information [Abstract] Summary of Allowance for Credit Loss Debt Securities, Available-for-Sale, Allowance for Credit Loss [Table Text Block] Tranche One Share-Based Payment Arrangement, Tranche One [Member] Consolidated Entities [Axis] Consolidated Entities [Axis] Variable Rate [Domain] Variable Rate [Domain] Included in net income Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Payable for investments purchased Broker-Dealer, Payable to Other Broker-Dealer and Clearing Organization Pay vs Performance Disclosure [Line Items] Entity Voluntary Filer Entity Voluntary Filers Net realized and unrealized gains on other investments Net Realized And Unrealized Gain Loss On Alternative Investments Net realized and the change in net unrealized (gains) losses related to investments in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest . Investments include, but are not limited to, investments in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Line of credit facility, utilization capacity Line Of Credit Facility, Utilization Capacity Line Of Credit Facility, Utilization Capacity Statistical Measurement [Domain] Statistical Measurement [Domain] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Preferred shares, liquidation preference per share (in usd per share) Preferred Stock, Liquidation Preference Per Share Nonvested restricted stock - beginning of year (in shares) Nonvested restricted stock - end of year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Unearned premiums Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve DEBT AND FINANCING ARRANGEMENTS Debt Disclosure [Text Block] Proceeds from the (purchase) sale of other assets, net Payments for (Proceeds from) Productive Assets Third Party Reinsurer Third Party Reinsurer [Member] Third Party Reinsurer Coverholders Distribution Networks, Coverholders [Member] Distribution Networks, Coverholders [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Operating Loss And Tax Credit Carryforwards [Table] Operating Loss And Tax Credit Carryforwards [Table] Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss and tax credit carryforwards. Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Effect of exchange rate changes on foreign currency cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Impairment charges Impairment of Intangible Assets, Finite-Lived Credit Loss Status [Domain] Credit Loss Status [Domain] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance Restricted Stock Units Performance Shares [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Transfers out of Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 Fixed maturities Fixed maturities Fixed Maturities [Member] Fixed maturities without a single maturity date (fair value) Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Restatement Determination Date: Restatement Determination Date [Axis] Investment, Name [Axis] Investment, Name [Axis] Summary of Total Unrealized and Realized Gains (Loss) on Derivatives Not Designated as Hedges Recorded in Earnings Derivatives Not Designated as Hedging Instruments [Table Text Block] Corporate debt Corporate Debt Securities [Member] Expected tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Commitments and Contingencies Commitments and Contingencies Expected cash flows Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Impairment charges Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Series E 5.50% Preferred Shares Series E preferred shares Series E Preferred Stock [Member] Accident and health Accident and Health Insurance Product Line [Member] Acquisition adjustments Deferred Tax Liabilities, Acquisition Adjustments Deferred Tax Liabilities, Acquisition Adjustments Geographical [Axis] Geographical [Axis] Amount shown on the balance sheet SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Amount INCOME TAXES Income Tax Disclosure [Text Block] Reserve for losses and loss expenses Reserve for losses and loss expenses Gross reserve for losses and loss expenses, beginning of year Gross reserve for losses and loss expenses, end of year Liability for Claims and Claims Adjustment Expense Accident Year 2016 Short-Duration Insurance Contracts, Accident Year 2016 [Member] Allowance for expected credit losses (as a percent) Allowance for Loan and Lease Losses, Real Estate, Percentage of Total Allowance for Loan and Lease Losses, Real Estate, Percentage of Total Supplementary Insurance Information [Table] SEC Schedule, 12-17, Insurance Companies, Reinsurance [Table] Gross Premiums Written Premiums Written Gross [Member] Total consideration paid and payable by direct policyholders for insurance contracts sold by the Entity during the period and premiums for all insurance assumed from other insurers, that is premiums ceded to the Entity by other insurers, when it serves as a benchmark in a concentration risk calculation. SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Table] SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Table] Concentration Risk [Line Items] Concentration Risk [Line Items] Number of directors required to sign affidavits in order to pay dividend/distribution greater than 25% of prior year statutory capital and surplus Statutory Accounting Practices Statutory Amount Available For Dividend Payments Number Of Director Affidavits Required To Pay Greater Amount The number of the entity's directors required to issue signed affidavits in order to pay a dividend and/or distribution in excess of a specified percentage. The directors must attest that the dividend and/or distribution would not cause the entity to fail to meet its relevant margins. Leases Lessee, Leases [Policy Text Block] Reinsurer 1 Reinsurer One [Member] Amount relating to the reinsuer with the largest balance. Investment Portfolio Investment Portfolio Investment Portfolio [Member] Derivative instruments related to the entity's investment portfolio. Included in OCI Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) Change in unrealized gain/(losses) Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) Unearned premiums Increase (Decrease) in Unearned Premiums U.K. branch assets and other foreign rate differentials SEC Schedule, 12-09, Valuation Allowance, Other Tax Carryforward [Member] Short-duration Insurance Contracts, Accident Year [Axis] Short-Duration Insurance Contracts, Accident Year [Axis] Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Axis] Preferred shares, par value per share (in usd per share) Preferred Stock, Par or Stated Value Per Share Business Acquisition [Line Items] Business Acquisition [Line Items] Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Loan advances made Loan balance receivable Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss Gross amounts Derivative Liability, Subject to Master Netting Arrangement, before Offset PEO Total Compensation Amount PEO Total Compensation Amount Goodwill Goodwill [Roll Forward] Insurance and reinsurance balances payable Reinsurance Payable Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Significant unobservable inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Treasury shares (in shares) Treasury shares, balance at beginning of year (in shares) Total treasury shares at end of year (in shares) Treasury Stock, Common, Shares Claims Development [Line Items] Claims Development [Line Items] SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] Fixed maturities, available for sale, at fair value (Amortized cost 2023: $12,634,254; 2022: $12,176,473 Allowance for expected credit losses 2023: $10,759; 2022: $11,733) Fair value Fair value Fixed maturities, available for sale Debt Securities, Available-for-Sale, Excluding Accrued Interest Due after five years through ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Unearned premiums SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Unearned Premium Net income Net income Net Income (Loss) Unrecorded Unconditional Purchase Obligation [Line Items] Unrecorded Unconditional Purchase Obligation [Line Items] Derivative Contract Type [Domain] Derivative Contract [Domain] Foreign Exchange Foreign Currency Transactions and Translations Policy [Policy Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Collateral in trust for third-party agreements Pledged Financial Instruments Not Separately Reported Securities For Third Party Insurance And Reinsurance Agreements The carrying amount as of the date of the latest financial statement presented of securities which are owned but transferred to serve as collateral for insurance and reinsurance agreements with third parties, and for which the transferee does not have the right by contract or custom to sell or re-pledge them to an unrelated party. Company Selected Measure Name Company Selected Measure Name Related Portfolio [Domain] Related Portfolio [Domain] The name that identifies a derivative or a group of derivatives, by related portfolio. Due after one year through five years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five LEASES Lessee, Operating Leases [Text Block] Deferred acquisition costs Deferred Policy Acquisition Cost Year 3 Short-Duration Insurance Contracts, Historical Claims Duration, Year Three Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Cumulative paid claims and allocated claim adjustment expenses Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net Derivative Instruments Gain Loss By Hedging Relationship By Income Statement Location By Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY Condensed Financial Information of Parent Company Only Disclosure [Text Block] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Gross unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Bermuda (domestic) Income (Loss) from Continuing Operations before Income Taxes, Domestic U.S. Internal Revenue Service (IRS) [Member] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Debt service coverage ratio, in excess of Weighted Average Debt Service Coverage Ratios Weighted Average Debt Service Coverage Ratios Summary of Additional Information Related to Share-based Compensation Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Summary of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Name Measure Name Name Forgone Recovery, Individual Name Short-term investments Payments to Acquire Short-Term Investments Goodwill Goodwill Goodwill AXIS Specialty Finance LLC AXIS Specialty Finance LLC [Member] AXIS Specialty Finance LLC Valuation Allowance [Table] Valuation Allowance [Table] Measurement Basis [Axis] Measurement Basis [Axis] Underlying Securities Award Underlying Securities Amount Total pension expenses Pension Cost (Reversal of Cost) Premiums - Gross Premiums Written Insurance Premiums Revenue Recognition, Policy [Policy Text Block] Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years OTHER COMPREHENSIVE INCOME (LOSS) Comprehensive Income (Loss) Note [Text Block] Total Intangible Assets Net Including Goodwill [Roll Forward] A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Fair Value Measurement [Domain] Fair Value Measurement [Domain] Collateral [Axis] Collateral Held [Axis] Common shares, dividends declared per share (in usd per share) Common Stock, Dividends, Per Share, Declared Acquisition cost ratio Acquisition Cost Ratio Unrealized gains (losses) arising during the year OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Settlements/ distributions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] Net Investment Income [Line Items] Net Investment Income [Line Items] Pantheon Pantheon [Member] Pantheon [Member] Net incurred losses and loss expenses related to: Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract] Summary of Contractual Maturities of Fixed Maturities Investments Classified by Contractual Maturity Date [Table Text Block] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Fair Value Inputs Assets Quantitative Information [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Dividends received from subsidiaries SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Maximum dividend limit - percentage of total statutory capital and surplus Statutory Accounting Practices Statutory Amount Available For Dividend Payments Potential Limit Percentage Of Total Statutory Capital And Surplus The potential limit (expressed as a percentage of total statutory capital and surplus) to the dividend that may be paid. Income Statement Location [Axis] Income Statement Location [Axis] Income Tax Expense Valuation Allowance, Income Tax Expense [Member] Valuation Allowance, Income Tax Expense [Member] Reinsurance Reinsurance [Member] Reinsurance segment Unamortized discount and debt issuance expenses Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net 5-year term Investment Funds, Term, Period One [Member] Investment Funds, Term, Period One Asset Pledged as Collateral Asset Pledged as Collateral [Member] Summary of Maturity and Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Foreign exchange forward contracts Foreign Exchange Forward [Member] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Pledged Status [Axis] Pledged Status [Axis] CMBS Commercial Mortgage-Backed Securities [Member] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Net Proceeds Proceeds from Debt, Net of Issuance Costs Net reserve for unpaid losses and loss expenses, beginning of year Net reserve for unpaid losses and loss expenses, end of year Liability for Unpaid Claims and Claims Adjustment Expense, Net Redemption notice period Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Investment Redemption, Notice Period Summary of Lease Expense and Related Cash Flows Lease, Cost [Table Text Block] Unrealized gains (losses) arising during the year, net of reclassification adjustment Unrealized gains (losses) arising during the year, net of reclassification adjustment Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Private company investment funds Private Company Investment Funds [Member] Private Company Investment Funds Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Plan Name [Domain] Plan Name [Domain] Net current tax receivables Income Taxes Receivable, Current Interest expense and financing costs Interest expense and financing costs Interest Expense Fixed maturities, held to maturity, at amortized cost Fixed Income Securities [Member] Maximum number of shares to be issued under the plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Trading Arrangement: Trading Arrangement [Axis] Use of Estimates Use of Estimates, Policy [Policy Text Block] Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Available for sale Debt Securities, Available-for-Sale [Abstract] Entity File Number Entity File Number Later years Lessee, Operating Lease, Liability, to be Paid, after Year Five Discount rate Measurement Input, Discount Rate [Member] 2026 Long-Term Debt, Maturity, Year Three Stone Point Group Stone Point Group [Member] Stone Point Group of Companies Unrealized gains (losses) on available for sale investments Unrealized gains (losses) on available-for-sale investments, net of tax Available for sale investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Auditor Firm ID Auditor Firm ID Amortization of intangible assets Amortization of intangible assets Amortization Amortization of Intangible Assets Entity Shell Company Entity Shell Company Gross realized investment losses Debt And Equity Securities, Realized Loss [Abstract] Debt and Equity Securities, Realized Loss [Abstract] Motor Motor [Member] Motor line of business Lloyd's Lloyd's [Member] Lloyd's of London. Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Loan advances made Loan advance Payments for Advance to Affiliate Restatement Determination Date Restatement Determination Date Other insurance related income (loss) Other Operating Income (Expense) [Member] Quarterly Redemption Quarterly Redemption [Member] Quarterly Redemption Additional Information Related to Net Incurred Losses [Line Items] Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items] Award Date [Domain] Award Date [Domain] Summary of Reconciliation of Development Tables to Consolidated Balance Sheet Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents and restricted cash - beginning of year Cash, cash equivalents and restricted cash - end of year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Asset Class [Axis] Asset Class [Axis] Equity securities Equity Securities, FV-NI, Realized Loss Amortized cost SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Cost Settlement Type [Axis] Settlement Type [Axis] Information by settlement type pertaining to equity-based compensation. Expected credit losses on securities where credit losses were not previously recognized Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Not Previously Recorded Schedule of Federal Home Loan Bank Advances, by Branch of FHLB Bank [Table] Schedule of Federal Home Loan Bank Advances, by Branch of FHLB Bank [Table] Operating lease expense Operating Lease, Cost 12 months or greater Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Underwriting income (loss) Underwriting Income Loss Net Net premiums earned less: net losses and loss expenses, acquisition costs and general and administrative expenses directly related to underwriting activities. Common shares, shares issued (in shares) Shares issued, balance at beginning of year (in shares) Total shares issued at end of year (in shares) Common Stock, Shares, Issued Summary of Activity of Cash-Settled Restricted Stock Units Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Depositary shares, each representing a 1/100th interest in a 5.50% Series E preferred share SeriesEPreferredDepositaryShareMember [Member] American Depositary Share, each representing a 1/100th interest in a 5.50% Series E preferred share Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Cyber Cyber Line [Member] Cyber Line Gross unrealized losses Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss Treasury shares, at cost (2023: 91,294; 2022: 91,912) Treasury shares, at cost (2023: 91,294; 2022: 91,912) Treasury Stock, Common, Value Reserve for losses and loss expenses SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Liability for Future Policy Benefit, Loss, Claim and Loss Expense Total Assets Assets, Fair Value Disclosure Total Unrealized loss position Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss 2027 Long-Term Debt, Maturity, Year Four Cumulative foreign currency translation adjustments, net of tax Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Income tax (expense) benefit Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent, Parenthetical Disclosure [Abstract] Expected weighted average period associated with the recognition of unrecognized share-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Net losses and loss expenses ratio Loss Ratio Reinsurer Concentration Reinsurer Concentration Risk [Member] Comprehensive income (loss) Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Short-term lease expense Short-Term Lease, Cost Entity Address, Address Line One Entity Address, Address Line One Operating Loss And Tax Credit Carryforwards [Line Items] Operating Loss And Tax Credit Carryforwards [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Statutory Financial Information [Line Items] Statutory Accounting Practices [Line Items] Stated interest rate (in percent) Related party transaction floating rate (as a percent) Related Party Transaction, Rate Concentration risk, number of brokers exceeding threshold Segment Reporting Disclosure Of Major Customers Number Of Major Customers Number of customers where transactions amount to 10 percent or more of the entity's revenues. Operating loss carryforwards Operating Loss Carryforwards Treasury shares reissued Stock Issued During Period, Value, Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations Equity impact of the value of treasury stock (units) reissued during the period. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding. Summary of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Shares issued (in shares) Stock Issued During Period, Shares, New Issues $500 Million Secured LOC LOC Facility Two [Member] LOC Facility Two [Member] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Gross amount Goodwill, Gross Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Foreign exchange and other Reinsurance recoverable on unpaid losses Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Exchange, Loss Portfolio Transfer, And Other Amount of other items that increase (decrease) the cost of settling unpaid claims after deduction of reinsurance recoveries, such as foreign exchange, loss portfolio transfer and other miscellaneous items. Credit Rating [Axis] External Credit Rating by Grouping [Axis] Derivative instruments Derivative liability fair value Net amounts Derivative Liability Accruals not currently deductible Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Receivable for investments sold Receivable from Broker-Dealer and Clearing Organization Fair value Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract] Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value Singapore Inland Revenue, Singapore (IRAS) [Member] Aon plc Aon plc [Member] Aon plc Minimum solvency margin percentage of ECR Statutory Accounting Practices Minimum Solvency Margin Percentage Of ECR Statutory Accounting Practices Minimum Solvency Margin Percentage Of ECR SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] Class of Stock [Line Items] Class of Stock [Line Items] Catastrophe and Weather-related Events Catastrophe [Member] Earnings per diluted common share Earnings Per Share, Diluted [Abstract] Summary of Reconciliation of Beginning and Ending Gross Reserve for Losses and Loss Expenses and Net Reserve for Unpaid Losses and Loss Expenses Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Foreign exchange (losses) gains Foreign Currency Gain (Loss) [Member] Tiernan Tiernan [Member] Tiernan Large brokers Distribution Networks, Large Brokers [Member] Distribution Networks, Large Brokers [Member] REINSURANCE Reinsurance [Text Block] Equity method investments Equity Method Investments Loss severity rate Measurement Input, Loss Severity [Member] Income Tax Expense Benefit By Tax Authority [Table] Income Tax Expense Benefit By Tax Authority [Table] A summary of current and deferred income tax expense, by tax jurisdiction. Other investments, at fair value Other Investments [Member] Financial Instrument [Axis] Financial Instrument [Axis] Financial instruments, as collateral, at fair value Financial Instruments, Owned, at Fair Value Derivative instruments Derivative [Member] Accrued interest receivable Interest Receivable Causes Of Increase Decrease In Liability For Unpaid Claims And Claims Adjustment Expense [Table] Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table] Syndicate capacity Syndicate Capacity [Member] The right to underwrite a certain allocated limit of premium in the Lloyd's market over an indefinite period. Insurance Loss Reserves [Abstract] Insurance Loss Reserves [Abstract] Total Shareholder Return Amount Total Shareholder Return Amount Repurchase of common shares - open market Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Liabilities for claims and claim adjustment expenses, net of reinsurance Net outstanding liabilities Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net Non-agency RMBS Mortgage-Backed Securities, Issued by Private Enterprises [Member] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Intangible assets with an indefinite life Indefinite-Lived Intangible Assets [Roll Forward] Segment [Domain] Segments [Domain] Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Proceeds from redemption of fixed maturities, held to maturity Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities Retained earnings Retained Earnings (Accumulated Deficit) Collateral [Domain] Collateral Held [Domain] Short-term investments Proceeds from Sale of Short-Term Investments Transfers into Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 Aggregate Principal Debt Instrument, Face Amount STATUTORY FINANCIAL INFORMATION Statutory Accounting Practices [Text Block] The entire disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority. Also includes information on regulatory restrictions on dividends and/or distributions. Income tax expense [Line Items] IncomeTaxExpenseBenefit [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Short-duration Insurance Contracts, Claims Development [Table] Short-Duration Insurance Contracts, Claims Development [Table] Leases [Abstract] Leases [Abstract] Prior years Prior year favorable (adverse) adjustments Prior Year Claims and Claims Adjustment Expense Acquisition Costs Deferred Policy Acquisition Costs, Policy [Policy Text Block] Deferred tax assets: Components of Deferred Tax Assets [Abstract] Accident Year 2020 Short-Duration Insurance Contract, Accident Year 2020 [Member] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] 5.150% Senior Notes 5.15% Senior Notes [Member] 5.15% Senior Notes [Member] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Proceeds from redemption of fixed maturities, available for sale Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Earnings per common share: Earnings per common share Earnings Per Share, Basic [Abstract] Net investment gains (losses) Gain (Loss) on Investments [Member] Debt Total senior notes and notes payable Notes Payable Fixed maturity investment portfolio Debt Securities, Available-for-Sale and Held-to-Maturity, after Allowance for Credit Loss Liability for Claims and Claims Adjustment Expense [Line Items] Liability for Claims and Claims Adjustment Expense [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Asset Class [Domain] Asset Class [Domain] Gross amounts Derivative Asset, Subject to Master Netting Arrangement, before Offset Other Redemption Restriction Other Redemption Restriction [Member] Redemption restriction on investments for which net asset value per share is calculated (including, but not limited to, by unit, membership interest, or other ownership interest) other than gates and lockups. Foreign currency translation adjustment Foreign currency translation adjustment Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Audit Information [Abstract] Audit Information Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Supplementary Insurance Information [Line Items] SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] Schedule of Held-to-maturity Securities [Line Items] Schedule of Held-to-Maturity Securities [Line Items] Class of Stock [Domain] Class of Stock [Domain] Federal Home Loan Bank Branch [Domain] Federal Home Loan Bank Branch [Domain] Customer [Domain] Customer [Domain] Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Net income available to common shareholders Net income available to common shareholders Net income available to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Accident Year 2015 Short-Duration Insurance Contracts, Accident Year 2015 [Member] Actual tax rate Effective Income Tax Rate Reconciliation, Percent Harrington Reinsurance Holdings Limited Harrington Reinsurance Holdings Limited [Member] Harrington Reinsurance Holdings Limited [Member] Operating lease liabilities Total discounted operating lease liabilities Operating Lease, Liability Unrealized gains (losses) arising during the period OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Fair value of securities transferred from available for sale to fixed maturities, held to maturity Transfer To Investments Available For Sale To Fixed Maturities Fair value of fixed maturities, available for sale transferred to fixed maturities, held to maturity during the period that was treated as a non-cash activity in the consolidated statement of cash flows. Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Other underwriting-related contracts Other Contract [Member] Accident and health Accident and Health [Member] Accident and Health Vesting [Domain] Vesting [Domain] Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Number of collateral dependent loan Number Of Collateral Dependent Loan Number Of Collateral Dependent Loan Full and Unconditional Guarantee of Debt Financial Guarantee [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Minimum solvency margin percentage of net written premiums Statutory Accounting Practices Minimum Solvency Margin Percentage Of Net Written Premiums The minimum solvency margin amount, which is a factor of the minimum statutory capital and surplus calculation, (expressed as a percentage of net written premiums) required to be maintained, in terms of the Insurance Act 1978, amendments thereto and Related Regulations of Bermuda. Plan Name [Axis] Plan Name [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Liability for Claims and Claims Adjustment Expense [Table] Liability for Claims and Claims Adjustment Expense [Table] Tax benefits associated with share-based compensation expense Share-Based Payment Arrangement, Expense, Tax Benefit Number of reportable segments Number of Reportable Segments Per share data Earnings Per Share [Abstract] Year 1 Short-Duration Insurance Contracts, Historical Claims Duration, Year One Common shares (shares issued 2023: 176,580; 2022: 176,580 shares outstanding 2023: 85,286; 2022: 84,668) Common shares (shares issued 2023: 176,580; 2022: 176,580 shares outstanding 2023: 85,286; 2022: 84,668) Common Stock, Value, Issued Due after one year through five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Marine and aviation Marine and Aviation [Member] Marine and Aviation Fixed maturities, available for sale, allowance for credit loss Allowance for expected credit losses Balance at beginning of period Balance at end of period Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest Purchase commitment Unrecorded Unconditional Purchase Obligation Fair value based on NAV practical expedient Fair Value Measured at Net Asset Value Per Share [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Capital loss carryforward Capital Loss Carryforward [Member] Senior Notes Senior Notes [Member] Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items] Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items] All Individuals All Individuals [Member] Total fixed maturities with a single maturity date (fair value) Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value Summary of Net Incurred and Paid Claims Development Tables by Accident Year Short-Duration Insurance Contracts, Claims Development [Table Text Block] Entity Filer Category Entity Filer Category Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Fixed maturities, held to maturity Payments to Acquire Held-to-Maturity Securities Summary of Share Repurchases Class of Treasury Stock [Table Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount All outstanding liabilities before 2014, net of reinsurance Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented Statement [Table] Statement [Table] Subsegments [Domain] Subsegments [Domain] Current Fiscal Year End Date Current Fiscal Year End Date Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Limited Partner Limited Partner [Member] Summary of Effective Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] In the open market: Open Market [Member] Open securities market, under repurchase plans authorized by the entity's Board of Directors. Fixed maturities, held to maturity, fair value Fair value Debt Securities, Held-to-Maturity, Fair Value Unrecognized tax benefits Unrecognized Tax Benefits PEO Name PEO Name Liability for Future Policy Benefit, by Product Segment [Line Items] Liability for Future Policy Benefit, by Product Segment [Line Items] Fair Value By Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Condensed Financial Information Disclosure [Abstract] Condensed Financial Information Disclosure [Abstract] Shares reissued (in shares) Stock Issued During Period Shares Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations Number of treasury shares (units) reissued during the period. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding. Fixed maturity investment portfolio percentage Fixed Maturity Investment Portfolio Percentage Fixed Maturity Investment Portfolio Percentage Tax credits Deferred Tax Assets, Tax Credit Carryforwards Tax Credit Carryforward Expiring 2032 Tax Credit Carryforward Expiring 2032 [Member] Tax Credit Carryforward Expiring 2032 Prepaid reinsurance premiums Prepaid Reinsurance Premiums Included in OCI Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) Other investments Payments to Acquire Other Investments Net premiums written NET AMOUNT Premiums Written, Net Corporate Corporate, Non-Segment [Member] ORGANIZATION Nature of Operations [Text Block] Other items Other items Increase (Decrease) in Other Operating Assets and Liabilities, Net Losses and Loss Expenses Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block] Interest rate (percent) Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total shareholders’ equity Balance at beginning of year Balance at end of the year Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Foreign Tax Credits Foreign Tax Credits [Member] Foreign Tax Credits Net premiums earned Net Premiums Earned, Net Common Shares Issued and Outstanding [Roll Forward] common shares issued and outstanding [Roll Forward] common shares issued and outstanding [Roll Forward] Proceeds from redemption of short-term investments Proceeds from Maturities, Prepayments and Calls of Short-Term Investments Summary of Level 3 Fair Value Measurement Inputs Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Deferred acquisition costs Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term  Total income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Reconciliation of effective tax rate (% of income before income taxes) [Line Items] Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Scheduled debt maturity Long-Term Debt, Fiscal Year Maturity [Abstract] Investments in subsidiaries Investment In Subsidiaries Equity Basis This item represents the carrying amount on the entity's balance sheet of its investment in common stock of its subsidiaries under the equity method. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of subsidiaries, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. This element is used for parent company stand-alone (i.e. non-consolidated) financial statements. Trading days proceeding and performance period Trading Days Proceeding Performance Period Trading Days Proceeding Performance Period Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Not Designated as Hedging Instruments Not Designated as Hedging Instrument [Member] Default rate Measurement Input, Default Rate [Member] Credit and political risk Credit And Political Risk Line [Member] Credit and political risk line of business Municipals US States and Political Subdivisions Debt Securities [Member] Hedging Designation [Domain] Hedging Designation [Domain] Significant other observable inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Current year Net losses and loss expenses, net of reinstatement premiums Current Year Claims and Claims Adjustment Expense Equity method investment, difference between carrying amount and underlying equity Equity Method Investment, Difference Between Carrying Amount and Underlying Equity Fair Value Investments Entities That Calculate Net Asset Value Per Share [Table] Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table] Unrecorded Unconditional Purchase Obligation [Table] Unrecorded Unconditional Purchase Obligation [Table] Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss [Abstract] Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss [Abstract] Equity securities Payments to Acquire Equity Securities, FV-NI Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Held to maturity securities due after ten years Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10 Engineering Engineering Engineering [Member] Engineering line of business REORGANIZATION EXPENSES Restructuring, Impairment, and Other Activities Disclosure [Text Block] Document fiscal period focus Document Fiscal Period Focus Liability for Future Policy Benefit, by Product Segment [Table] Liability for Future Policy Benefit, by Product Segment [Table] Dividends paid in year following declaration (in usd per share) Dividends Payable, Amount Per Share Useful life of finite lived intangible assets Finite-Lived Intangible Asset, Useful Life Ceded losses and loss expenses Policyholder Benefits and Claims Incurred, Ceded Expected cash flows, year four Lessee, Operating Lease, Liability, to be Paid, Year Four Share-based compensation expense, net of cash payments Share-based compensation expense, net of cash payments Share-Based Payment Arrangement, Noncash Expense Weighted average Weighted Average [Member] Summary of Gross Premiums Written by Geographical Location of Subsidiaries Revenue from External Customers by Geographic Areas [Table Text Block] Incurred claims and allocated claim adjustment expenses Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net Stone Point Credit Corporation Stone Point Credit Corporation [Member] Stone Point Credit Corporation City Area Code City Area Code Third Party - Loss Portfolio Transfer Third Party - Loss Portfolio Transfer [Member] Third Party - Loss Portfolio Transfer Income (loss) before income taxes Results of Operations, Income before Income Taxes [Abstract] Product and Service [Axis] Insurance Product Line [Axis] Product and Service [Axis] EARNINGS PER COMMON SHARE Earnings Per Share [Text Block] FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Asset, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration] Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Document fiscal year focus Document Fiscal Year Focus From employees: Employees [Member] Directly from employees of the entity to satisfy withholding tax liabilities upon vesting of restricted stock awards. These repurchases are not part of the entity's Board-authorized share repurchase program. Treasury Shares Issued and Outstanding [Roll Forward] Treasury Shares Issued and Outstanding [Roll Forward] Treasury Shares Issued and Outstanding [Roll Forward] Geographical [Domain] Geographical [Domain] Income (loss) before equity in net income of subsidiaries Income Loss From Continuing Operations Before Income Taxes Minority Interest Income Loss From Equity Method Investments And Equity In Net Earnings Of Subsidiaries Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. This item also excludes the entity's interest in net earnings of its subsidiaries and is used for parent company stand-alone (i.e. non-consolidated) financial statements. Share Repurchase Program [Domain] Share Repurchase Program [Domain] Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Change in fair value of investment derivatives Unrealized and realized gains (loss) recognized in earnings for derivatives not designated as hedges Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Accumulated Other Comprehensive Income (Loss) Valuation Allowance, Accumulated Other Comprehensive Income [Member] Valuation Allowance, Accumulated Other Comprehensive Income [Member] Treasury Shares [Line Items] Equity, Class of Treasury Stock [Line Items] Common share dividends Dividends, Common Stock, Cash Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Total Liabilities Liabilities, Fair Value Disclosure Derivative liabilities Derivative Liability [Abstract] Share Based Payment Arrangement Senior Leadership Share Based Payment Arrangement Senior Leadership [Member] Share Based Payment Arrangement Senior Leadership Income taxes paid Income Taxes Paid, Net Purchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Unrealized gains (losses) arising during the period OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax Amortization of fixed maturities Accretion (Amortization) of Discounts and Premiums, Investments Total liabilities and shareholders’ equity Liabilities and Equity Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Risk-free interest rate (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Arrangement Duration Trading Arrangement Duration Reinsurance receivables: Reinsurance Assets [Abstract] Reinsurance recoverable on unpaid losses and loss expenses Increase (Decrease) in Reinsurance Recoverable Securities sold/redeemed/matured Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Sold Summary of Prior Year Loss Development Schedule of Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Investment expenses Investment Income, Investment Expense Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Summary of Underwriting Results of Reportable Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Related Party Related Party [Member] Fixed maturities without a single maturity date Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost Net losses and loss expenses SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Benefit, Claim, Loss and Settlement Expenses Net investment income SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Net Investment Income Gross realized investment gains Debt And Equity Securities, Realized Gain Amount of realized gain on investment in debt and equity securities. Interest in income of equity method investments Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Summary of Restricted Investments and Cash Schedule of Financial Instruments Owned and Pledged as Collateral [Table Text Block] Termination Date Trading Arrangement Termination Date Authorized share capital, common (in shares) Common Stock, Shares Authorized Document Information [Table] Document Information [Table] Estimated maturity date (years) Fair Value Inputs Estimated Maturity Date The estimated remaining time to maturity of the CLO structure (expressed as a number of years). Capital support, percentage Capital Support Provision, Percentage The amount of capital support provided to Lloyd's Syndicate 1686. Fixed maturity portfolio - corporate issuer concentration limit above A- Concentration Risk Credit Risk Fixed Maturities Maximum Exposure Corporate Issuer A Minus Or Above Percentage Of Fixed Maturity Portfolio Reflects the maximum amount, expressed as a percentage of fixed maturity value, of concentration of credit risk to any single corporate debt issuer rated A- or above (excluding U.S. government and agency securities). SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Disclosure [Text Block] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Gross unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Short-term investments Short-Term Investments [Member] Arthur J. Gallagher & Co. Arthur J. Gallagher & Co. [Member] Arthur J. Gallagher & Co. Unrealized losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Bermuda Other Tax Authorities [Member] Tax departments of governments, other than those separately identified, entitled to levy and collect income taxes from the entity. FHLB program, maximum borrowing capacity Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Fair value of other investments subject to redemption restrictions Fair Value Investments Entities That Calculate Net Asset Value Redemption Restriction The total value of investments that cannot be redeemed because of a redemption restriction as of the statement of financial position date. Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss) Reclassification from AOCI, Current Period, Tax Award Timing Disclosures [Line Items] Mortgage loans, held for investment, at fair value (Allowance for expected credit losses 2023: $6,220; 2022: $nil) Total mortgage loans held for investment Mortgage Loans on Real Estate, Commercial and Consumer, Net Dividends payable Dividends Payable Year 4 Short-Duration Insurance Contracts, Historical Claims Duration, Year Four Fair value of restricted stock units vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Lockup Redemption Restriction Lockup Redemption Restriction [Member] Redemption restriction on investments for which net asset value per share is calculated (including, but not limited to, by unit, membership interest, or other ownership interest) due to lockups. Due after five years through ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Marsh & McLennan Companies Inc. Marsh & McLennan Companies Inc [Member] Marsh & McLennan Companies Inc Commercial Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss Insurance Insurance [Member] Insurance segment Document Information [Line Items] Document Information [Line Items] Belgium Administration of the Treasury, Belgium [Member] Pledged Status [Domain] Pledged Status [Domain] Income Taxes Income Tax, Policy [Policy Text Block] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Insider Trading Arrangements [Line Items] Related Party [Axis] Related Party, Type [Axis] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Foreign taxes at local expected rates Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Adjustment to Compensation, Amount Adjustment to Compensation Amount Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Transfers into Level 3 Fair Value Measurement With Unobservable Inputs, Reconciliation, Liability, Transfers From Level 2 Into Level 3 Fair Value Measurement With Unobservable Inputs, Reconciliation, Liability, Transfers From Level 2 Into Level 3 Other realized gains (losses) Available For Sale Securities Gross Realized Gain (Loss) Including Derivative Gains (Losses) Excluding Other Than Temporary Impairments This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include the change in fair value of investment-related derivatives not designated as hedges and any hedge ineffectiveness recognized in earnings in relation to investment portfolio-related fair value hedges. Fixed maturities with a single maturity date (% of total fair value) Available For Sale Securities Debt Maturities Single Maturity Date Percentage Of Fair Value Fair value of investment in available-for-sale debt securities with a single maturity date and expressed as a percentage of the total fair value of debt securities classified as available-for-sale. Auditor Name Auditor Name Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Reserve for losses incurred but not reported Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount Partner Type of Partners' Capital Account, Name [Domain] Partner Type of Partners' Capital Account, Name [Domain] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Preferred shares, dividend rate Preferred Stock, Dividend Rate, Percentage Summary of Financial Instruments Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary of Portfolio of Other Investments Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table Text Block] Entity central index key Entity Central Index Key Liabilities Liabilities, Fair Value Disclosure [Abstract] Included in net income Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Trident IX L.P. ("Trident IX") Trident IX L.P. ("Trident IX") [Member] Trident IX L.P. ("Trident IX") Share based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Fair value SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Fair Value Gross amount Finite-Lived Intangible Assets, Gross Summary of Operating and Capital Loss Carryforwards Summary of Operating Loss Carryforwards [Table Text Block] Preferred share dividends Dividends, Preferred Stock, Cash Reserve for losses and loss expenses Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve Equity in net income of subsidiaries Equity in income loss of subsidiaries Income Loss From Subsidiaries Equity Method This item represents the entity's proportionate share for the period of the net income (loss) of its subsidiaries. This item is used for parent company stand-alone (i.e. non-consolidated) financial statements. Investment Funds, Term [Axis] Investment Funds, Term [Axis] Investment Funds, Term Name Trading Arrangement, Individual Name Supplementary Insurance Information [Table] SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Table] Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Award Date [Axis] Award Date [Axis] Preferred shares, aggregate liquidation value issued Stock Issued During Period, Value, New Issues Restricted Investments [Line Items] Restricted Investments [Line Items] Restricted Investments [Line Items] Deferred tax assets for unrealized losses on fixed maturity securities Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss Entity [Domain] Entity [Domain] (Increase) decrease in allowance for expected credit losses, mortgage loans Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Period Increase (Decrease) Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment flag Amendment Flag Legal Entity [Axis] Legal Entity [Axis] Gross amounts offset Derivative Liability, Subject to Master Netting Arrangement, Asset Offset Tax Period [Domain] Tax Period [Domain] Weighted-average discount rate - operating lease Operating Lease, Weighted Average Discount Rate, Percent Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Transfers out of level 3 Fair Value Measurement With Unobservable Inputs, Reconciliation, Liability, Transfers Out Of Level 3 into Level 3 Fair Value Measurement With Unobservable Inputs, Reconciliation, Liability, Transfers Out Of Level 3 into Level 2 Axis Corporate Capital UK II Limited Axis Corporate Capital UK II Limited [Member] Axis Corporate Capital UK II Limited Assets Assets, Fair Value Disclosure [Abstract] Due in one year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Transfer of FHLB stock Other Significant Noncash Transaction, Value of Consideration Received Reconciliation of Beginning and Ending Gross Unpaid Losses and Loss Expenses Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Loan Agreement With Monarch Point Re Loan Agreement With Monarch Point Re [Member] Loan Agreement With Monarch Point Re Sales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales Summary of Net Investment Gains (Losses) Gain (Loss) on Securities [Table Text Block] Issue Price Debt Instrument, Issuance Price, Percent Debt Instrument, Issuance Price, Percent Weighted average diluted common shares outstanding (in shares) Weighted average diluted common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Reinsurance recoverable on paid losses and loss expenses Reinsurance Recoverable for Paid Claims and Claims Adjustments Grantee Status [Domain] Grantee Status [Domain] Collateral spread Measurement Input, Collateral Spreads [Member] Measurement Input, Collateral Spreads [Member] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Acquisition costs Acquisition costs Deferred Policy Acquisition Costs, Amortization Expense Derivative assets Derivative Asset [Abstract] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Reinsurance Reinsurance Accounting Policy [Policy Text Block] SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block] Additional share awards granted under the plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Fixed maturities and short-term investments Debt Securities, Available-for-Sale, Realized Loss Company Selected Measure Amount Company Selected Measure Amount Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Table] Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Table] Schedule reconciling the entity's statutory tax rate to its effective tax rate. Interest expense on FHLB borrowings Interest Expense, Federal Home Loan Bank and Federal Reserve Bank Advances, Short-Term 10-year term Investment Funds, Term, Period Two [Member] Investment Funds, Term, Period Two Europe European Tax Authorities [Member] Tax departments of European governments entitled to levy and collect income taxes from the entity. Debt Securities, Held-to-maturity [Table] Debt Securities, Held-to-Maturity [Table] Lease cost: Lease, Cost [Abstract] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Share Repurchase Program [Axis] Share Repurchase Program [Axis] Summary of Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance Short-Duration Insurance Contracts, Schedule of Historical Claims Duration [Table Text Block] Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 2028 Long-Term Debt, Maturity, Year Five Number of investment funds transferred from level 3 to NAV practical expedient Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers Out Of Level 3, Number Of Investment Funds Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers Out Of Level 3, Number Of Investment Funds Ceded Ceded Premiums Earned Significant Reconciling Items Segment Reconciling Items [Member] Statutory net income Statutory Accounting Practices, Statutory Net Income Amount Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Year 10 Short-Duration Insurance Contracts, Historical Claims Duration, Year 10 Total mortgage loans, held-for investment (as a percent) Total Mortgage Loans Held-For-Investment, Percent Total Mortgage Loans Held-For-Investment, Percent Summary of Breakdown of Gross and Net Premiums Written and Earned Effects of Reinsurance [Table Text Block] Vested (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Investment Funds, Term [Domain] Investment Funds, Term [Domain] Investment Funds, Term Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent Property Property Line [Member] Property Line Reinsurance recoverable on unpaid and paid losses Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Income before income taxes and interest in income of equity method investments Income before income taxes and interest in income of equity method investments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Non-PEO NEO Non-PEO NEO [Member] Impairment charges Goodwill and Intangible Asset Impairment Five-Year Treasury Rate US Treasury (UST) Interest Rate [Member] Adjustment to Compensation: Adjustment to Compensation [Axis] Equity securities, cost Cost Equity Securities, FV-NI, Cost Commercial mortgage loans, past due amount Mortgage Loans, Held for Investment, Amount Past Due This item represents the amortized cost of commercial mortgage loans held for investments that are past due. FEDERAL HOME LOAN BANK ADVANCES Federal Home Loan Bank Advances, Disclosure [Text Block] Gross amounts offset Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Statutory Accounting Practices, Jurisdiction [Domain] Statutory Accounting Practices, Jurisdiction [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Limit - prior year's total statutory capital surplus (Bermuda) Statutory Accounting Practices Statutory Amount Available For Dividend Or Distribution Payments Potential Limit Percentage Of Prior Year Statutory Capital And Surplus The potential limit (expressed as a percentage of prior year total statutory capital and surplus) to the dividend/distribution that may be paid, without signed affidavits from the entity's directors attesting that a dividend and/or distribution in excess of this amount would not cause the entity to fail to meet its relevant margins. STATUTORY FINANCIAL INFORMATION [Abstract] STATUTORY FINANCIAL INFORMATION [Abstract] Run-off lines Run Off Lines [Member] Run Off Lines Reclassifications and comparability Reclassification, Comparability Adjustment [Policy Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Federal Home Loan Bank Branch [Axis] Federal Home Loan Bank Branch [Axis] Summary of Reserve for Losses and Loss Expenses Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense Reported And Incurred But Not Reported Claims [Table Text Block] Schedule showing breakdown of the liability for unpaid claims and claims adjustment expense between that related to reported claims and to incurred but not reported (IBNR) claims. Supplementary Insurance Information [Line Items] SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] Revenues Revenues [Abstract] Related Party Transaction [Axis] Related Party Transaction [Axis] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Investment In Related Party Investment In Related Party [Member] Investment In Related Party Partner Type [Axis] Partner Type [Axis] Schedule of Condensed Financial Statements [Table] Condensed Financial Statements [Table] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Loan Agreement With Monarch Point Re Loan Agreement With Third Party Reinsurer [Member] Loan Agreement With Third Party Reinsurer Amortized cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Prior year adjustments Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] EX-101.PRE 6 axs-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-4.12 7 axs-2021231xexx412.htm EX-4.12 Document


Exhibit 4.12
DESCRIPTION OF AXIS CAPITAL HOLDINGS LIMITED’S SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT

The following is a brief description of the securities of AXIS Capital Holdings Limited (“AXIS Capital”) registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). This description of the terms of our stock does not purport to be complete and is qualified in its entirety by reference to the applicable provisions of the Bermuda Companies Act of 1981, as amended (the “Companies Act”), and the Certificate of Incorporation and Memorandum of Association of AXIS Capital, the Amended and Restated Bye-laws of AXIS Capital (the “bye-laws”), the Certificate of Designations creating the Series E Preferred Shares, which is included as an exhibit to the Annual Report on Form 10-K of AXIS Capital for the year ended December 31, 2023 and the form of depositary receipts evidencing the depositary shares. As used herein, “we,” “us” and “our” refer to AXIS Capital and not any of our subsidiaries. As of December 31, 2023, our common shares, par value $0.0125 per share, and our Depositary Shares (“depositary shares”), each representing a 1/100th interest in a 5.50% Series E Preferred Share, par value $0.0125 per share (“Series E Preferred Shares”), were the only classes of our securities registered under Section 12 of the Exchange Act.
General
We are authorized to issue up to an aggregate of 800,000,000 shares, par value $0.0125 per share.
Common Shares
Except as described below, our common shares have no pre-emptive rights or other rights to subscribe for additional common shares, no rights of redemption, conversion or exchange and no sinking fund rights.
Dividends
Holders of our common shares are entitled to receive dividends as may be lawfully declared from time to time by our board of directors.
Winding-Up or Distribution
In the event of winding-up or distribution, the holders of our common shares are entitled to receive at least the pro-rata portion of any cash distributed, if any remains after the payment of all our debts and liabilities and the liquidation preference of any outstanding preference shares.
Voting Rights
In general, and except as provided below, shareholders have one vote for each share held by them and are entitled to vote, on a non-cumulative basis, at all meetings of shareholders.
However, pursuant to a mechanism specified in our bye-laws, the voting rights exercisable by a shareholder may be limited. In any situation in which the “controlled shares” (as defined below) of a “United States person” (as defined in the Internal Revenue Code of 1986, as amended, hereinafter referred to as the “Code”) would constitute 9.5% or more of the votes conferred by the issued shares and such United States person would generally be required to recognize income with respect to AXIS Capital under Section 951(a)(1) of the Code, if AXIS Capital were a controlled foreign corporation as defined in Section 957 of the Code and if the ownership threshold under Section 951(b) of the Code were 9.5%, the voting rights exercisable by a shareholder with respect to such shares shall be reduced to the extent necessary so that no United States person is deemed to hold 9.5% or more of the voting power conferred by our shares. In addition, the voting power for a “Direct Foreign Shareholder Group” (as defined below) shall be reduced so that no Direct Foreign Shareholder Group is deemed to hold 9.5% or more of the voting power conferred by our shares. Our board of directors may also limit a shareholder’s voting rights where it deems it necessary to do so to avoid adverse tax, legal or regulatory consequences. “Controlled shares” includes, among other things, all shares of AXIS Capital that a United States person owns directly, indirectly or constructively (within the meaning of Section 958 of the Code). A “Direct Foreign Shareholder Group” includes a shareholder or group of
1



Exhibit 4.12
commonly controlled shareholders that are not United States persons. This provision will not apply if a shareholder owns greater than 75% of our issued and outstanding shares.
We also have the authority under our bye-laws to request information from any shareholder for the purpose of determining whether a shareholder’s voting rights are to be limited pursuant to the bye-laws. If a shareholder fails to respond to our request for information or submits incomplete or inaccurate information in response to a request by our board of directors, our board of directors may, in their sole discretion, eliminate the shareholder’s voting rights.
Preference Shares
From time to time, pursuant to the authority granted by our bye-laws to issue shares up to the amount of our authorized share capital, our board of directors may create and issue one or more series of preference shares having such preferred, deferred or other special rights or such restrictions, whether in regard to dividends, voting, return of capital or otherwise, as we may by resolution of the shareholders determine.
Pre-emptive Rights
No holder of preference shares, solely by reason of such holding, has or will have any pre-emptive right to subscribe to any additional issue of shares of any class or series or to any security convertible into such shares.
Bye-laws
In addition to the provisions described above, the following provisions are a summary of some of the other important provisions of our bye-laws.
Our Board of Directors. Our bye-laws provide that our board of directors shall consist of between 9 and 16 members, or such number as determined by the shareholders. The current board of directors is divided into three classes. Each director serves a three-year term, with termination staggered according to class. Shareholders may only remove a director for cause at an annual general meeting by the affirmative vote of shareholders holding a majority of the aggregate voting power of all of our issued and outstanding shares; provided that the notice of any such meeting convened for the purpose of removing a director shall contain a statement of the intention to do so and shall be provided to that director at least 14 days before that meeting. Such vacancy may be filled by the shareholders at the meeting at which such director is removed. Vacancies on the board of directors can be filled by the board of directors if the vacancy occurs as a result of death, disability, disqualification or resignation of a director, from an increase in the size of the board of directors or from a vacancy left unfilled at a general meeting.
Shareholder Action. At the commencement of any general meeting, two or more persons present in person and representing, in person or by proxy, more than 50% of the aggregate voting power of our shares shall constitute a quorum for the transaction of business. In general, any questions proposed for the consideration of the shareholders at any general meeting shall be decided by the affirmative votes of a majority of the votes cast in accordance with the bye-laws. In addition, most actions that may be approved by resolution of our shareholders in a general meeting may, without a meeting, be approved by a resolution in writing signed by all of the shareholders entitled to attend such meeting and vote on the resolution.
Voting of Subsidiary Shares. If we are required or entitled to vote at a general meeting of any of our direct subsidiaries on matters other than appointment, removal and remuneration of auditors, approval of financial statements and reports thereon and remuneration of directors during any period in which the voting rights of any of our shares are adjusted pursuant to our bye-laws, our directors must refer the subject matter of the vote to our shareholders on a poll and seek authority from our shareholders as to how they should vote on the resolution proposed by the subsidiary. Substantially similar provisions are contained in the bye-laws or equivalent governing documents of most of our non-U.S. subsidiaries.
Amendment. Our bye-laws may only be amended by a resolution adopted by our board of directors and by resolution of our shareholders.
2



Exhibit 4.12
Restrictions on Transfer of Shares
Our board of directors may decline to register a transfer of any common shares or preference shares (1) if it appears to the board of directors, in its sole and reasonable discretion, after taking into account the limitations on voting rights contained in our bye-laws, that any non-de minimis adverse tax, regulatory or legal consequences to us, any of our subsidiaries or any of our shareholders or their affiliates may occur as a result of such transfer or (2) subject to any applicable requirements of the New York Stock Exchange (“NYSE”), if a written opinion from counsel supporting the legality of the transaction under U.S. securities laws has not been provided or if any required governmental approvals have not been obtained.
Acquisition of Shares by Us
Under our bye-laws and subject to Bermuda law, if our board of directors determines that any shareholder’s ownership of common shares or preference shares may result in non-de minimis adverse tax, legal or regulatory consequences to us, any of our subsidiaries or any of our shareholders or their affiliates, we have the option, but not the obligation, to require such shareholder to sell to us or to a third party to whom we assign the repurchase right the minimum number of common shares or preference shares that is necessary to avoid or cure any such adverse consequences at a price determined in the good faith discretion of the board of directors to represent the shares’ fair market value.
Issuance of Shares
Subject to our bye-laws and Bermuda law, our board of directors has the power to issue any of our unissued common shares or preference shares as it determines, including the issuance of any common shares or class or series of shares with preferred, deferred or other special rights.
The restrictions on transfer, voting restrictions, right to acquire shares and right to issue additional shares or a new class or series of shares described above may have the effect of delaying, deferring or preventing a change in control of AXIS Capital.
Anti-Takeover Provisions and Insurance Regulations Concerning Change of Control
Some of the provisions of our bye-laws as well as some insurance regulations concerning change of control could delay or prevent a change of control.
Listing
Our common shares are listed on the NYSE under the trading symbol “AXS.”
Transfer Agent and Registrar
The transfer agent and registrar for the common shares is Computershare Trust Company, N.A., whose principal executive office is located at 150 Royall Street, Suite 101, Canton, Massachusetts 02021.
3



Exhibit 4.12
Series E Preferred Shares
General
The Series E Preferred Shares rank senior to our junior stock (as defined under “—Dividends”) and equally with each other series of our parity stock, if any (as defined under “—Dividends”) with respect to the payment of dividends and distributions of assets upon liquidation, dissolution or winding-up. At present, we have no issued shares that are senior to the Series E Preferred Shares with respect to payment of dividends and distribution of assets upon our liquidation, dissolution or winding-up.
The depositary is the sole holder of Series E Preferred Shares. The holders of depositary shares are required to exercise their proportional rights in the Series E Preferred Shares through the depositary, as described in “Description of Depositary Shares.”
Our board of directors may from time to time create and issue new junior shares and parity shares of other series without the approval of the holders of the Series E Preferred Shares and fix their relative rights, preferences and limitations.
We are generally able to pay dividends and distributions upon liquidation, dissolution or winding-up only out of lawfully available funds for such payment (i.e., after satisfaction of indebtedness and other non-equity claims). The Series E Preferred Shares are fully-paid and nonassessable.
Holders of the depositary shares and the Series E Preferred Shares represented thereby do not have preemptive or subscription rights to acquire more of our capital stock.
The Series E Preferred Shares are not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of ours or our property or assets. The Series E Preferred Shares have no stated maturity and are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or other obligation of ours to redeem, repurchase or retire the Series E Preferred Shares.
Dividends
Dividends on the Series E Preferred Shares are non-cumulative. Consequently, if our board of directors does not authorize and declare a dividend for any dividend period, holders of the Series E Preferred Shares are not entitled to receive a dividend for such period, and such undeclared dividend will not accumulate and will not be payable. We have no obligation to pay dividends for a dividend period after the dividend payment date for such period if our board of directors has not declared such dividend before the related dividend payment date, whether or not dividends are declared for any subsequent dividend period with respect to the Series E Preferred Shares.
Holders of Series E Preferred Shares are entitled to receive, only when, as and if declared by our board of directors, out of funds legally available for the payment of dividends under Bermuda law, non-cumulative cash dividends from and including the original issue date, quarterly in arrears on January 15, April 15, July 15 and October 15 of each year, commencing on January 15, 2017, without accumulation of any undeclared dividends. To the extent declared, these dividends will accumulate, with respect to each dividend period, in an amount per share equal to 5.50% of the liquidation preference per annum (equivalent to $137.50 per Series E Preferred Share and $1.375 per depositary share). In the event that we issue additional Series E Preferred Shares after the original issue date, to the extent declared, dividends on such additional Series E Preferred Shares may accumulate from and including the original issue date or any other date we specify at the time such additional Series E Preferred Shares are issued.
Dividends are payable to holders of record of the Series E Preferred Shares as they appear in our register of members on the applicable record date, which shall be the fifteenth day of the month preceding that dividend payment date or such other record date fixed by our board of directors that is not more than 60 nor less than 10 days prior to such dividend payment date. These dividend record dates apply regardless of whether a particular dividend record date is a business day. The corresponding dividend record dates for the depositary shares is the same as the dividend record dates for Series E Preferred Shares. As used herein, “business day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City generally are authorized or obligated by law or executive order to close.
4



Exhibit 4.12
A dividend period is the period from and including a dividend payment date to, but excluding, the next dividend payment date. Dividends payable on the Series E Preferred Shares are computed on the basis of a 360-day year consisting of twelve 30-day months. If any date on which dividends would otherwise be payable is not a business day, then the dividend payment date will be the next succeeding business day after the original dividend payment date, and no additional dividends will accumulate on the amount so payable from such date to such next succeeding business day.
Upon the payment of any dividends on the Series E Preferred Shares, holders of depositary shares receive a related proportionate payment. See “Depositary Shares—Dividends and Other Distributions.”
So long as any Series E Preferred Shares remain outstanding for any dividend period, unless the full dividends for the latest completed dividend period on all outstanding Series E Preferred Shares and any parity stock have been declared and paid or declared and a sum sufficient for the payment thereof has been set aside:
no dividend shall be paid or declared on our common shares or any other shares of our junior stock, other than a dividend payable solely in our common shares or other junior stock; and
no common shares or other junior stock shall be purchased, redeemed or otherwise acquired for consideration by us, directly or indirectly (other than (1) as a result of a reclassification of junior stock for or into other junior stock or the exchange or conversion of one share of junior stock for or into another share of junior stock, (2) through the use of the proceeds of a substantially contemporaneous sale of junior stock) or (3) as required by or necessary to fulfill the terms of any employment contract, benefit plan or similar arrangement with or for the benefit of one or more employees, directors or consultants.
When dividends are not paid or duly provided for in full on any dividend payment date upon the Series E Preferred Shares and any shares of parity stock, all dividends declared upon the Series E Preferred Shares and all such parity stock and payable on such dividend payment date shall be declared on a pro rata basis so that the respective amounts of such dividends shall bear the same ratio to each other as the full amount of dividends payable on the outstanding Series E Preferred Shares for such dividend period and the accumulated and unpaid dividends, or the full amount of dividends payable for such dividend period in the case of non-cumulative preferred stock, on all such parity stock bear to each other. In the case of any parity stock having dividend payment dates different from the dividend payment dates pertaining to the Series E Preferred Shares, the measurement date for such parity stock shall be the dividend payment date falling within the related dividend period for the Series E Preferred Shares.
As used herein, “junior stock” means any class or series of our capital stock that ranks junior to the applicable securities either as to the payment of dividends or as to the distribution of assets upon any liquidation, dissolution or winding-up of AXIS Capital. Junior stock includes our common shares.
As used herein, “parity stock” means any class or series of our capital stock that ranks equally with the applicable securities as to payment of dividends and the distribution of assets on any liquidation, dissolution or winding-up of AXIS Capital. As of December 31, 2023, there is no series of our capital stock that would be considered parity stock with the Series E Preferred Shares.
Certain Restrictions on Payment of Dividends
AXIS Capital is a holding company and has no direct operations. The ability of AXIS Capital to pay dividends or distributions depends almost exclusively on the ability of its subsidiaries to pay dividends or distributions to AXIS Capital.
Our operating subsidiaries are subject to significant regulatory restrictions limiting their ability to declare and pay dividends or distributions. For example, under the Insurance Act 1978 of Bermuda, dividends by a class 4 insurer, such as AXIS Specialty Limited, exceeding 25% of statutory capital and surplus are prohibited unless the insurer files (at least seven days before payment of such dividends) with the Bermuda Monetary Authority an affidavit signed by two directors and the principal representative of the insurer declaring that the insurer will remain in compliance with the solvency margin and liquidity requirements of the Insurance Act 1978 after payment of such dividend.
The Bermuda Monetary Authority has issued notice to AXIS Specialty Limited that it will act as group supervisor and that it has designated AXIS Specialty Limited as the ‘designated insurer’ of the AXIS group of insurance companies. In accordance with the Group Supervision Rules and the Group Solvency Rules, the AXIS
5



Exhibit 4.12
insurance group is required to prepare and submit annual audited group GAAP financial statements, annual group statutory financial statements, an annual group statutory financial return, an annual group capital and solvency return and quarterly group unaudited financial returns.
Under Bermuda law, we are not permitted to pay dividends on our securities (even if such dividends have been previously declared) if there are reasonable grounds for believing that we are, or would after the payment be, unable to pay our liabilities as they become due; or the realizable value of our assets would thereby be less than our liabilities or that we are or would after such payment be in breach of the Insurance Act 1978, the Group Solvency Rules, including the Group Enhanced Capital Requirement contained within the Group Solvency Rules, or under such other applicable rules and regulations as may from time to time be issued by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority) pursuant to the terms of the Insurance Act 1978, or any successor legislation.
Liquidation Rights
Upon any voluntary or involuntary liquidation, dissolution or winding-up of AXIS Capital, holders of the Series E Preferred Shares are entitled to receive out of our assets legally available for distribution to shareholders, after satisfaction of indebtedness and other non-equity claims, if any, a liquidation preference in the amount of $2,500 per Series E Preferred Share (equivalent to $25 per depositary share), plus declared and unpaid dividends, if any, to, but excluding, the date fixed for distribution, without accumulation of any undeclared dividends, before any distribution of assets is made to holders of our common shares, or any of our other shares of stock ranking junior to the Series E Preferred Shares. Holders of the Series E Preferred Shares will not be entitled to any other amounts from us after they have received their full liquidation preference.
In any such distribution, if our assets are not sufficient to pay the liquidation preference in full to all holders of the Series E Preferred Shares and all holders of parity stock, if any, the amounts paid to the holders of the Series E Preferred Shares and to the holders of parity stock will be paid pro rata in accordance with the respective aggregate liquidation preferences of those holders. If the liquidation preference has been paid in full to all holders of the Series E Preferred Shares and any holders of parity stock, the holders of our other capital stock shall be entitled to receive all of our remaining assets according to their respective rights and preferences.
A consolidation, amalgamation, merger, arrangement or reconstruction involving AXIS Capital or the sale or transfer of all or substantially all of the shares of capital stock or the property or business of AXIS Capital will not be deemed to constitute a liquidation, dissolution or winding-up of AXIS Capital.
Redemption
Under Bermuda law, the source of funds that may be used by a company to pay amounts to shareholders on the redemption of their shares in respect of the nominal or par value of their shares is limited to (1) the capital paid up on the shares being redeemed, (2) funds of the company otherwise available for payment of dividends or distributions or (3) the proceeds of a new issuance of shares made for purposes of the redemption, and in respect of the premium over the nominal or par value of their shares is limited to (a) funds otherwise available for dividends or distributions or (b) out of the company’s share premium account before the redemption date.
Under Bermuda law, no redemption may be made by us if there are reasonable grounds for believing that we are, or would after the payment be, unable to pay our liabilities as they become due; or the realizable value of our assets would thereby be less than our liabilities or that we are or would after such payment be in breach of the Insurance Act 1978, the Group Solvency Rules, including the Group Enhanced Capital Requirement contained within the Group Solvency Rules, or under such other applicable rules and regulations as may from time to time be issued by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority) pursuant to the terms of the Insurance Act 1978, or any successor legislation.
Our ability to effect a redemption of the Series E Preferred Shares is subject to regulatory approval.
Our ability to effect a redemption of the Series E Preferred Shares may be subject to the performance of our subsidiaries. Distribution to us from our insurance subsidiaries will also be subject to applicable insurance laws and regulatory constraints.
The Series E Preferred Shares are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or other similar provisions. The Series E Preferred Shares are not redeemable prior to November 7,
6



Exhibit 4.12
2021, except as described below. The Series E Preferred Shares are redeemable at our option, in whole or in part, upon not less than 30 nor more than 60 days, prior written notice, at a redemption price equal to $2,500 per Series E Preferred Share (equivalent to $25 per depositary share), plus declared and unpaid dividends, if any, to, but excluding, the date of redemption, without accumulation of any undeclared dividends:
(i) at any time following the occurrence of a tax event (as defined below);
(ii) at any time within 90 days following the occurrence of the date (a “capital redemption trigger date”) on which we have reasonably determined that, as a result of (a) any amendment to, or change in, the laws or regulations of Bermuda that is enacted or becomes effective after the initial issuance of the Series E Preferred Shares; (b) any proposed amendment to, or change in, those laws or regulations that is announced or becomes effective after the initial issuance of the Series E Preferred Shares; or (c) any official administrative decision or judicial decision or administrative action or other official pronouncement interpreting or applying those laws or regulations that is announced after the initial issuance of the Series E Preferred Shares, a “capital disqualification event” (as defined below) has occurred; provided that any such redemption in part may only be made if (x) we have reasonably determined that the portion of the Series E Preferred Shares to be redeemed are the subject of the capital disqualification event and (y) after giving effect to such redemption, we have reasonably determined that a capital disqualification event will not exist with respect to the then-outstanding Series E Preferred Shares and such redemption will not result in the suspension or removal of the Series E Preferred Shares from NYSE listing; and
(iii) on and after November 7, 2021.
As used herein, “tax event” means a “change in tax law” that, in our reasonable determination, results in a substantial probability that we or any entity formed by a consolidation, merger or amalgamation involving us or the entity to which we convey, transfer or lease substantially all our properties and assets would be required to pay any additional amounts (as defined below) with respect to the applicable securities.
As used herein, “change in tax law” means (a) a change in or amendment to laws, regulations or rulings of any relevant taxing jurisdiction (as defined below), (b) a change in the official application or interpretation of those laws, regulations or rulings, (c) any execution of or amendment to any treaty affecting taxation to which any relevant taxing jurisdiction is party after the date of the prospectus supplement relating to the applicable securities, or (d) a decision rendered by a court of competent jurisdiction in any relevant taxing jurisdiction, whether or not such decision was rendered with respect to AXIS Capital, in each case, described in (a)-(d) above occurring after the date of the prospectus supplement relating to the applicable securities.
As used herein, a “relevant taxing jurisdiction” is (a) Bermuda or any political subdivision or governmental authority of or in Bermuda with the power to tax, (b) any jurisdiction from or through which AXIS Capital or its dividend disbursing agent are making payments on the applicable securities or any political subdivision or governmental authority of or in that jurisdiction with the power to tax or (c) any other jurisdiction in which AXIS Capital or a successor corporation is organized or generally subject to taxation on a net income basis or any political subdivision or governmental authority of or in that jurisdiction with the power to tax.
As used herein, “capital adequacy regulations” means the solvency margin, capital adequacy regulations or any other regulatory capital rules applicable to us from time to time on an individual or group basis pursuant to Bermuda law and/or the laws of any other relevant jurisdiction and which set out the requirements to be satisfied by financial instruments to qualify as solvency margin or additional solvency margin or regulatory capital (or any equivalent terminology employed by the then applicable capital adequacy regulations).
As used herein, a “capital disqualification event” has occurred if the applicable securities cease to qualify, in whole or in part (including as a result of any transitional or grandfathering provisions), for purposes of determining our solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level of AXIS Capital or any member thereof, where subdivided into tiers, as Tier 1 or Tier 2 capital securities under then-applicable capital adequacy regulations imposed upon us by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority), which includes our individual and group Enhanced Capital Requirements under the Bermuda Monetary Authority’s capital regulations, except as a result of any applicable limitation on the amount of such capital. For the avoidance of doubt, a capital disqualification event shall not be deemed to have occurred so long as the applicable securities qualify as either Tier 1 or Tier 2 capital securities as described above.
7



Exhibit 4.12
At any time prior to November 7, 2021, if we submit to the holders of our common shares a proposal for an amalgamation or merger or if we submit any proposal for any other matter that requires, as a result of a change in Bermuda law after the date of the prospectus supplement relating to the Series E Preferred Shares, for its validation or effectuation an affirmative vote of the holders of the Series E Preferred Shares at the time outstanding, whether voting as a separate series or together with any other series or class of preference shares as a single class, we will have the option, upon not less than 30 nor more than 60 days prior written notice, to redeem all of the outstanding Series E Preferred Shares for cash at a redemption price of $2,600 per Series E Preferred Share (equivalent to $26 per depositary share), plus declared and unpaid dividends, if any, to, but excluding, the date of redemption, without accumulation of any undeclared dividends.
Neither holders of depositary shares nor holders of Series E Preferred Shares have the right to require the redemption or repurchase of the Series E Preferred Shares.
See “Description of Depositary Shares—Redemption of Depositary Shares” for information about redemption of the depositary shares relating to the Series E Preferred Shares.
If the Series E Preferred Shares or any depositary shares representing interest in the Series E Preferred Shares are to be redeemed, the notice of redemption shall be given by first class mail to the holders of record of the depositary shares representing interests in the Series E Preferred Shares to be redeemed within the time period provided above; provided that, if the depositary shares are held in book-entry form through The Depository Trust Company (“DTC”), we may give such notice in any manner permitted by DTC. Each notice of redemption will include a statement setting forth:
the redemption date;
the number of Series E Preferred Shares to be redeemed (and the corresponding number of depositary shares) and, if less than all the Series E Preferred Shares held by such holder are to be redeemed, the number of such Series E Preferred Shares to be redeemed from such holder;
the redemption price or methodology for determining the redemption price; and
the place or places where holders may surrender certificates evidencing the depositary shares representing interests in the Series E Preferred Shares for payment of the redemption price.
If notice of redemption of any Series E Preferred Shares has been given and if the funds necessary for such redemption have been set aside by us for the benefit of the holders of the Series E Preferred Shares so called for redemption, then, from and after the redemption date, dividends will cease to accumulate on such Series E Preferred Shares, such Series E Preferred Shares shall no longer be deemed outstanding and all rights of the holders of such Series E Preferred Shares will terminate, except the right to transfer the Series E Preferred Shares prior to the redemption date and the right to receive the redemption price. See “Description of Depositary Shares” below for information about redemption of the depositary shares relating to our Series E Preferred Shares.
In case of any redemption of only part of the Series E Preferred Shares at the time outstanding, the Series E Preferred Shares to be redeemed shall be selected either pro rata or in such other manner as we may determine to be fair and equitable.
Additional Amounts
We make all payments on the Series E Preferred Shares free and clear of and without withholding or deduction at source for, or on account of, any present or future taxes, fees, duties, assessments or governmental charges of whatever nature imposed or levied by or on behalf of any relevant taxing jurisdiction, unless such taxes, fees, duties, assessments or governmental charges are required to be withheld or deducted by (x) the laws (or any regulations or rulings promulgated thereunder) of any relevant taxing jurisdiction or (y) an official position regarding the application, administration, interpretation or enforcement of any such laws, regulations or rulings (including, without limitation, a holding by a court of competent jurisdiction or by a taxing authority in any relevant taxing jurisdiction). If a withholding or deduction at source is required we, subject to certain limitations and exceptions described below, pay to the holders of the Series E Preferred Shares such additional amounts (the “additional amounts”) as may be necessary so that every net payment made to such holders, after the withholding or deduction, will not be less than the amount provided for in the Certificate of Designations to be then due and payable. We are not required to pay any additional amounts for or on account of:
8



Exhibit 4.12
(a) any tax, fee, duty, assessment or governmental charge of whatever nature that would not have been imposed but for the fact that (i) the holder or beneficial owner of the Series E Preferred Shares was a resident, citizen, domiciliary or national of, or engaged in business or maintained a permanent establishment or was physically present in, the relevant taxing jurisdiction or otherwise had some connection with the relevant taxing jurisdiction other than by reason of the mere ownership of, or receipt of payment under, such Series E Preferred Shares or (ii) the holder presented, where presentation is required, such Series E Preferred Shares for payment more than 30 days after the relevant date (as defined below), except to the extent that the holder would have been entitled to such additional amounts if it had presented such Series E Preferred Shares for payment on any day within that 30-day period. The “relevant date” means, in respect of any payment, the date on which such payment first becomes due and payable, but if the full amount of the moneys payable has not been received by the dividend disbursing agent on or prior to such due date, it means the first date on which the full amount of such moneys has been so received and is available for payment to holders, and notice to that effect shall have been duly given to the holders of the Series E Preferred Shares;
(b) any estate, inheritance, gift, sale, transfer, personal property or similar tax, fee, duty, assessment or other governmental charge;
(c) any tax, fee, duty, assessment or other governmental charge that is payable otherwise than by withholding or deduction from payment of the liquidation preference of or any dividends on the Series E Preferred Shares;
(d) any tax, fee, duty, assessment or other governmental charge that is imposed or withheld by reason of the failure by the holder or beneficial owner of such Series E Preferred Shares to comply with any reasonable request by us addressed to the holder within 90 days of such request (a) to provide information concerning the nationality, citizenship, residence or identity of the holder or beneficial owner or (b) to make any declaration or other similar claim or satisfy any information or reporting requirement, which is required or imposed by statute, treaty, regulation or administrative practice of the relevant taxing jurisdiction as a precondition to exemption from all or part of such tax, fee, duty, assessment or other governmental charge;
(e) any withholding or deduction imposed on or in respect of the Series E Preferred Shares pursuant to Sections 1471 through 1474 of the Code, any current or future regulations or official interpretations thereof or intergovernmental agreements in connection therewith, and any agreements entered into pursuant to Section 1471(b)(1) of the Code; or
(f) any combination of items (a), (b), (c), (d) and (e).
In addition, we do not pay additional amounts with respect to any payment on any such Series E Preferred Shares to any holder who is a fiduciary, partnership, limited liability company or other pass-thru entity or a person other than the sole beneficial owner of such Series E Preferred Shares if such payment would be required by the laws of the relevant taxing jurisdiction to be included in the income for tax purposes of a beneficiary or settlor with respect to such fiduciary or a member of such partnership, limited liability company or other pass-thru entity or a beneficial owner to the extent such beneficiary, settlor, member or beneficial owner would not have been entitled to such additional amounts had it been the holder of the Series E Preferred Shares.
If there is a substantial probability that we or any successor corporation would be required to pay any additional amounts as a result of a change in tax law, we also have the option to redeem the Series E Preferred Shares. See “—Redemption” above.
Upon the payment of any additional amounts, holders of depositary shares receive a related proportionate payment. See “Description of Depositary Shares—Dividends and Other Distributions.”
Substitution or Variation
In lieu of redemption, at any time following a tax event or at any time following a capital disqualification event, we may, without the consent of any holders of the Series E Preferred Shares, vary the terms of the Series E Preferred Shares such that they remain securities, or exchange the Series E Preferred Shares with new securities, which (i) in the case of a tax event, would eliminate the substantial probability that we or any successor corporation would be required to pay any additional amounts with respect to the Series E Preferred Shares as a result of a change in tax law, and (ii) in the case of a capital disqualification event, for purposes of determining the solvency margin, capital adequacy ratios or any other comparable ratios, regulatory capital resource or level of AXIS Capital or any member thereof, where subdivided into tiers, qualify as Tier 1 or Tier 2 capital securities under then-applicable
9



Exhibit 4.12
capital adequacy regulations imposed upon us by the Bermuda Monetary Authority (or any successor agency or then-applicable regulatory authority), which includes our individual and group enhanced capital requirements. In either case, the terms of the varied securities or new securities considered in the aggregate cannot be less favorable to holders than the terms of the Series E Preferred Shares prior to being varied or exchanged; provided that no such variation of terms or securities received in exchange shall change the specified denominations of, any payment of dividend on, the redemption dates (other than any extension of the period during which an optional redemption may not be exercised by the Company) or currency of, the Series E Preferred Shares, reduce the liquidation preference thereof, dividend payable, lower the ranking of the securities, reduce the voting threshold for the issuance of senior stock or change the foregoing list of items that may not be so amended as part of such variation or exchange. Further, no such variation of terms or securities received in exchange shall impair the right of a holder of the securities to institute suit for the payment of any amounts due (as provided under the certificate of designations relating thereto), but unpaid with respect to such holder’s securities.
Prior to any variation or exchange, we are required to receive an opinion of independent legal advisers of recognized standing to the effect that holders and beneficial owners of the depositary shares and the Series E Preferred Shares represented thereby (including as holders and beneficial owners of the varied or exchanged securities) will not recognize income, gain or loss for United States federal income tax purposes as a result of such variation or exchange and will be subject to United States federal income tax on the same amounts, in the same manner and at the same times as would have been the case had such variation or exchange not occurred.
Any variation or exchange of the Series E Preferred Shares described above will be made after notice is given to the holders of the Series E Preferred Shares not less than 30 nor more than 60 days prior to the date fixed for variation or exchange, as applicable.
Voting Rights
Except as provided below, the holders of the Series E Preferred Shares have no voting rights.
Under Bermuda law, holders of the Series E Preferred Shares are entitled to one vote for each Series E Preferred Share held by them, voting together with all other shares of the Company, on any proposal for the amalgamation or merger of the Company with another entity. Alternatively, to the extent that the relevant amalgamation agreement or merger agreement contains a provision that would constitute a variation of the rights attaching to the Series E Preferred Shares, the holders of the Series E Preferred Shares are entitled to vote separately as a class on the proposal for the amalgamation or merger.
Whenever dividends payable on Series E Preferred Shares have not been declared by the board of directors and paid for an aggregate amount equivalent to six full dividend periods (whether or not consecutive) on all of the Series E Preferred Shares or any class or series of parity stock then outstanding, the holders of the Series E Preferred Shares, together with the holders of each such class or series of parity stock, have the right, voting together as a single class regardless of class or series, to elect two directors of our board of directors. We will use our best efforts to effectuate the election or appointment of these two directors.
Whenever dividends on the Series E Preferred Shares and any parity stock then outstanding have been paid in full, or declared and sufficient funds have been set aside, for at least four dividend periods, the right of holders of the Series E Preferred Shares and any such parity stock to be represented by directors as described in the preceding paragraph will cease (but subject always to the same provision for the vesting of such rights in the case of any future suspension of payments in an amount equivalent to dividends for six full dividend periods whether or not consecutive), and the terms of office of the additional directors elected or appointed to the board of directors will terminate.
At any time when such special voting power has vested in the holders of the Series E Preferred Shares and any parity stock as described in the preceding paragraph, such right may be exercised initially either at a special general meeting of the holders of the Series E Preferred Shares and any such parity stock or at any annual general meeting of shareholders, and thereafter at annual general meetings of shareholders. At any time when such special right has vested, our chairman or president will, upon the written request of the holders of record of at least 10% of the Series E Preferred Shares and any parity stock then outstanding addressed to our secretary, call a special general meeting of the holders of the Series E Preferred Shares and any parity stock for the purpose of electing directors. Such meeting will be held at the earliest practicable date in such place as may be designated pursuant to our bye-laws (or if there be no designation, at our principal office in Bermuda). If such meeting is not called by our proper
10



Exhibit 4.12
officers within 20 days after our secretary has been personally served with such request, or within 60 days after mailing the same by registered or certified mail addressed to our secretary at our principal office, then the holders of record of at least 10% of the Series E Preferred Shares and any parity stock then outstanding may designate in writing one of their number to call such meeting at our expense, and such meeting may be called by such person so designated upon the notice required for annual general meetings of shareholders and will be held in Bermuda, unless we otherwise designate. Any holder of the Series E Preferred Shares and any parity stock will have access to our register of members for the purpose of causing meetings of shareholders to be called pursuant to these provisions. Notwithstanding the foregoing, no such special meeting will be called during the period within 90 days immediately preceding the date fixed for the next annual general meeting of shareholders.
At any annual or special general meeting at which the holders of the Series E Preferred Shares and any parity stock have the special right to elect directors as described above, the presence, in person or by proxy, of the holders of 50% of the Series E Preferred Shares and any parity stock will be required to constitute a quorum for the election of any director by the holders of the Series E Preferred Shares and any parity stock, voting as a class. At any such meeting or adjournment thereof the absence of a quorum of the Series E Preferred Shares and any parity stock will not prevent the election of directors other than those to be elected by the Series E Preferred Shares and any parity stock, voting as a class, and the absence of a quorum for the election of such other directors will not prevent the election of the directors to be elected by the Series E Preferred Shares and any parity stock, voting as a class.
During any period in which the holders of the Series E Preferred Shares and any parity stock have the right to vote as a class for directors as described above, any vacancies in our board of directors will be filled by vote of a majority of our board of directors pursuant to our bye-laws. During such period, the directors so elected by the holders of the Series E Preferred Shares and any parity stock will continue in office (1) until the next succeeding annual general meeting or until their successors, if any, are elected by such holders and qualify or (2) unless required by applicable law, rule or regulation to continue in office for a longer period, until termination of the right of the holders of the Series E Preferred Shares and any parity stock to vote as a class for directors, if earlier. Immediately upon any termination of the right of the holders of the Series E Preferred Shares and any parity stock to vote as a class for directors as provided herein, the terms of office of the directors then in office so elected by the holders of the Series E Preferred Shares and the parity stock will terminate.
Except as set forth above under “—Substitution or Variation,” without the written consent of the holders of at least 75% of the Series E Preferred Shares at the time issued and outstanding or the sanction of a resolution passed by a majority of the votes cast at a separate meeting of the holders of the Series E Preferred Shares at which a quorum (consisting of the presence, in person or by proxy, of the holders of 50% of the Series E Preferred Shares) is present, we may not take any action necessary for effecting or validating any amendment, alteration or repeal of any of the provision of the Memorandum of Association of AXIS Capital, our bye-laws or our certificate of designation in respect of the Series E Preferred Shares that would vary the rights attached to the Series E Preferred Shares or effect any amalgamation that would affect the Series E Preferred Shares unless each Series E Preferred Share (1) shall remain outstanding with no variation in its rights, preference or voting powers of (2) shall be converted into or exchanged for a preference share of the surviving entity having rights, preferences and voting powers identical to that of a Series E Preferred Share. Without the written consent, or the sanction of a resolution passed at a separate meeting, of the holders of at least 67% of the Series E Preferred Shares at the time issued and outstanding, we may not authorize any creation or increase in the issued amount of, any shares of any series or any security convertible into shares of any series ranking prior to the Series E Preferred Shares with respect to payment of dividends and distribution of assets upon our liquidation, dissolution or winding-up of AXIS Capital.
We may create and issue additional series of parity stock and junior stock without the consent of any holder of the Series E Preferred Shares. Holders of the Series E Preferred Shares are not entitled to vote on any sale of all or substantially all of the assets of AXIS Capital.
On any item on which the holders of the Series E Preferred Shares are entitled to vote, such holders are entitled to one vote for each Series E Preferred Share held.
The foregoing voting provisions will not apply if, at or prior to the time when the act with respect to which such vote would otherwise be required shall be effected, all outstanding Series E Preferred Shares shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have been set aside by us for the benefit of the holders of Series E Preferred Shares to effect such redemption.
11



Exhibit 4.12
Holders of depositary shares must act through the depositary to exercise any voting rights, as described under “Description of Depositary Shares—Voting the Series E Preferred Shares.”
Conversion
The Series E Preferred Shares are not convertible into or exchangeable for any other securities or property of AXIS Capital.
Limitations on Transfer and Ownership
Holders of the Series E Preferred Shares only have the right to vote in limited circumstances, as set forth above under “—Voting Rights.” Pursuant to a mechanism specified in our bye-laws, the voting rights exercisable by a shareholder may be limited. In any situation in which (1) the “controlled shares” of a United States Person would constitute 9.5% or more of the votes conferred by our issued shares and such United States Person would be generally required to recognize income with respect to us under Section 951(a)(1) of the Code, if we were a controlled foreign corporation as defined in Section 957 of the Code and if the ownership threshold under Section 951(b) of the Code were 9.5% or (2) the shares held by a Direct Foreign Shareholder Group would constitute 9.5% or more of the votes conferred by our issued shares, the voting rights exercisable by a shareholder with respect to such shares will be limited so that no U.S. Person or Direct Foreign Shareholder Group is deemed to hold 9.5% or more of the voting power conferred by our shares. In addition, our board of directors may limit a shareholder’s voting rights where it deems it necessary to do so to avoid adverse tax, legal or regulatory consequences to us, our subsidiaries, any shareholders or their affiliates.
Under these provisions, certain shareholders may have their voting rights limited to less than one vote per share. Moreover, these provisions could have the effect of reducing the votes of certain shareholders who would not otherwise be subject to the 9.5% limitation by virtue of their direct share ownership. Our bye-laws also provide that shareholders will be notified of their voting interests prior to any vote to be taken by the shareholders.
Depositary, Transfer Agent and Registrar
The depositary for the Series E Preferred Shares is Computershare Inc. and Computershare Trust Company, N.A. The transfer agent and registrar for the Series E Preferred Shares is Computershare Trust Company, N.A. The principal executive office of the depositary, transfer agent and registrar is located at 150 Royall Street, Suite 101, Canton, Massachusetts 02021.
Depositary Shares
Each depositary share represents a 1/100th interest in a Series E Preferred Share, and is evidenced by depositary receipts. We deposited the underlying Series E Preferred Shares with a depositary pursuant to a deposit agreement among us, Computershare Inc. and Computershare Trust Company, N.A., acting as depositary, and the holders from time to time of the depositary receipts evidencing the depositary shares (the “Deposit Agreement”). Subject to the terms of the Deposit Agreement, each holder of a depositary share is entitled, through the depositary, in proportion to the applicable fraction of a Series E Preferred Share represented by such depositary share, to all the rights and preferences of the Series E Preferred Shares represented thereby (including dividend, voting, redemption and liquidation rights).
As used herein, references to “holders” of depositary shares mean those who own depositary shares registered in their own names on the books that we or the depositary maintain for this purpose. DTC is the only registered holder of the depositary receipts representing the depositary shares. References to “holders” of depositary shares do not include indirect holders who own beneficial interests in depositary shares registered in street name or issued in book-entry form through DTC.
Dividends and Other Distributions
Each dividend payable on a depositary share is in an amount equal to 1/100th of the dividend declared and payable on the related Series E Preferred Share.
The depositary distributes any cash dividends or other cash distributions received in respect of the deposited Series E Preferred Shares, including any additional amounts as described under “Series E Preferred Shares—Additional Amounts,” to the record holders of depositary shares relating to the underlying Series E Preferred
12



Exhibit 4.12
Shares in proportion to the number of depositary shares held by the holders. If we make a distribution other than in cash, the depositary will distribute any property received by it to the record holders of depositary shares entitled to those distributions, unless it determines that the distribution cannot be made proportionally among those holders or that it is not feasible to make a distribution. In that event, the depositary may, with our approval, sell the property and distribute the net proceeds from the sale to the holders of the depositary shares.
Record dates for the payment of dividends and other matters relating to the depositary shares are the same as the corresponding record dates for the Series E Preferred Shares.
Redemption of Depositary Shares
If we redeem the Series E Preferred Shares represented by the depositary shares, the depositary shares will be redeemed from the proceeds received by the depositary resulting from the redemption of the Series E Preferred Shares held by the depositary. The redemption price per depositary share is expected to be equal to 1/100th of the redemption price per share payable with respect to the Series E Preferred Shares, plus any declared and unpaid dividends.
Whenever we redeem Series E Preferred Shares held by the depositary, the depositary will redeem, as of the same redemption date, the number of depositary shares representing Series E Preferred Shares so redeemed. If fewer than all of the outstanding depositary shares are redeemed, the depositary will select the depositary shares to be redeemed pro rata or in such other manner as we may determine to be fair and equitable. The depositary will mail notice of redemption to record holders of the depositary receipts not less than 30 and not more than 60 days prior to the date fixed for redemption of the Series E Preferred Shares and a corresponding number of depositary shares.
Voting the Series E Preferred Shares
Because each depositary share represents a 1/100th interest in a Series E Preferred Share, holders of depositary receipts are entitled to 1/100th of a vote per depositary share under those limited circumstances in which holders of the Series E Preferred Shares are entitled to a vote.
When the depositary receives notice of any meeting at which the holders of the Series E Preferred Shares are entitled to vote, the depositary will mail the information contained in the notice to the record holders of the depositary shares relating to the Series E Preferred Shares. Each record holder of the depositary shares on the record date, which will be the same date as the record date for the Series E Preferred Shares, may instruct the depositary to vote the amount of the Series E Preferred Shares represented by the holder’s depositary shares. To the extent possible, the depositary will vote the amount of the Series E Preferred Shares represented by depositary shares in accordance with the instructions it receives. We will agree to take all reasonable actions that the depositary determines are necessary to enable the depositary to vote as instructed. If the depositary does not receive specific instructions from the holders of any depositary shares representing the Series E Preferred Shares, it will not vote the amount of the Series E Preferred Shares represented by such depositary shares.
Preemptive and Conversion Rights
The holders of the depositary shares do not have any preemptive or conversion rights.
Depositary, Transfer Agent and Registrar
Computershare, Inc. and Computershare Trust Company, N.A. is the depositary for the depositary shares. Computershare Trust Company, N.A. is the transfer agent and registrar for the depositary shares.
Form of Series E Preferred Shares and Depositary Shares
The depositary shares are issued in book-entry form through DTC, as described in “Book-Entry Procedures and Settlement.” The Series E Preferred Shares are issued in registered form to the depositary.
Listing of Depositary Shares
The depositary shares are listed on the NYSE under the symbol “AXSprE.”
13



Exhibit 4.12
The Deposit Agreement
Amendment and Termination of the Deposit Agreement
We and the depositary may generally amend the form of depositary receipt evidencing the depositary shares and any provision of the Deposit Agreement at any time without the consent of the holders of depositary shares. However, any amendment that materially and adversely alters the rights of the holders or would materially and adversely inconsistent with the rights granted to the Series E Preferred Shares will not be effective unless such amendment has been approved by holders of depositary shares representing at least a majority of the depositary shares then outstanding.
The Deposit Agreement may be terminated by us or the depositary if:
all outstanding depositary shares have been redeemed; or
there has been made a final distribution in respect of the Series E Preferred Shares in connection with our liquidation, dissolution or winding-up, and such distribution has been distributed to the holders of depositary shares.
Fees, Charges and Expenses
We pay all transfer and other taxes and governmental charges arising solely from the existence of the depositary arrangements regarding the depositary shares. We also paid all charges of the depositary in connection with the initial deposit of the Series E Preferred Shares and the initial issuance of the depositary shares, and will pay all charges of the depositary in connection with all withdrawals and any redemption of the Series E Preferred Shares. All other transfer and other taxes and governmental charges are at the expense of holders of depositary shares.
Resignation and Removal of Depositary
The depositary may resign at any time by delivering a notice to us of its election to do so. We may remove the depositary at any time by providing notice. Any such resignation or removal will take effect upon the appointment of a successor depositary and its acceptance of such appointment. The successor depository must, generally, be appointed within 60 days after delivery of the notice of resignation or removal and be a person with a principal office in the United States and having a combined capital and surplus (along with its affiliates) of at least $50 million. If a successor is not appointed within 60 days, the outgoing depositary may petition a court to do so.
Miscellaneous
The depositary is not liable for any delays or failures in performance of its obligations under the Deposit Agreement resulting from acts beyond its reasonable control. The depositary is not obligated to appear in, prosecute or defend any legal proceeding relating to any depositary shares or Series E Preferred Shares unless satisfactory indemnity is furnished.

14
EX-10.13 8 axs-20231231xexx1013.htm EX-10.13 Document




[Header]


December 14, 2016

Conrad D. Brooks
[Address]

Dear Conrad:

We are delighted that you have decided to continue your service with AXIS Specialty U.S. Services, Inc., a Delaware corporation (the "Company") and wholly owned, indirect subsidiary of AXIS Capital Holdings Limited, a Bermuda company (the "Parent"). We thought it would be useful to lay out the terms and conditions of our agreement in this letter agreement (this "Agreement").
1)Employment
a)Position and Duties. Effective January 2, 2017 the Company shall employ you in the position of Executive Vice President and General Counsel of Parent or in such other position as is mutually agreeable to you and the Company. You will report directly and exclusively to the Chief Executive Officer of the Parent, or any other individual as is mutually agreeable to you and the Company. You will be expected to devote your full business time and energy, attention, skills and ability to the performance of your duties and responsibilities to the Company and its direct and indirect subsidiaries (collectively, the “Parent Group”) on an exclusive basis, as requested by the Chief Executive Officer of Parent, and shall faithfully and diligently endeavor to promote the business and best interests of the Company and its subsidiaries and affiliates. Anything herein to the contrary notwithstanding, nothing shall preclude you from (i) upon the written approval of the Parent’s Board, serving on the board of directors of another corporation or a trade association; (ii) serving on the board of charitable organizations, (iii) engaging in charitable, community and other business affairs, and (iv) managing your personal investments and affairs; provided such activities do not, in the reasonable judgment of the Company, materially interfere with the proper performance of your responsibilities and duties hereunder.
b)Place of Performance. In connection with your employment during the Employment Term (as defined in Section 3(a)), you shall be based primarily at the Company’s offices in Alpharetta, GA, or as may otherwise be mutually agreed, except for necessary travel on Company business.
2)Compensation and Benefits
a)During the Employment Term, your annual base salary shall be no less than $400,000 (the base salary as may be increased from time to time at the sole discretion of the Company, referred to as "Base Salary"), and shall be paid pursuant to the Company's customary payroll practices.



b)In addition to the Base Salary, in each calendar year of the Parent ending during the Employment Term, you will be eligible to earn an annual cash bonus ("Annual Bonus"). Your target Annual Bonus commencing as of the effective date of this Agreement is 80% of your then current Base Salary if the Parent achieves certain performance objectives and subject to your individual performance pursuant to the Parent’s annual bonus plan. Except as provided in Section 4 below, the Annual Bonus for each period will be paid only if you are actively employed with the Company on the date of disbursement. Any Annual Bonus payable hereunder shall be paid in the calendar year following the applicable fiscal year of the Parent, after it has been determined by the Compensation Committee of the Parent. Your March 2017 annual bonus shall be calculated using your 2016 target metrics.
c)You will be eligible to participate in the Parent’s 2013 Executive Long-Term Equity Compensation Program (the “Program”) (as may be amended from time to time) or a successor plan with an initial annual target share or unit award commencing as of the effective date of this Agreement valued at $550,000 subject to the rules of the Program and an award agreement in such form as the Compensation Committee of the Parent may determine from time to time; provided, however, the parties acknowledge and agree that your March 2017 equity award shall be valued at $700,000.
d)During the Employment Term, you will be eligible to participate in or receive benefits under any 401(k) savings plan, medical and dental benefits plan, life insurance plan, short-term and long-term disability plans, supplemental and/or incentive compensation plans, or any other employee benefit or fringe benefit plan, generally made available by the Parent to senior executives in accordance with the eligibility requirements of such plans and subject to the terms and conditions set forth in this Agreement.
e)During the Employment Term, you will be entitled to 25 days of paid vacation per calendar year (prorated for any partial years of employment), subject to the applicable vacation policies and procedures on usage and carry over. You are also eligible for two personal days per year.
f)During the Employment Term, the Company will reimburse you for all reasonable business expenses incurred by you in the course of performing your duties under this Agreement which are consistent with the Company’s policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company’s requirements with respect to reporting and documentation of expenses. Reimbursements will be paid promptly after submission and review of appropriate documentation, but in any event no later than 2½ months after the end of the calendar year in which the expense was incurred.
3)Term of Employment
a)The employment period shall commence on January 2, 2017 and shall continue until terminated in accordance with this Agreement as follows:
i)Death. Your employment shall automatically terminate upon your death.



ii)Disability. The Company shall be entitled to terminate your employment if, as a result of your incapacity due to physical or mental illness or injury, you shall have been unable to perform your duties hereunder for a period of 181 days in any twelve-month period (your “Disability”).
iii)Cause. The Company may terminate your employment at any time for Cause which, for purposes of this Agreement, shall mean (i) any act or omission which constitutes a material breach by you of the terms of this Agreement, the employment policies of the Parent Group, or applicable law governing the Parent Group or your employment, (ii) the conviction of a felony or commission of any act which would rise to the level of a felony, (iii) the conviction (or commission of any act which would rise to the level of) a lesser crime or offense that adversely impacts or potentially could impact upon the business or reputation of the Parent Group in a material way, (iv) your willful violation of specific lawful and material directives of the Parent that are not contrary to this Agreement, (v) commission of a dishonest or wrongful act involving fraud, misrepresentation or moral turpitude causing damage to the Company, its parent and/or affiliates and subsidiaries, (vi) the willful failure to perform a substantial part of your substantial job functions after written notice from the Board requesting such performance, or (vii) material breach of fiduciary duty.
Anything to the contrary notwithstanding, you shall not be terminated for “Cause” within the meaning of clauses (i) through (vii), above, unless written notice stating the basis for the termination is provided to you and you are given 15 days to cure the event that is the basis of such claim, provided, however, the foregoing right to cure will not apply in the event of a termination for Cause due to any of the acts described in clauses (ii), (iii) or (v), above.
iv)Without Cause. The Company may terminate your employment at any time without Cause; provided, however, that the Company provides you with notice of its intent to terminate at least six (6) months in advance of the date of termination.
v)Voluntary Resignation. You may voluntarily terminate your employment hereunder; provided, however, that in the event you are not terminating for Good Reason pursuant to subparagraphs (vi) and (vii) below, you provide the Company with notice of your intent to terminate at least six (6) months in advance of the date of termination.
vi)Good Reason. You may terminate your employment for Good Reason if (i) (A) the scope of your position, authority or duties as Executive Vice President and General Counsel are materially adversely changed (except for changes during a Notice Period as authorized under Section 3(c) below), (B) your compensation under this Agreement is not paid or your Base Salary or your Target Bonus or equity award is reduced below the levels specified in Sections 2(a) and (b) or there is a material adverse change in your employee benefits (excluding changes in any benefits plan where such changes apply generally to participants in the plan), (C) you are notified by the Company that you are required to relocate to a place more than 50 miles from your place of employment in Alpharetta, GA, (D)



you are assigned duties that are materially inconsistent with your position with the Company/Parent, (E) you are required to report to anyone other than the Chief Executive Officer of the Parent or any other individual that is not mutually agreeable to you and the Company; (ii) you give the Company written notice of your intent to terminate your employment as a result of such event and provide the specific reasons therefore within sixty (60) days of such event occurring; (iii) the Company does not make the necessary corrections within sixty (60) days of receipt of your written notice; and (iv) you terminate employment no later than ten (10) days following the end of such sixty (60) day period.
vii)Good Reason following a Change in Control. You may terminate your employment for Good Reason if (i) during the twenty-four (24) month period immediately following a Change in Control (A) the scope of your position, authority or duties is materially adversely changed (except for changes during a Notice Period as authorized under Section 3 (c) below), (B) your compensation under this Agreement is not paid or your Base Salary or your Target Bonus or equity award is reduced below the levels specified in Sections 2(a) and (b) or there is a material adverse change in your employee benefits (excluding changes in any benefits plan where such changes apply generally to participants in the plan), (C) ) you are notified by the Company that you are required to relocate to a place more than 50 miles from your current place of employment in Alpharetta, GA, (D) you are assigned duties that are materially inconsistent with your position with the Company/Parent, (E) you are required to report to anyone other than the Chief Executive Officer of the Parent or any other individual that is not mutually agreeable to you and the Company, or (F) in the event that any other person or entity acquires all or substantially all of the Parent Group’s business and, the Company fails to obtain the assumption of this Agreement by the successor; (ii) you give the Company written notice of your intent to terminate your employment as a result of such event and provide the specific reasons therefore within sixty (60) days of your knowledge of such event occurring; (iii) the Company does not make the necessary corrections within sixty (60) days of receipt of your written notice; and (iv) you terminate employment no later than ten (10) days following the end of such sixty (60) day period. For purposes of this Agreement, the “Change in Control" will be deemed to have occurred as of the first day any of the following events occur:
1.Any person or entity is or becomes the "beneficial owner" (as defined in Rule 13d-3 under the U.S. Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of the Parent representing 50% or more of the combined voting power of the Parent’s then outstanding voting securities entitled to vote generally in the election of directors (the "Outstanding Parent Voting Securities"); provided, however, that for purposes of this Section 3(a)(vii)(1), the following acquisitions shall not constitute a Change in Control: (A) any acquisition directly from the Parent, (B) any acquisition by the Parent, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Parent or any affiliate of the Parent or (D) any acquisition by any entity pursuant to a transaction



which complies with clauses (A), (B) and (C) of Section 3(a)(vii)(3) hereof;
2.Individuals who, as of the date of this Agreement, constitute the Board (hereinafter referred to as the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Parent's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered a member of the Incumbent Board, excluding any individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person or entity other than the Board;
3.Consummation of a reorganization, merger, share exchange, amalgamation, recapitalization, consolidation or similar transaction by and among the Parent and another person or entity, including, for this purpose, a transaction as a result of which another person or entity owns the Parent or all or substantially all of the Parent's assets, either directly or through one or more subsidiaries (a "Business Combination"), in each case, unless, following such Business Combination, (A) all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Parent Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors (or equivalent management personnel) of the entity resulting from such Business Combination or that, as a result of such Business Combination, owns the Parent or all or substantially all of the Parent's assets, either directly or through one or more subsidiaries, in substantially the same proportions as their ownership of the Outstanding Parent Voting Securities immediately prior to such Business Combination; (B) no person or entity (excluding any entity resulting from such Business Combination, or that, as a result of such Business Combination, owns the Parent or all or substantially all of the Parent's assets, either directly or through one or more subsidiaries, or any employee benefit plan (or related trust) of the foregoing) beneficially owns, directly or indirectly, 50% or more of the then outstanding shares of common stock or the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors (or equivalent management personnel) of the entity resulting from such Business Combination or that, as a result of such Business Combination, owns the Parent or all or substantially all of the Parent's assets, either directly or through one or more subsidiaries, except to the extent that such ownership existed with respect to the Parent prior to



the Business Combination; or (C) at least a majority of the members of the board of directors (or equivalent management personnel) of the entity resulting from such Business Combination or that, as a result of such Business Combination, owns the Parent or all or substantially all of the Parent's assets, either directly or through one or more subsidiaries, were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, pursuant to which such Business Combination is effected or approved; or
4. Approval by the shareholders of the Parent of a complete liquidation or dissolution of the Parent or the sale or other disposition of all or substantially all of the Parent's assets.
a)Any termination of your employment by the Company or by you under this Section 3 (other than termination pursuant to Section 3(a)(i)) shall be communicated by a written notice to the other party hereto indicating the specific termination provision in this Agreement relied upon and specifying a date of termination.
b)The period between the date notice of termination is provided and your termination date shall be referred to as the “Notice Period.” During any Notice Period, the Company may, in its absolute discretion (i) require you to perform only such portion of your normal duties as it may allocate to you from time to time, (ii) require you not to perform any of your duties, (iii) require you not to have any contact with customers or clients of the Company nor any contact (other than purely social contact) with such employees of the Company as the Company shall determine, (iv) exclude you from any premises of the Company, and/or (v) require you to resign from all directorships and other offices that you hold in connection with your employment with the Company (including any directorships with subsidiaries or other affiliates of the Company) effective as of any date during the Notice Period. If the Company elects to take any such action, such election shall not constitute a breach by the Company of this Agreement or Good Reason for you to terminate your Employment under Sections 3(a)(vi) or (vii) and you shall not have any claim against the Company in connection therewith so long as, during the Notice Period, the Company continues to pay to you your Base Salary, Annual Bonus and equity and all of the other amounts described in Section 2 of this Agreement (to the extent permitted under applicable law) at the same time as such amounts would have been paid had you remained an active employee.
4)Severance Payments and Other Benefits Following Termination of Employment
a)In the event that your employment with the Company shall terminate for any reason, and except as otherwise set forth in this Agreement, the Company’s sole obligation under this Agreement shall be to pay to you any accrued but unpaid Base Salary for services rendered to the date of termination, any accrued but unpaid expenses required to be reimbursed under this Agreement, any unused vacation accrued to the date of termination. For the sake of clarity, this Section 4(a) does not limit any rights you may have under the Company’s retirement or welfare plans.



b)Death. In the event your employment is terminated due to your death pursuant to Section 3(a)(i), then in addition to the amounts provided under Section 4(a) above:
i)Your beneficiary will be paid a pro-rata portion of your Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, based on the number of days you were employed by the Parent Group during such year and calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination; and
ii)All outstanding and unvested restricted stock units granted pursuant to the 2007 Long-Term Equity Compensation Plan as it may be amended from time to time, or any successor plan, unless prohibited by such successor plan (“Restricted Stock Units”), shall immediately vest upon said termination.
c) Disability. In the event that the Company terminates your employment due to your Disability, pursuant to Section 3(a)(ii), then in addition to the amounts provided under Section 4(a) above:
i)You will be paid a pro-rata portion of your Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, based on the number of days you were employed by the Parent Group during such year and calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination; and
ii)All outstanding and unvested Restricted Stock Units shall immediately vest upon said termination.
d)Termination by the Company without Cause. In the event that the Company terminates your employment without Cause in accordance with the provisions of Section 3(a)(iv) hereof, and conditioned on your compliance with this Agreement during the Notice Period (but not for any other reason, including without limitation under Sections 3(a)(i), (ii), (iii), or (v)), then in addition to the amounts you have received during the Notice Period and any other amounts provided in Section 4(a), but subject to your timely satisfaction of the condition precedent in Section 4(h) below, the following will be provided to you following the termination of the Notice Period:
i)You will be paid a lump sum amount equal to one year’s Base Salary at the rate in effect immediately prior to said termination, to be paid no later than sixty (60) days following your termination;
ii)With respect to the Annual Bonus for the calendar year prior to the calendar year in which your termination occurs, you will be excused from the requirement in Section 2(b) that you must be actively employed with the Company on the date of disbursement in order to receive the Bonus;
iii)You will be paid an amount equal to the Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, calculated



as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
iv)You will be paid a pro-rata portion of your Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, based on the number of days you were employed by the Parent Group during such year and calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
v)You will be paid an amount equal to the premiums you would have paid if you had elected COBRA under the Company group health, dental and vision plans, as applicable, at the same level of coverage as you had immediately prior to your termination, for the twelve (12) month period following your termination. Such payment shall be paid in a lump sum no later than sixty (60) days following your termination; and
vi)In the event that the Company terminates your employment without Cause in accordance with the provisions of Section 3(a)(iv), then subject to your compliance with the obligations set forth in Sections 5, 7, 8, 9 and 10 below, all outstanding and unvested Restricted Stock Units shall immediately vest upon said termination.
e)Termination by the Company without Cause Following Change in Control. In the event that within 24 months following a Change in Control as defined in Section 3(a)(vii) (1 – 4) hereof the Company terminates your employment without Cause, (but not for any other reason, including without limitation under Sections 3(a)(i), (ii), (iii), or (v)) then in addition to the amounts you have received during the Notice Period and any other amounts provided in Section 4(a), but subject to your timely satisfaction of the condition precedent in Section 4(h) below, the following will be provided to you following the termination of the Notice Period:
i)You will be paid a lump sum amount equal to one (1) years’s Base Salary at the rate in effect immediately prior to said termination, to be paid no later than sixty (60) days following your termination;
ii)With respect to the Annual Bonus for the calendar year prior to the calendar year in which your termination occurs, you will be excused from the requirement in Section 2(b) that you must be actively employed with the Company on the date of disbursement in order to receive the Bonus;
iii)You will be paid an amount equal to two times the Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
iv)You will be paid a pro-rata portion of your Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, based on the number of days you were employed by the Parent Group during such year and



calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
v)You will be paid an amount equal to the premiums you would have paid if you had elected COBRA under the Company group health, dental and vision plans, as applicable, at the same level of coverage as you had immediately prior to your termination, for the twelve (12) month period following your termination. Such payment shall be paid in a lump sum no later than sixty (60) days following your termination; and
vi)All outstanding and unvested Restricted Stock Units shall immediately vest upon said termination.
f)Termination by You for Good Reason. In the event that you terminate for Good Reason in accordance with the provisions of Section 3(a)(vi) hereof, (but not for any other reason, including without limitation under Sections 3(a)(i), (ii), (iii), or (v)) then in addition to the amounts provided in Section 4(a), but subject to your timely satisfaction of the condition precedent in Section 4(h) below, the following will be provided to you:
i)You will be paid a lump sum amount equal to one year’s Base Salary at the rate in effect immediately prior to said termination, to be paid no later than sixty (60) days following your termination;
ii)With respect to the Annual Bonus for the calendar year prior to the calendar year in which your termination occurs, you will be excused from the requirement in Section 2(b) that you must be actively employed with the Company on the date of disbursement in order to receive the Bonus;
iii)You will be paid an amount equal to the Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
iv)You will be paid a pro-rata portion of your Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, based on the number of days you were employed by the Parent Group during such year and calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
v)You will be paid an amount equal to the premiums you would have paid if you had elected COBRA under the Company group health, dental and vision plans, as applicable, at the same level of coverage as you had immediately prior to your termination, for the twelve (12) month period following your termination. Such payment shall be paid in a lump sum no later than sixty (60) days following your termination; and
vi)In the event that you terminate for Good Reason in accordance with the provisions of Section 3(a)(vi), then subject to your compliance with the obligations set forth in



Sections 5, 7, 8, 9 and 10 below, all outstanding and unvested Restricted Stock Units shall immediately vest upon said termination.
g)Termination by You for Good Reason Following Change in Control. In the event that within 24 months following a Change of Control as defined in Section 3(a)(vii) (1 – 4) hereof you terminate for Good Reason in accordance with the provisions of Section 3(a)(vii) hereof, (but not for any other reason, including without limitation under Sections 3(a)(i), (ii), (iii), or (v)) then in addition to the amounts provided in Section 4(a), but subject to your timely satisfaction of the condition precedent in Section 4(h) below, the following will be provided to you:
i)You will be paid a lump sum amount equal to one (1) year’s Base Salary at the rate in effect immediately prior to said termination, to be paid no later than sixty (60) days following your termination;
ii)With respect to the Annual Bonus for the calendar year prior to the calendar year in which your termination occurs, you will be excused from the requirement in Section 2(b) that you must be actively employed with the Company on the date of disbursement in order to receive the Bonus;
iii)You will be paid a pro-rata portion of your Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, based on the number of days you were employed by the Parent Group during such year and calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
iv)You will be paid an amount equal to two times the Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
v)You will be paid an amount equal to the premiums you would have paid if you had elected COBRA under the Company group health, dental and vision plans, as applicable, at the same level of coverage as you had immediately prior to your termination, for the twelve (12) month period following your termination. Such payment shall be paid in a lump sum no later than sixty (60) days following your termination; and
vi) All outstanding and unvested Restricted Stock Units shall immediately vest upon said termination.
h)No severance benefits or payments provided pursuant to this Section 4, other than the amounts described in Section 4(a), will be provided to you unless you execute a waiver and release in the form specified in Exhibit A hereto (with such changes as may be required due to change in applicable law or regulation) within forty-five (45) days following your employment termination date and do not revoke such release. To the extent required to avoid penalty taxes under Section 409A of the Internal Revenue Code of 1986, as amended, and all Treasury Regulations and guidance promulgated thereunder



(“Section 409A of the Code”), in the event that any payment or benefit payable pursuant to Section 4 of this Agreement is subject to Section 409A of the Code and can be paid in more than one taxable year depending on when you execute the waiver and release agreement, such payment shall be made in the second taxable year.
i)In the event of any termination of your Employment by the Company, or by you in conformity with this Agreement, you shall be under no obligation to seek other employment, and there shall be no offset against amounts due you under this Agreement on account of any remuneration attributable to any subsequent employment you may obtain. Any amounts due under this Section 4 are considered to be reasonable by the Company and not in the nature of a penalty.
5)Resignation from Directorships and Other Offices
In addition, upon your termination of employment with the Company for any reason, you agree to resign from all directorships and other offices that you hold in connection with your employment with the Company (including any directorships with subsidiaries or other affiliates of the Company).
6)Conflict of Interest
During employment with the Company, you may not use your position, influence, knowledge of Confidential Information or Trade Secrets or the Company’s assets for personal gain. A direct or indirect financial interest (excluding investments in mutual funds or other similar investment vehicles), including joint ventures in or with a supplier, vendor, customer or prospective customer without disclosure and the express written approval of the Chief Executive Officer of the Parent is strictly prohibited during employment with the Company.
7)Confidential Information
a)As an executive of the Company, you will learn or have access to, or may assist in the development of, highly confidential and sensitive information and trade secrets about the Company, its operations, its subsidiaries and affiliates, its employees, and its customers, which are the property of the Company. Such Confidential Information and Trade Secrets include but are not limited to: (i) financial and business information relating to the Company, such as information with respect to costs, commissions, fees, profits, expenses, sales, markets, mailing lists, strategies and plans for future business, new business, product or other development, potential acquisitions or divestitures, and new marketing ideas; (ii) product and technical information relating to the Company, such as product formulations, new and innovative product ideas, methods, procedures, devices, machines, equipment, data processing programs, software, software codes, computer models, and research and development projects; (iii) customer information, such as the identity of the Company’s customers, the names of representatives of the Company’s customers responsible for entering into contracts with the Company, the amounts paid by such customers to the Company, specific customer needs and requirements, specific customer risk characteristics, policy expiration dates, policy terms and conditions, information regarding the markets or sources with which insurance is placed, and leads and referrals to prospective customers; (iv) personnel information, such as the identity



and number of the Company’s other employees, their salaries, bonuses, benefits, skills, qualifications, and abilities; (v) any and all information in whatever form relating to any client or prospective customer of the Company, including but not limited to, its business, employees, operations, systems, assets, liabilities, finances, products, and marketing, selling and operating practices; (vi) any information not included in (i) or (ii) above which you know or should know is subject to a restriction on disclosure or which you know or should know is considered by the Company or the Company’s customers or prospective customers to be confidential, sensitive, proprietary or a trade secret or is not readily available to the public; and (vii) intellectual property, including inventions and copyrightable works. Confidential Information and Trade Secrets are not generally known or available to the general public, but have been developed, compiled or acquired by the Company at its great effort and expense. Confidential Information and Trade Secrets can be in any form: oral, written or machine readable, including electronic files, but shall not included any information known generally to the public or within the Company’s industry.
b)You acknowledge and agree that the Company is engaged in a highly competitive business and that its competitive position depends upon its ability to maintain the confidentiality of the Confidential Information and Trade Secrets which were developed, compiled and acquired by the Company at its great effort and expense. You further acknowledge and agree that any disclosing, divulging, revealing, or using of any of the Confidential Information and Trade Secrets, other than in connection with the Company’s business or as appropriate to carry out your duties for the Parent Group, will be highly detrimental to the Company and cause it to suffer serious loss of business and pecuniary damage.
c)Accordingly, you agree that you will not, while associated with the Company and for so long thereafter as the pertinent information or documentation remains confidential, for any purpose whatsoever, directly or indirectly use, disseminate or disclose to any other person, organization or entity Confidential Information or Trade Secrets, except as appropriate to carry out your duties as an executive of the Parent and except (i) as expressly authorized by the Chief Executive Officer of the Company, (ii) appropriate to enforce the terms of this Agreement, or (iii) required by law or legal process; provided, that you give notice to the Company promptly on becoming aware of any obligations to disclose such information under this provision, and not less than ten days prior to making any such disclosure.
d)Immediately upon the termination of employment with the Company for any reason, or at any time the Company so requests, you will return to the Company: (i) any originals and all copies of all files, notes, documents, slides (including transparencies), computer disks, printouts, reports, lists of the Company’s clients or leads or referrals to prospective clients, and other media or property in Employee’s possession or control which contain or pertain to Confidential Information or Trade Secrets; and (ii) all property of the Company, including, but not limited to, supplies, keys, access devices, books, identification cards, computers, telephones and other equipment.





8)Intellectual Property
a)You agree that all inventions, improvements, products, designs, specifications, trademarks, service marks, discoveries, formulae, processes, software or computer programs, modifications of software or computer programs, data processing systems, analyses, techniques, trade secrets, creations, ideas, work product or contributions thereto, and any other intellectual property, regardless of whether patented, registered or otherwise protected or protectable, and regardless of whether containing or constituting Trade Secrets or Confidential Information as defined in this Agreement (referred to collectively as “Intellectual Property”), that were conceived, developed or made by you during the period of your employment by the Company and that relate directly to the Company’s insurance and reinsurance business and any other business in which the Company was engaged as of the date of your termination of employment with the Company (the “Proprietary Interests”), shall belong to and be the property of the Company.
b)You further covenant and agree that you will: (i) promptly disclose such Intellectual Property to the Company; (ii) make and maintain for the Company, adequate and current written records of your innovations, inventions, discoveries and improvements; (iii) assign to the Company, without additional compensation, the entire rights to Intellectual Property for the United States and all foreign countries; (iv) execute assignments and all other papers and do all acts necessary to carry out the above, including enabling the Company to file and prosecute applications for, acquire, ascertain and enforce in all countries, letters patent, trademark registrations and/or copyrights covering or otherwise relating to Intellectual Property and to enable the Company to protect its proprietary interests therein; and (v) give testimony, at the Company’s expense, in any action or proceeding to enforce rights in the Intellectual Property.
c)You further covenant and agree that it shall be conclusively presumed as against you that any Intellectual Property related to the Proprietary Interests described by you in a patent, service mark, trademark, or copyright application, disclosed by you in any manner to a third person, or created by you or any person with whom you have any business, financial or confidential relationship, within one (1) year after cessation of your employment with the Company, was conceived or made by you during the period of employment by the Company and that such Intellectual Property be the sole property of the Company.
d)Nothing in this Section 8 shall be construed as granting or implying any right to you under any patent or unpatented intellectual property right of the Company, or your right to use any invention covered thereby.
e)In the event that you are requested or required (by oral questions, interrogatories, requests for information or documents, subpoena or similar process) to disclose any information protected by Sections 7 and 8 (collectively, “Restricted Material,”) you agree to provide the Company with prompt notice of such request(s) so that the Company may seek an appropriate protective order or other appropriate remedy and/or waive your compliance with the provisions of this Agreement. In the event that such protective order or other



remedy is not obtained, or that the Company grants a waiver hereunder, you may furnish that portion (and only that portion) of the Restricted Material which you are legally compelled to disclose and will exercise your reasonable best efforts to obtain reliable assurance that confidential treatment will be accorded any Restricted Material so furnished.
9)Non-Competition
a)You acknowledge and agree that the Company is engaged in a highly competitive business and that by virtue of your senior executive position and responsibilities with the Company and your access to the Confidential Information and Trade Secrets, engaging in any business which is directly competitive with the Company during the six (6) month period following the termination of your employment will cause it great and irreparable harm.
b)Accordingly, you covenant and agree that so long as you are employed by the Company and for a period of six (6) months after such employment ends for any reason whatsoever, whether voluntarily or involuntarily and whether with or without cause, you will not, without the express written consent of the Chief Executive Officer of the Parent, directly or indirectly, own, manage, operate or control, or be employed in the same or substantially the same position or duties as the position(s) held by you with the Company or the Parent, by any company or entity engaged in the insurance or reinsurance business in which the Company is engaged or has announced an intention to become engaged as of the date of termination of employment, and for which you had responsibility or about which you had knowledge of or access to Confidential Information and Trade Secrets. In recognition of the nature of the Company’s business, which includes the sale of its products and services throughout the Alpharetta, GA and New York, NY area, and the nature of your senior executive position, this restriction shall only apply throughout a 50 mile radius from the Company’s Alpharetta, GA and New York, NY offices. In the event that the Company exercises its right to relieve you of your normal duties during the Notice Period as set forth and described in Section 3(c)(i) – (iv) of this Agreement (a “Garden Leave Period”), then the six (6) month non-competition period shall be reduced on a day-for-day basis by any such Garden Leave Period.
10)Non-Solicitation of Employees
a)You acknowledge and agree that solely as a result of employment with the Company, and in light of the broad responsibilities of such employment which include working with other employees of the Company, you have and will come into contact with and acquire Confidential Information and Trade Secrets regarding other employees of the Company, and will develop relationships with those employees.
Accordingly, you covenant and agree that for so long as you are employed by the Company and for a period of six (6) months after such employment ends for any reason whatsoever, whether voluntarily or involuntarily and whether with or without cause, you shall not, either on your own account or on behalf of any person, company, corporation, or other entity, directly or indirectly, solicit any employee of the Company to leave employment with the Company. This restriction shall apply to those employees of the



Company with whom you came into contact or about whom you obtained Confidential Information or Trade Secrets during the last two (2) years of your employment with the Company.
11)Enforcement
a)The parties acknowledge and agree that compliance with the covenants set forth in this Agreement is necessary to protect the Confidential Information and Trade Secrets, business and goodwill of the Company, and that any breach of this Agreement will result in irreparable and continuing harm to the Company, for which money damages may not provide adequate relief. Accordingly, in the event of any breach or anticipatory breach of this Agreement by you, or your claim in a declaratory judgment action that all or part of this Agreement is unenforceable, the parties agree that the Company shall be entitled to the following particular forms of relief as a result of such breach, in addition to any remedies otherwise available to it at law or equity: (a) injunctions, both preliminary and permanent, enjoining or restraining such breach or anticipatory breach, and you consent to the issuance thereof forthwith and without bond by any court of competent jurisdiction; and (b) recovery of all reasonable sums and costs, including attorneys’ fees, incurred by the Company to defend or enforce the provisions of this Agreement if you argue that such covenants are unreasonable or unenforceable. In addition to any and all remedies available to the Company upon breach of this Agreement, the Company expressly reserves the right to stop all future payments and recoup all prior payments made under this Agreement upon a final judicial determination, arbitration, mediation or agreement that a breach of its terms has occurred.
b)The parties hereto hereby declare that it is impossible to measure in money the damages that will accrue to the Company by reason of your failure to perform any of your obligations under Sections 7, 8, 9, and 10. Accordingly, if the Company institutes any action or proceeding to enforce the provisions hereof, to the extent permitted by applicable law, you hereby waive the claim or defense that the Company has an adequate remedy at law, and you shall not urge in any such action or proceeding the defense that any such remedy exists at law. The foregoing rights shall be in addition to any other rights and remedies available to the Company under law or in equity.
c)If any of the covenants contained in Sections 7, 8, 9, and 10, or any part thereof, is construed to be invalid or unenforceable, the same shall not affect the remainder of the covenant or covenants, which shall be given full effect, without regard to the invalid portion(s). In addition, if any of the covenants contained in Sections 7, 8, 9, and 10 hereof, or any part thereof, is held by any person or entity with jurisdiction over the matter to be invalid or unenforceable because of duration of such provision or the geographical area covered thereby, the parties agree that such person or entity shall have the power to reduce the duration and/or geographical area of such provision and, in its reduced form, said provisions shall then be enforceable.
d)It is understood and agreed that no failure or delay by the Company in exercising any right, power or privilege contained in Sections 7, 8, 9, and 10 shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further



exercise thereof or the exercise of any right, power or privilege contained in Sections 7, 8, 9, or 10.
e)It is understood and agreed that references to the “Company” in the foregoing Sections 7, 8, 9 and 10 include the Company, Parent and its affiliates.
12)Disclosure of Agreement
You agree that you will promptly disclose the existence of this Agreement and the post-employment restrictions contained herein to all subsequent employers until all such covenants have expired.
13)Confidential Information Belonging to Others
You affirm that you have informed the Company of any restrictive covenant or other contract or agreement of any kind which would prohibit, restrict or limit your employment with the Company. If you learn or become aware or are advised that you are subject to an additional actual or alleged restrictive covenant or other prior agreement which may prohibit or restrict employment by the Company, you shall immediately notify the Company of the same. You agree that you shall not disclose to the Company, use for the Company’s benefit, or induce the Company to use any trade secret or confidential information you may possess or any Intellectual Property belonging to any former employer or other third party.
14)Choice of Forum
The Parent is an international holding (re)insurance company, and has subsidiaries that conduct business in the United States (including New York) and other countries. You and the Company are desirous of having any disputes resolved in a forum having a substantial body of law and experience with the matters contained herein. As a result, you and the Company have a strong interest in providing a single forum and governing law for the convenience of you and the Company to resolve any and all legal claims. In addition, you recognize that the Company's and the Parent’s savings from limiting the forum for legal claims allow them and their affiliates to maintain lower business expenses, which help all of them provide more cost effective and competitive insurance products and services. For all of these reasons, you and the Company agree that any action or proceeding brought in any court or other forum with respect to this Agreement and Employee’s employment shall be brought exclusively in the Supreme Court of the State of New York, New York County, or in the United States District Court for the Southern District of New York, or in any other court of competent jurisdiction sitting in the County and State of New York, and the parties agree to the personal jurisdiction thereof. The parties hereby irrevocably waive any objection they may now or hereafter have to the laying of venue of any such action in the said court(s), and further irrevocably waive any claim they may now or hereafter have that any such action brought in said court(s) has been brought in an inconvenient forum. The parties recognize that, should any dispute or controversy arising from or relating to this agreement be submitted for adjudication to any court or other third party, the preservation of the secrecy of Confidential Information or Trade Secrets may be jeopardized. Consequently, the parties agree that all issues of fact shall be tried without a jury.



15)Governing Law
You and the Company agree that for the reasons recited in the foregoing paragraph 14, this Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to its conflict of laws provisions.
16)Section 409A and 457A
Although the Company does not guarantee the tax treatment of any payments under the Agreement, the intent of the Company is that the payments and benefits under this Agreement be exempt from, or comply with, Section 409A of the Code and to the maximum extent permitted the Agreement shall be limited, construed and interpreted in accordance with such intent. In no event whatsoever shall the Company or its affiliates or their respective officers, directors, employees or agents be liable for any additional tax, interest or penalties that may be imposed on Executive by Code Section 409A or damages for failing to comply with Code Section 409A. Notwithstanding any other provision of this Agreement to the contrary, to the extent that any reimbursement of expenses constitutes “deferred compensation” under Section 409A of the Code, such reimbursement shall be provided no later than December 31 of the year following the year in which the expense was incurred (or, where applicable, no later than such earlier time required by the Agreement). The amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind benefits provided in any other year. Notwithstanding any other provision of this Agreement to the contrary, and to the extent required by Section 409A of the Code (as amended from time to time), in the event that payment of nonqualified deferred compensation made pursuant to this Agreement is based upon or attributable to your termination of employment and you are at the time of your termination a “Specified Employee,” then any payment of nonqualified deferred compensation otherwise required to be made to you shall be deferred and paid in a lump sum to you on the day after the date that is six (6) months from the date of your “Separation from Service” within the meaning of Section 409A of the Code; provided, however, if you die prior to the expiration of such six (6) month period, payment to your beneficiary shall be made as soon as practicable following your death. You will be a “Specified Employee” for purposes of this Agreement if, on the date of your Separation from Service, you are an individual who is, under the method of determination adopted by the Company designated as, or within the category of employees deemed to be, a “specified employee” within the meaning and in accordance with Treasury Regulation Section 1.409A-1(i). The Company shall determine in its sole discretion all matters relating to who is a “Specified Employee” and the application of and effects of the change in such determination. No payments contemplated by this Agreement are intended to be nonqualified deferred compensation for purposes of Section 457A of the Code and to the maximum extent permitted the Agreement shall be limited, construed and interpreted in accordance with such intent.
17)Indemnification
The Parent shall indemnify you to the same extent and by the same means as provided to other officers generally (excluding the Parent’s Chief Executive Officer).



18)Miscellaneous
a)Any notice or other communication required or permitted under this Agreement shall be effective only if it is in writing and shall be deemed to be given when delivered personally or three days after it is mailed by registered or certified mail, postage prepaid, return receipt requested or one day after it is sent by a reputable overnight courier service and, in each case, addressed to the relevant party at the address provided for such party on the first page hereof, or to such other address as any party hereto may designate by notice to the other in accordance with the foregoing.
b)This Agreement constitutes the entire agreement among you and the Company, the Parent and any affiliate with respect to your employment by the Company, and supersedes and is in full substitution for any and all prior understandings or agreements with respect to your employment including, but not limited to, the offer letter to you from AXIS, dated November 6, 2006. This Agreement shall be binding upon execution by both parties, it being understood and agreed that your assignment as Parent’s Executive Vice President and General Counsel shall not commence until January 2, 2017.
c)This Agreement may be amended only by an instrument in writing signed by the parties hereto, and any provision hereof may be waived only by an instrument in writing signed by the party against whom or which enforcement of such waiver is sought. Any amendment to this Agreement must comply with the requirements of Section 409A of the Code.
d)The Company shall withhold from any compensation and benefits payable under this Agreement all applicable U.S. federal, state, local, or other taxes.
e)Except as otherwise set forth herein, in the event of any contest or dispute between you and the Company with respect to this Agreement, each of the parties shall be responsible for their respective legal fees and expenses.
f)If any term or provision of this Agreement is declared illegal or unenforceable by any court of competent jurisdiction and cannot be modified to be enforceable, such term or provision shall immediately become null and void, leaving the remainder of this Agreement in full force and effect.
g)Except as otherwise provided in this Agreement, this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, representatives, successors and assigns. Your rights and benefits under this Agreement are personal to you and no such right or benefit shall be subject to voluntary or involuntary alienation, assignment or transfer; provided, however, that nothing in this Section 18 shall preclude you from designating a beneficiary or beneficiaries to receive any benefit payable on your death.
h)The headings in this Agreement are inserted for convenience of reference only and shall not be a part of or control or affect the meaning of any provision hereof.



i)Except as otherwise expressly set forth in this Agreement, to the extent necessary to carry out the intentions of the parties hereunder, the respective rights and obligations of the parties hereunder shall survive any termination of your employment or expiration or termination of this Agreement.
j)Nothing in this Agreement shall be construed as giving you any claim against any specific assets of the Company, Parent or any affiliate or as imposing any trustee relationship upon the Company in respect of you. The Company shall not be required to establish a special or separate fund or to segregate any of its assets in order to provide for the satisfaction of its obligations under this Agreement. Your rights under this Agreement shall be limited to those of an unsecured general creditor of the Company, Parent and its affiliates;
k)Both parties, through their respective counsel, have participated in the preparation of this Agreement and its Exhibit A. Accordingly, both parties shall be deemed to be the drafter of this Agreement or its Exhibit A for purposes of construing their provisions. The language in all parts of this Agreement and its exhibits shall be interpreted according to its fair meaning, and shall not be interpreted for or against either of the Parties as the drafter of the language.
If the terms of this Agreement meet with your approval, please sign and return one copy to the Company.
AXIS SPECIALTY U.S. SERVICES, INC.


By: /s/ Andrew M. Weissert
Name: Andrew M. Weissert
Title: Sr. Vice President


Accepted and Agreed
as of the date first set forth above:

/s/ Conrad D. Brooks
Conrad D. Brooks

















Exhibit A to Employment Agreement

GENERAL RELEASE AND WAIVER


In consideration of the payment by AXIS Specialty U.S. Services, Inc. (the “Company”) to or for the benefit of Conrad D. Brooks of the payments and benefits set forth in that certain Employment Agreement by and between Conrad D. Brooks (“Executive”) and the Company effective January 2, 2017 (“Employment Agreement”), and in compliance with the terms of the Employment Agreement, Executive hereby makes and delivers to the Company this General Release and Waiver (“Release”) as set forth herein:
Release of All Claims
Executive voluntarily, knowingly and willingly on behalf of himself, his heirs, executors, administrators, successors and assigns, hereby irrevocably and unconditionally release the Company, its parents, their subsidiaries, divisions and affiliates, together with their respective owners, assigns, agents, directors, partners, officers, employees, consultants, shareholders, attorneys and representatives, and any of their predecessors and successors and each of their estates, heirs and assigns (collectively, the "Company Releasees") from any and all charges, complaints, claims, liabilities, obligations, promises, agreements, causes of action, rights, costs, losses, debts and expenses of any nature whatsoever, known or unknown, which he or his heirs, executors, administrators, successors or assigns ever had, now have or hereafter can, will or may have (either directly, indirectly, derivatively or in any other representative capacity) against the Company or any of the other Company Releasees by reason of any matter, cause or thing whatsoever arising on or before the date this General Release and Waiver is executed by Executive. In addition, this Release includes, without limitation, any rights or claims relating in any way to any and all employment relationships between Executive and the Company or any of the Company Releasees, or the termination thereof, arising under the Employment Act 2000 of Bermuda, the Human Rights Act 1981 of Bermuda, Title VII of the Civil Rights Act of 1964, Sections 1981 through 1988 of Title 42 of the United States Code, The Employee Retirement



Income Security Act of 1974 ("ERISA") (except for any vested benefits under any tax qualified benefit plan), The Immigration Reform and Control Act, The Americans with Disabilities Act of 1990, The Age Discrimination in Employment Act of 1967 (“ADEA”), The Workers Adjustment and Retraining Notification Act, The Fair Credit Reporting Act, New York State Human Rights Law, New York Human Rights Law, New York Rights of Persons With Disabilities, New York Confidentiality of Records of Genetic Tests, New York Whistleblower Law, New York Statutory Provision Regarding Retaliation/Discrimination for Filing a Workers’ Compensation Claim, New York Adoptive Parents’ Child Care Leave Law, New York Smokers’ Rights Law, New York Equal Pay Law, New York AIDS Testing Confidentiality Act, New York Nondiscrimination Against Genetic Disorders Law, New York Bone Marrow Leave Law, New York Equal Rights Law, New York Confidentiality of Records of Genetic Tests, New York Executive Law Section 290 et seq., The New York State Labor Relations Act, the general regulations of the New York State Division of Human Rights, The New York Labor Law, The New York Wage Hour and Wage Payment Laws, The New York Minimum Wage Law, as amended, The New York City Administrative Code, New York State Public Employee Safety and Health Act, New York Executive Law §290 et seq., the New York City Charter and Administrative Code, New York Labor Law §740 et seq., the New York Legal Activities Law, New York Labor Law §201-d, the New York occupational safety and health laws, the New Jersey Law Against Discrimination – N.J. Rev. Stat. §10:5-1 et seq,, New Jersey Statutory Provision Regarding Retaliation/Discrimination for Filing a Workers’ Compensation Claim – N.J. Rev. Stat. §34:15-39.1 et seq., New Jersey Family Leave Act – N.J. Rev. Stat. §34:11B-1 et seq., New Jersey Smokers’ Rights Law – N.J. Rev. Stat. §34:6B-1 et seq., New Jersey Equal Pay Act – N.J. Rev. Stat. §34:11-56.1 et seq., New Jersey Genetic Privacy Act – N.J. Rev. Stat. Title 10, Ch. 5, §10:5-43 et seq., New Jersey Conscientious Employee Protection Act (Whistleblower Protection) – N.J. Stat. Ann. §34:19-3 et seq., New Jersey Wage Payment and Work Hour Laws, The New Jersey Public Employees’ Occupational Safety and Health Act- N.J. Stat. Ann. §34:6A-25 et seq., New Jersey Fair Credit Reporting Act, and the New Jersey laws regarding Political Activities of Employees, Lie Detector Tests, Jury Duty, Employment Protection, and Discrimination, and any other federal, state or local law, statute, rule, regulation, or ordinance, any public policy, contract, tort, or common law whether of any state in the United States or Bermuda; or any basis for recovering costs, fees, or other expenses including attorneys' fees incurred in these matters. Notwithstanding anything in this Release to the contrary, Executive is not waiving, and shall not be deemed to have waived, any entitlements under the terms of the Employment Agreement, the Company’s Bye-Laws or the applicable terms of any other agreement, plan or program of the Company or its affiliates that survive a termination of employment.
Acknowledgements and Affirmations
Executive affirms and agrees that the Company has fulfilled all of its obligations to him under Bermudan employment law, including without limitation the Employment Act 2000 as may be amended from time to time, and has not violated his rights under Bermudan employment law. Executive affirms and acknowledges that the payments, that are referenced in this Release fully, fairly and finally compensate him for any and all monies that may be due or become to him under Bermudan law in connection with his employment or termination of his employment, including without limitation any severance allowance or repatriation expenses.



By signing this Release, Executive represents that Executive has not commenced or joined in any claim, charge, action or proceeding whatsoever against the Company or any of the Company Releasees with respect to the matters released hereby. Executive further represents that he will not be entitled to any personal recovery in any action or proceeding of any nature whatsoever against the Company or any of the other Company Releasees that may be commenced on his behalf arising out of any of the matters released hereby.
Executive also affirms that he has been paid and/or has received all compensation, wages, bonuses and/or commissions to which he may be entitled prior to the date hereof except as expressly provided in, or preserved by, this Release and Section 4 of the Employment Agreement. Executive affirms he has been granted any leave to which he was entitled under the Employment Act 2000 of Bermuda, the Family and Medical Leave Act or similar state or local leave or disability accommodation laws. Executive further affirms that he has no unreported workplace injuries or occupational diseases. The Company acknowledges that it shall comply with Section 4 of the Employment Agreement.
Return and Possession of Property
Executive affirms that he has returned all of the Company’s property, documents, and/or any confidential information in his possession or control to which he is not entitled.
Effect of Violation by Executive of Employment Agreement
Executive affirms and acknowledges that the provisions of Sections 7-10 of the Employment Agreement remain in full force and effect as to him according to their terms.
No Admission by Company
The Company's acceptance and acknowledgement of this Release and the payments and benefits set forth herein are not, and shall not be construed as, any admission of liability or wrongdoing on the part of the Company or any of the Company Releasees.
Revocation Rights
EXECUTIVE IS ADVISED THAT HE HAS UP TO TWENTY-ONE (21) CALENDAR DAYS TO CONSIDER THIS GENERAL RELEASE AND WAIVER. EXECUTIVE ALSO IS ADVISED TO CONSULT WITH AN ATTORNEY PRIOR TO HIS SIGNING OF THIS GENERAL RELEASE AND WAIVER.
EXECUTIVE MAY REVOKE THIS GENERAL RELEASE AND WAIVER FOR A PERIOD OF SEVEN (7) CALENDAR DAYS FOLLOWING THE DAY HE SIGNS THIS AGREEMENT AND GENERAL RELEASE. ANY REVOCATION WITHIN THIS PERIOD MUST BE SUBMITTED, IN WRITING, TO THE AXIS GENERAL COUNSEL AND STATE, "I HEREBY REVOKE MY ACCEPTANCE OF OUR AGREEMENT AND GENERAL RELEASE." THE REVOCATION MUST BE PERSONALLY DELIVERED TO THE GENERAL COUNSEL OR HIS/HER DESIGNEE, OR MAILED TO THE GENERAL COUNSEL AND POSTMARKED WITHIN SEVEN (7) CALENDAR DAYS AFTER EXECUTIVE SIGNS THIS AGREEMENT AND GENERAL RELEASE.



EXECUTIVE AGREES THAT ANY MODIFICATIONS, MATERIAL OR OTHERWISE, MADE TO THIS AGREEMENT AND GENERAL RELEASE, DO NOT RESTART OR AFFECT IN ANY MANNER THE ORIGINAL UP TO TWENTY-ONE (21) CALENDAR DAY CONSIDERATION PERIOD.
EXECUTIVE FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS AGREEMENT AND GENERAL RELEASE INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS EXECUTIVE HAS OR MIGHT HAVE AGAINST RELEASEES.
Descriptive Headings
The Section headings contained herein are for reference purposes only and will not in any way affect the meaning or interpretation of this Release.
Enforceability
It is the desire and intent of the parties that the provisions of this General Release and Waiver shall be enforced to the fullest extent permissible. In the event that any one or more of the provisions of this General Release and Waiver is held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remainder hereof will not in any way be affected or impaired thereby and any such provision or provisions will be enforced to the fullest extent permitted by law.
Each Party the Drafter
This General Release and Waiver, and the provisions contained in it, shall not be construed or interpreted for, or against, any party to this General Release and Waiver because that party drafted or caused that party's legal representatives to draft any of its provisions.
Governing Law
This General Release and Waiver shall be governed by, and construed and enforced in accordance with, the laws of New York, without reference to its choice of law rules. The parties hereby irrevocably consent to the jurisdiction of New York and courts located in New York for purposes of resolving any dispute under this General Release and Waiver and expressly waive any objections as to venue in any such courts.
No Other Assurances
Executive affirms and acknowledges that he has not relied on any representations, promises, or agreements of any kind made to him in connection with his decision to execute and deliver this General Release and Waiver, except for those set forth in or expressly referenced herein.
Now therefore, intending to be fully and irrevocably bound by the terms hereof, Executive has executed this General Release and Waiver and has delivered it to AXIS Capital Holdings Limited as of this ___ day of     ___________, 20___.




Executed and delivered by:             Accepted by:

                        AXIS SPECIALTY U.S. SERVICES, INC.



By:    ____________________________ By:     

______________________________
    Executive                        



EX-10.17 9 axs-20231231xexx1017.htm EX-10.17 Document

THIS CONTRACT is made        

BETWEEN:

(1)AXIS UK SERVICES LIMITED incorporated and registered in England and Wales with company number 05745749 whose registered office is at 52 Lime Street, London, England, EC3M 7AF (referred to as “the Company”), a wholly owned, indirect subsidiary of AXIS Capital Holdings Limited, a Bermuda company (the “Parent”) and

(2)DAN DRAPER (referred to as "the Employee" or “you” or “your” as the context requires)


1.COMMENCEMENT OF EMPLOYMENT

1.1.The Company shall employ you in the position of Group Chief Underwriting Officer, or in such other position as is mutually agreeable to you and the Company.

1.2.The “Employment Term” shall commence October 1, 2022 and shall terminate December 31, 2025; provided, however, that the Employment Term shall automatically be extended for successive one year periods unless either party shall give at least six (6) month’s prior notice of non-renewal or until earlier terminated by the Company or by you, as applicable, prior to the end of the Employment Term without any breach of this Agreement under the following circumstances:

1.1.1.Death. Your employment shall automatically terminate upon your death.

1.1.2.Disability. The Company shall be entitled to terminate your employment if, as a result of your incapacity due to physical or mental illness or injury, you shall have been unable to perform your duties hereunder for a period of one hundred eight-one (181) days in any twelve (12) month period (your "Disability").

1.1.3.Cause. The Company may terminate your employment at any time for Cause which, for purposes of this Agreement, shall mean an involuntary termination of your employment pursuant to Clause 15.1.

1.1.4.Without Cause. The Company may terminate your employment at any time without Cause; provided, however, that the Company provides you with notice of its intent to terminate at least six (6) months in advance of the date of termination (or pays you severance in lieu of all or a portion of such notice) as described in Clause 14.

1.1.5.Voluntary Resignation. You may voluntarily terminate your employment hereunder; provided, however, that in the event you are not terminating for Good Reason pursuant to Clause 1.2.6 below, you provide the Company with notice of your intent to terminate at least six (6) months in advance of the date of termination as described in Clause 14.

1.1.6.Good Reason. You may terminate your employment for Good Reason if (i) (A) the scope of your position, authority or duties is materially adversely changed (except for changes during a notice period as authorized under Clause 13), (B) your remuneration under this Contract is not paid or your base salary or your Target Bonus opportunity is reduced below the levels specified under this Contract, (C) you are assigned duties that are materially inconsistent with your position with the Company
1



or (D) in the event that any other person or entity acquires all or substantially all of the Company’s business, the Company fails to obtain the assumption of this Contract by the successor; (ii) you give the Company written notice of your intent to terminate your employment as a result of such event and provide the specific reasons therefore within sixty (60) days of such event occurring; (iii) the Company does not make the necessary corrections within thirty (30) days of receipt of your written notice; and (iv) you terminate employment no later than fifteen (15) days following the end of such thirty (30) day period.


1.1. You will report directly and exclusively to the Chief Executive Officer of the Parent or any individual as is mutually agreeable to you and the Company.

1.2.You warrant that by entering into this Contract or any other arrangements with the Company or a Group Company you will not be in breach of or subject to any express or implied terms of any contract with or other obligation to any third party binding on you, including without limitation, any notice period or the provisions of any restrictive covenants or confidentiality obligations arising out of any employment with any other employer or former employer.

1.3.You warrant that at the time of entering into this Contract you have the right to work in the United Kingdom and you agree to provide to the Company copies of all relevant documents in this respect at the request of the Company. If at any time during the course of this Agreement you cease to have the right to work in the United Kingdom, the Company may terminate your employment.

1.4.You may be providing services to a Company that is regulated by the Central Bank of Ireland (“CBI”), the UK’s Financial Conduct Authority (“FCA”) and/or the Prudential Regulation Authority (“PRA”). This means the Company, and certain employees, must comply with the applicable regulators’ codes of practice, Fitness and Probity Standards and other corporate governance guidelines in place from time to time (the “Standards”).  Although your current role is not subject to any Standards, in the future, should your role change or for any other reason should your employment be subject to these Standards, you accept that your employment and continued employment will be subject to compliance with these Standards.  If these Standards apply to you, you undertake to notify the Company immediately of any change in your circumstances that could reasonably be expected to compromise your ability to comply with the Standards. Failure to meet these Standards may result in an investigation by the CBI, PRA, FCA, Lloyds and/or the Company, and may result in disciplinary action being taken against you up to and including the termination of your employment.


2.JOB TITLES AND DUTIES

1.1.You shall serve the Company as Group Chief Underwriting Officer or in any other capacity as you and the Company may agree. The nature of the Company’s business may result in changes occurring to the content of your role from time to time. You may also be required to carry out such additional or alternative tasks as may from time to time be reasonably required of you.

1.2.The Company reserves the right to appoint any other person to act jointly or in conjunction with you.

1.3.You will be expected to devote your full business time and energy, attention, skills and ability to the performance of your duties and responsibilities to the Company and its direct and indirect affiliates (collectively, the “Parent Group”) on an exclusive basis, as requested by the Chief Executive Officer of the Parent, and shall faithfully and diligently endeavour to promote the business and best interests of the Company and its subsidiaries and affiliates.
2



Anything herein to the contrary notwithstanding, nothing shall preclude you from (i) upon the written prior approval of the Parent’s Board, serving on the board of directors of another corporation or a trade association; (ii) serving on the board of charitable organizations, (iii) engaging in charitable, community and other business affairs, and (iv) managing your personal investments and affairs; provided such activities do not, in the reasonable judgment of the Company, materially conflict with or interfere with the proper performance of your responsibilities and duties hereunder.

1.4.Except as provided in clause 2.3 above, you may not, without the prior written consent of the Company, engage, whether directly or indirectly in any business or employment which is similar to or competitive with the business of the Company or which may impair your ability to act at all times in the best interests of the Company.

3.PLACE OF WORK

1.1.Your place of work will be at the Company’s London office or such other place of business as the Company may reasonably require. You may also be expected to work at other locations as reasonably directed by the Company either on a temporary or permanent basis. In addition, you may be required to travel within the UK or abroad to carry out your responsibilities.

1.2.During your period of employment, you may also be required to work for a Group Company or at another office or location for such period(s) of time as the Company may reasonably require.

4.REMUNERATION

1.1.During the Employment Term, your annual base salary will be £375,000 per annum, less any deductions required by law (the base salary as may be increased from time to time referred to as “Base Salary”). It shall be paid in equal instalments monthly in arrears on or around the 24th of each month by credit transfer directly to your bank account or in such other manner not inconsistent with the manner in which other similarly situated executives are paid.

1.2.You agree that the Company may deduct from the Base Salary or any other sum due to you (including any pay in lieu of notice) any amounts due to any Group Company.

1.3.Your Base Salary shall be reviewed annually beginning at the end of the first complete calendar year of your employment.

1.4.During the Employment Term, you will be eligible to participate in the Parent’s Executive Long-Term Equity Compensation Program (the “Program”) as it may be amended from time to time, or a successor program, with an annual target equity award valued at $400,000, with the number of restricted stock units granted pursuant to the Company’s Long-Term Equity Compensation Plan as it may be amended from time to time, or any successor plan, unless prohibited by such successor plan (“Restricted Stock Units”) subject to: (i) the rules of the Program, which may include adjustment of the target award value or an actual award which varies from the target based on the Parent’s achievement of certain
3



performance objectives, and (ii) an award agreement in such form as the Human Capital and Compensation Committee of the Parent may determine from time to time. Any such award granted under the Program shall be subject in all respects to the Parent’s Executive Compensation Recoupment Policy, as it may be amended from time to time, or any successor policy thereto

5.DISCRETIONARY BONUS

1.1.During the Employment Term, you will be eligible to earn an annual cash bonus ("Annual Bonus"). Your target Annual Bonus is 100% of your then current Base Salary if the Parent achieves certain performance objectives and subject to your individual performance pursuant to the Parent’s Annual Incentive Plan. Except as provided in Section 20 below, the Annual Bonus for each period will be paid only if you are actively employed with the Company on the date of disbursement. Any Annual Bonus payable hereunder shall be paid in the calendar year following the applicable fiscal year of the Parent, after it has been determined by the Human Capital and Compensation Committee of the Parent. Any such Annual Bonus shall be subject in all respects to the Parent’s Executive Compensation Recoupment Policy, as it may be amended from time to time, or any successor policy thereto.

1.2.Any such bonus payment shall not form part of your contractual remuneration under this Contract. If the Company makes a bonus payment to you in respect of a particular financial year of the Company, it shall not be obliged to make subsequent bonus payments in respect of subsequent financial years of the Company.


6.PENSION SCHEME

1.1.You are eligible to participate in the Company’s pension scheme subject to and in accordance with the terms of the Scheme and in all cases at the discretion of the Company. The Company’s contribution will be 12.5% of your base salary. Pension contributions will begin from your commencement date of employment and you will be subject to the terms and conditions of the Pension Scheme.
1.2.The Company currently operates “Salary Sacrifice” in conjunction with the Company’s pension scheme. By participating in Salary Sacrifice you would be agreeing to a reduction in your base salary in exchange for an equivalent (additional) Company contribution to the pension scheme on your behalf. If you do not wish to participate in the Salary Sacrifice arrangement and prefer contributions to be taken from net pay, please contact the UK Benefits Team.

7.OTHER BENEFITS

1.1.From the commencement of your employment you shall be entitled, subject to any eligibility requirements or policy terms, to Life Assurance, Group Income Protection and Private Medical Insurance. The Company operates a flexible benefits scheme and you are entitled to select from a range of benefits at your discretion to suit your individual needs.
4



The range of benefits is non-contractual and the current options available are set out in the Benefits Schedule.

1.2.The Company reserves the right to terminate any or all of the schemes referred to in clauses 6 and 7 or to amend them at any time without compensation.

1.3.All insured benefits are subject to the policy terms and conditions upon which they are incepted or renewed. Private Medical Insurance is offered to you and, if appropriate, to your spouse/same sex civil partner and/or dependent children meeting the underwriting criteria acceptable to the Company. In the event that an insurer of any insured benefit provided to you under this Contract does not meet a claim made by you or on your behalf, then you shall have no claim against the Company in respect of that insured benefit.

8.EXPENSES

1.1.The Company shall reimburse all reasonable out of pocket expenses properly incurred by you in the performance of your employment duties provided you follow the Company’s guidelines/allowances in force at the relevant time and provided that you shall, where reasonably practicable, provide the Company with vouchers, invoices or such other evidence of such expenses as the Company may reasonably require.

9.HOURS OF WORK

1.1.Your normal working hours are 35 hours per week, Monday to Friday, with one hour for lunch on each working day. From time to time you may be required to work such other hours as the Company considers necessary for you to perform your duties for which no further remuneration is payable.

1.2.By entering into this Agreement you confirm, for the purposes of the Working Time Regulations 1998 (“the Regulations”), that you agree to work in excess of 48 hours per week if and when required. You may vary this additional hours consent by giving three months’ notice in writing to the human resources department. Please see the Working Time Policy in the Employee Handbook.

10.HOLIDAYS

1.1.In addition to the UK public holidays you will be entitled to 25 working days' paid holiday in each calendar year. The holiday will accrue on a pro rata basis throughout each calendar year.

1.2.Holidays may only be taken at such time or times as are approved beforehand by your manager. You must give reasonable notice of proposed holiday dates.

1.3.Manager approval is required for carryover in excess of five days (up to maximum of ten days) untaken holiday into the next calendar year. You will not generally be permitted to take more than 15 consecutive working days’ holiday at any one time.

1.4.Upon termination of your employment you will receive pay in lieu of accrued but untaken holiday and the Company may deduct an appropriate sum in respect of days taken
5



in excess of your pro rata entitlement from your final remuneration. The Company may require you to take any unused holiday entitlement during a Garden Leave period.

11.SICKNESS AND OTHER ABSENCE

1.1.If you are unable to attend at work by reason of sickness or injury or any authorised reason you must inform the Company as soon as possible on the first day of absence, and in any event not later than 10:00 on the first day of absence and, in the case of absence of uncertain duration, you must keep the Company regularly informed of the reason for your continued absence and your likely date of return. You are expected to observe this rule very strictly since failure to do so entitle the Company to stop payment in respect of each day you fail to notify the Company.

1.2.If your absence, due to sickness or injury, is for less than seven (7) days, on your return to work you are required to immediately complete a self-certification form available from Payroll/HR. If your absence continues for more than seven (7) consecutive days (whether or not working days) you must provide the Company with a doctor's certificate from the seventh consecutive day of sickness or injury. This doctor’s certificate must be provided to the Company promptly following the seventh consecutive day of absence. If illness continues after the expiry of the first certificate further certificates must be provided promptly to cover the whole period of absence.

1.3.Whether absent from work or not, you may be required to undergo a medical examination by a Company doctor and your consent will be sought for a report to be sent to the Company.

1.4.Provided that your sickness or injury leave is legitimate and that you comply with the sickness notification procedure set out above, you will continue to be paid normal salary for a period of up to six (6) months inclusive of statutory sick pay. However, any sums paid in excess of statutory sick pay will be at the Company’s sole discretion.

1.5.If due to sickness or injury you are unable to perform your normal duties, you may be required to undertake appropriate or reasonable alternative duties. Failure to comply with any reasonable request may entitle the Company to withhold the payment of the Company’s sick pay. This does not affect your right to statutory sick pay.

1.6.The payment of sick pay in accordance with this clause is without prejudice to the Company’s right to terminate this Agreement on the grounds of incapacity prior to the expiry of your right to payments irrespective of any permanent health or permanent or long term disability insurance scheme in force in relation to you.

12.GARDEN LEAVE

1.1.The Company reserves the right to require that you do not attend the Company premises or have contact with other employees or clients of the Company. This includes any period or part of any period during which you are serving notice as set out in clause 12 below (referred to in this Agreement as “Garden Leave”).

6



1.2.You will continue to owe all other duties and obligations (whether express or implied including fidelity and good faith) during such period of Garden Leave. During any period of Garden Leave you shall continue to receive full pay and benefits.

1.3.In the event that you are placed on Garden Leave, the Company is entitled to provide you with no duties or such duties as the Company shall in its absolute discretion determine. By placing you on Garden Leave, the Company will not be in breach of this Contract or any implied duty of any kind whatsoever nor will you have any claim against the Company or any Group Company in respect of any such action.

1.4.During any period of Garden Leave you will remain readily contactable and available for work. In the event that you are not available for work having been requested by the Company to do so, you will, notwithstanding any other provision of this Contract, forfeit any right to salary and contractual benefits.

1.5.During any period of Garden Leave, the Company may require you to deliver up any Confidential Information or property of the Company and upon instruction, delete any emails, spreadsheets or other Confidential Information and you will confirm your compliance with this clause 12.5 in writing if requested to do so by the Company.

1.6.During any period of Garden Leave, the Company may require you to take any outstanding holiday entitlement.

13.NOTICE PERIOD

1.1.Notwithstanding Clause 12 above the Company may in its absolute discretion:

(i)Require you to perform only such portion of your normal duties as it may allocate to you from time to time;

(ii) Require you not to perform any of your duties;

(iii)Require you not to have any contact with customers or clients of the Company nor any contact (other than purely social contact) with such employees of the Company as the Company shall determine;

(iv) exclude you from any premises of the Company.

1.2.If the Company elects to take such action as set out in clause 13.1 above such an election by the Company shall not constitute a breach by the Company of this Contract.

14.TERMINATION WITH NOTICE

1.1.If either party wishes to terminate your employment, it should give to the other six months’ notice in writing. This does not preclude the Company from terminating your employment without notice in certain circumstances, and does not preclude you from terminating employment for Good Reason (subject to meeting the requirements for a “Good Reason” termination as described in Clause 20).

1.2. The Company reserves the right in its absolute discretion to give written notice to terminate your employment forthwith and to make a payment to you in lieu of salary for all
7



or any un-expired part of the notice period. For the avoidance of doubt, any payment in lieu made pursuant to this clause 14.2 will not include any element in relation to:-

(i)any bonus payments that might otherwise have been due to you during the period for which the payment in lieu is made; and

(ii)any payment in respect of any holiday entitlement that would have accrued during the period for which the payment in lieu is made.

1.3. You are required to mitigate any loss where this Contract is terminated in accordance with this clause and any payment in lieu of notice may be reduced to take account of mitigation or any failure to mitigate on your part.

15.TERMINATION WITHOUT NOTICE

1.1.Your employment may be terminated immediately without notice where you:

(i)commit gross misconduct which includes, but is not limited to, dishonesty, fraud, theft, being under the influence of alcohol or drugs at work, causing actual or threatening physical harm and causing damage to company property;

(ii)breach of a fiduciary duty;

(iii)are adjudicated bankrupt;

(iv)commit a material or repeated breach of your duties or any of the provisions of this Contract or fail to observe the lawful directions of the Company as determined by the CEO;

(v)are convicted of a criminal offence (other than an offence under the road traffic legislation in the United Kingdom or elsewhere for which a non-custodial sentence is imposed);

(vi)fail to reach performance requirements set by the Company after receiving a written warning regarding your performance from the Company or you are disqualified or restricted from practising a profession which is essential to the performance of the duties of your position;

(vii)act in a manner which in the opinion of the Company, brings the Company into disrepute or otherwise prejudices or is considered likely to prejudice the reputation of the Company;

(viii)in the reasonable opinion of the Company, are guilty of any serious negligence in connection with or affecting the business or affairs of the Company; and

(ix)are deemed not to meet the Fitness and Probity Standards set by the Central Bank of Ireland, the UK’s Financial Conduct Authority and/or Prudential Regulation Authority (if applicable);

provided, however, that no such termination shall be effective pursuant to this Clause 15.1 unless you have been provided with notice of the event constituting grounds for termination pursuant to this Clause and, to the extent such event is capable of being cured, you have failed to cure such event within 30 days after receiving such notice.

1.2.Any delay or forbearance by the Company in exercising any right of termination in accordance with clause 14 will not constitute a waiver of such right.

1.3.The termination by the Company of your employment will be without prejudice to any claim which the Company may have for damages arising from your breach of this Contract.

16.DISCIPLINARY, DISMISSAL AND GRIEVANCE PROCEDURES

8



1.1.A copy of the Company’s disciplinary; dismissal and grievance policies are set out in the Employee Handbook. These policies do not form part of your contract of employment.

1.2.The Company reserves the right to suspend you on full pay and benefits at any time for a reasonable period to investigate any matter that it reasonably believes you may be or may have been involved.

17.OUTSIDE EMPLOYMENT, CONFIDENTIAL INFORMATION, CONFLICTING INTERESTS AND RETURN OF COMPANY PROPERTY

1.1.For the purposes of this Contract, the expression “Confidential Information” shall include, but not be limited to, information which relates to any and all information (whether or not recorded in documentary form or on computer disk or tape) which may be imparted in confidence or which is of a confidential nature or which you may reasonably regard as being confidential or a trade secret concerning the business, business performance or prospective business, financial information or arrangements, plans or internal affairs of the Company, any Group Company or any of their respective or prospective customers including without prejudice to the generality of the foregoing all client or customer lists, all information, records and materials relating to underwriting premiums or quotes, income and receipts, claims records and levels, renewals, policy wording and terms, reinsurance quotas, profit commission, syndicate projections and forecasts, broker lists, know how, price sensitive information, technical information, reports, interpretations, forecasts, records, corporate and business plans and accounts, business methods, financial details, projections and targets, remuneration and personnel details, planned products, planned services, marketing surveys, research reports, market share and pricing statistics, budgets, fee levels, computer passwords, the contents of any databases, tables, know how documents or materials, commissions, commission charges, pricing policies and all information about research and development, the Company’s or any Group Company's suppliers', customers' and clients' names, addresses (including email), telephone, facsimile or other contact numbers and contact names, the nature of their business operations, their requirements for services supplied by the Company or any Group Company and all confidential aspects of their relationship with the Company or any Group Company.

1.2.You shall not, without the prior written consent of the Company, either solely or jointly, directly or indirectly, carry on or be engaged, concerned or interested in any other trade or business, including, but not limited to, carrying on business with the Company’s suppliers or dealers, save that nothing in this clause 17.2 shall prevent you from holding (with the prior written consent of the Company which shall not be unreasonably delayed or withheld) up to three percent (3%) of the issued equity share capital of any company where those equity shares are listed on a recognised investment exchange (as defined in section 285 of the Financial Services and Markets Act 2000) or traded on the Alternative Investment Market of the London Stock Exchange. Failure to secure advance permission in accordance with this clause may result in summary dismissal.

1.3.You will not (except with the prior written consent of the Company) other than in the proper course of your duties during the continuance of this Contract, or at any time thereafter:

9



(i)disclose or use for your own or for another's purpose or benefit any Confidential Information of which you may learn while in the employment of the Company except as required by a court of law or any regulatory body or that which may be in or become part of the public domain other than through any act or default on your part;

(ii) copy or reproduce in any form or by or on any media or device or allow others access to copy or reproduce any documents (including without limitation letters, facsimiles and memoranda), disks, memory devices, notebooks, tapes or other medium whether or not eye-readable and copies thereof on which Confidential Information may from time to time be recorded or referred to ("Documents"); or

(iii)remove or transmit from the Company or any Group Company's premises any Documents on which Confidential Information may from time to time be recorded.

1.4.Upon termination of your employment for any reason by either party, you must immediately return to the Company all company property including but not limited to documents, papers, records, keys, credit cards, security passes, accounts, specifications, drawings, lists, correspondence, catalogues or the like relating to the Company's business which is in your possession or under your control and you must not take copies of the same without the Company's express written authority.

18.RESTRICTIVE COVENANTS

For the purpose of this clause the following expressions shall have the following meanings:-
"Prospective Customer" shall mean any person, firm, company or other business who was at the Termination Date negotiating with the Company or with any Group Company with a view to dealing with the Company or any Group Company as a customer;

"Restricted Business" shall mean any business that you have been engaged in during the twelve month period ending with the Termination Date;     

"Restricted Customers" shall mean any person, firm, company or other business who was at any time in the twelve month period ending with the Termination Date a customer of the Company or any Group Company;
    
"Restricted Period" shall mean (a) the period of six (6) months from the Termination Date with respect to Clauses 18.1(i)-(iii) and (b) the period of twelve (12) months from the Termination Date with respect to Clause 18.1(iv); and

"Termination Date" shall mean the date on which your employment under this Agreement terminates either due to you or the Company terminating in accordance with the terms of the Agreement or in breach of the terms of this Agreement.
1.1.During the course of your employment hereunder you are likely to obtain Confidential Information relating to the business of the Company or any Group Company and personal knowledge and influence over clients, customers, employees of the Company or any Group Company. You hereby agree with the Company that to protect the Company’s and any and all Group Company's business interests, customer connections and goodwill and the stability of its or their workforce, that you will not during the Restricted Period (and in respect of sub-Clauses (v) and (vi) below only, at any time):

(i)compete with the business of the Company or any Group Company by being directly or indirectly employed or engaged in any capacity by any person, firm or company which engages in or provides Restricted Business to Restricted Customers or Prospective Customers;

(ii)compete with the business of the Company or any Group Company either on your own account or for any person, firm or company directly or indirectly by having any business dealings or transacting business in relation to Restricted Business with any Restricted Customer or Prospective Customer of the Company or Group Company and with whom you personally dealt in respect of Restricted Business;

(iii)compete with the business of the Company or any Group Company either on your own account or for any person, firm or company directly or indirectly in relation to the supply of Restricted Business by soliciting or endeavouring to solicit or entice
10



the business or custom of any Restricted Customer or Prospective Customer and with whom you personally dealt in respect of Restricted Business;

(iv)either on your own account or for any person, firm or company, directly or indirectly solicit or entice away or endeavour to solicit or entice away or offer to employ or engage any director or employee of the Company or any Group Company with whom you have had material personal dealings in the twelve (12) months prior to the Termination Date whether or not such person would be in breach of contract as a result of such employment or engagement;

(v)from the Termination Date for the purpose of carrying on any trade or business represent or allow you to be represented or held out as having any present association with the Company or any Group Company; and

(vi)from the Termination Date carry on any trade or business whose name incorporates the word AXIS or any deviation or extension thereof which is likely or which may be confused with the name of the Company or any Group Company.

1.2.While the restrictions set out in clause 18.1 are considered by the parties to be reasonable in all the circumstances, it is agreed that if any one or more of such restrictions shall either taken by itself or themselves together be adjudged to go beyond what is reasonable in all the circumstances for the protection of the legitimate interests of the Company but would be adjudged reasonable if any particular restriction or restrictions were deleted or if any part or parts of the wording thereof were deleted, restricted or limited in a particular manner, then the restrictions set out in clause 18.1 shall apply with such deletions or restrictions or limitations as the case may be.

1.3.The restrictions contained in Clause 18.1 are held by the Company for itself and on trust for any other Group Company and shall be enforceable by the Company on their behalf or by any Group Company (at their request). You shall during the employment hereunder enter into direct agreements with any Group Company whereby you will accept restrictions in the same or substantially the same form as those contained in Clause 18.1.

1.4.In the event that the Company exercises its rights and places you on Garden Leave under Clause 12, the Restricted Period shall not be reduced by any period/s spent by you on Garden Leave prior to the Termination Date.

1.5.During the Restricted Period you shall provide a copy of the restrictions contained at Clauses 17 and 18 to any employer or prospective employer or any other party with whom you become or will become engaged or provide service or services to.

19.INTELLECTUAL PROPERTY

1.1.You agree that all inventions, improvements, products, designs, specifications, trademarks, service marks, discoveries, formulae, processes, software or computer programs, modifications of software or computer programs, data processing systems, analyses, techniques, trade secrets, creations, ideas, work product or contributions thereto, and any other intellectual property, regardless of whether patented, registered or otherwise protected or protectable, and regardless of whether containing or constituting Trade Secrets or Confidential Information as defined in this Agreement (referred to collectively as Intellectual Property), that were conceived, developed or made by you during the period of your employment by the Company and that relate directly to the Company’s insurance and reinsurance business and any other business in which the Company was engaged as of the date of your termination of employment with the Company (the Proprietary Interests), shall belong to and be the property of the Company.

1.2.You further covenant and agree that you will: (i) promptly disclose such Intellectual Property to the Company; (ii) make and maintain for the Company, adequate and current written records of your innovations, inventions, discoveries and improvements; (iii) assign to the Company, without additional compensation, the entire rights to Intellectual Property for the United States and all foreign countries; (iv) execute assignments and all other papers and do all acts necessary to carry out the above, including enabling the Company to file and prosecute applications for, acquire, ascertain and enforce in all countries, letters patent, trademark registrations and/or copyrights covering or otherwise relating to Intellectual Property and to enable the Company to protect its proprietary interests therein; and (v) give testimony, at the Company’s expense, in any action or proceeding to enforce rights in the Intellectual Property.

1.3.You further covenant and agree that it shall be conclusively presumed as against you that any Intellectual Property related to the Proprietary Interests described by you in a patent, service mark, trademark, or copyright application, disclosed by you in any manner to a third person, or created by you or any person with whom you have any business,
11



financial or confidential relationship, within one (1) year after cessation of your employment with the Company, was conceived or made by you during the period of employment by the Company and that such Intellectual Property be the sole property of the Company.

1.4.Nothing in this Section 19 shall be construed as granting or implying any right to you under any patent or unpatented intellectual property right of the Company, or your right to use any invention covered thereby.

1.5.In the event that you are requested or required (by oral questions, interrogatories, requests for information or documents, subpoena or similar process) to disclose any information protected by clauses 18 and 19 (collectively, Restricted Material,) you agree to provide the Company with prompt notice of such request(s) so that the Company may seek an appropriate protective order or other appropriate remedy and/or waive your compliance with the provisions of this Agreement. In the event that such protective order or other remedy is not obtained, or that the Company grants a waiver hereunder, you may furnish that portion (and only that portion) of the Restricted Material which you are legally compelled to disclose and will exercise your reasonable best efforts to obtain reliable assurance that confidential treatment will be accorded any Restricted Material so furnished.

20.SEVERANCE BENEFITS

1.1.In the event that your employment with the Company shall terminate for any reason, and except as otherwise set forth in this Contract the Company’s sole obligation hereunder shall be to pay to you any accrued but unpaid Base Salary for services rendered to the date of termination, any bonus awarded by the Human Capital and Compensation Committee in respect of a prior year’s target Annual Bonus but not yet paid as of the date of termination, any accrued but unpaid expenses required to be reimbursed under this Contract, any unused vacation accrued to the date of termination. For the sake of clarity, this Section 20.1 does not limit any rights you may have under the Company’s retirement or welfare plans. Additionally, the parties acknowledge and agree that any amounts described in Section 20 shall be offset in an amount equal to and to the extent the Company is required to pay additional or other severance benefits not described herein by U.K. statute, regulation or otherwise.

1.2.Death. In the event your employment is terminated due to your death pursuant to Clause 1.2.1, then in addition to the amounts provided under Clause 20.1 above:

1.6.1.Your beneficiary will be paid a pro-rata portion of your Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, based on the number of days you were employed by the Parent Group during such year and calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination; and

1.6.2.All outstanding and unvested Restricted Stock Units and other equity awards shall immediately vest upon said termination.

1.3.Disability. In the event that the Company terminates your employment due to your disability, pursuant to Clause 1.2.2 above, then in addition to the amounts provided under Clause 20.1 above:

1.6.1.You will be paid a pro-rata portion of your Annual Bonus that you would have been entitled to receive for the calendar year in which your termination occurs, based on the number of days you were employed by the Parent Group during such year and calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination; and

1.6.2.All outstanding and unvested Restricted Stock Units and other equity awards shall immediately vest upon the date of your termination.

1.4.Termination by the Company without Cause or by you for Good Reason. In the event that the Company terminates your employment without Cause or you terminate your employment for Good Reason, then conditioned on your compliance with this Contract during any applicable notice period, then in addition to the amounts you have received during the notice period and any other accrued salary and benefits earned through your Termination Date, but subject to your timely satisfaction of the condition precedent in Clause 20.6 below, the following will be provided to you following the Termination Date:

1.6.1.You will be paid a lump sum amount equal to six (6) months base salary at the rate in effect immediately prior to said termination, to be paid no later than sixty (60) days following your termination;
12



1.6.2.With respect to the discretionary annual bonus for the calendar year prior to the calendar year in which your termination occurs (to the extent not previously paid), you will be excused from the requirement in Clause 5.3(iii) that you must be actively employed with the Company on the date of disbursement in order to receive such bonus payment, and the bonus will be paid during the period set forth in Clause 20.1.1 above;
1.6.3.You will be paid an amount equal to 65% of your Target Bonus for the calendar year in which your termination occurs, calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
1.6.4.You will be paid a pro-rata portion of your Target Bonus for the calendar year in which your termination occurs, based on the number of days you were employed by the Company during such year and calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination;
1.6.5.For so long as you shall remain in full compliance with the obligations set forth in Clauses 17 through 19, and conditioned on such continued compliance, all Restricted Stock Units and other equity awards previously awarded to you which have not vested as of the date of your termination, if any, shall continue to vest on the applicable dates set forth in the applicable award agreements.
1.5.Termination by the Company without Cause or by you for Good Reason Following Change in Control. In the event that within twenty-four (24) months following a Change in Control as defined below the Company terminates your employment without Cause or you terminate your employment for Good Reason, then you shall be entitled to the same payments and benefits described in Clause 20.4 above subject to the terms thereof, except that:

1.6.1.for purposes of Clause 20.4.3, you will be paid an amount equal to 1.65 times our Target Bonus for the calendar year in which your termination occurs, calculated as if all targets were met, to be paid in a lump sum no later than sixty (60) days following your termination; and
1.6.2.for purposes of Clause 20.4.5, all outstanding and unvested Restricted Stock Units and other equity awards shall immediately vest upon said termination.
1.6.Release of Claims and Settlement Agreement. No severance benefits or payments provided pursuant to this Clause 20 will be provided to you unless you execute a settlement agreement in the Company's standard terms within 45 days of the termination of your employment.

1.7.Certain Definitions. For purposes of this Clause 20, the terms set forth below shall have the following definitions:

1.6.1.Cause” means an involuntary termination of your employment pursuant to Clause 15.1.
1.6.2.Change of Control” has the meaning assigned to such term under the Axis Capital Holdings Limited Amended and Restated 2017 Long-Term Equity Compensation Plan.
1.6.3.Good Reason” means a termination of your employment means your termination of employment pursuant to Clause 1.2.6
21.BUSINESS CONDUCT

1.1.Upon joining the Company and every year thereafter you will be required to sign a certificate that you fully understand your responsibilities to comply with the Code of Business Conduct and that you know of no violations of the Code of Business Conduct or, if there have been violations requiring disclosure, that they have been disclosed to your line manager or the General Counsel of AXIS Capital Holdings Limited.

22.COLLECTIVE AGREEMENTS

1.1.There are no collective agreements which directly affect your terms and conditions of employment.
13




23.DATA PROTECTION

1.1.You confirm that you have read and understood the Data Protection Policy and Employee Privacy Notice, which are available on the Company’s intranet site. The Company may change its Data Protection Policy at any time and will notify you in writing of any changes. You agree that you will comply with the Company’s Data Protection Policy in processing personal data about any individual in the course of your work.

24.THIRD PARTY RIGHTS

1.1.A person who is not a party to this Contract may not under the Contracts (Rights of Third Parties) Act 1999 enforce any of the terms contained herein.

25.GROUP COMPANIES

1.1.In this Agreement “Group Company” means a subsidiary or affiliate and any other company which is for the time being a holding company of the Company or another subsidiary or affiliate of any such holding company as defined by the Companies Act 1985 (as amended) and includes the Parent and any subsidiary or affiliate of the Parent and ‘Group Companies’ will be interpreted accordingly.

1.2.You may be providing services to a company that is authorized and supervised by the Irish Financial Supervisory Regulatory Authority and/or the UK’s Financial Conduct Authority and Prudential Regulation Authority. You should become familiar with the Company’s regulatory permissions and consult the Compliance Officer should you have any questions.

26.ENTIRE AGREEMENT

1.1.These terms and conditions constitute the entire agreement between the Company and you and supersede any other agreement whether written or oral previously entered into.

27.JURISDICTION AND CHOICE OF LAW

1.1.This Contract shall be governed by and interpreted in accordance with the laws of England and Wales, without regard to the conflict of laws principles thereof, and the exclusive jurisdiction of the English Courts in relation to any claim, dispute or matter arising out of or relating to this Contract.

28.NOTICES

1.1.Any notices with respect to this Contract shall be in writing and shall be deemed given if delivered personally (upon receipt), sent by facsimile (which is confirmed) or sent by first class post addressed, in the case of the Company, to its registered office for the attention of the human resources department and in your case addressed to your address last known to the Company.

29.SEVERABILITY

1.1.In the event that any condition contained in this contract is held to be void in whole or in part for any reason, such unenforceability will not affect the enforceability of the remaining conditions contained in this letter and such void conditions will be deemed to be severable.


30.RESIGNATION FROM DIRECTORSHIPS AND OTHER OFFICES

1.1.In addition, upon your termination of employment with the Company for any reason, you agree to resign from all directorships and other offices that you hold in connection with your employment with the Company (including any directorships with subsidiaries or other affiliates of the Company) effective as of any date during the notice period.

31.POWER OF ATTORNEY

1.1.You hereby irrevocably appoint any director of the Company, as your authorised attorney, to execute all documents and do everything necessary in your name and on your behalf to:

1.6.1.Give the Company the full benefit of the provision of clause 19
14



1.6.2.Effect your resignation in accordance with clause 30.1.

15







Executed and delivered as a deed on 19.1.23 by Dan Draper:

Signature    /s/ Dan Draper………………………………………………………………………


In the presence of this witness:


Witness signature    /s/ Paul Hibberd………………………………………………………………………

Name of witness    Paul Hibberd………………………………………………………………………

Address of witness    […………………]……………………………………………………

    ………………………………………………………………………



Executed and delivered as a deed on 1.19.23 by Axis UK Services Limited acting by Claire Butler, a director: -

Signature    /s/ Claire Butler………………………………………………………………………


In the presence of this witness:


Witness signature    /s/ Katherine Taylor………………………………………………………………………

Name of witness    Katherine Taylor………………………………………………………………………

Address of witness    […………………]………………………………………………

    ………………………………………………………………………




16

EX-10.22 10 axs-20231231xexx1022.htm EX-10.22 Document

AXIS CAPITAL HOLDINGS LIMITED
EXECUTIVE LONG-TERM EQUITY COMPENSATION PROGRAM

AXIS Capital Holdings Limited (the “Company”) has established the AXIS Capital Holdings Limited Executive Long-Term Equity Compensation Program (the “Program”) to enable eligible employees of the Company and its subsidiaries to share in the success of the Company through the grant of equity awards. The terms of the Program are as set forth herein.

1.Eligibility. Any Executive Committee Member who is employed by the Company or one of its subsidiaries shall be entitled to annual allocation from the equity pool (as defined in Section 2) and shall be a “Participant” in the Program.
2.Target Equity Allocation. Each Participant’s initial “Target Equity Allocation” shall be based on the Participant’s annual equity target value as set forth in their respective employment agreement, offer letter or as set by the Human Capital and Compensation Committee of the Company. This Target Equity Allocation shall be allocated between a time-based award and a performance-based award at the Compensation Committee’s discretion.
3.Time-Based Award. Time-based awards will vest 25% per year over a four-year vesting period.
4.Performance-Based Award. The performance-based portion of the Target Equity Allocation will be granted as initially determined without adjustment, but vesting will be subject to a performance condition. Specifically, performance-based awards will be eligible to vest in a range of 0%-200% of the initial Target Equity Allocation on the third anniversary of the date of grant, depending on the Company’s: (i) relative total shareholder return performance as of the time of vesting, as compared to the Company’s performance peers and (ii) absolute diluted book value per share growth.
5.Form of Awards. Awards may be made in the form of restricted stock or restricted stock units, at the Committee’s discretion.
6.Clawback. Any equity compensation award hereunder is subject to recoupment, at the Committee’s discretion, under the Company’s executive compensation recoupment, or “clawback”, policy.
7.Interpretation of Program. The Committee shall have the authority to administer the Program, to conclusively make all determinations under the Program and to interpret the Program, subject to and in accordance with the Company’s Second Amended and Restated 2017 Long-Term Equity Compensation Plan. Any such determinations or interpretations made by the Committee shall be binding on all persons.
8.Governing Law. The Program shall be governed by the laws of Bermuda.
9.No Guarantee of Continued Employment. Nothing in the Program shall interfere with or limit in any way the right of the Company or any of its subsidiaries to terminate any employee’s employment at any time, nor shall it confer upon any Participant any right to continue in the employ of the Company or any of its subsidiaries. For purposes of the Program, temporary absence from employment because of illness, vacation, approved leaves of absence and transfers of employment among the Company and its subsidiaries shall not be considered to terminate an employee’s employment.
10.Successors. All obligations of the Company under the Program shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect merger, consolidation, purchase of all or substantially all of the business and/or assets of the Company or otherwise.
11.Amendment and Termination. This Program may be amended or terminated at any time by the Committee.
February 2024

EX-10.23 11 axs-20231231xexx1023.htm EX-10.23 Document

AXIS CAPITAL HOLDINGS LIMITED
EXECUTIVE ANNUAL INCENTIVE PLAN
 
AXIS Capital Holdings Limited (the “Company”) has established the AXIS Capital Holdings Limited Executive Annual Incentive Plan (the “Plan”) to enable eligible employees of the Company and its subsidiaries to share in the success of the Company through the grant of cash incentive bonus awards.  The terms of the Plan are as set forth herein.
1.Eligibility.  Any Executive Committee Member who is employed by the Company or one of its subsidiaries shall be entitled to an annual allocation from the bonus pool (as defined in Section 2) and shall be a “Participant” in the Plan from and after January 1, 2014.
2.Target Incentive Allocation. Each Participant’s annual “Target Allocation” shall be based on the Participant’s base salary multiplied by their annual incentive target percentage, as set forth in their respective employment agreement, offer letter or other written document. This Target Allocation will then be adjusted as described in Section 3 below.
3.Adjustment to Target Incentive Allocation.  The “Adjustment to Target Incentive Allocation,” represents an adjustment to the Target Incentive Allocation in order to determine the final payment and is based on (i) the Company’s satisfaction of a performance target linked to the Company’s annual operating return on average common equity, as established each year by the Human Capital and Compensation Committee of the Company’s Board of Directors (the “Committee”), (ii) the achievement by the Participant of individualized, non-financial performance metrics as determined annually by the Chief Executive Officer or the Committee (in the case of the Chief Executive Officer), and (iii) for Business Unit leaders, the Business Unit’s performance as compared to pre-established metrics. In determining the Adjustment to Target Incentive Allocation, the metrics as described above are weighted based on the Participant’s role as a CEO, Business Unit leader or corporate function leader as determined by the Committee from time to time.
Each performance metric can result in a Payout Factor adjusted based on the assigned weighting.
The Adjustment to Target Incentive Allocation is the sum of each metric weighting multiplied by the Target Incentive Allocation to determine final incentive allocation for the fiscal year.
Without limiting the generality of the foregoing, the Committee shall have the authority to make positive or negative adjustments with respect to one or more performance metrics or performance targets in recognition of unusual or non-recurring events affecting the Company or its Business Units, in response to changes in applicable laws or regulations, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or related to the disposal of a segment of a business or related to a change in generally accepted accounting principles, or as the Committee determines to be appropriate to reflect a reasonable and fair measurement of the performance of the Company or its Business Units, as applicable.
4.Payment.  Each Participant’s final payment shall be paid in the calendar year following the applicable fiscal performance year of the Company, after the amount has been determined by the Committee. If a Participant’s employment with the Company and its subsidiaries terminates prior to the payment date for any reason, such Participant’s eligibility under the Plan shall cease and the final payment shall be forfeited as of the termination date and the Participant shall have no further rights to payments under the Plan, except to the extent of any contractual obligation to the Participant made by the Company or any of its subsidiaries.
5.Clawback. Any incentive compensation award hereunder is subject to recoupment, at the Committee’s discretion, under the Company’s executive compensation recoupment, or “clawback,” policy.



6.Interpretation of Plan.  The Committee shall have the authority to administer the Plan, to conclusively make all determinations under the Plan and to interpret the Plan.  Any such determinations or interpretations made by the Committee shall be binding on all persons.
7.Governing Law.  The Plan shall be governed by the laws of Bermuda.
8.No Guarantee of Continued Employment.  Nothing in the Plan shall interfere with, or limit in any way, the right of the Company or any of its subsidiaries to terminate any employee’s employment at any time, nor shall it confer upon any Participant any right to continue in the employ of the Company or any of its subsidiaries.  For purposes of the Plan, temporary absence from employment because of illness, vacation, approved leaves of absence and transfers of employment among the Company and its subsidiaries shall not be considered to terminate an employee’s employment.

9.Successors.  All obligations of the Company under the Plan shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect merger, consolidation, purchase of all or substantially all of the business and/or assets of the Company or otherwise.
10.Amendment and Termination.  This Plan may be amended or terminated at any time by the Committee.



























February 2024

EX-10.24 12 axs-20231231xexx1024.htm EX-10.24 Document
        
AXIS AMENDED AND RESTATED EXECUTIVE RSU RETIREMENT PLAN
 
AXIS Specialty U.S. Services, Inc. (the “Company”) has established the AXIS Executive RSU Retirement Plan (the “Plan”) to reward certain long-term employees of the Company and its employer affiliates for their dedicated service.  The terms of the Plan are as set forth herein.
1.Eligibility.  Except as otherwise provided in the Plan, any employee of the Company or its employer affiliates (other than those employees explicitly excluded from the Plan pursuant to Section 18 hereof) who is Retirement Eligible and who has an outstanding grant(s) of restricted stock units under the AXIS Capital Holdings Limited (“AXIS”) 2017 Long-Term Equity Compensation Plan and any successor equity compensation plan (the “Stock Plan”) as of the employee’s date of termination and who satisfies the requirements of this Plan shall be a participant in the Plan (a “Participant”).
An employee is “Retirement Eligible” if the employee is age 60 or older as of his or her date of termination; and
has at least ten Years of Service as of his or her date of termination.
o“Years of Service” means completed years of service with the Company or an employer affiliate of the Company.

2.Termination and Advance Notice Requirement. In order to earn and be paid the benefits provided under this Plan, a Participant: (i) must not have been provided a notice of termination from the Company for any reason, (ii) must be in good standing as of his or her date of termination (as determined by the Human Capital and Compensation Committee of the Board of AXIS (the “Committee”) in its sole discretion) and (iii) must provide not less than ninety (90) days advance notice of his or her termination if he or she voluntarily terminates employment, provided, however, that management retains discretion to require a period of notice up to one year as particular employment circumstances may dictate.

3.Restrictive Covenant Agreement. In order to earn and be paid the benefits provided under this Plan, to the extent permitted by law, a Participant must execute a Restrictive Covenant Agreement in a form acceptable to the Company (a “Covenant Agreement”) at the time required by the Company. The Company reserves the right to require a Participant to attest to continued compliance with the Covenant Agreement from time to time. Failure to do so will be deemed to be a breach of the Covenant Agreement.
4.Plan Benefit.
a.A Participant shall, except as provided below in Section 4(b), continue to vest in any restricted stock units granted pursuant to RSU Agreements that remain outstanding and unvested as of the date of his or her termination as though the Participant had not terminated employment with the Company (e.g., on the first, second, third and fourth anniversaries of the award date for time-based restricted stock units; on the third anniversary of the award date for performance-based restricted stock units; or as otherwise provided in the applicable RSU Agreement); provided that such vesting shall terminate if the Participant breaches any of the terms of the Covenant Agreement, in the determination of the Committee or its designee, to the extent permitted by law and all unvested restricted stock units shall terminate and be forfeited as of the date of the breach.
b.Notwithstanding Section 4(a), (1) with respect to any restricted stock units subject to time-based vesting granted in the twelve month period immediately prior to the Participant’s termination (the “Last Grant”), only the restricted stock units scheduled to vest on the first anniversary of such Last Grant, if any, shall be eligible to vest and the remaining restricted stock units shall be forfeited as of the Participant’s termination and (2) with respect to any restricted stock units subject to performance-based vesting granted in the Last Grant, only 25% of the restricted stock units scheduled to vest on the regularly scheduled vesting date
1


        
shall be eligible to vest, subject to performance goals being achieved, and 75% of such restricted stock units shall be forfeited as of the Participant’s termination.
c.     In the case of any restricted stock units subject to performance vesting, where the restricted stock units vest on the regularly scheduled vesting date as though the Participant had not terminated employment, the number of restricted stock units that vest shall be determined by applying the same Performance Multiplier (as defined in the applicable RSU Agreement) that would apply had the Participant not terminated employment.
d.     Notwithstanding the foregoing, the Committee shall have the sole authority to determine that no benefit shall be provided under this Plan in connection with certain outstanding restricted stock unit grants made to Participants.
5. Payment.  Payment of the Shares (as defined in the Employee Restricted Stock Unit Agreement pursuant to which the outstanding restricted stock units were granted (the “RSU Agreement”)) payable with respect to outstanding restricted stock units which vest pursuant to Section 4 hereof on or after a Participant’s termination of employment, shall be made as follows:
a.Subject to Section 12 hereof, payment shall be made at the same time and in the same form delivery would have been made under the RSU Agreement if the Participant had remained employed through the applicable vesting date (e.g., the first, second, third and fourth anniversaries of the award date for time-based restricted stock units; the third anniversary of the award date for performance-based restricted stock units; or as otherwise provided in the applicable RSU Agreement).
b.Notwithstanding the foregoing, in the event that a Participant dies or becomes Disabled (as defined in the applicable RSU Agreement) prior to delivery of the amounts described in Section 5(a) or 6(c), payment shall be made to the Participant or his or her beneficiary in a lump sum upon the earlier of the date provided in Section 5(a) or 6(c), as applicable, or within sixty (60) days following the Participant’s death or Disability, as applicable. In the case of any restricted stock units subject to performance vesting, the determination of the number of restricted stock units with respect to which payment will be made pursuant to this Section 5(b) shall be determined as described in the applicable award agreement. .
6.Special Vesting and Payment Rule for Terminations that Occur Within Twenty Four Months of a Change in Control.
a.Notwithstanding any provision of Section 4 to the contrary, if the Participant’s termination occurs within twenty four months following a Change in Control (as defined in the RSU Agreement), a Participant shall vest in any outstanding and unvested restricted stock units granted pursuant to RSU Agreements as of his or her termination, reduced as required pursuant to Section 4(b).
b.Where performance-based restricted stock units vest on the date of a Participant’s termination of employment within twenty four months following a Change in Control, the number of restricted stock units that vest shall be determined as described in the applicable award agreement.
c.Notwithstanding any provision of Section 5 to the contrary, if vesting occurs in connection with a termination that is within twenty four months following a Change in Control, payment shall be made at the same time and same form as delivery would have been made under the RSU Agreement had the Participant been terminated without Cause within twenty four months following a Change in Control, but in no event later than thirty (30) days following termination, subject to Section 12 hereof.
2


        
1.Termination Prior to Retirement Eligibility. If an employee’s employment with the Company and its employer affiliates terminates prior to the date that the employee becomes Retirement Eligible for any reason, such employee shall have no right to participate in or receive benefits under the Plan.
2.RSU Agreement. The applicable RSU Agreement shall govern the outstanding restricted stock units to the extent the RSU Agreement is not inconsistent with the Plan.
3.Beneficiary. To the extent not inconsistent with the Stock Plan, in the event of a Participant’s death, payment of the Participant’s Plan benefit, if any, shall be made to a beneficiary (or beneficiaries) designated by the Participant in the form and manner prescribed by the Committee. If a Participant does not have a properly designated beneficiary, payment shall be made to the Participant’s estate.

4.Clawback. Any Plan benefit hereunder is subject to recoupment, at the Committee’s discretion, under the AXIS executive compensation recoupment, or “clawback,” policy.
5.Administration and Interpretation of Plan.  The Committee, in consultation with AXIS management, shall have the authority to administer the Plan, to conclusively make all determinations under the Plan and to interpret the Plan.  Any such determinations or interpretations made by the Committee shall be binding on all persons.
6.Section 409A.
a.     Although the Company does not guarantee the tax treatment of any payments under the Plan, the intent of the Company is that the payments and benefits under this Plan comply with Section 409A of the Internal Revenue Code of 1986, as amended, and all Treasury Regulations and guidance promulgated thereunder (“Code Section 409A”) and to the maximum extent permitted the Plan shall be limited, construed and interpreted in accordance with such intent. In no event whatsoever shall the Committee, the Company or its affiliates or their respective officers, directors, employees or agents be liable for any additional tax, interest or penalties that may be imposed on a Participant by Code Section 409A or damages for failing to comply with Code Section 409A.
b.     Notwithstanding any other provision of this Plan to the contrary, if at the time of a Participant’s separation from service (as defined in Code Section 409A), the Participant is a “Specified Employee”, then the Company will defer the payment or commencement of any nonqualified deferred compensation subject to Code Section 409A payable upon separation from service (without any reduction in such payments or benefits ultimately paid or provided to the Participant) until the date that is six (6) months following separation from service or, if earlier, the earliest other date as is permitted under Code Section 409A (and any amounts that otherwise would have been paid during this deferral period will be paid in a lump sum on the day after the expiration of the six (6) month period or such shorter period, if applicable). The Company shall determine in its sole discretion all matters relating to who is a “Specified Employee” and the application of such determination.
c.Notwithstanding anything in this Plan or elsewhere to the contrary, a termination of employment shall not be deemed to have occurred for purposes of any provision of this Plan providing for the payment of any amounts or benefits that constitute “non-qualified deferred compensation” within the meaning of Code Section 409A upon or following a termination of the Participant’s employment unless such termination is also a “separation from service” within the meaning of Code Section 409A and, for purposes of any such provision of this Plan, references to a “termination,” “termination of employment” or like terms shall mean “separation from service” and the date of such separation from service shall be the date of termination for purposes of any such payment or benefits.
3


        
13.Governing Law.  The Plan shall be governed by the laws of New York without regard to its conflicts of law provisions.
14.Effective Date. The Plan shall continue until terminated by the Company.

15.No Guarantee of Continued Employment.  Nothing in the Plan shall interfere with, or limit in any way, the right of the Company or any of its affiliates to terminate any Participant’s employment at any time, nor shall it confer upon any Participant any right to continue in the employ of the Company or any of its affiliates.  For purposes of the Plan, temporary absence from employment because of illness, vacation, approved leaves of absence and transfers of employment among the Company and its affiliates shall not be considered to terminate a Participant’s employment unless such treatment would cause a violation of Code Section 409A.

16.Successors.  All obligations of the Company under the Plan shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect merger, consolidation, purchase of all or substantially all of the business and/or assets of the Company or otherwise.
17.No Claim Against Assets. Nothing in this Plan shall be construed as giving any Participant or his or her legal representative, or designated beneficiary, any claim against any specific assets of the Company or as imposing any trustee relationship upon the Company in respect of the Participant. The Company shall not be required to segregate any assets in order to provide for the satisfaction of the obligations hereunder. If and to the extent that the Participant or his or her legal representative or designated beneficiary acquires a right to receive any payment pursuant to this Plan, such right shall be no greater than the right of an unsecured general creditor of the Company.

18.Employees of AXIS Capital Holdings Limited. Unless determined otherwise by the Committee, in no event shall any employee (i) who is a United States resident or citizen whose compensation is allocated to AXIS and/or (ii) whose benefit under the Plan would be subject to Section 457A of the Internal Revenue Code, be a Participant in the Plan. Also, absent Committee approval, employees of non-wholly owned subsidiaries of AXIS will not be eligible to participate in the Plan.
19.ERISA. This Plan is intended to be a bonus program exempt from the Employee Retirement Income Security Act of 1974, as amended, pursuant to DOL Regulation Section 2510.3-2(c).
20.Amendment and Termination.  This Plan may be amended or terminated at any time by the Company without the consent of any employee or Participant to the extent permitted by law.




4

EX-10.35 13 axs-20231231xexx1035.htm EX-10.35 Document

AXIS Capital Holdings Limited

2017 Long-Term Equity Compensation Plan

Employee Restricted Stock Unit Agreement (Performance Vesting / 100% Stock Settled)

You (the “Participant”) have been granted an award of Restricted Stock Units (the “Award”) with a value based on ordinary shares, par value $0.0125 per share (“Shares”), of AXIS Capital Holdings Limited, a Bermuda company (the “Company”), pursuant to the AXIS Capital Holdings Limited 2017 Long-Term Equity Compensation Plan (the “Plan”). The date of grant of the Award (the “Award Date”), the vesting start date (the “Vesting Start Date”) and the base number of Restricted Stock Units subject to the Award (the “Target Number”) are as set forth in your restricted stock unit account maintained on the Morgan Stanley Benefit Access website or such other website as may be designated by the Compensation Committee of the Board of Directors of AXIS Capital Holdings Limited (the “Committee”). The actual number of Restricted Stock Units that you will be eligible to earn with respect to this Award (the “Award Units”), subject to meeting the applicable service and performance vesting requirements, will equal the Target Number multiplied by the applicable “Performance Multiplier” (as defined in Exhibit A hereto). This Award constitutes an unfunded and unsecured promise of the Company to deliver (or cause to be delivered to you) on the terms and conditions set forth herein the number of Shares corresponding to the earned Award Units.

By your acceptance of the grant of the Award on the Morgan Stanley Benefit Access website, you agree that the Award is granted under and governed by the terms and conditions of the Plan and this Restricted Stock Unit Agreement (the “Agreement”).

1. GRANT OF RESTRICTED STOCK UNITS.

(a) Award. On the terms and conditions set forth in this Agreement, the Company hereby grants to the Participant on the Award Date the Award.

(b) Plan and Defined Terms. The Award is granted pursuant to the Plan, a copy of which the Participant acknowledges having received. The terms and provisions of the Plan are incorporated into this Agreement by this reference. All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.

2. PERIOD OF RESTRICTION.

(i) The Restricted Stock Units subject to the Award shall be restricted during the period (the “Period of Restriction”) commencing on the Award Date and expiring on the first to occur of:
(a) The normal scheduled vesting of the Award Units. The Award Units shall vest in a single installment on the third anniversary of the Vesting Start Date (the “Anniversary Date”).

(b) The Participant’s death or permanent Disability; or
1



(c) The date of the Participant’s termination without Cause or termination for Good Reason, in each case, within 24 months following a Change of Control.

(d) Definitions. As used herein, the following terms shall have the meanings set forth below:

(1) “Cause” shall have the meaning set forth in the Participant’s employment agreement with the Company, if any, or in the absence of an employment agreement definition shall mean (A) any act or omission which constitutes a material breach by the Participant of the terms of his or her employment, (B) the Participant’s conviction of a felony or commission of any act which would rise to the level of a felony, (C) the Participant’s conviction or commission of a lesser crime or offense that adversely impacts or potentially could impact upon the business or reputation of the Company and/or affiliates and subsidiaries in a material way, (D) the Participant’s willful violation of specific lawful directives of the Company, (E) the Participant’s commission of a dishonest or wrongful act involving fraud, misrepresentation, or moral turpitude causing damage or potential damage to the Company and/or its affiliates and subsidiaries, (F) the Participant’s willful failure to perform a substantial part of the Participant’s duties or (G) the Participant’s breach of fiduciary duty.

(2) “Change of Control” shall have the meaning set forth in the Plan, provided however, that only an event that constitutes a change in control or ownership within the meaning of Treasury Regulation 1.409A-3(i)(5) shall be a Change of Control for purposes of this Agreement.

(3) “Disability” shall mean the Participant’s permanent disability which constitutes a disability within the meaning of Section 409A(a)(2)(C) of the Code.

(4) “Good Reason” shall have the meaning set forth in the Participant’s employment agreement with the Company, if any, or in the absence of an employment agreement definition shall mean (A) the scope of the Participant’s position, authority or duties with the Company is materially adversely changed, (B) the Participant’s compensation is not paid or is materially reduced or there is a material adverse change in the Participant’s employee benefits or (C) the Participant is required by the Company to relocate to a place more than 50 miles from the Participant’s current place of employment; provided that, in each case, “Good Reason” shall not exist unless the Participant provides the Company with written notice of the Participant’s intent to terminate employment as a result of such event, providing the specific reasons therefore, and the Company does not make the necessary corrections within thirty days of receipt of the Participant’s written notice, following which the Participant may terminate his or her employment for “Good Reason” within the ten days following expiration of such thirty day notice period.

(5) “RSU Retirement Plan” shall mean the AXIS Specialty U.S. Services, Inc. Executive RSU Retirement Plan, as in effect as of the date of this Agreement.

(ii) Absent subsequent Committee action, and except as otherwise provided under the RSU Retirement Plan (to the extent such plan is applicable to the Participant), the Award Units will not automatically vest upon or following the Participant’s retirement.
2



(iii) Notwithstanding the foregoing, to the extent that the Participant is party to an employment agreement with the Company that provides for vesting of the Participant’s restricted stock units on an accelerated or otherwise more favorable basis as compared to the terms set forth in this Section 2, then the Award Units shall vest pursuant to the terms set forth in such employment agreement.

3. ISSUANCE OF AWARD UNITS.

Subject to the Participant’s continued employment with the Company during the Period of Restriction through the applicable vesting dates, the Company shall deliver to the Participant within thirty (30) days following the Anniversary Date (or within thirty (30) days following any vesting event described under Section 2(i)(b) or 2(i)(c) hereof, if applicable) with respect to the number of Award Units earned as determined in accordance with Exhibit A hereto, 100% of the Shares underlying such earned Award Units as of the Anniversary Date with such Share delivery fully satisfying the Company’s obligations to the Participant with respect to such corresponding Award Units. In the event that the Participant’s employment terminates for any reason prior to the expiration of the Period of Restriction (except as described in Section 2(i)(b), 2(i)(c) or the RSU Retirement Plan, to the extent such plan is applicable to the Participant), the Award will immediately terminate and the Company will have no further obligation or liability to the Participant. Subject to Section 4, the Participant will have no rights as a shareholder of the Company with respect to the Shares underlying the Award Units until such time as the Shares underlying the Award Units are actually delivered to the Participant. For purposes of this Agreement, references to the Participant’s continued “employment” shall be deemed to refer to the Participant’s continued active employment together with any permitted leaves of absence as described under Section 4(d), but shall not include any periods of inactive employment during which the Participant is on “garden leave” or otherwise receiving salary continuation payments in lieu of notice or as a form of severance pay, unless otherwise determined by the Company in connection with or prior to the Participant’s commencement of any such period of inactive employment.

4. RESTRICTIONS, VOTING RIGHTS AND DIVIDEND EQUIVALENTS.

(a) Restrictions. The Award may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated at any time.
(b) Voting Rights. Prior to the delivery of Shares underlying the Award Units pursuant to this Agreement, the Participant shall not be entitled to exercise any voting rights with respect to the Award Units and, except as provided in Section 4(c), shall not be entitled to receive dividends or other distributions with respect to the Award Units.
(c) Dividend Equivalents. Dividend equivalents shall be paid to the Participant with respect to the Award Units during the Period of Restriction. Any dividend equivalents paid with respect to the Award Units during the Period of Restriction will be held by the Company, or a depository appointed by the Committee, for the Participant's account. All cash or share dividend equivalents so held shall be payable at the same time as the delivery of Shares are made with respect to the Award Units as set forth in Section 3 and shall be forfeited and shall not be paid in the event the Award is terminated as set forth in Section 3.
(d) Leaves of Absence. For any purpose under this Agreement, employment shall be deemed to continue while the Participant is on a bona fide leave of absence, if such leave
3



was approved by the Company in writing and if continued crediting of employment for such purpose is expressly required by the terms of such leave or by applicable law (as determined by the Company).

5. RESTRICTIONS ON TRANSFER.

(a) Transfer Restrictions. Regardless of whether the offering and sale of Units under the Plan have been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or otherwise, the Company, in its sole discretion, may impose restrictions upon the sale, pledge or other transfer of the Shares deliverable in respect of the Award Units (including the placement of appropriate legends on stock certificates or the imposition of stop-transfer instructions) if, in the judgment of the Company, such restrictions are necessary or desirable in order to achieve compliance with the Company's Bye-Laws, the Securities Act, the U.S. Securities Exchange Act of 1934, as amended, the securities laws of any country or state or any other applicable law, rule or regulation.

(b) Legends. All certificates evidencing Shares issued in respect of Award Units under this Agreement shall bear such restrictive legends as are required or deemed advisable by the Company under the provisions of any applicable law, rule or regulation (including to reflect any restrictions to which you may be subject under any applicable securities laws). If, in the opinion of the Company and its counsel, any legend placed on a stock certificate representing Shares issued under this Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but without such legend.

6. MISCELLANEOUS PROVISIONS.

(a) Bye-Laws. All Shares acquired pursuant to this Agreement shall be subject to any applicable restrictions contained in the Company's Bye-Laws.

(b) No Retention Rights. Nothing in this Agreement or in the Plan shall confer upon the Participant any right to continue employment for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company or any Affiliate employing or retaining the Participant or of the Participant, which rights are hereby expressly reserved by each, to terminate his or her employment at any time and for any reason, with or without Cause.

(c) Notice. Any notice required by the terms of this Agreement shall be given in writing and shall be deemed effective upon delivery by hand, upon delivery by reputable express courier or, if the recipient is located in the United States, upon deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid. Notice shall be addressed to the Company at its principal executive office and to the Participant at the address that he or she most recently provided in writing to the Company.

(d) Choice of Law. This Agreement shall be governed by, and construed in accordance with, the laws of Bermuda.
4



(e) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

(f) Modification or Amendment. This Agreement may be amended or modified by the Committee; provided that any amendment or modification that would adversely affect the Participant’s rights with respect to the Award must be made by written agreement executed by the parties hereto; and provided, that the adjustments permitted pursuant to Sections 4(b) and 7(b) of the Plan may be made without such written agreement.

(g) Severability. In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining provisions of this Agreement, and this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.

(h) Recoupment Policy. The Award is subject in all respects to the Company’s Executive Compensation Recoupment Policy, as the same may be amended from time to time, or any successor policy thereto (to the extent such plan is applicable to the Participant).













5



Exhibit A

Performance Metrics for Determining the Number of Earned Award Units

Performance LevelRelative TSR PercentilePerformance Multiplier
Maximum
85th or above
200%
Target
55th
100%
Threshold
25th
25%
Minimum
below 25th
0

The Performance Multiplier shall be determined by linear interpolation for achievement falling between the above percentages; provided, that there shall be no interpolation for achievement that is below threshold level performance or above maximum level performance.

For purposes of this Exhibit A, the following terms shall have the following meanings:

TSR” shall mean total stockholder return (assuming reinvestment of dividends) during the Performance Period.

TSR Percentile” shall mean the Company’s percentile rank among its Peer Group in terms of TSR during the Performance Period (rounded to the nearest hundredth of a percent), as determined by the Committee in good faith.

Peer Group” shall mean the performance peer companies identified by the Committee in the Company’s annual proxy statement filed with the U.S. Securities and Exchange Commission during the same calendar year in which the Award Date occurs; provided, however, that the Committee may equitably adjust the members of the Peer Group to account for any member company which ceases to be a publicly traded company (due to merger, corporate reorganization, bankruptcy or otherwise) or engages in a spin-off or similar transaction prior to the end of the Performance Period.

Performance Multiplier” shall mean the applicable multiplier as determined in accordance with the table above based on the achieved TSR Percentile; provided, however, that in the event that the Period of Restriction terminates prior to the end of the Performance Period due to an event described in Sections 2(i)(b) of the Agreement, then the Performance Multiplier shall automatically be deemed to equal 100%.

Performance Period” shall mean the period commencing on December 31 of the calendar year preceding the year in which the Award Date occurs and ending on the earlier to occur of (i) the first anniversary of such date (December 31, 2023) or (ii) the date of a Change of Control.

Notwithstanding the forgoing, in the event that the Company’s TSR is negative (i.e., less than zero), the Performance Multiplier shall be deemed to equal the lesser of (i) the applicable
6



multiplier determined in accordance with the methodologies stated above or (ii) 100% (i.e., the “target” level multiplier.

PAC ID 1217 (01 23)

7

EX-10.39 14 axs-20231231xexx1039.htm EX-10.39 Document

AXIS Capital Holdings Limited
2017 Long-Term Equity Compensation Plan
Employee Restricted Stock Unit Agreement (Performance Vesting / 100% Stock Settled)
You (the “Participant”) have been granted an award of Restricted Stock Units (the “Award”) with a value based on ordinary shares, par value $0.0125 per share (“Shares”), of AXIS Capital Holdings Limited, a Bermuda company (the “Company”), pursuant to the AXIS Capital Holdings Limited 2017 Long-Term Equity Compensation Plan, as amended (the “Plan”). The date of grant of the Award (the “Award Date”), the vesting start date (the “Vesting Start Date”) and the base number of Restricted Stock Units subject to the Award (the “Target Number”) are as set forth in your restricted stock unit account maintained on the Morgan Stanley Benefit Access website or such other website as may be designated by the Human Capital and Compensation Committee of the Board of Directors of the Company (the “Committee”). The actual number of Restricted Stock Units that you will be eligible to earn with respect to this Award (the “Award Units”), subject to meeting the applicable service and performance vesting requirements, will equal the Target Number multiplied by the Cumulative Performance Multiplier (as defined in Exhibit A hereto). This Award constitutes an unfunded and unsecured promise of the Company to deliver (or cause to be delivered to you) on the terms and conditions set forth herein the number of Shares corresponding to the earned Award Units.
By your acceptance of the grant of the Award on the Morgan Stanley Benefit Access website, you agree that the Award is granted under and governed by the terms and conditions of the Plan and this Restricted Stock Unit Agreement (the “Agreement”).
1.    GRANT OF RESTRICTED STOCK UNITS.
    (a)    Award. On the terms and conditions set forth in this Agreement, the Company hereby grants to the Participant on the Award Date the Award.
    (b)    Plan and Defined Terms. The Award is granted pursuant to the Plan, a copy of which the Participant acknowledges having received. The terms and provisions of the Plan are incorporated into this Agreement by this reference. All capitalized terms that are used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the Plan.
2.    PERIOD OF RESTRICTION.
(i)    The Restricted Stock Units subject to the Award shall be restricted during the period (the “Period of Restriction”) commencing on the Award Date and expiring on the first to occur of:
(a)    The normal scheduled vesting of the Award Units. The Award Units shall vest in a single installment on the third anniversary of the Vesting Start Date (the “Anniversary Date”).
        (b)    The Participant’s death or permanent Disability; or
        (c)    The date of the Participant’s termination without Cause or termination for Good Reason, in each case, within 24 months following a Change of Control.
1



        (d)    Definitions. As used herein, the following terms shall have the meanings set forth below:
(1)    “Cause” shall have the meaning set forth in the Participant’s employment agreement with the Company, if any, or in the absence of an employment agreement definition shall mean (A) any act or omission which constitutes a material breach by the Participant of the terms of his or her employment, (B) the Participant’s conviction of a felony or commission of any act which would rise to the level of a felony, (C) the Participant’s conviction or commission of a lesser crime or offense that adversely impacts or potentially could impact upon the business or reputation of the Company and/or affiliates and subsidiaries in a material way, (D) the Participant’s willful violation of specific lawful directives of the Company, (E) the Participant’s commission of a dishonest or wrongful act involving fraud, misrepresentation, or moral turpitude causing damage or potential damage to the Company and/or its affiliates and subsidiaries, (F) the Participant’s willful failure to perform a substantial part of the Participant’s duties or (G) the Participant’s breach of fiduciary duty.
(2)    “Change of Control” shall have the meaning set forth in the Plan, provided however, that only an event that constitutes a change in control or ownership within the meaning of Treasury Regulation 1.409A-3(i)(5) shall be a Change of Control for purposes of this Agreement.
(3)    “Disability” shall mean the Participant’s permanent disability which constitutes a disability within the meaning of Section 409A(a)(2)(C) of the Code.
(4)    “Good Reason” shall have the meaning set forth in the Participant’s employment agreement with the Company, if any, or in the absence of an employment agreement definition shall mean (A) the scope of the Participant’s position, authority or duties with the Company is materially adversely changed, (B) the Participant’s compensation is not paid or is materially reduced or there is a material adverse change in the Participant’s employee benefits or (C) the Participant is required by the Company to relocate to a place more than 50 miles from the Participant’s current place of employment; provided that, in each case, “Good Reason” shall not exist unless the Participant provides the Company with written notice of the Participant’s intent to terminate employment as a result of such event, providing the specific reasons therefore, and the Company does not make the necessary corrections within 30 days of receipt of the Participant’s written notice, following which the Participant may terminate his or her employment for “Good Reason” within the ten days following expiration of such thirty day notice period.
(5)    “RSU Retirement Plan” shall mean the AXIS Specialty U.S. Services, Inc. Executive RSU Retirement Plan, as in effect as of the date of this Agreement.
(ii)    Absent subsequent Committee action, and except as otherwise provided under the RSU Retirement Plan (to the extent such plan is applicable to the Participant), the Award Units will not automatically vest upon or following the Participant’s retirement.
(iii)    Notwithstanding the foregoing, to the extent that the Participant is party to an employment agreement with the Company that provides for vesting of the Participant’s restricted stock units on an accelerated or otherwise more favorable basis as compared to the terms set forth in this Section 2, then the Award Units shall vest pursuant to the terms set forth in such employment agreement.
2



3.    ISSUANCE OF AWARD UNITS.
Subject to the Participant’s continued employment with the Company during the Period of Restriction through the applicable vesting dates, the Company shall deliver to the Participant within 30 days following the Anniversary Date (or within 30 days following any vesting event described under Section 2(i)(b) or 2(i)(c) hereof, if applicable) with respect to the number of Award Units earned as determined in accordance with Exhibit A hereto, 100% of the Shares underlying such earned Award Units as of the Anniversary Date with such Share delivery fully satisfying the Company’s obligations to the Participant with respect to such corresponding Award Units. In the event that the Participant’s employment terminates for any reason prior to the expiration of the Period of Restriction (except as described in Section 2(i)(b), 2(i)(c) or the RSU Retirement Plan, to the extent such plan is applicable to the Participant), the Award will immediately terminate and the Company will have no further obligation or liability to the Participant. Subject to Section 4, the Participant will have no rights as a shareholder of the Company with respect to the Shares underlying the Award Units until such time as the Shares underlying the Award Units are actually delivered to the Participant. For purposes of this Agreement, references to the Participant’s continued “employment” shall be deemed to refer to the Participant’s continued active employment together with any permitted leaves of absence as described under Section 4(d), but shall not include any periods of inactive employment during which the Participant is on “garden leave” or otherwise receiving salary continuation payments in lieu of notice or as a form of severance pay, unless otherwise determined by the Company in connection with or prior to the Participant’s commencement of any such period of inactive employment.
4.    RESTRICTIONS, VOTING RIGHTS AND DIVIDEND EQUIVALENTS.
    (a)    Restrictions. The Award may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated at any time.
    (b)    Voting Rights. Prior to the delivery of Shares underlying the Award Units pursuant to this Agreement, the Participant shall not be entitled to exercise any voting rights with respect to the Award Units and, except as provided in Section 4(c), shall not be entitled to receive dividends or other distributions with respect to the Award Units.
    (c)    Dividend Equivalents. Dividend equivalents shall be paid to the Participant with respect to the Award Units during the Period of Restriction. Any dividend equivalents paid with respect to the Award Units during the Period of Restriction will be held by the Company, or a depository appointed by the Committee, for the Participant's account. All cash or share dividend equivalents so held shall be payable at the same time as the delivery of Shares are made with respect to the Award Units as set forth in Section 3 and shall be forfeited and shall not be paid in the event the Award is terminated as set forth in Section 3.
    (d)    Leaves of Absence.     For any purpose under this Agreement, employment shall be deemed to continue while the Participant is on a bona fide leave of absence, if such leave was approved by the Company in writing and if continued crediting of employment for such purpose is expressly required by the terms of such leave or by applicable law (as determined by the Company).
5.    RESTRICTIONS ON TRANSFER.
    (a)    Transfer Restrictions. Regardless of whether the offering and sale of Units under the Plan have been registered under the U.S. Securities Act of 1933, as amended (the
3



“Securities Act”) or otherwise, the Company, in its sole discretion, may impose restrictions upon the sale, pledge or other transfer of the Shares deliverable in respect of the Award Units (including the placement of appropriate legends on stock certificates or the imposition of stop-transfer instructions) if, in the judgment of the Company, such restrictions are necessary or desirable in order to achieve compliance with the Company's Bye-Laws, the Securities Act, the U.S. Securities Exchange Act of 1934, as amended, the securities laws of any country or state or any other applicable law, rule or regulation.
    (b)    Legends. All certificates evidencing Shares issued in respect of Award Units under this Agreement shall bear such restrictive legends as are required or deemed advisable by the Company under the provisions of any applicable law, rule or regulation (including to reflect any restrictions to which you may be subject under any applicable securities laws). If, in the opinion of the Company and its counsel, any legend placed on a stock certificate representing Shares issued under this Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but without such legend.
6.    MISCELLANEOUS PROVISIONS.
    (a)    Bye-Laws. All Shares acquired pursuant to this Agreement shall be subject to any applicable restrictions contained in the Company's Bye-Laws.
    (b)    No Retention Rights. Nothing in this Agreement or in the Plan shall confer upon the Participant any right to continue employment for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company or any Affiliate employing or retaining the Participant or of the Participant, which rights are hereby expressly reserved by each, to terminate his or her employment at any time and for any reason, with or without Cause.
    (c)    Notice. Any notice required by the terms of this Agreement shall be given in writing and shall be deemed effective upon delivery by hand, upon delivery by reputable express courier or, if the recipient is located in the United States, upon deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid. Notice shall be addressed to the Company at its principal executive office and to the Participant at the address that he or she most recently provided in writing to the Company.
    (d)    Choice of Law. This Agreement shall be governed by, and construed in accordance with, the laws of Bermuda.
    (e)    Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
    (f)    Modification or Amendment. This Agreement may be amended or modified by the Committee; provided that any amendment or modification that would adversely affect the Participant’s rights with respect to the Award must be made by written agreement executed by the parties hereto; and provided, that the adjustments permitted pursuant to Sections 4(b) and 7(b) of the Plan may be made without such written agreement.
    (g)    Severability. In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining
4



provisions of this Agreement, and this Agreement shall be construed and enforced as if such illegal or invalid provision had not been included.
(h)    Recoupment Policy. The Award is subject in all respects to the Company’s Executive Compensation Recoupment Policy, as the same may be amended from time to time, or any successor policy thereto (to the extent such plan is applicable to the Participant).



5



Exhibit A
Performance Metrics for Determining the Number of Earned Award Units

Each of the TSR Performance Metric and the DVPBS Performance Metric shall be determined by linear interpolation for achievement falling between the above percentages; provided, that there shall be no interpolation for achievement that is below threshold level performance or above maximum level performance. The Relative TSR Performance Metric and the DVPBS Performance Metric are measured independently of each other.

Relative TSR Performance Metric

Performance LevelRelative TSR PercentileRelative TSR Performance Multiplier
Maximum
85th or above
200%
Target
55th
100%
Threshold
25th
25%
Minimum
below 25th
0%

Diluted Book Value Per Share (DBVPS) Growth Performance Metric

Performance LevelDBVPS Growth RateDBVPS Performance Multiplier
Maximum
22.5%
200%
Target
15%
100%
Threshold
5%
50%
Minimum
Below 5%
0%


For purposes of this Exhibit A, the following terms shall have the following meanings:

Aggregate Dividend” means the aggregate per share dividends that have an ex-dividend date during the Performance Period.
6



Beginning Price” means the Share Value as of December 31 of the calendar year preceding the year in which the Award Date occurs (using the average of the closing trading price of the shares during the preceding 30 consecutive trading days (as determined by the New York Stock Exchange) ending on and including such date).
“Cumulative Performance Multiplier” shall mean the sum of (i) the product of the Relative TSR Performance Multiplier multiplied by a 50% weighting multiplier, plus (ii) the product of the DVBPS Performance Multiplier multiplied by a 50% weighting multiplier.
DBVPS” shall mean diluted book value per share and shall be calculated as follows: (i) common shareholders’ equity, excluding Performance Period movement in accumulated other comprehensive income (AOCI) and share buybacks by the Company and adjusted for dividends and any material accounting or tax changes, divided by (ii) diluted common shares outstanding as determined by the treasury stock method.
DBVPS Growth Rate” shall mean the average growth rate of the Company’s DBVPS over the Performance Period, as determined by the Committee in good faith.
DBVPS Performance Multiplier” shall mean the applicable multiplier as determined in accordance with the table above based on the achieved DBVPS; provided, however, that in the event that the Period of Restriction terminates prior to the end of the Performance Period due to an event described in Sections 2(i)(b) of the Agreement, then the DBVPS Performance Multiplier shall automatically be deemed to equal 100%.
Ending Price” means the Share Value as of the last day of the Performance Period.
Peer Group” shall mean the performance peer companies identified by the Committee in the Company’s annual proxy statement filed with the U.S. Securities and Exchange Commission during the same calendar year in which the Award Date occurs; provided, however, that the Committee may equitably adjust the members of the Peer Group to account for any member company which ceases to be a publicly traded company (due to merger, corporate reorganization, bankruptcy or otherwise) or engages in a spin-off or similar transaction prior to the end of the Performance Period.
Performance Period” shall mean the period commencing on December 31 of the calendar year preceding the year in which the Award Date occurs and ending on the earlier to occur of (i) the third anniversary of such date or (ii) the date of a Change of Control.
Relative TSR Performance Multiplier” shall mean the applicable performance multiplier as determined in accordance with the performance metric table above based on the achieved TSR Percentile; provided, however, that in the event that the Period of Restriction terminates prior to the end of the Performance Period due to an event described in Sections 2(i)(b) of the Agreement, then the Relative TSR Performance Multiplier shall automatically be deemed to equal 100%.
Share Value” as of any given date, means the average of the closing trading price of the Shares during the preceding 30 consecutive trading days ending on and including such date; provided, however, that if the Performance Period ends upon the consummation of a Change of Control, Share Value shall mean the price per Share paid by the acquiror in the Change of Control transaction or, to the extent that the consideration in the Change of Control transaction is paid in stock of the acquiror or its affiliate, then, unless otherwise determined by the Committee (in connection with valuing any shares that are not publicly traded), Share Value shall mean the value of the consideration paid per Share based on the average of the closing trading prices of a share of such acquiror stock on the principal exchange on which such shares are then traded for
7



each trading day during the preceding five consecutive trading days ending on and including the date on which a Change of Control occurs.
TSR” shall be calculated as follows (expressed as a percentage): (i) the sum of (A) the Ending Price minus (B) the Beginning Stock Price, plus (C) the Aggregate Dividend (assuming reinvestment in the Shares of all dividends comprising the Aggregate Dividend as of the ex-dividend date), divided by (ii) the Beginning Price.

TSR Percentile” shall mean the Company’s percentile rank among its Peer Group in terms of TSR during the Performance Period (rounded to the nearest hundredth of a percent), as determined by the Committee in good faith.
Notwithstanding the forgoing, in the event that the Company’s TSR is negative (i.e., less than zero), the Relative TSR Performance Multiplier shall be deemed to equal the lesser of (i) the applicable multiplier determined in accordance with the methodologies stated above or (ii) 100% (i.e., the “target” level multiplier.

PAC ID 1717 (01 24)


8

EX-10.42 15 axs-20231231xexx1042.htm EX-10.42 Document


DIRECTORS ANNUAL COMPENSATION PROGRAM
AXIS Capital Holdings Limited (the “Company”) has established the Directors Annual Compensation Program (the “Program”) to compensate the directors of the Company for their service to the Board of Directors (the “Board”) and its committees. The Board, in consultation with the Compensation Committee of the Board (the “Committee”) have determined the terms of the Program as set forth herein.
1.Eligibility. Any member of the Board who is not an employee of the Company or any of its subsidiaries shall be entitled to the compensation specified herein and shall be a “Participant” in the Program from and after January 1 of each year or, if later than January 1, the date on which such person becomes a member of the Board or is otherwise eligible to participate in the Program.
2.Compensation. Participants shall be entitled to the annual retainer amounts, as set forth on Attachment A, for: (i) board service plus, as applicable, service as Lead Independent Director and non-employee Chair of the Board (“Board Retainers”); and (ii) committee service plus additional service as committee chair, if applicable (“Committee Retainers”). The Board and Committee Retainers shall be paid in the manner as set forth in Attachment B.
3.Election of Common Shares in Lieu of Cash. Participants may elect to receive (i) 100% of their Board Retainers in AXIS common shares; and (ii) 100% of their Committee Retainers in AXIS common shares by notifying the Company of such election prior to January 1 of each year with such elections to apply to compensation earned through January of the following year.
4.Pro-Rated Payments. Members of the Board who become Participants after January 1 of any year shall receive pro-rated amount(s) based upon days of service during the calendar year. Payment of the Board and Committee Retainers will be pro-rated based on days of service during the calendar year using a 365 day daily rate.
5.Interpretation of Program. The Committee shall have the authority to administer and to interpret the Program. Any such determinations or interpretations made by the Committee shall be binding on all Participants.
6.Governing Law. The Program shall be governed by the laws of Bermuda.
7.Successors. All obligations of the Company under the Program shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect merger, consolidation, purchase of all or substantially all of the business and/or assets of the Company or otherwise.
8.Amendment and Termination. This Program may be amended or terminated at any time by the Board; provided, that no amendment shall be given effect to the extent that it would have the effect of reducing a Participant’s existing awards under the Program.



ATTACHMENT A
NON-EMPLOYEE DIRECTOR COMPENSATION
(Effective as of January 1, 2024)

     

Board Retainers $Annual Retainer
Director
 250,000
Lead Independent Director
15,000
Non-Employee (Non-Executive) Chair
150,000

        
Committee Retainers $Annual Retainer
Corporate Governance and Nominating Committee
 10,000
Finance Committee
 10,000
Compensation Committee
 10,000
Risk Committee
 10,000
Audit Committee
 15,000
 
Committee Chair Retainers $Annual Retainer
Corporate Governance and Nominating Committee
 15,000
Finance Committee
 15,000
Compensation Committee
 15,000
Risk Committee
 20,000
Audit Committee
 35,000
 

    


ATTACHMENT B
NON-EMPLOYEE DIRECTOR COMPENSATION
(Effective as of January 1, 2024)


Board Retainers(s)
Form of PaymentDate of Payment
Equity
(AXS Common Shares)
Cash
$150k to be paid in AXIS common shares
AXIS common shares to be issued annually on the tenth trading day of January1
N/A
$100k to be paid in accordance with director’s election to receive cash/equity
AXIS common shares to be issued annually on the tenth trading day of January1
Cash to be paid semi-annually in arrears in two payments no later than the tenth business day of July and the following January
Additional retainers for Lead Independent Chair and Non-Employee Chair, as applicable, to be paid in accordance with director’s election to receive cash/equity
AXIS common shares to be issued annually on the tenth trading day of January1
Cash to be paid semi-annually in arrears in two payments no later than the tenth business day of July and the following January
Committee Retainer(s)
Form of PaymentDate of Payment
Equity
(AXS Common Shares)
Cash
Committee Retainer(s) to be paid in accordance with director’s election to receive cash/equity
AXIS common shares to be issued annually on the tenth trading day of January1
Cash to be paid semi-annually in arrears in two payments no later than the tenth business day of July and the following January

1 Partial shares excluded.

EX-21.1 16 axs-20231231xexx211.htm EX-21.1 Document

Exhibit 21.1
AXIS CAPITAL HOLDINGS LIMITED
SUBSIDIARIES OF THE REGISTRANT
 
Subsidiaries
Jurisdiction of Incorporation
AXIS Specialty Holdings Bermuda Limited
Bermuda
AXIS Specialty Limited
Bermuda
AXIS Specialty Investments Limited
Bermuda
AXIS Specialty Investments II LimitedBermuda
AXIS ILS Ltd. (formerly AXIS Ventures Limited)Bermuda
AXIS Reinsurance Managers Limited
Bermuda
AXIS Re SE
Ireland
AXIS Specialty Europe SE
Ireland
AXIS Specialty Global Holdings Limited
Ireland
AXIS Specialty Holdings Ireland Limited
Ireland
AXIS Group Benefits LLC (formerly Ternian Insurance Group LLC)Arizona
AXIS Specialty Insurance Company
Connecticut
AXIS Group Services, Inc.
Delaware
AXIS Specialty Finance LLC
Delaware
AXIS Specialty U.S. Holdings, Inc.
Delaware
AXIS Specialty U.S. Services, Inc.
Delaware
AXIS ILS, Inc. (formerly AXIS Specialty Underwriters, Inc.)
Delaware
AXIS Insurance Company
Illinois
AXIS Surplus Insurance Company
Illinois
AXIS Reinsurance Company
New York
AXIS Managing Agency Ltd.United Kingdom
AXIS Specialty Finance PLCUnited Kingdom
AXIS Specialty UK Holdings Limited
United Kingdom
AXIS Corporate Capital UK Limited
United Kingdom
AXIS Corporate Capital UK II Limited
United Kingdom



Novae Group Limited
United Kingdom
AXIS UK Services Limited
United Kingdom
AXIS Underwriting Limited
United Kingdom
Contessa Limited
United Kingdom
AXIS Re SE Escritório de Representação No Brasil Ltda.
Brazil
AXIS Specialty Canada Services, ULC
British Columbia


EX-22.1 17 axs-20231231xexx221.htm EX-22.1 Document

Exhibit 22.1
Subsidiary Guarantors and Issuers of Guaranteed Securities
The table below sets forth the respective issuers and guarantors of the notes issued by AXIS Capital Holdings Limited’s financing subsidiaries and the jurisdiction of incorporation of each such entity.
Guaranteed SecuritiesIssuer (Jurisdiction)Guarantor (Jurisdiction)
5.150% Senior Notes due 2045
AXIS Specialty Finance PLC (United Kingdom)
AXIS Capital Holdings Limited (Bermuda)
4.000% Senior Notes due 2027
AXIS Specialty Finance PLC (United Kingdom)AXIS Capital Holdings Limited (Bermuda)
3.900% Senior Notes due 2029
AXIS Specialty Finance LLC (Delaware)AXIS Capital Holdings Limited (Bermuda)
4.900% Junior Subordinated Notes due 2040
AXIS Specialty Finance LLC (Delaware)
AXIS Capital Holdings Limited (Bermuda)


EX-23.1 18 axs-20231231xexx231.htm EX-23.1 Document

Exhibit 23.1

AXIS CAPITAL HOLDINGS LIMITED
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-268268 on Form S-3 and Registration Statement Nos. 333-181433, 333-159275, 333-217786, 333-256010 and 333-271790 on Form S-8 of our reports dated February 27, 2024, relating to the financial statements of AXIS Capital Holdings Limited and the effectiveness of the AXIS Capital Holdings Limited’s internal control over financial reporting appearing in this Annual Report on Form 10-K of AXIS Capital Holdings Limited for the year ended December 31, 2023.
/s/ Deloitte Ltd.
Hamilton, Bermuda
February 27, 2024


EX-31.1 19 axs-20231231xexx311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION
AXIS Capital Holdings Limited
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Vincent Tizzio, certify that:
 

1.I have reviewed this Annual Report on Form 10-K of AXIS Capital Holdings Limited for the year ended December 31, 2023;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
/s/ Vincent Tizzio
Date:February 27, 2024Vincent Tizzio
President and Chief Executive Officer


EX-31.2 20 axs-20231231xexx312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION
AXIS Capital Holdings Limited
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Peter Vogt, certify that:
 

1.I have reviewed this Annual Report on Form 10-K of AXIS Capital Holdings Limited for the year ended December 31, 2023;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
/s/ PETER VOGT
Date:February 27, 2024Peter Vogt
Chief Financial Officer


EX-32.1 21 axs-20231231xexx321.htm EX-32.1 Document

Exhibit 32.1
AXIS CAPITAL HOLDINGS LIMITED
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of AXIS Capital Holdings Limited (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Vincent Tizzio, Chief Executive Officer of the Company, hereby certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  
Date:February 27, 2024/s/ Vincent Tizzio
 
Vincent Tizzio
 President and Chief Executive Officer

This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.


EX-32.2 22 axs-20231231xexx322.htm EX-32.2 Document

Exhibit 32.2
AXIS CAPITAL HOLDINGS LIMITED
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of AXIS Capital Holdings Limited (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter Vogt, Chief Financial Officer of the Company, hereby certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  
Date:February 27, 2024/s/ PETER VOGT
 Peter Vogt
 Chief Financial Officer

This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.


EX-97.1 23 axs-20231231xexx971.htm EX-97.1 Document

AXIS CAPITAL HOLDINGS LIMITED
AMENDED AND RESTATED EXECUTIVE COMPENSATION RECOUPMENT POLICY
 
AXIS Capital Holdings Limited (the “Company”) has established the AXIS Capital Holdings Limited Amended and Restated Executive Compensation Recoupment, or “Clawback”, Policy (the “Policy”) to provide for the recovery of certain incentive compensation in the event of an Accounting Restatement (as defined below). This Policy is intended to comply with, and shall be interpreted to be consistent with, Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 promulgated under the Exchange Act and Section 303A.14 of the New York Stock Exchange (“NYSE”) Listed Company Manual (the “Listing Rules”). All capitalized terms used and not otherwise defined herein shall have the meanings set forth in Section 11 below.
1.Administration and Interpretation.  The Human Capital and Compensation Committee of the Board of Directors of the Company (the “Committee”) shall have full authority to interpret and enforce the Policy; provided, however, that the Policy shall be interpreted in a manner consistent with its intent to meet the requirements of the Listing Rules. As further set forth in Section 9 below, this Policy is intended to supplement any other clawback policies and procedures that the Company may have in place from time to time pursuant to other applicable law, plans, policies or agreements.
2.Covered Executives. The Policy applies to each current and former Executive Officer of the Company who serves or served as an Executive Officer at any time during a performance period in respect of which Incentive Compensation is Received, to the extent that any portion of such Incentive Compensation is (a) Received by the Executive Officer during the last three completed Fiscal Years or any applicable Transition Period preceding the Restatement Date and (b) determined to have included Erroneously Awarded Compensation. Executive Officers subject to this Policy pursuant to this Section 3 are referred to herein as “Covered Executives.”
3.Recovery of Erroneously Awarded Compensation. If any Erroneously Awarded Compensation is Received by a Covered Executive, the Company shall reasonably promptly take steps to recover such Erroneously Awarded Compensation in a manner described under Section 4 of this Policy.

4.Forms of Recovery. The Committee shall determine, in its sole discretion and in a manner that effectuates the purpose of the Listing Rules, one or more methods for recovering any Erroneously Awarded Compensation hereunder in accordance with Section 3 above, which may include, without limitation: (a) requiring cash reimbursement; (b) seeking recovery or forfeiture of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity-based awards; (c) offsetting the amount to be recouped from any compensation otherwise owed by the Company to the Covered Executive; (d) cancelling outstanding vested or unvested equity awards; or (e) taking any other remedial and recovery action permitted by law, as determined by the Committee. To the extent the Covered Executive refuses to pay to the Company an amount equal to the Erroneously Awarded Compensation, the Company shall have the right to sue for repayment and/or enforce the Covered Executive’s obligation to make payment through the reduction or cancellation of outstanding and future compensation. Any reduction, cancellation or forfeiture of compensation shall be done in compliance with Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

5.No Indemnification. The Company shall not indemnify any Covered Executive against the loss of Erroneously Awarded Compensation for which the Committee has determined to seek recoupment pursuant to this Policy.

6.Exceptions to the Recovery Requirement. Notwithstanding anything herein to the contrary, Erroneously Awarded Compensation need not be recovered pursuant to this Policy if the
1



Committee determines that recovery would be impracticable as a result of any of the following:

(i)the direct expenses paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered, provided that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on expense of enforcement, the Company has made a reasonable attempt to recover such Erroneously Awarded Compensation, documented such reasonable attempts to recover, and provided relevant documentation as required to the NYSE, or
(ii)recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company’s affiliates, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended, and regulations thereunder.

1.Committee Determinations Final. Any determination by the Committee with respect to the Policy shall be final, conclusive and binding on all interested parties.

2.Amendment.  The Policy may be amended by the Committee from time to time, to the extent permitted under Listing Rules.

3.Non-Exclusivity. Nothing in the Policy shall be viewed as limiting the right of the Company or the Committee to pursue additional remedies or recoupment under or as required by any similar policy adopted by the Company or under the Company’s compensation plans, award agreements, policies, employment agreements, or similar agreements or the applicable provisions of any law, rule or regulation which may require or permit recoupment to a greater degree or with respect to additional compensation as compared to this Policy (but without duplication as to any recoupment already made with respect to Erroneously Awarded Compensation pursuant to this Policy). This Policy shall be interpreted in all respects to comply with the Listing Rules.

4.Successors.  This Policy shall be binding and enforceable against all Covered Officers and their beneficiaries, heirs, executors, administrators or other legal representatives.
5.Defined Terms. For purposes of this Policy, the following capitalized terms shall have the meaning set forth below.

a.Accounting Restatement” means an accounting restatement (i) due to the material noncompliance of the Company with any financial reporting under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements (a “Big R” restatement), or (ii) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (a “little r” restatement).

b.Covered Executives” shall have the meaning set forth in Section 2 of this Policy.

c.Erroneously Awarded Compensation” means the amount of Incentive Compensation actually Received that exceeds the amount of Incentive Compensation that otherwise would have been Received had it been determined based on the restated amounts, and computed without regard to any taxes paid. For Incentive Compensation based on stock price or total shareholder return, where the amount of erroneously awarded Incentive Compensation is not subject to mathematical recalculation directly from the information in the Accounting Restatement:
2



(i)The calculation of Erroneously Awarded Compensation shall be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total shareholder return upon which the Incentive Compensation was Received; and
(ii)The Company shall maintain documentation of the determination of that reasonable estimate and provide such documentation as required to the NYSE.
a.Executive Officer” means each individual who is currently or was previously designated as an “officer” of the Company as defined in Rule 16a-1(f) under the Exchange Act. Identification of an executive officer for purposes of this Policy would include (at a minimum) executive officers identified pursuant to Item 401(b) of Regulation S-K.

b.Financial Reporting Measures” means the measures that are determined and presented in accordance with accounting principles used in preparing the Company’s financial statements, and all other measures that are derived wholly or in part from such measures. Financial Reporting Measures include but are not limited to the following (and any measures derived from the following): Company stock price and total shareholder return (and any measures that are derived wholly or in part from stock price or total shareholder return) shall for purposes of this Policy, be considered Financial Reporting Measures. For the avoidance of doubt, a Financial Reporting Measure need not be presented in the Company’s financial statements or included in a filing with the U.S. Securities and Exchange Commission.

c.Fiscal Year” means the Company’s fiscal year; provided that a Transition Period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months will be deemed a completed fiscal year.

d.Incentive Compensation” shall mean any compensation (whether cash or equity-based) that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure, and may include, but shall not be limited to, performance bonuses and long-term incentive awards such as stock options, stock appreciation rights, restricted stock, restricted stock units, performance share units or other equity-based awards. For the avoidance of doubt, Incentive Compensation does not include (i) awards that are granted, earned and vested exclusively upon completion of a specified employment period, without any performance condition, and (ii) bonus awards that are discretionary or based on subjective goals or goals unrelated to Financial Reporting Measures. Notwithstanding the foregoing, compensation amounts shall not be considered “Incentive Compensation” for purposes of the Policy unless such compensation is Received (1) while the Company has a class of securities listed on a national securities exchange or a national securities association and (2) on or after October 2, 2023, the effective date of the Listing Rules.

e.Listing Rules” shall have the mean set forth in the first paragraph of this Policy.

f.Incentive Compensation shall be deemed “Received” in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive Compensation award is attained, even if the payment or grant of the Incentive Compensation occurs after the end of that period.
g.Restatement Date” means the earlier to occur of (i) the date the Board, a committee of the Board or the officers of the Company authorized to take such action if Board action is not required, concludes or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (ii) the date a court, regulator or other legally authorized body directs the Company to prepare an Accounting Restatement.

3



h.Transition Period” shall mean any transition period that results from a change in the Company’s Fiscal Year within or immediately following the three completed Fiscal Years immediately preceding the Company’s requirement to prepare an Accounting Restatement.




Adopted on: September 20, 2023
4

GRAPHIC 24 axs-20231231_g1.jpg GRAPHIC begin 644 axs-20231231_g1.jpg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htm IDEA: XBRL DOCUMENT v3.24.0.1
COVER - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2023
Feb. 23, 2024
Jun. 30, 2023
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-31721    
Entity Registrant Name AXIS CAPITAL HOLDINGS LIMITED    
Entity Incorporation, State or Country Code D0    
Entity Tax Identification Number 98-0395986    
Entity Address, Address Line One 92 Pitts Bay Road    
Entity Address, City or Town Pembroke    
Entity Address, Country BM    
Entity Address, Postal Zip Code HM 08    
City Area Code 441    
Local Phone Number 496-2600    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filer No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 4.6
Entity Common Stock, Shares Outstanding   84,447,014  
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive proxy statement to be filed with the Securities and Exchange Commission pursuant to Regulation 14A relating to the annual meeting of shareholders to be held on May 16, 2024 are incorporated by reference in response to items 10, 11, 12, 13 and 14 in Part III of this Form 10-K. The definitive proxy statement will be filed with the Securities and Exchange Commission not later than 120 days after the registrant's fiscal year ended December 31, 2023.
   
Amendment flag false    
Document fiscal year focus 2023    
Document fiscal period focus FY    
Entity central index key 0001214816    
Common shares      
Document Information [Line Items]      
Title of 12(b) Security Common shares, par value $0.0125 per share    
Trading Symbol AXS    
Security Exchange Name NYSE    
Depositary shares, each representing a 1/100th interest in a 5.50% Series E preferred share      
Document Information [Line Items]      
Title of 12(b) Security Depositary shares, each representing a 1/100th interest in a 5.50% Series E preferred share    
Trading Symbol AXS PRE    
Security Exchange Name NYSE    
XML 26 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
AUDIT INFORMATION
12 Months Ended
Dec. 31, 2023
Audit Information [Abstract]  
Auditor Firm ID 5230
Auditor Name Deloitte Ltd.
Auditor Location Hamilton, Bermuda
XML 27 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Investments:    
Fixed maturities, available for sale, at fair value (Amortized cost 2023: $12,634,254; 2022: $12,176,473 Allowance for expected credit losses 2023: $10,759; 2022: $11,733) $ 12,234,742 $ 11,326,894
Fixed maturities, held to maturity, at amortized cost (Fair value 2023: $675,851; 2022: $674,743 Allowance for expected credit losses 2023: $nil; 2022: $nil) 686,296 698,351
Equity securities, at fair value (Cost 2023: $543,833; 2022: $494,356) 588,511 485,253
Mortgage loans, held for investment, at fair value (Allowance for expected credit losses 2023: $6,220; 2022: $nil) 610,148 627,437
Other investments, at fair value 949,413 996,751
Equity method investments 174,634 148,288
Short-term investments, at fair value 17,216 70,310
Total investments 15,260,960 14,353,284
Cash and cash equivalents 953,476 751,415
Restricted cash and cash equivalents 430,509 423,238
Accrued interest receivable 106,055 94,418
Insurance and reinsurance premium balances receivable (Allowance for expected credit losses 2023: $11,997; 2022: $9,521) 3,067,554 2,733,464
Reinsurance recoverable on unpaid losses and loss expenses (Allowance for expected credit losses 2023: $36,611; 2022: $30,715) 6,323,083 5,831,172
Reinsurance recoverable on paid losses and loss expenses 575,847 539,676
Deferred acquisition costs 450,950 473,569
Prepaid reinsurance premiums 1,916,087 1,550,370
Receivable for investments sold 8,767 16,052
Goodwill 100,801 100,801
Intangible assets 186,883 197,800
Operating lease right-of-use assets 108,093 92,214
Loan advances made 305,222 87,160
Other assets 456,385 438,338
Total assets 30,250,672 27,682,971
Liabilities    
Reserve for losses and loss expenses 16,434,018 15,168,863
Unearned premiums 4,747,602 4,361,447
Insurance and reinsurance balances payable 1,792,719 1,609,924
Debt 1,313,714 1,312,314
Federal Home Loan Bank advances 85,790 81,388
Payable for investments purchased 26,093 19,693
Operating lease liabilities 123,101 102,577
Other liabilities 464,439 386,855
Total liabilities 24,987,476 23,043,061
Commitments and Contingencies
Shareholders' equity    
Preferred shares 550,000 550,000
Common shares (shares issued 2023: 176,580; 2022: 176,580 shares outstanding 2023: 85,286; 2022: 84,668) 2,206 2,206
Additional paid-in capital 2,383,030 2,366,253
Accumulated other comprehensive income (loss) (365,836) (760,300)
Retained earnings 6,440,528 6,247,022
Treasury shares, at cost (2023: 91,294; 2022: 91,912) (3,746,732) (3,765,271)
Total shareholders’ equity 5,263,196 4,639,910
Total liabilities and shareholders’ equity $ 30,250,672 $ 27,682,971
XML 28 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]        
Fixed maturities, available for sale, amortized cost $ 12,634,254 $ 12,176,473    
Fixed maturities, available for sale, allowance for credit loss 10,759 11,733 $ 313 $ 323
Fixed maturities, held to maturity, fair value 675,851 674,743    
Fixed maturities, held to maturity, allowance for credit loss 0 0    
Equity securities, cost 543,833 494,356    
Allowance for expected credit losses 6,220 0    
Allowance for credit losses on premium balances receivable 11,997 9,521    
Allowance for credit losses on reinsurance recoverable for unpaid losses and loss expenses $ 36,611 $ 30,715 $ 30,000  
Common shares, shares issued (in shares) 176,580 176,580    
Common shares, shares outstanding (in shares) 85,286 84,668    
Treasury shares (in shares) 91,294 91,912    
XML 29 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues      
Net premiums earned $ 5,083,781 $ 5,160,326 $ 4,709,850
Net investment income 611,742 418,829 454,301
Other insurance related income 22,495 13,073 23,295
Net investment gains (losses):      
(Increase) decrease in allowance for expected credit losses (5,246) (11,421) 11
Impairment losses (12,757) (12,568) (22)
Other realized and unrealized investment gains (losses) (56,627) (432,800) 134,290
Total net investment gains (losses) (74,630) (456,789) 134,279
Total revenues 5,643,388 5,135,439 5,321,725
Expenses      
Net losses and loss expenses 3,393,102 3,242,410 3,008,783
Acquisition costs 1,000,945 1,022,017 921,834
General and administrative expenses 684,446 680,343 663,304
Foreign exchange losses (gains) 58,115 (157,945) 315
Interest expense and financing costs 68,421 63,146 62,302
Reorganization expenses 28,997 31,426 0
Amortization of value of business acquired 0 0 3,854
Amortization of intangible assets 10,917 10,917 12,424
Total expenses 5,244,943 4,892,314 4,672,816
Income before income taxes and interest in income of equity method investments 398,445 243,125 648,909
Income tax expense (26,316) (22,037) (62,384)
Interest in income of equity method investments 4,163 1,995 32,084
Net income 376,292 223,083 618,609
Preferred share dividends 30,250 30,250 30,250
Net income available to common shareholders $ 346,042 $ 192,833 $ 588,359
Earnings per common share:      
Earnings per common share (in dollars per share) $ 4.06 $ 2.27 $ 6.95
Earnings per diluted common share (in dollars per share) $ 4.02 $ 2.25 $ 6.90
Weighted average common shares outstanding (in shares) 85,142 84,864 84,707
Weighted average diluted common shares outstanding (in shares) 86,012 85,669 85,291
XML 30 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net income $ 376,292 $ 223,083 $ 618,609
Other comprehensive income (loss), net of tax:      
Unrealized gains (losses) arising during the year, net of reclassification adjustment 396,036 (805,850) (358,480)
Foreign currency translation adjustment (1,572) (10,986) 621
Total other comprehensive income (loss), net of tax 394,464 (816,836) (357,859)
Comprehensive income (loss) 770,756 (593,753) 260,750
Unrealized gains (losses) on available for sale investments      
Other comprehensive income (loss), net of tax:      
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss) 128,513 304,925 (87,114)
Unrealized gains (losses) arising during the year, net of reclassification adjustment 396,036 (805,850) (358,480)
Unrealized gains (losses) on available for sale investments | Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized      
Other comprehensive income (loss), net of tax:      
Unrealized gains (losses) arising during the year 257,940 (1,043,625) (271,447)
Unrealized gains (losses) on available for sale investments | Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized      
Other comprehensive income (loss), net of tax:      
Unrealized gains (losses) arising during the year $ 9,583 $ (67,150) $ 81
XML 31 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Preferred stocks
Common shares (par value)
Additional paid-in capital
Accumulated other comprehensive income (loss)
Unrealized gains (losses) on available-for-sale investments, net of tax
Cumulative foreign currency translation adjustments, net of tax
Retained earnings
Treasury shares, at cost
Balance at beginning of year at Dec. 31, 2020   $ 550,000 $ 2,206 $ 2,330,054 $ 414,395 $ 420,635 $ (6,240) $ 5,763,607 $ (3,764,568)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased                 (10,242)
Treasury shares reissued       (24,655)         25,800
Share-based compensation expense       40,780          
Unrealized gains (losses) arising during the year, net of reclassification adjustment $ (358,480)         (358,480)      
Foreign currency translation adjustment 621           621    
Net income 618,609             618,609  
Preferred share dividends [1]               (30,250)  
Common share dividends [1]               (147,221)  
Balance at end of the year at Dec. 31, 2021 5,410,656 550,000 2,206 2,346,179 56,536 62,155 (5,619) 6,204,745 (3,749,010)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased                 (48,981)
Treasury shares reissued       (31,175)         32,720
Share-based compensation expense       51,249          
Unrealized gains (losses) arising during the year, net of reclassification adjustment (805,850)         (805,850)      
Foreign currency translation adjustment (10,986)           (10,986)    
Net income 223,083             223,083  
Preferred share dividends [1]               (30,250)  
Common share dividends [1]               (150,556)  
Balance at end of the year at Dec. 31, 2022 4,639,910 550,000 2,206 2,366,253 (760,300) (743,695) (16,605) 6,247,022 (3,765,271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased                 (23,596)
Treasury shares reissued       (40,430)         42,135
Share-based compensation expense       57,207          
Unrealized gains (losses) arising during the year, net of reclassification adjustment 396,036         396,036      
Foreign currency translation adjustment (1,572)           (1,572)    
Net income 376,292             376,292  
Preferred share dividends [1]               (30,250)  
Common share dividends [1]               (152,536)  
Balance at end of the year at Dec. 31, 2023 $ 5,263,196 $ 550,000 $ 2,206 $ 2,383,030 $ (365,836) $ (347,659) $ (18,177) $ 6,440,528 $ (3,746,732)
[1] Refer to Note 15 'Shareholders' Equity' for details on dividends declared and paid related to the Company's common and preferred shares.
XML 32 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 376,292 $ 223,083 $ 618,609
Adjustments to reconcile net income to net cash provided by operating activities:      
Net investment (gains) losses 74,630 456,789 (134,279)
Net realized and unrealized gains on other investments (19,682) (55,757) (180,329)
Amortization of fixed maturities (20,167) 26,138 35,839
Interest in income of equity method investments (4,163) (1,995) (32,084)
Amortization of value of business acquired 0 0 3,854
Other amortization and depreciation 75,552 68,288 66,977
Share-based compensation expense, net of cash payments 54,120 48,494 37,744
Changes in:      
Accrued interest receivable (11,777) (30,432) 633
Reinsurance recoverable on unpaid losses and loss expenses (493,831) (825,608) (527,362)
Reinsurance recoverable on paid losses and loss expenses (60,860) 92,781 (210,660)
Deferred acquisition costs 21,499 (10,548) (34,386)
Prepaid reinsurance premiums (365,732) (176,498) (185,646)
Reserve for losses and loss expenses 1,272,999 544,459 737,342
Unearned premiums 388,747 287,082 409,858
Insurance and reinsurance balances, net 13,813 197,610 435,603
Other items (45,881) (45,848) 155,979
Net cash provided by operating activities 1,255,559 798,038 1,197,692
Purchases of:      
Fixed maturities, available for sale (6,348,753) (7,476,440) (12,133,755)
Fixed maturities, held to maturity (37,499) (255,610) (196,775)
Equity securities (89,502) (94,324) (137,247)
Mortgage loans (24,867) (117,023) (145,832)
Other investments (91,010) (147,717) (263,712)
Equity method investments (22,183) 0 0
Short-term investments (247,499) (176,968) (159,056)
Proceeds from the sale of:      
Fixed maturities, available for sale 4,848,826 6,110,148 9,203,241
Equity securities 55,651 138,542 24,862
Other investments 158,348 156,719 324,810
Short-term investments 227,318 116,752 177,672
Proceeds from redemption of fixed maturities, available for sale 934,017 1,018,922 1,817,482
Proceeds from redemption of fixed maturities, held to maturity 49,609 3,541 155,809
Proceeds from redemption of short-term investments 76,545 20,124 111,417
Proceeds from the repayment of mortgage loans 36,375 84,365 145,621
Proceeds from the (purchase) sale of other assets, net (31,144) (36,829) (38,732)
Loan advances made (349,842) (105,822) (82,870)
Net cash used in investing activities (855,610) (761,620) (1,197,065)
Cash flows from financing activities:      
Repurchase of common shares - open market 0 (34,987) 0
Taxes paid on withholding shares (23,596) (13,994) (10,242)
Dividends paid - common shares (153,775) (149,341) (145,603)
Dividends paid - preferred shares (30,250) (30,250) (30,250)
Federal Home Loan Bank advances, net 5,250 78,950 0
Net cash used in financing activities (202,371) (149,622) (186,095)
Effect of exchange rate changes on foreign currency cash, cash equivalents and restricted cash 11,754 (29,833) (74)
Increase (decrease) in cash, cash equivalents and restricted cash 209,332 (143,037) (185,542)
Cash, cash equivalents and restricted cash - beginning of year 1,174,653 1,317,690 1,503,232
Cash, cash equivalents and restricted cash - end of year 1,383,985 1,174,653 1,317,690
Supplemental disclosures of cash flow information:      
Income taxes paid 77,479 33,418 45,083
Interest paid $ 63,596 $ 59,886 $ 59,400
XML 33 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Ceded premiums $ 3,254,200 $ 2,951,539 $ 2,759,360
Ceded losses and loss expenses 1,754,000 1,754,000 1,782,000
Federal Home Loan Bank advances 85,790 81,388  
Fair value of securities transferred from available for sale to fixed maturities, held to maturity     405,000
Related Party      
Ceded premiums 107,000 88,000 74,000
Monarch Point Re | Related Party      
Non-cash repayment of advance 72,000    
Ceded premiums 287,000    
Ceded losses and loss expenses 37,000    
Monarch Point Re | Retrocession Agreement With Monarch Point Re | Related Party      
Ceded premiums 66,000    
Ceded losses and loss expenses 4,000    
Monarch Point Re | Loan Agreement With Monarch Point Re | Related Party      
Non-cash repayment of advance 72,000    
Interest received 12,000    
Third Party Reinsurer | Related Party      
Non-cash repayment of advance 110,000 90,000 71,000
Ceded losses and loss expenses 21,000 9,000 $ 3,000
Interest received $ 4,000 1,000  
Federal Home Loan Bank of Chicago      
Federal Home Loan Bank advances   81,000  
Transfer of FHLB stock   $ 2,000  
XML 34 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
ORGANIZATION
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION ORGANIZATION
AXIS Capital Holdings Limited ("AXIS Capital" and together with its wholly-owned subsidiaries the "Company"), was incorporated on December 9, 2002, under the laws of Bermuda. The Company is a global specialty underwriter and provider of insurance and reinsurance solutions. The Company's principal operating subsidiaries, located in Bermuda, the United States ("U.S."), Europe, Singapore and Canada, are described below:

AXIS Specialty Limited ("AXIS Specialty Bermuda"), a Bermuda domiciled company, is licensed to provide specialty lines insurance and treaty reinsurance products on a worldwide basis. In addition, AXIS Specialty Bermuda conducts insurance and reinsurance business through its branch in Singapore, AXIS Specialty Limited (Singapore Branch). AXIS Specialty Bermuda ceased writing new business through its branch in Singapore branch, effective 1 January 2024, and will close this branch, subject to meeting all regulatory and legal requirements.

AXIS Insurance Company, domiciled in Illinois, and AXIS Reinsurance Company, domiciled in New York, together with AXIS Reinsurance Company (Canadian Branch) are licensed to offer a range of specialty lines insurance and treaty reinsurance products to a variety of niche markets on a worldwide basis. AXIS Surplus Insurance Company, domiciled in Illinois, is eligible to write insurance on a surplus lines basis.

AXIS Specialty Europe SE ("AXIS Specialty Europe") is a European public limited liability company, incorporated as a non-life insurer under the laws of Ireland. It is a Societas Europaea (SE), or European society company registered in accordance with company law of the E.U. AXIS Specialty Europe also conducts insurance business through its branch in the United Kingdom ("U.K."), AXIS Specialty Europe SE ("UK Branch").

The U.K.'s withdrew from the European Union on January 31, 2020 and is now considered a third-country. In 2018, AXIS Specialty Europe submitted an application to have its UK Branch fully regulated by the Prudential Regulation Authority ("PRA") and the U.K. Financial Conduct Authority ("FCA") as a third-country branch. This application was approved by the PRA and FCA on October 28, 2022. Therefore, the UK Branch of AXIS Specialty Europe SE is now fully regulated by the PRA and FCA.

AXIS Re SE is a European public limited liability company, incorporated as a reinsurer under the laws of Ireland. AXIS Re SE is also a Societas Europaea (SE), or European society company registered in accordance with company law of the E.U. AXIS Re SE also conducts reinsurance business through its branch in Switzerland, AXIS Re SE, Dublin (Zurich Branch).

The Company operates in the Lloyd's of London ("Lloyd's") market through its corporate members AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited, which provide 70% and 30%, respectively, of AXIS Syndicate 1686's ("Syndicate 1686") capital support. AXIS Syndicate 1686 is managed by AXIS Managing Agency Ltd. ("AXIS Managing Agency").

On October 2, 2017, AXIS Specialty UK Holdings Limited, a limited liability holding company, incorporated under the laws of England and Wales, acquired a 100% ownership interest in Novae Group plc ("Novae"). AXIS Corporate Capital UK II Limited was the sole corporate member of Novae Syndicate 2007 ("Syndicate 2007"). Effective January 1, 2018, AXIS Managing Agency commenced management and oversight of Syndicate 2007. Effective January 1, 2019, Syndicate 2007 ceased accepting new business and was placed into run-off. Effective January 1, 2021, the Reinsurance to Close of the 2018 year of account of Syndicate 2007 was completed.

AXIS ILS, Ltd. (formerly AXIS Ventures Limited ("AXIS Ventures")) and AXIS Reinsurance Managers Limited ("AXIS Reinsurance Managers"), regulated by the BMA as insurance managers, generate fee income from services provided to strategic capital partners. Effective September 23, 2020, AXIS Ventures deregistered as an insurance manager with the BMA.
XML 35 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") and include AXIS Capital Holdings Limited and its wholly-owned subsidiaries.
All inter-company accounts and transactions have been eliminated.
To facilitate comparison of information across periods, certain reclassifications have been made to prior year amounts to conform to the current year's presentation. At December 31, 2023, the Company presented loan advances made in 2022 separately in the consolidated balance sheets. These loan advances made were previously included in insurance and reinsurance balances payable in the consolidated balance sheets. This presentation was adopted to facilitate comparison to loan advances made in 2023 (refer to Note 10 'Debt' and Note 18 'Related Party Transactions'). This reclassification did not impact results of operations, financial condition or liquidity.

Tabular dollar and share amounts are in thousands, with the exception of per share amounts. All amounts are reported in U.S. dollars.
Use of Estimates
The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. While management believes that the amounts included in the consolidated financial statements reflect its best estimates and assumptions, actual results could differ from those estimates. The Company’s principal estimates include: 
reserve for losses and loss expenses;
reinsurance recoverable on unpaid losses and loss expenses, including the allowance for expected credit losses;
gross premiums written and net premiums earned;
fair value measurements of financial assets and liabilities; and
the allowance for credit losses associated with fixed maturities, available for sale.
The Company's significant accounting policies are as follows:
a)    Investments
Fixed Maturities, Available for Sale, at Fair Value and Fixed Maturities, Held to Maturity, at Amortized Cost
Fixed maturities classified as available for sale are reported at fair value (refer to Note 6 'Fair Value Measurements') and are presented net of an allowance for expected credit losses. The change in fair values of fixed maturities, net of tax is recognized in accumulated other comprehensive income (loss) ("AOCI") in total shareholders’ equity.
Fixed maturities are classified as held to maturity when the Company has the positive intent and ability to hold the securities to maturity or redemption. Fixed maturities classified as held to maturity are reported at amortized cost and are presented net of an allowance for expected credit losses.
Net investment income includes interest income and the amortization of market premiums and discounts and is presented net of investment expenses. Investment income is recognized when earned. Purchases and sales of fixed maturities are recorded on a trade-date basis and realized gains (losses) on sales of fixed maturities are determined based on the specific identification method. Realized gains (losses) on fixed maturities are included in net investment gains (losses) in the consolidated statements of operations.
The Company recognizes investment income from fixed maturities based on the constant effective yield method, which includes an adjustment for estimated principal repayments, if applicable. The effective yield used to determine the amortization of fixed maturities subject to prepayment risk (e.g., asset-backed, mortgage-backed and other structured securities) is recalculated and adjusted periodically based on historical and/or projected future cash flows. Adjustments to the yield for highly rated prepayable fixed maturities are accounted for using the retrospective method. Adjustments to the yield for other prepayable fixed maturities are accounted for using the prospective method.
Credit Losses - Fixed Maturities, Available for Sale
A fixed maturity, available for sale security is impaired if the fair value of the investment is below amortized cost. On a quarterly basis, the Company evaluates all fixed maturities, available for sale securities for impairment losses.
If a fixed maturity, available for sale security is impaired and the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before its anticipated recovery, the full amount of the impairment loss is charged to net income (loss) and is included in net investment gains (losses).

In instances where the Company intends to hold the impaired fixed maturity, available for sale security the Company determines whether the decline in fair value below the amortized cost basis has resulted from a credit loss or other factors. If the Company does not anticipate to fully recover the amortized cost, an allowance for expected credit losses is established. The allowance for expected credit losses is limited to the difference between a security's amortized cost basis and its fair value. The allowance for expected credit losses is charged to net income (loss) and is included in net investment gains (losses).
On a quarterly basis, the Company assesses whether unrealized losses on fixed maturities, available for sale represent credit impairments by considering the following factors:
a.the extent to which the fair value is less than amortized cost;
b.adverse conditions related to the security, industry, or geographical area;
c.downgrades in the security's credit rating by a credit rating agency; and
d.failure of the issuer to make scheduled principal or interest payments.
The length of time a security has been in an unrealized loss position no longer impacts the determination of whether a credit loss exists.
If a security is assessed to be credit impaired, it is subject to a discounted cash flow analysis by comparing the present value of expected future cash flows with the amortized cost basis. If the present value of expected cash flows is less than the amortized cost, a credit loss exists and an allowance for expected credit losses is recognized. If the present value of expected future cash flows is equal to or greater than the amortized cost basis, an expected credit loss does not exist.

The non-credit impairment amount of the loss (i.e., related to interest rates, market conditions, etc.) is recognized in other comprehensive income.

The Company reports accrued interest receivable related to available for sale debt securities separately and has elected not to measure an allowance for expected credit losses for accrued interest receivable. Write-offs of accrued interest receivable balances are recognized in net investment gains (losses) in the period in which they are deemed uncollectible.
Credit Losses - Fixed Maturities, Held to Maturity
A fixed maturity, held to maturity security is impaired if the fair value of the investment is below amortized cost. On a quarterly basis, the Company evaluates all fixed maturities, held to maturity securities for impairment losses.
The Company's fixed maturity, held to maturity securities portfolio consists of asset-backed securities ("ABS") and corporate debt securities.
The Company's ABS, held to maturity consist of CLO debt tranched securities. The Company uses a scenario-based approach to review its CLO debt portfolio and reviews subordination levels of these securities to determine their ability to absorb credit losses of the underlying collateral. If losses are forecast to be below the subordination level for a tranche held by the Company, the security is determined not to have a credit loss.
To estimate expected credit losses for corporate debt securities, held to maturity, the Company's projected cash flows are primarily driven by assumptions regarding the severity of loss, which is a function of the probability of default and projected recovery rates. The Company's default and recovery rates are based on credit ratings, credit analysis and macroeconomic forecasts.
The allowance for expected credit losses is estimated based on the Company’s analysis of projected lifetime losses. The allowance for expected credit losses is charged to net income (loss) and is recognized in net investment gains (losses). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Equity Securities, at Fair Value
Equity securities are reported at fair value. The change in the fair values of equity securities, net of tax is recognized in net investment gains (losses) in the consolidated statements of operations.
Net investment income includes dividend income and is presented net of investment expenses. Investment income is recognized when earned. Purchases and sales of equity securities are recorded on a trade-date basis and realized gains (losses) on sales of equity securities are determined based on the specific identification method. Realized gains (losses) on equity securities are included in net investment gains (losses) in the consolidated statements of operations.
Mortgage Loans, Held for Investment, at Fair Value
Mortgage loans, held for investment are reported at amortized cost which is calculated as the unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses.
Interest income and prepayment fees are recognized when earned. Interest income is recognized based on an effective yield method which gives effect to the amortization of premiums and accretion of discounts.
Mortgage loans, held for investment are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company’s analysis of projected lifetime losses. These projections take into account the Company’s experience with credit quality indicators, loan losses, defaults, loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.
The allowance for expected credit losses is recognized in net investment gains (losses) in the consolidated statements of operations. Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Other Investments
Other investments are recorded at fair value (refer to Note 6 'Fair Value Measurements'). Changes in fair value and realized gains (losses) are reported in net investment income in the consolidated statements of operations.
Equity Method Investments
Investments in which the Company has significant influence over the operating and financial policies of the investee are classified as equity method investments and are accounted for using the equity method of accounting. In applying the equity method of accounting, investments are initially recorded at cost and are subsequently adjusted based on the Company’s proportionate share of net income or loss of the investee. Adjustments are based on the most recently available financial information from the investee. Changes in the carrying value of these investments are recorded in net income (loss) as interest in income (loss) of equity method investments.
Short-term Investments
Short-term investments primarily comprise highly liquid debt securities with maturities greater than three months but less than one year from the date of purchase. These investments are carried at amortized cost, which approximates fair value.
b)    Cash and Cash Equivalents
Cash equivalents include money-market funds, fixed interest deposits and reverse repurchase agreements with a maturity of under 90 days when purchased. Cash and cash equivalents are recorded at amortized cost, which approximates fair value due to the short-term, liquid nature of these securities. Restricted cash primarily relates to funds held in trust to support obligations in regulatory jurisdictions where the Company operates as a non-admitted carrier and to support underwriting activities at Lloyd's. 
c)    Premiums and Acquisition Costs
Premiums
Insurance premiums written are recorded in accordance with the terms of the underlying policies.
Reinsurance premiums are recorded at the inception of the contract based on estimates received from ceding companies.
For multi-year contracts insurance and reinsurance premiums are recorded at the inception of the contract based on management’s best estimate of total premiums to be received. Premiums are recognized on an annual basis for multi-year contracts where the cedant has the ability to unilaterally commute or cancel coverage within the term of the contract.
Any adjustments to insurance and reinsurance premium estimates are recognized in the period in which they are determined.
Insurance and reinsurance premiums are earned evenly over the period during which the Company is exposed to the underlying risk, which is generally one to two years with the exception of multi-year contracts. Unearned premiums represent the portion of premiums which relate to the unexpired term under contracts in force.
Reinstatement premiums are recognized and earned at the time a loss event occurs and losses are recorded, where the coverage limits for the remaining life of the contract are reinstated under pre-defined contract terms. The recognition of reinstatement premiums is based on estimates of losses and loss expenses, which reflects management’s judgment (refer to Note 2(d) 'Losses and Loss Expenses' below).
Insurance and reinsurance premium balances receivable ("premium balances receivable") are reviewed for impairment at least quarterly and are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company's analysis of amounts due, historical delinquencies and write-offs, and current economic conditions, together with reasonable and supportable forecasts of short-term economic conditions.
The allowance for expected credit losses is recognized in net income (loss). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Write-offs of premium balances receivable, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs.
Acquisition Costs
Acquisition costs vary with and are directly related to the successful acquisition efforts of acquiring new or renewing existing insurance and reinsurance contracts and consist primarily of fees and commissions paid to brokers and premium taxes. In addition, certain of our contracts include profit commission provisions or other adjustable features that are estimated based on expected losses and loss expenses for those contracts. Acquisition costs are shown net of commissions on reinsurance purchased. Net acquisition costs are deferred and charged to net income (loss) as the related premium is earned. Insurance and reinsurance premium balances receivable is presented net of acquisition costs when contract terms provide for the right of offset.
Anticipated losses and loss expenses, other costs and investment income related to these premiums are considered in assessing the recoverability of deferred acquisition costs. Deferred acquisition cost amounts that are assessed to be irrecoverable are recognized in net income (loss) in the period in which the determination is made. Compensation expenses for personnel involved in contract acquisition, and advertising costs, are charged to net income (loss) when incurred.
d)    Losses and Loss Expenses
Reserve for losses and loss expenses represents an estimate of the unpaid portion of the ultimate liability for losses and loss expenses for insured and reinsured events that have occurred at or before the balance sheet date. These amounts reflect claims that have been reported ("case reserves") and claims that have been incurred but have not yet been reported ("IBNR") and are reduced for estimated amounts of salvage and subrogation recoveries.
The Company reviews its reserve for losses and loss expenses on a quarterly basis. Case reserves are primarily established based on amounts reported by clients and/or their brokers. Management estimates IBNR after reviewing detailed actuarial analyses and applying informed judgment regarding qualitative factors that may not be fully captured in the actuarial estimates. A variety of actuarial methods are utilized in this process, including the Expected Loss Ratio, Chain Ladder and Bornhuetter-Ferguson methods. The estimate is highly dependent on management’s judgment as to which method(s) are most appropriate for a particular accident/underwriting year and line of business. Historical claims data may be supplemented with industry benchmarks when applying these methodologies.
Any adjustments to estimates of reserve for losses and loss expenses are recognized in the period in which they are determined. While the Company believes that its reserves for losses and loss expenses are adequate, this estimate requires significant judgment and new information, events or circumstances may result in ultimate losses that are materially greater or less than provided for in the consolidated balance sheets.
e)    Reinsurance
In the normal course of business, the Company purchases facultative and treaty reinsurance protection to limit its ultimate losses and to reduce its loss aggregation risk. The premiums paid to reinsurers (i.e., ceded premiums written) are recognized over the coverage period. Prepaid reinsurance premiums represent the portion of premiums ceded which relate to the unexpired term of the contracts in force. Reinstatement premiums are recognized and earned at the time a loss event occurs and losses are recorded, where the coverage limits for the remaining life of the contract are reinstated under pre-defined contract terms.
Reinsurance recoverable on unpaid losses and loss expenses ("reinsurance recoverables") related to case reserves is estimated on a case-by-case basis by applying the terms of applicable reinsurance cover to individual case reserve estimates. Reinsurance recoverables related to IBNR is generally developed as part of the Company's loss reserving process, therefore, its estimation is subject to similar risks and uncertainties as the estimation of IBNR. Estimates of amounts to be ceded under excess of loss reinsurance contracts also take into account pricing information for those contracts and require greater judgment than estimates for proportional contracts.
Reinsurance recoverable balances are reviewed for impairment at least quarterly and are presented net of an allowance for expected credit losses.
A case-specific allowance for expected credit losses against reinsurance recoverables that we deem are unlikely to be collected in full, is estimated based on the Company's analysis of amounts due, historical delinquencies and write-offs. In addition, a default analysis is used to estimate an allowance for expected credit losses on the remainder of the reinsurance recoverable balance. The principal components of the default analysis are reinsurance recoverable balances by reinsurer and default factors applied to estimate uncollectible amounts based on reinsurers’ credit ratings and the length of collection periods. The default factors are based on a model developed by a major rating agency. The default analysis considers current and forecasted economic conditions.
The allowance for expected credit losses is recognized in net income (loss). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined. Write-offs of reinsurance recoverable balances, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs.
Retroactive Reinsurance
Retroactive reinsurance reimburses a ceding company for liabilities incurred as a result of past insurable events covered under contracts subject to the reinsurance. In certain instances, reinsurance contracts cover losses both on a prospective basis and on a retroactive basis and where practical the Company bifurcates the prospective and retroactive elements of these reinsurance contracts and accounts for each element separately. Initial gains in connection with retroactive reinsurance contracts are deferred and amortized into net income over the claims settlement period while losses are recognized immediately. When changes in the estimated amount recoverable from the reinsurer or in the timing of receipts related to that amount occur, a cumulative amortization adjustment is recognized in net income in the period in which the change is determined so that the deferred gain reflects the balance that would have existed had the revised estimate been available at the inception of the reinsurance transaction.
f)    Foreign Exchange
The functional currency of the Company and the majority of its subsidiaries is the U.S. dollar. All foreign currency transactions are initially measured and recorded in functional currency using the rates of exchange prevailing at the transaction date.
Monetary assets and liabilities denominated in foreign currency are remeasured to functional currency at the rates of exchange in effect at the balance sheet date with the resulting foreign exchange losses (gains) generally being recognized in the consolidated statements of operations. Foreign exchange losses (gains) related to available for sale securities denominated in foreign currency represent an unrealized appreciation (depreciation) in the market value of the securities and are included in AOCI. Non-monetary assets and liabilities denominated in foreign currency are not subsequently remeasured.
The Company’s reporting currency is the U.S. dollar. Assets and liabilities of the Company's subsidiaries and branches where the functional currency is not the U.S. dollar, are translated into U.S. dollars using the rates of exchange in effect at the balance sheet date, and revenue and expenses are translated using the weighted average foreign exchange rates for the period. The effect of translation adjustments is reported as a separate component of AOCI in total shareholders’ equity.
g)    Share-based Compensation
The Company is authorized to issue restricted shares, restricted stock units, performance restricted stock units, stock options, stock appreciation rights and other equity-based awards to its employees and directors. The Company's plan includes share-settled and cash-settled service and performance awards.
Restricted Stock Units - Share-Settled and Cash-Settled
The fair value of share-settled and cash-settled service awards is based on market value of the Company's common shares measured at the grant date and is expensed over the requisite service period. The fair value of the cash-settled service awards is recognized as a liability in the consolidated balance sheets and is remeasured at the end of each reporting period. The Company recognizes forfeitures when they occur.
Performance Restricted Stock Units - Share-Settled
The fair value of share-settled performance awards which include a market condition is measured on the grant date using a Monte Carlo simulation model which requires inputs including share price, expected volatility, expected term, expected dividend yield and risk-free interest rates. The fair value of share-settled performance awards which include a performance condition is based on the market value of the Company's common shares measured at the grant date.
The fair value of share-settled performance awards is recognized on a straight-line basis over the requisite service period. The Company recognizes forfeitures when they occur.
h)    Derivative Instruments
The Company may enter into derivative instruments such as futures, options, interest rate swaps and foreign currency forward contracts as part of its overall foreign currency risk management strategy, to obtain exposure to a particular financial market or for yield enhancement.
From time to time the Company may also enter into insurance and reinsurance contracts that meet the Financial Accounting Standards Board's ("FASB") definition of a derivative contract.
The Company measures all derivative instruments at fair value (refer to Note 6 'Fair Value Measurements') and recognizes these instruments in either other assets or other liabilities in the consolidated balance sheets. Subsequent changes in fair value and realized gains (losses) are recognized in net income (loss) in the consolidated statements of operations.
i)    Goodwill and Intangible Assets
The Company recognizes goodwill and other intangible assets in connection with certain acquisitions. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired in these acquisitions and is not amortized. Other intangible assets with a finite life are amortized over the estimated useful live of the intangible asset. Other intangible assets with an indefinite life are not amortized.
The Company tests goodwill and indefinite-lived intangible assets for potential impairment during the fourth quarter each year and between annual tests if an event occurs or changes in circumstances indicate that the asset is impaired. Such events or circumstances may include an economic downturn in a geographic market or a change in the assessment of future operations.
For the purpose of evaluating goodwill for impairment, the Company may first perform a qualitative assessment to determine whether it is necessary to perform a quantitative goodwill impairment test. If determined to be necessary, the quantitative test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired. If the carrying amount of the reporting unit exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.
For the purpose of evaluating indefinite-lived intangibles for impairment, the Company may first perform a qualitative assessment to determine whether it is necessary to perform the quantitative impairment test. If the Company elects to perform a qualitative assessment, it first assesses qualitative factors to determine whether it is more likely than not that an indefinite lived intangible asset is impaired. If the Company determines that it is more likely than not that the indefinite lived intangible asset is impaired, the Company performs the quantitative impairment test.
For the purposes of evaluating goodwill and indefinite-lived intangible assets for impairment, the Company has an unconditional option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test. The Company may resume performing the qualitative assessment in any subsequent period.
For other finite-lived intangible assets the Company tests for recoverability whenever events or changes in circumstances indicate its carrying amount may not be recoverable. The Company recognizes an impairment loss if the carrying amount of
the asset is not recoverable and exceeds its fair value. The carrying amount of a finite-lived intangible asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.
If goodwill or an intangible asset is impaired, the carrying value of the asset is reduced to fair value and a corresponding expense is recorded in the consolidated statements of operations.
 j)    Income Taxes
Certain subsidiaries and branches of the Company operate in jurisdictions where they are subject to taxation.
Current and deferred income taxes are charged or credited to net income (loss), or in certain cases to AOCI, based on enacted tax laws and rates applicable in the relevant jurisdiction in the period in which the tax becomes accruable or realizable.
Deferred income taxes are provided for all temporary differences between the bases of assets and liabilities reported in the consolidated balance sheets and those reported in the various jurisdictional tax returns. When the assessment indicates that it is more likely than not that a portion of a deferred tax asset will not be realized in the foreseeable future, a valuation allowance against deferred tax assets is recorded. 
The Company recognizes the tax benefits of uncertain tax positions only when the position is more-likely-than-not to be sustained on audit by the relevant taxing authorities.
k)    Treasury Shares
Common shares repurchased by the Company and not subsequently canceled are classified as treasury shares and are recorded at cost. This results in a reduction of shareholders’ equity in the consolidated balance sheets. The Company uses the average cost method to determine the cost of shares reissued from treasury.
l)    Leases
The Company recognizes a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term related to office property and equipment leases.
The Company accounts for non-lease components separately from lease components. As a result, the non-lease components associated with the Company's leases are not included in the lease liabilities and right-of-use assets in the Company's consolidated balance sheets.
The Company does not record office property and equipment leases with an initial term of 12 months or less (short-term) in the Company's consolidated balance sheets.
m)    Recently Issued Accounting Standards Not Yet Adopted
Segment Reporting
In November 2023, the FASB issued Accounting Standards Update ("ASU" or "Update") ASU 2023-07 "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures". The amendments in this Update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this update:
1.    Require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss (collectively referred to as the “significant expense principle”).
2.     Require that a public entity disclose, on an annual and interim basis, an amount for other segment items by reportable segment and a description of its composition. The other segment items category is the difference between segment
revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss.
3.    Require that a public entity provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by Topic 280 in interim periods.
4.     Clarify that if the CODM uses more than one measure of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources, a public entity may report one or more of those additional measures of segment profit. However, at least one of the reported segment profit or loss measures (or the single reported measure, if only one is disclosed) should be the measure that is most consistent with the measurement principles used in measuring the corresponding amounts in the public entity’s consolidated financial statements. In other words, in addition to the measure that is most consistent with the measurement principles under generally accepted accounting principles (GAAP), a public entity is not precluded from reporting additional measures of a segment’s profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources.
5.    Require that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources.
6.    Require that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this Update and all existing segment disclosures in Topic 280.
This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. As this guidance relates solely to financial statement disclosures, the adoption of ASU 2023-07, will not impact the Company's results of operations, financial condition, or liquidity.
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures". The amendments in this Update provide more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information as follows:
Rate Reconciliation
The amendments in this Update require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate).
Income Taxes Paid
The amendments in this Update require that all entities disclose on an annual basis (1) the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes and (2) the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) if equal to or greater than 5 percent of total income taxes paid (net of refunds received).
Other Disclosures
The amendments in this Update require that all entities disclose (1) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and (2) income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign.

The amendments in this Update eliminate the requirement for all entities to (1) disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or (2) make a statement that an estimate of the range cannot be made.

The amendments in this Update remove the requirement to disclose the cumulative amount of each type of temporary difference when a deferred tax liability is not recognized because of the exceptions to comprehensive recognition of deferred taxes related to subsidiaries.
The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis. Retrospective application permitted.
XML 36 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
AXIS Capital's underwriting operations are organized around its global underwriting platforms, AXIS Insurance and AXIS Re. The Company has determined that it has two reportable segments, insurance and reinsurance. The Company does not allocate its assets by segment, with the exception of goodwill and intangible assets.
Insurance
The Company's insurance segment offers specialty insurance products to a variety of niche markets on a worldwide basis. The product lines in this segment are professional lines, property, liability, cyber, marine and aviation, accident and health, and credit and political risk.
Reinsurance
The Company's reinsurance segment provides treaty reinsurance to insurance companies on a worldwide basis. The product lines in this segment are liability, accident and health, professional lines, credit and surety, motor, agriculture, marine and aviation, and run-off lines which include catastrophe and property lines of business that the Company placed into run-off in 2022 and engineering lines of business that the Company placed into run-off in 2020.
The following tables present the underwriting results of the Company's reportable segments, as well as the carrying amounts of allocated goodwill and intangible assets:
At and year ended December 31, 2023InsuranceReinsuranceTotal
Gross premiums written$6,140,764 $2,215,761 $8,356,525 
Net premiums written3,758,720 1,343,605 5,102,325 
Net premiums earned3,461,700 1,622,081 5,083,781 
Other insurance related income (loss)(198)22,693 22,495 
Net losses and loss expenses(2,080,001)(1,313,101)(3,393,102)
Acquisition costs(648,463)(352,482)(1,000,945)
Underwriting-related general and administrative expenses(472,094)(79,373)(551,467)
Underwriting income (loss)$260,944 $(100,182)160,762 
Net investment income611,742 
Net investment gains (losses)(74,630)
Corporate expenses(132,979)
Foreign exchange (losses) gains(58,115)
Interest expense and financing costs(68,421)
Reorganization expenses(28,997)
Amortization of value of business acquired 
Amortization of intangible assets(10,917)
Income before income taxes and interest in income of equity method investments398,445 
Income tax expense(26,316)
Interest in income of equity method investments4,163 
Net income376,292 
Preferred share dividends30,250 
Net income available to common shareholders$346,042 
Net losses and loss expenses ratio60.1 %81.0 %66.7 %
Acquisition cost ratio18.7 %21.7 %19.7 %
General and administrative expense ratio 13.7 %4.9 %13.5 %
Combined ratio92.5 %107.6 %99.9 %
Goodwill and intangible assets$287,684 $ $287,684 
At and year ended December 31, 2022InsuranceReinsuranceTotal
Gross premiums written$5,585,581 $2,629,014 $8,214,595 
Net premiums written3,377,906 1,885,150 5,263,056 
Net premiums earned3,134,155 2,026,171 5,160,326 
Other insurance related income559 12,514 13,073 
Net losses and loss expenses(1,785,854)(1,456,556)(3,242,410)
Acquisition costs(577,838)(444,179)(1,022,017)
Underwriting-related general and administrative expenses(443,704)(106,585)(550,289)
Underwriting income$327,318 $31,365 358,683 
Net investment income418,829 
Net investment gains (losses)(456,789)
Corporate expenses(130,054)
Foreign exchange gains157,945 
Interest expense and financing costs(63,146)
Reorganization expenses(31,426)
Amortization of value of business acquired— 
Amortization of intangible assets(10,917)
Income before income taxes and interest in income of equity method investments243,125 
Income tax expense(22,037)
Interest in income of equity method investments1,995 
Net income223,083 
Preferred share dividends30,250 
Net income available to common shareholders$192,833 
Net losses and loss expenses ratio57.0 %71.9 %62.8 %
Acquisition cost ratio18.4 %21.9 %19.8 %
General and administrative expense ratio14.2 %5.3 %13.2 %
Combined ratio89.6 %99.1 %95.8 %
Goodwill and intangible assets$298,601 $— $298,601 
At and year ended December 31, 2021InsuranceReinsuranceTotal
Gross premiums written$4,863,232 $2,822,752 $7,685,984 
Net premiums written2,894,885 2,031,739 4,926,624 
Net premiums earned2,651,339 2,058,511 4,709,850 
Other insurance related income1,662 21,633 23,295 
Net losses and loss expenses(1,514,998)(1,493,785)(3,008,783)
Acquisition costs(484,344)(437,490)(921,834)
Underwriting-related general and administrative expenses(429,282)(107,552)(536,834)
Underwriting income$224,377 $41,317 265,694 
Net investment income454,301 
Net investment gains134,279 
Corporate expenses(126,470)
Foreign exchange (losses) gains(315)
Interest expense and financing costs(62,302)
Reorganization expenses— 
Amortization of value of business acquired(3,854)
Amortization of intangible assets(12,424)
Income before income taxes and interest in income of equity method investments648,909 
Income tax expense(62,384)
Interest in income of equity method investments32,084 
Net income618,609 
Preferred share dividends30,250 
Net income available to common shareholders$588,359 
Net losses and loss expenses ratio57.1 %72.6 %63.9 %
Acquisition cost ratio18.3 %21.3 %19.6 %
General and administrative expense ratio 16.2 %5.1 %14.0 %
Combined ratio91.6 %99.0 %97.5 %
Goodwill and intangible assets$309,518 $— $309,518 
 
The following table presents gross premiums written by the geographical location of the Company's subsidiaries:
Years ended December 31,202320222021
U.S.$4,484,789 $4,342,707 $4,002,748 
Ireland1,837,177 1,931,815 1,667,496 
Lloyd's of London1,759,990 1,567,458 1,473,047 
Bermuda274,569 372,615 542,693 
Gross premiums written$8,356,525 $8,214,595 $7,685,984 
The following table presents net premiums earned by segment and line of business:    
Years ended December 31,202320222021
Insurance
Professional lines$764,558 $817,924 $646,390 
Property878,849 755,986 711,297 
Liability496,381 459,775 354,787 
Cyber323,025 309,004 252,077 
Marine and aviation567,292 479,499 439,050 
Accident and health306,061 209,548 151,133 
Credit and political risk125,534 102,419 96,605 
Total Insurance3,461,700 3,134,155 2,651,339 
Reinsurance
Liability403,239 484,681 431,596 
Accident and health341,806 368,747 361,196 
Professional lines205,404 250,911 220,448 
Credit and surety236,408 192,926 158,549 
Motor155,942 205,774 247,099 
Agriculture121,628 122,289 82,743 
Marine and aviation65,658 78,504 58,775 
Run-off lines
Catastrophe33,963 156,232 238,775 
Property44,508 135,480 231,092 
Engineering13,525 30,627 28,238 
Total run-off lines91,996 322,339 498,105 
Total Reinsurance1,622,081 2,026,171 2,058,511 
Total$5,083,781 $5,160,326 $4,709,850 
XML 37 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS
12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS GOODWILL AND INTANGIBLE ASSETS
The table below provides details of goodwill and intangible assets related to the Company's insurance segment:
GoodwillIntangible
assets with an
indefinite life
Intangible
assets with a
finite life
Total
December 31, 2021
Gross amount$95,890 $120,784 $394,604 $611,278 
Accumulated amortizationn/an/a(291,901)(291,901)
Accumulated translation adjustment4,911 — — 4,911 
100,801 120,784 102,703 324,288 
Amortizationn/an/a(14,770)(14,770)
Impairment charges— — — — 
At December 31, 2022
Gross amount95,890 120,784 394,604 611,278 
Accumulated amortizationn/an/a(306,671)(306,671)
Accumulated translation adjustment4,911 — — 4,911 
100,801 120,784 87,933 309,518 
Amortizationn/an/a(10,917)(10,917)
Impairment charges— — — — 
At December 31, 2023
Gross amount95,890 120,784 394,604 611,278 
Accumulated amortizationn/an/a(317,588)(317,588)
Accumulated translation adjustment4,911   4,911 
100,801 120,784 77,016 298,601 
Amortizationn/an/a(10,917)(10,917)
Impairment charges    
$100,801 $120,784 $66,099 $287,684 
n/a – not applicable
Intangible Assets with an Indefinite Life
Intangible assets with an indefinite life include U.S. state licenses that provide a legal right to transact business indefinitely and the value of Lloyd's syndicate capacity, which represents the right to underwrite a certain allocated limit of premium in the Lloyd's market.
Impairment Review
The Company's impairment review of goodwill and indefinite lived intangibles did not result in the recognition of an impairment loss for the years ended December 31, 2023 and 2022 and 2021.



The tables below provide details of the gross amount and accumulated amortization by category of value of business acquired ("VOBA") and intangible assets:
VOBA and intangible assets
At December 31, 2023
Gross amountAccumulated amortizationTotal
U.S. state licenses$26,036 n/a$26,036 
Syndicate capacity (2)
94,748 n/a94,748 
Customer relationships and customers lists - Ternian (1)
13,330 (11,661)1,669 
VOBA - Novae (2)
256,942 (256,942)— 
Coverholders (2)
63,565 (33,110)30,455 
Large brokers (2)
46,641 (19,435)27,206 
SME brokers (2)
14,126 (7,357)6,769 
$515,388 $(328,505)$186,883 
n/a – not applicable
(1)    On April 1, 2015, the Company completed its acquisition of Ternian Insurance Group LLC (renamed AXIS Group Benefits LLC in 2022) and recognized the definite life intangible assets detailed above.
(2)    On October 2, 2017, the Company acquired Novae and recognized finite lived intangible assets, including VOBA, distribution networks, and indefinite lived intangible assets related to Lloyd's syndicate capacity, all detailed above.

VOBA and intangible assets
At December 31, 2022
Gross amountAccumulated amortizationTotal
U.S. state licenses$26,036 n/a$26,036 
Syndicate capacity (2)
94,748 n/a94,748 
Customer relationships and customers lists - Ternian (1)
13,330 (10,329)3,001 
VOBA - Novae (2)
256,942 (256,942)— 
Coverholders (2)
63,565 (27,812)35,753 
Large brokers (2)
46,641 (16,325)30,316 
SME brokers (2)
14,126 (6,180)7,946 
$515,388 $(317,588)$197,800 
n/a – not applicable
(1)     On April 1, 2015, the Company completed its acquisition of Ternian Insurance Group LLC (renamed AXIS Group Benefits LLC in 2022) and recognized the definite life intangible assets detailed above.
(2)    On October 2, 2017, the Company acquired Novae and recognized finite lived intangible assets, including VOBA, distribution networks, and indefinite lived intangible assets related to Lloyd's syndicate capacity, all detailed above.
The table below provides details of estimated amortization expense of intangible assets with a finite life:
Total
2024$10,916 
20259,919 
20269,583 
20279,583 
20289,583 
After 202816,515 
Total remaining amortization expense66,099 
Indefinite lived intangible assets120,784 
Total intangible assets$186,883 
The estimated remaining average useful life of finite lived intangible assets is 7 years.
XML 38 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS
12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
INVESTMENTS INVESTMENTS
a)    Fixed Maturities, Available for Sale

The following table provides the amortized cost and fair values of the Company's fixed maturities classified as available for sale:
Amortized
cost
Allowance for expected credit lossesGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Available for sale
U.S. government and agency$3,049,445 $ $13,211 $(55,128)$3,007,528 
Non-U.S. government729,761 (30)13,089 (18,861)723,959 
Corporate debt4,651,654 (10,438)49,434 (216,478)4,474,172 
Agency RMBS(1)
1,706,204  11,495 (83,038)1,634,661 
CMBS(2)
897,553  551 (58,408)839,696 
Non-agency RMBS165,910 (194)713 (13,033)153,396 
ABS(3)
1,265,187 (50)2,855 (25,021)1,242,971 
Municipals(4)
168,540 (47)414 (10,548)158,359 
Total fixed maturities, available for sale$12,634,254 $(10,759)$91,762 $(480,515)$12,234,742 
At December 31, 2022
Available for sale
U.S. government and agency$2,731,733 $— $5,386 $(97,789)$2,639,330 
Non-U.S. government612,546 — 2,395 (52,912)562,029 
Corporate debt4,680,798 (11,521)5,269 (418,990)4,255,556 
Agency RMBS(1)
1,297,423 — 4,663 (99,301)1,202,785 
CMBS(2)
1,029,863 — 60 (82,145)947,778 
Non-agency RMBS151,907 (123)275 (18,525)133,534 
ABS(3)
1,499,728 (35)555 (70,721)1,429,527 
Municipals(4)
172,475 (54)139 (16,205)156,355 
Total fixed maturities, available for sale$12,176,473 $(11,733)$18,742 $(856,588)$11,326,894 
(1)Residential mortgage-backed securities ("RMBS") originated by U.S. government-sponsored agencies.
(2)Commercial mortgage-backed securities ("CMBS").
(3)Asset-backed securities ("ABS") include debt tranched securities collateralized primarily by auto loans, student loans, credit card receivables and collateralized loan obligations ("CLOs").
(4)Municipals include bonds issued by states, municipalities and political subdivisions.
 
Contractual Maturities
Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
The table below provides the contractual maturities of fixed maturities classified as available for sale:
Amortized
cost
Fair
value
% of Total
fair value
At December 31, 2023
Maturity
Due in one year or less$474,557 $463,789 3.6 %
Due after one year through five years5,902,571 5,790,493 47.3 %
Due after five years through ten years2,064,619 1,954,449 16.0 %
Due after ten years157,653 155,287 1.3 %
8,599,400 8,364,018 68.2 %
Agency RMBS1,706,204 1,634,661 13.4 %
CMBS897,553 839,696 6.9 %
Non-agency RMBS165,910 153,396 1.3 %
ABS1,265,187 1,242,971 10.2 %
Total$12,634,254 $12,234,742 100.0 %
At December 31, 2022
Maturity
Due in one year or less$422,039 $409,972 3.7 %
Due after one year through five years5,349,123 5,078,273 44.8 %
Due after five years through ten years2,192,344 1,919,450 16.9 %
Due after ten years234,046 205,575 1.8 %
8,197,552 7,613,270 67.2 %
Agency RMBS1,297,423 1,202,785 10.6 %
CMBS1,029,863 947,778 8.4 %
Non-agency RMBS151,907 133,534 1.2 %
ABS1,499,728 1,429,527 12.6 %
Total$12,176,473 $11,326,894 100.0 %
Gross Unrealized Losses
The following table summarizes fixed maturities, available for sale in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position:
  12 months or greaterLess than 12 monthsTotal
  Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
At December 31, 2023
Fixed maturities, available for sale
U.S. government and agency$846,503 $(42,465)$867,733 $(12,663)$1,714,236 $(55,128)
Non-U.S. government233,038 (18,178)115,112 (683)348,150 (18,861)
Corporate debt2,623,304 (210,512)240,813 (5,966)2,864,117 (216,478)
Agency RMBS778,656 (80,070)218,606 (2,968)997,262 (83,038)
CMBS703,411 (54,856)75,242 (3,552)778,653 (58,408)
Non-agency RMBS98,483 (13,013)10,017 (20)108,500 (13,033)
ABS879,743 (24,747)83,582 (274)963,325 (25,021)
Municipals129,969 (10,156)6,238 (392)136,207 (10,548)
Total fixed maturities, available for sale$6,293,107 $(453,997)$1,617,343 $(26,518)$7,910,450 $(480,515)
At December 31, 2022
Fixed maturities, available for sale
U.S. government and agency$467,032 $(41,365)$1,414,181 $(56,424)$1,881,213 $(97,789)
Non-U.S. government207,637 (33,027)298,048 (19,885)505,685 (52,912)
Corporate debt1,562,355 (268,289)2,350,504 (150,701)3,912,859 (418,990)
Agency RMBS220,595 (40,469)771,191 (58,832)991,786 (99,301)
CMBS343,494 (40,888)599,877 (41,257)943,371 (82,145)
Non-agency RMBS75,137 (14,691)53,484 (3,834)128,621 (18,525)
ABS685,990 (48,913)686,190 (21,808)1,372,180 (70,721)
Municipals52,994 (10,120)96,003 (6,085)148,997 (16,205)
Total fixed maturities, available for sale$3,615,234 $(497,762)$6,269,478 $(358,826)$9,884,712 $(856,588)

At December 31, 2023, 3,535 fixed maturities (2022: 4,525) were in an unrealized loss position of $481 million (2022: $857 million) of which $13 million (2022: $64 million) was related to securities below investment grade or not rated.

At December 31, 2023, 3,212 fixed maturities (2022: 1,842) had been in a continuous unrealized loss position for twelve months or greater and had a fair value of $6,293 million (2022: $3,615 million).

The unrealized losses of $481 million (2022: $857 million) were due to non-credit factors and were expected to be recovered as the related securities approach maturity.

At December 31, 2023, the Company did not intend to sell the securities in an unrealized loss position and it is more likely than not that the Company will not be required to sell these securities before the anticipated recovery of their amortized costs.
b)    Fixed Maturities, Held to Maturity
The following table provides the amortized cost and fair values of the Company's fixed maturities classified as held to maturity:
Amortized
cost
Allowance for expected credit lossesNet carrying valueGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Held to maturity
Corporate debt$95,200 $ $95,200 $298 $(8,827)$86,671 
ABS(1)
591,096  591,096 5 (1,921)589,180 
Total fixed maturities, held to maturity$686,296 $ $686,296 $303 $(10,748)$675,851 
At December 31, 2022    
Held to maturity
Corporate debt$85,200 $— $85,200 $— $(11,428)$73,772 
ABS(1)
613,151 — 613,151 — (12,180)600,971 
Total fixed maturities, held to maturity$698,351 $— $698,351 $— $(23,608)$674,743 
(1)Asset-backed securities ("ABS") include debt tranched securities collateralized primarily by collateralized loan obligations ("CLOs").

At December 31, 2023, fixed maturities, held to maturity of $686 million (2022: $698 million) were presented net of an allowance for expected credit losses of $nil (2022: $nil).

The Company's ABS, held to maturity consist of CLO debt tranched securities. The Company uses a scenario-based approach to review its CLO debt portfolio and reviews subordination levels of these securities to determine their ability to absorb credit losses of the underlying collateral. If losses are forecast to be below the subordination level for a tranche held by the Company, the security is determined not to have a credit loss. At December 31, 2023 and 2022, the allowance for credit losses expected to be recognized over the life of the Company's ABS, held to maturity was $nil.

To estimate expected credit losses for corporate debt securities, held to maturity, the Company's projected cash flows are primarily driven by assumptions regarding the severity of loss, which is a function of the probability of default and projected recovery rates. The Company's default and recovery rates are based on credit ratings, credit analysis and macroeconomic forecasts. At December 31, 2023 and 2022, the allowance for credit losses expected to be recognized over the life of the Company's corporate debt, held to maturity was $nil.
Contractual Maturities
Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. ABS classified as held to maturity with a net carrying value of $591 million (2022: $613 million) do not have a single maturity date and cannot be allocated over several maturity groupings.

Corporate debt classified as held to maturity with a net carrying value of $95 million (2022: $81 million) is due between 3 years and 10 years and corporate debt classified as held to maturity with a net carrying value of $nil (2022: $4 million) is due after ten years.
c)    Equity Securities

The following table provides the cost and fair values of the Company's equity securities:
CostGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Equity securities
Common stocks$2,843 $101 $(398)$2,546 
Preferred stocks5,496 218 (113)5,601 
Exchange-traded funds182,989 105,858 (1,572)287,275 
Bond mutual funds352,505 4,119 (63,535)293,089 
Total equity securities$543,833 $110,296 $(65,618)$588,511 
At December 31, 2022
Equity securities
Common stocks$7,279 $636 $(442)$7,473 
Preferred stocks115 — (43)72 
Exchange-traded funds207,505 68,058 (5,757)269,806 
Bond mutual funds279,457 — (71,555)207,902 
Total equity securities$494,356 $68,694 $(77,797)$485,253 
d)    Mortgage Loans

The following table provides details of the Company's mortgage loans, held for investment:
  
December 31, 2023December 31, 2022
  
Carrying value% of TotalCarrying value% of Total
Mortgage loans held for investment:
Commercial$616,368 101 %$627,437 100 %
Allowance for expected credit losses
(6,220)(1 %)— — %
Total mortgage loans held for investment$610,148 100 %$627,437 100 %

The primary credit quality indicators for commercial mortgage loans are the debt service coverage ratio which compares a property’s net operating income to amounts needed to service the principal and interest due under the loan, (generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss) and the loan-to-value ratio which compares the unpaid principal balance of the loan to the estimated fair value of the underlying collateral (generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss). The debt service coverage ratio and loan-to-value ratio, as well as the values utilized in calculating these ratios, are updated quarterly.

The Company has a high quality mortgage loan portfolio with a weighted average debt service coverage ratio of 1.9x (2022: 2.3x) and a weighted average loan-to-value ratio of 71% (2022: 60%). At December 31, 2023 and 2022, there were no past due amounts associated with the commercial mortgage loans held by the Company.

On a quarterly basis, collateral dependent mortgage loans (e.g., when the borrower is experiencing financial difficulty, including when foreclosure is reasonably possible or probable) are evaluated individually for credit losses. The allowance for expected credit losses for a collateral dependent loan is established as the excess of amortized cost over the estimated fair value of the loan's underlying collateral, less selling cost when foreclosure is probable. Accordingly, the change in the estimated fair value of collateral dependent loans, which are evaluated individually for credit losses, is recognized as a change in the allowance for expected credit losses which is recorded in net investment gains (losses).

At December 31, 2023, there are two collateral dependent loans with estimated loan-to-value ratios in excess of 100%, resulting in an allowance for expected credit loss of $6 million (2022: $nil).
e)    Other Investments
The following table provides a summary of the Company's other investments, together with additional information relating to the liquidity of each category:
  Fair valueRedemption frequency
(if currently eligible)
Redemption
notice period
At December 31, 2023
Multi-strategy funds$24,619 3 %Quarterly
60-90 days
Direct lending funds192,270 20 %
Quarterly(1)
90 days
Private equity funds301,712 32 %n/an/a
Real estate funds317,325 33 %
Quarterly(2), Annually(3)
45-90 days
CLO-Equities5,300 1 %n/an/a
Other privately held investments108,187 11 %n/an/a
Total other investments$949,413 100 %
At December 31, 2022
Multi-strategy funds$32,616 %Quarterly
60-90 days
Direct lending funds258,626 26 %
Quarterly(1)
90 days
Private equity funds265,836 27 %n/an/a
Real estate funds298,499 30 %
Quarterly(2), Annually(3)
45-90 days
CLO-Equities5,016 — %n/an/a
Other privately held investments136,158 14 %n/an/a
Total other investments$996,751 100 %
n/a – not applicable
(1)Applies to one fund with a fair value of $17 million (2022: $39 million).
(2)Applies to one fund with a fair value of $66 million (2022: $73 million).
(3)Applies to one fund with a fair value of $25 million (2022: $27 million).
 
The investment strategies for the above funds are as follows:
 
Multi-strategy funds: Seek to achieve above-market returns by pursuing multiple investment strategies to diversify risks and reduce volatility. This category includes funds of hedge funds which invest in a large pool of hedge funds across a diversified range of hedge fund strategies.
Direct lending funds: Seek to achieve attractive risk-adjusted returns, including current income generation, by investing in funds which provide financing directly to borrowers.
Private equity funds: Seek to achieve attractive risk-adjusted returns by investing in private transactions over the course of several years.
Real estate funds: Seek to achieve attractive risk-adjusted returns by making and managing investments in real estate and real estate securities and businesses.
Two common redemption restrictions which may impact the Company's ability to redeem multi-strategy funds are gates and lockups. A gate is a suspension of redemptions which may be implemented by the general partner or investment manager of the fund in order to defer, in whole or in part, the redemption request in the event the aggregate amount of redemption requests exceeds a predetermined percentage of the fund’s net assets which may otherwise hinder the general partner or investment manager’s ability to liquidate holdings in an orderly fashion in order to generate the cash necessary to fund extraordinarily large redemption payouts. A lockup period is the initial amount of time an investor is contractually required to hold the security before having the ability to redeem. During 2023 and 2022, neither of these restrictions impacted the Company's redemption requests. At December 31, 2023, there were no multi-strategy fund holdings (2022: nil) where the Company is still within the lockup period.
At December 31, 2023, the Company had $28 million (2022: $26 million) of unfunded commitments as a limited partner in multi-strategy funds. Once the full amount of committed capital has been called by the General Partner of each of these funds, the assets will not be fully returned until after the completion of the funds' investment term. These funds have investment terms ranging from two years to the dissolution of the underlying fund.
At December 31, 2023, the Company had $192 million (2022: $183 million) of unfunded commitments as a limited partner in direct lending funds. Once the full amount of committed capital has been called by the General Partner of each of these funds, the assets will not be fully returned until the completion of the fund's investment term. These funds have investment terms ranging from four to ten years and the General Partners of certain funds have the option to extend the term by up to three years.
At December 31, 2023, the Company had $145 million (2022: $158 million) of unfunded commitments as a limited partner in private equity funds. The life of the funds is subject to the dissolution of the underlying funds. The Company expects the overall holding period to be over six years.

At December 31, 2023, the Company had $107 million (2022: $141 million) of unfunded commitments as a limited partner in real estate funds. These funds include an open-ended fund and funds with investment terms ranging from two years to the dissolution of the underlying fund.

At December 31, 2023, the Company had $30 million (2022: $16 million) of unfunded commitments as a limited partner in three private company investment funds focusing on financial services technology companies with an emphasis on insurance technology companies ("private company investment funds"). Two of these funds have investment terms of 5 years and one fund has an investment term of 10 years.

f)    Equity Method Investments

During 2023, the Company paid $22 million to acquire 18% of the common equity of Monarch Point Re (ISAC) Ltd. ("Monarch Point Re") and Monarch Point Re (ISA 2023) Ltd. (and collectively "Monarch Point Re"), a collateralized reinsurance company formed under the laws of Bermuda as an incorporated segregated accounts company under the Incorporated Segregated Accounts Companies Act 2019, as amended (the “ISAC Act”). Monarch Point Re is an independent reinsurer jointly sponsored by the Company and Stone Point Credit, LLC ("Stone Point").

The Company retrocedes a diversified portfolio of casualty reinsurance business to Monarch Point Re and Stone Point serves as its investment manager. The Company expects to benefit from underwriting fees generated by Monarch Point Re and the income and capital appreciation Stone Point seeks to deliver through its investment management services.

Monarch Point Re is not a Variable Interest Entity ("VIE") that is required to be included in the Company's consolidated financial statements. The Company accounts for its ownership interest in Monarch Point Re under the equity method of accounting.
During 2016, the Company paid $108 million including direct transaction costs to acquire 19% of the common equity of Harrington Reinsurance Holdings Limited ("Harrington"), the parent company of Harrington Re Ltd. ("Harrington Re"), an independent reinsurance company jointly sponsored by the Company and The Blackstone Group L.P. ("Blackstone").

Through long-term service agreements, the Company serves as Harrington Re's reinsurance underwriting manager and Blackstone serves as exclusive investment management service provider. As an investor, the Company expects to benefit from underwriting profit generated by Harrington Re and the income and capital appreciation Blackstone seeks to deliver through its investment management services. In addition, the Company has entered into an arrangement with Blackstone under which underwriting and investment related fees will be shared equally.

Harrington is not a VIE that is required to be included in the Company's consolidated financial statements. The Company accounts for its ownership interest in Harrington under the equity method of accounting. The Company's proportionate share of the underlying equity in net assets resulted in a basis difference of $5 million which represents initial transactions costs.

g)    Variable Interest Entities

In the normal course of investing activities, the Company actively manages allocations to non-controlling tranches of structured securities which are variable interests issued by VIEs. These structured securities include RMBS, CMBS and ABS.

The Company also invests in limited partnerships which represent 75% of the Company's other investments. The investments in limited partnerships include multi-strategy funds, direct lending funds, private equity funds, real estate funds and CLO equity tranched securities, which are variable interests issued by VIEs (refer to Note 5(e) 'Other Investments').

The Company does not have the power to direct the activities that are most significant to the economic performance of these VIEs. Therefore, the Company is not the primary beneficiary of these VIEs. The maximum exposure to loss on these interests is limited to the amount of commitment made by the Company. The Company has not provided financial or other support to these structured securities other than the original investment.

h)    Net Investment Income
Net investment income was derived from the following sources:
Year ended December 31,202320222021
Fixed maturities$514,842 $329,858 $262,049 
Other investments20,411 57,043 181,906 
Equity securities12,088 10,390 12,752 
Mortgage loans35,312 23,407 17,427 
Cash and cash equivalents50,261 20,273 4,454 
Short-term investments8,924 3,535 664 
Gross investment income641,838 444,506 479,252 
Investment expenses(30,096)(25,677)(24,951)
Net investment income$611,742 $418,829 $454,301 
 
i)    Net Investment Gains (Losses)
The following table provides an analysis of net investment gains (losses):
Year ended December 31,202320222021
Gross realized investment gains
Fixed maturities and short-term investments$32,920 $16,671 $137,729 
Equity securities16,847 7,687 5,413 
Gross realized investment gains49,767 24,358 143,142 
Gross realized investment losses
Fixed maturities and short-term investments(158,080)(328,493)(42,613)
Equity securities(639)(406)(696)
Gross realized investment losses(158,719)(328,899)(43,309)
(Increase) decrease in allowance for expected credit losses, fixed maturities, available for sale
974 (11,421)11 
(Increase) decrease in allowance for expected credit losses, mortgage loans
(6,220)— — 
Impairment losses(1)
(12,757)(12,568)(22)
Change in fair value of investment derivatives(2)
(1,456)7,656 4,346 
Net unrealized gains (losses) on equity securities53,781 (135,915)30,111 
Net investment gains (losses)$(74,630)$(456,789)$134,279 
(1)Related to instances where the Company intends to sell securities or it is more likely than not that the Company will be required to sell securities before their anticipated recovery.
(2)Refer to Note 7 'Derivative Instruments'.

The following table provides a reconciliation of the beginning and ending balances of the allowance for expected credit losses on fixed maturities classified as available for sale:
Year ended December 31,202320222021
Balance at beginning of period$11,733 $313 $323 
Expected credit losses on securities where credit losses were not previously recognized
5,200 17,830 95 
Additions (reductions) for expected credit losses on securities where credit losses were previously recognized
4,934 (3,831)50 
Impairments of securities which the Company intends to sell or more likely than not will be required to sell — — 
Securities sold/redeemed/matured(11,108)(2,579)(155)
Balance at end of period$10,759 $11,733 $313 
Fixed Maturities
The Company evaluates available for sale securities for expected credit losses when fair value is below amortized cost. If the Company intends to sell or will be required to sell the security before its anticipated recovery, the full amount of the impairment loss is charged to net income (loss). If the Company does not intend to sell or will not be required to sell the security before its anticipated recovery, an allowance for expected credit losses is established and the portion of the loss that relates to credit losses is recorded in net income (loss).
A summary of credit loss activity by asset class, the significant inputs and the methodology used to estimate credit losses are described below.
U.S. Government, U.S. Agency and U.S. Agency RMBS
Unrealized losses on securities issued or backed, either explicitly or implicitly by the U.S. government are not analyzed for credit losses. The Company has concluded that the possibility of a credit loss on these securities is highly unlikely due to the explicit U.S. government guarantee related to certain securities (e.g., Government National Mortgage Association issuances) and the implicit guarantee related to other securities that has been validated by past actions (e.g., U.S. government bailout of Federal National Mortgage Association and Federal Home Loan Mortgage Corporation during the 2008 credit crisis).
Although these securities are not analyzed for credit losses, they are evaluated for intention to sell and likely requirement to sell.
Non-U.S. Government
Non-U.S. government securities are evaluated for expected credit losses primarily through qualitative assessments of the likelihood of credit losses using information such as severity of unrealized losses, credit ratings and price volatility. At December 31, 2023, the gross unrealized losses of $19 million included foreign exchange losses of $6 million. At December 31, 2023, the allowance for expected credit losses on non-U.S. government fixed maturities related to loss severity where the forecasted recovery to amortized cost is uncertain.
At December 31, 2022, the gross unrealized losses of $53 million included foreign exchange losses of $24 million. At December 31, 2022, the Company did not anticipate any credit losses on its non-U.S. government fixed maturities.
Corporate Debt
To estimate expected credit losses for corporate debt securities, the Company's projected cash flows are primarily driven by assumptions regarding the severity of loss, probability of default and projected recovery rates. The Company's default and loss severity rates are based on credit rating, credit analysis and macroeconomic forecasts. At December 31, 2023 and 2022, the allowance for expected credit losses on corporate debt securities mainly related to loss severity where the forecasted recovery to amortized cost was uncertain.
 
CMBS
The Company's investments in CMBS are diversified and primarily rated AA or better. At December 31, 2023, CMBS had a weighted average estimated subordination percentage of 37% (2022: 38%). Based on discounted cash flows at December 31, 2023 and 2022, the current level of subordination is sufficient to cover the estimated loan losses on the underlying collateral of the CMBS.
Non-agency RMBS
To estimate expected credit losses for non-agency RMBS, the Company's projected cash flows incorporated underlying data from widely accepted third-party data sources along with certain internal assumptions and judgments regarding the future performance of the security. These assumptions included default, delinquency, loss severity and prepayment rates.
At December 31, 2023, the fair value of the Company's non-agency RMBS was $153 million (2022: $134 million), consisting primarily of $34 million (2022: $39 million) of Prime and $100 million (2022: $76 million) of Alt-A, Non-qualified, and Home Equity MBS. At December 31, 2023 and 2022, the allowance for expected credit losses on non-agency RMBS related to loss severity where the forecasted recovery to amortized cost is uncertain.
ABS

The Company's investments in ABS consist mainly of CLO debt tranched securities ("CLO Debt") purchased primarily as new issues between 2018 and 2023. Substantially all of these new issues had credit ratings of AA or better. The Company utilizes a scenario-based approach to review its CLO Debt portfolio based on the current asset market price. The Company also reviews subordination levels of these securities to determine their ability to absorb credit losses of underlying collateral. If losses are forecast to be below the subordination level for a tranche held by the Company, the security is determined not to have a credit loss. At December 31, 2023 and 2022, the allowance for expected credit losses on ABS related to loss severity where the forecasted recovery to amortized cost is uncertain.

Municipals

Municipal securities are evaluated for expected credit losses primarily through qualitative assessments of the likelihood of credit losses using information such as severity of unrealized losses, credit ratings and price volatility. At December 31, 2023 and 2022, the allowance for expected credit losses on municipals related to loss severity where the forecasted recovery to amortized cost is uncertain.
j)    Restricted Assets
In order to support the Company's obligations in regulatory jurisdictions where it operates as a non-admitted carrier, the Company provides collateral in the form of assets held in trust and, to a lesser extent, letters of credit (refer to Note 10(c) 'Debt and Financing Arrangements').
In addition, the Company operates in the Lloyd’s market through its corporate members, AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited, which provide 70% and 30%, respectively of Syndicate 1686's capital support. Lloyd’s sets capital requirements for corporate members annually through the application of a capital model that is based on regulatory rules pursuant to Directive 2009/138/EC of the European Parliament and of the Council of 25 November 2009 on the taking up and pursuit of business of Insurance and Reinsurance (Solvency II) ("Solvency II").
The capital provided to support underwriting, or Funds at Lloyd’s ("FAL"), may be satisfied by cash, certain investments and letters of credit provided by approved banks (refer to Note 12 'Commitments and Contingencies' and Note 22 'Statutory Financial Information').
At December 31, 2023, collateral held in trust for third-party agreements of $2,598 million (2022: $2,491 million) included $550 million (2022: $539 million) of fixed maturities, and cash of $296 million (2022: $217 million) held on deposit to support the underwriting activities of Syndicate 1686.
The Company's restricted investments and cash primarily consist of high-quality fixed maturity and short-term investment securities.
The table below provides the fair values of the Company's restricted investments and cash:
At December 31,20232022
Collateral in trust for inter-company agreements
$614,089 $790,449 
Collateral for secured letter of credit facility423,522 424,624 
Funds at Lloyd's893,177 748,573 
Collateral in trust for third-party agreements
2,597,633 2,491,317 
Securities on deposit or in trust with regulatory authorities772,472 731,660 
Total restricted investments and cash$5,300,893 $5,186,623 

 k)    Reverse Repurchase Agreements
At December 31, 2023, the Company held $12 million (2022: $nil) of reverse repurchase agreements. These loans are fully collateralized, are generally outstanding for a short period of time and are presented on a gross basis as part of cash and cash equivalents in the Company's consolidated balance sheets. The required collateral for these loans is either cash or U.S. Treasuries at a minimum rate of 102% of the loan principal. Upon maturity, the Company receives principal and interest income. The Company monitors the estimated fair value of the securities loaned and borrowed on a daily basis with additional collateral obtained as necessary throughout the duration of the transaction.
XML 39 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
Fair Value Hierarchy

Fair value is defined as the price to sell an asset or transfer a liability (i.e., the "exit price") in an orderly transaction between market participants. U.S. GAAP prescribes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to quoted prices in active markets and the lowest priority to unobservable data. The level in the hierarchy within which a given fair value measurement falls is determined based on the lowest level input that is significant to the measurement. The hierarchy is broken down into three levels as follows:

Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Level 2 - Valuations based on quoted prices in active markets for similar assets or liabilities, quoted prices for identical assets or liabilities in inactive markets, or for which significant inputs are observable (e.g., interest rates, yield curves, prepayment speeds, default rates, loss severities, etc.) or can be corroborated by observable market data.

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The unobservable inputs reflect the Company's judgments about assumptions that market participants might use.

The availability of observable inputs can vary from financial instrument to financial instrument and is affected by a wide variety of factors including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment.

Accordingly, the degree of judgment exercised by management in determining fair value is greatest for financial instruments categorized as Level 3. In periods of market dislocation, the observability of prices and inputs may be reduced for many financial instruments. This may lead the Company to change the selection of valuation technique (from market to cash flow approach) or may cause the Company to use multiple valuation techniques to estimate the fair value of a financial instrument. This circumstance could cause an instrument to be reclassified between levels within the fair value hierarchy.

Valuation Techniques

The valuation techniques, including significant inputs and assumptions generally used to determine the fair values of the Company's financial instruments as well as the classification of the fair values of its financial instruments in the fair value hierarchy are described in detail below.

Fixed Maturities

At each valuation date, the Company uses the market approach valuation technique to estimate the fair value of its fixed maturities portfolio, where possible. The market approach includes, but is not limited to, prices obtained from third-party pricing services for identical or comparable securities and the use of "pricing matrix models" using observable market inputs such as yield curves, credit risks and spreads, measures of volatility, and prepayment speeds. Pricing from third-party pricing services is sourced from multiple vendors, where available, and the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Where prices are unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers who are active in the corresponding markets. The valuation techniques including significant inputs and assumptions generally used to determine the fair values of the Company's fixed maturities by asset class as well as the classifications of the fair values of these securities in the fair value hierarchy are described in detail below.
U.S. Government and Agency

U.S. government and agency securities consist primarily of bonds issued by the U.S. Treasury and mortgage pass-through agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. As the fair values of U.S. Treasury securities are based on unadjusted quoted market prices in active markets, the fair values of these securities are classified as Level 1. The fair values of U.S. government agency securities are determined using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads are observable market inputs, the fair values of U.S. government agency securities are classified as Level 2.

Non-U.S. Government

Non-U.S. government securities include bonds issued by non-U.S. governments and their agencies along with supranational organizations (collectively also known as sovereign debt securities). The fair values of these securities are based on prices obtained from international indices or valuation models that include inputs such as interest rate yield curves, cross-currency basis index spreads and country credit spreads for structures similar to the sovereign bond in terms of issuer, maturity and seniority. As the significant inputs used to price these securities are observable market inputs, the fair values of non-U.S. government securities are classified as Level 2.

Corporate Debt

Corporate debt securities consist primarily of investment grade debt of a wide variety of corporate issuers and industries. The fair values of these securities are generally determined using the spread above the risk-free yield curve. These spreads are generally obtained from the new issue market, secondary trading and broker-dealer quotes. As the yields for the risk-free yield curve and the spreads are observable market inputs, the fair values of corporate debt securities are generally classified as Level 2. Where pricing is unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers to estimate fair value. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. In this event, the fair values of these securities are classified as Level 3.

Agency RMBS

Agency RMBS consist of bonds issued by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. The fair values of these securities are priced using a mortgage pool specific model which uses daily inputs from the active to be announced market and the spread associated with each mortgage pool based on vintage. As the significant inputs used to price these securities are observable market inputs, the fair values of Agency RMBS are classified as Level 2.

CMBS

CMBS mainly include investment grade bonds originated by non-agencies. The fair values of these securities are determined using a pricing model which uses dealer quotes and other available trade information along with security level characteristics to determine deal specific spreads. As the significant inputs used to price these securities are observable market inputs, the fair values of CMBS are generally classified as Level 2. Where pricing is unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers to estimate fair value. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. In this event, the fair values of these securities are classified as Level 3.
Non-agency RMBS

Non-agency RMBS mainly include investment grade bonds originated by non-agencies. The fair values of these securities are determined using an option adjusted spread model or other relevant models, which use inputs including available trade information or broker quotes, prepayment and default projections based on historical statistics of the underlying collateral and current market data. As the significant inputs used to price these securities are observable market inputs, the fair values of non-agency RMBS are generally classified as Level 2. Where pricing is unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers to estimate fair value. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. In this event, the fair values of these securities are classified as Level 3.

ABS

ABS mainly include investment grade bonds backed by pools of loans with a variety of underlying collateral, including auto loans, student loans, credit card receivables and collateralized loan obligations ("CLOs"), originated by a variety of financial institutions. The fair values of these securities are determined using a model which uses prepayment speeds and spreads sourced primarily from the new issue market. As the significant inputs used to price these securities are observable market inputs, the fair values of ABS are generally classified as Level 2. Where pricing is unavailable from pricing services, the Company obtains non-binding quotes from broker-dealers to estimate fair value. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. In this event, the fair values of these securities are classified as Level 3.

Municipals

Municipals comprise revenue bonds and general obligation bonds issued by U.S. domiciled state and municipal entities. The fair values of these securities are determined using spreads obtained from the new issue market, trade prices and broker-dealers quotes. As the significant inputs used to price these securities are observable market inputs, the fair values of municipals are classified as Level 2.

Equity Securities

Equity securities include common stocks, preferred stocks, exchange-traded funds and bond mutual funds. As the fair values of common stocks and exchange-traded funds are based on unadjusted quoted market prices in active markets, the fair values of these securities are classified as Level 1. As the significant inputs used to price preferred stocks are observable market inputs, the fair value of these securities are classified as Level 2. As bond mutual funds have daily liquidity, the fair values of these securities are classified as Level 2.

Other Investments

The fair value of an indirect investment in CLO-Equities is estimated using an income approach valuation technique, specifically an externally developed discounted cash flow model due to the lack of observable and relevant trades in secondary markets. As the significant inputs used to price this security are unobservable, the fair value of the indirect investment in CLO-Equities is classified as Level 3.
Other privately held investments include common shares, preferred shares, private company investment funds, investments in limited partnerships, convertible notes, convertible preferred shares, and a variable yield security. These investments are initially valued at cost, which approximates fair value. In subsequent measurement periods, the fair values of these investments are generally derived from one or a combination of valuation methodologies which consider factors including recent capital raises by the investee companies, comparable precedent transaction multiples, comparable publicly traded multiples, third-party valuations, discounted cash-flow models, and other techniques that consider the industry and development stage of each investee company. The fair value of the variable yield security is determined using an externally developed discounted cash flow model. In order to assess the reasonableness of the information received from investee companies, the Company maintains an understanding of current market conditions, historical results, and emerging trends that may impact the results of operations, financial condition or liquidity of these companies. In addition, the Company engages in regular communication with management at investee companies. As the significant inputs used to price these investments are unobservable, the fair values of other privately held investments are classified as Level 3. The fair values of private company investment funds are estimated using NAVs as advised by external fund managers or third-party administrators.
Short-term Investments

Short-term investments primarily comprise highly liquid securities with maturities greater than three months but less than one year from the date of purchase. These securities are typically not actively traded due to their approaching maturity, therefore their amortized cost approximates fair value. The fair values of short-term investments are classified as Level 2.

Derivative Instruments

Derivative instruments include foreign exchange forward contracts that are customized to the Company's economic hedging strategies and trade in the over-the-counter derivative market. The fair values of these derivatives are determined using a market approach valuation technique based on significant observable market inputs from third-party pricing vendors, non-binding broker-dealer quotes and/or recent trading activity. As the significant inputs used to price these derivatives are observable market inputs, the fair values of these derivatives are classified as Level 2.

Other underwriting-related derivatives include insurance and reinsurance contracts that are accounted for as derivatives. These derivative contracts are initially valued at cost which approximates fair value. In subsequent measurement periods, the fair values of these derivatives are determined using internally developed discounted cash flow models. As the significant inputs used to price these derivatives are unobservable, the fair values of these contracts are classified as Level 3.

Cash-Settled Awards

Cash-settled awards comprise restricted stock units that form part of the Company's compensation program. Although the fair values of these awards are determined using observable quoted market prices in active markets, the restricted stock units are not actively traded. As the significant inputs used to price these securities are observable market inputs, the fair values of these liabilities are classified as Level 2.
The tables below present the financial instruments measured at fair value on a recurring basis for the periods indicated:
Quoted prices in active markets
for identical assets (Level 1)
Significant other observable
inputs (Level 2)
Significant unobservable inputs (Level 3)Fair value based on NAV practical expedientTotal fair value
At December 31, 2023
Assets
Fixed maturities, available for sale
U.S. government and agency$2,989,612 $17,916 $ $ $3,007,528 
Non-U.S. government 723,959   723,959 
Corporate debt 4,338,419 135,753  4,474,172 
Agency RMBS 1,634,661   1,634,661 
CMBS 839,696   839,696 
Non-agency RMBS 153,396   153,396 
ABS 1,242,971   1,242,971 
Municipals 158,359   158,359 
 2,989,612 9,109,377 135,753 — 12,234,742 
Equity securities
Common stocks2,546    2,546 
Preferred stocks1 5,600   5,601 
Exchange-traded funds287,275    287,275 
Bond mutual funds 293,089   293,089 
 289,822 298,689   588,511 
Other investments
Multi-strategy funds
   24,619 24,619 
Direct lending funds   192,270 192,270 
Private equity funds   301,712 301,712 
Real estate funds   317,325 317,325 
CLO-Equities  5,300  5,300 
Other privately held investments  87,289 20,898 108,187 
  92,589 856,824 949,413 
Short-term investments 17,216   17,216 
Other assets
Derivative instruments (refer to Note 7) 4,424   4,424 
Total Assets$3,279,434 $9,429,706 $228,342 $856,824 $13,794,306 
Liabilities
Derivative instruments (refer to Note 7)$ $10,165 $ $ $10,165 
Cash-settled awards (refer to Note 17)     
Total Liabilities$ $10,165 $ $ $10,165 
Quoted prices in active markets
for identical assets (Level 1)
Significant other observable
inputs (Level 2)
Significant unobservable inputs (Level 3)Fair value based on NAV practical expedientTotal fair value
At December 31, 2022
Assets
Fixed maturities, available for sale
U.S. government and agency$2,600,636 $38,694 $— $— $2,639,330 
Non-U.S. government— 562,029 — — 562,029 
Corporate debt— 4,136,452 119,104 — 4,255,556 
Agency RMBS— 1,202,785 — — 1,202,785 
CMBS— 947,778 — — 947,778 
Non-agency RMBS— 133,534 — — 133,534 
ABS— 1,429,527 — — 1,429,527 
Municipals— 156,355 — — 156,355 
 2,600,636 8,607,154 119,104 — 11,326,894 
Equity securities
Common stocks7,473 — — — 7,473 
Preferred stocks72 — — — 72 
Exchange-traded funds269,806 — — — 269,806 
Bond mutual funds— 207,902 — — 207,902 
 277,351 207,902 — — 485,253 
Other investments
Multi-strategy funds
— — — 32,616 32,616 
Direct lending funds— — — 258,626 258,626 
Private equity funds— — — 265,836 265,836 
Real estate funds— — — 298,499 298,499 
CLO-Equities— — 5,016 — 5,016 
Other privately held investments— — 136,158 — 136,158 
— — 141,174 855,577 996,751 
Short-term investments— 70,310 — — 70,310 
Other assets
Derivative instruments (refer to Note 7)— 37,682 — — 37,682 
Total Assets$2,877,987 $8,923,048 $260,278 $855,577 $12,916,890 
Liabilities
Derivative instruments (refer to Note 7)$— $703 $— $— $703 
Cash-settled awards (refer to Note 17)— 4,792 — — 4,792 
Total Liabilities$— $5,495 $— $— $5,495 

 
The following table quantifies the significant unobservable inputs used in estimating fair values at December 31, 2023 of investments classified as Level 3 in the fair value hierarchy:
Asset fair valueValuation techniqueUnobservable inputAmount /RangeWeighted
average
Other investments - CLO-Equities$5,300 Discounted cash flowDefault rate4.5%4.5%
  Loss severity rate50.0%50.0%
  Collateral spread3.0%3.0%
Estimated maturity date4 years4 years
Other investments - Other privately
    held investments
$18,940 Discounted cash flowDiscount rate6.0%6.0%
Default rate0.5%0.5%
Loss absorption yield1.0%1.0%
Estimated maturity date
0 - 2 years
1 year
Note: Fixed maturities of $136 million that are classified as Level 3 are excluded from the above table as these securities are priced using broker-dealer quotes. In addition, other privately held investments of $68 million that are classified as Level 3 are excluded from the above table as these investments are priced using capital statements received from investee companies.

Other Investments - CLO-Equities

The CLO-Equities market continues to be relatively inactive with only a small number of transactions being observed, particularly related to transactions involving CLO-Equities held by the Company. Accordingly, the fair value of the Company's indirect investment in CLO-Equities is determined using a discounted cash flow model prepared by an external investment manager.

The default and loss severity rates are the most judgmental unobservable market inputs to the discounted cash flow model to which the valuation of the Company's indirect investment in CLO-Equities is most sensitive. A significant increase (decrease) in either of these significant inputs in isolation would result in a lower (higher) fair value estimate for the investment in CLO-Equities and, in general, a change in default rate assumptions would be accompanied by a directionally similar change in loss severity rate assumptions. Collateral spreads and estimated maturity dates are less judgmental inputs as they are based on the historical average of actual spreads and the weighted average life of the current underlying portfolios, respectively. A significant increase (decrease) in either of these significant inputs in isolation would result in a higher (lower) fair value estimate for the investment in CLO-Equities. In general, these inputs have no significant interrelationship with each other or with default and loss severity rates.

On a quarterly basis, the Company's valuation process for its indirect investment in CLO-Equities includes a review of the underlying cash flows and key assumptions used in the discounted cash flow model. The above significant unobservable inputs are reviewed and updated based on information obtained from secondary markets, including information received from the managers of the Company's CLO-Equities investment. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow model, the Company maintains an understanding of current market conditions, historical results, and emerging trends that may impact future cash flows. In addition, the assumptions the Company uses in its models are updated through regular communication with industry participants and ongoing monitoring of the deals in which the Company participates.
Other Investments - Other Privately Held Securities

Other privately held securities are initially valued at cost which approximates fair value. In subsequent measurement periods, the fair value of the variable yield security was determined using an externally developed discounted cash flow model. This model includes inputs that are specific to that investment. The inputs used in the fair value measurement include an appropriate discount rate, default rate, loss absorption rate and estimated maturity date. The selection of an appropriate discount rate is judgmental and is the most significant unobservable input used in the valuation of this investment. A significant increase (decrease) in this input in isolation could result in significantly lower (higher) fair value measurement for this investment. In order to assess the reasonableness of the inputs the Company uses in the discounted cash flow model, the Company maintains an understanding of current market conditions, historical results, as well as investee specific information that may impact future cash flows.
The following table presents changes in Level 3 for financial instruments measured at fair value on a recurring basis:
Opening
balance
Transfers
into
Level 3
Transfers
out of
Level 3
Included in net income(1)
Included
in OCI (2)
PurchasesSalesSettlements/
distributions
Closing
balance
Change in
unrealized
gains/(losses) (3)
Year ended December 31, 2023
Fixed maturities, available for sale         
Corporate debt$119,104 $ $ $(8,527)$2,438 $38,173 $(770)$(14,665)$135,753 $ 
 119,104   (8,527)2,438 38,173 (770)(14,665)135,753  
Other investments
CLO-Equities5,016   2,395    (2,111)5,300 2,395 
Other privately held investments136,158  (25,510)(9,904) 21,077 (34,532) 87,289 (17,986)
 141,174  (25,510)(7,509) 21,077 (34,532)(2,111)92,589 (15,591)
Total assets$260,278 $ $(25,510)$(16,036)$2,438 $59,250 $(35,302)$(16,776)$228,342 $(15,591)
Other liabilities
Derivative instruments$ $ $ $ $ $ $ $ $ $ 
Total liabilities$ $ $ $ $ $ $ $ $ $ 
Year ended December 31, 2022
Fixed maturities, available for sale         
Corporate debt$42,894 $— $— $(104)$(9,014)$90,130 $— $(4,802)$119,104 $— 
 42,894 — — (104)(9,014)90,130 — (4,802)119,104 — 
Other investments
CLO-Equities5,910 — — 2,611 — — — (3,505)5,016 2,611 
Other privately held investments104,521 — — 13,646 — 19,991 — (2,000)136,158 13,646 
 110,431 — — 16,257 — 19,991 — (5,505)141,174 16,257 
Total assets$153,325 $— $— $16,153 $(9,014)$110,121 $— $(10,307)$260,278 $16,257 
Other liabilities
Derivative instruments$5,630 $— $— $(3,542)$— $— $— $(2,088)$— $— 
Total liabilities$5,630 $— $— $(3,542)$— $— $— $(2,088)$— $— 
(1)    Realized gains (losses) on fixed maturities and realized and unrealized gains (losses) on other assets and other liabilities included in net income are included in net investment gains (losses). Realized and unrealized gains (losses) on other investments included in net income are included in net investment income.
(2)    Unrealized gains (losses) on fixed maturities are included in other comprehensive income ("OCI").
(3)    Change in unrealized gains (losses) relating to assets and liabilities held at the reporting date.
Transfers into Level 3 from Level 2
There were no transfers into Level 3 from Level 2 during 2023 and 2022.
Transfers out of Level 3 into Level 2
There were no transfers out of Level 3 into Level 2 during 2023 and 2022.
Other Transfers out of Level 3
During 2023, two private company investment funds included in other privately held investments in the consolidated balance sheets were transferred from Level 3 to the NAV practical expedient. In addition, the Company's investment in Monarch Point Re was transferred from Level 3 to Equity method investments (refer to Note 5(f) 'Equity Method Investments', Note 8 'Reserve for Losses and Loss Expenses' and Note 18 'Related Party Transactions').
Measuring the Fair Value of Other Investments Using Net Asset Valuations
The fair values of multi-strategy funds, direct lending funds, private equity funds, real estate funds and private company investment funds are estimated using net asset valuations ("NAVs") as advised by external fund managers or third-party administrators. For these funds, NAVs are based on the manager's or administrator's valuation of the underlying holdings in accordance with the fund's governing documents and in accordance with U.S. GAAP.
For multi-strategy funds, direct lending funds, private equity funds, real estate funds and private company investment funds, valuation statements are typically released on a reporting lag. Therefore, the Company estimates the fair value of these funds by starting with the most recent fund valuations and adjusting for capital calls, redemptions, drawdowns and distributions. Return estimates are not available from the relevant fund managers for these funds, therefore the Company typically has a reporting lag in its fair value measurements of these funds. At December 31, 2023 and 2022, all funds measured at fair value using NAVs are reported generally on a one quarter lag.
The Company often does not have access to financial information relating to the underlying securities held within the funds, therefore, management is unable to corroborate the fair values placed on the securities underlying the asset valuations provided by fund managers or fund administrators. In order to assess the reasonableness of the NAVs, the Company performs a number of monitoring procedures on a quarterly basis, to assess the quality of the information provided by fund managers and fund administrators. These procedures include, but are not limited to, regular review and discussion of each fund's performance with its manager, regular evaluation of fund performance against applicable benchmarks and the backtesting of the Company's fair value estimates against subsequently received NAVs. Backtesting involves comparing the Company's previously reported fair values for each fund against NAVs per audited financial statements (for year-end values) and final NAVs from fund managers and fund administrators (for interim values).
The fair values of multi-strategy funds, direct lending funds, private equity funds, real estate funds and private company investment funds, are measured using the NAV practical expedient, therefore the fair values of these funds have not been categorized within the fair value hierarchy.
Financial Instruments Disclosed, But Not Carried, at Fair Value
The fair value of financial instruments accounting guidance also applies to financial instruments disclosed, but not carried, at fair value, except for certain financial instruments, including insurance contracts.
At December 31, 2023, the carrying values of cash and cash equivalents including restricted amounts, accrued investment income, receivable for investments sold, certain other assets, payable for investments purchased and certain other liabilities approximated fair values due to their short maturities. As these financial instruments are not actively traded, their fair values are classified as Level 2.
At December 31, 2023, the Company's fixed maturities, held to maturity, were recorded at amortized cost with a carrying value of $686 million (2022: $698 million) and a fair value of $676 million (2022: $675 million). The fair values of these securities are determined using a model which uses prepayment speeds and spreads sourced primarily from the new issue market. As the significant inputs used to price these securities are observable market inputs, their fair values are classified as Level 2.
At December 31, 2023, the carrying value of mortgage loans, held for investment, approximated fair value. The fair values of mortgage loans are primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk or are determined from pricing for similar loans. As mortgage loans are not actively traded, their fair values are classified as Level 3.
At December 31, 2023, the Company's debt was recorded at amortized cost with a carrying value of $1,314 million (2022: $1,312 million) and a fair value of $1,198 million (2022: $1,160 million). The fair value of the Company's debt is based on prices obtained from a third-party pricing service and is determined using the spread above the risk-free yield curve. These spreads are generally obtained from the new issue market, secondary trading and broker-dealer quotes. As the yields for the risk-free yield curve and the spreads are observable market inputs, the fair value of this debt is classified as Level 2.
At December 31, 2023, Federal Home Loan Bank advances were recorded at amortized cost with a carrying value of $86 million (2022: $81 million) and a fair value of $86 million (2022: $81 million). As these advances are not actively traded, their fair values are classified as Level 2.
XML 40 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS
12 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS DERIVATIVE INSTRUMENTS
The following table provides the balance sheet classifications of derivatives recorded at fair value:
  December 31, 2023December 31, 2022
  Derivative
notional
amount
Derivative asset
fair
value(1)
Derivative liability
fair
value(1)
Derivative
notional
amount
Derivative asset
fair
value(1)
Derivative liability
fair
value(1)
Relating to investment portfolio:
Foreign exchange forward contracts$49,307 $66 $274 $54,076 $81 $559 
Relating to underwriting portfolio:
Foreign exchange forward contracts1,347,559 4,358 9,891 1,441,273 37,601 144 
Total derivatives$4,424 $10,165 $37,682 $703 
(1)Derivative assets and derivative liabilities are classified within other assets and other liabilities in the consolidated balance sheets.
The notional amounts of derivative contracts represent the basis on which amounts paid or received are calculated and are presented in the above table to quantify the volume of the Company's derivative activities. Notional amounts are not reflective of credit risk.
None of the Company's derivative instruments are designated as hedges.
Offsetting Assets and Liabilities

The Company's derivative instruments are generally traded under International Swaps and Derivatives Association master netting agreements which establish terms that apply to all transactions. In the event of a bankruptcy or other stipulated event, master netting agreements provide that individual positions be replaced with a new amount, usually referred to as the termination amount, determined by taking into account market prices and converting into a single currency. Effectively, this contractual close-out netting reduces credit exposure from gross to net exposure.

The following table provides a reconciliation of gross derivative assets and liabilities to the net amounts presented in the consolidated balance sheets, with the difference being attributable to the impact of master netting agreements:
December 31, 2023December 31, 2022
Gross amountsGross amounts offset
Net
amounts(1)
Gross amountsGross amounts offset
Net
amounts(1)
Derivative assets$8,708 $(4,284)$4,424 $41,762 $(4,080)$37,682 
Derivative liabilities$14,449 $(4,284)$10,165 $4,783 $(4,080)$703 
(1)Net asset and liability derivatives are classified within other assets and other liabilities in the consolidated balance sheets.

Refer to Note 5 'Investments' for information on reverse repurchase agreements.

a)     Relating to Investment Portfolio
Foreign Currency Risk
The Company's investment portfolio is exposed to foreign currency risk. Therefore, the fair values of its investments are partially influenced by changes in foreign exchange rates. The Company may enter into foreign exchange forward contracts to manage the effect of this foreign currency risk. These foreign currency hedging activities are not designated as specific hedges for financial reporting purposes.
b)     Relating to Underwriting Portfolio
Foreign Currency Risk
The Company's insurance and reinsurance subsidiaries and branches operate in various countries. Some of its business is written in currencies other than the U.S. dollar, therefore the underwriting portfolio is exposed to significant foreign currency risk. The Company manages foreign currency risk by seeking to match its foreign-denominated net liabilities under insurance and reinsurance contracts with cash and investments that are denominated in the same currencies. The Company uses derivative instruments, specifically, forward contracts to economically hedge foreign currency exposures.
Other Underwriting-related Risks

The Company enters into insurance and reinsurance contracts that are accounted for as derivatives. These insurance or reinsurance contracts provide indemnification to an insured or cedant as a result of a change in a variable as opposed to an identifiable insurable event. The Company considers these contracts to be part of its underwriting operations.

The following table provides the total unrealized and realized gains (losses) recognized in net income (loss) for derivatives not designated as hedges:
  Consolidated statement of operations line item that includes gain (loss) recognized
in net income (loss)
Amount of gain (loss) recognized in
net income (loss)
  202320222021
Relating to investment portfolio:
Foreign exchange forward contractsNet investment gains (losses)$(1,456)$7,656 $4,346 
Relating to underwriting portfolio:
Foreign exchange forward contractsForeign exchange (losses) gains8,121 (31,609)(50,738)
Other underwriting-related contractsOther insurance related income (loss) 3,542 2,742 
Total$6,665 $(20,411)$(43,650)
XML 41 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES
12 Months Ended
Dec. 31, 2023
Insurance Loss Reserves [Abstract]  
RESERVE FOR LOSSES AND LOSS EXPENSES RESERVE FOR LOSSES AND LOSS EXPENSES
Reserving Methodology
Sources of Information
The Company's loss reserving process begins with the collection and analysis of paid and incurred claim data for each of the Company's segments. The segment data is disaggregated by line of business and further disaggregated by underwriting year and accident year. Underwriting year or accident year information is used to analyze the Company's business and to estimate reserves for losses and loss expenses. Lines of business are reviewed to ensure that the underlying contracts have homogeneous loss development characteristics, while remaining large enough to make the estimation of trends credible. The Company's lines of business are reviewed on a regular basis and adjusted over time as the Company's business evolves. The paid and incurred claim data serves as a key input to many of the methods employed by the Company's actuaries.
Actuarial Analysis
Multiple actuarial methods are available to estimate ultimate losses. Each method has its own assumptions and its own advantages and disadvantages, with no single estimation method being better than the others in all situations and no one set of assumption variables being meaningful for all lines of business. The relative strengths and weaknesses of the particular estimation methods when applied to a particular group of claims can also change over time.
The following is a brief description of the reserve estimation methods commonly employed by the Company's actuaries including a discussion of their particular strengths and weaknesses: 
Expected Loss Ratio Method ("ELR Method"): This method estimates ultimate losses for an accident year or underwriting year by applying an expected loss ratio ("ELR") to the earned or written premium for that year. Generally, expected loss ratios are based on one or more of (a) an analysis of historical loss experience to date, (b) pricing information and (c) industry data, adjusted as appropriate, to reflect changes in rates, loss and exposure trends, and terms and conditions. This method is insensitive to actual incurred losses for the accident year or underwriting year in question and is, therefore, often useful in the early stages of development when very few losses have been incurred. Conversely, the lack of sensitivity to incurred/paid losses for the accident year or underwriting year in question means that this method is usually inappropriate in later stages of an accident year or underwriting year’s development.
Loss Development Method (also referred to as the "Chain Ladder Method" or "Link Ratio Method"): This method assumes that the losses incurred/paid for each accident year or underwriting year at a particular development stage follow a relatively similar pattern. It assumes that on average, every accident year or underwriting year will display the same percentage of ultimate losses incurred/paid at the same point in time after the inception of that year. The percentages incurred/paid are established for each development stage (e.g., 12 months, 24 months, etc.) after examining averages from historical loss development data and/or, in limited instances, external industry benchmark information. Ultimate losses are then estimated by multiplying the actual incurred/paid losses by the reciprocal of the established incurred/paid percentage. The strengths of this method are that it reacts to loss emergence/payments and that it makes full use of historical claim emergence/payment experience. However, this method has weaknesses when the underlying assumption of stable loss development/payment patterns is not valid. This could be the consequence of changes in business mix, claim inflation trends or claim reporting practices and/or the presence of large claims, among other things. Furthermore, this method tends to produce volatile estimates of ultimate losses where there is volatility in the underlying incurred/paid patterns. In particular, where the expected percentage of incurred/paid losses is low, small deviations between actual and expected claims can lead to very volatile estimates of ultimate losses. As a result, this method is often unsuitable at early development stages for an accident year or underwriting year.
Bornhuetter-Ferguson Method ("BF Method"): This method can be seen as a combination of the ELR and Loss Development Methods, under which the Loss Development Method is given progressively more weight as an accident year or underwriting year matures. The main advantage of the BF Method is that it provides a more stable estimate of ultimate losses than the Loss Development Method at earlier stages of development, while remaining more responsive to emerging loss development than the ELR Method. In addition, the BF Method allows for the incorporation of external
market information through the use of expected loss ratios, whereas the Loss Development Method does not incorporate such information.
As part of the loss reserving process, the Company's actuaries employ the estimation method(s) that they believe will produce the most reliable estimate of ultimate losses, at that particular evaluation date, for each line of business and accident year or underwriting year combination. Often, this is a blend (i.e., weighted average) of the results of two or more appropriate actuarial methods.
These ultimate loss estimates are generally utilized to evaluate the adequacy of ultimate loss estimates for previous accident or underwriting years, established in the prior reporting period. For the initial estimate of the current accident or underwriting year, the available claim data is typically insufficient to produce a reliable estimate of ultimate losses. As a result, initial estimates for an accident or underwriting year are generally based on the ELR Method for longer tailed lines and a BF Method for shorter tailed lines.
The initial ELR for each line of business is established by the Company's actuaries at the start of the year as part of the planning process, taking into consideration prior accident years’ or underwriting years' experience and industry benchmarks, adjusted after considering factors such as loss and exposure trends, rate differences, changes in contract terms and conditions, business mix changes and other known differences between the current and prior accident or underwriting years. The initial expected loss ratios for a given accident or underwriting year may be modified over time if the underlying assumptions, such as loss development or premium rate changes, differ from the original assumptions.
Key Actuarial Assumptions
The use of the above actuarial methods requires the Company to make certain explicit assumptions, the most significant of which are expected loss ratios and loss development patterns and the Company relies on historical loss experience in establishing these assumptions. In establishing expected loss ratios for the insurance segment, consideration is given to a number of other factors, including exposure trends, rate adequacy on new and renewal business, ceded reinsurance costs, changes in claims emergence and the Company's underwriters’ view of terms and conditions in the market environment. For the reinsurance segment, expected loss ratios are based on a contract-by-contract review, which considers information provided by clients together with estimates provided by the Company's underwriters and actuaries about the impact of changes in pricing, terms and conditions and coverage. Market experience for some lines of business as compiled and analyzed by an independent actuarial firm is also considered, as appropriate.
Reserving for Catastrophic Events

The Company cannot estimate losses from widespread catastrophic events, such as hurricanes and earthquakes, using the traditional actuarial methods described above. The magnitude and complexity of losses associated with certain of these events inherently increase the level of uncertainty and, therefore, the level of management judgment involved in arriving at estimated net reserves for losses and loss expenses. As a result, actual losses for these events may ultimately differ materially from current estimates.
Net reserves for losses and loss expenses related to catastrophes represent the Company's best estimate of losses and loss expenses that have been incurred at December 31, 2023. The determination of these net reserves for losses and loss expenses is estimated by management after a catastrophe occurs by completing an in-depth analysis of individual contracts which may potentially have been impacted by the catastrophic event. This in-depth analysis may rely on several sources of information including:
estimates of the size of insured industry losses from the catastrophic event and the Company's corresponding market share;
a review of the Company's portfolio of contracts to identify those contracts which may be exposed to the catastrophic event;
a review of modeled loss estimates based on information previously reported by customers and brokers, including exposure data obtained during the underwriting process;
a review of the coverage provided by the Company's ceded reinsurance;
discussions of the impact of the event with customers and brokers; and
catastrophe bulletins published by various independent statistical reporting agencies.
A blend of these information sources is generally used to arrive at aggregate estimates of the ultimate losses arising from these catastrophic events.
While the Company believes its estimate of net reserves for losses and loss expenses is adequate for losses and loss expenses that have been incurred at December 31, 2023 based on current facts and circumstances, the Company monitors changes in paid and incurred losses in relation to each catastrophe in subsequent reporting periods and adjustments are made to estimates of ultimate losses for each event if there are developments that are different from previous expectations. Adjustments are recorded in the period in which they are identified. Actual losses for these events may ultimately differ materially from the Company's current estimates.
Selection of Reported Reserves – Management’s Best Estimate
The Company's loss reserving process involves the collaboration of its underwriting, claims, actuarial, ceded reinsurance and finance departments, including multiple committee meetings and culminates with the approval of a single point best estimate by the Company's Group Reserving Committee, which comprises senior management. In selecting this best estimate, management considers actuarial estimates and applies informed judgment regarding qualitative factors that may not be fully captured in these actuarial estimates. Such factors include, but are not limited to, the timing of the emergence of claims, volume and complexity of claims, social and judicial trends, potential severity of individual claims and the extent of Company historical loss data versus industry information. While these qualitative factors are considered in arriving at the point estimate, no specific provisions for qualitative factors are established.

Reserve for Losses and Loss Expenses

Reserve for losses and loss expenses comprise the following:
At December 31,20232022
Reserve for reported losses and loss expenses$5,559,261 $5,555,865 
Reserve for losses incurred but not reported10,874,757 9,612,998 
Reserve for losses and loss expenses$16,434,018 $15,168,863 
Reserve Roll-forward
The following table presents a reconciliation of the Company's beginning and ending gross reserves for losses and loss expenses and net reserves for unpaid losses and loss expenses:
Year ended December 31,202320222021
Gross reserve for losses and loss expenses, beginning of year$15,168,863 $14,653,094 $13,926,766 
Less reinsurance recoverable on unpaid losses and loss expenses, beginning of year(5,831,172)(5,017,611)(4,496,641)
Net reserve for unpaid losses and loss expenses, beginning of year9,337,691 9,635,483 9,430,125 
Net incurred losses and loss expenses related to:
Current year2,981,220 3,267,943 3,041,193 
Prior years411,882 (25,533)(32,410)
 3,393,102 3,242,410 3,008,783 
Net paid losses and loss expenses related to:
Current year(488,016)(457,857)(490,011)
Prior years(2,185,588)(2,397,213)(2,274,240)
 (2,673,604)(2,855,070)(2,764,251)
Foreign exchange and other53,746 (685,132)(39,174)
Net reserve for unpaid losses and loss expenses, end of year10,110,935 9,337,691 9,635,483 
Reinsurance recoverable on unpaid losses and loss expenses, end of year6,323,083 5,831,172 5,017,611 
Gross reserve for losses and loss expenses, end of year$16,434,018 $15,168,863 $14,653,094 
The Company writes business with loss experience generally characterized as low frequency and high severity in nature, which can result in volatility in its financial results. During 2023, 2022 and 2021, the Company recognized catastrophe and weather-related losses, net of reinstatement premiums, of $138 million, $403 million and $443 million.
On September 22, 2023, the Company entered into a retrocession reinsurance agreement with a third-party reinsurer which was deemed to have met the established criteria for retroactive reinsurance accounting. At December 31, 2023, foreign exchange and other included an increase in reinsurance recoverable on unpaid losses of $74 million related to this transaction (refer to Note 5(f) 'Equity Method Investments', Note 6 'Fair Value Measurements' and Note 18 'Related Party Transactions').
On December 9, 2022, the Company entered into loss portfolio transfer reinsurance agreements with a third-party reinsurer which were deemed to have met the established criteria for retroactive reinsurance accounting. At December 31, 2022, foreign exchange and other included an increase in reinsurance recoverable on unpaid losses of $422 million related to this transaction.
At December 31, 2021, foreign exchange and other included a decrease in reinsurance recoverable on unpaid losses of $49 million related to the Reinsurance to Close of the 2018 year of account of Syndicate 2007.
Estimates for Catastrophe Events
At December 31, 2023, net reserves for losses and loss expenses included estimated amounts for numerous catastrophe events. The magnitude and complexity of losses arising from certain of these events inherently increase the level of uncertainty and, therefore, the level of management judgment involved in arriving at estimated net reserves for losses and loss expenses. These events include Cyclone Gabrielle in 2023, Hurricane Ian, Winter Storm Elliot, June European Convective Storms, the Russia-Ukraine war and COVID-19 in 2022, Hurricane Ida, U.S. Winter Storms Uri and Viola and July European Floods in 2021. As a result, actual losses for these events may ultimately differ materially from current estimates.
Prior Year Reserve Development
The Company's net favorable (adverse) prior year reserve development arises from changes to estimates for losses and loss expenses related to loss events that occurred in previous calendar years. The following table presents net prior year reserve development by segment:
Favorable (Adverse)
Insurance ReinsuranceTotal
Year ended December 31, 2023$(176,353)$(235,529)$(411,882)
Year ended December 31, 2022$16,350 $9,183 $25,533 
Year ended December 31, 2021$18,360 $14,049 $32,410 
The following sections provide further details on net prior year reserve development by segment, line of business and accident year.
Insurance Segment:
Favorable (Adverse)
Years ended December 31,202320222021
Property $16,195 $52,512 $71,032 
Accident and health(10,236)(12,856)15,844 
Marine and aviation26,977 27,927 42,535 
Cyber35,579 8,416 (7,329)
Professional lines(41,243)(29,093)(71,258)
Credit and political risk31,691 24,361 10,363 
Liability(235,316)(54,917)(42,827)
Total$(176,353)$16,350 $18,360 

In 2023, we recognized $176 million of net adverse prior year reserve development, the principal components of which were:

$235 million of net adverse prior year reserve development on liability business primarily due to reserve strengthening within the U.S. primary casualty book of business mainly related to the 2022 and older accident years and U.S. programs books of business mainly related to the 2017 through 2022 accident years. The reserve strengthening was attributable to updated trend assumptions, emerging development patterns and new industry data reflecting the impact of current economic and social inflation trends in the U.S. casualty market.
$41 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within the U.S. financial institutions, U.S. commercial management solutions, U.S. design professional and environmental, and international books of business related to 2019 and older accident years, and increases in loss estimates attributable to specific large claims within the international book of business related to 2012 and older accident years.

$10 million of net adverse prior year development on accident and health business primarily due to reserve strengthening within the international book of business mainly related to the 2021 and 2022 accident years.

$36 million of net favorable prior year reserve development on cyber business primarily due to better than expected loss emergence related to most accident years, partially offset by increases in loss estimates attributable to specific large claims related to the 2020 accident year.

$32 million of net favorable prior year reserve development on credit and political risk business primarily due to a decrease in the loss estimate attributable to a specific large claim related to the 2020 accident year and better than expected loss emergence related to several accident years.

$27 million of net favorable prior year reserve development on marine and aviation business primarily due to better than expected loss emergence attributable to the marine cargo and aviation books of business related to several accident years and better than expected loss emergence attributable to several catastrophe events.

$16 million of net favorable prior year reserve development on property business primarily due to better than expected loss emergence mainly related to the 2017 through 2019 accident years and better than expected loss emergence attributable to 2022 catastrophe events, partially offset by increases in loss estimates attributable to two specific large claims within the E&S book of business related to the 2016 and 2022 accident years.

In 2022, we recognized $16 million of net favorable prior year reserve development, the principal components of which were:

$53 million of net favorable prior year reserve development on property business primarily due to better than expected loss emergence attributable to 2018 and 2020 catastrophe events and decreases in loss estimates attributable to specific large claims related to 2012 and older accident years.

$28 million of net favorable prior year reserve development on marine and aviation business primarily due to better than expected loss emergence attributable to the marine cargo and specie, and marine offshore energy books of business mainly related to the 2018, 2019 and 2021 accident years, and better than expected loss emergence attributable to aviation business mainly related to the 2021 accident year.

$24 million of net favorable prior year reserve development on credit and political risk business primarily due to better than expected loss emergence mainly related to the 2017 through 2021 accident years.

$8 million of net favorable prior year reserve development on cyber business primarily due to better than expected loss emergence mainly related to 2020 and older accident years, partially offset by reserve strengthening related to the 2021 accident year.

$55 million of net adverse prior year reserve development on liability business primarily due to reserve strengthening within the U.S. programs book of business mainly related to the 2016 through 2021 accident years, and the U.S. primary casualty book of business mainly related to the 2015 through 2018 and the 2021 accident years.

$29 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within the U.S. commercial management solutions book of business mainly related to the 2015, 2018 and 2019 accident years.
$13 million of net adverse prior year development on accident and health business primarily due to reserve strengthening mainly related to the 2019 through 2021 accident years.

In 2021, we recognized $18 million of net favorable prior year reserve development, the principal components of which were:

$71 million of net favorable prior year reserve development on property business primarily due to decreases in loss estimates attributable to specific large claims related to the 2011 and 2012 accident years, and better than expected loss emergence attributable to 2018 to 2020 catastrophe events, and the global property book of business related to the 2017 through 2019 accident years.
 
$43 million of net favorable prior year reserve development on marine and aviation business primarily due to better than expected loss emergence attributable to marine cargo, marine offshore energy and marine specie books of business mainly related to the 2017, 2018 and 2020 accident years, decreases in loss estimates attributable to specific large marine claims related to the 2012 accident year, and better than expected loss emergence attributable to aviation business mainly related to the 2020 accident year.

$16 million of net favorable prior year reserve development on accident and health business primarily due to better than expected loss emergence related to the 2019 and 2020 accident years.

$10 million of net favorable prior year reserve development on credit and political risk business primarily due to better than expected loss emergence mainly related to the 2018 and 2019 accident years.

$71 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within run-off lines of business mainly related to the 2016 through 2019 accident years and the U.S. commercial management solutions book of business mainly related to the 2017 and 2019 accident years.

$43 million of net adverse prior year reserve development on liability business primarily due to reserve strengthening within the program book of business mainly related to the 2018 and 2019 accident years.

$7 million of net adverse prior year reserve development on cyber business primarily due to reserve strengthening within the global cyber and technology book of business mainly related to the 2019 accident year.
Reinsurance Segment:
Favorable (Adverse)
Years ended December 31,202320222021
Accident and health$29,947 $14,199 $5,861 
Agriculture10,781 11,703 423 
Marine and aviation12,595 2,597 (10,767)
Professional lines(92,181)(54,820)(23,718)
Credit and surety8,306 43,567 3,436 
Motor(9,653)18,161 43,968 
Liability(262,114)(58,148)(17,919)
Run-off lines
Catastrophe46,297 (504)(36)
Property15,225 42,523 17,651 
Engineering5,268 (10,095)(4,850)
Total run-off lines66,790 31,924 12,765 
Total$(235,529)$9,183 $14,049 
In 2023, we recognized $236 million of net adverse prior year reserve development, the principal components of which were:
$262 million of net adverse prior year reserve development on liability business primarily due to reserve strengthening within the U.S. casualty and U.S. multiline/regional books of business related to all accident years. The reserve strengthening was attributable to updated trend assumptions, emerging development patterns and new industry data reflecting the impact of current economic and social inflation trends in the U.S. casualty market.
$92 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within the U.S. proportional book of business mainly related to the accident years 2019 and older accident years, partially offset by better than expected loss emergence mainly related to the 2021 and 2022 accident years.

$10 million of net adverse prior year reserve development on motor business primarily due to reserve strengthening to reflect increased estimates of future loss trend due to inflation and reserve strengthening attributable to the proportional book of business mainly related to the 2018 through 2022 accident years.
$30 million of net favorable prior year reserve development on accident and health business primarily due to better than expected loss emergence mainly related to the 2018 through 2021 accident years.

$13 million of net favorable prior year reserve development on marine and aviation business primarily due to better than expected loss emergence mainly related to the 2021 and 2022 accident years.

$11 million of net favorable prior year reserve development on agriculture business primarily due to better than expected loss emergence mainly related to the 2022 accident year.

$8 million of net favorable prior year reserve development on credit and surety business primarily due to better than expected loss emergence attributable to the international credit and mortgage books of business mainly related to the 2018 and 2019 accident years and the 2021 and 2022 accident years, partially offset by increases in loss estimates attributable to specific large claims related to the 2020 accident year.
Run-off lines

$46 million of net favorable prior year reserve development on catastrophe business primarily due to better than expected loss emergence mainly attributable to 2022 events.

$15 million of net favorable prior year reserve development on property business primarily due to better than expected loss emergence mainly attributable to 2022 catastrophe events.

$5 million of net favorable prior year reserve development on engineering business primarily due to better than expected loss emergence mainly related to older accident years.

In 2022, we recognized $9 million of net favorable prior year reserve development, the principal components of which were:

$44 million of net favorable prior year reserve development on credit and surety business primarily due to better than expected loss emergence mainly related to the 2015 through 2021 accident years, most notably within the mortgage book of business related to the 2020 and 2021 accident years.

$18 million of net favorable prior year reserve development on motor business primarily due to better than expected loss emergence mainly related to the 2017 through 2020 accident years.

$14 million of net favorable prior year reserve development on accident and health business primarily due to better than expected loss emergence mainly related to the 2019 through 2021 accident years.

$12 million of net favorable prior year reserve development on agriculture business primarily due to better than expected loss emergence mainly related to the 2019 and 2021 accident years.

$58 million of net adverse prior year reserve development on liability business primarily due to increases in loss estimates attributable to specific large claims related to the 2018 and 2021 accident years and reserve strengthening within the U.S. non-proportional books of business related to the 2016 through 2019 accident years.

$55 million of net adverse prior year reserve development on professional lines business primarily due to increases in loss estimates attributable to one cedant related to several accident years, and reserve strengthening within the U.S. public D&O proportional books of business related to 2017 and older accident years.

Run-off lines

$43 million of net favorable prior year reserve development on property business primarily due to better than expected loss emergence attributable to 2017 through 2021 catastrophe events and better than expected attritional loss emergence attributable to the 2021 accident year.

$10 million of net adverse prior year reserve development on engineering business primarily due to increases in loss estimates attributable to specific large claims mainly related to the 2011, 2018 and 2019 accident years.

In 2021, we recognized $14 million of net favorable prior year reserve development, the principal components of which were:
$44 million of net favorable prior year reserve development on motor business primarily due to proportional and non-proportional treaty business mainly related to 2016 and older accident years.

$6 million of net favorable prior year development on accident and health business primarily due to better than expected loss emergence mainly related to the 2019 and 2020 accident years.
$24 million of net adverse prior year reserve development on professional lines business primarily due to reserve strengthening within the U.S. and European books of business related to the 2015 through 2018 accident years and increases in the loss estimates attributable to specific large claims related to the 2015 to 2017 accident years.

$18 million of net adverse prior year reserve development on liability business primarily due to increases in loss estimates attributable to specific large claims related to the 2017 and 2018 accident years and reserve strengthening within the commercial auto liability and U.S. multiline/regional books of business related to the 2018 accident year.

$11 million of net adverse prior year development on marine and aviation business primarily due to an increase in the loss estimate attributable to specific large claim mainly related to 2018 accident year.

Run-off lines

$18 million of net favorable prior year reserve development on property business primarily due to decreases in loss estimates attributable to specific large claims related to the 2009, and 2017 through 2019 accident years, and better than expected loss emergence attributable to 2017 through 2019 catastrophe events, partially offset by reserve strengthening attributable to 2020 catastrophe events.

$5 million of net adverse prior year development on engineering business primarily due to reserve strengthening mainly related to the 2016, 2017 and 2019 accident years, partially offset by decreases in loss estimates attributable to specific large claims related to the 2018 accident year.

Net Incurred and Paid Claims Development Tables by Accident Year
The following tables present net incurred and paid claims development by accident year, total incurred-but-not-reported liabilities plus expected development on reported claims, cumulative reported claims frequency and average annual percentage payout of incurred claims by age for each line of business. The loss development tables are presented on an accident year basis for each line of business in the insurance and reinsurance segments. The Company does not discount reserves for losses and loss expenses.
Non-U.S. dollar denominated loss data is converted to U.S. dollar at the rates of exchange in effect at the balance sheet date for material underlying currencies. Fluctuations in foreign currency exchange rates may cause material shifts in loss development. Reserves for losses and loss expenses disclosed in the consolidated balance sheets are also remeasured using the rates of exchange in effect at the balance sheet date.
There are many considerations in establishing net reserves for losses and loss expenses. An attempt to evaluate net reserves for losses and loss expenses using solely the paid losses and claim counts presented in these tables could be misleading. When projecting net reserves for losses and loss expenses, the Company relies on several inputs in addition to the information presented in this disclosure including case incurred loss projections, changes in mix of business, external trends, and additional qualitative information. The Company cautions against mechanical application of standard actuarial methodologies to project ultimate losses using data presented in this disclosure.
Insurance Segment
The reporting of cumulative claims frequency for the lines of business within the insurance segment has been measured by counting the number of unique claim references including claim references assigned to nil and nominal case reserves. Claim references are grouped by claimant by loss event for each line of business. For certain insurance facilities and business produced by managing general agents where underlying data is reported to the Company in an aggregated format, the information necessary to provide cumulative claims frequency is not available therefore reporting of claims frequency is deemed to be impracticable.
Insurance Property
The property line of business provides physical loss or damage, business interruption and machinery breakdown cover for virtually all types of property, including commercial buildings, residential premises, construction projects, property in transit, onshore renewable energy installations, and physical damage and business interruption following an act of terrorism. This line of business includes primary and excess risks, some of which are catastrophe-exposed.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of catastrophe events.
Insurance property
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$289,270 $287,431 $277,183 $262,701 $262,173 $259,792 $255,887 $253,279 $253,203 $253,414 $775 4,174
2015207,711 200,398 192,736 190,310 186,952 189,066 179,075 181,323 181,928 85 4,194
2016263,762 287,858 279,532 265,152 259,319 260,370 259,786 264,976 1,951 6,668
2017794,042 700,638 688,755 679,243 675,085 675,409 669,951 6,375 10,096
2018608,422 639,465 618,888 611,057 609,977 600,596 12,492 9,659
2019374,678 364,350 359,092 369,962 353,671 4,503 9,561
2020654,495 635,344 584,921 593,780 24,336 12,417
2021378,554 375,607 372,223 9,213 7,730
2022414,743 419,139 49,138 7,410
2023399,165 188,657 5,732
Total$4,108,843 
Insurance property
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$100,736 $201,931 $244,372 $250,321 $254,051 $254,858 $251,701 $252,772 $252,787 $252,526 
201567,621 145,027 166,211 179,727 179,409 186,010 177,227 182,038 181,716 
201682,583 206,979 243,050 250,662 250,822 256,476 253,891 260,115 
2017190,861 513,044 622,040 650,218 645,841 635,493 647,610 
2018221,345 468,431 563,191 573,034 590,739 577,000 
2019148,181 257,515 306,415 343,463 332,848 
2020182,611 425,893 481,646 531,448 
2021134,273 286,801 323,656 
202297,622 262,381 
202390,855 
Total3,460,155 
All outstanding liabilities before 2014, net of reinsurance14,248 
Liabilities for claims and claim adjustment expenses, net of reinsurance$662,936 
Insurance property
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
32.9%41.2%13.4%5.3%0.1%0.4%(1.3%)1.8%(0.1%)(0.1%)
Insurance Accident and Health
The accident and health line of business includes personal accident, travel insurance and specialty health products for employer and affinity groups, and pet insurance.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of catastrophe events. An increase in limited benefits medical business written in 2017 resulted in a significant increase in reported claims observed in that year and subsequent years.
Insurance accident and health
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$71,520 $67,380 $66,874 $65,347 $64,973 $65,710 $64,938 $64,070 $62,703 $64,392 $1,621 58,081
201570,622 69,494 66,013 64,219 64,771 64,441 63,772 64,433 61,759 1,049 44,138
201685,244 85,892 86,338 87,470 87,154 88,180 87,972 87,399 2,179 87,001
2017113,921 121,146 118,949 117,050 117,131 117,012 118,125 36 688,000
2018111,119 115,977 115,077 113,118 114,134 114,844 291 745,012
201973,926 75,093 65,623 69,203 68,344 121 675,634
202069,679 63,963 67,525 64,297 1,275 718,512
202169,543 72,044 78,478 3,605 433,643
202298,796 100,629 9,807 380,675
2023172,795 67,393 222,537
Total$931,062 
Insurance accident and health
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$31,662 $56,693 $60,682 $61,855 $62,513 $62,844 $62,716 $61,588 $61,996 $62,660 
201531,518 56,988 60,168 61,051 62,065 61,926 62,584 62,677 60,575 
201641,583 79,237 83,077 83,929 85,010 85,413 86,123 85,272 
201763,285 109,312 114,555 115,981 117,100 116,280 118,138 
201861,849 106,748 109,194 112,884 113,787 114,595 
201945,133 61,526 63,046 68,088 68,030 
202036,317 52,290 60,804 59,240 
202139,185 61,593 69,661 
202246,568 82,209 
202395,951 
Total816,331 
All outstanding liabilities before 2014, net of reinsurance(238)
Liabilities for claims and claim adjustment expenses, net of reinsurance$114,493 
Insurance accident and health
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
53.0%34.9%6.0%1.9%0.9%0.2%0.8%(0.9%)(1.4%)1.0%
Insurance Marine and Aviation
The marine line of business provides cover for a range of exposures including offshore energy, renewable offshore energy, cargo, liability including kidnap and ransom, fine art, specie, and hull war. Offshore energy coverage includes physical damage, business interruption, operator's extra expense and liability coverage for all aspects of offshore upstream energy from exploration and construction through the operation and distribution phases.

The complex nature of claims arising under marine policies tends to result in reporting and payment patterns that are longer than those of the property line of business with marine liability exhibiting the longest reporting and payment patterns as claims involve passengers and third parties. Exposure to natural perils such as windstorm and earthquake can result in volatility.
The aviation line of business provides cover for hull and liability, and specific war cover primarily for passenger airlines but also for cargo operations, general aviation operations, airports, aviation authorities, security firms and product manufacturers.
The claims reporting pattern varies by insurance coverage provided. Losses arising from war or terrorism and damage to hulls of aircraft are generally reported quickly compared with liability claims which involve passengers and third parties and generally exhibit longer reporting and payment patterns.
Insurance marine and aviation
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$80,064 $66,878 $71,051 $64,768 $65,913 $63,693 $55,526 $53,013 $52,286 $52,308 $830 3,566
2015187,067 165,908 161,465 153,737 140,673 146,174 145,447 145,394 143,900 111 4,312
2016115,520 111,878 109,478 101,928 101,351 100,488 101,388 102,345 2,038 4,836
2017262,628 229,801 227,355 225,397 217,443 217,232 215,683 6,867 8,577
2018238,117 255,652 241,715 234,901 228,369 229,903 14,910 8,742
2019215,911 210,536 213,480 226,586 224,914 14,884 7,697
2020208,542 180,156 163,700 164,808 14,618 6,439
2021240,182 221,864 204,483 34,829 6,754
2022265,181 257,637 92,387 7,159
2023298,845 210,136 5,172
Total$1,894,826 
Insurance marine and aviation
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$10,336 $22,874 $36,805 $39,439 $48,583 $52,793 $53,941 $48,435 $50,255 $50,383 
201529,498 69,563 125,369 130,290 133,087 135,881 142,268 142,437 142,432 
201622,886 50,976 83,039 90,273 92,239 94,184 97,274 97,951 
201735,415 106,527 140,126 172,205 180,904 184,824 196,724 
201847,525 123,434 159,948 173,667 185,455 197,961 
201954,028 103,253 145,927 171,372 178,967 
202044,655 84,391 106,403 119,063 
202126,924 69,687 108,772 
202230,101 101,228 
202336,613 
Total1,230,094 
All outstanding liabilities before 2014, net of reinsurance13,750 
Liabilities for claims and claim adjustment expenses, net of reinsurance$678,482 
Insurance marine and aviation
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
18.8%26.6%22.5%7.9%5.6%3.8%3.8%(3.2%)1.8%0.2%
Insurance Cyber
The cyber line of business provides cover for cyber, technology errors and omissions, media and miscellaneous professional liability. Cover is provided for a range of risks including data recovery and bricking, cyber-crime, liability and regulatory actions, business interruption, extortion, reputational harm, Payment Card Industry Data Security Standard and media liability.

Typically, this line of business takes longer to develop but specific first party coverages tend to develop more quickly than third party coverages.
Insurance cyber
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$70,557 $69,690 $69,955 $57,876 $47,342 $42,887 $39,516 $43,576 $39,832 $40,743 $604 1,159
201565,231 63,595 63,066 51,250 50,357 50,758 52,526 49,795 48,042 2,046 1,427
201658,741 56,565 58,261 40,266 37,322 29,929 27,873 25,258 1,072 1,667
201753,187 50,794 56,783 51,931 50,905 48,685 48,333 3,234 1,817
201833,429 31,966 33,962 31,111 26,732 24,495 4,574 2,152
201954,444 58,717 81,982 82,006 73,152 14,109 2,900
2020114,209 106,333 103,175 126,457 25,132 2,856
2021125,460 134,382 105,642 20,662 2,432
2022129,361 120,494 71,510 1,730
2023128,252 102,582 1,503
Total$740,868 
Insurance cyber
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$3,136 $12,162 $23,330 $29,962 $31,260 $33,819 $33,732 $35,440 $36,070 $38,043 
20155,572 15,333 25,544 28,501 30,865 39,470 42,515 43,635 45,432 
20161,348 4,637 14,141 18,502 21,333 23,136 23,207 24,054 
20179,354 19,165 28,331 35,897 38,031 40,557 39,995 
20182,171 7,327 9,874 14,810 19,267 18,334 
20192,787 20,950 32,608 60,961 57,318 
202017,732 50,344 63,813 82,625 
202124,108 65,577 75,369 
20227,830 37,861 
20239,237 
Total428,268 
All outstanding liabilities before 2014, net of reinsurance9,471 
Liabilities for claims and claim adjustment expenses, net of reinsurance$322,071 
Insurance cyber
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
10.7%23.5%19.0%18.5%6.2%6.5%1.3%3.3%2.6%4.8%
Insurance Professional Lines
The professional lines line of business provides directors’ and officers’ liability, errors and omissions liability, employment practices liability, fiduciary liability, crime, professional indemnity, medical malpractice and other financial insurance related covers for public and private commercial enterprises, financial institutions, not-for-profit organizations and other professional service providers. This business is predominantly written on a claims-made basis.
Typically, this line of business is anticipated to exhibit longer reporting and payment patterns than most other insurance lines of business. For some professional lines in the insurance segment, the Company also relies on the evaluation of the open claim inventory in addition to the commonly employed actuarial methods when establishing reserves.
Insurance professional lines
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$338,378 $338,670 $348,064 $331,044 $321,027 $308,193 $305,201 $304,657 $301,289 $305,060 $35,601 8,881
2015309,864 310,926 317,455 304,062 291,176 274,091 272,909 283,894 282,238 20,475 9,341
2016288,595 293,399 297,852 316,592 329,270 339,513 340,465 356,814 32,954 10,590
2017339,231 343,055 376,569 376,993 394,154 392,002 396,732 53,138 12,605
2018325,926 342,931 392,819 423,162 449,212 468,504 76,008 15,333
2019347,810 363,998 378,899 412,150 460,120 83,773 14,606
2020322,386 321,530 302,097 293,935 130,739 9,318
2021378,660 369,587 326,128 198,067 8,127
2022461,196 447,359 371,912 8,041
2023441,477 414,023 7,251
Total$3,778,367 
Insurance professional lines
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$20,263 $57,536 $105,155 $160,677 $190,560 $206,982 $216,811 $238,969 $244,776 $253,033 
201514,353 51,709 111,149 139,574 171,000 200,892 213,465 225,062 249,916 
201614,428 66,048 131,831 172,360 210,701 235,136 276,175 290,732 
201711,515 51,823 109,107 167,645 198,859 269,668 291,943 
201818,446 74,859 143,248 204,941 265,501 336,329 
201925,061 76,711 133,453 206,462 289,475 
20208,729 44,076 97,847 125,713 
20219,781 38,605 83,605 
202210,983 46,224 
202312,183 
Total1,979,153 
All outstanding liabilities before 2014, net of reinsurance131,134 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,930,348 


Insurance professional lines
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
3.9%11.3%16.1%13.3%11.7%11.1%6.2%5.2%5.4%2.7%
Insurance Credit and Political Risk
The credit and political risk line of business provides credit and political risk insurance products for banks, commodity traders, corporations and multilateral and export credit agencies. Cover is provided for a range of risks including sovereign and corporate credit default, political violence, currency inconvertibility and non-transfer, expropriation, aircraft non-repossession and contract frustration due to political events.
The credit insurance coverage is primarily for lenders seeking to mitigate the risk of non-payment from their borrowers. In order to claim compensation under a credit insurance contract, the insured (most often a bank) cannot assign, without the Company's prior agreement, the insured contract (most often a loan) to any third party and is normally obliged to hold a material portion of insured asset on their books, unhedged and uninsured. Claims for this business tend to be characterized by their severity risk, as opposed to their frequency risk.
Given the nature of the business, under the notification provisions of credit insurance policies issued by the Company, it anticipates being advised of an insured event within a relatively short time period. Consequently, the Company generally estimates ultimate losses based on a contract-by-contract analysis which considers the contracts’ terms, the facts and circumstances of underlying loss events and qualitative input from claims managers. Despite notification, credit and political
risk claim reporting and payment patterns are anticipated to be volatile and can take longer to develop due to the complex nature of claims and the potential additional time that may be required to realize subrogation assets.

Insurance credit and political risk
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$38,825 $70,712 $67,109 $68,323 $69,589 $71,274 $70,748 $69,113 $69,677 $69,677 $— 6
201530,329 30,368 27,524 26,012 25,930 24,851 24,189 23,309 23,309 — 2
201645,006 45,079 42,589 43,160 26,946 25,965 24,885 24,885 — 2
201748,181 32,808 26,044 18,269 16,022 11,068 8,566 2,086 4
201842,976 33,747 32,738 24,845 21,182 24,356 5,584 2
201953,332 81,470 75,610 74,066 71,270 11,546 31
202061,928 70,428 62,235 50,987 19,594 43
202142,417 37,104 26,322 13,363 23
202245,444 44,450 37,463 24
202359,258 54,333 19
Total$403,080 
Insurance credit and political risk
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,924 $39,952 $61,108 $57,857 $57,857 $64,050 $70,224 $70,224 $69,677 $69,677 
2015— 23,309 23,309 23,309 23,309 23,309 23,309 23,309 23,309 
2016— 24,885 24,885 24,885 24,885 24,885 24,885 24,885 
2017403 4,035 9,251 11,710 10,925 10,394 8,666 
20185,370 13,488 15,517 11,851 19,963 23,841 
201916,026 46,456 53,750 56,956 55,067 
20209,825 90,299 58,492 53,786 
20212,769 (370)8,228 
20222,796 8,115 
20232,743 
Total278,317 
All outstanding liabilities before 2014, net of reinsurance592 
Liabilities for claims and claim adjustment expenses, net of reinsurance$125,355 
Insurance credit and political risk
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
9.3%59.0%10.0%0.6%3.6%3.7%(2.8%)—%(0.4%)—%
Insurance Liability
The liability line of business primarily targets primary and low to mid-level excess and umbrella commercial liability risks in the U.S. wholesale markets in addition to primary and excess of loss employers, public, and products liability business predominately in the U.K. Target industry sectors include construction, manufacturing, transportation and trucking and other services.
Typically, this line of business is anticipated to exhibit longer claim reporting and payment patterns than most other insurance lines of business and claims are often reported and ultimately paid or settled years, or even decades, after the related loss events occur.

Insurance liability
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$107,126 $124,289 $129,750 $130,666 $132,013 $131,469 $132,565 $132,043 $132,474 $131,210 $9,697 5,820
2015128,436 127,299 137,477 164,982 182,690 188,004 186,931 188,261 189,795 18,423 6,769
2016124,313 130,160 128,854 127,451 120,199 120,187 125,614 124,969 17,081 7,648
2017167,334 166,052 184,781 200,391 204,533 214,707 250,887 37,518 8,812
2018167,552 167,672 190,639 204,519 216,038 251,875 38,901 8,644
2019192,468 193,435 222,885 238,035 300,584 66,863 8,183
2020224,616 225,038 230,921 249,189 88,543 6,180
2021232,051 245,585 302,023 141,022 6,748
2022323,261 357,574 246,679 7,365
2023364,604 331,464 5,168
Total$2,522,710 
Insurance liability
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,411 $18,633 $49,829 $71,589 $84,369 $93,569 $103,041 $106,205 $113,150 $116,384 
20155,438 22,353 39,581 92,598 120,136 140,809 150,640 159,004 162,656 
20166,315 23,260 36,356 56,403 66,290 79,519 95,787 102,773 
20175,463 29,432 58,988 115,568 143,440 168,615 190,475 
20189,374 34,860 72,219 119,152 158,622 188,910 
20197,833 39,846 83,692 139,077 192,435 
20208,148 25,174 75,907 118,306 
202113,397 51,859 103,892 
202213,212 53,507 
20239,855 
Total1,239,193 
All outstanding liabilities before 2014, net of reinsurance49,217 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,332,734 
Insurance liability
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
3.2%10.8%15.3%19.6%12.8%10.1%8.5%4.1%3.6%2.5%
Reinsurance Segment
The presentation of net incurred and paid claims development tables by accident year for the reinsurance segment is challenging due to the need to allocate loss information related to proportional treaties to the appropriate accident years. Information related to proportional treaty reinsurance contracts is generally submitted to the Company via quarterly bordereaux reporting by underwriting year, with a supplemental listing of large losses. Large losses can be allocated to the corresponding accident years accurately. The remaining losses can generally only be allocated to accident years based on estimated premiums earned and loss reporting patterns. To the extent management’s assumptions and allocation procedures differ from the actual loss development patterns, the actual loss development may differ materially from the net incurred and paid claims development presented in the tables below.
The reporting of cumulative claims frequency for the lines of business within the reinsurance segment is deemed to be impracticable as the information necessary to provide cumulative claims frequency for these lines of business is not available to the Company.
Reinsurance Accident and Health
The accident and health line of business includes personal accident, specialty health, accidental death, travel, life and disability reinsurance products which are offered on a proportional and catastrophic or per life excess of loss basis.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of catastrophe events.
Reinsurance accident and health
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$101,409 $102,403 $89,303 $86,833 $86,843 $86,846 $87,806 $88,095 $87,978 $87,664 $125 
201593,831 100,522 94,047 93,807 93,081 93,422 92,431 92,388 93,133 105 
2016170,687 191,299 188,454 190,067 189,538 190,574 190,534 190,662 16 
2017183,937 189,610 183,574 182,477 183,513 183,484 182,479 (16)
2018193,749 200,576 198,365 201,133 200,467 197,493 766 
2019217,477 212,307 207,794 205,403 199,419 1,328 
2020226,883 220,969 213,960 199,958 1,757 
2021232,091 227,326 222,718 9,765 
2022267,525 264,615 40,396 
2023243,174 91,280 
Total$1,881,315 
Reinsurance accident and health
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$36,571 $79,974 $85,931 $86,332 $86,534 $86,622 $87,302 $86,384 $86,771 $87,202 
201523,409 77,316 88,728 91,935 92,036 92,497 93,921 93,735 92,468 
201650,046 149,959 181,072 187,251 189,234 188,836 189,815 189,409 
201779,252 157,157 172,111 178,943 179,462 180,121 179,889 
201872,899 165,323 191,832 191,400 194,524 195,018 
201967,810 169,608 195,954 196,694 194,800 
202081,875 172,178 210,665 192,491 
202168,652 179,626 210,115 
2022101,596 214,611 
2023130,949 
Total1,686,952 
All outstanding liabilities before 2014, net of reinsurance(213)
Liabilities for claims and claim adjustment expenses, net of reinsurance$194,150 
Reinsurance accident and health
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
37.1%48.7%12.9%0.3%0.4%0.2%0.7%(0.5%)(0.5%)0.5%
Reinsurance Agriculture
The agriculture line of business provides protection for risks associated with the production of food and fiber on a global basis for primary insurance companies writing multi-peril crop insurance, crop hail, and named peril covers, as well as custom risk transfer mechanisms for agricultural dependent industries with exposures to crop yield and/or price deviations. This business is written on a proportional and aggregate stop loss reinsurance basis.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of extreme weather events and in some territories take longer to settle due to government involvement in the loss adjustment process.
Reinsurance agriculture
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$183,260 $164,351 $162,820 $162,388 $162,314 $162,327 $162,245 $162,068 $162,762 $162,927 $482 
2015103,199 95,608 95,346 95,332 95,339 95,516 95,503 95,634 96,251 (27)
2016124,229 117,960 111,045 109,633 109,863 109,068 109,012 109,763 (72)
2017151,768 144,401 138,439 139,510 138,984 137,516 136,658 (60)
2018141,040 147,359 140,883 140,618 139,989 142,760 646 
2019185,560 185,345 187,770 183,384 183,092 93 
202062,678 62,837 63,874 61,986 1,130 
202169,823 61,437 57,857 6,144 
2022101,082 91,534 16,972 
2023103,489 81,193 
Total$1,146,317 
Reinsurance agriculture
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$15,615 $133,137 $162,349 $161,575 $161,498 $162,011 $160,516 $161,167 $162,068 $162,194 
20151,716 65,870 92,979 94,535 94,873 95,468 95,457 95,612 96,224 
20169,489 62,530 108,378 109,922 109,410 109,172 109,211 109,762 
20177,444 124,528 137,502 138,640 137,482 137,429 136,605 
20185,115 127,577 135,674 141,768 138,398 144,070 
201928,854 154,533 174,250 178,264 177,760 
202017,454 47,377 54,269 55,359 
20212,953 32,846 46,117 
202215,347 55,508 
202314,633 
Total998,232 
All outstanding liabilities before 2014, net of reinsurance(463)
Liabilities for claims and claim adjustment expenses, net of reinsurance$147,622 
Reinsurance agriculture
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
10.9%63.5%18.5%1.7%(0.6%)0.9%(0.4%)0.4%0.6%0.1%
Reinsurance Marine and Aviation
The marine line of business includes specialty marine exposures such as cargo, hull, pleasure craft, marine liability, inland marine and offshore energy. The principal perils covered by policies in this portfolio include physical loss, damage and/or liability arising from natural perils of the seas or land, man-made events including fire and explosion, stranding/sinking/salvage, pollution, shipowners and maritime employers liability. This business is written on a non-proportional and proportional basis.
The aviation line of business provides cover for airline, aerospace and general aviation exposures. This business is written on a proportional and non-proportional basis. The Company exited Aviation business effective January 1, 2023.
Losses arising from marine and aviation lines of business are generally reported quickly with the exception of marine and aviation liability claims which tend to exhibit longer reporting and payment patterns as claims involve passengers and third parties.
Reinsurance marine and aviation
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$10,192 $9,162 $8,019 $7,209 $9,192 $8,535 $8,786 $9,025 $9,530 $9,841 $368 
201510,366 9,242 10,836 15,019 12,652 12,281 12,046 11,998 12,054 527 
201632,453 35,965 36,130 37,519 36,052 36,371 36,773 36,263 52 
201755,299 42,961 41,363 46,612 43,243 40,900 40,827 43 
201818,906 27,454 27,006 43,540 47,066 48,477 35 
201969,806 82,194 79,801 81,628 84,756 5,560 
202040,298 41,766 37,892 37,098 308 
202143,763 40,830 35,672 2,976 
202268,907 59,227 32,375 
202340,951 34,539 
Total$405,166 
Reinsurance marine and aviation
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,121 $2,307 $4,388 $5,256 $6,320 $6,499 $7,003 $7,370 $7,563 $8,477 
2015416 2,665 6,443 8,662 10,220 11,017 10,843 10,925 11,058 
20162,765 19,544 26,673 30,619 33,399 34,450 35,044 35,256 
20172,803 23,620 28,954 33,912 36,978 37,091 37,996 
20181,783 10,880 24,325 30,763 34,435 37,829 
201910,763 27,167 34,317 52,763 67,800 
20204,024 16,730 24,006 29,862 
20215,478 12,341 20,486 
20227,817 18,588 
20231,473 
Total268,825 
All outstanding liabilities before 2014, net of reinsurance1,923 
Liabilities for claims and claim adjustment expenses, net of reinsurance$138,264 
Reinsurance marine and aviation
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
8.9%26.4%20.5%14.4%10.7%3.7%1.9%1.7%1.6%9.3%
Reinsurance Professional Lines
The professional lines line of business provides protection for directors' and officers' liability, employment practices liability, medical malpractice, professional indemnity, environmental liability, cyber, and miscellaneous errors and omissions insurance risks. The underlying business is predominantly written on a claims-made basis. This business is written on a proportional and excess of loss basis.
Typically, this line of business is anticipated to exhibit longer claim reporting and payment patterns than most other reinsurance lines of business.
Reinsurance professional lines
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$219,162 $219,123 $219,052 $218,847 $233,169 $229,556 $228,193 $226,234 $234,311 $246,043 $13,578 
2015211,820 211,774 213,993 224,649 231,352 228,410 235,131 241,113 252,022 16,515 
2016195,019 196,073 199,715 227,468 255,088 255,012 266,979 278,699 26,195 
2017154,889 155,470 161,694 177,819 187,761 210,303 239,324 38,070 
2018145,994 148,458 155,390 165,981 173,954 195,575 24,160 
2019138,048 137,723 141,610 146,088 157,572 36,200 
2020140,886 141,559 136,107 134,478 69,314 
2021148,950 140,737 136,381 93,845 
2022169,576 153,853 125,013 
2023136,051 124,516 
Total$1,929,998 
Reinsurance professional lines
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$2,019 $13,062 $48,791 $74,479 $109,048 $146,917 $158,388 $178,058 $189,874 $196,444 
20153,134 13,504 41,512 79,208 111,743 131,543 152,328 170,555 184,073 
20161,765 20,487 52,540 95,084 124,881 153,575 181,141 202,925 
20172,813 14,871 39,857 62,723 88,791 116,293 137,492 
2018271 2,572 31,198 56,882 81,729 113,771 
2019368 13,614 33,628 53,221 76,094 
20203,823 13,969 26,926 40,718 
20214,337 11,366 22,619 
20223,234 11,713 
20233,435 
Total989,284 
All outstanding liabilities before 2014, net of reinsurance113,403 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,054,117 
Reinsurance professional lines
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
1.5%5.3%11.6%12.3%12.6%12.3%7.9%7.7%5.1%2.7%
Reinsurance Credit and Surety
The credit and surety line of business which provides reinsurance of trade credit insurance products and includes proportional and excess of loss structures. The underlying insurance indemnifies sellers of goods and services in the event of a payment default by the buyer of those goods and services. Surety reinsurance provides protection for losses arising from a broad array of surety bonds issued by insurers to satisfy regulatory demands or contract obligations in a variety of jurisdictions around the world. The Company also provides mortgage reinsurance to mortgage guaranty insurers and U.S. government sponsored entities for losses related to credit risk transfer into the private sector.
Initial and most recent underwriting year loss projections are generally based on the ELR Method, with consideration given to qualitative factors. Given that there is a quicker and more stable reporting pattern for trade credit and mortgage business, the Company generally commences the transition to experience-based methods sooner for these lines of business than for surety business.
Reinsurance credit and surety
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$134,434 $134,527 $141,621 $137,973 $126,744 $125,477 $121,780 $120,482 $120,790 $111,511 $1,914 
2015159,274 164,350 159,148 155,217 136,568 137,528 138,726 132,989 129,333 1,447 
2016140,892 140,188 147,955 122,495 114,957 112,631 110,316 112,465 35 
2017137,832 131,630 125,763 117,044 114,412 114,131 114,612 2,647 
2018111,022 119,227 113,535 110,531 105,503 94,229 4,053 
201974,101 67,825 67,759 65,573 57,322 6,315 
202076,917 83,559 68,987 94,943 8,385 
202152,005 43,967 41,463 13,732 
202263,653 51,231 33,129 
202386,367 64,350 
Total$893,476 
Reinsurance credit and surety
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$35,450 $60,597 $85,266 $94,274 $101,859 $106,267 $106,708 $106,519 $107,713 $98,533 
201532,863 81,001 98,709 115,549 117,462 121,115 121,975 120,617 118,116 
201641,937 72,691 91,490 101,065 102,149 100,682 100,426 102,558 
201737,246 73,362 89,715 101,337 99,463 102,390 103,252 
201838,868 67,839 72,096 83,736 85,505 87,073 
201919,301 30,985 44,702 46,835 49,050 
202025,339 34,050 39,495 43,888 
20214,471 9,170 17,175 
20226,883 11,302 
202310,335 
Total641,282 
All outstanding liabilities before 2014, net of reinsurance26,307 
Liabilities for claims and claim adjustment expenses, net of reinsurance$278,501 
Reinsurance credit and surety
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
26.5%22.1%15.0%8.6%2.3%2.0%0.4%0.2%(0.4%)(8.2%)
Reinsurance Motor
The motor line of business provides protection to insurers for motor liability and motor property damage losses arising out of any one occurrence. A loss occurrence can involve one or many claimants where the ceding insurer aggregates the claims from the occurrence. The Company offers traditional proportional and non-proportional reinsurance as well as structured solutions predominantly relating to European exposures.
The motor proportional business generally has a shorter reported and payment pattern, relative to the motor non-proportional business.
The motor non-proportional business consists of standard excess of loss contracts written for cedants in several European countries with most of the premium related to two major markets, U.K. and France. Since 2009/2010, an increasing number of large bodily injury settlements in the U.K. market were settled using indexed annuities (Periodical Payment Orders "PPOs"). This led to a materially longer development tail on the older accident years for the U.K. non-proportional motor book. This also resulted in the inclusion of capitalization clauses on a number of U.K. motor treaties which allow reinsurers to settle claims arising under PPOs with a lump sum payment, to help mitigate the lengthening of the development tail on more recent accident years.
In 2017, the U.K. Ministry of Justice announced a decrease in the discount rate to be used to calculate lump sum awards in U.K. bodily injury cases, known as the Ogden Rate. Effective March 20, 2017, the Ogden rate changed from plus 2.5% to minus 0.75%. This resulted in a trend toward a lower number of claims settlements using PPOs and an increase in projected ultimate losses, particularly related to recent accident years.
Effective August 5, 2019, the Ogden rate changed from minus 0.75% to minus 0.25%. This resulted in a decrease in projected ultimate losses, particularly related to recent accident years.
Reinsurance motor
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$181,056 $180,792 $175,983 $173,139 $168,796 $165,481 $162,212 $161,835 $162,730 $161,844 $2,346 
2015221,182 215,201 219,055 220,820 209,908 208,620 205,780 206,090 204,673 8,979 
2016244,395 259,912 261,592 251,675 243,353 240,717 244,553 245,098 4,366 
2017361,782 368,517 357,741 358,286 359,026 354,392 361,134 22,422 
2018355,561 353,384 364,664 360,907 348,323 361,117 17,400 
2019338,031 336,957 337,404 328,522 332,952 12,894 
2020215,257 218,224 215,572 197,439 10,872 
2021180,372 182,010 184,244 25,813 
2022160,697 173,870 35,986 
2023125,498 60,323 
Total$2,347,869 
Reinsurance motor
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$43,148 $73,129 $92,183 $100,071 $109,989 $119,355 $114,654 $135,455 $138,281 $141,456 
201557,638 92,382 112,128 129,175 144,878 145,593 168,295 173,373 175,479 
201660,689 103,868 127,404 145,160 158,004 182,077 189,563 198,144 
201772,143 133,447 163,724 198,778 221,060 244,440 262,741 
201883,831 141,391 205,874 215,988 240,535 260,818 
201990,328 183,841 201,210 223,167 242,207 
202043,752 96,208 115,689 127,881 
202141,869 76,338 94,500 
202235,213 52,971 
202326,040 
Total1,582,237 
All outstanding liabilities before 2014, net of reinsurance255,320 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,020,952 
Reinsurance motor
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
23.6%18.8%10.3%6.5%6.3%5.6%4.1%6.3%1.4%2.0%
Reinsurance Liability
The liability line of business provides protection to insurers of admitted casualty business, excess and surplus lines casualty business and specialty casualty programs. The primary focus of the underlying business is general liability, workers' compensation, auto liability and excess casualty.
Typically, this line of business is anticipated to exhibit longer claim reporting and payment patterns than most other reinsurance lines of business and claims are often reported and ultimately paid or settled years, or even decades, after the related loss events occur.
Reinsurance liability
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$199,575 $202,526 $204,240 $200,138 $198,893 $196,747 $187,245 $183,101 $189,047 $193,578 $14,361 
2015214,346 214,689 215,633 215,461 213,256 213,485 203,268 206,204 217,019 22,070 
2016239,971 245,286 250,247 253,525 263,195 267,241 274,615 315,793 46,678 
2017275,306 270,080 279,262 287,818 297,380 306,648 343,290 62,419 
2018264,003 268,812 274,110 286,876 307,032 352,697 72,183 
2019263,522 272,513 274,393 272,905 331,729 103,836 
2020283,606 284,216 278,743 306,011 148,977 
2021304,160 311,735 346,161 185,421 
2022347,387 343,773 232,850 
2023275,232 241,263 
Total$3,025,283 
Reinsurance liability
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$7,075 $28,652 $48,397 $70,069 $89,328 $109,859 $129,802 $137,103 $148,342 $156,421 
20157,269 27,451 54,486 80,822 108,857 130,767 141,519 151,919 166,842 
201611,868 37,666 69,445 111,698 142,837 166,645 189,536 216,534 
201712,449 42,144 78,574 120,747 158,653 193,274 224,655 
201819,357 49,938 85,207 127,946 166,378 207,016 
201919,311 45,269 79,728 120,266 159,068 
202016,940 49,059 82,389 119,678 
202110,931 58,540 99,228 
202218,066 52,197 
202315,003 
Total1,416,642 
All outstanding liabilities before 2014, net of reinsurance130,039 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,738,680 
Reinsurance liability
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
4.5%9.8%10.8%12.2%11.1%10.0%7.9%5.7%6.4%4.2%
Reinsurance Run-off lines
Run-off lines include catastrophe, property, and engineering lines of business.
The catastrophe line of business provides protection for most catastrophic losses that are covered in the underlying insurance policies written by the Company's cedants. The underlying policies principally cover property-related exposures but other exposures including worker's compensation and personal accident are also covered. The principal perils covered by policies in this portfolio include hurricane and windstorm, earthquake, flood, tornado, hail and fire. In some instances, terrorism may be a covered peril or the only peril. This business is written on a proportional and an excess of loss basis. The Company exited this line of business in June 2022.
The property line of business provides protection for property damage and related losses resulting from natural and man-made perils that are covered in underlying personal and commercial lines insurance policies written by the Company's cedants. The predominant exposure is to property damage, but other risks, including business interruption and other non-property losses, may also be covered when arising from a covered peril. The most significant perils covered by policies in this portfolio include windstorm, tornado and earthquake, but other perils such as freezes, riots, floods, industrial explosions, fires, hail and a number of other loss events are also included. This business is written on a proportional and excess of loss basis. The Company exited this line of business in June 2022.
The engineering line of business provides protection for all types of construction risks and risks associated with erection, testing and commissioning of machinery and plants during the construction stage. This line of business also includes cover for losses arising from operational failures of machinery, plant and equipment, and electronic equipment as well as business interruption. The Company exited this line of business in 2020.
In general, reporting and payment patterns are relatively short although they can be volatile due to the incidence of catastrophe events. Losses from engineering exposures tend to develop slower than the other reinsurance run-off lines of business.
Reinsurance run-off
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$242,347 $246,616 $236,768 $227,865 $224,135 $223,970 $219,953 $219,748 $218,896 $219,012 $201 
2015267,709 256,648 256,665 247,377 246,266 251,245 249,050 247,183 244,790 475 
2016286,264 285,973 282,705 277,349 280,836 281,204 281,137 274,291 2,838 
2017705,205 702,378 740,074 741,278 739,258 729,812 722,172 19,886 
2018523,351 614,222 628,722 614,573 600,516 600,640 15,506 
2019448,745 432,299 411,886 395,134 387,944 17,304 
2020520,537 553,538 548,846 553,124 41,243 
2021430,820 441,530 438,082 39,301 
2022265,797 225,697 47,820 
202364,191 28,272 
Total$3,729,943 
Reinsurance run-off
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$49,217 $136,404 $180,580 $197,284 $202,114 $206,234 $203,726 $210,435 $211,708 $213,063 
201546,199 119,103 178,596 203,661 213,978 218,469 232,671 234,318 235,258 
201665,343 141,975 201,290 232,366 246,602 253,543 258,939 257,802 
2017163,254 417,693 528,640 586,833 611,106 646,826 657,803 
2018116,816 331,848 427,126 479,911 526,746 548,005 
201954,985 214,066 274,503 310,612 335,546 
2020105,245 240,193 324,105 392,613 
202187,860 235,617 302,383 
202250,250 103,881 
202322,862 
Total3,069,216 
All outstanding liabilities before 2014, net of reinsurance37,075 
Liabilities for claims and claim adjustment expenses, net of reinsurance$697,802 
Reinsurance run-off
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
21.8%32.4%17.9%9.7%4.9%2.9%2.1%1.1%0.5%0.6%
Reconciliation of Loss Development Tables to Consolidated Balance Sheet
The following table reconciles the reserve for losses and loss expenses at December 31, 2023, included in the loss development tables to the reserve for losses and loss expenses reported in the consolidated balance sheet:
Reconciliation of the disclosure of incurred and paid claims development to the liability
for unpaid claims and claim adjustment expenses
At December 31, 2023
Net outstanding liabilitiesReinsurance recoverable on unpaid claimsGross outstanding liabilities
Insurance segment
Property$662,936 $402,222 $1,065,158 
Accident and health114,493 3,006 117,499 
Marine and aviation678,482 278,215 956,697 
Cyber322,071 430,627 752,698 
Professional lines1,930,348 1,442,546 3,372,894 
Credit and political risk125,355 35,191 160,546 
Liability1,332,734 1,885,232 3,217,966 
Total insurance segment5,166,419 4,477,039 9,643,458 
Reinsurance segment
Accident and health194,150 49,314 243,464 
Agriculture147,622 8,343 155,965 
Marine and aviation138,264 33,185 171,449 
Professional lines1,054,117 370,345 1,424,462 
Credit and surety278,501 103,174 381,675 
Motor1,020,952 315,344 1,336,296 
Liability1,738,680 690,141 2,428,821 
Run-off lines697,802 276,198 974,000 
Total reinsurance segment5,270,088 1,846,044 7,116,132 
Total$10,436,507 $6,323,083 16,759,590 
Unallocated claims adjustment expenses183,260 
Foreign exchange and other(1)
12,442 
Ceded reserves related to retroactive transactions (521,274)
Total liability for unpaid claims and claims adjustment expense$16,434,018 
(1)    Non-U.S. dollar denominated loss data is converted to U.S dollar at the rates of exchange in effect at the balance sheet date for material underlying currencies. Fluctuations in currency exchange rates may cause material shifts in loss development. Reserves for losses and loss expenses disclosed in the consolidated balance sheets are also remeasured using rates of exchange in effect at the balance sheet date.
XML 42 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
REINSURANCE
12 Months Ended
Dec. 31, 2023
Reinsurance Disclosures [Abstract]  
REINSURANCE REINSURANCE
In the normal course of business, the Company purchases treaty and facultative reinsurance protection to limit ultimate losses and reduce loss aggregation risk.

Facultative reinsurance provides cover for all or a portion of the losses incurred for a single policy and the Company separately negotiates each facultative contract.

Treaty reinsurance provides cover for a specified type or category of risks. The Company's treaty reinsurance agreements provide this cover on either an excess of loss or a proportional basis. Excess of loss covers provide a contractually set amount of coverage after a specified loss amount has been reached. These treaties can provide cover for a number of lines of business within one contract. Under proportional reinsurance, the Company cedes an agreed percentage of the premiums and the losses and loss expenses on the policies it underwrites. These treaties provide the Company with a specified percentage of coverage from the first dollar of loss.
All of these reinsurance contracts provide the Company with the right to recover a specified amount of losses and loss expenses from reinsurers. To the extent that reinsurers do not meet their obligations under these agreements due to solvency issues, contractual disputes over contract language or coverage and/or other reasons, the Company remains liable. The Company predominantly cedes its business to reinsurers rated A- or better by A.M. Best.

The following table presents gross and net premiums written and earned:
Year ended December 31,202320222021
  Premiums
written
Premiums
earned
Premiums
written
Premiums
earned
Premiums
written
Premiums
earned
Gross$8,356,525 $7,973,577 $8,214,595 $7,936,382 $7,685,984 $7,281,709 
Ceded(3,254,200)(2,889,796)(2,951,539)(2,776,056)(2,759,360)(2,571,859)
Net$5,102,325 $5,083,781 $5,263,056 $5,160,326 $4,926,624 $4,709,850 
For the year ended December 31, 2023, the Company recognized ceded losses and loss expenses of $1,754 million (2022: $1,754 million; 2021: $1,782 million).
At December 31, 2023, the Company's allowance for expected credit losses was $37 million (2022: $31 million; 2021: $30 million).
XML 43 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND FINANCING ARRANGEMENTS
12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
DEBT AND FINANCING ARRANGEMENTS DEBT AND FINANCING ARRANGEMENTS
a)    Debt

The following table summarizes the Company's debt:
Year ended December 31,20232022
5.150% Senior Notes
$246,789 $246,708 
4.000% Senior Notes
348,389 348,020 
3.900% Senior Notes
297,076 296,615 
Junior Subordinated Notes421,460 420,971 
Total Debt$1,313,714 $1,312,314 

The tables below provide the key terms of the Company's debt:
DescriptionIssuance DateAggregate PrincipalIssue PriceNet ProceedsMaturity Date
5.150% Senior Notes
March 13, 2014$250,000 99.474 %$246,000 April 1, 2045
4.000% Senior Notes
December 6, 2017$350,000 99.780 %$347,000 December 6, 2027
3.900% Senior Notes
June 19, 2019$300,000 99.360 %$296,000 July 15, 2029
Junior Subordinated NotesDecember 10, 2019$425,000 99.000 %$420,750 January 15, 2040

DescriptionInterest RateInterest Payments Due
5.150% Senior Notes
5.150 %Semi-annually in arrears on April 1 and October 1 of each year
4.000% Senior Notes
4.000 % Semi-annually in arrears on June 6 and December 6 of each year
3.900% Senior Notes
3.900 %Semi-annually in arrears on January 15 and July 15 of each year
Junior Subordinated Notes(1)
4.900 %Semi-annually on January 15 and July 15 of each year
(1)    The Junior Subordinated Notes accrue interest from the date of issuance to, but excluding, January 15, 2030 (the "Par Call Date") at the fixed rate of 4.900% and from, and including, the Par Call Date, at a rate equal to the Five-Year Treasury Rate as of the Reset Interest Determination Date, plus 3.186%. Interest on the Junior Notes is payable semi-annually on January 15 and July 15 of each year, beginning on July 15, 2020.
5.150% Senior Notes
The 5.150% Senior Notes are ranked as unsecured senior obligations of AXIS Specialty Finance PLC, a 100% owned finance subsidiary. AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance PLC under the 5.150% Senior Notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.
4.000% Senior Notes
The 4.000% Senior Notes are ranked as unsecured senior obligations of AXIS Specialty Finance PLC, a 100% owned finance subsidiary. AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance PLC under the 4.000% Senior Notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.
3.900% Senior Notes
The 3.900% Senior Notes are ranked as unsecured senior obligations of AXIS Specialty Finance LLC, a 100% owned finance subsidiary. AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance LLC under the
3.900% Senior Notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.
The Company has the option to redeem the Senior Notes at any time and from time to time, in whole or in part, at a ''make-whole'' redemption price, which is equal to the greater of the aggregate principal amount or the sum of the present values of the remaining scheduled payments of principal and interest. The related indentures contain various covenants, including limitations on liens on the stock of restricted subsidiaries, restrictions as to the disposition of the stock of restricted subsidiaries and limitations on mergers and consolidations. The Company was in compliance with all the covenants contained in the indentures at December 31, 2023.
Interest expense recognized in relation to the Senior Notes includes interest payable, amortization of the offering discounts and amortization of debt offering expenses. The offering discounts and debt offering expenses are amortized over the period of time during which the Senior Notes are outstanding. For the year ended December 31, 2023, the Company incurred interest expense of $40 million (2022: $40 million, 2021: $40 million).
Junior Subordinated Notes
The 4.900% Fixed-Rate Reset Junior Notes are ranked as unsecured junior subordinated obligations of AXIS Specialty Finance LLC, a 100% owned finance subsidiary. AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance LLC under the Junior Notes. AXIS Capital's obligation under this guarantee is an unsecured junior subordinated obligation and ranks equally with all future unsecured junior subordinated obligations of AXIS Capital, and junior in right of payment to all outstanding and future senior obligations of AXIS Capital.
Interest expense recognized in relation to the Junior Notes includes interest payable and amortization of debt offering expenses. The debt offering expenses are amortized over the period of time during which the Junior Notes are outstanding. For the year ended December 31, 2023, the Company incurred interest expense of $21 million (2022: $21 million).

Scheduled Debt Maturity
The following table provides the scheduled maturity of the Company's debt obligations at December 31, 2023:
Year ended December 31,
2024$— 
2025— 
2026— 
2027350,000 
2028— 
After 2028975,000 
Unamortized discount and debt issuance expenses(11,286)
Total senior notes and notes payable$1,313,714 
b)    Loan Advances made to a Third Party Reinsurer
During 2023, the Company advanced $102 million (2022: $116 million) to a third party reinsurer. This loan is being repaid in a manner consistent with the timing of amounts due to the third party reinsurer under retrocession agreements. At December 31, 2023, $82 million (2022: $80 million) was repaid and was treated as a non-cash activity in the consolidated statement of cash flows. The loan is expected to be repaid in full by February 15, 2026 (2022: February 15, 2025). The loan balance receivable at December 31, 2023, of $80 million (2022: $87 million) is included in loan advances made in the consolidated balance sheets. At December 31, 2023, the Company had committed to advance a further $26 million to the third party reinsurer.
Interest on this loan is payable at interest rates between 0.8% and 4.0% (2022: 0.8% and 4.0%). Interest of $1 million (2022: $1 million) related to this loan was received in advance and is included in other liabilities in the consolidated balance sheets and was treated as a non-cash activity in the consolidated statement of cash flows.

c)    Letter of Credit Facility
At December 31, 2023, certain of AXIS Capital’s operating subsidiaries (the "Participating Subsidiaries") had a $500 million letter of credit facility available from Citibank Europe plc ("Citibank") (the "$500 million Facility"). pursuant to a Master Reimbursement Agreement May 14, 2010, as amended, and Committed Letter of Credit Facility Letter dated December 18, 2015, as amended. (together, the "LOC Facility Documents").
Under the terms of the $500 million Facility, letters of credit to a maximum aggregate amount of $500 million are available for issuance on behalf of the Participating Subsidiaries. These letters of credit are principally used to support the reinsurance obligations of the Participating Subsidiaries. The $500 million Facility is subject to certain covenants, including the requirement to maintain sufficient collateral, as defined in the LOC Facility Documents to cover all of the obligations under the $500 million Facility. Such obligations include contingent reimbursement obligations for outstanding letters of credit and fees payable to Citibank. In the event of default, Citibank may exercise certain remedies, including the exercise of control over pledged collateral and the termination of the availability of the $500 million Facility to any or all of the Participating Subsidiaries.
On March 27, 2017, the Participating Subsidiaries amended their existing $500 million Facility to include an additional $250 million of secured letter of credit capacity (the "$250 million Facility"). Under the terms of the amended $750 million Facility, letters of credit to a maximum aggregate amount of $250 million are available for issuance on behalf of the Participating Subsidiaries once the $500 million Facility has been fully utilized.
On March 31, 2021, the Participating Subsidiaries amended their existing secured $750 million Facility to reduce the utilization capacity available under the $250 million Facility to $150 million, reducing the maximum aggregate utilization capacity of the credit facility from $750 million to $650 million.

On March 31, 2023, the $150 million secured letter of credit facility expired.

On December 29, 2023, the $500 million Facility was amended to extend the tenors of issuable letters of credit (i) denominated in a currency other than Australian or New Zealand dollars to March 31, 2025 and (ii) denominated in either Australian dollars or New Zealand dollars to March 31, 2026.

At December 31, 2023, letters of credit outstanding under the LOC Facility were $325 million (2022: $362 million). At December 31, 2023, the Participating Subsidiaries were in compliance with all LOC Facility covenants.
XML 44 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
FEDERAL HOME LOAN BANK ADVANCES
12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
FEDERAL HOME LOAN BANK ADVANCES FEDERAL HOME LOAN BANK ADVANCES
The Company's subsidiaries, AXIS Insurance Company and AXIS Surplus Insurance Company, are members of the Federal Home Loan Bank of Chicago ("FHLB").

Members may borrow from the FHLB at competitive rates subject to certain conditions. At December 31, 2023, the companies had admitted assets of approximately $3 billion (2022: $3 billion) which provides borrowing capacity of up to approximately $759 million (2022: $750 million). Conditions of membership include maintaining sufficient collateral deposits for funding, a requirement to maintain member stock at 0.4% of mortgage-related assets at December 31st of the prior year, and a requirement to purchase additional member stock of 2.0% or 4.5% of any amount borrowed.

At December 31, 2023, the Company had $86 million (2022: $81 million) of borrowings under the FHLB program, with maturities in 2024 and interest payable at interest rates between 5.6% and 5.9% (2022: 2.3% and 4.7%).
For the year ended December 31, 2023, the Company incurred interest expense of $5 million (2022: $1 million). The borrowings under the FHLB program are secured by cash and investments with a fair value of $95 million (2022: $91 million).
XML 45 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
a)    Concentrations of Credit Risk
Credit Risk Aggregation
The Company monitors and manages the aggregation of credit risk on a group-wide basis allowing it to consider exposure management strategies for individual companies, countries, regions, sectors and any other relevant inter-dependencies. The Company's credit exposures are aggregated based on the origin of risk. Credit risk aggregation is also managed through minimizing overlaps in underwriting, financing and investing activities. As part of its credit aggregation framework, the Company also assigns aggregate credit limits by country and by single counterparty (or parent of affiliated counterparties). These limits are based on and adjusted for a variety of factors including the prevailing economic environment and the nature of the underlying credit exposures.
The Company's credit aggregation measurement and reporting process is facilitated by its credit risk exposure database, which contains relevant information on counterparty details and credit risk exposures. The database is accessible by management throughout the Company, therefore providing transparency to allow for the implementation of active exposure management strategies. The Company also licenses third-party tools to provide credit risk assessments. The Company monitors all its credit aggregations and, where appropriate, adjusts its internal risk limits and/or takes specific actions to reduce our risk exposures.
The assets that potentially subject the Company to concentrations of credit risk consist principally of cash and investments, reinsurance recoverable on unpaid and paid claims, and insurance and reinsurance premiums balances receivable, as described below:
(i)     Cash and Investments
In order to mitigate concentration and operational risks related to cash and cash equivalents, the Company limits the maximum amount of cash that can be deposited with a single counterparty and limits acceptable counterparties based on current rating, outlook and other relevant factors.
The Company's fixed maturities portfolio, which represents approximately $12.9 billion or 43% of its total assets, is exposed to potential losses arising from the diminished creditworthiness of issuers of bonds. The Company's investment portfolio is managed by external investment managers in accordance with its investment guidelines. The Company limits credit risk through diversification and issuer exposure limits graded by ratings and, with respect to custodians, through contractual and other legal remedies. Excluding Government and agency securities, the Company limits its concentration of credit risk to any single corporate issuer to 1% of its investment grade fixed maturities portfolio for securities rated A- or above and less than 1% of its investment grade fixed maturities portfolio for securities rated below A-.
At December 31, 2023, the Company was in compliance with these limits.
(ii)     Reinsurance Recoverable on Unpaid and Paid Losses and Loss Expenses

The Company is exposed to the credit risk associated with reinsurance recoverable on unpaid and paid losses and loss expenses to the extent that any of its reinsurers fail to meet their obligations under reinsurance contracts. To help mitigate this risk, the Company's purchase of reinsurance is subject to financial security requirements specified by its Reinsurance Security Committee. This Committee maintains a list of approved reinsurers, performs credit risk assessments for potential new reinsurers, regularly monitors approved reinsurers with consideration for events which may have a material impact on their creditworthiness, recommends counterparty tolerance levels for different types of ceded business and monitors concentrations of credit risk. This assessment considers a wide range of individual attributes, including a review of the counterparty’s financial strength, industry position and other qualitative factors. Generally, the Committee requires that reinsurers who do not meet specified requirements provide collateral.
 At December 31, 2023, the three largest balances by reinsurer accounted for 14%, 9% and 4% (2022: 13%, 9% and 6%) of reinsurance recoverable on unpaid and paid losses and loss expenses.
At December 31, 2023, 83.1% (2022: 81.8%) of the Company's reinsurance recoverable on unpaid and paid losses and loss expenses were collectible from reinsurers rated the equivalent of A- or better by A.M. Best.
(iii)    Insurance and Reinsurance Premium Balances Receivable
The diversity of the Company's client base limits credit risk associated with its insurance and reinsurance premium balances receivable. In addition, for insurance contracts the Company has contractual rights to cancel coverage for non-payment of premiums and for reinsurance contracts the Company has contractual rights to offset premium balances receivable against corresponding payments for losses and loss expenses.
Brokers and other intermediaries collect premiums from customers on behalf of the Company. The Company has procedures in place to manage and monitor credit risk from intermediaries with a focus on day-to-day monitoring of the largest positions.
These contractual rights contribute to the mitigation of credit risk, together with the monitoring of aged premium balances receivable. In light of these mitigating factors and considering that a significant portion of premium balances receivable are not currently due based on the terms of the underlying contracts, the Company does not utilize specific credit quality indicators to monitor its premium balances receivable.
At December 31, 2023, the Company recorded an allowance for credit losses expected to be recognized over the life of the premium balances receivable of $12 million (2022: $10 million).
For the year ended December 31, 2023, bad debt expense was $2 million (2022: $nil; 2021: $nil).
b)    Brokers
The Company produces its business through brokers and direct relationships with insurance companies.
For the year ended December 31, 2023 and 2022, three brokers accounted for 38% and 43% of gross premiums written, respectively. Aon plc accounted for 15% (2022: 17%), Marsh & McLennan Companies Inc. accounted for 14% (2022: 17%), and Arthur J. Gallagher & Co. accounted for 9% (2022: 9%).
For the years ended December 31, 2021, three brokers accounted for 45% of gross premiums written. Marsh & McLennan Companies Inc. accounted for 18%, Aon plc accounted for 17%, and Willis Tower Watson plc accounted for 10%.
No other broker and no single insured or reinsured accounted for more than 10% of gross premiums written in any of the last three years.
c)    Reinsurance Purchase Commitment
In the normal course of business, the Company purchases reinsurance and retrocessional (collectively referred to as "reinsurance") protection for its insurance and reinsurance business. Minimum reinsurance premiums are contractually due in advance on a quarterly basis. At December 31, 2023, the Company had outstanding reinsurance purchase commitments of $6 million (2022: $11 million), all of which is due before June 30, 2025. Actual payments under the reinsurance contracts will depend on the underlying subject premium and may exceed the minimum reinsurance premiums.
d)    Legal Proceedings
From time to time, the Company is subject to routine legal proceedings, including arbitrations, arising in the ordinary course of business. These legal proceedings generally relate to claims asserted by or against the Company in the ordinary course of its insurance or reinsurance operations. Estimated amounts payable related to these proceedings are included in reserve for losses and loss expenses in the Company's consolidated balance sheets. The Company is not party to any material legal proceedings arising outside the ordinary course of business.
e)    Investments
At December 31, 2023, the Company has $502 million (2022: $524 million) of unfunded investment commitments related to its other investment portfolio, which are callable by investment managers (refer to Note 5(e) 'Investments'). At December 31, 2023 the Company has $10 million (2022: $25 million) of unfunded investment commitments to purchase commercial mortgage loans and $16 million (2022: $20 million) of unfunded investment commitments to purchase corporate debt.
f)    Funds at Lloyd's
The Company operates in the Lloyd’s market through its corporate members, AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited, which provide 70% and 30%, respectively of Syndicate 1686's capital support. Lloyd’s sets capital requirements for corporate members annually through the application of a capital model that is based on regulatory rules pursuant to Solvency II.
The capital provided to support underwriting or FAL may be satisfied by cash, certain investments and letters of credit provided by approved banks.
At December 31, 2023, investments and cash of $893 million (2022: $749 million) were restricted to satisfy the Company's FAL requirements (refer to Note 5 'Investments' and Note 22 'Statutory Financial Information').
XML 46 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASES LEASES
In the ordinary course of business, the Company renews and enters into new leases for office property and equipment, which expire at various dates.

At the lease inception date, the Company assesses whether a contract is or contains a lease. At the commencement date, the Company determines the classification of each separate lease component as either a finance lease or an operating lease. The Company's leases are all currently classified as operating leases. For operating leases that have a lease term of more than 12 months, the Company recognizes a lease liability and a right-of-use asset in the Company's consolidated balance sheets at the present value of the lease payments at the lease commencement date.

At the commencement date, the Company determines lease terms by assuming the exercise of those renewal options that are deemed to be reasonably certain. The exercise of lease renewal options is at the sole discretion of the Company.

As the lease contracts generally do not provide an implicit discount rate, the Company uses its incremental borrowing rate based on information available at the commencement date to determine the present value of lease payments. The incremental borrowing rate is based on a borrowing with a term that is similar to the term of the associated lease. The Company has made an accounting policy election not to include renewal, termination, or purchase options that are not reasonably certain of exercise when determining the term of the borrowing.

The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Operating lease rentals are expensed on a straight-line basis over the life of the lease beginning on the commencement date.

The following table presents the Company’s total lease expense and the cash flows arising from lease transactions:
Year ended December 31,202320222021
Lease cost:
Operating lease expense$21,499$20,611$21,864 
Short-term lease expense(1)
2,2918131,127 
Sublease income(2)
(4,531)(3,423)(3,116)
Total lease expense$19,259$18,001$19,875 
Other information:
Operating cash outflows from operating leases$20,190$22,932 $22,726 
Right-of-use assets obtained in exchange for new operating lease liabilities(3)
$34,988$6,514 $(1,739)
Weighted-average remaining lease term - operating leases(4)
9.8 years9.9 years10.0 years
Weighted-average discount rate - operating lease(5)
4.4%4.1 %4.1 %
(1)    Short-term lease expense is recognized on a straight-line basis over the lease term.
(2)    Sublease income largely relates to office properties in New York and Chicago.
(3)    In 2021, the Company modified a lease agreement to reflect a reduction in the floor space it occupies in its office property in Zurich.
(4)    Weighted-average remaining lease term was calculated on the basis of the remaining lease term and the lease liability balance for each lease at the reporting date.
(5)    Weighted-average discount was calculated on the basis of the discount rate that was used to calculate the lease liability balance for each lease at the reporting date and the remaining balance of the lease payments for each lease at the reporting date.
The following table presents the scheduled maturity of the Company's operating lease liabilities at December 31, 2023:
Year ended December 31,Expected cash flows
2024$17,543 
202518,122 
202615,767 
202713,519 
202812,691 
Later years74,852 
Discount(29,393)
Total discounted operating lease liabilities$123,101 

The following table presents the scheduled maturity of the Company's operating lease liabilities at December 31, 2022:
Year ended December 31,Expected cash flows
2023$19,774 
202413,725 
202513,148 
202611,052 
20279,052 
Later years58,516 
Discount(22,690)
Total discounted operating lease liabilities $102,577 
XML 47 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
EARNINGS PER COMMON SHARE
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
EARNINGS PER COMMON SHARE EARNINGS PER COMMON SHARE
The following table presents a comparison of earnings (loss) per common share and earnings (loss) per diluted common share:
At and year ended December 31,202320222021
Earnings per common share
Net income$376,292 $223,083 $618,609 
Less: Preferred share dividends30,250 30,250 30,250 
Net income available to common shareholders$346,042 $192,833 $588,359 
Weighted average common shares outstanding85,142 84,864 84,707 
Earnings per common share$4.06 $2.27 $6.95 
Earnings per diluted common share
Net income available to common shareholders$346,042 $192,833 $588,359 
Weighted average common shares outstanding85,142 84,864 84,707 
Share-based compensation plans870 805 584 
Weighted average diluted common shares outstanding86,012 85,669 85,291 
Earnings per diluted common share$4.02 $2.25 $6.90 
Weighted average anti-dilutive shares excluded from the dilutive computation405 324 656 
XML 48 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY
a)    Common Shares
The Company's authorized share capital is 800,000,000 common shares, par value of $0.0125 per share.
The following table presents changes in common shares issued and outstanding:
Year ended December 31,202320222021
Shares issued, balance at beginning of year176,580 176,580 176,580 
Shares issued — — 
Total shares issued at end of year176,580 176,580 176,580 
Treasury shares, balance at beginning of year(91,912)(91,806)(92,227)
Shares repurchased(398)(897)(205)
Shares reissued 1,016 791 626 
Total treasury shares at end of year(91,294)(91,912)(91,806)
Total shares outstanding85,286 84,668 84,774 
Treasury Shares
On December 7, 2023, the Company's Board of Directors renewed its authorization for the repurchase of up to $100 million of the Company's common shares, effective January 1, 2024, through December 31, 2024.
The following table presents common shares repurchased from shares held in Treasury:
Year ended December 31,202320222021
In the open market: (1)
Total shares 634 — 
Total cost$ $34,987 $— 
Average price per share(2)
$ $55.22 $— 
From employees:(3)
Total shares398 263 205 
Total cost$23,596 $13,994 $10,242 
Average price per share(2)
$59.15 $53.13 $49.93 
Total shares repurchased:
Total shares398 897 205 
Total cost$23,596 $48,981 $10,242 
Average price per share(2)
$59.15 $54.61 $49.93 
(1)    Shares were repurchased pursuant to the Company's Board-authorized share repurchase program announced in December 2021, effective January 1, 2022 through to December 31, 2022.
(2)    Calculated using whole numbers.
(3)    Shares are repurchased from employees to satisfy personal withholding tax liabilities that arise on the vesting of share-settled restricted stock units.

b)    Preferred Shares
Series E Preferred Shares

On November 7, 2016, the Company issued $550 million of 5.50% Series E preferred shares, par value $0.0125 per share, with a liquidation preference of $2,500 per share. The Company could redeem the Series E preferred shares on or after November 7, 2021 at a redemption price of $2,500 per share. Dividends on the Series E preferred shares are non-cumulative. Holders of the Series E preferred shares are entitled to receive, only when, as and if declared by the Board of Directors, non-cumulative cash dividends from the original issue date, quarterly in arrears on the fifteenth day of January, April, July and October of each year, commencing on January 15, 2017. To the extent declared, dividends accumulate, with respect to each dividend period, in an amount per share equal to 5.50% of the liquidation preference per annum.
Dividends
The following table presents dividends declared and paid related to the Company's common and preferred shares:
Per share data
Dividends declared Dividends paid in year of declarationDividends paid in year following declaration
Year ended December 31, 2023
Common shares$1.76 $1.32 $0.44 
Series E preferred shares$137.50 $103.13 $34.38 
Year ended December 31, 2022
Common shares$1.73 $1.29 $0.44 
Series E preferred shares$137.50 $103.13 $34.38 
Year ended December 31, 2021
  Common shares$1.69 $1.26 $0.43 
  Series E preferred shares$137.50 $103.13 $34.38 
XML 49 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
RETIREMENT PLANS
12 Months Ended
Dec. 31, 2023
Retirement Benefits [Abstract]  
RETIREMENT PLANS RETIREMENT PLANS
The Company maintains defined contribution plans to provide retirement benefits to eligible employees. Contributions to the plans, which are managed externally, are based on eligible compensation.
For eligible U.S. employees, the Company provides a non-qualified deferred compensation plan that enables employees to make contributions to the plan that are in excess of those permitted under the Company's 401(k) Plan. In addition, employees are permitted to make additional contributions from any bonus received and to benefit from discretionary employer contribution to the Plan.
For the year ended December 31, 2023, total pension expenses were $35 million (2022: $34 million and 2021: $34 million) for the above retirement benefit.
XML 50 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED COMPENSATION
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION
In May 2017, shareholders approved the establishment of the AXIS Capital Holdings Limited 2017 Long-Term Equity Compensation Plan (the "2017 Plan"). The 2017 Plan provides for, among other things, the issuance of restricted shares, restricted stock units (share-settled awards and cash-settled awards), performance units (share-settled awards and cash-settled
awards), stock options, stock appreciation rights and other equity-based awards to the Company's employees and directors.

The 2017 Plan authorizes the issuance of a total of 3,400,000 common shares. On May 7, 2021, at the Annual General Meeting of Shareholders of the Company, the Company’s shareholders approved an amendment to the Company’s 2017 Plan to increase by 1,600,000 the number of common shares authorized for issuance under the Plan. On May 4, 2023, at the Annual General Meeting of Shareholders of the Company, the Company’s shareholders approved an amendment to the Company’s 2017 Plan to increase by 1,125,000 the number of common shares authorized for issuance under the Plan.

At December 31, 2023, 2,864,183 equity-based awards remained available for grant pursuant to the 2017 Plan.

Restricted Stock Units - Share-Settled

The grant date fair value of share-settled restricted stock units granted pursuant to the 2017 Plan is established at the fair market value of the Company's common shares at the date of grant. These awards either cliff vest at the end of a three year period, vest in accordance with a three year graded vesting schedule in three annual installments beginning on the grant date, or vest in accordance with a four year graded vesting schedule in four annual installments beginning on the grant date.

Restricted Stock Units - Cash-Settled

The grant date fair value of cash-settled restricted stock units granted pursuant to the 2017 Plan is established at the fair market value of the Company's common shares at the date of grant. These awards are liability awards and generally cliff vest at the end of a three year period, or vest in accordance with a four year graded vesting schedule in four annual installments beginning on the grant date.

Performance Restricted Stock Units - Share-Settled

Performance restricted stock units granted pursuant to the 2017 Plan represent the right to receive a specified number of common shares in the future, based on the achievement of established performance criteria and continued service during the applicable performance period.

The grant date fair value of performance restricted stock units granted in 2023, 2022 and 2021 were measured on the grant date using a Monte Carlo simulation model.

The grant date fair values of performance restricted stock units granted prior to 2021 was established at the fair market value of the Company's common shares at the date of grant.

Awards granted pursuant to the 2017 Plan generally cliff vest at the end of a three year period. Compensation expense is recognized on a straight-line basis over the applicable requisite service period. Awards granted prior to 2021 are subject to periodic adjustment based on the achievement of established performance criteria during the applicable performance period.

Acceleration Provisions

Grants provided under the 2017 Plan generally allow for accelerated vesting provisions on the employee’s death, permanent disability, or certain terminations following a change in control of the Company occurring within two years of the change in control event. Notwithstanding these vesting provisions, the Compensation Committee of the Company's Board of Directors has broad authority to accelerate vesting at its discretion.
Retirement Plan

In 2016, the Company established the AXIS Executive Restricted Stock Unit Retirement Plan (the "Plan") to reward certain eligible long-term employees of the Company for their dedicated service. The Plan was implemented in 2017. Subject to certain conditions being met, eligible employees do not forfeit all of their outstanding share-settled restricted stock units, share-settled performance restricted stock units or cash-settled restricted stock units on or following their retirement. Absent the Plan, outstanding restricted stock units are generally forfeited on termination of employment.

a)    Performance Restricted Stock Units

Performance Restricted Stock Units granted in 2023, 2022 and 2021
Performance restricted stock units granted in 2023, 2022 and 2021 include a market condition which is the Company’s total shareholder return relative to its peer group ("Relative TSR") over the performance period. Relative TSR is calculated in accordance with the terms of the applicable award agreement. If performance goals are achieved, these awards will cliff vest at the end of a three-year performance period within a range of 0% to 200% of target. Performance restricted stock units granted in 2023, 2022 and 2021 were share-settled awards.

Performance Restricted Stock Units granted in the three months ended March 31, 2023 in relation to senior leadership transition

Share-settled performance restricted stock units granted in the three months ended March 31, 2023 to one senior leader include a market condition which is the Company’s total shareholder return relative to its peer group ("Relative TSR") over the performance period. Relative TSR is calculated in accordance with the terms of the applicable award agreement. If performance goals are achieved, fifty percent of these awards will vest at the end of a one-year performance period, and the remaining fifty percent of these awards will vest at the end of a three-year vest period within a range of 0% to 200% of target.

Performance Restricted Stock Units granted in the three months ended June 30, 3023 in relation to senior leadership transition

Share-settled performance restricted stock units granted in the three months ended June 30, 2023 to one senior leader include a market condition which is the Company’s total shareholder return's compound annual growth rate ("TSR CAGR") over the performance period. TSR CAGR is calculated in accordance with the terms of the applicable award agreement. If performance goals are achieved, these awards will cliff vest at the end of a three-year performance period within a range of 0% to 200% of target.
Valuation assumptions

The fair value of performance restricted stock units granted in 2023, 2022 and 2021 were measured on the grant date using a Monte Carlo simulation model.

The following table provides details of the significant inputs used in the Monte Carlo simulation model:
Year ended December 31,
2023 (1)
2023 (2)
2023 (3)
20222021
Expected volatility 36.24%29.30%30.05%33.44%32.99%
Expected term (in years)3.01.03.03.03.0
Expected dividend yieldn/an/an/an/an/a
Risk-free interest rate3.79%4.61%3.39%1.26%0.17%
n/a - not applicable
(1) Performance restricted stock units granted in the ordinary course of business
(2) Performance restricted stock units granted in the three months ended March 31, 2023 in relation to senior leadership transition
(3) Performance restricted stock units granted in the three months ended June 30, 2023 in relation to senior leadership transition

Beginning share price: The beginning share price was based on the average closing share price over the 10 trading days preceding and including the start of the performance period. The beginning share price of the awards granted in the three months ended June 30, 2023 to one senior leader was based on the average closing share price over the 30 trading days preceding and including the start of the performance period.

Ending share price: The ending share price was based on the average closing share price over the 10 trading days preceding and including the end of the performance period. The ending share price of the awards granted in the three months ended June 30, 2023 to one senior leader was based on the average closing share price over the 30 trading days preceding and including the end of the performance period.

Expected volatility: The expected volatility was estimated based on the Company's historical share price volatility.

Expected term: Performance for awards granted in 2023 is generally measured from January 1, 2023 to December 31, 2025, with performance for awards granted to one senior leader in the three months ended March 31, 2023 being measured from January 1, 2023 to December 31, 2023, and performance for awards granted to one senior leader in the three months ended June 30, 2023 being measured from May 4, 2023 to May 4, 2026. Performance for awards granted in 2022 is measured from January 1, 2022 to December 31, 2024, and performance for awards for awards granted in 2021 is measured from January 1, 2021 to December 31, 2023.

Expected dividend yield: The expected dividend yield is not applicable to the performance restricted stock units as dividends are paid at the end of the vesting period and do not affect the value of the performance restricted stock units.

Risk-free interest rate: The risk-free rate was estimated based on the yield on a U.S. treasury zero-coupon bond issued with a remaining term equal to the vesting period of the performance restricted stock units.

Compensation expense associated with performance restricted stock units granted in 2023, 2022 and 2021 is determined on the grant date based on the fair value calculated by the Monte Carlo simulation model and is recognized on a straight-line basis over the requisite service period. During the three months ended March 31, 2023, the transition in our senior leadership resulted in a modification of the previously existing vesting terms of the outstanding restricted stock units and performance restricted stock units granted in 2022 and earlier of one senior leader, and a modification of the performance period of that leader's performance restricted stock units granted in 2022. The modifications did not result in incremental compensation expense.
Performance Restricted Stock Units granted in 2020 and 2019
Performance restricted stock units granted in 2020 and 2019 and include a market condition which is the Company’s total shareholder return relative to its peer group ("Relative TSR") over the performance period. Relative TSR is calculated in accordance with the terms of the applicable award agreement. If performance goals are achieved, these awards will cliff vest at the end of a three-year performance period within a range of 75% to 125% of target. Performance restricted stock units granted in 2020 and 2019 were share-settled awards.

Compensation expense associated with performance restricted stock units granted in 2020 and 2019 is determined based on market value of the Company's common shares measured at the grant date, is recognized on a straight-line basis over the requisite service period and is subject to periodic adjustment based on the achievement of established performance criteria during the performance period.

b)     Share-Settled Awards

The following table provides an activity summary of the Company's share-settled restricted stock units:
Share-Settled Performance
Restricted Stock Units
Share-Settled Service
Restricted Stock Units
Number of
restricted
stock units
Weighted average grant date
fair value
Number of
restricted
stock units
Weighted average
grant date
fair value
Nonvested restricted stock units - December 31, 2021311 $54.75 2,062 $51.59 
Granted140 68.63 993 56.09 
Vested(100)54.70 (690)52.67 
Forfeited(21)62.26 (248)53.22 
Nonvested restricted stock units - December 31, 2022330 60.01 2,117 53.16 
Granted122 66.13 918 57.53 
Vested(88)63.88 (929)53.02 
Forfeited(220)58.15 (251)54.49 
Nonvested restricted stock units - December 31, 2023144 $65.69 1,855 $55.21 
c)    Cash-Settled Awards
The following table provides an activity summary of the Company's cash-settled restricted stock units:
Cash-Settled Service Restricted Stock Units
Number of
restricted stock units
Nonvested restricted stock units - December 31, 2021215 
Granted— 
Vested(145)
Forfeited(10)
Nonvested restricted stock units - December 31, 202260 
Granted 
Vested(59)
Forfeited(1)
Nonvested restricted stock units - December 31, 2023 

The following table provides additional information related to share-based compensation:
Year ended December 31,202320222021
Share-based compensation expense (1)
$57,729 $56,136 $49,415 
Tax benefits associated with share-based compensation expense$8,819 $8,839 $7,613 
Liability for cash-settled restricted stock units (2)
$— $4,792 $9,091 
Fair value of restricted stock units vested (3)
$64,156 $49,792 $42,967 
Unrecognized share-based compensation expense$62,416 $74,601 $80,805 
Expected weighted average period associated with the recognition of unrecognized share-based compensation expense2.4 years2.3 years2.4 years
(1)    Related to share-settled restricted stock units and cash-settled restricted stock units.
(2)    Included in other liabilities in the consolidated balance sheets.
(3)    Fair value is based on the closing price of the Company's common shares on the vest date.
XML 51 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS
A member of the Company’s Board of Directors, Mr. Charles Davis, is the Chief Executive Officer of Stone Point Capital, LLC ("Stone Point"). In the ordinary course of business, the Company engages SKY Harbor Capital Management, LLC, which is majority-owned by Stone Point's private equity fund Trident V L.P. ("Trident V"), to provide asset management services for certain high yield debt portfolios. For the year ended December 31, 2023, total fees paid to SKY Harbor Capital Management, LLC, were $3 million (2022: $2 million; 2021: $2 million).
In addition, the Company has an investment of $17 million in the Freedom Consumer Credit Fund, LLC - Series B. The manager of this fund is Freedom Financial Asset Management, LLC ("Freedom") which is an indirect subsidiary of Pantheon Partners, LLC ("Pantheon"). A Stone Point private equity fund, Trident VI L.P. ("Trident VI") owns approximately 14.5% of Pantheon. For the year ended December 31, 2023, fees paid to Freedom were $1 million (2022: $2 million; 2021: $3 million).
The Company has an investment of $87 million in Stone Point's private equity fund, Trident VIII L.P. ("Trident VIII") and co-investments of $26 million with Trident VIII. For the year ended December 31, 2023, fees paid to Stone Point in relation to Trident VIII were $2 million (2022: $2 million; 2021: $4 million).
The Company has an investment of $24 million in Stone Point's private equity fund, Trident IX L.P. ("Trident IX"). For the year ended December 31, 2023, fees paid to Stone Point in relation to Trident IX were $1 million (2022: $1 million; 2021: $nil).
The Company has an investment of $43 million with Rialto Real Estate IV-Property ("Rialto") and co-investments of $19 million with Rialto, a fund managed by a portfolio company of Stone Point's private equity fund, Trident VII L.P. ("Trident VII "). For the year ended December 31, 2023, fees paid to Rialto were $2 million (2022: $2 million; 2021: $1 million).
The Company has an investment of $18 million in Stone Point Credit Corporation. For the year ended December 31, 2023, fees paid to Stone Point in relation to Stone Point Credit Corporation were $0.5 million (2022: $0.3 million; 2021: $nil).
The Company has an investment of $18 million in Stone Point Credit Corporation bonds. For the year ended December 31, 2023, the Company earned income of $1 million (2022: $0.6 million) in relation to this bond.
The Company has an investment of $5 million in a syndicated accounts receivable loan for which Sound Point Capital Management LP ("Sound Point"), an affiliate of Stone Point, is the lead originator. For the year ended December 31, 2023, the Company has not paid any fees to Sound Point.
The Company has co-investments of $9 million with Gordon Brothers, which is majority-owned by Trident VII. For the year ended December 31, 2023, fees paid to Gordon Brothers were $0.1 million (2022: $0.1 million).
The Company has an investment of $7 million in a loan to Eagle Point Credit Management LLC ("Eagle Point"), which is majority-owned by Trident IX. For the year ended December 31, 2023, the Company has not paid any fees to Eagle Point.
The Company has an investment of $6 million in cumulative preferred shares of Aspida Holdings Ltd. ("Aspida"). The investment was syndicated to the Company by Stone Point. For the year ended December 31, 2023, the Company has not paid any fees to Aspida.
The Company has an investment of $22 million in Monarch Point Re (refer to Note 5 'Investments'), a newly created collateralized reinsurer which is jointly sponsored by the Company and Stone Point. For the year ended December 31, 2023, fees paid to Monarch Point Re were $0.1 million.
The Company's investment portfolio includes certain investments where it is considered to have the ability to exercise significant influence over the operating and financial policies of the investee. Significant influence is generally deemed to exist where the Company has an investment of 20% or more in the common stock of a corporation or an investment greater than 3% to 5% in closed end funds, limited partnerships, LLCs or similar investment vehicles. 
At December 31, 2023, the Company has $424 million (2022: $462 million) of investments where it is deemed to have the ability to exercise such significant influence. The Company generally pays management and performance fees to the
investment managers of these investments. The Company considers all fees paid to the investment managers to be at market rates consistent with negotiated arms-length contracts.
Retrocession Agreement with Monarch Point Re
On September 22, 2023 (the "closing date"), the Company entered into an agreement, with an effective date of January 1, 2023, to retrocede a diversified portfolio of casualty reinsurance business to Monarch Point Re.
The agreement covers losses both on a prospective basis and on a retroactive basis. Therefore, the Company has bifurcated the prospective and retroactive elements of the agreement and is accounting for each element separately.

Retroactive element
Reinsurance premiums of $119 million were allocated to the retroactive element of the agreement which was deemed to have met the established criteria for retroactive reinsurance accounting. At the closing date, the Company recognized acquisition costs of $33 million and a loss expense of $7 million in the consolidated statement of operations associated with the retroactive element of the agreement. In addition, the Company recognized reinsurance recoverable on unpaid losses of $76 million and reinsurance recoverable on paid losses of $4 million in the consolidated balance sheets associated with the retroactive element of the agreement (refer to Note 8 'Reserve for Losses and Loss Expenses').

Prospective element
For the year ended December 31, 2023, the Company ceded reinsurance premiums of $287 million and ceded losses of $37 million to Monarch Point Re. In addition, Monarch Point Re paid certain acquisition costs and administrative fees to the Company.
At December 31, 2023, the amount of reinsurance recoverable on unpaid and paid losses was $37 million and the amount of ceded reinsurance payable included in insurance and reinsurance balances payable was $166 million in the consolidated balance sheets.
This transaction was conducted at market rates consistent with negotiated arms-length contracts.
Loan to Monarch Point Re
During 2023, the Company advanced an amount of $297 million to Monarch Point Re. This loan will be repaid in a manner consistent with the timing of amounts due to Monarch Point Re under the retrocession agreement. At December 31, 2023, an amount of $72 million was repaid and was treated as a non-cash activity in the consolidated statement of cash flows. The loan is expected to be repaid in full by May 15, 2025. The loan balance receivable at December 31, 2023 of $225 million is included in loan advances made in the consolidated balance sheets. At December 31, 2023, the Company had committed to advance a further $16 million to Monarch Point Re.
Interest on this loan was payable for the three months ended December 31, 2023 at interest rates between 5.7% and 5.85%. Interest related to this loan was received in advance and is included in other liabilities in the consolidated balance sheets and interest income for this period is included in other insurance related income in the consolidated statement of operations.
Retrocession Agreement with Harrington Re
Harrington and Harrington Re commenced operations in 2016 (refer to Note 5 'Investments'). The Company has the ability to exercise significant influence over the operating and financial policies of Harrington and Harrington Re. In the normal course of business, the Company enters into certain reinsurance transactions with Harrington Re.
For the year ended December 31, 2023, the Company ceded reinsurance premiums of $298 million (2022: $324 million; 2021: $283 million) and ceded losses of $229 million (2022: $234 million; 2021: $188 million) to Harrington Re. In addition, Harrington Re paid certain acquisition costs and administrative fees to the Company.
At December 31, 2023, the amount of reinsurance recoverable on unpaid and paid losses was $933 million (2022: $819 million) and the amount of ceded reinsurance payable included in insurance and reinsurance balances payable was $219 million (2022: $220 million) in the consolidated balance sheets. This transaction was conducted at market rates consistent with negotiated arms-length contracts.
On June 29, 2021, the Company invested $10 million in 7.25% fixed to floating rate, senior unsecured notes due 2031, issued by Harrington.
XML 52 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
REORGANIZATION EXPENSES
12 Months Ended
Dec. 31, 2023
Restructuring and Related Activities [Abstract]  
REORGANIZATION EXPENSES REORGANIZATION EXPENSES
For the year ended December 31, 2023, reorganization expenses were $29 million (2022: $31 million and 2021: $nil).
In 2023, reorganization expenses included impairments of computer software assets and severance costs mainly related to the Company's "How We Work" program which is focused on simplifying and improving the Company’s operating structure.
In 2022, reorganization expenses included severance costs and software asset impairments attributable to the Company's exit from catastrophe and property reinsurance lines of business in June.
XML 53 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
Under current Bermuda law, AXIS Capital's Bermuda subsidiaries are not required to pay any taxes in Bermuda on income or capital gains. The Company has received assurance from the Minister of Finance in Bermuda that, in the event of any taxes being imposed, it will be exempt from taxation in Bermuda until March 2035. Notwithstanding the above, on December 27, 2023 the Bermuda government enacted a corporate income tax which will apply for accounting periods starting on or after January 1, 2025. Importantly, under the Corporate Income Tax Act 2023 of Bermuda, any liability to the tax will apply regardless of any assurances previously provided under the Exempted Undertakings Tax Protection Act 1966 of Bermuda.
AXIS Capital's primary Bermuda subsidiary has an operating branch in Singapore, which is subject to the relevant taxes in that jurisdiction. The Singapore branch is not under examination in that tax jurisdiction but remains subject to examination for tax years 2020 through 2023.
AXIS Capital's U.S. subsidiaries are subject to federal, state and local corporate income taxes, and other taxes applicable to U.S. corporations. The provision for federal income taxes has been determined under the principles of the consolidated tax provisions of the U.S. Internal Revenue Code and regulations. Should the U.S. subsidiaries pay a dividend outside the U.S. group, withholding taxes will apply. AXIS Capital's U.S. subsidiaries are not under examination but remain subject to examination for tax years 2020 through 2023. An Internal Revenue Service ("IRS") examination of the U.S. group was completed in 2023 with respect to tax years 2019 and 2020 and was closed without material adjustments.
In Canada, AXIS Capital's U.S. reinsurance company operates through a branch and its U.S. service company has an unlimited liability company subsidiary based in Canada. The Canadian operations are subject to the relevant taxes in that jurisdiction and remain subject to examination for tax years 2019 through 2023.
AXIS Capital had subsidiaries in Ireland, the U.K., and Brazil in 2023 and AXIS Capital's subsidiaries had branches in the U.K., Switzerland, and Belgium. The Company ceased operations in Dubai in March 2021 and in the Netherlands in December 2021. These subsidiaries and their branches are not under examination but remain subject to examination in all applicable jurisdictions for tax years 2019 through 2023.
In the U.K., the Company operates through a Lloyd’s syndicate whose income is subject to tax in the U.K., payable by its corporate members. The income from operations at Lloyd’s is also subject to taxes in other jurisdictions in which Lloyd's operates, including the U.S. Under a Closing Agreement between Lloyd’s and the IRS, Lloyd's corporate members pay U.S. income tax on U.S. connected income written by Lloyd’s syndicates. To the extent that the Lloyd’s syndicates incur taxes outside the U.K., they may claim a credit for foreign taxes incurred, limited to the U.K. equivalent tax on the same income.
The following table provides an analysis of income tax expense (benefit) and net tax assets:
Year ended December 31,202320222021
Current income tax expense (benefit)
U.S.$12,021 $11,491 $35,229 
Europe32,386 2,366 (6,082)
Bermuda
291 (147)— 
Deferred income tax expense (benefit)
U.S.(24,042)(8,147)(3,369)
Europe18,932 16,474 36,606 
Bermuda(1)
(13,272)— — 
Total income tax expense (benefit)$26,316 $22,037 $62,384 
Net current tax receivables$78,570 $46,704 $27,883 
Net deferred tax assets (liabilities)72,850 108,220 12,860 
Net tax assets$151,420 $154,924 $40,743 
(1)    Reflects the recognition of a tax benefit in Bermuda on unrealized investment losses included in other comprehensive income (loss) due to the enactment of corporate income tax that will take effect in 2025.
Deferred income taxes reflect the tax impact of temporary differences between the carrying amounts of assets and liabilities for financial reporting and income tax purposes. The following table provides details of the significant components of deferred tax assets and liabilities:
At December 31,20232022
Deferred tax assets:
Discounting of net reserves for losses and loss expenses$62,316 $52,992 
Unearned premiums54,104 56,146 
Net unrealized investments losses54,395 71,251 
Operating and capital loss carryforwards
100,907 152,896 
Accruals not currently deductible36,407 42,045 
Tax credits 11,602 7,619 
Other deferred tax assets4,149 8,590 
Deferred tax assets before valuation allowance323,880 391,539 
Valuation allowance(38,711)(60,069)
Deferred tax assets net of valuation allowance285,169 331,470 
Deferred tax liabilities:
Deferred acquisition costs(27,109)(35,211)
Other investment adjustments and impairments(7,173)(20,068)
Intangible assets(49,486)(51,993)
Equalization reserves(2,726)(2,530)
Acquisition adjustments(79,466)(72,351)
Lloyd’s deferred year of account results(38,194)(34,068)
Other deferred tax liabilities(8,165)(7,029)
Deferred tax liabilities(212,319)(223,250)
Net deferred tax assets (liabilities)$72,850 $108,220 
The following table summarizes total operating and capital loss carryforwards and tax credits:
At December 31,20232022
Operating and Capital Loss Carryforwards(1)
Singapore operating loss carryforward
$70,815 $73,769 
U.K. operating loss carryforward
293,533 415,274 
Ireland operating loss carryforward78,154 200,822 
Ireland capital loss carryforward716 716 
Switzerland operating loss carryforward(2)
123,453 187,057 
Tax Credits(1)
Ireland foreign tax credit$6,922 $655 
U.K. foreign tax credit2,605 2,372 
U.S. foreign tax credit(3)
2,074 4,592 
(1)    At December 31, 2023, the Singapore, U.K., and Ireland operating and capital loss carryforwards and tax credits can be carried forward
(2)    At December 31, 2023, the Swiss net operating losses can be carried forward 7 years of which $123,453 expires 2029.
(3)    At December 31, 2023, the U.S. foreign tax credit can be carried back 1 year and carried forward 10 years of which, $2,074 expires 2032.
The following table shows an analysis of the movement in the Company's valuation allowance:
At December 31,20232022
Income tax expense (benefit):
Valuation allowance - beginning of year$39,782 $16,918 
Operating loss carryforwards(8,713)21,724 
Foreign tax credit4,184 2,401 
U.K. branch assets and other foreign rate differentials(3,565)(1,261)
Valuation allowance - end of year$31,688 $39,782 
Accumulated other comprehensive income (loss):
Valuation allowance - beginning of year$20,287 $— 
Change in investment - related items(13,264)20,287 
Valuation allowance - end of year7,023 20,287 
Total valuation allowance - end of year$38,711 $60,069 
At December 31, 2023 and 2022, the Company had a full valuation allowance on operating loss carryforwards relating to operations in Singapore, Ireland and Switzerland, foreign tax credits available in Ireland and certain other deferred tax assets related to branch operations.
In 2023, the valuation allowance decreased by $21 million. The net gain incurred by the AXIS Re SE, the Irish reinsurance company, resulted in the release of a valuation allowance of $25 million against the net deferred tax assets of AXIS Re SE and AXIS Re Europe, the Swiss branch of the Irish reinsurance company, of which $12 million was released in net income (loss) and $13 million was released in other comprehensive income (loss). A valuation allowance of $2 million was also released against U.S. foreign tax credits that were utilized. A valuation allowance of $6 million was recorded against foreign tax credits held by AXIS Specialty Europe SE.
At December 31, 2023 and 2022, the Company's U.S. operations had a deferred tax asset of $54 million and $71 million, respectively, for the unrealized losses on its fixed maturities that were recorded in other comprehensive income (loss). The Company examined the need for a valuation allowance and after considering all positive and negative evidence concluded a valuation allowance against its net unrealized investment losses in the U.S was not required.
Although realization is not assured, management believes it is more likely than not that the tax benefit of the recorded net deferred tax assets will be realized. In evaluating the Company's ability to recover these tax assets within the jurisdiction from which they arise, it considered all available positive and negative evidence, including historical results, operating loss carry-back potential and scheduled reversals of deferred tax liabilities. The Company believes its U.S. and U.K. operations will produce significant taxable income in future periods and have deferred tax liabilities that will reverse in future periods, such that the Company believes sufficient ordinary taxable income is available to utilize all remaining ordinary deferred tax assets.
A deferred tax liability has not been recorded on undistributed earnings as the U.S. group satisfies the indefinite reversal criteria.
At December 31, 2023 and 2022, there were no unrecognized tax benefits.
The following table presents the distribution of income before income taxes between domestic and foreign jurisdictions and a reconciliation of the actual income tax rate to the amount computed by applying the effective tax rate of 0% under Bermuda law to income before income taxes:
Year ended December 31,202320222021
Income (loss) before income taxes
Bermuda (domestic)$213,539 $236,781 $431,310 
Foreign189,067 8,340 249,686 
 Total income before income taxes$402,606 $245,121 $680,996 
Reconciliation of effective tax rate (% of income before income taxes)
Expected tax rate0.0 %0.0 %0.0 %
Foreign taxes at local expected rates:
U.S.(2.5 %)0.2 %4.8 %
Europe11.9 %1.9 %2.0 %
Valuation allowance(2.0 %)9.5 %(0.5 %)
Prior year adjustments
1.3 %(0.3)%0.2 %
Incremental branch taxes
0.9 %(0.4)%1.5 %
Change in enacted tax rate(1)
(3.3 %)(2.2 %)1.5 %
Other0.2 %0.3 %(0.3 %)
Actual tax rate6.5 %9.0 %9.2 %
(1)    At December 31, 2023, the change in enacted tax rate represents the enactment of the Bermuda Corporate Income Tax Act of 2023 related to unrealized investment losses included in other comprehensive income (loss). At December 31, 2022, the change in enacted tax rate included a change in the UK tax rate from 19% to 25% and in Belgium from 30% to 25%.
XML 54 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER COMPREHENSIVE INCOME (LOSS)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
OTHER COMPREHENSIVE INCOME (LOSS) OTHER COMPREHENSIVE INCOME (LOSS)
The following table presents the tax effects allocated to each component of other comprehensive income (loss):
Before tax amountIncome tax (expense) benefitNet of tax amount
Year ended December 31, 2023
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$294,933 $(36,993)$257,940 
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized11,220 (1,637)9,583 
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)
142,324 (13,811)128,513 
Unrealized gains (losses) arising during the year, net of reclassification adjustment448,477 (52,441)396,036 
Foreign currency translation adjustment(1,572) (1,572)
Total other comprehensive income (loss), net of tax$446,905 $(52,441)$394,464 
Year ended December 31, 2022
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$(1,171,381)$127,756 $(1,043,625)
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized(73,063)5,913 (67,150)
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)335,294 (30,369)304,925 
Unrealized gains (losses) arising during the year, net of reclassification adjustment(909,150)103,300 (805,850)
Foreign currency translation adjustment(10,986)— (10,986)
Total other comprehensive income (loss), net of tax$(920,136)$103,300 $(816,836)
Year ended December 31, 2021
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$(310,710)$39,263 $(271,447)
Unrealized gains (losses) arising during the year for which an allowance
for expected credit losses has been recognized
81 — 81 
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)(94,749)7,635 (87,114)
Unrealized gains (losses) arising during the year, net of reclassification adjustment(405,378)46,898 (358,480)
Foreign currency translation adjustment621 — 621 
Total other comprehensive income (loss), net of tax$(404,757)$46,898 $(357,859)
The following table presents details of amounts reclassified from accumulated other comprehensive income (loss) ("AOCI") to net income (loss):
Amounts reclassified from AOCI(1)
AOCI componentsConsolidated statement of operations line item that includes reclassification adjustmentYear ended December 31,
202320222021
Unrealized gains (losses) on available for sale investments
Other realized gains (losses)
$(129,567)$(322,726)$94,771 
Impairment losses(12,757)(12,568)(22)
Total before tax(142,324)(335,294)94,749 
Income tax (expense) benefit13,811 30,369 (7,635)
Net of tax$(128,513)$(304,925)$87,114 
(1)    Amounts in parentheses are charges to net income (loss).
XML 55 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATUTORY FINANCIAL INFORMATION
12 Months Ended
Dec. 31, 2023
STATUTORY FINANCIAL INFORMATION [Abstract]  
STATUTORY FINANCIAL INFORMATION STATUTORY FINANCIAL INFORMATION
The Company's insurance and reinsurance operations are subject to laws and regulations in the jurisdictions in which they operate, the most significant of which include Bermuda, Ireland, and the U.S. In addition, the Company is regulated by Lloyd's. These regulations include certain restrictions on the amount of dividends or other distributions, such as loans or cash advances, available to shareholders without prior approval from insurance regulatory authorities.
The statutory capital and surplus in each of the Company's most significant regulatory jurisdictions is shown in the following table:
BermudaIrelandU.S.
At December 31,202320222023202220232022
Required statutory capital and surplus$1,269,943 $1,261,160 $755,076 $699,203 $739,829 $651,460 
Available statutory capital and surplus$3,170,556 $3,156,955 $1,160,932 $1,099,474 $2,187,371 $1,982,618 

Bermuda
Under the Insurance Act 1978, amendments thereto and related regulations of Bermuda (the "Act"), the Company's Bermuda subsidiary, AXIS Specialty Bermuda is required to maintain minimum statutory capital and surplus equal to the greater of a minimum solvency margin ("MSM") and the Enhanced Capital Requirement ("ECR"). The MSM is the greater of $100 million, 50% of net premiums written, 15% of net reserve for losses and loss expenses, and 25% of the ECR. The Company's ECR is calculated based on a standard risk-based capital model developed by the Bermuda Monetary Authority ("BMA"). In 2016, the BMA implemented an Economic Balance Sheet ("EBS") framework which is used as the basis to determine the ECR. At December 31, 2023 and 2022, the required and available statutory capital and surplus were based on this EBS framework.
Under the Act, AXIS Specialty Bermuda is restricted as to the payment of dividends for amounts greater than 25% of the prior year’s statutory capital and surplus, whereby an affidavit signed by at least two members of the Board of Directors is required, attesting that any dividend in excess of this amount would not cause the Company to fail to meet its relevant margins. At December 31, 2023, the maximum dividend AXIS Specialty Bermuda could pay, without a signed affidavit, having met minimum levels of statutory capital and surplus requirements, was approximately $730 million (2022: $709 million).
Ireland
Effective January 1, 2016, the Company's Irish subsidiaries, AXIS Specialty Europe and AXIS Re SE, are required to maintain the Minimum Capital Requirement ("MCR") and the Solvency Capital Requirement ("SCR") at all times. The capital requirements are calculated by reference to Solvency II definitions. If an entity falls below the MCR or SCR, the Central Bank of Ireland is authorized to take action to restore the financial position of the Company's Irish subsidiaries. During 2023 and 2022, the Company's Irish subsidiaries were in compliance with these requirements.
The Company's Irish subsidiaries may declare dividends subject to meeting their solvency and capital requirements. The maximum dividend is limited to "excess eligible own funds" which is defined as excess Solvency II capital over the SCR and may also be limited to "profits available for distribution'', which is defined as accumulated realized profits less accumulated realized losses and statutory reserves. The Central Bank of Ireland requires the Company's Irish subsidiaries to notify the regulator prior to any distribution being made. The Central Bank of Ireland then has 30 days to request further information from the Company's Irish subsidiaries and where no further communication is received from the regulator the Company's Irish subsidiaries are free to proceed with the dividend distribution. At December 31, 2023, the maximum dividend the Company's Irish subsidiaries could pay, having met their solvency and capital requirements was approximately $28 million (2022: $51 million).
United States
The Company's U.S. operations required statutory capital and surplus is determined using the risk-based capital formula ("RBC"), which is the National Association of Insurance Commissioners' (the "Commissioner") method of measuring the minimum capital appropriate for U.S. reporting entities to support its overall business operations in consideration of its size and risk profile. If a company falls below the authorized control level as determined under the RBC, the Commissioner is authorized to take whatever regulatory actions may be considered necessary to protect policyholders and creditors. The maximum dividend that may be paid by the Company's U.S. insurance subsidiaries is restricted by the regulatory requirements of the domiciliary states. Generally, the maximum dividend that may be paid by each of the Company's U.S. insurance subsidiaries is limited to unassigned surplus (statutory equivalent of retained earnings) and may also be limited to statutory net income, net investment income or 10% of total statutory capital and surplus. At December 31, 2023, the maximum dividend that the Company's U.S. insurance operations could pay without regulatory approval was approximately $181 million (2022: $119 million).
Lloyd's of London
The Company operates in the Lloyd’s market through its corporate members, AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited, which provide 70% and 30%, respectively, of Syndicate 1686's capital support. Syndicate 1686 is managed by AXIS Managing Agency.
Corporate members of Lloyd’s and Lloyd’s syndicates are bound by the rules of Lloyd’s, which are prescribed by Bye-laws and Requirements made by the Council of Lloyd’s under powers conferred by the Lloyd’s Act 1982. These rules prescribe members’ membership subscription, the level of their contribution to the Lloyd’s Central Fund and the assets they must deposit with Lloyd’s in support of their underwriting. The Council of Lloyd’s has broad powers to sanction breaches of its rules, including the power to restrict or prohibit a member’s participation on Lloyd’s syndicates.
The capital provided to support underwriting, or FAL, is not available for distribution for the payment of dividends or for working capital requirements. Corporate members may also be required to maintain funds under the control of Lloyd’s in excess of their capital requirements and such funds also may not be available for distribution for the payment of dividends. Lloyd’s sets the corporate members’ required capital annually and reviews funds held compared to latest capital requirements on a quarterly basis. This process is supported by the application of a capital model that is based on regulatory rules pursuant to Solvency II.
FAL may be satisfied by cash, certain investments and letters of credit provided by approved banks. At December 31, 2023, fixed maturities and short-term investments with a fair value of $587 million (2022: $530 million) and cash of $13 million (2022: $13 million), respectively, were restricted to satisfy AXIS Corporate Capital UK Limited FAL requirements. At December 31, 2023, fixed maturities and short-term investments with a fair value of $261 million (2022: $176 million), equity securities with a fair value of $27 million (2022: $23 million), and cash of $6 million (2022: $6 million) were restricted to satisfy AXIS Corporate Capital UK II Limited FAL requirements (refer to Note 5 'Investments' and Note 12 'Commitments and Contingencies').
Corporate members can apply to Lloyd's to release accumulated funds, whether syndicate profits or interest on FAL, which are in excess of the agreed FAL requirements on a quarterly basis. At December 31, 2023 and 2022, actual capital and assets exceeded the FAL requirements for Syndicate 1686. Both AXIS Corporate Capital UK Limited and AXIS Corporate Capital UK II Limited continue to support the FAL requirements of Syndicates 1686.

Branch Offices
The Company's operating subsidiaries in Bermuda and the U.S. maintain branch offices in Singapore and Canada, respectively. The Company's Irish operating subsidiaries maintain branch offices in the U.K., Switzerland and Belgium. The Company's Irish operating subsidiaries also maintained a branch office in the Netherlands until December 31, 2021. As branch offices are not considered separate entities for regulatory purposes, the required and actual statutory capital and surplus amounts for each jurisdiction in the table above, include amounts related to the applicable branch offices. The Company's branch offices in Singapore and Canada are subject to additional minimum capital or asset requirements in their countries of domicile. At December 31, 2023 and 2022, the actual capital/assets for each of these branches exceeded the relevant local regulatory requirements.
Total statutory net income (loss) of the Company's operating subsidiaries was $471 million, $134 million, and $569 million for 2023, 2022 and 2021, respectively. The differences between statutory financial statements and statements prepared in accordance with U.S. GAAP vary by jurisdiction, however, the primary differences are that statutory financial statements may not reflect deferred acquisition costs, certain net deferred tax assets, goodwill and intangible assets, unrealized gains (losses) on fixed maturities or certain unauthorized reinsurance recoverable balances.
XML 56 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES
12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]  
SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES
AXIS CAPITAL HOLDINGS LIMITED
SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES
 
At December 31, 2023
Amortized costFair valueAmount shown on the balance sheet
(in thousands)
Type of investment:
Fixed maturities, available for sale, at fair value
U.S. government and agency$3,049,445 $3,007,528 $3,007,528 
Non-U.S. government729,761 723,959 723,959 
Corporate debt4,651,654 4,474,172 4,474,172 
Agency RMBS1,706,204 1,634,661 1,634,661 
CMBS897,553 839,696 839,696 
Non-agency RMBS165,910 153,396 153,396 
ABS1,265,187 1,242,971 1,242,971 
Municipals168,540 158,359 158,359 
Total fixed maturities, available for sale$12,634,254 12,234,742 12,234,742 
Fixed maturities, held to maturity, at amortized cost
Corporate debt$95,200 86,671 95,200 
ABS591,096 589,180 591,096 
Total fixed maturities, held to maturity$686,296 675,851 686,296 
Mortgage loans, held for investment, at fair value610,148 610,148 
Short-term investments, at fair value17,216 17,216 
Equity securities, at fair value588,511 588,511 
Other investments, at fair value (1)
699,607 949,413 
Equity method investments (2)
 174,634 
Total investments$14,826,075 $15,260,960 
(1)Other investments exclude investments where the Company is considered to have the ability to exercise significant influence over the operating and financial policies of the investees.
(2)Equity method investments are excluded as the Company has the ability to exercise significant influence over the operating and financial policies of the investees.
XML 57 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY
AXIS CAPITAL HOLDINGS LIMITED
CONDENSED BALANCE SHEETS – PARENT COMPANY
DECEMBER 31, 2023 AND 2022
 
20232022
(in thousands)
Assets
Investments in subsidiaries$5,415,302 $4,943,126 
Cash and cash equivalents412 1,932 
Other assets4,751 4,432 
Total assets$5,420,465 $4,949,490 
Liabilities
Intercompany payable$89,430 $225,490 
Dividends payable51,749 52,992 
Other liabilities16,090 31,098 
Total liabilities157,269 309,580 
Shareholders’ equity
Preferred shares550,000 550,000 
Common shares (shares issued 2023: 176,580; 2022: 176,580
     shares outstanding 2023: 85,286; 2022: 84,668)
2,206 2,206 
Additional paid-in capital2,383,030 2,366,253 
Accumulated other comprehensive income (loss)(365,836)(760,300)
Retained earnings6,440,528 6,247,022 
Treasury shares, at cost (2023: 91,294; 2022: 91,912)
(3,746,732)(3,765,271)
Total shareholders’ equity5,263,196 4,639,910 
Total liabilities and shareholders’ equity$5,420,465 $4,949,490 

(1)AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance PLC, a 100% owned finance subsidiary, related to the issuance of $250 million aggregate principal amount of 5.15% senior unsecured notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.

(2)AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance PLC, a 100% owned finance subsidiary, related to the issuance of $350 million aggregate principal amount of 4.0% senior unsecured notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.

(3)AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance LLC, a 100% owned finance subsidiary, related to the issuance of $300 million aggregate principal amount of 3.9% senior unsecured notes. AXIS Capital's obligations under this guarantee are unsecured senior obligations and rank equally with all other senior obligations of AXIS Capital.

(4)AXIS Capital has fully and unconditionally guaranteed all obligations of AXIS Specialty Finance LLC, a 100% owned finance subsidiary, related to the issuance of $425 million aggregate principal amount of 4.9% fixed-rate reset junior unsecured notes. AXIS Capital's obligation under this guarantee is an unsecured junior subordinated obligation and ranks equally with all future unsecured and junior subordinated obligations of AXIS Capital, and junior in right of payment to all outstanding and future senior obligations of AXIS Capital.
SCHEDULE II
AXIS CAPITAL HOLDINGS LIMITED
CONDENSED STATEMENTS OF OPERATIONS – PARENT COMPANY
YEARS ENDED DECEMBER 31, 2023, 2022 AND 2021
 
202320222021
(in thousands)
Revenues
Net investment income
$ $— $— 
Total revenues — — 
Expenses
General and administrative expenses52,334 60,252 62,843 
Total expenses52,334 60,252 62,843 
Income (loss) before equity in net income of subsidiaries
(52,334)(60,252)(62,843)
Equity in net income of subsidiaries
428,626 283,335 681,452 
Net income376,292 223,083 618,609 
Preferred share dividends30,250 30,250 30,250 
Net income available to common shareholders$346,042 $192,833 $588,359 
Comprehensive income (loss)$770,756 $(593,753)$260,750 
SCHEDULE II
AXIS CAPITAL HOLDINGS LIMITED
CONDENSED STATEMENTS OF CASH FLOWS – PARENT COMPANY
YEARS ENDED DECEMBER 31, 2023, 2022 AND 2021
 
202320222021
 (in thousands)
Cash flows from operating activities:
Net income$376,292 $223,083 $618,609 
Adjustments to reconcile net income to net cash provided by operating activities:
Equity in income loss of subsidiaries
(428,626)(283,335)(681,452)
Change in intercompany payable(136,059)32,871 (96,868)
Dividends received from subsidiaries375,000 225,000 300,000 
Other items(34,626)(17,140)7,882 
Share-based compensation expense, net of cash payments54,119 48,494 37,744 
Net cash provided by operating activities206,100 228,973 185,915 
Cash flows from financing activities:
Taxes paid on withholding shares(23,595)(13,994)(10,242)
Dividends paid - common shares(153,775)(149,341)(145,603)
Repurchase of common shares - open market (34,987)— 
Dividends paid - preferred shares(30,250)(30,250)(30,250)
Net cash used in financing activities(207,620)(228,572)(186,095)
Increase (decrease) in cash, cash equivalents and restricted cash(1,520)401 (180)
Cash, cash equivalents and restricted cash - beginning of year1,932 1,531 1,711 
Cash, cash equivalents and restricted cash - end of year$412 $1,932 $1,531 
XML 58 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION
12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]  
SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION
AXIS CAPITAL HOLDINGS LIMITED
SUPPLEMENTARY INSURANCE INFORMATION
 
 At and year ended December 31, 2023
(in thousands)Deferred
acquisition
costs
Reserve
for losses
and loss
expenses
Unearned
premiums
Net
premiums
earned
Net
investment income(1)
Net losses
and loss
expenses
Acquisition
costs
Other
operating expenses(2)
Net
premiums
written
Insurance$298,249 $9,507,409 $3,507,519 $3,461,700 $ $2,080,001 $648,463 $472,094 $3,758,720 
Reinsurance152,701 6,926,609 1,240,083 1,622,081  1,313,101 352,482 79,373 1,343,605 
Corporate    611,742   132,979  
Total$450,950 $16,434,018 $4,747,602 $5,083,781 $611,742 $3,393,102 $1,000,945 $684,446 $5,102,325 
 At and year ended December 31, 2022
(in thousands)Deferred
acquisition
costs
Reserve
for losses
and loss
expenses
Unearned
premiums
Net
premiums
earned
Net
investment income(1)
Net losses
and loss
expenses
Acquisition
costs
Other
operating expenses(2)
Net
premiums
written
Insurance$249,407 $8,381,593 $3,077,628 $3,134,155 $— $1,785,854 $577,838 $443,704 $3,377,906 
Reinsurance224,162 6,787,270 1,283,819 2,026,171 — 1,456,556 444,179 106,585 1,885,150 
Corporate— — — — 418,829 — — 130,054 — 
Total$473,569 $15,168,863 $4,361,447 $5,160,326 $418,829 $3,242,410 $1,022,017 $680,343 $5,263,056 
 At and year ended December 31, 2021
(in thousands)Deferred
acquisition
costs
Reserve
for losses
and loss
expenses
Unearned
premiums
Net
premiums
earned
Net
investment income(1)
Net losses
and loss
expenses
Acquisition
costs
Other
operating expenses(2)
Net
premiums
written
Insurance$212,681 $7,803,529 $2,716,240 $2,651,339 $— $1,514,998 $484,344 $429,282 $2,894,885 
Reinsurance252,912 6,849,565 1,374,436 2,058,511 — 1,493,785 437,490 107,552 2,031,739 
Corporate— — — — 454,301 — — 126,470 — 
Total$465,593 $14,653,094 $4,090,676 $4,709,850 $454,301 $3,008,783 $921,834 $663,304 $4,926,624 
(1)The Company evaluates underwriting results of its reportable segments separately from the performance of its investment portfolio. Therefore, the Company believes it is appropriate to exclude net investment income from its underwriting profitability measure.
(2)Amounts related to the Company's reportable segments reflect underwriting-related general and administrative expenses, which includes those general and administrative expenses that are incremental and/or directly attributable to the Company's underwriting operations. Underwriting-related general and administrative expenses is a non-GAAP financial measure as defined in Item 10(e) of SEC Regulation S-K. The reconciliation to general and administrative expenses, the most comparable GAAP financial measure, presented in the table above, also includes corporate expenses of $133 million, $130 million, and $126 million for the years ended December 31, 2023, 2022 and 2021, respectively. Corporate expenses include holding company costs necessary to support our worldwide insurance and reinsurance operations and costs associated with operating as a publicly-traded company. As these costs are not incremental and/or directly attributable to the Company's underwriting operations, these expenses are excluded from underwriting-related general and administrative expenses.
XML 59 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION
12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]  
SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION
AXIS CAPITAL HOLDINGS LIMITED
SUPPLEMENTARY REINSURANCE INFORMATION
YEARS ENDED DECEMBER 31, 2023, 2022 AND 2021
 
(in thousands)
GROSS
AMOUNT
CEDED TO
OTHER
COMPANIES
ASSUMED
FROM
OTHER
COMPANIES
NET
AMOUNT
PERCENTAGE
OF AMOUNT
ASSUMED TO
NET
2023
Property and Casualty$5,223,919 $3,161,438 $2,402,378 $4,464,859 53.8 %
Accident and Health311,970 92,762 418,258 637,466 65.6 %
Total$5,535,889 $3,254,200 $2,820,636 $5,102,325 55.3 %
2022
Property and Casualty$4,858,629 $2,900,300 $2,685,677 $4,644,006 57.8 %
Accident and Health244,329 51,239 425,960 619,050 68.8 %
Total$5,102,958 $2,951,539 $3,111,637 $5,263,056 59.1 %
2021
Property and Casualty$4,233,758 $2,700,693 $2,874,687 $4,407,752 65.2 %
Accident and Health171,694 58,667 405,845 518,872 78.2 %
Total$4,405,452 $2,759,360 $3,280,532 $4,926,624 66.6 %
XML 60 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure      
Net income $ 376,292 $ 223,083 $ 618,609
XML 61 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 62 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation
These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") and include AXIS Capital Holdings Limited and its wholly-owned subsidiaries.
Tabular dollar and share amounts are in thousands, with the exception of per share amounts. All amounts are reported in U.S. dollars.
Consolidation/VIEs All inter-company accounts and transactions have been eliminated.
Reclassifications and comparability
To facilitate comparison of information across periods, certain reclassifications have been made to prior year amounts to conform to the current year's presentation. At December 31, 2023, the Company presented loan advances made in 2022 separately in the consolidated balance sheets. These loan advances made were previously included in insurance and reinsurance balances payable in the consolidated balance sheets. This presentation was adopted to facilitate comparison to loan advances made in 2023 (refer to Note 10 'Debt' and Note 18 'Related Party Transactions'). This reclassification did not impact results of operations, financial condition or liquidity.
Use of Estimates
The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. While management believes that the amounts included in the consolidated financial statements reflect its best estimates and assumptions, actual results could differ from those estimates. The Company’s principal estimates include: 
reserve for losses and loss expenses;
reinsurance recoverable on unpaid losses and loss expenses, including the allowance for expected credit losses;
gross premiums written and net premiums earned;
fair value measurements of financial assets and liabilities; and
the allowance for credit losses associated with fixed maturities, available for sale.
Investments
Fixed Maturities, Available for Sale, at Fair Value and Fixed Maturities, Held to Maturity, at Amortized Cost
Fixed maturities classified as available for sale are reported at fair value (refer to Note 6 'Fair Value Measurements') and are presented net of an allowance for expected credit losses. The change in fair values of fixed maturities, net of tax is recognized in accumulated other comprehensive income (loss) ("AOCI") in total shareholders’ equity.
Fixed maturities are classified as held to maturity when the Company has the positive intent and ability to hold the securities to maturity or redemption. Fixed maturities classified as held to maturity are reported at amortized cost and are presented net of an allowance for expected credit losses.
Net investment income includes interest income and the amortization of market premiums and discounts and is presented net of investment expenses. Investment income is recognized when earned. Purchases and sales of fixed maturities are recorded on a trade-date basis and realized gains (losses) on sales of fixed maturities are determined based on the specific identification method. Realized gains (losses) on fixed maturities are included in net investment gains (losses) in the consolidated statements of operations.
The Company recognizes investment income from fixed maturities based on the constant effective yield method, which includes an adjustment for estimated principal repayments, if applicable. The effective yield used to determine the amortization of fixed maturities subject to prepayment risk (e.g., asset-backed, mortgage-backed and other structured securities) is recalculated and adjusted periodically based on historical and/or projected future cash flows. Adjustments to the yield for highly rated prepayable fixed maturities are accounted for using the retrospective method. Adjustments to the yield for other prepayable fixed maturities are accounted for using the prospective method.
Credit Losses - Fixed Maturities, Available for Sale
A fixed maturity, available for sale security is impaired if the fair value of the investment is below amortized cost. On a quarterly basis, the Company evaluates all fixed maturities, available for sale securities for impairment losses.
If a fixed maturity, available for sale security is impaired and the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before its anticipated recovery, the full amount of the impairment loss is charged to net income (loss) and is included in net investment gains (losses).

In instances where the Company intends to hold the impaired fixed maturity, available for sale security the Company determines whether the decline in fair value below the amortized cost basis has resulted from a credit loss or other factors. If the Company does not anticipate to fully recover the amortized cost, an allowance for expected credit losses is established. The allowance for expected credit losses is limited to the difference between a security's amortized cost basis and its fair value. The allowance for expected credit losses is charged to net income (loss) and is included in net investment gains (losses).
On a quarterly basis, the Company assesses whether unrealized losses on fixed maturities, available for sale represent credit impairments by considering the following factors:
a.the extent to which the fair value is less than amortized cost;
b.adverse conditions related to the security, industry, or geographical area;
c.downgrades in the security's credit rating by a credit rating agency; and
d.failure of the issuer to make scheduled principal or interest payments.
The length of time a security has been in an unrealized loss position no longer impacts the determination of whether a credit loss exists.
If a security is assessed to be credit impaired, it is subject to a discounted cash flow analysis by comparing the present value of expected future cash flows with the amortized cost basis. If the present value of expected cash flows is less than the amortized cost, a credit loss exists and an allowance for expected credit losses is recognized. If the present value of expected future cash flows is equal to or greater than the amortized cost basis, an expected credit loss does not exist.

The non-credit impairment amount of the loss (i.e., related to interest rates, market conditions, etc.) is recognized in other comprehensive income.

The Company reports accrued interest receivable related to available for sale debt securities separately and has elected not to measure an allowance for expected credit losses for accrued interest receivable. Write-offs of accrued interest receivable balances are recognized in net investment gains (losses) in the period in which they are deemed uncollectible.
Credit Losses - Fixed Maturities, Held to Maturity
A fixed maturity, held to maturity security is impaired if the fair value of the investment is below amortized cost. On a quarterly basis, the Company evaluates all fixed maturities, held to maturity securities for impairment losses.
The Company's fixed maturity, held to maturity securities portfolio consists of asset-backed securities ("ABS") and corporate debt securities.
The Company's ABS, held to maturity consist of CLO debt tranched securities. The Company uses a scenario-based approach to review its CLO debt portfolio and reviews subordination levels of these securities to determine their ability to absorb credit losses of the underlying collateral. If losses are forecast to be below the subordination level for a tranche held by the Company, the security is determined not to have a credit loss.
To estimate expected credit losses for corporate debt securities, held to maturity, the Company's projected cash flows are primarily driven by assumptions regarding the severity of loss, which is a function of the probability of default and projected recovery rates. The Company's default and recovery rates are based on credit ratings, credit analysis and macroeconomic forecasts.
The allowance for expected credit losses is estimated based on the Company’s analysis of projected lifetime losses. The allowance for expected credit losses is charged to net income (loss) and is recognized in net investment gains (losses). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Equity Securities, at Fair Value
Equity securities are reported at fair value. The change in the fair values of equity securities, net of tax is recognized in net investment gains (losses) in the consolidated statements of operations.
Net investment income includes dividend income and is presented net of investment expenses. Investment income is recognized when earned. Purchases and sales of equity securities are recorded on a trade-date basis and realized gains (losses) on sales of equity securities are determined based on the specific identification method. Realized gains (losses) on equity securities are included in net investment gains (losses) in the consolidated statements of operations.
Mortgage Loans, Held for Investment, at Fair Value
Mortgage loans, held for investment are reported at amortized cost which is calculated as the unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses.
Interest income and prepayment fees are recognized when earned. Interest income is recognized based on an effective yield method which gives effect to the amortization of premiums and accretion of discounts.
Mortgage loans, held for investment are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company’s analysis of projected lifetime losses. These projections take into account the Company’s experience with credit quality indicators, loan losses, defaults, loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.
The allowance for expected credit losses is recognized in net investment gains (losses) in the consolidated statements of operations. Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Other Investments
Other investments are recorded at fair value (refer to Note 6 'Fair Value Measurements'). Changes in fair value and realized gains (losses) are reported in net investment income in the consolidated statements of operations.
Equity Method Investments
Investments in which the Company has significant influence over the operating and financial policies of the investee are classified as equity method investments and are accounted for using the equity method of accounting. In applying the equity method of accounting, investments are initially recorded at cost and are subsequently adjusted based on the Company’s proportionate share of net income or loss of the investee. Adjustments are based on the most recently available financial information from the investee. Changes in the carrying value of these investments are recorded in net income (loss) as interest in income (loss) of equity method investments.
Short-term Investments
Short-term investments primarily comprise highly liquid debt securities with maturities greater than three months but less than one year from the date of purchase. These investments are carried at amortized cost, which approximates fair value.
Cash and Cash Equivalents Cash equivalents include money-market funds, fixed interest deposits and reverse repurchase agreements with a maturity of under 90 days when purchased. Cash and cash equivalents are recorded at amortized cost, which approximates fair value due to the short-term, liquid nature of these securities. Restricted cash primarily relates to funds held in trust to support obligations in regulatory jurisdictions where the Company operates as a non-admitted carrier and to support underwriting activities at Lloyd's.
Premiums - Gross Premiums Written
Insurance premiums written are recorded in accordance with the terms of the underlying policies.
Reinsurance premiums are recorded at the inception of the contract based on estimates received from ceding companies.
For multi-year contracts insurance and reinsurance premiums are recorded at the inception of the contract based on management’s best estimate of total premiums to be received. Premiums are recognized on an annual basis for multi-year contracts where the cedant has the ability to unilaterally commute or cancel coverage within the term of the contract.
Any adjustments to insurance and reinsurance premium estimates are recognized in the period in which they are determined.
Premiums - Net Premiums Earned
Insurance and reinsurance premiums are earned evenly over the period during which the Company is exposed to the underlying risk, which is generally one to two years with the exception of multi-year contracts. Unearned premiums represent the portion of premiums which relate to the unexpired term under contracts in force.
Reinstatement premiums are recognized and earned at the time a loss event occurs and losses are recorded, where the coverage limits for the remaining life of the contract are reinstated under pre-defined contract terms. The recognition of reinstatement premiums is based on estimates of losses and loss expenses, which reflects management’s judgment (refer to Note 2(d) 'Losses and Loss Expenses' below).
Premiums - Receivables
Insurance and reinsurance premium balances receivable ("premium balances receivable") are reviewed for impairment at least quarterly and are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company's analysis of amounts due, historical delinquencies and write-offs, and current economic conditions, together with reasonable and supportable forecasts of short-term economic conditions.
The allowance for expected credit losses is recognized in net income (loss). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined.
Write-offs of premium balances receivable, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs.
Acquisition Costs
Acquisition costs vary with and are directly related to the successful acquisition efforts of acquiring new or renewing existing insurance and reinsurance contracts and consist primarily of fees and commissions paid to brokers and premium taxes. In addition, certain of our contracts include profit commission provisions or other adjustable features that are estimated based on expected losses and loss expenses for those contracts. Acquisition costs are shown net of commissions on reinsurance purchased. Net acquisition costs are deferred and charged to net income (loss) as the related premium is earned. Insurance and reinsurance premium balances receivable is presented net of acquisition costs when contract terms provide for the right of offset.
Anticipated losses and loss expenses, other costs and investment income related to these premiums are considered in assessing the recoverability of deferred acquisition costs. Deferred acquisition cost amounts that are assessed to be irrecoverable are recognized in net income (loss) in the period in which the determination is made. Compensation expenses for personnel involved in contract acquisition, and advertising costs, are charged to net income (loss) when incurred.
Losses and Loss Expenses
Reserve for losses and loss expenses represents an estimate of the unpaid portion of the ultimate liability for losses and loss expenses for insured and reinsured events that have occurred at or before the balance sheet date. These amounts reflect claims that have been reported ("case reserves") and claims that have been incurred but have not yet been reported ("IBNR") and are reduced for estimated amounts of salvage and subrogation recoveries.
The Company reviews its reserve for losses and loss expenses on a quarterly basis. Case reserves are primarily established based on amounts reported by clients and/or their brokers. Management estimates IBNR after reviewing detailed actuarial analyses and applying informed judgment regarding qualitative factors that may not be fully captured in the actuarial estimates. A variety of actuarial methods are utilized in this process, including the Expected Loss Ratio, Chain Ladder and Bornhuetter-Ferguson methods. The estimate is highly dependent on management’s judgment as to which method(s) are most appropriate for a particular accident/underwriting year and line of business. Historical claims data may be supplemented with industry benchmarks when applying these methodologies.
Any adjustments to estimates of reserve for losses and loss expenses are recognized in the period in which they are determined. While the Company believes that its reserves for losses and loss expenses are adequate, this estimate requires significant judgment and new information, events or circumstances may result in ultimate losses that are materially greater or less than provided for in the consolidated balance sheets.
Reinsurance
In the normal course of business, the Company purchases facultative and treaty reinsurance protection to limit its ultimate losses and to reduce its loss aggregation risk. The premiums paid to reinsurers (i.e., ceded premiums written) are recognized over the coverage period. Prepaid reinsurance premiums represent the portion of premiums ceded which relate to the unexpired term of the contracts in force. Reinstatement premiums are recognized and earned at the time a loss event occurs and losses are recorded, where the coverage limits for the remaining life of the contract are reinstated under pre-defined contract terms.
Reinsurance recoverable on unpaid losses and loss expenses ("reinsurance recoverables") related to case reserves is estimated on a case-by-case basis by applying the terms of applicable reinsurance cover to individual case reserve estimates. Reinsurance recoverables related to IBNR is generally developed as part of the Company's loss reserving process, therefore, its estimation is subject to similar risks and uncertainties as the estimation of IBNR. Estimates of amounts to be ceded under excess of loss reinsurance contracts also take into account pricing information for those contracts and require greater judgment than estimates for proportional contracts.
Reinsurance recoverable balances are reviewed for impairment at least quarterly and are presented net of an allowance for expected credit losses.
A case-specific allowance for expected credit losses against reinsurance recoverables that we deem are unlikely to be collected in full, is estimated based on the Company's analysis of amounts due, historical delinquencies and write-offs. In addition, a default analysis is used to estimate an allowance for expected credit losses on the remainder of the reinsurance recoverable balance. The principal components of the default analysis are reinsurance recoverable balances by reinsurer and default factors applied to estimate uncollectible amounts based on reinsurers’ credit ratings and the length of collection periods. The default factors are based on a model developed by a major rating agency. The default analysis considers current and forecasted economic conditions.
The allowance for expected credit losses is recognized in net income (loss). Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined. Write-offs of reinsurance recoverable balances, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs.
Retroactive Reinsurance
Retroactive reinsurance reimburses a ceding company for liabilities incurred as a result of past insurable events covered under contracts subject to the reinsurance. In certain instances, reinsurance contracts cover losses both on a prospective basis and on a retroactive basis and where practical the Company bifurcates the prospective and retroactive elements of these reinsurance contracts and accounts for each element separately. Initial gains in connection with retroactive reinsurance contracts are deferred and amortized into net income over the claims settlement period while losses are recognized immediately. When changes in the estimated amount recoverable from the reinsurer or in the timing of receipts related to that amount occur, a cumulative amortization adjustment is recognized in net income in the period in which the change is determined so that the deferred gain reflects the balance that would have existed had the revised estimate been available at the inception of the reinsurance transaction.
Foreign Exchange
The functional currency of the Company and the majority of its subsidiaries is the U.S. dollar. All foreign currency transactions are initially measured and recorded in functional currency using the rates of exchange prevailing at the transaction date.
Monetary assets and liabilities denominated in foreign currency are remeasured to functional currency at the rates of exchange in effect at the balance sheet date with the resulting foreign exchange losses (gains) generally being recognized in the consolidated statements of operations. Foreign exchange losses (gains) related to available for sale securities denominated in foreign currency represent an unrealized appreciation (depreciation) in the market value of the securities and are included in AOCI. Non-monetary assets and liabilities denominated in foreign currency are not subsequently remeasured.
The Company’s reporting currency is the U.S. dollar. Assets and liabilities of the Company's subsidiaries and branches where the functional currency is not the U.S. dollar, are translated into U.S. dollars using the rates of exchange in effect at the balance sheet date, and revenue and expenses are translated using the weighted average foreign exchange rates for the period. The effect of translation adjustments is reported as a separate component of AOCI in total shareholders’ equity.
Share-based Compensation
The Company is authorized to issue restricted shares, restricted stock units, performance restricted stock units, stock options, stock appreciation rights and other equity-based awards to its employees and directors. The Company's plan includes share-settled and cash-settled service and performance awards.
Restricted Stock Units - Share-Settled and Cash-Settled
The fair value of share-settled and cash-settled service awards is based on market value of the Company's common shares measured at the grant date and is expensed over the requisite service period. The fair value of the cash-settled service awards is recognized as a liability in the consolidated balance sheets and is remeasured at the end of each reporting period. The Company recognizes forfeitures when they occur.
Performance Restricted Stock Units - Share-Settled
The fair value of share-settled performance awards which include a market condition is measured on the grant date using a Monte Carlo simulation model which requires inputs including share price, expected volatility, expected term, expected dividend yield and risk-free interest rates. The fair value of share-settled performance awards which include a performance condition is based on the market value of the Company's common shares measured at the grant date.
The fair value of share-settled performance awards is recognized on a straight-line basis over the requisite service period. The Company recognizes forfeitures when they occur.
Derivative Instruments
The Company may enter into derivative instruments such as futures, options, interest rate swaps and foreign currency forward contracts as part of its overall foreign currency risk management strategy, to obtain exposure to a particular financial market or for yield enhancement.
From time to time the Company may also enter into insurance and reinsurance contracts that meet the Financial Accounting Standards Board's ("FASB") definition of a derivative contract.
The Company measures all derivative instruments at fair value (refer to Note 6 'Fair Value Measurements') and recognizes these instruments in either other assets or other liabilities in the consolidated balance sheets. Subsequent changes in fair value and realized gains (losses) are recognized in net income (loss) in the consolidated statements of operations.
Goodwill and Intangible Assets
The Company recognizes goodwill and other intangible assets in connection with certain acquisitions. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired in these acquisitions and is not amortized. Other intangible assets with a finite life are amortized over the estimated useful live of the intangible asset. Other intangible assets with an indefinite life are not amortized.
The Company tests goodwill and indefinite-lived intangible assets for potential impairment during the fourth quarter each year and between annual tests if an event occurs or changes in circumstances indicate that the asset is impaired. Such events or circumstances may include an economic downturn in a geographic market or a change in the assessment of future operations.
For the purpose of evaluating goodwill for impairment, the Company may first perform a qualitative assessment to determine whether it is necessary to perform a quantitative goodwill impairment test. If determined to be necessary, the quantitative test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered not impaired. If the carrying amount of the reporting unit exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.
For the purpose of evaluating indefinite-lived intangibles for impairment, the Company may first perform a qualitative assessment to determine whether it is necessary to perform the quantitative impairment test. If the Company elects to perform a qualitative assessment, it first assesses qualitative factors to determine whether it is more likely than not that an indefinite lived intangible asset is impaired. If the Company determines that it is more likely than not that the indefinite lived intangible asset is impaired, the Company performs the quantitative impairment test.
For the purposes of evaluating goodwill and indefinite-lived intangible assets for impairment, the Company has an unconditional option to bypass the qualitative assessment in any period and proceed directly to performing the quantitative impairment test. The Company may resume performing the qualitative assessment in any subsequent period.
For other finite-lived intangible assets the Company tests for recoverability whenever events or changes in circumstances indicate its carrying amount may not be recoverable. The Company recognizes an impairment loss if the carrying amount of
the asset is not recoverable and exceeds its fair value. The carrying amount of a finite-lived intangible asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.
If goodwill or an intangible asset is impaired, the carrying value of the asset is reduced to fair value and a corresponding expense is recorded in the consolidated statements of operations.
Income Taxes
Certain subsidiaries and branches of the Company operate in jurisdictions where they are subject to taxation.
Current and deferred income taxes are charged or credited to net income (loss), or in certain cases to AOCI, based on enacted tax laws and rates applicable in the relevant jurisdiction in the period in which the tax becomes accruable or realizable.
Deferred income taxes are provided for all temporary differences between the bases of assets and liabilities reported in the consolidated balance sheets and those reported in the various jurisdictional tax returns. When the assessment indicates that it is more likely than not that a portion of a deferred tax asset will not be realized in the foreseeable future, a valuation allowance against deferred tax assets is recorded. 
The Company recognizes the tax benefits of uncertain tax positions only when the position is more-likely-than-not to be sustained on audit by the relevant taxing authorities.
Treasury Shares
Common shares repurchased by the Company and not subsequently canceled are classified as treasury shares and are recorded at cost. This results in a reduction of shareholders’ equity in the consolidated balance sheets. The Company uses the average cost method to determine the cost of shares reissued from treasury.
Leases
The Company recognizes a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term related to office property and equipment leases.
The Company accounts for non-lease components separately from lease components. As a result, the non-lease components associated with the Company's leases are not included in the lease liabilities and right-of-use assets in the Company's consolidated balance sheets.
The Company does not record office property and equipment leases with an initial term of 12 months or less (short-term) in the Company's consolidated balance sheets.
Recently Issued Accounting Standards Not Yet Adopted Recently Issued Accounting Standards Not Yet Adopted
Segment Reporting
In November 2023, the FASB issued Accounting Standards Update ("ASU" or "Update") ASU 2023-07 "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures". The amendments in this Update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this update:
1.    Require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss (collectively referred to as the “significant expense principle”).
2.     Require that a public entity disclose, on an annual and interim basis, an amount for other segment items by reportable segment and a description of its composition. The other segment items category is the difference between segment
revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss.
3.    Require that a public entity provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by Topic 280 in interim periods.
4.     Clarify that if the CODM uses more than one measure of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources, a public entity may report one or more of those additional measures of segment profit. However, at least one of the reported segment profit or loss measures (or the single reported measure, if only one is disclosed) should be the measure that is most consistent with the measurement principles used in measuring the corresponding amounts in the public entity’s consolidated financial statements. In other words, in addition to the measure that is most consistent with the measurement principles under generally accepted accounting principles (GAAP), a public entity is not precluded from reporting additional measures of a segment’s profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources.
5.    Require that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources.
6.    Require that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this Update and all existing segment disclosures in Topic 280.
This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. As this guidance relates solely to financial statement disclosures, the adoption of ASU 2023-07, will not impact the Company's results of operations, financial condition, or liquidity.
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures". The amendments in this Update provide more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information as follows:
Rate Reconciliation
The amendments in this Update require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate).
Income Taxes Paid
The amendments in this Update require that all entities disclose on an annual basis (1) the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes and (2) the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) if equal to or greater than 5 percent of total income taxes paid (net of refunds received).
Other Disclosures
The amendments in this Update require that all entities disclose (1) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign and (2) income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign.

The amendments in this Update eliminate the requirement for all entities to (1) disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or (2) make a statement that an estimate of the range cannot be made.

The amendments in this Update remove the requirement to disclose the cumulative amount of each type of temporary difference when a deferred tax liability is not recognized because of the exceptions to comprehensive recognition of deferred taxes related to subsidiaries.
The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis. Retrospective application permitted.
XML 63 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Summary of Underwriting Results of Reportable Segments
The following tables present the underwriting results of the Company's reportable segments, as well as the carrying amounts of allocated goodwill and intangible assets:
At and year ended December 31, 2023InsuranceReinsuranceTotal
Gross premiums written$6,140,764 $2,215,761 $8,356,525 
Net premiums written3,758,720 1,343,605 5,102,325 
Net premiums earned3,461,700 1,622,081 5,083,781 
Other insurance related income (loss)(198)22,693 22,495 
Net losses and loss expenses(2,080,001)(1,313,101)(3,393,102)
Acquisition costs(648,463)(352,482)(1,000,945)
Underwriting-related general and administrative expenses(472,094)(79,373)(551,467)
Underwriting income (loss)$260,944 $(100,182)160,762 
Net investment income611,742 
Net investment gains (losses)(74,630)
Corporate expenses(132,979)
Foreign exchange (losses) gains(58,115)
Interest expense and financing costs(68,421)
Reorganization expenses(28,997)
Amortization of value of business acquired 
Amortization of intangible assets(10,917)
Income before income taxes and interest in income of equity method investments398,445 
Income tax expense(26,316)
Interest in income of equity method investments4,163 
Net income376,292 
Preferred share dividends30,250 
Net income available to common shareholders$346,042 
Net losses and loss expenses ratio60.1 %81.0 %66.7 %
Acquisition cost ratio18.7 %21.7 %19.7 %
General and administrative expense ratio 13.7 %4.9 %13.5 %
Combined ratio92.5 %107.6 %99.9 %
Goodwill and intangible assets$287,684 $ $287,684 
At and year ended December 31, 2022InsuranceReinsuranceTotal
Gross premiums written$5,585,581 $2,629,014 $8,214,595 
Net premiums written3,377,906 1,885,150 5,263,056 
Net premiums earned3,134,155 2,026,171 5,160,326 
Other insurance related income559 12,514 13,073 
Net losses and loss expenses(1,785,854)(1,456,556)(3,242,410)
Acquisition costs(577,838)(444,179)(1,022,017)
Underwriting-related general and administrative expenses(443,704)(106,585)(550,289)
Underwriting income$327,318 $31,365 358,683 
Net investment income418,829 
Net investment gains (losses)(456,789)
Corporate expenses(130,054)
Foreign exchange gains157,945 
Interest expense and financing costs(63,146)
Reorganization expenses(31,426)
Amortization of value of business acquired— 
Amortization of intangible assets(10,917)
Income before income taxes and interest in income of equity method investments243,125 
Income tax expense(22,037)
Interest in income of equity method investments1,995 
Net income223,083 
Preferred share dividends30,250 
Net income available to common shareholders$192,833 
Net losses and loss expenses ratio57.0 %71.9 %62.8 %
Acquisition cost ratio18.4 %21.9 %19.8 %
General and administrative expense ratio14.2 %5.3 %13.2 %
Combined ratio89.6 %99.1 %95.8 %
Goodwill and intangible assets$298,601 $— $298,601 
At and year ended December 31, 2021InsuranceReinsuranceTotal
Gross premiums written$4,863,232 $2,822,752 $7,685,984 
Net premiums written2,894,885 2,031,739 4,926,624 
Net premiums earned2,651,339 2,058,511 4,709,850 
Other insurance related income1,662 21,633 23,295 
Net losses and loss expenses(1,514,998)(1,493,785)(3,008,783)
Acquisition costs(484,344)(437,490)(921,834)
Underwriting-related general and administrative expenses(429,282)(107,552)(536,834)
Underwriting income$224,377 $41,317 265,694 
Net investment income454,301 
Net investment gains134,279 
Corporate expenses(126,470)
Foreign exchange (losses) gains(315)
Interest expense and financing costs(62,302)
Reorganization expenses— 
Amortization of value of business acquired(3,854)
Amortization of intangible assets(12,424)
Income before income taxes and interest in income of equity method investments648,909 
Income tax expense(62,384)
Interest in income of equity method investments32,084 
Net income618,609 
Preferred share dividends30,250 
Net income available to common shareholders$588,359 
Net losses and loss expenses ratio57.1 %72.6 %63.9 %
Acquisition cost ratio18.3 %21.3 %19.6 %
General and administrative expense ratio 16.2 %5.1 %14.0 %
Combined ratio91.6 %99.0 %97.5 %
Goodwill and intangible assets$309,518 $— $309,518 
Summary of Gross Premiums Written by Geographical Location of Subsidiaries
The following table presents gross premiums written by the geographical location of the Company's subsidiaries:
Years ended December 31,202320222021
U.S.$4,484,789 $4,342,707 $4,002,748 
Ireland1,837,177 1,931,815 1,667,496 
Lloyd's of London1,759,990 1,567,458 1,473,047 
Bermuda274,569 372,615 542,693 
Gross premiums written$8,356,525 $8,214,595 $7,685,984 
Summary of Net Premiums Earned by Segment and Line of Business
The following table presents net premiums earned by segment and line of business:    
Years ended December 31,202320222021
Insurance
Professional lines$764,558 $817,924 $646,390 
Property878,849 755,986 711,297 
Liability496,381 459,775 354,787 
Cyber323,025 309,004 252,077 
Marine and aviation567,292 479,499 439,050 
Accident and health306,061 209,548 151,133 
Credit and political risk125,534 102,419 96,605 
Total Insurance3,461,700 3,134,155 2,651,339 
Reinsurance
Liability403,239 484,681 431,596 
Accident and health341,806 368,747 361,196 
Professional lines205,404 250,911 220,448 
Credit and surety236,408 192,926 158,549 
Motor155,942 205,774 247,099 
Agriculture121,628 122,289 82,743 
Marine and aviation65,658 78,504 58,775 
Run-off lines
Catastrophe33,963 156,232 238,775 
Property44,508 135,480 231,092 
Engineering13,525 30,627 28,238 
Total run-off lines91,996 322,339 498,105 
Total Reinsurance1,622,081 2,026,171 2,058,511 
Total$5,083,781 $5,160,326 $4,709,850 
XML 64 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Goodwill and Intangible Assets
The table below provides details of goodwill and intangible assets related to the Company's insurance segment:
GoodwillIntangible
assets with an
indefinite life
Intangible
assets with a
finite life
Total
December 31, 2021
Gross amount$95,890 $120,784 $394,604 $611,278 
Accumulated amortizationn/an/a(291,901)(291,901)
Accumulated translation adjustment4,911 — — 4,911 
100,801 120,784 102,703 324,288 
Amortizationn/an/a(14,770)(14,770)
Impairment charges— — — — 
At December 31, 2022
Gross amount95,890 120,784 394,604 611,278 
Accumulated amortizationn/an/a(306,671)(306,671)
Accumulated translation adjustment4,911 — — 4,911 
100,801 120,784 87,933 309,518 
Amortizationn/an/a(10,917)(10,917)
Impairment charges— — — — 
At December 31, 2023
Gross amount95,890 120,784 394,604 611,278 
Accumulated amortizationn/an/a(317,588)(317,588)
Accumulated translation adjustment4,911   4,911 
100,801 120,784 77,016 298,601 
Amortizationn/an/a(10,917)(10,917)
Impairment charges    
$100,801 $120,784 $66,099 $287,684 
n/a – not applicable
Summary of Finite-Lived Intangible Assets
The tables below provide details of the gross amount and accumulated amortization by category of value of business acquired ("VOBA") and intangible assets:
VOBA and intangible assets
At December 31, 2023
Gross amountAccumulated amortizationTotal
U.S. state licenses$26,036 n/a$26,036 
Syndicate capacity (2)
94,748 n/a94,748 
Customer relationships and customers lists - Ternian (1)
13,330 (11,661)1,669 
VOBA - Novae (2)
256,942 (256,942)— 
Coverholders (2)
63,565 (33,110)30,455 
Large brokers (2)
46,641 (19,435)27,206 
SME brokers (2)
14,126 (7,357)6,769 
$515,388 $(328,505)$186,883 
n/a – not applicable
(1)    On April 1, 2015, the Company completed its acquisition of Ternian Insurance Group LLC (renamed AXIS Group Benefits LLC in 2022) and recognized the definite life intangible assets detailed above.
(2)    On October 2, 2017, the Company acquired Novae and recognized finite lived intangible assets, including VOBA, distribution networks, and indefinite lived intangible assets related to Lloyd's syndicate capacity, all detailed above.

VOBA and intangible assets
At December 31, 2022
Gross amountAccumulated amortizationTotal
U.S. state licenses$26,036 n/a$26,036 
Syndicate capacity (2)
94,748 n/a94,748 
Customer relationships and customers lists - Ternian (1)
13,330 (10,329)3,001 
VOBA - Novae (2)
256,942 (256,942)— 
Coverholders (2)
63,565 (27,812)35,753 
Large brokers (2)
46,641 (16,325)30,316 
SME brokers (2)
14,126 (6,180)7,946 
$515,388 $(317,588)$197,800 
n/a – not applicable
(1)     On April 1, 2015, the Company completed its acquisition of Ternian Insurance Group LLC (renamed AXIS Group Benefits LLC in 2022) and recognized the definite life intangible assets detailed above.
(2)    On October 2, 2017, the Company acquired Novae and recognized finite lived intangible assets, including VOBA, distribution networks, and indefinite lived intangible assets related to Lloyd's syndicate capacity, all detailed above.
Summary of Indefinite-Lived Intangible Assets
The tables below provide details of the gross amount and accumulated amortization by category of value of business acquired ("VOBA") and intangible assets:
VOBA and intangible assets
At December 31, 2023
Gross amountAccumulated amortizationTotal
U.S. state licenses$26,036 n/a$26,036 
Syndicate capacity (2)
94,748 n/a94,748 
Customer relationships and customers lists - Ternian (1)
13,330 (11,661)1,669 
VOBA - Novae (2)
256,942 (256,942)— 
Coverholders (2)
63,565 (33,110)30,455 
Large brokers (2)
46,641 (19,435)27,206 
SME brokers (2)
14,126 (7,357)6,769 
$515,388 $(328,505)$186,883 
n/a – not applicable
(1)    On April 1, 2015, the Company completed its acquisition of Ternian Insurance Group LLC (renamed AXIS Group Benefits LLC in 2022) and recognized the definite life intangible assets detailed above.
(2)    On October 2, 2017, the Company acquired Novae and recognized finite lived intangible assets, including VOBA, distribution networks, and indefinite lived intangible assets related to Lloyd's syndicate capacity, all detailed above.

VOBA and intangible assets
At December 31, 2022
Gross amountAccumulated amortizationTotal
U.S. state licenses$26,036 n/a$26,036 
Syndicate capacity (2)
94,748 n/a94,748 
Customer relationships and customers lists - Ternian (1)
13,330 (10,329)3,001 
VOBA - Novae (2)
256,942 (256,942)— 
Coverholders (2)
63,565 (27,812)35,753 
Large brokers (2)
46,641 (16,325)30,316 
SME brokers (2)
14,126 (6,180)7,946 
$515,388 $(317,588)$197,800 
n/a – not applicable
(1)     On April 1, 2015, the Company completed its acquisition of Ternian Insurance Group LLC (renamed AXIS Group Benefits LLC in 2022) and recognized the definite life intangible assets detailed above.
(2)    On October 2, 2017, the Company acquired Novae and recognized finite lived intangible assets, including VOBA, distribution networks, and indefinite lived intangible assets related to Lloyd's syndicate capacity, all detailed above.
Summary of Future Amortization Expense
The table below provides details of estimated amortization expense of intangible assets with a finite life:
Total
2024$10,916 
20259,919 
20269,583 
20279,583 
20289,583 
After 202816,515 
Total remaining amortization expense66,099 
Indefinite lived intangible assets120,784 
Total intangible assets$186,883 
XML 65 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Summary of Amortized Cost and Fair Values of Fixed Maturities
The following table provides the amortized cost and fair values of the Company's fixed maturities classified as available for sale:
Amortized
cost
Allowance for expected credit lossesGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Available for sale
U.S. government and agency$3,049,445 $ $13,211 $(55,128)$3,007,528 
Non-U.S. government729,761 (30)13,089 (18,861)723,959 
Corporate debt4,651,654 (10,438)49,434 (216,478)4,474,172 
Agency RMBS(1)
1,706,204  11,495 (83,038)1,634,661 
CMBS(2)
897,553  551 (58,408)839,696 
Non-agency RMBS165,910 (194)713 (13,033)153,396 
ABS(3)
1,265,187 (50)2,855 (25,021)1,242,971 
Municipals(4)
168,540 (47)414 (10,548)158,359 
Total fixed maturities, available for sale$12,634,254 $(10,759)$91,762 $(480,515)$12,234,742 
At December 31, 2022
Available for sale
U.S. government and agency$2,731,733 $— $5,386 $(97,789)$2,639,330 
Non-U.S. government612,546 — 2,395 (52,912)562,029 
Corporate debt4,680,798 (11,521)5,269 (418,990)4,255,556 
Agency RMBS(1)
1,297,423 — 4,663 (99,301)1,202,785 
CMBS(2)
1,029,863 — 60 (82,145)947,778 
Non-agency RMBS151,907 (123)275 (18,525)133,534 
ABS(3)
1,499,728 (35)555 (70,721)1,429,527 
Municipals(4)
172,475 (54)139 (16,205)156,355 
Total fixed maturities, available for sale$12,176,473 $(11,733)$18,742 $(856,588)$11,326,894 
(1)Residential mortgage-backed securities ("RMBS") originated by U.S. government-sponsored agencies.
(2)Commercial mortgage-backed securities ("CMBS").
(3)Asset-backed securities ("ABS") include debt tranched securities collateralized primarily by auto loans, student loans, credit card receivables and collateralized loan obligations ("CLOs").
(4)Municipals include bonds issued by states, municipalities and political subdivisions.
Summary of Contractual Maturities of Fixed Maturities
The table below provides the contractual maturities of fixed maturities classified as available for sale:
Amortized
cost
Fair
value
% of Total
fair value
At December 31, 2023
Maturity
Due in one year or less$474,557 $463,789 3.6 %
Due after one year through five years5,902,571 5,790,493 47.3 %
Due after five years through ten years2,064,619 1,954,449 16.0 %
Due after ten years157,653 155,287 1.3 %
8,599,400 8,364,018 68.2 %
Agency RMBS1,706,204 1,634,661 13.4 %
CMBS897,553 839,696 6.9 %
Non-agency RMBS165,910 153,396 1.3 %
ABS1,265,187 1,242,971 10.2 %
Total$12,634,254 $12,234,742 100.0 %
At December 31, 2022
Maturity
Due in one year or less$422,039 $409,972 3.7 %
Due after one year through five years5,349,123 5,078,273 44.8 %
Due after five years through ten years2,192,344 1,919,450 16.9 %
Due after ten years234,046 205,575 1.8 %
8,197,552 7,613,270 67.2 %
Agency RMBS1,297,423 1,202,785 10.6 %
CMBS1,029,863 947,778 8.4 %
Non-agency RMBS151,907 133,534 1.2 %
ABS1,499,728 1,429,527 12.6 %
Total$12,176,473 $11,326,894 100.0 %
Summary of Fixed Maturities and Equities in an Unrealized Loss Position
The following table summarizes fixed maturities, available for sale in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position:
  12 months or greaterLess than 12 monthsTotal
  Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
Fair
value
Unrealized
losses
At December 31, 2023
Fixed maturities, available for sale
U.S. government and agency$846,503 $(42,465)$867,733 $(12,663)$1,714,236 $(55,128)
Non-U.S. government233,038 (18,178)115,112 (683)348,150 (18,861)
Corporate debt2,623,304 (210,512)240,813 (5,966)2,864,117 (216,478)
Agency RMBS778,656 (80,070)218,606 (2,968)997,262 (83,038)
CMBS703,411 (54,856)75,242 (3,552)778,653 (58,408)
Non-agency RMBS98,483 (13,013)10,017 (20)108,500 (13,033)
ABS879,743 (24,747)83,582 (274)963,325 (25,021)
Municipals129,969 (10,156)6,238 (392)136,207 (10,548)
Total fixed maturities, available for sale$6,293,107 $(453,997)$1,617,343 $(26,518)$7,910,450 $(480,515)
At December 31, 2022
Fixed maturities, available for sale
U.S. government and agency$467,032 $(41,365)$1,414,181 $(56,424)$1,881,213 $(97,789)
Non-U.S. government207,637 (33,027)298,048 (19,885)505,685 (52,912)
Corporate debt1,562,355 (268,289)2,350,504 (150,701)3,912,859 (418,990)
Agency RMBS220,595 (40,469)771,191 (58,832)991,786 (99,301)
CMBS343,494 (40,888)599,877 (41,257)943,371 (82,145)
Non-agency RMBS75,137 (14,691)53,484 (3,834)128,621 (18,525)
ABS685,990 (48,913)686,190 (21,808)1,372,180 (70,721)
Municipals52,994 (10,120)96,003 (6,085)148,997 (16,205)
Total fixed maturities, available for sale$3,615,234 $(497,762)$6,269,478 $(358,826)$9,884,712 $(856,588)
Summary of Fixed Maturities, Held-to-Maturity
The following table provides the amortized cost and fair values of the Company's fixed maturities classified as held to maturity:
Amortized
cost
Allowance for expected credit lossesNet carrying valueGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Held to maturity
Corporate debt$95,200 $ $95,200 $298 $(8,827)$86,671 
ABS(1)
591,096  591,096 5 (1,921)589,180 
Total fixed maturities, held to maturity$686,296 $ $686,296 $303 $(10,748)$675,851 
At December 31, 2022    
Held to maturity
Corporate debt$85,200 $— $85,200 $— $(11,428)$73,772 
ABS(1)
613,151 — 613,151 — (12,180)600,971 
Total fixed maturities, held to maturity$698,351 $— $698,351 $— $(23,608)$674,743 
(1)Asset-backed securities ("ABS") include debt tranched securities collateralized primarily by collateralized loan obligations ("CLOs").
Summary of Cost and Fair Value of Equity Securities
The following table provides the cost and fair values of the Company's equity securities:
CostGross
unrealized
gains
Gross
unrealized
losses
Fair
value
At December 31, 2023
Equity securities
Common stocks$2,843 $101 $(398)$2,546 
Preferred stocks5,496 218 (113)5,601 
Exchange-traded funds182,989 105,858 (1,572)287,275 
Bond mutual funds352,505 4,119 (63,535)293,089 
Total equity securities$543,833 $110,296 $(65,618)$588,511 
At December 31, 2022
Equity securities
Common stocks$7,279 $636 $(442)$7,473 
Preferred stocks115 — (43)72 
Exchange-traded funds207,505 68,058 (5,757)269,806 
Bond mutual funds279,457 — (71,555)207,902 
Total equity securities$494,356 $68,694 $(77,797)$485,253 
Summary of Mortgage Loans Net of Valuation Allowance
The following table provides details of the Company's mortgage loans, held for investment:
  
December 31, 2023December 31, 2022
  
Carrying value% of TotalCarrying value% of Total
Mortgage loans held for investment:
Commercial$616,368 101 %$627,437 100 %
Allowance for expected credit losses
(6,220)(1 %)— — %
Total mortgage loans held for investment$610,148 100 %$627,437 100 %
Summary of Portfolio of Other Investments
The following table provides a summary of the Company's other investments, together with additional information relating to the liquidity of each category:
  Fair valueRedemption frequency
(if currently eligible)
Redemption
notice period
At December 31, 2023
Multi-strategy funds$24,619 3 %Quarterly
60-90 days
Direct lending funds192,270 20 %
Quarterly(1)
90 days
Private equity funds301,712 32 %n/an/a
Real estate funds317,325 33 %
Quarterly(2), Annually(3)
45-90 days
CLO-Equities5,300 1 %n/an/a
Other privately held investments108,187 11 %n/an/a
Total other investments$949,413 100 %
At December 31, 2022
Multi-strategy funds$32,616 %Quarterly
60-90 days
Direct lending funds258,626 26 %
Quarterly(1)
90 days
Private equity funds265,836 27 %n/an/a
Real estate funds298,499 30 %
Quarterly(2), Annually(3)
45-90 days
CLO-Equities5,016 — %n/an/a
Other privately held investments136,158 14 %n/an/a
Total other investments$996,751 100 %
n/a – not applicable
(1)Applies to one fund with a fair value of $17 million (2022: $39 million).
(2)Applies to one fund with a fair value of $66 million (2022: $73 million).
(3)Applies to one fund with a fair value of $25 million (2022: $27 million).
Summary of Net Investment Income
Net investment income was derived from the following sources:
Year ended December 31,202320222021
Fixed maturities$514,842 $329,858 $262,049 
Other investments20,411 57,043 181,906 
Equity securities12,088 10,390 12,752 
Mortgage loans35,312 23,407 17,427 
Cash and cash equivalents50,261 20,273 4,454 
Short-term investments8,924 3,535 664 
Gross investment income641,838 444,506 479,252 
Investment expenses(30,096)(25,677)(24,951)
Net investment income$611,742 $418,829 $454,301 
Summary of Net Investment Gains (Losses)
The following table provides an analysis of net investment gains (losses):
Year ended December 31,202320222021
Gross realized investment gains
Fixed maturities and short-term investments$32,920 $16,671 $137,729 
Equity securities16,847 7,687 5,413 
Gross realized investment gains49,767 24,358 143,142 
Gross realized investment losses
Fixed maturities and short-term investments(158,080)(328,493)(42,613)
Equity securities(639)(406)(696)
Gross realized investment losses(158,719)(328,899)(43,309)
(Increase) decrease in allowance for expected credit losses, fixed maturities, available for sale
974 (11,421)11 
(Increase) decrease in allowance for expected credit losses, mortgage loans
(6,220)— — 
Impairment losses(1)
(12,757)(12,568)(22)
Change in fair value of investment derivatives(2)
(1,456)7,656 4,346 
Net unrealized gains (losses) on equity securities53,781 (135,915)30,111 
Net investment gains (losses)$(74,630)$(456,789)$134,279 
(1)Related to instances where the Company intends to sell securities or it is more likely than not that the Company will be required to sell securities before their anticipated recovery.
(2)Refer to Note 7 'Derivative Instruments'.
Summary of Allowance for Credit Loss
The following table provides a reconciliation of the beginning and ending balances of the allowance for expected credit losses on fixed maturities classified as available for sale:
Year ended December 31,202320222021
Balance at beginning of period$11,733 $313 $323 
Expected credit losses on securities where credit losses were not previously recognized
5,200 17,830 95 
Additions (reductions) for expected credit losses on securities where credit losses were previously recognized
4,934 (3,831)50 
Impairments of securities which the Company intends to sell or more likely than not will be required to sell — — 
Securities sold/redeemed/matured(11,108)(2,579)(155)
Balance at end of period$10,759 $11,733 $313 
Summary of Restricted Investments and Cash
The table below provides the fair values of the Company's restricted investments and cash:
At December 31,20232022
Collateral in trust for inter-company agreements
$614,089 $790,449 
Collateral for secured letter of credit facility423,522 424,624 
Funds at Lloyd's893,177 748,573 
Collateral in trust for third-party agreements
2,597,633 2,491,317 
Securities on deposit or in trust with regulatory authorities772,472 731,660 
Total restricted investments and cash$5,300,893 $5,186,623 
XML 66 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Summary of Financial Instruments Measured at Fair Value on a Recurring Basis
The tables below present the financial instruments measured at fair value on a recurring basis for the periods indicated:
Quoted prices in active markets
for identical assets (Level 1)
Significant other observable
inputs (Level 2)
Significant unobservable inputs (Level 3)Fair value based on NAV practical expedientTotal fair value
At December 31, 2023
Assets
Fixed maturities, available for sale
U.S. government and agency$2,989,612 $17,916 $ $ $3,007,528 
Non-U.S. government 723,959   723,959 
Corporate debt 4,338,419 135,753  4,474,172 
Agency RMBS 1,634,661   1,634,661 
CMBS 839,696   839,696 
Non-agency RMBS 153,396   153,396 
ABS 1,242,971   1,242,971 
Municipals 158,359   158,359 
 2,989,612 9,109,377 135,753 — 12,234,742 
Equity securities
Common stocks2,546    2,546 
Preferred stocks1 5,600   5,601 
Exchange-traded funds287,275    287,275 
Bond mutual funds 293,089   293,089 
 289,822 298,689   588,511 
Other investments
Multi-strategy funds
   24,619 24,619 
Direct lending funds   192,270 192,270 
Private equity funds   301,712 301,712 
Real estate funds   317,325 317,325 
CLO-Equities  5,300  5,300 
Other privately held investments  87,289 20,898 108,187 
  92,589 856,824 949,413 
Short-term investments 17,216   17,216 
Other assets
Derivative instruments (refer to Note 7) 4,424   4,424 
Total Assets$3,279,434 $9,429,706 $228,342 $856,824 $13,794,306 
Liabilities
Derivative instruments (refer to Note 7)$ $10,165 $ $ $10,165 
Cash-settled awards (refer to Note 17)     
Total Liabilities$ $10,165 $ $ $10,165 
Quoted prices in active markets
for identical assets (Level 1)
Significant other observable
inputs (Level 2)
Significant unobservable inputs (Level 3)Fair value based on NAV practical expedientTotal fair value
At December 31, 2022
Assets
Fixed maturities, available for sale
U.S. government and agency$2,600,636 $38,694 $— $— $2,639,330 
Non-U.S. government— 562,029 — — 562,029 
Corporate debt— 4,136,452 119,104 — 4,255,556 
Agency RMBS— 1,202,785 — — 1,202,785 
CMBS— 947,778 — — 947,778 
Non-agency RMBS— 133,534 — — 133,534 
ABS— 1,429,527 — — 1,429,527 
Municipals— 156,355 — — 156,355 
 2,600,636 8,607,154 119,104 — 11,326,894 
Equity securities
Common stocks7,473 — — — 7,473 
Preferred stocks72 — — — 72 
Exchange-traded funds269,806 — — — 269,806 
Bond mutual funds— 207,902 — — 207,902 
 277,351 207,902 — — 485,253 
Other investments
Multi-strategy funds
— — — 32,616 32,616 
Direct lending funds— — — 258,626 258,626 
Private equity funds— — — 265,836 265,836 
Real estate funds— — — 298,499 298,499 
CLO-Equities— — 5,016 — 5,016 
Other privately held investments— — 136,158 — 136,158 
— — 141,174 855,577 996,751 
Short-term investments— 70,310 — — 70,310 
Other assets
Derivative instruments (refer to Note 7)— 37,682 — — 37,682 
Total Assets$2,877,987 $8,923,048 $260,278 $855,577 $12,916,890 
Liabilities
Derivative instruments (refer to Note 7)$— $703 $— $— $703 
Cash-settled awards (refer to Note 17)— 4,792 — — 4,792 
Total Liabilities$— $5,495 $— $— $5,495 
Summary of Level 3 Fair Value Measurement Inputs
The following table quantifies the significant unobservable inputs used in estimating fair values at December 31, 2023 of investments classified as Level 3 in the fair value hierarchy:
Asset fair valueValuation techniqueUnobservable inputAmount /RangeWeighted
average
Other investments - CLO-Equities$5,300 Discounted cash flowDefault rate4.5%4.5%
  Loss severity rate50.0%50.0%
  Collateral spread3.0%3.0%
Estimated maturity date4 years4 years
Other investments - Other privately
    held investments
$18,940 Discounted cash flowDiscount rate6.0%6.0%
Default rate0.5%0.5%
Loss absorption yield1.0%1.0%
Estimated maturity date
0 - 2 years
1 year
Note: Fixed maturities of $136 million that are classified as Level 3 are excluded from the above table as these securities are priced using broker-dealer quotes. In addition, other privately held investments of $68 million that are classified as Level 3 are excluded from the above table as these investments are priced using capital statements received from investee companies.
Summary of Changes in Level 3 Financial Instruments Measured at Fair Value on a Recurring Basis, Assets
The following table presents changes in Level 3 for financial instruments measured at fair value on a recurring basis:
Opening
balance
Transfers
into
Level 3
Transfers
out of
Level 3
Included in net income(1)
Included
in OCI (2)
PurchasesSalesSettlements/
distributions
Closing
balance
Change in
unrealized
gains/(losses) (3)
Year ended December 31, 2023
Fixed maturities, available for sale         
Corporate debt$119,104 $ $ $(8,527)$2,438 $38,173 $(770)$(14,665)$135,753 $ 
 119,104   (8,527)2,438 38,173 (770)(14,665)135,753  
Other investments
CLO-Equities5,016   2,395    (2,111)5,300 2,395 
Other privately held investments136,158  (25,510)(9,904) 21,077 (34,532) 87,289 (17,986)
 141,174  (25,510)(7,509) 21,077 (34,532)(2,111)92,589 (15,591)
Total assets$260,278 $ $(25,510)$(16,036)$2,438 $59,250 $(35,302)$(16,776)$228,342 $(15,591)
Other liabilities
Derivative instruments$ $ $ $ $ $ $ $ $ $ 
Total liabilities$ $ $ $ $ $ $ $ $ $ 
Year ended December 31, 2022
Fixed maturities, available for sale         
Corporate debt$42,894 $— $— $(104)$(9,014)$90,130 $— $(4,802)$119,104 $— 
 42,894 — — (104)(9,014)90,130 — (4,802)119,104 — 
Other investments
CLO-Equities5,910 — — 2,611 — — — (3,505)5,016 2,611 
Other privately held investments104,521 — — 13,646 — 19,991 — (2,000)136,158 13,646 
 110,431 — — 16,257 — 19,991 — (5,505)141,174 16,257 
Total assets$153,325 $— $— $16,153 $(9,014)$110,121 $— $(10,307)$260,278 $16,257 
Other liabilities
Derivative instruments$5,630 $— $— $(3,542)$— $— $— $(2,088)$— $— 
Total liabilities$5,630 $— $— $(3,542)$— $— $— $(2,088)$— $— 
(1)    Realized gains (losses) on fixed maturities and realized and unrealized gains (losses) on other assets and other liabilities included in net income are included in net investment gains (losses). Realized and unrealized gains (losses) on other investments included in net income are included in net investment income.
(2)    Unrealized gains (losses) on fixed maturities are included in other comprehensive income ("OCI").
(3)    Change in unrealized gains (losses) relating to assets and liabilities held at the reporting date.
Summary of Changes in Level 3 Financial Instruments Measured at Fair Value on a Recurring Basis, Liabilities
The following table presents changes in Level 3 for financial instruments measured at fair value on a recurring basis:
Opening
balance
Transfers
into
Level 3
Transfers
out of
Level 3
Included in net income(1)
Included
in OCI (2)
PurchasesSalesSettlements/
distributions
Closing
balance
Change in
unrealized
gains/(losses) (3)
Year ended December 31, 2023
Fixed maturities, available for sale         
Corporate debt$119,104 $ $ $(8,527)$2,438 $38,173 $(770)$(14,665)$135,753 $ 
 119,104   (8,527)2,438 38,173 (770)(14,665)135,753  
Other investments
CLO-Equities5,016   2,395    (2,111)5,300 2,395 
Other privately held investments136,158  (25,510)(9,904) 21,077 (34,532) 87,289 (17,986)
 141,174  (25,510)(7,509) 21,077 (34,532)(2,111)92,589 (15,591)
Total assets$260,278 $ $(25,510)$(16,036)$2,438 $59,250 $(35,302)$(16,776)$228,342 $(15,591)
Other liabilities
Derivative instruments$ $ $ $ $ $ $ $ $ $ 
Total liabilities$ $ $ $ $ $ $ $ $ $ 
Year ended December 31, 2022
Fixed maturities, available for sale         
Corporate debt$42,894 $— $— $(104)$(9,014)$90,130 $— $(4,802)$119,104 $— 
 42,894 — — (104)(9,014)90,130 — (4,802)119,104 — 
Other investments
CLO-Equities5,910 — — 2,611 — — — (3,505)5,016 2,611 
Other privately held investments104,521 — — 13,646 — 19,991 — (2,000)136,158 13,646 
 110,431 — — 16,257 — 19,991 — (5,505)141,174 16,257 
Total assets$153,325 $— $— $16,153 $(9,014)$110,121 $— $(10,307)$260,278 $16,257 
Other liabilities
Derivative instruments$5,630 $— $— $(3,542)$— $— $— $(2,088)$— $— 
Total liabilities$5,630 $— $— $(3,542)$— $— $— $(2,088)$— $— 
(1)    Realized gains (losses) on fixed maturities and realized and unrealized gains (losses) on other assets and other liabilities included in net income are included in net investment gains (losses). Realized and unrealized gains (losses) on other investments included in net income are included in net investment income.
(2)    Unrealized gains (losses) on fixed maturities are included in other comprehensive income ("OCI").
(3)    Change in unrealized gains (losses) relating to assets and liabilities held at the reporting date.
XML 67 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Summary of Location and Amounts of Derivative Fair Values on the Consolidated Balance Sheet
The following table provides the balance sheet classifications of derivatives recorded at fair value:
  December 31, 2023December 31, 2022
  Derivative
notional
amount
Derivative asset
fair
value(1)
Derivative liability
fair
value(1)
Derivative
notional
amount
Derivative asset
fair
value(1)
Derivative liability
fair
value(1)
Relating to investment portfolio:
Foreign exchange forward contracts$49,307 $66 $274 $54,076 $81 $559 
Relating to underwriting portfolio:
Foreign exchange forward contracts1,347,559 4,358 9,891 1,441,273 37,601 144 
Total derivatives$4,424 $10,165 $37,682 $703 
(1)Derivative assets and derivative liabilities are classified within other assets and other liabilities in the consolidated balance sheets.
Summary of Reconciliation of Gross Derivative Assets to Net Amounts Presented in Balance Sheets
The following table provides a reconciliation of gross derivative assets and liabilities to the net amounts presented in the consolidated balance sheets, with the difference being attributable to the impact of master netting agreements:
December 31, 2023December 31, 2022
Gross amountsGross amounts offset
Net
amounts(1)
Gross amountsGross amounts offset
Net
amounts(1)
Derivative assets$8,708 $(4,284)$4,424 $41,762 $(4,080)$37,682 
Derivative liabilities$14,449 $(4,284)$10,165 $4,783 $(4,080)$703 
(1)Net asset and liability derivatives are classified within other assets and other liabilities in the consolidated balance sheets.
Summary of Reconciliation of Gross Derivative Liabilities to Net Amounts Presented in Balance Sheets
The following table provides a reconciliation of gross derivative assets and liabilities to the net amounts presented in the consolidated balance sheets, with the difference being attributable to the impact of master netting agreements:
December 31, 2023December 31, 2022
Gross amountsGross amounts offset
Net
amounts(1)
Gross amountsGross amounts offset
Net
amounts(1)
Derivative assets$8,708 $(4,284)$4,424 $41,762 $(4,080)$37,682 
Derivative liabilities$14,449 $(4,284)$10,165 $4,783 $(4,080)$703 
(1)Net asset and liability derivatives are classified within other assets and other liabilities in the consolidated balance sheets.
Summary of Total Unrealized and Realized Gains (Loss) on Derivatives Not Designated as Hedges Recorded in Earnings
The following table provides the total unrealized and realized gains (losses) recognized in net income (loss) for derivatives not designated as hedges:
  Consolidated statement of operations line item that includes gain (loss) recognized
in net income (loss)
Amount of gain (loss) recognized in
net income (loss)
  202320222021
Relating to investment portfolio:
Foreign exchange forward contractsNet investment gains (losses)$(1,456)$7,656 $4,346 
Relating to underwriting portfolio:
Foreign exchange forward contractsForeign exchange (losses) gains8,121 (31,609)(50,738)
Other underwriting-related contractsOther insurance related income (loss) 3,542 2,742 
Total$6,665 $(20,411)$(43,650)
XML 68 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES (Tables)
12 Months Ended
Dec. 31, 2023
Insurance Loss Reserves [Abstract]  
Summary of Reserve for Losses and Loss Expenses
Reserve for losses and loss expenses comprise the following:
At December 31,20232022
Reserve for reported losses and loss expenses$5,559,261 $5,555,865 
Reserve for losses incurred but not reported10,874,757 9,612,998 
Reserve for losses and loss expenses$16,434,018 $15,168,863 
Summary of Reconciliation of Beginning and Ending Gross Reserve for Losses and Loss Expenses and Net Reserve for Unpaid Losses and Loss Expenses
The following table presents a reconciliation of the Company's beginning and ending gross reserves for losses and loss expenses and net reserves for unpaid losses and loss expenses:
Year ended December 31,202320222021
Gross reserve for losses and loss expenses, beginning of year$15,168,863 $14,653,094 $13,926,766 
Less reinsurance recoverable on unpaid losses and loss expenses, beginning of year(5,831,172)(5,017,611)(4,496,641)
Net reserve for unpaid losses and loss expenses, beginning of year9,337,691 9,635,483 9,430,125 
Net incurred losses and loss expenses related to:
Current year2,981,220 3,267,943 3,041,193 
Prior years411,882 (25,533)(32,410)
 3,393,102 3,242,410 3,008,783 
Net paid losses and loss expenses related to:
Current year(488,016)(457,857)(490,011)
Prior years(2,185,588)(2,397,213)(2,274,240)
 (2,673,604)(2,855,070)(2,764,251)
Foreign exchange and other53,746 (685,132)(39,174)
Net reserve for unpaid losses and loss expenses, end of year10,110,935 9,337,691 9,635,483 
Reinsurance recoverable on unpaid losses and loss expenses, end of year6,323,083 5,831,172 5,017,611 
Gross reserve for losses and loss expenses, end of year$16,434,018 $15,168,863 $14,653,094 
Summary of Prior Year Loss Development The following table presents net prior year reserve development by segment:
Favorable (Adverse)
Insurance ReinsuranceTotal
Year ended December 31, 2023$(176,353)$(235,529)$(411,882)
Year ended December 31, 2022$16,350 $9,183 $25,533 
Year ended December 31, 2021$18,360 $14,049 $32,410 
The following sections provide further details on net prior year reserve development by segment, line of business and accident year.
Insurance Segment:
Favorable (Adverse)
Years ended December 31,202320222021
Property $16,195 $52,512 $71,032 
Accident and health(10,236)(12,856)15,844 
Marine and aviation26,977 27,927 42,535 
Cyber35,579 8,416 (7,329)
Professional lines(41,243)(29,093)(71,258)
Credit and political risk31,691 24,361 10,363 
Liability(235,316)(54,917)(42,827)
Total$(176,353)$16,350 $18,360 
Reinsurance Segment:
Favorable (Adverse)
Years ended December 31,202320222021
Accident and health$29,947 $14,199 $5,861 
Agriculture10,781 11,703 423 
Marine and aviation12,595 2,597 (10,767)
Professional lines(92,181)(54,820)(23,718)
Credit and surety8,306 43,567 3,436 
Motor(9,653)18,161 43,968 
Liability(262,114)(58,148)(17,919)
Run-off lines
Catastrophe46,297 (504)(36)
Property15,225 42,523 17,651 
Engineering5,268 (10,095)(4,850)
Total run-off lines66,790 31,924 12,765 
Total$(235,529)$9,183 $14,049 
Summary of Net Incurred and Paid Claims Development Tables by Accident Year
Insurance property
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$289,270 $287,431 $277,183 $262,701 $262,173 $259,792 $255,887 $253,279 $253,203 $253,414 $775 4,174
2015207,711 200,398 192,736 190,310 186,952 189,066 179,075 181,323 181,928 85 4,194
2016263,762 287,858 279,532 265,152 259,319 260,370 259,786 264,976 1,951 6,668
2017794,042 700,638 688,755 679,243 675,085 675,409 669,951 6,375 10,096
2018608,422 639,465 618,888 611,057 609,977 600,596 12,492 9,659
2019374,678 364,350 359,092 369,962 353,671 4,503 9,561
2020654,495 635,344 584,921 593,780 24,336 12,417
2021378,554 375,607 372,223 9,213 7,730
2022414,743 419,139 49,138 7,410
2023399,165 188,657 5,732
Total$4,108,843 
Insurance property
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$100,736 $201,931 $244,372 $250,321 $254,051 $254,858 $251,701 $252,772 $252,787 $252,526 
201567,621 145,027 166,211 179,727 179,409 186,010 177,227 182,038 181,716 
201682,583 206,979 243,050 250,662 250,822 256,476 253,891 260,115 
2017190,861 513,044 622,040 650,218 645,841 635,493 647,610 
2018221,345 468,431 563,191 573,034 590,739 577,000 
2019148,181 257,515 306,415 343,463 332,848 
2020182,611 425,893 481,646 531,448 
2021134,273 286,801 323,656 
202297,622 262,381 
202390,855 
Total3,460,155 
All outstanding liabilities before 2014, net of reinsurance14,248 
Liabilities for claims and claim adjustment expenses, net of reinsurance$662,936 
Insurance accident and health
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$71,520 $67,380 $66,874 $65,347 $64,973 $65,710 $64,938 $64,070 $62,703 $64,392 $1,621 58,081
201570,622 69,494 66,013 64,219 64,771 64,441 63,772 64,433 61,759 1,049 44,138
201685,244 85,892 86,338 87,470 87,154 88,180 87,972 87,399 2,179 87,001
2017113,921 121,146 118,949 117,050 117,131 117,012 118,125 36 688,000
2018111,119 115,977 115,077 113,118 114,134 114,844 291 745,012
201973,926 75,093 65,623 69,203 68,344 121 675,634
202069,679 63,963 67,525 64,297 1,275 718,512
202169,543 72,044 78,478 3,605 433,643
202298,796 100,629 9,807 380,675
2023172,795 67,393 222,537
Total$931,062 
Insurance accident and health
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$31,662 $56,693 $60,682 $61,855 $62,513 $62,844 $62,716 $61,588 $61,996 $62,660 
201531,518 56,988 60,168 61,051 62,065 61,926 62,584 62,677 60,575 
201641,583 79,237 83,077 83,929 85,010 85,413 86,123 85,272 
201763,285 109,312 114,555 115,981 117,100 116,280 118,138 
201861,849 106,748 109,194 112,884 113,787 114,595 
201945,133 61,526 63,046 68,088 68,030 
202036,317 52,290 60,804 59,240 
202139,185 61,593 69,661 
202246,568 82,209 
202395,951 
Total816,331 
All outstanding liabilities before 2014, net of reinsurance(238)
Liabilities for claims and claim adjustment expenses, net of reinsurance$114,493 
Insurance marine and aviation
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$80,064 $66,878 $71,051 $64,768 $65,913 $63,693 $55,526 $53,013 $52,286 $52,308 $830 3,566
2015187,067 165,908 161,465 153,737 140,673 146,174 145,447 145,394 143,900 111 4,312
2016115,520 111,878 109,478 101,928 101,351 100,488 101,388 102,345 2,038 4,836
2017262,628 229,801 227,355 225,397 217,443 217,232 215,683 6,867 8,577
2018238,117 255,652 241,715 234,901 228,369 229,903 14,910 8,742
2019215,911 210,536 213,480 226,586 224,914 14,884 7,697
2020208,542 180,156 163,700 164,808 14,618 6,439
2021240,182 221,864 204,483 34,829 6,754
2022265,181 257,637 92,387 7,159
2023298,845 210,136 5,172
Total$1,894,826 
Insurance marine and aviation
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$10,336 $22,874 $36,805 $39,439 $48,583 $52,793 $53,941 $48,435 $50,255 $50,383 
201529,498 69,563 125,369 130,290 133,087 135,881 142,268 142,437 142,432 
201622,886 50,976 83,039 90,273 92,239 94,184 97,274 97,951 
201735,415 106,527 140,126 172,205 180,904 184,824 196,724 
201847,525 123,434 159,948 173,667 185,455 197,961 
201954,028 103,253 145,927 171,372 178,967 
202044,655 84,391 106,403 119,063 
202126,924 69,687 108,772 
202230,101 101,228 
202336,613 
Total1,230,094 
All outstanding liabilities before 2014, net of reinsurance13,750 
Liabilities for claims and claim adjustment expenses, net of reinsurance$678,482 
Insurance cyber
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$70,557 $69,690 $69,955 $57,876 $47,342 $42,887 $39,516 $43,576 $39,832 $40,743 $604 1,159
201565,231 63,595 63,066 51,250 50,357 50,758 52,526 49,795 48,042 2,046 1,427
201658,741 56,565 58,261 40,266 37,322 29,929 27,873 25,258 1,072 1,667
201753,187 50,794 56,783 51,931 50,905 48,685 48,333 3,234 1,817
201833,429 31,966 33,962 31,111 26,732 24,495 4,574 2,152
201954,444 58,717 81,982 82,006 73,152 14,109 2,900
2020114,209 106,333 103,175 126,457 25,132 2,856
2021125,460 134,382 105,642 20,662 2,432
2022129,361 120,494 71,510 1,730
2023128,252 102,582 1,503
Total$740,868 
Insurance cyber
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$3,136 $12,162 $23,330 $29,962 $31,260 $33,819 $33,732 $35,440 $36,070 $38,043 
20155,572 15,333 25,544 28,501 30,865 39,470 42,515 43,635 45,432 
20161,348 4,637 14,141 18,502 21,333 23,136 23,207 24,054 
20179,354 19,165 28,331 35,897 38,031 40,557 39,995 
20182,171 7,327 9,874 14,810 19,267 18,334 
20192,787 20,950 32,608 60,961 57,318 
202017,732 50,344 63,813 82,625 
202124,108 65,577 75,369 
20227,830 37,861 
20239,237 
Total428,268 
All outstanding liabilities before 2014, net of reinsurance9,471 
Liabilities for claims and claim adjustment expenses, net of reinsurance$322,071 
Insurance professional lines
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$338,378 $338,670 $348,064 $331,044 $321,027 $308,193 $305,201 $304,657 $301,289 $305,060 $35,601 8,881
2015309,864 310,926 317,455 304,062 291,176 274,091 272,909 283,894 282,238 20,475 9,341
2016288,595 293,399 297,852 316,592 329,270 339,513 340,465 356,814 32,954 10,590
2017339,231 343,055 376,569 376,993 394,154 392,002 396,732 53,138 12,605
2018325,926 342,931 392,819 423,162 449,212 468,504 76,008 15,333
2019347,810 363,998 378,899 412,150 460,120 83,773 14,606
2020322,386 321,530 302,097 293,935 130,739 9,318
2021378,660 369,587 326,128 198,067 8,127
2022461,196 447,359 371,912 8,041
2023441,477 414,023 7,251
Total$3,778,367 
Insurance professional lines
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$20,263 $57,536 $105,155 $160,677 $190,560 $206,982 $216,811 $238,969 $244,776 $253,033 
201514,353 51,709 111,149 139,574 171,000 200,892 213,465 225,062 249,916 
201614,428 66,048 131,831 172,360 210,701 235,136 276,175 290,732 
201711,515 51,823 109,107 167,645 198,859 269,668 291,943 
201818,446 74,859 143,248 204,941 265,501 336,329 
201925,061 76,711 133,453 206,462 289,475 
20208,729 44,076 97,847 125,713 
20219,781 38,605 83,605 
202210,983 46,224 
202312,183 
Total1,979,153 
All outstanding liabilities before 2014, net of reinsurance131,134 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,930,348 
Insurance credit and political risk
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$38,825 $70,712 $67,109 $68,323 $69,589 $71,274 $70,748 $69,113 $69,677 $69,677 $— 6
201530,329 30,368 27,524 26,012 25,930 24,851 24,189 23,309 23,309 — 2
201645,006 45,079 42,589 43,160 26,946 25,965 24,885 24,885 — 2
201748,181 32,808 26,044 18,269 16,022 11,068 8,566 2,086 4
201842,976 33,747 32,738 24,845 21,182 24,356 5,584 2
201953,332 81,470 75,610 74,066 71,270 11,546 31
202061,928 70,428 62,235 50,987 19,594 43
202142,417 37,104 26,322 13,363 23
202245,444 44,450 37,463 24
202359,258 54,333 19
Total$403,080 
Insurance credit and political risk
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,924 $39,952 $61,108 $57,857 $57,857 $64,050 $70,224 $70,224 $69,677 $69,677 
2015— 23,309 23,309 23,309 23,309 23,309 23,309 23,309 23,309 
2016— 24,885 24,885 24,885 24,885 24,885 24,885 24,885 
2017403 4,035 9,251 11,710 10,925 10,394 8,666 
20185,370 13,488 15,517 11,851 19,963 23,841 
201916,026 46,456 53,750 56,956 55,067 
20209,825 90,299 58,492 53,786 
20212,769 (370)8,228 
20222,796 8,115 
20232,743 
Total278,317 
All outstanding liabilities before 2014, net of reinsurance592 
Liabilities for claims and claim adjustment expenses, net of reinsurance$125,355 
Insurance liability
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claimsCumulative number of reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$107,126 $124,289 $129,750 $130,666 $132,013 $131,469 $132,565 $132,043 $132,474 $131,210 $9,697 5,820
2015128,436 127,299 137,477 164,982 182,690 188,004 186,931 188,261 189,795 18,423 6,769
2016124,313 130,160 128,854 127,451 120,199 120,187 125,614 124,969 17,081 7,648
2017167,334 166,052 184,781 200,391 204,533 214,707 250,887 37,518 8,812
2018167,552 167,672 190,639 204,519 216,038 251,875 38,901 8,644
2019192,468 193,435 222,885 238,035 300,584 66,863 8,183
2020224,616 225,038 230,921 249,189 88,543 6,180
2021232,051 245,585 302,023 141,022 6,748
2022323,261 357,574 246,679 7,365
2023364,604 331,464 5,168
Total$2,522,710 
Insurance liability
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,411 $18,633 $49,829 $71,589 $84,369 $93,569 $103,041 $106,205 $113,150 $116,384 
20155,438 22,353 39,581 92,598 120,136 140,809 150,640 159,004 162,656 
20166,315 23,260 36,356 56,403 66,290 79,519 95,787 102,773 
20175,463 29,432 58,988 115,568 143,440 168,615 190,475 
20189,374 34,860 72,219 119,152 158,622 188,910 
20197,833 39,846 83,692 139,077 192,435 
20208,148 25,174 75,907 118,306 
202113,397 51,859 103,892 
202213,212 53,507 
20239,855 
Total1,239,193 
All outstanding liabilities before 2014, net of reinsurance49,217 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,332,734 
Reinsurance accident and health
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$101,409 $102,403 $89,303 $86,833 $86,843 $86,846 $87,806 $88,095 $87,978 $87,664 $125 
201593,831 100,522 94,047 93,807 93,081 93,422 92,431 92,388 93,133 105 
2016170,687 191,299 188,454 190,067 189,538 190,574 190,534 190,662 16 
2017183,937 189,610 183,574 182,477 183,513 183,484 182,479 (16)
2018193,749 200,576 198,365 201,133 200,467 197,493 766 
2019217,477 212,307 207,794 205,403 199,419 1,328 
2020226,883 220,969 213,960 199,958 1,757 
2021232,091 227,326 222,718 9,765 
2022267,525 264,615 40,396 
2023243,174 91,280 
Total$1,881,315 
Reinsurance accident and health
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$36,571 $79,974 $85,931 $86,332 $86,534 $86,622 $87,302 $86,384 $86,771 $87,202 
201523,409 77,316 88,728 91,935 92,036 92,497 93,921 93,735 92,468 
201650,046 149,959 181,072 187,251 189,234 188,836 189,815 189,409 
201779,252 157,157 172,111 178,943 179,462 180,121 179,889 
201872,899 165,323 191,832 191,400 194,524 195,018 
201967,810 169,608 195,954 196,694 194,800 
202081,875 172,178 210,665 192,491 
202168,652 179,626 210,115 
2022101,596 214,611 
2023130,949 
Total1,686,952 
All outstanding liabilities before 2014, net of reinsurance(213)
Liabilities for claims and claim adjustment expenses, net of reinsurance$194,150 
Reinsurance agriculture
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$183,260 $164,351 $162,820 $162,388 $162,314 $162,327 $162,245 $162,068 $162,762 $162,927 $482 
2015103,199 95,608 95,346 95,332 95,339 95,516 95,503 95,634 96,251 (27)
2016124,229 117,960 111,045 109,633 109,863 109,068 109,012 109,763 (72)
2017151,768 144,401 138,439 139,510 138,984 137,516 136,658 (60)
2018141,040 147,359 140,883 140,618 139,989 142,760 646 
2019185,560 185,345 187,770 183,384 183,092 93 
202062,678 62,837 63,874 61,986 1,130 
202169,823 61,437 57,857 6,144 
2022101,082 91,534 16,972 
2023103,489 81,193 
Total$1,146,317 
Reinsurance agriculture
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$15,615 $133,137 $162,349 $161,575 $161,498 $162,011 $160,516 $161,167 $162,068 $162,194 
20151,716 65,870 92,979 94,535 94,873 95,468 95,457 95,612 96,224 
20169,489 62,530 108,378 109,922 109,410 109,172 109,211 109,762 
20177,444 124,528 137,502 138,640 137,482 137,429 136,605 
20185,115 127,577 135,674 141,768 138,398 144,070 
201928,854 154,533 174,250 178,264 177,760 
202017,454 47,377 54,269 55,359 
20212,953 32,846 46,117 
202215,347 55,508 
202314,633 
Total998,232 
All outstanding liabilities before 2014, net of reinsurance(463)
Liabilities for claims and claim adjustment expenses, net of reinsurance$147,622 
Reinsurance marine and aviation
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$10,192 $9,162 $8,019 $7,209 $9,192 $8,535 $8,786 $9,025 $9,530 $9,841 $368 
201510,366 9,242 10,836 15,019 12,652 12,281 12,046 11,998 12,054 527 
201632,453 35,965 36,130 37,519 36,052 36,371 36,773 36,263 52 
201755,299 42,961 41,363 46,612 43,243 40,900 40,827 43 
201818,906 27,454 27,006 43,540 47,066 48,477 35 
201969,806 82,194 79,801 81,628 84,756 5,560 
202040,298 41,766 37,892 37,098 308 
202143,763 40,830 35,672 2,976 
202268,907 59,227 32,375 
202340,951 34,539 
Total$405,166 
Reinsurance marine and aviation
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident Year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$1,121 $2,307 $4,388 $5,256 $6,320 $6,499 $7,003 $7,370 $7,563 $8,477 
2015416 2,665 6,443 8,662 10,220 11,017 10,843 10,925 11,058 
20162,765 19,544 26,673 30,619 33,399 34,450 35,044 35,256 
20172,803 23,620 28,954 33,912 36,978 37,091 37,996 
20181,783 10,880 24,325 30,763 34,435 37,829 
201910,763 27,167 34,317 52,763 67,800 
20204,024 16,730 24,006 29,862 
20215,478 12,341 20,486 
20227,817 18,588 
20231,473 
Total268,825 
All outstanding liabilities before 2014, net of reinsurance1,923 
Liabilities for claims and claim adjustment expenses, net of reinsurance$138,264 
Reinsurance professional lines
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$219,162 $219,123 $219,052 $218,847 $233,169 $229,556 $228,193 $226,234 $234,311 $246,043 $13,578 
2015211,820 211,774 213,993 224,649 231,352 228,410 235,131 241,113 252,022 16,515 
2016195,019 196,073 199,715 227,468 255,088 255,012 266,979 278,699 26,195 
2017154,889 155,470 161,694 177,819 187,761 210,303 239,324 38,070 
2018145,994 148,458 155,390 165,981 173,954 195,575 24,160 
2019138,048 137,723 141,610 146,088 157,572 36,200 
2020140,886 141,559 136,107 134,478 69,314 
2021148,950 140,737 136,381 93,845 
2022169,576 153,853 125,013 
2023136,051 124,516 
Total$1,929,998 
Reinsurance professional lines
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$2,019 $13,062 $48,791 $74,479 $109,048 $146,917 $158,388 $178,058 $189,874 $196,444 
20153,134 13,504 41,512 79,208 111,743 131,543 152,328 170,555 184,073 
20161,765 20,487 52,540 95,084 124,881 153,575 181,141 202,925 
20172,813 14,871 39,857 62,723 88,791 116,293 137,492 
2018271 2,572 31,198 56,882 81,729 113,771 
2019368 13,614 33,628 53,221 76,094 
20203,823 13,969 26,926 40,718 
20214,337 11,366 22,619 
20223,234 11,713 
20233,435 
Total989,284 
All outstanding liabilities before 2014, net of reinsurance113,403 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,054,117 
Reinsurance credit and surety
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$134,434 $134,527 $141,621 $137,973 $126,744 $125,477 $121,780 $120,482 $120,790 $111,511 $1,914 
2015159,274 164,350 159,148 155,217 136,568 137,528 138,726 132,989 129,333 1,447 
2016140,892 140,188 147,955 122,495 114,957 112,631 110,316 112,465 35 
2017137,832 131,630 125,763 117,044 114,412 114,131 114,612 2,647 
2018111,022 119,227 113,535 110,531 105,503 94,229 4,053 
201974,101 67,825 67,759 65,573 57,322 6,315 
202076,917 83,559 68,987 94,943 8,385 
202152,005 43,967 41,463 13,732 
202263,653 51,231 33,129 
202386,367 64,350 
Total$893,476 
Reinsurance credit and surety
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$35,450 $60,597 $85,266 $94,274 $101,859 $106,267 $106,708 $106,519 $107,713 $98,533 
201532,863 81,001 98,709 115,549 117,462 121,115 121,975 120,617 118,116 
201641,937 72,691 91,490 101,065 102,149 100,682 100,426 102,558 
201737,246 73,362 89,715 101,337 99,463 102,390 103,252 
201838,868 67,839 72,096 83,736 85,505 87,073 
201919,301 30,985 44,702 46,835 49,050 
202025,339 34,050 39,495 43,888 
20214,471 9,170 17,175 
20226,883 11,302 
202310,335 
Total641,282 
All outstanding liabilities before 2014, net of reinsurance26,307 
Liabilities for claims and claim adjustment expenses, net of reinsurance$278,501 
Reinsurance motor
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$181,056 $180,792 $175,983 $173,139 $168,796 $165,481 $162,212 $161,835 $162,730 $161,844 $2,346 
2015221,182 215,201 219,055 220,820 209,908 208,620 205,780 206,090 204,673 8,979 
2016244,395 259,912 261,592 251,675 243,353 240,717 244,553 245,098 4,366 
2017361,782 368,517 357,741 358,286 359,026 354,392 361,134 22,422 
2018355,561 353,384 364,664 360,907 348,323 361,117 17,400 
2019338,031 336,957 337,404 328,522 332,952 12,894 
2020215,257 218,224 215,572 197,439 10,872 
2021180,372 182,010 184,244 25,813 
2022160,697 173,870 35,986 
2023125,498 60,323 
Total$2,347,869 
Reinsurance motor
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$43,148 $73,129 $92,183 $100,071 $109,989 $119,355 $114,654 $135,455 $138,281 $141,456 
201557,638 92,382 112,128 129,175 144,878 145,593 168,295 173,373 175,479 
201660,689 103,868 127,404 145,160 158,004 182,077 189,563 198,144 
201772,143 133,447 163,724 198,778 221,060 244,440 262,741 
201883,831 141,391 205,874 215,988 240,535 260,818 
201990,328 183,841 201,210 223,167 242,207 
202043,752 96,208 115,689 127,881 
202141,869 76,338 94,500 
202235,213 52,971 
202326,040 
Total1,582,237 
All outstanding liabilities before 2014, net of reinsurance255,320 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,020,952 
Reinsurance liability
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$199,575 $202,526 $204,240 $200,138 $198,893 $196,747 $187,245 $183,101 $189,047 $193,578 $14,361 
2015214,346 214,689 215,633 215,461 213,256 213,485 203,268 206,204 217,019 22,070 
2016239,971 245,286 250,247 253,525 263,195 267,241 274,615 315,793 46,678 
2017275,306 270,080 279,262 287,818 297,380 306,648 343,290 62,419 
2018264,003 268,812 274,110 286,876 307,032 352,697 72,183 
2019263,522 272,513 274,393 272,905 331,729 103,836 
2020283,606 284,216 278,743 306,011 148,977 
2021304,160 311,735 346,161 185,421 
2022347,387 343,773 232,850 
2023275,232 241,263 
Total$3,025,283 
Reinsurance liability
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$7,075 $28,652 $48,397 $70,069 $89,328 $109,859 $129,802 $137,103 $148,342 $156,421 
20157,269 27,451 54,486 80,822 108,857 130,767 141,519 151,919 166,842 
201611,868 37,666 69,445 111,698 142,837 166,645 189,536 216,534 
201712,449 42,144 78,574 120,747 158,653 193,274 224,655 
201819,357 49,938 85,207 127,946 166,378 207,016 
201919,311 45,269 79,728 120,266 159,068 
202016,940 49,059 82,389 119,678 
202110,931 58,540 99,228 
202218,066 52,197 
202315,003 
Total1,416,642 
All outstanding liabilities before 2014, net of reinsurance130,039 
Liabilities for claims and claim adjustment expenses, net of reinsurance$1,738,680 
Reinsurance run-off
Incurred claims and allocated claim adjustment expenses, net of reinsuranceAt December 31, 2023
For the years ended December 31,Total of incurred-but-not-reported liabilities plus expected development on reported claims
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$242,347 $246,616 $236,768 $227,865 $224,135 $223,970 $219,953 $219,748 $218,896 $219,012 $201 
2015267,709 256,648 256,665 247,377 246,266 251,245 249,050 247,183 244,790 475 
2016286,264 285,973 282,705 277,349 280,836 281,204 281,137 274,291 2,838 
2017705,205 702,378 740,074 741,278 739,258 729,812 722,172 19,886 
2018523,351 614,222 628,722 614,573 600,516 600,640 15,506 
2019448,745 432,299 411,886 395,134 387,944 17,304 
2020520,537 553,538 548,846 553,124 41,243 
2021430,820 441,530 438,082 39,301 
2022265,797 225,697 47,820 
202364,191 28,272 
Total$3,729,943 
Reinsurance run-off
Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
For the years ended December 31,
Accident year2014 unaudited2015 unaudited2016 unaudited2017 unaudited2018 unaudited2019 unaudited2020 unaudited2021 unaudited2022 unaudited2023
2014$49,217 $136,404 $180,580 $197,284 $202,114 $206,234 $203,726 $210,435 $211,708 $213,063 
201546,199 119,103 178,596 203,661 213,978 218,469 232,671 234,318 235,258 
201665,343 141,975 201,290 232,366 246,602 253,543 258,939 257,802 
2017163,254 417,693 528,640 586,833 611,106 646,826 657,803 
2018116,816 331,848 427,126 479,911 526,746 548,005 
201954,985 214,066 274,503 310,612 335,546 
2020105,245 240,193 324,105 392,613 
202187,860 235,617 302,383 
202250,250 103,881 
202322,862 
Total3,069,216 
All outstanding liabilities before 2014, net of reinsurance37,075 
Liabilities for claims and claim adjustment expenses, net of reinsurance$697,802 
Summary of Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance
Insurance property
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
32.9%41.2%13.4%5.3%0.1%0.4%(1.3%)1.8%(0.1%)(0.1%)
Insurance accident and health
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
53.0%34.9%6.0%1.9%0.9%0.2%0.8%(0.9%)(1.4%)1.0%
Insurance marine and aviation
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
18.8%26.6%22.5%7.9%5.6%3.8%3.8%(3.2%)1.8%0.2%
Insurance cyber
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
10.7%23.5%19.0%18.5%6.2%6.5%1.3%3.3%2.6%4.8%
Insurance professional lines
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
3.9%11.3%16.1%13.3%11.7%11.1%6.2%5.2%5.4%2.7%
Insurance credit and political risk
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
9.3%59.0%10.0%0.6%3.6%3.7%(2.8%)—%(0.4%)—%
Insurance liability
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
3.2%10.8%15.3%19.6%12.8%10.1%8.5%4.1%3.6%2.5%
Reinsurance accident and health
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
37.1%48.7%12.9%0.3%0.4%0.2%0.7%(0.5%)(0.5%)0.5%
Reinsurance agriculture
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
10.9%63.5%18.5%1.7%(0.6%)0.9%(0.4%)0.4%0.6%0.1%
Reinsurance marine and aviation
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
8.9%26.4%20.5%14.4%10.7%3.7%1.9%1.7%1.6%9.3%
Reinsurance professional lines
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
1.5%5.3%11.6%12.3%12.6%12.3%7.9%7.7%5.1%2.7%
Reinsurance credit and surety
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
26.5%22.1%15.0%8.6%2.3%2.0%0.4%0.2%(0.4%)(8.2%)
Reinsurance motor
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
23.6%18.8%10.3%6.5%6.3%5.6%4.1%6.3%1.4%2.0%
Reinsurance liability
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
4.5%9.8%10.8%12.2%11.1%10.0%7.9%5.7%6.4%4.2%
Reinsurance run-off
Average annual percentage payout of incurred claims by age, net of reinsurance (unaudited)
Year 1Year 2Year 3Year 4Year 5Year 6Year 7Year 8Year 9Year 10
21.8%32.4%17.9%9.7%4.9%2.9%2.1%1.1%0.5%0.6%
Summary of Reconciliation of Development Tables to Consolidated Balance Sheet
The following table reconciles the reserve for losses and loss expenses at December 31, 2023, included in the loss development tables to the reserve for losses and loss expenses reported in the consolidated balance sheet:
Reconciliation of the disclosure of incurred and paid claims development to the liability
for unpaid claims and claim adjustment expenses
At December 31, 2023
Net outstanding liabilitiesReinsurance recoverable on unpaid claimsGross outstanding liabilities
Insurance segment
Property$662,936 $402,222 $1,065,158 
Accident and health114,493 3,006 117,499 
Marine and aviation678,482 278,215 956,697 
Cyber322,071 430,627 752,698 
Professional lines1,930,348 1,442,546 3,372,894 
Credit and political risk125,355 35,191 160,546 
Liability1,332,734 1,885,232 3,217,966 
Total insurance segment5,166,419 4,477,039 9,643,458 
Reinsurance segment
Accident and health194,150 49,314 243,464 
Agriculture147,622 8,343 155,965 
Marine and aviation138,264 33,185 171,449 
Professional lines1,054,117 370,345 1,424,462 
Credit and surety278,501 103,174 381,675 
Motor1,020,952 315,344 1,336,296 
Liability1,738,680 690,141 2,428,821 
Run-off lines697,802 276,198 974,000 
Total reinsurance segment5,270,088 1,846,044 7,116,132 
Total$10,436,507 $6,323,083 16,759,590 
Unallocated claims adjustment expenses183,260 
Foreign exchange and other(1)
12,442 
Ceded reserves related to retroactive transactions (521,274)
Total liability for unpaid claims and claims adjustment expense$16,434,018 
(1)    Non-U.S. dollar denominated loss data is converted to U.S dollar at the rates of exchange in effect at the balance sheet date for material underlying currencies. Fluctuations in currency exchange rates may cause material shifts in loss development. Reserves for losses and loss expenses disclosed in the consolidated balance sheets are also remeasured using rates of exchange in effect at the balance sheet date.
XML 69 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
REINSURANCE (Tables)
12 Months Ended
Dec. 31, 2023
Reinsurance Disclosures [Abstract]  
Summary of Breakdown of Gross and Net Premiums Written and Earned
The following table presents gross and net premiums written and earned:
Year ended December 31,202320222021
  Premiums
written
Premiums
earned
Premiums
written
Premiums
earned
Premiums
written
Premiums
earned
Gross$8,356,525 $7,973,577 $8,214,595 $7,936,382 $7,685,984 $7,281,709 
Ceded(3,254,200)(2,889,796)(2,951,539)(2,776,056)(2,759,360)(2,571,859)
Net$5,102,325 $5,083,781 $5,263,056 $5,160,326 $4,926,624 $4,709,850 
XML 70 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND FINANCING ARRANGEMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt Instruments
The following table summarizes the Company's debt:
Year ended December 31,20232022
5.150% Senior Notes
$246,789 $246,708 
4.000% Senior Notes
348,389 348,020 
3.900% Senior Notes
297,076 296,615 
Junior Subordinated Notes421,460 420,971 
Total Debt$1,313,714 $1,312,314 

The tables below provide the key terms of the Company's debt:
DescriptionIssuance DateAggregate PrincipalIssue PriceNet ProceedsMaturity Date
5.150% Senior Notes
March 13, 2014$250,000 99.474 %$246,000 April 1, 2045
4.000% Senior Notes
December 6, 2017$350,000 99.780 %$347,000 December 6, 2027
3.900% Senior Notes
June 19, 2019$300,000 99.360 %$296,000 July 15, 2029
Junior Subordinated NotesDecember 10, 2019$425,000 99.000 %$420,750 January 15, 2040

DescriptionInterest RateInterest Payments Due
5.150% Senior Notes
5.150 %Semi-annually in arrears on April 1 and October 1 of each year
4.000% Senior Notes
4.000 % Semi-annually in arrears on June 6 and December 6 of each year
3.900% Senior Notes
3.900 %Semi-annually in arrears on January 15 and July 15 of each year
Junior Subordinated Notes(1)
4.900 %Semi-annually on January 15 and July 15 of each year
(1)    The Junior Subordinated Notes accrue interest from the date of issuance to, but excluding, January 15, 2030 (the "Par Call Date") at the fixed rate of 4.900% and from, and including, the Par Call Date, at a rate equal to the Five-Year Treasury Rate as of the Reset Interest Determination Date, plus 3.186%. Interest on the Junior Notes is payable semi-annually on January 15 and July 15 of each year, beginning on July 15, 2020.
Summary of Debt Maturity
The following table provides the scheduled maturity of the Company's debt obligations at December 31, 2023:
Year ended December 31,
2024$— 
2025— 
2026— 
2027350,000 
2028— 
After 2028975,000 
Unamortized discount and debt issuance expenses(11,286)
Total senior notes and notes payable$1,313,714 
XML 71 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES (Tables)
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Summary of Lease Expense and Related Cash Flows
The following table presents the Company’s total lease expense and the cash flows arising from lease transactions:
Year ended December 31,202320222021
Lease cost:
Operating lease expense$21,499$20,611$21,864 
Short-term lease expense(1)
2,2918131,127 
Sublease income(2)
(4,531)(3,423)(3,116)
Total lease expense$19,259$18,001$19,875 
Other information:
Operating cash outflows from operating leases$20,190$22,932 $22,726 
Right-of-use assets obtained in exchange for new operating lease liabilities(3)
$34,988$6,514 $(1,739)
Weighted-average remaining lease term - operating leases(4)
9.8 years9.9 years10.0 years
Weighted-average discount rate - operating lease(5)
4.4%4.1 %4.1 %
(1)    Short-term lease expense is recognized on a straight-line basis over the lease term.
(2)    Sublease income largely relates to office properties in New York and Chicago.
(3)    In 2021, the Company modified a lease agreement to reflect a reduction in the floor space it occupies in its office property in Zurich.
(4)    Weighted-average remaining lease term was calculated on the basis of the remaining lease term and the lease liability balance for each lease at the reporting date.
(5)    Weighted-average discount was calculated on the basis of the discount rate that was used to calculate the lease liability balance for each lease at the reporting date and the remaining balance of the lease payments for each lease at the reporting date.
Summary of Maturity and Minimum Lease Payments
The following table presents the scheduled maturity of the Company's operating lease liabilities at December 31, 2023:
Year ended December 31,Expected cash flows
2024$17,543 
202518,122 
202615,767 
202713,519 
202812,691 
Later years74,852 
Discount(29,393)
Total discounted operating lease liabilities$123,101 

The following table presents the scheduled maturity of the Company's operating lease liabilities at December 31, 2022:
Year ended December 31,Expected cash flows
2023$19,774 
202413,725 
202513,148 
202611,052 
20279,052 
Later years58,516 
Discount(22,690)
Total discounted operating lease liabilities $102,577 
XML 72 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
EARNINGS PER COMMON SHARE (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Earnings (Loss) Per Common Share
The following table presents a comparison of earnings (loss) per common share and earnings (loss) per diluted common share:
At and year ended December 31,202320222021
Earnings per common share
Net income$376,292 $223,083 $618,609 
Less: Preferred share dividends30,250 30,250 30,250 
Net income available to common shareholders$346,042 $192,833 $588,359 
Weighted average common shares outstanding85,142 84,864 84,707 
Earnings per common share$4.06 $2.27 $6.95 
Earnings per diluted common share
Net income available to common shareholders$346,042 $192,833 $588,359 
Weighted average common shares outstanding85,142 84,864 84,707 
Share-based compensation plans870 805 584 
Weighted average diluted common shares outstanding86,012 85,669 85,291 
Earnings per diluted common share$4.02 $2.25 $6.90 
Weighted average anti-dilutive shares excluded from the dilutive computation405 324 656 
XML 73 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Summary of Common Shares Issued and Outstanding
The following table presents changes in common shares issued and outstanding:
Year ended December 31,202320222021
Shares issued, balance at beginning of year176,580 176,580 176,580 
Shares issued — — 
Total shares issued at end of year176,580 176,580 176,580 
Treasury shares, balance at beginning of year(91,912)(91,806)(92,227)
Shares repurchased(398)(897)(205)
Shares reissued 1,016 791 626 
Total treasury shares at end of year(91,294)(91,912)(91,806)
Total shares outstanding85,286 84,668 84,774 
Summary of Share Repurchases
The following table presents common shares repurchased from shares held in Treasury:
Year ended December 31,202320222021
In the open market: (1)
Total shares 634 — 
Total cost$ $34,987 $— 
Average price per share(2)
$ $55.22 $— 
From employees:(3)
Total shares398 263 205 
Total cost$23,596 $13,994 $10,242 
Average price per share(2)
$59.15 $53.13 $49.93 
Total shares repurchased:
Total shares398 897 205 
Total cost$23,596 $48,981 $10,242 
Average price per share(2)
$59.15 $54.61 $49.93 
(1)    Shares were repurchased pursuant to the Company's Board-authorized share repurchase program announced in December 2021, effective January 1, 2022 through to December 31, 2022.
(2)    Calculated using whole numbers.
(3)    Shares are repurchased from employees to satisfy personal withholding tax liabilities that arise on the vesting of share-settled restricted stock units.
Summary of Dividends Declared and Paid
The following table presents dividends declared and paid related to the Company's common and preferred shares:
Per share data
Dividends declared Dividends paid in year of declarationDividends paid in year following declaration
Year ended December 31, 2023
Common shares$1.76 $1.32 $0.44 
Series E preferred shares$137.50 $103.13 $34.38 
Year ended December 31, 2022
Common shares$1.73 $1.29 $0.44 
Series E preferred shares$137.50 $103.13 $34.38 
Year ended December 31, 2021
  Common shares$1.69 $1.26 $0.43 
  Series E preferred shares$137.50 $103.13 $34.38 
XML 74 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Additional Information Related to Share-based Compensation
The following table provides details of the significant inputs used in the Monte Carlo simulation model:
Year ended December 31,
2023 (1)
2023 (2)
2023 (3)
20222021
Expected volatility 36.24%29.30%30.05%33.44%32.99%
Expected term (in years)3.01.03.03.03.0
Expected dividend yieldn/an/an/an/an/a
Risk-free interest rate3.79%4.61%3.39%1.26%0.17%
n/a - not applicable
(1) Performance restricted stock units granted in the ordinary course of business
(2) Performance restricted stock units granted in the three months ended March 31, 2023 in relation to senior leadership transition
(3) Performance restricted stock units granted in the three months ended June 30, 2023 in relation to senior leadership transition
The following table provides additional information related to share-based compensation:
Year ended December 31,202320222021
Share-based compensation expense (1)
$57,729 $56,136 $49,415 
Tax benefits associated with share-based compensation expense$8,819 $8,839 $7,613 
Liability for cash-settled restricted stock units (2)
$— $4,792 $9,091 
Fair value of restricted stock units vested (3)
$64,156 $49,792 $42,967 
Unrecognized share-based compensation expense$62,416 $74,601 $80,805 
Expected weighted average period associated with the recognition of unrecognized share-based compensation expense2.4 years2.3 years2.4 years
(1)    Related to share-settled restricted stock units and cash-settled restricted stock units.
(2)    Included in other liabilities in the consolidated balance sheets.
(3)    Fair value is based on the closing price of the Company's common shares on the vest date.
Summary of Reconciliation of Beginning and Ending Balance of Non Vested Restricted Stock (Including RSUs) to be Settled in Shares
The following table provides an activity summary of the Company's share-settled restricted stock units:
Share-Settled Performance
Restricted Stock Units
Share-Settled Service
Restricted Stock Units
Number of
restricted
stock units
Weighted average grant date
fair value
Number of
restricted
stock units
Weighted average
grant date
fair value
Nonvested restricted stock units - December 31, 2021311 $54.75 2,062 $51.59 
Granted140 68.63 993 56.09 
Vested(100)54.70 (690)52.67 
Forfeited(21)62.26 (248)53.22 
Nonvested restricted stock units - December 31, 2022330 60.01 2,117 53.16 
Granted122 66.13 918 57.53 
Vested(88)63.88 (929)53.02 
Forfeited(220)58.15 (251)54.49 
Nonvested restricted stock units - December 31, 2023144 $65.69 1,855 $55.21 
Summary of Activity of Cash-Settled Restricted Stock Units
The following table provides an activity summary of the Company's cash-settled restricted stock units:
Cash-Settled Service Restricted Stock Units
Number of
restricted stock units
Nonvested restricted stock units - December 31, 2021215 
Granted— 
Vested(145)
Forfeited(10)
Nonvested restricted stock units - December 31, 202260 
Granted 
Vested(59)
Forfeited(1)
Nonvested restricted stock units - December 31, 2023 
XML 75 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Summary of Income Tax Expense and Net Tax Assets
The following table provides an analysis of income tax expense (benefit) and net tax assets:
Year ended December 31,202320222021
Current income tax expense (benefit)
U.S.$12,021 $11,491 $35,229 
Europe32,386 2,366 (6,082)
Bermuda
291 (147)— 
Deferred income tax expense (benefit)
U.S.(24,042)(8,147)(3,369)
Europe18,932 16,474 36,606 
Bermuda(1)
(13,272)— — 
Total income tax expense (benefit)$26,316 $22,037 $62,384 
Net current tax receivables$78,570 $46,704 $27,883 
Net deferred tax assets (liabilities)72,850 108,220 12,860 
Net tax assets$151,420 $154,924 $40,743 
(1)    Reflects the recognition of a tax benefit in Bermuda on unrealized investment losses included in other comprehensive income (loss) due to the enactment of corporate income tax that will take effect in 2025.
Summary of Deferred Tax Assets and Liabilities The following table provides details of the significant components of deferred tax assets and liabilities:
At December 31,20232022
Deferred tax assets:
Discounting of net reserves for losses and loss expenses$62,316 $52,992 
Unearned premiums54,104 56,146 
Net unrealized investments losses54,395 71,251 
Operating and capital loss carryforwards
100,907 152,896 
Accruals not currently deductible36,407 42,045 
Tax credits 11,602 7,619 
Other deferred tax assets4,149 8,590 
Deferred tax assets before valuation allowance323,880 391,539 
Valuation allowance(38,711)(60,069)
Deferred tax assets net of valuation allowance285,169 331,470 
Deferred tax liabilities:
Deferred acquisition costs(27,109)(35,211)
Other investment adjustments and impairments(7,173)(20,068)
Intangible assets(49,486)(51,993)
Equalization reserves(2,726)(2,530)
Acquisition adjustments(79,466)(72,351)
Lloyd’s deferred year of account results(38,194)(34,068)
Other deferred tax liabilities(8,165)(7,029)
Deferred tax liabilities(212,319)(223,250)
Net deferred tax assets (liabilities)$72,850 $108,220 
Summary of Tax Credits
The following table summarizes total operating and capital loss carryforwards and tax credits:
At December 31,20232022
Operating and Capital Loss Carryforwards(1)
Singapore operating loss carryforward
$70,815 $73,769 
U.K. operating loss carryforward
293,533 415,274 
Ireland operating loss carryforward78,154 200,822 
Ireland capital loss carryforward716 716 
Switzerland operating loss carryforward(2)
123,453 187,057 
Tax Credits(1)
Ireland foreign tax credit$6,922 $655 
U.K. foreign tax credit2,605 2,372 
U.S. foreign tax credit(3)
2,074 4,592 
(1)    At December 31, 2023, the Singapore, U.K., and Ireland operating and capital loss carryforwards and tax credits can be carried forward
(2)    At December 31, 2023, the Swiss net operating losses can be carried forward 7 years of which $123,453 expires 2029.
(3)    At December 31, 2023, the U.S. foreign tax credit can be carried back 1 year and carried forward 10 years of which, $2,074 expires 2032.
Summary of Operating and Capital Loss Carryforwards
The following table summarizes total operating and capital loss carryforwards and tax credits:
At December 31,20232022
Operating and Capital Loss Carryforwards(1)
Singapore operating loss carryforward
$70,815 $73,769 
U.K. operating loss carryforward
293,533 415,274 
Ireland operating loss carryforward78,154 200,822 
Ireland capital loss carryforward716 716 
Switzerland operating loss carryforward(2)
123,453 187,057 
Tax Credits(1)
Ireland foreign tax credit$6,922 $655 
U.K. foreign tax credit2,605 2,372 
U.S. foreign tax credit(3)
2,074 4,592 
(1)    At December 31, 2023, the Singapore, U.K., and Ireland operating and capital loss carryforwards and tax credits can be carried forward
(2)    At December 31, 2023, the Swiss net operating losses can be carried forward 7 years of which $123,453 expires 2029.
(3)    At December 31, 2023, the U.S. foreign tax credit can be carried back 1 year and carried forward 10 years of which, $2,074 expires 2032.
Summary of Valuation Allowance Roll Forward
The following table shows an analysis of the movement in the Company's valuation allowance:
At December 31,20232022
Income tax expense (benefit):
Valuation allowance - beginning of year$39,782 $16,918 
Operating loss carryforwards(8,713)21,724 
Foreign tax credit4,184 2,401 
U.K. branch assets and other foreign rate differentials(3,565)(1,261)
Valuation allowance - end of year$31,688 $39,782 
Accumulated other comprehensive income (loss):
Valuation allowance - beginning of year$20,287 $— 
Change in investment - related items(13,264)20,287 
Valuation allowance - end of year7,023 20,287 
Total valuation allowance - end of year$38,711 $60,069 
Summary of Effective Tax Rate Reconciliation
The following table presents the distribution of income before income taxes between domestic and foreign jurisdictions and a reconciliation of the actual income tax rate to the amount computed by applying the effective tax rate of 0% under Bermuda law to income before income taxes:
Year ended December 31,202320222021
Income (loss) before income taxes
Bermuda (domestic)$213,539 $236,781 $431,310 
Foreign189,067 8,340 249,686 
 Total income before income taxes$402,606 $245,121 $680,996 
Reconciliation of effective tax rate (% of income before income taxes)
Expected tax rate0.0 %0.0 %0.0 %
Foreign taxes at local expected rates:
U.S.(2.5 %)0.2 %4.8 %
Europe11.9 %1.9 %2.0 %
Valuation allowance(2.0 %)9.5 %(0.5 %)
Prior year adjustments
1.3 %(0.3)%0.2 %
Incremental branch taxes
0.9 %(0.4)%1.5 %
Change in enacted tax rate(1)
(3.3 %)(2.2 %)1.5 %
Other0.2 %0.3 %(0.3 %)
Actual tax rate6.5 %9.0 %9.2 %
(1)    At December 31, 2023, the change in enacted tax rate represents the enactment of the Bermuda Corporate Income Tax Act of 2023 related to unrealized investment losses included in other comprehensive income (loss). At December 31, 2022, the change in enacted tax rate included a change in the UK tax rate from 19% to 25% and in Belgium from 30% to 25%.
XML 76 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER COMPREHENSIVE INCOME (LOSS) (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss)
The following table presents the tax effects allocated to each component of other comprehensive income (loss):
Before tax amountIncome tax (expense) benefitNet of tax amount
Year ended December 31, 2023
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$294,933 $(36,993)$257,940 
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized11,220 (1,637)9,583 
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)
142,324 (13,811)128,513 
Unrealized gains (losses) arising during the year, net of reclassification adjustment448,477 (52,441)396,036 
Foreign currency translation adjustment(1,572) (1,572)
Total other comprehensive income (loss), net of tax$446,905 $(52,441)$394,464 
Year ended December 31, 2022
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$(1,171,381)$127,756 $(1,043,625)
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized(73,063)5,913 (67,150)
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)335,294 (30,369)304,925 
Unrealized gains (losses) arising during the year, net of reclassification adjustment(909,150)103,300 (805,850)
Foreign currency translation adjustment(10,986)— (10,986)
Total other comprehensive income (loss), net of tax$(920,136)$103,300 $(816,836)
Year ended December 31, 2021
Available for sale investments:
Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized$(310,710)$39,263 $(271,447)
Unrealized gains (losses) arising during the year for which an allowance
for expected credit losses has been recognized
81 — 81 
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)(94,749)7,635 (87,114)
Unrealized gains (losses) arising during the year, net of reclassification adjustment(405,378)46,898 (358,480)
Foreign currency translation adjustment621 — 621 
Total other comprehensive income (loss), net of tax$(404,757)$46,898 $(357,859)
Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders
The following table presents details of amounts reclassified from accumulated other comprehensive income (loss) ("AOCI") to net income (loss):
Amounts reclassified from AOCI(1)
AOCI componentsConsolidated statement of operations line item that includes reclassification adjustmentYear ended December 31,
202320222021
Unrealized gains (losses) on available for sale investments
Other realized gains (losses)
$(129,567)$(322,726)$94,771 
Impairment losses(12,757)(12,568)(22)
Total before tax(142,324)(335,294)94,749 
Income tax (expense) benefit13,811 30,369 (7,635)
Net of tax$(128,513)$(304,925)$87,114 
(1)    Amounts in parentheses are charges to net income (loss).
XML 77 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATUTORY FINANCIAL INFORMATION (Tables)
12 Months Ended
Dec. 31, 2023
STATUTORY FINANCIAL INFORMATION [Abstract]  
Summary of Statutory Capital and Surplus by Jurisdiction
The statutory capital and surplus in each of the Company's most significant regulatory jurisdictions is shown in the following table:
BermudaIrelandU.S.
At December 31,202320222023202220232022
Required statutory capital and surplus$1,269,943 $1,261,160 $755,076 $699,203 $739,829 $651,460 
Available statutory capital and surplus$3,170,556 $3,156,955 $1,160,932 $1,099,474 $2,187,371 $1,982,618 
XML 78 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
ORGANIZATION (Details)
12 Months Ended
Dec. 31, 2023
Oct. 02, 2017
Novae    
Business Acquisition [Line Items]    
Interests acquired   100.00%
Axis Corporate Capital UK Limited    
Business Acquisition [Line Items]    
Capital support, percentage 70.00%  
Axis Corporate Capital UK Limited II    
Business Acquisition [Line Items]    
Capital support, percentage 30.00%  
XML 79 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION - Summary of Underwriting Results of Reportable Segments (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
reportableSegment
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | reportableSegment 2      
Segment Information [Line Items]        
Gross premiums written $ 8,356,525 $ 8,214,595 $ 7,685,984  
Net premiums written 5,102,325 5,263,056 4,926,624  
Net premiums earned 5,083,781 5,160,326 4,709,850  
Other insurance related income (loss) 22,495 13,073 23,295  
Net losses and loss expenses (3,393,102) (3,242,410) (3,008,783)  
Acquisition costs (1,000,945) (1,022,017) (921,834)  
Underwriting-related general and administrative expenses (684,446) (680,343) (663,304)  
Net investment income 611,742 418,829 454,301  
Net investment gains (losses) (74,630) (456,789) 134,279  
Foreign exchange (losses) gains (58,115) 157,945 (315)  
Interest expense and financing costs (68,421) (63,146) (62,302)  
Reorganization expenses (28,997) (31,426) 0  
Amortization of value of business acquired 0 0 (3,854)  
Amortization of intangible assets (10,917) (10,917) (12,424)  
Income before income taxes and interest in income of equity method investments 398,445 243,125 648,909  
Income tax expense (26,316) (22,037) (62,384)  
Interest in income of equity method investments 4,163 1,995 32,084  
Net income 376,292 223,083 618,609  
Preferred share dividends 30,250 30,250 30,250  
Net income available to common shareholders 346,042 192,833 588,359  
Goodwill and intangible assets 287,684 298,601 309,518 $ 324,288
Operating Segments        
Segment Information [Line Items]        
Gross premiums written 8,356,525 8,214,595 7,685,984  
Net premiums written 5,102,325 5,263,056 4,926,624  
Net premiums earned 5,083,781 5,160,326 4,709,850  
Other insurance related income (loss) 22,495 13,073 23,295  
Net losses and loss expenses (3,393,102) (3,242,410) (3,008,783)  
Acquisition costs (1,000,945) (1,022,017) (921,834)  
Underwriting-related general and administrative expenses (551,467) (550,289) (536,834)  
Underwriting income (loss) $ 160,762 $ 358,683 $ 265,694  
Net losses and loss expenses ratio 66.70% 62.80% 63.90%  
Acquisition cost ratio 19.70% 19.80% 19.60%  
General and administrative expense ratio 13.50% 13.20% 14.00%  
Combined ratio 99.90% 95.80% 97.50%  
Goodwill and intangible assets $ 287,684 $ 298,601 $ 309,518  
Operating Segments | Insurance        
Segment Information [Line Items]        
Gross premiums written 6,140,764 5,585,581 4,863,232  
Net premiums written 3,758,720 3,377,906 2,894,885  
Net premiums earned 3,461,700 3,134,155 2,651,339  
Other insurance related income (loss) (198) 559 1,662  
Net losses and loss expenses (2,080,001) (1,785,854) (1,514,998)  
Acquisition costs (648,463) (577,838) (484,344)  
Underwriting-related general and administrative expenses (472,094) (443,704) (429,282)  
Underwriting income (loss) $ 260,944 $ 327,318 $ 224,377  
Net losses and loss expenses ratio 60.10% 57.00% 57.10%  
Acquisition cost ratio 18.70% 18.40% 18.30%  
General and administrative expense ratio 13.70% 14.20% 16.20%  
Combined ratio 92.50% 89.60% 91.60%  
Goodwill and intangible assets $ 287,684 $ 298,601 $ 309,518  
Operating Segments | Reinsurance        
Segment Information [Line Items]        
Gross premiums written 2,215,761 2,629,014 2,822,752  
Net premiums written 1,343,605 1,885,150 2,031,739  
Net premiums earned 1,622,081 2,026,171 2,058,511  
Other insurance related income (loss) 22,693 12,514 21,633  
Net losses and loss expenses (1,313,101) (1,456,556) (1,493,785)  
Acquisition costs (352,482) (444,179) (437,490)  
Underwriting-related general and administrative expenses (79,373) (106,585) (107,552)  
Underwriting income (loss) $ (100,182) $ 31,365 $ 41,317  
Net losses and loss expenses ratio 81.00% 71.90% 72.60%  
Acquisition cost ratio 21.70% 21.90% 21.30%  
General and administrative expense ratio 4.90% 5.30% 5.10%  
Combined ratio 107.60% 99.10% 99.00%  
Goodwill and intangible assets $ 0 $ 0 $ 0  
Significant Reconciling Items        
Segment Information [Line Items]        
Net investment income 611,742 418,829 454,301  
Net investment gains (losses) (74,630) (456,789) 134,279  
Foreign exchange (losses) gains (58,115) 157,945 (315)  
Interest expense and financing costs (68,421) (63,146) (62,302)  
Reorganization expenses (28,997) (31,426) 0  
Amortization of value of business acquired 0 0 (3,854)  
Amortization of intangible assets (10,917) (10,917) (12,424)  
Corporate        
Segment Information [Line Items]        
Underwriting-related general and administrative expenses $ (132,979) $ (130,054) $ (126,470)  
XML 80 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION - Summary of Gross Premiums Written by Geographical Location of Subsidiaries (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]      
Gross premiums written $ 8,356,525 $ 8,214,595 $ 7,685,984
U.S.      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Gross premiums written 4,484,789 4,342,707 4,002,748
Ireland      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Gross premiums written 1,837,177 1,931,815 1,667,496
Lloyd's of London      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Gross premiums written 1,759,990 1,567,458 1,473,047
Bermuda      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Gross premiums written $ 274,569 $ 372,615 $ 542,693
XML 81 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION - Summary of Net Premiums Earned by Segment and Line of Business (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Information [Line Items]      
Net premiums earned $ 5,083,781 $ 5,160,326 $ 4,709,850
Operating Segments      
Segment Information [Line Items]      
Net premiums earned 5,083,781 5,160,326 4,709,850
Operating Segments | Insurance      
Segment Information [Line Items]      
Net premiums earned 3,461,700 3,134,155 2,651,339
Operating Segments | Insurance | Professional lines      
Segment Information [Line Items]      
Net premiums earned 764,558 817,924 646,390
Operating Segments | Insurance | Property      
Segment Information [Line Items]      
Net premiums earned 878,849 755,986 711,297
Operating Segments | Insurance | Liability      
Segment Information [Line Items]      
Net premiums earned 496,381 459,775 354,787
Operating Segments | Insurance | Cyber      
Segment Information [Line Items]      
Net premiums earned 323,025 309,004 252,077
Operating Segments | Insurance | Marine and aviation      
Segment Information [Line Items]      
Net premiums earned 567,292 479,499 439,050
Operating Segments | Insurance | Accident and health      
Segment Information [Line Items]      
Net premiums earned 306,061 209,548 151,133
Operating Segments | Insurance | Credit and political risk      
Segment Information [Line Items]      
Net premiums earned 125,534 102,419 96,605
Operating Segments | Reinsurance      
Segment Information [Line Items]      
Net premiums earned 1,622,081 2,026,171 2,058,511
Operating Segments | Reinsurance | Run-off lines      
Segment Information [Line Items]      
Net premiums earned 91,996 322,339 498,105
Operating Segments | Reinsurance | Professional lines      
Segment Information [Line Items]      
Net premiums earned 205,404 250,911 220,448
Operating Segments | Reinsurance | Property | Run-off lines      
Segment Information [Line Items]      
Net premiums earned 44,508 135,480 231,092
Operating Segments | Reinsurance | Liability      
Segment Information [Line Items]      
Net premiums earned 403,239 484,681 431,596
Operating Segments | Reinsurance | Marine and aviation      
Segment Information [Line Items]      
Net premiums earned 65,658 78,504 58,775
Operating Segments | Reinsurance | Accident and health      
Segment Information [Line Items]      
Net premiums earned 341,806 368,747 361,196
Operating Segments | Reinsurance | Credit and surety      
Segment Information [Line Items]      
Net premiums earned 236,408 192,926 158,549
Operating Segments | Reinsurance | Motor      
Segment Information [Line Items]      
Net premiums earned 155,942 205,774 247,099
Operating Segments | Reinsurance | Agriculture      
Segment Information [Line Items]      
Net premiums earned 121,628 122,289 82,743
Operating Segments | Reinsurance | Catastrophe | Run-off lines      
Segment Information [Line Items]      
Net premiums earned 33,963 156,232 238,775
Operating Segments | Reinsurance | Engineering | Run-off lines      
Segment Information [Line Items]      
Net premiums earned $ 13,525 $ 30,627 $ 28,238
XML 82 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Summary of Goodwill and Intangible Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Goodwill        
Gross amount   $ 95,890 $ 95,890 $ 95,890
Accumulated translation adjustment   4,911 4,911 4,911
Goodwill $ 100,801 100,801 100,801 100,801
Impairment charges 0 0 0  
Intangible assets with an indefinite life        
Intangible assets with an indefinite life 120,784 120,784 120,784 120,784
Impairment charges 0 0 0  
Intangible assets with a finite life        
Gross amount   394,604 394,604 394,604
Accumulated amortization (328,505) (317,588) (306,671) (291,901)
Total finite-lived intangible assets 66,099 77,016 87,933 102,703
Amortization     (14,770)  
Amortization (10,917) (10,917) (12,424)  
Impairment charges 0 0 0  
Total        
Gross amount   611,278 611,278 611,278
Accumulated amortization (328,505) (317,588) (306,671) (291,901)
Accumulated translation adjustment   4,911 4,911 4,911
Goodwill and intangible assets net balance 287,684 298,601 309,518 $ 324,288
Amortization (10,917) (10,917) (12,424)  
Impairment charges $ 0 $ 0 $ 0  
XML 83 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]      
Impairment charges $ 0 $ 0 $ 0
Useful life of finite lived intangible assets 7 years    
XML 84 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Summary of Gross Amount and Accumulated Amortization by Category (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]        
Gross amount $ 515,388 $ 515,388    
Accumulated amortization (328,505) (317,588) $ (306,671) $ (291,901)
Total 186,883 197,800    
U.S. state licenses        
Finite-Lived Intangible Assets [Line Items]        
Gross amount 26,036 26,036    
Total 26,036 26,036    
Novae | VOBA - Novae        
Finite-Lived Intangible Assets [Line Items]        
Gross amount 256,942 256,942    
Accumulated amortization (256,942) (256,942)    
Total 0 0    
Novae | Coverholders        
Finite-Lived Intangible Assets [Line Items]        
Gross amount 63,565 63,565    
Accumulated amortization (33,110) (27,812)    
Total 30,455 35,753    
Novae | Large brokers        
Finite-Lived Intangible Assets [Line Items]        
Gross amount 46,641 46,641    
Accumulated amortization (19,435) (16,325)    
Total 27,206 30,316    
Novae | SME brokers        
Finite-Lived Intangible Assets [Line Items]        
Gross amount 14,126 14,126    
Accumulated amortization (7,357) (6,180)    
Total 6,769 7,946    
Novae | Syndicate capacity        
Finite-Lived Intangible Assets [Line Items]        
Gross amount 94,748 94,748    
Total 94,748 94,748    
Tiernan | Customer relationships and customers lists - Ternian        
Finite-Lived Intangible Assets [Line Items]        
Gross amount 13,330 13,330    
Accumulated amortization (11,661) (10,329)    
Total $ 1,669 $ 3,001    
XML 85 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS - Summary of Estimated Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]        
2024 $ 10,916      
2025 9,919      
2026 9,583      
2027 9,583      
2028 9,583      
After 2028 16,515      
Total finite-lived intangible assets 66,099 $ 77,016 $ 87,933 $ 102,703
Indefinite lived intangible assets 120,784 120,784 $ 120,784 $ 120,784
Total $ 186,883 $ 197,800    
XML 86 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Fixed Maturities Available For Sale (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Available for sale        
Amortized cost $ 12,634,254 $ 12,176,473    
Allowance for expected credit losses (10,759) (11,733) $ (313) $ (323)
Gross unrealized gains 91,762 18,742    
Gross unrealized losses (480,515) (856,588)    
Fair value 12,234,742 11,326,894    
U.S. government and agency        
Available for sale        
Amortized cost 3,049,445 2,731,733    
Allowance for expected credit losses 0 0    
Gross unrealized gains 13,211 5,386    
Gross unrealized losses (55,128) (97,789)    
Fair value 3,007,528 2,639,330    
Non-U.S. government        
Available for sale        
Amortized cost 729,761 612,546    
Allowance for expected credit losses (30) 0    
Gross unrealized gains 13,089 2,395    
Gross unrealized losses (18,861) (52,912)    
Fair value 723,959 562,029    
Corporate debt        
Available for sale        
Amortized cost 4,651,654 4,680,798    
Allowance for expected credit losses (10,438) (11,521)    
Gross unrealized gains 49,434 5,269    
Gross unrealized losses (216,478) (418,990)    
Fair value 4,474,172 4,255,556    
Agency RMBS        
Available for sale        
Amortized cost 1,706,204 1,297,423    
Allowance for expected credit losses 0 0    
Gross unrealized gains 11,495 4,663    
Gross unrealized losses (83,038) (99,301)    
Fair value 1,634,661 1,202,785    
CMBS        
Available for sale        
Amortized cost 897,553 1,029,863    
Allowance for expected credit losses 0 0    
Gross unrealized gains 551 60    
Gross unrealized losses (58,408) (82,145)    
Fair value 839,696 947,778    
Non-agency RMBS        
Available for sale        
Amortized cost 165,910 151,907    
Allowance for expected credit losses (194) (123)    
Gross unrealized gains 713 275    
Gross unrealized losses (13,033) (18,525)    
Fair value 153,396 133,534    
ABS        
Available for sale        
Amortized cost 1,265,187 1,499,728    
Allowance for expected credit losses (50) (35)    
Gross unrealized gains 2,855 555    
Gross unrealized losses (25,021) (70,721)    
Fair value 1,242,971 1,429,527    
Municipals        
Available for sale        
Amortized cost 168,540 172,475    
Allowance for expected credit losses (47) (54)    
Gross unrealized gains 414 139    
Gross unrealized losses (10,548) (16,205)    
Fair value $ 158,359 $ 156,355    
XML 87 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Contractual Maturities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Amortized cost    
Due in one year or less $ 474,557 $ 422,039
Due after one year through five years 5,902,571 5,349,123
Due after five years through ten years 2,064,619 2,192,344
Due after ten years 157,653 234,046
Total fixed maturities with a single maturity date (amortized cost) 8,599,400 8,197,552
Amortized cost 12,634,254 12,176,473
Fair value    
Due in one year or less 463,789 409,972
Due after one year through five years 5,790,493 5,078,273
Due after five years through ten years 1,954,449 1,919,450
Due after ten years 155,287 205,575
Total fixed maturities with a single maturity date (fair value) 8,364,018 7,613,270
Fair value $ 12,234,742 $ 11,326,894
% of Total fair value    
Due in one year or less 3.60% 3.70%
Due after one year through five years 47.30% 44.80%
Due after five years through ten years 16.00% 16.90%
Due after ten years 1.30% 1.80%
Fixed maturities with a single maturity date (% of total fair value) 68.20% 67.20%
Total 100.00% 100.00%
Agency RMBS    
Amortized cost    
Fixed maturities without a single maturity date $ 1,706,204 $ 1,297,423
Amortized cost 1,706,204 1,297,423
Fair value    
Fixed maturities without a single maturity date (fair value) 1,634,661 1,202,785
Fair value $ 1,634,661 $ 1,202,785
% of Total fair value    
Fixed maturities without a single maturity date (% of total fair value) 13.40% 10.60%
CMBS    
Amortized cost    
Fixed maturities without a single maturity date $ 897,553 $ 1,029,863
Amortized cost 897,553 1,029,863
Fair value    
Fixed maturities without a single maturity date (fair value) 839,696 947,778
Fair value $ 839,696 $ 947,778
% of Total fair value    
Fixed maturities without a single maturity date (% of total fair value) 6.90% 8.40%
Non-agency RMBS    
Amortized cost    
Fixed maturities without a single maturity date $ 165,910 $ 151,907
Amortized cost 165,910 151,907
Fair value    
Fixed maturities without a single maturity date (fair value) 153,396 133,534
Fair value $ 153,396 $ 133,534
% of Total fair value    
Fixed maturities without a single maturity date (% of total fair value) 1.30% 1.20%
ABS    
Amortized cost    
Fixed maturities without a single maturity date $ 1,265,187 $ 1,499,728
Amortized cost 1,265,187 1,499,728
Fair value    
Fixed maturities without a single maturity date (fair value) 1,242,971 1,429,527
Fair value $ 1,242,971 $ 1,429,527
% of Total fair value    
Fixed maturities without a single maturity date (% of total fair value) 10.20% 12.60%
XML 88 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Gross Unrealized Losses (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
security
Dec. 31, 2022
USD ($)
security
Fixed maturities    
Fair value    
12 months or greater $ 6,293,107 $ 3,615,234
Less than 12 months 1,617,343 6,269,478
Total 7,910,450 9,884,712
Unrealized losses    
12 months or greater (453,997) (497,762)
Less than 12 months (26,518) (358,826)
Total $ (480,515) $ (856,588)
Number of positions in an unrealized loss | security 3,535 4,525
Continuous unrealized loss position | security 3,212 1,842
Fixed maturities | Below Investment Grade or Not Rated    
Unrealized losses    
Total $ (13,000) $ (64,000)
U.S. government and agency    
Fair value    
12 months or greater 846,503 467,032
Less than 12 months 867,733 1,414,181
Total 1,714,236 1,881,213
Unrealized losses    
12 months or greater (42,465) (41,365)
Less than 12 months (12,663) (56,424)
Total (55,128) (97,789)
Non-U.S. government    
Fair value    
12 months or greater 233,038 207,637
Less than 12 months 115,112 298,048
Total 348,150 505,685
Unrealized losses    
12 months or greater (18,178) (33,027)
Less than 12 months (683) (19,885)
Total (18,861) (52,912)
Corporate debt    
Fair value    
12 months or greater 2,623,304 1,562,355
Less than 12 months 240,813 2,350,504
Total 2,864,117 3,912,859
Unrealized losses    
12 months or greater (210,512) (268,289)
Less than 12 months (5,966) (150,701)
Total (216,478) (418,990)
Agency RMBS    
Fair value    
12 months or greater 778,656 220,595
Less than 12 months 218,606 771,191
Total 997,262 991,786
Unrealized losses    
12 months or greater (80,070) (40,469)
Less than 12 months (2,968) (58,832)
Total (83,038) (99,301)
CMBS    
Fair value    
12 months or greater 703,411 343,494
Less than 12 months 75,242 599,877
Total 778,653 943,371
Unrealized losses    
12 months or greater (54,856) (40,888)
Less than 12 months (3,552) (41,257)
Total (58,408) (82,145)
Non-agency RMBS    
Fair value    
12 months or greater 98,483 75,137
Less than 12 months 10,017 53,484
Total 108,500 128,621
Unrealized losses    
12 months or greater (13,013) (14,691)
Less than 12 months (20) (3,834)
Total (13,033) (18,525)
ABS    
Fair value    
12 months or greater 879,743 685,990
Less than 12 months 83,582 686,190
Total 963,325 1,372,180
Unrealized losses    
12 months or greater (24,747) (48,913)
Less than 12 months (274) (21,808)
Total (25,021) (70,721)
Municipals    
Fair value    
12 months or greater 129,969 52,994
Less than 12 months 6,238 96,003
Total 136,207 148,997
Unrealized losses    
12 months or greater (10,156) (10,120)
Less than 12 months (392) (6,085)
Total $ (10,548) $ (16,205)
XML 89 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Fixed Maturities, Held to Maturity (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss [Abstract]    
Amortized cost $ 686,296 $ 698,351
Allowance for expected credit losses 0 0
Net carrying value 686,296 698,351
Gross unrealized gains 303 0
Gross unrealized losses (10,748) (23,608)
Fair value 675,851 674,743
Corporate debt    
Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss [Abstract]    
Amortized cost 95,200 85,200
Allowance for expected credit losses 0 0
Net carrying value 95,200 85,200
Gross unrealized gains 298 0
Gross unrealized losses (8,827) (11,428)
Fair value 86,671 73,772
ABS    
Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss [Abstract]    
Amortized cost 591,096 613,151
Allowance for expected credit losses 0 0
Net carrying value 591,096 613,151
Gross unrealized gains 5 0
Gross unrealized losses (1,921) (12,180)
Fair value $ 589,180 $ 600,971
XML 90 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Available For Sale Securities [Line Items]    
Fixed maturities, held to maturity, at amortized cost $ 686,296 $ 698,351
Allowance for expected credit losses 0 0
ABS    
Schedule Of Available For Sale Securities [Line Items]    
Fixed maturities, held to maturity, at amortized cost 591,096 613,151
Allowance for expected credit losses 0 0
Held to maturity securities with no single maturity date 591,000 613,000
Corporate debt    
Schedule Of Available For Sale Securities [Line Items]    
Fixed maturities, held to maturity, at amortized cost 95,200 85,200
Allowance for expected credit losses 0 0
Held to maturity securities debt maturities after three through ten years net carrying amount 95,000 81,000
Held to maturity securities due after ten years $ 0 $ 4,000
Corporate debt | Minimum    
Schedule Of Available For Sale Securities [Line Items]    
Debt securities, held-to-maturity, maturity period 3 years  
Corporate debt | Maximum    
Schedule Of Available For Sale Securities [Line Items]    
Debt securities, held-to-maturity, maturity period 10 years  
XML 91 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Equity Securities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Debt and Equity Securities, FV-NI [Line Items]    
Cost $ 543,833 $ 494,356
Gross unrealized gains 110,296 68,694
Gross unrealized losses (65,618) (77,797)
Fair value 588,511 485,253
Common stocks    
Debt and Equity Securities, FV-NI [Line Items]    
Cost 2,843 7,279
Gross unrealized gains 101 636
Gross unrealized losses (398) (442)
Fair value 2,546 7,473
Preferred stocks    
Debt and Equity Securities, FV-NI [Line Items]    
Cost 5,496 115
Gross unrealized gains 218 0
Gross unrealized losses (113) (43)
Fair value 5,601 72
Exchange-traded funds    
Debt and Equity Securities, FV-NI [Line Items]    
Cost 182,989 207,505
Gross unrealized gains 105,858 68,058
Gross unrealized losses (1,572) (5,757)
Fair value 287,275 269,806
Bond mutual funds    
Debt and Equity Securities, FV-NI [Line Items]    
Cost 352,505 279,457
Gross unrealized gains 4,119 0
Gross unrealized losses (63,535) (71,555)
Fair value $ 293,089 $ 207,902
XML 92 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Mortgage Loans (Details)
Dec. 31, 2023
USD ($)
loan
Dec. 31, 2022
USD ($)
Mortgage loans held for investment:    
Commercial $ 616,368,000 $ 627,437,000
Allowance for expected credit losses (6,220,000) 0
Total mortgage loans held for investment $ 610,148,000 $ 627,437,000
Commercial (as a percent) 101.00% 100.00%
Allowance for expected credit losses (as a percent) (1.00%) 0.00%
Total mortgage loans, held-for investment (as a percent) 100.00% 100.00%
Debt service coverage ratio, in excess of 1.9 2.3
Loan-to-value ratio, percent (less than) 71.00% 60.00%
Commercial mortgage loans, past due amount $ 0 $ 0
Number of collateral dependent loan | loan 2  
XML 93 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Other Investments (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
fund
Dec. 31, 2022
USD ($)
Other Investments [Line Items]    
Asset fair value $ 949,413 $ 996,751
Percentage of total fair value 100.00% 100.00%
Unfunded commitments related to other investments $ 502,000 $ 524,000
Multi-strategy funds    
Other Investments [Line Items]    
Asset fair value $ 24,619 $ 32,616
Percentage of total fair value 3.00% 3.00%
Multi-strategy funds | Lockup Redemption Restriction    
Other Investments [Line Items]    
Fair value of other investments subject to redemption restrictions $ 0 $ 0
Multi-strategy funds | Other Redemption Restriction    
Other Investments [Line Items]    
Redemption notice period 2 years  
Unfunded commitments related to other investments $ 28,000 $ 26,000
Multi-strategy funds | Minimum    
Other Investments [Line Items]    
Redemption notice period 60 days 60 days
Multi-strategy funds | Maximum    
Other Investments [Line Items]    
Redemption notice period 90 days 90 days
Direct lending funds    
Other Investments [Line Items]    
Asset fair value $ 192,270 $ 258,626
Percentage of total fair value 20.00% 26.00%
Redemption notice period 90 days 90 days
Direct lending funds | Quarterly Redemption    
Other Investments [Line Items]    
Asset fair value $ 17,000 $ 39,000
Number of funds | fund 1  
Direct lending funds | Other Redemption Restriction    
Other Investments [Line Items]    
Unfunded commitments related to other investments $ 192,000 183,000
Optional extension of investment term 3 years  
Direct lending funds | Minimum | Other Redemption Restriction    
Other Investments [Line Items]    
Investment term 4 years  
Direct lending funds | Maximum | Other Redemption Restriction    
Other Investments [Line Items]    
Investment term 10 years  
Private equity funds    
Other Investments [Line Items]    
Asset fair value $ 301,712 $ 265,836
Percentage of total fair value 32.00% 27.00%
Private equity funds | Other Redemption Restriction    
Other Investments [Line Items]    
Unfunded commitments related to other investments $ 145,000 $ 158,000
Investment term 6 years  
Real estate funds    
Other Investments [Line Items]    
Asset fair value $ 317,325 $ 298,499
Percentage of total fair value 33.00% 30.00%
Real estate funds | Quarterly Redemption    
Other Investments [Line Items]    
Asset fair value $ 66,000 $ 73,000
Number of funds | fund 1  
Real estate funds | Annually Redemption    
Other Investments [Line Items]    
Asset fair value $ 25,000 27,000
Number of funds | fund 1  
Real estate funds | Other Redemption Restriction    
Other Investments [Line Items]    
Unfunded commitments related to other investments $ 107,000 $ 141,000
Investment term 2 years  
Real estate funds | Minimum    
Other Investments [Line Items]    
Redemption notice period 45 days 45 days
Real estate funds | Maximum    
Other Investments [Line Items]    
Redemption notice period 90 days 90 days
CLO-Equities    
Other Investments [Line Items]    
Asset fair value $ 5,300 $ 5,016
Percentage of total fair value 1.00% 0.00%
Other privately held investments    
Other Investments [Line Items]    
Asset fair value $ 108,187 $ 136,158
Percentage of total fair value 11.00% 14.00%
Private company investment funds | Other Redemption Restriction    
Other Investments [Line Items]    
Unfunded commitments related to other investments $ 30,000 $ 16,000
Number of investment funds | fund 3  
Private company investment funds | Other Redemption Restriction | 5-year term    
Other Investments [Line Items]    
Investment term 5 years  
Number of investment funds | fund 2  
Private company investment funds | Other Redemption Restriction | 10-year term    
Other Investments [Line Items]    
Investment term 10 years  
Number of investment funds | fund 1  
XML 94 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Equity method investments (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2016
Schedule of Equity Method Investments [Line Items]        
Payments to acquire equity method investments $ 22,183 $ 0 $ 0  
Monarch Point Re        
Schedule of Equity Method Investments [Line Items]        
Payments to acquire equity method investments $ 22,000      
Equity method investment, ownership percentage 18.00%      
Harrington Reinsurance Holdings Limited        
Schedule of Equity Method Investments [Line Items]        
Payments to acquire equity method investments       $ 108,000
Equity method investment, ownership percentage       19.00%
Equity method investment, difference between carrying amount and underlying equity       $ 5,000
XML 95 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Variable Interest Entities (Details)
Dec. 31, 2023
Limited Partner  
Schedule Of Available For Sale Securities [Line Items]  
Percentage of investment composition (as a percent) 75.00%
XML 96 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Net Investment Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net Investment Income [Line Items]      
Gross investment income $ 641,838 $ 444,506 $ 479,252
Investment expenses (30,096) (25,677) (24,951)
Net investment income 611,742 418,829 454,301
Fixed maturities      
Net Investment Income [Line Items]      
Gross investment income 514,842 329,858 262,049
Other investments      
Net Investment Income [Line Items]      
Gross investment income 20,411 57,043 181,906
Equity securities      
Net Investment Income [Line Items]      
Gross investment income 12,088 10,390 12,752
Mortgage loans      
Net Investment Income [Line Items]      
Gross investment income 35,312 23,407 17,427
Cash and cash equivalents      
Net Investment Income [Line Items]      
Gross investment income 50,261 20,273 4,454
Short-term investments      
Net Investment Income [Line Items]      
Gross investment income $ 8,924 $ 3,535 $ 664
XML 97 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Net Investment Gains (Losses) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Gross realized investment gains      
Fixed maturities and short-term investments $ 32,920 $ 16,671 $ 137,729
Equity securities 16,847 7,687 5,413
Gross realized investment gains 49,767 24,358 143,142
Gross realized investment losses      
Fixed maturities and short-term investments (158,080) (328,493) (42,613)
Equity securities (639) (406) (696)
Gross realized investment losses (158,719) (328,899) (43,309)
(Increase) decrease in allowance for expected credit losses, fixed maturities, available for sale 974 (11,421) 11
(Increase) decrease in allowance for expected credit losses, mortgage loans (6,220) 0 0
Impairment losses (12,757) (12,568) (22)
Change in fair value of investment derivatives (1,456) 7,656 4,346
Net unrealized gains (losses) on equity securities 53,781 (135,915) 30,111
Total net investment gains (losses) $ (74,630) $ (456,789) $ 134,279
XML 98 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Summary of Allowance for Credit Loss (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]      
Balance at beginning of period $ 11,733 $ 313 $ 323
Expected credit losses on securities where credit losses were not previously recognized 5,200 17,830 95
Additions (reductions) for expected credit losses on securities where credit losses were previously recognized 4,934 (3,831) 50
Impairments of securities which the Company intends to sell or more likely than not will be required to sell 0 0 0
Securities sold/redeemed/matured (11,108) (2,579) (155)
Balance at end of period $ 10,759 $ 11,733 $ 313
XML 99 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Fixed Maturity Securities (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule Of Available For Sale Securities [Line Items]    
Fair value $ 12,234,742 $ 11,326,894
Non-U.S. government    
Schedule Of Available For Sale Securities [Line Items]    
Unrealized loss position (18,861) (52,912)
Foreign exchange losses 6,000 24,000
Fair value 723,959 562,029
CMBS    
Schedule Of Available For Sale Securities [Line Items]    
Unrealized loss position (58,408) (82,145)
Fair value $ 839,696 $ 947,778
CMBS | Weighted average    
Schedule Of Available For Sale Securities [Line Items]    
Subordination percentage input for determining credit losses 37.00% 38.00%
Non-agency RMBS    
Schedule Of Available For Sale Securities [Line Items]    
Unrealized loss position $ (13,033) $ (18,525)
Fair value 153,396 133,534
Non-agency RMBS | Prime    
Schedule Of Available For Sale Securities [Line Items]    
Fair value 34,000 39,000
Non-agency RMBS | Alt A    
Schedule Of Available For Sale Securities [Line Items]    
Fair value $ 100,000 $ 76,000
XML 100 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Restricted Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Restricted Investments [Line Items]    
Collateral in trust for inter-company agreements $ 614,089 $ 790,449
Collateral for secured letter of credit facility 423,522 424,624
Funds at Lloyd's 893,177 748,573
Collateral in trust for third-party agreements 2,597,633 2,491,317
Securities on deposit or in trust with regulatory authorities 772,472 731,660
Total restricted investments and cash 5,300,893 5,186,623
Syndicate 1686 | Fixed maturities    
Restricted Investments [Line Items]    
Collateral in trust for third-party agreements 550,000 539,000
Syndicate 1686 | Cash    
Restricted Investments [Line Items]    
Collateral in trust for third-party agreements $ 296,000 $ 217,000
Axis Corporate Capital UK Limited    
Restricted Investments [Line Items]    
Capital support, percentage 70.00%  
Axis Corporate Capital UK Limited II    
Restricted Investments [Line Items]    
Capital support, percentage 30.00%  
XML 101 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Reverse Repurchase Agreements (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]    
Value of reverse repurchase agreements $ 12 $ 0
Minimum required collateral for reverse repurchase agreements, expressed as a percentage of loan principal 102.00%  
XML 102 R78.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Fixed maturities, available for sale $ 12,234,742 $ 11,326,894
Equity securities 588,511 485,253
Other investments 949,413 996,751
Short-term investments 17,216 70,310
Derivative instruments 4,424 37,682
Total Assets 13,794,306 12,916,890
Liabilities    
Derivative instruments 10,165 703
Cash-settled awards 0 4,792
Total Liabilities 10,165 5,495
U.S. government and agency    
Assets    
Fixed maturities, available for sale 3,007,528 2,639,330
Non-U.S. government    
Assets    
Fixed maturities, available for sale 723,959 562,029
Corporate debt    
Assets    
Fixed maturities, available for sale 4,474,172 4,255,556
Agency RMBS    
Assets    
Fixed maturities, available for sale 1,634,661 1,202,785
CMBS    
Assets    
Fixed maturities, available for sale 839,696 947,778
Non-agency RMBS    
Assets    
Fixed maturities, available for sale 153,396 133,534
ABS    
Assets    
Fixed maturities, available for sale 1,242,971 1,429,527
Municipals    
Assets    
Fixed maturities, available for sale 158,359 156,355
Common stocks    
Assets    
Equity securities 2,546 7,473
Preferred stocks    
Assets    
Equity securities 5,601 72
Exchange-traded funds    
Assets    
Equity securities 287,275 269,806
Bond mutual funds    
Assets    
Equity securities 293,089 207,902
Multi-strategy funds    
Assets    
Other investments 24,619 32,616
Direct lending funds    
Assets    
Other investments 192,270 258,626
Private equity funds    
Assets    
Other investments 301,712 265,836
Real estate funds    
Assets    
Other investments 317,325 298,499
CLO-Equities    
Assets    
Other investments 5,300 5,016
Other privately held investments    
Assets    
Other investments 108,187 136,158
Quoted prices in active markets for identical assets (Level 1)    
Assets    
Fixed maturities, available for sale 2,989,612 2,600,636
Equity securities 289,822 277,351
Other investments 0 0
Short-term investments 0 0
Derivative instruments 0 0
Total Assets 3,279,434 2,877,987
Liabilities    
Derivative instruments 0 0
Cash-settled awards 0 0
Total Liabilities 0 0
Quoted prices in active markets for identical assets (Level 1) | U.S. government and agency    
Assets    
Fixed maturities, available for sale 2,989,612 2,600,636
Quoted prices in active markets for identical assets (Level 1) | Non-U.S. government    
Assets    
Fixed maturities, available for sale 0 0
Quoted prices in active markets for identical assets (Level 1) | Corporate debt    
Assets    
Fixed maturities, available for sale 0 0
Quoted prices in active markets for identical assets (Level 1) | Agency RMBS    
Assets    
Fixed maturities, available for sale 0 0
Quoted prices in active markets for identical assets (Level 1) | CMBS    
Assets    
Fixed maturities, available for sale 0 0
Quoted prices in active markets for identical assets (Level 1) | Non-agency RMBS    
Assets    
Fixed maturities, available for sale 0 0
Quoted prices in active markets for identical assets (Level 1) | ABS    
Assets    
Fixed maturities, available for sale 0 0
Quoted prices in active markets for identical assets (Level 1) | Municipals    
Assets    
Fixed maturities, available for sale 0 0
Quoted prices in active markets for identical assets (Level 1) | Common stocks    
Assets    
Equity securities 2,546 7,473
Quoted prices in active markets for identical assets (Level 1) | Preferred stocks    
Assets    
Equity securities 1 72
Quoted prices in active markets for identical assets (Level 1) | Exchange-traded funds    
Assets    
Equity securities 287,275 269,806
Quoted prices in active markets for identical assets (Level 1) | Bond mutual funds    
Assets    
Equity securities 0 0
Quoted prices in active markets for identical assets (Level 1) | Multi-strategy funds    
Assets    
Other investments 0 0
Quoted prices in active markets for identical assets (Level 1) | Direct lending funds    
Assets    
Other investments 0 0
Quoted prices in active markets for identical assets (Level 1) | Private equity funds    
Assets    
Other investments 0 0
Quoted prices in active markets for identical assets (Level 1) | Real estate funds    
Assets    
Other investments 0 0
Quoted prices in active markets for identical assets (Level 1) | CLO-Equities    
Assets    
Other investments 0 0
Quoted prices in active markets for identical assets (Level 1) | Other privately held investments    
Assets    
Other investments 0 0
Significant other observable inputs (Level 2)    
Assets    
Fixed maturities, available for sale 9,109,377 8,607,154
Equity securities 298,689 207,902
Other investments 0 0
Short-term investments 17,216 70,310
Derivative instruments 4,424 37,682
Total Assets 9,429,706 8,923,048
Liabilities    
Derivative instruments 10,165 703
Cash-settled awards 0 4,792
Total Liabilities 10,165 5,495
Significant other observable inputs (Level 2) | U.S. government and agency    
Assets    
Fixed maturities, available for sale 17,916 38,694
Significant other observable inputs (Level 2) | Non-U.S. government    
Assets    
Fixed maturities, available for sale 723,959 562,029
Significant other observable inputs (Level 2) | Corporate debt    
Assets    
Fixed maturities, available for sale 4,338,419 4,136,452
Significant other observable inputs (Level 2) | Agency RMBS    
Assets    
Fixed maturities, available for sale 1,634,661 1,202,785
Significant other observable inputs (Level 2) | CMBS    
Assets    
Fixed maturities, available for sale 839,696 947,778
Significant other observable inputs (Level 2) | Non-agency RMBS    
Assets    
Fixed maturities, available for sale 153,396 133,534
Significant other observable inputs (Level 2) | ABS    
Assets    
Fixed maturities, available for sale 1,242,971 1,429,527
Significant other observable inputs (Level 2) | Municipals    
Assets    
Fixed maturities, available for sale 158,359 156,355
Significant other observable inputs (Level 2) | Common stocks    
Assets    
Equity securities 0 0
Significant other observable inputs (Level 2) | Preferred stocks    
Assets    
Equity securities 5,600 0
Significant other observable inputs (Level 2) | Exchange-traded funds    
Assets    
Equity securities 0 0
Significant other observable inputs (Level 2) | Bond mutual funds    
Assets    
Equity securities 293,089 207,902
Significant other observable inputs (Level 2) | Multi-strategy funds    
Assets    
Other investments 0 0
Significant other observable inputs (Level 2) | Direct lending funds    
Assets    
Other investments 0 0
Significant other observable inputs (Level 2) | Private equity funds    
Assets    
Other investments 0 0
Significant other observable inputs (Level 2) | Real estate funds    
Assets    
Other investments 0 0
Significant other observable inputs (Level 2) | CLO-Equities    
Assets    
Other investments 0 0
Significant other observable inputs (Level 2) | Other privately held investments    
Assets    
Other investments 0 0
Significant unobservable inputs (Level 3)    
Assets    
Fixed maturities, available for sale 135,753 119,104
Equity securities 0 0
Other investments 92,589 141,174
Short-term investments 0 0
Derivative instruments 0 0
Total Assets 228,342 260,278
Liabilities    
Derivative instruments 0 0
Cash-settled awards 0 0
Total Liabilities 0 0
Significant unobservable inputs (Level 3) | U.S. government and agency    
Assets    
Fixed maturities, available for sale 0 0
Significant unobservable inputs (Level 3) | Non-U.S. government    
Assets    
Fixed maturities, available for sale 0 0
Significant unobservable inputs (Level 3) | Corporate debt    
Assets    
Fixed maturities, available for sale 135,753 119,104
Significant unobservable inputs (Level 3) | Agency RMBS    
Assets    
Fixed maturities, available for sale 0 0
Significant unobservable inputs (Level 3) | CMBS    
Assets    
Fixed maturities, available for sale 0 0
Significant unobservable inputs (Level 3) | Non-agency RMBS    
Assets    
Fixed maturities, available for sale 0 0
Significant unobservable inputs (Level 3) | ABS    
Assets    
Fixed maturities, available for sale 0 0
Significant unobservable inputs (Level 3) | Municipals    
Assets    
Fixed maturities, available for sale 0 0
Significant unobservable inputs (Level 3) | Common stocks    
Assets    
Equity securities 0 0
Significant unobservable inputs (Level 3) | Preferred stocks    
Assets    
Equity securities 0 0
Significant unobservable inputs (Level 3) | Exchange-traded funds    
Assets    
Equity securities 0 0
Significant unobservable inputs (Level 3) | Bond mutual funds    
Assets    
Equity securities 0 0
Significant unobservable inputs (Level 3) | Multi-strategy funds    
Assets    
Other investments 0 0
Significant unobservable inputs (Level 3) | Direct lending funds    
Assets    
Other investments 0 0
Significant unobservable inputs (Level 3) | Private equity funds    
Assets    
Other investments 0 0
Significant unobservable inputs (Level 3) | Real estate funds    
Assets    
Other investments 0 0
Significant unobservable inputs (Level 3) | CLO-Equities    
Assets    
Other investments 5,300 5,016
Significant unobservable inputs (Level 3) | Other privately held investments    
Assets    
Other investments 87,289 136,158
Fair value based on NAV practical expedient    
Assets    
Other investments 856,824 855,577
Total Assets 856,824 855,577
Fair value based on NAV practical expedient | Multi-strategy funds    
Assets    
Other investments 24,619 32,616
Fair value based on NAV practical expedient | Direct lending funds    
Assets    
Other investments 192,270 258,626
Fair value based on NAV practical expedient | Private equity funds    
Assets    
Other investments 301,712 265,836
Fair value based on NAV practical expedient | Real estate funds    
Assets    
Other investments 317,325 298,499
Fair value based on NAV practical expedient | CLO-Equities    
Assets    
Other investments 0 0
Fair value based on NAV practical expedient | Other privately held investments    
Assets    
Other investments $ 20,898 $ 0
XML 103 R79.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Summary of Level 3 Fair Value Measurement Inputs (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Fair Value Inputs Assets Quantitative Information [Line Items]    
Asset fair value $ 949,413 $ 996,751
Fixed maturities, available for sale 12,234,742 11,326,894
Significant unobservable inputs (Level 3)    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Asset fair value 92,589 141,174
Fixed maturities, available for sale 135,753 $ 119,104
Significant unobservable inputs (Level 3) | Discounted cash flow | CLO-Equities    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Asset fair value $ 5,300  
Estimated maturity date (years) 4 years  
Significant unobservable inputs (Level 3) | Discounted cash flow | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Asset fair value $ 18,940  
Significant unobservable inputs (Level 3) | Discounted cash flow | Minimum | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Estimated maturity date (years) 0 years  
Significant unobservable inputs (Level 3) | Discounted cash flow | Maximum | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Estimated maturity date (years) 2 years  
Significant unobservable inputs (Level 3) | Discounted cash flow | Weighted average | CLO-Equities    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Estimated maturity date (years) 4 years  
Significant unobservable inputs (Level 3) | Discounted cash flow | Weighted average | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Estimated maturity date (years) 1 year  
Significant unobservable inputs (Level 3) | Discounted cash flow | Discount rate | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.060  
Significant unobservable inputs (Level 3) | Discounted cash flow | Discount rate | Weighted average | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.060  
Significant unobservable inputs (Level 3) | Discounted cash flow | Default rate | CLO-Equities    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.045  
Significant unobservable inputs (Level 3) | Discounted cash flow | Default rate | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.005  
Significant unobservable inputs (Level 3) | Discounted cash flow | Default rate | Weighted average | CLO-Equities    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.045  
Significant unobservable inputs (Level 3) | Discounted cash flow | Default rate | Weighted average | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.005  
Significant unobservable inputs (Level 3) | Discounted cash flow | Loss severity rate | CLO-Equities    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.500  
Significant unobservable inputs (Level 3) | Discounted cash flow | Loss severity rate | Weighted average | CLO-Equities    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.500  
Significant unobservable inputs (Level 3) | Discounted cash flow | Collateral spread | CLO-Equities    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.030  
Significant unobservable inputs (Level 3) | Discounted cash flow | Collateral spread | Weighted average | CLO-Equities    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.030  
Significant unobservable inputs (Level 3) | Discounted cash flow | Loss absorption yield | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.010  
Significant unobservable inputs (Level 3) | Discounted cash flow | Loss absorption yield | Weighted average | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Discounted cash flow 0.010  
Significant unobservable inputs (Level 3) | Valuation, Market Approach | Other privately held investments    
Fair Value Inputs Assets Quantitative Information [Line Items]    
Asset fair value $ 68,000  
XML 104 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Summary of Changes in Level 3 for Financial Instruments Measured at Fair Value (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Opening balance $ 260,278 $ 153,325
Transfers into Level 3 0 0
Transfers out of Level 3 (25,510) 0
Included in net income (16,036) 16,153
Included in OCI 2,438 (9,014)
Purchases 59,250 110,121
Sales (35,302) 0
Settlements/ distributions (16,776) (10,307)
Closing balance $ 228,342 $ 260,278
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Net investment income, Net investment gains (losses) Net investment income, Net investment gains (losses)
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Net investment income, Net investment gains (losses) Net investment income, Net investment gains (losses)
Change in unrealized gain/(losses) $ (15,591) $ 16,257
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Opening balance 0 5,630
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Included in net income 0 (3,542)
Included in OCI 0 0
Purchases 0 0
Sales 0 0
Settlements/ distributions 0 (2,088)
Closing balance $ 0 $ 0
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Net investment income, Net investment gains (losses) Net investment income, Net investment gains (losses)
Change in unrealized gains/(losses) $ 0 $ 0
Fixed maturities    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Opening balance 119,104 42,894
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Included in net income (8,527) (104)
Included in OCI 2,438 (9,014)
Purchases 38,173 90,130
Sales (770) 0
Settlements/ distributions (14,665) (4,802)
Closing balance 135,753 119,104
Change in unrealized gain/(losses) 0 0
Other investments    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Opening balance 141,174 110,431
Transfers into Level 3 0 0
Transfers out of Level 3 (25,510) 0
Included in net income (7,509) 16,257
Included in OCI 0 0
Purchases 21,077 19,991
Sales (34,532) 0
Settlements/ distributions (2,111) (5,505)
Closing balance 92,589 141,174
Change in unrealized gain/(losses) (15,591) 16,257
Corporate debt | Fixed maturities    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Opening balance 119,104 42,894
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Included in net income (8,527) (104)
Included in OCI 2,438 (9,014)
Purchases 38,173 90,130
Sales (770) 0
Settlements/ distributions (14,665) (4,802)
Closing balance 135,753 119,104
Change in unrealized gain/(losses) 0 0
CLO-Equities | Other investments    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Opening balance 5,016 5,910
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Included in net income 2,395 2,611
Included in OCI 0 0
Purchases 0 0
Sales 0 0
Settlements/ distributions (2,111) (3,505)
Closing balance 5,300 5,016
Change in unrealized gain/(losses) 2,395 2,611
Other privately held investments | Other investments    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Opening balance 136,158 104,521
Transfers into Level 3 0 0
Transfers out of Level 3 (25,510) 0
Included in net income (9,904) 13,646
Included in OCI 0 0
Purchases 21,077 19,991
Sales (34,532) 0
Settlements/ distributions 0 (2,000)
Closing balance 87,289 136,158
Change in unrealized gain/(losses) (17,986) 13,646
Derivative instruments    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Opening balance 0 5,630
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Included in net income 0 (3,542)
Included in OCI 0 0
Purchases 0 0
Sales 0 0
Settlements/ distributions 0 (2,088)
Closing balance 0 0
Change in unrealized gains/(losses) $ 0 $ 0
XML 105 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Narrative (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
fund
Dec. 31, 2022
USD ($)
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Transfers into Level 3 $ 0 $ 0
Transfers into Level 3 0 0
Transfers out of level 3 0 0
Transfers out of level 3 $ 0 0
Number of investment funds transferred from level 3 to NAV practical expedient | fund 2  
Fixed maturities, held to maturity, at amortized cost $ 686,296 698,351
Fair value 675,851 674,743
Advances from FHLB 85,790 81,388
Borrowings from FHLB 86,000 81,000
Reported Value Measurement    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes 1,314,000 1,312,000
Estimate of Fair Value    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes $ 1,198,000 $ 1,160,000
XML 106 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Derivative Fair Values on Consolidated Balance Sheet [Line Items]    
Derivative asset fair value $ 4,424 $ 37,682
Derivative liability fair value $ 10,165 $ 703
Derivative asset, statement of financial position [Extensible Enumeration] Other assets Other assets
Derivative liability, statement of financial position [Extensible Enumeration] Other liabilities Other liabilities
Not Designated as Hedging Instruments    
Derivative Fair Values on Consolidated Balance Sheet [Line Items]    
Derivative asset fair value $ 4,424 $ 37,682
Derivative liability fair value 10,165 703
Not Designated as Hedging Instruments | Investment Portfolio | Foreign exchange forward contracts    
Derivative Fair Values on Consolidated Balance Sheet [Line Items]    
Derivative notional amount 49,307 54,076
Derivative asset fair value 66 81
Derivative liability fair value 274 559
Not Designated as Hedging Instruments | Underwriting Portfolio | Foreign exchange forward contracts    
Derivative Fair Values on Consolidated Balance Sheet [Line Items]    
Derivative notional amount 1,347,559 1,441,273
Derivative asset fair value 4,358 37,601
Derivative liability fair value $ 9,891 $ 144
XML 107 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS - Offsetting Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Derivative assets    
Gross amounts $ 8,708 $ 41,762
Gross amounts offset (4,284) (4,080)
Net amounts 4,424 37,682
Derivative liabilities    
Gross amounts 14,449 4,783
Gross amounts offset (4,284) (4,080)
Net amounts $ 10,165 $ 703
XML 108 R84.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS - Gains (Losses) on Derivatives Recognized in Net Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Unrealized and Realized Gains (Losses) Recognized in Earnings for Derivatives Not Designated As Hedges [Line Items]      
Unrealized and realized gains (loss) recognized in earnings for derivatives not designated as hedges $ (1,456) $ 7,656 $ 4,346
Not Designated as Hedging Instruments      
Unrealized and Realized Gains (Losses) Recognized in Earnings for Derivatives Not Designated As Hedges [Line Items]      
Unrealized and realized gains (loss) recognized in earnings for derivatives not designated as hedges 6,665 (20,411) (43,650)
Not Designated as Hedging Instruments | Investment Portfolio | Foreign exchange forward contracts | Net investment gains (losses)      
Unrealized and Realized Gains (Losses) Recognized in Earnings for Derivatives Not Designated As Hedges [Line Items]      
Unrealized and realized gains (loss) recognized in earnings for derivatives not designated as hedges (1,456) 7,656 4,346
Not Designated as Hedging Instruments | Underwriting Portfolio | Foreign exchange forward contracts | Foreign exchange (losses) gains      
Unrealized and Realized Gains (Losses) Recognized in Earnings for Derivatives Not Designated As Hedges [Line Items]      
Unrealized and realized gains (loss) recognized in earnings for derivatives not designated as hedges 8,121 (31,609) (50,738)
Not Designated as Hedging Instruments | Underwriting Portfolio | Other underwriting-related contracts | Other insurance related income (loss)      
Unrealized and Realized Gains (Losses) Recognized in Earnings for Derivatives Not Designated As Hedges [Line Items]      
Unrealized and realized gains (loss) recognized in earnings for derivatives not designated as hedges $ 0 $ 3,542 $ 2,742
XML 109 R85.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Narrative (Details) - Motor Reserve Class - Reinsurance
Aug. 05, 2019
Mar. 20, 2017
Minimum    
Claims Development [Line Items]    
Discount rate (percent) (0.75%) 2.50%
Maximum    
Claims Development [Line Items]    
Discount rate (percent) (0.25%) (0.75%)
XML 110 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve for Losses and Loss Expenses (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Insurance Loss Reserves [Abstract]        
Reserve for reported losses and loss expenses $ 5,559,261 $ 5,555,865    
Reserve for losses incurred but not reported 10,874,757 9,612,998    
Reserve for losses and loss expenses $ 16,434,018 $ 15,168,863 $ 14,653,094 $ 13,926,766
XML 111 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve Roll-forward (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Reconciliation of Beginning and Ending Gross Unpaid Losses and Loss Expenses      
Gross reserve for losses and loss expenses, beginning of year $ 15,168,863 $ 14,653,094 $ 13,926,766
Less reinsurance recoverable on unpaid losses and loss expenses, beginning of year (5,831,172) (5,017,611) (4,496,641)
Net reserve for unpaid losses and loss expenses, beginning of year 9,337,691 9,635,483 9,430,125
Net incurred losses and loss expenses related to:      
Current year 2,981,220 3,267,943 3,041,193
Prior years 411,882 (25,533) (32,410)
Net incurred losses and loss expenses 3,393,102 3,242,410 3,008,783
Net paid losses and loss expenses related to:      
Current year (488,016) (457,857) (490,011)
Prior years (2,185,588) (2,397,213) (2,274,240)
Net paid losses and loss expenses (2,673,604) (2,855,070) (2,764,251)
Foreign exchange and other 53,746 (685,132) (39,174)
Net reserve for unpaid losses and loss expenses, end of year 10,110,935 9,337,691 9,635,483
Reinsurance recoverable on unpaid losses and loss expenses, end of year 6,323,083 5,831,172 5,017,611
Gross reserve for losses and loss expenses, end of year $ 16,434,018 $ 15,168,863 $ 14,653,094
XML 112 R88.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Losses Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Additional Information Related to Net Incurred Losses [Line Items]      
Net losses and loss expenses, net of reinstatement premiums $ 2,981,220 $ 3,267,943 $ 3,041,193
Reinsurance recoverable on unpaid losses 53,746 (685,132) (39,174)
Third Party - Loss Portfolio Transfer      
Additional Information Related to Net Incurred Losses [Line Items]      
Reinsurance recoverable on unpaid losses 74,000 422,000  
Syndicate 2007      
Additional Information Related to Net Incurred Losses [Line Items]      
Reinsurance recoverable on unpaid losses     49,000
Catastrophe and Weather-related Events      
Additional Information Related to Net Incurred Losses [Line Items]      
Net losses and loss expenses, net of reinstatement premiums $ 138,000 $ 403,000 $ 443,000
XML 113 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Prior Year Reserve Development (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Liability for Claims and Claims Adjustment Expense [Line Items]      
Prior year favorable (adverse) adjustments $ (411,882) $ 25,533 $ 32,410
Insurance      
Liability for Claims and Claims Adjustment Expense [Line Items]      
Prior year favorable (adverse) adjustments (176,353) 16,350 18,360
Reinsurance      
Liability for Claims and Claims Adjustment Expense [Line Items]      
Prior year favorable (adverse) adjustments $ (235,529) $ 9,183 $ 14,049
XML 114 R90.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Summary of Prior Year Reserve Development by Segment and Reserving Class (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments $ (411,882) $ 25,533 $ 32,410
Insurance      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments (176,353) 16,350 18,360
Insurance | Property      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 16,195 52,512 71,032
Insurance | Accident and health      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments (10,236) (12,856) 15,844
Insurance | Marine and aviation      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 26,977 27,927 42,535
Insurance | Cyber      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 35,579 8,416 (7,329)
Insurance | Professional lines      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments (41,243) (29,093) (71,258)
Insurance | Credit and political risk      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 31,691 24,361 10,363
Insurance | Liability      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments (235,316) (54,917) (42,827)
Reinsurance      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments (235,529) 9,183 14,049
Reinsurance | Accident and health      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 29,947 14,199 5,861
Reinsurance | Marine and aviation      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 12,595 2,597 (10,767)
Reinsurance | Professional lines      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments (92,181) (54,820) (23,718)
Reinsurance | Liability      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments (262,114) (58,148) (17,919)
Reinsurance | Motor      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments (9,653) 18,161 43,968
Reinsurance | Credit and surety      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 8,306 43,567 3,436
Reinsurance | Agriculture      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 10,781 11,703 423
Reinsurance | Run-off lines      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 66,790 31,924 12,765
Reinsurance | Run-off lines | Property      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 15,225 42,523 17,651
Reinsurance | Run-off lines | Catastrophe      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments 46,297 (504) (36)
Reinsurance | Run-off lines | Engineering      
Liability for Future Policy Benefit, by Product Segment [Line Items]      
Prior year favorable (adverse) adjustments $ 5,268 $ (10,095) $ (4,850)
XML 115 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
claim
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Insurance | Property                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 4,108,843                  
Insurance | Property | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 253,414 $ 253,203 $ 253,279 $ 255,887 $ 259,792 $ 262,173 $ 262,701 $ 277,183 $ 287,431 $ 289,270
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 775                  
Cumulative number of reported claims | claim 4,174                  
Insurance | Property | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 181,928 181,323 179,075 189,066 186,952 190,310 192,736 200,398 207,711  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 85                  
Cumulative number of reported claims | claim 4,194                  
Insurance | Property | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 264,976 259,786 260,370 259,319 265,152 279,532 287,858 263,762    
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 1,951                  
Cumulative number of reported claims | claim 6,668                  
Insurance | Property | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 669,951 675,409 675,085 679,243 688,755 700,638 794,042      
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 6,375                  
Cumulative number of reported claims | claim 10,096                  
Insurance | Property | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 600,596 609,977 611,057 618,888 639,465 608,422        
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 12,492                  
Cumulative number of reported claims | claim 9,659                  
Insurance | Property | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 353,671 369,962 359,092 364,350 374,678          
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 4,503                  
Cumulative number of reported claims | claim 9,561                  
Insurance | Property | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 593,780 584,921 635,344 654,495            
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 24,336                  
Cumulative number of reported claims | claim 12,417                  
Insurance | Property | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 372,223 375,607 378,554              
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 9,213                  
Cumulative number of reported claims | claim 7,730                  
Insurance | Property | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 419,139 414,743                
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 49,138                  
Cumulative number of reported claims | claim 7,410                  
Insurance | Property | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 399,165                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 188,657                  
Cumulative number of reported claims | claim 5,732                  
Insurance | Accident and health                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 931,062                  
Insurance | Accident and health | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 64,392 62,703 64,070 64,938 65,710 64,973 65,347 66,874 67,380 71,520
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 1,621                  
Cumulative number of reported claims | claim 58,081                  
Insurance | Accident and health | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 61,759 64,433 63,772 64,441 64,771 64,219 66,013 69,494 70,622  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 1,049                  
Cumulative number of reported claims | claim 44,138                  
Insurance | Accident and health | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 87,399 87,972 88,180 87,154 87,470 86,338 85,892 85,244    
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 2,179                  
Cumulative number of reported claims | claim 87,001                  
Insurance | Accident and health | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 118,125 117,012 117,131 117,050 118,949 121,146 113,921      
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 36                  
Cumulative number of reported claims | claim 688,000                  
Insurance | Accident and health | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 114,844 114,134 113,118 115,077 115,977 111,119        
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 291                  
Cumulative number of reported claims | claim 745,012                  
Insurance | Accident and health | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 68,344 69,203 65,623 75,093 73,926          
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 121                  
Cumulative number of reported claims | claim 675,634                  
Insurance | Accident and health | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 64,297 67,525 63,963 69,679            
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 1,275                  
Cumulative number of reported claims | claim 718,512                  
Insurance | Accident and health | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 78,478 72,044 69,543              
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 3,605                  
Cumulative number of reported claims | claim 433,643                  
Insurance | Accident and health | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 100,629 98,796                
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 9,807                  
Cumulative number of reported claims | claim 380,675                  
Insurance | Accident and health | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 172,795                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 67,393                  
Cumulative number of reported claims | claim 222,537                  
Insurance | Marine and aviation                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 1,894,826                  
Insurance | Marine and aviation | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 52,308 52,286 53,013 55,526 63,693 65,913 64,768 71,051 66,878 80,064
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 830                  
Cumulative number of reported claims | claim 3,566                  
Insurance | Marine and aviation | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 143,900 145,394 145,447 146,174 140,673 153,737 161,465 165,908 187,067  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 111                  
Cumulative number of reported claims | claim 4,312                  
Insurance | Marine and aviation | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 102,345 101,388 100,488 101,351 101,928 109,478 111,878 115,520    
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 2,038                  
Cumulative number of reported claims | claim 4,836                  
Insurance | Marine and aviation | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 215,683 217,232 217,443 225,397 227,355 229,801 262,628      
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 6,867                  
Cumulative number of reported claims | claim 8,577                  
Insurance | Marine and aviation | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 229,903 228,369 234,901 241,715 255,652 238,117        
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 14,910                  
Cumulative number of reported claims | claim 8,742                  
Insurance | Marine and aviation | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 224,914 226,586 213,480 210,536 215,911          
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 14,884                  
Cumulative number of reported claims | claim 7,697                  
Insurance | Marine and aviation | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 164,808 163,700 180,156 208,542            
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 14,618                  
Cumulative number of reported claims | claim 6,439                  
Insurance | Marine and aviation | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 204,483 221,864 240,182              
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 34,829                  
Cumulative number of reported claims | claim 6,754                  
Insurance | Marine and aviation | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 257,637 265,181                
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 92,387                  
Cumulative number of reported claims | claim 7,159                  
Insurance | Marine and aviation | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 298,845                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 210,136                  
Cumulative number of reported claims | claim 5,172                  
Insurance | Cyber                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 740,868                  
Insurance | Cyber | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 40,743 39,832 43,576 39,516 42,887 47,342 57,876 69,955 69,690 70,557
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 604                  
Cumulative number of reported claims | claim 1,159                  
Insurance | Cyber | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 48,042 49,795 52,526 50,758 50,357 51,250 63,066 63,595 65,231  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 2,046                  
Cumulative number of reported claims | claim 1,427                  
Insurance | Cyber | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 25,258 27,873 29,929 37,322 40,266 58,261 56,565 58,741    
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 1,072                  
Cumulative number of reported claims | claim 1,667                  
Insurance | Cyber | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 48,333 48,685 50,905 51,931 56,783 50,794 53,187      
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 3,234                  
Cumulative number of reported claims | claim 1,817                  
Insurance | Cyber | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 24,495 26,732 31,111 33,962 31,966 33,429        
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 4,574                  
Cumulative number of reported claims | claim 2,152                  
Insurance | Cyber | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 73,152 82,006 81,982 58,717 54,444          
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 14,109                  
Cumulative number of reported claims | claim 2,900                  
Insurance | Cyber | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 126,457 103,175 106,333 114,209            
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 25,132                  
Cumulative number of reported claims | claim 2,856                  
Insurance | Cyber | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 105,642 134,382 125,460              
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 20,662                  
Cumulative number of reported claims | claim 2,432                  
Insurance | Cyber | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 120,494 129,361                
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 71,510                  
Cumulative number of reported claims | claim 1,730                  
Insurance | Cyber | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 128,252                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 102,582                  
Cumulative number of reported claims | claim 1,503                  
Insurance | Professional lines                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 3,778,367                  
Insurance | Professional lines | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 305,060 301,289 304,657 305,201 308,193 321,027 331,044 348,064 338,670 338,378
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 35,601                  
Cumulative number of reported claims | claim 8,881                  
Insurance | Professional lines | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 282,238 283,894 272,909 274,091 291,176 304,062 317,455 310,926 309,864  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 20,475                  
Cumulative number of reported claims | claim 9,341                  
Insurance | Professional lines | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 356,814 340,465 339,513 329,270 316,592 297,852 293,399 288,595    
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 32,954                  
Cumulative number of reported claims | claim 10,590                  
Insurance | Professional lines | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 396,732 392,002 394,154 376,993 376,569 343,055 339,231      
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 53,138                  
Cumulative number of reported claims | claim 12,605                  
Insurance | Professional lines | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 468,504 449,212 423,162 392,819 342,931 325,926        
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 76,008                  
Cumulative number of reported claims | claim 15,333                  
Insurance | Professional lines | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 460,120 412,150 378,899 363,998 347,810          
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 83,773                  
Cumulative number of reported claims | claim 14,606                  
Insurance | Professional lines | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 293,935 302,097 321,530 322,386            
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 130,739                  
Cumulative number of reported claims | claim 9,318                  
Insurance | Professional lines | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 326,128 369,587 378,660              
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 198,067                  
Cumulative number of reported claims | claim 8,127                  
Insurance | Professional lines | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 447,359 461,196                
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 371,912                  
Cumulative number of reported claims | claim 8,041                  
Insurance | Professional lines | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 441,477                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 414,023                  
Cumulative number of reported claims | claim 7,251                  
Insurance | Credit and political risk                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 403,080                  
Insurance | Credit and political risk | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 69,677 69,677 69,113 70,748 71,274 69,589 68,323 67,109 70,712 38,825
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 0                  
Cumulative number of reported claims | claim 6                  
Insurance | Credit and political risk | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 23,309 23,309 24,189 24,851 25,930 26,012 27,524 30,368 30,329  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 0                  
Cumulative number of reported claims | claim 2                  
Insurance | Credit and political risk | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 24,885 24,885 25,965 26,946 43,160 42,589 45,079 45,006    
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 0                  
Cumulative number of reported claims | claim 2                  
Insurance | Credit and political risk | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 8,566 11,068 16,022 18,269 26,044 32,808 48,181      
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 2,086                  
Cumulative number of reported claims | claim 4                  
Insurance | Credit and political risk | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 24,356 21,182 24,845 32,738 33,747 42,976        
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 5,584                  
Cumulative number of reported claims | claim 2                  
Insurance | Credit and political risk | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 71,270 74,066 75,610 81,470 53,332          
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 11,546                  
Cumulative number of reported claims | claim 31                  
Insurance | Credit and political risk | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 50,987 62,235 70,428 61,928            
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 19,594                  
Cumulative number of reported claims | claim 43                  
Insurance | Credit and political risk | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 26,322 37,104 42,417              
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 13,363                  
Cumulative number of reported claims | claim 23                  
Insurance | Credit and political risk | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 44,450 45,444                
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 37,463                  
Cumulative number of reported claims | claim 24                  
Insurance | Credit and political risk | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 59,258                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 54,333                  
Cumulative number of reported claims | claim 19                  
Insurance | Liability                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 2,522,710                  
Insurance | Liability | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 131,210 132,474 132,043 132,565 131,469 132,013 130,666 129,750 124,289 107,126
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 9,697                  
Cumulative number of reported claims | claim 5,820                  
Insurance | Liability | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 189,795 188,261 186,931 188,004 182,690 164,982 137,477 127,299 128,436  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 18,423                  
Cumulative number of reported claims | claim 6,769                  
Insurance | Liability | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 124,969 125,614 120,187 120,199 127,451 128,854 130,160 124,313    
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 17,081                  
Cumulative number of reported claims | claim 7,648                  
Insurance | Liability | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 250,887 214,707 204,533 200,391 184,781 166,052 167,334      
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 37,518                  
Cumulative number of reported claims | claim 8,812                  
Insurance | Liability | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 251,875 216,038 204,519 190,639 167,672 167,552        
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 38,901                  
Cumulative number of reported claims | claim 8,644                  
Insurance | Liability | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 300,584 238,035 222,885 193,435 192,468          
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 66,863                  
Cumulative number of reported claims | claim 8,183                  
Insurance | Liability | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 249,189 230,921 225,038 224,616            
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 88,543                  
Cumulative number of reported claims | claim 6,180                  
Insurance | Liability | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 302,023 245,585 232,051              
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 141,022                  
Cumulative number of reported claims | claim 6,748                  
Insurance | Liability | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 357,574 323,261                
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 246,679                  
Cumulative number of reported claims | claim 7,365                  
Insurance | Liability | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 364,604                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 331,464                  
Cumulative number of reported claims | claim 5,168                  
Reinsurance | Accident and health                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses $ 1,881,315                  
Reinsurance | Accident and health | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 87,664 87,978 88,095 87,806 86,846 86,843 86,833 89,303 102,403 101,409
Total of incurred-but-not-reported liabilities plus expected development on reported claims 125                  
Reinsurance | Accident and health | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 93,133 92,388 92,431 93,422 93,081 93,807 94,047 100,522 93,831  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 105                  
Reinsurance | Accident and health | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 190,662 190,534 190,574 189,538 190,067 188,454 191,299 170,687    
Total of incurred-but-not-reported liabilities plus expected development on reported claims 16                  
Reinsurance | Accident and health | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 182,479 183,484 183,513 182,477 183,574 189,610 183,937      
Total of incurred-but-not-reported liabilities plus expected development on reported claims (16)                  
Reinsurance | Accident and health | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 197,493 200,467 201,133 198,365 200,576 193,749        
Total of incurred-but-not-reported liabilities plus expected development on reported claims 766                  
Reinsurance | Accident and health | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 199,419 205,403 207,794 212,307 217,477          
Total of incurred-but-not-reported liabilities plus expected development on reported claims 1,328                  
Reinsurance | Accident and health | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 199,958 213,960 220,969 226,883            
Total of incurred-but-not-reported liabilities plus expected development on reported claims 1,757                  
Reinsurance | Accident and health | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 222,718 227,326 232,091              
Total of incurred-but-not-reported liabilities plus expected development on reported claims 9,765                  
Reinsurance | Accident and health | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 264,615 267,525                
Total of incurred-but-not-reported liabilities plus expected development on reported claims 40,396                  
Reinsurance | Accident and health | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 243,174                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 91,280                  
Reinsurance | Marine and aviation                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 405,166                  
Reinsurance | Marine and aviation | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 9,841 9,530 9,025 8,786 8,535 9,192 7,209 8,019 9,162 10,192
Total of incurred-but-not-reported liabilities plus expected development on reported claims 368                  
Reinsurance | Marine and aviation | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 12,054 11,998 12,046 12,281 12,652 15,019 10,836 9,242 10,366  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 527                  
Reinsurance | Marine and aviation | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 36,263 36,773 36,371 36,052 37,519 36,130 35,965 32,453    
Total of incurred-but-not-reported liabilities plus expected development on reported claims 52                  
Reinsurance | Marine and aviation | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 40,827 40,900 43,243 46,612 41,363 42,961 55,299      
Total of incurred-but-not-reported liabilities plus expected development on reported claims 43                  
Reinsurance | Marine and aviation | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 48,477 47,066 43,540 27,006 27,454 18,906        
Total of incurred-but-not-reported liabilities plus expected development on reported claims 35                  
Reinsurance | Marine and aviation | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 84,756 81,628 79,801 82,194 69,806          
Total of incurred-but-not-reported liabilities plus expected development on reported claims 5,560                  
Reinsurance | Marine and aviation | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 37,098 37,892 41,766 40,298            
Total of incurred-but-not-reported liabilities plus expected development on reported claims 308                  
Reinsurance | Marine and aviation | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 35,672 40,830 43,763              
Total of incurred-but-not-reported liabilities plus expected development on reported claims 2,976                  
Reinsurance | Marine and aviation | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 59,227 68,907                
Total of incurred-but-not-reported liabilities plus expected development on reported claims 32,375                  
Reinsurance | Marine and aviation | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 40,951                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 34,539                  
Reinsurance | Professional lines                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 1,929,998                  
Reinsurance | Professional lines | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 246,043 234,311 226,234 228,193 229,556 233,169 218,847 219,052 219,123 219,162
Total of incurred-but-not-reported liabilities plus expected development on reported claims 13,578                  
Reinsurance | Professional lines | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 252,022 241,113 235,131 228,410 231,352 224,649 213,993 211,774 211,820  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 16,515                  
Reinsurance | Professional lines | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 278,699 266,979 255,012 255,088 227,468 199,715 196,073 195,019    
Total of incurred-but-not-reported liabilities plus expected development on reported claims 26,195                  
Reinsurance | Professional lines | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 239,324 210,303 187,761 177,819 161,694 155,470 154,889      
Total of incurred-but-not-reported liabilities plus expected development on reported claims 38,070                  
Reinsurance | Professional lines | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 195,575 173,954 165,981 155,390 148,458 145,994        
Total of incurred-but-not-reported liabilities plus expected development on reported claims 24,160                  
Reinsurance | Professional lines | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 157,572 146,088 141,610 137,723 138,048          
Total of incurred-but-not-reported liabilities plus expected development on reported claims 36,200                  
Reinsurance | Professional lines | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 134,478 136,107 141,559 140,886            
Total of incurred-but-not-reported liabilities plus expected development on reported claims 69,314                  
Reinsurance | Professional lines | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 136,381 140,737 148,950              
Total of incurred-but-not-reported liabilities plus expected development on reported claims 93,845                  
Reinsurance | Professional lines | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 153,853 169,576                
Total of incurred-but-not-reported liabilities plus expected development on reported claims 125,013                  
Reinsurance | Professional lines | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 136,051                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 124,516                  
Reinsurance | Liability                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 3,025,283                  
Reinsurance | Liability | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 193,578 189,047 183,101 187,245 196,747 198,893 200,138 204,240 202,526 199,575
Total of incurred-but-not-reported liabilities plus expected development on reported claims 14,361                  
Reinsurance | Liability | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 217,019 206,204 203,268 213,485 213,256 215,461 215,633 214,689 214,346  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 22,070                  
Reinsurance | Liability | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 315,793 274,615 267,241 263,195 253,525 250,247 245,286 239,971    
Total of incurred-but-not-reported liabilities plus expected development on reported claims 46,678                  
Reinsurance | Liability | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 343,290 306,648 297,380 287,818 279,262 270,080 275,306      
Total of incurred-but-not-reported liabilities plus expected development on reported claims 62,419                  
Reinsurance | Liability | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 352,697 307,032 286,876 274,110 268,812 264,003        
Total of incurred-but-not-reported liabilities plus expected development on reported claims 72,183                  
Reinsurance | Liability | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 331,729 272,905 274,393 272,513 263,522          
Total of incurred-but-not-reported liabilities plus expected development on reported claims 103,836                  
Reinsurance | Liability | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 306,011 278,743 284,216 283,606            
Total of incurred-but-not-reported liabilities plus expected development on reported claims 148,977                  
Reinsurance | Liability | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 346,161 311,735 304,160              
Total of incurred-but-not-reported liabilities plus expected development on reported claims 185,421                  
Reinsurance | Liability | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 343,773 347,387                
Total of incurred-but-not-reported liabilities plus expected development on reported claims 232,850                  
Reinsurance | Liability | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 275,232                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 241,263                  
Reinsurance | Agriculture                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 1,146,317                  
Reinsurance | Agriculture | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 162,927 162,762 162,068 162,245 162,327 162,314 162,388 162,820 164,351 183,260
Total of incurred-but-not-reported liabilities plus expected development on reported claims 482                  
Reinsurance | Agriculture | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 96,251 95,634 95,503 95,516 95,339 95,332 95,346 95,608 103,199  
Total of incurred-but-not-reported liabilities plus expected development on reported claims (27)                  
Reinsurance | Agriculture | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 109,763 109,012 109,068 109,863 109,633 111,045 117,960 124,229    
Total of incurred-but-not-reported liabilities plus expected development on reported claims (72)                  
Reinsurance | Agriculture | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 136,658 137,516 138,984 139,510 138,439 144,401 151,768      
Total of incurred-but-not-reported liabilities plus expected development on reported claims (60)                  
Reinsurance | Agriculture | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 142,760 139,989 140,618 140,883 147,359 141,040        
Total of incurred-but-not-reported liabilities plus expected development on reported claims 646                  
Reinsurance | Agriculture | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 183,092 183,384 187,770 185,345 185,560          
Total of incurred-but-not-reported liabilities plus expected development on reported claims 93                  
Reinsurance | Agriculture | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 61,986 63,874 62,837 62,678            
Total of incurred-but-not-reported liabilities plus expected development on reported claims 1,130                  
Reinsurance | Agriculture | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 57,857 61,437 69,823              
Total of incurred-but-not-reported liabilities plus expected development on reported claims 6,144                  
Reinsurance | Agriculture | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 91,534 101,082                
Total of incurred-but-not-reported liabilities plus expected development on reported claims 16,972                  
Reinsurance | Agriculture | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 103,489                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 81,193                  
Reinsurance | Credit and surety                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 893,476                  
Reinsurance | Credit and surety | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 111,511 120,790 120,482 121,780 125,477 126,744 137,973 141,621 134,527 134,434
Total of incurred-but-not-reported liabilities plus expected development on reported claims 1,914                  
Reinsurance | Credit and surety | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 129,333 132,989 138,726 137,528 136,568 155,217 159,148 164,350 159,274  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 1,447                  
Reinsurance | Credit and surety | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 112,465 110,316 112,631 114,957 122,495 147,955 140,188 140,892    
Total of incurred-but-not-reported liabilities plus expected development on reported claims 35                  
Reinsurance | Credit and surety | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 114,612 114,131 114,412 117,044 125,763 131,630 137,832      
Total of incurred-but-not-reported liabilities plus expected development on reported claims 2,647                  
Reinsurance | Credit and surety | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 94,229 105,503 110,531 113,535 119,227 111,022        
Total of incurred-but-not-reported liabilities plus expected development on reported claims 4,053                  
Reinsurance | Credit and surety | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 57,322 65,573 67,759 67,825 74,101          
Total of incurred-but-not-reported liabilities plus expected development on reported claims 6,315                  
Reinsurance | Credit and surety | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 94,943 68,987 83,559 76,917            
Total of incurred-but-not-reported liabilities plus expected development on reported claims 8,385                  
Reinsurance | Credit and surety | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 41,463 43,967 52,005              
Total of incurred-but-not-reported liabilities plus expected development on reported claims 13,732                  
Reinsurance | Credit and surety | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 51,231 63,653                
Total of incurred-but-not-reported liabilities plus expected development on reported claims 33,129                  
Reinsurance | Credit and surety | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 86,367                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 64,350                  
Reinsurance | Motor                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 2,347,869                  
Reinsurance | Motor | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 161,844 162,730 161,835 162,212 165,481 168,796 173,139 175,983 180,792 181,056
Total of incurred-but-not-reported liabilities plus expected development on reported claims 2,346                  
Reinsurance | Motor | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 204,673 206,090 205,780 208,620 209,908 220,820 219,055 215,201 221,182  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 8,979                  
Reinsurance | Motor | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 245,098 244,553 240,717 243,353 251,675 261,592 259,912 244,395    
Total of incurred-but-not-reported liabilities plus expected development on reported claims 4,366                  
Reinsurance | Motor | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 361,134 354,392 359,026 358,286 357,741 368,517 361,782      
Total of incurred-but-not-reported liabilities plus expected development on reported claims 22,422                  
Reinsurance | Motor | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 361,117 348,323 360,907 364,664 353,384 355,561        
Total of incurred-but-not-reported liabilities plus expected development on reported claims 17,400                  
Reinsurance | Motor | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 332,952 328,522 337,404 336,957 338,031          
Total of incurred-but-not-reported liabilities plus expected development on reported claims 12,894                  
Reinsurance | Motor | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 197,439 215,572 218,224 215,257            
Total of incurred-but-not-reported liabilities plus expected development on reported claims 10,872                  
Reinsurance | Motor | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 184,244 182,010 180,372              
Total of incurred-but-not-reported liabilities plus expected development on reported claims 25,813                  
Reinsurance | Motor | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 173,870 160,697                
Total of incurred-but-not-reported liabilities plus expected development on reported claims 35,986                  
Reinsurance | Motor | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 125,498                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 60,323                  
Reinsurance | Run-off lines                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 3,729,943                  
Reinsurance | Run-off lines | Accident Year 2014                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 219,012 218,896 219,748 219,953 223,970 224,135 227,865 236,768 246,616 $ 242,347
Total of incurred-but-not-reported liabilities plus expected development on reported claims 201                  
Reinsurance | Run-off lines | Accident Year 2015                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 244,790 247,183 249,050 251,245 246,266 247,377 256,665 256,648 $ 267,709  
Total of incurred-but-not-reported liabilities plus expected development on reported claims 475                  
Reinsurance | Run-off lines | Accident Year 2016                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 274,291 281,137 281,204 280,836 277,349 282,705 285,973 $ 286,264    
Total of incurred-but-not-reported liabilities plus expected development on reported claims 2,838                  
Reinsurance | Run-off lines | Accident Year 2017                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 722,172 729,812 739,258 741,278 740,074 702,378 $ 705,205      
Total of incurred-but-not-reported liabilities plus expected development on reported claims 19,886                  
Reinsurance | Run-off lines | Accident Year 2018                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 600,640 600,516 614,573 628,722 614,222 $ 523,351        
Total of incurred-but-not-reported liabilities plus expected development on reported claims 15,506                  
Reinsurance | Run-off lines | Accident Year 2019                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 387,944 395,134 411,886 432,299 $ 448,745          
Total of incurred-but-not-reported liabilities plus expected development on reported claims 17,304                  
Reinsurance | Run-off lines | Accident Year 2020                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 553,124 548,846 553,538 $ 520,537            
Total of incurred-but-not-reported liabilities plus expected development on reported claims 41,243                  
Reinsurance | Run-off lines | Accident Year 2021                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 438,082 441,530 $ 430,820              
Total of incurred-but-not-reported liabilities plus expected development on reported claims 39,301                  
Reinsurance | Run-off lines | Accident Year 2022                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 225,697 $ 265,797                
Total of incurred-but-not-reported liabilities plus expected development on reported claims 47,820                  
Reinsurance | Run-off lines | Accident Year 2023                    
Claims Development [Line Items]                    
Incurred claims and allocated claim adjustment expenses 64,191                  
Total of incurred-but-not-reported liabilities plus expected development on reported claims $ 28,272                  
XML 116 R92.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Claims Development [Line Items]                    
Liabilities for claims and claim adjustment expenses, net of reinsurance $ 10,436,507                  
Insurance                    
Claims Development [Line Items]                    
Liabilities for claims and claim adjustment expenses, net of reinsurance 5,166,419                  
Insurance | Property                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 3,460,155                  
All outstanding liabilities before 2014, net of reinsurance 14,248                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 662,936                  
Insurance | Property | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 252,526 $ 252,787 $ 252,772 $ 251,701 $ 254,858 $ 254,051 $ 250,321 $ 244,372 $ 201,931 $ 100,736
Insurance | Property | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 181,716 182,038 177,227 186,010 179,409 179,727 166,211 145,027 67,621  
Insurance | Property | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 260,115 253,891 256,476 250,822 250,662 243,050 206,979 82,583    
Insurance | Property | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 647,610 635,493 645,841 650,218 622,040 513,044 190,861      
Insurance | Property | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 577,000 590,739 573,034 563,191 468,431 221,345        
Insurance | Property | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 332,848 343,463 306,415 257,515 148,181          
Insurance | Property | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 531,448 481,646 425,893 182,611            
Insurance | Property | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 323,656 286,801 134,273              
Insurance | Property | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 262,381 97,622                
Insurance | Property | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 90,855                  
Insurance | Accident and health                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 816,331                  
All outstanding liabilities before 2014, net of reinsurance (238)                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 114,493                  
Insurance | Accident and health | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 62,660 61,996 61,588 62,716 62,844 62,513 61,855 60,682 56,693 31,662
Insurance | Accident and health | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 60,575 62,677 62,584 61,926 62,065 61,051 60,168 56,988 31,518  
Insurance | Accident and health | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 85,272 86,123 85,413 85,010 83,929 83,077 79,237 41,583    
Insurance | Accident and health | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 118,138 116,280 117,100 115,981 114,555 109,312 63,285      
Insurance | Accident and health | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 114,595 113,787 112,884 109,194 106,748 61,849        
Insurance | Accident and health | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 68,030 68,088 63,046 61,526 45,133          
Insurance | Accident and health | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 59,240 60,804 52,290 36,317            
Insurance | Accident and health | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 69,661 61,593 39,185              
Insurance | Accident and health | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 82,209 46,568                
Insurance | Accident and health | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 95,951                  
Insurance | Marine and aviation                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 1,230,094                  
All outstanding liabilities before 2014, net of reinsurance 13,750                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 678,482                  
Insurance | Marine and aviation | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 50,383 50,255 48,435 53,941 52,793 48,583 39,439 36,805 22,874 10,336
Insurance | Marine and aviation | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 142,432 142,437 142,268 135,881 133,087 130,290 125,369 69,563 29,498  
Insurance | Marine and aviation | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 97,951 97,274 94,184 92,239 90,273 83,039 50,976 22,886    
Insurance | Marine and aviation | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 196,724 184,824 180,904 172,205 140,126 106,527 35,415      
Insurance | Marine and aviation | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 197,961 185,455 173,667 159,948 123,434 47,525        
Insurance | Marine and aviation | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 178,967 171,372 145,927 103,253 54,028          
Insurance | Marine and aviation | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 119,063 106,403 84,391 44,655            
Insurance | Marine and aviation | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 108,772 69,687 26,924              
Insurance | Marine and aviation | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 101,228 30,101                
Insurance | Marine and aviation | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 36,613                  
Insurance | Cyber                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 428,268                  
All outstanding liabilities before 2014, net of reinsurance 9,471                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 322,071                  
Insurance | Cyber | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 38,043 36,070 35,440 33,732 33,819 31,260 29,962 23,330 12,162 3,136
Insurance | Cyber | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 45,432 43,635 42,515 39,470 30,865 28,501 25,544 15,333 5,572  
Insurance | Cyber | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 24,054 23,207 23,136 21,333 18,502 14,141 4,637 1,348    
Insurance | Cyber | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 39,995 40,557 38,031 35,897 28,331 19,165 9,354      
Insurance | Cyber | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 18,334 19,267 14,810 9,874 7,327 2,171        
Insurance | Cyber | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 57,318 60,961 32,608 20,950 2,787          
Insurance | Cyber | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 82,625 63,813 50,344 17,732            
Insurance | Cyber | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 75,369 65,577 24,108              
Insurance | Cyber | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 37,861 7,830                
Insurance | Cyber | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 9,237                  
Insurance | Professional lines                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 1,979,153                  
All outstanding liabilities before 2014, net of reinsurance 131,134                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 1,930,348                  
Insurance | Professional lines | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 253,033 244,776 238,969 216,811 206,982 190,560 160,677 105,155 57,536 20,263
Insurance | Professional lines | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 249,916 225,062 213,465 200,892 171,000 139,574 111,149 51,709 14,353  
Insurance | Professional lines | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 290,732 276,175 235,136 210,701 172,360 131,831 66,048 14,428    
Insurance | Professional lines | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 291,943 269,668 198,859 167,645 109,107 51,823 11,515      
Insurance | Professional lines | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 336,329 265,501 204,941 143,248 74,859 18,446        
Insurance | Professional lines | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 289,475 206,462 133,453 76,711 25,061          
Insurance | Professional lines | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 125,713 97,847 44,076 8,729            
Insurance | Professional lines | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 83,605 38,605 9,781              
Insurance | Professional lines | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 46,224 10,983                
Insurance | Professional lines | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 12,183                  
Insurance | Credit and political risk                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 278,317                  
All outstanding liabilities before 2014, net of reinsurance 592                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 125,355                  
Insurance | Credit and political risk | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 69,677 69,677 70,224 70,224 64,050 57,857 57,857 61,108 39,952 1,924
Insurance | Credit and political risk | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 23,309 23,309 23,309 23,309 23,309 23,309 23,309 23,309 0  
Insurance | Credit and political risk | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 24,885 24,885 24,885 24,885 24,885 24,885 24,885 0    
Insurance | Credit and political risk | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 8,666 10,394 10,925 11,710 9,251 4,035 403      
Insurance | Credit and political risk | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 23,841 19,963 11,851 15,517 13,488 5,370        
Insurance | Credit and political risk | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 55,067 56,956 53,750 46,456 16,026          
Insurance | Credit and political risk | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 53,786 58,492 90,299 9,825            
Insurance | Credit and political risk | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 8,228 (370) 2,769              
Insurance | Credit and political risk | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 8,115 2,796                
Insurance | Credit and political risk | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 2,743                  
Insurance | Liability                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 1,239,193                  
All outstanding liabilities before 2014, net of reinsurance 49,217                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 1,332,734                  
Insurance | Liability | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 116,384 113,150 106,205 103,041 93,569 84,369 71,589 49,829 18,633 1,411
Insurance | Liability | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 162,656 159,004 150,640 140,809 120,136 92,598 39,581 22,353 5,438  
Insurance | Liability | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 102,773 95,787 79,519 66,290 56,403 36,356 23,260 6,315    
Insurance | Liability | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 190,475 168,615 143,440 115,568 58,988 29,432 5,463      
Insurance | Liability | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 188,910 158,622 119,152 72,219 34,860 9,374        
Insurance | Liability | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 192,435 139,077 83,692 39,846 7,833          
Insurance | Liability | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 118,306 75,907 25,174 8,148            
Insurance | Liability | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 103,892 51,859 13,397              
Insurance | Liability | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 53,507 13,212                
Insurance | Liability | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 9,855                  
Reinsurance                    
Claims Development [Line Items]                    
Liabilities for claims and claim adjustment expenses, net of reinsurance 5,270,088                  
Reinsurance | Accident and health                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 1,686,952                  
All outstanding liabilities before 2014, net of reinsurance (213)                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 194,150                  
Reinsurance | Accident and health | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 87,202 86,771 86,384 87,302 86,622 86,534 86,332 85,931 79,974 36,571
Reinsurance | Accident and health | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 92,468 93,735 93,921 92,497 92,036 91,935 88,728 77,316 23,409  
Reinsurance | Accident and health | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 189,409 189,815 188,836 189,234 187,251 181,072 149,959 50,046    
Reinsurance | Accident and health | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 179,889 180,121 179,462 178,943 172,111 157,157 79,252      
Reinsurance | Accident and health | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 195,018 194,524 191,400 191,832 165,323 72,899        
Reinsurance | Accident and health | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 194,800 196,694 195,954 169,608 67,810          
Reinsurance | Accident and health | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 192,491 210,665 172,178 81,875            
Reinsurance | Accident and health | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 210,115 179,626 68,652              
Reinsurance | Accident and health | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 214,611 101,596                
Reinsurance | Accident and health | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 130,949                  
Reinsurance | Marine and aviation                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 268,825                  
All outstanding liabilities before 2014, net of reinsurance 1,923                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 138,264                  
Reinsurance | Marine and aviation | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 8,477 7,563 7,370 7,003 6,499 6,320 5,256 4,388 2,307 1,121
Reinsurance | Marine and aviation | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 11,058 10,925 10,843 11,017 10,220 8,662 6,443 2,665 416  
Reinsurance | Marine and aviation | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 35,256 35,044 34,450 33,399 30,619 26,673 19,544 2,765    
Reinsurance | Marine and aviation | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 37,996 37,091 36,978 33,912 28,954 23,620 2,803      
Reinsurance | Marine and aviation | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 37,829 34,435 30,763 24,325 10,880 1,783        
Reinsurance | Marine and aviation | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 67,800 52,763 34,317 27,167 10,763          
Reinsurance | Marine and aviation | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 29,862 24,006 16,730 4,024            
Reinsurance | Marine and aviation | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 20,486 12,341 5,478              
Reinsurance | Marine and aviation | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 18,588 7,817                
Reinsurance | Marine and aviation | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 1,473                  
Reinsurance | Professional lines                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 989,284                  
All outstanding liabilities before 2014, net of reinsurance 113,403                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 1,054,117                  
Reinsurance | Professional lines | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 196,444 189,874 178,058 158,388 146,917 109,048 74,479 48,791 13,062 2,019
Reinsurance | Professional lines | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 184,073 170,555 152,328 131,543 111,743 79,208 41,512 13,504 3,134  
Reinsurance | Professional lines | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 202,925 181,141 153,575 124,881 95,084 52,540 20,487 1,765    
Reinsurance | Professional lines | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 137,492 116,293 88,791 62,723 39,857 14,871 2,813      
Reinsurance | Professional lines | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 113,771 81,729 56,882 31,198 2,572 271        
Reinsurance | Professional lines | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 76,094 53,221 33,628 13,614 368          
Reinsurance | Professional lines | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 40,718 26,926 13,969 3,823            
Reinsurance | Professional lines | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 22,619 11,366 4,337              
Reinsurance | Professional lines | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 11,713 3,234                
Reinsurance | Professional lines | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 3,435                  
Reinsurance | Liability                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 1,416,642                  
All outstanding liabilities before 2014, net of reinsurance 130,039                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 1,738,680                  
Reinsurance | Liability | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 156,421 148,342 137,103 129,802 109,859 89,328 70,069 48,397 28,652 7,075
Reinsurance | Liability | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 166,842 151,919 141,519 130,767 108,857 80,822 54,486 27,451 7,269  
Reinsurance | Liability | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 216,534 189,536 166,645 142,837 111,698 69,445 37,666 11,868    
Reinsurance | Liability | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 224,655 193,274 158,653 120,747 78,574 42,144 12,449      
Reinsurance | Liability | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 207,016 166,378 127,946 85,207 49,938 19,357        
Reinsurance | Liability | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 159,068 120,266 79,728 45,269 19,311          
Reinsurance | Liability | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 119,678 82,389 49,059 16,940            
Reinsurance | Liability | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 99,228 58,540 10,931              
Reinsurance | Liability | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 52,197 18,066                
Reinsurance | Liability | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 15,003                  
Reinsurance | Credit and surety                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 641,282                  
All outstanding liabilities before 2014, net of reinsurance 26,307                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 278,501                  
Reinsurance | Credit and surety | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 98,533 107,713 106,519 106,708 106,267 101,859 94,274 85,266 60,597 35,450
Reinsurance | Credit and surety | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 118,116 120,617 121,975 121,115 117,462 115,549 98,709 81,001 32,863  
Reinsurance | Credit and surety | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 102,558 100,426 100,682 102,149 101,065 91,490 72,691 41,937    
Reinsurance | Credit and surety | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 103,252 102,390 99,463 101,337 89,715 73,362 37,246      
Reinsurance | Credit and surety | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 87,073 85,505 83,736 72,096 67,839 38,868        
Reinsurance | Credit and surety | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 49,050 46,835 44,702 30,985 19,301          
Reinsurance | Credit and surety | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 43,888 39,495 34,050 25,339            
Reinsurance | Credit and surety | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 17,175 9,170 4,471              
Reinsurance | Credit and surety | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 11,302 6,883                
Reinsurance | Credit and surety | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 10,335                  
Reinsurance | Motor                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 1,582,237                  
All outstanding liabilities before 2014, net of reinsurance 255,320                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 1,020,952                  
Reinsurance | Motor | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 141,456 138,281 135,455 114,654 119,355 109,989 100,071 92,183 73,129 43,148
Reinsurance | Motor | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 175,479 173,373 168,295 145,593 144,878 129,175 112,128 92,382 57,638  
Reinsurance | Motor | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 198,144 189,563 182,077 158,004 145,160 127,404 103,868 60,689    
Reinsurance | Motor | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 262,741 244,440 221,060 198,778 163,724 133,447 72,143      
Reinsurance | Motor | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 260,818 240,535 215,988 205,874 141,391 83,831        
Reinsurance | Motor | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 242,207 223,167 201,210 183,841 90,328          
Reinsurance | Motor | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 127,881 115,689 96,208 43,752            
Reinsurance | Motor | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 94,500 76,338 41,869              
Reinsurance | Motor | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 52,971 35,213                
Reinsurance | Motor | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 26,040                  
Reinsurance | Agriculture                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 998,232                  
All outstanding liabilities before 2014, net of reinsurance (463)                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 147,622                  
Reinsurance | Agriculture | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 162,194 162,068 161,167 160,516 162,011 161,498 161,575 162,349 133,137 15,615
Reinsurance | Agriculture | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 96,224 95,612 95,457 95,468 94,873 94,535 92,979 65,870 1,716  
Reinsurance | Agriculture | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 109,762 109,211 109,172 109,410 109,922 108,378 62,530 9,489    
Reinsurance | Agriculture | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 136,605 137,429 137,482 138,640 137,502 124,528 7,444      
Reinsurance | Agriculture | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 144,070 138,398 141,768 135,674 127,577 5,115        
Reinsurance | Agriculture | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 177,760 178,264 174,250 154,533 28,854          
Reinsurance | Agriculture | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 55,359 54,269 47,377 17,454            
Reinsurance | Agriculture | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 46,117 32,846 2,953              
Reinsurance | Agriculture | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 55,508 15,347                
Reinsurance | Agriculture | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 14,633                  
Reinsurance | Run-off lines                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 3,069,216                  
All outstanding liabilities before 2014, net of reinsurance 37,075                  
Liabilities for claims and claim adjustment expenses, net of reinsurance 697,802                  
Reinsurance | Run-off lines | Accident Year 2014                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 213,063 211,708 210,435 203,726 206,234 202,114 197,284 180,580 136,404 $ 49,217
Reinsurance | Run-off lines | Accident Year 2015                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 235,258 234,318 232,671 218,469 213,978 203,661 178,596 119,103 $ 46,199  
Reinsurance | Run-off lines | Accident Year 2016                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 257,802 258,939 253,543 246,602 232,366 201,290 141,975 $ 65,343    
Reinsurance | Run-off lines | Accident Year 2017                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 657,803 646,826 611,106 586,833 528,640 417,693 $ 163,254      
Reinsurance | Run-off lines | Accident Year 2018                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 548,005 526,746 479,911 427,126 331,848 $ 116,816        
Reinsurance | Run-off lines | Accident Year 2019                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 335,546 310,612 274,503 214,066 $ 54,985          
Reinsurance | Run-off lines | Accident Year 2020                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 392,613 324,105 240,193 $ 105,245            
Reinsurance | Run-off lines | Accident Year 2021                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 302,383 235,617 $ 87,860              
Reinsurance | Run-off lines | Accident Year 2022                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses 103,881 $ 50,250                
Reinsurance | Run-off lines | Accident Year 2023                    
Claims Development [Line Items]                    
Cumulative paid claims and allocated claim adjustment expenses $ 22,862                  
XML 117 R93.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Details)
Dec. 31, 2023
Insurance | Property  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 32.90%
Year 2 41.20%
Year 3 13.40%
Year 4 5.30%
Year 5 0.10%
Year 6 0.40%
Year 7 (1.30%)
Year 8 1.80%
Year 9 (0.10%)
Year 10 (0.10%)
Insurance | Accident and health  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 53.00%
Year 2 34.90%
Year 3 6.00%
Year 4 1.90%
Year 5 0.90%
Year 6 0.20%
Year 7 0.80%
Year 8 (0.90%)
Year 9 (1.40%)
Year 10 1.00%
Insurance | Marine and aviation  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 18.80%
Year 2 26.60%
Year 3 22.50%
Year 4 7.90%
Year 5 5.60%
Year 6 3.80%
Year 7 3.80%
Year 8 (3.20%)
Year 9 1.80%
Year 10 0.20%
Insurance | Cyber  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 10.70%
Year 2 23.50%
Year 3 19.00%
Year 4 18.50%
Year 5 6.20%
Year 6 6.50%
Year 7 1.30%
Year 8 3.30%
Year 9 2.60%
Year 10 4.80%
Insurance | Professional lines  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 3.90%
Year 2 11.30%
Year 3 16.10%
Year 4 13.30%
Year 5 11.70%
Year 6 11.10%
Year 7 6.20%
Year 8 5.20%
Year 9 5.40%
Year 10 2.70%
Insurance | Credit and political risk  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 9.30%
Year 2 59.00%
Year 3 10.00%
Year 4 0.60%
Year 5 3.60%
Year 6 3.70%
Year 7 (2.80%)
Year 8 0.00%
Year 9 (0.40%)
Year 10 0.00%
Insurance | Liability  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 3.20%
Year 2 10.80%
Year 3 15.30%
Year 4 19.60%
Year 5 12.80%
Year 6 10.10%
Year 7 8.50%
Year 8 4.10%
Year 9 3.60%
Year 10 2.50%
Reinsurance | Accident and health  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 37.10%
Year 2 48.70%
Year 3 12.90%
Year 4 0.30%
Year 5 0.40%
Year 6 0.20%
Year 7 0.70%
Year 8 (0.50%)
Year 9 (0.50%)
Year 10 0.50%
Reinsurance | Marine and aviation  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 8.90%
Year 2 26.40%
Year 3 20.50%
Year 4 14.40%
Year 5 10.70%
Year 6 3.70%
Year 7 1.90%
Year 8 1.70%
Year 9 1.60%
Year 10 9.30%
Reinsurance | Professional lines  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 1.50%
Year 2 5.30%
Year 3 11.60%
Year 4 12.30%
Year 5 12.60%
Year 6 12.30%
Year 7 7.90%
Year 8 7.70%
Year 9 5.10%
Year 10 2.70%
Reinsurance | Liability  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 4.50%
Year 2 9.80%
Year 3 10.80%
Year 4 12.20%
Year 5 11.10%
Year 6 10.00%
Year 7 7.90%
Year 8 5.70%
Year 9 6.40%
Year 10 4.20%
Reinsurance | Credit and surety  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 26.50%
Year 2 22.10%
Year 3 15.00%
Year 4 8.60%
Year 5 2.30%
Year 6 2.00%
Year 7 0.40%
Year 8 0.20%
Year 9 (0.40%)
Year 10 (8.20%)
Reinsurance | Motor  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 23.60%
Year 2 18.80%
Year 3 10.30%
Year 4 6.50%
Year 5 6.30%
Year 6 5.60%
Year 7 4.10%
Year 8 6.30%
Year 9 1.40%
Year 10 2.00%
Reinsurance | Agriculture  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 10.90%
Year 2 63.50%
Year 3 18.50%
Year 4 1.70%
Year 5 (0.60%)
Year 6 0.90%
Year 7 (0.40%)
Year 8 0.40%
Year 9 0.60%
Year 10 0.10%
Reinsurance | Run-off lines  
Short-duration Insurance Contracts, Historical Claims Duration [Line Items]  
Year 1 21.80%
Year 2 32.40%
Year 3 17.90%
Year 4 9.70%
Year 5 4.90%
Year 6 2.90%
Year 7 2.10%
Year 8 1.10%
Year 9 0.50%
Year 10 0.60%
XML 118 R94.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESERVE FOR LOSSES AND LOSS EXPENSES - Reconciliation of Development Tables to Consolidated Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Claims Development [Line Items]        
Net outstanding liabilities $ 10,436,507      
Reinsurance recoverable on unpaid claims 6,323,083 $ 5,831,172 $ 5,017,611 $ 4,496,641
Gross outstanding liabilities 16,759,590      
Unallocated claims adjustment expenses 183,260      
Foreign exchange and other 12,442      
Ceded reserves related to retroactive transactions (521,274)      
Reserve for losses and loss expenses 16,434,018 $ 15,168,863 $ 14,653,094 $ 13,926,766
Insurance        
Claims Development [Line Items]        
Net outstanding liabilities 5,166,419      
Reinsurance recoverable on unpaid claims 4,477,039      
Gross outstanding liabilities 9,643,458      
Insurance | Property        
Claims Development [Line Items]        
Net outstanding liabilities 662,936      
Reinsurance recoverable on unpaid claims 402,222      
Gross outstanding liabilities 1,065,158      
Insurance | Accident and health        
Claims Development [Line Items]        
Net outstanding liabilities 114,493      
Reinsurance recoverable on unpaid claims 3,006      
Gross outstanding liabilities 117,499      
Insurance | Marine and aviation        
Claims Development [Line Items]        
Net outstanding liabilities 678,482      
Reinsurance recoverable on unpaid claims 278,215      
Gross outstanding liabilities 956,697      
Insurance | Cyber        
Claims Development [Line Items]        
Net outstanding liabilities 322,071      
Reinsurance recoverable on unpaid claims 430,627      
Gross outstanding liabilities 752,698      
Insurance | Professional lines        
Claims Development [Line Items]        
Net outstanding liabilities 1,930,348      
Reinsurance recoverable on unpaid claims 1,442,546      
Gross outstanding liabilities 3,372,894      
Insurance | Credit and political risk        
Claims Development [Line Items]        
Net outstanding liabilities 125,355      
Reinsurance recoverable on unpaid claims 35,191      
Gross outstanding liabilities 160,546      
Insurance | Liability        
Claims Development [Line Items]        
Net outstanding liabilities 1,332,734      
Reinsurance recoverable on unpaid claims 1,885,232      
Gross outstanding liabilities 3,217,966      
Reinsurance        
Claims Development [Line Items]        
Net outstanding liabilities 5,270,088      
Reinsurance recoverable on unpaid claims 1,846,044      
Gross outstanding liabilities 7,116,132      
Reinsurance | Accident and health        
Claims Development [Line Items]        
Net outstanding liabilities 194,150      
Reinsurance recoverable on unpaid claims 49,314      
Gross outstanding liabilities 243,464      
Reinsurance | Marine and aviation        
Claims Development [Line Items]        
Net outstanding liabilities 138,264      
Reinsurance recoverable on unpaid claims 33,185      
Gross outstanding liabilities 171,449      
Reinsurance | Professional lines        
Claims Development [Line Items]        
Net outstanding liabilities 1,054,117      
Reinsurance recoverable on unpaid claims 370,345      
Gross outstanding liabilities 1,424,462      
Reinsurance | Liability        
Claims Development [Line Items]        
Net outstanding liabilities 1,738,680      
Reinsurance recoverable on unpaid claims 690,141      
Gross outstanding liabilities 2,428,821      
Reinsurance | Agriculture        
Claims Development [Line Items]        
Net outstanding liabilities 147,622      
Reinsurance recoverable on unpaid claims 8,343      
Gross outstanding liabilities 155,965      
Reinsurance | Credit and surety        
Claims Development [Line Items]        
Net outstanding liabilities 278,501      
Reinsurance recoverable on unpaid claims 103,174      
Gross outstanding liabilities 381,675      
Reinsurance | Motor        
Claims Development [Line Items]        
Net outstanding liabilities 1,020,952      
Reinsurance recoverable on unpaid claims 315,344      
Gross outstanding liabilities 1,336,296      
Reinsurance | Run-off lines        
Claims Development [Line Items]        
Net outstanding liabilities 697,802      
Reinsurance recoverable on unpaid claims 276,198      
Gross outstanding liabilities $ 974,000      
XML 119 R95.htm IDEA: XBRL DOCUMENT v3.24.0.1
REINSURANCE (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Premiums written      
Gross $ 8,356,525 $ 8,214,595 $ 7,685,984
Ceded (3,254,200) (2,951,539) (2,759,360)
NET AMOUNT 5,102,325 5,263,056 4,926,624
Premiums earned      
Gross 7,973,577 7,936,382 7,281,709
Ceded (2,889,796) (2,776,056) (2,571,859)
Net 5,083,781 5,160,326 4,709,850
Reinsurance receivables:      
Ceded losses and loss expenses 1,754,000 1,754,000 1,782,000
Allowance for credit losses on reinsurance recoverable for unpaid losses and loss expenses $ 36,611 $ 30,715 $ 30,000
XML 120 R96.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND FINANCING ARRANGEMENTS - Summary of Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 10, 2019
Jun. 19, 2019
Dec. 06, 2017
Mar. 13, 2014
Debt Instrument [Line Items]            
Debt $ 1,313,714 $ 1,312,314        
Senior Notes | 5.150% Senior Notes            
Debt Instrument [Line Items]            
Interest rate (percent)           5.15%
Debt 246,789 246,708        
Senior Notes | 4.000% Senior Notes            
Debt Instrument [Line Items]            
Interest rate (percent)         4.00%  
Debt 348,389 348,020        
Senior Notes | 3.900% Senior Notes            
Debt Instrument [Line Items]            
Interest rate (percent)       3.90%    
Debt 297,076 296,615        
Junior Subordinated Notes            
Debt Instrument [Line Items]            
Interest rate (percent)     4.90%      
Debt $ 421,460 $ 420,971        
XML 121 R97.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND FINANCING ARRANGEMENTS - Debt terms (Details) - USD ($)
Dec. 10, 2019
Jun. 19, 2019
Dec. 06, 2017
Mar. 13, 2014
Senior Notes | 5.150% Senior Notes        
Debt Instrument [Line Items]        
Interest rate (percent)       5.15%
Aggregate Principal       $ 250,000,000
Issue Price       99.474%
Net Proceeds       $ 246,000,000
Senior Notes | 4.000% Senior Notes        
Debt Instrument [Line Items]        
Interest rate (percent)     4.00%  
Aggregate Principal     $ 350,000,000  
Issue Price     99.78%  
Net Proceeds     $ 347,000,000  
Senior Notes | 3.900% Senior Notes        
Debt Instrument [Line Items]        
Interest rate (percent)   3.90%    
Aggregate Principal   $ 300,000,000    
Issue Price   99.36%    
Net Proceeds   $ 296,000,000    
Junior Subordinated Notes        
Debt Instrument [Line Items]        
Interest rate (percent) 4.90%      
Aggregate Principal $ 425,000,000      
Issue Price 99.00%      
Net Proceeds $ 420,750,000      
Junior Subordinated Notes | Five-Year Treasury Rate        
Debt Instrument [Line Items]        
Basis spread on variable rate (percent) 3.186%      
XML 122 R98.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND FINANCING ARRANGEMENTS - Senior and Notes Payable (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 10, 2019
Jun. 19, 2019
Dec. 06, 2017
Mar. 13, 2014
Senior Notes              
Debt Instrument [Line Items]              
Interest expense $ 40 $ 40 $ 40        
Senior Notes | 5.150% Senior Notes              
Debt Instrument [Line Items]              
Interest rate (percent)             5.15%
Senior Notes | 4.000% Senior Notes              
Debt Instrument [Line Items]              
Interest rate (percent)           4.00%  
Senior Notes | 3.900% Senior Notes              
Debt Instrument [Line Items]              
Interest rate (percent)         3.90%    
Junior Subordinated Notes              
Debt Instrument [Line Items]              
Interest rate (percent)       4.90%      
Interest expense $ 21 $ 21          
AXIS Specialty Finance PLC | Subsidiary Issuer              
Debt Instrument [Line Items]              
Percentage ownership in subsidiary (percent) 100.00%         100.00% 100.00%
AXIS Specialty Finance LLC | Junior Subordinated Notes              
Debt Instrument [Line Items]              
Interest rate (percent)       4.90%      
AXIS Specialty Finance LLC | Subsidiary Issuer              
Debt Instrument [Line Items]              
Percentage ownership in subsidiary (percent) 100.00%       100.00%    
XML 123 R99.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND FINANCING ARRANGEMENTS - Summary of Debt Maturity (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Scheduled debt maturity    
2024 $ 0  
2025 0  
2026 0  
2027 350,000  
2028 0  
After 2028 975,000  
Unamortized discount and debt issuance expenses (11,286)  
Total senior notes and notes payable $ 1,313,714 $ 1,312,314
XML 124 R100.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND FINANCING ARRANGEMENTS - Loan Advances Made to a Third Party Reinsurer (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]      
Loan advance $ 349,842 $ 105,822 $ 82,870
Loan advances made 305,222 87,160  
Third Party Reinsurer | Related Party      
Debt Instrument [Line Items]      
Non-cash repayment of advance 110,000 90,000 $ 71,000
Interest received 4,000 1,000  
Third Party Reinsurer | Loan Agreement With Monarch Point Re | Related Party      
Debt Instrument [Line Items]      
Loan advance 102,000 116,000  
Non-cash repayment of advance 82,000 80,000  
Loan advances made 80,000 87,000  
Interest received 1,000 $ 1,000  
Other Commitment $ 26,000    
Third Party Reinsurer | Loan Agreement With Monarch Point Re | Related Party | Minimum      
Debt Instrument [Line Items]      
Stated interest rate (in percent) 0.80% 0.80%  
Third Party Reinsurer | Loan Agreement With Monarch Point Re | Related Party | Maximum      
Debt Instrument [Line Items]      
Stated interest rate (in percent) 4.00% 4.00%  
XML 125 R101.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND FINANCING ARRANGEMENTS - Letter of Credit facility (Details) - Letter of Credit Facility - USD ($)
Dec. 31, 2023
Dec. 29, 2023
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2021
Mar. 30, 2021
Mar. 27, 2017
Citibank              
Line of Credit Facility [Line Items]              
Maximum capacity             $ 500,000,000
Letters of credit outstanding $ 325,000,000     $ 362,000,000      
$500 Million Secured LOC              
Line of Credit Facility [Line Items]              
Maximum capacity $ 500,000,000 $ 500,000,000 $ 150,000,000        
$500 Million Secured LOC | Citibank              
Line of Credit Facility [Line Items]              
Maximum capacity             500,000,000
$250 Million Secured LOC | Citibank              
Line of Credit Facility [Line Items]              
Maximum capacity           $ 250,000,000 250,000,000
Line of credit facility, utilization capacity         $ 150,000,000    
$750 Million Secured LOC | Citibank              
Line of Credit Facility [Line Items]              
Maximum capacity         750,000,000   $ 750,000,000
Line of credit facility, aggregate utilization capacity         $ 650,000,000 $ 750,000,000  
XML 126 R102.htm IDEA: XBRL DOCUMENT v3.24.0.1
FEDERAL HOME LOAN BANK ADVANCES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]    
Federal Home Loan Bank advances $ 85,790 $ 81,388
Federal Home Loan Bank of Chicago    
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]    
FHLB program, admitted assets, actual 3,000,000 3,000,000
FHLB program, maximum borrowing capacity 759,000 750,000
Federal Home Loan Bank advances   81,000
Interest expense on FHLB borrowings 5,000 1,000
FHLB program, investments pledged as security $ 95,000 $ 91,000
Federal Home Loan Bank of Chicago | Minimum    
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]    
FHLB advances, interest rate (as a percent) 5.60% 2.30%
Federal Home Loan Bank of Chicago | Maximum    
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]    
FHLB advances, interest rate (as a percent) 5.90% 4.70%
XML 127 R103.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES - Cash and Investments (Details)
$ in Billions
Dec. 31, 2023
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Fixed maturity investment portfolio $ 12.9
Fixed maturity investment portfolio percentage 43.00%
Fixed maturity portfolio - corporate issuer concentration limit above A- 1.00%
Fixed maturity portfolio - corporate issuer concentration limit below A- 1.00%
XML 128 R104.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES - Reinsurance and Premiums (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
broker
Dec. 31, 2022
USD ($)
broker
Dec. 31, 2021
USD ($)
broker
Concentration Risk [Line Items]      
Allowance for estimated uncollectible premium balances receivable $ 11,997 $ 9,521  
Premiums receivable, bad debt expense charges $ 2,000 $ 0 $ 0
Reinsurance Recoverable On Unpaid And Paid Losses | Reinsurer Concentration | AM Best, A- Rating      
Concentration Risk [Line Items]      
Concentration risk, percentage of total 83.10% 81.80%  
Reinsurance Recoverable On Unpaid And Paid Losses | Reinsurer Concentration | Reinsurer 1      
Concentration Risk [Line Items]      
Concentration risk, percentage of total 14.00% 13.00%  
Reinsurance Recoverable On Unpaid And Paid Losses | Reinsurer Concentration | Reinsurer 2      
Concentration Risk [Line Items]      
Concentration risk, percentage of total 9.00% 9.00%  
Reinsurance Recoverable On Unpaid And Paid Losses | Reinsurer Concentration | Reinsurer 3      
Concentration Risk [Line Items]      
Concentration risk, percentage of total 4.00% 6.00%  
Gross Premiums Written | Customer Concentration      
Concentration Risk [Line Items]      
Concentration risk, number of brokers exceeding threshold | broker 3 3 3
Gross Premiums Written | Customer Concentration | Three Brokers      
Concentration Risk [Line Items]      
Concentration risk, percentage of total 38.00% 43.00% 45.00%
Gross Premiums Written | Customer Concentration | Marsh & McLennan Companies Inc.      
Concentration Risk [Line Items]      
Concentration risk, percentage of total 14.00% 17.00% 18.00%
Gross Premiums Written | Customer Concentration | Aon plc      
Concentration Risk [Line Items]      
Concentration risk, percentage of total 15.00% 17.00% 17.00%
Gross Premiums Written | Customer Concentration | Arthur J. Gallagher & Co.      
Concentration Risk [Line Items]      
Concentration risk, percentage of total 9.00% 9.00%  
Gross Premiums Written | Customer Concentration | Willis Towers Watson PLC      
Concentration Risk [Line Items]      
Concentration risk, percentage of total     10.00%
XML 129 R105.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES - Reinsurance Purchase Commitment, Investments and Funds at Lloyd's (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Unrecorded Unconditional Purchase Obligation [Line Items]    
Purchase commitment $ 6,000 $ 11,000
Unfunded commitments related to other investments 502,000 524,000
Collateral in trust for third-party agreements $ 2,597,633 2,491,317
Axis Corporate Capital UK Limited    
Unrecorded Unconditional Purchase Obligation [Line Items]    
Capital support, percentage 70.00%  
Axis Corporate Capital UK Limited II    
Unrecorded Unconditional Purchase Obligation [Line Items]    
Capital support, percentage 30.00%  
Corporate debt    
Unrecorded Unconditional Purchase Obligation [Line Items]    
Purchase commitment $ 16,000 20,000
CMBS    
Unrecorded Unconditional Purchase Obligation [Line Items]    
Purchase commitment 10,000 25,000
Lloyd's    
Unrecorded Unconditional Purchase Obligation [Line Items]    
Collateral in trust for third-party agreements $ 893,000 $ 749,000
XML 130 R106.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Summary of Lease Expense and Related Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Lease cost:      
Operating lease expense $ 21,499 $ 20,611 $ 21,864
Short-term lease expense 2,291 813 1,127
Sublease income (4,531) (3,423) (3,116)
Total lease expense 19,259 18,001 19,875
Other information:      
Operating cash outflows from operating leases 20,190 22,932 22,726
Right-of-use assets obtained in exchange for new operating lease liabilities $ 34,988 $ 6,514  
Right-of-use assets obtained in exchange for new operating lease liabilities     $ (1,739)
Weighted-average remaining lease term - operating leases 9 years 9 months 18 days 9 years 10 months 24 days 10 years
Weighted-average discount rate - operating lease 4.40% 4.10% 4.10%
XML 131 R107.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Summary of Maturity and Minimum Lease Payments (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Expected cash flows    
Expected cash flows, year one $ 17,543 $ 19,774
Expected cash flows, year two 18,122 13,725
Expected cash flows, year three 15,767 13,148
Expected cash flows, year four 13,519 11,052
Expected cash flows, year five 12,691 9,052
Later years 74,852 58,516
Discount (29,393) (22,690)
Total discounted operating lease liabilities $ 123,101 $ 102,577
XML 132 R108.htm IDEA: XBRL DOCUMENT v3.24.0.1
EARNINGS PER COMMON SHARE (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings per common share      
Net income $ 376,292 $ 223,083 $ 618,609
Less: Preferred share dividends 30,250 30,250 30,250
Net income available to common shareholders $ 346,042 $ 192,833 $ 588,359
Weighted average common shares outstanding (in shares) 85,142 84,864 84,707
Earnings per common share (in dollars per share) $ 4.06 $ 2.27 $ 6.95
Earnings per diluted common share      
Net income available to common shareholders $ 346,042 $ 192,833 $ 588,359
Weighted average common shares outstanding (in shares) 85,142 84,864 84,707
Share-based compensation plans (in shares) 870 805 584
Weighted average diluted common shares outstanding (in shares) 86,012 85,669 85,291
Earnings per diluted common share (in dollars per share) $ 4.02 $ 2.25 $ 6.90
Weighted average anti-dilutive shares excluded from the dilutive computation (in shares) 405 324 656
XML 133 R109.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY - Summary of Common Shares Issued and Outstanding (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Class of Stock [Line Items]      
Authorized share capital, common (in shares) 800,000,000    
Par value per share, common (in usd per share) $ 0.0125    
Common Shares Issued and Outstanding [Roll Forward]      
Shares issued, balance at beginning of year (in shares) 176,580,000    
Total shares issued at end of year (in shares) 176,580,000 176,580,000  
Treasury Shares Issued and Outstanding [Roll Forward]      
Treasury shares, balance at beginning of year (in shares) (91,912,000)    
Total treasury shares at end of year (in shares) (91,294,000) (91,912,000)  
Total shares outstanding (in shares) 85,286,000 84,668,000  
Common stocks      
Common Shares Issued and Outstanding [Roll Forward]      
Shares issued, balance at beginning of year (in shares) 176,580,000 176,580,000 176,580,000
Shares issued (in shares) 0 0 0
Total shares issued at end of year (in shares) 176,580,000 176,580,000 176,580,000
Treasury Shares Issued and Outstanding [Roll Forward]      
Treasury shares, balance at beginning of year (in shares) (91,912,000) (91,806,000) (92,227,000)
Shares repurchased (in shares) (398,000) (897,000) (205,000)
Shares reissued (in shares) 1,016,000 791,000 626,000
Total treasury shares at end of year (in shares) (91,294,000) (91,912,000) (91,806,000)
Total shares outstanding (in shares) 85,286,000 84,668,000 84,774,000
XML 134 R110.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY - Summary of Share Repurchases (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 07, 2023
Treasury Shares [Line Items]        
Stock repurchase program, authorized amount       $ 100,000
Common stocks        
Treasury Shares [Line Items]        
Total shares (in shares) 398 897 205  
Total cost $ 23,596 $ 48,981 $ 10,242  
Average price per share (in usd per share) $ 59.15 $ 54.61 $ 49.93  
Common stocks | In the open market:        
Treasury Shares [Line Items]        
Total shares (in shares) 0 634 0  
Total cost $ 0 $ 34,987 $ 0  
Average price per share (in usd per share) $ 0 $ 55.22 $ 0  
Common stocks | From employees:        
Treasury Shares [Line Items]        
Total shares (in shares) 398 263 205  
Total cost $ 23,596 $ 13,994 $ 10,242  
Average price per share (in usd per share) $ 59.15 $ 53.13 $ 49.93  
XML 135 R111.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY - Preferred Shares Narrative (Details) - Series E 5.50% Preferred Shares
$ / shares in Units, $ in Millions
Nov. 07, 2016
USD ($)
$ / shares
Class of Stock [Line Items]  
Preferred shares, aggregate liquidation value issued | $ $ 550
Preferred shares, dividend rate 5.50%
Preferred shares, par value per share (in usd per share) $ 0.0125
Preferred shares, liquidation preference per share (in usd per share) 2,500
Preferred shares, redemption price per share (in usd per share) $ 2,500
XML 136 R112.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY - Summary of Dividends Declared and Paid (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Class of Stock [Line Items]      
Common shares, dividends declared per share (in usd per share) $ 1.76 $ 1.73 $ 1.69
Common shares, dividends paid per share (in usd per share) 1.32 1.29 1.26
Dividends paid in year following declaration (in usd per share) 0.44 0.44 0.43
Series E preferred shares      
Class of Stock [Line Items]      
Preferred shares, dividend declared per share (in usd per share) 137.50 137.50 137.50
Preferred shares, dividends paid per share (in usd per share) 103.13 103.13 103.13
Dividends paid in year following declaration (in usd per share) $ 34.38 $ 34.38 $ 34.38
XML 137 R113.htm IDEA: XBRL DOCUMENT v3.24.0.1
RETIREMENT PLANS (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Retirement Benefits [Abstract]      
Total pension expenses $ 35 $ 34 $ 34
XML 138 R114.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED COMPENSATION - Narrative (Details)
3 Months Ended 12 Months Ended
May 04, 2023
shares
May 07, 2021
shares
Jun. 30, 2023
Trading_day
Mar. 31, 2023
Dec. 31, 2023
installment
Trading_day
shares
Dec. 31, 2022
Trading_day
May 31, 2017
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Trading days proceeding and performance period | Trading_day         10 10  
Share Based Payment Arrangement Senior Leadership              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Trading days proceeding and performance period | Trading_day     30        
Restricted Stock Units | Share Settled | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         3 years    
Number of installments | installment         3    
Restricted Stock Units | Share Settled | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         4 years    
Number of installments | installment         4    
Restricted Stock Units | Cash Settled | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         3 years    
Restricted Stock Units | Cash Settled | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         4 years    
Number of installments | installment         4    
Performance Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         3 years    
Performance Restricted Stock Units | Share Based Payment Arrangement Senior Leadership              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     3 years        
Performance Restricted Stock Units | Tranche One | Share Based Payment Arrangement Senior Leadership              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period       1 year      
Vesting percentage (as a percent)       50.00%      
Performance Restricted Stock Units | Tranche Two | Share Based Payment Arrangement Senior Leadership              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period       3 years      
Vesting percentage (as a percent)       50.00%      
Performance Restricted Stock Units | Performance Restricted Stock Units granted in 2020 and 2019              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         3 years    
Performance Restricted Stock Units | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage (as a percent)         0.00%    
Performance Restricted Stock Units | Minimum | Share Based Payment Arrangement Senior Leadership              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage (as a percent)     0.00%        
Performance Restricted Stock Units | Minimum | Tranche Two              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage (as a percent)       0.00%      
Performance Restricted Stock Units | Minimum | Performance Restricted Stock Units granted in 2020 and 2019              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage (as a percent)         75.00%    
Performance Restricted Stock Units | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage (as a percent)         200.00%    
Performance Restricted Stock Units | Maximum | Share Based Payment Arrangement Senior Leadership              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage (as a percent)     200.00%        
Performance Restricted Stock Units | Maximum | Tranche Two              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage (as a percent)       200.00%      
Performance Restricted Stock Units | Maximum | Performance Restricted Stock Units granted in 2020 and 2019              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage (as a percent)         125.00%    
2017 Long Term Equity Compensation Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Maximum number of shares to be issued under the plan (in shares) | shares             3,400,000
Additional share awards granted under the plan (in shares) | shares 1,125,000 1,600,000          
Number of awards available for grant under plan (in shares) | shares         2,864,183    
2017 Long Term Equity Compensation Plan | Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         2 years    
XML 139 R115.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED COMPENSATION - Valuation Assumptions (Details) - Performance Restricted Stock Units
3 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Expected volatility (as a percent) 30.05% 29.30% 36.24% 33.44% 32.99%
Expected term (in years) 3 years 1 year 3 years 3 years 3 years
Risk-free interest rate (as a percent) 3.39% 4.61% 3.79% 1.26% 0.17%
XML 140 R116.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED COMPENSATION - Summary of Shares and Cash Settled Awards (Details) - $ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Performance Restricted Stock Units | Share Settled    
Number of restricted stock units    
Nonvested restricted stock - beginning of year (in shares) 330 311
Granted (in shares) 122 140
Vested (in shares) (88) (100)
Forfeited (in shares) (220) (21)
Nonvested restricted stock - end of year (in shares) 144 330
Weighted average grant date fair value    
Nonvested restricted stock units - beginning of year (in usd per share) $ 60.01 $ 54.75
Granted (in usd per share) 66.13 68.63
Vested (in usd per share) 63.88 54.70
Forfeited (in usd per share) 58.15 62.26
Nonvested restricted stock units - end of year (in usd per share) $ 65.69 $ 60.01
Restricted Stock Units | Share Settled    
Number of restricted stock units    
Nonvested restricted stock - beginning of year (in shares) 2,117 2,062
Granted (in shares) 918 993
Vested (in shares) (929) (690)
Forfeited (in shares) (251) (248)
Nonvested restricted stock - end of year (in shares) 1,855 2,117
Weighted average grant date fair value    
Nonvested restricted stock units - beginning of year (in usd per share) $ 53.16 $ 51.59
Granted (in usd per share) 57.53 56.09
Vested (in usd per share) 53.02 52.67
Forfeited (in usd per share) 54.49 53.22
Nonvested restricted stock units - end of year (in usd per share) $ 55.21 $ 53.16
Restricted Stock Units | Cash Settled    
Number of restricted stock units    
Nonvested restricted stock - beginning of year (in shares) 60 215
Granted (in shares) 0 0
Vested (in shares) (59) (145)
Forfeited (in shares) (1) (10)
Nonvested restricted stock - end of year (in shares) 0 60
XML 141 R117.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED COMPENSATION - Schedule of Additional Information Related to Share-based Compensation (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Liability for cash-settled restricted stock units $ 0 $ 4,792  
Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share based compensation expense 57,729 56,136 $ 49,415
Tax benefits associated with share-based compensation expense 8,819 8,839 7,613
Fair value of restricted stock units vested 64,156 49,792 42,967
Unrecognized share-based compensation expense $ 62,416 $ 74,601 $ 80,805
Expected weighted average period associated with the recognition of unrecognized share-based compensation expense 2 years 4 months 24 days 2 years 3 months 18 days 2 years 4 months 24 days
Cash Settled | Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Liability for cash-settled restricted stock units $ 0 $ 4,792 $ 9,091
XML 142 R118.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTY TRANSACTIONS (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 22, 2023
Jun. 29, 2021
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]              
Other investments     $ 949,413 $ 949,413 $ 996,751    
Net premiums earned       5,083,781 5,160,326 $ 4,709,850  
Acquisition costs       1,000,945 1,022,017 921,834  
Net losses and loss expenses       3,393,102 3,242,410 3,008,783  
Reinsurance recoverable on unpaid claims     6,323,083 6,323,083 5,831,172 5,017,611 $ 4,496,641
Reinsurance recoverable on paid losses and loss expenses     575,847 575,847 539,676    
Ceded premiums       3,254,200 2,951,539 2,759,360  
Ceded losses and loss expenses       1,754,000 1,754,000 1,782,000  
Insurance and reinsurance balances payable     1,792,719 1,792,719 1,609,924    
Loan advance       349,842 105,822 82,870  
Loan balance receivable     305,222 305,222 87,160    
Related Party              
Related Party Transaction [Line Items]              
Other investments     424,000 424,000 462,000    
Ceded premiums       107,000 88,000 74,000  
Related Party | SKY Harbor Capital Management, LLC              
Related Party Transaction [Line Items]              
Income earned       3,000 2,000 2,000  
Related Party | Freedom              
Related Party Transaction [Line Items]              
Income earned       1,000 2,000 3,000  
Other investments     17,000 17,000      
Related Party | Stone Point Trident Fund VIII              
Related Party Transaction [Line Items]              
Income earned       2,000 2,000 4,000  
Other investments     87,000 87,000      
Related Party | Stone Point Trident VIII Co-Invest              
Related Party Transaction [Line Items]              
Other investments     26,000 26,000      
Related Party | Trident IX L.P. ("Trident IX")              
Related Party Transaction [Line Items]              
Income earned       1,000 1,000 0  
Other investments     24,000 24,000      
Related Party | Rialto Real Estate IV-Property              
Related Party Transaction [Line Items]              
Other investments     43,000 43,000      
Related Party | Rialto Real Estate Fund IV-Property              
Related Party Transaction [Line Items]              
Income earned       2,000 2,000 1,000  
Other investments     19,000 19,000      
Related Party | Stone Point Credit Corporation              
Related Party Transaction [Line Items]              
Income earned       500 300 0  
Other investments     18,000 18,000      
Related Party | Sound Point Capital Bond              
Related Party Transaction [Line Items]              
Other investments     5,000 5,000      
Related Party | Gordon Brothers              
Related Party Transaction [Line Items]              
Income earned       100 100    
Other investments     9,000 9,000      
Related Party | Eagle Point Credit Management, LLC              
Related Party Transaction [Line Items]              
Income earned       0      
Other investments     7,000 7,000      
Related Party | Aspida Holdings, Ltd              
Related Party Transaction [Line Items]              
Income earned       0      
Other investments     6,000 6,000      
Related Party | Monarch Point Re              
Related Party Transaction [Line Items]              
Income earned       100      
Other investments     22,000 22,000      
Net premiums earned $ 119,000            
Acquisition costs 33,000            
Net losses and loss expenses $ 7,000            
Reinsurance recoverable on unpaid claims     76,000 76,000      
Reinsurance recoverable on paid losses and loss expenses     4,000 4,000      
Ceded premiums       287,000      
Ceded losses and loss expenses       37,000      
Reinsurance recoverable on unpaid and paid losses     37,000 37,000      
Insurance and reinsurance balances payable     166,000 166,000      
Non-cash repayment of advance       72,000      
Related Party | Harrington Re              
Related Party Transaction [Line Items]              
Ceded premiums       298,000 324,000 283,000  
Ceded losses and loss expenses       229,000 234,000 $ 188,000  
Reinsurance recoverable on unpaid and paid losses     933,000 933,000 819,000    
Insurance and reinsurance balances payable     219,000 219,000 220,000    
Investment In Related Party | Senior Unsecured Notes Due 2031              
Related Party Transaction [Line Items]              
Other investments   $ 10,000          
Related party transaction floating rate (as a percent)   7.25%          
Loan Agreement With Monarch Point Re | Related Party | Monarch Point Re              
Related Party Transaction [Line Items]              
Loan advance       297,000      
Non-cash repayment of advance       72,000      
Loan balance receivable     225,000 225,000      
Other Commitment     $ 16,000 16,000      
Loan Agreement With Monarch Point Re | Related Party | Monarch Point Re | Minimum              
Related Party Transaction [Line Items]              
Related party transaction floating rate (as a percent)     5.70%        
Loan Agreement With Monarch Point Re | Related Party | Monarch Point Re | Maximum              
Related Party Transaction [Line Items]              
Related party transaction floating rate (as a percent)     5.85%        
Stone Pointe Credit Corporation Bonds | Related Party | Stone Point Credit Corporation              
Related Party Transaction [Line Items]              
Income earned       1,000 $ 600    
Other investments     $ 18,000 $ 18,000      
Stone Point Group | Related Party | Pantheon              
Related Party Transaction [Line Items]              
Percentage ownership by related parties       14.50%      
XML 143 R119.htm IDEA: XBRL DOCUMENT v3.24.0.1
REORGANIZATION EXPENSES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restructuring and Related Activities [Abstract]      
Reorganization expenses $ 28,997 $ 31,426 $ 0
XML 144 R120.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Summary of Income Tax Expense and Net Tax Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income tax expense [Line Items]      
Total income tax expense (benefit) $ 26,316 $ 22,037 $ 62,384
Net current tax receivables 78,570 46,704 27,883
Net deferred tax assets (liabilities) 72,850 108,220 12,860
Net tax assets 151,420 154,924 40,743
U.S.      
Income tax expense [Line Items]      
Current income tax expense (benefit) 12,021 11,491 35,229
Deferred income tax expense (benefit) (24,042) (8,147) (3,369)
Europe      
Income tax expense [Line Items]      
Current income tax expense (benefit) 32,386 2,366 (6,082)
Deferred income tax expense (benefit) 18,932 16,474 36,606
Bermuda      
Income tax expense [Line Items]      
Current income tax expense (benefit) 291 (147) 0
Deferred income tax expense (benefit) $ (13,272) $ 0 $ 0
XML 145 R121.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Summary of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:      
Discounting of net reserves for losses and loss expenses $ 62,316 $ 52,992  
Unearned premiums 54,104 56,146  
Net unrealized investments losses 54,395 71,251  
Operating and capital loss carryforwards 100,907 152,896  
Accruals not currently deductible 36,407 42,045  
Tax credits 11,602 7,619  
Other deferred tax assets 4,149 8,590  
Deferred tax assets before valuation allowance 323,880 391,539  
Valuation allowance (38,711) (60,069)  
Deferred tax assets net of valuation allowance 285,169 331,470  
Deferred tax liabilities:      
Deferred acquisition costs (27,109) (35,211)  
Other investment adjustments and impairments (7,173) (20,068)  
Intangible assets (49,486) (51,993)  
Equalization reserves (2,726) (2,530)  
Acquisition adjustments (79,466) (72,351)  
Lloyd’s deferred year of account results (38,194) (34,068)  
Other deferred tax liabilities (8,165) (7,029)  
Deferred tax liabilities (212,319) (223,250)  
Net deferred tax assets (liabilities) $ 72,850 $ 108,220 $ 12,860
XML 146 R122.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Summary of Operating and Capital Loss Carryforwards and Tax Credits (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Singapore    
Operating Loss And Tax Credit Carryforwards [Line Items]    
Operating loss carryforwards $ 70,815 $ 73,769
U.K.    
Operating Loss And Tax Credit Carryforwards [Line Items]    
Operating loss carryforwards 293,533 415,274
Tax credits 2,605 2,372
Ireland    
Operating Loss And Tax Credit Carryforwards [Line Items]    
Operating loss carryforwards 78,154 200,822
Tax credits 6,922 655
Ireland | Capital loss carryforward    
Operating Loss And Tax Credit Carryforwards [Line Items]    
Capital loss carryforwards 716 716
Switzerland    
Operating Loss And Tax Credit Carryforwards [Line Items]    
Operating loss carryforwards 123,453 187,057
Switzerland | Tax Carry Forward Expiry 2028    
Operating Loss And Tax Credit Carryforwards [Line Items]    
Operating loss carryforwards 123,453  
U.S.    
Operating Loss And Tax Credit Carryforwards [Line Items]    
Tax credits 2,074 $ 4,592
U.S. | Tax Credit Carryforward Expiring 2032    
Operating Loss And Tax Credit Carryforwards [Line Items]    
Operating loss carryforwards $ 2,074  
XML 147 R123.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Summary of Valuation Allowance (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Valuation allowance movement [Line Items]    
Valuation allowance - beginning of year $ 60,069  
Change in valuation allowance (21,000)  
Valuation allowance - end of year 38,711 $ 60,069
Income Tax Expense    
Valuation allowance movement [Line Items]    
Valuation allowance - beginning of year 39,782 16,918
Valuation allowance - end of year 31,688 39,782
Operating loss carryforwards    
Valuation allowance movement [Line Items]    
Change in valuation allowance (8,713) 21,724
Foreign tax credit    
Valuation allowance movement [Line Items]    
Change in valuation allowance 4,184 2,401
U.K. branch assets and other foreign rate differentials    
Valuation allowance movement [Line Items]    
Change in valuation allowance (3,565) (1,261)
Accumulated Other Comprehensive Income (Loss)    
Valuation allowance movement [Line Items]    
Valuation allowance - beginning of year 20,287 0
Valuation allowance - end of year 7,023 20,287
Change in investment - related items    
Valuation allowance movement [Line Items]    
Change in valuation allowance $ (13,264) $ 20,287
XML 148 R124.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Valuation allowance movement [Line Items]    
Increase in (release of) valuation allowance $ (21,000,000)  
Deferred tax assets for unrealized losses on fixed maturity securities 54,000,000 $ 71,000,000
Unrecognized tax benefits 0 $ 0
Ireland    
Valuation allowance movement [Line Items]    
Increase in (release of) valuation allowance (25,000,000)  
Ireland | Foreign Tax Credits    
Valuation allowance movement [Line Items]    
Increase in (release of) valuation allowance 6,000,000  
U.S. | Foreign Tax Credits    
Valuation allowance movement [Line Items]    
Increase in (release of) valuation allowance (2,000,000)  
Other Comprehensive Income | Ireland    
Valuation allowance movement [Line Items]    
Increase in (release of) valuation allowance (13,000,000)  
Net income (loss) | Ireland    
Valuation allowance movement [Line Items]    
Increase in (release of) valuation allowance $ (12,000,000)  
XML 149 R125.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Summary of Effective Tax Rate Reconciliation (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income (loss) before income taxes        
Bermuda (domestic) $ 213,539 $ 236,781 $ 431,310  
Foreign 189,067 8,340 249,686  
 Total income before income taxes $ 402,606 $ 245,121 $ 680,996  
Reconciliation of effective tax rate (% of income before income taxes)        
Expected tax rate 0.00% 0.00% 0.00%  
Valuation allowance (2.00%) 9.50% (0.50%)  
Prior year adjustments 1.30% (0.30%) 0.20%  
Incremental branch taxes 0.90% (0.40%) 1.50%  
Other 0.20% 0.30% (0.30%)  
Actual tax rate 6.50% 9.00% 9.20%  
U.S.        
Reconciliation of effective tax rate (% of income before income taxes)        
Foreign taxes at local expected rates (2.50%) 0.20% 4.80%  
Europe        
Reconciliation of effective tax rate (% of income before income taxes)        
Foreign taxes at local expected rates 11.90% 1.90% 2.00%  
Change in enacted tax rate (3.30%) (2.20%) 1.50%  
United Kingdom        
Reconciliation of effective tax rate (% of income before income taxes)        
Expected tax rate     25.00% 19.00%
Belgium        
Reconciliation of effective tax rate (% of income before income taxes)        
Expected tax rate     25.00% 30.00%
XML 150 R126.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Before tax amount      
Unrealized gains (losses) arising during the year, net of reclassification adjustment $ 448,477 $ (909,150) $ (405,378)
Foreign currency translation adjustment (1,572) (10,986) 621
Total other comprehensive income (loss), net of tax 446,905 (920,136) (404,757)
Income tax (expense) benefit      
Unrealized gains (losses) arising during the year, net of reclassification adjustment (52,441) 103,300 46,898
Foreign currency translation adjustment 0 0 0
Total other comprehensive income (loss), net of tax (52,441) 103,300 46,898
Net of tax amount      
Unrealized gains (losses) arising during the year, net of reclassification adjustment 396,036 (805,850) (358,480)
Foreign currency translation adjustment (1,572) (10,986) 621
Total other comprehensive income (loss), net of tax 394,464 (816,836) (357,859)
Available for sale investments      
Before tax amount      
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss) 142,324 335,294 (94,749)
Income tax (expense) benefit      
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss) (13,811) (30,369) 7,635
Net of tax amount      
Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss) 128,513 304,925 (87,114)
Unrealized gains (losses) arising during the year, net of reclassification adjustment 396,036 (805,850) (358,480)
Available for sale investments | Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized      
Before tax amount      
Unrealized gains (losses) arising during the period 294,933 (1,171,381) (310,710)
Income tax (expense) benefit      
Unrealized gains (losses) arising during the period (36,993) 127,756 39,263
Net of tax amount      
Unrealized gains (losses) arising during the period 257,940 (1,043,625) (271,447)
Available for sale investments | Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized      
Before tax amount      
Unrealized gains (losses) arising during the period 11,220 (73,063) 81
Income tax (expense) benefit      
Unrealized gains (losses) arising during the period (1,637) 5,913 0
Net of tax amount      
Unrealized gains (losses) arising during the period $ 9,583 $ (67,150) $ 81
XML 151 R127.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Reclassification out of accumulated comprehensive income into net income available to common shareholders [Line Items]      
Impairment losses $ (12,757) $ (12,568) $ (22)
Income before income taxes and interest in income of equity method investments 398,445 243,125 648,909
Income tax (expense) benefit (26,316) (22,037) (62,384)
Net income 376,292 223,083 618,609
Reclassification out of Accumulated Other Comprehensive Income | Unrealized gains (losses) on available for sale investments      
Reclassification out of accumulated comprehensive income into net income available to common shareholders [Line Items]      
Other realized gains (losses) (129,567) (322,726) 94,771
Impairment losses (12,757) (12,568) (22)
Income before income taxes and interest in income of equity method investments (142,324) (335,294) 94,749
Income tax (expense) benefit 13,811 30,369 (7,635)
Net income $ (128,513) $ (304,925) $ 87,114
XML 152 R128.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATUTORY FINANCIAL INFORMATION (Details)
12 Months Ended
Dec. 31, 2023
USD ($)
board_member
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Statutory Financial Information [Line Items]      
Statutory net income $ 471,000,000 $ 134,000,000 $ 569,000,000
Axis Corporate Capital UK Limited      
Statutory Financial Information [Line Items]      
Capital support, percentage 70.00%    
Axis Corporate Capital UK Limited II      
Statutory Financial Information [Line Items]      
Capital support, percentage 30.00%    
Axis Corporate Capital UK Limited | Fixed maturities and short-term investments | Asset Pledged as Collateral      
Statutory Financial Information [Line Items]      
Financial instruments, as collateral, at fair value $ 587,000,000 530,000,000  
Axis Corporate Capital UK Limited | Cash | Asset Pledged as Collateral      
Statutory Financial Information [Line Items]      
Financial instruments, as collateral, at fair value 13,000,000 13,000,000  
Axis Corporate Capital UK II Limited | Fixed maturities and short-term investments | Asset Pledged as Collateral      
Statutory Financial Information [Line Items]      
Financial instruments, as collateral, at fair value 261,000,000 176,000,000  
Axis Corporate Capital UK II Limited | Cash | Asset Pledged as Collateral      
Statutory Financial Information [Line Items]      
Financial instruments, as collateral, at fair value 6,000,000 6,000,000  
Axis Corporate Capital UK II Limited | Equity securities | Asset Pledged as Collateral      
Statutory Financial Information [Line Items]      
Financial instruments, as collateral, at fair value 27,000,000 23,000,000  
Bermuda      
Statutory Financial Information [Line Items]      
Required statutory capital and surplus 1,269,943,000 1,261,160,000  
Available statutory capital and surplus 3,170,556,000 3,156,955,000  
Minimum solvency margin amount $ 100,000,000    
Minimum solvency margin percentage of net written premiums 50.00%    
Minimum solvency margin percentage of net reserves 15.00%    
Minimum solvency margin percentage of ECR 25.00%    
Limit - prior year's total statutory capital surplus (Bermuda) 25.00%    
Number of directors required to sign affidavits in order to pay dividend/distribution greater than 25% of prior year statutory capital and surplus | board_member 2    
Maximum dividend/distribution payable without regulatory approval $ 730,000,000 709,000,000  
Ireland      
Statutory Financial Information [Line Items]      
Required statutory capital and surplus 755,076,000 699,203,000  
Available statutory capital and surplus 1,160,932,000 1,099,474,000  
Maximum dividend/distribution payable with regulatory approval 28,000,000 51,000,000  
U.S.      
Statutory Financial Information [Line Items]      
Required statutory capital and surplus 739,829,000 651,460,000  
Available statutory capital and surplus 2,187,371,000 1,982,618,000  
Maximum dividend/distribution payable without regulatory approval $ 181,000,000 $ 119,000,000  
Maximum dividend limit - percentage of total statutory capital and surplus 10.00%    
XML 153 R129.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Fair value $ 14,826,075
Amount shown on the balance sheet 15,260,960
Fixed maturities  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 12,634,254
Fair value 12,234,742
Amount shown on the balance sheet 12,234,742
Fixed maturities | U.S. government and agency  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 3,049,445
Fair value 3,007,528
Amount shown on the balance sheet 3,007,528
Fixed maturities | Non-U.S. government  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 729,761
Fair value 723,959
Amount shown on the balance sheet 723,959
Fixed maturities | Corporate debt  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 4,651,654
Fair value 4,474,172
Amount shown on the balance sheet 4,474,172
Fixed maturities | Agency RMBS  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 1,706,204
Fair value 1,634,661
Amount shown on the balance sheet 1,634,661
Fixed maturities | CMBS  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 897,553
Fair value 839,696
Amount shown on the balance sheet 839,696
Fixed maturities | Non-agency RMBS  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 165,910
Fair value 153,396
Amount shown on the balance sheet 153,396
Fixed maturities | ABS  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 1,265,187
Fair value 1,242,971
Amount shown on the balance sheet 1,242,971
Fixed maturities | Municipals  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 168,540
Fair value 158,359
Amount shown on the balance sheet 158,359
Fixed maturities, held to maturity, at amortized cost  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 686,296
Fair value 675,851
Amount shown on the balance sheet 686,296
Fixed maturities, held to maturity, at amortized cost | Corporate debt  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 95,200
Fair value 86,671
Amount shown on the balance sheet 95,200
Fixed maturities, held to maturity, at amortized cost | ABS  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Amortized cost 591,096
Fair value 589,180
Amount shown on the balance sheet 591,096
Mortgage loans  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Fair value 610,148
Amount shown on the balance sheet 610,148
Short-term investments  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Fair value 17,216
Amount shown on the balance sheet 17,216
Equity securities  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Fair value 588,511
Amount shown on the balance sheet 588,511
Other investments, at fair value  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Fair value 699,607
Amount shown on the balance sheet 949,413
Equity method investments  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Fair value 0
Amount shown on the balance sheet $ 174,634
XML 154 R130.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE II - CONDENSED BALANCE SHEETS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Assets      
Cash and cash equivalents $ 953,476 $ 751,415  
Other assets 456,385 438,338  
Total assets 30,250,672 27,682,971  
Liabilities      
Other liabilities 464,439 386,855  
Total liabilities 24,987,476 23,043,061  
Shareholders’ equity      
Preferred shares 550,000 550,000  
Common shares (shares issued 2023: 176,580; 2022: 176,580 shares outstanding 2023: 85,286; 2022: 84,668) 2,206 2,206  
Additional paid-in capital 2,383,030 2,366,253  
Accumulated other comprehensive income (loss) (365,836) (760,300)  
Retained earnings 6,440,528 6,247,022  
Treasury shares, at cost (2023: 91,294; 2022: 91,912) (3,746,732) (3,765,271)  
Total shareholders’ equity 5,263,196 4,639,910 $ 5,410,656
Total liabilities and shareholders’ equity 30,250,672 27,682,971  
AXIS Capital Holdings Limited      
Assets      
Investments in subsidiaries 5,415,302 4,943,126  
Cash and cash equivalents 412 1,932  
Other assets 4,751 4,432  
Total assets 5,420,465 4,949,490  
Liabilities      
Dividends payable 51,749 52,992  
Other liabilities 16,090 31,098  
Total liabilities 157,269 309,580  
Shareholders’ equity      
Preferred shares 550,000 550,000  
Common shares (shares issued 2023: 176,580; 2022: 176,580 shares outstanding 2023: 85,286; 2022: 84,668) 2,206 2,206  
Additional paid-in capital 2,383,030 2,366,253  
Accumulated other comprehensive income (loss) (365,836) (760,300)  
Retained earnings 6,440,528 6,247,022  
Treasury shares, at cost (2023: 91,294; 2022: 91,912) (3,746,732) (3,765,271)  
Total shareholders’ equity 5,263,196 4,639,910  
Total liabilities and shareholders’ equity 5,420,465 4,949,490  
AXIS Capital Holdings Limited | Affiliate      
Liabilities      
Intercompany payable $ 89,430 $ 225,490  
XML 155 R131.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE II - CONDENSED BALANCE SHEETS - Additional Information (Details) - shares
shares in Thousands
Dec. 31, 2023
Dec. 31, 2022
Condensed Financial Information of Parent Company [Line Items]    
Common shares, shares issued (in shares) 176,580 176,580
Common shares, shares outstanding (in shares) 85,286 84,668
Treasury shares (in shares) 91,294 91,912
AXIS Capital Holdings Limited    
Condensed Financial Information of Parent Company [Line Items]    
Common shares, shares issued (in shares) 176,580 176,580
Common shares, shares outstanding (in shares) 85,286 84,668
Treasury shares (in shares) 91,294 91,912
XML 156 R132.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE II - CONDENSED BALANCE SHEETS - Footnotes (Details) - USD ($)
Dec. 31, 2023
Dec. 10, 2019
Jun. 19, 2019
Dec. 06, 2017
Mar. 13, 2014
Senior Notes | 5.150% Senior Notes          
Condensed Financial Information of Parent Company [Line Items]          
Aggregate Principal         $ 250,000,000
Interest rate (percent)         5.15%
Senior Notes | 4.000% Senior Notes          
Condensed Financial Information of Parent Company [Line Items]          
Aggregate Principal       $ 350,000,000  
Interest rate (percent)       4.00%  
Senior Notes | 3.900% Senior Notes          
Condensed Financial Information of Parent Company [Line Items]          
Aggregate Principal     $ 300,000,000    
Interest rate (percent)     3.90%    
Junior Subordinated Notes          
Condensed Financial Information of Parent Company [Line Items]          
Aggregate Principal   $ 425,000,000      
Interest rate (percent)   4.90%      
AXIS Specialty Finance LLC | Junior Subordinated Notes          
Condensed Financial Information of Parent Company [Line Items]          
Interest rate (percent)   4.90%      
Subsidiary Issuer | AXIS Specialty Finance PLC          
Condensed Financial Information of Parent Company [Line Items]          
Percentage ownership in subsidiary (percent) 100.00%     100.00% 100.00%
Subsidiary Issuer | AXIS Specialty Finance LLC          
Condensed Financial Information of Parent Company [Line Items]          
Percentage ownership in subsidiary (percent) 100.00%   100.00%    
Full and Unconditional Guarantee of Debt | Subsidiary Issuer | AXIS Specialty Finance PLC | Senior Notes | 5.150% Senior Notes          
Condensed Financial Information of Parent Company [Line Items]          
Aggregate Principal $ 250,000,000        
Interest rate (percent) 5.15%        
Full and Unconditional Guarantee of Debt | Subsidiary Issuer | AXIS Specialty Finance PLC | Senior Notes | 4.000% Senior Notes          
Condensed Financial Information of Parent Company [Line Items]          
Aggregate Principal $ 350,000,000        
Interest rate (percent) 4.00%        
Full and Unconditional Guarantee of Debt | Subsidiary Issuer | AXIS Specialty Finance LLC | Senior Notes | 3.900% Senior Notes          
Condensed Financial Information of Parent Company [Line Items]          
Aggregate Principal $ 300,000,000        
Interest rate (percent) 3.90%        
Full and Unconditional Guarantee of Debt | Subsidiary Issuer | AXIS Specialty Finance LLC | Junior Subordinated Notes | 2010 AXIS Specialty Finance LLC Senior Notes          
Condensed Financial Information of Parent Company [Line Items]          
Aggregate Principal $ 425,000,000        
Interest rate (percent) 4.90%        
XML 157 R133.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE II - CONDENSED STATEMENTS OF OPERATIONS (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues      
Total revenues $ 5,643,388 $ 5,135,439 $ 5,321,725
Expenses      
Net income 376,292 223,083 618,609
Preferred share dividends 30,250 30,250 30,250
Net income available to common shareholders 346,042 192,833 588,359
Comprehensive income (loss) 770,756 (593,753) 260,750
AXIS Capital Holdings Limited      
Revenues      
Net investment income 0 0 0
Total revenues 0 0 0
Expenses      
General and administrative expenses 52,334 60,252 62,843
Total expenses 52,334 60,252 62,843
Income (loss) before equity in net income of subsidiaries (52,334) (60,252) (62,843)
Equity in net income of subsidiaries 428,626 283,335 681,452
Net income 376,292 223,083 618,609
Preferred share dividends 30,250 30,250 30,250
Net income available to common shareholders 346,042 192,833 588,359
Comprehensive income (loss) $ 770,756 $ (593,753) $ 260,750
XML 158 R134.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE II - CONDENSED STATEMENTS OF CASH FLOWS (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 376,292 $ 223,083 $ 618,609
Adjustments to reconcile net income to net cash provided by operating activities:      
Other items (45,881) (45,848) 155,979
Share-based compensation expense, net of cash payments 54,120 48,494 37,744
Net cash provided by operating activities 1,255,559 798,038 1,197,692
Cash flows from financing activities:      
Taxes paid on withholding shares (23,596) (13,994) (10,242)
Dividends paid - common shares (153,775) (149,341) (145,603)
Repurchase of common shares - open market 0 (34,987) 0
Dividends paid - preferred shares (30,250) (30,250) (30,250)
Net cash used in financing activities (202,371) (149,622) (186,095)
Increase (decrease) in cash, cash equivalents and restricted cash 209,332 (143,037) (185,542)
Cash, cash equivalents and restricted cash - beginning of year 1,174,653 1,317,690 1,503,232
Cash, cash equivalents and restricted cash - end of year 1,383,985 1,174,653 1,317,690
AXIS Capital Holdings Limited      
Cash flows from operating activities:      
Net income 376,292 223,083 618,609
Adjustments to reconcile net income to net cash provided by operating activities:      
Equity in income loss of subsidiaries (428,626) (283,335) (681,452)
Change in intercompany payable (136,059) 32,871 (96,868)
Dividends received from subsidiaries 375,000 225,000 300,000
Other items (34,626) (17,140) 7,882
Share-based compensation expense, net of cash payments 54,119 48,494 37,744
Net cash provided by operating activities 206,100 228,973 185,915
Cash flows from financing activities:      
Taxes paid on withholding shares (23,595) (13,994) (10,242)
Dividends paid - common shares (153,775) (149,341) (145,603)
Repurchase of common shares - open market 0 (34,987) 0
Dividends paid - preferred shares (30,250) (30,250) (30,250)
Net cash used in financing activities (207,620) (228,572) (186,095)
Increase (decrease) in cash, cash equivalents and restricted cash (1,520) 401 (180)
Cash, cash equivalents and restricted cash - beginning of year 1,932 1,531 1,711
Cash, cash equivalents and restricted cash - end of year $ 412 $ 1,932 $ 1,531
XML 159 R135.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Supplementary Insurance Information [Line Items]      
Deferred acquisition costs $ 450,950 $ 473,569 $ 465,593
Reserve for losses and loss expenses 16,434,018 15,168,863 14,653,094
Unearned premiums 4,747,602 4,361,447 4,090,676
Net premiums earned 5,083,781 5,160,326 4,709,850
Net investment income 611,742 418,829 454,301
Net losses and loss expenses 3,393,102 3,242,410 3,008,783
Acquisition costs 1,000,945 1,022,017 921,834
Other operating expenses 684,446 680,343 663,304
Net premiums written 5,102,325 5,263,056 4,926,624
Operating Segments | Insurance      
Supplementary Insurance Information [Line Items]      
Deferred acquisition costs 298,249 249,407 212,681
Reserve for losses and loss expenses 9,507,409 8,381,593 7,803,529
Unearned premiums 3,507,519 3,077,628 2,716,240
Net premiums earned 3,461,700 3,134,155 2,651,339
Net investment income 0 0 0
Net losses and loss expenses 2,080,001 1,785,854 1,514,998
Acquisition costs 648,463 577,838 484,344
Other operating expenses 472,094 443,704 429,282
Net premiums written 3,758,720 3,377,906 2,894,885
Operating Segments | Reinsurance      
Supplementary Insurance Information [Line Items]      
Deferred acquisition costs 152,701 224,162 252,912
Reserve for losses and loss expenses 6,926,609 6,787,270 6,849,565
Unearned premiums 1,240,083 1,283,819 1,374,436
Net premiums earned 1,622,081 2,026,171 2,058,511
Net investment income 0 0 0
Net losses and loss expenses 1,313,101 1,456,556 1,493,785
Acquisition costs 352,482 444,179 437,490
Other operating expenses 79,373 106,585 107,552
Net premiums written 1,343,605 1,885,150 2,031,739
Corporate      
Supplementary Insurance Information [Line Items]      
Deferred acquisition costs 0 0 0
Reserve for losses and loss expenses 0 0 0
Unearned premiums 0 0 0
Net premiums earned 0 0 0
Net investment income 611,742 418,829 454,301
Net losses and loss expenses 0 0 0
Acquisition costs 0 0 0
Other operating expenses 132,979 130,054 126,470
Net premiums written $ 0 $ 0 $ 0
XML 160 R136.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Supplementary Insurance Information [Line Items]      
GROSS AMOUNT $ 5,535,889 $ 5,102,958 $ 4,405,452
CEDED TO OTHER COMPANIES 3,254,200 2,951,539 2,759,360
ASSUMED FROM OTHER COMPANIES 2,820,636 3,111,637 3,280,532
NET AMOUNT $ 5,102,325 $ 5,263,056 $ 4,926,624
PERCENTAGE OF AMOUNT ASSUMED TO NET 55.30% 59.10% 66.60%
Property and Casualty      
Supplementary Insurance Information [Line Items]      
GROSS AMOUNT $ 5,223,919 $ 4,858,629 $ 4,233,758
CEDED TO OTHER COMPANIES 3,161,438 2,900,300 2,700,693
ASSUMED FROM OTHER COMPANIES 2,402,378 2,685,677 2,874,687
NET AMOUNT $ 4,464,859 $ 4,644,006 $ 4,407,752
PERCENTAGE OF AMOUNT ASSUMED TO NET 53.80% 57.80% 65.20%
Accident and health      
Supplementary Insurance Information [Line Items]      
GROSS AMOUNT $ 311,970 $ 244,329 $ 171,694
CEDED TO OTHER COMPANIES 92,762 51,239 58,667
ASSUMED FROM OTHER COMPANIES 418,258 425,960 405,845
NET AMOUNT $ 637,466 $ 619,050 $ 518,872
PERCENTAGE OF AMOUNT ASSUMED TO NET 65.60% 68.80% 78.20%
EXCEL 162 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 163 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 164 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 166 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1737 656 1 true 240 0 false 13 false false R1.htm 0000001 - Document - COVER Sheet http://www.axiscapital.com/role/COVER COVER Cover 1 false false R2.htm 0000002 - Document - AUDIT INFORMATION Sheet http://www.axiscapital.com/role/AUDITINFORMATION AUDIT INFORMATION Cover 2 false false R3.htm 0000003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY Sheet http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Statements 9 false false R10.htm 0000010 - Disclosure - ORGANIZATION Sheet http://www.axiscapital.com/role/ORGANIZATION ORGANIZATION Notes 10 false false R11.htm 0000011 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Notes 11 false false R12.htm 0000012 - Disclosure - SEGMENT INFORMATION Sheet http://www.axiscapital.com/role/SEGMENTINFORMATION SEGMENT INFORMATION Notes 12 false false R13.htm 0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETS GOODWILL AND INTANGIBLE ASSETS Notes 13 false false R14.htm 0000014 - Disclosure - INVESTMENTS Sheet http://www.axiscapital.com/role/INVESTMENTS INVESTMENTS Notes 14 false false R15.htm 0000015 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 15 false false R16.htm 0000016 - Disclosure - DERIVATIVE INSTRUMENTS Sheet http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTS DERIVATIVE INSTRUMENTS Notes 16 false false R17.htm 0000017 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSES RESERVE FOR LOSSES AND LOSS EXPENSES Notes 17 false false R18.htm 0000018 - Disclosure - REINSURANCE Sheet http://www.axiscapital.com/role/REINSURANCE REINSURANCE Notes 18 false false R19.htm 0000019 - Disclosure - DEBT AND FINANCING ARRANGEMENTS Sheet http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTS DEBT AND FINANCING ARRANGEMENTS Notes 19 false false R20.htm 0000020 - Disclosure - FEDERAL HOME LOAN BANK ADVANCES Sheet http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCES FEDERAL HOME LOAN BANK ADVANCES Notes 20 false false R21.htm 0000021 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 21 false false R22.htm 0000022 - Disclosure - LEASES Sheet http://www.axiscapital.com/role/LEASES LEASES Notes 22 false false R23.htm 0000023 - Disclosure - EARNINGS PER COMMON SHARE Sheet http://www.axiscapital.com/role/EARNINGSPERCOMMONSHARE EARNINGS PER COMMON SHARE Notes 23 false false R24.htm 0000024 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://www.axiscapital.com/role/SHAREHOLDERSEQUITY SHAREHOLDERS' EQUITY Notes 24 false false R25.htm 0000025 - Disclosure - RETIREMENT PLANS Sheet http://www.axiscapital.com/role/RETIREMENTPLANS RETIREMENT PLANS Notes 25 false false R26.htm 0000026 - Disclosure - SHARE-BASED COMPENSATION Sheet http://www.axiscapital.com/role/SHAREBASEDCOMPENSATION SHARE-BASED COMPENSATION Notes 26 false false R27.htm 0000027 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 27 false false R28.htm 0000028 - Disclosure - REORGANIZATION EXPENSES Sheet http://www.axiscapital.com/role/REORGANIZATIONEXPENSES REORGANIZATION EXPENSES Notes 28 false false R29.htm 0000029 - Disclosure - INCOME TAXES Sheet http://www.axiscapital.com/role/INCOMETAXES INCOME TAXES Notes 29 false false R30.htm 0000030 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) Sheet http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSS OTHER COMPREHENSIVE INCOME (LOSS) Notes 30 false false R31.htm 0000031 - Disclosure - STATUTORY FINANCIAL INFORMATION Sheet http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATION STATUTORY FINANCIAL INFORMATION Notes 31 false false R32.htm 0000032 - Disclosure - SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES Sheet http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIES SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES Notes 32 false false R33.htm 0000033 - Disclosure - SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY Sheet http://www.axiscapital.com/role/SCHEDULEIICONDENSEDFINANCIALSTATEMENTSOFPARENTCOMPANY SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY Notes 33 false false R34.htm 0000034 - Disclosure - SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION Sheet http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATION SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION Notes 34 false false R35.htm 0000035 - Disclosure - SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION Sheet http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATION SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION Notes 35 false false R36.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 36 false false R37.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 37 false false R38.htm 9954471 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 38 false false R39.htm 9954472 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.axiscapital.com/role/SEGMENTINFORMATIONTables SEGMENT INFORMATION (Tables) Tables http://www.axiscapital.com/role/SEGMENTINFORMATION 39 false false R40.htm 9954473 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETS 40 false false R41.htm 9954474 - Disclosure - INVESTMENTS (Tables) Sheet http://www.axiscapital.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://www.axiscapital.com/role/INVESTMENTS 41 false false R42.htm 9954475 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTS 42 false false R43.htm 9954476 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) Sheet http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSTables DERIVATIVE INSTRUMENTS (Tables) Tables http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTS 43 false false R44.htm 9954477 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES (Tables) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESTables RESERVE FOR LOSSES AND LOSS EXPENSES (Tables) Tables http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSES 44 false false R45.htm 9954478 - Disclosure - REINSURANCE (Tables) Sheet http://www.axiscapital.com/role/REINSURANCETables REINSURANCE (Tables) Tables http://www.axiscapital.com/role/REINSURANCE 45 false false R46.htm 9954479 - Disclosure - DEBT AND FINANCING ARRANGEMENTS (Tables) Sheet http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSTables DEBT AND FINANCING ARRANGEMENTS (Tables) Tables http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTS 46 false false R47.htm 9954480 - Disclosure - LEASES (Tables) Sheet http://www.axiscapital.com/role/LEASESTables LEASES (Tables) Tables http://www.axiscapital.com/role/LEASES 47 false false R48.htm 9954481 - Disclosure - EARNINGS PER COMMON SHARE (Tables) Sheet http://www.axiscapital.com/role/EARNINGSPERCOMMONSHARETables EARNINGS PER COMMON SHARE (Tables) Tables http://www.axiscapital.com/role/EARNINGSPERCOMMONSHARE 48 false false R49.htm 9954482 - Disclosure - SHAREHOLDERS' EQUITY (Tables) Sheet http://www.axiscapital.com/role/SHAREHOLDERSEQUITYTables SHAREHOLDERS' EQUITY (Tables) Tables http://www.axiscapital.com/role/SHAREHOLDERSEQUITY 49 false false R50.htm 9954483 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONTables SHARE-BASED COMPENSATION (Tables) Tables http://www.axiscapital.com/role/SHAREBASEDCOMPENSATION 50 false false R51.htm 9954484 - Disclosure - INCOME TAXES (Tables) Sheet http://www.axiscapital.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://www.axiscapital.com/role/INCOMETAXES 51 false false R52.htm 9954485 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) (Tables) Sheet http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables OTHER COMPREHENSIVE INCOME (LOSS) (Tables) Tables http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSS 52 false false R53.htm 9954486 - Disclosure - STATUTORY FINANCIAL INFORMATION (Tables) Sheet http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONTables STATUTORY FINANCIAL INFORMATION (Tables) Tables http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATION 53 false false R54.htm 9954487 - Disclosure - ORGANIZATION (Details) Sheet http://www.axiscapital.com/role/ORGANIZATIONDetails ORGANIZATION (Details) Details http://www.axiscapital.com/role/ORGANIZATION 54 false false R55.htm 9954488 - Disclosure - SEGMENT INFORMATION - Summary of Underwriting Results of Reportable Segments (Details) Sheet http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails SEGMENT INFORMATION - Summary of Underwriting Results of Reportable Segments (Details) Details 55 false false R56.htm 9954489 - Disclosure - SEGMENT INFORMATION - Summary of Gross Premiums Written by Geographical Location of Subsidiaries (Details) Sheet http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails SEGMENT INFORMATION - Summary of Gross Premiums Written by Geographical Location of Subsidiaries (Details) Details 56 false false R57.htm 9954490 - Disclosure - SEGMENT INFORMATION - Summary of Net Premiums Earned by Segment and Line of Business (Details) Sheet http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails SEGMENT INFORMATION - Summary of Net Premiums Earned by Segment and Line of Business (Details) Details 57 false false R58.htm 9954491 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Goodwill and Intangible Assets (Details) Sheet http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails GOODWILL AND INTANGIBLE ASSETS - Summary of Goodwill and Intangible Assets (Details) Details 58 false false R59.htm 9954492 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) Sheet http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) Details 59 false false R60.htm 9954493 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Gross Amount and Accumulated Amortization by Category (Details) Sheet http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails GOODWILL AND INTANGIBLE ASSETS - Summary of Gross Amount and Accumulated Amortization by Category (Details) Details 60 false false R61.htm 9954494 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Estimated Amortization Expense (Details) Sheet http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails GOODWILL AND INTANGIBLE ASSETS - Summary of Estimated Amortization Expense (Details) Details 61 false false R62.htm 9954495 - Disclosure - INVESTMENTS - Fixed Maturities Available For Sale (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails INVESTMENTS - Fixed Maturities Available For Sale (Details) Details 62 false false R63.htm 9954496 - Disclosure - INVESTMENTS - Contractual Maturities (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails INVESTMENTS - Contractual Maturities (Details) Details 63 false false R64.htm 9954497 - Disclosure - INVESTMENTS - Gross Unrealized Losses (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails INVESTMENTS - Gross Unrealized Losses (Details) Details 64 false false R65.htm 9954498 - Disclosure - INVESTMENTS - Fixed Maturities, Held to Maturity (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails INVESTMENTS - Fixed Maturities, Held to Maturity (Details) Details 65 false false R66.htm 9954499 - Disclosure - INVESTMENTS - Narrative (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails INVESTMENTS - Narrative (Details) Details 66 false false R67.htm 9954500 - Disclosure - INVESTMENTS - Equity Securities (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails INVESTMENTS - Equity Securities (Details) Details 67 false false R68.htm 9954501 - Disclosure - INVESTMENTS - Mortgage Loans (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails INVESTMENTS - Mortgage Loans (Details) Details 68 false false R69.htm 9954502 - Disclosure - INVESTMENTS - Other Investments (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails INVESTMENTS - Other Investments (Details) Details 69 false false R70.htm 9954503 - Disclosure - INVESTMENTS - Equity method investments (Narrative) (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails INVESTMENTS - Equity method investments (Narrative) (Details) Details 70 false false R71.htm 9954504 - Disclosure - INVESTMENTS - Variable Interest Entities (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSVariableInterestEntitiesDetails INVESTMENTS - Variable Interest Entities (Details) Details 71 false false R72.htm 9954505 - Disclosure - INVESTMENTS - Net Investment Income (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails INVESTMENTS - Net Investment Income (Details) Details 72 false false R73.htm 9954506 - Disclosure - INVESTMENTS - Net Investment Gains (Losses) (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails INVESTMENTS - Net Investment Gains (Losses) (Details) Details 73 false false R74.htm 9954507 - Disclosure - INVESTMENTS - Summary of Allowance for Credit Loss (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSSummaryofAllowanceforCreditLossDetails INVESTMENTS - Summary of Allowance for Credit Loss (Details) Details 74 false false R75.htm 9954508 - Disclosure - INVESTMENTS - Fixed Maturity Securities (Narrative) (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails INVESTMENTS - Fixed Maturity Securities (Narrative) (Details) Details 75 false false R76.htm 9954509 - Disclosure - INVESTMENTS - Restricted Assets (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails INVESTMENTS - Restricted Assets (Details) Details 76 false false R77.htm 9954510 - Disclosure - INVESTMENTS - Reverse Repurchase Agreements (Details) Sheet http://www.axiscapital.com/role/INVESTMENTSReverseRepurchaseAgreementsDetails INVESTMENTS - Reverse Repurchase Agreements (Details) Details 77 false false R78.htm 9954511 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Details 78 false false R79.htm 9954512 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Level 3 Fair Value Measurement Inputs (Details) Sheet http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails FAIR VALUE MEASUREMENTS - Summary of Level 3 Fair Value Measurement Inputs (Details) Details 79 false false R80.htm 9954513 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Level 3 for Financial Instruments Measured at Fair Value (Details) Sheet http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails FAIR VALUE MEASUREMENTS - Summary of Changes in Level 3 for Financial Instruments Measured at Fair Value (Details) Details 80 false false R81.htm 9954514 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) Sheet http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails FAIR VALUE MEASUREMENTS - Narrative (Details) Details 81 false false R82.htm 9954515 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) Sheet http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details) Details 82 false false R83.htm 9954516 - Disclosure - DERIVATIVE INSTRUMENTS - Offsetting Assets and Liabilities (Details) Sheet http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails DERIVATIVE INSTRUMENTS - Offsetting Assets and Liabilities (Details) Details 83 false false R84.htm 9954517 - Disclosure - DERIVATIVE INSTRUMENTS - Gains (Losses) on Derivatives Recognized in Net Income (Details) Sheet http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails DERIVATIVE INSTRUMENTS - Gains (Losses) on Derivatives Recognized in Net Income (Details) Details 84 false false R85.htm 9954518 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Narrative (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Narrative (Details) Details 85 false false R86.htm 9954519 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve for Losses and Loss Expenses (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveforLossesandLossExpensesDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve for Losses and Loss Expenses (Details) Details 86 false false R87.htm 9954520 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve Roll-forward (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve Roll-forward (Details) Details 87 false false R88.htm 9954521 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Losses Narrative (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Losses Narrative (Details) Details 88 false false R89.htm 9954522 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Prior Year Reserve Development (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Prior Year Reserve Development (Details) Details 89 false false R90.htm 9954523 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Summary of Prior Year Reserve Development by Segment and Reserving Class (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Summary of Prior Year Reserve Development by Segment and Reserving Class (Details) Details 90 false false R91.htm 9954524 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details) Details 91 false false R92.htm 9954525 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details) Details 92 false false R93.htm 9954526 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Details) Details 93 false false R94.htm 9954527 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reconciliation of Development Tables to Consolidated Balance Sheet (Details) Sheet http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails RESERVE FOR LOSSES AND LOSS EXPENSES - Reconciliation of Development Tables to Consolidated Balance Sheet (Details) Details 94 false false R95.htm 9954528 - Disclosure - REINSURANCE (Details) Sheet http://www.axiscapital.com/role/REINSURANCEDetails REINSURANCE (Details) Details http://www.axiscapital.com/role/REINSURANCETables 95 false false R96.htm 9954529 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Summary of Debt (Details) Sheet http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails DEBT AND FINANCING ARRANGEMENTS - Summary of Debt (Details) Details 96 false false R97.htm 9954530 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Debt terms (Details) Sheet http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails DEBT AND FINANCING ARRANGEMENTS - Debt terms (Details) Details 97 false false R98.htm 9954531 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Senior and Notes Payable (Details) Notes http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails DEBT AND FINANCING ARRANGEMENTS - Senior and Notes Payable (Details) Details 98 false false R99.htm 9954532 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Summary of Debt Maturity (Details) Sheet http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails DEBT AND FINANCING ARRANGEMENTS - Summary of Debt Maturity (Details) Details 99 false false R100.htm 9954533 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Loan Advances Made to a Third Party Reinsurer (Details) Sheet http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails DEBT AND FINANCING ARRANGEMENTS - Loan Advances Made to a Third Party Reinsurer (Details) Details 100 false false R101.htm 9954534 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Letter of Credit facility (Details) Sheet http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails DEBT AND FINANCING ARRANGEMENTS - Letter of Credit facility (Details) Details 101 false false R102.htm 9954535 - Disclosure - FEDERAL HOME LOAN BANK ADVANCES (Details) Sheet http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails FEDERAL HOME LOAN BANK ADVANCES (Details) Details http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCES 102 false false R103.htm 9954536 - Disclosure - COMMITMENTS AND CONTINGENCIES - Cash and Investments (Details) Sheet http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESCashandInvestmentsDetails COMMITMENTS AND CONTINGENCIES - Cash and Investments (Details) Details 103 false false R104.htm 9954537 - Disclosure - COMMITMENTS AND CONTINGENCIES - Reinsurance and Premiums (Details) Sheet http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails COMMITMENTS AND CONTINGENCIES - Reinsurance and Premiums (Details) Details 104 false false R105.htm 9954538 - Disclosure - COMMITMENTS AND CONTINGENCIES - Reinsurance Purchase Commitment, Investments and Funds at Lloyd's (Details) Sheet http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails COMMITMENTS AND CONTINGENCIES - Reinsurance Purchase Commitment, Investments and Funds at Lloyd's (Details) Details 105 false false R106.htm 9954539 - Disclosure - LEASES - Summary of Lease Expense and Related Cash Flows (Details) Sheet http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails LEASES - Summary of Lease Expense and Related Cash Flows (Details) Details 106 false false R107.htm 9954540 - Disclosure - LEASES - Summary of Maturity and Minimum Lease Payments (Details) Sheet http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails LEASES - Summary of Maturity and Minimum Lease Payments (Details) Details 107 false false R108.htm 9954541 - Disclosure - EARNINGS PER COMMON SHARE (Details) Sheet http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails EARNINGS PER COMMON SHARE (Details) Details http://www.axiscapital.com/role/EARNINGSPERCOMMONSHARETables 108 false false R109.htm 9954542 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Common Shares Issued and Outstanding (Details) Sheet http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails SHAREHOLDERS' EQUITY - Summary of Common Shares Issued and Outstanding (Details) Details 109 false false R110.htm 9954543 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Share Repurchases (Details) Sheet http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails SHAREHOLDERS' EQUITY - Summary of Share Repurchases (Details) Details 110 false false R111.htm 9954544 - Disclosure - SHAREHOLDERS' EQUITY - Preferred Shares Narrative (Details) Sheet http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails SHAREHOLDERS' EQUITY - Preferred Shares Narrative (Details) Details 111 false false R112.htm 9954545 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Dividends Declared and Paid (Details) Sheet http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails SHAREHOLDERS' EQUITY - Summary of Dividends Declared and Paid (Details) Details 112 false false R113.htm 9954546 - Disclosure - RETIREMENT PLANS (Details) Sheet http://www.axiscapital.com/role/RETIREMENTPLANSDetails RETIREMENT PLANS (Details) Details http://www.axiscapital.com/role/RETIREMENTPLANS 113 false false R114.htm 9954547 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) Sheet http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails SHARE-BASED COMPENSATION - Narrative (Details) Details 114 false false R115.htm 9954548 - Disclosure - SHARE-BASED COMPENSATION - Valuation Assumptions (Details) Sheet http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails SHARE-BASED COMPENSATION - Valuation Assumptions (Details) Details 115 false false R116.htm 9954549 - Disclosure - SHARE-BASED COMPENSATION - Summary of Shares and Cash Settled Awards (Details) Sheet http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails SHARE-BASED COMPENSATION - Summary of Shares and Cash Settled Awards (Details) Details 116 false false R117.htm 9954550 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Additional Information Related to Share-based Compensation (Details) Sheet http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails SHARE-BASED COMPENSATION - Schedule of Additional Information Related to Share-based Compensation (Details) Details 117 false false R118.htm 9954551 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONS 118 false false R119.htm 9954552 - Disclosure - REORGANIZATION EXPENSES (Details) Sheet http://www.axiscapital.com/role/REORGANIZATIONEXPENSESDetails REORGANIZATION EXPENSES (Details) Details http://www.axiscapital.com/role/REORGANIZATIONEXPENSES 119 false false R120.htm 9954553 - Disclosure - INCOME TAXES - Summary of Income Tax Expense and Net Tax Assets (Details) Sheet http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails INCOME TAXES - Summary of Income Tax Expense and Net Tax Assets (Details) Details 120 false false R121.htm 9954554 - Disclosure - INCOME TAXES - Summary of Deferred Tax Assets and Liabilities (Details) Sheet http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails INCOME TAXES - Summary of Deferred Tax Assets and Liabilities (Details) Details 121 false false R122.htm 9954555 - Disclosure - INCOME TAXES - Summary of Operating and Capital Loss Carryforwards and Tax Credits (Details) Sheet http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails INCOME TAXES - Summary of Operating and Capital Loss Carryforwards and Tax Credits (Details) Details 122 false false R123.htm 9954556 - Disclosure - INCOME TAXES - Summary of Valuation Allowance (Details) Sheet http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails INCOME TAXES - Summary of Valuation Allowance (Details) Details 123 false false R124.htm 9954557 - Disclosure - INCOME TAXES - Narrative (Details) Sheet http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails INCOME TAXES - Narrative (Details) Details 124 false false R125.htm 9954558 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate Reconciliation (Details) Sheet http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails INCOME TAXES - Summary of Effective Tax Rate Reconciliation (Details) Details 125 false false R126.htm 9954559 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) (Details) Sheet http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) (Details) Details http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables 126 false false R127.htm 9954560 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders (Details) Sheet http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders (Details) Details http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables 127 false false R128.htm 9954561 - Disclosure - STATUTORY FINANCIAL INFORMATION (Details) Sheet http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails STATUTORY FINANCIAL INFORMATION (Details) Details http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONTables 128 false false R129.htm 9954562 - Disclosure - SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES (Details) Sheet http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES (Details) Details http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIES 129 false false R130.htm 9954563 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS (Details) Sheet http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails SCHEDULE II - CONDENSED BALANCE SHEETS (Details) Details 130 false false R131.htm 9954564 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS - Additional Information (Details) Sheet http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails SCHEDULE II - CONDENSED BALANCE SHEETS - Additional Information (Details) Details 131 false false R132.htm 9954565 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS - Footnotes (Details) Notes http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails SCHEDULE II - CONDENSED BALANCE SHEETS - Footnotes (Details) Details 132 false false R133.htm 9954566 - Disclosure - SCHEDULE II - CONDENSED STATEMENTS OF OPERATIONS (Details) Sheet http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails SCHEDULE II - CONDENSED STATEMENTS OF OPERATIONS (Details) Details 133 false false R134.htm 9954567 - Disclosure - SCHEDULE II - CONDENSED STATEMENTS OF CASH FLOWS (Details) Sheet http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails SCHEDULE II - CONDENSED STATEMENTS OF CASH FLOWS (Details) Details 134 false false R135.htm 9954568 - Disclosure - SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION (Details) Sheet http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION (Details) Details http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATION 135 false false R136.htm 9954569 - Disclosure - SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION (Details) Sheet http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION (Details) Details http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATION 136 false false All Reports Book All Reports axs-20231231.htm axs-20231231.xsd axs-20231231_cal.xml axs-20231231_def.xml axs-20231231_lab.xml axs-20231231_pre.xml axs-20231231_g1.jpg http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 169 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "axs-20231231.htm": { "nsprefix": "axs", "nsuri": "http://www.axiscapital.com/20231231", "dts": { "inline": { "local": [ "axs-20231231.htm" ] }, "schema": { "local": [ "axs-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "axs-20231231_cal.xml" ] }, "definitionLink": { "local": [ "axs-20231231_def.xml" ] }, "labelLink": { "local": [ "axs-20231231_lab.xml" ] }, "presentationLink": { "local": [ "axs-20231231_pre.xml" ] } }, "keyStandard": 569, "keyCustom": 87, "axisStandard": 60, "axisCustom": 5, "memberStandard": 112, "memberCustom": 106, "hidden": { "total": 17, "http://fasb.org/us-gaap/2023": 13, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 1737, "entityCount": 1, "segmentCount": 240, "elementCount": 1273, "unitCount": 13, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 5103, "http://xbrl.sec.gov/dei/2023": 41, "http://fasb.org/srt/2023": 5, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.axiscapital.com/role/COVER", "longName": "0000001 - Document - COVER", "shortName": "COVER", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.axiscapital.com/role/AUDITINFORMATION", "longName": "0000002 - Document - AUDIT INFORMATION", "shortName": "AUDIT INFORMATION", "isDefault": "false", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "dei:AuditorFirmId", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:AuditorFirmId", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R4": { "role": "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R5": { "role": "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PremiumsEarnedNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "axs:AllowanceForCreditLossPeriodIncreaseDecrease", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R6": { "role": "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R7": { "role": "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-22", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "us-gaap:StockholdersEquity", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-22", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "us-gaap:StockholdersEquity", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "axs:NetRealizedAndUnrealizedGainLossOnAlternativeInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R9": { "role": "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CededPremiumsWritten", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EffectsOfReinsuranceTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-9", "name": "axs:TransferToInvestmentsAvailableForSaleToFixedMaturities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R10": { "role": "http://www.axiscapital.com/role/ORGANIZATION", "longName": "0000010 - Disclosure - ORGANIZATION", "shortName": "ORGANIZATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES", "longName": "0000011 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.axiscapital.com/role/SEGMENTINFORMATION", "longName": "0000012 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETS", "longName": "0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS", "shortName": "GOODWILL AND INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.axiscapital.com/role/INVESTMENTS", "longName": "0000014 - Disclosure - INVESTMENTS", "shortName": "INVESTMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTS", "longName": "0000015 - Disclosure - FAIR VALUE MEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTS", "longName": "0000016 - Disclosure - DERIVATIVE INSTRUMENTS", "shortName": "DERIVATIVE INSTRUMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSES", "longName": "0000017 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.axiscapital.com/role/REINSURANCE", "longName": "0000018 - Disclosure - REINSURANCE", "shortName": "REINSURANCE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ReinsuranceTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ReinsuranceTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTS", "longName": "0000019 - Disclosure - DEBT AND FINANCING ARRANGEMENTS", "shortName": "DEBT AND FINANCING ARRANGEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCES", "longName": "0000020 - Disclosure - FEDERAL HOME LOAN BANK ADVANCES", "shortName": "FEDERAL HOME LOAN BANK ADVANCES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FederalHomeLoanBankAdvancesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FederalHomeLoanBankAdvancesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIES", "longName": "0000021 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.axiscapital.com/role/LEASES", "longName": "0000022 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHARE", "longName": "0000023 - Disclosure - EARNINGS PER COMMON SHARE", "shortName": "EARNINGS PER COMMON SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.axiscapital.com/role/SHAREHOLDERSEQUITY", "longName": "0000024 - Disclosure - SHAREHOLDERS' EQUITY", "shortName": "SHAREHOLDERS' EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.axiscapital.com/role/RETIREMENTPLANS", "longName": "0000025 - Disclosure - RETIREMENT PLANS", "shortName": "RETIREMENT PLANS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATION", "longName": "0000026 - Disclosure - SHARE-BASED COMPENSATION", "shortName": "SHARE-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONS", "longName": "0000027 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.axiscapital.com/role/REORGANIZATIONEXPENSES", "longName": "0000028 - Disclosure - REORGANIZATION EXPENSES", "shortName": "REORGANIZATION EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.axiscapital.com/role/INCOMETAXES", "longName": "0000029 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSS", "longName": "0000030 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS)", "shortName": "OTHER COMPREHENSIVE INCOME (LOSS)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATION", "longName": "0000031 - Disclosure - STATUTORY FINANCIAL INFORMATION", "shortName": "STATUTORY FINANCIAL INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "axs:StatutoryAccountingPracticesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "axs:StatutoryAccountingPracticesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIES", "longName": "0000032 - Disclosure - SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES", "shortName": "SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDFINANCIALSTATEMENTSOFPARENTCOMPANY", "longName": "0000033 - Disclosure - SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY", "shortName": "SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATION", "longName": "0000034 - Disclosure - SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION", "shortName": "SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATION", "longName": "0000035 - Disclosure - SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION", "shortName": "SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R36": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R37": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "37", "firstAnchor": { "contextRef": "c-1697", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1697", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies", "longName": "9954471 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.axiscapital.com/role/SEGMENTINFORMATIONTables", "longName": "9954472 - Disclosure - SEGMENT INFORMATION (Tables)", "shortName": "SEGMENT INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSTables", "longName": "9954473 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.axiscapital.com/role/INVESTMENTSTables", "longName": "9954474 - Disclosure - INVESTMENTS (Tables)", "shortName": "INVESTMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSTables", "longName": "9954475 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSTables", "longName": "9954476 - Disclosure - DERIVATIVE INSTRUMENTS (Tables)", "shortName": "DERIVATIVE INSTRUMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESTables", "longName": "9954477 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES (Tables)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "axs:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedAndIncurredButNotReportedClaimsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "axs:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedAndIncurredButNotReportedClaimsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.axiscapital.com/role/REINSURANCETables", "longName": "9954478 - Disclosure - REINSURANCE (Tables)", "shortName": "REINSURANCE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectsOfReinsuranceTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectsOfReinsuranceTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSTables", "longName": "9954479 - Disclosure - DEBT AND FINANCING ARRANGEMENTS (Tables)", "shortName": "DEBT AND FINANCING ARRANGEMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.axiscapital.com/role/LEASESTables", "longName": "9954480 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHARETables", "longName": "9954481 - Disclosure - EARNINGS PER COMMON SHARE (Tables)", "shortName": "EARNINGS PER COMMON SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYTables", "longName": "9954482 - Disclosure - SHAREHOLDERS' EQUITY (Tables)", "shortName": "SHAREHOLDERS' EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONTables", "longName": "9954483 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "shortName": "SHARE-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.axiscapital.com/role/INCOMETAXESTables", "longName": "9954484 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables", "longName": "9954485 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) (Tables)", "shortName": "OTHER COMPREHENSIVE INCOME (LOSS) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONTables", "longName": "9954486 - Disclosure - STATUTORY FINANCIAL INFORMATION (Tables)", "shortName": "STATUTORY FINANCIAL INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "53", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StatutoryAccountingPracticesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StatutoryAccountingPracticesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.axiscapital.com/role/ORGANIZATIONDetails", "longName": "9954487 - Disclosure - ORGANIZATION (Details)", "shortName": "ORGANIZATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-78", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-78", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails", "longName": "9954488 - Disclosure - SEGMENT INFORMATION - Summary of Underwriting Results of Reportable Segments (Details)", "shortName": "SEGMENT INFORMATION - Summary of Underwriting Results of Reportable Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "reportablesegment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "reportablesegment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails", "longName": "9954489 - Disclosure - SEGMENT INFORMATION - Summary of Gross Premiums Written by Geographical Location of Subsidiaries (Details)", "shortName": "SEGMENT INFORMATION - Summary of Gross Premiums Written by Geographical Location of Subsidiaries (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PremiumsWrittenGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-103", "name": "us-gaap:PremiumsWrittenGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R57": { "role": "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "longName": "9954490 - Disclosure - SEGMENT INFORMATION - Summary of Net Premiums Earned by Segment and Line of Business (Details)", "shortName": "SEGMENT INFORMATION - Summary of Net Premiums Earned by Segment and Line of Business (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PremiumsEarnedNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-115", "name": "us-gaap:PremiumsEarnedNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R58": { "role": "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails", "longName": "9954491 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Goodwill and Intangible Assets (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Summary of Goodwill and Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:GoodwillGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "us-gaap:GoodwillGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails", "longName": "9954492 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R60": { "role": "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails", "longName": "9954493 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Gross Amount and Accumulated Amortization by Category (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Summary of Gross Amount and Accumulated Amortization by Category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails", "longName": "9954494 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Estimated Amortization Expense (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Summary of Estimated Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "longName": "9954495 - Disclosure - INVESTMENTS - Fixed Maturities Available For Sale (Details)", "shortName": "INVESTMENTS - Fixed Maturities Available For Sale (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R63": { "role": "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "longName": "9954496 - Disclosure - INVESTMENTS - Contractual Maturities (Details)", "shortName": "INVESTMENTS - Contractual Maturities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "longName": "9954497 - Disclosure - INVESTMENTS - Gross Unrealized Losses (Details)", "shortName": "INVESTMENTS - Gross Unrealized Losses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-199", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-199", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails", "longName": "9954498 - Disclosure - INVESTMENTS - Fixed Maturities, Held to Maturity (Details)", "shortName": "INVESTMENTS - Fixed Maturities, Held to Maturity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:HeldToMaturitySecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:HeldToMaturitySecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "longName": "9954499 - Disclosure - INVESTMENTS - Narrative (Details)", "shortName": "INVESTMENTS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:HeldToMaturitySecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-189", "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R67": { "role": "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails", "longName": "9954500 - Disclosure - INVESTMENTS - Equity Securities (Details)", "shortName": "INVESTMENTS - Equity Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:EquitySecuritiesFvNiCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGain", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R68": { "role": "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails", "longName": "9954501 - Disclosure - INVESTMENTS - Mortgage Loans (Details)", "shortName": "INVESTMENTS - Mortgage Loans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails", "longName": "9954502 - Disclosure - INVESTMENTS - Other Investments (Details)", "shortName": "INVESTMENTS - Other Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AlternativeInvestment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "axs:AlternativeInvestmentsFairValueDisclosurePercentageOfTotal", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R70": { "role": "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails", "longName": "9954503 - Disclosure - INVESTMENTS - Equity method investments (Narrative) (Details)", "shortName": "INVESTMENTS - Equity method investments (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-271", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R71": { "role": "http://www.axiscapital.com/role/INVESTMENTSVariableInterestEntitiesDetails", "longName": "9954504 - Disclosure - INVESTMENTS - Variable Interest Entities (Details)", "shortName": "INVESTMENTS - Variable Interest Entities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-275", "name": "axs:PercentageOfInvestmentComposition", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-275", "name": "axs:PercentageOfInvestmentComposition", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "longName": "9954505 - Disclosure - INVESTMENTS - Net Investment Income (Details)", "shortName": "INVESTMENTS - Net Investment Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-1", "name": "axs:InvestmentIncomeForInvestmentsAndCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentIncomeTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "axs:InvestmentIncomeForInvestmentsAndCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentIncomeTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails", "longName": "9954506 - Disclosure - INVESTMENTS - Net Investment Gains (Losses) (Details)", "shortName": "INVESTMENTS - Net Investment Gains (Losses) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:GainLossOnInvestmentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:GainLossOnInvestmentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.axiscapital.com/role/INVESTMENTSSummaryofAllowanceforCreditLossDetails", "longName": "9954507 - Disclosure - INVESTMENTS - Summary of Allowance for Credit Loss (Details)", "shortName": "INVESTMENTS - Summary of Allowance for Credit Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R75": { "role": "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "longName": "9954508 - Disclosure - INVESTMENTS - Fixed Maturity Securities (Narrative) (Details)", "shortName": "INVESTMENTS - Fixed Maturity Securities (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-294", "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R76": { "role": "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "longName": "9954509 - Disclosure - INVESTMENTS - Restricted Assets (Details)", "shortName": "INVESTMENTS - Restricted Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-6", "name": "axs:PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForIntercompanyInsuranceAndReinsuranceAgreements", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "axs:PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForIntercompanyInsuranceAndReinsuranceAgreements", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.axiscapital.com/role/INVESTMENTSReverseRepurchaseAgreementsDetails", "longName": "9954510 - Disclosure - INVESTMENTS - Reverse Repurchase Agreements (Details)", "shortName": "INVESTMENTS - Reverse Repurchase Agreements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:SecuritiesForReverseRepurchaseAgreements", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:SecuritiesForReverseRepurchaseAgreements", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "longName": "9954511 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R79": { "role": "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "longName": "9954512 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Level 3 Fair Value Measurement Inputs (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Summary of Level 3 Fair Value Measurement Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AlternativeInvestment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-446", "name": "us-gaap:AlternativeInvestment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R80": { "role": "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "longName": "9954513 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Level 3 for Financial Instruments Measured at Fair Value (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Summary of Changes in Level 3 for Financial Instruments Measured at Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-63", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R81": { "role": "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "longName": "9954514 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c-1", "name": "axs:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersFromLevel2IntoLevel3", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "axs:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersFromLevel2IntoLevel3", "axs:FairValueMeasurementWithUnobservableInputsReconciliationAssetsTransfersFromLevel2IntoLevel3", "axs:FairValueMeasurementWithUnobservableInputsReconciliationAssetsTransfersFromLevel2IntoLevel3", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "axs:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersFromLevel2IntoLevel3", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "axs:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersFromLevel2IntoLevel3", "axs:FairValueMeasurementWithUnobservableInputsReconciliationAssetsTransfersFromLevel2IntoLevel3", "axs:FairValueMeasurementWithUnobservableInputsReconciliationAssetsTransfersFromLevel2IntoLevel3", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R82": { "role": "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "longName": "9954515 - Disclosure - DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)", "shortName": "DERIVATIVE INSTRUMENTS - Schedule of Derivative Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-504", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R83": { "role": "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails", "longName": "9954516 - Disclosure - DERIVATIVE INSTRUMENTS - Offsetting Assets and Liabilities (Details)", "shortName": "DERIVATIVE INSTRUMENTS - Offsetting Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R84": { "role": "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "longName": "9954517 - Disclosure - DERIVATIVE INSTRUMENTS - Gains (Losses) on Derivatives Recognized in Net Income (Details)", "shortName": "DERIVATIVE INSTRUMENTS - Gains (Losses) on Derivatives Recognized in Net Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:GainLossOnInvestmentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-515", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R85": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "longName": "9954518 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Narrative (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c-1258", "name": "us-gaap:ShortDurationContractsDiscountedLiabilitiesDiscountRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1258", "name": "us-gaap:ShortDurationContractsDiscountedLiabilitiesDiscountRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R86": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveforLossesandLossExpensesDetails", "longName": "9954519 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve for Losses and Loss Expenses (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve for Losses and Loss Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "axs:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedAndIncurredButNotReportedClaimsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "axs:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedAndIncurredButNotReportedClaimsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R87": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails", "longName": "9954520 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve Roll-forward (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Reserve Roll-forward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-64", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R88": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails", "longName": "9954521 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Losses Narrative (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Losses Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-521", "name": "axs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignExchangeLossPortfolioTransferAndOther", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R89": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails", "longName": "9954522 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Prior Year Reserve Development (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Prior Year Reserve Development (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R90": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "longName": "9954523 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Summary of Prior Year Reserve Development by Segment and Reserving Class (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Summary of Prior Year Reserve Development by Segment and Reserving Class (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-530", "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R91": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "longName": "9954524 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "c-639", "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-639", "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R92": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "longName": "9954525 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Cumulative Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-639", "name": "us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R93": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "longName": "9954526 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "c-639", "name": "us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-639", "name": "us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R94": { "role": "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "longName": "9954527 - Disclosure - RESERVE FOR LOSSES AND LOSS EXPENSES - Reconciliation of Development Tables to Consolidated Balance Sheet (Details)", "shortName": "RESERVE FOR LOSSES AND LOSS EXPENSES - Reconciliation of Development Tables to Consolidated Balance Sheet (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "axs:ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R95": { "role": "http://www.axiscapital.com/role/REINSURANCEDetails", "longName": "9954528 - Disclosure - REINSURANCE (Details)", "shortName": "REINSURANCE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PremiumsWrittenGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "axs:PremiumsEarnedGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EffectsOfReinsuranceTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R96": { "role": "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "longName": "9954529 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Summary of Debt (Details)", "shortName": "DEBT AND FINANCING ARRANGEMENTS - Summary of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:NotesPayable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1431", "name": "us-gaap:NotesPayable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R97": { "role": "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "longName": "9954530 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Debt terms (Details)", "shortName": "DEBT AND FINANCING ARRANGEMENTS - Debt terms (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "c-1430", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1430", "name": "axs:DebtInstrumentIssuancePricePercent", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R98": { "role": "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "longName": "9954531 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Senior and Notes Payable (Details)", "shortName": "DEBT AND FINANCING ARRANGEMENTS - Senior and Notes Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "c-1450", "name": "us-gaap:InterestExpenseDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1450", "name": "us-gaap:InterestExpenseDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R99": { "role": "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails", "longName": "9954532 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Summary of Debt Maturity (Details)", "shortName": "DEBT AND FINANCING ARRANGEMENTS - Summary of Debt Maturity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R100": { "role": "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "longName": "9954533 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Loan Advances Made to a Third Party Reinsurer (Details)", "shortName": "DEBT AND FINANCING ARRANGEMENTS - Loan Advances Made to a Third Party Reinsurer (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PaymentsForAdvanceToAffiliate", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1457", "name": "us-gaap:PaymentsForAdvanceToAffiliate", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R101": { "role": "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails", "longName": "9954534 - Disclosure - DEBT AND FINANCING ARRANGEMENTS - Letter of Credit facility (Details)", "shortName": "DEBT AND FINANCING ARRANGEMENTS - Letter of Credit facility (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "c-1470", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1470", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R102": { "role": "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails", "longName": "9954535 - Disclosure - FEDERAL HOME LOAN BANK ADVANCES (Details)", "shortName": "FEDERAL HOME LOAN BANK ADVANCES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AdvancesFromFederalHomeLoanBanks", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1478", "name": "axs:FederalHomeLoanBankAdmittedAssetsActual", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-9", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R103": { "role": "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESCashandInvestmentsDetails", "longName": "9954536 - Disclosure - COMMITMENTS AND CONTINGENCIES - Cash and Investments (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES - Cash and Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R104": { "role": "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails", "longName": "9954537 - Disclosure - COMMITMENTS AND CONTINGENCIES - Reinsurance and Premiums (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES - Reinsurance and Premiums (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:PremiumsReceivableAllowanceForDoubtfulAccounts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R105": { "role": "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "longName": "9954538 - Disclosure - COMMITMENTS AND CONTINGENCIES - Reinsurance Purchase Commitment, Investments and Funds at Lloyd's (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES - Reinsurance Purchase Commitment, Investments and Funds at Lloyd's (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R106": { "role": "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails", "longName": "9954539 - Disclosure - LEASES - Summary of Lease Expense and Related Cash Flows (Details)", "shortName": "LEASES - Summary of Lease Expense and Related Cash Flows (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R107": { "role": "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails", "longName": "9954540 - Disclosure - LEASES - Summary of Maturity and Minimum Lease Payments (Details)", "shortName": "LEASES - Summary of Maturity and Minimum Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R108": { "role": "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails", "longName": "9954541 - Disclosure - EARNINGS PER COMMON SHARE (Details)", "shortName": "EARNINGS PER COMMON SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R109": { "role": "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails", "longName": "9954542 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Common Shares Issued and Outstanding (Details)", "shortName": "SHAREHOLDERS' EQUITY - Summary of Common Shares Issued and Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R110": { "role": "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails", "longName": "9954543 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Share Repurchases (Details)", "shortName": "SHAREHOLDERS' EQUITY - Summary of Share Repurchases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "c-1517", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1517", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R111": { "role": "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails", "longName": "9954544 - Disclosure - SHAREHOLDERS' EQUITY - Preferred Shares Narrative (Details)", "shortName": "SHAREHOLDERS' EQUITY - Preferred Shares Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "c-1524", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1524", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R112": { "role": "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails", "longName": "9954545 - Disclosure - SHAREHOLDERS' EQUITY - Summary of Dividends Declared and Paid (Details)", "shortName": "SHAREHOLDERS' EQUITY - Summary of Dividends Declared and Paid (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DividendsDeclaredTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DividendsDeclaredTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R113": { "role": "http://www.axiscapital.com/role/RETIREMENTPLANSDetails", "longName": "9954546 - Disclosure - RETIREMENT PLANS (Details)", "shortName": "RETIREMENT PLANS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R114": { "role": "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "longName": "9954547 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)", "shortName": "SHARE-BASED COMPENSATION - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "c-6", "name": "axs:TradingDaysProceedingPerformancePeriod", "unitRef": "trading_day", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "axs:TradingDaysProceedingPerformancePeriod", "unitRef": "trading_day", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R115": { "role": "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails", "longName": "9954548 - Disclosure - SHARE-BASED COMPENSATION - Valuation Assumptions (Details)", "shortName": "SHARE-BASED COMPENSATION - Valuation Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "c-1552", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1552", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R116": { "role": "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails", "longName": "9954549 - Disclosure - SHARE-BASED COMPENSATION - Summary of Shares and Cash Settled Awards (Details)", "shortName": "SHARE-BASED COMPENSATION - Summary of Shares and Cash Settled Awards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "c-1563", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1559", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R117": { "role": "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "longName": "9954550 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Additional Information Related to Share-based Compensation (Details)", "shortName": "SHARE-BASED COMPENSATION - Schedule of Additional Information Related to Share-based Compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1574", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R118": { "role": "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "longName": "9954551 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AlternativeInvestment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1619", "name": "us-gaap:AlternativeInvestment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R119": { "role": "http://www.axiscapital.com/role/REORGANIZATIONEXPENSESDetails", "longName": "9954552 - Disclosure - REORGANIZATION EXPENSES (Details)", "shortName": "REORGANIZATION EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "119", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R120": { "role": "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails", "longName": "9954553 - Disclosure - INCOME TAXES - Summary of Income Tax Expense and Net Tax Assets (Details)", "shortName": "INCOME TAXES - Summary of Income Tax Expense and Net Tax Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "120", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:IncomeTaxesReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R121": { "role": "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails", "longName": "9954554 - Disclosure - INCOME TAXES - Summary of Deferred Tax Assets and Liabilities (Details)", "shortName": "INCOME TAXES - Summary of Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "121", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R122": { "role": "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails", "longName": "9954555 - Disclosure - INCOME TAXES - Summary of Operating and Capital Loss Carryforwards and Tax Credits (Details)", "shortName": "INCOME TAXES - Summary of Operating and Capital Loss Carryforwards and Tax Credits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "122", "firstAnchor": { "contextRef": "c-1640", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1640", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R123": { "role": "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails", "longName": "9954556 - Disclosure - INCOME TAXES - Summary of Valuation Allowance (Details)", "shortName": "INCOME TAXES - Summary of Valuation Allowance (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "123", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1655", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfValuationAllowanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R124": { "role": "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "longName": "9954557 - Disclosure - INCOME TAXES - Narrative (Details)", "shortName": "INCOME TAXES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "124", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R125": { "role": "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "longName": "9954558 - Disclosure - INCOME TAXES - Summary of Effective Tax Rate Reconciliation (Details)", "shortName": "INCOME TAXES - Summary of Effective Tax Rate Reconciliation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "125", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R126": { "role": "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails", "longName": "9954559 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) (Details)", "shortName": "OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "126", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R127": { "role": "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails", "longName": "9954560 - Disclosure - OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders (Details)", "shortName": "OTHER COMPREHENSIVE INCOME (LOSS) - Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "127", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:GainLossOnInvestmentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1677", "name": "axs:AvailableForSaleSecuritiesGrossRealizedGainLossIncludingDerivativeGainsLossesExcludingOtherThanTemporaryImpairments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R128": { "role": "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails", "longName": "9954561 - Disclosure - STATUTORY FINANCIAL INFORMATION (Details)", "shortName": "STATUTORY FINANCIAL INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "128", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R129": { "role": "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails", "longName": "9954562 - Disclosure - SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES (Details)", "shortName": "SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "129", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R130": { "role": "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails", "longName": "9954563 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS (Details)", "shortName": "SCHEDULE II - CONDENSED BALANCE SHEETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "130", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1715", "name": "axs:InvestmentInSubsidiariesEquityBasis", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R131": { "role": "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "longName": "9954564 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS - Additional Information (Details)", "shortName": "SCHEDULE II - CONDENSED BALANCE SHEETS - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "131", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1715", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R132": { "role": "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails", "longName": "9954565 - Disclosure - SCHEDULE II - CONDENSED BALANCE SHEETS - Footnotes (Details)", "shortName": "SCHEDULE II - CONDENSED BALANCE SHEETS - Footnotes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "132", "firstAnchor": { "contextRef": "c-1430", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1720", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R133": { "role": "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails", "longName": "9954566 - Disclosure - SCHEDULE II - CONDENSED STATEMENTS OF OPERATIONS (Details)", "shortName": "SCHEDULE II - CONDENSED STATEMENTS OF OPERATIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "133", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1724", "name": "us-gaap:InvestmentIncomeNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R134": { "role": "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails", "longName": "9954567 - Disclosure - SCHEDULE II - CONDENSED STATEMENTS OF CASH FLOWS (Details)", "shortName": "SCHEDULE II - CONDENSED STATEMENTS OF CASH FLOWS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "134", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1724", "name": "us-gaap:IncreaseDecreaseInDueToAffiliates", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "unique": true } }, "R135": { "role": "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "longName": "9954568 - Disclosure - SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION (Details)", "shortName": "SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "135", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } }, "R136": { "role": "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails", "longName": "9954569 - Disclosure - SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION (Details)", "shortName": "SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "136", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DirectPremiumsWritten", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DirectPremiumsWritten", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "axs-20231231.htm", "first": true, "unique": true } } }, "tag": { "axs_A2017LongTermEquityCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "A2017LongTermEquityCompensationPlanMember", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2017 Long Term Equity Compensation Plan", "label": "2017 Long Term Equity Compensation Plan [Member]", "documentation": "2017 Long Term Equity Compensation Plan" } } }, "auth_ref": [] }, "axs_A3.900SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "A3.900SeniorNotesMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "3.900% Senior Notes", "label": "3.900% Senior Notes [Member]", "documentation": "3.900% Senior Notes [Member]" } } }, "auth_ref": [] }, "axs_A4.000SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "A4.000SeniorNotesMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "4.000% Senior Notes", "label": "4.000% Senior Notes [Member]", "documentation": "4.000% Senior Notes [Member]" } } }, "auth_ref": [] }, "axs_A5.15SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "A5.15SeniorNotesMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5.150% Senior Notes", "label": "5.15% Senior Notes [Member]", "documentation": "5.15% Senior Notes [Member]" } } }, "auth_ref": [] }, "srt_AMBestAMinusRatingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AMBestAMinusRatingMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AM Best, A- Rating", "label": "AM Best, A- Rating [Member]", "documentation": "A- credit rating as defined by the external credit rating agency, AM Best." } } }, "auth_ref": [] }, "axs_AXISSpecialtyFinanceLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AXISSpecialtyFinanceLLCMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AXIS Specialty Finance LLC", "label": "AXIS Specialty Finance LLC [Member]", "documentation": "AXIS Specialty Finance LLC" } } }, "auth_ref": [] }, "axs_AXISSpecialtyFinancePLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AXISSpecialtyFinancePLCMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AXIS Specialty Finance PLC", "label": "AXIS Specialty Finance PLC [Member]", "documentation": "AXIS Specialty Finance PLC" } } }, "auth_ref": [] }, "axs_AXISSyndicate1686Member": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AXISSyndicate1686Member", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Syndicate 1686", "label": "AXIS Syndicate 1686 [Member]", "documentation": "AXIS Syndicate 1686 [Member]" } } }, "auth_ref": [] }, "us-gaap_AccidentAndHealthInsuranceSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccidentAndHealthInsuranceSegmentMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident\u00a0and health", "label": "Accident and Health Insurance Product Line [Member]", "documentation": "Product line consisting of insurance against loss by illness or injury, including but not limited to medical, dental, disability, workmen's compensation and long-term care." } } }, "auth_ref": [ "r877", "r878", "r879", "r880", "r881", "r882", "r1416" ] }, "axs_AccidentAndHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AccidentAndHealthMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident and health", "label": "Accident and Health [Member]", "documentation": "Accident and Health" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intercompany payable", "label": "Accounts Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r152", "r1400" ] }, "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization of fixed maturities", "label": "Accretion (Amortization) of Discounts and Premiums, Investments", "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r201" ] }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Unrealized gains (losses) on available for sale investments", "netLabel": "Unrealized gains (losses) on available-for-sale investments, net of tax", "terseLabel": "Available for sale investments", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r326", "r327", "r328", "r330", "r339", "r340", "r1243" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r338", "r339", "r742", "r743", "r744", "r745", "r746", "r747" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r53", "r54", "r187", "r321", "r849", "r901", "r902" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r338", "r339", "r742", "r743", "r744", "r745", "r746", "r747" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r19", "r54", "r706", "r709", "r764", "r896", "r897", "r1243", "r1244", "r1245", "r1261", "r1262", "r1263" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative foreign currency translation adjustments, net of tax", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r3", "r19", "r54", "r339", "r340", "r743", "r744", "r745", "r746", "r747", "r1243" ] }, "us-gaap_AcquisitionCostRatio": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquisitionCostRatio", "calculation": { "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": "us-gaap_CombinedRatio", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition cost ratio", "label": "Acquisition Cost Ratio", "documentation": "Ratio of non-life acquisition costs to non-life net premiums earned." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r1175" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r178" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r659", "r660", "r661", "r928", "r1261", "r1262", "r1263", "r1372", "r1423" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r1181" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r1181" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r1181" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r1181" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r109", "r110", "r621" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "verboseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdministrationOfTheTreasuryBelgiumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdministrationOfTheTreasuryBelgiumMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Belgium", "label": "Administration of the Treasury, Belgium [Member]", "documentation": "Designated tax department of the government of Belgium." } } }, "auth_ref": [] }, "us-gaap_AdvancesFromFederalHomeLoanBanks": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvancesFromFederalHomeLoanBanks", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Home Loan Bank advances", "verboseLabel": "Advances from FHLB", "label": "Advance from Federal Home Loan Bank", "documentation": "Amount of borrowings as of the balance sheet date from the Federal Home Loan Bank, which are primarily used to cover shortages in the required reserve balance and liquidity shortages." } } }, "auth_ref": [ "r240" ] }, "srt_AffiliatedEntityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AffiliatedEntityMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Affiliate", "label": "Affiliated Entity [Member]", "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity." } } }, "auth_ref": [ "r285", "r982", "r1073", "r1123", "r1336", "r1380", "r1381", "r1382" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1145", "r1157", "r1167", "r1193" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r1148", "r1160", "r1170", "r1196" ] }, "axs_AgricultureLineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AgricultureLineMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agriculture", "label": "Agriculture Line [Member]", "documentation": "Agriculture line of business" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r1181" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r1188" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r1152", "r1161", "r1171", "r1188", "r1197", "r1201", "r1209" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r1207" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r654", "r666" ] }, "axs_AllowanceForCreditLossPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AllowanceForCreditLossPeriodIncreaseDecrease", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "axs_NetInvestmentGainLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "(Increase) decrease in allowance for expected credit losses", "label": "Allowance for Credit Loss, Period Increase (Decrease)", "documentation": "Amount of Increase (Decrease) in the Total Allowance for Credit Loss of Investments" } } }, "auth_ref": [] }, "us-gaap_AllowanceForLoanAndLeaseLossesRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForLoanAndLeaseLossesRealEstate", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails": { "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for expected credit losses", "negatedTerseLabel": "Allowance for expected credit losses", "label": "Allowance for Loan and Lease Losses, Real Estate", "documentation": "The reserve to cover probable credit losses related to specifically identified fixed maturity real estate loans as well as probable credit losses inherent in the remainder of that loan portfolio." } } }, "auth_ref": [] }, "axs_AllowanceForLoanAndLeaseLossesRealEstatePercentageOfTotal": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AllowanceForLoanAndLeaseLossesRealEstatePercentageOfTotal", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails": { "parentTag": "axs_TotalMortgageLoansHeldForInvestmentPercent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for expected credit losses (as a percent)", "label": "Allowance for Loan and Lease Losses, Real Estate, Percentage of Total", "documentation": "Allowance for Loan and Lease Losses, Real Estate, Percentage of Total" } } }, "auth_ref": [] }, "axs_AltaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AltaMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alt A", "label": "Alta [Member]", "documentation": "Residential mortgages with higher risk profile than prime mortgages due to lower credit scores or lower loan to value (LTV) ratios but have a better risk profile than subprime mortgages." } } }, "auth_ref": [] }, "us-gaap_AlternativeInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AlternativeInvestment", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other investments, at fair value", "terseLabel": "Asset fair\u00a0value", "netLabel": "Other investments", "label": "Alternative Investment", "documentation": "Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund." } } }, "auth_ref": [ "r716", "r728" ] }, "us-gaap_AlternativeInvestmentMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AlternativeInvestmentMeasurementInput", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discounted cash flow", "label": "Alternative Investment, Measurement Input", "documentation": "Value of input used to measure alternative investment." } } }, "auth_ref": [ "r721" ] }, "axs_AlternativeInvestmentsFairValueDisclosurePercentageOfTotal": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AlternativeInvestmentsFairValueDisclosurePercentageOfTotal", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of total fair value", "label": "Alternative Investments Fair Value Disclosure Percentage Of Total", "documentation": "The percentage of the total fair value of investments in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest. Investments include, but are not limited to, investments in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds." } } }, "auth_ref": [] }, "axs_AlternativeInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AlternativeInvestmentsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other investments", "label": "Alternative Investments [Member]", "documentation": "Fair value of investments in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest. Investments include, but are not limited to, investments in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDeferredCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDeferredCharges", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization", "label": "Amortization of Deferred Charges", "documentation": "The amount of amortization of deferred charges applied against earnings during the period." } } }, "auth_ref": [ "r193" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets", "negatedTerseLabel": "Amortization of intangible assets", "negatedLabel": "Amortization", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9", "r85", "r90" ] }, "us-gaap_AmortizationOfValueOfBusinessAcquiredVOBA": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfValueOfBusinessAcquiredVOBA", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of value of business acquired", "verboseLabel": "Amortization of value of business acquired", "negatedLabel": "Amortization of value of business acquired", "label": "Amortization of Value of Business Acquired (VOBA)", "documentation": "The adjustment that represents the periodic charge against earnings to reduce the value of business acquired (VOBA) over the expected life of the underlying insurance contracts. VOBA reflects the estimated fair value of a life insurance business in force and represents the portion of the cost to acquire the business that is allocated to the value of the right to receive future cash flows from insurance contracts existing at the date of acquisition. Such value is the present value of the actuarially determined projected cash flows for the acquired policies. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9" ] }, "axs_AnnuallyRedemptionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AnnuallyRedemptionMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annually Redemption", "label": "Annually Redemption [Member]", "documentation": "Annually Redemption" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average anti-dilutive shares excluded from the dilutive computation (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r396" ] }, "us-gaap_AociGainLossDebtSecuritiesAvailableForSaleWithAllowanceForCreditLossParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AociGainLossDebtSecuritiesAvailableForSaleWithAllowanceForCreditLossParentMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has been recognized", "label": "AOCI, Gain (Loss), Debt Securities, Available-for-Sale, with Allowance for Credit Loss, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with allowance for credit loss, attributable to parent." } } }, "auth_ref": [ "r492" ] }, "us-gaap_AociGainLossDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AociGainLossDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossParentMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains (losses) arising during the year for which an allowance for expected credit losses has not been recognized", "label": "AOCI, Gain (Loss), Debt Securities, Available-for-Sale, without Allowance for Credit Loss, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without allowance for credit loss, attributable to parent." } } }, "auth_ref": [ "r492" ] }, "axs_AonplcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AonplcMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aon plc", "label": "Aon plc [Member]", "documentation": "Aon plc" } } }, "auth_ref": [] }, "axs_ArthurJGallagherCoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ArthurJGallagherCoMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Arthur J. Gallagher & Co.", "label": "Arthur J. Gallagher & Co. [Member]", "documentation": "Arthur J. Gallagher & Co." } } }, "auth_ref": [] }, "axs_AspidaHoldingsLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AspidaHoldingsLtdMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aspida Holdings, Ltd", "label": "Aspida Holdings, Ltd [Member]", "documentation": "Aspida Holdings, Ltd" } } }, "auth_ref": [] }, "us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ABS", "label": "Asset-Backed Securities, Securitized Loans and Receivables [Member]", "documentation": "Securities that are primarily serviced with cash flows derived financial assets that are being securitized for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans. Excludes mortgage-backed securities." } } }, "auth_ref": [ "r1276", "r1286", "r1294", "r1335" ] }, "us-gaap_AssetPledgedAsCollateralMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetPledgedAsCollateralMember", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Pledged as Collateral", "label": "Asset Pledged as Collateral [Member]", "documentation": "Asset pledged as collateral." } } }, "auth_ref": [ "r697", "r955", "r1113", "r1392" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r227", "r316", "r359", "r407", "r422", "r428", "r478", "r540", "r541", "r543", "r544", "r545", "r547", "r549", "r551", "r552", "r697", "r699", "r735", "r844", "r975", "r1115", "r1134", "r1326", "r1327", "r1383" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Assets", "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r134" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsHeldByInsuranceRegulators": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldByInsuranceRegulators", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleRestricted", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Securities on deposit or in trust with regulatory authorities", "label": "Assets Held by Insurance Regulators", "documentation": "Carrying amount of cash and investment securities on deposit with state regulatory authorities in connection with capital requirements." } } }, "auth_ref": [ "r910" ] }, "us-gaap_AssumedPremiumsWritten": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssumedPremiumsWritten", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails": { "parentTag": "us-gaap_PremiumsWrittenNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ASSUMED FROM OTHER COMPANIES", "label": "Assumed Premiums Written", "documentation": "Amount of written premiums assumed from other entities." } } }, "auth_ref": [ "r906" ] }, "axs_AuditInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AuditInformationAbstract", "lang": { "en-us": { "role": { "label": "Audit Information [Abstract]", "documentation": "Audit Information" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.axiscapital.com/role/AUDITINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Firm ID", "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r1139", "r1140", "r1153" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.axiscapital.com/role/AUDITINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Location", "label": "Auditor Location" } } }, "auth_ref": [ "r1139", "r1140", "r1153" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.axiscapital.com/role/AUDITINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Name", "label": "Auditor Name" } } }, "auth_ref": [ "r1139", "r1140", "r1153" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross unrealized gains", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r444" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross unrealized losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r445" ] }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available for sale", "label": "Debt Securities, Available-for-Sale [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized losses", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after five years through ten years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r1279" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after five years through ten years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r450", "r833" ] }, "axs_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsPercentageOfFairValue": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsPercentageOfFairValue", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "axs_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDatePercentageOfFairValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after five years through ten years", "label": "Available For Sale Securities Debt Maturities After Five Through Ten Years Percentage Of Fair Value", "documentation": "Amount of available-for-sale debt securities at fair value maturing in sixth through tenth fiscal year following latest fiscal year, expressed as a percentage of the total fair value of debt securities classified as available-for-sale." } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after one year through five years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r1278" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after one year through five years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r449", "r832" ] }, "axs_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsPercentageOfFairValue": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsPercentageOfFairValue", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "axs_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDatePercentageOfFairValue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after one year through five years", "label": "Available For Sale Securities Debt Maturities After One Through Five Years Percentage Of Fair Value", "documentation": "Amount of available-for-sale debt securities at fair value maturing in second through fifth fiscal year following latest fiscal year, expressed as a percentage of the total fair value of debt securities classified as available-for-sale." } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after ten years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r1280" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after ten years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r451", "r834" ] }, "axs_AvailableForSaleSecuritiesDebtMaturitiesAfterYearTenPercentageOfFairValue": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterYearTenPercentageOfFairValue", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "axs_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDatePercentageOfFairValue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after ten years", "label": "Available For Sale Securities Debt Maturities After Year Ten Percentage Of Fair Value", "documentation": "Amount of available-for-sale debt securities at fair value maturing in the tenth fiscal year following latest fiscal year, expressed as a percentage of the total fair value of debt securities classified as available-for-sale." } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value", "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total fixed maturities with a single maturity date (fair value)", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date." } } }, "auth_ref": [ "r1275", "r1276", "r1394" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total fixed maturities with a single maturity date (amortized cost)", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date." } } }, "auth_ref": [ "r1275", "r1276", "r1393" ] }, "axs_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDatePercentageOfFairValue": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDatePercentageOfFairValue", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "axs_AvailableForSaleSecuritiesDebtSecuritiesPercentageOfFairValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Fixed maturities with a single maturity date (% of total fair value)", "label": "Available For Sale Securities Debt Maturities Single Maturity Date Percentage Of Fair Value", "documentation": "Fair value of investment in available-for-sale debt securities with a single maturity date and expressed as a percentage of the total fair value of debt securities classified as available-for-sale." } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in one year or less", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r1277" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in one year or less", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r448", "r831" ] }, "axs_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearPercentageOfFairValue": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearPercentageOfFairValue", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "axs_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDatePercentageOfFairValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in one year or less", "label": "Available For Sale Securities Debt Maturities Within One Year Percentage Of Fair Value", "documentation": "Amount of available-for-sale debt securities at fair value maturing in the next fiscal year following the latest fiscal year, expressed as a percentage of the total fair value of debt securities classified as available-for-sale." } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities without a single maturity date", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r1275", "r1276" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fixed maturities without a single maturity date (fair value)", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r447", "r830", "r1275" ] }, "axs_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDatePercentageOfFairValue": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDatePercentageOfFairValue", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": "axs_AvailableForSaleSecuritiesDebtSecuritiesPercentageOfFairValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities without a single maturity date (% of total fair value)", "label": "Available For Sale Securities Debt Maturities Without Single Maturity Date Percentage Of Fair Value", "documentation": "Amount of available-for-sale debt securities at fair value that do not have a single maturity date and which the entity has decided to disclose separately rather than allocating the fair value over several maturity groupings, expressed as a percentage of the total fair value of debt securities classified as available-for-sale." } } }, "auth_ref": [] }, "axs_AvailableForSaleSecuritiesDebtSecuritiesPercentageOfFairValue": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesDebtSecuritiesPercentageOfFairValue", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Available For Sale Securities Debt Securities Percentage Of Fair Value", "documentation": "Amount of available-for-sale debt securities at fair value, expressed as a percentage of the total fair value of debt securities classified as available-for-sale." } } }, "auth_ref": [] }, "axs_AvailableForSaleSecuritiesGrossRealizedGainLossIncludingDerivativeGainsLossesExcludingOtherThanTemporaryImpairments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesGrossRealizedGainLossIncludingDerivativeGainsLossesExcludingOtherThanTemporaryImpairments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other realized gains (losses)", "label": "Available For Sale Securities Gross Realized Gain (Loss) Including Derivative Gains (Losses) Excluding Other Than Temporary Impairments", "documentation": "This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include the change in fair value of investment-related derivatives not designated as hedges and any hedge ineffectiveness recognized in earnings in relation to investment portfolio-related fair value hedges." } } }, "auth_ref": [] }, "axs_AvailableForSaleSecuritiesPercentageOfFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AvailableForSaleSecuritiesPercentageOfFairValueAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "%\u00a0of\u00a0Total fair value", "label": "Available For Sale Securities Percentage Of Fair Value [Abstract]", "documentation": "Available For Sale Securities Percentage Of Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Date [Axis]", "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r1337", "r1338", "r1339", "r1340", "r1341", "r1342", "r1343", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Date [Domain]", "label": "Award Date [Domain]", "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r1337", "r1338", "r1339", "r1340", "r1341", "r1342", "r1343", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r1204" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r1205" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r1200" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r1200" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r1200" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r1200" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r1200" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r1200" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r649", "r650", "r651", "r652", "r653" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r1203" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r1202" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r1201" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r1201" ] }, "axs_AxisCorporateCapitalUKIILimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AxisCorporateCapitalUKIILimitedMember", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Axis Corporate Capital UK II Limited", "label": "Axis Corporate Capital UK II Limited [Member]", "documentation": "Axis Corporate Capital UK II Limited" } } }, "auth_ref": [] }, "axs_AxisCorporateCapitalUKLimitedIIMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AxisCorporateCapitalUKLimitedIIMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/ORGANIZATIONDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Axis Corporate Capital UK Limited II", "label": "Axis Corporate Capital UK Limited II [Member]", "documentation": "Axis Corporate Capital UK Limited II [Member]" } } }, "auth_ref": [] }, "axs_AxisCorporateCapitalUKLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "AxisCorporateCapitalUKLimitedMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/ORGANIZATIONDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Axis Corporate Capital UK Limited", "label": "Axis Corporate Capital UK Limited [Member]", "documentation": "Axis Corporate Capital UK Limited" } } }, "auth_ref": [] }, "country_BM": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "BM", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bermuda", "label": "BERMUDA" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" ], "lang": { "en-us": { "role": { "terseLabel": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r202" ] }, "us-gaap_BenefitsLossesAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BenefitsLossesAndExpenses", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Total expenses", "label": "Benefits, Losses and Expenses", "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs." } } }, "auth_ref": [ "r241" ] }, "us-gaap_BenefitsLossesAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BenefitsLossesAndExpensesAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses", "label": "Benefits, Losses and Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails", "http://www.axiscapital.com/role/ORGANIZATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r696", "r1108", "r1109" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails", "http://www.axiscapital.com/role/ORGANIZATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r115", "r117", "r696", "r1108", "r1109" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.axiscapital.com/role/ORGANIZATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r696" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://www.axiscapital.com/role/ORGANIZATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interests acquired", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r116" ] }, "us-gaap_CapitalLossCarryforwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalLossCarryforwardMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Capital loss carryforward", "label": "Capital Loss Carryforward [Member]", "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year." } } }, "auth_ref": [] }, "axs_CapitalSupportProvisionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "CapitalSupportProvisionPercentage", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/ORGANIZATIONDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital support, percentage", "label": "Capital Support Provision, Percentage", "documentation": "The amount of capital support provided to Lloyd's Syndicate 1686." } } }, "auth_ref": [] }, "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition Costs", "label": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs." } } }, "auth_ref": [ "r257", "r258" ] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reported Value Measurement", "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r139", "r140" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r61", "r312", "r1080" ] }, "us-gaap_CashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r62" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash - beginning of year", "periodEndLabel": "Cash, cash equivalents and restricted cash - end of year", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r61", "r199", "r356" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash", "terseLabel": "Increase (decrease) in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r199" ] }, "us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends received from subsidiaries", "label": "SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries", "documentation": "This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries." } } }, "auth_ref": [ "r368" ] }, "us-gaap_CashMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits." } } }, "auth_ref": [ "r312" ] }, "axs_CashSettledMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "CashSettledMember", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Settled", "label": "Cash Settled [Member]", "documentation": "Share-based compensation to be settled in cash." } } }, "auth_ref": [] }, "us-gaap_CatastropheMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CatastropheMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Catastrophe and Weather-related Events", "label": "Catastrophe [Member]", "documentation": "Natural event resulting in great loss." } } }, "auth_ref": [] }, "axs_CatastropheReinsuranceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "CatastropheReinsuranceMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Catastrophe", "label": "Catastrophe Reinsurance [Member]", "documentation": "Catastrophe line of business" } } }, "auth_ref": [] }, "us-gaap_CatastrophicEventDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CatastrophicEventDomain", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Catastrophic Event [Domain]", "label": "Catastrophic Event [Domain]", "documentation": "Catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion." } } }, "auth_ref": [] }, "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Information Related to Net Incurred Losses [Line Items]", "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Causes Of Increase Decrease In Liability For Unpaid Claims And Claims Adjustment Expense [Table]", "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]", "documentation": "Description of the reasons for the change in incurred claims and claim adjustment expenses recognized in the income statement attributable to insured events of prior fiscal years. Also includes disclosures of additional premiums or return premiums accrued as a result of changes in incurred claims and claim adjustment expenses." } } }, "auth_ref": [ "r242", "r245" ] }, "us-gaap_CededCreditRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CededCreditRiskAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ceded Credit Risk [Axis]", "label": "Reinsurer, Name [Axis]", "documentation": "Information by name of reinsurer or group of reinsurers in reinsurance contract." } } }, "auth_ref": [ "r1221", "r1397" ] }, "us-gaap_CededCreditRiskReinsurerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CededCreditRiskReinsurerDomain", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ceded Credit Risk, Reinsurer [Domain]", "label": "Reinsurer, Name [Domain]", "documentation": "Name of reinsurer or group of reinsurers in reinsurance contract." } } }, "auth_ref": [ "r1397" ] }, "us-gaap_CededPremiumsEarned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CededPremiumsEarned", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/REINSURANCEDetails": { "parentTag": "us-gaap_PremiumsEarnedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/REINSURANCEDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Ceded", "label": "Ceded Premiums Earned", "documentation": "Amount of earned premiums ceded to other entities." } } }, "auth_ref": [ "r879", "r903", "r904", "r907", "r908", "r1407" ] }, "us-gaap_CededPremiumsWritten": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CededPremiumsWritten", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/REINSURANCEDetails": { "parentTag": "us-gaap_PremiumsWrittenNet", "weight": -1.0, "order": 2.0 }, "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails": { "parentTag": "us-gaap_PremiumsWrittenNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/REINSURANCEDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Ceded premiums", "negatedLabel": "Ceded", "terseLabel": "CEDED TO OTHER COMPANIES", "label": "Ceded Premiums Written", "documentation": "Amount of written premiums ceded to other entities." } } }, "auth_ref": [ "r246", "r247" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r1179" ] }, "axs_CitibankMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "CitibankMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Citibank", "label": "Citibank [Member]", "documentation": "Citibank Europe plc" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClaimsDevelopmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClaimsDevelopmentLineItems", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Claims Development [Line Items]", "label": "Claims Development [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.axiscapital.com/role/COVER", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r278", "r318", "r319", "r320", "r359", "r386", "r390", "r393", "r395", "r401", "r402", "r478", "r540", "r543", "r544", "r545", "r551", "r552", "r583", "r584", "r587", "r590", "r597", "r735", "r919", "r920", "r921", "r922", "r928", "r929", "r930", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r963", "r985", "r1009", "r1053", "r1054", "r1055", "r1056", "r1057", "r1216", "r1251", "r1264" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Line Items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r318", "r319", "r320", "r401", "r583", "r584", "r585", "r587", "r590", "r595", "r597", "r919", "r920", "r921", "r922", "r1101", "r1216", "r1251" ] }, "us-gaap_ClassOfTreasuryStockTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfTreasuryStockTable", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class Of Treasury Stock [Table]", "label": "Class of Treasury Stock [Table]", "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r103", "r104", "r105", "r106" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1180" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r1180" ] }, "us-gaap_CollateralAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollateralAxis", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collateral [Axis]", "label": "Collateral Held [Axis]", "documentation": "Information by category of collateral or no collateral, from lender's perspective." } } }, "auth_ref": [ "r1090" ] }, "us-gaap_CollateralDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollateralDomain", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collateral [Domain]", "label": "Collateral Held [Domain]", "documentation": "Category of collateral or no collateral, from lender's perspective." } } }, "auth_ref": [] }, "us-gaap_CollateralizedLoanObligationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollateralizedLoanObligationsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "CLO-Equities", "label": "Collateralized Loan Obligations [Member]", "documentation": "Securities collateralized by a pool of loans." } } }, "auth_ref": [] }, "us-gaap_CombinedRatio": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CombinedRatio", "calculation": { "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Combined ratio", "label": "Combined Ratio", "documentation": "Ratio of non-life losses and loss expenses, non-life acquisition expenses and non-life general and administrative expenses, to non-life net premiums earned." } } }, "auth_ref": [] }, "us-gaap_CommercialMortgageBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommercialMortgageBackedSecuritiesMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "CMBS", "label": "Commercial Mortgage-Backed Securities [Member]", "documentation": "Securities collateralized by commercial real estate mortgage loans." } } }, "auth_ref": [ "r1276", "r1286", "r1294", "r1335" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r49", "r154", "r845", "r962" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIES" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r208", "r528", "r530", "r1063", "r1322" ] }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareCashPaid", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares, dividends paid per share (in usd per share)", "label": "Common Stock, Dividends, Per Share, Cash Paid", "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r213" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares, dividends declared per share (in usd per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r213" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/COVER", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "netLabel": "Common shares", "terseLabel": "Common shares (par value)", "verboseLabel": "Common stocks", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r1120", "r1121", "r1122", "r1124", "r1125", "r1126", "r1127", "r1261", "r1262", "r1372", "r1418", "r1423" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Par value per share, common (in usd per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r177" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Authorized share capital, common (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r177", "r963" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "calculation": { "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails": { "parentTag": "us-gaap_CommonStockSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares, shares issued (in shares)", "periodStartLabel": "Shares issued, balance at beginning of year (in shares)", "periodEndLabel": "Total shares issued at end of year (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r177" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "calculation": { "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Common shares, shares outstanding (in shares)", "totalLabel": "Total shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r20", "r177", "r963", "r981", "r1423", "r1424" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares (shares issued 2023: 176,580; 2022: 176,580 shares outstanding 2023: 85,286; 2022: 84,668)", "verboseLabel": "Common shares (shares issued 2023: 176,580; 2022: 176,580 shares outstanding 2023: 85,286; 2022: 84,668)", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r177", "r848", "r1115" ] }, "axs_CommonsharesissuedandoutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "CommonsharesissuedandoutstandingRollForward", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Shares Issued and Outstanding [Roll Forward]", "label": "common shares issued and outstanding [Roll Forward]", "documentation": "common shares issued and outstanding [Roll Forward]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r1185" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r1184" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r1186" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r1183" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Retirement Benefits [Abstract]", "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxAssetsAbstract", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets:", "label": "Components of Deferred Tax Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities:", "label": "Components of Deferred Tax Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income (loss)", "terseLabel": "Comprehensive income (loss)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r55", "r334", "r336", "r344", "r824", "r859" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER COMPREHENSIVE INCOME (LOSS)", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r185", "r343", "r823", "r857" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r68", "r70", "r141", "r142", "r436", "r1062" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r68", "r70", "r141", "r142", "r436", "r911", "r1062" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r68", "r70", "r141", "r142", "r436", "r1062", "r1221" ] }, "axs_ConcentrationRiskCreditRiskFixedMaturitiesMaximumExposureCorporateIssuerAMinusOrAbovePercentageOfFixedMaturityPortfolio": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ConcentrationRiskCreditRiskFixedMaturitiesMaximumExposureCorporateIssuerAMinusOrAbovePercentageOfFixedMaturityPortfolio", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESCashandInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturity portfolio - corporate issuer concentration limit above A-", "label": "Concentration Risk Credit Risk Fixed Maturities Maximum Exposure Corporate Issuer A Minus Or Above Percentage Of Fixed Maturity Portfolio", "documentation": "Reflects the maximum amount, expressed as a percentage of fixed maturity value, of concentration of credit risk to any single corporate debt issuer rated A- or above (excluding U.S. government and agency securities)." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1062" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Concentration risk, percentage of total", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r68", "r70", "r141", "r142", "r436" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r67", "r68", "r70", "r71", "r141", "r222", "r1062" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r68", "r70", "r141", "r142", "r436", "r1062" ] }, "axs_Concentrationriskcreditriskfixedmaturitiesmaximumexposurecorporateissuerbelowaminuspercentageoffixedmaturityportfolio": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "Concentrationriskcreditriskfixedmaturitiesmaximumexposurecorporateissuerbelowaminuspercentageoffixedmaturityportfolio", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESCashandInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturity portfolio - corporate issuer concentration limit below A-", "label": "ConcentrationRiskCreditRiskFixedMaturitiesMaximumExposureCorporateIssuerBelowAMinusPercentageOfFixedMaturityPortfolio", "documentation": "Reflects the maximum amount, expressed as a percentage of fixed maturity value, of concentration of credit risk to any single corporate debt issuer rated below A- (excluding U.S. government and agency securities)." } } }, "auth_ref": [] }, "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Condensed Financial Information Disclosure [Abstract]", "label": "Condensed Financial Information Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDFINANCIALSTATEMENTSOFPARENTCOMPANY" ], "lang": { "en-us": { "role": { "terseLabel": "SCHEDULE II - CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY", "label": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]", "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document." } } }, "auth_ref": [ "r309", "r367", "r1217" ] }, "srt_CondensedFinancialStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedFinancialStatementsCaptionsLineItems", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Condensed Financial Information of Parent Company [Line Items]", "label": "Condensed Financial Statements, Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r280", "r305", "r306", "r307", "r367", "r1217" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/ORGANIZATIONDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r285", "r367", "r697", "r698", "r699", "r700", "r773", "r1073", "r1231", "r1234", "r1235", "r1325", "r1328", "r1329" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/ORGANIZATIONDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r285", "r367", "r697", "r698", "r699", "r700", "r773", "r1073", "r1231", "r1234", "r1235", "r1325", "r1328", "r1329" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r367", "r409", "r420", "r421", "r422", "r423", "r424", "r426", "r430", "r540", "r541", "r542", "r543", "r545", "r546", "r548", "r550", "r551", "r1232", "r1233", "r1326", "r1327" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r367", "r409", "r420", "r421", "r422", "r423", "r424", "r426", "r430", "r540", "r541", "r542", "r543", "r545", "r546", "r548", "r550", "r551", "r1232", "r1233", "r1326", "r1327" ] }, "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation/VIEs", "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest." } } }, "auth_ref": [ "r263" ] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate debt", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r1105", "r1107", "r1417" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r27", "r421", "r422", "r423", "r424", "r430", "r1267" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails": { "parentTag": "axs_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestIncomeLossFromEquityMethodInvestmentsAndEquityInNetEarningsOfSubsidiaries", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r192" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r304", "r364", "r365", "r557", "r585", "r771", "r1082", "r1085" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover page.", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "axs_CreditAndPoliticalRiskLineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "CreditAndPoliticalRiskLineMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit and political risk", "label": "Credit And Political Risk Line [Member]", "documentation": "Credit and political risk line of business" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditLossStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditLossStatusAxis", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Loss Status [Axis]", "label": "Credit Loss Status [Axis]", "documentation": "Information by credit loss status of financial asset." } } }, "auth_ref": [ "r1271", "r1306", "r1313" ] }, "us-gaap_CreditLossStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditLossStatusDomain", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Loss Status [Domain]", "label": "Credit Loss Status [Domain]", "documentation": "Credit loss status of financial asset." } } }, "auth_ref": [] }, "srt_CreditRatingAMBestAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CreditRatingAMBestAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Rating, AM Best [Axis]", "label": "Credit Rating, AM Best [Axis]", "documentation": "Information by AM Best rating." } } }, "auth_ref": [ "r1091", "r1269", "r1312", "r1370" ] }, "srt_CreditRatingAMBestDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CreditRatingAMBestDomain", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Rating, AM Best [Domain]", "label": "Credit Rating, AM Best [Domain]", "documentation": "Credit rating as defined by AM Best." } } }, "auth_ref": [] }, "axs_CreditandSuretyBusinessMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "CreditandSuretyBusinessMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit and surety", "label": "Credit and Surety Business [Member]", "documentation": "Credit and Surety Business [Member]" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current income tax expense (benefit)", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r218", "r684", "r690", "r1254" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r69", "r436" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships and customers lists - Ternian", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r118" ] }, "axs_CyberLineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "CyberLineMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cyber", "label": "Cyber Line [Member]", "documentation": "Cyber Line" } } }, "auth_ref": [] }, "axs_DebtAndEquitySecuritiesRealizedGain": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DebtAndEquitySecuritiesRealizedGain", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_NetInvestmentGainLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross realized investment gains", "label": "Debt And Equity Securities, Realized Gain", "documentation": "Amount of realized gain on investment in debt and equity securities." } } }, "auth_ref": [] }, "axs_DebtAndEquitySecuritiesRealizedGainAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DebtAndEquitySecuritiesRealizedGainAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross realized investment gains", "label": "Debt And Equity Securities, Realized Gain [Abstract]", "documentation": "Debt and Equity Securities, Realized Gain [Abstract]" } } }, "auth_ref": [] }, "axs_DebtAndEquitySecuritiesRealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DebtAndEquitySecuritiesRealizedLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_NetInvestmentGainLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Gross realized investment losses", "label": "Debt And Equity Securities, Realized Loss", "documentation": "Amount of realized loss on investment in debt and equity securities." } } }, "auth_ref": [] }, "axs_DebtAndEquitySecuritiesRealizedLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DebtAndEquitySecuritiesRealizedLossAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Gross realized investment losses", "label": "Debt And Equity Securities, Realized Loss [Abstract]", "documentation": "Debt and Equity Securities, Realized Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "DEBT AND FINANCING ARRANGEMENTS", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r209", "r357", "r553", "r559", "r560", "r561", "r562", "r563", "r564", "r569", "r576", "r577", "r579" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r42", "r171", "r172", "r228", "r231", "r367", "r554", "r555", "r556", "r557", "r558", "r560", "r565", "r566", "r567", "r568", "r570", "r571", "r572", "r573", "r574", "r575", "r749", "r1096", "r1097", "r1098", "r1099", "r1100", "r1252" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate (percent)", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Principal", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r144", "r146", "r554", "r749", "r1097", "r1098" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate (percent)", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r47", "r555" ] }, "axs_DebtInstrumentIssuancePricePercent": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DebtInstrumentIssuancePricePercent", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issue Price", "label": "Debt Instrument, Issuance Price, Percent", "documentation": "Debt Instrument, Issuance Price, Percent" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r367", "r554", "r555", "r556", "r557", "r558", "r560", "r565", "r566", "r567", "r568", "r570", "r571", "r572", "r573", "r574", "r575", "r578", "r749", "r1096", "r1097", "r1098", "r1099", "r1100", "r1252" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r48", "r367", "r554", "r555", "r556", "r557", "r558", "r560", "r565", "r566", "r567", "r568", "r570", "r571", "r572", "r573", "r574", "r575", "r749", "r1096", "r1097", "r1098", "r1099", "r1100", "r1252" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r48", "r97", "r101", "r143", "r144", "r146", "r156", "r211", "r212", "r367", "r554", "r555", "r556", "r557", "r558", "r560", "r565", "r566", "r567", "r568", "r570", "r571", "r572", "r573", "r574", "r575", "r578", "r749", "r1096", "r1097", "r1098", "r1099", "r1100", "r1252" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails": { "parentTag": "us-gaap_NotesPayable", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized discount and debt issuance expenses", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r145", "r565", "r580", "r1097", "r1098" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossRollForward", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSSummaryofAllowanceforCreditLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]", "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Allowance for Credit Loss", "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss [Table Text Block]", "documentation": "Tabular disclosure of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r499" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 2.0 }, "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_NetInvestmentGainLoss", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment losses", "negatedTerseLabel": "Impairment losses", "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Writeoff", "documentation": "Amount of writeoff of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r504" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSSummaryofAllowanceforCreditLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities, available for sale, allowance for credit loss", "negatedTerseLabel": "Allowance for expected credit losses", "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest", "documentation": "Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r491" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fixed maturities, available for sale, amortized cost", "terseLabel": "Amortized cost", "totalLabel": "Amortized cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss", "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r491" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturity", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESCashandInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturity investment portfolio", "label": "Debt Securities, Available-for-Sale and Held-to-Maturity, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r822", "r1272" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "12 months or greater", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r256", "r497", "r1094" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "12 months or greater", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r256", "r497" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Continuous unrealized loss position", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions", "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r1316" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less than 12 months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r256", "r497", "r1094" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less than 12 months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r256", "r497" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 4.0 }, "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities, available for sale, at fair value (Amortized cost 2023: $12,634,254; 2022: $12,176,473 Allowance for expected credit losses 2023: $10,759; 2022: $11,733)", "netLabel": "Fair value", "totalLabel": "Fair value", "verboseLabel": "Fixed maturities, available for sale", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest", "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r1314" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSSummaryofAllowanceforCreditLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected credit losses on securities where credit losses were not previously recognized", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Not Previously Recorded", "documentation": "Amount, excluding accrued interest, of credit loss expense on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with no credit loss previously recorded." } } }, "auth_ref": [ "r500" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSSummaryofAllowanceforCreditLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions (reductions) for expected credit losses on securities where credit losses were previously recognized", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)", "documentation": "Amount, excluding accrued interest, of credit loss expense (reversal of expense) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with previously recorded allowance and not intended to be sold and not more likely than not will be required to sell before recovery of amortized cost basis." } } }, "auth_ref": [ "r503" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_NetInvestmentGainLoss", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "(Increase) decrease in allowance for expected credit losses, fixed maturities, available for sale", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Period Increase (Decrease)", "documentation": "Amount, excluding accrued interest, of increase (decrease) in allowance for credit loss of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r1317" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSSummaryofAllowanceforCreditLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Securities sold/redeemed/matured", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Sold", "documentation": "Amount, excluding accrued interest, of decrease in allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) from sale." } } }, "auth_ref": [ "r501" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSSummaryofAllowanceforCreditLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairments of securities which the Company intends to sell or more likely than not will be required to sell", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Sell before Recovery", "documentation": "Amount, excluding accrued interest, of decrease in allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) from intent to sell or more likely than not will be required to sell before recovery of amortized cost basis." } } }, "auth_ref": [ "r502" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "axs_NetInvestmentGainLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Impairment losses", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff", "documentation": "Amount, excluding accrued interest, of decrease in allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) from writeoff." } } }, "auth_ref": [ "r504" ] }, "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleRealizedGain", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_DebtAndEquitySecuritiesRealizedGain", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities and short-term investments", "label": "Debt Securities, Available-for-Sale, Realized Gain", "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r470" ] }, "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleRealizedLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_DebtAndEquitySecuritiesRealizedLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Fixed maturities and short-term investments", "label": "Debt Securities, Available-for-Sale, Realized Loss", "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r470" ] }, "us-gaap_DebtSecuritiesAvailableForSaleRestricted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleRestricted", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total restricted investments and cash", "label": "Debt Securities, Available-for-Sale, Restricted", "documentation": "Amount of restricted investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r788", "r1060", "r1061" ] }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleTable", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Available-for-sale [Table]", "label": "Debt Securities, Available-for-Sale [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss." } } }, "auth_ref": [ "r253", "r494", "r1094" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total", "negatedTerseLabel": "Unrealized loss position", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r254", "r495" ] }, "axs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value", "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]", "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Fixed Maturities and Equities in an Unrealized Loss Position", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r252", "r1094", "r1315" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of positions in an unrealized loss", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions", "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r255", "r496" ] }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails_1": { "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities, held to maturity, allowance for credit loss", "verboseLabel": "Allowance for expected credit losses", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest", "documentation": "Amount, excluding accrued interest, of allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r1307" ] }, "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 7.0 }, "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities, held to maturity, at amortized cost (Fair value 2023: $675,851; 2022: $674,743 Allowance for expected credit losses 2023: $nil; 2022: $nil)", "totalLabel": "Net carrying value", "verboseLabel": "Fixed maturities, held to maturity, at amortized cost", "label": "Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss", "documentation": "Amount excluding accrued interest, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r455", "r457", "r1307" ] }, "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails_1": { "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized cost", "label": "Debt Securities, Held-to-Maturity, Excluding Accrued Interest, before Allowance for Credit Loss", "documentation": "Amount excluding accrued interest, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r488", "r490", "r1307" ] }, "axs_DebtSecuritiesHeldToMaturityMaturityPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DebtSecuritiesHeldToMaturityMaturityPeriod", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt securities, held-to-maturity, maturity period", "label": "Debt Securities, Held-to-Maturity, Maturity Period", "documentation": "Debt Securities, Held-to-Maturity, Maturity Period" } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash-settled awards", "verboseLabel": "Liability for cash-settled restricted stock units", "label": "Deferred Compensation Share-Based Arrangements, Liability, Current and Noncurrent", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax expense (benefit)", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r9", "r218", "r270", "r689", "r690", "r1254" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r174", "r175", "r229", "r678" ] }, "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredPolicyAcquisitionCostAmortizationExpense", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": "axs_UnderwritingIncomeLossNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition costs", "negatedLabel": "Acquisition costs", "label": "Deferred Policy Acquisition Costs, Amortization Expense", "documentation": "Amount of amortization expense (reversal of expense) for deferred policy acquisition costs." } } }, "auth_ref": [ "r259", "r863", "r884", "r885", "r899", "r1116", "r1250", "r1396" ] }, "us-gaap_DeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredPolicyAcquisitionCosts", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred acquisition costs", "label": "Deferred Policy Acquisition Cost", "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force." } } }, "auth_ref": [ "r261", "r853", "r885", "r886", "r899", "r1116" ] }, "us-gaap_DeferredTaxAssetDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetDomain", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Tax Asset [Domain]", "label": "Deferred Tax Asset [Domain]", "documentation": "Identification of the deferred tax asset for which a valuation reserve exists." } } }, "auth_ref": [ "r111" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax assets before valuation allowance", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r679" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails": { "parentTag": "axs_TaxAssetsLiabilitiesNet", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net deferred tax assets (liabilities)", "totalLabel": "Net deferred tax assets (liabilities)", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1364" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax assets net of valuation allowance", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1364" ] }, "axs_DeferredTaxAssetsNetUnrealizedLossesOnSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DeferredTaxAssetsNetUnrealizedLossesOnSecurities", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized investments losses", "label": "Deferred Tax Assets Net Unrealized Losses On Securities", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to taxable temporary differences from net unrealized losses on investments (excluding impairments)." } } }, "auth_ref": [] }, "axs_DeferredTaxAssetsOperatingAndCapitalLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DeferredTaxAssetsOperatingAndCapitalLossCarryforwards", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating and capital loss carryforwards", "label": "Deferred Tax Assets Operating And Capital Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating and capital loss carryforwards." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other deferred tax assets", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r114", "r1365" ] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credits", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards." } } }, "auth_ref": [ "r113", "r114", "r1365" ] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Tax credits", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards." } } }, "auth_ref": [ "r113", "r114", "r1365" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accruals not currently deductible", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities." } } }, "auth_ref": [ "r114", "r1365" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discounting of net reserves for losses and loss expenses", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from loss reserves other than estimated credit losses." } } }, "auth_ref": [ "r114", "r1365" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned premiums", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the unearned premiums reserve." } } }, "auth_ref": [ "r114", "r1365" ] }, "us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets for unrealized losses on fixed maturity securities", "label": "Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r1365" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "periodStartLabel": "Valuation allowance - beginning of year", "periodEndLabel": "Valuation allowance - end of year", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r680" ] }, "axs_DeferredTaxLiabilitiesAcquisitionAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DeferredTaxLiabilitiesAcquisitionAdjustments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Acquisition adjustments", "label": "Deferred Tax Liabilities, Acquisition Adjustments", "documentation": "Deferred Tax Liabilities, Acquisition Adjustments" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesDeferredExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesDeferredExpense", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Lloyd\u2019s deferred year of account results", "label": "Deferred Tax Liabilities, Deferred Expense", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs." } } }, "auth_ref": [ "r114", "r1365" ] }, "us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred acquisition costs", "label": "Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost", "documentation": "The amount as of the balance sheet date of the estimated future tax effects attributable to policy acquisition costs being expensed for tax purposes but capitalized in conformity with generally accepted accounting principles, which will reverse in future periods when amortization of such capitalized costs cannot be deducted for tax purposes." } } }, "auth_ref": [ "r114", "r1365" ] }, "axs_DeferredTaxLiabilitiesEqualizationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DeferredTaxLiabilitiesEqualizationReserves", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Equalization reserves", "label": "Deferred Tax Liabilities Equalization Reserves", "documentation": "Amount of deferred tax liability attributable to tax deductible temporary differences from credit insurance reserve increases." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Intangible assets", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill." } } }, "auth_ref": [ "r114", "r1365" ] }, "us-gaap_DeferredTaxLiabilitiesInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesInvestments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other investment adjustments and impairments", "label": "Deferred Tax Liabilities, Investments", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments)." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other deferred tax liabilities", "label": "Deferred Tax Liabilities, Other", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other." } } }, "auth_ref": [ "r114", "r1365" ] }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetFairValueGrossLiability", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross amounts offset", "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset", "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r24", "r41", "r125", "r1039", "r1040" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative asset, statement of financial position [Extensible Enumeration]", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r701" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 }, "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative instruments", "verboseLabel": "Derivative asset fair value", "totalLabel": "Net amounts", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r323", "r325", "r734", "r941", "r942", "r943", "r945", "r946", "r948", "r949", "r950", "r952", "r953", "r969", "r970", "r1032", "r1035", "r1038", "r1039", "r1041", "r1042", "r1085", "r1122", "r1419" ] }, "us-gaap_DerivativeAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsAbstract", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative assets", "label": "Derivative Asset [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract Type [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r950", "r953", "r968", "r969", "r970", "r971", "r972", "r973", "r974", "r976", "r977", "r978", "r979", "r996", "r997", "r998", "r999", "r1002", "r1003", "r1004", "r1005", "r1032", "r1033", "r1038", "r1041", "r1120", "r1122" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amounts", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r36", "r125", "r184", "r322", "r1085" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amounts", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r36", "r125", "r184", "r322", "r1085" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument Risk [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r123", "r126", "r127", "r129", "r950", "r953", "r968", "r969", "r970", "r971", "r972", "r973", "r974", "r976", "r977", "r978", "r979", "r996", "r997", "r998", "r999", "r1002", "r1003", "r1004", "r1005", "r1032", "r1033", "r1038", "r1041", "r1085", "r1120", "r1122" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "DERIVATIVE INSTRUMENTS", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r220", "r704", "r711" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments Gain Loss By Hedging Relationship By Income Statement Location By Derivative Instrument Risk [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r21", "r123", "r127", "r129", "r132", "r133", "r702" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized and Realized Gains (Losses) Recognized in Earnings for Derivatives Not Designated As Hedges [Line Items]", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r702" ] }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_NetInvestmentGainLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in fair value of investment derivatives", "terseLabel": "Unrealized and realized gains (loss) recognized in earnings for derivatives not designated as hedges", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments." } } }, "auth_ref": [ "r128", "r1222" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative instruments", "verboseLabel": "Derivative liability fair value", "totalLabel": "Net amounts", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r323", "r325", "r734", "r941", "r942", "r943", "r945", "r948", "r949", "r950", "r952", "r953", "r976", "r978", "r979", "r1033", "r1034", "r1035", "r1038", "r1039", "r1041", "r1042", "r1085", "r1419" ] }, "us-gaap_DerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesAbstract", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Derivative Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityFairValueGrossAsset", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSOffsettingAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross amounts offset", "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset", "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r24", "r41", "r125", "r1039", "r1040", "r1083" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability, statement of financial position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r701" ] }, "us-gaap_DerivativeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative instruments", "label": "Derivative [Member]", "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender)." } } }, "auth_ref": [ "r221" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1367", "r1368" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Fair Values on Consolidated Balance Sheet [Line Items]", "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r21", "r119", "r120", "r121", "r131", "r366" ] }, "axs_DirectLendingFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DirectLendingFundsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Direct lending funds", "label": "Direct Lending Funds [Member]", "documentation": "Investments in funds that provide financing directly to borrowers." } } }, "auth_ref": [] }, "us-gaap_DirectPremiumsWritten": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectPremiumsWritten", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails": { "parentTag": "us-gaap_PremiumsWrittenNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "GROSS AMOUNT", "label": "Direct Premiums Written", "documentation": "Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums written." } } }, "auth_ref": [ "r905" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATION" ], "lang": { "en-us": { "role": { "terseLabel": "SHARE-BASED COMPENSATION", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r619", "r624", "r655", "r656", "r658", "r1111" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Additional Information Related to Share-based Compensation", "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]", "documentation": "Tabular disclosure of share-based payment arrangement." } } }, "auth_ref": [ "r13", "r107" ] }, "axs_DistributionNetworksCoverholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DistributionNetworksCoverholdersMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Coverholders", "label": "Distribution Networks, Coverholders [Member]", "documentation": "Distribution Networks, Coverholders [Member]" } } }, "auth_ref": [] }, "axs_DistributionNetworksLargeBrokersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DistributionNetworksLargeBrokersMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Large brokers", "label": "Distribution Networks, Large Brokers [Member]", "documentation": "Distribution Networks, Large Brokers [Member]" } } }, "auth_ref": [] }, "axs_DistributionNetworksSmallAndMidsizedEnterpriseBrokersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "DistributionNetworksSmallAndMidsizedEnterpriseBrokersMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "SME brokers", "label": "Distribution Networks, Small And Mid-sized Enterprise Brokers [Member]", "documentation": "Distribution Networks, Small And Mid-sized Enterprise Brokers [Member]" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedLabel": "Common share dividends", "label": "Dividends, Common Stock, Cash", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r213" ] }, "us-gaap_DividendsDeclaredTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsDeclaredTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Dividends Declared and Paid", "label": "Dividends Declared [Table Text Block]", "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends." } } }, "auth_ref": [] }, "us-gaap_DividendsPayableAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableAmountPerShare", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends paid in year following declaration (in usd per share)", "label": "Dividends Payable, Amount Per Share", "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date." } } }, "auth_ref": [ "r64" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends payable", "label": "Dividends Payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r172", "r173", "r230", "r1131", "r1400" ] }, "us-gaap_DividendsPreferredStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPreferredStockCash", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedLabel": "Preferred share dividends", "label": "Dividends, Preferred Stock, Cash", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r5", "r213" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Annual Report", "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r1139", "r1140", "r1153" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Financial Statement Error Correction", "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r1139", "r1140", "r1153", "r1189" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document fiscal period focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document fiscal year focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1174" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Documents Incorporated by Reference", "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r1137" ] }, "axs_EaglePointCreditManagementLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "EaglePointCreditManagementLLCMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Eagle Point Credit Management, LLC", "label": "Eagle Point Credit Management, LLC [Member]", "documentation": "Eagle Point Credit Management, LLC" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Per share data", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per common share (in dollars per share)", "verboseLabel": "Earnings per common share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r345", "r374", "r375", "r376", "r377", "r378", "r383", "r386", "r393", "r394", "r395", "r399", "r714", "r715", "r825", "r860", "r1086" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per common share:", "verboseLabel": "Earnings per common share", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per diluted common share (in dollars per share)", "verboseLabel": "Earnings per diluted common share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r345", "r374", "r375", "r376", "r377", "r378", "r386", "r393", "r394", "r395", "r399", "r714", "r715", "r825", "r860", "r1086" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per diluted common share", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHARE" ], "lang": { "en-us": { "role": { "terseLabel": "EARNINGS PER COMMON SHARE", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r382", "r396", "r397", "r398" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on foreign currency cash, cash equivalents and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r741" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Actual tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r672" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of effective tax rate (% of income before income taxes)", "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]" } } }, "auth_ref": [] }, "axs_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationLineItems", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of effective tax rate (% of income before income taxes) [Line Items]", "label": "Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "axs_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationTable", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Table]", "label": "Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Table]", "documentation": "Schedule reconciling the entity's statutory tax rate to its effective tax rate." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected tax rate", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r361", "r672", "r692" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation allowance", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r1363", "r1366" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in enacted tax rate", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates." } } }, "auth_ref": [ "r692", "r1363" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign taxes at local expected rates", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile." } } }, "auth_ref": [ "r1363", "r1366" ] }, "axs_EffectiveIncomeTaxRateReconciliationIncrementalBranchTaxesPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationIncrementalBranchTaxesPercent", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental branch taxes", "label": "Effective Income Tax Rate Reconciliation, Incremental Branch Taxes, Percent", "documentation": "Effective Income Tax Rate Reconciliation, Incremental Branch Taxes, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r1363", "r1366" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior year adjustments", "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense." } } }, "auth_ref": [ "r1363", "r1366" ] }, "us-gaap_EffectsOfReinsuranceTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectsOfReinsuranceTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/REINSURANCETables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Breakdown of Gross and Net Premiums Written and Earned", "label": "Effects of Reinsurance [Table Text Block]", "documentation": "Tabular disclosure of the effects of reinsurance, for example, but not limited to, disclosure of direct, assumed, and ceded insurance." } } }, "auth_ref": [ "r15" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized share-based compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r657" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected weighted average period associated with the recognition of unrecognized share-based compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r657" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax benefits associated with share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r654" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "axs_EmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "EmployeesMember", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "From employees:", "label": "Employees [Member]", "documentation": "Directly from employees of the entity to satisfy withholding tax liabilities upon vesting of restricted stock awards. These repurchases are not part of the entity's Board-authorized share repurchase program." } } }, "auth_ref": [] }, "axs_EngineeringMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "EngineeringMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Engineering", "terseLabel": "Engineering", "label": "Engineering [Member]", "documentation": "Engineering line of business" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Country", "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity central index key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1136" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1136" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1136" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1214" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Public Float", "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1136" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1136" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1136" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1136" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Voluntary Filer", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r1215" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityClassOfTreasuryStockLineItems", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Shares [Line Items]", "label": "Equity, Class of Treasury Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r20", "r308", "r338", "r339", "r340", "r369", "r370", "r371", "r373", "r379", "r381", "r400", "r479", "r480", "r598", "r659", "r660", "r661", "r685", "r686", "r705", "r706", "r707", "r708", "r709", "r710", "r713", "r742", "r743", "r744", "r745", "r746", "r747", "r764", "r896", "r897", "r898", "r928", "r1009" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Domain]", "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r474", "r475", "r477" ] }, "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment, difference between carrying amount and underlying equity", "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity", "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee." } } }, "auth_ref": [ "r476" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment, ownership percentage", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r474" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investments", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r417", "r473", "r1238", "r1304" ] }, "us-gaap_EquityMethodInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investments", "label": "Equity Method Investments [Member]", "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition." } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 4.0 }, "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity securities, at fair value (Cost 2023: $543,833; 2022: $494,356)", "terseLabel": "Fair value", "netLabel": "Equity securities", "label": "Equity Securities, FV-NI, Current", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r317", "r732", "r1081" ] }, "us-gaap_EquitySecuritiesFvNiCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiCost", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities, cost", "verboseLabel": "Cost", "label": "Equity Securities, FV-NI, Cost", "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r842" ] }, "us-gaap_EquitySecuritiesFvNiRealizedGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiRealizedGain", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_DebtAndEquitySecuritiesRealizedGain", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Equity Securities, FV-NI, Realized Gain", "documentation": "Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r1303" ] }, "us-gaap_EquitySecuritiesFvNiRealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiRealizedLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_DebtAndEquitySecuritiesRealizedLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity securities", "label": "Equity Securities, FV-NI, Realized Loss", "documentation": "Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r1303" ] }, "us-gaap_EquitySecuritiesFvNiUnrealizedGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiUnrealizedGain", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross unrealized gains", "label": "Equity Securities, FV-NI, Unrealized Gain", "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r472" ] }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_NetInvestmentGainLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gains (losses) on equity securities", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)", "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r862", "r1303" ] }, "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiUnrealizedLoss", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross unrealized losses", "label": "Equity Securities, FV-NI, Unrealized Loss", "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r472" ] }, "us-gaap_EquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Equity Securities [Member]", "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants." } } }, "auth_ref": [ "r82", "r1128", "r1129", "r1130", "r1426" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r1182" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r1145", "r1157", "r1167", "r1193" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r1142", "r1154", "r1164", "r1190" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimate of Fair Value", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r567", "r734", "r1097", "r1098" ] }, "axs_EuropeanTaxAuthoritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "EuropeanTaxAuthoritiesMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "European Tax Authorities [Member]", "documentation": "Tax departments of European governments entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_ExchangeTradedFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExchangeTradedFundsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange-traded funds", "label": "Exchange Traded Funds [Member]", "documentation": "Investment that follows an index, commodity or basket of assets that trades similar to a stock on an exchange." } } }, "auth_ref": [ "r1335", "r1373" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r1188" ] }, "us-gaap_ExternalCreditRatingByGroupingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExternalCreditRatingByGroupingAxis", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Rating [Axis]", "label": "External Credit Rating by Grouping [Axis]", "documentation": "Information by external rating classified as investment grade or non investment grade." } } }, "auth_ref": [ "r81", "r703", "r1312" ] }, "us-gaap_ExternalCreditRatingByGroupingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExternalCreditRatingByGroupingDomain", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Rating [Domain]", "label": "External Credit Rating by Grouping [Domain]", "documentation": "External credit rating classified as investment grade or non-investment grade." } } }, "auth_ref": [ "r130" ] }, "us-gaap_ExternalCreditRatingNonInvestmentGradeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExternalCreditRatingNonInvestmentGradeMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Below Investment Grade or Not Rated", "label": "External Credit Rating, Non Investment Grade [Member]", "documentation": "External credit-rating that could be used to describe the current status of the payment and performance risk of credit derivatives and guarantee obligations that connote non-investment grade." } } }, "auth_ref": [ "r130" ] }, "us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes unrealized gain (loss) from asset measured at fair value using unobservable input (level 3) and still held." } } }, "auth_ref": [ "r725" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r718", "r719", "r726" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r718", "r719", "r726" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Inputs Assets Quantitative Information [Line Items]", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Inputs Assets Quantitative Information [Table]", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r22" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Level 3 Fair Value Measurement Inputs", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r22" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in unrealized gain/(losses)", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)", "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held." } } }, "auth_ref": [ "r725" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Domain]", "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r23" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in Level 3 Financial Instruments Measured at Fair Value on a Recurring Basis [Line Items]", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Table]", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset." } } }, "auth_ref": [ "r23", "r136" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Changes in Level 3 Financial Instruments Measured at Fair Value on a Recurring Basis, Assets", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset." } } }, "auth_ref": [ "r23", "r136" ] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Axis]", "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r134", "r136" ] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value By Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r134", "r139", "r140" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value By Fair Value Hierarchy Level [Axis]", "verboseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r567", "r602", "r603", "r604", "r605", "r606", "r607", "r719", "r777", "r778", "r779", "r1097", "r1098", "r1105", "r1106", "r1107" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis [Axis]", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r39", "r134", "r567", "r1097", "r1098" ] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement [Domain]", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r567", "r1097", "r1098" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "FAIR VALUE MEASUREMENTS", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r717" ] }, "axs_FairValueInputsEstimatedMaturityDate": { "xbrltype": "durationItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FairValueInputsEstimatedMaturityDate", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated maturity date (years)", "label": "Fair Value Inputs Estimated Maturity Date", "documentation": "The estimated remaining time to maturity of the CLO structure (expressed as a number of years)." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quoted prices in active markets for identical assets (Level 1)", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r567", "r602", "r607", "r719", "r777", "r1105", "r1106", "r1107" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant other\u00a0observable inputs (Level 2)", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r567", "r602", "r607", "r719", "r778", "r1097", "r1098", "r1105", "r1106", "r1107" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant unobservable inputs (Level 3)", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r567", "r602", "r603", "r604", "r605", "r606", "r607", "r719", "r779", "r1097", "r1098", "r1105", "r1106", "r1107" ] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption notice period", "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Investment Redemption, Notice Period", "documentation": "Notice period the entity is required to deliver before it can redeem an investment calculated using net asset value per share, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, investments calculated by per unit, per membership interest, other equity or ownership interest and alternative investments." } } }, "auth_ref": [ "r138" ] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareLineItems", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Investments [Line Items]", "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment term", "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Redemption Restriction Period", "documentation": "Remaining period of a redemption restriction related to investments for which net asset value per share is calculated, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r729" ] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTable", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Investments Entities That Calculate Net Asset Value Per Share [Table]", "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table]", "documentation": "Disclosure of information about investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis." } } }, "auth_ref": [ "r39" ] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Portfolio of Other Investments", "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Table Text Block]", "documentation": "Tabular disclosure of investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis." } } }, "auth_ref": [ "r39" ] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unfunded commitments related to other investments", "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments", "documentation": "The amount of unfunded commitments for which the entity is obligated, to those certain investments for which net asset value per share is calculated (including by unit, membership interest, or other equity (ownership interest) unit measure) (alternative investments)." } } }, "auth_ref": [ "r137" ] }, "axs_FairValueInvestmentsEntitiesThatCalculateNetAssetValueRedemptionRestriction": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValueRedemptionRestriction", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of other investments subject to redemption restrictions", "label": "Fair Value Investments Entities That Calculate Net Asset Value Redemption Restriction", "documentation": "The total value of investments that cannot be redeemed because of a redemption restriction as of the statement of financial position date." } } }, "auth_ref": [] }, "axs_FairValueInvestmentsEntitiesThatCalculateNetAssetValueRedemptionRestrictionPeriodOptionalExtension": { "xbrltype": "durationItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValueRedemptionRestrictionPeriodOptionalExtension", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Optional extension of investment term", "label": "Fair Value Investments Entities That Calculate Net Asset Value Redemption Restriction Period Optional Extension", "documentation": "Period by which the General Partner of an investment for which net asset value per share is calculated has the option to extend a redemption restriction related to investments for which net asset value per share is calculated, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in unrealized gains/(losses)", "label": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)", "documentation": "Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held." } } }, "auth_ref": [ "r725" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Changes in Level 3 Financial Instruments Measured at Fair Value on a Recurring Basis, Liabilities", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r23", "r136" ] }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value based on NAV practical expedient", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "documentation": "Fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r602", "r716", "r727" ] }, "axs_FairValueMeasurementWithUnobservableInputsReconciliationAssetTransfersOutOfLevel3IntoLevel2": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationAssetTransfersOutOfLevel3IntoLevel2", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers out of level 3", "label": "Fair Value Measurement With Unobservable Inputs, Reconciliation, Asset, Transfers Out Of Level 3 into Level 2", "documentation": "Fair Value Measurement With Unobservable Inputs, Reconciliation, Asset, Transfers Out Of Level 3 into Level 2" } } }, "auth_ref": [] }, "axs_FairValueMeasurementWithUnobservableInputsReconciliationAssetsTransfersFromLevel2IntoLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationAssetsTransfersFromLevel2IntoLevel3", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers into Level 3", "label": "Fair Value Measurement With Unobservable Inputs, Reconciliation, Assets, Transfers From Level 2 Into Level 3", "documentation": "Fair Value Measurement With Unobservable Inputs, Reconciliation, Assets, Transfers From Level 2 Into Level 3" } } }, "auth_ref": [] }, "axs_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersFromLevel2IntoLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersFromLevel2IntoLevel3", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers into Level 3", "label": "Fair Value Measurement With Unobservable Inputs, Reconciliation, Liability, Transfers From Level 2 Into Level 3", "documentation": "Fair Value Measurement With Unobservable Inputs, Reconciliation, Liability, Transfers From Level 2 Into Level 3" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers into Level 3", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3", "documentation": "Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r724" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Transfers out of Level 3", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3", "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r724" ] }, "axs_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3IntoLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3IntoLevel3", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers out of level 3", "label": "Fair Value Measurement With Unobservable Inputs, Reconciliation, Liability, Transfers Out Of Level 3 into Level 3", "documentation": "Fair Value Measurement With Unobservable Inputs, Reconciliation, Liability, Transfers Out Of Level 3 into Level 2" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Included in net income", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r722" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Included in OCI", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)", "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r723" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases", "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Sales", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales", "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Settlements/ distributions", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements", "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers into Level 3", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3", "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r724" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Transfers out of Level 3", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3", "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r724" ] }, "axs_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3NumberOfInvestmentFunds": { "xbrltype": "integerItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3NumberOfInvestmentFunds", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of investment funds transferred from level 3 to NAV practical expedient", "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers Out Of Level 3, Number Of Investment Funds", "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers Out Of Level 3, Number Of Investment Funds" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Opening balance", "periodEndLabel": "Closing balance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r23" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Included\u00a0in net income", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r722" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Included in\u00a0OCI", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)", "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r723" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Sales", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales", "documentation": "Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Settlements/ distributions", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Opening balance", "periodEndLabel": "Closing balance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r23" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements Fair Value Hierarchy [Domain]", "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r567", "r602", "r603", "r604", "r605", "r606", "r607", "r777", "r778", "r779", "r1097", "r1098", "r1105", "r1106", "r1107" ] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from asset measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r722" ] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag", "label": "Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Asset, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which other comprehensive income (OCI) is reported that includes gain (loss) from asset measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r723" ] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r722" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r122", "r124", "r132" ] }, "axs_FederalHomeLoanBankAdmittedAssetsActual": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FederalHomeLoanBankAdmittedAssetsActual", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FHLB program, admitted assets, actual", "label": "Federal Home Loan Bank, Admitted Assets, Actual", "documentation": "The amount of qualifying assets calculated using statutory rules that are used as a basis for borrowing capacity." } } }, "auth_ref": [] }, "srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Home Loan Bank Branch [Axis]", "label": "Federal Home Loan Bank Branch [Axis]", "documentation": "Information by branch of Federal Home Loan Bank." } } }, "auth_ref": [ "r1395" ] }, "us-gaap_FederalHomeLoanBankAdvancesBranchOfFHLBBankLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankAdvancesBranchOfFHLBBankLineItems", "presentation": [ "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]", "label": "Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Home Loan Bank Branch [Domain]", "label": "Federal Home Loan Bank Branch [Domain]", "documentation": "Twelve regional cooperative banks that U.S. lending institutions use to finance housing and economic development in their communities." } } }, "auth_ref": [] }, "us-gaap_FederalHomeLoanBankAdvancesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankAdvancesDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCES" ], "lang": { "en-us": { "role": { "terseLabel": "FEDERAL HOME LOAN BANK ADVANCES", "label": "Federal Home Loan Bank Advances, Disclosure [Text Block]", "documentation": "The entire disclosure for borrowing from the Federal Home Loan Bank, including: (i) general description; (ii) title and nature of obligation; (iii) interest rate; (iv) payment terms; (v) maturity dates by year; (vi) collateral requirements; (vii) restrictive covenants; (viii) priority; (ix) conversion or redemption features; (x) carrying value of assets pledged as collateral; (xi) combined aggregate maturities for next five years; (xii) unused or available balances." } } }, "auth_ref": [ "r11", "r151", "r156", "r240" ] }, "us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FHLB program, investments pledged as security", "label": "Federal Home Loan Bank, Advances, General Debt Obligations, Disclosures, Collateral Pledged", "documentation": "Amount of the collateral pledged in support of federal home loan bank advances outstanding." } } }, "auth_ref": [ "r158", "r240" ] }, "us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresInterestRateAtPeriodEnd": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresInterestRateAtPeriodEnd", "presentation": [ "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FHLB advances, interest rate (as a percent)", "label": "Federal Home Loan Bank, Advances, General Debt Obligations, Disclosures, Interest Rate at Period End", "documentation": "States the interest rate applicable to Federal Home Loan Bank advances outstanding as of the Balance Sheet date." } } }, "auth_ref": [ "r157", "r240" ] }, "us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "FHLB program, maximum borrowing capacity", "label": "Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available", "documentation": "Amount of maximum advances or credit lines available from the Federal Home Loan Bank (FHLB)." } } }, "auth_ref": [ "r46", "r233", "r240" ] }, "us-gaap_FederalHomeLoanBankBorrowingsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankBorrowingsFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings from FHLB", "label": "Federal Home Loan Bank Borrowings, Fair Value Disclosure", "documentation": "Fair value portion of borrowing from Federal Home Loan Bank (FHLBank)." } } }, "auth_ref": [ "r233" ] }, "srt_FederalHomeLoanBankOfChicagoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "FederalHomeLoanBankOfChicagoMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Home Loan Bank of Chicago", "label": "Federal Home Loan Bank of Chicago [Member]", "documentation": "Federal Home Loan Bank (FHLBank) located in Chicago, Illinois." } } }, "auth_ref": [] }, "us-gaap_FinancialGuaranteeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialGuaranteeMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Full and Unconditional Guarantee of Debt", "label": "Financial Guarantee [Member]", "documentation": "An agreement (contract) that requires the guarantor to make payments to the guaranteed party based on another entity's failure to pay specified obligations, such as debt, to a lender." } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r482", "r483", "r486", "r487", "r489", "r493", "r498", "r499", "r578", "r595", "r711", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r858", "r1094", "r1224", "r1225", "r1226", "r1227", "r1228", "r1229", "r1230", "r1299", "r1300", "r1301", "r1302" ] }, "us-gaap_FinancialInstrumentsOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentsOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial instruments, as collateral, at fair value", "label": "Financial Instruments, Owned, at Fair Value", "documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings." } } }, "auth_ref": [ "r149" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan advances made", "verboseLabel": "Loan balance receivable", "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss", "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease." } } }, "auth_ref": [ "r1307" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": "axs_NetInvestmentGainLoss", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "(Increase) decrease in allowance for expected credit losses, mortgage loans", "label": "Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Period Increase (Decrease)", "documentation": "Amount, excluding accrued interest, of increase (decrease) in allowance for credit loss on financing receivable. Excludes net investment in lease." } } }, "auth_ref": [ "r1308" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails": { "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial", "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss", "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease." } } }, "auth_ref": [ "r488", "r490", "r1307" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Useful life of finite lived intangible assets", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": -1.0, "order": 2.0 }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails", "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated amortization", "negatedLabel": "Accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r314", "r520" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After 2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r206" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r206" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r206" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r206" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r206" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r517", "r519", "r520", "r522", "r807", "r808" ] }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]", "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "axs_IntangibleAssetsIncludingGoodwillGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r205", "r808" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r807" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r86", "r89" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails", "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total finite-lived intangible assets", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r205", "r807" ] }, "us-gaap_FiniteLivedIntangibleAssetsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsRollForward", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets\u00a0with\u00a0a finite life", "label": "Finite-Lived Intangible Assets [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FixedIncomeSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FixedIncomeSecuritiesMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities, held to maturity, at amortized cost", "label": "Fixed Income Securities [Member]", "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity." } } }, "auth_ref": [ "r1107", "r1120", "r1121", "r1335" ] }, "axs_FixedMaturitiesAndShortTermInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FixedMaturitiesAndShortTermInvestmentsMember", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities and short-term investments", "label": "Fixed Maturities And Short-Term Investments [Member]", "documentation": "This element provides types of investments that may be contained within the fixed maturity category which are securities having a stated final repayment date. Examples of items within this category may include bonds, including convertibles and bonds with warrants, and redeemable preferred stocks. This element also includes investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet." } } }, "auth_ref": [] }, "us-gaap_FixedMaturitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FixedMaturitiesMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities", "verboseLabel": "Fixed maturities", "label": "Fixed Maturities [Member]", "documentation": "This element provides types of investments that may be contained within the fixed maturity category which are securities having a stated final repayment date. Examples of items within this category may include bonds, including convertibles and bonds with warrants, and redeemable preferred stocks." } } }, "auth_ref": [ "r16" ] }, "axs_FixedMaturityInvestmentPortfolioPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FixedMaturityInvestmentPortfolioPercentage", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESCashandInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturity investment portfolio percentage", "label": "Fixed Maturity Investment Portfolio Percentage", "documentation": "Fixed Maturity Investment Portfolio Percentage" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyGainLossMember", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange (losses) gains", "label": "Foreign Currency Gain (Loss) [Member]", "documentation": "Primary financial statement caption encompassing foreign currency gain (loss)." } } }, "auth_ref": [ "r1369" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign exchange losses (gains)", "verboseLabel": "Foreign exchange (losses) gains", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r737", "r738", "r739", "r740", "r1006" ] }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossUnrealized", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign exchange losses", "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r201", "r983", "r1132", "r1376", "r1377", "r1422" ] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Exchange", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r736" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange forward contracts", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r969", "r973", "r978", "r998", "r1004", "r1036", "r1037", "r1038", "r1122" ] }, "us-gaap_ForeignGovernmentDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignGovernmentDebtSecuritiesMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-U.S. government", "label": "Debt Security, Government, Non-US [Member]", "documentation": "Debt security issued by government not domiciled in United States of America (US)." } } }, "auth_ref": [ "r1335", "r1417" ] }, "axs_ForeignTaxCreditsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ForeignTaxCreditsMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Tax Credits", "label": "Foreign Tax Credits [Member]", "documentation": "Foreign Tax Credits" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r1149", "r1161", "r1171", "r1197" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r1149", "r1161", "r1171", "r1197" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r1149", "r1161", "r1171", "r1197" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r1149", "r1161", "r1171", "r1197" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r1149", "r1161", "r1171", "r1197" ] }, "axs_FreedomFinancialAssetManagementLLCFreedomMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "FreedomFinancialAssetManagementLLCFreedomMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Freedom", "label": "Freedom Financial Asset Management, LLC (\"Freedom\") [Member]", "documentation": "Freedom Consumer Credit Fund, LLC Series B [Member]" } } }, "auth_ref": [] }, "country_GB": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "GB", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lloyd's of London", "label": "UNITED KINGDOM" } } }, "auth_ref": [] }, "us-gaap_GainLossOnInvestmentsMember1": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestmentsMember1", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment gains (losses)", "label": "Gain (Loss) on Investments [Member]", "documentation": "Primary financial statement caption encompassing gain (loss) on investments." } } }, "auth_ref": [] }, "us-gaap_GainLossOnInvestmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestmentsTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Net Investment Gains (Losses)", "label": "Gain (Loss) on Securities [Table Text Block]", "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security." } } }, "auth_ref": [ "r1246", "r1247" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative expenses", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r194", "r987" ] }, "us-gaap_GeneralAndAdministrativeExpenseRatio": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpenseRatio", "calculation": { "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": "us-gaap_CombinedRatio", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative expense ratio", "label": "General and Administrative Expense Ratio", "documentation": "Ratio of non-life general and administrative expenses to non-life net premiums earned." } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "totalLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r313", "r505", "r821", "r1095", "r1115", "r1318", "r1319" ] }, "axs_GoodwillAccumulatedTranslationAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "GoodwillAccumulatedTranslationAdjustments", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_Goodwill", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated translation adjustment", "verboseLabel": "Accumulated translation adjustment", "label": "Goodwill Accumulated Translation Adjustments", "documentation": "Cumulative amount of increase (decrease) from foreign currency translation adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Impairment charges", "label": "Goodwill and Intangible Asset Impairment", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETS" ], "lang": { "en-us": { "role": { "terseLabel": "GOODWILL AND INTANGIBLE ASSETS", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r204" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r14", "r83" ] }, "us-gaap_GoodwillGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillGross", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_Goodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Gross amount", "label": "Goodwill, Gross", "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r508", "r515", "r1095" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_GoodwillAndIntangibleAssetImpairment", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails", "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment charges", "terseLabel": "Impairment charges", "label": "Goodwill, Impairment Loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r9", "r506", "r512", "r516", "r1095" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "axs_GordonBrothersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "GordonBrothersMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gordon Brothers", "label": "Gordon Brothers [Member]", "documentation": "Gordon Brothers" } } }, "auth_ref": [] }, "us-gaap_GranteeStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusAxis", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grantee Status [Axis]", "label": "Grantee Status [Axis]", "documentation": "Information by status of recipient to whom award is granted." } } }, "auth_ref": [ "r620", "r622", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r649", "r650", "r651", "r652", "r653" ] }, "us-gaap_GranteeStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusDomain", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grantee Status [Domain]", "label": "Grantee Status [Domain]", "documentation": "Status of recipient to whom award is granted." } } }, "auth_ref": [ "r620", "r622", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r649", "r650", "r651", "r652", "r653" ] }, "us-gaap_GuaranteeObligationsByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsByNatureAxis", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Guarantor Obligations, Nature [Axis]", "label": "Guarantor Obligations, Nature [Axis]", "documentation": "Information by nature of guarantee." } } }, "auth_ref": [ "r536", "r537", "r538", "r539" ] }, "us-gaap_GuaranteeObligationsNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsNatureDomain", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Guarantor Obligations, Nature [Domain]", "label": "Guarantor Obligations, Nature [Domain]", "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees." } } }, "auth_ref": [ "r536", "r537", "r538", "r539" ] }, "axs_HarringtonReMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "HarringtonReMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Harrington Re", "label": "Harrington Re [Member]", "documentation": "Harrington Re [Member]" } } }, "auth_ref": [] }, "axs_HarringtonReinsuranceHoldingsLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "HarringtonReinsuranceHoldingsLimitedMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Harrington Reinsurance Holdings Limited", "label": "Harrington Reinsurance Holdings Limited [Member]", "documentation": "Harrington Reinsurance Holdings Limited [Member]" } } }, "auth_ref": [] }, "us-gaap_HedgeFundsMultistrategyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgeFundsMultistrategyMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multi-strategy funds", "label": "Hedge Funds, Multi-strategy [Member]", "documentation": "Investments in registered hedge funds structured to implement multiple investment strategies with the purpose of portfolio diversification." } } }, "auth_ref": [ "r1107", "r1335" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r21", "r702" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r21" ] }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails": { "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross unrealized gains", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain", "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r250", "r463" ] }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails": { "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross unrealized losses", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r251", "r464" ] }, "us-gaap_HeldToMaturitySecuritiesClassifiedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesClassifiedAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss [Abstract]", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Held to maturity securities due after ten years", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r461", "r829" ] }, "axs_HeldToMaturitySecuritiesDebtMaturitiesAfterThreeThroughTenYearsNetCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterThreeThroughTenYearsNetCarryingAmount", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Held to maturity securities debt maturities after three through ten years net carrying amount", "label": "Held To Maturity Securities Debt Maturities After Three Through Ten Years Net Carrying Amount", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in third through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Held to maturity securities with no single maturity date", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r457", "r828" ] }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesFairValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails": { "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities, held to maturity, fair value", "verboseLabel": "Fair value", "label": "Debt Securities, Held-to-Maturity, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r249", "r462", "r822", "r842" ] }, "us-gaap_HeldToMaturitySecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Fixed Maturities, Held-to-Maturity", "label": "Debt Securities, Held-to-Maturity [Table Text Block]", "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r1281", "r1282", "r1283", "r1284", "r1285", "r1286", "r1287", "r1288", "r1289", "r1290", "r1291", "r1292", "r1293", "r1294", "r1295", "r1296", "r1297", "r1298" ] }, "us-gaap_HerMajestysRevenueAndCustomsHMRCMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HerMajestysRevenueAndCustomsHMRCMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "U.K.", "terseLabel": "United Kingdom", "label": "Her Majesty's Revenue and Customs (HMRC) [Member]", "documentation": "Designated tax department of the government of United Kingdom." } } }, "auth_ref": [] }, "country_IE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "IE", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ireland", "label": "IRELAND" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "ICFR Auditor Attestation Flag", "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r1139", "r1140", "r1153" ] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_GoodwillAndIntangibleAssetImpairment", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Impairment charges", "label": "Impairment of Intangible Assets, Finite-Lived", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r1250", "r1320" ] }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_GoodwillAndIntangibleAssetImpairment", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment charges", "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)", "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value." } } }, "auth_ref": [ "r1250", "r1320" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bermuda (domestic)", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r360", "r691" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r189", "r236", "r407", "r421", "r427", "r430", "r826", "r855", "r1088" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r360", "r691" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income taxes and interest in income of equity method investments", "terseLabel": "Income before income taxes and interest in income of equity method investments", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r407", "r421", "r427", "r430", "r864", "r1088" ] }, "axs_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestIncomeLossFromEquityMethodInvestmentsAndEquityInNetEarningsOfSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestIncomeLossFromEquityMethodInvestmentsAndEquityInNetEarningsOfSubsidiaries", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) before equity in net income of subsidiaries", "label": "Income Loss From Continuing Operations Before Income Taxes Minority Interest Income Loss From Equity Method Investments And Equity In Net Earnings Of Subsidiaries", "documentation": "Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. This item also excludes the entity's interest in net earnings of its subsidiaries and is used for parent company stand-alone (i.e. non-consolidated) financial statements." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest in income of equity method investments", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r9", "r190", "r235", "r414", "r473", "r854" ] }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest in income of equity method investments", "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions", "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities." } } }, "auth_ref": [ "r9" ] }, "axs_IncomeLossFromSubsidiariesEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "IncomeLossFromSubsidiariesEquityMethod", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 }, "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity in net income of subsidiaries", "negatedLabel": "Equity in income loss of subsidiaries", "label": "Income Loss From Subsidiaries Equity Method", "documentation": "This item represents the entity's proportionate share for the period of the net income (loss) of its subsidiaries. This item is used for parent company stand-alone (i.e. non-consolidated) financial statements." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r523", "r525", "r992" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r525", "r992" ] }, "us-gaap_IncomeTaxAuthorityNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameAxis", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority, Name [Axis]", "label": "Income Tax Authority, Name [Axis]", "documentation": "Information by name of taxing authority." } } }, "auth_ref": [ "r17" ] }, "us-gaap_IncomeTaxAuthorityNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameDomain", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority, Name [Domain]", "label": "Income Tax Authority, Name [Domain]", "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXES" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r361", "r667", "r673", "r675", "r682", "r687", "r693", "r694", "r695", "r924" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax expense", "negatedTerseLabel": "Income tax expense", "totalLabel": "Total income tax expense (benefit)", "negatedNetLabel": "Income tax (expense) benefit", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r262", "r273", "r380", "r381", "r415", "r671", "r688", "r865" ] }, "axs_IncomeTaxExpenseBenefitByTaxAuthorityTable": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "IncomeTaxExpenseBenefitByTaxAuthorityTable", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Expense Benefit By Tax Authority [Table]", "label": "Income Tax Expense Benefit By Tax Authority [Table]", "documentation": "A summary of current and deferred income tax expense, by tax jurisdiction." } } }, "auth_ref": [] }, "axs_IncomeTaxExpenseBenefitLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "IncomeTaxExpenseBenefitLineItems", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense [Line Items]", "label": "IncomeTaxExpenseBenefit [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r337", "r669", "r670", "r675", "r676", "r681", "r683", "r918" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes paid", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r63" ] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails": { "parentTag": "axs_TaxAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net current tax receivables", "label": "Income Taxes Receivable, Current", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r150", "r1241" ] }, "us-gaap_IncreaseDecreaseDueFromAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseDueFromAffiliates", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Non-cash repayment of advance", "label": "Increase (Decrease) Due from Affiliates", "documentation": "The increase (decrease) during the reporting period in receivables to be collected from an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedInvestmentIncomeReceivable", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued interest receivable", "label": "Increase (Decrease) in Accrued Investment Income Receivable", "documentation": "The increase (decrease) during the reporting period in investment income that has been earned but not yet received in cash." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredPolicyAcquisitionCosts", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred acquisition costs", "label": "Increase (Decrease) in Deferred Policy Acquisition Costs", "documentation": "The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInDueToAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueToAffiliates", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in intercompany payable", "label": "Increase (Decrease) in Due to Affiliates", "documentation": "The increase (decrease) in obligations owed to an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve for losses and loss expenses", "label": "Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve", "documentation": "Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other items", "negatedTerseLabel": "Other items", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r8" ] }, "axs_IncreaseDecreaseInPremiumsReceivableAndReinsurancePayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "IncreaseDecreaseInPremiumsReceivableAndReinsurancePayableNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Insurance and reinsurance balances, net", "label": "(Increase) Decrease In Premiums Receivable And Reinsurance Payable Net", "documentation": "The net change in the premium receivable and the amount due to other insurance companies on the balance sheet." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidReinsurancePremiums", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid reinsurance premiums", "label": "Increase (Decrease) in Prepaid Reinsurance Premiums", "documentation": "The change in prepaid reinsurance premiums recorded on the balance sheet, which is needed to adjust net income to arrive at net cash flows provided by or used in operations." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInReinsuranceRecoverable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInReinsuranceRecoverable", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Reinsurance recoverable on unpaid losses and loss expenses", "label": "Increase (Decrease) in Reinsurance Recoverable", "documentation": "The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInUnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInUnearnedPremiums", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned premiums", "label": "Increase (Decrease) in Unearned Premiums", "documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income." } } }, "auth_ref": [ "r8" ] }, "axs_IncreaseDecreaseReinsuranceRecoverableOnPaidLossesAndLossExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "IncreaseDecreaseReinsuranceRecoverableOnPaidLossesAndLossExpenses", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reinsurance recoverable on paid losses and loss expenses", "label": "Increase Decrease Reinsurance Recoverable On Paid Losses And Loss Expenses", "documentation": "Increase Decrease Reinsurance Recoverable On Paid Losses And Loss Expenses" } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation plans (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r387", "r388", "r389", "r395", "r623" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets [Axis]", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r518", "r521" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": "axs_IntangibleAssetsIncludingGoodwillGross", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails", "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets\u00a0with\u00a0an indefinite life", "verboseLabel": "Indefinite lived intangible assets", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r207" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r87", "r207" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsRollForward", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets\u00a0with\u00a0an indefinite life", "label": "Indefinite-Lived Intangible Assets [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r1152", "r1161", "r1171", "r1188", "r1197", "r1201", "r1209" ] }, "us-gaap_InlandRevenueSingaporeIRASMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InlandRevenueSingaporeIRASMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Singapore", "label": "Inland Revenue, Singapore (IRAS) [Member]", "documentation": "Designated tax department of the government of Singapore." } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r1207" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r1141", "r1213" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r1141", "r1213" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r1141", "r1213" ] }, "us-gaap_InsuranceLossReservesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuranceLossReservesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Insurance Loss Reserves [Abstract]", "label": "Insurance Loss Reserves [Abstract]" } } }, "auth_ref": [] }, "axs_InsuranceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InsuranceMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance", "label": "Insurance [Member]", "documentation": "Insurance segment" } } }, "auth_ref": [] }, "us-gaap_InsurancePremiumsRevenueRecognitionPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsurancePremiumsRevenueRecognitionPolicy", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Premiums - Gross Premiums Written", "label": "Insurance Premiums Revenue Recognition, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue recognition of insurance premium. Includes, but is not limited to, basis for measurement and timing of recognition of revenue from insurance premium received from contract holder and method used in performing premium deficiency testing." } } }, "auth_ref": [ "r269" ] }, "us-gaap_IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "VOBA - Novae", "label": "Intangible Assets Arising from Insurance Contracts Acquired in Business Combination [Member]", "documentation": "An intangible asset that arises from measuring the difference between (a) the fair value of the contractual insurance and reinsurance assets acquired and liabilities assumed and (b) the assets and liabilities measured in accordance with the acquirer's policies for insurance and reinsurance contracts that it issues or holds. This element is used for business combinations entered into on or after December 15, 2008." } } }, "auth_ref": [ "r170" ] }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsGrossExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount", "label": "Intangible Assets, Gross (Excluding Goodwill)", "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill." } } }, "auth_ref": [ "r313" ] }, "axs_IntangibleAssetsIncludingGoodwillGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "IntangibleAssetsIncludingGoodwillGross", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross amount", "label": "Intangible Assets Including Goodwill Gross", "documentation": "Amount before accumulated impairment loss of goodwill and intangible assets, both finite and indefinite-lived." } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 11.0 }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofEstimatedAmortizationExpenseDetails", "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "totalLabel": "Total", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r84", "r88" ] }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetIncludingGoodwill", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill and intangible assets", "totalLabel": "Goodwill and intangible assets net balance", "label": "Intangible Assets, Net (Including Goodwill)", "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance." } } }, "auth_ref": [] }, "axs_IntangibleAssetsNetIncludingGoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "IntangibleAssetsNetIncludingGoodwillRollForward", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Intangible Assets Net Including Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense and financing costs", "negatedLabel": "Interest expense and financing costs", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r145", "r238", "r341", "r411", "r748", "r993", "r1132", "r1421" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r196", "r573", "r581", "r1099", "r1100" ] }, "us-gaap_InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense on FHLB borrowings", "label": "Interest Expense, Federal Home Loan Bank and Federal Reserve Bank Advances, Short-Term", "documentation": "Interest expense incurred during the reporting period on short-term borrowings associated with Federal Home Loan Bank and Federal Reserve Bank advances." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r351", "r354", "r355" ] }, "us-gaap_InterestReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestReceivable", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest receivable", "label": "Interest Receivable", "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable." } } }, "auth_ref": [ "r1241", "r1425" ] }, "us-gaap_InternalCreditAssessmentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InternalCreditAssessmentAxis", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Internal Credit Assessment [Axis]", "label": "Internal Credit Assessment [Axis]", "documentation": "Information by entity-defined rating." } } }, "auth_ref": [ "r81", "r703", "r1092", "r1093", "r1312" ] }, "us-gaap_InternalCreditAssessmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InternalCreditAssessmentDomain", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Internal Credit Assessment [Domain]", "label": "Internal Credit Assessment [Domain]", "documentation": "Entity defined credit risk rating." } } }, "auth_ref": [] }, "us-gaap_InternalRevenueServiceIRSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InternalRevenueServiceIRSMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S.", "label": "Internal Revenue Service (IRS) [Member]", "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "axs_InvestmentFundsTermAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentFundsTermAxis", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Funds, Term [Axis]", "label": "Investment Funds, Term [Axis]", "documentation": "Investment Funds, Term" } } }, "auth_ref": [] }, "axs_InvestmentFundsTermDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentFundsTermDomain", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Funds, Term [Domain]", "label": "Investment Funds, Term [Domain]", "documentation": "Investment Funds, Term" } } }, "auth_ref": [] }, "axs_InvestmentFundsTermPeriodOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentFundsTermPeriodOneMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5-year term", "label": "Investment Funds, Term, Period One [Member]", "documentation": "Investment Funds, Term, Period One" } } }, "auth_ref": [] }, "axs_InvestmentFundsTermPeriodTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentFundsTermPeriodTwoMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "10-year term", "label": "Investment Funds, Term, Period Two [Member]", "documentation": "Investment Funds, Term, Period Two" } } }, "auth_ref": [] }, "axs_InvestmentInRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentInRelatedPartyMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment In Related Party", "label": "Investment In Related Party [Member]", "documentation": "Investment In Related Party" } } }, "auth_ref": [] }, "axs_InvestmentInSubsidiariesEquityBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentInSubsidiariesEquityBasis", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in subsidiaries", "label": "Investment In Subsidiaries Equity Basis", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of its subsidiaries under the equity method. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of subsidiaries, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. This element is used for parent company stand-alone (i.e. non-consolidated) financial statements." } } }, "auth_ref": [] }, "axs_InvestmentIncomeForInvestmentsAndCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentIncomeForInvestmentsAndCashAndCashEquivalents", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails": { "parentTag": "axs_InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross investment income", "label": "Investment Income For Investments And Cash And Cash Equivalents", "documentation": "The net gain or loss (both realized and unrealized) related to investments in certain entities that calculate net asset value per share and the amount after accretion (amortization) of discount (premium), of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeInvestmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInvestmentExpense", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails": { "parentTag": "axs_InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Investment expenses", "label": "Investment Income, Investment Expense", "documentation": "Amount of expenses related to the generation of investment income." } } }, "auth_ref": [ "r197", "r1132", "r1408" ] }, "us-gaap_InvestmentIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment income", "label": "Investment Income, Net", "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r195", "r196" ] }, "axs_InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentIncomeNetForInvestmentsAndCashAndCashEquivalents", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment income", "totalLabel": "Net investment income", "label": "Investment Income Net For Investments And Cash And Cash Equivalents", "documentation": "The net gain or loss (both realized and unrealized) related to investments in certain entities that calculate net asset value per share and the amount after accretion (amortization) of discount (premium) of interest income and dividend income on nonoperating securities, net of investment expense." } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Net Investment Income", "label": "Investment Income [Table Text Block]", "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments." } } }, "auth_ref": [ "r195", "r196", "r197", "r1409" ] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r861", "r914", "r915", "r916", "r917", "r1022", "r1023" ] }, "axs_InvestmentPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "InvestmentPortfolioMember", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Investment Portfolio", "terseLabel": "Investment Portfolio", "label": "Investment Portfolio [Member]", "documentation": "Derivative instruments related to the entity's investment portfolio." } } }, "auth_ref": [] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Type [Axis]", "verboseLabel": "Schedule Of Investment Income Reported Amounts By Category [Axis]", "label": "Investment Type [Axis]", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r942", "r944", "r945", "r948", "r951", "r1018", "r1021", "r1026", "r1030", "r1031", "r1043", "r1044", "r1047", "r1048", "r1049", "r1050", "r1051", "r1122" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Type Categorization [Domain]", "label": "Investments [Domain]", "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r942", "r944", "r945", "r948", "r951", "r1018", "r1021", "r1026", "r1030", "r1031", "r1043", "r1044", "r1047", "r1048", "r1049", "r1050", "r1051", "r1122" ] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Investments", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total investments", "label": "Investments", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r841" ] }, "us-gaap_InvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Investments:", "label": "Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Contractual Maturities of Fixed Maturities", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments." } } }, "auth_ref": [] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Investments, Debt and Equity Securities [Abstract]", "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTMENTS", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "documentation": "The entire disclosure for investments in certain debt and equity securities." } } }, "auth_ref": [ "r224", "r239", "r248", "r279", "r437", "r439", "r730", "r731" ] }, "us-gaap_JuniorSubordinatedDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "JuniorSubordinatedDebtMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Junior Subordinated Notes", "label": "Junior Subordinated Debt [Member]", "documentation": "Borrowing that has a lower priority than senior instruments in event of liquidation of the entity's assets." } } }, "auth_ref": [] }, "axs_LOCFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LOCFacilityMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$250 Million Secured LOC", "label": "LOC Facility [Member]", "documentation": "LOC Facility [Member]" } } }, "auth_ref": [] }, "axs_LOCFacilityThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LOCFacilityThreeMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$750 Million Secured LOC", "label": "LOC Facility Three [Member]", "documentation": "LOC Facility Three" } } }, "auth_ref": [] }, "axs_LOCFacilityTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LOCFacilityTwoMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$500 Million Secured LOC", "label": "LOC Facility Two [Member]", "documentation": "LOC Facility Two [Member]" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease expense", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r755", "r1114" ] }, "us-gaap_LeaseCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostAbstract", "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease cost:", "label": "Lease, Cost [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/LEASESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Lease Expense and Related Cash Flows", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1378" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "axs_LeasesOtherInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LeasesOtherInformationAbstract", "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other information:", "label": "Leases Other Information [Abstract]", "documentation": "Leases Other Information [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r754" ] }, "axs_LesseeOperatingLeaseLiabilityDiscountedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LesseeOperatingLeaseLiabilityDiscountedAmount", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Discount", "label": "Lessee, Operating Lease, Liability, Discounted Amount", "documentation": "Lessee, Operating Lease, Liability, Discounted Amount" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/LEASESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Maturity and Minimum Lease Payments", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1379" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Later years", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r763" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected cash flows, year one", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r763" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected cash flows, year five", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r763" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected cash flows, year four", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r763" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected cash flows, year three", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r763" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected cash flows, year two", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r763" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.axiscapital.com/role/LEASES" ], "lang": { "en-us": { "role": { "terseLabel": "LEASES", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r750" ] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LetterOfCreditMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of Credit Facility", "label": "Letter of Credit [Member]", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letters of credit outstanding", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r45", "r359", "r478", "r540", "r541", "r543", "r544", "r545", "r547", "r549", "r551", "r552", "r698", "r699", "r700", "r735", "r961", "r1087", "r1134", "r1326", "r1383", "r1384" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "verboseLabel": "Liabilities", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r182", "r232", "r852", "r1115", "r1253", "r1305", "r1375" ] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r134" ] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForCatastropheClaimsByCatastrophicEventAxis", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability For Catastrophe Claims By Catastrophic Event [Axis]", "label": "Catastrophic Event [Axis]", "documentation": "Information by type of catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion." } } }, "auth_ref": [ "r242" ] }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveforLossesandLossExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveforLossesandLossExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve for losses and loss expenses", "totalLabel": "Reserve for losses and loss expenses", "periodStartLabel": "Gross reserve for losses and loss expenses, beginning of year", "periodEndLabel": "Gross reserve for losses and loss expenses, end of year", "label": "Liability for Claims and Claims Adjustment Expense", "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date." } } }, "auth_ref": [ "r159", "r244" ] }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]", "label": "Liability for Claims and Claims Adjustment Expense [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]", "label": "Liability for Claims and Claims Adjustment Expense [Table]", "documentation": "Disclosure of information about the liability for claims and claims adjustment expense." } } }, "auth_ref": [] }, "us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForFuturePolicyBenefitByProductSegmentLineItems", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for Future Policy Benefit, by Product Segment [Line Items]", "label": "Liability for Future Policy Benefit, by Product Segment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForFuturePolicyBenefitByProductSegmentTable", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for Future Policy Benefit, by Product Segment [Table]", "label": "Liability for Future Policy Benefit, by Product Segment [Table]", "documentation": "Reflects the carrying amount of and other relevant, pertinent information about the liability as of the balance sheet date for future benefits to be paid to or on behalf of policyholders and related expenses less the present value of future net premiums by major product line segment." } } }, "auth_ref": [] }, "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSES" ], "lang": { "en-us": { "role": { "terseLabel": "RESERVE FOR LOSSES AND LOSS EXPENSES", "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]", "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net paid losses and loss expenses related to:", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails": { "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Current year", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs." } } }, "auth_ref": [ "r26" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails": { "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Prior years", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs." } } }, "auth_ref": [ "r26" ] }, "axs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignExchangeLossPortfolioTransferAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignExchangeLossPortfolioTransferAndOther", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange and other", "verboseLabel": "Reinsurance recoverable on unpaid losses", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Exchange, Loss Portfolio Transfer, And Other", "documentation": "Amount of other items that increase (decrease) the cost of settling unpaid claims after deduction of reinsurance recoveries, such as foreign exchange, loss portfolio transfer and other miscellaneous items." } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveforLossesandLossExpensesDetails": { "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveforLossesandLossExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve for losses incurred but not reported", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount", "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement." } } }, "auth_ref": [ "r160" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": "axs_UnderwritingIncomeLossNet", "weight": -1.0, "order": 4.0 }, "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net losses and loss expenses", "negatedTerseLabel": "Net losses and loss expenses", "totalLabel": "Net incurred losses and loss expenses", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process." } } }, "auth_ref": [ "r243" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net incurred losses and loss expenses related to:", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Net reserve for unpaid losses and loss expenses, beginning of year", "periodEndLabel": "Net reserve for unpaid losses and loss expenses, end of year", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net", "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims." } } }, "auth_ref": [ "r159", "r244", "r1399" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Beginning and Ending Gross Unpaid Losses and Loss Expenses", "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveforLossesandLossExpensesDetails": { "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveforLossesandLossExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve for reported losses and loss expenses", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount", "documentation": "Costs of settling insured claims and costs incurred in the claims settlement process for the specified year specifically for claims that have already been submitted to the insurance company for reimbursement." } } }, "auth_ref": [] }, "axs_LiabilityLineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LiabilityLineMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability", "label": "Liability Line [Member]", "documentation": "Liability line of business" } } }, "auth_ref": [] }, "us-gaap_LimitedPartnerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnerMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Partner", "label": "Limited Partner [Member]", "documentation": "Party to a partnership business who has limited liability." } } }, "auth_ref": [] }, "axs_LineOfCreditFacilityAggregateUtilizationCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LineOfCreditFacilityAggregateUtilizationCapacity", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, aggregate utilization capacity", "label": "Line Of Credit Facility, Aggregate Utilization Capacity", "documentation": "Line Of Credit Facility, Aggregate Utilization Capacity" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lender Name [Axis]", "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r43", "r1252" ] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility, Lender [Domain]", "label": "Line of Credit Facility, Lender [Domain]", "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r43", "r1252" ] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Line Items]", "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1252" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r43" ] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Table]", "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r43", "r1252" ] }, "axs_LineOfCreditFacilityUtilizationCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LineOfCreditFacilityUtilizationCapacity", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLetterofCreditfacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, utilization capacity", "label": "Line Of Credit Facility, Utilization Capacity", "documentation": "Line Of Credit Facility, Utilization Capacity" } } }, "auth_ref": [] }, "axs_LloydsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LloydsMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lloyd's", "label": "Lloyd's [Member]", "documentation": "Lloyd's of London." } } }, "auth_ref": [] }, "axs_LoanAgreementWithMonarchPointReMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LoanAgreementWithMonarchPointReMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan Agreement With Monarch Point Re", "label": "Loan Agreement With Monarch Point Re [Member]", "documentation": "Loan Agreement With Monarch Point Re" } } }, "auth_ref": [] }, "axs_LoanAgreementWithThirdPartyReinsurerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LoanAgreementWithThirdPartyReinsurerMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan Agreement With Monarch Point Re", "label": "Loan Agreement With Third Party Reinsurer [Member]", "documentation": "Loan Agreement With Third Party Reinsurer" } } }, "auth_ref": [] }, "us-gaap_LoansAndLeasesReceivableDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansAndLeasesReceivableDisclosureAbstract", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mortgage loans held for investment:", "label": "Loans and Leases Receivable Disclosure [Abstract]" } } }, "auth_ref": [] }, "axs_LoansHeldForInvestmentCommercialPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LoansHeldForInvestmentCommercialPercent", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails": { "parentTag": "axs_TotalMortgageLoansHeldForInvestmentPercent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial (as a percent)", "label": "Loans Held For Investment, Commercial, Percent", "documentation": "Loans Held For Investment, Commercial, Percent" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "axs_LockupRedemptionRestrictionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "LockupRedemptionRestrictionMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lockup Redemption Restriction", "label": "Lockup Redemption Restriction [Member]", "documentation": "Redemption restriction on investments for which net asset value per share is calculated (including, but not limited to, by unit, membership interest, or other ownership interest) due to lockups." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtByMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtByMaturityAbstract", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scheduled debt maturity", "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails": { "parentTag": "us-gaap_NotesPayable", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After 2028", "label": "Long-Term Debt, Maturity, after Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r367", "r1331" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails": { "parentTag": "us-gaap_NotesPayable", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r367", "r571" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails": { "parentTag": "us-gaap_NotesPayable", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Long-Term Debt, Maturity, Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r367", "r571" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails": { "parentTag": "us-gaap_NotesPayable", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r367", "r571" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails": { "parentTag": "us-gaap_NotesPayable", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r367", "r571" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails": { "parentTag": "us-gaap_NotesPayable", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r11", "r367", "r571" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r48" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r48", "r92" ] }, "us-gaap_LossRatio": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossRatio", "calculation": { "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": "us-gaap_CombinedRatio", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net losses and loss expenses ratio", "label": "Loss Ratio", "documentation": "Ratio of non-life losses and loss expenses to non-life net premiums earned." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r436", "r1104", "r1334", "r1411", "r1415" ] }, "axs_MarineAndAviationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "MarineAndAviationMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marine and aviation", "label": "Marine and Aviation [Member]", "documentation": "Marine and Aviation" } } }, "auth_ref": [] }, "us-gaap_MarketApproachValuationTechniqueMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketApproachValuationTechniqueMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation, Market Approach", "label": "Valuation, Market Approach [Member]", "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities." } } }, "auth_ref": [ "r22" ] }, "us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "axs_NetInvestmentGainLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Other realized and unrealized investment gains (losses)", "label": "Marketable Security, Gain (Loss)", "documentation": "Amount of realized and unrealized gain (loss) on investment in marketable security." } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Cost and Fair Value of Equity Securities", "label": "Marketable Securities [Table Text Block]", "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets." } } }, "auth_ref": [] }, "axs_MarshMcLennanCompaniesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "MarshMcLennanCompaniesIncMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marsh & McLennan Companies Inc.", "label": "Marsh & McLennan Companies Inc [Member]", "documentation": "Marsh & McLennan Companies Inc" } } }, "auth_ref": [] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Reconciling Items", "label": "Segment Reconciling Items [Member]", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r78" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r532", "r533", "r534", "r535", "r618", "r805", "r895", "r952", "r953", "r1019", "r1024", "r1028", "r1029", "r1045", "r1074", "r1075", "r1089", "r1101", "r1110", "r1117", "r1330", "r1385", "r1386", "r1387", "r1388", "r1389", "r1390" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r1180" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r1180" ] }, "axs_MeasurementInputCollateralSpreadsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "MeasurementInputCollateralSpreadsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collateral spread", "label": "Measurement Input, Collateral Spreads [Member]", "documentation": "Measurement Input, Collateral Spreads [Member]" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputDefaultRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputDefaultRateMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Default rate", "label": "Measurement Input, Default Rate [Member]", "documentation": "Measurement input using likelihood loan will not be repaid as proportion of outstanding loan." } } }, "auth_ref": [ "r1374" ] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount rate", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r1374" ] }, "axs_MeasurementInputLossAbsorptionYieldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "MeasurementInputLossAbsorptionYieldMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss absorption yield", "label": "Measurement Input, Loss Absorption Yield [Member]", "documentation": "Measurement Input, Loss Absorption Yield" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputLossSeverityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputLossSeverityMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss severity rate", "label": "Measurement Input, Loss Severity [Member]", "documentation": "Measurement input using loss, including, but not limited to, interest and write-down of principal, incurred on defaulted security as proportion of principal balance." } } }, "auth_ref": [ "r1374" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Axis]", "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r720" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Domain]", "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r532", "r533", "r534", "r535", "r618", "r805", "r895", "r952", "r953", "r1019", "r1024", "r1028", "r1029", "r1045", "r1074", "r1075", "r1089", "r1101", "r1110", "r1117", "r1330", "r1385", "r1386", "r1387", "r1388", "r1389", "r1390" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r1200" ] }, "axs_MonarchPointReMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "MonarchPointReMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Monarch Point Re", "label": "Monarch Point Re [Member]", "documentation": "Monarch Point Re (ISAC) Ltd. and Monarch Point Re (ISA 2023) Ltd." } } }, "auth_ref": [] }, "us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-agency RMBS", "label": "Mortgage-Backed Securities, Issued by Private Enterprises [Member]", "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by non-governmental sponsored enterprises." } } }, "auth_ref": [ "r1274", "r1276", "r1281", "r1286", "r1294", "r1335" ] }, "us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agency RMBS", "label": "Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member]", "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by US Government Sponsored Enterprises, such as Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac)." } } }, "auth_ref": [ "r1276", "r1286", "r1294", "r1335" ] }, "axs_MortgageLoansHeldForInvestmentAmountPastDue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "MortgageLoansHeldForInvestmentAmountPastDue", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial mortgage loans, past due amount", "label": "Mortgage Loans, Held for Investment, Amount Past Due", "documentation": "This item represents the amortized cost of commercial mortgage loans held for investments that are past due." } } }, "auth_ref": [] }, "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 3.0 }, "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mortgage loans, held for investment, at fair value (Allowance for expected credit losses 2023: $6,220; 2022: $nil)", "totalLabel": "Total mortgage loans held for investment", "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net", "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio." } } }, "auth_ref": [ "r839" ] }, "us-gaap_MortgagesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgagesMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mortgage loans", "label": "Mortgages [Member]", "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan." } } }, "auth_ref": [] }, "axs_MotorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "MotorMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Motor", "label": "Motor [Member]", "documentation": "Motor line of business" } } }, "auth_ref": [] }, "axs_MotorReserveClassMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "MotorReserveClassMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Motor Reserve Class", "label": "Motor Reserve Class [Member]", "documentation": "Motor Reserve Class" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r1208" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r436", "r1104", "r1334", "r1411", "r1415" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r1181" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://www.axiscapital.com/role/ORGANIZATION" ], "lang": { "en-us": { "role": { "terseLabel": "ORGANIZATION", "label": "Nature of Operations [Text Block]", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r264", "r277" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r353" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r353" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r199", "r200", "r201" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 }, "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r191", "r201", "r237", "r311", "r332", "r335", "r340", "r359", "r372", "r374", "r375", "r376", "r377", "r380", "r381", "r391", "r407", "r421", "r427", "r430", "r478", "r540", "r541", "r543", "r544", "r545", "r547", "r549", "r551", "r552", "r715", "r735", "r856", "r984", "r1007", "r1008", "r1088", "r1132", "r1326" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income available to common shareholders", "verboseLabel": "Net income available to common shareholders", "terseLabel": "Net income available to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r346", "r374", "r375", "r376", "r377", "r383", "r384", "r392", "r395", "r407", "r421", "r427", "r430", "r1088" ] }, "axs_NetIncomeLossMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NetIncomeLossMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income (loss)", "label": "Net Income (Loss) [Member]", "documentation": "Net Income (Loss)" } } }, "auth_ref": [] }, "axs_NetInvestmentGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NetInvestmentGainLoss", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 4.0 }, "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentGainsLossesDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total net investment gains (losses)", "negatedLabel": "Net investment (gains) losses", "terseLabel": "Net investment gains (losses)", "label": "Net Investment Gain (Loss)", "documentation": "This item represents the net realized gains and losses on available for sale debt securities, the net realized and unrealized gains and losses on equity securities with FV recorded in net income, together with the change in fair value of investment derivatives, and expected and realized credit losses." } } }, "auth_ref": [] }, "axs_NetRealizedAndUnrealizedGainLossOnAlternativeInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NetRealizedAndUnrealizedGainLossOnAlternativeInvestments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Net realized and unrealized gains on other investments", "label": "Net Realized And Unrealized Gain Loss On Alternative Investments", "documentation": "Net realized and the change in net unrealized (gains) losses related to investments in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest . Investments include, but are not limited to, investments in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued Accounting Standards Not Yet Adopted", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r1180" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r1149", "r1161", "r1171", "r1188", "r1197" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r1178" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r1177" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r1188" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1208" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1208" ] }, "axs_NonUnitedStatesBondMutualFundMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NonUnitedStatesBondMutualFundMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bond mutual funds", "label": "Non United States Bond Mutual Fund [Member]", "documentation": "An investment in a fund that invests in non-U.S. fixed maturities and provides daily liquidity." } } }, "auth_ref": [] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not Designated as Hedging Instruments", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_NotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayable", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 }, "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "totalLabel": "Total senior notes and notes payable", "label": "Notes Payable", "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r42", "r231", "r1401" ] }, "us-gaap_NotesPayableFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior notes", "label": "Notes Payable, Fair Value Disclosure", "documentation": "Fair value portion of notes payable." } } }, "auth_ref": [ "r44" ] }, "axs_NovaeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NovaeMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails", "http://www.axiscapital.com/role/ORGANIZATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Novae", "label": "Novae [Member]", "documentation": "Novae [Member]" } } }, "auth_ref": [] }, "axs_NovaeSyndicate2007Member": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NovaeSyndicate2007Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Syndicate 2007", "label": "Novae Syndicate 2007 [Member]", "documentation": "Novae Syndicate 2007 [Member]" } } }, "auth_ref": [] }, "axs_NumberOfCollateralDependentLoan": { "xbrltype": "integerItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NumberOfCollateralDependentLoan", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of collateral dependent loan", "label": "Number Of Collateral Dependent Loan", "documentation": "Number Of Collateral Dependent Loan" } } }, "auth_ref": [] }, "axs_NumberOfFundsRedemption": { "xbrltype": "integerItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NumberOfFundsRedemption", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of funds", "label": "Number of Funds Redemption", "documentation": "The number of funds that are currently eligible for redemption at the stated frequency." } } }, "auth_ref": [] }, "axs_NumberOfInvestmentFunds": { "xbrltype": "integerItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "NumberOfInvestmentFunds", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of investment funds", "label": "Number Of Investment Funds", "documentation": "Number Of Investment Funds" } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r1266" ] }, "us-gaap_OffsettingAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Reconciliation of Gross Derivative Assets to Net Amounts Presented in Balance Sheets", "label": "Offsetting Assets [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r183", "r324" ] }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingLiabilitiesTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Reconciliation of Gross Derivative Liabilities to Net Amounts Presented in Balance Sheets", "label": "Offsetting Liabilities [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r183", "r324" ] }, "axs_OpenMarketMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OpenMarketMember", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In the open market:", "label": "Open Market [Member]", "documentation": "Open securities market, under repurchase plans authorized by the entity's Board of Directors." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r756", "r1114" ] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected cash flows", "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 }, "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/LEASESSummaryofMaturityandMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "totalLabel": "Total discounted operating lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r752" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating cash outflows from operating leases", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r753", "r759" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r751" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average discount rate - operating lease", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r762", "r1114" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining lease term - operating leases", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r761", "r1114" ] }, "axs_OperatingLossAndTaxCreditCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OperatingLossAndTaxCreditCarryforwardsLineItems", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss And Tax Credit Carryforwards [Line Items]", "label": "Operating Loss And Tax Credit Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "axs_OperatingLossAndTaxCreditCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OperatingLossAndTaxCreditCarryforwardsTable", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss And Tax Credit Carryforwards [Table]", "label": "Operating Loss And Tax Credit Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss and tax credit carryforwards." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforwards", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r113" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r420", "r421", "r422", "r423", "r424", "r430" ] }, "axs_OrdinarySharesOutstandingHeldByRelatedPartiesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OrdinarySharesOutstandingHeldByRelatedPartiesPercentage", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage ownership by related parties", "label": "Ordinary Shares Outstanding Held By Related Parties, Percentage", "documentation": "Percentage of NXT Capital's ordinary shares outstanding held by Stone Point Capital." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r226", "r315", "r843", "r1134" ] }, "us-gaap_OtherCommitment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitment", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Commitment", "label": "Other Commitment", "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails_1": { "parentTag": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Unrealized gains (losses) arising during the year, net of reclassification adjustment", "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, before Tax, Portion Attributable to Parent", "documentation": "Amount, before tax and after reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r6", "r18", "r219" ] }, "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Unrealized gains (losses) arising during the year, net of reclassification adjustment", "terseLabel": "Unrealized gains (losses) arising during the year, net of reclassification adjustment", "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r6", "r18", "r219" ] }, "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails_1": { "parentTag": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Unrealized gains (losses) arising during the year, net of reclassification adjustment", "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities, Tax, Portion Attributable to Parent", "documentation": "Amount, after reclassification adjustment, of tax expense (benefit) for gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r6", "r18", "r219" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent", "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r6", "r18", "r219" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustment", "verboseLabel": "Foreign currency translation adjustment", "totalLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r6", "r18", "r219" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r6", "r18", "r219" ] }, "us-gaap_OtherComprehensiveIncomeLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLocationAxis", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income Location [Axis]", "label": "Other Comprehensive Income Location [Axis]", "documentation": "Information by location in other comprehensive income." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLocationDomain", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income Location [Domain]", "label": "Other Comprehensive Income Location [Domain]", "documentation": "Location in other comprehensive income." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Unrealized gains (losses) arising during the period", "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r326", "r327" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent", "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r6", "r18", "r219" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Before tax amount", "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), net of tax:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r6", "r18", "r219", "r333", "r336" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net of tax amount", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r6", "r18", "r219" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax (expense) benefit", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent, Parenthetical Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income", "label": "Other Comprehensive Income (Loss) [Member]", "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included." } } }, "auth_ref": [ "r34" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains (losses) arising during the period", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax", "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r326", "r329", "r471" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains (losses) arising during the year", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r326", "r329", "r471" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unrealized gains (losses) arising during the period", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax", "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r4", "r327" ] }, "us-gaap_OtherContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherContractMember", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other underwriting-related contracts", "label": "Other Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is classified as other." } } }, "auth_ref": [ "r1076", "r1085", "r1105" ] }, "us-gaap_OtherDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other amortization and depreciation", "label": "Other Depreciation and Amortization", "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other." } } }, "auth_ref": [ "r9", "r91", "r193" ] }, "us-gaap_OtherInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestmentsMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other investments, at fair value", "label": "Other Investments [Member]", "documentation": "Primary financial statement caption encompassing other investments." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilities", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r153", "r838", "r957", "r958", "r1134", "r1420" ] }, "us-gaap_OtherOperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeExpenseMember", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other insurance related income (loss)", "label": "Other Operating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other operating income (expense)." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 3.0 }, "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": "axs_UnderwritingIncomeLossNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other insurance related income", "terseLabel": "Other insurance related income (loss)", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1180" ] }, "axs_OtherPrivatelyHeldInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OtherPrivatelyHeldInvestmentsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other privately held investments", "label": "Other Privately Held Investments [Member]", "documentation": "Other Privately Held Investments [Member]" } } }, "auth_ref": [] }, "axs_OtherRedemptionRestrictionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OtherRedemptionRestrictionMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Redemption Restriction", "label": "Other Redemption Restriction [Member]", "documentation": "Redemption restriction on investments for which net asset value per share is calculated (including, but not limited to, by unit, membership interest, or other ownership interest) other than gates and lockups." } } }, "auth_ref": [] }, "us-gaap_OtherShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherShortTermInvestments", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Investments", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments, at fair value", "verboseLabel": "Short-term investments", "label": "Other Short-Term Investments", "documentation": "Amount of short-term investments classified as other." } } }, "auth_ref": [ "r155", "r840", "r1242" ] }, "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSignificantNoncashTransactionValueOfConsiderationReceived1", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer of FHLB stock", "label": "Other Significant Noncash Transaction, Value of Consideration Received", "documentation": "The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r64", "r65", "r66" ] }, "axs_OtherTaxAuthoritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OtherTaxAuthoritiesMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bermuda", "label": "Other Tax Authorities [Member]", "documentation": "Tax departments of governments, other than those separately identified, entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "axs_OtherThanTemporaryImpairmentLossesInvestmentsAvailableForSaleSecuritiesPortionRecognizedInEarningsNetQualitativeDisclosuresLevelOfSubordinationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OtherThanTemporaryImpairmentLossesInvestmentsAvailableForSaleSecuritiesPortionRecognizedInEarningsNetQualitativeDisclosuresLevelOfSubordinationPercentage", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subordination percentage input for determining credit losses", "label": "Other Than Temporary Impairment Losses Investments Available for sale Securities Portion Recognized In Earnings Net Qualitative Disclosures Level Of Subordination Percentage", "documentation": "This item represents the current level of subordination of the entity's receipt of consideration should the assets underlying the security be liquidated when the level of subordination was considered as one of the potential factors in reaching a conclusion that the available-for-sale investments are other than temporarily impaired and the amount of such impairment determined to be related to credit loss recognized in earnings." } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1147", "r1159", "r1169", "r1195" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r1150", "r1162", "r1172", "r1198" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r1150", "r1162", "r1172", "r1198" ] }, "axs_OwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "OwnershipPercentageByParent", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage ownership in subsidiary (percent)", "label": "Ownership Percentage By Parent", "documentation": "The parent entity's ownership interest in the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "axs_PantheonMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PantheonMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pantheon", "label": "Pantheon [Member]", "documentation": "Pantheon [Member]" } } }, "auth_ref": [] }, "srt_ParentCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ParentCompanyMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AXIS Capital Holdings Limited", "label": "Parent Company [Member]", "documentation": "Registrant with controlling financial interest in one or more subsidiaries. Controlling interest in subsidiary includes, but is not limited to, primary beneficiary of variable interest entity (VIE). Controlling interest in subsidiary excludes broker-dealer with controlling financial interest in subsidiary but control is likely to be temporary." } } }, "auth_ref": [ "r367" ] }, "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnerTypeOfPartnersCapitalAccountAxis", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Partner Type [Axis]", "label": "Partner Type [Axis]", "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests." } } }, "auth_ref": [ "r102", "r931" ] }, "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Partner Type of Partners' Capital Account, Name [Domain]", "label": "Partner Type of Partners' Capital Account, Name [Domain]", "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests." } } }, "auth_ref": [ "r214", "r931" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r1176" ] }, "srt_PayablesToBrokerDealersAndClearingOrganizations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "PayablesToBrokerDealersAndClearingOrganizations", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Payable for investments purchased", "label": "Broker-Dealer, Payable to Other Broker-Dealer and Clearing Organization", "documentation": "Amount payable to other broker-dealer and clearing organization, including, but not limited to, security failed-to-receive, deposit received for security loaned, open transaction, and floor-brokerage payable." } } }, "auth_ref": [ "r1236" ] }, "us-gaap_PaymentsForAdvanceToAffiliate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForAdvanceToAffiliate", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loan advances made", "terseLabel": "Loan advance", "label": "Payments for Advance to Affiliate", "documentation": "The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity)." } } }, "auth_ref": [ "r58" ] }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForLossesAndLossAdjustmentExpense", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Net paid losses and loss expenses", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process." } } }, "auth_ref": [ "r7", "r26" ] }, "us-gaap_PaymentsForProceedsFromProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromProductiveAssets", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Proceeds from the (purchase) sale of other assets, net", "label": "Payments for (Proceeds from) Productive Assets", "documentation": "The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles." } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchase of common shares - open market", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r60" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid - common shares", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r60" ] }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid - preferred shares", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity." } } }, "auth_ref": [ "r60" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Taxes paid on withholding shares", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r350" ] }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Fixed maturities, available for sale", "label": "Payments to Acquire Debt Securities, Available-for-Sale", "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r58", "r347", "r438" ] }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Equity method investments", "verboseLabel": "Payments to acquire equity method investments", "label": "Payments to Acquire Equity Method Investments", "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence." } } }, "auth_ref": [ "r59" ] }, "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquitySecuritiesFvNi", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity securities", "label": "Payments to Acquire Equity Securities, FV-NI", "documentation": "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity." } } }, "auth_ref": [ "r260", "r352" ] }, "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireHeldToMaturitySecurities", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Fixed maturities, held to maturity", "label": "Payments to Acquire Held-to-Maturity Securities", "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities." } } }, "auth_ref": [ "r58", "r438" ] }, "us-gaap_PaymentsToAcquireInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireInvestmentsAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases of:", "label": "Payments to Acquire Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireMortgageNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireMortgageNotesReceivable", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Mortgage loans", "label": "Payments to Acquire Mortgage Notes Receivable", "documentation": "The cash outflow from the purchase of receivables arising from the mortgage note on real estate." } } }, "auth_ref": [ "r58" ] }, "us-gaap_PaymentsToAcquireOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireOtherInvestments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other investments", "label": "Payments to Acquire Other Investments", "documentation": "Amount of cash outflow to acquire investments classified as other." } } }, "auth_ref": [ "r198" ] }, "us-gaap_PaymentsToAcquireShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireShortTermInvestments", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Short-term investments", "label": "Payments to Acquire Short-Term Investments", "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r198" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r1179" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1179" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/RETIREMENTPLANS" ], "lang": { "en-us": { "role": { "terseLabel": "RETIREMENT PLANS", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r599", "r600", "r601", "r607", "r608", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r1107" ] }, "us-gaap_PensionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionExpense", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/RETIREMENTPLANSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total pension expenses", "label": "Pension Cost (Reversal of Cost)", "documentation": "Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits." } } }, "auth_ref": [] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r1178" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r1188" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r1181" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r1177" ] }, "axs_PercentageOfInvestmentComposition": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PercentageOfInvestmentComposition", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of investment composition (as a percent)", "label": "Percentage Of Investment Composition", "documentation": "Percentage Of Investment Composition" } } }, "auth_ref": [] }, "axs_PerformanceRestrictedStockUnitsGrantedIn2020And2019Member": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PerformanceRestrictedStockUnitsGrantedIn2020And2019Member", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Restricted Stock Units granted in 2020 and 2019", "label": "Performance Restricted Stock Units Granted In 2020 and 2019 [Member]", "documentation": "Performance Restricted Stock Units Granted In 2020 and 2019" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Restricted Stock Units", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1337", "r1338", "r1339", "r1340", "r1341", "r1342", "r1343", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1337", "r1338", "r1339", "r1340", "r1341", "r1342", "r1343", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362" ] }, "axs_PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForIntercompanyInsuranceAndReinsuranceAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForIntercompanyInsuranceAndReinsuranceAgreements", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleRestricted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collateral in trust for inter-company agreements", "label": "Pledged Financial Instruments Not Separately Reported Securities For Intercompany Insurance And Reinsurance Agreements", "documentation": "The carrying amount as of the date of the latest financial statement presented of securities which are owned but transferred to serve as collateral for inter-company insurance and reinsurance agreements, and for which the transferee does not have the right by contract or custom to sell or re-pledge them to an unrelated party." } } }, "auth_ref": [] }, "axs_PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacility": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacility", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleRestricted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collateral for secured letter of credit facility", "label": "Pledged Financial Instruments, Not Separately Reported, Securities For Letter Of Credit Facility", "documentation": "Pledged Financial Instruments, Not Separately Reported, Securities For Letter Of Credit Facility" } } }, "auth_ref": [] }, "axs_PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForThirdPartyInsuranceAndReinsuranceAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForThirdPartyInsuranceAndReinsuranceAgreements", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleRestricted", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collateral in trust for third-party agreements", "label": "Pledged Financial Instruments Not Separately Reported Securities For Third Party Insurance And Reinsurance Agreements", "documentation": "The carrying amount as of the date of the latest financial statement presented of securities which are owned but transferred to serve as collateral for insurance and reinsurance agreements with third parties, and for which the transferee does not have the right by contract or custom to sell or re-pledge them to an unrelated party." } } }, "auth_ref": [] }, "axs_PledgedFinancialInstrumentsUnderwritingSupport": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PledgedFinancialInstrumentsUnderwritingSupport", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleRestricted", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Funds at Lloyd's", "label": "Pledged Financial Instruments, Underwriting Support", "documentation": "Pledged Financial Instruments, Underwriting Support" } } }, "auth_ref": [] }, "us-gaap_PledgedStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgedStatusAxis", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pledged Status [Axis]", "label": "Pledged Status [Axis]", "documentation": "Information by pledged or not pledged status of asset owned by entity." } } }, "auth_ref": [ "r697", "r955", "r1113" ] }, "us-gaap_PledgedStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgedStatusDomain", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pledged Status [Domain]", "label": "Pledged Status [Domain]", "documentation": "Pledged or not pledged status of asset owned by entity." } } }, "auth_ref": [ "r697", "r955", "r1113" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion at Fair Value Measurement", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r733" ] }, "us-gaap_PreferredStockDividendRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendRatePercentage", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares, dividend rate", "label": "Preferred Stock, Dividend Rate, Percentage", "documentation": "The percentage rate used to calculate dividend payments on preferred stock." } } }, "auth_ref": [ "r584", "r1020", "r1025", "r1027", "r1046" ] }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsIncomeStatementImpact", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred share dividends", "verboseLabel": "Less: Preferred share dividends", "label": "Preferred Stock Dividends, Income Statement Impact", "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders." } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendsPerShareCashPaid": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsPerShareCashPaid", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Preferred shares, dividends paid per share (in usd per share)", "label": "Preferred Stock, Dividends, Per Share, Cash Paid", "documentation": "Aggregate dividends paid during the period for each share of preferred stock outstanding." } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsPerShareDeclared", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares, dividend declared per share (in usd per share)", "label": "Preferred Stock, Dividends Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding." } } }, "auth_ref": [] }, "us-gaap_PreferredStockLiquidationPreference": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockLiquidationPreference", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares, liquidation preference per share (in usd per share)", "label": "Preferred Stock, Liquidation Preference Per Share", "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share." } } }, "auth_ref": [ "r97", "r98", "r176", "r1251", "r1332" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stocks", "verboseLabel": "Preferred stocks", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r1120", "r1121", "r1124", "r1125", "r1126", "r1127", "r1418", "r1423" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares, par value per share (in usd per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r176", "r583" ] }, "us-gaap_PreferredStockRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockRedemptionPricePerShare", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares, redemption price per share (in usd per share)", "label": "Preferred Stock, Redemption Price Per Share", "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer." } } }, "auth_ref": [ "r96", "r97", "r100" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r176", "r847", "r1115" ] }, "axs_PremiumsEarnedGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PremiumsEarnedGross", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/REINSURANCEDetails": { "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/REINSURANCEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross", "label": "Premiums Earned Gross", "documentation": "Amount, before premiums ceded to other entities, of premiums earned." } } }, "auth_ref": [] }, "us-gaap_PremiumsEarnedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsEarnedNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": "axs_UnderwritingIncomeLossNet", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/REINSURANCEDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/REINSURANCEDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net premiums earned", "totalLabel": "Net", "label": "Premiums Earned, Net", "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned." } } }, "auth_ref": [ "r275", "r276", "r881", "r909" ] }, "axs_PremiumsPercentageAssumedToNetWritten": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PremiumsPercentageAssumedToNetWritten", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PERCENTAGE OF AMOUNT ASSUMED TO NET", "label": "PremiumsPercentageAssumedToNetWritten", "documentation": "Percentage of assumed premiums written by the entity to net premiums written." } } }, "auth_ref": [] }, "us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsReceivableAllowanceForDoubtfulAccounts", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails", "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for credit losses on premium balances receivable", "verboseLabel": "Allowance for estimated uncollectible premium balances receivable", "label": "Premium Receivable, Allowance for Credit Loss", "documentation": "The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value." } } }, "auth_ref": [ "r1220", "r1270", "r1309", "r1311", "r1406" ] }, "us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Premiums - Receivables", "label": "Premiums Receivable, Allowance for Doubtful Accounts, Estimation Methodology, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the estimated allowance for doubtful accounts for premium amounts due from policyholders, insureds, and other insurance entities. May include factors that management considered, such as historical loss experience and current economic and competitive conditions." } } }, "auth_ref": [] }, "us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premiums receivable, bad debt expense charges", "label": "Premium Receivable, Allowance for Credit Loss, Writeoff", "documentation": "Amount of writeoff of premium receivable, charged against allowance for credit loss." } } }, "auth_ref": [ "r1268", "r1310" ] }, "us-gaap_PremiumsReceivableAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsReceivableAtCarryingValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance and reinsurance premium balances receivable (Allowance for expected credit losses 2023: $11,997; 2022: $9,521)", "label": "Premiums Receivable, Net", "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts." } } }, "auth_ref": [ "r1403", "r1404", "r1405" ] }, "us-gaap_PremiumsWrittenGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsWrittenGross", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/REINSURANCEDetails": { "parentTag": "us-gaap_PremiumsWrittenNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/REINSURANCEDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross premiums written", "verboseLabel": "Gross", "label": "Premiums Written, Gross", "documentation": "Amount of direct and assumed premiums written." } } }, "auth_ref": [ "r15" ] }, "axs_PremiumsWrittenGrossMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PremiumsWrittenGrossMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Premiums Written", "label": "Premiums Written Gross [Member]", "documentation": "Total consideration paid and payable by direct policyholders for insurance contracts sold by the Entity during the period and premiums for all insurance assumed from other insurers, that is premiums ceded to the Entity by other insurers, when it serves as a benchmark in a concentration risk calculation." } } }, "auth_ref": [] }, "us-gaap_PremiumsWrittenNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsWrittenNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/REINSURANCEDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/REINSURANCEDetails", "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net premiums written", "totalLabel": "NET AMOUNT", "label": "Premiums Written, Net", "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums written." } } }, "auth_ref": [ "r1218", "r1219" ] }, "us-gaap_PremiumsWrittenNetConsolidatedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsWrittenNetConsolidatedAbstract", "presentation": [ "http://www.axiscapital.com/role/REINSURANCEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premiums written", "label": "Premiums Written, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PrepaidReinsurancePremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidReinsurancePremiums", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid reinsurance premiums", "label": "Prepaid Reinsurance Premiums", "documentation": "The unexpired portion of premiums ceded on policies in force as of the balance sheet date." } } }, "auth_ref": [ "r888", "r913" ] }, "us-gaap_PrimeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrimeMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prime", "label": "Prime [Member]", "documentation": "Credit rating classification of borrowers with strong credit histories and who have a low risk of default and qualify for the prime rate." } } }, "auth_ref": [ "r1312" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassifications and comparability", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r1237" ] }, "axs_PrivateCompanyInvestmentFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PrivateCompanyInvestmentFundsMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private company investment funds", "label": "Private Company Investment Funds [Member]", "documentation": "Private Company Investment Funds" } } }, "auth_ref": [] }, "us-gaap_PrivateEquityFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivateEquityFundsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private equity funds", "label": "Private Equity Funds [Member]", "documentation": "Investments held in private equity funds." } } }, "auth_ref": [ "r1335" ] }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDebtNetOfIssuanceCosts", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Proceeds", "label": "Proceeds from Debt, Net of Issuance Costs", "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination." } } }, "auth_ref": [ "r349" ] }, "us-gaap_ProceedsFromFederalHomeLoanBankBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromFederalHomeLoanBankBorrowings", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Home Loan Bank advances, net", "label": "Proceeds from FHLBank Borrowings, Financing Activities", "documentation": "Amount of cash inflow from Federal Home Loan Bank (FHLBank) borrowing, classified as financing activity." } } }, "auth_ref": [ "r1248" ] }, "us-gaap_ProceedsFromInterestReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromInterestReceived", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest received", "label": "Proceeds from Interest Received", "documentation": "Interest received on loans and other debt instruments during the current period." } } }, "auth_ref": [ "r1249" ] }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from redemption of fixed maturities, available for sale", "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale", "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r347", "r348", "r1273" ] }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from redemption of fixed maturities, held to maturity", "label": "Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities", "documentation": "The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity." } } }, "auth_ref": [ "r57", "r1273" ] }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from redemption of short-term investments", "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments", "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r56", "r198" ] }, "us-gaap_ProceedsFromSaleAndCollectionOfMortgageNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndCollectionOfMortgageNotesReceivable", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from the repayment of mortgage loans", "label": "Proceeds from Sale and Collection of Mortgage Notes Receivable", "documentation": "The cash inflow from proceeds from sale of receivables arising from the mortgage note on real estate; includes collections on mortgage notes receivable that are not classified as operating cash flows." } } }, "auth_ref": [ "r57" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other investments", "label": "Proceeds from Sale and Maturity of Other Investments", "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy." } } }, "auth_ref": [ "r56" ] }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestmentsAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from the sale of:", "label": "Proceeds from Sale, Maturity and Collection of Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed maturities, available for sale", "label": "Proceeds from Sale of Debt Securities, Available-for-Sale", "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r57", "r347", "r438", "r470" ] }, "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfEquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Proceeds from Sale of Equity Securities, FV-NI", "documentation": "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity." } } }, "auth_ref": [ "r260", "r352" ] }, "us-gaap_ProceedsFromSaleOfShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfShortTermInvestments", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments", "label": "Proceeds from Sale of Short-Term Investments", "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r56" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "verboseLabel": "Insurance Product Line [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r432", "r806", "r877", "r878", "r879", "r880", "r881", "r882", "r1077", "r1102", "r1116", "r1223", "r1323", "r1324", "r1334", "r1411" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r432", "r806", "r877", "r878", "r879", "r880", "r881", "r882", "r1077", "r1102", "r1116", "r1223", "r1323", "r1324", "r1334", "r1411" ] }, "us-gaap_ProfessionalLiabilityInsuranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalLiabilityInsuranceMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Professional lines", "label": "Professional Liability Insurance [Member]", "documentation": "Contract providing insurance coverage against loss by professional in course of practice." } } }, "auth_ref": [ "r1416" ] }, "us-gaap_PropertyInsuranceProductLineMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyInsuranceProductLineMember", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Property", "label": "Property Insurance [Member]", "documentation": "Contract providing insurance coverage against damage to or theft of property." } } }, "auth_ref": [ "r1416" ] }, "us-gaap_PropertyLiabilityAndCasualtyInsuranceSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyLiabilityAndCasualtyInsuranceSegmentMember", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Casualty", "label": "Property, Liability and Casualty Insurance Product Line [Member]", "documentation": "Contract providing insurance coverage against property-related loss. Includes, but is not limited to, damage, theft, or legal liability for personal injury." } } }, "auth_ref": [ "r877", "r878", "r879", "r880", "r881", "r882", "r1416" ] }, "axs_PropertyLineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "PropertyLineMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property", "label": "Property Line [Member]", "documentation": "Property Line" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r1176" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r1176" ] }, "axs_QuarterlyRedemptionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "QuarterlyRedemptionMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quarterly Redemption", "label": "Quarterly Redemption [Member]", "documentation": "Quarterly Redemption" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r532", "r533", "r534", "r535", "r600", "r618", "r650", "r651", "r652", "r780", "r805", "r895", "r952", "r953", "r1019", "r1024", "r1028", "r1029", "r1045", "r1074", "r1075", "r1089", "r1101", "r1110", "r1117", "r1122", "r1321", "r1330", "r1386", "r1387", "r1388", "r1389", "r1390" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r532", "r533", "r534", "r535", "r600", "r618", "r650", "r651", "r652", "r780", "r805", "r895", "r952", "r953", "r1019", "r1024", "r1028", "r1029", "r1045", "r1074", "r1075", "r1089", "r1101", "r1110", "r1117", "r1122", "r1321", "r1330", "r1386", "r1387", "r1388", "r1389", "r1390" ] }, "us-gaap_RealEstateFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateFundsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate funds", "label": "Real Estate Funds [Member]", "documentation": "Investments in funds that invest in commercial or residential real estate." } } }, "auth_ref": [] }, "us-gaap_RealizedInvestmentGainsLossesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealizedInvestmentGainsLossesAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment gains (losses):", "label": "Realized Investment Gains (Losses) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesFromBrokersDealersAndClearingOrganizations", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Receivable for investments sold", "label": "Receivable from Broker-Dealer and Clearing Organization", "documentation": "Amount receivable from broker-dealers and clearing organizations, including, but not limited to, securities failed-to-deliver, certain deposits for securities borrowed, open transactions, good faith and margin deposits, commissions and floor brokerage receivables." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of accumulated comprehensive income into net income available to common shareholders [Line Items]", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r340" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r54", "r339", "r742", "r746", "r747", "r857", "r1243" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)", "negatedTotalLabel": "Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r40", "r54", "r339", "r742", "r746", "r747", "r1243" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAociCurrentPeriodTax", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails": { "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment for reclassification of net realized (gains) losses and impairment losses recognized in net income (loss)", "label": "Reclassification from AOCI, Current Period, Tax", "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r4", "r331", "r338", "r857" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r340" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "documentation": "Item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r340" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r340" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassifications Out of Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r340" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Reclassifications Out of AOCI Into Net Income Available to Common Shareholders", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r1142", "r1154", "r1164", "r1190" ] }, "axs_RedemptionFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RedemptionFrequencyAxis", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Frequency [Axis]", "label": "Redemption Frequency [Axis]", "documentation": "Redemption frequency for funds currently eligible" } } }, "auth_ref": [] }, "axs_RedemptionFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RedemptionFrequencyDomain", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Frequency [Domain]", "label": "Redemption Frequency [Domain]", "documentation": "Redemption Frequency" } } }, "auth_ref": [] }, "axs_RedemptionRestrictionTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RedemptionRestrictionTypeAxis", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Restriction Type [Axis]", "label": "Redemption Restriction Type [Axis]", "documentation": "Information by type of redemption restriction." } } }, "auth_ref": [] }, "axs_RedemptionRestrictionTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RedemptionRestrictionTypeDomain", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSOtherInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Restriction Type [Domain]", "label": "Redemption Restriction Type [Domain]", "documentation": "Circumstances in which an otherwise redeemable investment, comprising or included in the major category, of those certain investments for which net asset value per share is calculated (including by unit, membership interest, or other equity (ownership interest) unit measure) (alternative investments) is not redeemable (for example, investments subject to a lockup or gate)." } } }, "auth_ref": [] }, "us-gaap_ReinsuranceAccountingPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceAccountingPolicy", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurance", "label": "Reinsurance Accounting Policy [Policy Text Block]", "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy." } } }, "auth_ref": [ "r1118", "r1119" ] }, "us-gaap_ReinsuranceDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Reinsurance Disclosures [Abstract]", "label": "Reinsurance Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/REINSURANCEDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ceded losses and loss expenses", "label": "Policyholder Benefits and Claims Incurred, Ceded", "documentation": "Amount of reduction of provision for policy benefits and costs incurred for policies ceded." } } }, "auth_ref": [ "r1397", "r1410" ] }, "axs_ReinsuranceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ReinsuranceMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurance", "label": "Reinsurance [Member]", "documentation": "Reinsurance segment" } } }, "auth_ref": [] }, "us-gaap_ReinsurancePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsurancePayable", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance and reinsurance balances payable", "label": "Reinsurance Payable", "documentation": "The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements." } } }, "auth_ref": [] }, "srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplementary Insurance Information [Line Items]", "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r283", "r877", "r878", "r879", "r880", "r881", "r882" ] }, "us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract", "presentation": [ "http://www.axiscapital.com/role/REINSURANCEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premiums earned", "label": "Premiums Earned, Net [Abstract]" } } }, "auth_ref": [] }, "srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplementary Insurance Information [Table]", "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Table]", "documentation": "Disclosure of supplemental information about reinsurance including, but not limited to, type of insurance, gross amount of premium, premium ceded to another company, premium assumed from another company, net amount of premium revenue, and percentage of premium assumed to net premium revenue." } } }, "auth_ref": [ "r283", "r877", "r878", "r879", "r880", "r881", "r882" ] }, "us-gaap_ReinsuranceReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceReceivablesAbstract", "presentation": [ "http://www.axiscapital.com/role/REINSURANCEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurance receivables:", "label": "Reinsurance Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails": { "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "weight": -1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurance recoverable on unpaid losses and loss expenses (Allowance for expected credit losses 2023: $36,611; 2022: $30,715)", "negatedPeriodStartLabel": "Less reinsurance recoverable on unpaid losses and loss expenses, beginning of year", "periodEndLabel": "Reinsurance recoverable on unpaid losses and loss expenses, end of year", "verboseLabel": "Reinsurance recoverable on unpaid claims", "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments", "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer." } } }, "auth_ref": [ "r159", "r244", "r1398", "r1413", "r1414" ] }, "us-gaap_ReinsuranceRecoverableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverableMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurance Recoverable On Unpaid And Paid Losses", "label": "Reinsurance Recoverable Including Reinsurance Premium Paid [Member]", "documentation": "Reinsurance recoverable, after valuation allowance, under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves." } } }, "auth_ref": [] }, "us-gaap_ReinsuranceRecoverablesAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverablesAllowance", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/REINSURANCEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for credit losses on reinsurance recoverable for unpaid losses and loss expenses", "label": "Reinsurance Recoverable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on reinsurance recoverable." } } }, "auth_ref": [ "r481", "r484", "r485", "r837", "r887" ] }, "us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverablesOnPaidAndUnpaidLosses", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurance recoverable on unpaid and paid losses", "label": "Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments", "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts." } } }, "auth_ref": [ "r912", "r1398", "r1412", "r1413", "r1414" ] }, "us-gaap_ReinsuranceRecoverablesOnPaidLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverablesOnPaidLosses", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurance recoverable on paid losses and loss expenses", "label": "Reinsurance Recoverable for Paid Claims and Claims Adjustments", "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to and paid by the ceding insurer." } } }, "auth_ref": [ "r1398", "r1413", "r1414" ] }, "us-gaap_ReinsuranceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceTextBlock", "presentation": [ "http://www.axiscapital.com/role/REINSURANCE" ], "lang": { "en-us": { "role": { "terseLabel": "REINSURANCE", "label": "Reinsurance [Text Block]", "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts." } } }, "auth_ref": [ "r835", "r836", "r1118", "r1119" ] }, "us-gaap_ReinsurerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsurerConcentrationRiskMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurer Concentration", "label": "Reinsurer Concentration Risk [Member]", "documentation": "Concentration risk of a reinsurer to a specified benchmark, such as reinsurance recoverables." } } }, "auth_ref": [] }, "axs_ReinsurerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ReinsurerOneMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurer 1", "label": "Reinsurer One [Member]", "documentation": "Amount relating to the reinsuer with the largest balance." } } }, "auth_ref": [] }, "axs_ReinsurerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ReinsurerThreeMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurer 3", "label": "Reinsurer Three [Member]", "documentation": "Amount relating to the reinsuer with the third largest balance." } } }, "auth_ref": [] }, "axs_ReinsurerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ReinsurerTwoMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reinsurer 2", "label": "Reinsurer Two [Member]", "documentation": "Amount relating to the reinsuer with the second largest balance." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Domain]", "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r609", "r768", "r769", "r956", "r957", "r958", "r959", "r960", "r980", "r982", "r1017" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r362", "r363", "r768", "r769", "r770", "r771", "r956", "r957", "r958", "r959", "r960", "r980", "r982", "r1017" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income earned", "label": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r148", "r768" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Axis]", "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r768", "r769", "r1382" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Domain]", "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Line Items]", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r988", "r989", "r992" ] }, "us-gaap_RelatedPartyTransactionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionRate", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Stated interest rate (in percent)", "terseLabel": "Related party transaction floating rate (as a percent)", "label": "Related Party Transaction, Rate", "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions [Abstract]", "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Axis]", "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r609", "r768", "r769", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r956", "r957", "r958", "r959", "r960", "r980", "r982", "r1017", "r1382" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONS" ], "lang": { "en-us": { "role": { "terseLabel": "RELATED PARTY TRANSACTIONS", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r765", "r766", "r767", "r769", "r772", "r925", "r926", "r927", "r990", "r991", "r992", "r1014", "r1016" ] }, "axs_RelatedPortfolioAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RelatedPortfolioAxis", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Portfolio [Axis]", "label": "Related Portfolio [Axis]", "documentation": "Information that identifies a derivative or a group of derivatives by related portfolio." } } }, "auth_ref": [] }, "axs_RelatedPortfolioDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RelatedPortfolioDomain", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Portfolio [Domain]", "label": "Related Portfolio [Domain]", "documentation": "The name that identifies a derivative or a group of derivatives, by related portfolio." } } }, "auth_ref": [] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails", "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r364", "r365", "r557", "r585", "r771", "r1084", "r1085" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r1143", "r1155", "r1165", "r1191" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r1144", "r1156", "r1166", "r1192" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r1151", "r1163", "r1173", "r1199" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash and cash equivalents", "label": "Restricted Cash and Cash Equivalents", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r61", "r225", "r312", "r356", "r846" ] }, "axs_RestrictedInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RestrictedInvestmentsLineItems", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Investments [Line Items]", "label": "Restricted Investments [Line Items]", "documentation": "Restricted Investments [Line Items]" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/REORGANIZATIONEXPENSES" ], "lang": { "en-us": { "role": { "terseLabel": "REORGANIZATION EXPENSES", "label": "Restructuring, Impairment, and Other Activities Disclosure [Text Block]", "documentation": "The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [] }, "us-gaap_RestructuringSettlementAndImpairmentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringSettlementAndImpairmentProvisions", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/REORGANIZATIONEXPENSESDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reorganization expenses", "negatedTerseLabel": "Reorganization expenses", "label": "Restructuring, Settlement and Impairment Provisions", "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss." } } }, "auth_ref": [ "r193" ] }, "us-gaap_ResultsOfOperationsIncomeBeforeIncomeTaxesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResultsOfOperationsIncomeBeforeIncomeTaxesAbstract", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofEffectiveTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income (loss) before income taxes", "label": "Results of Operations, Income before Income Taxes [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r179", "r213", "r850", "r900", "r902", "r923", "r964", "r1115" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r308", "r369", "r370", "r371", "r373", "r379", "r381", "r479", "r480", "r659", "r660", "r661", "r685", "r686", "r705", "r707", "r708", "r710", "r713", "r896", "r898", "r928", "r1423" ] }, "axs_RetrocessionAgreementWithMonarchPointReMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RetrocessionAgreementWithMonarchPointReMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Retrocession Agreement With Monarch Point Re", "label": "Retrocession Agreement With Monarch Point Re [Member]", "documentation": "Retrocession Agreement With Monarch Point Re" } } }, "auth_ref": [] }, "us-gaap_RevenueCommissionersIrelandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueCommissionersIrelandMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ireland", "label": "Revenue Commissioners, Ireland [Member]", "documentation": "Designated tax department of the government of Ireland." } } }, "auth_ref": [] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Gross Premiums Written by Geographical Location of Subsidiaries", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r28" ] }, "us-gaap_RevenueRecognitionPremiumsEarnedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPremiumsEarnedPolicy", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Premiums - Net Premiums Earned", "label": "Revenue Recognition, Premiums Earned, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining revenue and timing of recognition as revenue of premiums received from policyholders, insureds and other insurance entities (the effects of ceding and assuming insurance policy risks) for the entity's insurance products." } } }, "auth_ref": [ "r168", "r169" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails": { "parentTag": "axs_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestIncomeLossFromEquityMethodInvestmentsAndEquityInNetEarningsOfSubsidiaries", "weight": 1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenues", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r342", "r359", "r408", "r409", "r420", "r425", "r426", "r432", "r434", "r436", "r478", "r540", "r541", "r543", "r544", "r545", "r547", "r549", "r551", "r552", "r735", "r826", "r1326" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "axs_RialtoRealEstateFundIVPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RialtoRealEstateFundIVPropertyMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rialto Real Estate Fund IV-Property", "label": "Rialto Real Estate Fund IV-Property [Member]", "documentation": "Rialto Real Estate Fund IV-Property" } } }, "auth_ref": [] }, "axs_RialtoRealEstateIVPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RialtoRealEstateIVPropertyMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rialto Real Estate IV-Property", "label": "Rialto Real Estate IV-Property [Member]", "documentation": "Rialto Real Estate IV-Property" } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r760", "r1114" ] }, "axs_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingModifiedLeaseAdjustmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityIncludingModifiedLeaseAdjustmentNet", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Including Modified Lease Adjustment, Net", "documentation": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Including Modified Lease Adjustment, Net" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1208" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1208" ] }, "axs_RunOffLinesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "RunOffLinesMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Run-off lines", "label": "Run Off Lines [Member]", "documentation": "Run Off Lines" } } }, "auth_ref": [] }, "axs_SKYHarborCapitalManagementLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SKYHarborCapitalManagementLLCMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SKY Harbor Capital Management, LLC", "label": "SKY Harbor Capital Management, LLC [Member]", "documentation": "SKY Harbor Capital Management, LLC" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Mortgage Loans Net of Valuation Allowance", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r51" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Available For Sale Securities [Line Items]", "label": "Debt Securities, Available-for-Sale [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Amortized Cost and Fair Values of Fixed Maturities", "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.axiscapital.com/role/ORGANIZATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r115", "r117", "r696" ] }, "us-gaap_ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTextBlock", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Prior Year Loss Development", "label": "Schedule of Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "documentation": "Tabular disclosure of the reasons for the change in incurred claims and claim adjustment expenses recognized in the income statement attributable to insured events of prior fiscal years. Also includes disclosures of additional premiums or return premiums accrued as a result of changes in incurred claims and claim adjustment expenses." } } }, "auth_ref": [ "r242", "r245" ] }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Common Shares Issued and Outstanding", "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]", "documentation": "Tabular disclosure of the change in common stock outstanding." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Income Tax Expense and Net Tax Assets", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r217" ] }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Tax Effects Allocated to Each Component of Other Comprehensive Income (Loss)", "label": "Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans." } } }, "auth_ref": [ "r186" ] }, "srt_ScheduleOfCondensedFinancialStatementsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedFinancialStatementsTable", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFOPERATIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Condensed Financial Statements [Table]", "label": "Condensed Financial Statements [Table]", "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows." } } }, "auth_ref": [ "r280", "r305", "r306", "r307", "r367", "r1217" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-Term Debt Instruments", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r48", "r97", "r101", "r143", "r144", "r146", "r156", "r211", "r212", "r1097", "r1099", "r1255" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Deferred Tax Assets and Liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r216" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Location and Amounts of Derivative Fair Values on the Consolidated Balance Sheet", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r124" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHARETables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Basic and Diluted Earnings (Loss) Per Common Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1265" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Effective Tax Rate Reconciliation", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r215" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Net Premiums Earned by Segment and Line of Business", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information." } } }, "auth_ref": [ "r79" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails", "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Axis]", "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r474", "r475", "r477" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Method Investments [Line Items]", "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r359", "r474", "r475", "r477", "r478", "r735" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitymethodinvestmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Method Investments [Table]", "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r311", "r359", "r474", "r475", "r477", "r478", "r735" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Financial Instruments Measured at Fair Value on a Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r718", "r719" ] }, "us-gaap_ScheduleOfFederalHomeLoanBankAdvancesByBranchOfFHLBBankTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFederalHomeLoanBankAdvancesByBranchOfFHLBBankTable", "presentation": [ "http://www.axiscapital.com/role/FEDERALHOMELOANBANKADVANCESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Federal Home Loan Bank Advances, by Branch of FHLB Bank [Table]", "label": "Schedule of Federal Home Loan Bank Advances, by Branch of FHLB Bank [Table]", "documentation": "Represents the total amount of advances due to the Federal Home Loan Bank, by Branch, as of the balance sheet date." } } }, "auth_ref": [ "r156", "r234", "r240" ] }, "us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Restricted Investments and Cash", "label": "Schedule of Financial Instruments Owned and Pledged as Collateral [Table Text Block]", "documentation": "Tabular disclosure of financial instruments held by the entity for its own account for trading or investment purposes that are carried at fair value and pledged to counterparties as collateral for financing transactions. Description may include equity, fixed income, debt or other securities." } } }, "auth_ref": [ "r223", "r1391" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r86", "r89", "r807" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r86", "r89" ] }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Held-to-maturity Securities [Line Items]", "label": "Schedule of Held-to-Maturity Securities [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469" ] }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfHeldToMaturitySecuritiesTable", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Held-to-maturity [Table]", "label": "Debt Securities, Held-to-Maturity [Table]", "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Indefinite-Lived Intangible Assets", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r25", "r207" ] }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Goodwill and Intangible Assets", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class." } } }, "auth_ref": [ "r83" ] }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Investment Income [Line Items]", "label": "Net Investment Income [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r858" ] }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "http://www.axiscapital.com/role/INVESTMENTSVariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Investment Income Reported Amounts By Category [Table]", "label": "Investment Income [Table]", "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments." } } }, "auth_ref": [ "r195", "r196", "r858" ] }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Reconciliation of Beginning and Ending Gross Reserve for Losses and Loss Expenses and Net Reserve for Unpaid Losses and Loss Expenses", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims." } } }, "auth_ref": [ "r242" ] }, "axs_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedAndIncurredButNotReportedClaimsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedAndIncurredButNotReportedClaimsTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Reserve for Losses and Loss Expenses", "label": "Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense Reported And Incurred But Not Reported Claims [Table Text Block]", "documentation": "Schedule showing breakdown of the liability for unpaid claims and claims adjustment expense between that related to reported claims and to incurred but not reported (IBNR) claims." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Debt Maturity", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Activity of Cash-Settled Restricted Stock Units", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units." } } }, "auth_ref": [ "r108" ] }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Total Unrealized and Realized Gains (Loss) on Derivatives Not Designated as Hedges Recorded in Earnings", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument." } } }, "auth_ref": [ "r128", "r1222" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r147", "r148", "r988", "r989", "r992" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r80", "r188" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r75", "r76", "r77", "r83" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Underwriting Results of Reportable Segments", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r75", "r76", "r77", "r83" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r620", "r622", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r649", "r650", "r651", "r652", "r653" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Reconciliation of Beginning and Ending Balance of Non Vested Restricted Stock (Including RSUs) to be Settled in Shares", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock by Class [Table]", "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r93", "r94", "r95", "r97", "r98", "r99", "r101", "r211", "r212", "r213", "r318", "r319", "r320", "r401", "r583", "r584", "r585", "r587", "r590", "r595", "r597", "r919", "r920", "r921", "r922", "r1101", "r1216", "r1251" ] }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]", "label": "Debt and Equity Securities, FV-NI [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTreasuryStockByClassTextBlock", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Share Repurchases", "label": "Class of Treasury Stock [Table Text Block]", "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r103", "r104", "r105", "r106" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Future Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r89" ] }, "us-gaap_SecuritiesForReverseRepurchaseAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuritiesForReverseRepurchaseAgreements", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSReverseRepurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of reverse repurchase agreements", "label": "Securities for Reverse Repurchase Agreements", "documentation": "The carrying value of securities purchased to be resold in reverse repurchase transactions as of the balance sheet date." } } }, "auth_ref": [] }, "axs_SecuritiesPurchasedUnderAgreementsToResellRequiredCollateralPercentageOfPrincipal": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SecuritiesPurchasedUnderAgreementsToResellRequiredCollateralPercentageOfPrincipal", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSReverseRepurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum required collateral for reverse repurchase agreements, expressed as a percentage of loan principal", "label": "Securities Purchased Under Agreements To Resell, Required Collateral, Percentage Of Principal", "documentation": "Minimum value of securities received as collateral against securities purchased under agreement to resell, expressed as a percentage of loan principal." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1135" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1138" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r404", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r436", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r526", "r527", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r1095", "r1223", "r1411" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r284", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r434", "r435", "r943", "r947", "r949", "r1021", "r1026", "r1031", "r1047", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1078", "r1103", "r1122", "r1334", "r1411" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "axs_SegmentReportingDisclosureOfMajorCustomersNumberOfMajorCustomers": { "xbrltype": "integerItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SegmentReportingDisclosureOfMajorCustomersNumberOfMajorCustomers", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk, number of brokers exceeding threshold", "label": "Segment Reporting Disclosure Of Major Customers Number Of Major Customers", "documentation": "Number of customers where transactions amount to 10 percent or more of the entity's revenues." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "SEGMENT INFORMATION", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r403", "r404", "r405", "r406", "r407", "r419", "r424", "r428", "r429", "r430", "r431", "r432", "r433", "r436" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": "axs_UnderwritingIncomeLossNet", "weight": -1.0, "order": 1.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative expenses", "negatedLabel": "Underwriting-related general and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r194" ] }, "axs_SeniorNotesAxisSpecialtyFinanceLlc2010Member": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SeniorNotesAxisSpecialtyFinanceLlc2010Member", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2010 AXIS Specialty Finance LLC Senior Notes", "label": "Senior Notes Axis Specialty Finance Llc 2010 [Member]", "documentation": "Senior notes issued by AXIS Specialty Finance LLC on March 23, 2010." } } }, "auth_ref": [] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotesMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSummaryofDebtDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "axs_SeniorUnsecuredNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SeniorUnsecuredNotesDue2031Member", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Unsecured Notes Due 2031", "label": "Senior Unsecured Notes Due 2031 [Member]", "documentation": "Senior Unsecured Notes Due 2031" } } }, "auth_ref": [] }, "axs_SeriesEPreferredDepositaryShareMemberMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SeriesEPreferredDepositaryShareMemberMember", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Depositary shares, each representing a 1/100th interest in a 5.50% Series E preferred share", "label": "SeriesEPreferredDepositaryShareMember [Member]", "documentation": "American Depositary Share, each representing a 1/100th interest in a 5.50% Series E preferred share" } } }, "auth_ref": [] }, "us-gaap_SeriesEPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesEPreferredStockMember", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series E 5.50% Preferred Shares", "verboseLabel": "Series E preferred shares", "label": "Series E Preferred Stock [Member]", "documentation": "Series E preferred stock." } } }, "auth_ref": [ "r1239", "r1240", "r1333" ] }, "axs_SettlementTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SettlementTypeAxis", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement Type [Axis]", "label": "Settlement Type [Axis]", "documentation": "Information by settlement type pertaining to equity-based compensation." } } }, "auth_ref": [] }, "axs_SettlementTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SettlementTypeDomain", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement Type [Domain]", "label": "Settlement Type [Domain]", "documentation": "[Domain] for Information by settlement type pertaining to equity-based compensation." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDSTATEMENTSOFCASHFLOWSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense, net of cash payments", "verboseLabel": "Share-based compensation expense, net of cash payments", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r1111" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r642" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r642" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r640" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r640" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Nonvested restricted stock - beginning of year (in shares)", "periodEndLabel": "Nonvested restricted stock - end of year (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r637", "r638" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number\u00a0of restricted stock units", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Nonvested restricted stock units - beginning of year (in usd per share)", "periodEndLabel": "Nonvested restricted stock units - end of year (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r637", "r638" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted\u00a0average grant date fair\u00a0value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r641" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of restricted stock units vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash." } } }, "auth_ref": [ "r644" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r641" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r650" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r652" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "verboseLabel": "Reconciliation of Beginning and Ending Balance of Nonvested Restricted Stock (including RSUs) [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r620", "r622", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r649", "r650", "r651", "r652", "r653" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional share awards granted under the plan (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "axs_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments": { "xbrltype": "integerItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of installments", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Installments", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Installments" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum number of shares to be issued under the plan (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r1112" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of awards available for grant under plan (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r107" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONScheduleofAdditionalInformationRelatedtoSharebasedCompensationDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "verboseLabel": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r649", "r650", "r651", "r652", "r653" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tranche One", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tranche Two", "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r619", "r628", "r647", "r648", "r649", "r650", "r653", "r662", "r663", "r664", "r665" ] }, "axs_ShareBasedPaymentArrangementSeniorLeadershipMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ShareBasedPaymentArrangementSeniorLeadershipMember", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Based Payment Arrangement Senior Leadership", "label": "Share Based Payment Arrangement Senior Leadership [Member]", "documentation": "Share Based Payment Arrangement Senior Leadership" } } }, "auth_ref": [] }, "us-gaap_ShareRepurchaseProgramAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramAxis", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Axis]", "label": "Share Repurchase Program [Axis]", "documentation": "Information by share repurchase program." } } }, "auth_ref": [] }, "us-gaap_ShareRepurchaseProgramDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramDomain", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Domain]", "label": "Share Repurchase Program [Domain]", "documentation": "Name of the share repurchase program." } } }, "auth_ref": [] }, "axs_ShareSettledMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ShareSettledMember", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONSummaryofSharesandCashSettledAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Settled", "label": "Share Settled [Member]", "documentation": "Share-based compensation to be settled in stock." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting percentage (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r1337" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r649" ] }, "us-gaap_ShortDurationContractsDiscountedLiabilitiesDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationContractsDiscountedLiabilitiesDiscountRate", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount rate (percent)", "label": "Short-Duration Contract, Discounted Liability, Discount Rate", "documentation": "Discount rate used to obtain present value of liability for unpaid claim and claim adjustment expense for short-duration contract issued by insurance entity." } } }, "auth_ref": [ "r894" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2019Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2019Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2019", "label": "Short-Duration Insurance Contract, Accident Year 2019 [Member]", "documentation": "Accident year 2019 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r893" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2020Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2020Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2020", "label": "Short-Duration Insurance Contract, Accident Year 2020 [Member]", "documentation": "Accident year 2020 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r893" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2021Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2021Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2021", "label": "Short-Duration Insurance Contract, Accident Year 2021 [Member]", "documentation": "Accident year 2021 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r893" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2022Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2022Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2022", "label": "Short-Duration Insurance Contract, Accident Year 2022 [Member]", "documentation": "Accident year 2022 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r893" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2023Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2023Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2023", "label": "Short-Duration Insurance Contract, Accident Year 2023 [Member]", "documentation": "Accident year 2023 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r893" ] }, "us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractsAccidentYear2017Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2017", "label": "Short-Duration Insurance Contracts, Accident Year 2017 [Member]", "documentation": "Accident year 2017 in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractsAccidentYear2018Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2018", "label": "Short-Duration Insurance Contracts, Accident Year 2018 [Member]", "documentation": "Accident year 2018 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r893" ] }, "axs_ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseGross", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails": { "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross outstanding liabilities", "label": "Short-Duration Insurance Contracts, Liability For Unpaid Claims And Allocated Claim Adjustment Expense, Gross", "documentation": "Undiscounted amount, before reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [] }, "us-gaap_ShortTermInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestmentsMember", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSNetInvestmentIncomeDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments", "label": "Short-Term Investments [Member]", "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet." } } }, "auth_ref": [ "r1049", "r1050", "r1051", "r1079" ] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term lease expense", "label": "Short-Term Lease, Cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r757", "r1114" ] }, "us-gaap_ShortdurationInsuranceContractsAccidentYear2014Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsAccidentYear2014Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2014", "label": "Short-Duration Insurance Contracts, Accident Year 2014 [Member]", "documentation": "Accident year 2014 in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsAccidentYear2015Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2015", "label": "Short-Duration Insurance Contracts, Accident Year 2015 [Member]", "documentation": "Accident year 2015 in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsAccidentYear2016Member", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accident Year 2016", "label": "Short-Duration Insurance Contracts, Accident Year 2016 [Member]", "documentation": "Accident year 2016 in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsAccidentYearAxis", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]", "label": "Short-Duration Insurance Contracts, Accident Year [Axis]", "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsAccidentYearDomain", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]", "label": "Short-Duration Insurance Contracts, Accident Year [Domain]", "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTable", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-duration Insurance Contracts, Claims Development [Table]", "label": "Short-Duration Insurance Contracts, Claims Development [Table]", "documentation": "Disclosure of information about undiscounted information about claims development by accident year for short-duration insurance contracts." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Net Incurred and Paid Claims Development Tables by Accident Year", "label": "Short-Duration Insurance Contracts, Claims Development [Table Text Block]", "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative paid claims and allocated claim adjustment expenses", "label": "Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net", "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r31" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationLineItems", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-duration Insurance Contracts, Historical Claims Duration [Line Items]", "label": "Short-Duration Insurance Contracts, Historical Claims Duration [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationTable", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-duration Insurance Contracts, Historical Claims Duration [Table]", "label": "Short-Duration Insurance Contracts, Historical Claims Duration [Table]", "documentation": "Disclosure of information about average annual percentage payout of incurred claims by age, after reinsurance, for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 8", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year Eight", "documentation": "Percentage of average annual payout, after reinsurance, in the eighth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 5", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year Five", "documentation": "Percentage of average annual payout, after reinsurance, in the fifth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 4", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year Four", "documentation": "Percentage of average annual payout, after reinsurance, in the fourth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 9", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year Nine", "documentation": "Percentage of average annual payout, after reinsurance, in the ninth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 1", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year One", "documentation": "Percentage of average annual payout, after reinsurance, in the first year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 7", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year Seven", "documentation": "Percentage of average annual payout, after reinsurance, in the seventh year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 6", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year Six", "documentation": "Percentage of average annual payout, after reinsurance, in the sixth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 10", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year 10", "documentation": "Percentage of average annual payout, after reinsurance, in the tenth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 3", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year Three", "documentation": "Percentage of average annual payout, after reinsurance, in the third year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year 2", "label": "Short-Duration Insurance Contracts, Historical Claims Duration, Year Two", "documentation": "Percentage of average annual payout, after reinsurance, in the second year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total of incurred-but-not-reported liabilities plus expected development on reported claims", "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net", "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r33", "r37" ] }, "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Incurred claims and allocated claim adjustment expenses", "label": "Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net", "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Liabilities for claims and claim adjustment expenses, net of reinsurance", "totalLabel": "Net outstanding liabilities", "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net", "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r29", "r32" ] }, "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All outstanding liabilities before 2014, net of reinsurance", "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented", "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails": { "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ceded reserves related to retroactive transactions", "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item", "documentation": "Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedForeignExchange": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedForeignExchange", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails": { "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange and other", "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expense, Accumulated Foreign Exchange", "documentation": "Amount of accumulated increase (decrease) to the liability for unpaid claims and claim adjustment expenses used for claim development from a foreign exchange rate (gain) loss." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails": { "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unallocated claims adjustment expenses", "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expense, Accumulated Unallocated Claim Adjustment Expense", "documentation": "Amount of liability for unallocated claim adjustment expense for short-duration insurance contracts." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsNumberOfReportedClaims", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cumulative number of reported claims", "label": "Short-Duration Insurance Contract, Cumulative Number of Reported Claims", "documentation": "Cumulative number of reported claims for short-duration insurance contracts." } } }, "auth_ref": [ "r35" ] }, "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Reconciliation of Development Tables to Consolidated Balance Sheet", "label": "Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]", "documentation": "Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance", "label": "Short-Duration Insurance Contracts, Schedule of Historical Claims Duration [Table Text Block]", "documentation": "Tabular disclosure of average annual percentage payout of incurred claims by age, after reinsurance, for short-duration insurance contracts." } } }, "auth_ref": [ "r38" ] }, "axs_SoundPointCapitalBondMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SoundPointCapitalBondMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sound Point Capital Bond", "label": "Sound Point Capital Bond [Member]", "documentation": "Sound Point Capital Bond" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r310", "r404", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r436", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r524", "r526", "r527", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r1095", "r1223", "r1411" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.axiscapital.com/role/COVER", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofDividendsDeclaredandPaidDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r278", "r318", "r319", "r320", "r359", "r386", "r390", "r393", "r395", "r401", "r402", "r478", "r540", "r543", "r544", "r545", "r551", "r552", "r583", "r584", "r587", "r590", "r597", "r735", "r919", "r920", "r921", "r922", "r928", "r929", "r930", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r963", "r985", "r1009", "r1053", "r1054", "r1055", "r1056", "r1057", "r1216", "r1251", "r1264" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofReclassificationsOutofAOCIIntoNetIncomeAvailabletoCommonShareholdersDetails", "http://www.axiscapital.com/role/OTHERCOMPREHENSIVEINCOMELOSSSummaryofTaxEffectsAllocatedtoEachComponentofOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "verboseLabel": "Statement, Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r20", "r50", "r308", "r338", "r339", "r340", "r369", "r370", "r371", "r373", "r379", "r381", "r400", "r479", "r480", "r598", "r659", "r660", "r661", "r685", "r686", "r705", "r706", "r707", "r708", "r709", "r710", "r713", "r742", "r743", "r744", "r745", "r746", "r747", "r764", "r896", "r897", "r898", "r928", "r1009" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r284", "r294", "r434", "r435", "r943", "r947", "r949", "r1021", "r1026", "r1031", "r1047", "r1059", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1078", "r1103", "r1122", "r1334", "r1411" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r369", "r370", "r371", "r400", "r806", "r914", "r940", "r954", "r956", "r957", "r958", "r959", "r960", "r963", "r966", "r967", "r968", "r969", "r970", "r971", "r972", "r973", "r974", "r976", "r977", "r978", "r979", "r980", "r982", "r986", "r987", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1009", "r1123" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r369", "r370", "r371", "r400", "r806", "r914", "r940", "r954", "r956", "r957", "r958", "r959", "r960", "r963", "r966", "r967", "r968", "r969", "r970", "r971", "r972", "r973", "r974", "r976", "r977", "r978", "r979", "r980", "r982", "r986", "r987", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1009", "r1123" ] }, "us-gaap_StatutoryAccountingPracticesByJurisdictionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesByJurisdictionAxis", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Jurisdiction [Axis]", "label": "Jurisdiction [Axis]", "documentation": "Information by jurisdiction." } } }, "auth_ref": [ "r161", "r164", "r165" ] }, "us-gaap_StatutoryAccountingPracticesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Statutory Capital and Surplus by Jurisdiction", "label": "Statutory Accounting Practices Disclosure [Table Text Block]", "documentation": "Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority." } } }, "auth_ref": [ "r161", "r164", "r165", "r166", "r167", "r1402" ] }, "us-gaap_StatutoryAccountingPracticesJurisdictionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesJurisdictionDomain", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory Accounting Practices, Jurisdiction [Domain]", "label": "Statutory Accounting Practices, Jurisdiction [Domain]", "documentation": "The state or country of domicile in which statutory financial statements are required. Insurance holding companies generally are required to file reports in jurisdictions in which subsidiaries with significant underwritings are domiciled." } } }, "auth_ref": [] }, "us-gaap_StatutoryAccountingPracticesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesLineItems", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory Financial Information [Line Items]", "label": "Statutory Accounting Practices [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1402" ] }, "axs_StatutoryAccountingPracticesMinimumSolvencyMarginAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryAccountingPracticesMinimumSolvencyMarginAmount", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum solvency margin amount", "label": "Statutory Accounting Practices Minimum Solvency Margin Amount", "documentation": "The minimum solvency margin amount, which is a factor of the minimum statutory capital and surplus calculation, required to be maintained, in terms of the Insurance Act 1978, amendments thereto and Related Regulations of Bermuda." } } }, "auth_ref": [] }, "axs_StatutoryAccountingPracticesMinimumSolvencyMarginPercentageOfECR": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryAccountingPracticesMinimumSolvencyMarginPercentageOfECR", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum solvency margin percentage of ECR", "label": "Statutory Accounting Practices Minimum Solvency Margin Percentage Of ECR", "documentation": "Statutory Accounting Practices Minimum Solvency Margin Percentage Of ECR" } } }, "auth_ref": [] }, "axs_StatutoryAccountingPracticesMinimumSolvencyMarginPercentageOfNetReserves": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryAccountingPracticesMinimumSolvencyMarginPercentageOfNetReserves", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum solvency margin percentage of net reserves", "label": "Statutory Accounting Practices Minimum Solvency Margin Percentage Of Net Reserves", "documentation": "The minimum solvency margin amount, which is a factor of the minimum statutory capital and surplus calculation, (expressed as a percentage of net reserve for losses and loss adjustment expenses) required to be maintained, in terms of the Insurance Act 1978, amendments thereto and Related Regulations of Bermuda." } } }, "auth_ref": [] }, "axs_StatutoryAccountingPracticesMinimumSolvencyMarginPercentageOfNetWrittenPremiums": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryAccountingPracticesMinimumSolvencyMarginPercentageOfNetWrittenPremiums", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum solvency margin percentage of net written premiums", "label": "Statutory Accounting Practices Minimum Solvency Margin Percentage Of Net Written Premiums", "documentation": "The minimum solvency margin amount, which is a factor of the minimum statutory capital and surplus calculation, (expressed as a percentage of net written premiums) required to be maintained, in terms of the Insurance Act 1978, amendments thereto and Related Regulations of Bermuda." } } }, "auth_ref": [] }, "axs_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendOrDistributionPaymentsPotentialLimitPercentageOfPriorYearStatutoryCapitalAndSurplus": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendOrDistributionPaymentsPotentialLimitPercentageOfPriorYearStatutoryCapitalAndSurplus", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Limit - prior year's total statutory capital surplus (Bermuda)", "label": "Statutory Accounting Practices Statutory Amount Available For Dividend Or Distribution Payments Potential Limit Percentage Of Prior Year Statutory Capital And Surplus", "documentation": "The potential limit (expressed as a percentage of prior year total statutory capital and surplus) to the dividend/distribution that may be paid, without signed affidavits from the entity's directors attesting that a dividend and/or distribution in excess of this amount would not cause the entity to fail to meet its relevant margins." } } }, "auth_ref": [] }, "axs_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsNumberOfDirectorAffidavitsRequiredToPayGreaterAmount": { "xbrltype": "integerItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsNumberOfDirectorAffidavitsRequiredToPayGreaterAmount", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of directors required to sign affidavits in order to pay dividend/distribution greater than 25% of prior year statutory capital and surplus", "label": "Statutory Accounting Practices Statutory Amount Available For Dividend Payments Number Of Director Affidavits Required To Pay Greater Amount", "documentation": "The number of the entity's directors required to issue signed affidavits in order to pay a dividend and/or distribution in excess of a specified percentage. The directors must attest that the dividend and/or distribution would not cause the entity to fail to meet its relevant margins." } } }, "auth_ref": [] }, "axs_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsPotentialLimitPercentageOfTotalStatutoryCapitalAndSurplus": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsPotentialLimitPercentageOfTotalStatutoryCapitalAndSurplus", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum dividend limit - percentage of total statutory capital and surplus", "label": "Statutory Accounting Practices Statutory Amount Available For Dividend Payments Potential Limit Percentage Of Total Statutory Capital And Surplus", "documentation": "The potential limit (expressed as a percentage of total statutory capital and surplus) to the dividend that may be paid." } } }, "auth_ref": [] }, "us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithRegulatoryApproval": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithRegulatoryApproval", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum dividend/distribution payable with regulatory approval", "label": "Statutory Accounting Practices, Statutory Amount Available for Dividend Payments with Regulatory Approval", "documentation": "Amount of dividends that can be declared or paid with approval of regulatory agency." } } }, "auth_ref": [] }, "us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum dividend/distribution payable without regulatory approval", "label": "Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval", "documentation": "Amount of dividends that can be declared or paid without approval of regulatory agency." } } }, "auth_ref": [] }, "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available statutory capital and surplus", "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance", "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country." } } }, "auth_ref": [ "r162", "r851" ] }, "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Required statutory capital and surplus", "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required", "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices." } } }, "auth_ref": [ "r163" ] }, "us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesStatutoryNetIncomeAmount", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory net income", "label": "Statutory Accounting Practices, Statutory Net Income Amount", "documentation": "Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators." } } }, "auth_ref": [ "r851" ] }, "us-gaap_StatutoryAccountingPracticesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesTable", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSRestrictedAssetsDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory Accounting Practices [Table]", "label": "Statutory Accounting Practices [Table]", "documentation": "Detail by state, country, or other jurisdiction of domicile in which financial statements are filed reflecting statutory capital and surplus, net income and the differences between financial reports which are in conformity with generally accepted accounting principles and the statutory financial statements which also use state permitted or prescribed accounting practices." } } }, "auth_ref": [ "r161", "r164", "r165", "r166", "r167", "r1402" ] }, "axs_StatutoryAccountingPracticesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryAccountingPracticesTextBlock", "presentation": [ "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "STATUTORY FINANCIAL INFORMATION", "label": "Statutory Accounting Practices [Text Block]", "documentation": "The entire disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority. Also includes information on regulatory restrictions on dividends and/or distributions." } } }, "auth_ref": [] }, "axs_StatutoryFinancialInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StatutoryFinancialInformationAbstract", "lang": { "en-us": { "role": { "terseLabel": "STATUTORY FINANCIAL INFORMATION [Abstract]", "label": "STATUTORY FINANCIAL INFORMATION [Abstract]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r1146", "r1158", "r1168", "r1194" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r20", "r176", "r177", "r213", "r919", "r1009", "r1054" ] }, "axs_StockIssuedDuringPeriodSharesTreasuryStockReissuedIncludingToSatisfyEquityBasedCompensationObligations": { "xbrltype": "sharesItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissuedIncludingToSatisfyEquityBasedCompensationObligations", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares reissued (in shares)", "label": "Stock Issued During Period Shares Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations", "documentation": "Number of treasury shares (units) reissued during the period. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYPreferredSharesNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Preferred shares, aggregate liquidation value issued", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r20", "r176", "r177", "r213", "r928", "r1009", "r1054", "r1133" ] }, "axs_StockIssuedDuringPeriodValueTreasuryStockReissuedIncludingToSatisfyEquityBasedCompensationObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StockIssuedDuringPeriodValueTreasuryStockReissuedIncludingToSatisfyEquityBasedCompensationObligations", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury shares reissued", "label": "Stock Issued During Period, Value, Treasury Stock Reissued Including To Satisfy Equity Based Compensation Obligations", "documentation": "Equity impact of the value of treasury stock (units) reissued during the period. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding." } } }, "auth_ref": [] }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, authorized amount", "label": "Stock Repurchase Program, Authorized Amount", "documentation": "Amount of stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total shareholders\u2019 equity", "periodStartLabel": "Balance at beginning of year", "periodEndLabel": "Balance at end of the year", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r177", "r180", "r181", "r203", "r965", "r981", "r1010", "r1011", "r1115", "r1134", "r1253", "r1305", "r1375", "r1423" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' equity", "verboseLabel": "Shareholders\u2019 equity", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity Note [Abstract]", "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "SHAREHOLDERS' EQUITY", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r210", "r358", "r582", "r584", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r596", "r598", "r712", "r1012", "r1015", "r1058" ] }, "us-gaap_StockholdersEquityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityPolicyTextBlock", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Shares", "label": "Stockholders' Equity, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income." } } }, "auth_ref": [ "r12", "r1013" ] }, "axs_StonePointCreditCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StonePointCreditCorporationMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stone Point Credit Corporation", "label": "Stone Point Credit Corporation [Member]", "documentation": "Stone Point Credit Corporation" } } }, "auth_ref": [] }, "axs_StonePointGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StonePointGroupMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stone Point Group", "label": "Stone Point Group [Member]", "documentation": "Stone Point Group of Companies" } } }, "auth_ref": [] }, "axs_StonePointTridentFundVIIIMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StonePointTridentFundVIIIMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stone Point Trident Fund VIII", "label": "Stone Point Trident Fund VIII [Member]", "documentation": "Stone Point Trident Fund VIII [Member]" } } }, "auth_ref": [] }, "axs_StonePointTridentVIIICoInvestMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StonePointTridentVIIICoInvestMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stone Point Trident VIII Co-Invest", "label": "Stone Point Trident VIII Co-Invest [Member]", "documentation": "Stone Point Trident VIII Co-Invest" } } }, "auth_ref": [] }, "axs_StonePointeCreditCorporationBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "StonePointeCreditCorporationBondsMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stone Pointe Credit Corporation Bonds", "label": "Stone Pointe Credit Corporation Bonds [Member]", "documentation": "Stone Pointe Credit Corporation Bonds" } } }, "auth_ref": [] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails": { "parentTag": "us-gaap_LeaseCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.axiscapital.com/role/LEASESSummaryofLeaseExpenseandRelatedCashFlowsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Sublease income", "label": "Sublease Income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r758", "r1114" ] }, "us-gaap_SubsegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsegmentsAxis", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Axis]", "label": "Subsegments [Axis]", "documentation": "Information by business subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsegmentsDomain", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESAverageAnnualPercentagePayoutofIncurredClaimsbyAgeNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESCumulativePaidClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredClaimsandAllocatedClaimAdjustmentExpensesNetofReinsuranceDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReconciliationofDevelopmentTablestoConsolidatedBalanceSheetDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails", "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofNetPremiumsEarnedbySegmentandLineofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Domain]", "label": "Subsegments [Domain]", "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [] }, "srt_SubsidiaryIssuerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SubsidiaryIssuerMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSSeniorandNotesPayableDetails", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSFootnotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary Issuer", "label": "Subsidiary Issuer [Member]", "documentation": "Entity in which controlling financial interest is held guaranteeing issuance of security by another subsidiary or parent. Includes, but is not limited to, variable interest entity (VIE) consolidated by primary beneficiary. Excludes entity in which broker-dealer holds controlling financial interest but control is likely to be temporary." } } }, "auth_ref": [] }, "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]", "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount shown on the balance sheet", "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Amount", "documentation": "Amount of investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r1051" ] }, "us-gaap_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortized cost", "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Cost", "documentation": "Cost of investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r1049" ] }, "us-gaap_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value", "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Fair Value", "documentation": "Fair value of investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r1050" ] }, "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]", "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r281", "r1052" ] }, "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTable", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Table]", "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Table]", "documentation": "Disclosure of information about investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r281", "r1052" ] }, "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIES" ], "lang": { "en-us": { "role": { "terseLabel": "SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES", "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Text Block]", "documentation": "The entire disclosure of information about investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r281", "r1052" ] }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Operating and Capital Loss Carryforwards", "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r112" ] }, "us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfTaxCreditCarryforwardsTextBlock", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Tax Credits", "label": "Summary of Tax Credit Carryforwards [Table Text Block]", "documentation": "Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances." } } }, "auth_ref": [ "r112" ] }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfValuationAllowanceTextBlock", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Valuation Allowance Roll Forward", "label": "Summary of Valuation Allowance [Table Text Block]", "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance." } } }, "auth_ref": [ "r111" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current year", "verboseLabel": "Net losses and loss expenses, net of reinstatement premiums", "label": "Current Year Claims and Claims Adjustment Expense", "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs." } } }, "auth_ref": [ "r891" ] }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESPriorYearReserveDevelopmentDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESReserveRollforwardDetails", "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESSummaryofPriorYearReserveDevelopmentbySegmentandReservingClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior years", "negatedTerseLabel": "Prior year favorable (adverse) adjustments", "label": "Prior Year Claims and Claims Adjustment Expense", "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs." } } }, "auth_ref": [ "r891" ] }, "srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract", "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]", "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]" } } }, "auth_ref": [] }, "srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIVSUPPLEMENTARYREINSURANCEINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "SCHEDULE IV - SUPPLEMENTARY REINSURANCE INFORMATION", "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block]", "documentation": "The entire disclosure for the supplemental schedule of reinsurance information. Reinsurance schedule includes, but is not limited to, the type of insurance, gross amount of premiums, premiums ceded to other entities, premiums assumed from other entities, net amount of premium revenue, and the percentage of the premiums assumed to net premium revenue." } } }, "auth_ref": [ "r283", "r883" ] }, "srt_SupplementaryInsuranceInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementaryInsuranceInformationAbstract", "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition costs", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Cost", "documentation": "Amount of amortization of deferred policy acquisition cost recognized, as disclosed in supplementary insurance information." } } }, "auth_ref": [ "r874" ] }, "us-gaap_SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net losses and loss expenses", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Benefit, Claim, Loss and Settlement Expenses", "documentation": "Amount of insurance benefit, claim, loss and settlement expenses incurred, as disclosed in supplementary insurance information." } } }, "auth_ref": [ "r873" ] }, "srt_SupplementaryInsuranceInformationBySegmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementaryInsuranceInformationBySegmentLineItems", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplementary Insurance Information [Line Items]", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r282", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876" ] }, "srt_SupplementaryInsuranceInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementaryInsuranceInformationBySegmentTable", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplementary Insurance Information [Table]", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Table]", "documentation": "Disclosure of information about supplementary insurance information by segment. Includes, but is not limited to, deferred policy acquisition cost; future policy benefit, loss, claim and loss expenses; unearned premium; other policy claim and benefit payable; premium revenue; net investment income; benefit, claim, loss and settlement expenses; amortization of deferred policy acquisition cost; other operating expense; and premium written." } } }, "auth_ref": [ "r282", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876" ] }, "us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred acquisition costs", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Deferred Policy Acquisition Cost", "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force, as disclosed in supplementary insurance information." } } }, "auth_ref": [ "r867" ] }, "srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Disclosure [Text Block]", "documentation": "The entire disclosure for supplementary insurance information by segment. Includes, but is not limited to, deferred policy acquisition cost; future policy benefit, loss, claim and loss expenses; unearned premium; other policy claim and benefit payable; premium revenue; net investment income; benefit, claim, loss and settlement expenses; amortization of deferred policy acquisition cost; other operating expense; and premium written." } } }, "auth_ref": [ "r271", "r272", "r282" ] }, "us-gaap_SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve for losses and loss expenses", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Liability for Future Policy Benefit, Loss, Claim and Loss Expense", "documentation": "Amount of reserve for future policy claim payable and loss expense to be incurred, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r868" ] }, "us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationNetInvestmentIncome", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment income", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Net Investment Income", "documentation": "Amount of net investment income earned, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r872" ] }, "us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationOtherOperatingExpense", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating expenses", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense", "documentation": "Amount of operating expense classified as other, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r875" ] }, "us-gaap_SupplementaryInsuranceInformationPremiumRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationPremiumRevenue", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net premiums earned", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Revenue", "documentation": "Amount of premium revenue earned, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r871" ] }, "us-gaap_SupplementaryInsuranceInformationPremiumsWritten": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationPremiumsWritten", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net premiums written", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Written", "documentation": "Amount, after premiums ceded and assumed, of premium written, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r876" ] }, "us-gaap_SupplementaryInsuranceInformationUnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationUnearnedPremiums", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/SCHEDULEIIISUPPLEMENTARYINSURANCEINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned premiums", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Unearned Premium", "documentation": "Amount of premium not yet earned, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r869" ] }, "us-gaap_SwissFederalTaxAdministrationFTAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SwissFederalTaxAdministrationFTAMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Switzerland", "label": "Swiss Federal Tax Administration (FTA) [Member]", "documentation": "Designated tax department of the government of Switzerland." } } }, "auth_ref": [] }, "axs_SyndicateCapacityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "SyndicateCapacityMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Syndicate capacity", "label": "Syndicate Capacity [Member]", "documentation": "The right to underwrite a certain allocated limit of premium in the Lloyd's market over an indefinite period." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r1187" ] }, "axs_TaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofIncomeTaxExpenseandNetTaxAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net tax assets", "label": "Tax Assets Liabilities Net", "documentation": "Amount of deferred tax assets, net of any valuation allowance and deferred tax liabilities, which result from applying the applicable tax rate to taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. This amount also includes the carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [] }, "axs_TaxCarryForwardExpiry2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TaxCarryForwardExpiry2029Member", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Carry Forward Expiry 2028", "label": "Tax Carry Forward Expiry 2029 [Member]", "documentation": "Tax Carry Forward Expiry 2029" } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital loss carryforwards", "label": "Tax Credit Carryforward, Amount", "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r113" ] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward [Axis]", "label": "Tax Credit Carryforward [Axis]", "documentation": "Information by specific tax credit related to an unused tax credit." } } }, "auth_ref": [ "r112" ] }, "axs_TaxCreditCarryforwardExpiring2032Member": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TaxCreditCarryforwardExpiring2032Member", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward Expiring 2032", "label": "Tax Credit Carryforward Expiring 2032 [Member]", "documentation": "Tax Credit Carryforward Expiring 2032" } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward, Name [Domain]", "label": "Tax Credit Carryforward, Name [Domain]", "documentation": "The name of the tax credit carryforward." } } }, "auth_ref": [ "r112" ] }, "us-gaap_TaxPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxPeriodAxis", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Period [Axis]", "label": "Tax Period [Axis]", "documentation": "Information about the period subject to enacted tax laws." } } }, "auth_ref": [] }, "us-gaap_TaxPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxPeriodDomain", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofOperatingandCapitalLossCarryforwardsandTaxCreditsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Period [Domain]", "label": "Tax Period [Domain]", "documentation": "Identified tax period." } } }, "auth_ref": [] }, "axs_ThirdPartyLossPortfolioTransferMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ThirdPartyLossPortfolioTransferMember", "presentation": [ "http://www.axiscapital.com/role/RESERVEFORLOSSESANDLOSSEXPENSESIncurredLossesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Third Party - Loss Portfolio Transfer", "label": "Third Party - Loss Portfolio Transfer [Member]", "documentation": "Third Party - Loss Portfolio Transfer" } } }, "auth_ref": [] }, "axs_ThirdPartyReinsurerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ThirdPartyReinsurerMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSLoanAdvancesMadetoaThirdPartyReinsurerDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Third Party Reinsurer", "label": "Third Party Reinsurer [Member]", "documentation": "Third Party Reinsurer" } } }, "auth_ref": [] }, "axs_ThreeBrokersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ThreeBrokersMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Three Brokers", "label": "Three Brokers [Member]", "documentation": "Three Brokers" } } }, "auth_ref": [] }, "axs_TiernanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TiernanMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tiernan", "label": "Tiernan [Member]", "documentation": "Tiernan" } } }, "auth_ref": [] }, "axs_TotalMortgageLoansHeldForInvestmentPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TotalMortgageLoansHeldForInvestmentPercent", "calculation": { "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total mortgage loans, held-for investment (as a percent)", "label": "Total Mortgage Loans Held-For-Investment, Percent", "documentation": "Total Mortgage Loans Held-For-Investment, Percent" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1179" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r1186" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r1207" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r1209" ] }, "axs_TradingDaysProceedingPerformancePeriod": { "xbrltype": "integerItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TradingDaysProceedingPerformancePeriod", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trading days proceeding and performance period", "label": "Trading Days Proceeding Performance Period", "documentation": "Trading Days Proceeding Performance Period" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.axiscapital.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "axs_TransferToInvestmentsAvailableForSaleToFixedMaturities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TransferToInvestmentsAvailableForSaleToFixedMaturities", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of securities transferred from available for sale to fixed maturities, held to maturity", "label": "Transfer To Investments Available For Sale To Fixed Maturities", "documentation": "Fair value of fixed maturities, available for sale transferred to fixed maturities, held to maturity during the period that was treated as a non-cash activity in the consolidated statement of cash flows." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinLevel3forFinancialInstrumentsMeasuredatFairValueDetails", "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSContractualMaturitiesDetails", "http://www.axiscapital.com/role/INVESTMENTSEquitySecuritiesDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesHeldtoMaturityDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/INVESTMENTSNarrativeDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r578", "r595", "r711", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r858", "r1224", "r1225", "r1226", "r1227", "r1228", "r1229", "r1230", "r1299", "r1300", "r1301", "r1302" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r1210" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r1211" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r1209" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r1209" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r1212" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r1210" ] }, "axs_TreasurySharesIssuedandOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TreasurySharesIssuedandOutstandingRollForward", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Shares Issued and Outstanding [Roll Forward]", "label": "Treasury Shares Issued and Outstanding [Roll Forward]", "documentation": "Treasury Shares Issued and Outstanding [Roll Forward]" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockAcquiredAverageCostPerShare", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average price per share (in usd per share)", "label": "Shares Acquired, Average Cost Per Share", "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased." } } }, "auth_ref": [ "r103" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Treasury shares, at cost", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r103" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "calculation": { "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails": { "parentTag": "us-gaap_CommonStockSharesOutstanding", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSAdditionalInformationDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury shares (in shares)", "negatedPeriodStartLabel": "Treasury shares, balance at beginning of year (in shares)", "negatedPeriodEndLabel": "Total treasury shares at end of year (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r103" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.axiscapital.com/role/SCHEDULEIICONDENSEDBALANCESHEETSDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury shares, at cost (2023: 91,294; 2022: 91,912)", "negatedTerseLabel": "Treasury shares, at cost (2023: 91,294; 2022: 91,912)", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r52", "r103", "r106" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofCommonSharesIssuedandOutstandingDetails", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares repurchased (in shares)", "terseLabel": "Total shares (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r20", "r177", "r213" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.axiscapital.com/role/SHAREHOLDERSEQUITYSummaryofShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares repurchased", "terseLabel": "Total cost", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r20", "r103", "r213" ] }, "axs_TridentIXLPTridentIXMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "TridentIXLPTridentIXMember", "presentation": [ "http://www.axiscapital.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trident IX L.P. (\"Trident IX\")", "label": "Trident IX L.P. (\"Trident IX\") [Member]", "documentation": "Trident IX L.P. (\"Trident IX\")" } } }, "auth_ref": [] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofGrossPremiumsWrittenbyGeographicalLocationofSubsidiariesDetails", "http://www.axiscapital.com/role/STATUTORYFINANCIALINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S.", "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_USStatesAndPoliticalSubdivisionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USStatesAndPoliticalSubdivisionsMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Municipals", "label": "US States and Political Subdivisions Debt Securities [Member]", "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments." } } }, "auth_ref": [ "r1105", "r1417" ] }, "us-gaap_USTreasuryAndGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasuryAndGovernmentMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitiesAvailableForSaleDetails", "http://www.axiscapital.com/role/INVESTMENTSGrossUnrealizedLossesDetails", "http://www.axiscapital.com/role/SCHEDULEISUMMARYOFINVESTMENTSOTHERTHANINVESTMENTSINRELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. government and agency", "label": "US Treasury and Government [Member]", "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)." } } }, "auth_ref": [ "r827", "r1105", "r1417" ] }, "axs_UnderwritingIncomeLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "UnderwritingIncomeLossNet", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/SEGMENTINFORMATIONSummaryofUnderwritingResultsofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Underwriting income (loss)", "label": "Underwriting Income Loss Net", "documentation": "Net premiums earned less: net losses and loss expenses, acquisition costs and general and administrative expenses directly related to underwriting activities." } } }, "auth_ref": [] }, "axs_UnderwritingPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "UnderwritingPortfolioMember", "presentation": [ "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSGainsLossesonDerivativesRecognizedinNetIncomeDetails", "http://www.axiscapital.com/role/DERIVATIVEINSTRUMENTSScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Underwriting Portfolio", "terseLabel": "Underwriting Portfolio", "label": "Underwriting Portfolio [Member]", "documentation": "Derivative instruments related to the entity's underwriting portfolio." } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r1206" ] }, "us-gaap_UnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnearnedPremiums", "crdr": "credit", "calculation": { "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned premiums", "label": "Unearned Premiums", "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date." } } }, "auth_ref": [ "r274" ] }, "axs_UnitesStatesStateLicensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "UnitesStatesStateLicensesMember", "presentation": [ "http://www.axiscapital.com/role/GOODWILLANDINTANGIBLEASSETSSummaryofGrossAmountandAccumulatedAmortizationbyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. state licenses", "label": "Unites States, State licenses [Member]", "documentation": "U.S. state licenses that provide a legal right to transact business indefinitely." } } }, "auth_ref": [] }, "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Losses and Loss Expenses", "label": "Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims." } } }, "auth_ref": [ "r890", "r892" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r668", "r674" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase commitment", "label": "Unrecorded Unconditional Purchase Obligation", "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts)." } } }, "auth_ref": [ "r529" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationLineItems", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded Unconditional Purchase Obligation [Line Items]", "label": "Unrecorded Unconditional Purchase Obligation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r528", "r529", "r531" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationTable", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsurancePurchaseCommitmentInvestmentsandFundsatLloydsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded Unconditional Purchase Obligation [Table]", "label": "Unrecorded Unconditional Purchase Obligation [Table]", "documentation": "Describes each unrecorded unconditional purchase obligation arrangement to purchase goods and services that extend over multiple periods, any assets pledged to secure payment, and the fixed or determinable amount of payments due in each of the next five years and thereafter." } } }, "auth_ref": [ "r528", "r529", "r531" ] }, "us-gaap_UsTreasuryUstInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UsTreasuryUstInterestRateMember", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Five-Year Treasury Rate", "label": "US Treasury (UST) Interest Rate [Member]", "documentation": "Interest rate on direct treasury obligation of U.S. government (UST)." } } }, "auth_ref": [ "r1371" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.axiscapital.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r72", "r73", "r74", "r265", "r266", "r267", "r268" ] }, "axs_ValuationAllowanceAccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ValuationAllowanceAccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "label": "Valuation Allowance, Accumulated Other Comprehensive Income [Member]", "documentation": "Valuation Allowance, Accumulated Other Comprehensive Income [Member]" } } }, "auth_ref": [] }, "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceByDeferredTaxAssetAxis", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]", "label": "Valuation Allowance by Deferred Tax Asset [Axis]", "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences." } } }, "auth_ref": [ "r111" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in valuation allowance", "verboseLabel": "Increase in (release of) valuation allowance", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r677" ] }, "axs_ValuationAllowanceIncomeTaxExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ValuationAllowanceIncomeTaxExpenseMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Expense", "label": "Valuation Allowance, Income Tax Expense [Member]", "documentation": "Valuation Allowance, Income Tax Expense [Member]" } } }, "auth_ref": [] }, "axs_ValuationAllowanceInvestmentRelatedItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "ValuationAllowanceInvestmentRelatedItemsMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in investment - related items", "label": "Valuation Allowance Investment Related Items [Member]", "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing investment related items for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [] }, "us-gaap_ValuationAllowanceLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceLineItems", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation allowance movement [Line Items]", "label": "Valuation Allowance [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ValuationAllowanceOperatingLossCarryforwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceOperatingLossCarryforwardsMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforwards", "label": "SEC Schedule, 12-09, Valuation Allowance, Operating Loss Carryforward [Member]", "documentation": "Valuation allowance of deferred tax asset attributable to operating loss carryforward." } } }, "auth_ref": [ "r1256", "r1257", "r1258", "r1259", "r1260" ] }, "us-gaap_ValuationAllowanceOtherTaxCarryforwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceOtherTaxCarryforwardMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.K. branch assets and other foreign rate differentials", "label": "SEC Schedule, 12-09, Valuation Allowance, Other Tax Carryforward [Member]", "documentation": "Valuation allowance of deferred tax asset attributable to carryforward, classified as other." } } }, "auth_ref": [ "r1256", "r1257", "r1258", "r1259", "r1260" ] }, "us-gaap_ValuationAllowanceTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceTable", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESNarrativeDetails", "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation Allowance [Table]", "label": "Valuation Allowance [Table]", "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance." } } }, "auth_ref": [ "r111" ] }, "us-gaap_ValuationAllowanceTaxCreditCarryforwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceTaxCreditCarryforwardMember", "presentation": [ "http://www.axiscapital.com/role/INCOMETAXESSummaryofValuationAllowanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign tax credit", "label": "SEC Schedule, 12-09, Valuation Allowance, Tax Credit Carryforward [Member]", "documentation": "Valuation allowance of deferred tax asset attributable to tax credit carryforward." } } }, "auth_ref": [ "r1256", "r1257", "r1258", "r1259", "r1260" ] }, "us-gaap_ValuationTechniqueAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationTechniqueAxis", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation Approach and Technique [Axis]", "label": "Valuation Approach and Technique [Axis]", "documentation": "Information by valuation approach and technique." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ValuationTechniqueDiscountedCashFlowMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationTechniqueDiscountedCashFlowMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discounted cash flow", "label": "Valuation Technique, Discounted Cash Flow [Member]", "documentation": "Valuation technique calculating present value of future cash flows." } } }, "auth_ref": [ "r1374" ] }, "us-gaap_ValuationTechniqueDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationTechniqueDomain", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation Approach and Technique [Domain]", "label": "Valuation Approach and Technique [Domain]", "documentation": "Valuation approach and technique." } } }, "auth_ref": [ "r22" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.axiscapital.com/role/DEBTANDFINANCINGARRANGEMENTSDebttermsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Axis]", "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1337", "r1338", "r1339", "r1340", "r1341", "r1342", "r1343", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://www.axiscapital.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Domain]", "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1337", "r1338", "r1339", "r1340", "r1341", "r1342", "r1343", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362" ] }, "axs_WeightedAverageDebtServiceCoverageRatios": { "xbrltype": "pureItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "WeightedAverageDebtServiceCoverageRatios", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt service coverage ratio, in excess of", "label": "Weighted Average Debt Service Coverage Ratios", "documentation": "Weighted Average Debt Service Coverage Ratios" } } }, "auth_ref": [] }, "axs_WeightedAverageLoanToValueRatios": { "xbrltype": "percentItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "WeightedAverageLoanToValueRatios", "presentation": [ "http://www.axiscapital.com/role/INVESTMENTSMortgageLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan-to-value ratio, percent (less than)", "label": "Weighted Average Loan-To-Value Ratios", "documentation": "Weighted average loan-to-value ratios" } } }, "auth_ref": [] }, "srt_WeightedAverageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "WeightedAverageMember", "presentation": [ "http://www.axiscapital.com/role/FAIRVALUEMEASUREMENTSSummaryofLevel3FairValueMeasurementInputsDetails", "http://www.axiscapital.com/role/INVESTMENTSFixedMaturitySecuritiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average", "label": "Weighted Average [Member]", "documentation": "Average of a range of values, calculated with consideration of proportional relevance." } } }, "auth_ref": [ "r1074", "r1075", "r1385", "r1387", "r1390" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average diluted common shares outstanding (in shares)", "totalLabel": "Weighted average diluted common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r385", "r395" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.axiscapital.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.axiscapital.com/role/EARNINGSPERCOMMONSHAREDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r383", "r395" ] }, "axs_WillisTowerWatsonPLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.axiscapital.com/20231231", "localname": "WillisTowerWatsonPLCMember", "presentation": [ "http://www.axiscapital.com/role/COMMITMENTSANDCONTINGENCIESReinsuranceandPremiumsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Willis Towers Watson PLC", "label": "Willis Tower Watson PLC [Member]", "documentation": "Willis Tower Watson PLC" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481833/940-20-45-3" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "605", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "80", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b),(d)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "a", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4B" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4B" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4B" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4C" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4D" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4D" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4E" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4G" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-8" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20,22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22 (b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-29" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-11" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB TOPIC 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a),(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4K" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "6A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "940", "SubTopic": "320", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481961/940-320-45-2" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.W)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479583/944-40-S99-1" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-1" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-3" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-6" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479956/944-505-55-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479956/944-505-55-2" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "605", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479774/944-605-25-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "605", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479774/944-605-25-2" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "805", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479919/944-805-30-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220/tableOfContent" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "45", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r214": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r215": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r216": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r217": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r218": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r219": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r220": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r221": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "83", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480647/815-10-15-83" }, "r222": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r223": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r224": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "940", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//940-320/tableOfContent" }, "r225": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r226": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r227": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r228": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r229": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r230": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r231": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r232": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r233": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r234": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13,16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r235": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r236": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r237": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r238": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r239": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//942-320/tableOfContent" }, "r240": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480876/942-470-45-1" }, "r241": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04.5,6,7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r242": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r243": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r244": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(cc)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r245": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479583/944-40-S99-1" }, "r246": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r247": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r248": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//946-320/tableOfContent" }, "r249": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r250": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r251": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r252": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r253": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r254": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r255": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r256": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-7" }, "r257": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r258": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r259": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "10", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479567/321-10-45-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479408/944-825-45-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "SubTopic": "60", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479482/944-60-50-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G)(Footnote 3))", "SubTopic": "235", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J)(Footnote 3))", "SubTopic": "235", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))", "SubTopic": "210", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(1))", "SubTopic": "220", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(c))", "SubTopic": "220", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1403", "Paragraph": "(b)", "Publisher": "SEC" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "15", "Publisher": "SEC" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "16", "Publisher": "SEC" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Publisher": "SEC" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "(m)", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "5", "Subsection": "04", "Paragraph": "c", "Subparagraph": "Schedule I", "Publisher": "SEC" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "7", "Subsection": "05", "Paragraph": "c", "Subparagraph": "Schedule II", "Publisher": "SEC" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "9", "Subsection": "06", "Publisher": "SEC" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.5-04(Schedule I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480922/205-10-S99-6" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-19" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3B" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-5" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4K" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-3" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-4" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-5" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479616/944-310-45-5" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479928/944-340-25-1" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//944-40/tableOfContent" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-1" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4B" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-5" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479686/944-605-45-1" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1A" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r917": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r918": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r919": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r920": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r921": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r922": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r923": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r924": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r925": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r926": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r927": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r928": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r929": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r930": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r931": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-3" }, "r932": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r933": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r934": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r935": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r936": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r937": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r938": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r939": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r940": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r941": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r942": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r943": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r944": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r945": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r946": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r947": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r948": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r949": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r950": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r951": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r952": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r953": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r954": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r955": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r956": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r957": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r958": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r959": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r960": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r961": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r962": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r963": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r964": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r965": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r966": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r967": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r968": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r969": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r970": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r971": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r972": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r973": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r974": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r975": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r976": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r977": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r978": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r979": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r980": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r981": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r982": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r983": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6" }, "r984": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r985": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r986": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r987": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r988": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r989": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r990": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r991": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r992": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r993": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r994": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r995": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r996": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r997": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r998": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r999": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1000": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1001": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1002": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1003": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1004": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1005": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1006": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1007": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1008": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1009": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1010": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1011": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1012": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r1013": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r1014": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r1015": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r1016": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r1017": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r1018": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1019": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1020": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1021": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1022": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12" }, "r1023": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r1024": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1025": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1026": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1027": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1028": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1029": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1030": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1031": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1032": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r1033": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r1034": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r1035": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r1036": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r1037": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r1038": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r1039": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r1040": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r1041": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r1042": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r1043": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r1044": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r1045": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1046": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1047": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1048": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1049": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1050": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1051": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1052": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1053": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r1054": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r1055": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r1056": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r1057": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r1058": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r1059": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r1060": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-4" }, "r1061": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480602/954-210-50-2" }, "r1062": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r1063": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r1064": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1065": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1066": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1067": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1068": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1069": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1070": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1071": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1072": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1073": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1074": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r1075": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r1076": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(6)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r1077": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1078": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1079": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "SubTopic": "320", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1080": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r1081": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r1082": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r1083": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20" }, "r1084": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r1085": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r1086": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r1087": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r1088": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r1089": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r1090": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12" }, "r1091": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-15" }, "r1092": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-15" }, "r1093": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "79", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-79" }, "r1094": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r1095": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r1096": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1097": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r1098": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r1099": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r1100": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r1101": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r1102": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1103": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1104": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1105": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1106": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1107": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r1108": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r1109": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r1110": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r1111": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1112": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1113": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r1114": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r1115": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r1116": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r1117": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r1118": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479629/944-605-55-12" }, "r1119": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479629/944-605-55-15" }, "r1120": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r1121": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1122": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r1123": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r1124": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1125": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1126": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1127": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1128": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1129": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1130": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r1131": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2" }, "r1132": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r1133": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r1134": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r1135": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1136": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1137": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r1138": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r1139": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r1140": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r1141": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r1142": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r1143": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r1144": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1145": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1146": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1147": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1148": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1149": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r1150": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r1151": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r1152": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r1153": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r1154": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r1155": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r1156": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1157": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1158": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1159": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1160": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1161": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r1162": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r1163": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r1164": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r1165": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r1166": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1167": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1168": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1169": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1170": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1171": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r1172": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r1173": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r1174": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r1175": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r1176": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r1177": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r1178": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r1179": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r1180": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r1181": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r1182": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r1183": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r1184": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r1185": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r1186": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r1187": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r1188": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r1189": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r1190": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r1191": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r1192": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1193": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1194": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1195": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1196": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1197": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r1198": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r1199": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r1200": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r1201": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r1202": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r1203": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r1204": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r1205": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r1206": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r1207": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1208": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1209": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1210": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1211": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1212": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1213": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1214": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1215": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r1216": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r1217": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11" }, "r1218": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "SubTopic": "605", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r1219": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "SubTopic": "605", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r1220": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r1221": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r1222": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CC" }, "r1223": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r1224": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r1225": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r1226": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1227": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1228": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r1232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(ii)", "Publisher": "SEC" }, "r1233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)", "Publisher": "SEC" }, "r1234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Rule 15c3-1", "Number": "240", "Section": "15c3-1", "Publisher": "SEC" }, "r1237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r1238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r1244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r1245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r1246": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r1247": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r1248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r1249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-16" }, "r1250": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1251": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1252": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1253": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1254": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1255": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r1256": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1257": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1258": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1259": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1260": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1261": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1262": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1263": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1264": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r1265": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1266": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r1267": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r1268": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r1269": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-29" }, "r1270": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r1271": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//310-30/tableOfContent" }, "r1272": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1" }, "r1273": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r1274": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1275": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1276": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1277": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1278": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1279": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1280": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1281": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1282": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1283": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1284": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1285": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1286": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1287": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1288": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1289": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1290": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1291": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r1292": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r1293": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r1294": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r1295": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r1296": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r1297": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r1298": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r1299": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r1300": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1301": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1302": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1303": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4" }, "r1304": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1305": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1306": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//326-20/tableOfContent" }, "r1307": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r1308": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r1309": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r1310": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r1311": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r1312": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r1313": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//326-30/tableOfContent" }, "r1314": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r1315": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r1316": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r1317": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r1318": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1319": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1320": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r1321": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1326": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1327": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1328": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1329": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r1330": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1331": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r1332": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r1333": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r1334": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1335": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1336": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1337": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1338": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1339": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1340": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1341": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1342": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1343": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1344": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1345": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1346": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1347": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1348": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r1368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r1369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r1370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4K" }, "r1371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r1372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r1377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r1378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r1381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r1382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r1392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r1393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3" }, "r1394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r1395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480876/942-470-45-1" }, "r1396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479868/944-20-45-2" }, "r1397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-3" }, "r1398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-5" }, "r1399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479616/944-310-45-5" }, "r1413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479616/944-310-45-6" }, "r1414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479584/944-310-50-2" }, "r1415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-9C" }, "r1417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r1418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1421": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1422": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1423": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r1426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" } } } ZIP 170 0001214816-24-000024-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214816-24-000024-xbrl.zip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�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